Citrus Sinensis ID: 041689

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650--
Protein Sequence
MFSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI
Secondary Structure (PSIPRED)
ccccccccEEEEcccccccccccccccccccccEEccccEEEccccHHHHHcccccEEcccccccEEEcccccccccccccccccccccccccccccEEEcccccccEEccccccccccccccEEEccccEEEEEccccccccccccEEEcccccccccccHHHHccccccEEEccccEEEEcccHHccccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccccEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEcccccEEEEEEEccccccccccHHHHHHHHHcccccccccEEEEEEccccEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccEEEEcccccccccccccccEEEEEccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccEEEEEEEcccccccccc
Secondary Structure Prediction (SSPRO)
ccccccEEEEEccccccccccccHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccccHEEEcccccccccccHHHccccccEEEEEccccccccccHHHHHHHHccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHccccccEEEcccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHcccHcHHHHHEEEccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHHEccccccccEEHEcccccccccHHcEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccccc
Coil and Loop (DISEMBL)
mfsisigklelnvddiespceipseinphnLEELLLGqnnlvgvvpaaifdvstlkdlalqdnylsgslssiadnyltsstpelsflsslSNCKSLVVFLLsnnplngilprmsignlshsleifdmskcnvsggipeeignltnLTAIylggnklngsipFTLRELQKLQYvglkdnklegtipydIFRLVKLYKldlggnklsGSILTCFSNLASLRTLslsyndgplpleigNLKVLIGIDfsmnnfssvipttigslKDLQYLFLGYNilkgsipdsvgdlislkslnfsnnnlsgAIPLLLEKLSYLEHLNLSFNklegeipkggsfgnfsaesfegnkllcgspnlhvppcktsihhtsrKNALFLGIVLSFSTIFMVVVILLIVKYqkrenwppndanmppkatwRRFSYLEVCRAtygfnennligkggfgtiyksrigdGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLehmphgslekclyssnciLDIFQRLNIMIDVASVLEYLHFNFLVpvihcdlkpsnvlldDTMVAHLsdfgitklligedqsmtqTQTLATIgyiapeygregrvfangdvySFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI
Flexible Loop (DISEMBL)
mfsisigklelnvddiESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGlkdnklegtipYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYqkrenwppndanmppkATWRRFSYLEVCRATYgfnennligkggFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIeslelrinakei
Low Complexity Region (SEG)
MFSISIGKLELNVDDIESPCEIPSEINPHnleelllgqnnlvgvvPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDlislkslnfsnnnlsGAIPllleklsylehlnlSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI
Disordered region (IsUnstruct)
*********ELNVDDIE*PCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWP*******PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRI*****
Disordered Region (DISOPRED)
MFSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP*********************LGIVLSFSTIFMVVVILLIVK********************RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESL**RI*****
Disordered Region (DISEMBL)
MFSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI
Disordered Region (DISPRO)
*FSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKR*********MPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRIN****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	652	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.912	0.589	0.373	1e-106
C0LGT6	1031	LRR receptor-like serine/	no	no	0.900	0.569	0.360	9e-95
Q9SD62	1025	Putative receptor-like pr	no	no	0.911	0.579	0.365	2e-90
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.915	0.609	0.335	2e-88
Q9FL28	1173	LRR receptor-like serine/	no	no	0.932	0.518	0.324	1e-80
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.938	0.513	0.330	9e-79
Q42371	976	LRR receptor-like serine/	no	no	0.906	0.605	0.314	2e-75
Q9LJF3	1164	Receptor-like protein kin	no	no	0.888	0.497	0.303	2e-74
Q6XAT2	967	LRR receptor-like serine/	no	no	0.940	0.633	0.316	5e-74
C0LGW6	966	LRR receptor-like serine/	no	no	0.944	0.637	0.319	6e-74

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 247/661 (37%), Positives = 364/661 (55%), Gaps = 66/661 (9%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD-----------NYLT 78
           NL    +G N   G +P  + ++STL+ L + +N L+GS+ +  +           N L 
Sbjct: 260 NLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPTFGNVPNLKLLFLHTNSLG 319

Query: 79  S-STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP 137
           S S+ +L FL+SL+NC  L    +  N L G LP +SI NLS  L   D+    +SG IP
Sbjct: 320 SDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIP 378

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
            +IGNL NL  + L  N L+G +P +L +L  L+Y+ L  N+L G IP  I  +  L  L
Sbjct: 379 YDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETL 438

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
           DL  N   G + T   N + L  L +  N  +G +PLEI  ++ L+ +D S N+    +P
Sbjct: 439 DLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLP 498

Query: 256 TTIGSLKDLQYLFLGYNILKGSIPDSVGD-----------------------LISLKSLN 292
             IG+L++L  L LG N L G +P ++G+                       L+ +K ++
Sbjct: 499 QDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVD 558

Query: 293 FSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS-PN 351
            SNN+LSG+IP      S LE+LNLSFN LEG++P  G F N +  S  GN  LCG    
Sbjct: 559 LSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMG 618

Query: 352 LHVPPCKTSI-----HHTSRKNALFLGIVLSFSTI---FMVVVILLIVKYQKRENWPPND 403
             + PC +        H+SR   + +G+ +  + +   FM  V L+ ++ +K+     N 
Sbjct: 619 FQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNP 678

Query: 404 ANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG 462
                +    + SY ++  AT GF+ +N++G G FGT+YK+ +  +   VAVKV ++Q  
Sbjct: 679 TPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRR 738

Query: 463 RAFKSFDIECEIMKSIHYRNLVKIISSCSN-----EEFKELVLEHMPHGSLEKCLYSSNC 517
            A KSF  ECE +K I +RNLVK++++CS+      EF+ L+ E MP+GSL+  L+    
Sbjct: 739 GAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV 798

Query: 518 --------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF 569
                    L + +RLNI IDVASVL+YLH +   P+ HCDLKPSNVLLDD + AH+SDF
Sbjct: 799 EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDF 858

Query: 570 GITKLLIGEDQ-----SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           G+ +LL+  D+      ++      TIGY APEYG  G+   NGDVYSFGI+L+E+ + K
Sbjct: 859 GLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGK 918

Query: 625 Q 625
           +
Sbjct: 919 R 919

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  348 bits (892), Expect = 9e-95,   Method: Compositional matrix adjust.
 Identities = 237/658 (36%), Positives = 340/658 (51%), Gaps = 71/658 (10%)

Query: 37  GQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS-------------LSSIADNYLTSSTPE 83
           G N   G +P  + ++S+L+   +  NYLSGS             L    ++   +S+  
Sbjct: 274 GTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSG 333

Query: 84  LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNL 143
           L F+ +++NC  L    +  N L G LP  SI NLS +L    + +  +SG IP +IGNL
Sbjct: 334 LEFIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNL 392

Query: 144 TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN- 202
            +L  + L  N L+G +P +  +L  LQ V L  N + G IP     + +L KL L  N 
Sbjct: 393 VSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNS 452

Query: 203 -----------------------KLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNL 237
                                  +L+G+I      + SL  + LS N   G  P E+G L
Sbjct: 453 FHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKL 512

Query: 238 KVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNN 297
           ++L+G+  S N  S  +P  IG    +++LF+  N   G+IPD +  L+SLK+++FSNNN
Sbjct: 513 ELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNN 571

Query: 298 LSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS-PNLHVPP 356
           LSG IP  L  L  L +LNLS NK EG +P  G F N +A S  GN  +CG    + + P
Sbjct: 572 LSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKP 631

Query: 357 CKTSIHHTSRK-----NALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKAT 411
           C        RK       +  GI +  +++ +++++  +  + KR+         P  +T
Sbjct: 632 CIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDST 691

Query: 412 -----WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAF 465
                  + SY E+  AT  F+  NLIG G FG ++K  +G +   VAVKV +L    A 
Sbjct: 692 TLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGAT 751

Query: 466 KSFDIECEIMKSIHYRNLVKIISSCSN-----EEFKELVLEHMPHGSLEKCLY------- 513
           KSF  ECE  K I +RNLVK+I+ CS+      +F+ LV E MP GSL+  L        
Sbjct: 752 KSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERV 811

Query: 514 -SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT 572
              +  L   ++LNI IDVAS LEYLH +   PV HCD+KPSN+LLDD + AH+SDFG+ 
Sbjct: 812 NDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLA 871

Query: 573 KLLIGEDQ-----SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           +LL   D+       +      TIGY APEYG  G+    GDVYSFGI+L+E+ S K+
Sbjct: 872 QLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKK 929

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  333 bits (855), Expect = 2e-90,   Method: Compositional matrix adjust.
 Identities = 243/664 (36%), Positives = 351/664 (52%), Gaps = 70/664 (10%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSL-------------SSIADNY 76
           NL+ L +G N+  G +P  + ++S+L+ L +  N+L+G +                 ++ 
Sbjct: 275 NLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSL 334

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
              S+ +L FL +L+NC  L    +  N L G LP + I NLS  L    +    +SG I
Sbjct: 335 GNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSI 393

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ------------------------Y 172
           P  IGNL +L  + LG N L G +P +L EL +L+                        Y
Sbjct: 394 PHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTY 453

Query: 173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPL 230
           + L +N  EG+IP  +     L  L+LG NKL+GSI      L SL  L++S+N   GPL
Sbjct: 454 LYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPL 513

Query: 231 PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKS 290
             +IG LK L+ +D S N  S  IP T+ +   L++L L  N   G IPD  G L  L+ 
Sbjct: 514 RQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRF 572

Query: 291 LNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS- 349
           L+ S NNLSG IP  +   S L++LNLS N  +G +P  G F N SA S  GN  LCG  
Sbjct: 573 LDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGI 632

Query: 350 PNLHVPPCKTSI--HHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQK------RENWPP 401
           P+L + PC   +   H+S +  + + +    + + ++ + ++ + + K      R N   
Sbjct: 633 PSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNE 692

Query: 402 NDANMPP-KATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHL 459
           ND +  P K+ + + SY E+ + T GF+ +NLIG G FG ++K  +G     VA+KV +L
Sbjct: 693 NDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNL 752

Query: 460 QCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-----KELVLEHMPHGSLEKCLYS 514
               A KSF  ECE +  I +RNLVK+++ CS+ +F     + LV E MP+G+L+  L+ 
Sbjct: 753 CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP 812

Query: 515 SNC--------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL 566
                       L +F RLNI IDVAS L YLH     P+ HCD+KPSN+LLD  + AH+
Sbjct: 813 DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHV 872

Query: 567 SDFGITKLLIGEDQSMTQTQ-----TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIH 621
           SDFG+ +LL+  D+     Q        TIGY APEYG  G     GDVYSFGI+L+EI 
Sbjct: 873 SDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIF 932

Query: 622 SAKQ 625
           + K+
Sbjct: 933 TGKR 936

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  327 bits (839), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 235/701 (33%), Positives = 347/701 (49%), Gaps = 104/701 (14%)

Query: 21  EIPSEINPH--NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
           EIP   + H   L  LLL  N L G VP+++ + + LK + L+ N LSG L S     + 
Sbjct: 181 EIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPS----QVI 236

Query: 79  SSTPELS--------------------FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNL 118
           S  P+L                     F +SL+N   L    L+ N L G +   S+ +L
Sbjct: 237 SKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITS-SVRHL 295

Query: 119 SHSLEIFDMSKCNVSGGIPEEIG------------------------NLTNLTAIYLGGN 154
           S +L    + +  + G IP EI                          L+ L  +YL  N
Sbjct: 296 SVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNN 355

Query: 155 KLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSN 214
            L G IP  L ++ +L  + +  N L G+IP     L +L +L L GN LSG++      
Sbjct: 356 HLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGK 415

Query: 215 LASLRTLSLSYND----------------------------GPLPLEIGNLKVLIGIDFS 246
             +L  L LS+N+                            GP+PLE+  + +++ +D S
Sbjct: 416 CINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLS 475

Query: 247 MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLL 306
            N  S  IP  +GS   L++L L  N    ++P S+G L  LK L+ S N L+GAIP   
Sbjct: 476 SNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSF 535

Query: 307 EKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSR 366
           ++ S L+HLN SFN L G +   GSF   + ESF G+ LLCGS        K   + +  
Sbjct: 536 QQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVL 595

Query: 367 KNALFLGIVLSFSTIFMVVVI--------LLIVKYQKRENWPPNDANMPPKATWRRFSYL 418
              L   I      +F   ++        L +   ++ E+    + N P    + R SY 
Sbjct: 596 LPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDP---KYPRISYQ 652

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK-SFDIECEIMKS 477
           ++  AT GFN ++LIG G FG +YK  + +  +VAVKV   +    F  SF  EC+I+K 
Sbjct: 653 QLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKR 712

Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASV 534
             +RNL++II++CS   F  LVL  MP+GSLE+ LY    S+  LD+ Q +NI  DVA  
Sbjct: 713 TRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEG 772

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA----- 589
           + YLH    V V+HCDLKPSN+LLDD M A ++DFGI++L+ G +++++   +++     
Sbjct: 773 IAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTD 832

Query: 590 -----TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
                ++GYIAPEYG   R   +GDVYSFG++L+EI S ++
Sbjct: 833 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRR 873

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  301 bits (770), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 222/685 (32%), Positives = 350/685 (51%), Gaps = 77/685 (11%)

Query: 21   EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS---------- 70
            EIP      NL  + +G+N+  G +P  IF+ S L+ L++ DN L+G+L           
Sbjct: 423  EIPRGFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLR 482

Query: 71   --SIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
               ++ N LT   P       + N K L +  L +N   G +PR  + NL+  L+   M 
Sbjct: 483  ILQVSYNSLTGPIPR-----EIGNLKDLNILYLHSNGFTGRIPR-EMSNLTL-LQGLRMY 535

Query: 129  KCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI 188
              ++ G IPEE+ ++  L+ + L  NK +G IP    +L+ L Y+ L+ NK  G+IP  +
Sbjct: 536  SNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASL 595

Query: 189  FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------DGPLPLEIGNLKVLIG 242
              L  L   D+  N L+G+I      LASL+ + L  N       G +P E+G L+++  
Sbjct: 596  KSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQE 653

Query: 243  IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-------------------- 282
            ID S N FS  IP ++ + K++  L    N L G IPD V                    
Sbjct: 654  IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGE 713

Query: 283  -----GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSA 337
                 G++  L SL+ S+NNL+G IP  L  LS L+HL L+ N L+G +P+ G F N +A
Sbjct: 714  IPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINA 773

Query: 338  ESFEGNKLLCGSPNLHVPPC--KTSIHHTSRKNALFLGIVLSFSTIFMV----------V 385
                GN  LCGS    + PC  K    H S++  + L I+ S + + +V           
Sbjct: 774  SDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCK 832

Query: 386  VILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR 445
                 ++     + P  D+ +      +RF   E+ +AT  FN  N+IG     T+YK +
Sbjct: 833  KKEKKIENSSESSLPDLDSAL----KLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQ 888

Query: 446  IGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIIS-SCSNEEFKELVLEH 502
            + DG  +AVKV +L+     + K F  E + +  + +RNLVKI+  +  + + K LVL  
Sbjct: 889  LEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPF 948

Query: 503  MPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT 561
            M +G+LE  ++ S   I  + +++++ + +AS ++YLH  +  P++HCDLKP+N+LLD  
Sbjct: 949  MENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSD 1008

Query: 562  MVAHLSDFGITKLL-IGEDQSMTQTQTL--ATIGYIAPEYGREGRVFANGDVYSFGIMLM 618
             VAH+SDFG  ++L   ED S T + +    TIGY+APE+    +V    DV+SFGI++M
Sbjct: 1009 RVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMM 1068

Query: 619  EIHSAKQQCVSFVFNLAMECTIESL 643
            E+ + KQ+  S     + + T+  L
Sbjct: 1069 ELMT-KQRPTSLNDEDSQDMTLRQL 1092

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  295 bits (754), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 230/696 (33%), Positives = 335/696 (48%), Gaps = 84/696 (12%)

Query: 9    LELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG 67
            + L++D      EIP  +    NL E     N L G +PA I + ++LK L L DN L+G
Sbjct: 427  MALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTG 486

Query: 68   -------SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPR-------- 112
                    L+S++   L ++  +      L +C SL    L +N L G +P         
Sbjct: 487  EIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQL 546

Query: 113  ----MSIGNLS-----------HSLE-----------IFDMSKCNVSGGIPEEIGNLTNL 146
                +S  NLS           H +E           IFD+S   +SG IPEE+G    L
Sbjct: 547  QCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVL 606

Query: 147  TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
              I L  N L+G IP +L  L  L  + L  N L G+IP ++   +KL  L+L  N+L+G
Sbjct: 607  VEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNG 666

Query: 207  SILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL 264
             I   F  L SL  L+L+ N  DGP+P  +GNLK L  +D S NN S  + + + +++ L
Sbjct: 667  HIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKL 726

Query: 265  QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG 324
              L++  N   G IP  +G+L  L+ L+ S N LSG IP  +  L  LE LNL+ N L G
Sbjct: 727  VGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRG 786

Query: 325  EIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNAL-FLGIVLSFSTIFM 383
            E+P  G   + S     GNK LCG     V      I  T  ++A    G++L F+ I  
Sbjct: 787  EVPSDGVCQDPSKALLSGNKELCG----RVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVF 842

Query: 384  VVVILL----IVKYQKRENWPPN----------DANMPPKATWRRFSYL----------- 418
            V V  L    + K  K+ + P            D N+   +  R    L           
Sbjct: 843  VFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPL 902

Query: 419  ------EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIEC 472
                  ++  AT  F++ N+IG GGFGT+YK+ +     VAVK       +  + F  E 
Sbjct: 903  LKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEM 962

Query: 473  EIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF---QRLNIMI 529
            E +  + + NLV ++  CS  E K LV E+M +GSL+  L +   +L++    +RL I +
Sbjct: 963  ETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAV 1022

Query: 530  DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
              A  L +LH  F+  +IH D+K SN+LLD      ++DFG+ + LI   +S   T    
Sbjct: 1023 GAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLAR-LISACESHVSTVIAG 1081

Query: 590  TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
            T GYI PEYG+  R    GDVYSFG++L+E+ + K+
Sbjct: 1082 TFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKE 1117

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  284 bits (726), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 222/705 (31%), Positives = 339/705 (48%), Gaps = 114/705 (16%)

Query: 22  IPSEINP-HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS---------- 70
           IPS ++   NL+ L L QN L G +P  I+    L+ L L+ N L G++S          
Sbjct: 156 IPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLW 215

Query: 71  --SIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPR----MSIGNLS----- 119
              + +N LT S PE     ++ NC +  V  LS N L G +P     + +  LS     
Sbjct: 216 YFDVRNNSLTGSIPE-----TIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVATLSLQGNQ 270

Query: 120 ------------HSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLREL 167
                        +L + D+S   +SG IP  +GNLT    +YL  NKL GSIP  L  +
Sbjct: 271 LSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNM 330

Query: 168 QKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG------------------------GNK 203
            KL Y+ L DN L G IP ++ +L  L+ L++                         GNK
Sbjct: 331 SKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNK 390

Query: 204 LSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
            SG+I   F  L S+  L+LS N+  GP+P+E+  +  L  +D S N  + +IP+++G L
Sbjct: 391 FSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDL 450

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS----------- 310
           + L  + L  N + G +P   G+L S+  ++ SNN++SG IP  L +L            
Sbjct: 451 EHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNN 510

Query: 311 ------------YLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCK 358
                        L  LN+S N L G+IPK  +F  FS +SF GN  LCGS      PC 
Sbjct: 511 LTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS--WLNSPC- 567

Query: 359 TSIHHTSRKN---ALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPN-DANMPPKATWRR 414
               H SR+    ++    +L  +   +V+++++++   +  N PP  D ++    T+  
Sbjct: 568 ----HDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYST 623

Query: 415 ------------FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG 462
                         Y ++ R T   +E  +IG G   T+YK  + +   VA+K  +    
Sbjct: 624 PKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNP 683

Query: 463 RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY--SSNCILD 520
           ++ K F+ E E++ SI +RNLV + +   +     L  +++ +GSL   L+  +    LD
Sbjct: 684 QSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLD 743

Query: 521 IFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ 580
              RL I    A  L YLH +    +IH D+K SN+LLD  + A L+DFGI K L    +
Sbjct: 744 WDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLC-VSK 802

Query: 581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           S T T  + TIGYI PEY R  R+    DVYS+GI+L+E+ + ++
Sbjct: 803 SHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRK 847

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  280 bits (717), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 215/708 (30%), Positives = 327/708 (46%), Gaps = 129/708 (18%)

Query: 39   NNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS---------------IADNYLTSSTPE 83
            NN+ G VP ++ + S L+ L L  N  +G + S               IA+NYL+ + P 
Sbjct: 361  NNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVP- 419

Query: 84   LSFLSSLSNCKSLVVFLLSNNPLNGILPR------------MSIGNLSH----------- 120
                  L  CKSL    LS N L G++P+            M   NL+            
Sbjct: 420  ----VELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVDGG 475

Query: 121  SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKL 180
            +LE   ++   ++G +PE I   TN+  I L  N L G IP  + +L+KL  + L +N L
Sbjct: 476  NLETLILNNNLLTGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLGNNSL 535

Query: 181  EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASL--------RTLSLSYNDG---- 228
             G IP ++     L  LDL  N L+G++    ++ A L        +  +   N+G    
Sbjct: 536  TGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDC 595

Query: 229  --------------------PLPLEIGNLKV--------------LIGIDFSMNNFSSVI 254
                                P+       ++              +I +D S N  S  I
Sbjct: 596  RGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSI 655

Query: 255  PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
            P   G++  LQ L LG+N+L G+IPDS G L ++  L+ S+N+L G +P  L  LS+L  
Sbjct: 656  PLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGGLSFLSD 715

Query: 315  LNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCK-----TSIHHTSRKNA 369
            L++S N L G IP GG    F    +  N  LCG P   +PPC      T  H   +K +
Sbjct: 716  LDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVP---LPPCSSGSRPTRSHAHPKKQS 772

Query: 370  LFLGIVLSFSTIFMVVVILLIVKYQKR-------------ENWP--------------PN 402
            +  G+       FM +V+L++  Y+ R             E+ P              P 
Sbjct: 773  IATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTSGSSSWKLSSVHEPL 832

Query: 403  DANMPP-KATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC 461
              N+   +   R+ ++  +  AT GF+ +++IG GGFG +YK+++ DG  VA+K      
Sbjct: 833  SINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVT 892

Query: 462  GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN----C 517
            G+  + F  E E +  I +RNLV ++  C   E + LV E+M +GSLE  L+        
Sbjct: 893  GQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGI 952

Query: 518  ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG 577
             LD   R  I I  A  L +LH + +  +IH D+K SNVLLD   VA +SDFG+ +L+  
Sbjct: 953  FLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSA 1012

Query: 578  EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
             D  ++ +    T GY+ PEY +  R  A GDVYS+G++L+E+ S K+
Sbjct: 1013 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKK 1060

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1

 Score =  279 bits (713), Expect = 5e-74,   Method: Compositional matrix adjust.
 Identities = 229/723 (31%), Positives = 344/723 (47%), Gaps = 110/723 (15%)

Query: 2   FSIS-IGKLE-LNVDDIESPCEIPSEINP-HNLEELLLGQNNLVGVVPAAIFDVSTLKDL 58
           FSIS + +LE LN+ + +    IP+ +    NL+ L L +N L G +P  ++    L+ L
Sbjct: 139 FSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLLYWNEVLQYL 198

Query: 59  ALQDNYLSGSLS------------SIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL 106
            L+ N L+G+LS             +  N LT + PE     S+ NC S  +  +S N +
Sbjct: 199 GLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPE-----SIGNCTSFEILDVSYNQI 253

Query: 107 NGILPR----MSIGNLS-----------------HSLEIFDMSKCNVSGGIPEEIGNLTN 145
            G++P     + +  LS                  +L + D+S   ++G IP  +GNL+ 
Sbjct: 254 TGVIPYNIGFLQVATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSF 313

Query: 146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG----- 200
              +YL GNKL G IP  L  + +L Y+ L DN+L G IP ++ +L +L++L+L      
Sbjct: 314 TGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLV 373

Query: 201 -------------------GNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKV 239
                              GN LSG++   F NL SL  L+LS N   G +P E+G++  
Sbjct: 374 GLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELGHIIN 433

Query: 240 LIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS 299
           L  +D S NNFS  IP T+G L+ L  L L  N L G++P   G+L S++ ++ S N L+
Sbjct: 434 LDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSFNFLA 493

Query: 300 GAIPLLLEKLSY------------------------LEHLNLSFNKLEGEIPKGGSFGNF 335
           G IP  L +L                          L +LN+SFN L G IP   +F  F
Sbjct: 494 GVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKNFTRF 553

Query: 336 SAESFEGNKLLCGSPNLHVPPCKTSIHHTSR-KNALFLGIVLSFSTIFMVVVILLIVKYQ 394
           S  SF GN  LCG  N     C  S+  +        + +VL F T+   + ++ I  Y+
Sbjct: 554 SPASFFGNPFLCG--NWVGSICGPSLPKSQVFTRVAVICMVLGFITL---ICMIFIAVYK 608

Query: 395 KRENWP--PNDANMPPKAT--------WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKS 444
            ++  P     +  P  +T            ++ ++ R T   +E  +IG G   T+YK 
Sbjct: 609 SKQQKPVLKGSSKQPEGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKC 668

Query: 445 RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP 504
                  +A+K  + Q    F+ F+ E E + SI +RN+V +     +     L  ++M 
Sbjct: 669 TSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYME 728

Query: 505 HGSLEKCLY--SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM 562
           +GSL   L+       LD   RL I +  A  L YLH +    +IH D+K SN+LLD   
Sbjct: 729 NGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNF 788

Query: 563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            A LSDFGI K  I   ++   T  L TIGYI PEY R  R+    D+YSFGI+L+E+ +
Sbjct: 789 EARLSDFGIAK-SIPATKTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLT 847

Query: 623 AKQ 625
            K+
Sbjct: 848 GKK 850

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  279 bits (713), Expect = 6e-74,   Method: Compositional matrix adjust.
 Identities = 230/719 (31%), Positives = 343/719 (47%), Gaps = 103/719 (14%)

Query: 2   FSIS-IGKLE-LNVDDIESPCEIPSEINP-HNLEELLLGQNNLVGVVPAAIFDVSTLKDL 58
           FSIS + +LE LN+ + +    +P+ +    NL+ L L  N+L G +   ++    L+ L
Sbjct: 137 FSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRLLYWNEVLQYL 196

Query: 59  ALQDNYLSGSLSS------------IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL 106
            L+ N L+G+LSS            +  N LT + PE     S+ NC S  +  +S N +
Sbjct: 197 GLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPE-----SIGNCTSFQILDISYNQI 251

Query: 107 NGILPR----MSIGNLS-----------------HSLEIFDMSKCNVSGGIPEEIGNLTN 145
            G +P     + +  LS                  +L + D+S   + G IP  +GNL+ 
Sbjct: 252 TGEIPYNIGFLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSF 311

Query: 146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG----- 200
              +YL GN L G IP  L  + +L Y+ L DNKL GTIP ++ +L +L++L+L      
Sbjct: 312 TGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLV 371

Query: 201 -------------------GNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKV 239
                              GN LSGSI   F NL SL  L+LS N+  G +P+E+G++  
Sbjct: 372 GPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIIN 431

Query: 240 LIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS 299
           L  +D S NNFS  IP T+G L+ L  L L  N L G +P   G+L S++ ++ S N LS
Sbjct: 432 LDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLS 491

Query: 300 GAIPLLLEKLSY------------------------LEHLNLSFNKLEGEIPKGGSFGNF 335
           G IP  L +L                          L +LN+SFN L G +P   +F  F
Sbjct: 492 GVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRF 551

Query: 336 SAESFEGNKLLCGS--PNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKY 393
           +  SF GN  LCG+   ++  P  K+ +        + LG++     IF+ V   +  + 
Sbjct: 552 APASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAVYKSM--QQ 609

Query: 394 QKRENWPPNDANMPPKATWRRF-----SYLEVCRATYGFNENNLIGKGGFGTIYKSRIGD 448
           +K        A    K           ++ ++ R T   NE  +IG G   T+YK  +  
Sbjct: 610 KKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKS 669

Query: 449 GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL 508
              +A+K  + Q     + F+ E E + SI +RN+V +     +     L  ++M +GSL
Sbjct: 670 SRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSL 729

Query: 509 EKCLYSS--NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL 566
              L+ S     LD   RL I +  A  L YLH +    +IH D+K SN+LLD+   AHL
Sbjct: 730 WDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHL 789

Query: 567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           SDFGI K  I   ++   T  L TIGYI PEY R  R+    D+YSFGI+L+E+ + K+
Sbjct: 790 SDFGIAK-SIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKK 847

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	652
255585401	843	serine-threonine protein kinase, plant-t	0.946	0.731	0.459	1e-154
359485453	1202	PREDICTED: probable LRR receptor-like se	0.958	0.519	0.443	1e-149
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.947	0.494	0.467	1e-149
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.984	0.441	0.422	1e-148
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.947	0.503	0.464	1e-147
255578886	1043	serine-threonine protein kinase, plant-t	0.921	0.576	0.482	1e-147
255572272	1089	serine-threonine protein kinase, plant-t	0.949	0.568	0.467	1e-147
224139658	1019	predicted protein [Populus trichocarpa]	0.923	0.590	0.475	1e-147
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.964	0.442	0.443	1e-146
224116832	1061	predicted protein [Populus trichocarpa]	0.952	0.585	0.446	1e-145

>gi|255585401|ref|XP_002533396.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526770|gb|EEF28996.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  551 bits (1419), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 324/705 (45%), Positives = 427/705 (60%), Gaps = 88/705 (12%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS------------SIADNYL 77
           NLEEL + +N  +G +P +I + S L  L    N LSG +             ++ADN  
Sbjct: 125 NLEELYITRNQFIGTLPPSISNASKLTILESSSNSLSGPIPDTLCNLKNLKRLNLADN-- 182

Query: 78  TSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP 137
            S T EL FL+SL+ CK L   +L  NPLN  LP  SIGNLS S+E F++  CN+ G IP
Sbjct: 183 -SFTDELGFLASLARCKELRRLVLIGNPLNSTLP-TSIGNLS-SIEYFNVQSCNIKGNIP 239

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
            EIG L+NL  ++L  N+L GSIP T+  LQKLQ + L  N L G+IP DI  L  L +L
Sbjct: 240 SEIGVLSNLITLHLQNNELVGSIPVTIGGLQKLQRLYLHGNLLYGSIPTDICHLSNLGEL 299

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYND--------------------------GPLP 231
            L  N L G +  CF +L SLR L L  N+                          G +P
Sbjct: 300 FLSNNSLFGPLPACFGDLISLRILHLHSNNFTSGIPFSLWSLKDVLELNLSSNSLSGHIP 359

Query: 232 LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSL 291
           L IGNLKVL  +DFS N+ S +IP  IGSL++L  L L +N  +G IP+  G+LISL+SL
Sbjct: 360 LSIGNLKVLTQVDFSYNSLSGIIPNAIGSLRNLMSLSLTHNRFEGPIPEPFGELISLESL 419

Query: 292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPN 351
           + S+NNLSG IP  LE+L YL++LN+SFN L+GE+P  G+F NFSA SF GN  LCGS  
Sbjct: 420 DLSSNNLSGKIPKSLEQLKYLKYLNVSFNNLDGEVPNKGAFANFSASSFLGNLALCGSRL 479

Query: 352 LHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKAT 411
           L + PCK + H  S+ +   L I +  ++I  +  IL+ ++ QK +    N  ++    T
Sbjct: 480 LPLMPCKNNTHGGSKTSTKLLLIYVLPASILTIAFILVFLRCQKVKLELENVMDIITVGT 539

Query: 412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIE 471
           WRR S+ E+ +AT GF  +NL+G GG+G++YK R+ DG  VA+KVF+L    AFK FD E
Sbjct: 540 WRRISFQELEQATDGFCASNLLGAGGYGSVYKGRLEDGTNVAIKVFNLGVEGAFKIFDTE 599

Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
           CE+M SI +RNLVKIIS CSN++FK +VLE+MP+GSLEK LYS N  L+I QRL +MIDV
Sbjct: 600 CEVMSSIRHRNLVKIISCCSNQDFKAIVLEYMPNGSLEKWLYSHNYCLNIQQRLEVMIDV 659

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           AS LEYLH  F  P++HCDLKPSNVLLD  MV H++DFG+ KLL GE   +TQT+TLATI
Sbjct: 660 ASALEYLHHGFSAPIVHCDLKPSNVLLDQDMVGHVADFGMAKLL-GEGDLITQTKTLATI 718

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLME---------------------------IHSA- 623
           GY+APEYG +G V  +GDVYSFGI+LME                           +H+A 
Sbjct: 719 GYMAPEYGSKGIVSISGDVYSFGILLMETFTRMKPTDDMFGERVLSLKQYIEDALLHNAV 778

Query: 624 ----------------KQQCVSFVFNLAMECTIESLELRINAKEI 652
                            + CVS +  LA++C++E    RI+  ++
Sbjct: 779 SEIADANFLIDEKNLSTKDCVSSILGLALDCSVELPHGRIDMSQV 823

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  534 bits (1376), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 320/721 (44%), Positives = 430/721 (59%), Gaps = 96/721 (13%)

Query: 22   IPSEINPH--NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS----------- 68
            +PS I     NLE+LL+G N   G++P +I ++S L  L + DN+  G+           
Sbjct: 471  LPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQL 530

Query: 69   -LSSIADNYLTS--STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
             L  ++ N LT+  S  EL+FL+SL+NC  L    +S+NPL G++P  S+GNLS SLEI 
Sbjct: 531  QLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLSISDNPLKGMIPN-SLGNLSISLEII 589

Query: 126  DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
              S C + G IP  I NLTNL  + L  N L G IP     LQKLQ + +  N++ G+IP
Sbjct: 590  YASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIP 649

Query: 186  YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------------------- 226
              +  L  L  LDL  NKLSG+I +C  NL  LR + L  N                   
Sbjct: 650  SGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVL 709

Query: 227  -------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
                   +  LPL++GN+K L+ +D S N FS  IP+TI  L++L  L+L +N L+G IP
Sbjct: 710  NLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIP 769

Query: 280  DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES 339
             + GDL+SL+SL+ S NNLSG IP  LE L YLE+LN+SFNKL+GEIP GG F NF+AES
Sbjct: 770  PNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAES 829

Query: 340  FEGNKLLCGSPNLHVPPCKTSIHHTSRKN--ALFLGIVLSFS-TIFMVVVILLIVKYQKR 396
            F  N  LCG+P   V  C+      SRKN  +L L  ++  S ++  +++++L V++++R
Sbjct: 830  FISNLALCGAPRFQVMACEKD----SRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRR 885

Query: 397  E--NWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAV 454
            +  +  P   ++      R   + E+  AT  F E+NLIGKG  G +YK  + DG+ VAV
Sbjct: 886  QTKSETPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAV 945

Query: 455  KVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS 514
            KVF+L+   AFKSF++ECE+M++I +RNL KIISSCSN +FK LVLE+MP+GSLEK LYS
Sbjct: 946  KVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYS 1005

Query: 515  SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL 574
             N  LD  QRL IMIDVAS LEYLH  +  PV+HCDLKPSNVLLDD MVAH+SDFGI KL
Sbjct: 1006 HNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKL 1065

Query: 575  LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI-------------- 620
            L+G  + M +T+TL T+GY+APEYG EG V   GD+YS+GI+LME               
Sbjct: 1066 LMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEE 1124

Query: 621  -----------------------------HSAKQQCVSFVFNLAMECTIESLELRINAKE 651
                                          + K+ C S +  LA++CT+E  E RIN K+
Sbjct: 1125 LTLKSWVESSTNNIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEPPEKRINTKD 1184

Query: 652  I 652
            +
Sbjct: 1185 V 1185

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  533 bits (1374), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 313/669 (46%), Positives = 416/669 (62%), Gaps = 51/669 (7%)

Query: 22   IPSEINPH--NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS--------- 70
            +PS I+    +LE L +G N   G +P +I ++S L  L + DNY  G++          
Sbjct: 500  LPSSISTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFIGNVPKDLSNLRKL 559

Query: 71   ---SIADNYLTSS--TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
               ++A N LT    T E+ FL+SL+NCK L    +  NPL G LP  S+GNLS +LE F
Sbjct: 560  EVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESF 618

Query: 126  DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
              S C+  G IP  IGNLTNL  + LG N L GSIP TL +LQKLQ + +  N+++G+IP
Sbjct: 619  TASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGQLQKLQRLYIAGNRIQGSIP 678

Query: 186  YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------------------- 226
             D+F L  L  L L  NKLSGSI +CF +L +LR LSL  N                   
Sbjct: 679  NDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVL 738

Query: 227  -------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
                    G LP E+GN+K +  +D S N  S  IP  +G L++L  L L  N L+GSIP
Sbjct: 739  SLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIP 798

Query: 280  DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES 339
               GDL+SL+S++ S NNLSG IP  LE L YL+HLN+SFNKL+GEIP GG F NF+AES
Sbjct: 799  VEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLKHLNVSFNKLQGEIPDGGPFVNFTAES 858

Query: 340  FEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFL--GIVLSFSTIF-MVVVILLIVKYQKR 396
            F  N+ LCG+P+  V  C  + H  S K   F+   I+L   +I  +V  I+L ++ Q  
Sbjct: 859  FIFNEALCGAPHFQVIACDKNNHTQSWKTKSFILKYILLPVGSIVTLVAFIVLWIRRQDN 918

Query: 397  ENWP-PNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVK 455
               P P D+ +P      + S  ++  AT  F E+NLIGKG  G +YK  + +G+ VA+K
Sbjct: 919  TEIPAPIDSWLP--GAHEKISQQQLLYATNDFGEDNLIGKGSLGMVYKGVLSNGLTVAIK 976

Query: 456  VFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS 515
            VF+L+   A +SFD ECE+M+ I +RNL++II+ CSN +FK LVLE+MP GSL+K LYS 
Sbjct: 977  VFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSH 1036

Query: 516  NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL 575
            N  LD+FQRLNIMIDVA  LEYLH +    V+HCDLKPSNVLLD+ MVAH++DFGI +LL
Sbjct: 1037 NYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLL 1096

Query: 576  IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-FVFNL 634
              E +SM QT+TL TIGY+APEYG +G V   GDVYS+GI+LME+ + K+     F  ++
Sbjct: 1097 T-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFTGDV 1155

Query: 635  AMECTIESL 643
             ++  +ESL
Sbjct: 1156 TLKTWVESL 1164

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  533 bits (1372), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 332/785 (42%), Positives = 442/785 (56%), Gaps = 143/785 (18%)

Query: 5    SIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDN 63
            ++  LEL  ++I+    IP+E+ N  NL+ L L +NNL G++P AIF++S L+ L+L  N
Sbjct: 663  ALQDLELGDNNIQG--NIPNELGNLINLQNLKLSENNLTGIIPEAIFNISKLQSLSLAQN 720

Query: 64   YLSGSLSS-------------------------------------IADNYLTSSTP---- 82
            + SGSL S                                     I DN+ T   P    
Sbjct: 721  HFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLG 780

Query: 83   ----------------------ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH 120
                                  E+ FL+SL+NC  L    + +NPL GILP  S+GNLS 
Sbjct: 781  NLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNPLKGILPN-SLGNLSI 839

Query: 121  SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKL 180
            SLE FD S C   G IP  IGNLT+L ++ LG N L G IP TL +L+KLQ +G+  N+L
Sbjct: 840  SLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRL 899

Query: 181  EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN-------------- 226
             G+IP D+ RL  L  L L  N+L+GSI +C   L  LR L L  N              
Sbjct: 900  RGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLR 959

Query: 227  ------------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL 274
                         G LP E+GN+K +  +D S N  S  IP T+G L++L+ L L  N L
Sbjct: 960  GLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRL 1019

Query: 275  KGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
            +G IP   GDL+SLK L+ S NNLSG IP  L+ L+YL++LN+SFNKL+GEIP GG F N
Sbjct: 1020 QGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMN 1079

Query: 335  FSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALF-LGIVLS--FSTIFMVVVILLIV 391
            F+AESF  N+ LCG+P+  V  C  S    S +  LF L  +L    S I +VV ++L +
Sbjct: 1080 FTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWI 1139

Query: 392  KYQKRENWP-PNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGM 450
            + +K    P P D+ +P   +  + S+ ++  AT  F E+NLIGKG    +YK  + +G+
Sbjct: 1140 RRRKNLEVPTPIDSWLP--GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGL 1197

Query: 451  EVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEK 510
             VAVKVF+L+   AF+SFD ECE+M+SI +RNLVKII+ CSN +FK LVLE+MP GSL+K
Sbjct: 1198 TVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDK 1257

Query: 511  CLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
             LYS N  LD+ QRLNIMIDVAS LEYLH +    V+HCDLKP+N+LLDD MVAH+ DFG
Sbjct: 1258 WLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFG 1317

Query: 571  ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ----- 625
            I +LL  E +SM QT+TL TIGY+APEYG +G V   GDV+S+GIMLME+ + K+     
Sbjct: 1318 IARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEM 1376

Query: 626  --------------------------------------QCVSFVFNLAMECTIESLELRI 647
                                                   C+S +  LA+ CT +S E RI
Sbjct: 1377 FNGDLTLKSWVESLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERI 1436

Query: 648  NAKEI 652
            + K++
Sbjct: 1437 DMKDV 1441

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  528 bits (1361), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 311/669 (46%), Positives = 414/669 (61%), Gaps = 51/669 (7%)

Query: 22   IPSEINPH--NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS--------- 70
            +PS I     +LE L +G N   G +P +I ++S L  L + DNY +G++          
Sbjct: 500  LPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKL 559

Query: 71   ---SIADNYLTSS--TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
               ++A N LT    T E+ FL+SL+NCK L    +  NPL G LP  S+GNLS +LE F
Sbjct: 560  EVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESF 618

Query: 126  DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
              S C+  G IP  IGNLTNL  + LG N L GSIP TL  LQKLQ + +  N+++G+IP
Sbjct: 619  TASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIP 678

Query: 186  YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------------------- 226
             D+  L  L  L L  NKLSGSI +CF +L +LR LSL  N                   
Sbjct: 679  NDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVL 738

Query: 227  -------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
                    G LP E+GN+K +  +D S N  S  IP  +G L++L  L L  N L+GSIP
Sbjct: 739  SLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIP 798

Query: 280  DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES 339
               GDL+SL+S++ S NNL G IP  LE L YL+HLN+SFNKL+GEIP GG F NF+AES
Sbjct: 799  VEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAES 858

Query: 340  FEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFL--GIVLSF-STIFMVVVILLIVKYQKR 396
            F  N+ LCG+P+  V  C  +    S K   F+   I+L   S + +V  I+L ++ +  
Sbjct: 859  FIFNEALCGAPHFQVIACDKNNRTQSWKTKSFILKYILLPVGSAVTLVAFIVLWIRRRDN 918

Query: 397  ENWP-PNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVK 455
               P P D+ +P      + S  ++  AT GF E+NLIGKG  G +YK  + +G+ VA+K
Sbjct: 919  TEIPAPIDSWLP--GAHEKISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIK 976

Query: 456  VFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS 515
            VF+L+   A +SFD ECE+M+ I +RNL++II+ CSN +FK LVLE+MP GSL+K LYS 
Sbjct: 977  VFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSH 1036

Query: 516  NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL 575
            N  LD+FQRLNIMIDVAS LEYLH +    V+HCDLKPSNVLLD+ MVAH++DFGI +LL
Sbjct: 1037 NYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLL 1096

Query: 576  IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-FVFNL 634
              E +SM QT+TL TIGY+APEYG +G V   GDVYS+GI+LME+ + K+     F  ++
Sbjct: 1097 T-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFTGDV 1155

Query: 635  AMECTIESL 643
             ++  +ESL
Sbjct: 1156 TLKTWVESL 1164

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  528 bits (1359), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 313/649 (48%), Positives = 414/649 (63%), Gaps = 48/649 (7%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS----------- 70
           +PS  N  NLE  ++  NN  G +P ++F+ S L ++ L  N   G +            
Sbjct: 311 LPSSSNLPNLEFFIIEDNNFTGPIPVSLFNASKLGNIDLGWNSFYGPIPDELGNLKSLEV 370

Query: 71  -SIADNYLT--SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
            S   N+LT  SS+  LS  SSL+ CK L  F LSNNPLNG LP +S+GNLS SLE+ ++
Sbjct: 371 FSFWVNHLTVKSSSSGLSLFSSLTKCKHLRRFDLSNNPLNGNLP-ISVGNLSSSLEVVEI 429

Query: 128 SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
             C ++G IP+EIGNL++L+ + LG N L G+IP T+R+L KLQ + L  N+LEG+ PY+
Sbjct: 430 FDCGITGTIPKEIGNLSSLSWLDLGANDLRGTIPTTIRKLGKLQELKLHYNRLEGSFPYE 489

Query: 188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLP-------------- 231
           +  L  L  L L  N LSG I +C  N+ SLRTLS+  N     +P              
Sbjct: 490 LCDLQSLAYLYLEVNALSGQIPSCLGNVNSLRTLSMGMNKFSSTIPSTLWRLADILELNL 549

Query: 232 ----------LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS 281
                     ++IGNLK +  ID S N  S  IP++IG LK L  L L  N L+GSIP  
Sbjct: 550 SSNSLSGSLAVDIGNLKAVTLIDLSGNQLSGHIPSSIGGLKTLLNLSLAVNRLEGSIPQL 609

Query: 282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE 341
            GD ISL+ L+ SNNNLSG IP  LE+L YL + N+SFN+L+GEIP G +F N SA+SF 
Sbjct: 610 FGDAISLQLLDLSNNNLSGEIPKSLEELRYLTYFNVSFNELQGEIPNGRAFINLSAKSFM 669

Query: 342 GNKLLCGSPNLHVPPCKTSIHHTSR---KNALFLGIVLSFSTIFMVVVILLIVKYQKREN 398
           GNK LCG+  L V PC+TS H  S+   K AL  G++ +  TI  V  + +I    ++ N
Sbjct: 670 GNKGLCGAAKLQVQPCETSTHQGSKAASKLALRYGLMATGLTILAVAAVAIIFIRSRKRN 729

Query: 399 WPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFH 458
               +  + P AT +R SY E+ +AT  FNE NL+G+G FG++YK    DG  VAVKVF+
Sbjct: 730 MRITEG-LLPLATLKRISYRELEQATDKFNEMNLLGRGSFGSVYKGTFSDGSSVAVKVFN 788

Query: 459 LQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS--NEEFKELVLEHMPHGSLEKCLYSSN 516
           LQ   AFKSFD+ECE+++ I +RNLVKII+SCS  N +FK LVLE MP+ SLEK L S  
Sbjct: 789 LQVEGAFKSFDVECEVLRMIRHRNLVKIITSCSDINIDFKALVLEFMPNYSLEKWLCSPK 848

Query: 517 CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L++ +RLNIM+DVAS +EYLH  + +P++HCDLKPSN+LLD+ MVAH++DFGI KLL 
Sbjct: 849 HFLELLERLNIMLDVASAVEYLHHGYAMPIVHCDLKPSNILLDENMVAHVTDFGIAKLL- 907

Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           G++ S  QT TLAT+GY+APEYG EG V   GD+YSFGI+LME  + K+
Sbjct: 908 GDEHSFIQTITLATVGYMAPEYGSEGVVSTGGDIYSFGILLMETFTRKK 956

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  527 bits (1357), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 311/665 (46%), Positives = 414/665 (62%), Gaps = 46/665 (6%)

Query: 9    LELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG 67
            L L ++ +  P  IPS I N   L  L L  N+  G +P ++ D+  L+ L L  N LS 
Sbjct: 366  LYLGINKLSGP--IPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSS 423

Query: 68   SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
              +S           EL+  SSL NC++L    LS NPL+G LP  S+GNLS+SLE F  
Sbjct: 424  KKTS----------QELTIFSSLKNCQNLKYLWLSYNPLDGYLPH-SVGNLSNSLESFLA 472

Query: 128  SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
            S   + G + E IGNL++LT + LG N L G IP T+  L+ LQ + L  N L+G+IP +
Sbjct: 473  SDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSE 532

Query: 188  IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--------------------- 226
            +  L  LY L+L GNKLSGSI TCFSNL SLR L L+ N                     
Sbjct: 533  LCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNL 592

Query: 227  -----DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS 281
                  G LP EI NL+ +  I+ S N  S  IP +IG L+DL  L+L  N L+G IP S
Sbjct: 593  ASNYLTGSLPSEIENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQS 652

Query: 282  VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE 341
            VGD+ SL+ L+ S+NNLSG IP  L+ L YL++ N+SFN L+GEIP+GGSF NFSA+SF 
Sbjct: 653  VGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFI 712

Query: 342  GNKLLCGSPNLHVPPCKTSIHHTSRK--NALFLGIVLS--FSTIFMVVVILLIVKYQKRE 397
            GN+ LCGS  L V PCK      +    + + L  VL      +F++  ++++ +Y +R+
Sbjct: 713  GNEALCGSARLQVSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERK 772

Query: 398  NWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVF 457
                 + +     T RR SY E+  AT GF E+N +G G FG++YK  + DG  +A KVF
Sbjct: 773  AKFSIEDDFLALTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVF 832

Query: 458  HLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC 517
            +LQ  RAFKSFD ECE+++++ +RNLVKII+SCS   FK LVLE MP+ SLEK LYS + 
Sbjct: 833  NLQLERAFKSFDTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDY 892

Query: 518  ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG 577
             L+  QRLNIM+DVASVLEYLH  + +P+ HCD+KPSNVLL++ MVA L+DFGI+KLL G
Sbjct: 893  FLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-G 951

Query: 578  EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-FVFNLAM 636
            E+ S+ QT TLATIGY+APEYG EG V   GDVYS+G++LME  + K+     F   L++
Sbjct: 952  EEGSVMQTMTLATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSL 1011

Query: 637  ECTIE 641
            +  +E
Sbjct: 1012 KSWVE 1016

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  527 bits (1357), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 308/648 (47%), Positives = 404/648 (62%), Gaps = 46/648 (7%)

Query: 22  IPSE--INPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS--------- 70
           IP E  I+  NLEEL L  N + G +P  + ++S L+ L L  N ++G++          
Sbjct: 283 IPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRAL 342

Query: 71  ---SIADNYLTS--STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
              S+  N  T+  S+  L+F++SL+N + L    + +NPL+G+LP  S+GNLS  L  F
Sbjct: 343 QVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIGDNPLDGMLPN-SVGNLSSFLTKF 401

Query: 126 DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
            +    + G IP EIGNL+NL  + L  N L G IP T+  L+K+Q + L  N L G+IP
Sbjct: 402 YVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIP 461

Query: 186 YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------------------- 226
            DI    +L  + L  N LSG I +C  NL SLR L L +N                   
Sbjct: 462 SDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLIL 521

Query: 227 -------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
                   G LP ++G ++  IGI  S N  S  IP+TIGSL++L    L  N  +GSIP
Sbjct: 522 NLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIP 581

Query: 280 DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES 339
           ++ G L+SL+ L+ S NNLSG IP  LE L YLE  ++SFN L+GEIP+GG F NF+A S
Sbjct: 582 EAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARS 641

Query: 340 FEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVL-SFSTIFMVVV-ILLIVKYQKRE 397
           F  NK LCG   L VPPC       S+  +  L   L + ++I +VV  I L++  ++R 
Sbjct: 642 FIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRY 701

Query: 398 NWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVF 457
              P    +P  A  RR SYLE+  AT  F+E+NL+G G FG++Y+ R+ DG+ VAVK+F
Sbjct: 702 RKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIF 761

Query: 458 HLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC 517
           +LQ  RAF+SFD ECEIM++I +RNLVKII SCSN +FK LVLE+MP GSLEK LYS N 
Sbjct: 762 NLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNY 821

Query: 518 ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG 577
            LDI QR+NIMIDVAS LEYLH  +  PV+HCDLKPSNVLLD+ MVAH+ DFGI KLL G
Sbjct: 822 CLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLL-G 880

Query: 578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           E++S  QT+TLATIGY+APEYG +G V    DVYSFGIMLME+ + K+
Sbjct: 881 ENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKR 928

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  525 bits (1351), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 318/717 (44%), Positives = 417/717 (58%), Gaps = 88/717 (12%)

Query: 22   IPSEINPH--NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS--------- 70
            +PS I     +LE L +G N   G++P +I ++S L  L +  N+ +G +          
Sbjct: 472  LPSSIGTQLPDLEGLAIGXNEFSGIIPMSISNMSELTVLDIWANFFTGDVPKDLGNLRRL 531

Query: 71   ---SIADNYLTS--STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
               ++  N LT   ST E+ FL+SL+NCK L    + +NPL GILP  S+GNLS SLE F
Sbjct: 532  EFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRLWIEDNPLKGILPN-SLGNLSISLESF 590

Query: 126  DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
            D S C   G IP  IGNL NL  + L  N L G IP +   LQKLQ+  +  N++ G+IP
Sbjct: 591  DASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLIPISFGHLQKLQWFAISGNRIHGSIP 650

Query: 186  YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------------------- 226
              +  L  L  LDL  NKLSG+I  CF NL +LR +SL  N                   
Sbjct: 651  SVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRNISLHSNGLASEIPSSLWTLRDLLVL 710

Query: 227  -------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
                   +  LPLE+GN+K L+ +D S N FS  IP+TI  L++L  L+L +N L+G +P
Sbjct: 711  NLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHMP 770

Query: 280  DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES 339
             + G L+SL+ L+ S NN SG IP  LE L YL++LN+SFNKL+GEIP  G F NF+AES
Sbjct: 771  PNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKYLNVSFNKLQGEIPNRGPFANFTAES 830

Query: 340  FEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIV-KYQKREN 398
            F  N  LCG+P   V  C+      ++   L   + LS S   M++V+L  + K ++ E+
Sbjct: 831  FISNLALCGAPRFQVMACEKDARRNTKSLLLKCIVPLSVSLSTMILVVLFTLWKRRQTES 890

Query: 399  WPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFH 458
              P   ++      R  S+ E+  AT  F E NLIGKG  G +YK  + DG+ VAVKVF+
Sbjct: 891  ESPVQVDLLLPRMHRLISHQELLYATSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFN 950

Query: 459  LQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI 518
            L+   AFKSF++ECE+M++I +RNL KIISSCSN +FK LVLE+MP+ SLEK LYS N  
Sbjct: 951  LELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYC 1010

Query: 519  LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
            LD  QRL IMIDVAS LEYLH ++  PV+HCDLKPSNVLLDD MVAH+SDFGI KLL+G 
Sbjct: 1011 LDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGS 1070

Query: 579  DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI------------------ 620
             + M +T+TL TIGY+APEYG EG V    D YS+GI+LMEI                  
Sbjct: 1071 -EFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVRKKPTDEMFVEELTLK 1129

Query: 621  -------------------------HSAKQQCVSFVFNLAMECTIESLELRINAKEI 652
                                      + KQ C S +  LA++CTIE  E RIN K++
Sbjct: 1130 SWVESSANNIMEVIDANLLTEEDESFALKQACFSSIMTLALDCTIEPPEKRINMKDV 1186

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  520 bits (1340), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 316/708 (44%), Positives = 412/708 (58%), Gaps = 87/708 (12%)

Query: 30   NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS------------SIADNYL 77
            NLEEL L +N L G +P +I + S L  L L  N  SG +             ++A+N L
Sbjct: 333  NLEELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENIL 392

Query: 78   TSSTPELSFLSSLS--NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG 135
            TS +         S  NC+SL     + NPL G LP +SIGNLS SLE      C + G 
Sbjct: 393  TSKSLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGN 451

Query: 136  IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY 195
            IP  IGNL+NL  + L  N+L G+IP  +  L+ LQ   L  NKL+G IP +I  L +L 
Sbjct: 452  IPRGIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLS 511

Query: 196  KLDLGGNKLSGSILTCFSNLASLRTL-----------------------SLSYND--GPL 230
             L L  N  SGS+  C SN+ SLR L                       +LS+N   G L
Sbjct: 512  YLYLLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTL 571

Query: 231  PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKS 290
            PLEIGNLKV+  IDFS N  S  IPT+I  L++L +  L  N ++G IP S GDL+SL+ 
Sbjct: 572  PLEIGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEF 631

Query: 291  LNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP 350
            L+ S N+LSGAIP  LEKL +L+  N+SFN+L+GEI  GG F NFS  SF  N+ LCG  
Sbjct: 632  LDLSRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPI 691

Query: 351  NLHVPPCKT-SIHHTSRKNALFL--GIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMP 407
             + VPPCK+ S H  S++   F+   IV + + I +V+ + +I+  +  +       +  
Sbjct: 692  RMQVPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPL 751

Query: 408  PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
            P ATWR+ SY E+ RAT GFNE NL+G G  G++YK  + DG+ +AVKVFHLQ       
Sbjct: 752  PPATWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMR 811

Query: 468  FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
            FD ECE+++ + +RNLVKIISSC N +FK L+LE +PHGSLEK LYS N  LDI QRLNI
Sbjct: 812  FDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNI 871

Query: 528  MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
            MIDVAS LEYLH     PV+HCDLKPSNVL+++ MVAH+SDFGI++LL GE  ++TQT T
Sbjct: 872  MIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLT 930

Query: 588  LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS------------------------- 622
            LATIGY+APEYG EG V   GDVYS+GI LME  +                         
Sbjct: 931  LATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPK 990

Query: 623  ------------------AKQQCVSFVFNLAMECTIESLELRINAKEI 652
                              AK+ C++ + NLA+EC+ +    RI  +++
Sbjct: 991  AITEVIDANLLIEEEHFVAKKDCITSILNLALECSADLPGERICMRDV 1038

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	652
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.703	0.454	0.321	4.3e-52
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.815	0.519	0.355	3.1e-83
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.411	0.265	0.390	7.1e-79
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.621	0.395	0.338	3.3e-54
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.825	0.548	0.345	4.1e-72
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.622	0.324	0.310	1.9e-71
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.877	0.487	0.322	7.7e-70
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.814	0.525	0.335	1.5e-68
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.647	0.409	0.319	1.2e-48
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.831	0.540	0.332	7.6e-64

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 4.3e-52, Sum P(2) = 4.3e-52
 Identities = 159/495 (32%), Positives = 246/495 (49%)

Query:    51 DVSTLKDLALQDNYLSGSLSSIADNYLTSST--PELSFLS------------SLSNCKSL 96
             +V  LK L L  N L GS SS    +LTS T   +L  L             S++N  + 
Sbjct:   304 NVPNLKLLFLHTNSL-GSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAK 362

Query:    97 VVFL-LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK 155
             +V L L    ++G +P   IGNL + L+   + +  +SG +P  +G L NL  + L  N+
Sbjct:   363 LVTLDLGGTLISGSIP-YDIGNLIN-LQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNR 420

Query:   156 LNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNL 215
             L+G IP  +  +  L+ + L +N  EG +P  +     L +L +G NKL+G+I      +
Sbjct:   421 LSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKI 480

Query:   216 ASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNI 273
               L  L +S N   G LP +IG L+ L  +    N  S  +P T+G+   ++ LFL  N+
Sbjct:   481 QQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNL 540

Query:   274 LKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLEGEIPKGGSFG 333
               G IPD  G                G+IP              SFN LEG++P  G F 
Sbjct:   541 FYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFE 599

Query:   334 NFSAESFEGNKLLCGS-PNLHVPPCKT---SI--HHTSRKNALFLGIVLSFSTI---FMV 384
             N +  S  GN  LCG      + PC +   S+   H+SR   + +G+ +  + +   FM 
Sbjct:   600 NATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMA 659

Query:   385 VVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKS 444
              V L+ ++ +K+     N      +    + SY ++  AT GF+ +N++G G FGT+YK+
Sbjct:   660 SVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKA 719

Query:   445 RI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-----EEFKEL 498
              +  +   VAVKV ++Q   A KSF  ECE +K I +RNLVK++++CS+      EF+ L
Sbjct:   720 LLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRAL 779

Query:   499 VLEHMPHGSLEKCLY 513
             + E MP+GSL+  L+
Sbjct:   780 IYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
 Identities = 199/559 (35%), Positives = 302/559 (54%)

Query:    88 SSLSNCKSLVVFL-LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
             +S SN  + + FL L  N + G +P+  IGNL   L+   +   N  G +P  +G L NL
Sbjct:   369 NSFSNLSTSLSFLALELNKITGSIPK-DIGNLI-GLQHLYLCNNNFRGSLPSSLGRLKNL 426

Query:   147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
               +    N L+GSIP  +  L +L  + L  NK  G IPY +  L  L  L L  N LSG
Sbjct:   427 GILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSG 486

Query:   207 SILTCFSNLASLRTL-SLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
              I +   N+ +L  + ++S N  +G +P EIG+LK L+      N  S  IP T+G  + 
Sbjct:   487 PIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQL 546

Query:   264 LQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLE 323
             L+YL+L  N+L GSIP ++G                G IP              SFN   
Sbjct:   547 LRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFV 606

Query:   324 GEIPKGGSFGNFSAESFEGNKLLCGS-PNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIF 382
             GE+P  G+F   S  S +GN  LCG  P+LH+P C   + +      L + + L+ +   
Sbjct:   607 GEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAI 666

Query:   383 MVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIY 442
             +  + LLI  +++ +   P+  +M         SY ++ +AT GF   NL+G G FG++Y
Sbjct:   667 LSSLYLLITWHKRTKKGAPSRTSMKGHPL---VSYSQLVKATDGFAPTNLLGSGSFGSVY 723

Query:   443 KSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-----EEFKE 497
             K ++     VAVKV  L+  +A KSF  ECE ++++ +RNLVKI++ CS+      +FK 
Sbjct:   724 KGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKA 783

Query:   498 LVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +V + MP+GSLE  ++      +    L++ +R+ I++DVA  L+YLH +   PV+HCD+
Sbjct:   784 IVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDI 843

Query:   552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-----LATIGYIAPEYGREGRVFA 606
             K SNVLLD  MVAH+ DFG+ ++L+ +  S+ Q  T     + TIGY APEYG       
Sbjct:   844 KSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIAST 902

Query:   607 NGDVYSFGIMLMEIHSAKQ 625
             +GD+YS+GI+++EI + K+
Sbjct:   903 HGDIYSYGILVLEIVTGKR 921

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 7.1e-79, Sum P(2) = 7.1e-79
 Identities = 114/292 (39%), Positives = 178/292 (60%)

Query:   355 PPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPP--NDANMPPKATW 412
             PP +T   H S    + +G+ +  + + ++ ++ L   ++KR+N     N A    +   
Sbjct:   630 PPVET--RHPSLLKKVAIGVSVGIALLLLLFIVSLSW-FKKRKNNQKINNSAPFTLEIFH 686

Query:   413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIE 471
              + SY ++  AT GF+ +N++G G FGT++K+ +  +   VAVKV ++Q   A KSF  E
Sbjct:   687 EKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAE 746

Query:   472 CEIMKSIHYRNLVKIISSCSN-----EEFKELVLEHMPHGSLEKCLYSSNC--------I 518
             CE +K I +RNLVK++++C++      EF+ L+ E MP+GSL+K L+             
Sbjct:   747 CESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRT 806

Query:   519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
             L + +RLNI IDVASVL+YLH +   P+ HCDLKPSN+LLDD + AH+SDFG+ +LL+  
Sbjct:   807 LTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKF 866

Query:   579 DQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
             DQ      ++      TIGY APEYG  G+   +GDVYSFG++++E+ + K+
Sbjct:   867 DQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKR 918

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 3.3e-54, Sum P(2) = 3.3e-54
 Identities = 144/425 (33%), Positives = 218/425 (51%)

Query:    86 FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTN 145
             F+++LS    L    L  N ++G +P   IGNL  SL+  D+ +  ++G +P  +G L+ 
Sbjct:   371 FIANLST--QLTELSLGGNLISGSIPH-GIGNLV-SLQTLDLGENLLTGKLPPSLGELSE 426

Query:   146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLS 205
             L  + L  N L+G IP +L  +  L Y+ L +N  EG+IP  +     L  L+LG NKL+
Sbjct:   427 LRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLN 486

Query:   206 GSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
             GSI      L SL  L++S+N   GPL  +IG LK L+ +D S N  S  IP T+ +   
Sbjct:   487 GSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLS 546

Query:   264 LQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLE 323
             L++L L  N   G IPD  G                G IP              S N  +
Sbjct:   547 LEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFD 605

Query:   324 GEIPKGGSFGNFSAESFEGNKLLCGS-PNLHVPPCKTSI--HHTSRKNALFLGIVLSFST 380
             G +P  G F N SA S  GN  LCG  P+L + PC   +   H+S +  + + +    + 
Sbjct:   606 GAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAA 665

Query:   381 IFMVVVILLIVKYQK------RENWPPNDANMPP-KATWRRFSYLEVCRATYGFNENNLI 433
             + ++ + ++ + + K      R N   ND +  P K+ + + SY E+ + T GF+ +NLI
Sbjct:   666 LLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLI 725

Query:   434 GKGGFGTIYKSRIGD-GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
             G G FG ++K  +G     VA+KV +L C R A KSF  ECE +  I +RNLVK+++ CS
Sbjct:   726 GSGNFGAVFKGFLGSKNKAVAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICS 784

Query:   492 NEEFK 496
             + +F+
Sbjct:   785 SSDFE 789

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 729 (261.7 bits), Expect = 4.1e-72, P = 4.1e-72
 Identities = 196/567 (34%), Positives = 302/567 (53%)

Query:    47 AAIFDVSTLKDLALQDNYLSGSLSS----IADN----YLTSSTPELSFLSSLSNCKSLVV 98
             A++ + S L++L L  N L G ++S    ++ N    +L  +    S    +SN  +L +
Sbjct:   266 ASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTL 325

Query:    99 FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
               LS+N L+G +PR  +  LS  LE   +S  +++G IP E+G++  L  + +  N L+G
Sbjct:   326 LNLSSNLLSGPIPR-ELCKLS-KLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSG 383

Query:   159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSI-LTCFSNLAS 217
             SIP +   L +L+ + L  N L GT+P  + + + L  LDL  N L+G+I +   SNL +
Sbjct:   384 SIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRN 443

Query:   218 LRT-LSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL 274
             L+  L+LS N   GP+PLE+  + +++ +D S N  S  IP  +GS   L++L L  N  
Sbjct:   444 LKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGF 503

Query:   275 KGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLEGEIPKGGSFGN 334
               ++P S+G                GAIP              SFN L G +   GSF  
Sbjct:   504 SSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSK 563

Query:   335 FSAESFEGNKLLCGSPNLHVPPCKTSIHHTSRKNALFLGIVLS-FSTIFMVVVILL---- 389
              + ESF G+ LLCGS    +  CK    + S    + L ++ +    +F   ++      
Sbjct:   564 LTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFG 622

Query:   390 --IVKYQKRENWPPNDANM-PPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI 446
               +  Y K E       N   PK  + R SY ++  AT GFN ++LIG G FG +YK  +
Sbjct:   623 KNLTVYAKEEVEDEEKQNQNDPK--YPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL 680

Query:   447 GDGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH 505
              +  +VAVKV   +    F  SF  EC+I+K   +RNL++II++CS   F  LVL  MP+
Sbjct:   681 RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPN 740

Query:   506 GSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM 562
             GSLE+ LY    S+  LD+ Q +NI  DVA  + YLH    V V+HCDLKPSN+LLDD M
Sbjct:   741 GSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEM 800

Query:   563 VAHLSDFGITKLLIGEDQSMTQTQTLA 589
              A ++DFGI++L+ G +++++   +++
Sbjct:   801 TALVTDFGISRLVQGVEETVSTDDSVS 827

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 435 (158.2 bits), Expect = 1.9e-71, Sum P(2) = 1.9e-71
 Identities = 135/435 (31%), Positives = 202/435 (46%)

Query:    46 PAAIFDVSTLKDLALQDNYLSGSLSSI--ADNYLTSSTPELSFLSS----LSNCKSLVVF 99
             P ++ ++  L  +    N  +GS+S +  + +YL+    E  F       L    +L   
Sbjct:   546 PDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRL 605

Query:   100 LLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGS 159
              L  N   G +PR + G +S  L + D+S+ ++SG IP E+G    LT I L  N L+G 
Sbjct:   606 RLGKNQFTGRIPR-TFGKISE-LSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGV 663

Query:   160 IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
             IP  L +L  L  + L  NK  G++P +IF L  +  L L GN L+GSI     NL +L 
Sbjct:   664 IPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALN 723

Query:   220 TLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY-LFLGYNILKG 276
              L+L  N   GPLP  IG L  L  +  S N  +  IP  IG L+DLQ  L L YN   G
Sbjct:   724 ALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTG 783

Query:   277 SIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLEGEIPKGGSFGNFS 336
              IP ++                 G +P              S+N LEG++ K   F  + 
Sbjct:   784 RIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQ 841

Query:   337 AESFEGNKLLCGSPNLHVPPCKTSIHHT-SRKNALFLGIVLSFSTI-FMVVVILLIVK-- 392
             A++F GN  LCGSP  H     +    + S K  + +  + S + I  MV+VI+L  K  
Sbjct:   842 ADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQN 901

Query:   393 ---YQK----RENWPPNDANM--PPKATWRRFSYL---EVCRATYGFNENNLIGKGGFGT 440
                ++K       +  N ++   P  +     S +   ++  AT+  NE  +IG GG G 
Sbjct:   902 HDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGK 961

Query:   441 IYKSRIGDGMEVAVK 455
             +YK+ + +G  +AVK
Sbjct:   962 VYKAELKNGETIAVK 976

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 7.7e-70, P = 7.7e-70
 Identities = 193/598 (32%), Positives = 303/598 (50%)

Query:    67 GSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFD 126
             G+L  +   YL S+         +SN   L    + +N L G +P          L + D
Sbjct:   500 GNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFD--MKLLSVLD 557

Query:   127 MSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY 186
             +S    SG IP     L +LT + L GNK NGSIP +L+ L  L    + DN L GTIP 
Sbjct:   558 LSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPG 617

Query:   187 DIFRLVK---LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLI 241
             ++   +K   LY L+   N L+G+I      L  ++ + LS N   G +P  +   K + 
Sbjct:   618 ELLASLKNMQLY-LNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676

Query:   242 GIDFSMNNFSSVIPTTIGSLKDLQY-LFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXG 300
              +DFS NN S  IP  +    D+   L L  N   G IP S G+               G
Sbjct:   677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736

Query:   301 AIPXXXXXXXXXXXXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPC--K 358
              IP              + N L+G +P+ G F N +A    GN  LCGS    + PC  K
Sbjct:   737 EIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIK 795

Query:   359 TSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKY-QKRENWPPN--DANMPPKAT---W 412
                 H S++  + L I+ S + + +V++++LI+   +K+E    N  ++++P   +    
Sbjct:   796 QKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKL 855

Query:   413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDI 470
             +RF   E+ +AT  FN  N+IG     T+YK ++ DG  +AVKV +L+     + K F  
Sbjct:   856 KRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYT 915

Query:   471 ECEIMKSIHYRNLVKIIS-SCSNEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIM 528
             E + +  + +RNLVKI+  +  + + K LVL  M +G+LE  ++ S   I  + +++++ 
Sbjct:   916 EAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLC 975

Query:   529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQT 587
             + +AS ++YLH  +  P++HCDLKP+N+LLD   VAH+SDFG  ++L   ED S T + +
Sbjct:   976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTS 1035

Query:   588 L--ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESL 643
                 TIGY+APE+    +V    DV+SFGI++ME+ + KQ+  S     + + T+  L
Sbjct:  1036 AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMT-KQRPTSLNDEDSQDMTLRQL 1092

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 698 (250.8 bits), Expect = 1.5e-68, P = 1.5e-68
 Identities = 195/582 (33%), Positives = 297/582 (51%)

Query:    68 SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
             SL+ I  N+   S P+      + N   L    L  N L G LP  S+G L   L +  +
Sbjct:   366 SLNLIG-NHFFGSIPQ-----DIGNLIGLQRLQLGKNMLTGPLPT-SLGKLLR-LGLLSL 417

Query:   128 SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
                 +SG IP  IGNLT L  +YL  N   G +P +L +   +  + +  NKL GTIP +
Sbjct:   418 YSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKE 477

Query:   188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDF 245
             I ++  L  L + GN LSGS+     +L +L  LSL  N   G LP  +GN   +  +  
Sbjct:   478 IMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFL 537

Query:   246 SMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXX 305
               N+F   IP   G L  ++ + L  N L GSIP+   +               G +P  
Sbjct:   538 QGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSK 596

Query:   306 XXXXXXXXXXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNL-HVPPCKTSIHHT 364
                                       FGN +     G K L   P L   PP +T     
Sbjct:   597 GNFQNSTIVFV---------------FGNKNLCG--GIKDLKLKPCLAQEPPVETKHSSH 639

Query:   365 SRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKAT--WRRFSYLEVCR 422
              +K A+ + I ++   + ++  ++L    ++R+N   N+  +P K      + SY ++  
Sbjct:   640 LKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNL-VPSKLEIFHEKISYGDLRN 698

Query:   423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR 481
             AT GF+ +N++G G FGT++K+ +  +   VAVKV ++Q   A KSF  ECE +K   +R
Sbjct:   699 ATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHR 758

Query:   482 NLVKIISSCSN-----EEFKELVLEHMPHGSLEKCLYSSNC--------ILDIFQRLNIM 528
             NLVK++++C++      EF+ L+ E++P+GS++  L+             L + +RLNI+
Sbjct:   759 NLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIV 818

Query:   529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS--MTQTQ 586
             IDVASVL+YLH +   P+ HCDLKPSNVLL+D + AH+SDFG+ +LL+  D+   + Q  
Sbjct:   819 IDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLS 878

Query:   587 TLA---TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
             +     TIGY APEYG  G+   +GDVYSFG++L+E+ + K+
Sbjct:   879 SAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKR 920

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 517 (187.1 bits), Expect = 1.2e-48, P = 1.2e-48
 Identities = 142/445 (31%), Positives = 212/445 (47%)

Query:    88 SSLSNCKSLVVFL-LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
             +S++N  + +  L L  N ++G +P   IGNL  SL+   +    +SG +P   G L NL
Sbjct:   362 ASIANLSTTLTSLFLGQNLISGTIPH-DIGNLV-SLQELSLETNMLSGELPVSFGKLLNL 419

Query:   147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
               + L  N ++G IP     + +LQ + L  N   G IP  + R   L  L +  N+L+G
Sbjct:   420 QVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNG 479

Query:   207 SILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL 264
             +I      + SL  + LS N   G  P E+G L++L+G+  S N  S  +P  IG    +
Sbjct:   480 TIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSM 539

Query:   265 QYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXXXXXXSFNKLEG 324
             ++LF+  N   G+IPD +                 G IP              S NK EG
Sbjct:   540 EFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEG 598

Query:   325 EIPKGGSFGNFSAESFEGNKLLCGSPN-LHVPPCKTSIHHTSRK-----NALFLGIVLSF 378
              +P  G F N +A S  GN  +CG    + + PC        RK       +  GI +  
Sbjct:   599 RVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGI 658

Query:   379 STIFMVVVILLIVKYQKRENWP-PNDANMPPKATWRRF----SYLEVCRATYGFNENNLI 433
             +++ +++++  +  + KR+     +D N     T   F    SY E+  AT  F+  NLI
Sbjct:   659 ASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLI 718

Query:   434 GKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
             G G FG ++K  +G +   VAVKV +L    A KSF  ECE  K I +RNLVK+I+ CS+
Sbjct:   719 GSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSS 778

Query:   493 -----EEFKELVLEHMPHGSLEKCL 512
                   +F+ LV E MP GSL+  L
Sbjct:   779 LDSEGNDFRALVYEFMPKGSLDMWL 803

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 656 (236.0 bits), Expect = 7.6e-64, P = 7.6e-64
 Identities = 189/568 (33%), Positives = 274/568 (48%)

Query:    74 DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILP-RMSIGNLSHSLEIFDMSKCNV 132
             +N  T S P+      L     LV+  LS+N L G LP  M  GN    + +  +    +
Sbjct:   344 ENNFTGSIPQ-----KLGENGRLVILDLSSNKLTGTLPPNMCSGN--RLMTLITLGNF-L 395

Query:   133 SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV 192
              G IP+ +G   +LT I +G N LNGSIP  L  L KL  V L+DN L G +P     + 
Sbjct:   396 FGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVS 455

Query:   193 -KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNN 249
               L ++ L  N+LSGS+     NL+ ++ L L  N   G +P EIG L+ L  +DFS N 
Sbjct:   456 GDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNL 515

Query:   250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXX 309
             FS  I   I   K L ++ L  N L G IP+ +                 G+IP      
Sbjct:   516 FSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASM 575

Query:   310 XXXXXXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIH--HTSRK 367
                     S+N L G +P  G F  F+  SF GN  LCG P  ++ PC    H  H    
Sbjct:   576 QSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCG-P--YLGPCGKGTHQSHVKPL 632

Query:   368 NALF-LGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLEVCRATY- 425
             +A   L +VL      MV  I+ I+K +   N   ++A       ++R  +   C     
Sbjct:   633 SATTKLLLVLGLLFCSMVFAIVAIIKARSLRN--ASEAKAWRLTAFQRLDF--TCDDVLD 688

Query:   426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVK-VFHLQCGRAFK-SFDIECEIMKSIHYRNL 483
                E+N+IGKGG G +YK  +  G  VAVK +  +  G +    F+ E + +  I +R++
Sbjct:   689 SLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHI 748

Query:   484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNF 542
             V+++  CSN E   LV E+MP+GSL + L+      L    R  I ++ A  L YLH + 
Sbjct:   749 VRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDC 808

Query:   543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
                ++H D+K +N+LLD    AH++DFG+ K L     S   +    + GYIAPEY    
Sbjct:   809 SPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTL 868

Query:   603 RVFANGDVYSFGIMLMEIHSAKQQCVSF 630
             +V    DVYSFG++L+E+ + K+    F
Sbjct:   869 KVDEKSDVYSFGVVLLELITGKKPVGEF 896

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	652
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-34
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-28
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-15
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	7e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-08
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-05
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-05
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-04
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.001
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.001
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.002
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.002
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	0.004
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  204 bits (521), Expect = 6e-56
 Identities = 185/668 (27%), Positives = 296/668 (44%), Gaps = 75/668 (11%)

Query: 4   ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQD 62
            S+  L+L  +++  P  IPS + N  NL+ L L QN L G +P +IF +  L  L L D
Sbjct: 236 TSLNHLDLVYNNLTGP--IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD 293

Query: 63  NYLSGSLSSIA------------DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGIL 110
           N LSG +  +              N  T   P      +L++   L V  L +N  +G +
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV-----ALTSLPRLQVLQLWSNKFSGEI 348

Query: 111 PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL 170
           P+ ++G   ++L + D+S  N++G IPE + +  NL  + L  N L G IP +L   + L
Sbjct: 349 PK-NLGK-HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406

Query: 171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--- 227
           + V L+DN   G +P +  +L  +Y LD+  N L G I +   ++ SL+ LSL+ N    
Sbjct: 407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466

Query: 228 ----------------------GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ 265
                                 G +P ++G+L  L+ +  S N  S  IP  + S K L 
Sbjct: 467 GLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526

Query: 266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGE 325
            L L +N L G IP S  ++  L  L+ S N LSG IP  L  +  L  +N+S N L G 
Sbjct: 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586

Query: 326 IPKGGSFGNFSAESFEGNKLLCGSPNLH-VPPCKTSIHHTSRKNALFLGIVLSFSTIFMV 384
           +P  G+F   +A +  GN  LCG      +PPCK      S     +  I  +     ++
Sbjct: 587 LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSW----WFYITCTLGAFLVL 642

Query: 385 VVILLIVKYQKRENWPPNDANMPPKATWR------RFS-YLEVCRATYGFNENNLIGKGG 437
            ++     + +  N            TW       + S  + +        E N+I +G 
Sbjct: 643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGK 702

Query: 438 FGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK 496
            G  YK + I +GM+  VK    +          E   M  + + N+VK+I  C +E+  
Sbjct: 703 KGASYKGKSIKNGMQFVVK----EINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758

Query: 497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNV 556
            L+ E++   +L + L +    L   +R  I I +A  L +LH      V+  +L P  +
Sbjct: 759 YLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814

Query: 557 LLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
           ++D     HL    +  LL       T T+   +  Y+APE      +    D+Y FG++
Sbjct: 815 IIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLI 867

Query: 617 LMEIHSAK 624
           L+E+ + K
Sbjct: 868 LIELLTGK 875

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  149 bits (378), Expect = 2e-41
 Identities = 72/224 (32%), Positives = 112/224 (50%), Gaps = 17/224 (7%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           +G+GGFGT+Y +R    G +VA+K+   +      +    E EI+K +++ N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            +E    LV+E+   GSL+  L  +   L   + L I++ +   LEYLH N    +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 551 LKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF-ANG 608
           LKP N+LLD D     L+DFG++KLL            + T  Y+APE       +    
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 609 DVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI 652
           D++S G++L E+   K         L  +   +  E R +AKEI
Sbjct: 176 DIWSLGVILYELPELKD--------LIRKMLQKDPEKRPSAKEI 211

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  160 bits (407), Expect = 3e-41
 Identities = 110/294 (37%), Positives = 154/294 (52%), Gaps = 42/294 (14%)

Query: 36  LGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKS 95
           L   N+ G + +AIF +  ++ + L +N LSG    I D+  T+S+             S
Sbjct: 76  LSGKNISGKISSAIFRLPYIQTINLSNNQLSGP---IPDDIFTTSS-------------S 119

Query: 96  LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK 155
           L    LSNN   G +PR SI NL    E  D+S   +SG IP +IG+ ++L  + LGGN 
Sbjct: 120 LRYLNLSNNNFTGSIPRGSIPNL----ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175

Query: 156 LNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNL 215
           L G IP +L  L  L+++ L  N+L G IP ++ ++  L  + LG N LSG I       
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI------- 228

Query: 216 ASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILK 275
                          P EIG L  L  +D   NN +  IP+++G+LK+LQYLFL  N L 
Sbjct: 229 ---------------PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273

Query: 276 GSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
           G IP S+  L  L SL+ S+N+LSG IP L+ +L  LE L+L  N   G+IP  
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA 327

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  153 bits (389), Expect = 7e-39
 Identities = 110/302 (36%), Positives = 160/302 (52%), Gaps = 24/302 (7%)

Query: 31  LEELLLGQNNLVGVVPAAIFDVS-TLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS 89
           ++ + L  N L G +P  IF  S +L+ L L +N  +GS+                   S
Sbjct: 95  IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR----------------GS 138

Query: 90  LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAI 149
           + N ++L    LSNN L+G +P   IG+ S SL++ D+    + G IP  + NLT+L  +
Sbjct: 139 IPNLETLD---LSNNMLSGEIPN-DIGSFS-SLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193

Query: 150 YLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSIL 209
            L  N+L G IP  L +++ L+++ L  N L G IPY+I  L  L  LDL  N L+G I 
Sbjct: 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Query: 210 TCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYL 267
           +   NL +L+ L L  N   GP+P  I +L+ LI +D S N+ S  IP  +  L++L+ L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313

Query: 268 FLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
            L  N   G IP ++  L  L+ L   +N  SG IP  L K + L  L+LS N L GEIP
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Query: 328 KG 329
           +G
Sbjct: 374 EG 375

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  131 bits (333), Expect = 1e-34
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 26/199 (13%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVKII 487
           +G G FGT+YK    G G  VAVK+   +        D     E  I++ + + N+V++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            +  +++   LV+E+   G L     S    L   +   I + +   LEYLH N    +I
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---II 120

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-------YGR 600
           H DLKP N+LLD+  V  ++DFG+ K L+    S+T T    T  Y+APE       YG 
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGP 178

Query: 601 EGRVFANGDVYSFGIMLME 619
           +       DV+S G++L E
Sbjct: 179 K------VDVWSLGVILYE 191

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (327), Expect = 7e-34
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 21/198 (10%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIIS 488
             +G+G FG +Y +R    G  VA+KV   +  +   +    E +I+K + + N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +E+   LV+E+   G L   L      L   +    +  + S LEYLH      ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREG 602
            DLKP N+LLD+     L+DFG+ + L   ++  T   T     Y+APE      YG+  
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKA- 176

Query: 603 RVFANGDVYSFGIMLMEI 620
                 D++S G++L E+
Sbjct: 177 -----VDIWSLGVILYEL 189

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  119 bits (302), Expect = 2e-30
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +YK        G   +VAVK           + F  E  IMK + + N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           +  C+  E   +V E+MP G L   L      L +   L + + +A  +EYL        
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK---NF 123

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DL   N L+ + +V  +SDFG+++ +  +D    +      I ++APE  ++G+  +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 607 NGDVYSFGIMLMEI 620
             DV+SFG++L EI
Sbjct: 184 KSDVWSFGVLLWEI 197

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  118 bits (299), Expect = 5e-30
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 10/197 (5%)

Query: 430 NNLIGKGGFGTIYKSRIGD-----GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNL 483
              +G+G FG +YK ++        +EVAVK           + F  E  IM+ + + N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++  C+ EE   +V+E+M  G L   L  +   L +   L+  + +A  +EYL     
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK-- 121

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              IH DL   N L+ + +V  +SDFG+++  + +D    +      I ++APE  +EG+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 604 VFANGDVYSFGIMLMEI 620
             +  DV+SFG++L EI
Sbjct: 180 FTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  112 bits (283), Expect = 6e-28
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 430 NNLIGKGGFGTIYKSRIGDG-----MEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNL 483
              +G+G FG +YK  +        +EVAVK        +  + F  E  IM+ + + N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCL-YSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           VK++  C+ EE   +V+E+MP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
               IH DL   N L+ + +V  +SDFG+++  + +D           I ++APE  +EG
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 603 RVFANG-DVYSFGIMLMEI 620
           + F +  DV+SFG++L EI
Sbjct: 180 K-FTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (300), Expect = 7e-28
 Identities = 80/215 (37%), Positives = 109/215 (50%), Gaps = 6/215 (2%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLREL-QKLQYVGL 175
           N S  + I D+S  N+SG I   I  L  +  I L  N+L+G IP  +      L+Y+ L
Sbjct: 67  NSSRVVSI-DLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLE 233
            +N   G+IP        L  LDL  N LSG I     + +SL+ L L  N   G +P  
Sbjct: 126 SNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNF 293
           + NL  L  +  + N     IP  +G +K L++++LGYN L G IP  +G L SL  L+ 
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243

Query: 294 SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK 328
             NNL+G IP  L  L  L++L L  NKL G IP 
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Length = 968

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 431 NLIGKGGFGTIYK----SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVK 485
             +G+G FG +YK     + G   EVAVK          +  F  E  +MK + + N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNC--------ILDIFQRLNIMIDVASVLEY 537
           ++  C+ EE   LVLE+M  G L   L  S           L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           L        +H DL   N L+ + +V  +SDFG+++ +  +D    +T     I ++APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 598 YGREGRVFANGDVYSFGIMLMEI 620
             ++G   +  DV+SFG++L EI
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEI 200

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  110 bits (277), Expect = 5e-25
 Identities = 72/198 (36%), Positives = 102/198 (51%), Gaps = 7/198 (3%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV-KLYKLDLG 200
           N + + +I L G  ++G I   +  L  +Q + L +N+L G IP DIF     L  L+L 
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 201 GNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI 258
            N  +GSI      + +L TL LS N   G +P +IG+   L  +D   N     IP ++
Sbjct: 127 NNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 259 GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLS 318
            +L  L++L L  N L G IP  +G + SLK +    NNLSG IP  +  L+ L HL+L 
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244

Query: 319 FNKLEGEIPKGGSFGNFS 336
           +N L G IP   S GN  
Sbjct: 245 YNNLTGPIPS--SLGNLK 260

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  103 bits (260), Expect = 8e-25
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 431 NLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRA--FKSFDIECEIMKSIHYRNLVKII 487
            L+G+G FG++Y +   D G  +AVK   L        ++ + E  I+ S+ + N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 488 SSCSNEEFKEL--VLEHMPHGSLEKCLYSSNCILDIFQRLNI------MIDVASVLEYLH 539
            S  +EE   L   LE++  GSL         +L  F +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEY 598
            N    ++H D+K +N+L+D   V  L+DFG  K  +G+ ++   T ++  T  ++APE 
Sbjct: 119 SN---GIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 599 GREGRVFANGDVYSFGIMLMEIHSAKQ 625
            R        D++S G  ++E+ + K 
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 67/195 (34%), Positives = 99/195 (50%), Gaps = 17/195 (8%)

Query: 432 LIGKGGFGTIYKSRIGD--GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIIS 488
            IGKG FG +     GD  G +VAVK   L+    A ++F  E  +M ++ + NLV+++ 
Sbjct: 13  TIGKGEFGDVML---GDYRGQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
                    +V E+M  GSL   L S    ++ + Q+L   +DV   +EYL     V   
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV--- 124

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           H DL   NVL+ + +VA +SDFG+ K     + S  Q      + + APE  RE +    
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTK 179

Query: 608 GDVYSFGIMLMEIHS 622
            DV+SFGI+L EI+S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 64/192 (33%), Positives = 95/192 (49%), Gaps = 4/192 (2%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVKIISSC 490
            IGKG FG +YK  +    EVAVK          K  F  E EI+K   + N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             ++   +V+E +P GSL   L      L + + L + +D A+ +EYL        IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRD 118

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L   N L+ +  V  +SDFG+++   G   +++       I + APE    GR  +  DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 611 YSFGIMLMEIHS 622
           +S+GI+L E  S
Sbjct: 179 WSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 54/268 (20%)

Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG ++           D   VAVK         A K F+ E E++ +  + N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------------SNCI-LDIFQRLNIMIDVA 532
               C+  +   +V E+M HG L K L S            S    L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 533 SVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           S + YL   HF      +H DL   N L+   +V  + DFG+++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ----------------------- 626
            I ++ PE     +     DV+SFG++L EI +  +Q                       
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRP 246

Query: 627 --CVSFVFNLAMECTIESLELRINAKEI 652
             C S V+++ + C     + RIN K+I
Sbjct: 247 RTCPSEVYDIMLGCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.3 bits (238), Expect = 2e-21
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)

Query: 426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYR 481
            +     +G+G FG +Y +R  D   VA+KV   +     +  + F  E +I+ S+ H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEK--CLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           N+VK+     +E    LV+E++  GSLE           L   + L I+  + S LEYLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 540 FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLA----TIGYI 594
                 +IH D+KP N+LLD D  V  L DFG+ KLL     + +     +    T GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 595 APEY---GREGRVFANGDVYSFGIMLMEIHSAK 624
           APE           ++ D++S GI L E+ +  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 17/194 (8%)

Query: 433 IGKGGFGTIYKSRIGD--GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IGKG FG +    +GD  G +VAVK   ++     ++F  E  +M  + + NLV+++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 491 SNEEFK-ELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             E+    +V E+M  GSL   L S    +L     L   +DV   +EYL  N  V   H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV---H 125

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   NVL+ +  VA +SDFG+TK     + S TQ      + + APE  RE +     
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L EI+S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 91.9 bits (229), Expect = 8e-21
 Identities = 62/188 (32%), Positives = 92/188 (48%), Gaps = 7/188 (3%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IGKGGFG +YK+R    G EVA+KV  L+     +    E +I+K   + N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            ++   +V+E    GSL+  L S+N  L   Q   +  ++   LEYLH N    +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDI 124

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K +N+LL       L DFG++  L       T    + T  ++APE           D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIW 181

Query: 612 SFGIMLME 619
           S GI  +E
Sbjct: 182 SLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 16/194 (8%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++        +VAVK   L+ G  + ++F  E +IMK + +  LV++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID----VASVLEYLH-FNFLVPV 546
            EE   +V E+M  GSL   L S         RL  ++D    +A  + YL   N+    
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNY---- 124

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+L+ + +V  ++DFG+ + LI +D+   +      I + APE    GR   
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 607 NGDVYSFGIMLMEI 620
             DV+SFGI+L EI
Sbjct: 184 KSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 12/201 (5%)

Query: 431 NLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
             +G+G FG +   R        G +VAVK  +       +S F+ E EI++++ + N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 485 KIISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           K    C     +   L++E++P GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGRE 601
               IH DL   N+L++   +  +SDFG+ K+L   +D    +    + I + APE  R 
Sbjct: 130 Y---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 602 GRVFANGDVYSFGIMLMEIHS 622
            +  +  DV+SFG+ L E+ +
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 62/191 (32%), Positives = 97/191 (50%), Gaps = 10/191 (5%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +++    +   VAVK   L+ G    K F  E +IMK + +  L+++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHC 549
            EE   +V E M +GSL + L       L + Q +++   VAS + YL   N+    IH 
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY----IHR 127

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   NVL+ +  +  ++DFG+ + +I ED    +      I + APE     R     D
Sbjct: 128 DLAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 610 VYSFGIMLMEI 620
           V+SFGI+L EI
Sbjct: 187 VWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.9 bits (215), Expect = 5e-19
 Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 13/195 (6%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG+G FG + +     G +VAVK   ++C    ++F  E  +M  +H++NLV+++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 493 EEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
                +V+E M  G+L   L +    ++ + Q L   +DVA  +EYL    LV   H DL
Sbjct: 71  NGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV---HRDL 126

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
              N+L+ +  VA +SDFG+ ++      SM    +   + + APE  +  +  +  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181

Query: 612 SFGIMLMEIHSAKQQ 626
           S+G++L E+ S  + 
Sbjct: 182 SYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 9/194 (4%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVKIISSC 490
           L+GKG FG ++K  + D   VAVK       +  K  F  E  I+K   + N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           +  +   +V+E +P G     L      L   Q +   +D A+ + YL        IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGREGRVFANG 608
           L   N L+ +  V  +SDFG+++    ED  +  +  L    I + APE    GR  +  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 609 DVYSFGIMLMEIHS 622
           DV+S+GI+L E  S
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 29/200 (14%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIISSC 490
           +G+G  G +YK R    G   A+K  H+     F K    E + ++S     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 491 SNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               +KE    +VLE+M  GSL   L     I +      I   +   L+YLH      +
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHTK--RHI 121

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPE------YG 599
           IH D+KPSN+L++      ++DFGI+K+L   + ++ Q  T + T+ Y++PE      Y 
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESYS 178

Query: 600 REGRVFANGDVYSFGIMLME 619
                    D++S G+ L+E
Sbjct: 179 Y------AADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 31/232 (13%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +++    + + VA+K+         + F  E + +K + +++L+ + + CS 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E   ++ E M  GSL   L S    +L +   +++   VA  + YL        IH DL
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDL 130

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
              N+L+ + +V  ++DFG+ +L+  ++     +       + APE    G      DV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188

Query: 612 SFGIMLMEI-------------HSAKQQ------------CVSFVFNLAMEC 638
           SFGI+L E+             H    Q            C   ++ + +EC
Sbjct: 189 SFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 41/210 (19%)

Query: 431 NLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIHYRNL 483
             IGKG FG +Y   R  DG    +K   L          A      E +I+K +++ N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 484 VKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIF---QRLNIMIDVASVL 535
           +K   S     F+E     +V+E+   G L + +         F   Q L+  + +   L
Sbjct: 62  IKYYES-----FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +YLH      ++H D+KP N+ L    +  L DFGI+K+L      + +T  + T  Y++
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLS 171

Query: 596 PEYGREGRVFAN------GDVYSFGIMLME 619
           PE      +  N       D++S G +L E
Sbjct: 172 PE------LCQNKPYNYKSDIWSLGCVLYE 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.8 bits (207), Expect = 6e-18
 Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 5/190 (2%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E ++M  + +  LV++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
                LV E M HG L   L +          L + +DV   + YL  +    VIH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLA 127

Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     +  +  DV+S
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 187 FGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 83.8 bits (208), Expect = 9e-18
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 23/197 (11%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS-- 489
           IG+G  G +YK+     G EVA+K   L+     +    E  IMK   + N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
             +E +  +V+E+M  GSL   +  +   ++  Q   +  +V   LEYLH      VIH 
Sbjct: 86  VGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHR 140

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGR 603
           D+K  N+LL       L+DFG    L  +++S   +  + T  ++APE      YG   +
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSV-VGTPYWMAPEVIKRKDYGP--K 196

Query: 604 VFANGDVYSFGIMLMEI 620
           V    D++S GIM +E+
Sbjct: 197 V----DIWSLGIMCIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 54/212 (25%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +YK  +          +V +  L+     +  + F  E E+M  + + N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMID 530
           ++  C+ E+   ++ E++ HG L + L  ++                 LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A+ +EYL  +  V   H DL   N L+ + +   +SDFG+++ +   D    Q+++L  
Sbjct: 133 IAAGMEYLSSHHFV---HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++ PE    G+     D++SFG++L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 8/190 (4%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKIISSC 490
           +G G  G + K      G  +AVK   L+   A  K    E +I+   +   +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            N     + +E+M  GSL+K L      +       I + V   L YLH      +IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           +KPSN+L++      L DFG++  L+    S+ +T    T  Y+APE  +        D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 611 YSFGIMLMEI 620
           +S G+ L+E+
Sbjct: 183 WSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 34/248 (13%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++       S   D M VAVK        A K F  E E++ ++ + ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYS---------------SNCILDIFQRLNIMIDV 531
              C + +   +V E+M HG L K L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 532 ASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           AS + YL   HF      +H DL   N L+   ++  + DFG+++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLEL-- 645
             I ++ PE     +     DV+SFG++L EI +  KQ          +EC  +   L  
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246

Query: 646 -RINAKEI 652
            R+  KE+
Sbjct: 247 PRVCPKEV 254

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 61/194 (31%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIEC---E--IMKSIHYRNLVKI 486
           +GKG FG +   R    G   A+KV   +  +  K  ++E    E  I+  I++  +VK+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKK--KIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             +   EE   LVLE+ P G L   L       +   R     ++   LEYLH      +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLHSLG---I 114

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVF 605
           I+ DLKP N+LLD      L+DFG+ K L  E     +T T   T  Y+APE        
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYG 171

Query: 606 ANGDVYSFGIMLME 619
              D +S G++L E
Sbjct: 172 KAVDWWSLGVLLYE 185

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 14/197 (7%)

Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +          G G  VAVK    +CG+   S +  E  I+K++++ N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 487 ISSCSN--EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              CS    +  +L++E++P GSL   L      L++ Q L     +   + YLH     
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHY- 128

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH DL   NVLLD+  +  + DFG+ K +  G +    +    + + + A E  +E +
Sbjct: 129 --IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG+ L E+
Sbjct: 187 FSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            EE   +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 126

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 185 DVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 84.1 bits (208), Expect = 6e-17
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 9/162 (5%)

Query: 239 VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNL 298
            + G+          IP  I  L+ LQ + L  N ++G+IP S+G + SL+ L+ S N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 299 SGAIPLLLEKLSYLEHLNLSFNKLEGEIPK--GGSFGNFSAESFEGNKLLCGSPNLHVPP 356
           +G+IP  L +L+ L  LNL+ N L G +P   GG   + ++ +F  N  LCG P L    
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--A 536

Query: 357 CKTSIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKREN 398
           C   +   ++     +GI    S  F+ +VI  +  +++R+N
Sbjct: 537 CGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573

Length = 623

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 30/237 (12%)

Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D M VAVK        A + F  E E++  + ++++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNC---ILD-----------IFQRLNIMIDVA 532
              C+      +V E+M HG L + L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 533 SVLEY---LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           S + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLEL 645
            I ++ PE     +     D++SFG++L EI +  KQ         A+EC  +  EL
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 10/194 (5%)

Query: 433 IGKGGFGTIYKSR-IGDG----MEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKI 486
           +G G FGT+YK   I +G    + VA+KV   +    A K    E  +M S+ + ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           +  C + +  +L+ + MP G L   + +    +     LN  + +A  + YL    LV  
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLV-- 131

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
            H DL   NVL+       ++DFG+ KLL  +++          I ++A E         
Sbjct: 132 -HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 607 NGDVYSFGIMLMEI 620
             DV+S+G+ + E+
Sbjct: 191 KSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 5/190 (2%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG ++  +    ++VA+K+   +   +   F  E ++M  + + NLV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    +V E+M +G L   L      L     L++  DV   +EYL  N     IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLA 127

Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+ + ++ +DQ  +   T   + +  PE     R  +  DV+S
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186

Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 187 FGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 18/211 (8%)

Query: 425 YGFNENN---LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           Y ++EN    ++GKG +G +Y +R +   + +A+K    +  R  +    E  +   + +
Sbjct: 5   YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI----DVASVLE 536
           RN+V+ + S S   F ++ +E +P GSL   L S    L   +    +I     +   L+
Sbjct: 65  RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLK 122

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           YLH N    ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ Y+A
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 596 PEYGREG-RVF-ANGDVYSFGIMLMEIHSAK 624
           PE   +G R + A  D++S G  ++E+ + K
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 32/220 (14%)

Query: 431 NLIGKGGFGTIY----KSRIGDGME---VAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           N +G G FG +Y       +G G     VAVK   L+ G   +  K F  E  +M + ++
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT--LRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC------ILDIFQRLNIMIDVA-- 532
            N+VK++  C   E + +++E M  G L   L  +        +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 533 -SVLEYLHFNFLVPVIHCDLKPSNVLL-----DDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
              LE +HF      IH DL   N L+     D   V  + DFG+ + +   D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
            L  + ++APE   +G+     DV+SFG+++ EI +  QQ
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 433 IGKGGFGTIYKSRIG-DGME----VAVKVFH-LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+  FG IYK  +   GM+    VA+K    +   + +  F  E  +M  +H+ N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLY----------SSN------CILDIFQRLNIMID 530
           +   + E+   ++ E++  G L + L           SS+        LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A+ +EYL  +F    +H DL   N+L+ + +   +SD G+++ +   D    Q ++L  
Sbjct: 133 IAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           I ++ PE    G+  ++ D++SFG++L EI S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 7/192 (3%)

Query: 431 NLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           + +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           C+ E    ++ E M +G+L   L   N   ++    L +   ++S +EYL        IH
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IH 127

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 609 DVYSFGIMLMEI 620
           DV++FG++L EI
Sbjct: 187 DVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 9/194 (4%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIISSC 490
           IG+G FG ++  R+  D   VAVK          K+ F  E  I+K   + N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           + ++   +V+E +  G     L +    L + + + ++ + A+ +EYL        IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI--GYIAPEYGREGRVFANG 608
           L   N L+ +  V  +SDFG+++    ED     T  +  I   + APE    GR  +  
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E  S
Sbjct: 178 DVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 13/192 (6%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++        +VAVK   L+ G  + +SF  E +IMK + +  LV++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +V E+M  GSL   L       L +   +++   VA+ + Y+   N+    IH 
Sbjct: 72  EEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IHR 126

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ D +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 185 DVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 25/207 (12%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG+    +Y  + G  +EVAVK     H+  G+  K F  E  +M  + +  +V+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYL---HF 540
           +I  C  E    LV+E  P G L K L       + D+     +   VA  + YL   HF
Sbjct: 61  LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYG 599
                 +H DL   NVLL +   A +SDFG+++ L  G D     T     + + APE  
Sbjct: 117 ------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 600 REGRVFANGDVYSFGIMLMEIHSAKQQ 626
             G+  +  DV+S+G+ L E  S   +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/240 (24%), Positives = 112/240 (46%), Gaps = 38/240 (15%)

Query: 432 LIGKGGFGTIYKS--RIGDGMEVAVKVFHLQCGRAFKS---FDIECEIMKSIHYRNLVKI 486
           +IG G FG +++   ++    EVAV +  L+ G   K    F  E  IM    + N++++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVP 545
               +  +   ++ E+M +G+L+K L   +     +Q + ++  +A+ ++YL   N+   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY--- 128

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG--YIAPEYGREGR 603
            +H DL   N+L++  +   +SDFG++++L  +D   T T +   I   + APE     +
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 604 VFANGDVYSFGIMLMEIHS-------------------------AKQQCVSFVFNLAMEC 638
             +  DV+SFGI++ E+ S                         A   C S V+ L ++C
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQC 246

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 431 NLIGKGGFGTIYKSRI---GDGMEVAVKVF-HLQCGRAFKSFDIECEIM-KSIHYRNLVK 485
           ++IG+G FG + ++ I   G  M  A+K+          + F  E E++ K  H+ N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMID 530
           ++ +C N  +  + +E+ P+G+L   L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA+ ++YL        IH DL   NVL+ + + + ++DFG+++   GE+  + +T     
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++A E           DV+SFG++L EI S
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 13/211 (6%)

Query: 432 LIGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
            +GKG FG++   R   + D  G  VAVK          + F+ E EI+KS+ + N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 487 ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C +   +   LV+E++P+GSL   L      LD  + L     +   +EYL      
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK--- 127

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREGR 603
             +H DL   N+L++      + DFG+TK+L   ++    +    + I + APE   E +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187

Query: 604 VFANGDVYSFGIMLMEI--HSAKQQCVSFVF 632
                DV+SFG++L E+  +S K       F
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)

Query: 431 NLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKII 487
           +LIG+G FG +YK   +  G  VA+K   L+     A KS   E +++K++ + N+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 488 SSCSNEEFKELVLEHMPHGSLEK------CLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
            S    +   ++LE+  +GSL +          S   + ++Q       V   L YLH  
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------VLQGLAYLHEQ 118

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
               VIH D+K +N+L     V  L+DFG+ TKL    D S      + T  ++APE   
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWMAPEVIE 172

Query: 601 EGRVFANGDVYSFGIMLME 619
                   D++S G  ++E
Sbjct: 173 MSGASTASDIWSLGCTVIE 191

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 11/191 (5%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++        +VA+K   L+ G    ++F  E +IMK + +  LV + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS-VLEYLHFNFLVPVIHCD 550
            EE   +V E M  GSL   L   +     + +L  ++D+A+ + + + +   +  IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANGD 609
           L+ +N+L+ D +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     D
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 610 VYSFGIMLMEI 620
           V+SFGI+L E+
Sbjct: 186 VWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 26/212 (12%)

Query: 431 NLIGKGGFGTIYKSRI-GDG--MEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLVK 485
           ++IG+G FG + K+RI  DG  M+ A+K       +   + F  E E++  + H+ N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMID 530
           ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA  ++YL        IH DL   N+L+ +  VA ++DFG+++   G++  + +T     
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++A E         N DV+S+G++L EI S
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 10/195 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IG G    +Y +  + +  +VA+K   L +C  +      E + M   ++ N+VK  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +   LV+ ++  GSL   + SS     LD      ++ +V   LEYLH N     IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLI--GEDQSMTQTQTLATIGYIAPEYGREGRVF- 605
            D+K  N+LL +     ++DFG++  L   G+     +   + T  ++APE   +   + 
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 606 ANGDVYSFGIMLMEI 620
              D++SFGI  +E+
Sbjct: 186 FKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 33/212 (15%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIM-KSIHYRNLVKI 486
           +IG+G F T+  ++      E A+K+     L   +  K   IE E++ +   +  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 487 ISSCSNEEFKELVLEHMPHGSLEK--CLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
             +  +EE    VLE+ P+G L +    Y S   LD         ++   LEYLH     
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG------------ 592
            +IH DLKP N+LLD  M   ++DFG  K+L   + S    +  AT              
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 593 -------YIAPEYGREGRVFANGDVYSFGIML 617
                  Y++PE   E     + D+++ G ++
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 433 IGKGGFGTIYK---SRIGDG---MEVAVK-VFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+     +  G     VA+K V      R    F  E  +MK  +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCILDIFQRLNIM---IDVASVLE 536
           ++   S  +   +V+E M  G L+  L S      +N  L        +    ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL     V   H DL   N ++ + +   + DFG+T+ +   D      + L  + ++AP
Sbjct: 134 YLAAKKFV---HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L E+ +  +Q
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQ 220

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 17/197 (8%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MKSIHYRNLVK 485
           LIG+G +G +Y+ + +  G  VA+K+ +L         DI+ E+     ++     N+ K
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
              S        +++E+   GS+ + L  +  I + +  + I+ +V   L+Y+H    V 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVG 121

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY-IAPEYGREGRV 604
           VIH D+K +N+L+ +T    L DFG+  LL   +Q+ ++  T     Y +APE   EG+ 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 605 F-ANGDVYSFGIMLMEI 620
           +    D++S GI + E+
Sbjct: 179 YDTKADIWSLGITIYEM 195

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 426 GFNENNLIGKGGFGTIYKSRIGD-----GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
            F    +IGKG FG +   +  D      M+   K   ++ G      + E  I++ +++
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVL 535
             LV +  S  +EE   LV++ +  G L     +K  +S   +     +   + ++   L
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----KF-WICEIVLAL 113

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           EYLH      +IH D+KP N+LLD+    H++DF I   +     ++T T T  T GY+A
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGTPGYMA 167

Query: 596 PE-YGREGRVFANGDVYSFGIMLME 619
           PE   R+G   A  D +S G+   E
Sbjct: 168 PEVLCRQGYSVAV-DWWSLGVTAYE 191

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 73.3 bits (181), Expect = 3e-14
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 27/202 (13%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVKII 487
           IG+G +G +YK+R    G  VA+K   ++  +  + F I    E ++++ + + N+V++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 488 SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
              +++      +V E+M H  L   L S        Q    M  +   L+YLH N    
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---G 120

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-------Y 598
           ++H D+K SN+L+++  V  L+DFG+ +       S   T  + T+ Y  PE       Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRY 179

Query: 599 GREGRVFANGDVYSFGIMLMEI 620
           G E  V    D++S G +L E+
Sbjct: 180 GPE--V----DMWSVGCILAEL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 55/190 (28%), Positives = 99/190 (52%), Gaps = 8/190 (4%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++     +  +VAVK   L+ G  + ++F  E  +MK++ +  LV++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV-ASVLEYLHFNFLVPVIHCD 550
            EE   ++ E+M  GSL   L S      +  +L   ID  A + E + +      IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRD 128

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L+ +NVL+ ++++  ++DFG+ + +I +++   +      I + APE    G      DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 611 YSFGIMLMEI 620
           +SFGI+L EI
Sbjct: 188 WSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 10/197 (5%)

Query: 432 LIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVK 485
           L+G G FGT++K   I +G    + VA+K    + GR  F+        M S+ +  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++  C      +LV +  P GSL   +      LD  + LN  + +A  + YL  + +V 
Sbjct: 74  LLGICPGASL-QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV- 131

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
             H +L   N+LL    +  ++DFG+  LL  +D+    ++    I ++A E    GR  
Sbjct: 132 --HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 606 ANGDVYSFGIMLMEIHS 622
              DV+S+G+ + E+ S
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIHYRNLV 484
            ++GKG +GT+Y      G  +AVK   L         + ++    E +++KS+ + N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDI-FQRL--NIMIDVASVLEYLHFN 541
           + + +C ++    + +E +P GS+   L     + +  F +    I+  VA    YLH N
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNN 121

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG----YIAPE 597
               V+H D+K +NV+L    +  L DFG  + L       T +  L ++     ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 598 YGREGRVFANGDVYSFGIMLMEIHSAK 624
              E       D++S G  + E+ + K
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 28/231 (12%)

Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D + VAVK        A K F  E E++ ++ + ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSN------------CILDIFQRLNIMIDVASV 534
              C   +   +V E+M HG L K L +                L   Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 535 LEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           + YL   HF      +H DL   N L+ + ++  + DFG+++ +   D       T+  I
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIE 641
            ++ PE     +     DV+S G++L EI +  KQ       N  +EC  +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 46/194 (23%), Positives = 90/194 (46%), Gaps = 5/194 (2%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M  + +  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    +V E+M +G L   L          Q L +  DV   + YL        IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLA 127

Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+DD     +SDFG+++ ++ +D+  +   +   + +  PE     +  +  DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 613 FGIMLMEIHSAKQQ 626
           FG+++ E++S  + 
Sbjct: 187 FGVLMWEVYSLGKM 200

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHL-QCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IGKG FGT+ K  R  DG  +  K           K   + E  I++ + + N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 490 CSNEEFKEL--VLEHMPHGSLEKCLYSSNCILDIFQRL------NIMIDVASVLEYLHFN 541
             +   + L  V+E+   G L + +    C  +  + +       I+  +   L   H N
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEEFIWRILTQLLLALYECH-N 123

Query: 542 FLVP---VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
              P   V+H DLKP+N+ LD      L DFG+ K+L G D S  +T  + T  Y++PE 
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPEQ 181

Query: 599 GREGRVFANGDVYSFGIMLMEI 620
                     D++S G ++ E+
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 432 LIGKGGFGTIYKSRI----GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVK 485
           ++G+G FG++ + ++    G  ++VAVK   L        + F  E   MK   + N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 486 IISSCSNEEFKE------LVLEHMPHGSLEKCLYSSNC-----ILDIFQRLNIMIDVASV 534
           +I  C      +      ++L  M HG L   L  S        L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 535 LEYL-HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           +EYL + NF    IH DL   N +L + M   ++DFG++K +   D           + +
Sbjct: 126 MEYLSNRNF----IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 594 IAPEYGREGRVF-ANGDVYSFGIMLMEI 620
           IA E     RV+ +  DV++FG+ + EI
Sbjct: 182 IAIE-SLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 49/190 (25%), Positives = 94/190 (49%), Gaps = 5/190 (2%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG ++  +    ++VA+K  + +   + + F  E ++M  + +  LV++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           ++   +V E M +G L   L      L     L++  DV   +EYL  N     IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLA 127

Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+  T V  +SDFG+T+ ++ +D+  + +     + +  PE     +  +  DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 613 FGIMLMEIHS 622
           FG+++ E+ +
Sbjct: 187 FGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 20/200 (10%)

Query: 433 IGKGGFGTIY---KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           I KG +G ++   K   GD    A+KV     +           E +I+       +VK+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             S   ++   LV+E++P G L   L +    LD       + ++   LEYLH N    +
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSN---GI 114

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ------TQTLATIGYIAPE-YG 599
           IH DLKP N+L+D      L+DFG++K+ +   Q           + + T  YIAPE   
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 600 REGRVFANGDVYSFGIMLME 619
            +G      D +S G +L E
Sbjct: 175 GQGHSKTV-DWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 52/190 (27%), Positives = 98/190 (51%), Gaps = 9/190 (4%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG ++        +VA+K    Q   + ++F  E  +MK + +  LV++ +  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHCD 550
           E    ++ E+M +GSL   L +   I L I + +++   +A  + ++   N+    IH D
Sbjct: 73  EPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY----IHRD 127

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L+ +N+L+ +T+   ++DFG+ + LI +++   +      I + APE    G      DV
Sbjct: 128 LRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 611 YSFGIMLMEI 620
           +SFGI+L EI
Sbjct: 187 WSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 431 NLIGKGGFGTIYKSRI---GDGMEVAVKVF-HLQCGRAFKSFDIECEIM-KSIHYRNLVK 485
           ++IG+G FG + K+RI   G  M+ A+K           + F  E E++ K  H+ N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMID 530
           ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA  ++YL        IH DL   N+L+ +  VA ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++A E         N DV+S+G++L EI S
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 10/199 (5%)

Query: 430 NNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG + + R+       ++VA+K        +    F  E  IM    + N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFL 543
           ++    +      ++ E+M +GSL+K L  ++    + Q + ++  +AS ++YL   N+ 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              +H DL   N+L++  +V  +SDFG+++ L   + + T       I + APE     +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+SFGI++ E+ S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHLQC-GRAFKSFDIECE-IMKSIHYRNLVKIIS 488
            IG+G FGT+ K      G  +AVK        +  K   ++ + +M+S     +VK   
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM--IDVASV--LEYLHFNFLV 544
           +   E    + +E M   SL+K       +L       I+  I VA+V  L YL     +
Sbjct: 71  ALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--L 127

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            +IH D+KPSN+LLD      L DFGI+  L+    S+ +T+      Y+APE     R+
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPE-----RI 179

Query: 605 FANG--------DVYSFGIMLMEIHSAK 624
             +         DV+S GI L E+ + K
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)

Query: 427 FNENNLIGKGGFGTI----YKSRIGDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHY 480
           F    ++GKG FG++     KS  G   +VAVK+    +      + F  E   MK   +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 481 RNLVKIISSCSNEEFKE------LVLEHMPHGSLEKCLYSSNC-----ILDIFQRLNIMI 529
            N++K+I        K       ++L  M HG L   L  S        L +   +  MI
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 530 DVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           D+AS +EYL   NF    IH DL   N +L++ M   ++DFG++K +   D       + 
Sbjct: 121 DIASGMEYLSSKNF----IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
             + ++A E   +     + DV++FG+ + EI +  Q
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 53/200 (26%), Positives = 102/200 (51%), Gaps = 13/200 (6%)

Query: 432 LIGKGGFGTIYKS-RIGDGMEVAVKVF--HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           ++G+G FG ++   R  D   V +K             +   EC+++K + + N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
           +   ++   +V+E+ P G+L + +    N +LD    L+  + +   L ++H   ++   
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL--- 123

Query: 548 HCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF- 605
           H DLK  N+LLD   MV  + DFGI+K+L  + ++ T    + T  YI+PE   EG+ + 
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELC-EGKPYN 179

Query: 606 ANGDVYSFGIMLMEIHSAKQ 625
              D+++ G +L E+ S K+
Sbjct: 180 QKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 35/204 (17%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG G +G +YK+R I  G  VA+KV  L+ G  F+    E  ++K   + N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID---VASV-------LEYLHFN 541
             +   +V+E+   GSL+          DI+Q     +    +A V       L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEY 598
                IH D+K +N+LL +     L+DFG++  L     ++ + ++   IG   ++APE 
Sbjct: 121 G---KIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAPEV 172

Query: 599 G---REGRVFANGDVYSFGIMLME 619
               R+G      D+++ GI  +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 72.2 bits (177), Expect = 5e-13
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 16/183 (8%)

Query: 449 GMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-FKELVLEHMP 504
           G EVA+K+      +       F  E  +   +++ N+V ++ S          V E++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDT 561
             +L + L +++  L   +   +M+ V   L   H      ++H DLKP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118

Query: 562 MVAHLSDFGITKLLIGEDQSMTQTQTLAT--IG---YIAPEYGREGRVFANGDVYSFGIM 616
             A + DFGI  LL G   +   T T  T  +G   Y APE  R   V  N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 617 LME 619
            +E
Sbjct: 179 FLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 34/208 (16%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F+    +G+G +G++YK+     G  VA+KV  +      +    E  I+K      +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID---VASV-------L 535
              S        +V+E+   GS          + DI +  N  +    +A++       L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG--- 592
           EYLH N     IH D+K  N+LL++   A L+DFG++  L     +M +  T+  IG   
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTV--IGTPF 164

Query: 593 YIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++APE  +E       D++S GI  +E+
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 426 GFNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRN 482
            F     +GKG +G++YK  R+ D    A+K   L      +  D   E  I+ S+++ N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 483 LVKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQR---LNIMIDVASV 534
           ++        E F +     +V+E+ P G L K +        +        I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+ LH      ++H DLK +N+LL    +  + D GI+K+L    ++M +TQ   T  Y+
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYM 168

Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE  +        D++S G +L E+
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 10/195 (5%)

Query: 432 LIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           ++G G FGT+YK   + +G    + VA+K+ +   G +A   F  E  IM S+ + +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++  C +    +LV + MPHG L   ++     +     LN  + +A  + YL    LV 
Sbjct: 74  LLGVCLSPTI-QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV- 131

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
             H DL   NVL+       ++DFG+ +LL G+++          I ++A E     +  
Sbjct: 132 --HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 606 ANGDVYSFGIMLMEI 620
              DV+S+G+ + E+
Sbjct: 190 HQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHL------QCGRAFKSFDIECEIMKSIHYRNL 483
             +G+G +  +YK+R    G  VA+K   L      + G  F +   E ++++ + + N+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           + ++    ++    LV E M    LEK +   + +L      + M+     LEYLH N+ 
Sbjct: 65  IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW- 122

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE--YGRE 601
             ++H DLKP+N+L+    V  L+DFG+ +     ++ MT  Q + T  Y APE  +G  
Sbjct: 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFG-- 176

Query: 602 GRVFANG-DVYSFGIMLME 619
            R +  G D++S G +  E
Sbjct: 177 ARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 433 IGKGGFGTIYKSRI---GD--GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +   R    GD  G +VAVK    +  G        E EI++++++ N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C+ +     +L++E +P GSL++ L  +   +++ Q+L   + +   ++YL      
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR--- 128

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPEYGREGR 603
             +H DL   NVL++      + DFG+TK +  + +  T    L + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 189 FYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 50/200 (25%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 432 LIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKI 486
           +IG G FG + + R+      E+ V +  L+ G   +  + F  E  IM    + N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVP 545
               +      ++ E M +G+L+  L  ++    + Q + ++  +A+ ++YL   N+   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY--- 127

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA---TIGYIAPEYGREG 602
            +H DL   N+L++  +V  +SDFG+++ L  +    T T +L     I + APE     
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 603 RVFANGDVYSFGIMLMEIHS 622
           +  +  DV+S+GI++ E+ S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 32/228 (14%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHL-----QCGRAFKSFDIECEIMKSIHYRNLVK 485
           L+G+G FG +Y     D G E+AVK         +  +   + + E +++K++ +  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
                 ++E   + +E+MP GS++  L +   + +   R      +   +EYLH N +V 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSNMIV- 126

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPE----- 597
             H D+K +N+L D      L DFG +K L  +    + T   +  G   +++PE     
Sbjct: 127 --HRDIKGANILRDSAGNVKLGDFGASKRL--QTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 598 -YGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----VFNLAMECT 639
            YGR+       DV+S G  ++E+ + K     F     +F +A + T
Sbjct: 183 GYGRK------ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 224

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 40/249 (16%)

Query: 433 IGKGGFGTI----YKSRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKII 487
           +G G FG +    YK R    ++VA+KV   +  ++ +   + E EIM  +    +V++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPV 546
             C  E    LV+E    G L K L      + +   + +M  V+  ++YL   NF    
Sbjct: 62  GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF---- 116

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGREGRV 604
           +H DL   NVLL +   A +SDFG++K L G D S  + ++     + + APE     + 
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 605 FANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAMECT 639
            +  DV+S+GI + E  S  Q+                         C   ++ L  +C 
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235

Query: 640 IESLELRIN 648
           I   E R N
Sbjct: 236 IYKWEDRPN 244

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 10/190 (5%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           IG+G  GT+Y +  +  G EVA+K  +LQ  +  K   I E  +M+   + N+V  + S 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
              +   +V+E++  GSL   +  +   +D  Q   +  +    LE+LH N    VIH D
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           +K  N+LL       L+DFG    +  E     ++  + T  ++APE           D+
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 611 YSFGIMLMEI 620
           +S GIM +E+
Sbjct: 199 WSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 431 NLIGKGGFGTIYKS----RIGDG--MEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNL 483
             +G G FG +Y+     R GD   ++VAVK     C    +S F +E  IM   +++N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASV 534
           V++I        + ++LE M  G L+  L          SS  + D+   L    DVA  
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LFCARDVAKG 128

Query: 535 LEYL---HFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTL 588
            +YL   HF      IH D+   N LL       VA ++DFG+ + +          + +
Sbjct: 129 CKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
             I ++ PE   +G   +  DV+SFG++L EI S
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 39/209 (18%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           N IG G  GT+YK      G   A+KV    H    R  +    E EI++ +++ N+VK 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEILRDVNHPNVVK- 136

Query: 487 ISSC-----SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
              C      N E  +++LE M  GSLE        I D     ++   + S + YLH  
Sbjct: 137 ---CHDMFDHNGEI-QVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAYLHRR 187

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPE--- 597
            +V   H D+KPSN+L++      ++DFG++++L    Q+M     ++ TI Y++PE   
Sbjct: 188 HIV---HRDIKPSNLLINSAKNVKIADFGVSRIL---AQTMDPCNSSVGTIAYMSPERIN 241

Query: 598 ----YGR-EGRVFANGDVYSFGIMLMEIH 621
               +G  +G  +A GD++S G+ ++E +
Sbjct: 242 TDLNHGAYDG--YA-GDIWSLGVSILEFY 267

Length = 353

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 50/201 (24%), Positives = 100/201 (49%), Gaps = 9/201 (4%)

Query: 432 LIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKI 486
           +IG G FG +   R+      E+ V +  L+ G   +  + F  E  IM    + N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGY 127

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGREGRVF 605
           +H DL   N+L++  +V  +SDFG++++L  + + + T       I + APE     +  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187

Query: 606 ANGDVYSFGIMLMEIHSAKQQ 626
           +  DV+S+GI++ E+ S  ++
Sbjct: 188 SASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 431 NLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGR--AFKSFDIECEIMKSIHYRNLVKII 487
           N IG G FG +Y +  +  G  +AVK   +Q       K    E ++++ + + NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD--IFQRLNIMIDVASVLEYLHFNFLVP 545
               + E   + +E+   G+LE+ L     ILD  + +   + +     L YLH +    
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEG--LAYLHSH---G 119

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-TQTQTLA-TIGYIAPEYGREGR 603
           ++H D+KP+N+ LD   V  L DFG    L     +M  + Q+LA T  Y+APE    G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 604 VFANG---DVYSFGIMLMEIHSAK 624
              +G   D++S G +++E+ + K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 11/194 (5%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  + G+  A K+  ++     + F +E +I+    + N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E    +++E    G+L+  +      L   Q   +   +   L +LH +    VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDL 129

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GREGRVFA 606
           K  N+LL       L+DFG++       Q   +   + T  ++APE       ++     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 607 NGDVYSFGIMLMEI 620
             D++S GI L+E+
Sbjct: 188 KADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.9 bits (166), Expect = 7e-12
 Identities = 40/125 (32%), Positives = 59/125 (47%), Gaps = 23/125 (18%)

Query: 173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPL 232
           +GL +  L G IP DI +L  L  ++L GN + G+I     ++ SL  L LSYN      
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS----- 477

Query: 233 EIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSL 291
                            F+  IP ++G L  L+ L L  N L G +P ++G  L+   S 
Sbjct: 478 -----------------FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520

Query: 292 NFSNN 296
           NF++N
Sbjct: 521 NFTDN 525

Length = 623

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 432 LIGKGGFGTIYKS-RIGDGMEVAVKVFHL------QCGRAFKSFDI---ECEIMKSIHYR 481
           LIG G FG++Y       G  +AVK   L         R     D    E  ++K + + 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N+V+ + S  + +   + LE++P GS+   L +     +   R N +  +   L YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLHNR 125

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT----LATIGYIAPE 597
               +IH D+K +N+L+D+     +SDFGI+K L     S            ++ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 598 YGREGRVFANGDVYSFGIMLMEIHSAK 624
             ++       D++S G +++E+ + K
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKS 477
           E+ R +    +   +G G FG ++ +      +VAVK   ++ G  + ++F  E  +MK+
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKT 57

Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV-ASVLE 536
           + +  LVK+ +  + E    ++ E M  GSL   L S        Q L  +ID  A + E
Sbjct: 58  LQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAE 113

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIA 595
            + F      IH DL+ +N+L+  ++V  ++DFG+ +++  ED   T  +     I + A
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTA 171

Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE    G      DV+SFGI+LMEI
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 38/215 (17%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI------HYRNLV 484
            +G G F + Y++R +  G  +AVK        + +  ++   + K I      ++ +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
           +++ +   +    L +E M  GS+   L         ++     +N    +   L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121

Query: 541 NFLVPVIHCDLKPSNVLLDDT-MVAHLSDFG----ITKLLIGEDQSMTQTQTLATIGYIA 595
           N    +IH D+K +N+L+D T     ++DFG    +     G  +   Q Q L TI ++A
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMA 176

Query: 596 PE------YGREGRVFANGDVYSFGIMLMEIHSAK 624
           PE      YGR      + DV+S G +++E+ +AK
Sbjct: 177 PEVLRGEQYGR------SCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 37/217 (17%)

Query: 431 NLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVK 485
             IG+G +G +YK+R  D G  VA+K   L   +  + F I    E +I++ +++RN+V 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70

Query: 486 IISSCSNE----EFKE------LVLEHMPH---GSLEKCL--YSSNCILDIFQRLNIMID 530
           +    +++    +FK+      LV E+M H   G LE  L  +S + I    ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
               L Y H  NFL    H D+K SN+LL++     L+DFG+ +L   E+     T  + 
Sbjct: 126 -LEGLNYCHKKNFL----HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVI 179

Query: 590 TIGYIAPE--YGREGRVFANGDVYSFGIMLMEIHSAK 624
           T+ Y  PE   G E R     DV+S G +L E+ + K
Sbjct: 180 TLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 14/198 (7%)

Query: 430 NNLIGKGGFGT----IYKSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
              IG+G FG     +Y S   + + VAVK        + +  F  E  IM+   + ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFL 543
           K+I   + E    +V+E  P G L   L  +   LD+   +     +++ L YL    F 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRF- 128

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-TQTQTLATIGYIAPEYGREG 602
              +H D+   NVL+       L DFG+++ L  ED+S    ++    I ++APE     
Sbjct: 129 ---VHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFR 183

Query: 603 RVFANGDVYSFGIMLMEI 620
           R  +  DV+ FG+ + EI
Sbjct: 184 RFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 28/209 (13%)

Query: 426 GFNENNLIGKGGFGTIYKSRI-GDGMEVAVKV--------FHLQCGRAFKSFDIECEIMK 476
              E + +G+G  G++ K R+   GM  A+K            Q  R       E EI K
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-------ELEINK 54

Query: 477 SIHYRNLVKIISSCSNEEFKEL--VLEHMPHGSLE---KCLYSSNCILDIFQRLNIMIDV 531
           S     +VK   +  +E    +   +E+   GSL+   K +      +       I   V
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESV 114

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              L YLH      +IH D+KPSN+LL       L DFG++  L+    S+  T T  T 
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFT-GTS 167

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            Y+APE  +        DV+S G+ L+E+
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 37/225 (16%)

Query: 430 NNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL---------------QCGRAFKSFDIECE 473
              +G+G +G + K+     G  VA+K   +                CG  F +   E +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72

Query: 474 IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
           IM  I + N++ ++      +F  LV++ M    L+K +      L   Q   I++ + +
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILN 130

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK-----LLIGE--DQSMTQ-- 584
            L  LH  + +   H DL P+N+ ++   +  ++DFG+ +                 Q  
Sbjct: 131 GLNVLHKWYFM---HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 585 ---TQTLATIGYIAPE--YGREGRVFANGDVYSFGIMLMEIHSAK 624
              T  + T+ Y APE   G E   FA  D++S G +  E+ + K
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.0 bits (157), Expect = 3e-11
 Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 27/177 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECE-----------IMKSIHY 480
           +G+G +G +YK+R    G  VA+K   L         D E E           ++K + +
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISLLKELKH 57

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            N+VK++     E    LV E+     L+K L      L      +IM  +   L Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           +    ++H DLKP N+L++   V  L+DFG+ +      ++   T  + T+ Y APE
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 11/202 (5%)

Query: 432 LIGKGGFGTI----YKSRIGDGMEVAVKVFH-LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
            +G G FG +    + +  G  + VAVK     +       F  E  IM S+ + NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVP 545
                      +V E  P GSL   L         I    +  + +A+ + YL       
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF-- 118

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITK-LLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            IH DL   N+LL       + DFG+ + L   ED  + +        + APE  R    
Sbjct: 119 -IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 605 FANGDVYSFGIMLMEIHSAKQQ 626
               DV+ FG+ L E+ +  ++
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 433 IGKGGFGTIYKSRIGDG---MEVAVKVFHLQ-CGRA-FKSFDIECEIMKSIHYRNLVKII 487
           +G+G FG++ + ++      ++VAVK   +  C R+  + F  E   MK   + N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 488 SSC----SNEEFKE--LVLEHMPHGSLEKCLYSSNC-----ILDIFQRLNIMIDVASVLE 536
             C     +E +    ++L  M HG L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 537 YLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           YL   +F    IH DL   N +L++ M   ++DFG++K +   D           + +IA
Sbjct: 127 YLSSKSF----IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 596 PEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
            E   +       DV+SFG+ + EI +  Q
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS---------SNCILDIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 134 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 220

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 433 IGKGGFGTIYKSRIGDGME------VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D ++      VAVK  +     R    F  E  +MK     ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS-----SNCILDIFQRLNIMI----DVASVLE 536
           ++   S  +   +V+E M HG L+  L S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 134 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 220

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 37/225 (16%)

Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVK 485
           IG+G FG ++++R            VAVK+   +     ++ F  E  +M    + N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSN---------------------CILDIFQR 524
           ++  C+  +   L+ E+M +G L + L   +                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 525 LNIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
           L I   VA+ + YL    F      +H DL   N L+ + MV  ++DFG+++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
                    I ++ PE     R     DV+++G++L EI S   Q
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 17/186 (9%)

Query: 420 VCRATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQC---GRAFKSFDIECEIM 475
            CR+   F + N IG+G +G +Y++R     E VA+K   +     G    S   E  ++
Sbjct: 2   RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLL 60

Query: 476 KSIHYRNLVK----IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
            ++ + N+V+    ++    +  F  LV+E+     L   L +        Q   +M+ +
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQL 117

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              L+YLH NF   +IH DLK SN+LL D     ++DFG+ +      + M  T  + T+
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTL 172

Query: 592 GYIAPE 597
            Y APE
Sbjct: 173 WYRAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 60/191 (31%), Positives = 93/191 (48%), Gaps = 12/191 (6%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS-- 489
           IG+G  GT++ +  +  G EVA+K  +LQ     +    E  +MK +   N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
             +E F  +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH 
Sbjct: 87  VGDELF--VVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLHAN---QVIHR 139

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           D+K  NVLL       L+DFG    +  E QS   T  + T  ++APE           D
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVD 197

Query: 610 VYSFGIMLMEI 620
           ++S GIM +E+
Sbjct: 198 IWSLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 12/195 (6%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVA---VKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +YK+  + DG  VA   V++F +   +A +    E +++K + + N++K ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 489 SCSNEEFKELVLEHMPHGSLE---KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           S        +VLE    G L    K       ++         + + S LE++H      
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---R 126

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           ++H D+KP+NV +  T V  L D G+ +      ++      + T  Y++PE   E    
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 606 ANGDVYSFGIMLMEI 620
              D++S G +L E+
Sbjct: 185 FKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 15/195 (7%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +GKGGFG +   ++   G   A K      L+  +  +    E +I++ +  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEYLHFNFLVP 545
           +   ++   LV+  M  G L+  +Y+       F     +   A +   LE+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR--- 115

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +++ DLKP NVLLDD     +SD G+   L G            T GY+APE  +     
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYD 172

Query: 606 ANGDVYSFGIMLMEI 620
            + D ++ G  L E+
Sbjct: 173 FSVDWFALGCTLYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 30/228 (13%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKV--FHLQCGRAFKSFD-IECEI--MKSIHYRNLVK 485
           L+G+G FG +Y     D G E+AVK   F        K  + +ECEI  +K++ +  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 486 IISSCSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
                 + E K+L +  E+MP GS++  L +   + +   R      +   + YLH N +
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLHSNMI 127

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY-IAPE----- 597
           V   H D+K +N+L D      L DFG +K +     S T  +++    Y ++PE     
Sbjct: 128 V---HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 598 -YGREGRVFANGDVYSFGIMLMEIHSAKQ-----QCVSFVFNLAMECT 639
            YGR+       DV+S    ++E+ + K      + ++ +F +A + T
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 59/249 (23%), Positives = 109/249 (43%), Gaps = 45/249 (18%)

Query: 411 TWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHL-----QCGRA 464
            WRR                 L+G+G FG +Y    +  G E+A K         +  + 
Sbjct: 3   NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE 47

Query: 465 FKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV--LEHMPHGSLEKCLYSSNCILDIF 522
             + + E +++K++ +  +V+      +   K L   +E+MP GS++  L +   + +  
Sbjct: 48  VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107

Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
            R      +   + YLH N +V   H D+K +N+L D      L DFG +K L     S 
Sbjct: 108 TR-KYTRQILEGMSYLHSNMIV---HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163

Query: 583 TQTQTLATIGY-IAPE------YGREGRVFANGDVYSFGIMLMEIHS-----AKQQCVSF 630
           T  +++    Y ++PE      YGR+       DV+S G  ++E+ +     A+ + ++ 
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRK------ADVWSLGCTVVEMLTEKPPWAEYEAMAA 217

Query: 631 VFNLAMECT 639
           +F +A + T
Sbjct: 218 IFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 30/228 (13%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHL-----QCGRAFKSFDIECEIMKSIHYRNLVK 485
           L+G+G FG +Y     D G E+AVK         +  +   + + E +++K++ +  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 486 IISSCSNEEFKEL--VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
                 +   + L   +EHMP GS++  L S   + +   R      +  V  YLH N +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS-YLHSNMI 127

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY-IAPE----- 597
           V   H D+K +N+L D      L DFG +K L     S T  +++    Y ++PE     
Sbjct: 128 V---HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184

Query: 598 -YGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----VFNLAMECT 639
            YGR+       D++S G  ++E+ + K     F     +F +A + T
Sbjct: 185 GYGRK------ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 24/201 (11%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK---VFHLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG+G F  +Y++  + DG+ VA+K   +F L   +A      E +++K +++ N++K  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 489 SCSNEEFKELVLEHMPHGSL---------EKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           S   +    +VLE    G L         +K L     +   F      + + S LE++H
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------VQLCSALEHMH 123

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
                 V+H D+KP+NV +  T V  L D G+ +      ++      + T  Y++PE  
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 178

Query: 600 REGRVFANGDVYSFGIMLMEI 620
            E       D++S G +L E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 23/185 (12%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MKSIHY 480
           + E   IG+G +GT+YK+R +  G  VA+K   +             EI     ++S  +
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 481 RNLVKIISSCSNEEFKE-----LVLEHMP---HGSLEKCLYSSNCILDIFQRLNIMIDVA 532
            N+V+++  C            LV EH+       L KC       L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
             +++LH +    ++H DLKP N+L+       ++DFG+ ++       M  T  + T+ 
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLW 171

Query: 593 YIAPE 597
           Y APE
Sbjct: 172 YRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 26/180 (14%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVKII 487
           IG+G  G ++K++    G  VA+K   L   R           E + +++  +  +VK++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVAL--RRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 488 ------SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
                 S         LV+E+MP   L + L      L   Q  + M  +   + Y+H N
Sbjct: 66  DVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE--YG 599
               ++H DLKP+N+L+    V  ++DFG+ +L   E++    +  +AT  Y APE  YG
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.5 bits (149), Expect = 5e-10
 Identities = 82/262 (31%), Positives = 118/262 (45%), Gaps = 11/262 (4%)

Query: 78  TSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP 137
            SS   L   SSLS   SL    L +      L           L   D++  N      
Sbjct: 54  LSSNTLLLLPSSLSRLLSL---DLLSPSGISSLDGSENLLNLLPLPSLDLN-LNRLRSNI 109

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
            E+  LTNLT++ L  N +    P        L+ + L DNK+E ++P  +  L  L  L
Sbjct: 110 SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNL 168

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           DL  N LS  +    SNL++L  L LS N    LP EI  L  L  +D S NN    + +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLS-NNSIIELLS 226

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN 316
           ++ +LK+L  L L  N L+  +P+S+G+L +L++L+ SNN +S      L  L+ L  L+
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELD 283

Query: 317 LSFNKLEGEIPKGGSFGNFSAE 338
           LS N L   +P           
Sbjct: 284 LSGNSLSNALPLIALLLLLLEL 305

Length = 394

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 18/198 (9%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQ------CGRAFKSFDIECEIMKSIHYRNLVK 485
           IG+G +G +YK+R    G  VA+K   L+         A +    E +++K +++ N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++    ++    LV E M    L K +      L      + +  +   L + H +    
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           ++H DLKP N+L++   V  L+DFG+ +           T  + T  Y APE     + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 606 ANG-DVYSFGIMLMEIHS 622
           +   D++S G +  E+ S
Sbjct: 177 STPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 16/191 (8%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVF-HLQCGRAFKSFDI-ECEIMKSIHYRNLVKIIS 488
           L+G+G +G + K +  + G  VA+K F   +  +  K   + E  ++K + + NLV +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               ++   LV E + H  L+      N  LD  +    +  +   +E+ H +    +IH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEFCHSH---NIIH 123

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-------YGRE 601
            D+KP N+L+  + V  L DFG  + L    +    T  +AT  Y APE       YGR 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGRA 181

Query: 602 GRVFANGDVYS 612
             ++A G + +
Sbjct: 182 VDIWAVGCLVT 192

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 8/189 (4%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E     ++  + T  ++APE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 201 SLGIMAIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 7e-10
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 2/85 (2%)

Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           L N  L G +P   I  L H L+  ++S  ++ G IP  +G++T+L  + L  N  NGSI
Sbjct: 425 LDNQGLRGFIPN-DISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 161 PFTLRELQKLQYVGLKDNKLEGTIP 185
           P +L +L  L+ + L  N L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 432 LIGKGGFGTIYKS-RIGDGMEVAVKVFHL---QCGR-------AFKSFDIECEIMKSIHY 480
           LIGKG +G +Y +  +  G  +AVK   L     GR         K+   E E +K + +
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            N+V+ +   + EE+  + LE++P GS+  CL +     +   R      V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-FFTEQVLEGLAYLHS 126

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL---LIGEDQSMTQTQTLATIGYIAPE 597
                ++H DLK  N+L+D   +  +SDFGI+K    +   DQ+M+      ++ ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAPE 180

Query: 598 ------YGREGRVFANGDVYSFGIMLMEIHSAKQ 625
                  G   +V    D++S G +++E+ + ++
Sbjct: 181 VIHSYSQGYSAKV----DIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 35/227 (15%)

Query: 433 IGKGGFGTIYKSRIGDGM---EVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG G FG +    +  G    +V VK   +    +    F  E +  +S+ + NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSN------CILDIFQRLNIMIDVASVLEYLHFNF 542
            C+      LV+E  P G L+  L S              QR+    ++A  L +LH N 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHLHKN- 119

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
               IH DL   N LL   +   + D+G++     ED  +T  Q    + +IAPE   E 
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE- 176

Query: 603 RVFAN---------GDVYSFGIMLMEI---------HSAKQQCVSFV 631
            V  N          +V+S G+ + E+         H + +Q +++ 
Sbjct: 177 -VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 26/182 (14%)

Query: 431 NLIGKGGFGTIYKSRIGD-GMEVAVK----VFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
             IG G +G +  +     G +VA+K    VF   +   R  +    E ++++ + + N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 484 VK---IISSCSNEEFKEL--VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL 538
           +    I+   S E+F ++  V E M    L K + S   + D   +   +  +   L+YL
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119

Query: 539 HF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIA 595
           H  N    VIH DLKPSN+L++      + DFG+ +  +  D+      T  + T  Y A
Sbjct: 120 HSAN----VIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWYRA 174

Query: 596 PE 597
           PE
Sbjct: 175 PE 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 25/219 (11%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHL----QCGR-AFKSFDIECEIMKSIHYRNLVK 485
           L+G G FG++Y+    D G   AVK   L    Q G+ A K  + E  ++  + + N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
            + +   E+   + LE +P GSL K L                  +   LEYLH      
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDR---N 122

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEY-GRE 601
            +H D+K +N+L+D   V  L+DFG+ K      Q +  +   +  G   ++APE   ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176

Query: 602 GRVFANGDVYSFGIMLMEIHSAK-----QQCVSFVFNLA 635
           G      D++S G  ++E+ + K      + V+ VF + 
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 16/195 (8%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG G +G +YK+R +  G   A+KV  L+ G  F     E  +MK   + N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   + +E    GSL+  +Y     L   Q   +  +    L YLH       +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDI 132

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYG---REGRVF 605
           K +N+LL D     L+DFG++  +     + T  +  + IG   ++APE     R+G   
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 606 ANGDVYSFGIMLMEI 620
              D+++ GI  +E+
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 8/189 (4%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  I  G EVA+K  +LQ     +    E  +M+     N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    L++LH N    VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDI 141

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E QS   T  + T  ++APE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 200 SLGIMAIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 43/208 (20%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G GGFG +   +        A+K     H+      +    E EI++  ++  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID------VASV---LEYLH 539
           +  ++++  +++E+   G L            I +   +  +      +A V    EYLH
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL----------WTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE- 597
                 +I+ DLKP N+LLD      L DFG  K L    +S  +T T   T  Y+APE 
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEI 163

Query: 598 -----YGREGRVFANGDVYSFGIMLMEI 620
                Y          D +S GI+L E+
Sbjct: 164 ILNKGYDF----SV--DYWSLGILLYEL 185

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 13/199 (6%)

Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ-CGRAFKSFDI-ECEIMKSIHYRNL 483
           F   N IGKG FG ++K  R  D    A+K   L    R  +   I E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHF 540
           ++   S  ++    +V+E+  +G L K L          D   R  I I +   L +LH 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLHS 119

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                ++H D+K  N+ LD      + D G+ KLL   D +      + T  Y++PE   
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCE 174

Query: 601 EGRVFANGDVYSFGIMLME 619
           +       DV++ G++L E
Sbjct: 175 DKPYNEKSDVWALGVVLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 19/103 (18%)

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
           I + +   LEYLH    + VIH D+KPSNVL++      L DFGI+  L+    S+ +T 
Sbjct: 108 IAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 587 TLATIGYIAPEYGREGRVFANG---------DVYSFGIMLMEI 620
                 Y+APE     R+             DV+S GI ++E+
Sbjct: 163 DAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 11/191 (5%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIISSC 490
           +G G  G++ K   I  G  +A KV H+    +  K    E +IM       +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            NE    + +E M  GSL++       I ++I  +  I + V   L YL+   +  ++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYN--VHRIMHR 128

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           D+KPSN+L++      L DFG++  LI    S+  T  + T  Y++PE  + G+     D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184

Query: 610 VYSFGIMLMEI 620
           V+S GI ++E+
Sbjct: 185 VWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK   I +G    + VA+K        +A K    E  +M S+  
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 69  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 117

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  +++          
Sbjct: 118 IAKGMNYLEERRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/281 (20%), Positives = 116/281 (41%), Gaps = 52/281 (18%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRI-----GDGME-VAVKVFHLQCGRAFKS-FDIE 471
           E+  +T  F E   +G+  FG +YK  +     G+  + VA+K    +     +  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY---------------SSN 516
             +   + + N+V ++   + E+   ++  +  H  L + L                +  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 517 CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L+    ++I+  +A+ +E+L  +    V+H DL   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ---------- 626
             D       +L  I +++PE    G+   + D++S+G++L E+ S   Q          
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235

Query: 627 ---------------CVSFVFNLAMECTIESLELRINAKEI 652
                          C ++V+ L +EC  E    R   K+I
Sbjct: 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 29/209 (13%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEI-----MKSIHYRNLVKI 486
           IG G +GT+YK+R    G  VA+K   +Q            E+     +++  + N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 487 ISSC----SNEEFK-ELVLEHMPH---GSLEKCL---YSSNCILDIFQRLNIMIDVASVL 535
           +  C    ++ E K  LV EH+       L+K       +  I D+ ++          L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------LRGL 121

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           ++LH N    ++H DLKP N+L+       L+DFG+ ++       M  T  + T+ Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRA 175

Query: 596 PEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           PE   +       D++S G +  E+   K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 22/196 (11%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  +     G +VAVK   L+  +  +    E  IM+   + N+V++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  +   ++  Q   + + V   L +LH      VIH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQ---GVIHRDI 141

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY-IAPE------YGREGRV 604
           K  ++LL       LSDFG    +    + + + ++L    Y +APE      YG E   
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGTE--- 195

Query: 605 FANGDVYSFGIMLMEI 620
               D++S GIM++E+
Sbjct: 196 ---VDIWSLGIMVIEM 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 28/213 (13%)

Query: 432 LIGKGGFGTIYKSR-IG-----DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRNL 483
            +G+G FG + K+  +G     +   VAVK+       +       E E+MK I  ++N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRL------NIM 528
           + ++  C+ E    +V+E+  HG+L   L          S +      + L      +  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
             VA  +E+L        IH DL   NVL+ +  V  ++DFG+ + +   D     T   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 589 ATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEI 620
             + ++APE     RV+    DV+SFG++L EI
Sbjct: 196 LPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 29/216 (13%)

Query: 433 IGKGGFGTIYKS-------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLV 484
           +G+G FG + K+       R G    VAVK+       +  +    E  ++K +++ +++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGY-TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI----LDIFQRLNIMIDVASVLEYLHF 540
           K+  +CS +    L++E+  +GSL   L  S  +    L      N           L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 541 NFLVP----------------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
             L+                 ++H DL   NVL+ +     +SDFG+++ +  ED  + +
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR 186

Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++    + ++A E   +       DV+SFG++L EI
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 61/194 (31%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 432 LIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFD-IECE---IMKSIHYRNLVKI 486
           +IGKG FG +    R  DG   AVKV   +     K  + I  E   ++K++ +  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             S    E    VL+++  G L   L    C L+   R     +VAS + YLH    + +
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNI 117

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           I+ DLKP N+LLD      L+DFG+ K   G +   T +    T  Y+APE  R+     
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175

Query: 607 NGDVYSFGIMLMEI 620
             D +  G +L E+
Sbjct: 176 TVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)

Query: 433 IGKGGFGTI----YKSRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKI 486
           +G G FGT+    YK +  +   VAVK+            ++  E  +M+ +    +V++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           I  C  E +  LV+E    G L K L  +  + +      ++  V+  ++YL     V  
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNFV-- 117

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGREGRV 604
            H DL   NVLL     A +SDFG++K L G D++  + +T     + + APE     + 
Sbjct: 118 -HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 605 FANGDVYSFGIMLMEIHSAKQQ 626
            +  DV+SFG+++ E  S  Q+
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 13/195 (6%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  + G   A KV   +     + + +E EI+ + ++  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDI-FQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            +    +++E  P G+++  +      LD       I +    +LE L +   + +IH D
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLE----LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GREGRVF 605
           LK  NVLL       L+DFG++   +   Q   +   + T  ++APE       ++    
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYD 193

Query: 606 ANGDVYSFGIMLMEI 620
              D++S GI L+E+
Sbjct: 194 YKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 45/180 (25%), Positives = 80/180 (44%), Gaps = 21/180 (11%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVKII 487
           IG+G FG ++K+R       VA+K   +      + F I    E +I++ + + N+V +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 488 SSCSNEEFKE--------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
             C  +            LV E   H  L   L + N    + +   +M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK--LLIGEDQSMTQTQTLATIGYIAPE 597
            N    ++H D+K +N+L+    +  L+DFG+ +   L    +    T  + T+ Y  PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 23/213 (10%)

Query: 427 FNENNL-----IGKGGFGTIYK------SRIGDGMEVAVKVF----HLQCGRAFKSFDIE 471
           F  NNL     +G G FG + +      S+    M+VAVK+     H     A  S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 472 CEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMI 529
            +IM  + ++ N+V ++ +C+      ++ E+  +G L   L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
            VA  + +L        IH DL   NVLL    +  + DFG+ + ++ +   + +     
Sbjct: 149 QVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + ++APE           DV+S+GI+L EI S
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 30/82 (36%), Positives = 42/82 (51%), Gaps = 2/82 (2%)

Query: 156 LNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNL 215
           L G IP  + +L+ LQ + L  N + G IP  +  +  L  LDL  N  +GSI      L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 216 ASLRTLSLSYN--DGPLPLEIG 235
            SLR L+L+ N   G +P  +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 11/198 (5%)

Query: 431 NLIGKGGFGTIYKSRI----GDGMEVAVKVFH-LQCGRAFKSFDIECEIMKSIHYRNLVK 485
            +IGKG FG +Y   +    G  +  AVK  + +      + F  E  IMK   + N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 486 IISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++  C   E   LV L +M HG L   + S      +   +   + VA  +EYL     V
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGREG 602
              H DL   N +LD++    ++DFG+ + +  ++       T A   + ++A E  +  
Sbjct: 121 ---HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 603 RVFANGDVYSFGIMLMEI 620
           +     DV+SFG++L E+
Sbjct: 178 KFTTKSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 123

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 124 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 178

Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 179 YSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 37/205 (18%)

Query: 432 LIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            IGKG FG +YK+        VA+KV  L+        +IE +I + I      + +S C
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEI------QFLSQC 56

Query: 491 SNEEFKE------------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL 538
            +    +            +++E+   GS    L      LD      I+ +V   LEYL
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYL 114

Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIA 595
           H       IH D+K +N+LL +     L+DFG++  L     + T ++    +G   ++A
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGTPFWMA 166

Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE  ++       D++S GI  +E+
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 67/219 (30%)

Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDI-----------ECEIMKSIHY 480
           +G G FG +   R     +  A+K+             I           E  I++SI +
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--------KIVKLKQVEHVLNEKRILQSIRH 60

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM----IDVA---- 532
             LV +  S  ++    LV+E++P G             ++F  L         VA    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYA 107

Query: 533 ----SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
                 LEYLH   +V   + DLKP N+LLD      ++DFG  K + G      +T TL
Sbjct: 108 AQVVLALEYLHSLDIV---YRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158

Query: 589 -ATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
             T  Y+APE      YG+        D ++ GI++ E+
Sbjct: 159 CGTPEYLAPEIILSKGYGKA------VDWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 21/205 (10%)

Query: 452 VAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEK 510
           VAVK+      + A   F  E +IM  +   N+++++  C +++   ++ E+M +G L +
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 511 CL-----YS----SNCI--LDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDLKPSNVLL 558
            L      S    +N I  + I   L + + +AS ++YL   NF    +H DL   N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF----VHRDLATRNCLV 162

Query: 559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLM 618
            +     ++DFG+++ L   D    Q + +  I ++A E    G+     DV++FG+ L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 619 EIHS-AKQQCVSFVFNLAMECTIES 642
           E+ +  K+Q  S    L+ E  IE+
Sbjct: 223 EMFTLCKEQPYSL---LSDEQVIEN 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 29/75 (38%), Positives = 43/75 (57%)

Query: 134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK 193
           G IP +I  L +L +I L GN + G+IP +L  +  L+ + L  N   G+IP  + +L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 194 LYKLDLGGNKLSGSI 208
           L  L+L GN LSG +
Sbjct: 492 LRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 427 FNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F +  ++GKGGFG +   ++   G   A K    +  +  K   +   E +I++ ++ R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFN 541
           +V +  +   ++   LVL  M  G L+  +Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
            +V   + DLKP N+LLDD     +SD G+  + + E Q++     + T+GY+APE  + 
Sbjct: 122 RIV---YRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAPEVVKN 175

Query: 602 GRVFANGDVYSFGIMLMEI 620
            R   + D ++ G +L E+
Sbjct: 176 ERYTFSPDWWALGCLLYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 31/84 (36%), Positives = 44/84 (52%), Gaps = 17/84 (20%)

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           VIH D+KPSN+LLD +    L DFGI+  L+    S  +T++     Y+APE     R+ 
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPE-----RID 187

Query: 606 AN---------GDVYSFGIMLMEI 620
                       DV+S GI L+E+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 12/213 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK---VFHLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG+G F  +Y++  + D   VA+K   +F +   +A +    E +++K +++ N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 489 SCSNEEFKELVLEHMPHGSLEKCL-YSSNCILDIFQRL--NIMIDVASVLEYLHFNFLVP 545
           S   +    +VLE    G L + + Y       I +R      + + S +E++H      
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           V+H D+KP+NV +  T V  L D G+ +      ++      + T  Y++PE   E    
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 606 ANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMEC 638
              D++S G +L E+ + +        NL   C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 12/199 (6%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +GKGGFG +   ++   G   A K  +   L+  + ++   +E  I+  +H R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEYLHFNFLVP 545
           +   +    LV+  M  G L   +Y+ +     F         A +   LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +I+ DLKP NVLLD+     +SD G+   L  + QS T+     T G++APE  +     
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYA-GTPGFMAPELLQGEEYD 175

Query: 606 ANGDVYSFGIMLMEIHSAK 624
            + D ++ G+ L E+ +A+
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 21/229 (9%)

Query: 433 IGKGGFG--TIYKSRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG  T+Y+ R  D   V  K  +L      +  D   E  I+  + + N++   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 489 SCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              ++    + +E+   G+L +K +     + +    L  +  + S + Y+H      ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GIL 123

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           H D+K  N+ L    +  L DFGI+K+L G + SM +T  + T  Y++PE  +  +    
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFK 181

Query: 608 GDVYSFGIMLMEIHSAKQQ---------CVSFVF-NLAMECTIESLELR 646
            D+++ G +L E+ + K+           V  V  N     ++ S EL 
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 11/170 (6%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFD-IECE---IMKSIHYRNLVKII 487
           IGKG FG +  ++   DG   AVKV   +     K    I  E   ++K++ +  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            S    +    VL+++  G L   L       +   R     ++AS L YLH    + +I
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           + DLKP N+LLD      L+DFG+ K   G + S T +    T  Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 47/220 (21%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMK-----SIHYRNLVKI 486
           +IG+GGFG +Y  R  D      K++ ++C       D +   MK     +++ R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKC------LDKKRIKMKQGETLALNERIMLSL 50

Query: 487 ISS-------CSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S+       C +  F        +L+ M  G L   L        +F    +    A +
Sbjct: 51  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEAEMRFYAAEI 106

Query: 535 ---LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLAT 590
              LE++H  F   V++ DLKP+N+LLD+     +SD G+       D S  +   ++ T
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 158

Query: 591 IGYIAPEYGREGRVF-ANGDVYSFGIMLMEI---HSAKQQ 626
            GY+APE  ++G  + ++ D +S G ML ++   HS  +Q
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 45/220 (20%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 427 FNENNL-----IGKGGFGTIYKSRI------GDGMEVAVKVF-HLQCGRAFKSFDIECEI 474
           F  +NL     +G+G FG ++ ++       G    V VK     +       F  E ++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 475 MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--------LDIFQRLN 526
            + + ++N+V+++  C   E   ++LE+   G L++ L ++           L   Q++ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
           +   +A  +++L     V   H DL   N L+       +S   ++K +   +    +  
Sbjct: 122 LCTQIALGMDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-N 177

Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
            L  + ++APE  +E       DV+SFG+++ E+ +  + 
Sbjct: 178 ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 24/212 (11%)

Query: 433 IGKGGFGTIYKSRIGDGMEVA-VKVFHLQCGRAFK---SFDIECEIMKSIHYRNLVKIIS 488
           IG G FG +       GM  A V V  L+          F  E +  + +++ N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCIL------DIFQRLNIMIDVASVLEYLH-FN 541
            C       LVLE  P G L+  L S+  ++      D+ QR+    +VAS L +LH  +
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQAD 120

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
           F    IH DL   N  L   +   + D+G+      ED  +T+      + ++APE    
Sbjct: 121 F----IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 602 -------GRVFANGDVYSFGIMLMEIHSAKQQ 626
                         +++S G+ + E+ +A  Q
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 18/196 (9%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +YK+R +  G   AVK+  L+ G  F     E  ++K   + N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           + E   + +E+   GSL+  +Y     L   Q   +  +    L YLH       +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDI 132

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREGRVFANG-- 608
           K +N+LL D     L+DFG+   +     ++ + ++ + T  ++APE      V  NG  
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGY 186

Query: 609 ----DVYSFGIMLMEI 620
               D+++ GI  +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 35/214 (16%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS-- 489
           +IG+GGFG +Y  R  D      K++ ++C    K   ++     +++ R ++ ++S+  
Sbjct: 1   IIGRGGFGEVYGCRKAD----TGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGD 55

Query: 490 -----CSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LE 536
                C    F        +L+ M  G L   L        +F    +      +   LE
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLE 111

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           ++H  F   V++ DLKP+N+LLD+     +SD G    L  +        ++ T GY+AP
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAP 164

Query: 597 EYGREGRVF-ANGDVYSFGIMLMEI---HSAKQQ 626
           E  ++G  + ++ D +S G ML ++   HS  +Q
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 51/191 (26%), Positives = 95/191 (49%), Gaps = 11/191 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G G  G + K +    G+ +A K+ HL+   A ++  I E +++   +   +V    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            ++    + +EHM  GSL++ L  +  I  +I  +++I   V   L YL       ++H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKH--QIMHR 128

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +        D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSD 184

Query: 610 VYSFGIMLMEI 620
           ++S G+ L+E+
Sbjct: 185 IWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 31/204 (15%)

Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI-------ECEIMKSIHYRNL 483
           ++G+G +G + K R    G  VA+K F     +  +  +        E ++++ + + N+
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-----KESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V +  +   +    LV E++    LE  L +S   L      + +  +   + Y H +  
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------ 597
             +IH D+KP N+L+ ++ V  L DFG  + L     S   T  +AT  Y APE      
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDT 177

Query: 598 -YGREGRVFANGDVYSFGIMLMEI 620
            YG+        DV++ G ++ E+
Sbjct: 178 NYGKP------VDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 10/195 (5%)

Query: 432 LIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           ++G G FGT+YK   I DG    + VA+KV       +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++  C      +LV + MP+G L   +  +   +     LN  + +A  + YL     V 
Sbjct: 74  LLGICLTSTV-QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           ++H DL   NVL+       ++DFG+ +LL  ++           I ++A E     R  
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 606 ANGDVYSFGIMLMEI 620
              DV+S+G+ + E+
Sbjct: 190 HQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 11/197 (5%)

Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G+G + T+YK R     E VA+K  HL       S  I E  +MK + + N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 491 SNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             E    LV E+M    L+K +  +     LD     +    +   + + H N    V+H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLKP N+L++      L+DFG+ +   G   + T +  + T+ Y AP+     R ++  
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR-AFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 609 -DVYSFGIMLMEIHSAK 624
            D++S G ++ E+ + +
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 11/197 (5%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGME--VAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNL 483
           F +   IGKG FG ++K  I +  +  VA+K+  L+      +    E  ++       +
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            K   S        +++E++  GS    L +     D FQ   ++ ++   L+YLH    
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE-- 120

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++  
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 604 VFANGDVYSFGIMLMEI 620
             +  D++S GI  +E+
Sbjct: 178 YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 11/197 (5%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGME--VAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNL 483
           F +   IGKG FG ++K  I +  +  VA+K+  L+      +    E  ++       +
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            K   S   +    +++E++  GS    L      LD  Q   I+ ++   L+YLH    
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE-- 120

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++  
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 604 VFANGDVYSFGIMLMEI 620
             +  D++S GI  +E+
Sbjct: 178 YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 27/64 (42%), Positives = 42/64 (65%), Gaps = 2/64 (3%)

Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           LS N + G +P  S+G+++ SLE+ D+S  + +G IPE +G LT+L  + L GN L+G +
Sbjct: 449 LSGNSIRGNIP-PSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 161 PFTL 164
           P  L
Sbjct: 507 PAAL 510

Length = 623

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 33/196 (16%)

Query: 452 VAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL 508
           VAVKV  L+      A + F  E +I+  +   N+ +++  C+ +    +++E+M +G L
Sbjct: 49  VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 509 EKCLY----------------SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDL 551
            + L                 S + +      L +   +AS + YL   NF    +H DL
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTL------LYMATQIASGMRYLESLNF----VHRDL 156

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
              N L+       ++DFG+++ L   D    Q +    I ++A E    G+     DV+
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216

Query: 612 SFGIMLMEIHS-AKQQ 626
           +FG+ L EI +  ++Q
Sbjct: 217 AFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 24/175 (13%)

Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +G+G + T+YK +   +G  VA+KV  LQ   G  F +   E  ++K + + N+V +   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 490 CSNEEFKELVLEHMPHGSLEKC-------LYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
              +E   LV E++ H  L +        L+  N  L +FQ L         L Y+H  +
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY 123

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
              ++H DLKP N+L+ DT    L+DFG+ +       S T +  + T+ Y  P+
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)

Query: 153 GNKLNGSIPFTLRELQKLQYVGLKDNKLEG--TIPYDIFRLVKLYKLDLGGNKLSGSILT 210
            N  + ++      L +L  + L             ++  L+ L  LDL  N+L  +I  
Sbjct: 52  LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE 111

Query: 211 CFSNLASLRTLSLSYNDG-PLPLEIGNLKVLIGI-DFSMNNFSSVIPTTIGSLKDLQYLF 268
               L +L +L L  N+   +P  IG LK  +   D S N   S +P+ + +L +L+ L 
Sbjct: 112 LL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLD 169

Query: 269 LGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK 328
           L +N L   +P  + +L +L +L+ S N +S  +P  +E LS LE L+LS N +   +  
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSS 227

Query: 329 GGSFGNFSAESFEGNKLLC 347
             +  N S      NKL  
Sbjct: 228 LSNLKNLSGLELSNNKLED 246

Length = 394

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 48/206 (23%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFD---------IECEIMKSIHYRN 482
           IG+G +G ++K R  + G  VA+K F        +S D          E  ++K + + N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 483 LVKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQR----LNIMIDVAS 533
           LV +I     E F+      LV E+  H  L +        L+   R      I   +  
Sbjct: 62  LVNLI-----EVFRRKRKLHLVFEYCDHTVLNE--------LEKNPRGVPEHLIKKIIWQ 108

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
            L+ ++F      IH D+KP N+L+       L DFG  ++L G       T  +AT  Y
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWY 166

Query: 594 IAPE-------YGREGRVFANGDVYS 612
            APE       YG    V+A G V++
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFA 192

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 19/194 (9%)

Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G+GG+G ++ ++  D  E VA+K      L      +    E +I+ +     LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI--MIDVASVLEYLHFNFLVPV 546
           +  ++E+  L +E++P G     L +   + +   R  +  M +    L  L +      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY------ 122

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DLKP N L+D +    L+DFG++K ++    S+     + +  Y+APE  R G+ + 
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLR-GKGYD 176

Query: 607 NG-DVYSFGIMLME 619
              D +S G ML E
Sbjct: 177 FTVDYWSLGCMLYE 190

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 25/201 (12%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  + G+  A KV   +     + + +E +I+ S  + N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E    +++E    G+++  +      L   Q   +       L YLH N    +IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-------ATIGYIAPEY-----G 599
           K  N+L        L+DFG+         S   T+T+        T  ++APE       
Sbjct: 130 KAGNILFTLDGDIKLADFGV---------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 600 REGRVFANGDVYSFGIMLMEI 620
           ++       DV+S GI L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 22/178 (12%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDI------ECEIMKSIHYRNLVK 485
           IG G +G +  +     G +VA+K    +   AF    +      E +I++   + N++ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELKILRHFKHDNIIA 68

Query: 486 I--ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           I  I      +FK+  +V++ M    L   ++S   + +   R   +  +   L+Y+H  
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIH-- 124

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG--EDQSMTQTQTLATIGYIAPE 597
               VIH DLKPSN+L+++     + DFG+ + L     +     T+ +AT  Y APE
Sbjct: 125 -SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 427 FNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F +  ++GKGGFG +   ++   G   A K    +  +  K   +   E +I++ ++ + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFN 541
           +V +  +   ++   LVL  M  G L+  +Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
                ++ DLKP N+LLDD     +SD G+  + I E +S+     + T+GY+APE    
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESI--RGRVGTVGYMAPEVLNN 175

Query: 602 GRVFANGDVYSFGIMLMEI 620
            R   + D +  G ++ E+
Sbjct: 176 QRYTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 19/114 (16%)

Query: 520 DIFQRLN--IMI----------DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLS 567
           D+F RL+  +M           ++A  L++LH    + +I+ DLKP N+LLD+     L+
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140

Query: 568 DFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREGRVFANGDVYSFGIMLMEI 620
           DFG++K  I  D          T+ Y+APE   R G   +  D +SFG+++ E+
Sbjct: 141 DFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEM 191

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y    + D    F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEI 620
              + ++APE     RV+ +  DV+SFG+++ EI
Sbjct: 200 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 433 IGKGGFGTIYKSR---------IGDGMEVAV--KVFHLQCGRAFKSFDIECEIMKSIHYR 481
           +G+G F  IYK           +G G EV+V  KV      R   +F     +M  + ++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           +LVK+   C  +E   +V E++  G L+  L+     + +  +L++   +AS L YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120

Query: 542 FLVPVIHCDLKPSNVLL-------DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
            L   +H ++   N+L+              LSD GI   +      +++ + +  I +I
Sbjct: 121 KL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV------LSREERVERIPWI 171

Query: 595 APEYGREGRVF--ANGDVYSFGIMLMEI 620
           APE  R G+       D +SFG  L+EI
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCI----LDIFQRLNI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y+   +    L     ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEI 620
              + ++APE     R++ +  DV+SFG++L EI
Sbjct: 203 RLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 47/199 (23%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 432 LIGKGGFGTIYKS--RIGDGMEVAVKVFHLQCGRAFK---SFDIECEIMKSIHYRNLVKI 486
           ++G G FG + +   ++    E+ V +  L+ G + K    F  E   +    + N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               +      +V E+M +G+L+  L      L   Q + ++  +AS ++YL     +  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGY 128

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL---ATIGYIAPEYGREGR 603
           +H  L    VL++  +V  +S F   +    ED+S     T+   + + + APE  +   
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+SFGI++ E+ S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 39/215 (18%)

Query: 431 NLIGKGGFG----TIYKSRIGDGMEVAVKVF-----HLQCGRAFKSFDIECEIMKSIHYR 481
           + IG+G +G      +K     G++VA+K          C R  +    E +I++   + 
Sbjct: 11  SYIGEGAYGMVCSATHKPT---GVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHE 63

Query: 482 NLVKI---ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILD-----IFQRLNIMIDV 531
           N++ I   I   S E F +  +V E M    L K + + +   D     ++Q L      
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR----- 117

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLAT 590
              L+Y+H      V+H DLKPSN+LL+      + DFG+ ++     D +   T+ +AT
Sbjct: 118 --GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 591 IGYIAPEYGREGRVFANG-DVYSFGIMLMEIHSAK 624
             Y APE     + +    D++S G +L E+ S +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 57/251 (22%), Positives = 92/251 (36%), Gaps = 49/251 (19%)

Query: 8   KLELNVDDIESPCEIPSEINPH-NLEELLLGQNNL------VGVVPAAIFDVSTLKDLAL 60
           +LE N    E+   + S + P  +L+EL L  N        +  +   +     L++L L
Sbjct: 29  RLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDL 88

Query: 61  QDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNL-- 118
            DN L      + ++ L SS+              L    L+NN L     R+    L  
Sbjct: 89  SDNALGPDGCGVLESLLRSSS--------------LQELKLNNNGLGDRGLRLLAKGLKD 134

Query: 119 -SHSLEIFDMSKCNVSGGIPEEIGNL----TNLTAIYLGGNKLNGS-IPFTLREL---QK 169
              +LE   + +  + G   E +        +L  + L  N +  + I      L     
Sbjct: 135 LPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCN 194

Query: 170 LQYVGLKDN--------KLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSN-----LA 216
           L+ + L +N         L  T+      L  L  L+LG N L+ +     ++       
Sbjct: 195 LEVLDLNNNGLTDEGASALAETLA----SLKSLEVLNLGDNNLTDAGAAALASALLSPNI 250

Query: 217 SLRTLSLSYND 227
           SL TLSLS ND
Sbjct: 251 SLLTLSLSCND 261

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 433 IGKGGFGT--------IYKSRIGDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRN 482
           +G+G FG         I K +    + VAVK+       +       E E+MK I  ++N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YS-SNCILD----IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L         YS   C L      F+ L + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEI 620
              + ++APE     RV+ +  DV+SFG++L EI
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 59/228 (25%), Positives = 88/228 (38%), Gaps = 53/228 (23%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF-----HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +IG+G FG ++  R    G   A+KV        +   A      E +I+       +VK
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLV 544
           +  S  +EE   LV+E+MP G L   L   +   +   R  I   V ++ + +H   F  
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLAL-DSVHKLGF-- 122

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ------------------ 586
             IH D+KP N+L+D      L+DFG+ K +                             
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 587 ---------TLATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
                    T+ T  YIAPE      YG E       D +S G++L E
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 48/184 (26%), Positives = 93/184 (50%), Gaps = 15/184 (8%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           CR+   + + N I +G +G +Y++R    G  VA+K   L+  +  + F I    E  I+
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 476 KSIHYRNLVKI--ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
             + + N+V +  +   SN +   +V+E++ H  L+  + +        +   +M+ + S
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
            + +LH N+   ++H DLK SN+LL++  +  + DFG+ +      +    TQ + T+ Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWY 172

Query: 594 IAPE 597
            APE
Sbjct: 173 RAPE 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 60/194 (30%), Positives = 87/194 (44%), Gaps = 11/194 (5%)

Query: 432 LIGKGGFGTIY-KSRIGDGMEVAVKVFHLQC---GRAFKSFDIECEIM-KSIHYRNLVKI 486
           +IGKG FG +    R  DG   AVKV   +     +  K    E  ++ K++ +  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             S    E    VL+ +  G L   L       +   R     ++AS L YLH    + +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           ++ DLKP N+LLD      L+DFG+ K   G  QS T T    T  Y+APE  R+     
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 607 NGDVYSFGIMLMEI 620
             D +  G +L E+
Sbjct: 176 TVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 24/196 (12%)

Query: 445 RIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM 503
           R G  + VAVK+      + A   F  E +I+  +   N+++++  C +E+   ++ E+M
Sbjct: 42  RKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101

Query: 504 PHGSLEKCLYS----------------SNCILDI-FQRL-NIMIDVASVLEYLH-FNFLV 544
            +G L + L S                ++C+  I +  L ++ + +AS ++YL   NF  
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF-- 159

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             +H DL   N L+ + +   ++DFG+++ L   D    Q + +  I ++A E    G+ 
Sbjct: 160 --VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217

Query: 605 FANGDVYSFGIMLMEI 620
               DV++FG+ L EI
Sbjct: 218 TTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 15/192 (7%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR-NLVKII 487
           I KG FG++Y ++    G   A+KV     +       +   E  IM        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            S  ++++  LV+E++  G     + +   + + + +   + +V   +E LH      +I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLHQR---GII 119

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           H D+KP N+L+D T    L+DFG+++   G        + + T  Y+APE          
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAPETILGVGDDKM 173

Query: 608 GDVYSFGIMLME 619
            D +S G ++ E
Sbjct: 174 SDWWSLGCVIFE 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 36/213 (16%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDI-----ECEIMKSI 478
           F+   +IG+G FG +   R     + + +V+ ++    F   K  D      E +IM   
Sbjct: 45  FDVIKVIGRGAFGEVQLVR----HKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL 538
           +   +V++  +  ++++  +V+E+MP G L   L S+  I + + R     +V   L+ +
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAI 158

Query: 539 H-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           H   F    IH D+KP N+LLD +    L+DFG T + +  +  +     + T  YI+PE
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDTAVGTPDYISPE 213

Query: 598 ----------YGREGRVFANGDVYSFGIMLMEI 620
                     YGRE       D +S G+ L E+
Sbjct: 214 VLKSQGGDGYYGRE------CDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.0 bits (122), Expect = 7e-07
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 48/211 (22%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G  GT+YK+  +     +AVKV  L         DI  E+ K I     ++I+  C 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57

Query: 492 N------------EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------NIMIDVAS 533
           +            E    +  E M  GSL           D+++++       I + V  
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVK 106

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
            L YL   + + ++H D+KPSN+L++      L DFG++  L+    S+ +T  + T  Y
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAY 159

Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           +APE     +   + DV+S GI  ME+   +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.9 bits (121), Expect = 8e-07
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 27/210 (12%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F +   IG G FG +Y +R     EV A+K       ++ + +    +I+K + +   +K
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIK 83

Query: 486 IISSCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------LEY 537
             +S    E+K   L EH     +E CL S++ +L++ ++    +++A++       L Y
Sbjct: 84  HPNSI---EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LH + +   IH D+K  N+LL +     L+DFG   +      +      + T  ++APE
Sbjct: 141 LHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPE 191

Query: 598 Y---GREGRVFANGDVYSFGIMLMEIHSAK 624
                 EG+     DV+S GI  +E+   K
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 26/176 (14%)

Query: 433 IGKGGFGTIYK--SRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G+G + T+YK  SRI +G  VA+KV  ++   G  F +   E  ++K + + N+V +  
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 489 SCSNEEFKELVLEHMPHGSLEKC-------LYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
               +E    V E+M H  L +        L+  N  L +FQ L         L Y+H  
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ 122

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
               ++H DLKP N+L+       L+DFG+ +       S T +  + T+ Y  P+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 40/187 (21%)

Query: 432 LIGKGGFGTIYKSRIGDG--------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL 483
           ++GKGG+G +++ R   G        M+V  K   ++  +       E  I++++ +  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 484 VKIISSCSNEEFKELVLEHMPHGSL----EK---------CLYSSNCILDIFQRLNIMID 530
           V +I +        L+LE++  G L    E+         C Y S   L           
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISL----------- 111

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
               LE+LH      +I+ DLKP N+LLD      L+DFG+ K  I E  ++T T    T
Sbjct: 112 ---ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGT 163

Query: 591 IGYIAPE 597
           I Y+APE
Sbjct: 164 IEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 20/195 (10%)

Query: 433 IGKGGFGTI-YKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +   +    G +VAVK   L+  +  +    E  IM+  H+ N+V + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  +   ++  Q   + + V   L YLH      VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQ---GVIHRDI 144

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTE---- 198

Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 199 --VDIWSLGIMVIEM 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 30/206 (14%)

Query: 433 IGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MKSIHYRNLVK 485
           IG+G +G ++K+R     G  VA+K   +Q G          E+     +++  + N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 486 IISSCS----NEEFK-ELVLEHMPHG---SLEKCL---YSSNCILDIFQRLNIMIDVASV 534
           +   C+    + E K  LV EH+       L+K       +  I D+      M  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM------MFQLLRG 122

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L++LH +    V+H DLKP N+L+  +    L+DFG+ ++       M  T  + T+ Y 
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYR 176

Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE   +       D++S G +  E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS--------FDIECEIMKSIHYRNL 483
           +IG+G FG +   R     +   KV+ ++    F+         F  E +IM   +   +
Sbjct: 50  VIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V++  +  ++ +  +V+E+MP G L   L S+  + + + R     +V   L+ +H    
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIHS--- 160

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------ 597
           +  IH D+KP N+LLD +    L+DFG T + + ++  +     + T  YI+PE      
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 598 ----YGREGRVFANGDVYSFGIMLMEI 620
               YGRE       D +S G+ L E+
Sbjct: 220 GDGYYGRE------CDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 35/208 (16%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSF-DI--ECEIMKSIHYRNLVKIIS 488
           IG G FG +Y +R +     VA+K       ++ + + DI  E   ++ + + N +    
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI---- 78

Query: 489 SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------LEYLHF 540
                E+K   L EH     +E CL S++ IL++ ++    +++A++       L YLH 
Sbjct: 79  -----EYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEY- 598
           +     IH D+K  N+LL +     L+DFG   L       ++   + + T  ++APE  
Sbjct: 134 H---ERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANSFVGTPYWMAPEVI 183

Query: 599 --GREGRVFANGDVYSFGIMLMEIHSAK 624
               EG+     DV+S GI  +E+   K
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 55/174 (31%), Positives = 79/174 (45%), Gaps = 17/174 (9%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIM-------KSIHYRNL 483
           +IGKG FG +  +R   +    AVKV      +A      E  IM       K++ +  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V +  S    +    VL+++  G L   L    C L+   R     ++AS L YLH    
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS--- 114

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           + +++ DLKP N+LLD      L+DFG+ K  I E    T T    T  Y+APE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST-FCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 9/196 (4%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLV 484
           F +   IGKG FG +YK       EV A+K+  L+      +    E  ++       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +   S        +++E++  GS    L      L+      I+ ++   L+YLH     
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE--- 120

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++   
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 605 FANGDVYSFGIMLMEI 620
               D++S GI  +E+
Sbjct: 179 DFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 19/196 (9%)

Query: 432 LIGKGGFGTIY--KSRIGDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKI 486
            +G G FG ++  + RI      A+KV  +      +  +    E  ++K + +  ++++
Sbjct: 8   TVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             +  ++ F  +++E++P G L   L +S    +         ++   LEYLH   +V  
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHSKEIV-- 123

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE-YGREGRV 604
            + DLKP N+LLD      L+DFG  K L        +T TL  T  Y+APE    +G  
Sbjct: 124 -YRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHN 176

Query: 605 FANGDVYSFGIMLMEI 620
            A  D ++ GI++ E+
Sbjct: 177 KAV-DWWALGILIYEM 191

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 33/207 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL---QCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG G FG +Y +R + +   VA+K       Q    ++    E   ++ + + N +    
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---- 78

Query: 489 SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------LEYLHF 540
                +++   L EH     +E CL S++ +L++ ++    +++A+V       L YLH 
Sbjct: 79  -----QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-- 598
           + +   IH D+K  N+LL +  +  L DFG   ++            + T  ++APE   
Sbjct: 134 HNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 599 -GREGRVFANGDVYSFGIMLMEIHSAK 624
              EG+     DV+S GI  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 12/199 (6%)

Query: 433 IGKGGFG--TIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +GKG +G  ++ + R  DG +  +K  +L+    R  K+ + E +++  + + N+V    
Sbjct: 8   VGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 489 SCSNEE-FKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           S   E+    +V+     G L   L      +L   Q +   + +A  L+YLH      +
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---I 123

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DLK  NV L  T +  + D GI ++L  E+Q    +  + T  Y++PE         
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 607 NGDVYSFGIMLMEIHSAKQ 625
             DV++ G  + E+ + K 
Sbjct: 182 KSDVWALGCCVYEMATLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 46/161 (28%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIEC----EIMKSI----HYRNL 483
           +G G FG++Y +R    G  VA+K       + F S++ EC    E+ KS+     + N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 484 VKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRL-------NIMIDV 531
           VK+      E F+E      V E+M     E  LY    + D   +        +I+  +
Sbjct: 61  VKLK-----EVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQI 108

Query: 532 ASVLEYLHFN--FLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
              L ++H +  F     H DLKP N+L+    V  ++DFG
Sbjct: 109 LQGLAHIHKHGFF-----HRDLKPENLLVSGPEVVKIADFG 144

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 11/193 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              E    LV E + H  L+K + +S    + +    + +  +   L + H +    V+H
Sbjct: 68  IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 123

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     + ++  
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181

Query: 609 -DVYSFGIMLMEI 620
            D++S G +  E+
Sbjct: 182 VDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 15/196 (7%)

Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIECEIMK------SIHYRNLV 484
           ++GKG FG +  + +    EV A+KV  L+     +  D++C + +      +  +  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +      ++    V+E++  G L   +  S    +   R     +V   L +LH +   
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHRH--- 115

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            VI+ DLK  N+LLD      L+DFG+ K  I     +T T    T  YIAPE  +E   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173

Query: 605 FANGDVYSFGIMLMEI 620
             + D ++ G+++ E+
Sbjct: 174 GPSVDWWALGVLMYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 18/199 (9%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKIISSC 490
           +GKG +G++YK      G+ +A+K   L+   + F    +E +I+       +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             E    + +E+M  GSL+K          I + +   I  A V           +IH D
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREGRVFAN 607
           +KP+NVL++      L DFG++  L+    S+ +T     IG   Y+APE  + G    N
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGPNQN 181

Query: 608 G------DVYSFGIMLMEI 620
                  DV+S G+ ++E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 433 IGKGGFGTIYKS---RIGDG-----MEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +G+G F  I+K     +GD       EV +KV    H       +SF     +M  + ++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYS---ESFFEAASMMSQLSHK 59

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           +LV     C   +   +V E++  GSL+  L  +  +++I  +L +   +A  L +L   
Sbjct: 60  HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119

Query: 542 FLVPVIHCDLKPSNVLL----DDTM----VAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
            L    H ++   NVLL    D          LSD GI+  ++ ++        L  I +
Sbjct: 120 GLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPW 170

Query: 594 IAPEYGREGRVFA-NGDVYSFGIMLMEIHSAKQQCVS 629
           + PE     +  +   D +SFG  L EI S   + +S
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 7/121 (5%)

Query: 500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD 559
           +EHM  GSL++ L  +  I +      I I V   L YL       ++H D+KPSN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREK--HKIMHRDVKPSNILVN 134

Query: 560 DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLME 619
                 L DFG++  LI    SM  +  + T  Y++PE  +        D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190

Query: 620 I 620
           +
Sbjct: 191 M 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 10/190 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  +R    G +VAVK+  L+  +  +    E  IM+   ++N+V++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             E   +++E +  G+L   +  S   L+  Q   +   V   L YLH      VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDI 143

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY-IAPEYGREGRVFANGDV 610
           K  ++LL       LSDFG    +    + + + ++L    Y +APE           D+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 611 YSFGIMLMEI 620
           +S GIM++E+
Sbjct: 201 WSLGIMVIEM 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 37/232 (15%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGME------------------VAVKVFHLQ 460
           E  R    F E   +G+G FG ++     +GME                  VAVK+    
Sbjct: 1   EFPRKRLTFKEK--LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLRED 57

Query: 461 CGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCL------- 512
             + A   F  E +IM  +   N++++++ C   +   ++ E+M +G L + L       
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 513 --YSSNCILDIFQRLNIM-IDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSD 568
               ++ +   +  L  M   +AS ++YL   NF    +H DL   N L+       ++D
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNF----VHRDLATRNCLVGKNYTIKIAD 173

Query: 569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           FG+++ L   D    Q + +  I +++ E    G+     DV++FG+ L EI
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 36/208 (17%)

Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS--------FDIECEIMKSIHYRNL 483
           +IG+G FG +   R     + + KV+ ++    F+         F  E +IM   +   +
Sbjct: 50  VIGRGAFGEVQLVR----HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V++  +  ++++  +V+E+MP G L   L S+  + + + +     +V   L+ +H    
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIHS--- 160

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPE----- 597
           + +IH D+KP N+LLD      L+DFG    +  ++  M +  T + T  YI+PE     
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 598 -----YGREGRVFANGDVYSFGIMLMEI 620
                YGRE       D +S G+ L E+
Sbjct: 219 GGDGYYGRE------CDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 32/209 (15%)

Query: 433 IGKGGFGTIY--KSRIGDGM----EVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           IG+G FG IY  K++         E+ +    ++   A K   I    MK   + N+V  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK---HPNIVTF 64

Query: 487 ISSCSNEEFKELVLEHMPHGSLEK-------CLYSSNCILDIFQRLNIMIDVASVLEYLH 539
            +S        +V+E+   G L K        L+S + IL  F      + ++  L+++H
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH 118

Query: 540 FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPE 597
                 ++H D+K  N+ L  + MVA L DFGI + L   + SM    T   T  Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPE 172

Query: 598 YGREGRVFANG-DVYSFGIMLMEIHSAKQ 625
              + R + N  D++S G +L E+ + K 
Sbjct: 173 IC-QNRPYNNKTDIWSLGCVLYELCTLKH 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 7/144 (4%)

Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFHLQ-CGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +GT++K++  +  E VA+K   L        S  + E  ++K + ++N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
             +++   LV E+     L+K   S N  +D     + M  +   L + H +    V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHR 123

Query: 550 DLKPSNVLLDDTMVAHLSDFGITK 573
           DLKP N+L++      L+DFG+ +
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 6/155 (3%)

Query: 171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GP 229
           +      +     +P  + RL+ L  L   G   S        NL  L +L L+ N    
Sbjct: 49  RLALNLSSNTLLLLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLNLNRLRS 107

Query: 230 LPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD-LQYLFLGYNILKGSIPDSVGDLISL 288
              E+  L  L  +D   NN +  IP  IG LK  L+ L L  N ++ S+P  + +L +L
Sbjct: 108 NISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNL 165

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
           K+L+ S N+LS  +P LL  LS L +L+LS NK+ 
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Length = 394

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 51/195 (26%), Positives = 91/195 (46%), Gaps = 15/195 (7%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVF-----HLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +GKGGFG +   ++ + G   A K         + G   K   +E EI++ ++   +V +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVP 545
             +  ++    LV+  M  G L+  +Y+     L++ + ++    +   + +LH    + 
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +++ D+KP NVLLDD     LSD G   L +      T TQ   T GY+APE  +E    
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLG---LAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 606 ANGDVYSFGIMLMEI 620
              D ++ G  + E+
Sbjct: 173 YPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 432 LIGKGGFGTIYKSRIGDG--------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN- 482
           ++G G +G ++  R   G        M+V  K   +Q  +  +    E  +++  H R  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE--HVRQS 64

Query: 483 --LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEY 537
             LV +  +   E    L+L+++  G +   LY      D F    +      +   LE+
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEH 120

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LH    + +++ D+K  N+LLD      L+DFG++K  + E++  T +    TI Y+APE
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPE 176

Query: 598 YGR----EGRVFANGDVYSFGIMLMEI 620
             R     G+     D +S GI++ E+
Sbjct: 177 IIRGKGGHGKAV---DWWSLGILIFEL 200

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFHL---QCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG G FG +Y +      E VAVK       Q    ++    E + ++ + + N +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---- 84

Query: 489 SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------LEYLHF 540
                E+K   L EH     +E CL S++ +L++ ++    +++A++       L YLH 
Sbjct: 85  -----EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-- 598
           + +   IH D+K  N+LL +     L+DFG         +S      + T  ++APE   
Sbjct: 140 HNM---IHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVIL 190

Query: 599 -GREGRVFANGDVYSFGIMLMEIHSAK 624
              EG+     DV+S GI  +E+   K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 22/215 (10%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS-----GSLSSIAD 74
            +PS + N  NL+ L L  N+L   +P  + ++S L +L L  N +S       L S  +
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALE 212

Query: 75  NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG 134
               S+   +  LSSLSN K+L    LSNN L  +    SIGNLS +LE  D+S   +S 
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP--ESIGNLS-NLETLDLSNNQIS- 268

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
                +G+LTNL  + L GN L+ ++P           + L    L   +       +KL
Sbjct: 269 -SISSLGSLTNLRELDLSGNSLSNALPLIA-------LLLLLLELLLNLLLTLKALELKL 320

Query: 195 YKLDLGGNKLS---GSILTCFSNLASLRTLSLSYN 226
             + L  N LS    S     S L SL  L    N
Sbjct: 321 NSILLNNNILSNGETSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 20/195 (10%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  +   ++  Q   + + V   L  LH      VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDI 142

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPE---- 196

Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 197 --VDIWSLGIMVIEM 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 47/202 (23%)

Query: 426 GFNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCGRAFKSFDIEC---------E 473
            +     IG+G +G +YK++     DG E A+K         FK    +          E
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIK--------KFKGDKEQYTGISQSACRE 52

Query: 474 IM--KSIHYRNLVKIISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRL---N 526
           I   + + + N+V ++        K   L+ ++  H   +   +               +
Sbjct: 53  IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGIT-------KLL 575
           ++  + + + YLH N+   V+H DLKP+N+L+     +  V  + D G+        K L
Sbjct: 113 LLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 576 IGEDQSMTQTQTLATIGYIAPE 597
              D        + TI Y APE
Sbjct: 170 ADLD------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 427 FNENNLIGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR 481
           F+  +L+G+G FG +   R    GD   M+V +K   L        F+ E +I+   +  
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
            + ++  +  +++   LV+E+ P G L   L   N   D F        +A ++  +H  
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
             +  +H D+KP NVL+D T    L+DFG    L   ++ +     + T  YIAPE
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 58/187 (31%), Positives = 90/187 (48%), Gaps = 41/187 (21%)

Query: 433 IGKGGFGTIYKSRIGD---GMEVAVK-VFHLQCGRAF-------KSFDIECEIM---KSI 478
           +GKG +G ++K+   D      VA+K +F      AF       ++F    EIM   +  
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFD-----AFRNATDAQRTFR---EIMFLQELG 64

Query: 479 HYRNLVKIISSCSNEEFKE--LVLEHMP---HGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
            + N+VK+++    E  K+  LV E+M    H  +       N + D+ +R  IM  +  
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMYQLLK 118

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL--IGEDQSM-TQTQTLAT 590
            L+Y+H      VIH DLKPSN+LL+      L+DFG+ + L  + E+      T  +AT
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 591 IGYIAPE 597
             Y APE
Sbjct: 176 RWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)

Query: 432 LIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMK----SIHYRN--LV 484
           ++GKG FG +  + + G G   AVK   L+        D+EC +++    ++ + N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +  +   +E    V+E +  G L   +       D+++      ++   L++LH     
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKL-LIGEDQSMTQTQTLATIGYIAPEYGREGR 603
            +I+ DLK  NV+LD      ++DFG+ K  + G++++ T      T  YIAPE  +  +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172

Query: 604 VFANGDVYSFGIMLMEI 620
              + D +SFG++L E+
Sbjct: 173 YTFSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 11/199 (5%)

Query: 427 FNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F    ++GKGGFG +   ++   G   A K    +  +  K   +   E  I++ ++ R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFN 541
           +V +  +   ++   LVL  M  G L+  +Y+  N   D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
            +V   + DLKP N+LLDD     +SD G+  + I E +++     + T+GY+APE    
Sbjct: 122 RIV---YRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV--RGRVGTVGYMAPEVINN 175

Query: 602 GRVFANGDVYSFGIMLMEI 620
            +   + D +  G ++ E+
Sbjct: 176 EKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFHL-QCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G +YK+R     E +A+K   L Q      S  I E  ++K + + N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI----MIDVASVLEYLHFNFLVP 545
             +E+   LV E++    L+K + SS    D  +   +    +  +   + Y H +    
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH---R 122

Query: 546 VIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
           V+H DLKP N+L+D  T    L+DFG+ +         T T  + T+ Y APE     R 
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 605 FANG-DVYSFGIMLMEIHSAK 624
           ++   D++S G +  E+ + K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 40/239 (16%)

Query: 420 VCRA---TYGFNE------------NNLIGKGGFGTI-YKSRIGDGMEVAVKVFHLQ--- 460
           VCR    T+  +E            + ++G G  GT+    R+ DG   AVKV  ++   
Sbjct: 12  VCRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS 71

Query: 461 ---CGRAFKSFDIECEIMKSIHYRNLVK-----IISSCSNEE---FKELVLEHMPHGSLE 509
                RA    ++ C  + +  + ++VK           N E      LVL++   G L 
Sbjct: 72  EADKNRA--QAEVCC--LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLR 127

Query: 510 KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF 569
           + + S       F+     +    VL  +H      +IH D+K +N+LL    +  L DF
Sbjct: 128 QEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187

Query: 570 GITKLL---IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           G +K+    + +D   T      T  Y+APE  R        D++S G++L E+ + K+
Sbjct: 188 GFSKMYAATVSDDVGRT---FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 433 IGKGGFGTIYK---SRIGDGMEVAVK----VFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           IG G FG ++     R  DG  VA+K    VF   + C R F+   + C   K  +  + 
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLC-FFKHDNVLSA 64

Query: 484 VKIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + I+     + F+E+ V+  +    L K + S   +     ++  +  +   L+YLH   
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH--- 120

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              ++H D+KP N+L++   V  + DFG+ ++    D+S   TQ + T  Y APE     
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 603 RVFANG-DVYSFGIMLMEIHSAK 624
           R + +  D++S G +  E+   +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 3e-05
 Identities = 21/59 (35%), Positives = 27/59 (45%)

Query: 264 LQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           L+ L L  N L      +   L +LK L+ S NNL+   P     L  L  L+LS N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 29/169 (17%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVK---------VFHLQCGRAFKSFDI 470
           C     +     +G+G FG +YK+R I  G  VA+K          F +   R       
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR------- 56

Query: 471 ECEIMKSIHYRNLVKII------SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIF 522
           E +I+K + + N+V +I         S  +     +V  +M H  L   L + +  L   
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115

Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI 571
           Q    M+ +   + YLH N    ++H D+K +N+L+D+  +  ++DFG+
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 32/215 (14%)

Query: 433 IGKGGFGTIYKSRIGDGME---------VAVKVFHLQCG-RAFKSFDIECEIMKSI-HYR 481
           +G+G FG + ++    G++         VAVK+       +       E E+MK I  ++
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS-----NCILDI---------FQRL-N 526
           N++ ++  C+ E    +++E+   G+L + L +      +   DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     + 
Sbjct: 139 CAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 587 TLATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEI 620
               + ++APE     RV+ +  DV+SFGI++ EI
Sbjct: 196 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 44/215 (20%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI---MKSIHYRNLVK-- 485
           +IG+G +G +YK+R    G  VA+K+  +      +  +I+ E     K  ++ N+    
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDI---IEDEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 486 ---IISSCSNEEFK-ELVLEHMPHGS---LEKCLYSSNCILDIFQRLN------IMIDVA 532
              I  +    + +  LV+E    GS   L K L          +RL       I+ +  
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILRETL 123

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
             L YLH N    VIH D+K  N+LL       L DFG++  L   D ++ +  T   IG
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FIG 175

Query: 593 ---YIAPE-----YGREGRVFANGDVYSFGIMLME 619
              ++APE        +    A  DV+S GI  +E
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 13/128 (10%)

Query: 498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEYLHFNFLVPVIHCDLKPS 554
           L+L+++  G L   LY      + F    + + +A +   L++LH    + +I+ D+K  
Sbjct: 82  LILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLE 134

Query: 555 NVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG--DVYS 612
           N+LLD      L+DFG++K  + E++    +    TI Y+APE  R G    +   D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWS 193

Query: 613 FGIMLMEI 620
            G++  E+
Sbjct: 194 LGVLTFEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 431 NLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           N+IG G FG +Y++   D  E VA+K   LQ    +K  + E  IMK++++ N++ +   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQ-DPQYK--NRELLIMKNLNHINIIFLKDY 127

Query: 490 CSNEEFKE--------LVLEHMPHGSLEKCLYSS--NCILDIFQRLNIMIDVASVLEYLH 539
              E FK+        +V+E +P    +   + +  N  L +F        +   L Y+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 540 FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
             F   + H DLKP N+L+D +T    L DFG  K L+   +S++    + +  Y APE 
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRAPEL 241

Query: 599 GREGRVFANG-DVYSFGIMLMEI 620
                 +    D++S G ++ E+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEM 264

Length = 440

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 7/92 (7%)

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL- 588
           ++   L++LH      +I+ DLK  NVLLD      ++DFG+ K  I    +   T T  
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFC 157

Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            T  YIAPE           D ++ G++L E+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 3/104 (2%)

Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           L     L+    VA  +E+L     V   H DL   NVLL    +  + DFG+ + ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              +++  T   + ++APE   +       DV+S+GI+L EI S
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 6e-05
 Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 3/63 (4%)

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN 295
           NLK L   D S N  + +       L +L+ L L  N L    P++   L SL+SL+ S 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 296 NNL 298
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 22/198 (11%)

Query: 433 IGKGGFGTIYKSRIGDGMEV----AVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG FG + + R  D   +     ++  H+           E  ++  ++   +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPVI 547
           S  + E   LVL  +  G L   L       D+ +      ++   LE LH FN    VI
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLHKFN----VI 115

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE----YGREG 602
           + DLKP N+LLD      L DFG+ KL + +D    +T T   T  Y+APE    +G   
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTK 172

Query: 603 RVFANGDVYSFGIMLMEI 620
            V    D ++ G++L E+
Sbjct: 173 AV----DWWTLGVLLYEM 186

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 49/197 (24%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 432 LIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMK----SIHYRN--LV 484
           ++GKG FG ++ + + G     A+K   L+        D+EC +++    S+ + +  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +  +   +E    V+E++  G L   + S +   D+ +      ++   L++LH     
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK--- 115

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKL-LIGEDQSMTQTQTLATIGYIAPEYGREGR 603
            +++ DLK  N+LLD      ++DFG+ K  ++G+ ++ T      T  YIAPE     +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQK 172

Query: 604 VFANGDVYSFGIMLMEI 620
              + D +SFG++L E+
Sbjct: 173 YNTSVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 42/213 (19%)

Query: 427 FNENNLIGKGGFGTIYKSRI--GDGMEVAVKVFHLQCGRAFKSFD---IECEIMKSIHYR 481
           FN    +G G FG +  +     D   VA+K F        K  D    E +I+  I++ 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEK-------------CLYSSNCILDIFQRLNIM 528
             V +  S  +E +  LVLE +  G                 C Y++  +L         
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL--------- 142

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
                + EYL     + +++ DLKP N+LLD      ++DFG  K++       T+T TL
Sbjct: 143 -----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTL 188

Query: 589 -ATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             T  YIAPE           D ++ GI + EI
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221

Length = 340

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)

Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVFHLQCGRAFK------SFDIECEIMKSI 478
           F    ++GKGGFG +   + R    M    K   L+  R  K      + + E +I++ +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKK---LEKKRIKKRKGEAMALN-EKQILEKV 57

Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---L 535
           + R +V +  +   ++   LVL  M  G L+  +Y  N     F     +   A +   L
Sbjct: 58  NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGL 115

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           E LH   +V   + DLKP N+LLDD     +SD G+  + I E +++     + T+GY+A
Sbjct: 116 EDLHRERIV---YRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI--RGRVGTVGYMA 169

Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE  +  R   + D +  G ++ E+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 8e-05
 Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 8/88 (9%)

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGY 593
           LE+LH      +++ DLKP N+LLD T    L DFG++K  + ++++   T T   T  Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEY 162

Query: 594 IAPEYGREGRVFANG-DVYSFGIMLMEI 620
           +APE   + + +    D +S G+++ E+
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 29/87 (33%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGY 593
           L++LH      +I+ DLK  NVLLD      ++DFG+ K  +  +    +  T   T  Y
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDY 162

Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
           IAPE  +  +   + D +SFG++L E+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 9e-05
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI---MIDVASVLEYLHFNFLVPV 546
             +E    LV E +    L+K  Y  +  L       I   +  +   + Y H +    V
Sbjct: 67  VHSENKLYLVFEFLDL-DLKK--YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RV 120

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITK-----LLIGEDQSMTQTQTLATIGYIAPEYGRE 601
           +H DLKP N+L+D      L+DFG+ +     +        T T  + T+ Y APE    
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPV-------RTYTHEVVTLWYRAPEILLG 173

Query: 602 GRVFANG-DVYSFGIMLME 619
            R ++   D++S G +  E
Sbjct: 174 SRQYSTPVDIWSIGCIFAE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 12/146 (8%)

Query: 433 IGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           +G+G + T+YK  S++ D + VA+K   L+         I E  ++K + + N+V +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 490 CSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              E+   LV E+     L+K L  Y  +C  +     N+ + +  +L  L++     V+
Sbjct: 73  IHTEKSLTLVFEY-----LDKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITK 573
           H DLKP N+L+++     L+DFG+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G +YK R    G  VA+K   L+       S  I E  ++K + + N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-------FNF 542
              E    L+ E +    L+K L S              +D   V  YL+       F  
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              V+H DLKP N+L+D+  V  L+DFG+ +   G    +  T  + T+ Y APE     
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRV-YTHEVVTLWYRAPEVLLGS 176

Query: 603 RVFANG-DVYSFGIMLMEIHSAK 624
             ++   D++S G +  E+ + K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 3/104 (2%)

Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           LD+   L     VA  +++L        IH D+   NVLL D  VA + DFG+ + ++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)

Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80

Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 81  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 138

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 139 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 184

Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 47/215 (21%)

Query: 433 IGKGGFGTI---YKSRIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNL 483
           +G G +G++   Y +R+    +VAVK    +  R F+S         E  ++K + + N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 484 VKIIS----SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL---NIMIDVASVLE 536
           + ++     + S E F E+ L     G+        N I+   Q+L   ++   +  +L 
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            L +     +IH DLKPSNV +++     + DFG+ +     D  MT        GY+A 
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT--------GYVAT 178

Query: 597 EYGREGRVFANG-------DVYSFGIMLMEIHSAK 624
            + R   +  N        D++S G ++ E+   K
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 28/207 (13%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI---MKSIHYRNLVKII 487
           ++G G +G +YK R +  G   A+KV  +      +  +I+ EI    K  H+RN+    
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 488 ------SSCSNEEFKELVLEHMPHGSLEKCLYSS--NCILDIFQRLNIMIDVASVLEYLH 539
                 S   +++   LV+E    GS+   + ++  N + + +    I  ++   L +LH
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH 138

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEY 598
            +    VIH D+K  NVLL +     L DFG++  L   D+++ +  T + T  ++APE 
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEV 192

Query: 599 -----GREGRVFANGDVYSFGIMLMEI 620
                  +       D++S GI  +E+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 28/105 (26%)

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI---------GEDQSMTQ- 584
           LEYLH N+   ++H DLKP N+L+       L+DFG++K+ +         G  +  T+ 
Sbjct: 114 LEYLH-NY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 585 ---TQTLATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
               Q   T  YIAPE      YG+        D ++ GI+L E 
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEF 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 34/205 (16%)

Query: 432 LIGKGGFGTIYKSRIGDGME-VAVKVF---------------HLQCGRAFKSFDIECEIM 475
           ++G+G +G + K R  +  E VA+K F                L+  R  K  +I  E+ 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI-VELK 66

Query: 476 KSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVL 535
           ++   R  + ++     +   EL LE MP+G   + + S      I+Q       +   +
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPEKVRSY-----IYQ-------LIKAI 113

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
            + H N    ++H D+KP N+L+    V  L DFG  + L  E  +   T+ +AT  Y +
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRS 169

Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE           D++S G +L E+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 432 LIGKGGFGTIYKSRIGDGME--VAVK---VFHLQCGRAFKSFD-------IECEIMK-SI 478
            +G G FG +YK R  +  +  +A+K   V +   G+  +  D        E  I+K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF--QRL-NIMIDVASVL 535
            + N+V+   +    +   +V++ +    L +   S       F  +R+ NI + +   L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
            YLH      ++H DL P+N++L +     ++DFG+ K     +  +  T  + TI Y  
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKL--TSVVGTILYSC 181

Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE  +        DV++FG +L ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 23/76 (30%), Positives = 39/76 (51%)

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE   +     
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 607 NGDVYSFGIMLMEIHS 622
             DV+SFG++L EI S
Sbjct: 256 QSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 23/76 (30%), Positives = 39/76 (51%)

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE   +     
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 607 NGDVYSFGIMLMEIHS 622
             DV+SFG++L EI S
Sbjct: 261 QSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKII--- 487
           IGKG +G +YK +   DG   AVK+         +  + E  I++S+ ++ N+VK     
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 488 ---SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLN------IMIDVASVLEYL 538
                    +   LVLE    GS+ + +     +L   QRL+      I+      L++L
Sbjct: 89  YKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHL 144

Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE- 597
           H N    +IH D+K +N+LL       L DFG++  L      + +  ++ T  ++APE 
Sbjct: 145 HNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEV 199

Query: 598 --------YGREGRVFANGDVYSFGIMLMEI 620
                   Y  + R     DV+S GI  +E+
Sbjct: 200 IACEQQYDYSYDARC----DVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           ++ S L +LH      +I+ DLK  NVLLD      L+DFG+ K  I      T +    
Sbjct: 104 EITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCG 158

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           T  YIAPE  +E     + D ++ G++L E+
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 39/146 (26%), Positives = 74/146 (50%), Gaps = 12/146 (8%)

Query: 433 IGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           +G+G + T++K  S++ + + VA+K   L+         I E  ++K + + N+V +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 490 CSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              ++   LV E+     L+K L  Y  +C  +I    N+ I +  +L  L +     V+
Sbjct: 73  VHTDKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITK 573
           H DLKP N+L+++     L+DFG+ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 2/77 (2%)

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE   + +V+ 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYT 253

Query: 607 N-GDVYSFGIMLMEIHS 622
              DV+SFG++L EI S
Sbjct: 254 TQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           ++   LE+LH    + +I+ D+K  N+LLD      L+DFG++K    ED+         
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCG 168

Query: 590 TIGYIAPEYGREGRVFANG--DVYSFGIMLMEI 620
           TI Y+AP+  R G    +   D +S G+++ E+
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 7/151 (4%)

Query: 470 IECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
           IE  +++++++ +++++  +  +     +VL H     L   L   +  L I Q L I  
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
            +   L YLH      +IH D+K  N+ ++D     + D G  +  +     +    T+ 
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           T    APE     +  +  D++S GI+L E+
Sbjct: 222 T---NAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 13/122 (10%)

Query: 504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV 563
           P  +    L + +  L     +     VA+ +E+L     V   H DL   NVL+ +  +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKL 277

Query: 564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN-----GDVYSFGIMLM 618
             + DFG+ + ++ +   +++  T   + ++APE      +F N      DV+SFGI+L 
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE-----SIFNNLYTTLSDVWSFGILLW 332

Query: 619 EI 620
           EI
Sbjct: 333 EI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 42.0 bits (99), Expect = 7e-04
 Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 18/93 (19%)

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+Y+H      V+H DLKPSN+LL+      + DFG+ +    +   M  T+ + T  Y 
Sbjct: 121 LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175

Query: 595 APE-------YGREGRVFANGDVYSFGIMLMEI 620
           APE       Y          DV+S G +  E+
Sbjct: 176 APELLLNCSEYT------TAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 8e-04
 Identities = 22/59 (37%), Positives = 29/59 (49%)

Query: 169 KLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND 227
            L+ + L +N+L          L  L  LDL GN L+      FS L SLR+L LS N+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Length = 60

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 42/217 (19%)

Query: 433 IGKGGFGTIYKSR---IGDGMEVAVK----VFH--LQCGRAFKSFDIECEIMKSIHYR-- 481
           +G+G +G +  +R     +   VA+K    VF   +   RA +      E+    H+R  
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR------ELKLLRHFRGH 61

Query: 482 -NLVKIISS--CSNEEFKELVL-EHMPHGSLEKCLYSSNCILD------IFQRLNIMIDV 531
            N+  +          F EL L E +    L + + S   + D      I+Q L      
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL------ 115

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ---TQTL 588
              L+Y+H      V+H DLKP N+L++      + DFG+ +    E+        T+ +
Sbjct: 116 -CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYV 170

Query: 589 ATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHSAK 624
           AT  Y APE     + +    DV+S G +L E+   K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 41.7 bits (98), Expect = 8e-04
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 29/185 (15%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII---- 487
           +G G  G ++ +   D    VAVK   L   ++ K    E +I++ + + N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 488 --SSCSNEEFKEL--------VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
              S   E+   L        V E+M    L   L     + +   RL  M  +   L+Y
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEEHARL-FMYQLLRGLKY 129

Query: 538 LHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQ----TQTLATIG 592
           +H      V+H DLKP+NV ++ + +V  + DFG+ +++   D   +     ++ L T  
Sbjct: 130 IHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKW 183

Query: 593 YIAPE 597
           Y +P 
Sbjct: 184 YRSPR 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 433 IGKGGFGTIYKSRIGDGMEVA-VKVFHLQCGRAFK---SFDIECEIMKSIHYRNLVKIIS 488
           IG G FG +  S I     VA V V  L+   + K    F  + +  + + + N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSS-----NCILDIFQRLNIMIDVASVLEYLH-FNF 542
            C       LV E+   G L+  L        N  L + QR+    ++A+ + ++H  NF
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKHNF 120

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY--GR 600
           L    H DL   N  L   +   + D+GI      ED   T+      + ++APE     
Sbjct: 121 L----HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 601 EGRVFAN-----GDVYSFGIMLMEI-HSAKQ 625
            G +         +V++ G+ L E+  +A Q
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQ 207

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 13/104 (12%)

Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
           F    ++I + SV + LH+      +H D+KP N+L+D      L+DFG + L + ED +
Sbjct: 106 FYLAEMVIAIDSVHQ-LHY------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGT 157

Query: 582 MTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEI 620
           +  +  + T  YI+PE  +     +G+     D +S G+ + E+
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 39/209 (18%)

Query: 433 IGKGGFGTIY-----KSRIGDGMEV--AVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +GKG FGT+Y     K+   + ++V   + V  L      ++ + E +++  + +  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 486 IISS-------------CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVA 532
             +S             C   +    + E    G       S N + + F +L + +   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK----TLSENQVCEWFIQLLLGVH-- 120

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATI 591
               Y+H      ++H DLK  N+ L + ++  + DFG+++LL+G  D + T T    T 
Sbjct: 121 ----YMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTP 169

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            Y++PE  +     +  D++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.9 bits (95), Expect = 0.001
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 24/205 (11%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISS 489
           L+G G +G +YK R +  G   A+KV  +  G   +    E  ++K   H+RN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 490 C------SNEEFKELVLEHMPHGSLEKCLYSS--NCILDIFQRLNIMIDVASVLEYLHFN 541
                    ++   LV+E    GS+   + ++  N + + +    I  ++   L +LH +
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQH 130

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEY-- 598
               VIH D+K  NVLL +     L DFG++  L   D+++ +  T + T  ++APE   
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184

Query: 599 ---GREGRVFANGDVYSFGIMLMEI 620
                +       D++S GI  +E+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 50/203 (24%), Positives = 76/203 (37%), Gaps = 74/203 (36%)

Query: 431 NLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           + +G G +G +  +     G +VA+K       R F+S         +IH +        
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQS---------AIHAKRT------ 61

Query: 490 CSNEEFKEL-VLEHMPHGSLEKCLYSSN--CILDIF---QRLNIMIDVASVLEYL----- 538
                ++EL +L+HM H          N   +LD+F     L    DV  V   +     
Sbjct: 62  -----YRELRLLKHMDH---------ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLN 107

Query: 539 -----------HFNFLV-------------PVIHCDLKPSNVLLDDTMVAHLSDFGITKL 574
                      H  FLV              +IH DLKPSN+ +++     + DFG+ + 
Sbjct: 108 NIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167

Query: 575 LIGEDQSMTQTQTLATIGYIAPE 597
               D  M  T  +AT  Y APE
Sbjct: 168 T---DDEM--TGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 38/171 (22%)

Query: 432 LIGKGGFGTIY----KSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           LIG GGFG +Y     S      +   K+         ++ + E  +M+++ Y N+  I 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKI---------ENLENETIVMETLVYNNIYDID 69

Query: 488 SSCSNEEFKELVLEHMPH----GSLEKCLYSSNCIL---------DIFQRL--------- 525
                +    +    +P     GS ++C      IL         +IF+R+         
Sbjct: 70  KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK 129

Query: 526 NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
           NIM D+ + LEY+H +    + H D+KP N+++D     ++ D+GI    I
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177

Length = 294

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 31/229 (13%)

Query: 417 YLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGM-----EVAVKVF-----HLQCGRAFK 466
            +   R T      +L+ +G FG I+   + D       EV VK        +Q     +
Sbjct: 2   AISRDRVTLS----DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ 57

Query: 467 SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE-HMPHGSLEKCLYSSNCI------- 518
               E  ++  + ++N++ I+  C  +     VL  +M  G+L+  L             
Sbjct: 58  ----ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA 113

Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           L   Q +++ I +A  + YLH      VIH D+   N ++D+ +   ++D  +++ L   
Sbjct: 114 LSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM 170

Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHSAKQQ 626
           D           + ++A E     + +++  DV+SFG++L E+ +  Q 
Sbjct: 171 DYHCLGDNENRPVKWMALE-SLVNKEYSSASDVWSFGVLLWELMTLGQT 218

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 17/129 (13%)

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           N++ K+ + EH+P    E  L     +L               L+ +H   +   +H DL
Sbjct: 153 NKQIKQRLKEHLPFQEYEVGLLFYQIVL--------------ALDEVHSRKM---MHRDL 195

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K +N+ L  T +  L DFG +K           +    T  Y+APE     R     D++
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255

Query: 612 SFGIMLMEI 620
           S G++L E+
Sbjct: 256 SLGVILYEL 264

Length = 478

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 17/155 (10%)

Query: 474 IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
           +M  + + +L  +   C       +V E + HG L+ CL      + +  ++ +   +AS
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH-------LSDFGITKLLIGEDQSMTQTQ 586
            L YL    LV   H ++   N+LL    +A        LSD G++        ++++ +
Sbjct: 129 ALSYLEDKNLV---HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF------TALSREE 179

Query: 587 TLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
            +  I +IAPE    G   +   D +SFG  L+EI
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 22/66 (33%), Positives = 36/66 (54%), Gaps = 14/66 (21%)

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+Y+H      V+H DLKPSN+L+++     + DFG+ ++   +D  MT        GY+
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMT--------GYV 166

Query: 595 APEYGR 600
           +  Y R
Sbjct: 167 STRYYR 172

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 6/143 (4%)

Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G+G + T++K R       VA+K   L+         I E  ++K++ + N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             E    LV E++    L++  Y  NC  ++    N+ I +  +L  L +     ++H D
Sbjct: 73  HTERCLTLVFEYL-DSDLKQ--YLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 551 LKPSNVLLDDTMVAHLSDFGITK 573
           LKP N+L+++     L+DFG+ +
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 19/98 (19%)

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL- 588
           ++A  L +LH      +I+ DLK  NV+LD      ++DFG+ K  I   ++   T+T  
Sbjct: 109 EIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFC 162

Query: 589 ATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
            T  YIAPE      YG+      + D ++FG++L E+
Sbjct: 163 GTPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEM 194

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 37/210 (17%)

Query: 432 LIGKGGFGT-----------IYKSRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSI 478
           +IG+G FG            IY  +I +  E+ +K     C R  ++  +  +C+ + ++
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTL 66

Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNI--MIDVASVL 535
           HY        +  +E +  LV+++   G L   L    + + +   R  I  M+     +
Sbjct: 67  HY--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
             LH+      +H D+KP NVLLD      L+DFG + L + +D ++  +  + T  YI+
Sbjct: 119 HQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYIS 171

Query: 596 PEYGRE-----GRVFANGDVYSFGIMLMEI 620
           PE  +      G+     D +S G+ + E+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 45/184 (24%), Positives = 87/184 (47%), Gaps = 26/184 (14%)

Query: 449 GMEVAVKVF------HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS----SCSNEEFKE- 497
           G+ VAVK             RA++    E  ++K ++++N++ +++      S EEF++ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101

Query: 498 -LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNV 556
            LV+E M   +L + ++     LD  +   ++  +   +++LH      +IH DLKPSN+
Sbjct: 102 YLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154

Query: 557 LLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
           ++       + DFG+ +       +   T  + T  Y APE         N D++S G +
Sbjct: 155 VVKSDCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 211

Query: 617 LMEI 620
           + E+
Sbjct: 212 MGEL 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 6/79 (7%)

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR-----E 601
           +H D+KP NVLLD      L+DFG + L +  D ++     + T  YI+PE  +     +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 602 GRVFANGDVYSFGIMLMEI 620
           GR     D +S G+ + E+
Sbjct: 183 GRYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 28/104 (26%), Positives = 46/104 (44%), Gaps = 3/104 (2%)

Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           LD    L+    VA  + +L        IH DL   N+LL    +  + DFG+ + +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + +      + ++APE           DV+S+GI+L EI S
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 37/211 (17%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G +G +YK+R    G  VA+K   L+         ++ E +     R  + ++   S
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLE---------MDEEGIPPTALRE-ISLLQMLS 58

Query: 492 NEEF--KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV----------ASVLEYLH 539
              +  + L +EH+   + +  LY     LD    L   +D           A  ++   
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD--SDLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 540 FNFLVPVIHC--------DLKPSNVLLDDT-MVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +  L  V HC        DLKP N+L+D    +  ++D G+ +      +S   T  + T
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174

Query: 591 IGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
           + Y APE       ++   D++S G +  E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 31/207 (14%)

Query: 427 FNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFD---IECEIMKSIHYRN 482
           F     +G G FG +  ++  G G   A+K    +     K       E  I+  + +  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS----NCILDIFQRLNIMIDVASVLEYL 538
           +V ++ S  +E     +LE +  G L   L  +    N +   +       ++    EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE 597
           H      +I+ DLKP N+LLD+     ++DFG  K      +   +T TL  T  Y+APE
Sbjct: 135 HS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPE 185

Query: 598 Y----GREGRVFANGDVYSFGIMLMEI 620
                G    V    D ++ G++L E 
Sbjct: 186 VIQSKGHGKAV----DWWTMGVLLYEF 208

Length = 329

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 39.3 bits (92), Expect = 0.004
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 24/152 (15%)

Query: 433 IGKGGFGTIYK--SRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G+G + T+YK  S++   + VA+K   L+   G  F +   E  ++K + + N+V +  
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 489 SCSNEEFKELVLEHMPHGSL----EKC---LYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
               ++   LV E++    L    + C   L   N  L +FQ L         L Y H  
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQR 122

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK 573
               V+H DLKP N+L+ +     L+DFG+ +
Sbjct: 123 R---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	652
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.91
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
smart00090	237	RIO RIO-like kinase.	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.56
PLN03150	623	hypothetical protein; Provisional	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.34
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.31
PLN03150	623	hypothetical protein; Provisional	99.31
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.29
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.29
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.21
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.04
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.02
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.0
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.87
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.74
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.72
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.65
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.61
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.55

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.9e-80  Score=729.06  Aligned_cols=624  Identities=29%  Similarity=0.465  Sum_probs=441.6

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCC-------ccc
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI-------ADN   75 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-------~~~   75 (652)
                      ++|+.|+|+.|.+..  .+|..+ ++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..       ...
T Consensus       236 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  313 (968)
T PLN00113        236 TSLNHLDLVYNNLTG--PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL  313 (968)
T ss_pred             CCCCEEECcCceecc--ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEE
Confidence            467777887777653  577766 6777778888777777777777777777777777777776554432       111


Q ss_pred             cccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCc-----------------
Q 041689           76 YLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE-----------------  138 (652)
Q Consensus        76 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~-----------------  138 (652)
                      .+..+......+..+..+++|+.|+|++|.+++..|. .++.+++ |+.|++++|++++..|.                 
T Consensus       314 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~~~~-L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~  391 (968)
T PLN00113        314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK-NLGKHNN-LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS  391 (968)
T ss_pred             ECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCCh-HHhCCCC-CcEEECCCCeeEeeCChhHhCcCCCCEEECcCCE
Confidence            2222222112223455556666666666666555444 4444443 55555555555544444                 


Q ss_pred             -------cccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccccccc
Q 041689          139 -------EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC  211 (652)
Q Consensus       139 -------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  211 (652)
                             .+..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++.+|..+..+++|+.|+|++|++.+..|..
T Consensus       392 l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~  471 (968)
T PLN00113        392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS  471 (968)
T ss_pred             ecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcc
Confidence                   4445555555555555555555555555555555555555555555555555555555555555555555554


Q ss_pred             CCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCc
Q 041689          212 FSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLK  289 (652)
Q Consensus       212 ~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  289 (652)
                      + ..++|+.|++++|+  +..|..+.++++|+.|++++|++.+.+|..+.++++|++|+|++|.+++.+|..|..+++|+
T Consensus       472 ~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  550 (968)
T PLN00113        472 F-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS  550 (968)
T ss_pred             c-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCC
Confidence            4 24667777777775  56677788899999999999999999999999999999999999999999999999999999


Q ss_pred             ceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCCCC-CCCCCCCCccccccccc
Q 041689          290 SLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPN-LHVPPCKTSIHHTSRKN  368 (652)
Q Consensus       290 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~-~~~~~~~~~~~~~~~~~  368 (652)
                      .|+|++|++++.+|..+..++.|+.|++++|++++.+|..+.+..+....+.||+..|+.+. ...++|.....  ....
T Consensus       551 ~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~  628 (968)
T PLN00113        551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSW  628 (968)
T ss_pred             EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--ccee
Confidence            99999999999999999999999999999999999999988888888889999999998653 23456643211  1112


Q ss_pred             chhhhhhHhhhhhh-hhhhhhhhhhhcccCC---CCCCCCCCC----CCCccccccHHHHHHHhcCCCccceeccccceE
Q 041689          369 ALFLGIVLSFSTIF-MVVVILLIVKYQKREN---WPPNDANMP----PKATWRRFSYLEVCRATYGFNENNLIGKGGFGT  440 (652)
Q Consensus       369 ~~~~~~v~~~~~~~-~~~~~~~~~~~~kr~~---~~~~~~~~~----~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~  440 (652)
                      ++++++++++++++ ++++++++++++++.+   .........    .....+.++..++.   ..|...+.||+|+||.
T Consensus       629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~  705 (968)
T PLN00113        629 WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGA  705 (968)
T ss_pred             eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCee
Confidence            22233333322222 2222222222222111   111010000    00111234444443   4577888999999999


Q ss_pred             EEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCC
Q 041689          441 IYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCIL  519 (652)
Q Consensus       441 Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l  519 (652)
                      ||+|+. .++..||||+++....    ....|++++++++|||||++++++.+++..++||||+++|+|.++++    .+
T Consensus       706 Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l  777 (968)
T PLN00113        706 SYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NL  777 (968)
T ss_pred             EEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cC
Confidence            999986 4789999999864322    22356889999999999999999999999999999999999999986    37


Q ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCcccc
Q 041689          520 DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG  599 (652)
Q Consensus       520 ~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  599 (652)
                      ++.++.+++.|+++|++|||..+.++|+||||||+||+++.++.+++. ||.+....      ......+++.|+|||++
T Consensus       778 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~  850 (968)
T PLN00113        778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETR  850 (968)
T ss_pred             CHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccc
Confidence            889999999999999999996666699999999999999999888876 66554321      11223578999999999


Q ss_pred             ccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------------------------hhhhhhccc
Q 041689          600 REGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------------------------FVFNLAMEC  638 (652)
Q Consensus       600 ~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------------------------~l~~l~~~~  638 (652)
                      .+..++.++|||||||++|||+||+.||+.                                         ++.+++.+|
T Consensus       851 ~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C  930 (968)
T PLN00113        851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHC  930 (968)
T ss_pred             cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhh
Confidence            999999999999999999999999999632                                         134677899


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||++||
T Consensus       931 l~~~P~~RPt~~ev  944 (968)
T PLN00113        931 TATDPTARPCANDV  944 (968)
T ss_pred             CcCCchhCcCHHHH
Confidence            99999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=378.49  Aligned_cols=200  Identities=28%  Similarity=0.425  Sum_probs=182.5

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ...+|...+.||+|+||+||+|+++ ++.+||||.+...  ..+..+.+..|+++|+.++|||||++++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4567888999999999999999865 5899999999766  455677789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC------CcEEEecccCCc
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT------MVAHLSDFGITK  573 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~------~~~kl~Dfg~~~  573 (652)
                      ||||.||||.+|++.++ .+++..+..++.|+|.||++||++   +||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999876 799999999999999999999999   99999999999999754      579999999999


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~  629 (652)
                      .+.   ........+|++.|||||++...+|+.|+|+||.|+++|+|++|+.||+.
T Consensus       164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            873   33445677899999999999999999999999999999999999999884

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-47  Score=392.27  Aligned_cols=222  Identities=25%  Similarity=0.302  Sum_probs=203.6

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|...+.||+|||+.||.++. .+|..||+|++.+.   .....+.+.+|++|.++++|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5689999999999999999997 78999999999764   3445678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+|+.++|.++++. +..+++.++..+++||+.||.|||+.   +|+|||||..|+|++++..+||+|||+|..+..  .
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--D  171 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC--c
Confidence            99999999999884 44899999999999999999999999   999999999999999999999999999998742  3


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~  637 (652)
                      .......+|||.|.|||++....++..+||||+|||||.|+.|++||...                       .++++.+
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~  251 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK  251 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence            34456789999999999999999999999999999999999999997765                       6799999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      +|+.||.+|||+++|
T Consensus       252 lL~~~P~~Rpsl~~v  266 (592)
T KOG0575|consen  252 LLRPNPSERPSLDEV  266 (592)
T ss_pred             HhcCCcccCCCHHHH
Confidence            999999999999875

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=372.96  Aligned_cols=217  Identities=25%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-eEEEEEccC
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-KELVLEHMP  504 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~  504 (652)
                      +..+.||+|..|+||+|+++ +++.+|+|.+... .....+++.+|+++++..+||+||++||.|..++. .+|+||||.
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD  161 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD  161 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence            44578999999999999876 6888999999655 34567789999999999999999999999999984 999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +|+|+++++..+ ++++....+|+.++++||.|||. .   +||||||||+|||++..|.+||||||.++.+..    ..
T Consensus       162 gGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn----S~  233 (364)
T KOG0581|consen  162 GGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN----SI  233 (364)
T ss_pred             CCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh----hh
Confidence            999999887664 79999999999999999999996 5   999999999999999999999999999997732    25


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC------------------------------cchhhhh
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------------------------------CVSFVFN  633 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p------------------------------~~~~l~~  633 (652)
                      ....+||..|||||.+.+..|+.++||||||++++|+++|+.|                              |++++++
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~  313 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS  313 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            5678899999999999999999999999999999999999988                              4445899


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++..|+++||.+||+++|+
T Consensus       314 FV~~CL~Kdp~~R~s~~qL  332 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSAKQL  332 (364)
T ss_pred             HHHHHhcCCcccCCCHHHH
Confidence            9999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-47  Score=372.39  Aligned_cols=220  Identities=24%  Similarity=0.300  Sum_probs=192.6

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccc-------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG-------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      ..|.+.+.+|+|+||.|-+|.. ++|+.||||+++++..       ......++|+++|++++|||||+++++|+..+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            4577889999999999999974 5799999999975521       1223467999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEecccCCc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITK  573 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~~~  573 (652)
                      |+||||++||+|.+.+-.++ .+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||+|+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999988776 678888889999999999999999   99999999999999755   889999999999


Q ss_pred             cccCCCCccccccccCCccccCccccccCcc---CcccchhhHHHHHHHHHhCCCCcchh--------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRV---FANGDVYSFGIMLMEIHSAKQQCVSF--------------------  630 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltg~~p~~~~--------------------  630 (652)
                      ...   ........+||+.|.|||++....+   ..++|+||+||++|-+++|.+||++.                    
T Consensus       328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~  404 (475)
T KOG0615|consen  328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL  404 (475)
T ss_pred             ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence            762   3344567899999999999887643   34779999999999999999997765                    


Q ss_pred             --------hhhhhcccchhhhccccCccC
Q 041689          631 --------VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 --------l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                              ..+++.+||..||++|||++|
T Consensus       405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~e  433 (475)
T KOG0615|consen  405 QWDRISEEALDLINWMLVVDPENRPSADE  433 (475)
T ss_pred             hhhhhhHHHHHHHHHhhEeCcccCcCHHH
Confidence                    688999999999999999986

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=384.34  Aligned_cols=240  Identities=40%  Similarity=0.626  Sum_probs=211.4

Q ss_pred             ccccccHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeee
Q 041689          411 TWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC  490 (652)
Q Consensus       411 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  490 (652)
                      ..+.|++.|+..+|++|...+.||+|+||.||+|...+|..||||++.........+|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            67789999999999999999999999999999999999999999988765432145699999999999999999999999


Q ss_pred             ecCC-ceEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          491 SNEE-FKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       491 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      .+.+ +.++|+||+++|+|.+++..... .++|..+++|+.++|+||+|||+.+.+.||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 49999999999999999998776 899999999999999999999999888999999999999999999999999


Q ss_pred             ccCCccccCCCCccccccc-cCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------
Q 041689          569 FGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------  630 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------  630 (652)
                      ||+|+.....  ....... .||.+|+|||+...+..+.|+|||||||++.|++||++|.+..                 
T Consensus       221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999754221  1111122 7999999999999999999999999999999999999873310                 


Q ss_pred             -------------------------hhhhhcccchhhhccccCccCC
Q 041689          631 -------------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -------------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               +..+..+|++.+|++||++.||
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V  345 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQV  345 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence                                     3456778999999999998764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=362.36  Aligned_cols=219  Identities=27%  Similarity=0.321  Sum_probs=196.6

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..++|++.+.||+|+||+||.++.+ +++-||+|++++..   ....+....|..++.+++||.||+++..|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3457899999999999999999865 58899999997652   2345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+||+.||.|..++.+.+ .+++..+.-++.+|+.||.|||++   |||||||||+|||+|++|+++|+|||+++...  
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--  176 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc--
Confidence            999999999999998766 799999999999999999999999   99999999999999999999999999999542  


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF------------------------VFNL  634 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~------------------------l~~l  634 (652)
                      .........+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...                        .+++
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl  256 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDL  256 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence            2333445579999999999999999999999999999999999999995443                        7899


Q ss_pred             hcccchhhhcccc
Q 041689          635 AMECTIESLELRI  647 (652)
Q Consensus       635 ~~~~l~~~p~~Rp  647 (652)
                      +.+.++.||++|-
T Consensus       257 l~~LL~rdp~~RL  269 (357)
T KOG0598|consen  257 LKKLLKRDPRQRL  269 (357)
T ss_pred             HHHHhccCHHHhc
Confidence            9999999999995

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=378.53  Aligned_cols=219  Identities=30%  Similarity=0.433  Sum_probs=191.7

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-ceEEEEEccCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-FKELVLEHMPH  505 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  505 (652)
                      ..+.+|+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|++.+.. ..++||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3456999999999999996544599999976532  22568999999999999999999999999887 78999999999


Q ss_pred             CChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCCCCCCeeeCCCC-cEEEecccCCccccCCCCcc
Q 041689          506 GSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVP-VIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       506 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      |+|.+++... ...+++..+..++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            9999999883 55899999999999999999999999   7 99999999999999997 99999999998653211  3


Q ss_pred             ccccccCCccccCccccc--cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhhhh
Q 041689          583 TQTQTLATIGYIAPEYGR--EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFNLA  635 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~l~  635 (652)
                      ..+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||..                         .+..++
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~  279 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLM  279 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            334467999999999999  56999999999999999999999988544                         378899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||..||+.||++.||
T Consensus       280 ~~CW~~dp~~RP~f~ei  296 (362)
T KOG0192|consen  280 ERCWLVDPSRRPSFLEI  296 (362)
T ss_pred             HHhCCCCCCcCCCHHHH
Confidence            99999999999999875

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=355.86  Aligned_cols=221  Identities=23%  Similarity=0.354  Sum_probs=191.6

Q ss_pred             CCCccceeccccceEEEEEE-eCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEe-eeecCCc-eEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIIS-SCSNEEF-KELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~  500 (652)
                      +|.+.+.||+|+||+||+++ ..+|..||.|.++-+  +.+..+++..|+.+|++++|||||++++ .+..+.. .+|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            47778899999999999997 568999999999754  3456778899999999999999999998 4444444 89999


Q ss_pred             EccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          501 EHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      |||.+|||.++++.   .+..+++..+++++.|++.||.++|.+. +.  |+||||||.||+++..|.+||+|||+++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999998863   3347999999999999999999999842 24  999999999999999999999999999987


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------hh
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SF  630 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~  630 (652)
                      .  .........+|||.||+||.+.+.+|++||||||+||++|||+.-++||.                         ..
T Consensus       179 ~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  179 S--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             c--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence            3  22334456789999999999999999999999999999999999888843                         34


Q ss_pred             hhhhhcccchhhhccccCc
Q 041689          631 VFNLAMECTIESLELRINA  649 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~  649 (652)
                      +..++..|+..||+.||+.
T Consensus       257 l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHccCCcccCCCc
Confidence            8889999999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=345.88  Aligned_cols=222  Identities=23%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      +.|+...++|+|+||+||+|+.+ +|+.||||++...  +....+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45788889999999999999976 5999999999643  23345567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||+. ++.+-+......++...+.++++|++.|+.|+|++   ++|||||||+||||+.+|.+||||||+|+.+..  ..
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence            9988 55555666666799999999999999999999999   999999999999999999999999999998743  44


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcchh------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVSF------------------------------  630 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~------------------------------  630 (652)
                      ...+..+.|.+|+|||.+.+ .+|+..+||||.||++.||++|.+-|+..                              
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            55667789999999999887 68999999999999999999999864432                              


Q ss_pred             ------------------------hhhhhcccchhhhccccCccCC
Q 041689          631 ------------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 ------------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                              +.++++.|+..||++|++.+|+
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql  281 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL  281 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence                                    6789999999999999998764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=365.54  Aligned_cols=228  Identities=25%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .+...+|..++.||+|+|++||+|+.. ++++||||++.+.   ..+..+.+.+|-.+|.++ .||.|++++-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            556678999999999999999999854 6999999998654   233455677899999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+|+||+++|+|.+++...+ .+++..++.++.||+.||+|||++   |||||||||+|||+|+++++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998876 899999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCc---------cc--cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------
Q 041689          576 IGEDQS---------MT--QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------  628 (652)
Q Consensus       576 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------  628 (652)
                      .+....         ..  ....+||..|.+||++..+..+..+|+|||||++|+|+.|++||.                
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            543221         11  144789999999999999999999999999999999999999944                


Q ss_pred             -------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             ..+.+++++.|..||.+|+|++||
T Consensus       305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence                   448999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=367.49  Aligned_cols=220  Identities=30%  Similarity=0.488  Sum_probs=194.2

Q ss_pred             CCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +...+.||+|-||+||.|.+.....||+|.++... ...++|.+|+++|++++|++||+++++|..++.+|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34457899999999999999877899999998763 34578889999999999999999999999988999999999999


Q ss_pred             Chhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          507 SLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       507 ~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      +|.++++. .+..+...+...++.|||+|++||+++   ++|||||.++|||++++..+||+|||+|+.. .++......
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~  362 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASE  362 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc-CCCceeecC
Confidence            99999997 445789999999999999999999999   9999999999999999999999999999944 222233333


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------------cchhhhhhhcccch
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------------CVSFVFNLAMECTI  640 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------------~~~~l~~l~~~~l~  640 (652)
                      ...-...|.|||.+..+.++.|||||||||+||||+| |+.|                        |++.+.++|..||.
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~  442 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWH  442 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence            3445678999999999999999999999999999998 5555                        66779999999999


Q ss_pred             hhhccccCccC
Q 041689          641 ESLELRINAKE  651 (652)
Q Consensus       641 ~~p~~Rpt~~e  651 (652)
                      .+|++||||+.
T Consensus       443 ~~P~~RPtF~~  453 (468)
T KOG0197|consen  443 EDPEDRPTFET  453 (468)
T ss_pred             CCcccCCCHHH
Confidence            99999999964

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-44  Score=352.96  Aligned_cols=225  Identities=28%  Similarity=0.416  Sum_probs=194.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--ceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--FKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  501 (652)
                      .++...+.||+|+||.||++... +|..+|||.+........+.+++|+++|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677799999999999999865 48999999997664333677899999999999999999999855554  6899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCCccccC-CC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIG-ED  579 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~-~~  579 (652)
                      |+++|+|.+++...++.+++..+..+.+|+++||+|||++   ||+||||||+|||++. ++.+||+|||.++.... ..
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            9999999999998766799999999999999999999999   9999999999999999 79999999999987643 11


Q ss_pred             CccccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCcch--------------------------hhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVF  632 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~  632 (652)
                      .........||+.|||||++..+. ...++||||+||++.||+||++||..                          ..+
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~  253 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAK  253 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHH
Confidence            122234567999999999998643 34589999999999999999999776                          378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+|+..||++||||+|+
T Consensus       254 ~Fl~~C~~~~p~~Rpta~eL  273 (313)
T KOG0198|consen  254 DFLRKCFKRDPEKRPTAEEL  273 (313)
T ss_pred             HHHHHHhhcCcccCcCHHHH
Confidence            99999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-43  Score=351.80  Aligned_cols=222  Identities=26%  Similarity=0.299  Sum_probs=195.1

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  499 (652)
                      +.|+..++||+|+||.||+|++ .+|+.||+|+++.+.  .....-..+|+.||++++||||+++.+...+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            3467778999999999999985 479999999998664  33445668999999999999999999988776  689999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +|||+. ||.-++....-.+++.++..++.|++.||+|+|.+   ||+|||||.+|||||.+|.+||+|||+|+++... 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~-  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS-  271 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC-
Confidence            999988 99998887766899999999999999999999999   9999999999999999999999999999987433 


Q ss_pred             CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCC--------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQ--------------------------------  626 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p--------------------------------  626 (652)
                      .....+..+.|.+|+|||++.+. .|+.+.|+||.|||+.||++|++.                                
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            33446777899999999998775 699999999999999999999986                                


Q ss_pred             --------------------cchhhhhhhcccchhhhccccCccC
Q 041689          627 --------------------CVSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       627 --------------------~~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                          |+....+++..+|..||.+|.||.+
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~  396 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS  396 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence                                3334678999999999999999865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=326.70  Aligned_cols=214  Identities=25%  Similarity=0.288  Sum_probs=193.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|+..+.+|.|+||.|.+++.+ +|..||+|+++.+.-   +..+....|..+|+.+.||+++++++.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            35778899999999999999865 588999999976632   33455678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||++||.|..+++..+ ++++..+.-++.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+...    
T Consensus       124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----  195 (355)
T ss_pred             eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec----
Confidence            9999999999998766 799999999999999999999999   99999999999999999999999999999752    


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-----------------------chhhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-----------------------VSFVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-----------------------~~~l~~l~~~  637 (652)
                       ......+|||.|+|||+++..+|..++|.|||||++|||+.|.+||                       +..++++++.
T Consensus       196 -~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  196 -GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK  274 (355)
T ss_pred             -CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence             2355678999999999999999999999999999999999999994                       4458999999


Q ss_pred             cchhhhcccc
Q 041689          638 CTIESLELRI  647 (652)
Q Consensus       638 ~l~~~p~~Rp  647 (652)
                      .++.|-.+|.
T Consensus       275 LL~vD~t~R~  284 (355)
T KOG0616|consen  275 LLQVDLTKRF  284 (355)
T ss_pred             HHhhhhHhhh
Confidence            9999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=355.30  Aligned_cols=221  Identities=22%  Similarity=0.279  Sum_probs=193.9

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhh-hHHHHHHHHHhcC-CCeeeeEEeeeecCC-ceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIH-YRNLVKIISSCSNEE-FKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv  499 (652)
                      .++|...++||.|+||.||+|+. .+|..||||+++.......+ .-.+|++.|+++. |||||++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            35788999999999999999984 46899999999876433322 3368999999998 999999999999888 99999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||||+. +|+++++.++..+++..+..|++||++||+|+|++   |+.|||+||+|||+.....+||+|||+|+.+   .
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev---~  161 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV---R  161 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc---c
Confidence            999976 99999999988999999999999999999999999   9999999999999998889999999999976   3


Q ss_pred             CccccccccCCccccCcccc-ccCccCcccchhhHHHHHHHHHhCCCCcc------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYG-REGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------------  628 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------------  628 (652)
                      .....+..+.|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++-|+                              
T Consensus       162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            44556778899999999976 56678999999999999999998666432                              


Q ss_pred             -----------------------hhhhhhhcccchhhhccccCccC
Q 041689          629 -----------------------SFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       629 -----------------------~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                             .+..+++.+|+++||++||||+|
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~  287 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ  287 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence                                   23678999999999999999976

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-42  Score=321.17  Aligned_cols=221  Identities=24%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccch--hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGR--AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .+|...+++|+|.||.||+|++ .+|+.||||+++....+  ......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688889999999999999985 47999999999866322  24467899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++. +|+..++.+...++..++..++.++++|++|+|.+   .|+||||||.|+||+++|.+||+|||+|+.+....  
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--  155 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC--
Confidence            9987 99999999888999999999999999999999999   99999999999999999999999999999875433  


Q ss_pred             cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCc---------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQC---------------------------------  627 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~---------------------------------  627 (652)
                      ......+.|.+|+|||.+.+. .|+...||||.|||+.||+-|.+-|                                 
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            333444789999999988765 6899999999999999999877631                                 


Q ss_pred             ------------------chhhhhhhcccchhhhccccCccC
Q 041689          628 ------------------VSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       628 ------------------~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                        ++.+-|++..|+..||.+|++++|
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q  277 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ  277 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence                              222688999999999999999976

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=356.83  Aligned_cols=221  Identities=25%  Similarity=0.348  Sum_probs=201.2

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..|...++||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4577778999999999999974 478999999998877677788899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +||+|.+.+....  +++.++..|++++++||+|||.+   ||+|||||.+|||++.+|.+||+|||+|..+...  ...
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSK  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCc
Confidence            9999999887654  89999999999999999999999   9999999999999999999999999999877432  234


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~~  637 (652)
                      ....+||++|||||+.....|++|+||||||++++||+-|.+||-                          ..+++|+.+
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            566789999999999999999999999999999999999999943                          338999999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++|++|.|+
T Consensus       506 cL~~dv~~RasA~eL  520 (550)
T KOG0578|consen  506 CLVVDVEQRASAKEL  520 (550)
T ss_pred             HhhcchhcCCCHHHH
Confidence            999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.3e-43  Score=354.40  Aligned_cols=220  Identities=26%  Similarity=0.356  Sum_probs=197.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+.  .++..+.+.+|++|++.++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999865 6889999999654  34556778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+.| +|..++.... .+++..+..++.|++.||.|||+.   +|+|||+||.||+++.++.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9988 9999988765 799999999999999999999999   999999999999999999999999999997633  33


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhccc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAMEC  638 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~~  638 (652)
                      ...+...|||.|||||+..+++|+..+|+||+||++|||++|++||-..                       ..+++...
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHH
Confidence            4455667999999999999999999999999999999999999996543                       56788889


Q ss_pred             chhhhccccCccC
Q 041689          639 TIESLELRINAKE  651 (652)
Q Consensus       639 l~~~p~~Rpt~~e  651 (652)
                      +.+||.+|.|..+
T Consensus       235 L~kdP~~RltW~~  247 (808)
T KOG0597|consen  235 LIKDPAQRLTWTD  247 (808)
T ss_pred             hhcChhhcccHHH
Confidence            9999999998654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-42  Score=348.80  Aligned_cols=222  Identities=24%  Similarity=0.294  Sum_probs=194.3

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ...++|+....||+|+||.||+|+.+ +|..||+|++++..   ....+.+..|..+|...++|.||+++..|.+.++.|
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY  217 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY  217 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence            35678999999999999999999865 69999999998653   234556788999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||++|||+..++...+ .+++..+..++.+++.|++.||+.   |+|||||||+|+|||..|++||+|||+++.+..
T Consensus       218 LiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence            9999999999999998876 799999999999999999999999   999999999999999999999999999864321


Q ss_pred             C--------------------CCccc-------------------------cccccCCccccCccccccCccCcccchhh
Q 041689          578 E--------------------DQSMT-------------------------QTQTLATIGYIAPEYGREGRVFANGDVYS  612 (652)
Q Consensus       578 ~--------------------~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvws  612 (652)
                      .                    .....                         ....+|||.|||||++.+..|+...|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                    00000                         01457999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcchh---------------------------hhhhhcccchhhhccccC
Q 041689          613 FGIMLMEIHSAKQQCVSF---------------------------VFNLAMECTIESLELRIN  648 (652)
Q Consensus       613 lG~vl~elltg~~p~~~~---------------------------l~~l~~~~l~~~p~~Rpt  648 (652)
                      +|||||||+.|.+||..+                           .+|+|.+|+. ||++|.-
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999996553                           7899999999 9999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=358.05  Aligned_cols=229  Identities=24%  Similarity=0.367  Sum_probs=199.4

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      +++....+++.+.+.||+|+||+||+|+|.  ..||||++...  .....+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            445555566677899999999999999984  47999999765  34467889999999999999999999999998887


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                       .||..+|+|.+|+.+++..+..++..+.+.|+.|+++|+.|||.+   +|||||||..|||+.++++|||+|||++..-
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence             999999999999999998877899999999999999999999999   9999999999999999999999999998753


Q ss_pred             cCCCCccccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      .............|..-|||||+++.   .+|++++||||||||+|||++|..||.                        
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~  618 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR  618 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence            32333334455668889999998864   479999999999999999999999944                        


Q ss_pred             ----hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          .++++++..||..++++||.+.+|
T Consensus       619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~i  646 (678)
T KOG0193|consen  619 SNCPKAMKRLLSDCWKFDREERPLFPQL  646 (678)
T ss_pred             ccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence                348999999999999999998764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=354.44  Aligned_cols=225  Identities=21%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc----cc-hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCC
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ----CG-RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEE  494 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  494 (652)
                      ....+|...+.||+|+||.|+.|... ++..||+|++..+    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            44568999999999999999999754 6899999987654    11 23456778999999998 999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITK  573 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~  573 (652)
                      ..|+||||+.||+|.+++.. .+++.+.++..+++|++.|++|+|++   ||+||||||+||++|.+ +.+||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 55899999999999999999999999   99999999999999998 999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCc-cC-cccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGR-VF-ANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++                      
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~  247 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL  247 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence            763  2334556788999999999999877 86 778999999999999999999554                      


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+|+..||.+|+|+.||
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i  272 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEI  272 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHH
Confidence              35889999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=337.08  Aligned_cols=227  Identities=24%  Similarity=0.345  Sum_probs=197.4

Q ss_pred             HhcCCCccceeccccceEEEEEE-eCCCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ...+|+..+.||.|..++||+|+ .+.+..||||++..+ +....+.+++|+..|+.++||||++++..|..++..|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34568889999999999999998 457899999999866 3445688999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      .||.+|++.+.++..- ..+++..+..|.+++++||.|||.+   |.||||||+.||||+++|.|||+|||.+..+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999987543 2589999999999999999999999   99999999999999999999999999987765433


Q ss_pred             Ccccc--ccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          580 QSMTQ--TQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       580 ~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      .....  ...+||+.|||||++..  ..|+.|+||||||++..|+.+|+.||..                          
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence            22111  45579999999999543  4799999999999999999999998543                          


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+++++..|+.+||.+||||+++
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskL  290 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKL  290 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHH
Confidence                   36789999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-42  Score=370.74  Aligned_cols=224  Identities=31%  Similarity=0.490  Sum_probs=197.9

Q ss_pred             CCCccceeccccceEEEEEEe------CCCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      +....+.||+|+||+||+|+.      .+...||||.++..... ..++|++|+++++.++|||||+++|+|..++..++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            344568899999999999973      23566999999877555 78899999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC-------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEE
Q 041689          499 VLEHMPHGSLEKCLYSSNC-------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH  565 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~-------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k  565 (652)
                      |+|||..|||.+++.....             +++..+.+.|+.|||.|++||-++   .+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence            9999999999999874322             378889999999999999999999   999999999999999999999


Q ss_pred             EecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------
Q 041689          566 LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------  626 (652)
Q Consensus       566 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------  626 (652)
                      |+|||+++.+...+.........-..+|||||.+..++|+++|||||||||+||+++ |+.|                  
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l  723 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL  723 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence            999999998765544443344556788999999999999999999999999999997 7777                  


Q ss_pred             ------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            ++.+++++|.+||..+|++||+|+||
T Consensus       724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence                  66679999999999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-43  Score=346.44  Aligned_cols=222  Identities=26%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..|+..+.||+|+||.||+|.+. +++.||+|++..+. ....+++++|+.++.+++++||.++|+.|..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999864 68899999998763 34567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      |.||++.+.++... .+++.++.-++++++.|+.|+|.+   +.+|||||+.||++..+|.+|++|||++..+....  .
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--K  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh--h
Confidence            99999999888765 458888888999999999999999   99999999999999999999999999998764322  2


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC------------------------cchhhhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------------------------CVSFVFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p------------------------~~~~l~~l~~~~  638 (652)
                      .....+||+.|||||++....|+.|+||||+|++.+||++|.+|                        |++.+++++..|
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            23678899999999999988999999999999999999999999                        555599999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||+|+++
T Consensus       247 L~k~P~~RpsA~~L  260 (467)
T KOG0201|consen  247 LDKNPEFRPSAKEL  260 (467)
T ss_pred             hhcCcccCcCHHHH
Confidence            99999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-42  Score=354.09  Aligned_cols=219  Identities=24%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             CCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |..++.||+|+.|.|-.|++ .+|+.+|||++...   .......+++|+-+|+.+.||||+++|++++...+.|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            56678999999999999985 47999999999655   223456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++|.|.+++..++ ++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-   ....
T Consensus        94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK  166 (786)
T ss_pred             cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence            99999999998876 789999999999999999999999   9999999999999999999999999999853   2333


Q ss_pred             ccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~~  638 (652)
                      .....||++.|.|||++.+.+|+ .++||||+|||+|.|+||+.||++.                       .++++.+|
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m  246 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM  246 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence            45677899999999999999986 8899999999999999999999876                       79999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      +..||++|+|.+||
T Consensus       247 l~VDp~~RiT~~eI  260 (786)
T KOG0588|consen  247 LDVDPSTRITTEEI  260 (786)
T ss_pred             hccCccccccHHHH
Confidence            99999999999886

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-41  Score=323.38  Aligned_cols=225  Identities=23%  Similarity=0.270  Sum_probs=193.0

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch--hhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cc
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR--AFKSFDIECEIMKSIHYRNLVKIISSCSNE--EF  495 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  495 (652)
                      ++..+.|+..+.|++|+||.||+|+++ +++.||+|+++.+..+  ..-...+|+.++.+++|||||.+-.+....  +.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            344456788899999999999999965 6888999999865322  223457899999999999999999887543  67


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      +|+|||||+. ||..++...+.++...++..++.|+++|++|||.+   .|+||||||+|+|+...|.+||+|||+|+.+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999999988 99999988777899999999999999999999999   9999999999999999999999999999987


Q ss_pred             cCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ..  .....+..+.|.+|+|||++.+. .|+++.|+||+|||+.||+++++-|+.                         
T Consensus       228 gs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  228 GS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             cC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            43  33445667789999999998775 588999999999999999998875222                         


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                    .-.+++..++..||.+|.||+|
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence                                          2468999999999999999976

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=334.97  Aligned_cols=234  Identities=25%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---------c-----hhhhhHHHHHHHHHhcC
Q 041689          415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---------G-----RAFKSFDIECEIMKSIH  479 (652)
Q Consensus       415 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~  479 (652)
                      +...+-.+..++|++.+.||+|.||.|-+|+.. +++.||||++.+..         .     ...+...+|+.+|++++
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            334455667789999999999999999999865 69999999995431         0     11347889999999999


Q ss_pred             CCeeeeEEeeeecC--CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          480 YRNLVKIISSCSNE--EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       480 h~niv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                      |||||+++++..+.  +..|+|+|||..|.+...--... .+.+.+++.|+++++.||+|||.+   |||||||||+|+|
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL  242 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL  242 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence            99999999998765  68899999999888765432222 388999999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEecccCCccccCC---CCccccccccCCccccCccccccCc---c-CcccchhhHHHHHHHHHhCCCCcchh
Q 041689          558 LDDTMVAHLSDFGITKLLIGE---DQSMTQTQTLATIGYIAPEYGREGR---V-FANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      ++++|++||+|||.+......   +........+|||.|+|||...++.   + +.+.||||+||++|.|+.|+.||-+.
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            999999999999999865322   1122234578999999999877632   3 46779999999999999999996553


Q ss_pred             -------------------------hhhhhcccchhhhccccCccCC
Q 041689          631 -------------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -------------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               +++++.+||.+||++|++..||
T Consensus       323 ~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i  369 (576)
T KOG0585|consen  323 FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI  369 (576)
T ss_pred             hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence                                     7999999999999999998875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-40  Score=347.55  Aligned_cols=227  Identities=22%  Similarity=0.355  Sum_probs=189.0

Q ss_pred             HhcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC-
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE-  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-  493 (652)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|+++... ......+.+|+++++++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346789999999999999999963      235679999987542 23346788999999999 899999999988764 


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---------------------------------------------------------
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---------------------------------------------------------  516 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  516 (652)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46889999999999999886432                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCcc
Q 041689          517 ----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG  592 (652)
Q Consensus       517 ----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  592 (652)
                          ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++...............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                1367778889999999999999999   999999999999999999999999999986532222222223346678


Q ss_pred             ccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch-------------------------hhhhhhcccchhhhccc
Q 041689          593 YIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-------------------------FVFNLAMECTIESLELR  646 (652)
Q Consensus       593 y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-------------------------~l~~l~~~~l~~~p~~R  646 (652)
                      |+|||++.+..++.++|||||||++|||++ |..||..                         .+.+++.+||+.||++|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999998999999999999999999997 8888643                         26789999999999999


Q ss_pred             cCccCC
Q 041689          647 INAKEI  652 (652)
Q Consensus       647 pt~~ei  652 (652)
                      ||+.||
T Consensus       322 Ps~~el  327 (338)
T cd05102         322 PTFSAL  327 (338)
T ss_pred             cCHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=315.93  Aligned_cols=221  Identities=23%  Similarity=0.355  Sum_probs=195.3

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++.|++.+.||+|.|+.||++.. .+|+.+|+|++...  .....+.+++|++|.+.++||||+++.+.+.+.++.|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45677788999999999999964 57999999998644  3446788999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~  577 (652)
                      |+|.|++|..-+-.+ ..+++..+..+++||+.||.|+|.+   +|||||+||+|+++.   ...-+||+|||+|.... 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997765544 3678888999999999999999999   999999999999995   45579999999999773 


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh---------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF---------------------------  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~---------------------------  630 (652)
                        .........|||.|||||+++..+|+..+|||+.||++|-++.|.+||.++                           
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~  242 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE  242 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence              334445678999999999999999999999999999999999999997662                           


Q ss_pred             hhhhhcccchhhhccccCccC
Q 041689          631 VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                      .++++.+|+..||.+|+|+.|
T Consensus       243 Ak~LvrrML~~dP~kRIta~E  263 (355)
T KOG0033|consen  243 AKSLIRRMLTVNPKKRITADE  263 (355)
T ss_pred             HHHHHHHHhccChhhhccHHH
Confidence            789999999999999999976

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=326.44  Aligned_cols=221  Identities=22%  Similarity=0.287  Sum_probs=200.3

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|++.+.+|+|+||.|-+|.. ..|+.||||.+++.   +.++...+.+|++||+.++||||+.+|++|+..+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677788999999999999975 67999999999765   3455667889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||..+|.|++|+.+.+ .+++.++..+++||..|+.|+|.+   +++|||||.+|||+|.++.+||+|||++..+..   
T Consensus       133 EYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            9999999999998876 799999999999999999999999   999999999999999999999999999987632   


Q ss_pred             ccccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcchh----------------------hhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCVSF----------------------VFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~----------------------l~~l~~~  637 (652)
                      ......++|++-|.+||++.+.+|. +.+|-||+||++|.++.|..||+..                      ..-+++.
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRw  285 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRW  285 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHH
Confidence            2344668999999999999999885 8899999999999999999998775                      5669999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      |+..+|++|-|+.||
T Consensus       286 mLmVNP~RRATieDi  300 (668)
T KOG0611|consen  286 MLMVNPERRATIEDI  300 (668)
T ss_pred             HHhcCcccchhHHHH
Confidence            999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=343.33  Aligned_cols=221  Identities=22%  Similarity=0.245  Sum_probs=194.6

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      ...++|...++||+|.||+|++|..+ +++.||||+++++.   ..+.+....|.+|+... +||.++.++.+|.+.++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34467899999999999999999865 68899999998762   34567788899998887 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |.||||+.||++..+.+  ...+++..+.-|+..++.||+|||++   |||+||||.+|||+|.+|.+||+|||+++.- 
T Consensus       445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~-  518 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG-  518 (694)
T ss_pred             EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc-
Confidence            99999999999443333  23699999999999999999999999   9999999999999999999999999999964 


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhh
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFN  633 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~  633 (652)
                       .......++.+||+.|||||++.+..|+.++|+|||||+||||+.|..||..+                       ..+
T Consensus       519 -m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  519 -MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             -CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHH
Confidence             22334567789999999999999999999999999999999999999997743                       677


Q ss_pred             hhcccchhhhccccCc
Q 041689          634 LAMECTIESLELRINA  649 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~  649 (652)
                      ++++++..+|++|--+
T Consensus       598 il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhccCcccccCC
Confidence            9999999999999765

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-41  Score=340.04  Aligned_cols=223  Identities=23%  Similarity=0.310  Sum_probs=199.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-eEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-KELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  500 (652)
                      ++|...+.+|+|+||.++.++++ +++.||+|.+...  ..........|+.++++++|||||.+.+.|+.++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999865 6889999999755  34445578899999999999999999999998887 99999


Q ss_pred             EccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +||+||++.+.+...+ ..+++..+..|+.|++.|+.|||+.   .|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999998766 4789999999999999999999988   99999999999999999999999999999874322


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~  635 (652)
                        ......+||+.||.||++.+.+|+.|+||||+||++|||++-+++|..                        +++.++
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV  238 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence              245667899999999999999999999999999999999998887544                        488999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      +.|++.+|+.||++.|+
T Consensus       239 ~~~l~~~P~~RPsa~~L  255 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALEL  255 (426)
T ss_pred             HHHhhcCCccCCCHHHH
Confidence            99999999999999764

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-41  Score=306.24  Aligned_cols=221  Identities=24%  Similarity=0.316  Sum_probs=197.8

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++++.+|+|.||.||.|+.+ ++.-||+|++-+.   ......++.+|++|-+.++||||.++|++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            46889999999999999999854 6888999998543   2345678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||.+.|++...+...+. .+++.....++.|+|.|+.|+|.+   +|+||||||+|+|++..+.+|++|||.+..-    
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~----  174 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA----  174 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec----
Confidence            99999999999985443 688899999999999999999999   9999999999999999999999999998743    


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~  636 (652)
                      ........+||..|.|||+..+..++..+|+|++|++.||++.|.+||...                       +.|++.
T Consensus       175 p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~  254 (281)
T KOG0580|consen  175 PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLIS  254 (281)
T ss_pred             CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHH
Confidence            234455678999999999999999999999999999999999999997654                       789999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +|+..+|.+|.+..|+
T Consensus       255 ~ll~~~p~~r~~l~~v  270 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEV  270 (281)
T ss_pred             HHhccCccccccHHHH
Confidence            9999999999987654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=337.14  Aligned_cols=215  Identities=22%  Similarity=0.303  Sum_probs=190.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   .+..+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999875 68999999997542   234456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++....   
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---  153 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---  153 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC---
Confidence            9999999999987655 688999999999999999999999   999999999999999999999999999986522   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                        ......|++.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++++
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  231 (291)
T cd05612         154 --RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK  231 (291)
T ss_pred             --CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence              12234689999999999988999999999999999999999999633                       36899999


Q ss_pred             cchhhhccccC
Q 041689          638 CTIESLELRIN  648 (652)
Q Consensus       638 ~l~~~p~~Rpt  648 (652)
                      ||+.||.+||+
T Consensus       232 ~l~~dp~~R~~  242 (291)
T cd05612         232 LLVVDRTRRLG  242 (291)
T ss_pred             HcCCCHHHccC
Confidence            99999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=340.02  Aligned_cols=209  Identities=23%  Similarity=0.364  Sum_probs=185.8

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ..+-+|+|+.|.||+|+. .++.||||+++.       .-+.+++-|++++||||+.+.|+|.....+|||||||+.|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            346799999999999998 478999998752       224578889999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+.++..+ .+.......|..+||.|+.|||.+   .|||||||.-||||..+..|||+|||-++.....   .....++
T Consensus       200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa  272 (904)
T KOG4721|consen  200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA  272 (904)
T ss_pred             HHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence            99999876 677777888999999999999999   9999999999999999999999999999876322   3344578


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhhhhhcccchhhh
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVFNLAMECTIESL  643 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~~l~~~~l~~~p  643 (652)
                      ||..|||||+++..+.++|+||||||||+|||+||..||.                         +.++-++++||+-.|
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence            9999999999999999999999999999999999999943                         337789999999999


Q ss_pred             ccccCccCC
Q 041689          644 ELRINAKEI  652 (652)
Q Consensus       644 ~~Rpt~~ei  652 (652)
                      ..||+|.+|
T Consensus       353 RNRPSFrqi  361 (904)
T KOG4721|consen  353 RNRPSFRQI  361 (904)
T ss_pred             CCCccHHHH
Confidence            999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=320.67  Aligned_cols=225  Identities=24%  Similarity=0.273  Sum_probs=193.3

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEee--cccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-----C
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-----E  493 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~  493 (652)
                      .....|...+.||+|+||.|+.|..+ +|+.||+|++.  -+.....++..+|+++++.++|+||+.+.+.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456666799999999999999865 69999999987  3344566778899999999999999999998865     3


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ..+|+|+|+|+. +|.+.++... .++...+..+++|+++||+|+|+.   +|+|||+||.|++++.+..+||+|||+|+
T Consensus        99 ~DvYiV~elMet-DL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen   99 NDVYLVFELMET-DLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             ceeEEehhHHhh-HHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence            578999999954 9999888765 599999999999999999999999   99999999999999999999999999999


Q ss_pred             cccCCCCccccccccCCccccCccccc-cCccCcccchhhHHHHHHHHHhCCCCcchh----------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGR-EGRVFANGDVYSFGIMLMEIHSAKQQCVSF----------------------  630 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~----------------------  630 (652)
                      ...........+..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++-|...                      
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            875432344456778999999999864 467999999999999999999999863332                      


Q ss_pred             --------------------------------hhhhhcccchhhhccccCccC
Q 041689          631 --------------------------------VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 --------------------------------l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                      ..+++.+||..||.+|+|++|
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e  306 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE  306 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence                                            678999999999999999976

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-39  Score=338.52  Aligned_cols=198  Identities=23%  Similarity=0.337  Sum_probs=174.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|+.. ++..||+|+++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999875 68889999987653 2345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+.+  +|+||||||+||++++++.+||+|||++.....    
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----  156 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  156 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence            999999999987654 6889999999999999999999752  699999999999999999999999999876522    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      .......|++.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       157 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            12233468999999999999899999999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.2e-40  Score=339.19  Aligned_cols=211  Identities=22%  Similarity=0.246  Sum_probs=184.9

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                      +|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++....  .......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccc
Confidence            9999887654 689999999999999999999999   999999999999999999999999999875321  1122234


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhhh
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIESL  643 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~p  643 (652)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+||..||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            5699999999999999999999999999999999999999632                       36889999999999


Q ss_pred             cccc
Q 041689          644 ELRI  647 (652)
Q Consensus       644 ~~Rp  647 (652)
                      ++||
T Consensus       235 ~~R~  238 (323)
T cd05571         235 KQRL  238 (323)
T ss_pred             HHcC
Confidence            9999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.9e-40  Score=340.59  Aligned_cols=216  Identities=21%  Similarity=0.262  Sum_probs=191.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|.+.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888999999999999999875 58999999997542   233456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....  
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            9999999999987654 688888999999999999999999   9999999999999999999999999999865221  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.+
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence               1234689999999999999999999999999999999999999633                       36789999


Q ss_pred             cchhhhccccCc
Q 041689          638 CTIESLELRINA  649 (652)
Q Consensus       638 ~l~~~p~~Rpt~  649 (652)
                      ||+.||++||+.
T Consensus       249 ~L~~dP~~R~~~  260 (329)
T PTZ00263        249 LLQTDHTKRLGT  260 (329)
T ss_pred             HhhcCHHHcCCC
Confidence            999999999974

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-39  Score=330.33  Aligned_cols=218  Identities=22%  Similarity=0.302  Sum_probs=189.2

Q ss_pred             CCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++++++|++|+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377789999999999999986 479999999986542   2233457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......  
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--  155 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--  155 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence            999999988876433 3688999999999999999999999   9999999999999999999999999999865221  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFN  633 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~  633 (652)
                       .......|+..|+|||++.+..++.++||||+||++|||++|+.||..                           .+.+
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (285)
T cd05631         156 -ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS  234 (285)
T ss_pred             -CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence             122345689999999999999999999999999999999999999642                           2678


Q ss_pred             hhcccchhhhccccCc
Q 041689          634 LAMECTIESLELRINA  649 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~  649 (652)
                      ++.+||+.||++||++
T Consensus       235 li~~~l~~~P~~R~~~  250 (285)
T cd05631         235 ICRMLLTKNPKERLGC  250 (285)
T ss_pred             HHHHHhhcCHHHhcCC
Confidence            9999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-39  Score=332.41  Aligned_cols=222  Identities=21%  Similarity=0.295  Sum_probs=190.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .+|.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999865 68999999987542 22345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ +|.+++......+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  ..
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TK  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cc
Confidence            985 99998876655688999999999999999999999   9999999999999999999999999998754211  11


Q ss_pred             ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.                                 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233467899999998865 568899999999999999999998863                                 


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          .+..+++.+|++.||.+|||++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~  282 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA  282 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence                                224679999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-39  Score=334.19  Aligned_cols=225  Identities=24%  Similarity=0.375  Sum_probs=188.7

Q ss_pred             cCCCccceeccccceEEEEEEeCC-----------------CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-----------------GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKI  486 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  486 (652)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|+++... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3469999987643 3345678999999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhhhhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 041689          487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSN------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIH  548 (652)
Q Consensus       487 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  548 (652)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++..+..++.|++.||+|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            999999999999999999999999885432                  1357778899999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh--CCCC
Q 041689          549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS--AKQQ  626 (652)
Q Consensus       549 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p  626 (652)
                      |||||+||++++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986533222222233446788999999988899999999999999999986  4455


Q ss_pred             cc-------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          627 CV-------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ~~-------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      |.                               ..+.+++.+||+.||++|||++||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i  298 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI  298 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            32                               347799999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-39  Score=334.12  Aligned_cols=223  Identities=22%  Similarity=0.268  Sum_probs=190.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999875 688999999875422 223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++ +++.+++......+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....  .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            996 588888776656788999999999999999999999   9999999999999999999999999998754211  1


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------------  629 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------------  629 (652)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..                               
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234568899999998765 4578899999999999999999999742                               


Q ss_pred             -------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               .+.+++.+|++.||++|||++|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~  285 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA  285 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence                                     24589999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=339.70  Aligned_cols=219  Identities=23%  Similarity=0.320  Sum_probs=194.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999876 58999999997542   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999987654 688999999999999999999999   999999999999999999999999999986422   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------------h
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------------S  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------------~  629 (652)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.                               .
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~  231 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD  231 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence              2334568999999999999999999999999999999999999963                               3


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||..+|++||+++||
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~l  254 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDI  254 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHH
Confidence            36779999999999999998874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.3e-39  Score=380.55  Aligned_cols=342  Identities=32%  Similarity=0.463  Sum_probs=274.2

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCC-------ccc
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI-------ADN   75 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-------~~~   75 (652)
                      ++|+.|+|+.|.+..  .+|..+ ++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..       ...
T Consensus       212 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  289 (968)
T PLN00113        212 KSLKWIYLGYNNLSG--EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL  289 (968)
T ss_pred             CCccEEECcCCccCC--cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEE
Confidence            478899999998874  789888 8999999999999999999999999999999999999998765532       222


Q ss_pred             cccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcc
Q 041689           76 YLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK  155 (652)
Q Consensus        76 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  155 (652)
                      .+..+......+..+.++++|++|++++|.+++..|. .+..+++ |+.|++++|++++.+|..+..+++|+.|+|++|+
T Consensus       290 ~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~  367 (968)
T PLN00113        290 DLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV-ALTSLPR-LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN  367 (968)
T ss_pred             ECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh-hHhcCCC-CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCe
Confidence            3333332223445678999999999999999988887 7888887 9999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCC---------
Q 041689          156 LNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---------  226 (652)
Q Consensus       156 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N---------  226 (652)
                      +++..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|         
T Consensus       368 l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  447 (968)
T PLN00113        368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR  447 (968)
T ss_pred             eEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChh
Confidence            98777777666666666666666666555555555555555555555555555555555555555555544         


Q ss_pred             ---------------C--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCc
Q 041689          227 ---------------D--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLK  289 (652)
Q Consensus       227 ---------------~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  289 (652)
                                     .  +.+|..+ ..++|+.|++++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|+
T Consensus       448 ~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  526 (968)
T PLN00113        448 KWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV  526 (968)
T ss_pred             hccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCC
Confidence                           3  2233322 346788888888888888888999999999999999999999999999999999


Q ss_pred             ceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCCCCcccccccCCccCCCCC
Q 041689          290 SLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       290 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      .|+|++|.+++.+|..|..+++|+.|+|++|++++.+|.. ..+..++.+++++|++.+.-|
T Consensus       527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             EEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            9999999999999999999999999999999999888764 667889999999999887444

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=333.51  Aligned_cols=211  Identities=24%  Similarity=0.256  Sum_probs=184.9

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 5889999999753   223445678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....  ........
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccccc
Confidence            99987654 689999999999999999999999   9999999999999999999999999998753221  12233456


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhhhcc
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIESLEL  645 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~p~~  645 (652)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+||+.||++
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  234 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR  234 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence            89999999999999999999999999999999999999643                       3788999999999999


Q ss_pred             ccCc
Q 041689          646 RINA  649 (652)
Q Consensus       646 Rpt~  649 (652)
                      ||++
T Consensus       235 R~~~  238 (312)
T cd05585         235 RLGY  238 (312)
T ss_pred             cCCC
Confidence            9865

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-39  Score=331.36  Aligned_cols=223  Identities=20%  Similarity=0.237  Sum_probs=191.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999975 58889999987542  2334667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++.+..+.. ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            999877765443 334688999999999999999999999   99999999999999999999999999998653211 1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||..                                
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            122335689999999999988999999999999999999999998742                                


Q ss_pred             -----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             .+.+++.+||+.||++|||++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~  281 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC  281 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence                                   26789999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-39  Score=334.78  Aligned_cols=198  Identities=23%  Similarity=0.348  Sum_probs=173.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|.+. ++..||+|+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999875 68889999987542 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+..  +|+||||||+||++++++.+||+|||++.....    
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----  156 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  156 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence            999999999987654 6888899999999999999999742  799999999999999999999999999875422    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            11233468899999999998889999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-39  Score=333.77  Aligned_cols=212  Identities=21%  Similarity=0.256  Sum_probs=184.5

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                      +|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence            9998887654 689999999999999999999999   9999999999999999999999999998753211  122234


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhhh
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIESL  643 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~p  643 (652)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.                       ..+.+++.+||+.||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            568999999999999999999999999999999999999963                       236789999999999


Q ss_pred             ccccC
Q 041689          644 ELRIN  648 (652)
Q Consensus       644 ~~Rpt  648 (652)
                      ++||+
T Consensus       235 ~~R~~  239 (323)
T cd05595         235 KQRLG  239 (323)
T ss_pred             HHhCC
Confidence            99983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-39  Score=314.80  Aligned_cols=221  Identities=24%  Similarity=0.312  Sum_probs=189.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCe-eeeEEeeeecCC------
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRN-LVKIISSCSNEE------  494 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------  494 (652)
                      ..|...++||+|+||+||+|+.. +|+.||+|+++...+  .......+|+.+++.++|+| |+.+++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666788999999999999854 789999999986643  24456789999999999999 999999998776      


Q ss_pred             ceEEEEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ..++|+||+.. +|.+++....   ..++...+..+++|++.||+|||++   +|+||||||+||+|+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78999999976 9999998766   3577788999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch---------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS---------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~---------------------  629 (652)
                      |+...-  .....+..++|.+|+|||++.+. .|+...||||+||+++||+++++-|+.                     
T Consensus       167 Ara~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            986521  22335667799999999998877 789999999999999999997765322                     


Q ss_pred             --------------------------------hhhhhhcccchhhhccccCccC
Q 041689          630 --------------------------------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 --------------------------------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                      ...+++.+|++.+|.+|.|++.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~  298 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG  298 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence                                            2678999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.9e-39  Score=327.04  Aligned_cols=214  Identities=21%  Similarity=0.245  Sum_probs=184.6

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceEEEEEc
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKELVLEH  502 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  502 (652)
                      ...||+|++|.||+|.. +|+.||||.++....   ...+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 689999999975422   224678899999999999999999999876    3578899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++|+|.+++.... .+++.....++.|++.|+.|||+..  +++||||||+||++++++.+||+|||+++.....    
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----  176 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----  176 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc----
Confidence            99999999997654 6888999999999999999999732  7889999999999999999999999998865221    


Q ss_pred             ccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhhhh
Q 041689          583 TQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFNLA  635 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~l~  635 (652)
                       .....++..|+|||++.+  ..++.++|||||||++|||++|+.||..                         .+.+++
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li  255 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV  255 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence             123457889999999876  6899999999999999999999999543                         277999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       256 ~~cl~~dp~~Rps~~el  272 (283)
T PHA02988        256 EACTSHDSIKRPNIKEI  272 (283)
T ss_pred             HHHhcCCcccCcCHHHH
Confidence            99999999999999875

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-40  Score=321.00  Aligned_cols=215  Identities=26%  Similarity=0.380  Sum_probs=179.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC---C--ceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE---E--FKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~--~~~lv  499 (652)
                      .|...+++|+|+||.||+|... ++++||||++-.+.    +--.+|+++|++++|||||++.-+|...   +  +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4677799999999999999854 57999999986442    1224699999999999999999887533   2  33589


Q ss_pred             EEccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCccc
Q 041689          500 LEHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITKLL  575 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~~~  575 (652)
                      |||+|. +|.++++..   +..++...+.-+++|+.+||.|||+.   ||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999988 999988742   33678888888999999999999998   99999999999999965 99999999999987


Q ss_pred             cCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ....   .......|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|..                         
T Consensus       177 ~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            4333   23445678999999988765 699999999999999999999875333                         


Q ss_pred             ---------------------------hhhhhhcccchhhhccccCccC
Q 041689          630 ---------------------------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 ---------------------------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                 +..+++.++++++|.+|.++.|
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~  302 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE  302 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence                                       3678999999999999998765

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-39  Score=340.81  Aligned_cols=226  Identities=22%  Similarity=0.321  Sum_probs=189.6

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|+++++.+ +||||+++++++..++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688889999999999999963      246689999987542 33456788999999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC-----------------------------------------------------------
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-----------------------------------------------------------  516 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  516 (652)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          517 ---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       517 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                                     ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1367788899999999999999999   9999999999999999999999999999865332221


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------hhhhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------SFVFNLA  635 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~~l~~l~  635 (652)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.                         .++.+++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            11222335677999999999999999999999999999998 777753                         2367999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++||+++||
T Consensus       351 ~~cl~~dP~~RPs~~ei  367 (375)
T cd05104         351 KSCWDADPLKRPTFKQI  367 (375)
T ss_pred             HHHccCChhHCcCHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=316.68  Aligned_cols=221  Identities=23%  Similarity=0.281  Sum_probs=190.6

Q ss_pred             cCCCccceeccccceEEEEEEeCC-CcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|+..+.||+|.-|.||+|+..+ +..+|+|++.+..   .+...+.+.|.+||+.++||.++.+|..|+.+++.|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            345667899999999999999764 6889999997663   334557788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC-
Q 041689          501 EHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-  578 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  578 (652)
                      |||+||+|..+.+.... .+++..+.-++.+++-||+|||-.   |||.|||||+||||-++|++.|+||.++...... 
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            99999999998776544 789999999999999999999999   9999999999999999999999999987543110 


Q ss_pred             --------------------------------CC---------------------ccccccccCCccccCccccccCccC
Q 041689          579 --------------------------------DQ---------------------SMTQTQTLATIGYIAPEYGREGRVF  605 (652)
Q Consensus       579 --------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  605 (652)
                                                      ..                     .......+||-.|.|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                            00                     0111244689999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCcchh-------------------------hhhhhcccchhhhccccC
Q 041689          606 ANGDVYSFGIMLMEIHSAKQQCVSF-------------------------VFNLAMECTIESLELRIN  648 (652)
Q Consensus       606 ~~sDvwslG~vl~elltg~~p~~~~-------------------------l~~l~~~~l~~~p~~Rpt  648 (652)
                      .++|+|+|||++|||+.|..||...                         .+|+|++.|.+||.+|..
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            9999999999999999999995443                         799999999999999987

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-39  Score=337.17  Aligned_cols=214  Identities=24%  Similarity=0.255  Sum_probs=188.4

Q ss_pred             cCCCccceeccccceEEEEEEeCC--CcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD--GMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|.+.+.||+|+||.||+|....  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999997543  4689999986532   23445678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++....  
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence            99999999999987655 688999999999999999999999   999999999999999999999999999986521  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                         ......||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.++++
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        184 ---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK  260 (340)
T ss_pred             ---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence               12345689999999999988899999999999999999999999643                       3678999


Q ss_pred             ccchhhhcccc
Q 041689          637 ECTIESLELRI  647 (652)
Q Consensus       637 ~~l~~~p~~Rp  647 (652)
                      +|++.||++|+
T Consensus       261 ~~l~~dp~~R~  271 (340)
T PTZ00426        261 KLLSHDLTKRY  271 (340)
T ss_pred             HHcccCHHHcC
Confidence            99999999996

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.6e-39  Score=332.98  Aligned_cols=211  Identities=22%  Similarity=0.273  Sum_probs=184.7

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542   234457788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                      +|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9998887654 689999999999999999999999   9999999999999999999999999998753211  122234


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhhh
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIESL  643 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~p  643 (652)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.                       ..+.+++.+||..||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP  234 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence            568999999999998999999999999999999999999963                       237789999999999


Q ss_pred             cccc
Q 041689          644 ELRI  647 (652)
Q Consensus       644 ~~Rp  647 (652)
                      ++||
T Consensus       235 ~~R~  238 (328)
T cd05593         235 NKRL  238 (328)
T ss_pred             HHcC
Confidence            9998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-39  Score=340.11  Aligned_cols=226  Identities=23%  Similarity=0.347  Sum_probs=189.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|+..      ++..||+|+++... ......+.+|+++++.+ +||||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346888999999999999998742      24579999997542 23345688999999999 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC-----------------------------------------------------------
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-----------------------------------------------------------  516 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  516 (652)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999875421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          517 ----------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       517 ----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                                ..+++.++.+++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      1367788899999999999999999   999999999999999999999999999986532221111222


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------hhhhhhhcccch
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------SFVFNLAMECTI  640 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~~l~~l~~~~l~  640 (652)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.                         ..+.+++.+||+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            335678999999988899999999999999999997 998853                         337789999999


Q ss_pred             hhhccccCccCC
Q 041689          641 ESLELRINAKEI  652 (652)
Q Consensus       641 ~~p~~Rpt~~ei  652 (652)
                      .||++|||+.||
T Consensus       354 ~dp~~RPs~~~l  365 (374)
T cd05106         354 LEPTERPTFSQI  365 (374)
T ss_pred             CChhhCcCHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-39  Score=335.14  Aligned_cols=222  Identities=21%  Similarity=0.292  Sum_probs=186.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----CceE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EFKE  497 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  497 (652)
                      +|++.+.||+|+||.||+|+.. ++..||||+++..  .......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999865 6899999998643  223345688999999999999999999987543     2479


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||++ ++|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999996 58998887654 689999999999999999999999   999999999999999999999999999985432


Q ss_pred             CCCc-cccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          578 EDQS-MTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       578 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      .... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..                         
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2211 11234568999999998765  6789999999999999999999998732                         


Q ss_pred             -----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   .+.+++.+||+.||++|||++||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~  287 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA  287 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH
Confidence                                         24689999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=348.10  Aligned_cols=231  Identities=23%  Similarity=0.271  Sum_probs=193.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeCCC-cEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEee-eec-----
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIGDG-MEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISS-CSN-----  492 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~-----  492 (652)
                      .....++++.+.|.+|||+.||.|+...+ .+||+|++-...+...+.+.+|+++|++++ |+|||.++|. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            44566788899999999999999997665 999999987777788889999999999996 9999999993 221     


Q ss_pred             -CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          493 -EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       493 -~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                       .-++++.||||+||.|-+++..+- ..+++.++++|++|+++|+++||.. .++|||||||-+||||+.++..||||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence             135679999999999999987432 2599999999999999999999977 5679999999999999999999999999


Q ss_pred             CCccccCCCCccc-------cccccCCccccCcccc---ccCccCcccchhhHHHHHHHHHhCCCCcchh----------
Q 041689          571 ITKLLIGEDQSMT-------QTQTLATIGYIAPEYG---REGRVFANGDVYSFGIMLMEIHSAKQQCVSF----------  630 (652)
Q Consensus       571 ~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~~----------  630 (652)
                      .|...........       .-....|+.|+|||++   .+.+.++|+||||+||++|-||....||+..          
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y  271 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY  271 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc
Confidence            9875322111100       0122468999999974   5678999999999999999999988885543          


Q ss_pred             -----------hhhhhcccchhhhccccCccCC
Q 041689          631 -----------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -----------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 +++||+.||++||++||++.+|
T Consensus       272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv  304 (738)
T KOG1989|consen  272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV  304 (738)
T ss_pred             cCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence                       8999999999999999998764

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.3e-39  Score=331.65  Aligned_cols=212  Identities=25%  Similarity=0.316  Sum_probs=183.6

Q ss_pred             ceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +.||+|+||.||+|+.    .+++.||+|+++...    ......+..|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    357889999997532    22345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++.... .+.+..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....  ..
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GT  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CC
Confidence            99999999887654 678888889999999999999999   9999999999999999999999999998754221  12


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECT  639 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l  639 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.+||
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  235 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL  235 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            22335689999999999988899999999999999999999999643                       3679999999


Q ss_pred             hhhhccccC
Q 041689          640 IESLELRIN  648 (652)
Q Consensus       640 ~~~p~~Rpt  648 (652)
                      +.||++||+
T Consensus       236 ~~~p~~R~~  244 (323)
T cd05584         236 KRNPSSRLG  244 (323)
T ss_pred             ccCHhHcCC
Confidence            999999993

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=358.55  Aligned_cols=224  Identities=28%  Similarity=0.471  Sum_probs=193.8

Q ss_pred             CCCccceeccccceEEEEEEeCC--Cc----EEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGD--GM----EVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+..+.||+|.||.||.|...+  |.    .||+|.++.. +.+...+|.+|..+|++++|||||+++|++.+.+..+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34566889999999999998543  43    3899998765 34567789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          499 VLEHMPHGSLEKCLYSS------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      ++|||++|+|..++++.      ...++..+.+.++.|||+|+.||+++   ++|||||..+|+|+++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence            99999999999999987      45788999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------------c
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------------C  627 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------------~  627 (652)
                      +.+...+.........-...|||||.+..+.++.|+|||||||++||++| |..|                        |
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C  929 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC  929 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence            96644433332222234578999999999999999999999999999998 5555                        5


Q ss_pred             chhhhhhhcccchhhhccccCccCC
Q 041689          628 VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+.++|.+||+.+|++||+|..|
T Consensus       930 P~~ly~lM~~CW~~~pe~RP~F~~i  954 (1025)
T KOG1095|consen  930 PEKLYQLMLQCWKHDPEDRPSFRTI  954 (1025)
T ss_pred             ChHHHHHHHHHccCChhhCccHHHH
Confidence            5568999999999999999999754

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-38  Score=330.88  Aligned_cols=217  Identities=22%  Similarity=0.269  Sum_probs=185.5

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHH---HhcCCCeeeeEEeeeecCCceEEE
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIM---KSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      |++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|++++   +.++||||+++++++..++..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999865 68999999997542   22345566676665   456799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|..++...  .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||+++..... 
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence            9999999999887653  589999999999999999999999   9999999999999999999999999998753211 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ........|++.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  233 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR  233 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             1222345689999999999999999999999999999999999999643                       2678999


Q ss_pred             ccchhhhccccCcc
Q 041689          637 ECTIESLELRINAK  650 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~  650 (652)
                      +||..||++||+++
T Consensus       234 ~~L~~dP~~R~~~~  247 (324)
T cd05589         234 RLLRRNPERRLGSG  247 (324)
T ss_pred             HHhhcCHhHcCCCC
Confidence            99999999999654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-39  Score=347.95  Aligned_cols=224  Identities=20%  Similarity=0.239  Sum_probs=194.0

Q ss_pred             CCCccceeccccceEEEEEEeC-C-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-D-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+++++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888999999999999999754 3 6789999876555555567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          504 PHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       504 ~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ++|+|.+++...   ...+++.++..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542   23688999999999999999999999   999999999999999999999999999987643222


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~  636 (652)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..                        .+.+++.
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  304 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD  304 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence            2223445699999999999999999999999999999999999998542                        3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..||++||+++|+
T Consensus       305 ~~L~~dP~~Rps~~~~  320 (478)
T PTZ00267        305 PLLSKNPALRPTTQQL  320 (478)
T ss_pred             HHhccChhhCcCHHHH
Confidence            9999999999998764

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.9e-39  Score=319.97  Aligned_cols=223  Identities=25%  Similarity=0.366  Sum_probs=192.6

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|++.+.||+|+||.||+|+++++..+|+|.+.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4578889999999999999998888899999886442 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            9999999876555689999999999999999999999   99999999999999999999999999987642211 1111


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l  639 (652)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||..                        .+.+++.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~  238 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW  238 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            22335668999999988889999999999999999999 8888543                        2678999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.+|++||+++||
T Consensus       239 ~~~p~~Rps~~~l  251 (256)
T cd05114         239 HEKPEGRPTFAEL  251 (256)
T ss_pred             cCCcccCcCHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-38  Score=329.17  Aligned_cols=214  Identities=24%  Similarity=0.285  Sum_probs=185.1

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.++++.. +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999997542   23345667788888876 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccc
Confidence            99999887654 689999999999999999999999   999999999999999999999999999875321  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++++||+.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  234 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN  234 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            45689999999999988999999999999999999999999643                       3678999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (320)
T cd05590         235 PTMRLGSL  242 (320)
T ss_pred             HHHCCCCC
Confidence            99999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-39  Score=337.99  Aligned_cols=219  Identities=23%  Similarity=0.297  Sum_probs=189.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999865 68999999997542   233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987654 689999999999999999999999   999999999999999999999999999875422110


Q ss_pred             cc------------------------------------ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCC
Q 041689          581 SM------------------------------------TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK  624 (652)
Q Consensus       581 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~  624 (652)
                      ..                                    .....+||+.|+|||++....++.++|||||||++|||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011245899999999999999999999999999999999999


Q ss_pred             CCcch---------------------------hhhhhhcccchhhhccccC
Q 041689          625 QQCVS---------------------------FVFNLAMECTIESLELRIN  648 (652)
Q Consensus       625 ~p~~~---------------------------~l~~l~~~~l~~~p~~Rpt  648 (652)
                      .||..                           .+.+++.+|+. +|.+|++
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            99632                           36789999996 9999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=337.61  Aligned_cols=224  Identities=28%  Similarity=0.393  Sum_probs=191.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCC--C---cEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD--G---MEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      .++....++||+|+||.||+|+...  +   ..||||..+..   ......++.+|+++|++++|||||++||++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3445556899999999999998542  2   23899998853   34567789999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++|||+|.||+|.++++..+..++..++..++.+.|.||+|||++   +++||||..+|+|++.++.+||+|||+++.-
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999999999887799999999999999999999999   9999999999999999999999999998753


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcchh------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSF------------------------  630 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~------------------------  630 (652)
                      .  ..........-...|+|||.+..+.|++++|||||||++||+++ |..|+...                        
T Consensus       313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            1  11111112235678999999999999999999999999999998 78785443                        


Q ss_pred             -hhhhhcccchhhhccccCccCC
Q 041689          631 -VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       +..++.+||..+|++||++.+|
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i  413 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTI  413 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHH
Confidence             7789999999999999999764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.8e-38  Score=327.64  Aligned_cols=214  Identities=21%  Similarity=0.270  Sum_probs=183.5

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+....|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58889999997542   22334456677777654 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887654 689999999999999999999999   99999999999999999999999999997542211  2233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.                       ..+.+++.+||..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~  234 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD  234 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            4568999999999998899999999999999999999999964                       23678999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05592         235 PTKRLGVD  242 (316)
T ss_pred             HHHcCCCh
Confidence            99999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-38  Score=328.20  Aligned_cols=218  Identities=21%  Similarity=0.218  Sum_probs=187.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCC-CeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  500 (652)
                      +|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.++++.+.| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999865 57889999997542   2344567789999999976 56888999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence            9999999999887654 688999999999999999999999   9999999999999999999999999998743211  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  234 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG  234 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            1222345689999999999999999999999999999999999999742                       25689999


Q ss_pred             cchhhhccccCc
Q 041689          638 CTIESLELRINA  649 (652)
Q Consensus       638 ~l~~~p~~Rpt~  649 (652)
                      ||..||++||++
T Consensus       235 ~l~~~P~~R~~~  246 (324)
T cd05587         235 LLTKHPAKRLGC  246 (324)
T ss_pred             HhhcCHHHcCCC
Confidence            999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.1e-39  Score=321.78  Aligned_cols=225  Identities=21%  Similarity=0.313  Sum_probs=191.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+|++.+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999753    367899999876532 334578899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++.+++.++.|++.||+|||++   +++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999887655789999999999999999999999   9999999999999999999999999987643211


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      . ........++..|+|||.+.+..++.++|||||||++||+++ |+.||.                        ..+.+
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            1 111112235678999999999999999999999999999775 988853                        34788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.+|++||+++||
T Consensus       240 li~~c~~~~p~~RP~~~~i  258 (266)
T cd05064         240 LMLDCWQKERGERPRFSQI  258 (266)
T ss_pred             HHHHHcCCCchhCCCHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=342.53  Aligned_cols=240  Identities=24%  Similarity=0.408  Sum_probs=207.3

Q ss_pred             CCccccccHHHHHHHhcCC---------CccceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHH
Q 041689          409 KATWRRFSYLEVCRATYGF---------NENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEI  474 (652)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~y---------~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~  474 (652)
                      +...+.++++|-.++...|         .+.+.||.|.||+||+|+.+-    ...||||.++.. .++...+|..|+.|
T Consensus       604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI  683 (996)
T KOG0196|consen  604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI  683 (996)
T ss_pred             eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh
Confidence            3445666776666555554         467899999999999998652    456999999876 45567789999999


Q ss_pred             HHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 041689          475 MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPS  554 (652)
Q Consensus       475 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  554 (652)
                      |.+++||||+++.|+.......+||.|||++|+|+.+++.+++.+++.+...+.++||.|++||-..   ++|||||.+.
T Consensus       684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR  760 (996)
T KOG0196|consen  684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR  760 (996)
T ss_pred             cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999   9999999999


Q ss_pred             CeeeCCCCcEEEecccCCccccCCCCccccccccC--CccccCccccccCccCcccchhhHHHHHHHHHh-CCCC-----
Q 041689          555 NVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA--TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ-----  626 (652)
Q Consensus       555 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p-----  626 (652)
                      |||++.+-.+|++|||+++.+.++. ....+...|  ..+|.|||.+..++++.+|||||||+||||.++ |.+|     
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS  839 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  839 (996)
T ss_pred             heeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence            9999999999999999999774433 222232333  568999999999999999999999999999875 7777     


Q ss_pred             -------------------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 -------------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 -------------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                         |+..+.++|..||++|-.+||.|+||
T Consensus       840 NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qi  884 (996)
T KOG0196|consen  840 NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQI  884 (996)
T ss_pred             hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence                               55669999999999999999999875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-38  Score=335.50  Aligned_cols=200  Identities=24%  Similarity=0.309  Sum_probs=173.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++.+++||+|+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999865 58999999997542   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999987654 689999999999999999999999   999999999999999999999999999875422110


Q ss_pred             c---------------------------------cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc
Q 041689          581 S---------------------------------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC  627 (652)
Q Consensus       581 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~  627 (652)
                      .                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999999999999999999999999999996


Q ss_pred             c
Q 041689          628 V  628 (652)
Q Consensus       628 ~  628 (652)
                      .
T Consensus       237 ~  237 (363)
T cd05628         237 C  237 (363)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-40  Score=336.16  Aligned_cols=216  Identities=28%  Similarity=0.412  Sum_probs=194.2

Q ss_pred             eeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhh
Q 041689          432 LIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEK  510 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  510 (652)
                      .+|+|+||+||.|++.+ ...+|||-+.....+..+.+..|+.+-++++|+|||+++|.+..++++-|.||.+|||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            78999999999999764 66799999987777788889999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEecccCCccccCCCCccccccc
Q 041689          511 CLYSSNCIL--DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQT  587 (652)
Q Consensus       511 ~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  587 (652)
                      +++..-+++  .+...-.+..||++||.|||..   .|||||||-+||+|+ -.|.+||+|||-++.+.  .-.......
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc--cCCcccccc
Confidence            999877766  6778888999999999999999   999999999999995 78999999999999873  233445667


Q ss_pred             cCCccccCccccccC--ccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcccc
Q 041689          588 LATIGYIAPEYGREG--RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAMECT  639 (652)
Q Consensus       588 ~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~~l  639 (652)
                      .||..|||||++..+  .|+.++|||||||++.||.||++||-.                          +.+.++.+|+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            899999999999876  488999999999999999999999533                          3788999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      .+||.+||+|+++
T Consensus       817 epd~~~R~sA~~L  829 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDL  829 (1226)
T ss_pred             CCCcccCccHHHh
Confidence            9999999999874

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-38  Score=329.85  Aligned_cols=213  Identities=21%  Similarity=0.234  Sum_probs=185.2

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..+++++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999865 68899999997542   23345678899999998 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccc
Confidence            99998886554 689999999999999999999999   999999999999999999999999999874311  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------------hhhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------FVFN  633 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------~l~~  633 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+.                                .+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  234 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            45689999999999999999999999999999999999999841                                1568


Q ss_pred             hhcccchhhhccccCc
Q 041689          634 LAMECTIESLELRINA  649 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~  649 (652)
                      ++.+||+.||++||++
T Consensus       235 li~~~L~~dP~~R~~~  250 (329)
T cd05588         235 VLKGFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhccCHHHcCCC
Confidence            9999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.9e-39  Score=334.28  Aligned_cols=223  Identities=22%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999865 68999999997542   234456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999999987655799999999999999999999999   999999999999999999999999999986532221


Q ss_pred             ccccccccCCccccCccccc------cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGR------EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                       .......||+.|+|||++.      ...++.++|||||||++|||++|+.||..                         
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence             1223346899999999876      45678999999999999999999999632                         


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+|+. +|++|||++++
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l  260 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGL  260 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHH
Confidence              25778999998 99999998864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-39  Score=321.37  Aligned_cols=221  Identities=33%  Similarity=0.510  Sum_probs=183.7

Q ss_pred             ccceeccccceEEEEEEeC-----CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          429 ENNLIGKGGFGTIYKSRIG-----DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+.||.|+||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999865     26779999996543 33468899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++|+|.+++... ...+++.++..|+.|++.||.|||+.   +++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 55799999999999999999999999   9999999999999999999999999999865222222


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------------chhhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------------VSFVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------------~~~l~~l~~  636 (652)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+                        +..+.+++.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence            22233456788999999999999999999999999999999 66774                        334889999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       240 ~C~~~~p~~RPs~~~i  255 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEI  255 (259)
T ss_dssp             HHT-SSGGGS--HHHH
T ss_pred             HHcCCChhhCcCHHHH
Confidence            9999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-38  Score=327.02  Aligned_cols=214  Identities=21%  Similarity=0.280  Sum_probs=184.3

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +|+.||+|+++...   .........|.+++... +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999875 68899999997542   22345566788888765 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCcee
Confidence            99999887654 688999999999999999999999   999999999999999999999999999874311  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+||..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  234 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD  234 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence            45689999999999999999999999999999999999999643                       3678999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05620         235 PTRRLGVV  242 (316)
T ss_pred             HHHcCCCh
Confidence            99999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.4e-39  Score=331.60  Aligned_cols=211  Identities=21%  Similarity=0.246  Sum_probs=183.3

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 68999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      +|.+++.... .+++..+..++.|++.||+|||+ .   ||+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence            9998887654 68999999999999999999997 7   9999999999999999999999999998753211  12223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.                       ..+.+++.+||+.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  234 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD  234 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            4568999999999999999999999999999999999999963                       23688999999999


Q ss_pred             hcccc
Q 041689          643 LELRI  647 (652)
Q Consensus       643 p~~Rp  647 (652)
                      |++|+
T Consensus       235 P~~R~  239 (325)
T cd05594         235 PKQRL  239 (325)
T ss_pred             HHHhC
Confidence            99997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-38  Score=331.24  Aligned_cols=220  Identities=22%  Similarity=0.299  Sum_probs=187.7

Q ss_pred             CCCccceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          426 GFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      +|++.+.||+|+||.||+|+.    .+++.||+|+++...    ....+.+..|+++++++ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999975    358899999997432    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 688999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      .... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..                          
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG  235 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            2221 122345689999999998765 478899999999999999999999741                          


Q ss_pred             -hhhhhhcccchhhhccccCcc
Q 041689          630 -FVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       630 -~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                       .+.+++.+||+.||++||++.
T Consensus       236 ~~~~~li~~~l~~dp~~R~~~~  257 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLGAG  257 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCC
Confidence             257899999999999999543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=297.10  Aligned_cols=232  Identities=21%  Similarity=0.240  Sum_probs=195.0

Q ss_pred             HHHHhcCCCccceeccccceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----  493 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  493 (652)
                      +.....+|++.+.+|+|||+.||.++ ..+++.||+|++.....+..+...+|++..++++|||+++++++...+     
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34556789999999999999999998 567899999999877777788899999999999999999999987433     


Q ss_pred             CceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          494 EFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      ...|++++|...|+|.+.+..   ++..+++.+++.|+.++++||++||+. .+++.||||||.||++.+.+.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            358999999999999998764   334789999999999999999999988 3359999999999999999999999999


Q ss_pred             CCccccCCCCcc-------ccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcchh----------
Q 041689          571 ITKLLIGEDQSM-------TQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCVSF----------  630 (652)
Q Consensus       571 ~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~----------  630 (652)
                      .++...-.-...       .......|..|+|||.+.-   ...++++|||||||++|+|+.|..||+..          
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            987642110000       0112347899999998754   35679999999999999999999995543          


Q ss_pred             -----------------hhhhhcccchhhhccccCccCC
Q 041689          631 -----------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -----------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                       +.++++.|++.||.+||++.|+
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l  293 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL  293 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence                             7899999999999999998764

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-38  Score=326.17  Aligned_cols=214  Identities=21%  Similarity=0.292  Sum_probs=184.0

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   .........|..+++.. +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999997642   22344566788888764 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence            99999887643 688899999999999999999999   9999999999999999999999999998753211  11223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+||..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE  234 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence            45689999999999988999999999999999999999999632                       2578999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05619         235 PERRLGVK  242 (316)
T ss_pred             HhhcCCCh
Confidence            99999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=336.10  Aligned_cols=223  Identities=26%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999875 68999999997542   234567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC-
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED-  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  579 (652)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999998776 3689999999999999999999998   99999999999999999999999999998653222 


Q ss_pred             --------------------------CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----
Q 041689          580 --------------------------QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----  628 (652)
Q Consensus       580 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----  628 (652)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||.     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      0012234568999999999999999999999999999999999999963     


Q ss_pred             ----------------------hhhhhhhcccchhhhccccC-ccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRIN-AKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt-~~ei  652 (652)
                                            ..+.+++.+|+. ||++||+ ++|+
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l  282 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI  282 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence                                  336789999997 9999999 7764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-38  Score=326.72  Aligned_cols=218  Identities=21%  Similarity=0.227  Sum_probs=187.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      +|.+.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|.+++... +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999865 57899999997542   22334566788888777 5899999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....  .
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--D  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC--C
Confidence            9999999999887654 688999999999999999999999   999999999999999999999999999875321  1


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.+
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG  234 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence            1223345689999999999999999999999999999999999999643                       36779999


Q ss_pred             cchhhhccccCc
Q 041689          638 CTIESLELRINA  649 (652)
Q Consensus       638 ~l~~~p~~Rpt~  649 (652)
                      |++.||++|+++
T Consensus       235 ~l~~~p~~R~~~  246 (323)
T cd05616         235 LMTKHPGKRLGC  246 (323)
T ss_pred             HcccCHHhcCCC
Confidence            999999999986

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=334.14  Aligned_cols=217  Identities=25%  Similarity=0.342  Sum_probs=183.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3556789999999999999865 68999999986542 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++|+|....     ..++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.+...  ...
T Consensus       155 ~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  224 (353)
T PLN00034        155 DGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDP  224 (353)
T ss_pred             CCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc--ccc
Confidence            999986532     356677888999999999999999   9999999999999999999999999999865321  112


Q ss_pred             cccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhh
Q 041689          584 QTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFV  631 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l  631 (652)
                      .....||..|+|||++..     ...+.++|||||||++|||++|+.||.                           ..+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            234568999999998743     234568999999999999999999974                           236


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       305 ~~li~~~l~~~P~~Rpt~~el  325 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQL  325 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHH
Confidence            889999999999999999875

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-38  Score=329.11  Aligned_cols=213  Identities=23%  Similarity=0.260  Sum_probs=184.0

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.++++.+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 58899999997542   23345567788888876 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|..++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence            99998887654 688999999999999999999999   9999999999999999999999999998754221  12233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.                       ..+.+++.+||..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d  234 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN  234 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4568999999999998899999999999999999999999963                       34678999999999


Q ss_pred             hccccCc
Q 041689          643 LELRINA  649 (652)
Q Consensus       643 p~~Rpt~  649 (652)
                      |++||++
T Consensus       235 p~~R~~~  241 (321)
T cd05591         235 PNKRLGC  241 (321)
T ss_pred             HHHcCCC
Confidence            9999943

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-38  Score=336.54  Aligned_cols=217  Identities=21%  Similarity=0.235  Sum_probs=187.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+|.+.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++..++..++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999864 68899999653      23467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +. ++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NAN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc-ccc
Confidence            96 58888876654 688999999999999999999999   9999999999999999999999999999753211 111


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------------  628 (652)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.|+-                                  
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2234569999999999999999999999999999999999986531                                  


Q ss_pred             -------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                     ..+.+++.+||+.||++|||++|+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el  373 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL  373 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence                                           135678999999999999999875

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=313.77  Aligned_cols=218  Identities=25%  Similarity=0.323  Sum_probs=198.2

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |.+.+++|+|+||.||+|.++ +|+.||+|.+..+  .+.+++.+|+.++++++.|++|++||.|......|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            677889999999999999765 6999999998654  4678899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+..+.++.++..+.+.++..+++..++||+|||..   .-+|||||..|||++-+|.+||+|||.|..+.  +......
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhC
Confidence            999999998888999999999999999999999998   88999999999999999999999999998763  2333445


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC--------------------------cchhhhhhhcccc
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ--------------------------CVSFVFNLAMECT  639 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p--------------------------~~~~l~~l~~~~l  639 (652)
                      ...||+.|||||++..-.|+.++||||+|++..||..|++|                          |+++..+++++|+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            67899999999999999999999999999999999999998                          4555889999999


Q ss_pred             hhhhccccCccC
Q 041689          640 IESLELRINAKE  651 (652)
Q Consensus       640 ~~~p~~Rpt~~e  651 (652)
                      .+.|++|-||-+
T Consensus       268 iK~PE~R~TA~~  279 (502)
T KOG0574|consen  268 IKKPEERKTALR  279 (502)
T ss_pred             cCCHHHHHHHHH
Confidence            999999988754

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-38  Score=328.07  Aligned_cols=213  Identities=22%  Similarity=0.236  Sum_probs=184.2

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++..   .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 5889999999754   223445677899888877 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|..++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....  ......
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccc
Confidence            99998876654 689999999999999999999999   999999999999999999999999999875321  112223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------------hhhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------FVFN  633 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------~l~~  633 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..                                .+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            45689999999999999999999999999999999999999831                                1468


Q ss_pred             hhcccchhhhccccCc
Q 041689          634 LAMECTIESLELRINA  649 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~  649 (652)
                      ++.+||+.||++||++
T Consensus       235 ll~~~L~~dP~~R~~~  250 (329)
T cd05618         235 VLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCHHHcCCC
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-38  Score=335.78  Aligned_cols=223  Identities=21%  Similarity=0.267  Sum_probs=187.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999864 68899999997542   2344578899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC-
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ-  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  580 (652)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++++||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987654 688888999999999999999999   999999999999999999999999999754310000 


Q ss_pred             --------------------------------------------ccccccccCCccccCccccccCccCcccchhhHHHH
Q 041689          581 --------------------------------------------SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM  616 (652)
Q Consensus       581 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~v  616 (652)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999998899999999999999


Q ss_pred             HHHHHhCCCCcch---------------------------hhhhhhcc--cchhhhccccCccCC
Q 041689          617 LMEIHSAKQQCVS---------------------------FVFNLAME--CTIESLELRINAKEI  652 (652)
Q Consensus       617 l~elltg~~p~~~---------------------------~l~~l~~~--~l~~~p~~Rpt~~ei  652 (652)
                      +|||++|+.||..                           ...+++.+  |+..+|..||+++||
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999632                           25677777  445666679998764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.7e-39  Score=330.17  Aligned_cols=215  Identities=24%  Similarity=0.312  Sum_probs=187.0

Q ss_pred             ceeccccceEEEEEEe----CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          431 NLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      +.||+|+||.||+++.    .+|+.||+|+++...  ......+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    358899999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +|+|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....  ....
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCce
Confidence            999999886554 689999999999999999999999   9999999999999999999999999998764221  1222


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchh
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIE  641 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~  641 (652)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||.                       ..+.+++.+||+.
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            34568999999999988889999999999999999999999964                       2368899999999


Q ss_pred             hhccccCccC
Q 041689          642 SLELRINAKE  651 (652)
Q Consensus       642 ~p~~Rpt~~e  651 (652)
                      ||++||++.+
T Consensus       236 ~P~~R~~a~~  245 (318)
T cd05582         236 NPANRLGAGP  245 (318)
T ss_pred             CHhHcCCCCC
Confidence            9999999765

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=337.01  Aligned_cols=222  Identities=24%  Similarity=0.284  Sum_probs=186.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.++++.|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999864 68999999986532   233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987654 688889999999999999999999   999999999999999999999999999864311000


Q ss_pred             c------------c---------------------------------ccccccCCccccCccccccCccCcccchhhHHH
Q 041689          581 S------------M---------------------------------TQTQTLATIGYIAPEYGREGRVFANGDVYSFGI  615 (652)
Q Consensus       581 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~  615 (652)
                      .            .                                 ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246899999999999889999999999999


Q ss_pred             HHHHHHhCCCCcch---------------------------hhhhhhcccchhhhcccc---CccC
Q 041689          616 MLMEIHSAKQQCVS---------------------------FVFNLAMECTIESLELRI---NAKE  651 (652)
Q Consensus       616 vl~elltg~~p~~~---------------------------~l~~l~~~~l~~~p~~Rp---t~~e  651 (652)
                      ++|||++|+.||..                           .+.+++.+|+. +|.+|+   ++.|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999632                           24678888997 777764   7655

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-38  Score=327.53  Aligned_cols=224  Identities=23%  Similarity=0.368  Sum_probs=190.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc----EEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|.++... ....+++..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999853 333    48999986542 34456788999999999999999999998765 5679


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999987766788999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |+.||..                        .+.+
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  242 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            22222222334678999999999999999999999999999998 8888643                        3677


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..+|++||++.||
T Consensus       243 li~~cl~~~p~~Rps~~~l  261 (316)
T cd05108         243 IMVKCWMIDADSRPKFREL  261 (316)
T ss_pred             HHHHHccCChhhCcCHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.3e-38  Score=326.36  Aligned_cols=214  Identities=21%  Similarity=0.248  Sum_probs=185.9

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 57899999997542   23345678899999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCcee
Confidence            99998886554 689999999999999999999999   999999999999999999999999999875321  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------------hhhhhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------FVFNLA  635 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------~l~~l~  635 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..                              .+.+++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            45689999999999999999999999999999999999999841                              267899


Q ss_pred             cccchhhhccccCcc
Q 041689          636 MECTIESLELRINAK  650 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~  650 (652)
                      .+||+.||++||+++
T Consensus       235 ~~~L~~dP~~R~~~~  249 (327)
T cd05617         235 KGFLNKDPKERLGCQ  249 (327)
T ss_pred             HHHhccCHHHcCCCC
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=326.63  Aligned_cols=225  Identities=24%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ....+.++||+|.||+|..|....+..||||.++..... ...+|.+|+++|.+++|||||+++|+|..++.+++|+||+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            346678999999999999999877899999999877443 4589999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCC-CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNCIL-DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l-~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|+|.+++..+..+. ......+|+.||+.|++||.+.   ++||||+.+.|+|+|.++++||+|||+++-+...+...
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            9999999998875433 5556778999999999999999   99999999999999999999999999999776555555


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh--CCCC-------------------------------cch
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS--AKQQ-------------------------------CVS  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p-------------------------------~~~  629 (652)
                      .....+-..+|||||.+.-++++.++|||+||+++||+++  ...|                               |+.
T Consensus       695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence            5556667889999999999999999999999999999865  4444                               566


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.|.++||+|++|
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHH
Confidence            68999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-38  Score=322.30  Aligned_cols=225  Identities=28%  Similarity=0.440  Sum_probs=193.2

Q ss_pred             cCCCccceeccccceEEEEEEe------CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|.+.+.||+|+||.||++..      .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4688889999999999999974      2345689999876655566789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          499 VLEHMPHGSLEKCLYSSN------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                      ||||+++++|.+++....            ..+++.++..++.|++.||+|||++   |++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999986432            2489999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-----------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-----------------  628 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-----------------  628 (652)
                      +|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.                 
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999986533222222233445778999999998899999999999999999998 888742                 


Q ss_pred             -------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             ..+.+++.+||+.||.+|||++||
T Consensus       242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v  272 (288)
T cd05093         242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEI  272 (288)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                   347889999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=345.93  Aligned_cols=229  Identities=21%  Similarity=0.273  Sum_probs=194.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC---
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE---  494 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---  494 (652)
                      .....+|.+.+.||+|+||.||+|+.. +|+.||||++...  .......+.+|+.++..++|+||+++++.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            344568999999999999999999854 6899999999754  2334567888999999999999999988765332   


Q ss_pred             -----ceEEEEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          495 -----FKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       495 -----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                           ..++||||+++|+|.+++....   ..+++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 3679999999999999886432   3688999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------  629 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------  629 (652)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..                 
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999999865332222223445699999999999999999999999999999999999999642                 


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.||++||++.|+
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~el  294 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKL  294 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                   37789999999999999998764

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-38  Score=335.56  Aligned_cols=224  Identities=22%  Similarity=0.254  Sum_probs=190.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457899999999999999999865 68899999996431   2234457789999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999988754  478888889999999999999999   9999999999999999999999999999865322


Q ss_pred             CCccccccccCCccccCccccccC----ccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREG----RVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      . ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||..                         
T Consensus       196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  274 (370)
T cd05596         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI  274 (370)
T ss_pred             C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence            1 1122345699999999987653    478999999999999999999999543                         


Q ss_pred             --hhhhhhcccchhhhcc--ccCccCC
Q 041689          630 --FVFNLAMECTIESLEL--RINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~--Rpt~~ei  652 (652)
                        .+.+++.+|++.+|++  ||+++||
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~el  301 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEI  301 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHH
Confidence              2678899999999988  9998774

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-38  Score=321.39  Aligned_cols=225  Identities=28%  Similarity=0.479  Sum_probs=191.6

Q ss_pred             cCCCccceeccccceEEEEEEeCC------CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD------GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .+|++.+.||+|+||.||+|....      ...||+|.++... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            368888999999999999997542      2579999986543 234567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC
Q 041689          498 LVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM  562 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~  562 (652)
                      ++|||+++++|.+++....               ..+++.++..++.|++.||.|||+.   +++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            9999999999999886532               2477888999999999999999999   999999999999999999


Q ss_pred             cEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------
Q 041689          563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------  628 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------  628 (652)
                      .+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||.             
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986533222222334456788999999988899999999999999999998 888743             


Q ss_pred             -----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 ..+.+++.+||+.||++||++.||
T Consensus       242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i  276 (283)
T cd05048         242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI  276 (283)
T ss_pred             CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                       347899999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.5e-38  Score=326.67  Aligned_cols=214  Identities=29%  Similarity=0.301  Sum_probs=182.4

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHH-HHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECE-IMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 68999999997542   122234444544 56788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccc
Confidence            99999887654 688999999999999999999999   999999999999999999999999999875321  122233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.+|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD  234 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            45689999999999999999999999999999999999999643                       2678999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 p~~R~~~~  242 (323)
T cd05575         235 RTKRLGAK  242 (323)
T ss_pred             HHhCCCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.6e-38  Score=317.90  Aligned_cols=214  Identities=24%  Similarity=0.311  Sum_probs=183.6

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||+||+|... +++.||+|.+.....   ...+.+..|++++++++||||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 688999999865422   2335667899999999999999999999999999999999999999


Q ss_pred             hhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          509 EKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       509 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      ..++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||.+..+....  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            887743   223689999999999999999999999   99999999999999999999999999997653221  1223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhhhccc
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNLAMEC  638 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l~~~~  638 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..                           .+.+++.+|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            34689999999999999999999999999999999999999642                           367899999


Q ss_pred             chhhhccccCccC
Q 041689          639 TIESLELRINAKE  651 (652)
Q Consensus       639 l~~~p~~Rpt~~e  651 (652)
                      |+.||++||++++
T Consensus       236 l~~~P~~R~~~~~  248 (280)
T cd05608         236 LAKDPEKRLGFRD  248 (280)
T ss_pred             hcCCHHHhcCCCC
Confidence            9999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.3e-38  Score=321.18  Aligned_cols=221  Identities=25%  Similarity=0.350  Sum_probs=184.0

Q ss_pred             cCCCccceeccccceEEEEEEeC--CCcEEEEEEeeccc--chhhhhHHHHHHHHHhc---CCCeeeeEEeeee-----c
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI---HYRNLVKIISSCS-----N  492 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~  492 (652)
                      .+|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46889999987542  22234556777777766   6999999999875     2


Q ss_pred             CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999997 58988886543 3588999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      ++.....   .......|++.|+|||++.+..++.++|||||||++|||++|++||..                      
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9765221   223345689999999999888999999999999999999999998642                      


Q ss_pred             ----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  .+.+++.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  284 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  284 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence                                        13689999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-37  Score=315.95  Aligned_cols=213  Identities=25%  Similarity=0.316  Sum_probs=183.8

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+++.+ +|+.||+|.+....   ......+..|++++++++||||+++++++..+.+.++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999865 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccc
Q 041689          509 EKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT  587 (652)
Q Consensus       509 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  587 (652)
                      .+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            98876543 2588889999999999999999999   9999999999999999999999999998765321   122345


Q ss_pred             cCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------------hhhhhhcccc
Q 041689          588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------FVFNLAMECT  639 (652)
Q Consensus       588 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------~l~~l~~~~l  639 (652)
                      .|+..|+|||++.+..++.++||||+||++|||++|+.||..                            .+.+++.+||
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence            688999999999988999999999999999999999999642                            2688999999


Q ss_pred             hhhhccccCccC
Q 041689          640 IESLELRINAKE  651 (652)
Q Consensus       640 ~~~p~~Rpt~~e  651 (652)
                      +.||++||+++|
T Consensus       235 ~~~P~~R~~~~~  246 (277)
T cd05607         235 AKKPEDRLGSRE  246 (277)
T ss_pred             ccCHhhCCCCcc
Confidence            999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-39  Score=297.42  Aligned_cols=223  Identities=25%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             HHhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc--------chhhhhHHHHHHHHHhc-CCCeeeeEEeeee
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSI-HYRNLVKIISSCS  491 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  491 (652)
                      ...+.|...+.+|.|..++|-+|.+ .+|+++|+|++....        ....+.-.+|+.|++++ .||+|+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3445688889999999999999875 478999999985431        12234556799999998 6999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      .+...++|+|.|+.|.|.+++...- .+++.+..+|++|+..|++|||..   +||||||||+|||+|++..+||+|||+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            9999999999999999999998765 789999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCcccccc------CccCcccchhhHHHHHHHHHhCCCCc------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGRE------GRVFANGDVYSFGIMLMEIHSAKQQC------------------  627 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~------------------  627 (652)
                      ++.+.   ........+|||+|.|||.+.-      ..|+..+|+||+||+||.++.|.+||                  
T Consensus       170 a~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  170 ACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             eeccC---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            99873   3344566789999999997643      36888899999999999999999992                  


Q ss_pred             ---------chhhhhhhcccchhhhccccCccC
Q 041689          628 ---------VSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       628 ---------~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                               ++..++++.+|++.||.+|.|++|
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake  279 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKE  279 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHH
Confidence                     334899999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-38  Score=333.21  Aligned_cols=227  Identities=23%  Similarity=0.359  Sum_probs=190.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEE  494 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  494 (652)
                      ..++|.+.+.||+|+||.||+|...      .+..||||+++... ....+.+.+|+++++++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3568899999999999999999742      23469999997542 234567889999999996 999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN----------------------------------------------------------  516 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  516 (652)
                      ..|+||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC
Q 041689          517 -------------------------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD  559 (652)
Q Consensus       517 -------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~  559 (652)
                                                           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                                 1367778889999999999999999   999999999999999


Q ss_pred             CCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch---------
Q 041689          560 DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS---------  629 (652)
Q Consensus       560 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~---------  629 (652)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..         
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            999999999999986533222222233456788999999988899999999999999999997 8777532         


Q ss_pred             ----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                      .+.+++.+||+.||++|||+.+|
T Consensus       352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l  390 (400)
T cd05105         352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL  390 (400)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHH
Confidence                            36889999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-38  Score=335.94  Aligned_cols=223  Identities=22%  Similarity=0.264  Sum_probs=187.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999865 58999999986432   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999987654 688888899999999999999999   999999999999999999999999999753210000


Q ss_pred             -----------------------------------------ccccccccCCccccCccccccCccCcccchhhHHHHHHH
Q 041689          581 -----------------------------------------SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLME  619 (652)
Q Consensus       581 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e  619 (652)
                                                               ........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000112468999999999999999999999999999999


Q ss_pred             HHhCCCCcch---------------------------hhhhhhcccchhhhcccc---CccCC
Q 041689          620 IHSAKQQCVS---------------------------FVFNLAMECTIESLELRI---NAKEI  652 (652)
Q Consensus       620 lltg~~p~~~---------------------------~l~~l~~~~l~~~p~~Rp---t~~ei  652 (652)
                      |++|+.||..                           ...+++.+|+ .+|++|+   ++.|+
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999642                           2566777776 5999999   66653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.1e-38  Score=325.29  Aligned_cols=213  Identities=23%  Similarity=0.245  Sum_probs=185.1

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 58899999997542   23345667888999888 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|..++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCccc
Confidence            99998887654 689999999999999999999999   999999999999999999999999999875321  112223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.+||..|
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d  234 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN  234 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence            34689999999999999999999999999999999999999642                       3678999999999


Q ss_pred             hccccCc
Q 041689          643 LELRINA  649 (652)
Q Consensus       643 p~~Rpt~  649 (652)
                      |++||++
T Consensus       235 P~~R~s~  241 (318)
T cd05570         235 PEKRLGC  241 (318)
T ss_pred             HHHcCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.8e-38  Score=335.27  Aligned_cols=218  Identities=21%  Similarity=0.260  Sum_probs=185.0

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999864 68899999997542   2334578889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC-
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ-  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-  580 (652)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999887654 688888999999999999999999   999999999999999999999999999753210000 


Q ss_pred             --------------------------------------------ccccccccCCccccCccccccCccCcccchhhHHHH
Q 041689          581 --------------------------------------------SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM  616 (652)
Q Consensus       581 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~v  616 (652)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000112468999999999999999999999999999


Q ss_pred             HHHHHhCCCCcch---------------------------hhhhhhcccchhhhccccC
Q 041689          617 LMEIHSAKQQCVS---------------------------FVFNLAMECTIESLELRIN  648 (652)
Q Consensus       617 l~elltg~~p~~~---------------------------~l~~l~~~~l~~~p~~Rpt  648 (652)
                      +|||++|+.||..                           ...+++.+|+ .+|++|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~  295 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG  295 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence            9999999999642                           2566777776 49999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.3e-38  Score=324.14  Aligned_cols=222  Identities=21%  Similarity=0.290  Sum_probs=189.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999865 68889999987542 22334677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ ++.+++......+++..+..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  ..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TK  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC--cc
Confidence            986 88888876665688999999999999999999999   9999999999999999999999999998754221  11


Q ss_pred             ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..                                
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2223457889999998765 4688999999999999999999988632                                


Q ss_pred             ---------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           ...+++.+|++.||++|||++|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  283 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA  283 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence                                 34679999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-38  Score=332.96  Aligned_cols=226  Identities=22%  Similarity=0.249  Sum_probs=188.9

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334568999999999999999999875 5889999998643   122345678899999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |+||||+++|+|.+++...  .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++...
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999999998754  478889999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccccccccCCccccCccccccC----ccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREG----RVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      ... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||..                       
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            211 1122345699999999998654    378899999999999999999999642                       


Q ss_pred             ----hhhhhhcccchhhhcc--ccCccCC
Q 041689          630 ----FVFNLAMECTIESLEL--RINAKEI  652 (652)
Q Consensus       630 ----~l~~l~~~~l~~~p~~--Rpt~~ei  652 (652)
                          .+++++.+|+..++.+  ||+++|+
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~  301 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEI  301 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHH
Confidence                2578888888755543  7787663

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.6e-38  Score=319.98  Aligned_cols=225  Identities=30%  Similarity=0.447  Sum_probs=192.7

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .+|.+.+.||+|+||.||+|...      +++.||+|.++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            45788899999999999999753      3578999998765333 4578999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          498 LVLEHMPHGSLEKCLYSSN-------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      +||||+++++|.+++....             ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999987542             2478888999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------  628 (652)
                      ||+|||.++...............+++.|+|||++.++.++.++|||||||++|||++ |+.||.               
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR  241 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876432221112223345788999999999999999999999999999998 998853               


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||+.||++||++.||
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                     347899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.2e-38  Score=325.13  Aligned_cols=215  Identities=27%  Similarity=0.270  Sum_probs=181.7

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHH-HHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIEC-EIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 57889999997542   12223344444 356788999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+.+..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++....  ......
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcc
Confidence            99999887654 578888888999999999999999   999999999999999999999999999875422  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD  234 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence            45689999999999999999999999999999999999999643                       2678999999999


Q ss_pred             hccccCccC
Q 041689          643 LELRINAKE  651 (652)
Q Consensus       643 p~~Rpt~~e  651 (652)
                      |.+||++.+
T Consensus       235 p~~R~~~~~  243 (325)
T cd05602         235 RTKRLGAKD  243 (325)
T ss_pred             HHHCCCCCC
Confidence            999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=318.90  Aligned_cols=217  Identities=24%  Similarity=0.323  Sum_probs=188.0

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|++.+.||+|+||.||++... +++.||+|++.....   .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999864 689999999865421   223456789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++......  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--  155 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence            999999998876533 3689999999999999999999999   9999999999999999999999999998865221  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFN  633 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~  633 (652)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||..                           .+.+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05605         156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS  234 (285)
T ss_pred             -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence             112334689999999999988999999999999999999999999743                           2678


Q ss_pred             hhcccchhhhccccC
Q 041689          634 LAMECTIESLELRIN  648 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt  648 (652)
                      ++.+||..||++||+
T Consensus       235 li~~~l~~~P~~R~~  249 (285)
T cd05605         235 ICRQLLTKDPGFRLG  249 (285)
T ss_pred             HHHHHccCCHHHhcC
Confidence            999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-38  Score=315.20  Aligned_cols=226  Identities=24%  Similarity=0.396  Sum_probs=194.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC----CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|.+.    +...||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            356889999999999999999864    24579999987543 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999987666789999999999999999999999   9999999999999999999999999999876422


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |..||.                        ..+.+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            22222222335678999999998899999999999999999998 888852                        34788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.+|++||++.||
T Consensus       240 li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             HHHHHcCCCcccCcCHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.2e-38  Score=314.35  Aligned_cols=223  Identities=23%  Similarity=0.357  Sum_probs=192.4

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|++.+.||+|+||.||.|+..++..||+|.++... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999988777789999987442 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +|+|.+++......+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            9999999877555789999999999999999999999   99999999999999999999999999987653221 1111


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l  639 (652)
                      ....++..|+|||...+..++.++|||||||++|||++ |+.||..                        .+.+++.+||
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW  238 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            22335678999999988889999999999999999998 8888532                        3688999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      ..+|++||++.+|
T Consensus       239 ~~~p~~Rp~~~~l  251 (256)
T cd05113         239 HEKAEERPTFQQL  251 (256)
T ss_pred             CCCcccCCCHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.1e-38  Score=312.63  Aligned_cols=219  Identities=26%  Similarity=0.376  Sum_probs=185.9

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999865 68999999886442 33456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+++......+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999876655689999999999999999999999   99999999999999999999999999987542211111111112


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccchhhh
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECTIESL  643 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l~~~p  643 (652)
                      .+..|+|||.+.++.++.++|||||||++|||++ |..||.                        ..+.+++.+||..+|
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            3457999999998899999999999999999998 877742                        337889999999999


Q ss_pred             ccccCccCC
Q 041689          644 ELRINAKEI  652 (652)
Q Consensus       644 ~~Rpt~~ei  652 (652)
                      ++|||+.||
T Consensus       238 ~~Rps~~~~  246 (252)
T cd05084         238 GQRPSFSTV  246 (252)
T ss_pred             hhCcCHHHH
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8e-38  Score=323.74  Aligned_cols=219  Identities=20%  Similarity=0.230  Sum_probs=187.5

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  500 (652)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999865 68899999997542   223456778888988885 577888999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence            9999999999887654 689999999999999999999999   9999999999999999999999999998753211  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~  637 (652)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||...                       +.+++.+
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG  234 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence            11223456899999999999889999999999999999999999996432                       5679999


Q ss_pred             cchhhhccccCcc
Q 041689          638 CTIESLELRINAK  650 (652)
Q Consensus       638 ~l~~~p~~Rpt~~  650 (652)
                      ||..+|++|+++.
T Consensus       235 ~l~~~p~~R~~~~  247 (323)
T cd05615         235 LMTKHPSKRLGCG  247 (323)
T ss_pred             HcccCHhhCCCCC
Confidence            9999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=323.91  Aligned_cols=220  Identities=24%  Similarity=0.292  Sum_probs=197.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  498 (652)
                      ...|...+.||+|.||.||+|+.+ +|+.+|+|++.+...   .....+.+|+++|+++. |||||.++++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999866 599999999976533   24568999999999998 9999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC----CCcEEEecccCCcc
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD----TMVAHLSDFGITKL  574 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfg~~~~  574 (652)
                      |||++.||.|.+.+...  .+++..+..++.|++.|++|+|+.   ||+|||+||+|+|+..    ++.+|++|||++..
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999998876  389999999999999999999999   9999999999999963    35899999999997


Q ss_pred             ccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF------------------------  630 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~------------------------  630 (652)
                      ...   .......+||+.|+|||++...+|+..+||||+||++|.|++|.+||..+                        
T Consensus       189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            632   34556778999999999999999999999999999999999999995443                        


Q ss_pred             ---hhhhhcccchhhhccccCccC
Q 041689          631 ---VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 ---l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                         +++++.+|+..||.+|+|+.+
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~  289 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQ  289 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHH
Confidence               799999999999999999876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.6e-38  Score=315.11  Aligned_cols=224  Identities=24%  Similarity=0.384  Sum_probs=193.5

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            35788999999999999999998888899999986542 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++... ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+....... ..
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YT  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc-ee
Confidence            999999998654 33678889999999999999999999   99999999999999999999999999998653211 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                      ......++..|+|||++..+.++.++|||||||++|||++ |+.||.                        ..+.+++.+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT  239 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            1122335678999999988889999999999999999998 888853                        347889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++++|
T Consensus       240 ~l~~~p~~Rp~~~~i  254 (261)
T cd05072         240 CWKEKAEERPTFDYL  254 (261)
T ss_pred             HccCCcccCcCHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-38  Score=324.07  Aligned_cols=214  Identities=28%  Similarity=0.295  Sum_probs=181.6

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHH-HHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECE-IMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 58899999997542   222334555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      ++|...+.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....  ......
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccc
Confidence            99998886544 688888999999999999999999   999999999999999999999999999875321  112233


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...                       +.+++.+|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            456899999999999889999999999999999999999996432                       678999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 p~~R~~~~  242 (321)
T cd05603         235 QRRRLGAK  242 (321)
T ss_pred             HhhcCCCC
Confidence            99999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=313.21  Aligned_cols=222  Identities=26%  Similarity=0.383  Sum_probs=191.2

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            477889999999999999998777889999986442 2345678899999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      ++|.+++......+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++...... .....
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~  159 (256)
T cd05059          84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQ  159 (256)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc-ccccC
Confidence            999999987655789999999999999999999999   99999999999999999999999999987653211 11111


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccch
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECTI  640 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l~  640 (652)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.                        ..+.+++.+||.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  239 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH  239 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            2224457999999998899999999999999999999 788753                        338899999999


Q ss_pred             hhhccccCccCC
Q 041689          641 ESLELRINAKEI  652 (652)
Q Consensus       641 ~~p~~Rpt~~ei  652 (652)
                      .+|++|||+.||
T Consensus       240 ~~p~~Rpt~~~~  251 (256)
T cd05059         240 EKPEDRPAFKKL  251 (256)
T ss_pred             CChhhCcCHHHH
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-37  Score=314.04  Aligned_cols=223  Identities=24%  Similarity=0.319  Sum_probs=192.3

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+|++.+.||+|+||.||+|+. .+++.||+|+++.........+++|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999986 46889999999765444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++.... .+++..+..++.|++.|++|||+.   +|+|||+||+||++++++.+||+|||++......  ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence            99999999886544 689999999999999999999999   9999999999999999999999999999865221  11


Q ss_pred             ccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcc----------------------------hhh
Q 041689          583 TQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------SFV  631 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------~~l  631 (652)
                      ......++..|+|||.+.   ...++.++||||+||++|||++|+.|+.                            ..+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            122345788999999874   3457889999999999999999998842                            236


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||..+|++|||+++|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~i  262 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERL  262 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHH
Confidence            789999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.4e-38  Score=325.00  Aligned_cols=214  Identities=29%  Similarity=0.319  Sum_probs=182.2

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHH-HHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECE-IMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 68999999997542   223344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|..++.... .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||+++....  ......
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcc
Confidence            99998887554 689999999999999999999999   999999999999999999999999999875321  112223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhcccchhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAMECTIES  642 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~~l~~~  642 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...                       +.+++.+|+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~  234 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD  234 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence            456899999999999999999999999999999999999996432                       568999999999


Q ss_pred             hccccCcc
Q 041689          643 LELRINAK  650 (652)
Q Consensus       643 p~~Rpt~~  650 (652)
                      |++||++.
T Consensus       235 p~~R~~~~  242 (325)
T cd05604         235 RQRRLGAK  242 (325)
T ss_pred             HHhcCCCC
Confidence            99999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-38  Score=319.78  Aligned_cols=224  Identities=20%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ...|++.++||+||.+.||++...+.+-||+|++...  +.+....|..|+..|.++ .|.+||++++|-..+++.|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3568899999999999999999888888888877533  445667899999999999 5999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||-+- +|.+++..+....+...+..+..|++.|+.++|.+   ||||.||||.|+++-. |.+||+|||.|..+..+..
T Consensus       440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            98754 99999988776566457888999999999999999   9999999999999875 5899999999998876666


Q ss_pred             ccccccccCCccccCccccccC-----------ccCcccchhhHHHHHHHHHhCCCCcchh-------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREG-----------RVFANGDVYSFGIMLMEIHSAKQQCVSF-------------------  630 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~vl~elltg~~p~~~~-------------------  630 (652)
                      .......+||+.||+||.+...           +.+.++||||+|||+|+|+.|+.||...                   
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief  594 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF  594 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence            6666777899999999986543           2568899999999999999999995442                   


Q ss_pred             --------hhhhhcccchhhhccccCccCC
Q 041689          631 --------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 --------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                              +.++|+.||..||.+||++.|+
T Consensus       595 p~~~~~~~li~~mK~CL~rdPkkR~si~eL  624 (677)
T KOG0596|consen  595 PDIPENDELIDVMKCCLARDPKKRWSIPEL  624 (677)
T ss_pred             cCCCCchHHHHHHHHHHhcCcccCCCcHHH
Confidence                    7889999999999999999874

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=313.25  Aligned_cols=224  Identities=26%  Similarity=0.390  Sum_probs=192.6

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688899999999999999998778889999987543 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.+||+|||+++...... ..
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence            9999999987644 4689999999999999999999999   99999999999999999999999999998763211 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.||.                        ..+.+++.+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD  239 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            1112223457999999998899999999999999999999 887753                        237889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||++++|
T Consensus       240 ~l~~~P~~Rp~~~~l  254 (261)
T cd05068         240 CWKEDPDDRPTFETL  254 (261)
T ss_pred             HhhcCcccCCCHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.5e-38  Score=317.43  Aligned_cols=225  Identities=27%  Similarity=0.420  Sum_probs=190.0

Q ss_pred             cCCCccceeccccceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|++.+.||+|+||.||+|..     .++..||+|.+.... ......+.+|++++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577889999999999999974     246789999987432 2344678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC
Q 041689          499 VLEHMPHGSLEKCLYSSN----------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM  562 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~  562 (652)
                      ||||+++++|.+++....                ..+++.++..++.|++.||+|||++   +++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999885321                2477888899999999999999999   999999999999999999


Q ss_pred             cEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------
Q 041689          563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------  628 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------  628 (652)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.             
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986533222222233445678999999988889999999999999999998 887752             


Q ss_pred             -----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 ..+.+++.+||+.||++||++.+|
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  276 (283)
T cd05090         242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI  276 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence                       336789999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.9e-38  Score=316.52  Aligned_cols=224  Identities=25%  Similarity=0.380  Sum_probs=187.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc----EEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|++.+.||+|+||.||+|.+. ++.    .|++|.+.... .....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999864 344    47778775432 2334677888889999999999999998754 45778


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ++||+++|+|.+++......+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999987666789999999999999999999999   9999999999999999999999999999865333


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ..........++..|+|||.+.++.++.++|||||||++|||++ |+.||..                        .+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM  242 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence            22222334456778999999998899999999999999999998 8888533                        2567


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..||++|||+.||
T Consensus       243 li~~c~~~~p~~Rps~~el  261 (279)
T cd05111         243 VMVKCWMIDENVRPTFKEL  261 (279)
T ss_pred             HHHHHcCCCcccCcCHHHH
Confidence            8899999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.7e-38  Score=318.64  Aligned_cols=225  Identities=28%  Similarity=0.440  Sum_probs=192.9

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|...+.||+|+||.||+|+..      ++..|++|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35778899999999999999742      356689999876655556788999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          499 VLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||++   +|+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999986532               2478899999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------------  628 (652)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.              
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            99999999976533222222233456788999999998999999999999999999999 999852              


Q ss_pred             ----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ..+.+++.+||+.+|++|||++||
T Consensus       242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v  275 (291)
T cd05094         242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI  275 (291)
T ss_pred             CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                      237889999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.9e-38  Score=329.87  Aligned_cols=228  Identities=23%  Similarity=0.252  Sum_probs=189.8

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      .++....++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555689999999999999999999875 58899999986431   22345577899999999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      +..++||||+++|+|.+++...  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999988754  478888899999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccC----ccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREG----RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      ..... .........||+.|+|||++...    .++.++||||+||++|||++|+.||..                    
T Consensus       191 ~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  269 (371)
T cd05622         191 KMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  269 (371)
T ss_pred             EcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence            65322 11222345699999999998654    378999999999999999999999643                    


Q ss_pred             -------hhhhhhcccchhhhcc---ccCccCC
Q 041689          630 -------FVFNLAMECTIESLEL---RINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~---Rpt~~ei  652 (652)
                             .+.+++.+|+. +|..   ||+++||
T Consensus       270 ~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei  301 (371)
T cd05622         270 DDNDISKEAKNLICAFLT-DREVRLGRNGVEEI  301 (371)
T ss_pred             CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHH
Confidence                   25678889997 5554   5666553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.9e-38  Score=315.55  Aligned_cols=226  Identities=25%  Similarity=0.426  Sum_probs=197.1

Q ss_pred             HHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++..+|++.+.||+|+||.||+|...+++.||+|++..........+..|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999988899999999987655556788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++++|.+++.... ..+++.++..++.|++.|++|||+.   |++||||||+||++++++.+||+|||.+......  
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--  157 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED--  157 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence            999999999997643 3689999999999999999999999   9999999999999999999999999999765321  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~  635 (652)
                      ........++..|+|||......++.++||||||+++|+|++ |+.||.                        ..+.+++
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence            111223345678999999988899999999999999999998 788853                        2378899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       238 ~~~l~~~p~~Rpt~~~l  254 (261)
T cd05148         238 LECWAAEPEDRPSFKAL  254 (261)
T ss_pred             HHHcCCCchhCcCHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-37  Score=327.91  Aligned_cols=220  Identities=22%  Similarity=0.250  Sum_probs=186.5

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-----
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-----  494 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  494 (652)
                      ...+|++.+.||+|+||.||+|+.. +|..||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999864 6899999998643  2234567788999999999999999999986443     


Q ss_pred             -ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          495 -FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       495 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                       ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999976 56665532   478888999999999999999999   99999999999999999999999999997


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ....   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.                         
T Consensus       172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            5421   122234568999999999999999999999999999999999999873                         


Q ss_pred             ----------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                              ..+.+++.+||..||++|||++|+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  312 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA  312 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence                                                    235689999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-37  Score=315.77  Aligned_cols=227  Identities=24%  Similarity=0.392  Sum_probs=189.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      ..++|+..+.||+|+||.||+|...      ++..||+|.++... ......+.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998742      35679999986432 2344568899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          496 KELVLEHMPHGSLEKCLYSSN---------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                      .++||||+++++|.+++....         ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         1356778899999999999999999   9999999999999999999999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-----------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-----------------  628 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-----------------  628 (652)
                      +|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.                 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999876532222122222345778999999998899999999999999999999 677643                 


Q ss_pred             -------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             ..+.+++.+||+.+|++|||+.|+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  271 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  271 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                   237789999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=314.49  Aligned_cols=220  Identities=22%  Similarity=0.286  Sum_probs=196.9

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |...+.||+|-|++|-+|++- +|..||||++.+..  .-....+.+|++.|+.++|||||++|++....-..|+|+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            667788999999999999854 79999999997652  234456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee-CCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL-DDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      .+|+|.+|+..+...+.+.-+.+++.||+.|+.|+|+-   .+|||||||+||.+ ..-|-+||.|||++..+.   ...
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~---PG~  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ---PGK  173 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC---Ccc
Confidence            99999999998888899999999999999999999999   89999999999865 677999999999998763   344


Q ss_pred             ccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~~~~  638 (652)
                      ..+..+|+..|.|||++.+..|+ +++||||+|||+|.++.|++||...                       -++++.+|
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM  253 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM  253 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence            55678999999999999999998 5679999999999999999997654                       58899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |..||.+|-+.+||
T Consensus       254 LvRdPkkRAslEeI  267 (864)
T KOG4717|consen  254 LVRDPKKRASLEEI  267 (864)
T ss_pred             HhcCchhhccHHHH
Confidence            99999999998876

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.2e-38  Score=324.85  Aligned_cols=226  Identities=23%  Similarity=0.381  Sum_probs=188.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeec-CC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSN-EE  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~  494 (652)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++... ....+.+..|+++++++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357889999999999999999632      35789999987542 23345677899999999 89999999998764 45


Q ss_pred             ceEEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN----------------------------------------------------------  516 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  516 (652)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999875421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCcccc
Q 041689          517 --CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI  594 (652)
Q Consensus       517 --~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  594 (652)
                        ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++..+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              1578888999999999999999999   99999999999999999999999999998753322222223344677899


Q ss_pred             CccccccCccCcccchhhHHHHHHHHHh-CCCCcch-------------------------hhhhhhcccchhhhccccC
Q 041689          595 APEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-------------------------FVFNLAMECTIESLELRIN  648 (652)
Q Consensus       595 aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-------------------------~l~~l~~~~l~~~p~~Rpt  648 (652)
                      |||++.+..++.++|||||||++|||++ |..||..                         .+.+++.+||+.+|++||+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999999999998 9988632                         3578899999999999999


Q ss_pred             ccCC
Q 041689          649 AKEI  652 (652)
Q Consensus       649 ~~ei  652 (652)
                      +.||
T Consensus       323 ~~el  326 (337)
T cd05054         323 FSEL  326 (337)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-37  Score=317.34  Aligned_cols=221  Identities=26%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46888899999999999999854 68999999997665555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++...  .+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||.+.......  ..
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc--cc
Confidence            999999988654  478899999999999999999999   99999999999999999999999999987643221  11


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..                          .+.+++.+
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence            2234688899999999888899999999999999999999999632                          26789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++.||
T Consensus       253 ~l~~~p~~Rpt~~ei  267 (296)
T cd06654         253 CLDMDVEKRGSAKEL  267 (296)
T ss_pred             HCcCCcccCcCHHHH
Confidence            999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-38  Score=332.29  Aligned_cols=219  Identities=23%  Similarity=0.244  Sum_probs=188.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|++++++++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999743   3678999987543     34568999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |++. +++.+++... ..+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.......
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9996 5888888443 3789999999999999999999999   999999999999999999999999999986543332


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------------  629 (652)
                      ........||+.|+|||++....++.++|||||||++|||++|+.||..                               
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            2333345699999999999999999999999999999999999988621                               


Q ss_pred             -----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   .+.+++.+||..||++|||+.|+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~  372 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI  372 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence                                         24568999999999999999875

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.9e-38  Score=328.26  Aligned_cols=220  Identities=24%  Similarity=0.299  Sum_probs=187.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++.+++||+|+++++.+.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999865 68999999997532   234456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987654 689999999999999999999999   999999999999999999999999999875421100


Q ss_pred             c---------------------------------cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc
Q 041689          581 S---------------------------------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC  627 (652)
Q Consensus       581 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~  627 (652)
                      .                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012346899999999999999999999999999999999999996


Q ss_pred             ch---------------------------hhhhhhcccchhhhccccCc
Q 041689          628 VS---------------------------FVFNLAMECTIESLELRINA  649 (652)
Q Consensus       628 ~~---------------------------~l~~l~~~~l~~~p~~Rpt~  649 (652)
                      ..                           .+.+++.+++. ||++|++.
T Consensus       237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~  284 (360)
T cd05627         237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS  284 (360)
T ss_pred             CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence            32                           25667777764 99999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-37  Score=309.75  Aligned_cols=222  Identities=23%  Similarity=0.316  Sum_probs=194.2

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|++|.||+|... +++.|++|.+...  .......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999865 6899999998643  234566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++... ...+++..+..++.|++.||.|||+.   |++||||||+||++++++.+||+|||.++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            9999999998765 34788999999999999999999999   99999999999999999999999999988653221  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~  637 (652)
                      .......+++.|+|||+..+..++.++|+|||||++|||++|+.||.                        ..+.+++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            12233457889999999999999999999999999999999999853                        237889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||++.||
T Consensus       236 ~l~~~p~~Rp~~~~l  250 (256)
T cd08529         236 CLTKDYRQRPDTFQL  250 (256)
T ss_pred             HccCCcccCcCHHHH
Confidence            999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-37  Score=315.66  Aligned_cols=225  Identities=27%  Similarity=0.409  Sum_probs=192.2

Q ss_pred             cCCCccceeccccceEEEEEEe------CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|...+.||+|+||.||+|..      .++..||+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4577789999999999999963      2356799999876655666789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          499 VLEHMPHGSLEKCLYSSN--------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      ||||+++++|.+++....              ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            999999999999987543              2478889999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------  628 (652)
                      ||+|||++................+++.|+|||...+..++.++|||||||++|||++ |+.||.               
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            9999999876532221111223345678999999998999999999999999999998 888852               


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||+.||++||+++||
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l  274 (280)
T cd05092         242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI  274 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                     237899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=325.31  Aligned_cols=216  Identities=25%  Similarity=0.335  Sum_probs=192.4

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |...+.||.|+||.||-|++. +...||||.+.-.   ......++.+|++.|++++|||++.+.|+|..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555678999999999999864 6788999998643   334556888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      |-| +-.+++.-.+.++.+.++..|..+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.|..+      .
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------~  177 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIM------A  177 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhc------C
Confidence            965 88888877777899999999999999999999999   9999999999999999999999999999865      3


Q ss_pred             ccccccCCccccCcccc---ccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhhhh
Q 041689          583 TQTQTLATIGYIAPEYG---REGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNL  634 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~~l  634 (652)
                      +...++|||.|||||++   ..+.|+-++||||+|++..|+.-+++|                         |++...+|
T Consensus       178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  257 (948)
T ss_pred             chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence            34567899999999975   568999999999999999999999999                         66668999


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +..|+++-|++|||.+++
T Consensus       258 vd~CLqKipqeRptse~l  275 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEEL  275 (948)
T ss_pred             HHHHHhhCcccCCcHHHH
Confidence            999999999999998753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-37  Score=328.78  Aligned_cols=221  Identities=23%  Similarity=0.277  Sum_probs=186.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-----ceE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-----FKE  497 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  497 (652)
                      +|+..+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 6899999998643  2234467889999999999999999999998776     789


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+. ++|.+.+.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999997 48888776544 689999999999999999999999   999999999999999999999999999986432


Q ss_pred             CCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc----------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV----------------------------  628 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~----------------------------  628 (652)
                      .. ........+++.|+|||++.+. .++.++||||+||++|||++|+.||.                            
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            21 1222334578899999998764 47899999999999999999998863                            


Q ss_pred             ---------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                 ..+.+++.+||..||++|||++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  285 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA  285 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH
Confidence                                       235689999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-37  Score=317.38  Aligned_cols=220  Identities=23%  Similarity=0.326  Sum_probs=192.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|... ++..||+|.++... .....++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999865 58889999987542 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... .+++..+..++.|++.||.|||+ .   +++||||||+||++++++.+||+|||++.....    
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  152 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  152 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence            99999999987654 68899999999999999999997 5   899999999999999999999999999875421    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      .......++..|+|||.+.+..++.++|||||||++|||++|+.||.                                 
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence            11233568899999999988889999999999999999999998853                                 


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||..+|++|||+.||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  284 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL  284 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                                        246799999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=334.62  Aligned_cols=219  Identities=24%  Similarity=0.328  Sum_probs=180.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--------
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--------  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  493 (652)
                      ...+|.+.+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999864 68899999885432    2345799999999999999999876432        


Q ss_pred             CceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecc
Q 041689          494 EFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDF  569 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Df  569 (652)
                      ...++||||+++ ++.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.+ +.+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999986 77666542   234689999999999999999999999   99999999999999865 47999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch-------------------
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS-------------------  629 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~-------------------  629 (652)
                      |+++.+....   ......||+.|+|||++.+. .++.++||||+||++|||++|++||..                   
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9998653221   22335689999999987654 689999999999999999999998742                   


Q ss_pred             ---------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                       ++.+++.+||+.||.+|||+.|+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~  348 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA  348 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                                             35689999999999999999764

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-37  Score=314.12  Aligned_cols=225  Identities=28%  Similarity=0.420  Sum_probs=190.0

Q ss_pred             cCCCccceeccccceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  497 (652)
                      .+|.+.+.||+|+||.||+|..     .++..||+|.++.......+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788899999999999999974     2578999999976655556788999999999999999999998754  34688


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++++|.+++......+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999999976655689999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCcccc-ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC------------------------------
Q 041689          578 EDQSMTQ-TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------------------------------  626 (652)
Q Consensus       578 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p------------------------------  626 (652)
                      ....... ....++..|+|||+..+..++.++|||||||++|||++|..|                              
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            2221111 112234569999999888999999999999999999997443                              


Q ss_pred             ----------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ----------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ----------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ++..+.+++.+||+.+|++|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL  276 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                      12358899999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-37  Score=310.34  Aligned_cols=222  Identities=20%  Similarity=0.263  Sum_probs=192.9

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +|++.+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788899999999999999865 6899999998643 2344567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++.+++... ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++++|||.+......  ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence            999999988653 33578899999999999999999999   9999999999999999999999999998765321  11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~~~  638 (652)
                      ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||..                        .+.+++.+|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            22334588899999999888899999999999999999999999643                        267899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++||++.||
T Consensus       236 l~~~P~~Rp~~~~i  249 (255)
T cd08219         236 FKRNPRSRPSATTI  249 (255)
T ss_pred             HhCCcccCCCHHHH
Confidence            99999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.3e-38  Score=324.86  Aligned_cols=191  Identities=25%  Similarity=0.334  Sum_probs=167.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-C-----CeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-Y-----RNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  498 (652)
                      +|.+.+.||+|+||.|.+|.+. +++.||||+++... ....+...|+.+|..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8899999999999999999854 69999999998663 44566778999999996 4     489999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--CCcEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--TMVAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~~~~~  575 (652)
                      |+|.++. +|.++++.... .++...++.++.||+.||.+||+.   +|||+||||+|||+.+  ...+||+|||.++..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999966 99999997664 688999999999999999999999   9999999999999963  347999999999864


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      .     ........+..|+|||++.+.+|+.+.||||||||++||++|.+.
T Consensus       342 ~-----q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL  387 (586)
T KOG0667|consen  342 S-----QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL  387 (586)
T ss_pred             C-----CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence            2     112256678899999999999999999999999999999999653

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-37  Score=315.15  Aligned_cols=220  Identities=27%  Similarity=0.354  Sum_probs=183.1

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhc---CCCeeeeEEeeeec-----CC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSI---HYRNLVKIISSCSN-----EE  494 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~  494 (652)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999865 688999999875421  2233556777777665   69999999998764     24


Q ss_pred             ceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ..++||||+++ ++.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999985 8888876543 3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ....   ........++..|+|||++.+..++.++||||+||++|||++|++||.                         
T Consensus       157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSC---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccC---cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            6522   112233467899999999998899999999999999999999998862                         


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+|++.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~  282 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA  282 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence                                     124689999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=308.55  Aligned_cols=215  Identities=30%  Similarity=0.389  Sum_probs=180.5

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHh--cCCCeeeeEEeeeecCC----ceEEEEEcc
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS--IHYRNLVKIISSCSNEE----FKELVLEHM  503 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~  503 (652)
                      .+.||+|+||.||+|+. +++.||||++..+   ..+.|+.|.+|++.  ++|+||++++++-....    .+++|+||.
T Consensus       215 ~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             HHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            35699999999999998 4599999999743   56788889888876  48999999999876554    889999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN------FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +.|+|.+|++.+.  .+|.+..+++..+++||+|||+.      ++++|+|||||.+|||+.+|+++.|+|||+|..+..
T Consensus       291 ~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p  368 (534)
T KOG3653|consen  291 PKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP  368 (534)
T ss_pred             cCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence            9999999999875  89999999999999999999975      457899999999999999999999999999998865


Q ss_pred             CCCccccccccCCccccCccccccCc------cCcccchhhHHHHHHHHHhCCC------------Ccch----------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGR------VFANGDVYSFGIMLMEIHSAKQ------------QCVS----------  629 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~------------p~~~----------  629 (652)
                      .......-..+||.+|||||++.+.-      .-.+.||||+|.|+|||+++-.            ||..          
T Consensus       369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~  448 (534)
T KOG3653|consen  369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE  448 (534)
T ss_pred             CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence            54444445578999999999976542      1234699999999999987321            1221          


Q ss_pred             -------------------------hhhhhhcccchhhhccccCcc
Q 041689          630 -------------------------FVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       630 -------------------------~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                                               .+.+.+..||..||+.|.|+.
T Consensus       449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                                     178899999999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=327.39  Aligned_cols=273  Identities=23%  Similarity=0.261  Sum_probs=127.6

Q ss_pred             eeceeEeccCCCcCCccCCCCCC-CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            5 SIGKLELNVDDIESPCEIPSEIN-PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      +|+++.|..|.++   +||.+.. ..+|+.|+|.+|.|+.+..+.+..++.|+.||||.|.|+.++..            
T Consensus       103 nLq~v~l~~N~Lt---~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~------------  167 (873)
T KOG4194|consen  103 NLQEVNLNKNELT---RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKP------------  167 (873)
T ss_pred             cceeeeeccchhh---hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCC------------
Confidence            4444444444444   5666653 33466666666666666666666666666666666666644432            


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                           +|..-.++++|+|++|+|+.+..+ .|.++. +|..|.|+.|+|+.+++..|.+|++|+.|+|..|+|.-..--+
T Consensus       168 -----sfp~~~ni~~L~La~N~It~l~~~-~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt  240 (873)
T KOG4194|consen  168 -----SFPAKVNIKKLNLASNRITTLETG-HFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT  240 (873)
T ss_pred             -----CCCCCCCceEEeeccccccccccc-cccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence                 233334444444444444444433 344443 2444444444444444444444444444444444444222334


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccc
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLI  241 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~  241 (652)
                      |.+|++|+.|.|..|.|...-...|..+.+++.|+|+.|+++.+-.+++-++++|+.|+||+|.  ...++.+....+|+
T Consensus       241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~  320 (873)
T KOG4194|consen  241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK  320 (873)
T ss_pred             hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence            4444444444444444444444444444444444444444444444444444444444444442  22233344444444


Q ss_pred             eEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccC
Q 041689          242 GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       242 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      .|||+.|+|+...+..|..+..|++|+|++|.++..-..+|..+++|+.|||++|.|+
T Consensus       321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls  378 (873)
T KOG4194|consen  321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELS  378 (873)
T ss_pred             eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEE
Confidence            4444444444444444444444444444444444333333444444444444444443

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=308.46  Aligned_cols=224  Identities=25%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++|...+.||+|++|.||+|... ++++||+|.+....     ....+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999864 68999999986432     1233568889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+||+++++|.+++.... .+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++|+|||.++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999887654 588889999999999999999999   9999999999999999999999999998765321


Q ss_pred             CCccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhh
Q 041689          579 DQSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVF  632 (652)
Q Consensus       579 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~  632 (652)
                      ..... .....++..|+|||+..+..++.++||||+|+++|||++|+.||..                         .+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR  237 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence            11111 1234578899999999998899999999999999999999998533                         367


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++|||+.||
T Consensus       238 ~li~~~l~~~p~~Rpt~~~l  257 (263)
T cd06625         238 NFLRRTFVENAKKRPSAEEL  257 (263)
T ss_pred             HHHHHHhhcCcccCCCHHHH
Confidence            89999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-37  Score=312.12  Aligned_cols=222  Identities=24%  Similarity=0.320  Sum_probs=192.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999864 68899999997665555567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++.... .+++.++..++.|++.|+.|||+.   |++|+||||+||+++.++.+||+|||.+.....  ....
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~  162 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence            9999999887654 689999999999999999999999   999999999999999999999999999876522  1122


Q ss_pred             cccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcc----------------------------hhhh
Q 041689          584 QTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------SFVF  632 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------~~l~  632 (652)
                      .....|+..|+|||++.   ...++.++||||+||++|||++|+.||.                            ..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23446889999999874   4568899999999999999999998852                            1256


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.+|++||+++||
T Consensus       243 ~li~~~l~~~P~~R~~~~~l  262 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKL  262 (267)
T ss_pred             HHHHHHccCCchhCcCHHHH
Confidence            79999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-37  Score=312.77  Aligned_cols=221  Identities=23%  Similarity=0.340  Sum_probs=191.3

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            667789999999999999875 5788999998766555667788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      +++..++......+++..+..++.|++.||.|||+.   |++||||||+||+++.++.+||+|||++......  .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            999988766555789999999999999999999999   9999999999999999999999999998754221  11223


Q ss_pred             cccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhh
Q 041689          586 QTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNL  634 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l  634 (652)
                      ...++..|+|||++.     +..++.++|||||||++|||++|+.||.                          ..+.++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            346889999999873     4457889999999999999999999853                          237899


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.+|++||+++||
T Consensus       242 i~~~l~~~p~~Rp~~~~i  259 (282)
T cd06643         242 LKKCLEKNVDARWTTTQL  259 (282)
T ss_pred             HHHHccCChhhCcCHHHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.5e-37  Score=310.42  Aligned_cols=223  Identities=22%  Similarity=0.350  Sum_probs=192.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|++.+.||+|+||.||+|+.. +++.||||.++..   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999864 6899999988642   2334456888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   223578889999999999999999999   999999999999999999999999999886532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SF  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~  630 (652)
                      .  ........+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.                           ..
T Consensus       159 ~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             h--hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            1  112223458889999999988889999999999999999999998852                           22


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..+|++||++.||
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~v  258 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYV  258 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHH
Confidence            7889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=316.90  Aligned_cols=228  Identities=25%  Similarity=0.370  Sum_probs=191.3

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      ...++|+..+.||+|+||.||+|...      ....||+|.++.. ..+....+.+|+++++++ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34456888999999999999999753      2367999998754 233445688999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSS---------------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..+++|||+++|+|.+++...               ...+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            9999999999999999998642               23678889999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------  628 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------  628 (652)
                      ++++.+||+|||.++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||.         
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999986533222122222335678999999988899999999999999999997 877743         


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||..||++|||++||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ei  284 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL  284 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHH
Confidence                           347889999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=320.52  Aligned_cols=200  Identities=23%  Similarity=0.300  Sum_probs=172.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999865 5899999999753   1223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-  156 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence            99999999999976555789999999999999999999999   99999999999999999999999999987653221 


Q ss_pred             ccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          581 SMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ........||+.|+|||++..     +.++.++||||+||++|||++|+.||.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            112223468999999999863     457889999999999999999999963

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.3e-37  Score=312.84  Aligned_cols=223  Identities=23%  Similarity=0.299  Sum_probs=193.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999875 58899999997766566778889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +++++..++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.....  ....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc--cccc
Confidence            99999988776555789999999999999999999999   999999999999999999999999999875321  1112


Q ss_pred             cccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhh
Q 041689          584 QTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVF  632 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~  632 (652)
                      .....+++.|+|||++.     ...++.++|||||||++|||++|+.||..                          .+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            23345788999999874     34578899999999999999999999532                          367


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++||+++||
T Consensus       247 ~li~~~l~~~p~~Rp~~~~i  266 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQL  266 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHH
Confidence            79999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.8e-37  Score=311.79  Aligned_cols=216  Identities=24%  Similarity=0.328  Sum_probs=187.5

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |+..+.||+|+||.||+|... +++.||+|.+....   ......+..|+.++++++|++|+++++.+.+++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999865 68999999986542   12234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......   
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---  155 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---  155 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---
Confidence            99999999886433 3588999999999999999999999   9999999999999999999999999998754221   


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l  634 (652)
                      .......|+..|+|||++.+..++.++||||+||++|||++|+.||..                           .+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         156 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            112234689999999999999999999999999999999999999752                           26889


Q ss_pred             hcccchhhhccccC
Q 041689          635 AMECTIESLELRIN  648 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt  648 (652)
                      +.+||+.||++|||
T Consensus       236 i~~~l~~~p~~R~s  249 (285)
T cd05630         236 CKMLLCKDPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHccC
Confidence            99999999999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-37  Score=315.57  Aligned_cols=224  Identities=24%  Similarity=0.376  Sum_probs=188.2

Q ss_pred             CCCccceeccccceEEEEEEeC------CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      +|.+.+.||+|+||.||+|...      +++.||+|+++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4667789999999999999753      257899999975532 234568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          499 VLEHMPHGSLEKCLYSS---------------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      ++||+++++|.+++...               ...+++..+..++.|++.||+|+|++   ||+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            99999999999987532               12478888999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------------  628 (652)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||.              
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999886533222222233346778999999988899999999999999999998 777743              


Q ss_pred             ----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ..+.+++.+||+.+|++||+++||
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence                      237889999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-37  Score=308.89  Aligned_cols=213  Identities=22%  Similarity=0.313  Sum_probs=180.8

Q ss_pred             ceeccccceEEEEEEeCC-------------CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          431 NLIGKGGFGTIYKSRIGD-------------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      +.||+|+||.||+|...+             ...||+|.+..........+.+|+.++++++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997432             2358889887654455567888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc-------EEEeccc
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV-------AHLSDFG  570 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-------~kl~Dfg  570 (652)
                      +||||+++|+|..++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999998876655789999999999999999999999   9999999999999986654       8999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccc-cCccCcccchhhHHHHHHHHH-hCCCCcc--------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGR-EGRVFANGDVYSFGIMLMEIH-SAKQQCV--------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~ell-tg~~p~~--------------------  628 (652)
                      .+.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+.                    
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP  231 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCC
Confidence            9875421      12345788899999886 467889999999999999997 5777743                    


Q ss_pred             --hhhhhhhcccchhhhccccCccCC
Q 041689          629 --SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        ..+.+++.+||+.||++||++.||
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~i  257 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAI  257 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHH
Confidence              346789999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.8e-37  Score=310.41  Aligned_cols=216  Identities=24%  Similarity=0.298  Sum_probs=188.1

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 46889999998654 233446788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++++..+.     .+++..+..++.|++.||+|||+.   ||+|+||||+||+++.++.+||+|||++.....    .
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----S  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----c
Confidence            9999997542     467888899999999999999999   999999999999999999999999999976522    1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------------h
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------F  630 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------~  630 (652)
                      ......++..|+|||++.+..++.++|||||||++|+|++|+.||..                                .
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            22345688999999999988999999999999999999999998742                                2


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..+|++||+++|+
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~ei  250 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENL  250 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHH
Confidence            5689999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-37  Score=312.29  Aligned_cols=225  Identities=24%  Similarity=0.363  Sum_probs=189.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCc----EEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .++|+..+.||+|+||.||+|++. ++.    .||+|+++.. .......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            356888999999999999999853 444    4899998654 233456788999999999999999999998754 567


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ++|||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987666789999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~  632 (652)
                      ...........+++.|+|||...+..++.++|||||||++|||++ |..||+.                        .+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            222111222335678999999988899999999999999999998 8888543                        256


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..||++||++.||
T Consensus       242 ~li~~~l~~dp~~Rp~~~~l  261 (279)
T cd05109         242 MIMVKCWMIDSECRPRFREL  261 (279)
T ss_pred             HHHHHHcCCChhhCcCHHHH
Confidence            89999999999999999874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.5e-37  Score=309.71  Aligned_cols=223  Identities=26%  Similarity=0.397  Sum_probs=190.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|++.+.||+|+||.||+|... +++.||+|+++.. ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35778899999999999999865 5889999998754 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+....... ..
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce-ee
Confidence            9999999986543 3588999999999999999999999   99999999999999999999999999998653211 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~  637 (652)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||+.                        .+.+++.+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  240 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA  240 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            1112234567999999998899999999999999999998 8888532                        37889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||++.|+
T Consensus       241 cl~~~p~~Rp~~~~l  255 (263)
T cd05052         241 CWQWNPSDRPSFAEI  255 (263)
T ss_pred             HccCCcccCCCHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.8e-37  Score=309.61  Aligned_cols=228  Identities=26%  Similarity=0.377  Sum_probs=193.7

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++.+++.+.....||+|+||.||+|++. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4456667777789999999999999854 578899999876655566788999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCLYSSNCIL--DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~~~~  575 (652)
                      |+||+++++|.+++......+  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+|||.+...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999987654445  7888889999999999999999   9999999999999976 679999999998765


Q ss_pred             cCCCCccccccccCCccccCccccccCc--cCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGR--VFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....  .......++..|+|||++....  ++.++||||||+++|+|++|+.||..                        
T Consensus       160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06624         160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL  237 (268)
T ss_pred             ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence            3211  1222345788999999986643  78899999999999999999998532                        


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+||+.+|++|||+.||
T Consensus       238 ~~~~~~li~~~l~~~p~~Rpt~~~l  262 (268)
T cd06624         238 SAEAKNFILRCFEPDPDKRASAHDL  262 (268)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHH
Confidence              36779999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-37  Score=310.49  Aligned_cols=218  Identities=22%  Similarity=0.307  Sum_probs=188.6

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |+..+.||+|+||+||+|.+. +++.||+|.+....   ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677789999999999999864 68899999986542   22334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---  155 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence            99999998876543 3689999999999999999999999   9999999999999999999999999998754221   


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l  634 (652)
                      .......|+..|+|||++.+..++.++|+||+||++|||++|+.||..                           .+.++
T Consensus       156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            112334689999999999888999999999999999999999999643                           26789


Q ss_pred             hcccchhhhccccCcc
Q 041689          635 AMECTIESLELRINAK  650 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~  650 (652)
                      +.+||+.||++||++.
T Consensus       236 i~~~l~~~P~~R~~~~  251 (285)
T cd05632         236 CKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             HHHHccCCHhHcCCCc
Confidence            9999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.9e-37  Score=342.85  Aligned_cols=223  Identities=23%  Similarity=0.283  Sum_probs=189.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999865 58999999996542   233567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          501 EHMPHGSLEKCLYSS----------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       501 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      ||++||+|.+++...          ....++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988632          11355677889999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCC----------------ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----
Q 041689          571 ITKLLIGEDQ----------------SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----  629 (652)
Q Consensus       571 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----  629 (652)
                      +++.......                ........||+.|+|||++.+..++.++||||+||++|||+||+.||..     
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                0011224689999999999999999999999999999999999999632     


Q ss_pred             ---------------------hhhhhhcccchhhhccccCcc
Q 041689          630 ---------------------FVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       630 ---------------------~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                                           .+.+++.+|+..||++||+..
T Consensus       239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~  280 (932)
T PRK13184        239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSV  280 (932)
T ss_pred             hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHH
Confidence                                 267899999999999998753

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=315.33  Aligned_cols=226  Identities=25%  Similarity=0.383  Sum_probs=188.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCC---------------CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD---------------GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKII  487 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~  487 (652)
                      .++|++.+.||+|+||.||+|+...               ...||+|.++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987532               2348999987542 23445788999999999999999999


Q ss_pred             eeeecCCceEEEEEccCCCChhhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 041689          488 SSCSNEEFKELVLEHMPHGSLEKCLYSSN-----------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNV  556 (652)
Q Consensus       488 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NI  556 (652)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            99999999999999999999999886432           1367888999999999999999999   999999999999


Q ss_pred             eeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh--CCCCcc------
Q 041689          557 LLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS--AKQQCV------  628 (652)
Q Consensus       557 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~------  628 (652)
                      ++++++.+||+|||++................++..|+|||+..++.++.++|||||||++|||++  |..||.      
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976532222112223345678999999988899999999999999999988  455542      


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+||+.||++||++++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i  289 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI  289 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence                                     236789999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.4e-37  Score=306.64  Aligned_cols=217  Identities=27%  Similarity=0.395  Sum_probs=182.8

Q ss_pred             eeccccceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCC
Q 041689          432 LIGKGGFGTIYKSRIG---DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999753   35679999987553 2344678899999999999999999998864 56789999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc-ccc
Q 041689          508 LEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QTQ  586 (652)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~  586 (652)
                      |.+++......+++..+..++.|++.||+|||++   |++||||||+||+++.++.+||+|||++........... ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999876666789999999999999999999999   999999999999999999999999999975532221111 112


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccchh
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECTIE  641 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l~~  641 (652)
                      ..++..|+|||.+....++.++|||||||++||+++ |+.||.                        ..+.+++.+||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            223578999999988889999999999999999996 998863                        3477899999999


Q ss_pred             hhccccCccCC
Q 041689          642 SLELRINAKEI  652 (652)
Q Consensus       642 ~p~~Rpt~~ei  652 (652)
                      +|++||++.+|
T Consensus       238 ~~~~Rp~~~~i  248 (257)
T cd05115         238 KWEDRPNFAKV  248 (257)
T ss_pred             ChhhCcCHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-37  Score=330.12  Aligned_cols=219  Identities=21%  Similarity=0.201  Sum_probs=187.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+|.+.+.||+|+||.||+|.+. +++.||||...      ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999875 58889999642      23457899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +. ++|.+++......+++.++..|+.|++.||.|||++   ||+||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 689888876555799999999999999999999999   99999999999999999999999999998653322222


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-----------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-----------------------------------  627 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-----------------------------------  627 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+                                   
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            223456999999999999999999999999999999998865321                                   


Q ss_pred             ------------------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ------------------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ------------------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    +..+.+++.+||+.||.+|||++|+
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~el  452 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAEL  452 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHH
Confidence                                          1135679999999999999999875

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.3e-37  Score=305.36  Aligned_cols=218  Identities=28%  Similarity=0.382  Sum_probs=187.1

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChh
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLE  509 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  509 (652)
                      +.||+|+||.||+|...++..||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4689999999999998888999999987553 233456889999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccC
Q 041689          510 KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA  589 (652)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  589 (652)
                      +++......+++..+..++.|++.||.|+|+.   +++||||||+||++++++.+||+|||++....... ........+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            99876655688999999999999999999999   99999999999999999999999999987532111 111112234


Q ss_pred             CccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccchhhhc
Q 041689          590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECTIESLE  644 (652)
Q Consensus       590 t~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l~~~p~  644 (652)
                      +..|+|||++..+.++.++||||||+++||+++ |..||.                        ..+.+++.+||+.+|+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            567999999988889999999999999999998 887753                        3478899999999999


Q ss_pred             cccCccCC
Q 041689          645 LRINAKEI  652 (652)
Q Consensus       645 ~Rpt~~ei  652 (652)
                      +||++.||
T Consensus       237 ~Rp~~~~l  244 (250)
T cd05085         237 NRPKFSEL  244 (250)
T ss_pred             cCCCHHHH
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=312.64  Aligned_cols=224  Identities=23%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|... ++..||+|+++.......+.+..|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888999999999999999864 6889999999866555667888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++......+++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||.+......  ..
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            999999999877655799999999999999999999999   9999999999999999999999999998754221  11


Q ss_pred             ccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhh
Q 041689          583 TQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFV  631 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l  631 (652)
                      ......+++.|+|||.+.     ...++.++|||||||++|||++|+.||.                          ..+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            223345888999999864     3457789999999999999999999853                          236


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||..+|++||++.+|
T Consensus       239 ~~li~~~l~~~p~~Rps~~~i  259 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAEL  259 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHH
Confidence            789999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=307.74  Aligned_cols=224  Identities=24%  Similarity=0.341  Sum_probs=196.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++..++..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357889999999999999999864 5788999999866555667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++......+++.++..++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.+......  ..
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence            999999999877645789999999999999999999999   9999999999999999999999999998765321  11


Q ss_pred             ccccccCCccccCccccccC---ccCcccchhhHHHHHHHHHhCCCCcch----------------------------hh
Q 041689          583 TQTQTLATIGYIAPEYGREG---RVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------FV  631 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~----------------------------~l  631 (652)
                      ......++..|+|||.+...   .++.++|||||||++|||++|+.||..                            .+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            12234578889999998776   788999999999999999999998532                            25


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||..+|++|||++||
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHH
Confidence            799999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.7e-37  Score=312.02  Aligned_cols=226  Identities=27%  Similarity=0.367  Sum_probs=188.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467889999999999999999864      35678999886443 23345688999999999999999999999998899


Q ss_pred             EEEEEccCCCChhhhhhcCCC------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC---cEEEe
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM---VAHLS  567 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~  567 (652)
                      ++||||+++++|.+++.....      .+++..+..++.|++.|++|||+.   +++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999875432      588899999999999999999999   999999999999998654   69999


Q ss_pred             cccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch-----------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-----------------  629 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-----------------  629 (652)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||+.                 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999986522211111122234567999999998999999999999999999997 8888643                 


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.+|++||++.||
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v  271 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATI  271 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                   36789999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.3e-37  Score=315.50  Aligned_cols=222  Identities=22%  Similarity=0.275  Sum_probs=189.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999865 68899999987542 23345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ +|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......  ..
T Consensus        86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~  159 (301)
T cd07873          86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  159 (301)
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CC
Confidence            974 89988876655788999999999999999999999   9999999999999999999999999998754221  11


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      ......+++.|+|||++.+. .++.++|||||||++|||++|+.||..                                
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            12234568899999987653 578899999999999999999988632                                


Q ss_pred             ---------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           .+.+++.+|+..||.+|||++||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei  283 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA  283 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence                                 24689999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-37  Score=307.65  Aligned_cols=223  Identities=27%  Similarity=0.398  Sum_probs=189.6

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|++++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            346888999999999999999988888999999875432 3467899999999999999999999875 45678999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++.... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc-cc
Confidence            9999999987543 3588999999999999999999999   99999999999999999999999999997653221 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~  637 (652)
                      ......++..|+|||+..+..++.++||||||+++|||++ |+.||..                        .+.+++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ  238 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            1122235667999999988889999999999999999999 8887533                        36799999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++|||++++
T Consensus       239 ~l~~~p~~Rpt~~~l  253 (260)
T cd05070         239 CWKKDPEERPTFEYL  253 (260)
T ss_pred             HcccCcccCcCHHHH
Confidence            999999999999764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-37  Score=320.03  Aligned_cols=200  Identities=21%  Similarity=0.269  Sum_probs=172.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 5888999998653   1223445788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-  156 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-
Confidence            99999999999987555789999999999999999999999   99999999999999999999999999997653221 


Q ss_pred             ccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          581 SMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ........||+.|+|||++.+     +.++.++||||+||++|||++|+.||.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            112233568999999998865     567899999999999999999999963

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-37  Score=315.36  Aligned_cols=225  Identities=23%  Similarity=0.341  Sum_probs=190.9

Q ss_pred             cCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      ++|.+.+.||+|+||.||+|..      .++..||+|.++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4688899999999999999963      135679999987542 33446788999999999 799999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ++||||+++|+|.+++..... .+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+|++|||.++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            999999999999999875432 489999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------h
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------S  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~  629 (652)
                      .............++..|+|||.+.+..++.++||||+||++|||++ |+.||.                         .
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA  271 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence            33221111222345778999999999999999999999999999998 888853                         2


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||..+|++|||+.||
T Consensus       272 ~~~~li~~cl~~~p~~Rpt~~el  294 (302)
T cd05055         272 EIYDIMKTCWDADPLKRPTFKQI  294 (302)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHH
Confidence            36789999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.7e-37  Score=313.90  Aligned_cols=227  Identities=25%  Similarity=0.373  Sum_probs=189.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998643      24579999886442 2334567889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          496 KELVLEHMPHGSLEKCLYSSN---------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                      .++||||+++|+|.+++....         ...+...+..++.|++.||.|||++   +|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986432         2346677889999999999999999   9999999999999999999999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------  627 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------  627 (652)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||                  
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999886533222222222345678999999998899999999999999999998 67664                  


Q ss_pred             ------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            +..+.+++.+||+.||++|||+.|+
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  271 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEI  271 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                  2347899999999999999999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-37  Score=313.57  Aligned_cols=221  Identities=26%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788999999999999999986 479999999997655555577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++...  .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||.+.......  ..
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~  171 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  171 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cC
Confidence            999999988654  478889999999999999999999   99999999999999999999999999987653221  11


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      .....+++.|+|||...+..++.++|||||||++|+|++|+.||..                          .+.+++.+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence            2234578899999999888899999999999999999999998632                          25789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||+++||
T Consensus       252 ~l~~~p~~Rps~~~i  266 (297)
T cd06656         252 CLEMDVDRRGSAKEL  266 (297)
T ss_pred             HccCChhhCcCHHHH
Confidence            999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.4e-37  Score=306.40  Aligned_cols=222  Identities=26%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|+..+.||+|+||.||+|+..+ ++.||+|.+.....  .+.+.+|++++++++||||+++++++.+++..|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4678999999999999999999764 88999999875532  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++......+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.+||+|||.+.......  .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            999999999876666789999999999999999999999   99999999999999999999999999988653221  1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAM  636 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~  636 (652)
                      ......++..|+|||++.+..++.++|||||||++|+|++|+.||.                          ..+.+++.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            2233457889999999988899999999999999999999999853                          24678999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.+|++|||+.||
T Consensus       235 ~~l~~~P~~Rps~~~i  250 (256)
T cd06612         235 KCLVKDPEERPSAIQL  250 (256)
T ss_pred             HHHhcChhhCcCHHHH
Confidence            9999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=325.53  Aligned_cols=221  Identities=22%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             CCccceeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |.++..+|.|+||.||+|..++ +-..|.|++..+.....++|.-|++||+.++||+||++++.|+..+..+|..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4556779999999999998664 445677998888778889999999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |-.+..+.+-+..+++.++.-+++|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+...  ........
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRD  188 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRD  188 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc--hhHHhhhc
Confidence            999998888777899999999999999999999999   9999999999999999999999999998643  12223345


Q ss_pred             cccCCccccCcccc-----ccCccCcccchhhHHHHHHHHHhCCCC--------------------------cchhhhhh
Q 041689          586 QTLATIGYIAPEYG-----REGRVFANGDVYSFGIMLMEIHSAKQQ--------------------------CVSFVFNL  634 (652)
Q Consensus       586 ~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~p--------------------------~~~~l~~l  634 (652)
                      .+.|||+|||||+.     ...+|+.++||||||+++.||..+.+|                          |+....|+
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF  268 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence            67899999999974     456899999999999999999999988                          66678999


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++||..||..||++++|
T Consensus       269 Lk~cL~Knp~~Rp~aaql  286 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRPPAAQL  286 (1187)
T ss_pred             HHHHHhcCCccCCCHHHH
Confidence            999999999999999875

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.4e-37  Score=311.63  Aligned_cols=221  Identities=26%  Similarity=0.319  Sum_probs=186.9

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|++.+.||+|++|.||+|+.. ++..||+|.++...  ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999865 68999999986442  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ++ +++.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 58888876433  3688999999999999999999999   9999999999999999999999999998754221  


Q ss_pred             ccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-------------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-------------------------------  628 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-------------------------------  628 (652)
                      ........+++.|+|||++.+. .++.++|||||||++|||++|+.||.                               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1122234568899999987654 57889999999999999999998874                               


Q ss_pred             ---------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           .++.+++.+||..||++|||+.||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~l  279 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKA  279 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence                                 224479999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-37  Score=308.50  Aligned_cols=223  Identities=25%  Similarity=0.406  Sum_probs=186.2

Q ss_pred             CCccceeccccceEEEEEEeCC----CcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-----
Q 041689          427 FNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-----  495 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  495 (652)
                      |.+.+.||+|+||.||+|....    +..||+|+++...  ......+..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998542    4679999987542  2345678899999999999999999998866543     


Q ss_pred             -eEEEEEccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          496 -KELVLEHMPHGSLEKCLYSS-----NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       496 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                       .++||||+++|+|.+++...     ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             78999999999999887532     22588899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------------------
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------------------  628 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------------------  628 (652)
                      |+++...............++..|+|||.+....++.++|||||||++|||++ |..||.                    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99986643322222222335678999999988889999999999999999999 777743                    


Q ss_pred             ----hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          ..+.+++.+||+.||++|||+.||
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~  265 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRPTFTKL  265 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                347899999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.3e-37  Score=306.86  Aligned_cols=223  Identities=24%  Similarity=0.378  Sum_probs=191.1

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|.+.++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            45788899999999999999998889999999987543 23467889999999999999999999874 45789999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++.... ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence            9999999886543 3688899999999999999999998   99999999999999999999999999997653211 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                      ......++..|+|||++....++.++||||||+++|||++ |+.||.                        ..+.+++.+
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL  238 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            1223345678999999988889999999999999999999 998863                        248899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++++|
T Consensus       239 ~l~~~p~~Rp~~~~l  253 (260)
T cd05067         239 CWKEKPEERPTFEYL  253 (260)
T ss_pred             HccCChhhCCCHHHH
Confidence            999999999999764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-37  Score=308.53  Aligned_cols=220  Identities=28%  Similarity=0.433  Sum_probs=190.9

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhh--hhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAF--KSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |+..+.||+|+||.||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999976 467899999986643322  23356999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++.... .+++.++..++.|+++||++||+.   +|+|+||||+||++++++.++|+|||.+...  ......
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             ccccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccc
Confidence            9999999998333 689999999999999999999999   9999999999999999999999999999754  122233


Q ss_pred             cccccCCccccCccccc-cCccCcccchhhHHHHHHHHHhCCCCcch------------------------------hhh
Q 041689          584 QTQTLATIGYIAPEYGR-EGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------FVF  632 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------~l~  632 (652)
                      .....++..|+|||+.. +..++.++||||+|+++|+|++|..||..                              .+.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            44566899999999988 78899999999999999999999998443                              378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++||++.|+
T Consensus       235 ~li~~~l~~~p~~R~~~~~l  254 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEEL  254 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHH
T ss_pred             HHHHHHccCChhHCcCHHHH
Confidence            89999999999999998764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.8e-37  Score=317.01  Aligned_cols=193  Identities=20%  Similarity=0.277  Sum_probs=157.7

Q ss_pred             cceeccccceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCceEEEEEccC
Q 041689          430 NNLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFKELVLEHMP  504 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  504 (652)
                      .++||+|+||.||+|+..   +++.||+|.++...  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999986442  23456789999999999999999998854  456889999996


Q ss_pred             CCChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----CCCCcEEEecccCC
Q 041689          505 HGSLEKCLYSS--------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGIT  572 (652)
Q Consensus       505 ~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~~  572 (652)
                      + ++.+++...        ...+++..+..++.|++.||+|||++   +|+||||||+||++    +..+.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 887776532        12578889999999999999999999   99999999999999    45679999999999


Q ss_pred             ccccCCCCc-cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          573 KLLIGEDQS-MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       573 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      +........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            865322111 12234568999999999876 458899999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.1e-37  Score=324.04  Aligned_cols=220  Identities=22%  Similarity=0.231  Sum_probs=186.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  493 (652)
                      ..++|...+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999865 5889999998754  223446677899999999999999999988543      


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ...++||||+++ ++.+.+..   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            356899999976 66666543   478888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....   ........+|+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       168 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            5421   2222345689999999999988999999999999999999999988632                        


Q ss_pred             -----------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                               .+.+++.+|+..||++|||+.||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el  308 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA  308 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence                                                     24689999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-37  Score=318.75  Aligned_cols=223  Identities=18%  Similarity=0.235  Sum_probs=185.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+++.. +++.||+|++....   ......+..|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999865 57889999986431   223345788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            99999999999987555789999999999999999999999   99999999999999999999999999987543221 


Q ss_pred             ccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      ........||+.|+|||++.     .+.++.++|||||||++|||++|+.||..                          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  236 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV  236 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence            12223356899999999876     34688999999999999999999999632                          


Q ss_pred             --hhhhhhcccchhhhcc--ccCccC
Q 041689          630 --FVFNLAMECTIESLEL--RINAKE  651 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~--Rpt~~e  651 (652)
                        .+.+++.+|+..++++  |++++|
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~  262 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIED  262 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHH
Confidence              2577888888654443  566655

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.8e-37  Score=312.50  Aligned_cols=221  Identities=27%  Similarity=0.360  Sum_probs=194.0

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4588899999999999999985 468999999997655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++...  .+++.++..++.|++.|++|||+.   |++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988654  489999999999999999999999   999999999999999999999999999876532211  1


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..                          .+.+++.+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            2234578899999999888899999999999999999999998642                          26788999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++||++.||
T Consensus       252 ~l~~dp~~Rpt~~~i  266 (296)
T cd06655         252 CLEMDVEKRGSAKEL  266 (296)
T ss_pred             HhhcChhhCCCHHHH
Confidence            999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6e-37  Score=307.80  Aligned_cols=223  Identities=25%  Similarity=0.382  Sum_probs=189.2

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..+|++.+.||+|+||.||+|++.++..||+|+++... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            35689999999999999999988777789999987532 234578899999999999999999998754 5678999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|+|.+++.... ..+++..+..++.|++.||+|+|+.   +++||||||+||++++++.+||+|||.++.+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997643 3578899999999999999999999   999999999999999999999999999976532221 1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                      ......++..|+|||+..+..++.++|||||||++|||++ |+.||.                        ..+.+++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  238 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            1223346678999999988899999999999999999999 777753                        337889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||+++++
T Consensus       239 ~l~~~p~~Rp~~~~~  253 (262)
T cd05071         239 CWRKEPEERPTFEYL  253 (262)
T ss_pred             HccCCcccCCCHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=325.02  Aligned_cols=338  Identities=20%  Similarity=0.179  Sum_probs=288.7

Q ss_pred             ceeEeccCCCcCC--ccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCC------cccccc
Q 041689            7 GKLELNVDDIESP--CEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI------ADNYLT   78 (652)
Q Consensus         7 ~~l~l~~~~~~~~--~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~------~~~~l~   78 (652)
                      ..||.+.+.++.+  ..++.++ +...+.||+|+|+|..+.+..|.++++|++++|.+|.++.++...      ....+.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~l-p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFL-PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcC-ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeee
Confidence            4566666666631  2235555 677888999999988888888888999999999988888665532      222333


Q ss_pred             CCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccc
Q 041689           79 SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG  158 (652)
Q Consensus        79 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  158 (652)
                      .+.+.-..-+.+..++.|+.||||.|.|+.++.. .|..-.+ +++|+|++|.|+.+..+.|.++.+|..|.|+.|+|+.
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~-sfp~~~n-i~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt  211 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKP-SFPAKVN-IKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT  211 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCC-CCCCCCC-ceEEeeccccccccccccccccchheeeecccCcccc
Confidence            3333323335688899999999999999988766 5655444 9999999999999999999999999999999999998


Q ss_pred             cCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCC
Q 041689          159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGN  236 (652)
Q Consensus       159 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~  236 (652)
                      +++..|..|++|+.|+|..|+|.-..--.|.++++|+.|.|..|.|.....++|..+.++++|+|+.|+  ..-..++.+
T Consensus       212 Lp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfg  291 (873)
T KOG4194|consen  212 LPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFG  291 (873)
T ss_pred             cCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccc
Confidence            888999999999999999999995546789999999999999999999999999999999999999997  334556889


Q ss_pred             CCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEE
Q 041689          237 LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN  316 (652)
Q Consensus       237 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  316 (652)
                      |+.|+.|+||.|.|..+.++.+.-.++|++|+|++|+|+...++.|..+.+|+.|+|++|+++.....+|..+++|+.||
T Consensus       292 Lt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~Ld  371 (873)
T KOG4194|consen  292 LTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLD  371 (873)
T ss_pred             cchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999988889999999999999


Q ss_pred             eecCcCcccCCCC----CCCCCcccccccCCccCC
Q 041689          317 LSFNKLEGEIPKG----GSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       317 L~~N~l~~~~p~~----~~~~~l~~~~~~~N~~~c  347 (652)
                      |++|.|+..+.+.    ..++.++.+.+.||.+..
T Consensus       372 Lr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~  406 (873)
T KOG4194|consen  372 LRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS  406 (873)
T ss_pred             CcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence            9999999887764    457788899999998755

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-37  Score=310.05  Aligned_cols=226  Identities=23%  Similarity=0.371  Sum_probs=191.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457888999999999999999753      24689999986542 23445788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 041689          497 ELVLEHMPHGSLEKCLYSSN---------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLS  567 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~  567 (652)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         1367888999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------  628 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------  628 (652)
                      |||+++...............++..|+|||.+.++.++.++|||||||++||+++ |+.||.                  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            9999886533322222233456788999999988889999999999999999998 887753                  


Q ss_pred             ------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            ..+.+++.+||+.+|++|||+.||
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l  271 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYNPKMRPTFLEI  271 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                  347899999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.6e-37  Score=310.92  Aligned_cols=224  Identities=25%  Similarity=0.428  Sum_probs=189.4

Q ss_pred             CCCccceeccccceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceE
Q 041689          426 GFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKE  497 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  497 (652)
                      -|.+.+.||+|+||.||+|+.     .++..||+|.++... ......+.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999973     357889999987542 33456789999999999999999999998765  5688


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++++|.+++......+++.++..++.|++.||+|||+.   |++||||||+||++++++.+||+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            99999999999999876555689999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCcc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC------------------------------
Q 041689          578 EDQSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------------------------------  626 (652)
Q Consensus       578 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p------------------------------  626 (652)
                      ..... ......++..|+|||+..+..++.++|||||||++|||++++.|                              
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            22111 11234467789999999888899999999999999999986543                              


Q ss_pred             ---------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ---------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ---------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ++..+.+++.+||+.+|++|||++||
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  276 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL  276 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence                     23457899999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9e-37  Score=305.64  Aligned_cols=216  Identities=25%  Similarity=0.350  Sum_probs=182.5

Q ss_pred             eeccccceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          432 LIGKGGFGTIYKSRI---GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      .||+|+||.||+|.+   .++..||+|+++...  ....+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   357889999986543  2345678899999999999999999998754 5678999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc-cc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QT  585 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~~  585 (652)
                      +|.+++.... .+++..+..++.|++.|++|+|++   +|+||||||+||++++++.+||+|||.+........... ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999987554 688999999999999999999999   999999999999999999999999999986533221111 12


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccch
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECTI  640 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l~  640 (652)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||..                        .+.+++.+||+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2234578999999988889999999999999999998 9988642                        37899999999


Q ss_pred             hhhccccCccCC
Q 041689          641 ESLELRINAKEI  652 (652)
Q Consensus       641 ~~p~~Rpt~~ei  652 (652)
                      .||++||++++|
T Consensus       237 ~~p~~Rp~~~~i  248 (257)
T cd05116         237 YGVDERPGFAVV  248 (257)
T ss_pred             cCchhCcCHHHH
Confidence            999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.2e-37  Score=312.08  Aligned_cols=224  Identities=23%  Similarity=0.355  Sum_probs=188.5

Q ss_pred             CCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... ......+.+|+.++++++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999752      23568899886543 2345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 041689          499 VLEHMPHGSLEKCLYSSN-----------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSN  555 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  555 (652)
                      ||||+++++|.+++....                       ..+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999876421                       2477888999999999999999999   99999999999


Q ss_pred             eeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------
Q 041689          556 VLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------  628 (652)
Q Consensus       556 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------  628 (652)
                      |++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||+      
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999976533222222223345678999999888889999999999999999998 887754      


Q ss_pred             ------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                        ..+.+++.+||+.+|++||+++||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i  279 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI  279 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                              247789999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.8e-37  Score=308.70  Aligned_cols=224  Identities=24%  Similarity=0.417  Sum_probs=189.9

Q ss_pred             CCCccceeccccceEEEEEEeC-CC---cEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DG---MEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      +|++.+.||+|+||.||+|... ++   ..||+|.++.. .......+..|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            4778899999999999999864 23   36999998754 2334568899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++......+++.++..++.|++.|++|||++   |++||||||+||+++.++.+|++|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999999887666789999999999999999999999   999999999999999999999999999876533221


Q ss_pred             cccccccc---CCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          581 SMTQTQTL---ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       581 ~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      ........   .+..|+|||++.+..++.++|||||||++|||++ |..||.                        ..+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  241 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH  241 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHH
Confidence            11111111   2457999999998999999999999999999886 888852                        2478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++||++.+|
T Consensus       242 ~li~~~l~~~p~~Rp~~~~i  261 (269)
T cd05065         242 QLMLDCWQKDRNARPKFGQI  261 (269)
T ss_pred             HHHHHHcCCChhhCcCHHHH
Confidence            89999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-37  Score=320.71  Aligned_cols=222  Identities=22%  Similarity=0.255  Sum_probs=187.2

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC---
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE---  493 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  493 (652)
                      .....++|.+.+.||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445678999999999999999999864 68899999986542  22345677899999999999999999987543   


Q ss_pred             ---CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          494 ---EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       494 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                         ...|++||++ +++|.+++...  .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence               3568999988 67998877643  589999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      +++....     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..                    
T Consensus       164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9986522     1233468999999999876 5688999999999999999999998742                    


Q ss_pred             ----------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                        .+.+++.+|+..||++|||++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                                              14588999999999999999875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-36  Score=305.85  Aligned_cols=223  Identities=24%  Similarity=0.377  Sum_probs=192.6

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeeccc------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      +|.+.+.||+|+||.||+|...+++.||+|.++...      .+....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            578889999999999999998889999999986432      12345688899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999987654 678899999999999999999999   99999999999999999999999999987542111


Q ss_pred             C----ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          580 Q----SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       580 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      .    ........++..|+|||++.+..++.++||||+||++|||++|+.||..                          
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA  236 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence            1    1112234588899999999988899999999999999999999999632                          


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||..+|++||++.|+
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~  259 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQL  259 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHH
Confidence            26789999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.8e-37  Score=312.47  Aligned_cols=226  Identities=26%  Similarity=0.368  Sum_probs=191.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++... ......+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999853      46789999987543 23456788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 041689          497 ELVLEHMPHGSLEKCLYSSN---------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSN  555 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  555 (652)
                      ++||||+++|+|.+++....                     ..+++.+++.++.|++.||+|||..   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999986432                     1467888899999999999999999   99999999999


Q ss_pred             eeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc-------
Q 041689          556 VLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC-------  627 (652)
Q Consensus       556 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~-------  627 (652)
                      |++++++.+||+|||.+.................+..|+|||.+.+..++.++|||||||++|||++ |..||       
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875432221111222335667999999988899999999999999999997 77664       


Q ss_pred             -----------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 -----------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -----------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                       +..+.+++.+||+.+|++|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el  282 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI  282 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence                             2358899999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=320.51  Aligned_cols=212  Identities=24%  Similarity=0.250  Sum_probs=177.9

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc---CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI---HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      ||+|+||.||+|+.. +++.||+|++....   .........|..++...   +||+|+++++++......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 58999999996532   12233445566777665   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCcc
Confidence            99998887654 689999999999999999999999   9999999999999999999999999998753221  12233


Q ss_pred             cccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcccch
Q 041689          586 QTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAMECTI  640 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~~l~  640 (652)
                      ...||+.|+|||++.+. .++.++||||+||++|||++|+.||.                        ..+.+++.+||.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~  234 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence            45689999999998754 47899999999999999999999953                        235789999999


Q ss_pred             hhhccccCcc
Q 041689          641 ESLELRINAK  650 (652)
Q Consensus       641 ~~p~~Rpt~~  650 (652)
                      .||++||++.
T Consensus       235 ~~P~~R~~~~  244 (330)
T cd05586         235 RNPQHRLGAH  244 (330)
T ss_pred             CCHHHCCCCC
Confidence            9999999643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.6e-37  Score=310.02  Aligned_cols=222  Identities=27%  Similarity=0.425  Sum_probs=186.5

Q ss_pred             CC-CccceeccccceEEEEEEe-----CCCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cce
Q 041689          426 GF-NENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       426 ~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  496 (652)
                      +| ...+.||+|+||+||++..     .++..||+|.++.... .....+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 7889999999999988642     3578899999975532 3456788999999999999999999987653  467


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++...  .+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            8999999999999998764  489999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          577 GEDQSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       577 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      ....... .....++..|+|||...+..++.++||||||+++|||++|..|+.                           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            2221111 122335667999999988899999999999999999999987742                           


Q ss_pred             ------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                  ..+.+++.+||+.+|++|||+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence                        357789999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-37  Score=323.16  Aligned_cols=220  Identities=21%  Similarity=0.225  Sum_probs=186.5

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  493 (652)
                      ...+|.+.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3568999999999999999999865 5889999998653  233446678899999999999999999987543      


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999976 77776643   478888999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....   ........+|+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            6421   1222345689999999999999999999999999999999999988741                        


Q ss_pred             -----------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                               .+.+++.+|+..||++|||+.|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~  315 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  315 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence                                                     24689999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.4e-37  Score=334.11  Aligned_cols=198  Identities=22%  Similarity=0.272  Sum_probs=163.9

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCC------CeeeeEEeeeec
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY------RNLVKIISSCSN  492 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~  492 (652)
                      +.....+|.+.+.||+|+||.||+|... +++.||||+++... ........|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999864 58889999996432 233455678888877754      458889998875


Q ss_pred             C-CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCC--------
Q 041689          493 E-EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTM--------  562 (652)
Q Consensus       493 ~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~--------  562 (652)
                      . ++.++|||++ +++|.+++.... .+++..+..|+.|++.||+|||+ .   ||+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999988 668888887654 68999999999999999999996 6   999999999999998665        


Q ss_pred             --------cEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          563 --------VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       563 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                              .+||+|||.+...     ........||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             cccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                    4999999987642     122334578999999999999999999999999999999999999974

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-36  Score=311.90  Aligned_cols=226  Identities=25%  Similarity=0.361  Sum_probs=191.2

Q ss_pred             hcCCCccceeccccceEEEEEEeCC-----------------CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeee
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD-----------------GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVK  485 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  485 (652)
                      ..+|++.+.||+|+||.||+|....                 +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999987532                 2458999987553 334567889999999999999999


Q ss_pred             EEeeeecCCceEEEEEccCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCC
Q 041689          486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSN----------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSN  555 (652)
Q Consensus       486 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~N  555 (652)
                      +++++..++..++||||+++++|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999986543          2578999999999999999999999   99999999999


Q ss_pred             eeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh--CCCCc------
Q 041689          556 VLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS--AKQQC------  627 (652)
Q Consensus       556 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~------  627 (652)
                      |++++++.++|+|||.++...............++..|+|||++.++.++.++|||||||++|||++  |..||      
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876533222222233446778999999988889999999999999999998  55552      


Q ss_pred             -------------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 -------------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -------------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               +.++.+++.+||+.||++|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el  290 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI  290 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence                                     2357899999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-36  Score=307.73  Aligned_cols=223  Identities=24%  Similarity=0.388  Sum_probs=183.4

Q ss_pred             CCccceeccccceEEEEEEeCC-Cc--EEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------Cc
Q 041689          427 FNENNLIGKGGFGTIYKSRIGD-GM--EVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------EF  495 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  495 (652)
                      |.+.+.||+|+||.||+|+..+ +.  .||+|.++..  .....+.+..|++++++++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999998654 32  5899988654  233456788999999999999999999986432      24


Q ss_pred             eEEEEEccCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          496 KELVLEHMPHGSLEKCLYS-----SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      .+++|||+++|+|.+++..     ....+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999987742     223578999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------------  628 (652)
                      +++.+.............+++.|+|||...+..++.++|||||||++|||++ |+.||.                     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP  237 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            9987533221111222346778999999998899999999999999999999 777753                     


Q ss_pred             ---hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         ..+.+++.+||..||++|||+.||
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l  264 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETL  264 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence               237889999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.9e-37  Score=323.19  Aligned_cols=227  Identities=22%  Similarity=0.372  Sum_probs=189.2

Q ss_pred             HhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEE  494 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  494 (652)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|+++... ....+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3445778899999999999999853      34679999997542 223456889999999997 999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN----------------------------------------------------------  516 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  516 (652)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886432                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          517 ---------------------------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       517 ---------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                                                             ..+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                                   1356677888999999999999998   9999999999999


Q ss_pred             eCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------
Q 041689          558 LDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------  628 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------  628 (652)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.        
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986532222112223456788999999988889999999999999999998 777753        


Q ss_pred             -----------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                       ..+.+++.+||..+|++||+++||
T Consensus       352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el  392 (401)
T cd05107         352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL  392 (401)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                             236689999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=305.16  Aligned_cols=219  Identities=31%  Similarity=0.487  Sum_probs=191.2

Q ss_pred             ceeccccceEEEEEEeCC----CcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|....    +..||+|.++..... ..+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    788999999765433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          506 GSLEKCLYSS--------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       506 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ++|.+++...        ...+++.++..++.|++.||+|||++   +++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        35789999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      ...........++..|+|||.+....++.++||||+||++|||++ |..||.                        ..+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            322222334557889999999988889999999999999999999 587753                        3478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++|||+.|+
T Consensus       238 ~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             HHHHHHccCCcccCcCHHHH
Confidence            89999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-36  Score=316.19  Aligned_cols=197  Identities=20%  Similarity=0.243  Sum_probs=163.9

Q ss_pred             ccceeccc--cceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          429 ENNLIGKG--GFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       429 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +.+.||+|  +|++||+++.. +|+.||+|+++...  ......+++|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  68899999864 68999999997542  234456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|++.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986542 3588999999999999999999999   99999999999999999999999998754432111100


Q ss_pred             -----ccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          583 -----TQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       583 -----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                 1122346778999999876  468899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-37  Score=322.01  Aligned_cols=192  Identities=21%  Similarity=0.291  Sum_probs=165.2

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ....+|.+.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34467999999999999999999875 5788999975322      2356999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+. +++.+++......+++.++..|+.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++....   
T Consensus       137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---  209 (357)
T ss_pred             EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence            9995 588888876666799999999999999999999999   999999999999999999999999999875321   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      ........||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            1122345689999999999999999999999999999999985443

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-36  Score=304.93  Aligned_cols=223  Identities=24%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999876 7999999988643   2233567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++++|.+++...   ...+++.++..++.|++.|+.|||+.   |++||||||+||++++++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988642   33578999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------h
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------F  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~  630 (652)
                      ..  .......++..|+|||.+.+..++.++|||||||++|+|++|+.||..                           .
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            21  112234578889999999888899999999999999999999988521                           3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..+|++|||+.||
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~i  258 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYV  258 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHH
Confidence            7789999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.8e-37  Score=315.05  Aligned_cols=226  Identities=24%  Similarity=0.352  Sum_probs=188.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      ..+|.+.+.||+|+||.||+|+..        ....||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            356888999999999999999742        24569999987542 33456788899999999 699999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||++   |++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            99999999999999999986532               2478888999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------  628 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------  628 (652)
                      ++++.+||+|||.++...............++..|+|||++.++.++.++|||||||++|||++ |..||.         
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999986532221111122234567999999988899999999999999999998 777642         


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||..+|++|||+.||
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  286 (314)
T cd05099         248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL  286 (314)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                           247889999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.3e-37  Score=308.98  Aligned_cols=225  Identities=23%  Similarity=0.310  Sum_probs=190.6

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC------
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE------  493 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------  493 (652)
                      .+++.|+..+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677889999999999999999865 58899999986543 3345788899999998 799999999998653      


Q ss_pred             CceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      ...++||||+++++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46789999999999999887643 3688999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                      ......  ........|+..|+|||++.     +..++.++||||+||++|||++|+.||.                   
T Consensus       159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            764221  11223456889999999876     3457889999999999999999999863                   


Q ss_pred             ------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            ..+.+++.+||..+|.+|||++||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  266 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQL  266 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                  347889999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.9e-37  Score=313.28  Aligned_cols=226  Identities=22%  Similarity=0.353  Sum_probs=189.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      ..+|.+.+.||+|+||.||+|+..        ++..||+|.++... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            456888899999999999999631        24579999986542 34456788999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||++   |++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            99999999999999999987532               2467788999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------  628 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------  628 (652)
                      ++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.         
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            9999999999999986533222222223345678999999988889999999999999999998 666632         


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||..+|++|||+.||
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~  289 (304)
T cd05101         251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL  289 (304)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence                           347889999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.3e-37  Score=312.08  Aligned_cols=221  Identities=24%  Similarity=0.272  Sum_probs=187.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999865 68999999986542  22235677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ ++.+++......+++..+..++.|+++||.|||++   +++||||||+||+++.++.+||+|||.++......  .
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~  154 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R  154 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence            975 88887766555789999999999999999999999   99999999999999999999999999987542211  1


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCc----------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQC----------------------------------  627 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~----------------------------------  627 (652)
                      ......++..|+|||++.+. .++.++|||||||++|||++|..|+                                  
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            12334578899999987664 4689999999999999999998873                                  


Q ss_pred             -------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 -------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                         +..+.+++.+||..||++|||++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i  278 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA  278 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence                               1235689999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-36  Score=311.79  Aligned_cols=225  Identities=23%  Similarity=0.355  Sum_probs=187.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-----------------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-----------------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKI  486 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  486 (652)
                      ++|++.+.||+|+||.||+|+..                 ++..||+|.++... ......+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 23468999987542 3345678999999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCe
Q 041689          487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSN----------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNV  556 (652)
Q Consensus       487 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NI  556 (652)
                      ++++..++..++||||+++++|.+++....          ..+++.++..++.|++.|++|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            999999999999999999999999886542          1366778999999999999999999   999999999999


Q ss_pred             eeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh--CCCCcc------
Q 041689          557 LLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS--AKQQCV------  628 (652)
Q Consensus       557 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~------  628 (652)
                      ++++++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||.      
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986532221111222334678999999888899999999999999999998  556642      


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+||+.||++||+++||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i  290 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI  290 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                                     336789999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-36  Score=311.84  Aligned_cols=222  Identities=26%  Similarity=0.408  Sum_probs=185.9

Q ss_pred             cCCCccceeccccceEEEEEEeCC-Cc--EEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-GM--EVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+..|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            478889999999999999998653 33  4788888643 233456788999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          500 LEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      |||+++++|.+++....               ..+++..+..++.|++.|++|||++   ||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            99999999999986532               2478889999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------  628 (652)
                      ||+|||++....   ..........+..|+|||+.....++.++|||||||++|||++ |..||.               
T Consensus       159 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         159 KIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999986421   1111111223557999999988889999999999999999997 888852               


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||+.+|.+||++++|
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  268 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI  268 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                     337799999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=302.41  Aligned_cols=219  Identities=32%  Similarity=0.446  Sum_probs=187.7

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChh
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLE  509 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  509 (652)
                      +.||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999767999999998765333 4567899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccC
Q 041689          510 KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA  589 (652)
Q Consensus       510 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  589 (652)
                      +++......+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99876655788999999999999999999999   999999999999999999999999999875421111111112234


Q ss_pred             CccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccchhhhc
Q 041689          590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECTIESLE  644 (652)
Q Consensus       590 t~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l~~~p~  644 (652)
                      +..|+|||.+.++.++.++|||||||++|||++ |..||.                        ..+.+++.+||..+|+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            567999999988899999999999999999999 777743                        3478899999999999


Q ss_pred             cccCccCC
Q 041689          645 LRINAKEI  652 (652)
Q Consensus       645 ~Rpt~~ei  652 (652)
                      +|||+.||
T Consensus       238 ~Rp~~~el  245 (251)
T cd05041         238 NRPSFSEI  245 (251)
T ss_pred             hCcCHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-36  Score=305.65  Aligned_cols=223  Identities=24%  Similarity=0.374  Sum_probs=191.1

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.....         ...+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 588999998864321         123567889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997654 688889999999999999999999   9999999999999999999999999999866


Q ss_pred             cCCCCcc----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          576 IGEDQSM----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       576 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      .......    ......++..|+|||.+.+..++.++||||+||++|+|++|+.||..                      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI  236 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence            4221111    11223478899999999988899999999999999999999999643                      


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+||+.||++||++.||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i  261 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTAAEL  261 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHH
Confidence              26889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=305.25  Aligned_cols=225  Identities=28%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            356789999999999999999998788889999987543 3346788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... ..+++.++..++.|++.|++|||+.   +++|+||||+||++++++.+|++|||.++...... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999987654 3689999999999999999999999   99999999999999999999999999988653211 1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~  636 (652)
                      ........+..|+|||...+..++.++||||+||++|||++ |+.||..                        .+.+++.
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML  238 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            11122234568999999998889999999999999999998 8887532                        4788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.+|++||+++||
T Consensus       239 ~~l~~~p~~Rp~~~~l  254 (261)
T cd05034         239 QCWDKDPEERPTFEYL  254 (261)
T ss_pred             HHcccCcccCCCHHHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-36  Score=306.58  Aligned_cols=225  Identities=23%  Similarity=0.385  Sum_probs=191.0

Q ss_pred             cCCCccceeccccceEEEEEEeC----CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .+|++.+.||+|+||.||+|+..    .+..||+|.++... ....+.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46888899999999999999853    23479999986542 33456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++......+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.+..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999987666789999999999999999999999   99999999999999999999999999998653222


Q ss_pred             Cccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          580 QSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       580 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      .... .....++..|+|||.+.++.++.++|+|||||++||+++ |+.||.                        ..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ  240 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence            1111 111223567999999998899999999999999999886 998852                        24788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.+|++||++.+|
T Consensus       241 li~~~l~~~p~~Rp~~~~i  259 (267)
T cd05066         241 LMLDCWQKDRNERPKFEQI  259 (267)
T ss_pred             HHHHHcccCchhCCCHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.6e-37  Score=313.77  Aligned_cols=225  Identities=23%  Similarity=0.346  Sum_probs=188.4

Q ss_pred             cCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      ++|.+.+.||+|+||.||+|+..        ++..||+|.++... ......+..|+++++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46899999999999999999742        23569999997542 33456788899999999 7999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD  559 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~  559 (652)
                      ..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||+.   |++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence            9999999999999999987542               2478889999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc----------
Q 041689          560 DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV----------  628 (652)
Q Consensus       560 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~----------  628 (652)
                      +++.+||+|||.++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.          
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            999999999999876532111111122234568999999988889999999999999999998 777632          


Q ss_pred             --------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                    ..+.+++.+||..+|++|||+.||
T Consensus       255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev  292 (307)
T cd05098         255 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  292 (307)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                          247889999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-36  Score=304.86  Aligned_cols=218  Identities=26%  Similarity=0.350  Sum_probs=178.1

Q ss_pred             ceeccccceEEEEEEeC---CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|...   ++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999754   346799998865432 33457888999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          507 SLEKCLYSSN----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       507 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +|.+++....    ...++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986532    1456677888999999999999999   99999999999999999999999999987542222111


Q ss_pred             ccccccCCccccCccccccC-------ccCcccchhhHHHHHHHHHh-CCCCcch-------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-------RVFANGDVYSFGIMLMEIHS-AKQQCVS-------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~vl~ellt-g~~p~~~-------------------------  629 (652)
                      ......++..|+|||++.+.       .++.++|||||||++|||++ |+.||..                         
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            22234567889999987542       35789999999999999996 9988642                         


Q ss_pred             ----hhhhhhcccchhhhccccCccCC
Q 041689          630 ----FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          .+.+++.+|| .+|++|||++||
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l  263 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEV  263 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHH
Confidence                2457899998 589999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-36  Score=303.92  Aligned_cols=223  Identities=26%  Similarity=0.383  Sum_probs=192.0

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.++... .....+.+|++++++++||+|+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999988778899999986542 234578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+....... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            9999999887665688999999999999999999999   99999999999999999999999999987542211 1111


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l  639 (652)
                      ....++..|+|||...++.++.++||||+|+++|||++ |+.||.                        ..+.+++.+||
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  238 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW  238 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence            22335678999999988899999999999999999998 888853                        22678999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      ..+|++|||+.|+
T Consensus       239 ~~~p~~Rp~~~~~  251 (256)
T cd05112         239 KERPEDRPSFSLL  251 (256)
T ss_pred             ccChhhCCCHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-36  Score=312.85  Aligned_cols=222  Identities=28%  Similarity=0.450  Sum_probs=185.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc--EEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM--EVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++..++..|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46888899999999999999864 454  45777765432 23456788899999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          500 LEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      |||+++++|.+++....               ..+++.++..++.|++.|++|||+.   |++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            99999999999986432               2478889999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------  628 (652)
                      ||+|||++....   .........++..|+|||++.+..++.++|||||||++|||+| |..||.               
T Consensus       164 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         164 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            999999986321   1111112234567999999988889999999999999999998 888853               


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||+.+|++||+++++
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  273 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  273 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                     336789999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.8e-36  Score=303.98  Aligned_cols=222  Identities=26%  Similarity=0.388  Sum_probs=188.3

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      ++|.+.+.||+|+||.||+|....+..||+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4688889999999999999998777789999886542 23467889999999999999999999875 456789999999


Q ss_pred             CCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          505 HGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       505 ~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +++|.+++.... ..+++..+..++.|++.||+|||+.   |++||||||+||++++++.++|+|||.+....... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence            999999987543 3578899999999999999999999   99999999999999999999999999997653221 111


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMEC  638 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~  638 (652)
                      .....++..|+|||...++.++.++|||||||++|||++ |+.||..                        .+.+++.+|
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC  239 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            122345678999999988899999999999999999999 8887532                        377899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |..||++||++++|
T Consensus       240 l~~~p~~Rp~~~~i  253 (260)
T cd05069         240 WKKDPDERPTFEYI  253 (260)
T ss_pred             ccCCcccCcCHHHH
Confidence            99999999999764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.7e-37  Score=340.86  Aligned_cols=228  Identities=21%  Similarity=0.256  Sum_probs=188.7

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCce
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFK  496 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  496 (652)
                      ...++|.+.+.||+|+||.||+|+.. ++..||+|++...  .......+..|+.++++++|||||+++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999865 5778999998654  23345678899999999999999999998854  4568


Q ss_pred             EEEEEccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEecCCCCCCeeeCC---------
Q 041689          497 ELVLEHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFL----VPVIHCDLKPSNVLLDD---------  560 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~iiH~dlkp~NIll~~---------  560 (652)
                      |+||||+++|+|.+++...   ...+++..++.|+.||+.||+|||....    .+||||||||+|||++.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999988652   2368999999999999999999998521    25999999999999964         


Q ss_pred             --------CCcEEEecccCCccccCCCCccccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch-
Q 041689          561 --------TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS-  629 (652)
Q Consensus       561 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~-  629 (652)
                              .+.+||+|||++..+...   .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.. 
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    345999999999865221   12234568999999998854  4588999999999999999999999642 


Q ss_pred             -----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             .+.+++.+||..+|++||++.|+
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql  292 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQC  292 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence                                   37889999999999999999764

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=307.45  Aligned_cols=212  Identities=23%  Similarity=0.331  Sum_probs=178.1

Q ss_pred             eeccccceEEEEEEeCC-------------------------CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeE
Q 041689          432 LIGKGGFGTIYKSRIGD-------------------------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI  486 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  486 (652)
                      +||+|+||.||+|....                         ...||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999986311                         23588998875544445678889999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----
Q 041689          487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----  562 (652)
Q Consensus       487 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----  562 (652)
                      ++++..+...++||||+++|+|..++......+++..+..++.|++.||+|||++   +|+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999876555789999999999999999999999   999999999999997543    


Q ss_pred             ---cEEEecccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHH-hCCCCcc---------
Q 041689          563 ---VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIH-SAKQQCV---------  628 (652)
Q Consensus       563 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~ell-tg~~p~~---------  628 (652)
                         .+|++|||.+.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.         
T Consensus       159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               489999998764321      122346788999998865 56889999999999999994 6888753         


Q ss_pred             -------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                   ..+.+++.+||+.+|++|||++||
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  269 (274)
T cd05076         233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTI  269 (274)
T ss_pred             HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHH
Confidence                         237889999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-36  Score=305.22  Aligned_cols=226  Identities=23%  Similarity=0.403  Sum_probs=191.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CC---cEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DG---MEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|+..+.||+|+||.||+|+.. ++   ..||+|.++.. .....+.+..|++++++++||||+++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            346888899999999999999864 33   36999998654 23345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++++|.+++......+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999977656789999999999999999999999   9999999999999999999999999998765322


Q ss_pred             CCcccc-ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          579 DQSMTQ-TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       579 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      ...... .....+..|+|||++....++.++|||||||++|||++ |+.||.                        ..+.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            211111 11223457999999988889999999999999999997 998853                        2367


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.+|++||++.||
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHH
Confidence            89999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-36  Score=308.27  Aligned_cols=227  Identities=22%  Similarity=0.297  Sum_probs=191.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC-----CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD-----GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEF  495 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  495 (652)
                      ..++|.+.+.||+|+||.||+|.+..     +..||+|++.... ......+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678889999999999999998654     6889999886542 3345678899999999999999999998765 567


Q ss_pred             eEEEEEccCCCChhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      .++++||+++++|.+++....       ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999986532       3588999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------  628 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------  628 (652)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.                   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            999986533222212223346778999999988889999999999999999999 888853                   


Q ss_pred             -----hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           +.+.+++.+||..||++|||+.|+
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~  269 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQL  269 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                 237899999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=306.05  Aligned_cols=221  Identities=25%  Similarity=0.296  Sum_probs=194.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999865 68899999987553 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++...  .+++..+..++.|++.|+.|||++   +++||||+|+||++++++.++|+|||.++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  689999999999999999999999   99999999999999999999999999998763221  2


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~~l~~~  637 (652)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||.                         ..+.+++.+
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  233 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL  233 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence            2234467888999999998889999999999999999999999963                         347899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++|||++||
T Consensus       234 ~l~~~p~~Rpt~~~i  248 (274)
T cd06609         234 CLNKDPKERPSAKEL  248 (274)
T ss_pred             HhhCChhhCcCHHHH
Confidence            999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-36  Score=303.77  Aligned_cols=218  Identities=23%  Similarity=0.357  Sum_probs=187.8

Q ss_pred             ceeccccceEEEEEEeCC--C--cEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIGD--G--MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  3699999976654 566789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc-c
Q 041689          506 GSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-T  583 (652)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~  583 (652)
                      ++|.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999987755 4689999999999999999999999   99999999999999999999999999998764322111 1


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------hhhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------SFVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~~l~~l~~~  637 (652)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.                         ..+.+++.+
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            123346788999999988899999999999999999998 999862                         347789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||+++||
T Consensus       237 ~l~~~p~~Rps~~~~  251 (257)
T cd05040         237 CWAHNPADRPTFAAL  251 (257)
T ss_pred             HCCCCcccCCCHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-36  Score=307.23  Aligned_cols=222  Identities=23%  Similarity=0.304  Sum_probs=189.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999876 58999999986442  2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++.+..+..... .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765443 689999999999999999999999   999999999999999999999999999986532221 


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------------  629 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------------  629 (652)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..                               
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457788999998866 4578999999999999999999988631                               


Q ss_pred             -----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             .+.+++.+||+.+|++||++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  280 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL  280 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence                                   25689999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-36  Score=306.04  Aligned_cols=223  Identities=23%  Similarity=0.359  Sum_probs=191.9

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+...   ......++.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 47899999988643   2234467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++++|.+++..   ....+++..+..++.|++.|+.|||+.   |++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998763   223688999999999999999999999   999999999999999999999999999876532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SF  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~  630 (652)
                      ..  .......++..|+|||...+..++.++||||||+++|||++|..||.                           ..
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            21  11223458889999999988889999999999999999999998852                           23


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..+|++|||+.+|
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i  258 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYV  258 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHH
Confidence            7889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-36  Score=316.84  Aligned_cols=226  Identities=23%  Similarity=0.368  Sum_probs=186.3

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC-C
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE-E  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  494 (652)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35789999999999999999973      347889999997543 23345688899999999 689999999987654 5


Q ss_pred             ceEEEEEccCCCChhhhhhcCC----------------------------------------------------------
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN----------------------------------------------------------  516 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  516 (652)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999886421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          517 --------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       517 --------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                              ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1357778889999999999999999   99999999999999999999999999988653222211222234


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------hhhhhhhcccchhh
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------SFVFNLAMECTIES  642 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~~l~~l~~~~l~~~  642 (652)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||.                         ..+.+++.+||..|
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            5678999999988899999999999999999997 887753                         23678899999999


Q ss_pred             hccccCccCC
Q 041689          643 LELRINAKEI  652 (652)
Q Consensus       643 p~~Rpt~~ei  652 (652)
                      |++|||+.||
T Consensus       323 p~~Rps~~ei  332 (343)
T cd05103         323 PSQRPTFSEL  332 (343)
T ss_pred             hhhCcCHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-36  Score=300.85  Aligned_cols=222  Identities=23%  Similarity=0.332  Sum_probs=190.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  501 (652)
                      +|++.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999865 57889999986542  2345578889999999999999999998764 446789999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++++|.+++.... ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999887643 3589999999999999999999999   99999999999999999999999999998653221 


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~  636 (652)
                       .......+++.|+|||+..+..++.++||||+||++|||++|+.||+.                        .+.+++.
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence             122334578899999999999999999999999999999999988542                        2678999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.+|++|||+.||
T Consensus       236 ~~l~~~p~~Rp~~~~~  251 (257)
T cd08223         236 TMLSKRPEKRPSVKSI  251 (257)
T ss_pred             HHhccCcccCCCHHHH
Confidence            9999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.5e-36  Score=304.74  Aligned_cols=224  Identities=24%  Similarity=0.344  Sum_probs=189.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|.+.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568888999999999999998543    3468999887554 3455678999999999999999999998875 45789


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            9999999999999987655689999999999999999999999   9999999999999999999999999998865322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      . ........++..|+|||.+....++.++|||||||++|||++ |+.||.                        ..+.+
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            1 111222334568999999888889999999999999999986 988852                        34788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..+|++|||+.|+
T Consensus       240 li~~~l~~~P~~Rpt~~~~  258 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTEL  258 (270)
T ss_pred             HHHHHcCCChhhCcCHHHH
Confidence            9999999999999999764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-36  Score=301.04  Aligned_cols=219  Identities=30%  Similarity=0.425  Sum_probs=191.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|.+.+.||+|+||.||+|... |+.||+|.++.... ..+++..|+.++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            356888999999999999999874 78999999976543 4577889999999999999999999999899999999999


Q ss_pred             CCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++..... .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~----  155 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc----
Confidence            99999999876542 589999999999999999999999   9999999999999999999999999999865211    


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------------chhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------------VSFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------------~~~l~~l~~~  637 (652)
                       ......+..|+|||.+..+.++.++||||||+++|||++ |+.||                        +..+.+++.+
T Consensus       156 -~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         156 -QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             -cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence             112334667999999988889999999999999999997 87773                        3457899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++|||++||
T Consensus       235 ~l~~~p~~Rp~~~~l  249 (256)
T cd05039         235 CWELDPAKRPTFKQL  249 (256)
T ss_pred             HhccChhhCcCHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=305.91  Aligned_cols=224  Identities=25%  Similarity=0.369  Sum_probs=189.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc----EEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|++.+.||+|+||.||+|... +|.    .||+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            46788899999999999999854 333    58999886553 2345678899999999999999999999887 78899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999999987666789999999999999999999998   9999999999999999999999999999865422


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ..........++..|+|||.+....++.++|+|||||++||+++ |+.||..                        .+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM  242 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            22221122224568999999988899999999999999999998 9988543                        3678


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..+|++||++.++
T Consensus       243 ~~~~~l~~~p~~Rp~~~~l  261 (279)
T cd05057         243 VLVKCWMIDAESRPTFKEL  261 (279)
T ss_pred             HHHHHcCCChhhCCCHHHH
Confidence            8999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.4e-36  Score=304.93  Aligned_cols=221  Identities=24%  Similarity=0.341  Sum_probs=192.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+++++++.||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999865 58899999987542 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++...  .+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++.......  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            9999999988754  588889999999999999999999   99999999999999999999999999997653221  1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~~~  638 (652)
                      ......++..|+|||++.+..++.++|+|||||++|||++|+.||..                        .+.+++.+|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            22234578889999999888899999999999999999999999642                        367899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |..+|++||+++||
T Consensus       237 l~~~p~~Rp~~~~i  250 (277)
T cd06640         237 LNKDPSFRPTAKEL  250 (277)
T ss_pred             cccCcccCcCHHHH
Confidence            99999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.7e-37  Score=305.91  Aligned_cols=213  Identities=25%  Similarity=0.321  Sum_probs=180.8

Q ss_pred             ceeccccceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRIGD--------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +.||+|+||.||+|....        ..+||+|.+........+.+..|+.++++++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        234888888655545566788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc--------EEEecccCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV--------AHLSDFGITKL  574 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~Dfg~~~~  574 (652)
                      +++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987665789999999999999999999999   9999999999999987654        69999998865


Q ss_pred             ccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCC-CCcc----------------------hh
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAK-QQCV----------------------SF  630 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~-~p~~----------------------~~  630 (652)
                      ...      .....++..|+|||++.+. .++.++|||||||++|||++|. .|+.                      ..
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE  231 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence            421      2234578889999998764 5789999999999999999995 4421                      33


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++||
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~i  253 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAI  253 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHH
Confidence            7789999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-36  Score=308.09  Aligned_cols=232  Identities=23%  Similarity=0.294  Sum_probs=192.8

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeee-
Q 041689          415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCS-  491 (652)
Q Consensus       415 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-  491 (652)
                      +.++.+..+.++|++.+.||+|+||.||+|... +++.||+|++... ......+..|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445566678889999999999999999999865 5889999987643 22345678899999999 6999999999874 


Q ss_pred             ----cCCceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          492 ----NEEFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       492 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                          .++..++||||+++++|.+++..   ....+++..+..++.|++.|+.|||+.   +++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34578999999999999988753   223678889999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcc-----------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCV-----------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~-----------  628 (652)
                      ||+|||+++.....  ........|++.|+|||++..     ..++.++||||+||++|||++|+.|+.           
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             EEccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            99999998765321  112233458899999998753     457889999999999999999998842           


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||+.||++|||+.||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  280 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL  280 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence                           236789999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4e-36  Score=306.76  Aligned_cols=224  Identities=22%  Similarity=0.281  Sum_probs=188.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++.+|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999864 688999999865432 22346678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+. +++.+++......+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP--  156 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC--
Confidence            9996 577777665545678888899999999999999999   9999999999999999999999999998754221  


Q ss_pred             ccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-------------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-------------------------------  628 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-------------------------------  628 (652)
                      ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.                               
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            1112334578899999988654 57889999999999999999999873                               


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+|+..||++|||++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~  285 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA  285 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence                                     135679999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=307.23  Aligned_cols=222  Identities=23%  Similarity=0.301  Sum_probs=188.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999865 688999999875422 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ +|.+++......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||.++.....  ..
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence            985 99998876655789999999999999999999999   9999999999999999999999999998753211  11


Q ss_pred             ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.                                 
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1222346788999998765 457899999999999999999998873                                 


Q ss_pred             -----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             ....+++.+|++.+|++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~  285 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEA  285 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence                                   223489999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-36  Score=306.26  Aligned_cols=222  Identities=23%  Similarity=0.298  Sum_probs=191.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888899999999999999864 68999999987543  33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      + +++|.+++......+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 9999999876656799999999999999999999999   999999999999999999999999999886532221 1


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      ......++..|+|||++.+. .++.++||||+||++|||++|++||.                                 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            22345688999999987654 46899999999999999999977652                                 


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+|+..+|++|||++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~  279 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA  279 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHH
Confidence                                335689999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=299.99  Aligned_cols=217  Identities=27%  Similarity=0.365  Sum_probs=183.0

Q ss_pred             ceeccccceEEEEEEeCC----CcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|....    +..||+|.++.... ...+.+.+|+++++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997532    36899999875533 34567889999999999999999999876 4567999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc-c
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-Q  584 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~  584 (652)
                      ++|.+++.... .+++..+..++.|++.|++|||..   +++||||||+||+++.++.+||+|||.++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 689999999999999999999999   999999999999999999999999999986533222111 1


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l  639 (652)
                      ....++..|+|||...+..++.++|||||||++|||++ |+.||..                        .+.+++.+||
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            11223567999999988899999999999999999998 8998643                        3689999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.+|++||++.||
T Consensus       236 ~~~p~~Rp~~~~l  248 (257)
T cd05060         236 KYRPEDRPTFSEL  248 (257)
T ss_pred             cCChhhCcCHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.7e-36  Score=311.03  Aligned_cols=192  Identities=20%  Similarity=0.280  Sum_probs=156.6

Q ss_pred             ceeccccceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  505 (652)
                      .+||+|+||.||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++..  +...++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            68999999999999864   45789999886442  23457789999999999999999998853  4678999999975


Q ss_pred             CChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----CCCCcEEEecccCCc
Q 041689          506 GSLEKCLYSS--------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITK  573 (652)
Q Consensus       506 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~~~  573 (652)
                       ++.+++...        ...+++..+..++.|++.||+|||+.   +|+||||||+||++    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777766421        12578888999999999999999999   99999999999999    567799999999998


Q ss_pred             cccCCCCc-cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          574 LLIGEDQS-MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       574 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ........ .......+|+.|+|||++.+ ..++.++||||+||++|||+||++||.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            65322211 11234468899999999876 457899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=312.08  Aligned_cols=222  Identities=26%  Similarity=0.416  Sum_probs=192.1

Q ss_pred             CCCccceeccccceEEEEEEeCC---C--cEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGD---G--MEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+..+.||.|.||.||+|...+   |  -.||||..+.+ .....+.|..|+.+|+.++||||++++|.|.+. ..|||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34556889999999999997432   3  34899998875 344577899999999999999999999999765 67899


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||.++-|.|+.|++.++..++......+++||+.||+|||+.   ..|||||...|||+.+...+|++|||+++.+.+..
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            999999999999999888999999999999999999999999   99999999999999999999999999999874433


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------------cchhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------------CVSFVFNL  634 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------------~~~~l~~l  634 (652)
                       ....+...-...|||||.+..++++.+||||-|||.|||+++ |..|                        |++.+..+
T Consensus       546 -yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  546 -YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL  624 (974)
T ss_pred             -hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence             233333345667999999999999999999999999999976 6666                        55669999


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||.+||.+||++.||
T Consensus       625 mskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             HHHHhccCcccCCcHHHH
Confidence            999999999999999875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4e-36  Score=305.32  Aligned_cols=232  Identities=22%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeec
Q 041689          415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSN  492 (652)
Q Consensus       415 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  492 (652)
                      .+..++..+...|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            456666677788999999999999999999864 68899999986543 3345678899999998 79999999999853


Q ss_pred             ------CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEE
Q 041689          493 ------EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH  565 (652)
Q Consensus       493 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k  565 (652)
                            .+..+++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||+.   +++||||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999887543 3578888899999999999999999   999999999999999999999


Q ss_pred             EecccCCccccCCCCccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch-----------
Q 041689          566 LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------  629 (652)
Q Consensus       566 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~-----------  629 (652)
                      |+|||++......  ........+++.|+|||.+.     ...++.++|||||||++|||++|+.||..           
T Consensus       162 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~  239 (282)
T cd06636         162 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP  239 (282)
T ss_pred             EeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence            9999998754211  11223356889999999875     34678899999999999999999998632           


Q ss_pred             --------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                    .+.+++.+||+.||.+|||+.||
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el  276 (282)
T cd06636         240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL  276 (282)
T ss_pred             hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence                          36799999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-36  Score=301.17  Aligned_cols=223  Identities=25%  Similarity=0.401  Sum_probs=190.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..+|.+.+.||+|+||.||+|...++..||+|.++... .....+.+|++++++++|+||+++++.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            45788999999999999999998778889999887542 334678899999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++.... ...++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            9999999987643 3578888999999999999999998   99999999999999999999999999987653221 11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~  637 (652)
                      ......++..|+|||++..+.++.++|+|||||++|++++ |+.||..                        .+.+++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  238 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR  238 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence            1222345677999999988889999999999999999999 8888543                        37789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++.++
T Consensus       239 ~l~~~p~~Rp~~~~l  253 (260)
T cd05073         239 CWKNRPEERPTFEYI  253 (260)
T ss_pred             HcccCcccCcCHHHH
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-36  Score=309.97  Aligned_cols=219  Identities=24%  Similarity=0.293  Sum_probs=189.6

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            333467999999999999864 6889999998765555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      ++|.+++...  .+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++.......  ....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            9999987543  488999999999999999999999   99999999999999999999999999987542211  1223


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcccc
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAMECT  639 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~~l  639 (652)
                      ...++..|+|||...+..++.++||||||+++|||++|+.||..                          .+.+++.+||
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            34588899999999888899999999999999999999998532                          2577899999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      ..||++|||++||
T Consensus       257 ~~~P~~Rpt~~~i  269 (292)
T cd06658         257 VREPSQRATAQEL  269 (292)
T ss_pred             cCChhHCcCHHHH
Confidence            9999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.6e-36  Score=300.55  Aligned_cols=223  Identities=22%  Similarity=0.337  Sum_probs=187.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  496 (652)
                      .+|...+.||+|+||.||+|... ++..||+|++....     .+....+.+|+.++++++||||+++++++..  ++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999864 58999999986431     2234568889999999999999999998865  3577


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      +++|||+++++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999887654 588899999999999999999999   99999999999999999999999999987542


Q ss_pred             CCCC-ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------h
Q 041689          577 GEDQ-SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------F  630 (652)
Q Consensus       577 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~  630 (652)
                      .... ........++..|+|||.+.+..++.++||||+||++|||++|+.||..                         .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            2111 1111234578899999999888899999999999999999999999642                         2


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++ +||..+|++||+++||
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~ei  258 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEEL  258 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHH
Confidence            45666 6888999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.8e-36  Score=299.04  Aligned_cols=222  Identities=22%  Similarity=0.290  Sum_probs=193.5

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|+||.||.++.. +++.|++|.+...  .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999854 6889999998654  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++... ...+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--  155 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--  155 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc--
Confidence            9999999998765 34689999999999999999999999   99999999999999999999999999998653222  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~  637 (652)
                      .......+++.|+|||+..+..++.++||||||+++|||++|+.||.                        ..+.+++.+
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence            12234468899999999988888999999999999999999988843                        347889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||+++|+
T Consensus       236 ~l~~~p~~R~s~~~l  250 (256)
T cd08221         236 LLQQDPEKRPTADEV  250 (256)
T ss_pred             HcccCcccCCCHHHH
Confidence            999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-36  Score=306.94  Aligned_cols=221  Identities=23%  Similarity=0.331  Sum_probs=189.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.. .......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888899999999999999875 6899999998754 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSS--NCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++++|..++...  ...+++..+..++.|++.|+.|||+ .   +|+||||||+||+++.++.+||+|||.+...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988764  2268999999999999999999996 5   8999999999999999999999999998754221 


Q ss_pred             CccccccccCCccccCccccccCc------cCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGR------VFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                         ......++..|+|||.+.+..      ++.++||||+||++|||++|+.||..                        
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence               122345788899999875543      47899999999999999999999632                        


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||..+|++||+++||
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l  259 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQL  259 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHH
Confidence               25688999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=302.20  Aligned_cols=221  Identities=23%  Similarity=0.297  Sum_probs=194.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .+.|+.-+.||+|+||+||-|+.+ +|+-||+|.+.+..   .........|..+++++..+.||.+-..|++.+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356788899999999999999865 69999999885442   22344567899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          500 LEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      +..|.||+|.-+++..+. .+++..+.-++.+|+.||++||..   +||.||+||+|||+|+.|+++|+|.|+|..+.. 
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~-  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE-  339 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence            999999999998887653 699999999999999999999999   999999999999999999999999999998732 


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC---------------------------cchhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ---------------------------CVSFV  631 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p---------------------------~~~~l  631 (652)
                        .......+||.+|||||++.++.|+..+|.||+||++|||+.|+.|                           |+.+.
T Consensus       340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA  417 (591)
T ss_pred             --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence              3334556899999999999999999999999999999999999999                           44557


Q ss_pred             hhhhcccchhhhccccCcc
Q 041689          632 FNLAMECTIESLELRINAK  650 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~  650 (652)
                      +++.+..|..||++|-...
T Consensus       418 kslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHHccCHHHhccCC
Confidence            8888889999999986543

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-36  Score=303.59  Aligned_cols=218  Identities=23%  Similarity=0.316  Sum_probs=175.3

Q ss_pred             ceeccccceEEEEEEeCC---CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIGD---GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999997433   4568888775442 234456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          507 SLEKCLYSSNC----ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       507 ~L~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +|.+++.....    ..++.....++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999876432    345677889999999999999999   99999999999999999999999999987542221111


Q ss_pred             ccccccCCccccCcccccc-------CccCcccchhhHHHHHHHHHh-CCCCcchh------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-------GRVFANGDVYSFGIMLMEIHS-AKQQCVSF------------------------  630 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~~------------------------  630 (652)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||...                        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence            1223345678999998643       356789999999999999999 77774321                        


Q ss_pred             -----hhhhhcccchhhhccccCccCC
Q 041689          631 -----VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -----l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           ..+++..|| .||++|||++||
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v  263 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEV  263 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHH
Confidence                 455777888 599999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.8e-36  Score=300.19  Aligned_cols=217  Identities=30%  Similarity=0.406  Sum_probs=186.3

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeee-cCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS-NEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  503 (652)
                      .+|.+.+.||+|+||.||+|.. .|..||+|.++...  ..+.+.+|+.++++++|++++++++++. .++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4688889999999999999976 47889999986442  3467889999999999999999999764 556789999999


Q ss_pred             CCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++|.+++..... .+++..+..++.|++.||+|||++   |++||||||+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----  155 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence            99999999876543 478899999999999999999999   9999999999999999999999999998754221    


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                       .....++..|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.+++.+
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05082         156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence             122334567999999988899999999999999999997 888753                        237889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++|||+.|+
T Consensus       235 ~l~~~p~~Rpt~~~l  249 (256)
T cd05082         235 CWHLDAATRPSFLQL  249 (256)
T ss_pred             HhcCChhhCcCHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-36  Score=309.81  Aligned_cols=225  Identities=26%  Similarity=0.416  Sum_probs=187.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCc----EEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ..+|+..+.||+|+||.||+|.+. ++.    .||+|.+..... .....+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            346788899999999999999854 343    478888865432 2344688899999999999999999998754 467


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +++||+++|++.+++......+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999999999887665789999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~  632 (652)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||..                        .+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY  241 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            222222223345778999999988899999999999999999997 8888643                        257


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++||+++||
T Consensus       242 ~li~~c~~~~p~~Rp~~~~l  261 (303)
T cd05110         242 MVMVKCWMIDADSRPKFKEL  261 (303)
T ss_pred             HHHHHHcCCChhhCcCHHHH
Confidence            78999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.2e-36  Score=309.38  Aligned_cols=218  Identities=24%  Similarity=0.295  Sum_probs=189.4

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      .....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33457999999999999864 68999999997654445567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                      +|..++...  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......  ......
T Consensus       104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~  176 (297)
T cd06659         104 ALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS  176 (297)
T ss_pred             CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccc
Confidence            999977653  488999999999999999999999   9999999999999999999999999998754221  112233


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhcccch
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAMECTI  640 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~~~l~  640 (652)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.                          ..+.+++.+||+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence            568899999999988889999999999999999999999852                          236889999999


Q ss_pred             hhhccccCccCC
Q 041689          641 ESLELRINAKEI  652 (652)
Q Consensus       641 ~~p~~Rpt~~ei  652 (652)
                      .+|++||+++||
T Consensus       257 ~~P~~Rps~~~l  268 (297)
T cd06659         257 REPQERATAQEL  268 (297)
T ss_pred             CCcccCcCHHHH
Confidence            999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=311.56  Aligned_cols=225  Identities=24%  Similarity=0.301  Sum_probs=200.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ......|.+...||+|.|++|..|++. ++..||+|.+++..  ....+.+.+|+++|+.++|||||+++++.+.....|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            344567899999999999999999865 69999999997653  233455889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+.+|.+++|+...+ +..+..+..++.|+.+|++|+|++   .|||||||++||+++.+..+||+|||++..+. 
T Consensus       132 lV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence            9999999999999999877 556688899999999999999999   99999999999999999999999999999873 


Q ss_pred             CCCccccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcchh-----------------------hhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFN  633 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~  633 (652)
                        ........+|++.|.|||++.+.+|+ +++|+||+|+++|.|+.|..||+..                       .++
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~  284 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCED  284 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHH
Confidence              33444567899999999999988875 8899999999999999999998854                       588


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+++..+|.+|+++++|
T Consensus       285 lLrk~lvl~Pskr~~~dqi  303 (596)
T KOG0586|consen  285 LLRKFLVLNPSKRGPCDQI  303 (596)
T ss_pred             HHHHhhccCccccCCHHHh
Confidence            9999999999999999875

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-36  Score=306.58  Aligned_cols=220  Identities=24%  Similarity=0.327  Sum_probs=190.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999865 57889999987442 344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++...  .+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++......  ...
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc--chh
Confidence            999999988653  588899999999999999999999   9999999999999999999999999998765321  112


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAMECT  639 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~~l  639 (652)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.|+.                        ..+.+++.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            223457889999999998889999999999999999999999853                        23788999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.+|++||++.||
T Consensus       238 ~~~p~~Rp~~~~i  250 (277)
T cd06642         238 NKDPRFRPTAKEL  250 (277)
T ss_pred             cCCcccCcCHHHH
Confidence            9999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5e-36  Score=301.09  Aligned_cols=219  Identities=24%  Similarity=0.393  Sum_probs=180.9

Q ss_pred             ceeccccceEEEEEEeC----CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeee-cCCceEEEEEccC
Q 041689          431 NLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCS-NEEFKELVLEHMP  504 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  504 (652)
                      +.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2457999988543 2334567888999999999999999999765 4566889999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc--c
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS--M  582 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~  582 (652)
                      +|+|.+++.......++..+..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999876655677888889999999999999999   9999999999999999999999999998754322111  1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhC-CCCc------------------------chhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA-KQQC------------------------VSFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~------------------------~~~l~~l~~~  637 (652)
                      ......++..|+|||.+....++.++|||||||++|||++| .+||                        +..+.+++.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            11223456789999999888999999999999999999995 4443                        3457899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++.||
T Consensus       238 cl~~~p~~Rp~~~~i  252 (262)
T cd05058         238 CWHPKPEMRPTFSEL  252 (262)
T ss_pred             HcCCChhhCCCHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-36  Score=301.66  Aligned_cols=216  Identities=29%  Similarity=0.460  Sum_probs=180.8

Q ss_pred             ceeccccceEEEEEEeCC-Cc--EEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIGD-GM--EVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|+..+ +.  .+|+|.++.. .....+.+..|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998653 43  4688888643 233456788999999999 799999999999999999999999999


Q ss_pred             CChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          506 GSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       506 g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      |+|.+++....               ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999986532               2478889999999999999999998   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------------  628 (652)
                      ++....   ..........+..|+|||++....++.++|||||||++|||++ |..||.                     
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            986321   1111112234567999999988889999999999999999997 888853                     


Q ss_pred             ---hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         ..+.+++.+||..+|.+|||+.||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~i  261 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQI  261 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHH
Confidence               237789999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.4e-36  Score=298.91  Aligned_cols=222  Identities=29%  Similarity=0.502  Sum_probs=191.0

Q ss_pred             CCccceeccccceEEEEEEeCC-----CcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          427 FNENNLIGKGGFGTIYKSRIGD-----GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      +++.+.||+|+||.||+|+..+     +..||+|+++..... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998653     378999999765433 5678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||+++++|.+++...... +++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999998765543 89999999999999999999999   99999999999999999999999999998654321


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNL  634 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l  634 (652)
                      ... .....+++.|+|||...+..++.++||||+|+++|||++ |+.||.                        ..+.++
T Consensus       158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            111 112336788999999988889999999999999999998 777753                        347889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.+|++|||+.|+
T Consensus       237 i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      237 MLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             HHHHCcCChhhCcCHHHH
Confidence            999999999999999874

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5e-36  Score=312.13  Aligned_cols=225  Identities=24%  Similarity=0.355  Sum_probs=187.6

Q ss_pred             cCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      .+|.+.+.||+|+||.||+|+..        .+..||+|.++... ....+.+.+|+++++++ +||||+++++++..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999742        12368999887542 33456788999999999 7999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD  559 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~  559 (652)
                      ..+++|||+++|+|.+++....               ..+++.++..++.|++.||+|||++   |++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence            9999999999999999986532               2477888999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch---------
Q 041689          560 DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS---------  629 (652)
Q Consensus       560 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~---------  629 (652)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..         
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999986532221111222334567999999999999999999999999999998 7777432         


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||..+|++|||+.||
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~el  286 (334)
T cd05100         249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL  286 (334)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence                           36789999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.1e-36  Score=306.01  Aligned_cols=232  Identities=25%  Similarity=0.311  Sum_probs=193.1

Q ss_pred             ccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeec
Q 041689          415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSN  492 (652)
Q Consensus       415 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  492 (652)
                      ++..++..++++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455666677889999999999999999999864 68899999986432 2345678899999999 89999999999864


Q ss_pred             C-----CceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          493 E-----EFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       493 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      .     +..++||||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998753   233688999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccC-----ccCcccchhhHHHHHHHHHhCCCCcch----------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-----RVFANGDVYSFGIMLMEIHSAKQQCVS----------  629 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~----------  629 (652)
                      ||+|||.+.......  .......++..|+|||.+...     .++.++|||||||++|||++|+.||..          
T Consensus       168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            999999987653211  112234578899999987644     367899999999999999999998532          


Q ss_pred             ----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                      .+.+++.+||..+|++||++.||
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  284 (291)
T cd06639         246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL  284 (291)
T ss_pred             hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence                            25679999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8e-36  Score=298.55  Aligned_cols=222  Identities=20%  Similarity=0.293  Sum_probs=192.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|+||.||.++.. +|+.||+|.+...  .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999854 6889999998643  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... ..+++.++..++.|++.|+.|||++   +++|+||+|+||+++.++.++++|||.+......  .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~--~  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST--V  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc--h
Confidence            99999999887643 3578899999999999999999999   9999999999999999999999999999765221  1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~  637 (652)
                      .......+++.|+|||+..+..++.++|+|||||++|+|++|+.||.                        ..+.+++.+
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence            11223457888999999988889999999999999999999998853                        347899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.+|++||++.||
T Consensus       236 ~l~~~p~~Rp~~~~v  250 (256)
T cd08218         236 LFKRNPRDRPSVNSI  250 (256)
T ss_pred             HhhCChhhCcCHHHH
Confidence            999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-36  Score=308.22  Aligned_cols=222  Identities=25%  Similarity=0.343  Sum_probs=189.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999875 589999998864322  234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++++.++..... .+++.++..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            999998888765443 589999999999999999999999   99999999999999999999999999988653222  


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......++..|+|||+..+ ..++.++|||||||++|||++|++||.                                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22233457889999998765 347789999999999999999988762                                


Q ss_pred             ----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            ..+.+++.+||..+|++||+++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence                                  236789999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-37  Score=316.17  Aligned_cols=214  Identities=24%  Similarity=0.385  Sum_probs=185.4

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeec----ccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc--eEEEEEcc
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHL----QCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF--KELVLEHM  503 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~  503 (652)
                      ..||+|+|-+||+|.+. +|.+||--.++.    +.....++|..|+++|+.++||||+++|++|.+...  ..+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            57999999999999865 588887544432    234556889999999999999999999999987654  67899999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ..|+|+.|.++.+ ..+...+..|++||++||.|||++ .|+|||||||-+||||+ ..|.|||+|.|+|+...    ..
T Consensus       126 TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----~s  199 (632)
T KOG0584|consen  126 TSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----KS  199 (632)
T ss_pred             cCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh----cc
Confidence            9999999999877 688889999999999999999997 67899999999999997 67999999999999762    22


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAM  636 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~  636 (652)
                      ......|||.|||||++. ..|+..+||||||++|.||+|+.+|++.                          +++++|.
T Consensus       200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe  278 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE  278 (632)
T ss_pred             ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence            233478999999999876 7899999999999999999999999544                          3899999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +|+.. ..+|||+.|+
T Consensus       279 kCl~~-~~~R~sa~eL  293 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKEL  293 (632)
T ss_pred             HHhcC-chhccCHHHH
Confidence            99999 9999999874

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=316.34  Aligned_cols=220  Identities=22%  Similarity=0.382  Sum_probs=191.3

Q ss_pred             ccceeccccceEEEEEEeCC--C--cEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          429 ENNLIGKGGFGTIYKSRIGD--G--MEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..++||+|.||+|++|.|..  |  ..||||+++..... ...+|.+|+.+|.+++|||++++||...+ ....+|||.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            34789999999999998752  4  45899999876433 67899999999999999999999999887 6678999999


Q ss_pred             CCCChhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +.|+|.+.+.. ....+.......++.|||.|+.||..+   +.|||||...|+++.....+||+|||+.+.+...+...
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            99999999987 444788888899999999999999999   99999999999999999999999999999876555444


Q ss_pred             cc-ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------------cchhhhhhhc
Q 041689          583 TQ-TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------------CVSFVFNLAM  636 (652)
Q Consensus       583 ~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------------~~~~l~~l~~  636 (652)
                      .. ....-...|+|||.+..+.++.++|||+|||++|||+| |..|                        |+.+++++++
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk  349 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMK  349 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHH
Confidence            33 23345678999999999999999999999999999998 4444                        6667999999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..+|++||||.+|
T Consensus       350 ~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  350 NCWAHNPADRPTFSAI  365 (1039)
T ss_pred             HhccCCccccccHHHH
Confidence            9999999999999764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=310.95  Aligned_cols=225  Identities=26%  Similarity=0.407  Sum_probs=194.2

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...+.....+||-|.||.||.|.|+. .-.||||.++.+. ...++|.+|+.+|+.++|||+|+++|+|..+..+|||.|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456677899999999999999875 6679999997653 456889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||..|+|.+|+++... .++....+.++.||+.|++||..+   ++|||||...|.|+.++..+|++|||+++.+..+ .
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-T  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-T  419 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC-c
Confidence            9999999999987554 456666778999999999999999   9999999999999999999999999999987432 2


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC------------------------cchhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ------------------------CVSFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p------------------------~~~~l~~l~  635 (652)
                      ........-...|.|||-+....++.|+|||+|||++||+.| |..|                        |+..++++|
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM  499 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence            222222334567999999999999999999999999999987 5555                        666699999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      ..||++.|.+||+|+||
T Consensus       500 raCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHhcCCcccCccHHHH
Confidence            99999999999999885

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.9e-36  Score=304.01  Aligned_cols=214  Identities=26%  Similarity=0.281  Sum_probs=189.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999865 58999999986542   234567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||+.   |++||||+|+||++++++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987664 689999999999999999999999   9999999999999999999999999999865322  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~  637 (652)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.                       ..+.+++.+
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  231 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN  231 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence               233458899999999988888999999999999999999999953                       236789999


Q ss_pred             cchhhhcccc
Q 041689          638 CTIESLELRI  647 (652)
Q Consensus       638 ~l~~~p~~Rp  647 (652)
                      ||..||.+||
T Consensus       232 ~l~~~p~~R~  241 (290)
T cd05580         232 LLQVDLTKRL  241 (290)
T ss_pred             HccCCHHHcc
Confidence            9999999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-35  Score=299.28  Aligned_cols=223  Identities=23%  Similarity=0.336  Sum_probs=187.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  496 (652)
                      .+|++.+.||+|+||.||.|... ++..||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999865 58999999886331     12345788899999999999999999988764  467


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 578888999999999999999999   99999999999999999999999999987543


Q ss_pred             CCCCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------h
Q 041689          577 GEDQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------F  630 (652)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~  630 (652)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||..                         .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence            21111 112234588899999999888899999999999999999999999632                         2


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+|+. +|++||+++||
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~i  258 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADEL  258 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHH
Confidence            5678999985 99999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-36  Score=303.30  Aligned_cols=219  Identities=28%  Similarity=0.458  Sum_probs=184.1

Q ss_pred             ceeccccceEEEEEEeCC-------CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRIGD-------GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +.||+|+||.||+|+..+       +..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998542       2579999886542 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-----cEEEecccC
Q 041689          503 MPHGSLEKCLYSS------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-----VAHLSDFGI  571 (652)
Q Consensus       503 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-----~~kl~Dfg~  571 (652)
                      +++++|.+++...      ...+++.++..++.|++.|++|||+.   +++|+||||+||++++++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      22478889999999999999999998   999999999999999877     899999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch---------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS---------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~---------------------  629 (652)
                      ++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..                     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            876532222122223345678999999999999999999999999999998 8888532                     


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||+.+|++||++++|
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i  263 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRI  263 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHH
Confidence               37899999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-36  Score=305.16  Aligned_cols=221  Identities=24%  Similarity=0.326  Sum_probs=192.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999865 58899999886543 34457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++...+ .+++..+..++.|++.|+.|||+.+  +++||||||+||++++++.++|+|||++......    
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----  157 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence            99999999887644 6889999999999999999999632  8999999999999999999999999998654211    


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------------  629 (652)
                      ......++..|+|||++.++.++.++|||||||++|+|++|+.||+.                                 
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence            12234688999999999888999999999999999999999999742                                 


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||+.||++|||++||
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~  263 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQL  263 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHH
Confidence               25679999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-35  Score=299.57  Aligned_cols=225  Identities=24%  Similarity=0.301  Sum_probs=194.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999854 68899999986442 33557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      +++++|.+++....  ..+++..+..++.|++.|++|||+.   |++||||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987542  3688999999999999999999999   999999999999999999999999999887643322


Q ss_pred             cc--ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-----------------------------
Q 041689          581 SM--TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-----------------------------  628 (652)
Q Consensus       581 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-----------------------------  628 (652)
                      ..  ......++..|+|||++... .++.++|+|||||++|||++|+.||.                             
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS  237 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence            21  12334588899999998776 78899999999999999999999964                             


Q ss_pred             hhhhhhhcccchhhhccccCccCC
Q 041689          629 SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ..+.+++.+||..||++||+++||
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~l  261 (267)
T cd06610         238 KSFRKMISLCLQKDPSKRPTAEEL  261 (267)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHH
Confidence            235789999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.2e-36  Score=304.71  Aligned_cols=225  Identities=25%  Similarity=0.385  Sum_probs=191.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-----CCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-----DGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  496 (652)
                      .+|...+.||+|+||.||+|+..     ++..||+|+++..... ..+.+.+|++++++++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35777899999999999999853     3788999999765432 46789999999999999999999999877  5578


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987665789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          577 GEDQSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       577 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      ....... .....++..|+|||...+..++.++||||||+++|||++|+.|+.                           
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2221111 112234567999999988899999999999999999999988743                           


Q ss_pred             ------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                  ..+.+++.+||+.+|++|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL  276 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence                        236689999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-36  Score=298.11  Aligned_cols=220  Identities=25%  Similarity=0.351  Sum_probs=191.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      +|+..+.||+|+||.||+|... +++.||+|.+....     ....+.+..|++++++++|+||+++++++..++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 78999999986542     23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987654 588999999999999999999999   99999999999999999999999999987653221


Q ss_pred             CccccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFN  633 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~  633 (652)
                         ......++..|+|||.+.... ++.++|+|||||++|+|++|+.||..                         .+.+
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence               223455888999999987766 89999999999999999999998532                         2677


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.+|++||++.|+
T Consensus       234 li~~~l~~~p~~Rp~~~~~  252 (258)
T cd06632         234 FILKCLQRDPSLRPTAAEL  252 (258)
T ss_pred             HHHHHhhcCcccCcCHHHH
Confidence            8999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3e-36  Score=303.21  Aligned_cols=221  Identities=25%  Similarity=0.309  Sum_probs=193.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778899999999999999876 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++......+++..+..++.|++.|++|+|+ .   +++|+||||+||++++++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            99999999998764578999999999999999999999 7   99999999999999999999999999987552211  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------------hh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------FV  631 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------~l  631 (652)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..                              .+
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              1125678899999999888999999999999999999999988632                              26


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||..+|++|||+.||
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~l  254 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKEL  254 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHH
Confidence            779999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.2e-36  Score=304.58  Aligned_cols=221  Identities=27%  Similarity=0.336  Sum_probs=193.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999854 68899999987554455577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++...  .+++.++..++.|++.|+.|||+.   |++||||||+||+++.++.+||+|||++.......  ..
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~  171 (293)
T cd06647          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  171 (293)
T ss_pred             CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc--cc
Confidence            999999998754  478889999999999999999999   99999999999999999999999999887553221  12


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      .....+++.|+|||.+....++.++|||||||++|++++|+.||..                          .+.+++.+
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence            2234588899999999888899999999999999999999998642                          26789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..+|++||++.||
T Consensus       252 ~l~~~p~~Rp~~~~i  266 (293)
T cd06647         252 CLEMDVEKRGSAKEL  266 (293)
T ss_pred             HccCChhhCcCHHHH
Confidence            999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.7e-36  Score=306.23  Aligned_cols=221  Identities=24%  Similarity=0.317  Sum_probs=188.0

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch-----hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR-----AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      +|+..+.||+|+||.||+|... +++.||+|.++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999865 6899999999754322     334567899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+ +++|.+++......+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 8899999876554689999999999999999999999   99999999999999999999999999998653221


Q ss_pred             CccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV------------------------------  628 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~------------------------------  628 (652)
                        .......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.                              
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence              12223346788999998754 457889999999999999999977642                              


Q ss_pred             ---------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           ..+.+++.+||+.||++|||++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~  279 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA  279 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence                                 235578999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.6e-36  Score=299.60  Aligned_cols=211  Identities=26%  Similarity=0.375  Sum_probs=179.7

Q ss_pred             ceeccccceEEEEEEeCC-C----------cEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          431 NLIGKGGFGTIYKSRIGD-G----------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      +.||+|+||.||+|...+ +          ..|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999998754 3          25788877654332 6788899999999999999999999888 778999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-------cEEEecccCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-------VAHLSDFGIT  572 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-------~~kl~Dfg~~  572 (652)
                      |||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987665789999999999999999999999   999999999999999887       7999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccC--ccCcccchhhHHHHHHHHHhC-CCCcc---------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREG--RVFANGDVYSFGIMLMEIHSA-KQQCV---------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg-~~p~~---------------------  628 (652)
                      .....      .....++..|+|||++...  .++.++|||||||++|||++| ..|+.                     
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD  229 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence            86422      2234467789999998876  788999999999999999994 65531                     


Q ss_pred             -hhhhhhhcccchhhhccccCccCC
Q 041689          629 -SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       ..+.+++.+||..+|++|||+.||
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~i  254 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAI  254 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHH
Confidence             246789999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-35  Score=303.86  Aligned_cols=222  Identities=23%  Similarity=0.266  Sum_probs=189.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|...+.||+|+||.||+|... +++.||+|.+....   ......+.+|+++++.++||||+++++.+..+++.++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999865 58899999987553   223456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC-
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED-  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-  579 (652)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999987654 688899999999999999999999   99999999999999999999999999986421000 


Q ss_pred             ------------CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          580 ------------QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       580 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                                  .........++..|+|||.+.+..++.++|+|||||++|||++|+.||.                   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                        0001112357888999999988889999999999999999999998853                   


Q ss_pred             -------hhhhhhhcccchhhhccccCcc
Q 041689          629 -------SFVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       629 -------~~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                             ..+.+++.+||+.+|++||++.
T Consensus       237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~  265 (305)
T cd05609         237 EGDEALPADAQDLISRLLRQNPLERLGTG  265 (305)
T ss_pred             CccccCCHHHHHHHHHHhccChhhccCcc
Confidence                   2378899999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-35  Score=300.07  Aligned_cols=223  Identities=26%  Similarity=0.382  Sum_probs=189.2

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc----------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG----------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEE  494 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  494 (652)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+..|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999854 689999998863211          12346778999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++++|||.++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987764 688999999999999999999999   999999999999999999999999999976


Q ss_pred             ccCCCCccccccccCCccccCccccccCc--cCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGR--VFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      ..............++..|+|||.+....  ++.++|+||||+++||+++|..||.                        
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            43221111223345788999999987654  7899999999999999999999853                        


Q ss_pred             -----hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           ..+.+++.+||..+|++|||++||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~i  266 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTAREL  266 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence                 236789999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=289.38  Aligned_cols=218  Identities=21%  Similarity=0.219  Sum_probs=192.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|+..+.+|+|.||+|-+|+.+ +++.||+|+++++.-   .....-..|-++++..+||.+..+...|...+..|.||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56888899999999999999855 699999999987632   23344567999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+.||.|.-++...+ .+++....-+..+|+.||.|||++   +||.||+|.+|.++|.+|++||+|||+++.-  -..
T Consensus       248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKY  321 (516)
T ss_pred             EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc--ccc
Confidence            9999999988887655 688888888999999999999999   9999999999999999999999999999853  233


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      .......+|||.|.|||++....|+.++|.|.+|||||||+.|+.||-.                       +.+.++..
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence            4456778999999999999999999999999999999999999999533                       36778888


Q ss_pred             cchhhhccccC
Q 041689          638 CTIESLELRIN  648 (652)
Q Consensus       638 ~l~~~p~~Rpt  648 (652)
                      .+.+||.+|-.
T Consensus       402 LL~kdP~kRLG  412 (516)
T KOG0690|consen  402 LLKKDPKKRLG  412 (516)
T ss_pred             HhhcChHhhcC
Confidence            99999999953

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=292.05  Aligned_cols=223  Identities=26%  Similarity=0.393  Sum_probs=183.0

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc--CCCeeeeEEeeeecCC----
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI--HYRNLVKIISSCSNEE----  494 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----  494 (652)
                      .....+....+.||+|.||+||+|++ .|+.||||+|...   ++..+.+|.+|++.+  +|+||..+++.-..+.    
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             HhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            33445677889999999999999999 5899999999743   456788899988865  9999999998765442    


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN-----FLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      ..|+|.+|.+.|||.+|+...  .++....++++..+|.||+|||..     .+|.|.|||||..|||+.+++.+-|+|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            568999999999999999885  589999999999999999999954     4688999999999999999999999999


Q ss_pred             cCCccccCCC--CccccccccCCccccCccccccC------ccCcccchhhHHHHHHHHHhC----------CCCcch--
Q 041689          570 GITKLLIGED--QSMTQTQTLATIGYIAPEYGREG------RVFANGDVYSFGIMLMEIHSA----------KQQCVS--  629 (652)
Q Consensus       570 g~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg----------~~p~~~--  629 (652)
                      |+|.......  ........+||.+|||||++.+.      .....+||||||.|+||++.+          +.||.+  
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998764432  23345677899999999998654      223568999999999999752          123111  


Q ss_pred             ---------------------------------hhhhhhcccchhhhccccCc
Q 041689          630 ---------------------------------FVFNLAMECTIESLELRINA  649 (652)
Q Consensus       630 ---------------------------------~l~~l~~~~l~~~p~~Rpt~  649 (652)
                                                       .+.++|+.||..+|..|-||
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA  493 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA  493 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence                                             16789999999999999876

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-36  Score=302.12  Aligned_cols=225  Identities=26%  Similarity=0.321  Sum_probs=190.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC-----
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE-----  494 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----  494 (652)
                      .++++|++.+.||+|++|.||+|... +++.||+|++..... ..+.+.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999875 578999999875532 346789999999999 7999999999986544     


Q ss_pred             -ceEEEEEccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          495 -FKELVLEHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       495 -~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                       ..++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             489999999999999987643   24789999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcch----------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCVS----------------  629 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~----------------  629 (652)
                      .+.....  .........++..|+|||++..     ..++.++|||||||++|+|++|+.||..                
T Consensus       159 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         159 VSAQLDS--TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             cceeccc--chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            9876422  1122234458889999998753     3467889999999999999999999642                


Q ss_pred             ----------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                .+.+++.+||..||++|||++||
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l  269 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEEL  269 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence                      36799999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-36  Score=304.23  Aligned_cols=223  Identities=23%  Similarity=0.293  Sum_probs=191.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999865 5889999998653  22345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++.+..+.... ..+++.++..++.|++.|+.|||+.   +++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99987776655443 3689999999999999999999999   999999999999999999999999999887643221 


Q ss_pred             cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.                                
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122335578889999999888 78899999999999999999987753                                


Q ss_pred             -----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             ..+.+++++||..+|++||++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  282 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL  282 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHH
Confidence                                   336789999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.9e-36  Score=304.20  Aligned_cols=222  Identities=23%  Similarity=0.259  Sum_probs=188.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  499 (652)
                      ++|++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.++++++||||+++++++...  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999876 588999999975432  2234567899999999999999999998877  889999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++ +|.+++......+++.++..++.|++.||+|||++   +++||||||+||++++++.+||+|||.+.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 99988876655689999999999999999999999   99999999999999999999999999988653321


Q ss_pred             CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV------------------------------  628 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~------------------------------  628 (652)
                        .......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.                              
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              122334578889999988654 46889999999999999999988752                              


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+||+.+|++|||++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el  287 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA  287 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence                                     336689999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-35  Score=300.89  Aligned_cols=224  Identities=21%  Similarity=0.348  Sum_probs=190.3

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .+|++.+.||+|+||.||+|+.+      +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999853      2467999988655433 4567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          498 LVLEHMPHGSLEKCLYSSN--------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987543        1588999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc---------------------
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC---------------------  627 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~---------------------  627 (652)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||                     
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            9987542211 112223346778999999888888999999999999999998 66664                     


Q ss_pred             ----chhhhhhhcccchhhhccccCccCC
Q 041689          628 ----VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ----~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          +..+.+++.+||+.+|++|||+.||
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~  269 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSEL  269 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                2347899999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-35  Score=297.47  Aligned_cols=222  Identities=26%  Similarity=0.333  Sum_probs=195.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++..... .....+..|++.+++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999876 599999999876543 4467889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++.... .+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--  154 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--  154 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence            99999999987653 68999999999999999999999 8   99999999999999999999999999998653222  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------SFVFN  633 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------~~l~~  633 (652)
                      .......++..|+|||.+....++.++|+||||+++|+|++|+.||.                            ..+.+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            11123457889999999998889999999999999999999998853                            23788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..+|++||++.||
T Consensus       235 li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         235 FISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             HHHHHccCChhhCCCHHHH
Confidence            9999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.3e-35  Score=293.96  Aligned_cols=221  Identities=30%  Similarity=0.394  Sum_probs=196.5

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      +|+..+.||+|++|.||+|... ++..|++|++..........+.+|++++++++||+++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999875 688999999976655566788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++......+++..+..++.|++.|++|||..   +++||||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            9999999887655789999999999999999999998   999999999999999999999999999886532221   2


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAMEC  638 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~~~  638 (652)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.                          ..+.+++.+|
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHH
Confidence            34567889999999988889999999999999999999998853                          3378999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||+.|+
T Consensus       235 l~~~p~~R~t~~~~  248 (253)
T cd05122         235 LQKNPEKRPTAEQL  248 (253)
T ss_pred             ccCChhhCCCHHHH
Confidence            99999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-35  Score=296.87  Aligned_cols=223  Identities=27%  Similarity=0.373  Sum_probs=193.4

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|...+.||+|+||.||+|... +++.||+|.++....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999864 689999999976543  3567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++.... .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987654 578889999999999999999999   99999999999999999999999999988653322211


Q ss_pred             c--cccccCCccccCccccccCc---cCcccchhhHHHHHHHHHhCCCCcc---------------------------hh
Q 041689          583 T--QTQTLATIGYIAPEYGREGR---VFANGDVYSFGIMLMEIHSAKQQCV---------------------------SF  630 (652)
Q Consensus       583 ~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~---------------------------~~  630 (652)
                      .  .....++..|+|||++....   ++.++||||||+++|||++|+.||.                           ..
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence            1  11345788999999988766   8899999999999999999999973                           23


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.+|++|||+.||
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i  258 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASEL  258 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHH
Confidence            5789999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.9e-35  Score=295.65  Aligned_cols=221  Identities=24%  Similarity=0.377  Sum_probs=190.8

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|+||.||+|... +++.||+|.+...  .......+..|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888899999999999999864 6889999998654  233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~  580 (652)
                      +++++|.+++.... ..+++..+..++.|++.|++|||++   +++||||||+||+++++ +.+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997643 3588999999999999999999999   99999999999999854 568999999998653221 


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~  636 (652)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.                        ..+.+++.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence              1223457889999999988889999999999999999999988853                        23788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..+|++|||+.||
T Consensus       235 ~~l~~~p~~Rpt~~~l  250 (256)
T cd08220         235 SMLNLDPSKRPQLSQI  250 (256)
T ss_pred             HHccCChhhCCCHHHH
Confidence            9999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-35  Score=302.50  Aligned_cols=221  Identities=25%  Similarity=0.316  Sum_probs=186.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|+..+.||+|++|.||+|+.. +++.||||.++...  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999865 68999999986442  22335788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +. +++.+++.... ..+++..+..++.|++.||+|||..   +++||||+|+||++++++.+||+|||.+.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 58888876533 3688999999999999999999999   99999999999999999999999999987552211  


Q ss_pred             cccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......++..|+|||++.+.. ++.++|||||||++|||+||+.||.                                
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            1122334678899999876644 5888999999999999999998762                                


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+||+.||++|||++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  278 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA  278 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence                                234579999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=305.98  Aligned_cols=221  Identities=26%  Similarity=0.308  Sum_probs=190.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|+..+.||+|+||.||+|... +++.||+|.+.....   ...+.+..|++++++++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999875 489999999975432   24557888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999887543 3689999999999999999999999   99999999999999999999999999987542211


Q ss_pred             Cc---------------------------cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----
Q 041689          580 QS---------------------------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----  628 (652)
Q Consensus       580 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----  628 (652)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           01112357889999999998889999999999999999999999962    


Q ss_pred             ---------------------hhhhhhhcccchhhhccccC
Q 041689          629 ---------------------SFVFNLAMECTIESLELRIN  648 (652)
Q Consensus       629 ---------------------~~l~~l~~~~l~~~p~~Rpt  648 (652)
                                           ..+.+++.+||..||++||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence                                 33789999999999999999

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-35  Score=298.24  Aligned_cols=223  Identities=25%  Similarity=0.365  Sum_probs=190.8

Q ss_pred             CCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 468999999986432      1235678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccccC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIG  577 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~  577 (652)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||++   |++|+||||+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987654 688999999999999999999999   999999999999998765 699999999876643


Q ss_pred             CCCc--cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          578 EDQS--MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       578 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.                           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            2111  11123457889999999988889999999999999999999999863                           


Q ss_pred             -hhhhhhhcccchhhhccccCccCC
Q 041689          629 -SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       ..+.+++.+||..+|++||++.|+
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~~~l  261 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPSREL  261 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHH
Confidence             225679999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.9e-35  Score=299.31  Aligned_cols=220  Identities=24%  Similarity=0.275  Sum_probs=191.2

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .|...+.||+|++|.||+|... +++.||+|+++.......+.+.+|+.++++++||||+++++++..++..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999854 688999999876544455678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++...  .+++.++..++.|++.|++|||++   +++||||+|+||+++.++.++|+|||.+.......  ...
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            99999988773  588999999999999999999999   99999999999999999999999999887542211  112


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAMEC  638 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~~~  638 (652)
                      ....++..|+|||...+..++.++|||||||++|||++|+.||.                          ..+.+++.+|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            23458889999999988889999999999999999999998852                          3478999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |..+|++||++.||
T Consensus       253 l~~~p~~Rpt~~~i  266 (285)
T cd06648         253 LVRDPAQRATAAEL  266 (285)
T ss_pred             cccChhhCcCHHHH
Confidence            99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-35  Score=300.09  Aligned_cols=224  Identities=27%  Similarity=0.332  Sum_probs=195.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ....|+..+.+|+|+||.||+|... ++..||+|++..... ..+.+..|++++++++|+||+++++++...+..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566888899999999999999876 688999999976543 45678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++......+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--  170 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--  170 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence            9999999999987654689999999999999999999998   99999999999999999999999999987543221  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLA  635 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~  635 (652)
                      .......++..|+|||++.+..++.++|||||||++|+|++|+.||.                          ..+.+++
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            11223347788999999988889999999999999999999998732                          3478899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.+|.+||++.||
T Consensus       251 ~~~l~~~p~~Rpt~~~i  267 (286)
T cd06614         251 NKCLVKDPEKRPSAEEL  267 (286)
T ss_pred             HHHhccChhhCcCHHHH
Confidence            99999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.8e-35  Score=302.92  Aligned_cols=218  Identities=25%  Similarity=0.303  Sum_probs=187.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..|...+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999865 68999999986432   233456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++ ++.+++......+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||++.....   
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---  167 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---  167 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence            99974 77777665555789999999999999999999999   999999999999999999999999999875421   


Q ss_pred             ccccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVF  632 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~  632 (652)
                         .....++..|+|||++.   .+.++.++||||||+++|||++|+.||.                         ..+.
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence               12345788899999874   4568899999999999999999998853                         2368


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.+|++||++.+|
T Consensus       245 ~li~~~l~~~p~~Rp~~~~i  264 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEEL  264 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHH
Confidence            89999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-35  Score=296.70  Aligned_cols=222  Identities=23%  Similarity=0.299  Sum_probs=190.0

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  500 (652)
                      +|++.+.||+|+||.||+|... +++.||+|.++..  .....+.+..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999854 6889999998643  23345678889999999999999999998754  45678999


Q ss_pred             EccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          501 EHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLH-----FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       501 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      ||+++++|.+++...   ...+++..++.++.|++.||+|||     +.   +++|+||||+||++++++.+||+|||.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988653   347899999999999999999999     66   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      .......  .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.                        
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd08217         158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS  235 (265)
T ss_pred             ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence            8653222  11233468899999999998889999999999999999999999864                        


Q ss_pred             hhhhhhhcccchhhhccccCccCC
Q 041689          629 SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ..+.+++.+|++.+|++||+++||
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~i  259 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEEL  259 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHH
Confidence            337889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-35  Score=299.54  Aligned_cols=222  Identities=26%  Similarity=0.350  Sum_probs=183.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHH-HHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEI-MKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++... ......+..|..+ ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999865 69999999987542 2233455556665 566789999999999999999999999


Q ss_pred             ccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |++ |+|.+++..   ....+++..+..++.|++.||+|||++.  +++||||||+||++++++.+||+|||.+..+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 588777653   2236899999999999999999999742  8999999999999999999999999998865221


Q ss_pred             CCccccccccCCccccCcccccc----CccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          579 DQSMTQTQTLATIGYIAPEYGRE----GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                         .......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||..                         
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence               11223457889999998765    4568899999999999999999998642                         


Q ss_pred             -hhhhhhcccchhhhccccCccCC
Q 041689          630 -FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       .+.+++.+||..+|++||+++||
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~i  258 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPEL  258 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHH
Confidence             26789999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-35  Score=305.01  Aligned_cols=224  Identities=25%  Similarity=0.267  Sum_probs=187.6

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  497 (652)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            4567999999999999999999865 689999999875422  2233566899999999999999999998755  5689


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++ +|.+++......+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|||.+.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99999975 88888876555789999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc----------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------  628 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~----------------------------  628 (652)
                      ..  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.                            
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            21  12223345788999998765 457899999999999999999998862                            


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ....+++.+|+..||++|||++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i  287 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA  287 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                                     224579999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-35  Score=297.28  Aligned_cols=219  Identities=25%  Similarity=0.356  Sum_probs=190.4

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      |+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            677889999999999999864 68899999986432 3345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++...  .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......  ...
T Consensus        86 ~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06641          86 GGSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence            99999988653  588999999999999999999999   99999999999999999999999999987653221  112


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhcccch
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAMECTI  640 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~~l~  640 (652)
                      ....++..|+|||...+..++.++|+|||||++|+|++|..|+.                        ..+.+++.+||.
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            23457888999999988888999999999999999999999963                        247889999999


Q ss_pred             hhhccccCccCC
Q 041689          641 ESLELRINAKEI  652 (652)
Q Consensus       641 ~~p~~Rpt~~ei  652 (652)
                      .+|++||+++|+
T Consensus       239 ~~p~~Rp~~~~~  250 (277)
T cd06641         239 KEPSFRPTAKEL  250 (277)
T ss_pred             CChhhCcCHHHH
Confidence            999999998874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-35  Score=297.08  Aligned_cols=218  Identities=22%  Similarity=0.309  Sum_probs=173.7

Q ss_pred             ceeccccceEEEEEEeCCC---cEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          431 NLIGKGGFGTIYKSRIGDG---MEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.||+|+||.||+|+..++   ..+++|.++... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999975433   345667665432 234568899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          507 SLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       507 ~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +|.+++....   ...++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999987542   2456677788999999999999999   999999999999999999999999999864322111112


Q ss_pred             cccccCCccccCcccccc-------CccCcccchhhHHHHHHHHHhC-CCCcc---------------------------
Q 041689          584 QTQTLATIGYIAPEYGRE-------GRVFANGDVYSFGIMLMEIHSA-KQQCV---------------------------  628 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltg-~~p~~---------------------------  628 (652)
                      .....++..|+|||++..       ..++.++|||||||++|||+++ ..||.                           
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            234457889999998743       2457889999999999999974 55642                           


Q ss_pred             --hhhhhhhcccchhhhccccCccCC
Q 041689          629 --SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        +.+.+++..|| .+|++||+++||
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i  262 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEV  262 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHH
Confidence              22556888899 679999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=298.01  Aligned_cols=220  Identities=24%  Similarity=0.382  Sum_probs=190.0

Q ss_pred             CCCccceeccccceEEEEEEe-CCCcEEEEEEeecc-cchhhhhHHHHHHHHHhcC---CCeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIH---YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.++.. .......+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999986 46899999998754 2334567889999999996   999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999988654  588999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             ccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVFNL  634 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~~l  634 (652)
                       .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.                         ..+.++
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHH
Confidence             222334688899999987654 46899999999999999999999852                         247889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||..||++||++.||
T Consensus       235 i~~~l~~~p~~R~~~~~i  252 (277)
T cd06917         235 VAACLDEEPKERLSAEEL  252 (277)
T ss_pred             HHHHcCCCcccCcCHHHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-35  Score=295.58  Aligned_cols=216  Identities=26%  Similarity=0.439  Sum_probs=185.3

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.++++++||||+++++++..++ .++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            4588899999999999999875 67889999986542  3467889999999999999999999987654 689999999


Q ss_pred             CCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          505 HGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       505 ~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +++|.+++..... .+++..+..++.|++.|+.|||+.   |++||||||+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            9999999876543 578899999999999999999999   9999999999999999999999999998753211     


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMEC  638 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~  638 (652)
                      ......+..|+|||.+.++.++.++|+|||||++|||++ |+.||.                        ..+.+++.+|
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence            112234567999999988899999999999999999997 888853                        2367899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.+|++||+++||
T Consensus       234 l~~~p~~Rp~~~~l  247 (254)
T cd05083         234 WETEPKKRPSFHKL  247 (254)
T ss_pred             cCCChhhCcCHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-35  Score=296.38  Aligned_cols=221  Identities=22%  Similarity=0.365  Sum_probs=187.8

Q ss_pred             CCCccceeccccceEEEEEEeCC--CcEEEEEEeecc----------cchhhhhHHHHHHHHHh-cCCCeeeeEEeeeec
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGD--GMEVAVKVFHLQ----------CGRAFKSFDIECEIMKS-IHYRNLVKIISSCSN  492 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  492 (652)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998754  688999988532          12233456778888865 799999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          493 EEFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|+.|||+ .   +++|+||||+||++++++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   33468899999999999999999996 5   899999999999999999999999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------  628 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------  628 (652)
                      ||.+.......   ......++..|+|||...++.++.++||||||+++|||++|+.||.                    
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP  234 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence            99998653221   2334568889999999998889999999999999999999999842                    


Q ss_pred             -----hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           ..+.+++.+||+.||++||++.|+
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~  263 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQV  263 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence                 347889999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=279.94  Aligned_cols=218  Identities=23%  Similarity=0.303  Sum_probs=185.0

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccC
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .....+|.|+.|.|++++.. +|..+|||.+... .....+++...+.++.+- +.|+||+.+|+|..+..+++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34567999999999999865 5889999999765 334556677777776655 48999999999999999999999985


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      . .++.+++....++++..+-++...++.||.||.+++  +|+|||+||+|||+|+.|.+|+||||.+..+.+   +...
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAh  248 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAH  248 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec---cccc
Confidence            4 667777766668999888899999999999999876  999999999999999999999999999987632   3344


Q ss_pred             ccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCC---------------------------cchhhhhh
Q 041689          585 TQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQ---------------------------CVSFVFNL  634 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p---------------------------~~~~l~~l  634 (652)
                      +...|.+.|||||.+.-   ..|+.++||||||++++|+.||+.|                           |++...++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence            55678999999998764   4789999999999999999999999                           55558899


Q ss_pred             hcccchhhhccccCccC
Q 041689          635 AMECTIESLELRINAKE  651 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~e  651 (652)
                      +..||++|+.+||...+
T Consensus       329 v~~CL~kd~r~RP~Y~~  345 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNK  345 (391)
T ss_pred             HHHHhhcCcccCcchHH
Confidence            99999999999997654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-35  Score=297.24  Aligned_cols=220  Identities=25%  Similarity=0.312  Sum_probs=193.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999875 58999999997542   2345788899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++... ..+++.++..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998766 3689999999999999999999999   99999999999999999999999999987653221  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLA  635 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~  635 (652)
                       ......++..|+|||.+....++.++|+||+|+++|+|++|+.||.                          ..+.+++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI  233 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence             2233457889999999988889999999999999999999999854                          3478899


Q ss_pred             cccchhhhccccCc--cCC
Q 041689          636 MECTIESLELRINA--KEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~--~ei  652 (652)
                      .+||+.||.+||++  +|+
T Consensus       234 ~~~l~~~p~~R~~~~~~~l  252 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDL  252 (258)
T ss_pred             HHHccCChhHcCCccHHHH
Confidence            99999999999999  653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=311.95  Aligned_cols=198  Identities=31%  Similarity=0.471  Sum_probs=169.6

Q ss_pred             CCccceeccccceEEEEEE-eCCCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------CceEE
Q 041689          427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------EFKEL  498 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  498 (652)
                      +...+.||+|+||.||+++ ..+|+.||||.++.. ..+..+..-+|++++++++|||||++++.-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445789999999999999 457999999999764 234556778999999999999999999986544      35679


Q ss_pred             EEEccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC----CCCcEEEecccCC
Q 041689          499 VLEHMPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD----DTMVAHLSDFGIT  572 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~----~~~~~kl~Dfg~~  572 (652)
                      |||||.||||+.++.+..  ..+++.+.+.+..+++.||.|||++   ||+||||||.||++-    ..-.-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999997543  3799999999999999999999999   999999999999983    3336899999999


Q ss_pred             ccccCCCCccccccccCCccccCccccc-cCccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGR-EGRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      +...++   ......+||..|.+||++. .+.|+..+|.|||||++||.+||..||.+.
T Consensus       172 rel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            987432   3556778999999999988 488899999999999999999999997654

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-35  Score=295.79  Aligned_cols=213  Identities=24%  Similarity=0.294  Sum_probs=183.5

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+|... +|+.||+|.+....   ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999855 68999999986532   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccc
Q 041689          509 EKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT  587 (652)
Q Consensus       509 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  587 (652)
                      .+++.... ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.+||+|||.+.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99887644 2689999999999999999999999   999999999999999999999999999876532   1122334


Q ss_pred             cCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhhhhhhcccch
Q 041689          588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFVFNLAMECTI  640 (652)
Q Consensus       588 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l~~l~~~~l~  640 (652)
                      .++..|+|||.+.++.++.++||||+||++|+|++|+.||.                           +.+.+++.+||+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            57889999999988889999999999999999999999963                           237889999999


Q ss_pred             hhhccccCccC
Q 041689          641 ESLELRINAKE  651 (652)
Q Consensus       641 ~~p~~Rpt~~e  651 (652)
                      .||++||++.|
T Consensus       235 ~~p~~R~~~~~  245 (277)
T cd05577         235 KDPEKRLGCRG  245 (277)
T ss_pred             CChhHccCCCc
Confidence            99999996654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-35  Score=298.30  Aligned_cols=221  Identities=25%  Similarity=0.278  Sum_probs=188.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  500 (652)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999975 58899999987542 23456788999999999999999999988643  4689999


Q ss_pred             EccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887643   233678889999999999999999999   999999999999999999999999999875422


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------  629 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------  629 (652)
                      .    ......++..|+|||.+.+..++.++||||+||++|||++|+.||..                            
T Consensus       158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            1    11234577889999999988999999999999999999999988643                            


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||..+|++|||+.||
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei  263 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDM  263 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence                   24689999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.8e-35  Score=302.36  Aligned_cols=225  Identities=22%  Similarity=0.297  Sum_probs=185.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999865 68999999986542  222345668999999999999999999886553      


Q ss_pred             --ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          495 --FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       495 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                        ..++||||+++ ++.+++......+++.++..++.|++.||+|||++   +++|+||||+||++++++.+||+|||.+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              45999999975 88888776655789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc---------------------
Q 041689          573 KLLIGEDQS--MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV---------------------  628 (652)
Q Consensus       573 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~---------------------  628 (652)
                      .........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.                     
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            865332211  112234578889999987654 46889999999999999999988752                     


Q ss_pred             ----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                        ..+.+++.+||..||++|||++|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~  304 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA  304 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence                                              123479999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.3e-35  Score=298.05  Aligned_cols=221  Identities=25%  Similarity=0.337  Sum_probs=187.5

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +|++.+.||+|++|.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999975 688999999875532 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          504 PHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       504 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ++ ++.+++....  ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+|++|||.+......  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence            85 8888876543  3689999999999999999999999   9999999999999999999999999998754221  1


Q ss_pred             cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......++..|+|||++.+. .++.++|||||||++|||++|+.||.                                
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            112234568889999987654 56889999999999999999998864                                


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+|++.||++||+++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~  278 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA  278 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence                                234588999999999999998874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.2e-35  Score=299.88  Aligned_cols=222  Identities=23%  Similarity=0.260  Sum_probs=184.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCc-----
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEF-----  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----  495 (652)
                      ++|++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++++. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999865 689999999865422  23356788999999995 6999999999877665     


Q ss_pred             eEEEEEccCCCChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEeccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSN----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFG  570 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg  570 (652)
                      .|+||||+++ ++.+++....    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8888775432    2578999999999999999999999   9999999999999998 8999999999


Q ss_pred             CCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc---------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~---------------------  628 (652)
                      .+..+....  .......+++.|+|||++.+ ..++.++||||||+++|||++|..||.                     
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            987652211  11223356788999998765 457899999999999999999998763                     


Q ss_pred             ------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    ..+.+++.+||..||++||+++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei  288 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA  288 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence                                          236679999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.1e-36  Score=326.85  Aligned_cols=229  Identities=25%  Similarity=0.330  Sum_probs=187.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec------
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN------  492 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------  492 (652)
                      .+...+|++.+.||+||||.||+++.+ ||+.||||++... ..+....+.+|+..+++++|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            556678889999999999999999976 8999999999755 33445667889999999999999999865411      


Q ss_pred             -------------------------------------------------C------------------------------
Q 041689          493 -------------------------------------------------E------------------------------  493 (652)
Q Consensus       493 -------------------------------------------------~------------------------------  493 (652)
                                                                       .                              
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                              


Q ss_pred             ----------------------------------CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 041689          494 ----------------------------------EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH  539 (652)
Q Consensus       494 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH  539 (652)
                                                        ...||-||||+...+++++..+...-.....++++++|+.||+|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              0247889999998888887766532256788999999999999999


Q ss_pred             cCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc----------------CCCCccccccccCCccccCccccccCc
Q 041689          540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI----------------GEDQSMTQTQTLATIGYIAPEYGREGR  603 (652)
Q Consensus       540 ~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~  603 (652)
                      ++   |||||||||.|||+|+++.|||+|||+|+...                ........+..+||.-|+|||++.+..
T Consensus       715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            99   99999999999999999999999999998721                011122345678999999999987654


Q ss_pred             ---cCcccchhhHHHHHHHHHh-----------------CCCCcchh--------hhhhhcccchhhhccccCccCC
Q 041689          604 ---VFANGDVYSFGIMLMEIHS-----------------AKQQCVSF--------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       604 ---~~~~sDvwslG~vl~ellt-----------------g~~p~~~~--------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         |+.|+|+||+|||++||+.                 |..|+++.        -..++..|+++||.+||||.|+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence               9999999999999999985                 55565521        4679999999999999999874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.6e-35  Score=296.81  Aligned_cols=218  Identities=22%  Similarity=0.266  Sum_probs=182.5

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecC--CceEEEEE
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNE--EFKELVLE  501 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  501 (652)
                      |++.+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. ||||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999864 68999999987542 222234457888899885 99999999999887  88999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++ ++.+.+......+++.++..++.|++.||+|||+.   +++||||||+||++++ +.+||+|||.++......  
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--  153 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--  153 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence            9975 88888776555789999999999999999999999   9999999999999999 999999999998653221  


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                       ......++..|+|||++.. +.++.++||||+||++|||++|+.||.                                
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence             1223457889999997644 557889999999999999999998874                                


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+||..+|++||+++||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~  276 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA  276 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence                                346789999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=306.67  Aligned_cols=223  Identities=23%  Similarity=0.277  Sum_probs=185.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  496 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999854 6899999998643 233445678899999999999999999886544     357


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++|+||+++ ++.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999975 888877554  589999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCcc-ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          577 GEDQSM-TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       577 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ...... ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.                          
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            221111 1123467889999998654 568899999999999999999998873                          


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||+.+|++|||+.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~  289 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA  289 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence                                        225689999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=302.80  Aligned_cols=199  Identities=22%  Similarity=0.323  Sum_probs=165.4

Q ss_pred             CCCccceeccccceEEEEEEeC---CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKE  497 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  497 (652)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999864   47899999997632   33346678899999999999999999999888  7899


Q ss_pred             EEEEccCCCChhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC----CCcEEEecc
Q 041689          498 LVLEHMPHGSLEKCLYSS----NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD----TMVAHLSDF  569 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Df  569 (652)
                      +||||+++ ++.+.+...    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 676655422    12678899999999999999999999   9999999999999999    999999999


Q ss_pred             cCCccccCCCC-ccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          570 GITKLLIGEDQ-SMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       570 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      |+++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~  217 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK  217 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            99986533222 1122334578899999987664 57899999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=336.95  Aligned_cols=226  Identities=25%  Similarity=0.369  Sum_probs=192.4

Q ss_pred             HhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .+-++.....||.|.||.||.|.. .+|.-.|+|-++.+  ..+....+.+|..++..++|||+|+++|+-..++..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            344567788999999999999984 46888999988654  344566788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||||++|+|.+.+...+ ..++.-...+..|++.|+.|||++   |||||||||+||+++.+|.+|++|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999887654 566666677899999999999999   99999999999999999999999999998875432


Q ss_pred             Cc--cccccccCCccccCccccccCc---cCcccchhhHHHHHHHHHhCCCCcchh------------------------
Q 041689          580 QS--MTQTQTLATIGYIAPEYGREGR---VFANGDVYSFGIMLMEIHSAKQQCVSF------------------------  630 (652)
Q Consensus       580 ~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~------------------------  630 (652)
                      ..  .......||+.|||||++.+..   ...++||||+|||+.||+||++||...                        
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence            11  1224567999999999987643   567889999999999999999996543                        


Q ss_pred             -hhhhhcccchhhhccccCccCC
Q 041689          631 -VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       -.+++.+|+..||++|-++.||
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~ql 1491 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQL 1491 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHH
Confidence             5899999999999999888553

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.9e-35  Score=307.04  Aligned_cols=220  Identities=22%  Similarity=0.241  Sum_probs=186.1

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  493 (652)
                      ...+|+..+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4577999999999999999999865 6899999998643  223345677899999999999999999988643      


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ...|+||||+.+ ++.+.+...   +++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||.++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            357999999965 888877543   78889999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .....   .......++..|+|||.+.+..++.++||||+||++|+|++|+.||..                        
T Consensus       167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            65221   112334578899999999999999999999999999999999987631                        


Q ss_pred             ------------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                                .+.+++.+||+.||++|||+.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence                                                      24689999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4e-35  Score=293.59  Aligned_cols=222  Identities=23%  Similarity=0.291  Sum_probs=190.9

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|...+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999865 58899999986542  23446778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~  580 (652)
                      +++++|.+++..... .+++..+..++.|++.|++|||+.   +++|+||||+||++++++ .+|++|||.+......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--  155 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC--
Confidence            999999998876443 578999999999999999999999   999999999999998775 5799999998765321  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~  636 (652)
                      ........|++.|+|||+.....++.++|+||||+++|||++|+.||..                        .+.+++.
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence            1122234588899999999888899999999999999999999998542                        3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..+|++|||+.||
T Consensus       236 ~~l~~~p~~Rpt~~~l  251 (257)
T cd08225         236 QLFKVSPRDRPSITSI  251 (257)
T ss_pred             HHhccChhhCcCHHHH
Confidence            9999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.2e-35  Score=294.60  Aligned_cols=223  Identities=26%  Similarity=0.419  Sum_probs=183.7

Q ss_pred             CCccceeccccceEEEEEEeC----CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          427 FNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999743    4688999998754  2334567889999999999999999999876432      


Q ss_pred             ceEEEEEccCCCChhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          495 FKELVLEHMPHGSLEKCLYSS-----NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      ..++++||+++|++.+++...     ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998876432     12578888999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------------------
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------------------  628 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------------------  628 (652)
                      |.++...............+++.|++||......++.++|||||||++|||++ |+.||.                    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99886532221112223345678999999988889999999999999999999 777742                    


Q ss_pred             ----hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          ..+.+++.+||+.+|++||++.||
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~  265 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRPSFQHL  265 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                347889999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-34  Score=299.33  Aligned_cols=216  Identities=25%  Similarity=0.317  Sum_probs=185.6

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |...+.||+|+||.||+|+.. ++..||+|.+...   .......+..|++++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999864 6889999998643   223345788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ ++.+.+......+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||++.....     
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            975 78777765555789999999999999999999999   999999999999999999999999999875421     


Q ss_pred             ccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhhh
Q 041689          583 TQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFNL  634 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~l  634 (652)
                       .....+++.|+|||++.   .+.++.++|||||||++|||++|+.||..                         .+.++
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  256 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  256 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence             22345788999999873   45688999999999999999999998422                         36789


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.+|++||++.||
T Consensus       257 i~~~l~~~p~~Rpt~~~i  274 (317)
T cd06635         257 VDSCLQKIPQDRPTSEEL  274 (317)
T ss_pred             HHHHccCCcccCcCHHHH
Confidence            999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-35  Score=296.75  Aligned_cols=220  Identities=26%  Similarity=0.330  Sum_probs=186.2

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |++.+.||+|++|.||+|... +|..||+|++....  ......+.+|++++++++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667889999999999999865 69999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      + ++|.+++.... ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.+......  ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence            5 58999886544 3589999999999999999999999   9999999999999999999999999998754221  11


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||.                                 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            12233568889999987654 57889999999999999999998863                                 


Q ss_pred             -------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                         ..+.+++.+||+.||++|||++||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i  277 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA  277 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                               235678999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-34  Score=294.00  Aligned_cols=209  Identities=22%  Similarity=0.276  Sum_probs=173.7

Q ss_pred             eeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHH---hcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          432 LIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMK---SIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++   ..+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 588999999865421   11223344444433   3479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999887654 689999999999999999999999   9999999999999999999999999998754211    12


Q ss_pred             ccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          585 TQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      ....|+..|+|||.... ..++.++||||+||++|||++|+.||..                          .+.+++.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence            23468999999998764 5688999999999999999999999742                          25789999


Q ss_pred             cchhhhccccC
Q 041689          638 CTIESLELRIN  648 (652)
Q Consensus       638 ~l~~~p~~Rpt  648 (652)
                      ||..||++||+
T Consensus       233 ~l~~~p~~R~~  243 (279)
T cd05633         233 LLQRDVSKRLG  243 (279)
T ss_pred             HhcCCHHHhcC
Confidence            99999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-35  Score=296.25  Aligned_cols=221  Identities=25%  Similarity=0.322  Sum_probs=188.4

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEEEE
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELVLE  501 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  501 (652)
                      |++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999876 48899999997653  33345688899999999999999999999888  88999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++ ++.+++......+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 89888876655789999999999999999999999   999999999999999999999999999986633221 


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.                                
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            12233456788999997764 457899999999999999999998863                                


Q ss_pred             ----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            ..+.+++.+||+.+|++||+++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  281 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA  281 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                                  335678999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-34  Score=289.23  Aligned_cols=223  Identities=26%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELVL  500 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  500 (652)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999876 689999999876532  4567889999999999999999999999888  8899999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999988765 789999999999999999999998   999999999999999999999999999987643322


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNL  634 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l  634 (652)
                      ........++..|+|||......++.++||||||+++|+|++|+.||..                          .+.++
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            1113345688899999999888899999999999999999999988633                          37899


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+|+..+|++||++.|+
T Consensus       237 i~~~l~~~p~~Rp~~~~l  254 (260)
T cd06606         237 LRKCLRRDPKKRPTADEL  254 (260)
T ss_pred             HHHhCcCChhhCCCHHHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.7e-35  Score=297.02  Aligned_cols=222  Identities=24%  Similarity=0.289  Sum_probs=184.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|++|.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999865 68899999986442  2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCCccccCCC
Q 041689          502 HMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |+++ ++.+++..... ..++..+..++.|++.||+|||++   +++||||+|+||++++ ++.+||+|||++...... 
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            9965 78777754332 367788889999999999999999   9999999999999985 567999999999754221 


Q ss_pred             CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV------------------------------  628 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~------------------------------  628 (652)
                       ........+++.|+|||++.+. .++.++||||+||++|+|+||+.||.                              
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence             1112234568899999987664 57899999999999999999998863                              


Q ss_pred             ----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            ..+.+++.+|++.+|++||++.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~  281 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA  281 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence                                  224579999999999999998764

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-34  Score=297.45  Aligned_cols=226  Identities=27%  Similarity=0.305  Sum_probs=188.8

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----  494 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  494 (652)
                      ...++|++.+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999875 58899999997542  223356778999999999999999999887654    


Q ss_pred             ------ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          495 ------FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       495 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 77777766555789999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                      ||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|++||.                   
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999986533221 11222346778999998765 357889999999999999999998763                   


Q ss_pred             ----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                        ..+.+++.+||..+|++||++.||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                                              236789999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.4e-35  Score=292.06  Aligned_cols=214  Identities=28%  Similarity=0.346  Sum_probs=186.4

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+|... +|+.||+|++.....   ...+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 499999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC------cc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ------SM  582 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------~~  582 (652)
                      .+++.... .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987655 689999999999999999999999   999999999999999999999999999875432211      11


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-------------------------chhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-------------------------VSFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-------------------------~~~l~~l~~~  637 (652)
                      ......++..|+|||......++.++||||||+++||+++|+.||                         +..+.+++.+
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence            223345788899999998888999999999999999999999985                         4557899999


Q ss_pred             cchhhhccccCcc
Q 041689          638 CTIESLELRINAK  650 (652)
Q Consensus       638 ~l~~~p~~Rpt~~  650 (652)
                      ||+.+|++|||+.
T Consensus       237 ~l~~~p~~Rpt~~  249 (265)
T cd05579         237 LLVPDPEKRLGAK  249 (265)
T ss_pred             HhcCCHhhcCCCc
Confidence            9999999999993

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=287.65  Aligned_cols=221  Identities=27%  Similarity=0.379  Sum_probs=194.3

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 588999999976543  4556889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++.... .+++..+..++.|++.|+.|||+.   |++||||||+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            99999999887653 789999999999999999999999   999999999999999999999999999987633221  


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhhccc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLAMEC  638 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~~~~  638 (652)
                      ......++..|+|||...+..++.++||||+|+++|+|++|+.||.                        ..+.+++.+|
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            1233457889999999888888999999999999999999999863                        3478899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |..+|++|||+.|+
T Consensus       235 l~~~p~~R~~~~~~  248 (254)
T cd06627         235 FQKDPNLRPTAKQL  248 (254)
T ss_pred             HhCChhhCcCHHHH
Confidence            99999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8e-35  Score=296.94  Aligned_cols=216  Identities=24%  Similarity=0.270  Sum_probs=187.3

Q ss_pred             cceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          430 NNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ...||+|+||.||++... ++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999864 6899999998655445566788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+++...  .+++..+..++.|++.|++|||+.   |++||||+|+||++++++.++|+|||.+.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  478899999999999999999999   99999999999999999999999999987553221  1123345


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhhhcccchhh
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNLAMECTIES  642 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l~~~~l~~~  642 (652)
                      +++.|+|||...+..++.++|+||+|+++|||++|+.||.                          ..+.+++.+||..+
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            7889999999888888999999999999999999999853                          22678899999999


Q ss_pred             hccccCccCC
Q 041689          643 LELRINAKEI  652 (652)
Q Consensus       643 p~~Rpt~~ei  652 (652)
                      |.+||++.||
T Consensus       258 P~~R~~~~~l  267 (292)
T cd06657         258 PAQRATAAEL  267 (292)
T ss_pred             cccCcCHHHH
Confidence            9999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.9e-34  Score=289.04  Aligned_cols=222  Identities=20%  Similarity=0.227  Sum_probs=184.5

Q ss_pred             cHHHHHHHhcCCCcccee--ccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeee
Q 041689          416 SYLEVCRATYGFNENNLI--GKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCS  491 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  491 (652)
                      +..+.....++|++.+.+  |+|+||.||+++.. ++..+|+|.+.......     .|+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            344555566778887777  99999999999864 68889999986542111     122222222 7999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEeccc
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFG  570 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg  570 (652)
                      .++..++||||+++++|.+++.... .+++.++..++.|+++|++|||+.   +++||||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999999987765 789999999999999999999999   999999999999999888 99999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------  628 (652)
                      .++....      .....++..|+|||++.+..++.++||||+||++|||++|+.||.                      
T Consensus       156 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T PHA03390        156 LCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF  229 (267)
T ss_pred             cceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence            9875421      122357889999999998899999999999999999999999963                      


Q ss_pred             -----hhhhhhhcccchhhhccccC-ccCC
Q 041689          629 -----SFVFNLAMECTIESLELRIN-AKEI  652 (652)
Q Consensus       629 -----~~l~~l~~~~l~~~p~~Rpt-~~ei  652 (652)
                           ..+.+++.+||+.+|++||+ ++|+
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  259 (267)
T PHA03390        230 IKNVSKNANDFVQSMLKYNINYRLTNYNEI  259 (267)
T ss_pred             ccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence                 22678999999999999996 4653

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.2e-34  Score=288.09  Aligned_cols=222  Identities=25%  Similarity=0.343  Sum_probs=194.9

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|.+.+.||+|+||.||+|... ++..||+|++.....  .....+..|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999865 589999999975532  4566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++++|.+++....   ..+++.++..++.|++.|+.|||+.   |++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987652   5789999999999999999999999   99999999999999999999999999998653221


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~  635 (652)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..                        .+.+++
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              122334688899999999888899999999999999999999998533                        478899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||..+|++|||+.|+
T Consensus       236 ~~~l~~~p~~Rp~~~~l  252 (258)
T cd08215         236 SSLLQKDPEERPSIAQI  252 (258)
T ss_pred             HHHcCCChhhCcCHHHH
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.6e-35  Score=296.48  Aligned_cols=221  Identities=27%  Similarity=0.361  Sum_probs=182.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556688999999999999865 58999999986542 234567889999999996 99999999999999999999999


Q ss_pred             cCCCChhhh---hhc-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          503 MPHGSLEKC---LYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       503 ~~~g~L~~~---l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ++. ++.++   +.. ....+++..+..++.|++.||+|||+..  +++||||||+||++++++.+||+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            865 55443   222 2246899999999999999999999632  8999999999999999999999999998765321


Q ss_pred             CCccccccccCCccccCccccccC---ccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREG---RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                         .......++..|+|||++...   .++.++||||+||++|||++|+.||..                          
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         162 ---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence               112334578899999998776   688999999999999999999999632                          


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||+.+|++|||++||
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i  264 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKEL  264 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHH
Confidence               25789999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=278.09  Aligned_cols=226  Identities=22%  Similarity=0.325  Sum_probs=189.8

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          417 YLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       417 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      ++|..+-+     .+.+|+|+|+.|-.|. ..+|.+||||++.++......++.+|++++.+. .|+||++++++|+++.
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            45554444     3689999999999886 668999999999888777788899999999998 5999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEecccC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGI  571 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~  571 (652)
                      .+|+|||.|.||+|..++.++. .+++.++.++..+|+.||.|||.+   ||.|||+||+|||-...   .-+|||||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence            9999999999999999998876 699999999999999999999999   99999999999998644   3599999988


Q ss_pred             CccccCCC-----CccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch------------
Q 041689          572 TKLLIGED-----QSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS------------  629 (652)
Q Consensus       572 ~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~------------  629 (652)
                      ..-+....     ........+|+..|||||+..     ...|+.+.|.||+|||+|-|++|.+||..            
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            75432111     112223567899999999743     23578899999999999999999999433            


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                    +.++++...+..||.+|-++.+
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~  357 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ  357 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence                                          2688999999999999988765

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-35  Score=303.40  Aligned_cols=224  Identities=23%  Similarity=0.256  Sum_probs=187.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  496 (652)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999865 69999999987542  2344567789999999999999999998753    3467


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+. ++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999996 58988886554 589999999999999999999999   99999999999999999999999999997653


Q ss_pred             CCCCc--cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          577 GEDQS--MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       577 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      .....  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.                         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            22211  11123468889999998765 468899999999999999999999872                         


Q ss_pred             -----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   ..+.+++.+||+.+|++||+++|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~  291 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA  291 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                                         235689999999999999999764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-35  Score=320.08  Aligned_cols=198  Identities=20%  Similarity=0.225  Sum_probs=157.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC--CcEEEEEEe--------------ec---ccchhhhhHHHHHHHHHhcCCCee
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD--GMEVAVKVF--------------HL---QCGRAFKSFDIECEIMKSIHYRNL  483 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni  483 (652)
                      ...+|++.+.||+|+||.||+|..+.  +..++.|.+              ..   ........+++|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35689999999999999999986432  222222211              00   112234567899999999999999


Q ss_pred             eeEEeeeecCCceEEEEEccCCCChhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC
Q 041689          484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD  559 (652)
Q Consensus       484 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~  559 (652)
                      +++++++...+..|+|+|++.+ ++.+++....    ......++..++.|++.||+|||++   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            9999999999999999999964 7777765432    1234566778999999999999999   999999999999999


Q ss_pred             CCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCC
Q 041689          560 DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ  625 (652)
Q Consensus       560 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~  625 (652)
                      .++.+||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~  366 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF  366 (501)
T ss_pred             CCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            99999999999998663221 112234568999999999999999999999999999999999874

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-34  Score=298.98  Aligned_cols=220  Identities=20%  Similarity=0.215  Sum_probs=180.5

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.+.+|.|+++.||++.. +++.||+|+++..  .....+.+..|++++++++||||+++++++...+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555544 6899999999754  3345568899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc----
Q 041689          507 SLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS----  581 (652)
Q Consensus       507 ~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----  581 (652)
                      ++.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998754 23588889999999999999999999   9999999999999999999999999998755322111    


Q ss_pred             -cccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch-----------------------------
Q 041689          582 -MTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------------  629 (652)
Q Consensus       582 -~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------------  629 (652)
                       .......++..|+|||++..  ..++.++|||||||++|||++|+.||..                             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11123346778999999865  3588999999999999999999999752                             


Q ss_pred             ----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  .+.+++.+||..||++|||++|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  292 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL  292 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH
Confidence                                        24568999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-34  Score=288.87  Aligned_cols=209  Identities=24%  Similarity=0.308  Sum_probs=183.4

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 48999999997542   23456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+++.... .+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99987654 588999999999999999999999   99999999999999999999999999998653221   222345


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhhhcccchh
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNLAMECTIE  641 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l~~~~l~~  641 (652)
                      ++..|+|||.+.+..++.++|+||+|+++|||++|+.||..                           .+.+++.+||..
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            78899999998888899999999999999999999999632                           257799999999


Q ss_pred             hhccccC
Q 041689          642 SLELRIN  648 (652)
Q Consensus       642 ~p~~Rpt  648 (652)
                      +|++||+
T Consensus       234 ~p~~R~~  240 (262)
T cd05572         234 NPEERLG  240 (262)
T ss_pred             ChhhCcC
Confidence            9999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=287.98  Aligned_cols=223  Identities=21%  Similarity=0.290  Sum_probs=188.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-----cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-----CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  496 (652)
                      .+|++.+.||+|+||.||+|+.. ++..||+|.+...     .......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47889999999999999999864 6899999987532     123446788999999999999999999998664  467


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++.... .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999887654 578889999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCC-ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------h
Q 041689          577 GEDQ-SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------F  630 (652)
Q Consensus       577 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~  630 (652)
                      .... ........++..|+|||.+.+..++.++|+|||||++|||++|+.||..                         .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence            2111 1111234588899999999888899999999999999999999998532                         3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||. +|..||++.++
T Consensus       238 ~~~~i~~~l~-~~~~r~~~~~~  258 (264)
T cd06653         238 CRDFLKQIFV-EEKRRPTAEFL  258 (264)
T ss_pred             HHHHHHHHhc-CcccCccHHHH
Confidence            7889999999 57999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=294.26  Aligned_cols=220  Identities=24%  Similarity=0.298  Sum_probs=189.6

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |++.+.||+|++|.||+|... +++.+|+|.++....  .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999865 688999999875432  24567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++ ++.+++......+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            76 88888877555789999999999999999999999   99999999999999999999999999987653322  12


Q ss_pred             cccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc----------------------------------
Q 041689          584 QTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV----------------------------------  628 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~----------------------------------  628 (652)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.                                  
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2234578889999998776 78899999999999999999998762                                  


Q ss_pred             -------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                         ..+.+++.+||..||.+||++.||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence                               246789999999999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-34  Score=301.79  Aligned_cols=224  Identities=26%  Similarity=0.318  Sum_probs=186.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC--Cce
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~  496 (652)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999865 5889999988542  223345677899999999 999999999988643  467


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++ +|..++...  .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||.+....
T Consensus        85 ~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            999999975 999888765  578888999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCc---cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          577 GEDQS---MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       577 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      .....   .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.                        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221   12233458889999998754 457889999999999999999998863                        


Q ss_pred             ------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    ..+.+++.+||+.||++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~i  292 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEA  292 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHH
Confidence                                          235779999999999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.4e-34  Score=294.65  Aligned_cols=216  Identities=24%  Similarity=0.276  Sum_probs=185.1

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |...+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999864 68899999986432   23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +.+ ++.+++......+++.++..++.|++.|+.|||+.   |++||||+|+||++++++.+||+|||.+....      
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            964 78777766555789999999999999999999999   99999999999999999999999999986431      


Q ss_pred             ccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhhh
Q 041689          583 TQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFNL  634 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~l  634 (652)
                      ......++..|+|||++.   .+.++.++|||||||++|||++|..||..                         .+.++
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            122346888999999874   45688999999999999999999998532                         37889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.+|++||++.|+
T Consensus       253 i~~~l~~~P~~Rp~~~~~  270 (313)
T cd06633         253 VDYCLQKIPQERPASAEL  270 (313)
T ss_pred             HHHHccCChhhCcCHHHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=286.77  Aligned_cols=210  Identities=23%  Similarity=0.261  Sum_probs=178.2

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHH-HhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIM-KSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|... +++.||+|.++....   .....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999864 589999999865421   2223344555544 445899999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      ++|.+++.... .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987654 688999999999999999999999   999999999999999999999999999875321      22


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc---------------------------chhhhhhhccc
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC---------------------------VSFVFNLAMEC  638 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~---------------------------~~~l~~l~~~~  638 (652)
                      ...++..|+|||...+..++.++||||+|+++|||++|..||                           +..+.+++.+|
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            345788899999998888899999999999999999999885                           23478899999


Q ss_pred             chhhhccccCcc
Q 041689          639 TIESLELRINAK  650 (652)
Q Consensus       639 l~~~p~~Rpt~~  650 (652)
                      |+.+|++||++.
T Consensus       232 l~~~p~~R~~~~  243 (260)
T cd05611         232 LCMDPAKRLGAN  243 (260)
T ss_pred             ccCCHHHccCCC
Confidence            999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5e-34  Score=291.13  Aligned_cols=219  Identities=21%  Similarity=0.300  Sum_probs=185.3

Q ss_pred             CCCccceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          426 GFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      +|++.+.||+|+||.||.|+.    .+|..||+|+++...    ....+.+..|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    368899999997532    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 688889999999999999999999   99999999999999999999999999987653


Q ss_pred             CCCCccccccccCCccccCccccccC--ccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREG--RVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ... ........++..|+|||.....  .++.++||||||+++|+|++|+.||.                          
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T cd05613         157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  235 (290)
T ss_pred             ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccC
Confidence            221 1122234588899999988653  46788999999999999999999863                          


Q ss_pred             -hhhhhhhcccchhhhccccCc
Q 041689          629 -SFVFNLAMECTIESLELRINA  649 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~  649 (652)
                       ..+.+++.+||+.||++||+.
T Consensus       236 ~~~~~~ll~~~l~~~p~~R~~~  257 (290)
T cd05613         236 SALAKDIIQRLLMKDPKKRLGC  257 (290)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCC
Confidence             226789999999999999853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=322.30  Aligned_cols=208  Identities=25%  Similarity=0.291  Sum_probs=182.2

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      .++.-..++|.+.+.||+|+||.|..++++ +++.||+|++.+..   ......|..|..+|..-+.+-|+.++..|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555678999999999999999999875 68889999997641   23446788999999999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      .+.|+||||++||||-.++.... ++++.-+..|+..|+.||.-||+.   |+|||||||+|||+|..|++||+|||.+-
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999999999999998877 799998999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccc----c-CccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGR----E-GRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      .+.. +........+|||.|.+||+++    + +.|+...|+||+||++|||+.|..||-.+
T Consensus       224 km~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  224 KMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             hcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence            7743 3344556778999999999875    3 57899999999999999999999995443

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.3e-34  Score=298.88  Aligned_cols=195  Identities=21%  Similarity=0.282  Sum_probs=160.2

Q ss_pred             ceeccc--cceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKG--GFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      ..||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356766  89999999864 79999999987542  23456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc-
Q 041689          506 GSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-  583 (652)
Q Consensus       506 g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-  583 (652)
                      +++.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++||+.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999887643 2588899999999999999999999   999999999999999999999999986543211111100 


Q ss_pred             ----cccccCCccccCccccccC--ccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          584 ----QTQTLATIGYIAPEYGREG--RVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       584 ----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                          .....++..|+|||++.+.  .++.++||||+||++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  211 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ  211 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                1112345679999998764  47899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-34  Score=293.97  Aligned_cols=221  Identities=24%  Similarity=0.314  Sum_probs=184.5

Q ss_pred             cCCCccceeccccceEEEEEEeCC-CcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|.+.+ ++.||||.++... ......+..|+.++.+. .||||+++++++.++...|+|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568888999999999999999764 8999999997542 22344566677767666 49999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++ ++.++.......+++..+..++.|++.|++|||+ .   +|+||||+|+||++++++.+||+|||.+..+...  
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~--  168 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--  168 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC--
Confidence            9864 7777766545578999999999999999999996 5   8999999999999999999999999998765321  


Q ss_pred             ccccccccCCccccCccccccCc----cCcccchhhHHHHHHHHHhCCCCcch---------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREGR----VFANGDVYSFGIMLMEIHSAKQQCVS---------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~---------------------------  629 (652)
                       .......++..|+|||.+....    ++.++||||||+++|||++|+.||..                           
T Consensus       169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         169 -KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             -CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence             1122335778899999986553    78899999999999999999999643                           


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||..||++||+++||
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~i  270 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYREL  270 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHH
Confidence            25789999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-35  Score=278.81  Aligned_cols=197  Identities=22%  Similarity=0.323  Sum_probs=163.9

Q ss_pred             cCCCccceeccccceEEEEEEeC---C--CcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG---D--GMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  496 (652)
                      ..|+....||+|+||.||+|..+   +  .+.+|+|.++.+.+  ......-+|+.+++.++|||++.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46889999999999999999532   2  34799999975522  234566789999999999999999999877 7789


Q ss_pred             EEEEEccCCCChhhhhhcCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC----CcEEEec
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC----ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT----MVAHLSD  568 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~----~~~kl~D  568 (652)
                      ++++||.+. +|.+.++.++.    .++...+..|++||+.|+.|||++   =|+||||||.||++..+    |+|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999988 99998875432    578888999999999999999999   89999999999999866    9999999


Q ss_pred             ccCCccccCCCCcc-ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCC
Q 041689          569 FGITKLLIGEDQSM-TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQ  625 (652)
Q Consensus       569 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~  625 (652)
                      ||+++.+...-... .....+.|.+|+|||.+.+. .|+.+.||||.||++.||+|-.+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~P  238 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEP  238 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCc
Confidence            99999875432222 33456789999999998876 47788899999999999998544

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-34  Score=300.14  Aligned_cols=229  Identities=21%  Similarity=0.255  Sum_probs=191.3

Q ss_pred             ccccHHHHHHHhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEee
Q 041689          413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISS  489 (652)
Q Consensus       413 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~  489 (652)
                      ++....++....++|.+.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++++++||||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            4455667788889999999999999999999985 468999999986532  2234567789999999999999999998


Q ss_pred             eecC------CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          490 CSNE------EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       490 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      +...      ...+++++++ +++|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            7543      3467888877 77998877654  489999999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------  628 (652)
                      +||+|||++.....     ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.              
T Consensus       159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999875421     1223457889999998766 568899999999999999999999873              


Q ss_pred             ----------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                              ..+.+++.+|+..||++||++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence                                                    224679999999999999998764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-34  Score=292.77  Aligned_cols=221  Identities=22%  Similarity=0.315  Sum_probs=187.3

Q ss_pred             CCCccceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          426 GFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      +|++.+.||+|+||.||+|+.    .++..||||+++...    ....+.+..|+++++++ +||+|+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999874    357889999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++.... .+++..+..++.|+++||+|||..   +++||||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999887544 688899999999999999999998   99999999999999999999999999987653


Q ss_pred             CCCCccccccccCCccccCccccccCc--cCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGR--VFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ... ........++..|+|||...+..  .+.++||||||+++|||++|..||.                          
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd05583         157 AEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM  235 (288)
T ss_pred             ccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCccc
Confidence            221 11122345788999999987655  7889999999999999999999862                          


Q ss_pred             -hhhhhhhcccchhhhccccCccC
Q 041689          629 -SFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                       ..+.+++.+||+.||++|||+.+
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~  259 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANG  259 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcch
Confidence             34788999999999999999765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.4e-34  Score=289.58  Aligned_cols=212  Identities=23%  Similarity=0.300  Sum_probs=175.9

Q ss_pred             eeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHH---HHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          432 LIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECE---IMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .||+|+||.||+|+.. +++.||+|.+.....   .....+..|..   .++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999999865421   11122333433   3444579999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++......    ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            999999886544 689999999999999999999999   9999999999999999999999999998754221    12


Q ss_pred             ccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          585 TQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      ....|+..|+|||++.++ .++.++||||+||++|||++|+.||..                          .+.+++.+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence            234689999999998754 688999999999999999999999642                          36789999


Q ss_pred             cchhhhcccc-----CccC
Q 041689          638 CTIESLELRI-----NAKE  651 (652)
Q Consensus       638 ~l~~~p~~Rp-----t~~e  651 (652)
                      |+..+|++||     ++.|
T Consensus       233 ~l~~~p~~R~~~~~~~~~~  251 (278)
T cd05606         233 LLQRDVNRRLGCLGRGAQE  251 (278)
T ss_pred             HhhcCHHhccCCCCCCHHH
Confidence            9999999999     6655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-34  Score=296.08  Aligned_cols=217  Identities=24%  Similarity=0.324  Sum_probs=184.8

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|+..+.||+|+||.||+|+.. ++..||+|.+...   ......++.+|+++++.++|+|++++++++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3666788999999999999865 5788999998642   22334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+. |++.+.+......+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.....    
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            997 588777765555689999999999999999999999   999999999999999999999999999875421    


Q ss_pred             cccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhh
Q 041689          582 MTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFN  633 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~  633 (652)
                        .....++..|+|||.+.   .+.++.++|||||||++|||++|+.||..                         .+.+
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence              12345788999999874   35678899999999999999999988422                         2678


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..+|++||+++||
T Consensus       246 li~~cl~~~P~~Rp~~~~l  264 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVL  264 (308)
T ss_pred             HHHHHhhCCcccCCCHHHH
Confidence            9999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-34  Score=300.24  Aligned_cols=222  Identities=23%  Similarity=0.268  Sum_probs=186.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  495 (652)
                      ..+|.+.+.||+|+||.||+|+.. +++.||||.++..  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999864 6899999998653  223345677899999999999999999987644     35


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 58988887654 689999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ....  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..                         
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            3221  12233457889999998765 4688999999999999999999988731                         


Q ss_pred             -----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   .+.+++.+||+.+|++|||++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el  288 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA  288 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence                                         24689999999999999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-34  Score=299.92  Aligned_cols=222  Identities=23%  Similarity=0.275  Sum_probs=190.5

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-----ceE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-----FKE  497 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  497 (652)
                      +|.+.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999875 48999999987543  344567889999999999999999999987765     789


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++ +|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999985 8988887655 789999999999999999999999   999999999999999999999999999987633


Q ss_pred             CCCc-cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          578 EDQS-MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       578 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      .... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||.                           
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            2210 112334578899999999887 78999999999999999999998873                           


Q ss_pred             ---------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                 ..+.+++.+||+.+|++||+++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l  286 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA  286 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence                                       235689999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-34  Score=290.08  Aligned_cols=219  Identities=26%  Similarity=0.343  Sum_probs=183.7

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhc---CCCeeeeEEeeeecCCc-----
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSI---HYRNLVKIISSCSNEEF-----  495 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  495 (652)
                      |++.+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            667889999999999999976 489999999974422  2234566788777666   59999999999988776     


Q ss_pred             eEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      .+++|||+.+ ++.+++.... ..+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8888876543 2589999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ....   .......++..|+|||++.+..++.++|||||||++|||++|++||..                         
T Consensus       157 ~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFE---MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCC---cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            5322   112233478889999999999999999999999999999999988642                         


Q ss_pred             -------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               .+.+++.+||+.||++||+++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i  281 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA  281 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence                                     24578999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.7e-34  Score=297.60  Aligned_cols=223  Identities=22%  Similarity=0.275  Sum_probs=184.2

Q ss_pred             cCCCc-cceeccccceEEEEEEeC-CCcEEEEEEeecccchh--------------hhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          425 YGFNE-NNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRA--------------FKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       425 ~~y~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      ++|.. .+.||+|+||.||+|... +++.||+|.++......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45653 477999999999999865 68999999986442211              124678999999999999999999


Q ss_pred             eeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       489 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      ++..++..++||||++ |++.+++.... .+++.....++.|++.||+|||+.   |++||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence            9999999999999997 58998886544 688999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCC------------CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-------
Q 041689          569 FGITKLLIGED------------QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-------  628 (652)
Q Consensus       569 fg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-------  628 (652)
                      ||.+.......            .........++..|+|||.+.+. .++.++||||+||++|||++|+.||.       
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99987653110            01111223467889999988764 46899999999999999999998763       


Q ss_pred             --------------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                                  ..+.+++.+||+.+|++|||++|+
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence                                                        235689999999999999999875

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-34  Score=291.76  Aligned_cols=221  Identities=25%  Similarity=0.366  Sum_probs=192.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|...+.||+|+||.||+|... +++.||+|++...   .......+..|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999865 6999999998653   2233467888999999998 99999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999988765 699999999999999999999999   99999999999999999999999999987653322


Q ss_pred             Cc------------------cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------
Q 041689          580 QS------------------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------  628 (652)
Q Consensus       580 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------  628 (652)
                      ..                  .......++..|+|||......++.++||||+|++++++++|+.||.             
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence            11                  11223457889999999888889999999999999999999999854             


Q ss_pred             ----------hhhhhhhcccchhhhccccCc
Q 041689          629 ----------SFVFNLAMECTIESLELRINA  649 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~  649 (652)
                                ..+.+++.+||+.+|++||++
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             cCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence                      246799999999999999999

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.6e-34  Score=296.32  Aligned_cols=225  Identities=23%  Similarity=0.281  Sum_probs=185.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNE-------  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  493 (652)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            568999999999999999999865 689999999865422  2234667899999999999999999987543       


Q ss_pred             -CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          494 -EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       494 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                       ...++||||+.+ ++...+......+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346999999975 77777765555799999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCcc---------ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc--------------
Q 041689          573 KLLIGEDQSM---------TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV--------------  628 (652)
Q Consensus       573 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~--------------  628 (652)
                      ..........         ......+++.|+|||.+.+. .++.++|||||||++|||++|++||.              
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            7653221111         11223467889999987654 57899999999999999999998864              


Q ss_pred             ---------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                             ..+.+++.+|+..||++|||+.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el  305 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA  305 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence                                                   135589999999999999998774

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-34  Score=287.08  Aligned_cols=220  Identities=24%  Similarity=0.331  Sum_probs=191.6

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +|++.+.||+|+||.||+++.. +++.||+|.+....  ......+.+|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999754 68899999987542  23455677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++++|.+++...   ...+++..+..++.|++.||+|||+.   |++|+||+|+||++++++.+|++|||.+...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   23588899999999999999999999   9999999999999999999999999999865332 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~~l~  635 (652)
                         ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||.                        ..+.+++
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI  233 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence               2223457889999999998889999999999999999999999854                        2378999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.+|++||++.|+
T Consensus       234 ~~~l~~~p~~Rp~~~~~  250 (256)
T cd08530         234 RSMLQVKPKLRPNCDKI  250 (256)
T ss_pred             HHHcCCCcccCCCHHHH
Confidence            99999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-34  Score=296.68  Aligned_cols=222  Identities=24%  Similarity=0.282  Sum_probs=187.3

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCc
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEF  495 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  495 (652)
                      +...+++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+..|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999855 7899999988543  22334677889999999999999999998865 567


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++||||+ +++|.+++...  .+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.+||+|||.+...
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            89999998 45898887654  478888889999999999999999   9999999999999999999999999998754


Q ss_pred             cCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ..     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.                          
T Consensus       159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            21     1123356788999998765 568899999999999999999998862                          


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||+.+|++|||++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el  285 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA  285 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                                        246789999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=290.75  Aligned_cols=219  Identities=21%  Similarity=0.251  Sum_probs=185.8

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |.+.+.||+|++|.||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999976 478899999865422 22234457899999998 999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                       +|++.+++.... ..+++.++..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||.++.....   .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---P  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC---C
Confidence             779988887654 4689999999999999999999999   9999999999999999999999999999865321   1


Q ss_pred             ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      ......++..|+|||++.. ..++.++|+||||+++|||++|+.||.                                 
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            2233457889999998754 457899999999999999999998762                                 


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+||+.+|++|||++||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  277 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA  277 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence                                346789999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-34  Score=298.45  Aligned_cols=217  Identities=21%  Similarity=0.255  Sum_probs=182.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      ..+|...+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999864 68999999986532  223456788999999999999999999886542      


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..++|+||+.. ++..+..   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999965 7776542   2578899999999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ...     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..                        
T Consensus       167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            421     1223457888999998866 4688999999999999999999988642                        


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    .+.+++.+||+.||++||+++|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                                          25689999999999999998764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=305.04  Aligned_cols=221  Identities=25%  Similarity=0.385  Sum_probs=193.2

Q ss_pred             CccceeccccceEEEEEEe-CC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          428 NENNLIGKGGFGTIYKSRI-GD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...++||+|+||.||+|.+ ..    ..+||+|++... ..+...++..|+-+|.+++|||++++++++.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3458899999999999975 23    456899998654 3455678999999999999999999999998765 789999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++.|+|.+|++.++..+-....+.|..|||+||.|||.+   +++||||..+|||+.+-..+||.|||+++....++..
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999888888899999999999999999999   9999999999999999999999999999987665555


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------------chhhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------------VSFVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------------~~~l~~l~~  636 (652)
                      .........+.|||-|.++...|+.++|||||||++||++| |..|+                        .-++..++.
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence            55555556778999999999999999999999999999988 77773                        334788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..|++.||+|+++
T Consensus       935 kCwmid~~~rp~fkel  950 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFKEL  950 (1177)
T ss_pred             HHhccCcccCccHHHH
Confidence            9999999999999864

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-34  Score=299.75  Aligned_cols=222  Identities=21%  Similarity=0.253  Sum_probs=184.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC----------
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE----------  493 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------  493 (652)
                      .+|.+.+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57899999999999999999864 6899999999766555567788999999999999999999876544          


Q ss_pred             ----CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEec
Q 041689          494 ----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSD  568 (652)
Q Consensus       494 ----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~D  568 (652)
                          ...++||||+++ +|.+++...  .+++..+..++.|++.||+|||+.   ||+||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence                357899999974 898877643  588999999999999999999999   999999999999997 556799999


Q ss_pred             ccCCccccCCCC-ccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc------------------
Q 041689          569 FGITKLLIGEDQ-SMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV------------------  628 (652)
Q Consensus       569 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~------------------  628 (652)
                      ||.++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||.                  
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999876422111 111122357888999997654 567889999999999999999999873                  


Q ss_pred             -----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                         ..+.+++.+||+.||++|||++||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  297 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA  297 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence                                               224579999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.8e-34  Score=291.63  Aligned_cols=224  Identities=20%  Similarity=0.287  Sum_probs=172.3

Q ss_pred             hcCCCccceeccccceEEEEEEeCC----CcEEEEEEeecccchhh-----------hhHHHHHHHHHhcCCCeeeeEEe
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQCGRAF-----------KSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      ..+|.+.+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..++|++|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3579999999999999999998654    44567775432221110           01122333455678999999998


Q ss_pred             eeecCC----ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          489 SCSNEE----FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       489 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      ++....    ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence            765443    44788888754 6666555432 357788889999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh---------
Q 041689          565 HLSDFGITKLLIGEDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF---------  630 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~---------  630 (652)
                      ||+|||+++.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||...         
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999865322211     1112346999999999999999999999999999999999999996422         


Q ss_pred             ----------------------hhhhhcccchhhhccccCccCC
Q 041689          631 ----------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 ----------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            +.+++..||+.+|++||++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l  289 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDAL  289 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence                                  5679999999999999999874

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=290.25  Aligned_cols=220  Identities=27%  Similarity=0.312  Sum_probs=189.3

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+..|++++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999865 58999999997652  333466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++ +|.+++......+++..+..++.|++.||+|||+.   +|+||||+|+||++++++.+||+|||.++......  ..
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~  154 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RT  154 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cc
Confidence            85 99999987645689999999999999999999999   99999999999999999999999999988653221  12


Q ss_pred             cccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc----------------------------------
Q 041689          584 QTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV----------------------------------  628 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~----------------------------------  628 (652)
                      .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.                                  
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2233467789999998766 78899999999999999999988863                                  


Q ss_pred             ------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                        ..+.+++.+||..||++||+++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~  276 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA  276 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence                              237789999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=274.83  Aligned_cols=219  Identities=21%  Similarity=0.235  Sum_probs=184.5

Q ss_pred             HhcCCCcc-ceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC----Cc
Q 041689          423 ATYGFNEN-NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE----EF  495 (652)
Q Consensus       423 ~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  495 (652)
                      .+++|++. ++||-|-.|.|..|..+ +|+.+|+|++.     +....++|++.--+. .|||||.++++|+..    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556554 67899999999999754 79999999874     234456788775555 699999999998643    45


Q ss_pred             eEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccC
Q 041689          496 KELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGI  571 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~  571 (652)
                      ..+|||.++||.|...+.+++. .+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence            6799999999999999987664 699999999999999999999999   999999999999996   567899999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      |+.-.   ........+.|+.|.|||++...+|+...|+||+||++|-|+.|.+||-.                      
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            99632   23344567789999999999999999999999999999999999999422                      


Q ss_pred             ---------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+++++.+|+.+|.+|.|+.|+
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~  319 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV  319 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence                     37999999999999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=251.32  Aligned_cols=195  Identities=25%  Similarity=0.321  Sum_probs=169.2

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .|...++||+|.||+||+|+.+ +++.||+|+++.+.  +.......+|+-+++.++|+|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4677789999999999999854 68889999998653  33445778999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      |.. +|.++...-.+.++.+.+..++.|+++||.|+|++   ++.|||+||.|.+|+.+|++|++|||+++.+.-  .-.
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi--pvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVR  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC--ceE
Confidence            966 99998888777899999999999999999999999   999999999999999999999999999986521  122


Q ss_pred             ccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCC
Q 041689          583 TQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p  626 (652)
                      ..+..+.|.+|++|.++.+.+ |++..|+||.||++.|+....+|
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            345567899999999988765 67888999999999999875554

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-34  Score=296.02  Aligned_cols=222  Identities=22%  Similarity=0.272  Sum_probs=186.5

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--  494 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--  494 (652)
                      +....++|++.+.||+|+||.||+|... ++..||||++...  .......+.+|++++++++||||+++++++..+.  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3445678999999999999999999854 6899999998643  2223456788999999999999999999887553  


Q ss_pred             ----ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          495 ----FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       495 ----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                          ..++||||+ ++++.+++...  .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+|++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 67998887653  589999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      ++.....     ......+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||..                    
T Consensus       164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9875421     1223457889999998765 4578999999999999999999998742                    


Q ss_pred             ----------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                        .+.+++.+|+..||++|||+.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~  295 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA  295 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence                                              24678899999999999998764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=282.26  Aligned_cols=219  Identities=21%  Similarity=0.224  Sum_probs=186.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+|.....||+|+||.|-+|..+ +.+.||||+++++.   ..+.+--..|-++|+.- +-|.+++++.+|..-+..|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356888999999999999999755 56779999998662   22334445677888766 57889999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+.||+|--.+++-+ .+.+..+.-++.+||-||-|||++   ||+.||||.+||++|.+|++||+|||+++.-.  
T Consensus       428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--  501 (683)
T ss_pred             EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--
Confidence            999999999988887765 688888889999999999999999   99999999999999999999999999998531  


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-----------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-----------------------VFNLA  635 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-----------------------l~~l~  635 (652)
                      -........+||+.|+|||++...+|+..+|+|||||++|||+.|++||+.+                       ..++.
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic  581 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC  581 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence            2234455678999999999999999999999999999999999999997765                       45566


Q ss_pred             cccchhhhccccC
Q 041689          636 MECTIESLELRIN  648 (652)
Q Consensus       636 ~~~l~~~p~~Rpt  648 (652)
                      +..+...|.+|-.
T Consensus       582 kg~ltK~P~kRLG  594 (683)
T KOG0696|consen  582 KGLLTKHPGKRLG  594 (683)
T ss_pred             HHHhhcCCccccC
Confidence            6677888888853

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-34  Score=297.97  Aligned_cols=220  Identities=22%  Similarity=0.279  Sum_probs=186.5

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc---
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF---  495 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  495 (652)
                      ...++|++.+.||+|++|.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34568999999999999999999875 5889999998643  22234567789999999999999999998766554   


Q ss_pred             ---eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          496 ---KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       496 ---~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                         .++|+||+ +++|.+++...  .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||.+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999998 56999988753  589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-----------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-----------------------  628 (652)
                      ......     .....++..|+|||...+ ..++.++||||+||++|||++|+.||.                       
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            865221     233457888999998765 367899999999999999999998862                       


Q ss_pred             -------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                     ..+.+++.+||..+|++|||+.||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence                                           335689999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-33  Score=292.70  Aligned_cols=222  Identities=22%  Similarity=0.226  Sum_probs=182.4

Q ss_pred             CCCccceeccccceEEEEEEeC-C--CcEEEEEEeeccc--chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC----Cc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-D--GMEVAVKVFHLQC--GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE----EF  495 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  495 (652)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999864 4  7789999986432  22345678899999999 599999999875332    45


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++++||+. ++|.+++.... .+++..+..++.|++.||+|||+.   ||+||||||+||++++++.+||+|||.++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999986 58988886544 689999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCc--cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          576 IGEDQS--MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       576 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      ......  .......|+..|+|||+..+ ..++.++||||+||++|+|++|+.||.                        
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            322111  11223468899999998765 468899999999999999999998863                        


Q ss_pred             ------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    ..+.+++.+|++.||++|||+.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l  289 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA  289 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                                          236689999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=295.21  Aligned_cols=215  Identities=24%  Similarity=0.271  Sum_probs=184.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      +.+|.....+|.|+|+.|-.+... +++..++|++...    ..+..+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            566777888999999999998754 6889999999755    23445677776666 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee-CCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL-DDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll-~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ++.|+-+.+.+...+  ....++..|+++|+.|+.|||.+   ||||||+||+|||+ ++.+.++|+|||.++.....  
T Consensus       397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            999998888777655  22267778999999999999999   99999999999999 59999999999999865322  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------hhhhhhhccc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------SFVFNLAMEC  638 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------~~l~~l~~~~  638 (652)
                         ....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.                      +..++++.+|
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQL  546 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHh
Confidence               334567889999999999999999999999999999999999843                      3489999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||.+||+++||
T Consensus       547 L~~dP~~Rl~~~~i  560 (612)
T KOG0603|consen  547 LQVDPALRLGADEI  560 (612)
T ss_pred             ccCChhhCcChhhh
Confidence            99999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=283.25  Aligned_cols=225  Identities=25%  Similarity=0.340  Sum_probs=187.6

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc-------chhhhhHHHHHHHHHhcCCCeeeeEEeeee-cCCc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC-------GRAFKSFDIECEIMKSIHYRNLVKIISSCS-NEEF  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~  495 (652)
                      ++|-...++|+|+|++||+|.+ ...+.||||+-....       ....+..-+|.+|-+.++||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            4577778999999999999985 457889999875331       112334567999999999999999999986 4577


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCC
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGIT  572 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~  572 (652)
                      +|-|+|||+|.+|+-|++.++ ..++.++..|+.||+.||.||.+. .++|||-||||.|||+.   ..|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            899999999999999999877 789999999999999999999976 66899999999999995   4588999999999


Q ss_pred             ccccCCCCc-----cccccccCCccccCccccccC----ccCcccchhhHHHHHHHHHhCCCCcchh-------------
Q 041689          573 KLLIGEDQS-----MTQTQTLATIGYIAPEYGREG----RVFANGDVYSFGIMLMEIHSAKQQCVSF-------------  630 (652)
Q Consensus       573 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~-------------  630 (652)
                      +.+.++...     ...+...||.+|.+||.+.-+    ..+.|+||||.||++|..+.|+.||...             
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            998654332     223566799999999987544    4678999999999999999999995443             


Q ss_pred             ----------------hhhhhcccchhhhccccCccC
Q 041689          631 ----------------VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 ----------------l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                      .++++++||.+--++|.+..+
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q  737 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ  737 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence                            789999999998888876544

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-33  Score=275.89  Aligned_cols=201  Identities=19%  Similarity=0.141  Sum_probs=171.5

Q ss_pred             ccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhc
Q 041689          436 GGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS  514 (652)
Q Consensus       436 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  514 (652)
                      |.+|.||+|++. +++.||+|++....     .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999865 68999999997542     233455555666799999999999999999999999999999998876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCcccc
Q 041689          515 SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI  594 (652)
Q Consensus       515 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  594 (652)
                      .. .+++..+..++.|++.||+|+|+.   +|+||||||+||++++++.++++|||.+.....     ......++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCcccc
Confidence            54 589999999999999999999999   999999999999999999999999998765421     112234567799


Q ss_pred             CccccccCccCcccchhhHHHHHHHHHhCCCC-------------------cchhhhhhhcccchhhhccccCcc
Q 041689          595 APEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------CVSFVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       595 aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------~~~~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                      |||......++.++||||+|+++|||++|+.|                   ++..+.+++.+|++.||++||++.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            99999888899999999999999999999865                   233477899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-33  Score=283.21  Aligned_cols=221  Identities=22%  Similarity=0.289  Sum_probs=184.1

Q ss_pred             CCCccceeccccceEEEEEEeCC-CcEEEEEEeecc-----cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQ-----CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      +|.+.+.||+|+||.||+++... +..+++|+++..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998653 455666665432     122334567799999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          500 LEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |||+++++|.+++..   ....+++.++..++.|++.|+.|||+.   |++|+||||+||++++ +.+||+|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988753   233689999999999999999999999   9999999999999986 469999999987653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------hhhh
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------SFVF  632 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------~~l~  632 (652)
                      ...  .......++..|+|||...+..++.++|+||||+++|+|++|..||.                        ..+.
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            221  12223457889999999888888999999999999999999998854                        3477


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++||++.||
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i  254 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEI  254 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHH
Confidence            89999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=273.54  Aligned_cols=216  Identities=27%  Similarity=0.333  Sum_probs=180.0

Q ss_pred             ceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccCCCC
Q 041689          431 NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      ..||.|+||+|++-.++ .|+..|||+++... .+..+++..|.+...+- +.||||++||.+..++..|+.||.|.- +
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence            67999999999998754 79999999998664 35667888888875554 799999999999999999999999954 7


Q ss_pred             hhhhhh---c-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          508 LEKCLY---S-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       508 L~~~l~---~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++.+.+   . ....+++.-.-.|....+.||.||.+..  .|||||+||+|||+|..|.+||||||.+..+.   .+..
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~SiA  223 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSIA  223 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH---HHHH
Confidence            665432   1 2236888888888888999999998764  89999999999999999999999999997652   3344


Q ss_pred             cccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch------------------------------hh
Q 041689          584 QTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------FV  631 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------~l  631 (652)
                      .+...|..+|||||.+..  ..|+.+|||||+|+++||+.||+.|+..                              .+
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~  303 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM  303 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence            556678999999998754  3589999999999999999999999433                              37


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ..++..|+.+|-..||...++
T Consensus       304 ~~fintCl~Kd~~~Rpky~~L  324 (361)
T KOG1006|consen  304 VRFINTCLIKDRSDRPKYDDL  324 (361)
T ss_pred             HHHHHHHhhcccccCcchhhh
Confidence            889999999999999987764

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=277.57  Aligned_cols=212  Identities=28%  Similarity=0.299  Sum_probs=185.4

Q ss_pred             eccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      ||+|+||.||+|... +++.||+|++.....   .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 589999999875432   2445788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      .+++.... .+++..+..++.|+++|+.|+|+.   +++|+||+|+||++++++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99987664 589999999999999999999998   99999999999999999999999999988653221  1233455


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcccchhhhcc
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAMECTIESLEL  645 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~~l~~~p~~  645 (652)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||.                       +.+.+++.+||..||++
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~  234 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK  234 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence            7889999999988888999999999999999999999863                       23789999999999999


Q ss_pred             ccCcc
Q 041689          646 RINAK  650 (652)
Q Consensus       646 Rpt~~  650 (652)
                      ||+++
T Consensus       235 R~~~~  239 (250)
T cd05123         235 RLGSG  239 (250)
T ss_pred             CCCcc
Confidence            99993

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=285.08  Aligned_cols=216  Identities=25%  Similarity=0.366  Sum_probs=184.5

Q ss_pred             ccceeccccceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          429 ENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      ..+.+|+|.||+||-|++ ++|+.||||++.+-  ..+...++++|+.||++++||.||.+--.|+..+..++|||.+.|
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            357899999999999985 47999999999654  234457889999999999999999999999999999999999976


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCccccCCCCcc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      .-|+-.+....+++++....-++.||+.||.|||.+   +|+|+||||+|||+.+   --.+||||||+|+.+..   ..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence            444445555666899888888999999999999999   9999999999999963   35799999999998732   22


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-------------------------hhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-------------------------VFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-------------------------l~~l~~~  637 (652)
                      .....+||+.|.|||+++...|...-|+||.||++|.-++|..||...                         ..|++..
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            344578999999999999999999999999999999999999996553                         5778888


Q ss_pred             cchhhhccccCcc
Q 041689          638 CTIESLELRINAK  650 (652)
Q Consensus       638 ~l~~~p~~Rpt~~  650 (652)
                      .++..-++|.+.+
T Consensus       802 LLqVkm~kRysvd  814 (888)
T KOG4236|consen  802 LLQVKMRKRYSVD  814 (888)
T ss_pred             HHHHHHHHhcchH
Confidence            8888888887754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-33  Score=312.51  Aligned_cols=146  Identities=27%  Similarity=0.350  Sum_probs=131.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|+++...   ......+..|+.+++.++||||+++++++...++.|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            357899999999999999999876 68999999997542   23346788899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      |||+++++|.+++.... .+++..++.|+.||+.||+|||.+   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999987654 578889999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-35  Score=266.81  Aligned_cols=223  Identities=22%  Similarity=0.306  Sum_probs=184.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--------C
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--------E  493 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~  493 (652)
                      ..|....+||+|.||+||+|+.+ +|+.||+|++-.+  ....-....+|++++..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666789999999999999855 6888999876432  22233456789999999999999999988743        2


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ..+|+||.+|+. +|.-++.....+++..++.+++.++..||.|+|..   .|+|||+||+|++|+.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            358999999988 99998887767899999999999999999999999   99999999999999999999999999997


Q ss_pred             cccCCCC--ccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCC------------------------
Q 041689          574 LLIGEDQ--SMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQ------------------------  626 (652)
Q Consensus       574 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p------------------------  626 (652)
                      .+...+.  ....+..+.|.+|++||.+.+ ..|+++.|||+.|||+.||.||.+-                        
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            6643332  223455667999999998765 5689999999999999999998764                        


Q ss_pred             ----------------------------------cchhhhhhhcccchhhhccccCccC
Q 041689          627 ----------------------------------CVSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       627 ----------------------------------~~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                        -++...+++..++..||.+||++++
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence                                              1122568999999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=286.71  Aligned_cols=217  Identities=21%  Similarity=0.281  Sum_probs=191.0

Q ss_pred             cCCCccceeccccceEEEEEEeCC-CcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++.+...+|-|+||.|=+++... ...+|+|++++.   ..+..+.+..|-++|...+.|.||++|..|.+..++|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            345566789999999999988654 334899988654   2344556778999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |-|-||.+...++.++ .++.....-++..+++|++|||++   +||.|||||+|.++|.+|.+||.|||+|+.+.   .
T Consensus       500 EaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~  572 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S  572 (732)
T ss_pred             HhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence            9999999999988776 788888889999999999999999   99999999999999999999999999999873   3


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-------------------------hhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-------------------------VFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-------------------------l~~l~  635 (652)
                      .......+||+.|.|||++.+...+.++|.||+|+++||+++|.+||+..                         ..+++
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI  652 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence            44556789999999999999999999999999999999999999997664                         57889


Q ss_pred             cccchhhhccccC
Q 041689          636 MECTIESLELRIN  648 (652)
Q Consensus       636 ~~~l~~~p~~Rpt  648 (652)
                      ++.++.+|.+|-.
T Consensus       653 k~LCr~~P~ERLG  665 (732)
T KOG0614|consen  653 KKLCRDNPTERLG  665 (732)
T ss_pred             HHHHhcCcHhhhc
Confidence            9999999999864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-33  Score=264.02  Aligned_cols=220  Identities=21%  Similarity=0.224  Sum_probs=191.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  497 (652)
                      ..++|+..+.||+|+|++|..++.+ +.+.||+|+++++   ..++..-.+.|-.+..+. +||.+|.+..+|..+...+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3467888999999999999999854 6888999999866   334555678888888887 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +|.||++||+|--++...+ .+++..+.-+..+|.-||.|||++   |||.||+|.+|+++|..|++|++|+|+++.-  
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~--  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--  401 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC--
Confidence            9999999999987776655 799999999999999999999999   9999999999999999999999999999853  


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh---------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF---------------------------  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~---------------------------  630 (652)
                      -......+..+||+.|.|||++++..|+..+|+|++||+|+||+.|+.||+--                           
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce
Confidence            23445567789999999999999999999999999999999999999996532                           


Q ss_pred             ----hhhhhcccchhhhccccC
Q 041689          631 ----VFNLAMECTIESLELRIN  648 (652)
Q Consensus       631 ----l~~l~~~~l~~~p~~Rpt  648 (652)
                          ...+++.-+++||.+|-.
T Consensus       482 lsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  482 LSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             eehhhHHHHHHhhcCCcHHhcC
Confidence                344666778889998864

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-33  Score=305.85  Aligned_cols=229  Identities=24%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC----C----CcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEee
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG----D----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISS  489 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~  489 (652)
                      ++...++..+.+.+|+|.||.|++|...    .    ...||||..+.. .....+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3344444566679999999999999632    1    456999998755 335667899999999999 69999999999


Q ss_pred             eecCCceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 041689          490 CSNEEFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPS  554 (652)
Q Consensus       490 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  554 (652)
                      +..++..++|+||++.|+|.++++..+               ..+.......+++|||.|++||++.   +++||||.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999998877               3488889999999999999999999   9999999999


Q ss_pred             CeeeCCCCcEEEecccCCccccCCCCcccccccc--CCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc----
Q 041689          555 NVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL--ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC----  627 (652)
Q Consensus       555 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~----  627 (652)
                      ||++.++..+||+|||+|+.....+... .....  -...|||||.+....|+.++|||||||++||++| |..|+    
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999653322222 12222  2345999999999999999999999999999988 55553    


Q ss_pred             ---------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ---------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ---------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           ..++.++|+.||..+|++||+|.|+
T Consensus       527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~  572 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC  572 (609)
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence                                 3447899999999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=291.98  Aligned_cols=230  Identities=23%  Similarity=0.305  Sum_probs=195.6

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeee---
Q 041689          417 YLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCS---  491 (652)
Q Consensus       417 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~---  491 (652)
                      ++.+...+.-|++.+.||+|.+|.||+++. ++++.+|+|+..... ...++.+.|.++++.. .|||++.++|+|.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334445567789999999999999999984 468999999987653 3446778899999888 6999999999985   


Q ss_pred             --cCCceEEEEEccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          492 --NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       492 --~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                        .++..|+|||||.+|+..++++.- +..+.|..+..|++.++.|+.+||..   .++|||||-.||+++.++.+|++|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence              346899999999999999988754 33788999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccC-----ccCcccchhhHHHHHHHHHhCCCC-----------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-----RVFANGDVYSFGIMLMEIHSAKQQ-----------------  626 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p-----------------  626 (652)
                      ||++....  ..........||+.|||||++...     .|+.++|+||+|++..||.-|.+|                 
T Consensus       167 FGvSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP  244 (953)
T KOG0587|consen  167 FGVSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP  244 (953)
T ss_pred             eeeeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC
Confidence            99998763  233445567899999999987643     467889999999999999999998                 


Q ss_pred             ---------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ---------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ---------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               |.....+++..|+..|-++||+..++
T Consensus       245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l  279 (953)
T KOG0587|consen  245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL  279 (953)
T ss_pred             CccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence                     44457899999999999999998763

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-33  Score=271.63  Aligned_cols=192  Identities=22%  Similarity=0.262  Sum_probs=164.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-C-C----eeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-Y-R----NLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~  496 (652)
                      +++|.+.+.+|+|.||.|..+.+. .+..||||+++.- .+..+....|+++++++. + |    -+|++.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999999754 4788999998643 345567778999999993 2 2    388999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---------------
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---------------  560 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---------------  560 (652)
                      |||+|.+ |-++.+++..+.. +++...+..+++|++++++|||+.   +++|-||||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999988 5599999987543 789999999999999999999999   9999999999999831               


Q ss_pred             -----CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCC
Q 041689          561 -----TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ  625 (652)
Q Consensus       561 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~  625 (652)
                           ...++++|||.|+.-...     .+..+.|..|+|||++.+-+++.+.||||+|||++|++||..
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                 345999999999864221     245678999999999999999999999999999999999765

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=266.68  Aligned_cols=234  Identities=20%  Similarity=0.279  Sum_probs=193.9

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEeCC------CcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          416 SYLEVCRATYGFNENNLIGKGGFGTIYKSRIGD------GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      ...|+.....+++....+.+|.||.||+|.+.+      .+.|-+|.++....+ ....+..|.-.+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            345556666778888899999999999997543      455777877655333 3456778888888899999999999


Q ss_pred             eeecC-CceEEEEEccCCCChhhhhhcC-----C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC
Q 041689          489 SCSNE-EFKELVLEHMPHGSLEKCLYSS-----N--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD  560 (652)
Q Consensus       489 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~-----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~  560 (652)
                      ++.++ ...+.++.++.-|+|..++..-     .  ..++..+...++.|++.|++|||.+   +|||.||..+|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            87654 5678888999999999998722     1  2466677888999999999999999   9999999999999999


Q ss_pred             CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC-------------
Q 041689          561 TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ-------------  626 (652)
Q Consensus       561 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p-------------  626 (652)
                      .-++||+|=.+++.+.+.+.............||+||.+....|+.++|||||||++|||+| |+.|             
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            99999999999998765554443344456788999999999999999999999999999988 6666             


Q ss_pred             -----------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 -----------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 -----------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 |+++++.+|.-||..+|++||+++|+
T Consensus       512 kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql  548 (563)
T KOG1024|consen  512 KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL  548 (563)
T ss_pred             hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence                       77789999999999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=244.13  Aligned_cols=205  Identities=25%  Similarity=0.319  Sum_probs=168.3

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCce
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  496 (652)
                      +....++......||+|+||.|-+-++. +|+..|+|.++.. ..+..++...|+.+..+- .+|.+|++||.+...+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344455666788999999999877754 7999999999765 334556777888876554 799999999999999999


Q ss_pred             EEEEEccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          497 ELVLEHMPHGSLEKCLY---SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      ++.||.|.- +|..+-+   ..+...++...-+|+..+..||.|||++-  .++|||+||+||||+.+|++|+||||.+.
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999965 7766543   34457899999999999999999999874  89999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCcccccc----CccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGRE----GRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      .+.   .+...+...|...|||||.+..    ..|+.+|||||+|+++.||.+++.|++..
T Consensus       198 ~L~---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  198 YLV---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             eeh---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            762   2233344568889999998653    37899999999999999999999997765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7e-32  Score=295.83  Aligned_cols=222  Identities=19%  Similarity=0.184  Sum_probs=159.9

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-C----CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEee------ee
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-D----GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS------CS  491 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  491 (652)
                      ..++|...+.||+|+||.||+|.+. +    +..||+|++......  +....|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999865 4    689999987643211  111111  1112222222222211      24


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCIL-------------------DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK  552 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  552 (652)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            5567899999999999999887543211                   1233567999999999999999   99999999


Q ss_pred             CCCeeeCC-CCcEEEecccCCccccCCCCccccccccCCccccCccccccC----------------------ccCcccc
Q 041689          553 PSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG----------------------RVFANGD  609 (652)
Q Consensus       553 p~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  609 (652)
                      |+|||+++ ++.+||+|||+++.+.... ........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 6799999999998653221 2223445789999999965322                      2345669


Q ss_pred             hhhHHHHHHHHHhCCCCcchh-------------------------------------------hhhhhcccchhhhccc
Q 041689          610 VYSFGIMLMEIHSAKQQCVSF-------------------------------------------VFNLAMECTIESLELR  646 (652)
Q Consensus       610 vwslG~vl~elltg~~p~~~~-------------------------------------------l~~l~~~~l~~~p~~R  646 (652)
                      |||+||++|||+++..|.+..                                           ..+++.+|++.||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999999876653321                                           1279999999999999


Q ss_pred             cCccCC
Q 041689          647 INAKEI  652 (652)
Q Consensus       647 pt~~ei  652 (652)
                      ||++|+
T Consensus       442 ~ta~e~  447 (566)
T PLN03225        442 ISAKAA  447 (566)
T ss_pred             CCHHHH
Confidence            999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=288.66  Aligned_cols=218  Identities=27%  Similarity=0.393  Sum_probs=181.8

Q ss_pred             CCccceeccccce-EEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccC
Q 041689          427 FNENNLIGKGGFG-TIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       427 y~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      |...+.+|.|+.| .||+|.. +|++||||++-.+   .....++|+..++.- +|||||++++.-.++.+.||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4555778899887 5699988 6889999998643   345668899999888 69999999999999999999999997


Q ss_pred             CCChhhhhhcCCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-----CCcEEEecccCCcccc
Q 041689          505 HGSLEKCLYSSNC---ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLI  576 (652)
Q Consensus       505 ~g~L~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~~~~~~  576 (652)
                      . +|.+++.....   .......+.+..|++.||++||+.   +||||||||.||||+.     ..+++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 99999987411   111134567899999999999998   9999999999999975     3589999999999886


Q ss_pred             CCCCccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhC-CCCcchh------------------------
Q 041689          577 GEDQSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA-KQQCVSF------------------------  630 (652)
Q Consensus       577 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~~~~------------------------  630 (652)
                      .+..... .....||-+|+|||++.....+.++||||+|||+|+.++| .+||.+.                        
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e  742 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE  742 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence            5544333 2455699999999999998888899999999999999987 8886553                        


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ..+++.+|+.++|..||+|.+|
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~V  764 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDV  764 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHH
Confidence            6789999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.8e-31  Score=272.54  Aligned_cols=202  Identities=22%  Similarity=0.279  Sum_probs=171.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .-|..++.||-|+||+|.+++.. +...||.|.+++.+.   .....++.|..||+..+.+-||++|..|.+.+..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34778899999999999999754 467799999876532   23445678999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc----
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI----  576 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~----  576 (652)
                      +|++||++-.++-..+ .+++.-+..++.++..|+++.|..   |+|||||||+|||||.+|++||+|||+++-+.    
T Consensus       709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence            9999999999887665 788888899999999999999999   99999999999999999999999999986431    


Q ss_pred             -----CCCCc-------------------------------cccccccCCccccCccccccCccCcccchhhHHHHHHHH
Q 041689          577 -----GEDQS-------------------------------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI  620 (652)
Q Consensus       577 -----~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el  620 (652)
                           ..+..                               ......+||+.|+|||++....|+...|+||.|||+|||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 00000                               000134699999999999999999999999999999999


Q ss_pred             HhCCCCcchh
Q 041689          621 HSAKQQCVSF  630 (652)
Q Consensus       621 ltg~~p~~~~  630 (652)
                      +.|+.||-+.
T Consensus       865 ~~g~~pf~~~  874 (1034)
T KOG0608|consen  865 LVGQPPFLAD  874 (1034)
T ss_pred             hhCCCCccCC
Confidence            9999996553

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=1.2e-33  Score=288.06  Aligned_cols=309  Identities=26%  Similarity=0.367  Sum_probs=237.4

Q ss_pred             ceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcc
Q 041689            7 GKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELS   85 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~   85 (652)
                      +-.|+++|+... ..+|... .+++++-|.|...++. .+|+.++.+.+|+.|.+++|++..+..               
T Consensus        10 rGvDfsgNDFsg-~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhG---------------   72 (1255)
T KOG0444|consen   10 RGVDFSGNDFSG-DRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHG---------------   72 (1255)
T ss_pred             ecccccCCcCCC-CcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhh---------------
Confidence            345788888874 4789888 7899999999999997 689999999999999999999875443               


Q ss_pred             cccccCCCCCCcEEEcccCCCc--ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           86 FLSSLSNCKSLVVFLLSNNPLN--GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        86 ~~~~l~~l~~L~~L~Ls~N~l~--~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                         .++.|+.|+.+++..|++.  |+++  .+..+.. |+.||||+|+++ ..|..+...+++-.|+||+|+|..++...
T Consensus        73 ---ELs~Lp~LRsv~~R~N~LKnsGiP~--diF~l~d-Lt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l  145 (1255)
T KOG0444|consen   73 ---ELSDLPRLRSVIVRDNNLKNSGIPT--DIFRLKD-LTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL  145 (1255)
T ss_pred             ---hhccchhhHHHhhhccccccCCCCc--hhccccc-ceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH
Confidence               3567788888888888886  3444  3555665 888888888888 67888888888888888888888666677


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC---CCCCcccCCCCcc
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND---GPLPLEIGNLKVL  240 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---~~~~~~~~~l~~L  240 (652)
                      |.+|+.|-+||||+|++. .+|+.+..+..|++|+|++|.+....-..+..+++|+.|++|+-+   ..+|.++..+.+|
T Consensus       146 finLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL  224 (1255)
T KOG0444|consen  146 FINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL  224 (1255)
T ss_pred             HHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence            888888888888888888 677778888888888888888876555566677778888887764   5678888888888


Q ss_pred             ceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecC
Q 041689          241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       241 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                      ..+|+|.|.+. +.|..+..+.+|+.|+||+|+|+ .+.-....+.+|+.|+||.|+|+ .+|++++.+++|+.|++.+|
T Consensus       225 ~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~N  301 (1255)
T KOG0444|consen  225 RDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNN  301 (1255)
T ss_pred             hhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccC
Confidence            88888888887 57788888888888888888887 55556667777888888888887 77777777777777777777


Q ss_pred             cCc--ccCCCCCCCCCcccccccCC
Q 041689          321 KLE--GEIPKGGSFGNFSAESFEGN  343 (652)
Q Consensus       321 ~l~--~~~p~~~~~~~l~~~~~~~N  343 (652)
                      +++  |.+...+.+..+..+..++|
T Consensus       302 kL~FeGiPSGIGKL~~Levf~aanN  326 (1255)
T KOG0444|consen  302 KLTFEGIPSGIGKLIQLEVFHAANN  326 (1255)
T ss_pred             cccccCCccchhhhhhhHHHHhhcc
Confidence            764  33333344444444444444

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=7e-31  Score=259.82  Aligned_cols=209  Identities=30%  Similarity=0.352  Sum_probs=183.8

Q ss_pred             cceEEEEEEeC-CCcEEEEEEeecccchh-hhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhc
Q 041689          437 GFGTIYKSRIG-DGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS  514 (652)
Q Consensus       437 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  514 (652)
                      +||.||+|... +++.||+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999997664433 67899999999999999999999999998999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCcccc
Q 041689          515 SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI  594 (652)
Q Consensus       515 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  594 (652)
                      .. .+++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            54 388899999999999999999999   99999999999999999999999999998753221   233455788999


Q ss_pred             CccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhhhcccchhhhcccc
Q 041689          595 APEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNLAMECTIESLELRI  647 (652)
Q Consensus       595 aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l~~~~l~~~p~~Rp  647 (652)
                      |||......++.++||||+|+++|+|++|..||..                           .+.+++.+||..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999888899999999999999999999888644                           367899999999999999


Q ss_pred             CccCC
Q 041689          648 NAKEI  652 (652)
Q Consensus       648 t~~ei  652 (652)
                      ++.|+
T Consensus       234 ~~~~~  238 (244)
T smart00220      234 TAEEA  238 (244)
T ss_pred             CHHHH
Confidence            99864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.97  E-value=1.6e-33  Score=287.05  Aligned_cols=316  Identities=28%  Similarity=0.397  Sum_probs=219.7

Q ss_pred             eceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCe--eccCCCccccccCCCC
Q 041689            6 IGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS--GSLSSIADNYLTSSTP   82 (652)
Q Consensus         6 l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~~l~~~~~   82 (652)
                      ++-|.|+...+.   .+|..+ .+.+|+.|.+++|++.. +-+.+..|+.|+.+++.+|++.  |+++.           
T Consensus        34 ~~WLkLnrt~L~---~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LKnsGiP~d-----------   98 (1255)
T KOG0444|consen   34 MTWLKLNRTKLE---QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLKNSGIPTD-----------   98 (1255)
T ss_pred             eeEEEechhhhh---hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccccCCCCch-----------
Confidence            334444444333   677776 66777777777777763 4445566666666666666654  23332           


Q ss_pred             CcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCc
Q 041689           83 ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF  162 (652)
Q Consensus        83 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  162 (652)
                             +.+|..|+.||||+|+++..+..  +..-. ++-+|+||+|+|.+++...|-+|+.|-.||||+|++. .+|.
T Consensus        99 -------iF~l~dLt~lDLShNqL~EvP~~--LE~AK-n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPP  167 (1255)
T KOG0444|consen   99 -------IFRLKDLTILDLSHNQLREVPTN--LEYAK-NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPP  167 (1255)
T ss_pred             -------hcccccceeeecchhhhhhcchh--hhhhc-CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCH
Confidence                   33455555555555555544332  22222 2555555555555544445555555555555555555 3344


Q ss_pred             cccCCCCCcEEecccCccc-------------------------cccCccccCCCCCcEEEccCCcccccccccCCCCCC
Q 041689          163 TLRELQKLQYVGLKDNKLE-------------------------GTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLAS  217 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  217 (652)
                      ....|.+|++|+|++|.+.                         .-+|..+..+.+|..+|||.|.+. ..|+++-++++
T Consensus       168 Q~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~  246 (1255)
T KOG0444|consen  168 QIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRN  246 (1255)
T ss_pred             HHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhh
Confidence            4455555555555555432                         246777888888888999999987 78888888999


Q ss_pred             CCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCC-cccccccccccCcceeccc
Q 041689          218 LRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG-SIPDSVGDLISLKSLNFSN  295 (652)
Q Consensus       218 L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~  295 (652)
                      |+.|+||+|+ ..+....+.+.+|++|+||.|+++ .+|.++..+++|+.|++.+|+|+- -+|..++.+.+|+.+..++
T Consensus       247 LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aan  325 (1255)
T KOG0444|consen  247 LRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAAN  325 (1255)
T ss_pred             hheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhc
Confidence            9999999997 555666777888899999999998 478899999999999999998873 4688899999999999999


Q ss_pred             cccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCCC
Q 041689          296 NNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       296 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      |.|. .+|+.++.+.+|+.|.|+.|++-..+...-.++.+..+++..||-+.-+|
T Consensus       326 N~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  326 NKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             cccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence            9997 89999999999999999999998776666788889999999998776555

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=6.2e-32  Score=244.34  Aligned_cols=231  Identities=18%  Similarity=0.287  Sum_probs=189.0

Q ss_pred             CCCccccccHHHHHHHhcCCCccceeccccceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeee
Q 041689          408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVK  485 (652)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  485 (652)
                      |...|............++|++.+++|+|.|++||.|. ..+.++++||++++-   ..+.+.+|+.|++.+. ||||++
T Consensus        21 p~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~   97 (338)
T KOG0668|consen   21 PREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIK   97 (338)
T ss_pred             chhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeee
Confidence            33444444433344566789999999999999999997 456889999999754   3467889999999996 999999


Q ss_pred             EEeeeecC--CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCC
Q 041689          486 IISSCSNE--EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTM  562 (652)
Q Consensus       486 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~  562 (652)
                      +++...+.  ....+|+||+.+.+...+..    .++...+..++.+++.||.|+|+.   ||+|||+||.|++|| +..
T Consensus        98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhc
Confidence            99998765  45679999999987766433    467778889999999999999999   999999999999998 456


Q ss_pred             cEEEecccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCc--------------
Q 041689          563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQC--------------  627 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~--------------  627 (652)
                      .++|+|+|+|.++..   .......+.+..|-.||.+.. ..|+..-|+|||||++..|+..+.||              
T Consensus       171 kLrlIDWGLAEFYHp---~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa  247 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA  247 (338)
T ss_pred             eeeeeecchHhhcCC---CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence            799999999998733   233445667888999998765 45778889999999999999999882              


Q ss_pred             -----------------------------------------------chhhhhhhcccchhhhccccCccC
Q 041689          628 -----------------------------------------------VSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       628 -----------------------------------------------~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                                                                     ++++.|++.+.+..|-.+|+||+|
T Consensus       248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence                                                           223678999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.3e-30  Score=275.34  Aligned_cols=226  Identities=18%  Similarity=0.187  Sum_probs=169.1

Q ss_pred             HhcCCCccceeccccceEEEEEEe-----------------CCCcEEEEEEeecccchhhh--------------hHHHH
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-----------------GDGMEVAVKVFHLQCGRAFK--------------SFDIE  471 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  471 (652)
                      ..++|++.++||+|+||.||+|..                 ..++.||||+++.......+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            366899999999999999999863                 23567999998654322222              23447


Q ss_pred             HHHHHhcCCCee-----eeEEeeeec--------CCceEEEEEccCCCChhhhhhcCCC---------------------
Q 041689          472 CEIMKSIHYRNL-----VKIISSCSN--------EEFKELVLEHMPHGSLEKCLYSSNC---------------------  517 (652)
Q Consensus       472 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  517 (652)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777866554     667777643        3567999999999999998864211                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccC
Q 041689          518 --ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA  595 (652)
Q Consensus       518 --~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  595 (652)
                        ..++..+..++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||++..+.... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence              235667888999999999999999   99999999999999999999999999997542211 111122335789999


Q ss_pred             ccccccCc--------------------cC--cccchhhHHHHHHHHHhCCC-Ccc------------------------
Q 041689          596 PEYGREGR--------------------VF--ANGDVYSFGIMLMEIHSAKQ-QCV------------------------  628 (652)
Q Consensus       596 PE~~~~~~--------------------~~--~~sDvwslG~vl~elltg~~-p~~------------------------  628 (652)
                      ||.+....                    ++  .+.||||+||++|||++|.. |+.                        
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875432                    11  24699999999999999875 432                        


Q ss_pred             ------------hhhhhhhcccchhhh---ccccCccCC
Q 041689          629 ------------SFVFNLAMECTIESL---ELRINAKEI  652 (652)
Q Consensus       629 ------------~~l~~l~~~~l~~~p---~~Rpt~~ei  652 (652)
                                  +..++++.+++..+|   .+|+|++|+
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ea  497 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQA  497 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence                        225789999999766   689999763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-31  Score=267.44  Aligned_cols=195  Identities=21%  Similarity=0.309  Sum_probs=169.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--------chhhhhHHHHHHHHHhcC---CCeeeeEEeeeec
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSIH---YRNLVKIISSCSN  492 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  492 (652)
                      .+|+..+.+|+|+||.|+.|.++ +..+|+||.+.+..        .+....+--|++||+.++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999876 46779999886541        122234556999999997   9999999999999


Q ss_pred             CCceEEEEEcc-CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          493 EEFKELVLEHM-PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       493 ~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ++++|++||-. ++.+|.+++..++ .+++.++..|++|++.|+++||.+   ||||||||-+||.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            99999999975 4569999998776 799999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCc
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQC  627 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~  627 (652)
                      +...    ...+....+||..|.|||++.+.+|- ..-||||+|+++|.++...-||
T Consensus       717 aa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  717 AAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             hhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            8764    34455677899999999999999885 5569999999999998888775

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-31  Score=273.25  Aligned_cols=223  Identities=24%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...+|...+.+|+|+||.||+|++. +++..|+|+++.....+..-.+.|+-+++..+|||||.+++.+...+..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3467888999999999999999965 689999999998877788888999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||.+|+|++.-+. .+++++.++...+++.++|++|||+.   |-+|||||-.||++++.|.+|++|||.+..+..  .-
T Consensus        93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            9999999995443 44899999999999999999999999   889999999999999999999999999876632  22


Q ss_pred             cccccccCCccccCcccc---ccCccCcccchhhHHHHHHHHHhCCCC----------------------------cchh
Q 041689          582 MTQTQTLATIGYIAPEYG---REGRVFANGDVYSFGIMLMEIHSAKQQ----------------------------CVSF  630 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p----------------------------~~~~  630 (652)
                      .......||+.|||||+.   +.+.|..+.|||+.|+...|+---++|                            |...
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            233456799999999974   567899999999999999998765555                            5556


Q ss_pred             hhhhhcccchhhhccccCccC
Q 041689          631 VFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                      +.++++.++..+|.+||+++.
T Consensus       247 fh~fvK~altknpKkRptaek  267 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEK  267 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhh
Confidence            889999999999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=1.7e-32  Score=266.91  Aligned_cols=324  Identities=27%  Similarity=0.436  Sum_probs=211.6

Q ss_pred             eeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCcc------ccccCC
Q 041689            8 KLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD------NYLTSS   80 (652)
Q Consensus         8 ~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------~~l~~~   80 (652)
                      .|+.++|.+.   ++|..+ ...++..|+.++|++. ..|+.++.+-.|+.|+..+|+|++.+++...      ..+.++
T Consensus        95 ~l~vs~n~ls---~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n  170 (565)
T KOG0472|consen   95 SLNVSHNKLS---ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGN  170 (565)
T ss_pred             HhhcccchHh---hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhcccc
Confidence            3344444444   344444 4444555555555544 3444444444555555555555444443211      001111


Q ss_pred             CCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccC
Q 041689           81 TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI  160 (652)
Q Consensus        81 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  160 (652)
                      ... ..++..-+++.|+.||..+|-+..++|+  ++.+.+ |+.|+|..|+|. ..| .|.+|..|++|+++.|+|. .+
T Consensus       171 ~l~-~l~~~~i~m~~L~~ld~~~N~L~tlP~~--lg~l~~-L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~l  243 (565)
T KOG0472|consen  171 KLK-ALPENHIAMKRLKHLDCNSNLLETLPPE--LGGLES-LELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-ML  243 (565)
T ss_pred             chh-hCCHHHHHHHHHHhcccchhhhhcCChh--hcchhh-hHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hh
Confidence            000 1112233477788888888888777764  566665 888888888888 455 7888888888888888888 45


Q ss_pred             Ccc-ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCC--------
Q 041689          161 PFT-LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPL--------  230 (652)
Q Consensus       161 ~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~--------  230 (652)
                      |.+ ..+++++..|||.+|+++ ..|+.++-+.+|++||+|+|.|++ .|..++++ .|+.|.+.+|. .++        
T Consensus       244 pae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~g  320 (565)
T KOG0472|consen  244 PAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKG  320 (565)
T ss_pred             HHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHccc
Confidence            544 458889999999999998 888889999999999999999984 56667777 77777777772 000        


Q ss_pred             ------------------------------Ccc-cCC---C--------------------------CccceEecccccC
Q 041689          231 ------------------------------PLE-IGN---L--------------------------KVLIGIDFSMNNF  250 (652)
Q Consensus       231 ------------------------------~~~-~~~---l--------------------------~~L~~L~ls~N~l  250 (652)
                                                    |.+ +..   +                          .-.+..+++.|++
T Consensus       321 T~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL  400 (565)
T KOG0472|consen  321 TQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQL  400 (565)
T ss_pred             HHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchH
Confidence                                          000 000   0                          0012333444433


Q ss_pred             Cc-----------------------cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccC--------
Q 041689          251 SS-----------------------VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS--------  299 (652)
Q Consensus       251 ~~-----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--------  299 (652)
                      ..                       .+|..+..+++|..|+|++|.+. .+|..++.+..|+.||+|.|++.        
T Consensus       401 ~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~  479 (565)
T KOG0472|consen  401 CELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYE  479 (565)
T ss_pred             hhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhh
Confidence            32                       34555667778888888888887 67777888878888888877764        


Q ss_pred             ---------------CCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccC
Q 041689          300 ---------------GAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       300 ---------------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~  346 (652)
                                     ...|..+.++.+|..|||.+|.+...+|..+.+.+++.+.+.|||+.
T Consensus       480 lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  480 LQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence                           33344477889999999999999999999999999999999999986

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-31  Score=244.72  Aligned_cols=193  Identities=23%  Similarity=0.324  Sum_probs=158.8

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----CceEEE
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EFKELV  499 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  499 (652)
                      +..+.||-|+||+||.+.+. +|+.||+|++..-  .-...+.+-+|++++..++|.|+...++...-.     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44578999999999999865 7999999988532  223456788899999999999999888876543     256788


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      .|.+.. +|.+.+-... .++...+.-+.+||++||+|||+.   +|.||||||.|.+++++..+||||||+++..+ .+
T Consensus       136 TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~d  209 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD-QR  209 (449)
T ss_pred             HHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc-hh
Confidence            898854 8888776544 688888888999999999999999   99999999999999999999999999998643 23


Q ss_pred             CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCC
Q 041689          580 QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      .....+..+.|..|+|||++.+. .|+.+.||||.||++.|++.++..
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL  257 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL  257 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh
Confidence            33344566788999999998775 588999999999999999875543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=243.63  Aligned_cols=217  Identities=23%  Similarity=0.251  Sum_probs=180.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------Cc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------EF  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  495 (652)
                      .+|.-.+.+|.|.- .|..|.+. .+++||+|.+...  .....++..+|...+..+.|+||++++.+|.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46667788888887 56556543 5899999987543  223446678899999999999999999998644      36


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+|||+|.. +|.+.+..   .++...+..|.+|++.|++|+|+.   ||+||||||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc
Confidence            7999999965 88888773   467788899999999999999999   9999999999999999999999999999853


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                         ......+..+.|..|.|||++.+..+.+.+||||.||++.||++|+--|..                          
T Consensus       169 ---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  169 ---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             ---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence               223455677889999999999998899999999999999999997653211                          


Q ss_pred             ---------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                             .+++++.+||..||++|.+++|+
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da  307 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA  307 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence                                                   16889999999999999998763

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.6e-28  Score=237.13  Aligned_cols=207  Identities=34%  Similarity=0.495  Sum_probs=181.0

Q ss_pred             eccccceEEEEEEeCC-CcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhh
Q 041689          433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEK  510 (652)
Q Consensus       433 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  510 (652)
                      ||+|++|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999765332 34678999999999999999999999999899999999999999999


Q ss_pred             hhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCCccccCCCCccccccccC
Q 041689          511 CLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLA  589 (652)
Q Consensus       511 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  589 (652)
                      ++......+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            9887634688999999999999999999999   9999999999999999 89999999999986532211  1233457


Q ss_pred             CccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcchhhhhhhcccchhhhccccCccCC
Q 041689          590 TIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       590 t~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ...|++||..... .++.++|+|++|+++++|        ..+.+++.+|++.+|++||+++|+
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------~~~~~~l~~~l~~~p~~R~~~~~l  211 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------PELKDLIRKMLQKDPEKRPSAKEI  211 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------HHHHHHHHHHhhCCcccCcCHHHH
Confidence            7889999998877 788999999999999999        789999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.4e-30  Score=259.20  Aligned_cols=197  Identities=24%  Similarity=0.259  Sum_probs=166.7

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC------CCeeeeEEeeeecC
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH------YRNLVKIISSCSNE  493 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~  493 (652)
                      +.-..+|.+....|+|-|+.|.+|.+. .|+.||||++.... ...+.=.+|+++|++++      --|+++++..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            345678999999999999999999865 48899999997652 23355578999999995      25899999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEeccc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFG  570 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg  570 (652)
                      .+.|+|+|-+.- +|.++++..+.  .+....+..++.|+.-||..|...   ||+|.||||+|||+++ ...+||||||
T Consensus       507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCc
Confidence            999999998855 99999986554  577888999999999999999999   9999999999999985 4679999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      .|......    ..+....+..|.|||++.+-+|+..-|+||.||++||++||+-.
T Consensus       583 SA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  583 SASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             cccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence            99875322    22344567789999999999999999999999999999998764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9e-29  Score=246.86  Aligned_cols=130  Identities=25%  Similarity=0.304  Sum_probs=109.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-----C---CeeeeEEeeeec---
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-----Y---RNLVKIISSCSN---  492 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~---  492 (652)
                      .+|.+.++||.|-|++||+|.+. ..+.||+|+++.. ....+....|+++|++++     |   ..||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67899999999999999999865 5678999999755 334456678999999983     3   469999999964   


Q ss_pred             -CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          493 -EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       493 -~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                       +.++|+|+|++ |-+|..+|.... ..++...+.+|++|++.||.|||..+  ||||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             45899999998 558888776543 36899999999999999999999987  99999999999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.96  E-value=6.5e-32  Score=262.88  Aligned_cols=304  Identities=27%  Similarity=0.400  Sum_probs=231.3

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCc---------
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIA---------   73 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~---------   73 (652)
                      +++.+|+.+.|+..   ++|..+ .+..++.|+..+|+|+ ..|+.+..+.+|..|++.+|++...++...         
T Consensus       114 ~~l~~l~~s~n~~~---el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld  189 (565)
T KOG0472|consen  114 ISLVKLDCSSNELK---ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLD  189 (565)
T ss_pred             hhhhhhhcccccee---ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcc
Confidence            35667777777777   788888 7889999999999998 578888899999999999999987776431         


Q ss_pred             --cccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEe
Q 041689           74 --DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL  151 (652)
Q Consensus        74 --~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  151 (652)
                        .|.+...      ++.++.+.+|+.|+|.+|+|..++   .|++... |++|+++.|+|+....+...++++|..|||
T Consensus       190 ~~~N~L~tl------P~~lg~l~~L~~LyL~~Nki~~lP---ef~gcs~-L~Elh~g~N~i~~lpae~~~~L~~l~vLDL  259 (565)
T KOG0472|consen  190 CNSNLLETL------PPELGGLESLELLYLRRNKIRFLP---EFPGCSL-LKELHVGENQIEMLPAEHLKHLNSLLVLDL  259 (565)
T ss_pred             cchhhhhcC------ChhhcchhhhHHHHhhhcccccCC---CCCccHH-HHHHHhcccHHHhhHHHHhcccccceeeec
Confidence              2333333      345889999999999999998765   3566665 999999999999544445569999999999


Q ss_pred             cCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccc-----------------------
Q 041689          152 GGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSI-----------------------  208 (652)
Q Consensus       152 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----------------------  208 (652)
                      ..|+++ ..|..+.-+.+|++||+|+|.|+ .+|..++++ .|+.|-+.+|.+..+-                       
T Consensus       260 RdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dg  336 (565)
T KOG0472|consen  260 RDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDG  336 (565)
T ss_pred             cccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCC
Confidence            999999 78999999999999999999999 677778887 7777777777653211                       


Q ss_pred             --------------------------------------------------------------------------------
Q 041689          209 --------------------------------------------------------------------------------  208 (652)
Q Consensus       209 --------------------------------------------------------------------------------  208 (652)
                                                                                                      
T Consensus       337 lS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~  416 (565)
T KOG0472|consen  337 LSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTD  416 (565)
T ss_pred             CCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHH
Confidence                                                                                            


Q ss_pred             -----------cccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCC
Q 041689          209 -----------LTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG  276 (652)
Q Consensus       209 -----------~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  276 (652)
                                 |..++.+++|..|+|++|- ..+|.+++.+..|+.||+|+|++. .+|.....+..++.+-.++|++..
T Consensus       417 l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~  495 (565)
T KOG0472|consen  417 LVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS  495 (565)
T ss_pred             HHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence                       1112334455555565553 455555555555666666666555 345555555555555555566665


Q ss_pred             cccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          277 SIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       277 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      +.|+.+.+|.+|..|||.+|.|. .+|..++++.+|++|++.+|+|. .++
T Consensus       496 vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr  544 (565)
T KOG0472|consen  496 VDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPR  544 (565)
T ss_pred             cChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCH
Confidence            66666899999999999999998 88889999999999999999999 443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.2e-27  Score=234.05  Aligned_cols=199  Identities=27%  Similarity=0.353  Sum_probs=172.9

Q ss_pred             CCccceeccccceEEEEEEeCC-CcEEEEEEeecccch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      |+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999998764 889999999866444 56788999999999999999999999998899999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +++|.+++......+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            9999999876553378899999999999999999999   999999999999999999999999999887633220 122


Q ss_pred             ccccCCccccCcccc-ccCccCcccchhhHHHHHHHHHhCCCCcch
Q 041689          585 TQTLATIGYIAPEYG-REGRVFANGDVYSFGIMLMEIHSAKQQCVS  629 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~p~~~  629 (652)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999998 666788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-29  Score=231.38  Aligned_cols=205  Identities=20%  Similarity=0.325  Sum_probs=163.3

Q ss_pred             CCCccccccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeee
Q 041689          408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVK  485 (652)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  485 (652)
                      +..+....++.|.      |.+.+.+|+|.||.+-+|+++ +.+.+|+|.+.... ....+|.+|...--.+ .|.||+.
T Consensus        13 ~~~el~kv~l~d~------y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~   85 (378)
T KOG1345|consen   13 PMEELKKVDLEDV------YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIID   85 (378)
T ss_pred             ccccccccchhhh------hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhH
Confidence            4455556666554      899999999999999999876 57889999987552 3457888888765555 5899998


Q ss_pred             EEee-eecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee--CCCC
Q 041689          486 IISS-CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL--DDTM  562 (652)
Q Consensus       486 ~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll--~~~~  562 (652)
                      -|+. |+..+.++++|||+|.|+|..-+...+  +-+.....++.|+++|+.|+|++   ++||||||.+||||  .+..
T Consensus        86 tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~  160 (378)
T KOG1345|consen   86 TYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFY  160 (378)
T ss_pred             HHHHHhhcCceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCcc
Confidence            7764 677788889999999999999877654  77888889999999999999999   99999999999999  2455


Q ss_pred             cEEEecccCCccccCCCCccccccccCCccccCcccccc---C--ccCcccchhhHHHHHHHHHhCCCCcch
Q 041689          563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE---G--RVFANGDVYSFGIMLMEIHSAKQQCVS  629 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDvwslG~vl~elltg~~p~~~  629 (652)
                      ++|+||||..+..     .........+..|.|||....   +  ...+.+|+|.||+++|.++||+.||..
T Consensus       161 rvKlcDFG~t~k~-----g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  161 RVKLCDFGLTRKV-----GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             EEEeeeccccccc-----CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            8999999998753     122222335667999996432   2  245778999999999999999999554

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-31  Score=256.40  Aligned_cols=315  Identities=21%  Similarity=0.237  Sum_probs=253.7

Q ss_pred             cCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCC
Q 041689           13 VDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSN   92 (652)
Q Consensus        13 ~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~   92 (652)
                      .|+...+.+||..+ |...++++|..|+|+.+.|++|..+++|+.||||+|+|+.+-|                 .+|.+
T Consensus        52 dCr~~GL~eVP~~L-P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p-----------------~AF~G  113 (498)
T KOG4237|consen   52 DCRGKGLTEVPANL-PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAP-----------------DAFKG  113 (498)
T ss_pred             EccCCCcccCcccC-CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcCh-----------------Hhhhh
Confidence            36777888999999 9999999999999999999999999999999999999987666                 47889


Q ss_pred             CCCCcEEEccc-CCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCc
Q 041689           93 CKSLVVFLLSN-NPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ  171 (652)
Q Consensus        93 l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  171 (652)
                      +++|..|-+.+ |+|+.++.+ .|++|.. |+.|.+.-|++.-+..++|..|++|..|.|..|.+..+...+|..+..++
T Consensus       114 L~~l~~Lvlyg~NkI~~l~k~-~F~gL~s-lqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~  191 (498)
T KOG4237|consen  114 LASLLSLVLYGNNKITDLPKG-AFGGLSS-LQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIK  191 (498)
T ss_pred             hHhhhHHHhhcCCchhhhhhh-HhhhHHH-HHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccc
Confidence            99987776666 999999888 8999987 99999999999999999999999999999999999977677999999999


Q ss_pred             EEecccCcc------------ccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEE--EccCC--C-CCCCcc-
Q 041689          172 YVGLKDNKL------------EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTL--SLSYN--D-GPLPLE-  233 (652)
Q Consensus       172 ~L~L~~N~l------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~Ls~N--~-~~~~~~-  233 (652)
                      .+.+..|.+            ....|-.++...-.....+.++++..+.+..|..-  ++.+  .++.+  . ...|.. 
T Consensus       192 tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~c  269 (498)
T KOG4237|consen  192 TLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKC  269 (498)
T ss_pred             hHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHH
Confidence            999999983            22344555665556666677777776666555432  3333  22222  2 334443 


Q ss_pred             cCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       234 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      |..+++|+.|+|++|+|+++-+.+|.+...+++|+|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+.+|.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            88999999999999999999999999999999999999999988888899999999999999999989999999999999


Q ss_pred             eEEeecCcCcccCCCCCCCCCcccccccCCccCCCCC
Q 041689          314 HLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       314 ~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      .|+|-.|++.|...-.+.-.+++.-...||| .|++|
T Consensus       350 ~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~-~Cq~p  385 (498)
T KOG4237|consen  350 TLNLLSNPFNCNCRLAWLGEWLRKKSVVGNP-RCQSP  385 (498)
T ss_pred             eeehccCcccCccchHHHHHHHhhCCCCCCC-CCCCC
Confidence            9999999998765433222233333333443 35544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.94  E-value=4.1e-26  Score=251.94  Aligned_cols=259  Identities=24%  Similarity=0.255  Sum_probs=206.7

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      +.|+|+.+.++   ++|..+ +.+|+.|++++|+|+. +|.   .+++|++|+|++|+|+.++.                
T Consensus       204 ~~LdLs~~~Lt---sLP~~l-~~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~----------------  259 (788)
T PRK15387        204 AVLNVGESGLT---TLPDCL-PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV----------------  259 (788)
T ss_pred             cEEEcCCCCCC---cCCcch-hcCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccC----------------
Confidence            46888888777   699988 6699999999999995 554   36899999999999985532                


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccC
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRE  166 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  166 (652)
                           ..++|+.|+|++|.|+.++.      ++.+|+.|++++|+|+.+ |.   ..++|+.|+|++|+|+++ |...  
T Consensus       260 -----lp~sL~~L~Ls~N~L~~Lp~------lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~lp--  321 (788)
T PRK15387        260 -----LPPGLLELSIFSNPLTHLPA------LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PALP--  321 (788)
T ss_pred             -----cccccceeeccCCchhhhhh------chhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCCc--
Confidence                 13578999999999986643      344599999999999954 44   347899999999999964 4332  


Q ss_pred             CCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEec
Q 041689          167 LQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDF  245 (652)
Q Consensus       167 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~l  245 (652)
                       .+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|++++ ..   ..+|+.|++++|+ ..+|..   ..+|+.|++
T Consensus       322 -~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP-~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdL  389 (788)
T PRK15387        322 -SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASLP-TL---PSELYKLWAYNNRLTSLPAL---PSGLKELIV  389 (788)
T ss_pred             -ccccccccccCccc-ccccc---ccccceEecCCCccCCCC-CC---CcccceehhhccccccCccc---ccccceEEe
Confidence             46888999999998 45542   248999999999999644 32   3578899999997 455543   357899999


Q ss_pred             ccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCccc
Q 041689          246 SMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       246 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      ++|+|++ +|..   .++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.
T Consensus       390 s~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~  460 (788)
T PRK15387        390 SGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER  460 (788)
T ss_pred             cCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCch
Confidence            9999996 4443   367999999999999 466543   46889999999998 7899999999999999999999987


Q ss_pred             CCC
Q 041689          326 IPK  328 (652)
Q Consensus       326 ~p~  328 (652)
                      .+.
T Consensus       461 ~~~  463 (788)
T PRK15387        461 TLQ  463 (788)
T ss_pred             HHH
Confidence            654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=7.6e-27  Score=230.47  Aligned_cols=198  Identities=24%  Similarity=0.318  Sum_probs=163.0

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      +..-.+.|...++||+|+|+.||+|...    ..+.||+|.+....  ...++..|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999642    46789999986543  346688999999999 5899999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEecccCCc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITK  573 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~~~  573 (652)
                      ...+|+||++..+..++...    ++..++..+++.+..||+++|..   |||||||||.|++.+ ..++-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888887764    66788999999999999999999   999999999999997 45678899999987


Q ss_pred             cccCCC--------------C----------------------------ccccccccCCccccCcccccc-CccCcccch
Q 041689          574 LLIGED--------------Q----------------------------SMTQTQTLATIGYIAPEYGRE-GRVFANGDV  610 (652)
Q Consensus       574 ~~~~~~--------------~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv  610 (652)
                      ......              .                            ........||++|+|||++.. ...+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            221000              0                            000013359999999998754 457889999


Q ss_pred             hhHHHHHHHHHhCCCC
Q 041689          611 YSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       611 wslG~vl~elltg~~p  626 (652)
                      ||.||++.-+++++.|
T Consensus       262 ws~GVI~Lslls~~~P  277 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYP  277 (418)
T ss_pred             eeccceeehhhccccc
Confidence            9999999999999998

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-28  Score=261.63  Aligned_cols=327  Identities=31%  Similarity=0.364  Sum_probs=244.6

Q ss_pred             eceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCcc----------
Q 041689            6 IGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----------   74 (652)
Q Consensus         6 l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----------   74 (652)
                      |+.|.++.|.++   ++|..+ ++++|++|.|.+|.++ ..|..+..+++|+.|++|+|++...+.-+..          
T Consensus        70 L~~ln~s~n~i~---~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s  145 (1081)
T KOG0618|consen   70 LRQLNLSRNYIR---SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAAS  145 (1081)
T ss_pred             HhhcccchhhHh---hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhh
Confidence            445555666666   567666 7889999999999988 6888999999999999999998754442211          


Q ss_pred             -c--------------cccCCCCCcccc-------------------cccCCC--------------------CCCcEEE
Q 041689           75 -N--------------YLTSSTPELSFL-------------------SSLSNC--------------------KSLVVFL  100 (652)
Q Consensus        75 -~--------------~l~~~~~~~~~~-------------------~~l~~l--------------------~~L~~L~  100 (652)
                       |              .+..+.....++                   ..+.++                    ++|+.|+
T Consensus       146 ~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~  225 (1081)
T KOG0618|consen  146 NNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALY  225 (1081)
T ss_pred             cchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheee
Confidence             0              000000000000                   111222                    3445555


Q ss_pred             cccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCcc
Q 041689          101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKL  180 (652)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  180 (652)
                      .++|.++.+.+    ...|.+|+++++++|+++. +|+++..+.+|+.|+..+|+|+ ..|..+...++|+.|.+..|.+
T Consensus       226 a~~n~l~~~~~----~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel  299 (1081)
T KOG0618|consen  226 ADHNPLTTLDV----HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL  299 (1081)
T ss_pred             eccCcceeecc----ccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence            55555553322    2346679999999999995 5599999999999999999996 7788888889999999999999


Q ss_pred             ccccCccccCCCCCcEEEccCCcccccccccCCC-------------------------CCCCCEEEccCCC--CCCCcc
Q 041689          181 EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSN-------------------------LASLRTLSLSYND--GPLPLE  233 (652)
Q Consensus       181 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------------------------l~~L~~L~Ls~N~--~~~~~~  233 (652)
                      + .+|+...+++.|++|+|..|+|...++..|..                         ++.|+.|++.+|.  ...-+.
T Consensus       300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~  378 (1081)
T KOG0618|consen  300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV  378 (1081)
T ss_pred             h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence            8 77777888999999999999998655443322                         2345666667774  344455


Q ss_pred             cCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       234 ~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      +.+.++|+.|+|++|+|...+...+.++..|++|+||+|+|+ .+|+.+..++.|++|...+|+|. ..| .+..++.|+
T Consensus       379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            777888999999999999877778889999999999999998 78899999999999999999998 677 788999999


Q ss_pred             eEEeecCcCcc-cCCCCCCCCCcccccccCCccC
Q 041689          314 HLNLSFNKLEG-EIPKGGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       314 ~L~L~~N~l~~-~~p~~~~~~~l~~~~~~~N~~~  346 (652)
                      .+|++.|.|+- .+|....+++++.+++.||.|.
T Consensus       456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             EEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99999999984 4455556689999999999974

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=2.2e-26  Score=265.47  Aligned_cols=172  Identities=15%  Similarity=0.212  Sum_probs=132.4

Q ss_pred             hcCC-CeeeeEEeeee-------cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 041689          477 SIHY-RNLVKIISSCS-------NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH  548 (652)
Q Consensus       477 ~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  548 (652)
                      .++| +||+.++++|.       ..+.++.+|||+ +++|.+++......+++.++..++.||++||+|||++   ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            3445 57778888772       234567788887 5599999976555799999999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCC-------------------CcEEEecccCCccccCCCC--------------ccccccccCCccccC
Q 041689          549 CDLKPSNVLLDDT-------------------MVAHLSDFGITKLLIGEDQ--------------SMTQTQTLATIGYIA  595 (652)
Q Consensus       549 ~dlkp~NIll~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~a  595 (652)
                      |||||+|||++..                   +.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4556666666553210000              000112357889999


Q ss_pred             ccccccCccCcccchhhHHHHHHHHHhCCCCcchh----------------------hhhhhcccchhhhccccCccCC
Q 041689          596 PEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF----------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       596 PE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~----------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ||++.+..++.++|||||||++|||++|.+|+...                      ..+++.+||..+|.+||++.||
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            99999999999999999999999999998885421                      3567788999999999999875

>PLN03210 Resistant to P

Probab=99.92  E-value=8.6e-24  Score=251.25  Aligned_cols=308  Identities=25%  Similarity=0.285  Sum_probs=225.9

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST   81 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~   81 (652)
                      +|.+|+.|.++.+.++   .+|..+.+.+|++|+|++|+|. .+|..+..+++|+.|+|++|.....+|           
T Consensus       587 lp~~Lr~L~~~~~~l~---~lP~~f~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-----------  651 (1153)
T PLN03210        587 LPPKLRLLRWDKYPLR---CMPSNFRPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-----------  651 (1153)
T ss_pred             cCcccEEEEecCCCCC---CCCCcCCccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-----------
Confidence            4667888888877766   6787777888888888888887 467777888888888888765322222           


Q ss_pred             CCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP  161 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  161 (652)
                             .+..+++|+.|+|++|......|. .+..+++ |+.|++++|.-.+.+|..+ ++++|+.|+|++|......|
T Consensus       652 -------~ls~l~~Le~L~L~~c~~L~~lp~-si~~L~~-L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p  721 (1153)
T PLN03210        652 -------DLSMATNLETLKLSDCSSLVELPS-SIQYLNK-LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFP  721 (1153)
T ss_pred             -------ccccCCcccEEEecCCCCccccch-hhhccCC-CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccc
Confidence                   356678888888888765444454 5777775 8888888865444566555 78888888888886554555


Q ss_pred             ccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcc-------cccccccCCCCCCCCEEEccCCC--CCCCc
Q 041689          162 FTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL-------SGSILTCFSNLASLRTLSLSYND--GPLPL  232 (652)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-------~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~  232 (652)
                      ..   .++|++|+|++|.++ .+|..+ .+++|++|++.++..       ....+..+...++|+.|+|++|.  ..+|.
T Consensus       722 ~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~  796 (1153)
T PLN03210        722 DI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPS  796 (1153)
T ss_pred             cc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccCh
Confidence            32   457888888888887 566544 577888888876432       22222233445789999999985  66888


Q ss_pred             ccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCC
Q 041689          233 EIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL  312 (652)
Q Consensus       233 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  312 (652)
                      .++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   ..+|+.|+|++|.++ .+|..+..+++|
T Consensus       797 si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L  871 (1153)
T PLN03210        797 SIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNL  871 (1153)
T ss_pred             hhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCC
Confidence            89999999999999875444566655 6889999999987554455543   357899999999998 678889999999


Q ss_pred             ceEEeec-CcCcccCCCCCCCCCcccccccCCc
Q 041689          313 EHLNLSF-NKLEGEIPKGGSFGNFSAESFEGNK  344 (652)
Q Consensus       313 ~~L~L~~-N~l~~~~p~~~~~~~l~~~~~~~N~  344 (652)
                      +.|+|++ |++++.++....+..++.+++.+.+
T Consensus       872 ~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        872 SFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            9999998 7777766666777777777776554

syringae 6; Provisional

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.8e-24  Score=221.70  Aligned_cols=167  Identities=18%  Similarity=0.132  Sum_probs=129.5

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC--CCcEEEEEEeecc-----cchhhhhHHHHHHHHHhcCCCeeee-EEeeeec
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQ-----CGRAFKSFDIECEIMKSIHYRNLVK-IISSCSN  492 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~  492 (652)
                      .....+|+..+.||+|+||+||+|++.  +++.||||++...     .......+.+|++++++++|+|+++ ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            344567999999999999999999864  5777899987533     1223567899999999999999985 4432   


Q ss_pred             CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCeeeCCCCcEEEecccC
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL-KPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfg~  571 (652)
                       +..|+||||++|++|... ..    ..   ...++.|+++||+|||++   ||+|||| ||+||+++.++.+||+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence             457999999999999732 11    11   146789999999999999   9999999 99999999999999999999


Q ss_pred             CccccCCCCccc------cccccCCccccCccccccC
Q 041689          572 TKLLIGEDQSMT------QTQTLATIGYIAPEYGREG  602 (652)
Q Consensus       572 ~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  602 (652)
                      |+.+........      .....+++.|+|||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            987643321111      1344578889999987644

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.4e-24  Score=239.81  Aligned_cols=248  Identities=24%  Similarity=0.284  Sum_probs=197.7

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST   81 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~   81 (652)
                      +|.+|+.|+++.|.++   ++|..  +++|++|+|++|+|+. +|..   .++|+.|+|++|.|+.++.           
T Consensus       220 l~~~L~~L~L~~N~Lt---~LP~l--p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~Lp~-----------  279 (788)
T PRK15387        220 LPAHITTLVIPDNNLT---SLPAL--PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTHLPA-----------  279 (788)
T ss_pred             hhcCCCEEEccCCcCC---CCCCC--CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhhhhh-----------
Confidence            4568899999999888   57764  6899999999999995 4543   4689999999999985432           


Q ss_pred             CCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP  161 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  161 (652)
                                -.++|+.|+|++|+|+.++..      +++|+.|+|++|+|+++ |...   .+|+.|++++|+|++ +|
T Consensus       280 ----------lp~~L~~L~Ls~N~Lt~LP~~------p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~-LP  338 (788)
T PRK15387        280 ----------LPSGLCKLWIFGNQLTSLPVL------PPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTS-LP  338 (788)
T ss_pred             ----------chhhcCEEECcCCcccccccc------ccccceeECCCCccccC-CCCc---ccccccccccCcccc-cc
Confidence                      125688999999999977542      34599999999999964 4433   468899999999985 44


Q ss_pred             ccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCcc
Q 041689          162 FTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVL  240 (652)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L  240 (652)
                      ..   ..+|++|+|++|+|+ .+|..   ..+|+.|++++|+|+++ |..   ..+|+.|+|++|. ..+|..   .++|
T Consensus       339 ~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l---~s~L  404 (788)
T PRK15387        339 TL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL---PSEL  404 (788)
T ss_pred             cc---ccccceEecCCCccC-CCCCC---CcccceehhhccccccC-ccc---ccccceEEecCCcccCCCCc---ccCC
Confidence            32   257999999999999 45643   24788999999999964 443   3679999999997 445543   3578


Q ss_pred             ceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCC
Q 041689          241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL  309 (652)
Q Consensus       241 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  309 (652)
                      +.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+
T Consensus       405 ~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        405 KELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            999999999997 4543   356889999999999 789999999999999999999999888877443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-26  Score=225.69  Aligned_cols=296  Identities=20%  Similarity=0.186  Sum_probs=225.8

Q ss_pred             EEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCc
Q 041689           33 ELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPR  112 (652)
Q Consensus        33 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~  112 (652)
                      ..|-++-.++ .+|..+-  ..-+.++|..|+|+.+++.                 +|+.+++|++||||+|+|+.|.|+
T Consensus        50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~-----------------aF~~l~~LRrLdLS~N~Is~I~p~  109 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPG-----------------AFKTLHRLRRLDLSKNNISFIAPD  109 (498)
T ss_pred             eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChh-----------------hccchhhhceecccccchhhcChH
Confidence            4566677777 4565442  3678899999999988874                 688999999999999999999998


Q ss_pred             cchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCC
Q 041689          113 MSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV  192 (652)
Q Consensus       113 ~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  192 (652)
                       .|.++..-++-+++++|+|+.+..++|.+|..|+.|.+.-|++..+...+|..+++|..|.|-+|.+..+....|..+.
T Consensus       110 -AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~  188 (498)
T KOG4237|consen  110 -AFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLA  188 (498)
T ss_pred             -hhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchh
Confidence             7888887444555666999988889999999999999999999988899999999999999999999944444888999


Q ss_pred             CCcEEEccCCccc------------ccccccCCCCCCCCEEEccCCC-CCCCc-ccC-CCCccc-eEecccccCCccCcc
Q 041689          193 KLYKLDLGGNKLS------------GSILTCFSNLASLRTLSLSYND-GPLPL-EIG-NLKVLI-GIDFSMNNFSSVIPT  256 (652)
Q Consensus       193 ~L~~L~L~~N~l~------------~~~~~~~~~l~~L~~L~Ls~N~-~~~~~-~~~-~l~~L~-~L~ls~N~l~~~~~~  256 (652)
                      +++.+.+..|.+-            ...|-.++...-..-..+.+++ ..++. .|. .+..+. .+....+.....+..
T Consensus       189 ~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~  268 (498)
T KOG4237|consen  189 AIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAK  268 (498)
T ss_pred             ccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHH
Confidence            9999999999842            1222223333322223333332 11111 111 111221 122222233323345


Q ss_pred             cccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCCCCc
Q 041689          257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSFGNF  335 (652)
Q Consensus       257 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~l  335 (652)
                      .|..+++|+.|+|++|+|+++-+.+|..+..++.|.|..|+|..+....|.++..|+.|+|.+|+|++..|.. ..+..+
T Consensus       269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l  348 (498)
T KOG4237|consen  269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSL  348 (498)
T ss_pred             HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccccee
Confidence            6999999999999999999999999999999999999999999888899999999999999999999987754 566678


Q ss_pred             ccccccCCccCCCC
Q 041689          336 SAESFEGNKLLCGS  349 (652)
Q Consensus       336 ~~~~~~~N~~~c~~  349 (652)
                      +.+.+-+|||.|..
T Consensus       349 ~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  349 STLNLLSNPFNCNC  362 (498)
T ss_pred             eeeehccCcccCcc
Confidence            88999999999964

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=9.6e-25  Score=205.09  Aligned_cols=129  Identities=22%  Similarity=0.183  Sum_probs=113.6

Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |+|.+++...+..+++.++..|+.|++.||+|||++   +      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc-------
Confidence            689999987665799999999999999999999988   5      999999999999999  9998865221       


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------------hhh
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------------FVF  632 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------------~l~  632 (652)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..                                 .+.
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA  142 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence            12578999999999999999999999999999999999998532                                 367


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..+|++||++.||
T Consensus       143 ~~i~~cl~~~p~~Rp~~~~l  162 (176)
T smart00750      143 DFMRVCASRLPQRREAANHY  162 (176)
T ss_pred             HHHHHHHhcccccccCHHHH
Confidence            89999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.91  E-value=2e-26  Score=246.34  Aligned_cols=315  Identities=25%  Similarity=0.299  Sum_probs=214.5

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTP   82 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~   82 (652)
                      +.|+.|+|+.|.+.   .+|..| .+.+|++|+++.|-|. ..|.....+.+|++|+|..|++...+.+           
T Consensus        45 v~L~~l~lsnn~~~---~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~lP~~-----------  109 (1081)
T KOG0618|consen   45 VKLKSLDLSNNQIS---SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQSLPAS-----------  109 (1081)
T ss_pred             eeeEEeeccccccc---cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhcCchh-----------
Confidence            45888999988887   688888 7789999999999998 5778888999999999999998865543           


Q ss_pred             CcccccccCCCCCCcEEEcccCCCcccCCcc-------------------------------------------------
Q 041689           83 ELSFLSSLSNCKSLVVFLLSNNPLNGILPRM-------------------------------------------------  113 (652)
Q Consensus        83 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-------------------------------------------------  113 (652)
                             +..+++|++||+|.|++..++.-.                                                 
T Consensus       110 -------~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~  182 (1081)
T KOG0618|consen  110 -------ISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQ  182 (1081)
T ss_pred             -------HHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhee
Confidence                   344444555555555443332200                                                 


Q ss_pred             -----------chhcccc-------------------cCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689          114 -----------SIGNLSH-------------------SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus       114 -----------~~~~l~~-------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                                 ...+++.                   +|+.|+.++|.+....+.  ..-.+|+++++++|+++ .+|.+
T Consensus       183 ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~w  259 (1081)
T KOG0618|consen  183 LDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEW  259 (1081)
T ss_pred             eecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHH
Confidence                       0000000                   122222222222211110  01123455555555555 23355


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccC-------
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIG-------  235 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~-------  235 (652)
                      +..+.+|+.++..+|+|+ .+|..+...++|++|++.+|.+. -+|....++++|++|+|..|. ..+|+.+-       
T Consensus       260 i~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l  337 (1081)
T KOG0618|consen  260 IGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASL  337 (1081)
T ss_pred             HHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHH
Confidence            555555555555555554 55555555555666666666665 345556678888999998885 44444211       


Q ss_pred             -------------------CCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceecccc
Q 041689          236 -------------------NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN  296 (652)
Q Consensus       236 -------------------~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  296 (652)
                                         ..+.|+.|.+.+|.++...-..+.++++|+.|+|++|+|.......+.++..|+.|+||+|
T Consensus       338 ~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGN  417 (1081)
T KOG0618|consen  338 NTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGN  417 (1081)
T ss_pred             HHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccc
Confidence                               1235777888888888766667888999999999999999665667889999999999999


Q ss_pred             ccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCC
Q 041689          297 NLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       297 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c  347 (652)
                      +|+ .+|..+..+..|++|...+|++.+.| ....++.++.++++.|.+.-
T Consensus       418 kL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  418 KLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             hhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhh
Confidence            998 88899999999999999999999665 88899999999999997654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=1.5e-23  Score=233.44  Aligned_cols=244  Identities=24%  Similarity=0.382  Sum_probs=117.9

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      ..|+++.+.+.   ++|..+ +++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|++++..               
T Consensus       181 ~~L~L~~~~Lt---sLP~~I-p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsLP~~---------------  238 (754)
T PRK15370        181 TELRLKILGLT---TIPACI-PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSIPAT---------------  238 (754)
T ss_pred             eEEEeCCCCcC---cCCccc-ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccCChh---------------
Confidence            44555554444   455544 4455555555555553 333332  3555555555555433221               


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccC
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRE  166 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  166 (652)
                         +  ..+|+.|+|++|++..++..     ++++|+.|++++|+|+. +|..+.  ++|+.|+|++|+|++ +|..+. 
T Consensus       239 ---l--~~~L~~L~Ls~N~L~~LP~~-----l~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp-  303 (754)
T PRK15370        239 ---L--PDTIQEMELSINRITELPER-----LPSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP-  303 (754)
T ss_pred             ---h--hccccEEECcCCccCcCChh-----HhCCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch-
Confidence               1  12355555555555543221     12235555555555552 333332  345555555555553 222221 


Q ss_pred             CCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecc
Q 041689          167 LQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFS  246 (652)
Q Consensus       167 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls  246 (652)
                       ++|+.|++++|+++ .+|..+.  ++|+.|++++|.+++                       +|..+.  ++|+.|+++
T Consensus       304 -~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-----------------------LP~~l~--~sL~~L~Ls  354 (754)
T PRK15370        304 -SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-----------------------LPASLP--PELQVLDVS  354 (754)
T ss_pred             -hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-----------------------CChhhc--CcccEEECC
Confidence             24455555555555 2333222  245555555555543                       333222  355556666


Q ss_pred             cccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhh----cCCCCCceEEeecCcC
Q 041689          247 MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLL----EKLSYLEHLNLSFNKL  322 (652)
Q Consensus       247 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l  322 (652)
                      +|+|+. +|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|+ .+|..+    ..++.+..|++.+|++
T Consensus       355 ~N~L~~-LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npl  427 (754)
T PRK15370        355 KNQITV-LPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPF  427 (754)
T ss_pred             CCCCCc-CChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCc
Confidence            666653 343332  45666666666666 3444333  24666666666665 334332    3345666666666666


Q ss_pred             c
Q 041689          323 E  323 (652)
Q Consensus       323 ~  323 (652)
                      +
T Consensus       428 s  428 (754)
T PRK15370        428 S  428 (754)
T ss_pred             c
Confidence            5

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=208.20  Aligned_cols=200  Identities=24%  Similarity=0.302  Sum_probs=165.8

Q ss_pred             CCCccceeccccceEEEEEEeCCC--cEEEEEEeecccchhhhhHHHHHHHHHhcCC----CeeeeEEeee-ecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDG--MEVAVKVFHLQCGRAFKSFDIECEIMKSIHY----RNLVKIISSC-SNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  498 (652)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|+.++..+..    +++..+++.. ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999986553  5789998765533333378889999998863    6899999998 57788999


Q ss_pred             EEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-----CcEEEecccCC
Q 041689          499 VLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-----MVAHLSDFGIT  572 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-----~~~kl~Dfg~~  572 (652)
                      ||+.+ |.+|.++..... ..++..++..|+.|++.+|+++|+.   |++||||||+|+.++..     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 669999775554 5799999999999999999999999   99999999999999754     46999999999


Q ss_pred             c--cccCCCCc----c-c-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch
Q 041689          573 K--LLIGEDQS----M-T-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS  629 (652)
Q Consensus       573 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~  629 (652)
                      +  .+......    . . .....||..|+++....+...+.+.|+||++.++.|+..|..||..
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence            8  43222211    1 1 1235599999999999999999999999999999999999999744

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.1e-23  Score=189.61  Aligned_cols=202  Identities=22%  Similarity=0.272  Sum_probs=169.0

Q ss_pred             HhcCCCccceeccccceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC-CeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  500 (652)
                      ....|...++||+|+||.+|.|. ..+|.+||+|.-+...  ...++..|.++...+++ ..|+.+..+..+..+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34679999999999999999997 5679999999865442  33567889999999975 67888888888888999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~  577 (652)
                      +.. |.+|+++..-....++..+++-.+-|++.-++|+|.+   +++||||||+|+++.   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            988 6799998876666799999999999999999999999   999999999999996   345799999999998754


Q ss_pred             CCCcc-----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          578 EDQSM-----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       578 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      .....     ......||..|.+-....+...+.+.|+=|+|.++.+...|..||...
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            33221     113345899999988887778889999999999999999999998664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=7.7e-23  Score=227.67  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=152.1

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .+..+|++++++++. +|..+.  ++|+.|+|++|+|++++..                  +  .++|++|+|++|+|++
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~LtsLP~~------------------l--~~nL~~L~Ls~N~Lts  234 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKSLPEN------------------L--QGNIKTLYANSNQLTS  234 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCcCChh------------------h--ccCCCEEECCCCcccc
Confidence            345667777776663 454442  3566777777766643321                  1  1356666666666665


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      ++..     ++.+|+.|+|++|+|. .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|+ .+|..+
T Consensus       235 LP~~-----l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l  302 (754)
T PRK15370        235 IPAT-----LPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHL  302 (754)
T ss_pred             CChh-----hhccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccc
Confidence            4321     1234666666666666 3344332  355666666666652 333332  24555555555555 233322


Q ss_pred             cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEE
Q 041689          189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLF  268 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~  268 (652)
                      .  .+|+.|++++|+++.                       +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|+
T Consensus       303 p--~sL~~L~Ls~N~Lt~-----------------------LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~  352 (754)
T PRK15370        303 P--SGITHLNVQSNSLTA-----------------------LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLD  352 (754)
T ss_pred             h--hhHHHHHhcCCcccc-----------------------CCccc--cccceeccccCCcccc-CChhhc--CcccEEE
Confidence            2  234444455544442                       33222  1467888888898886 565554  6899999


Q ss_pred             ccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC----CCCCCcccccccCCc
Q 041689          269 LGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG----GSFGNFSAESFEGNK  344 (652)
Q Consensus       269 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~~~l~~~~~~~N~  344 (652)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|++.+...    ...+.+..+++.+|+
T Consensus       353 Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Np  426 (754)
T PRK15370        353 VSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNP  426 (754)
T ss_pred             CCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCC
Confidence            9999998 5676553  68999999999999 4565554  36999999999999554322    233567788999999


Q ss_pred             cCC
Q 041689          345 LLC  347 (652)
Q Consensus       345 ~~c  347 (652)
                      +..
T Consensus       427 ls~  429 (754)
T PRK15370        427 FSE  429 (754)
T ss_pred             ccH
Confidence            864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-22  Score=193.08  Aligned_cols=200  Identities=18%  Similarity=0.245  Sum_probs=171.0

Q ss_pred             cCCCccceeccccceEEEEEE-eCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      -.|.++++||+|+||+++.|. .-++++||||.-...+  ...++..|.+.++.+ ..++|..+|.+..++.+-.+|+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            369999999999999999997 4479999999764432  336778899999988 479999999998888888999998


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-----CCcEEEecccCCccccC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLIG  577 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~~~~~~~  577 (652)
                      + |.+|+++..-.+..++..++..++.|++.-++|+|++   ..|.|||||+|+||..     ...+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 6699998877777899999999999999999999999   9999999999999963     45799999999998865


Q ss_pred             CCCcc-----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          578 EDQSM-----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       578 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      .....     ......||.+||+-....+.+.+.+.|+=|+|-|+.+.+.|..||..-
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            43321     123445999999999999999999999999999999999999997653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.3e-23  Score=195.14  Aligned_cols=215  Identities=20%  Similarity=0.331  Sum_probs=175.1

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      ...+|.+...|+.|+|++ .|..+++|++...  ..+...+|..|.-.++-+.||||..+++.|.......++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            345788889999999999 4677788887644  3445578999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          507 SLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       507 ~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      +|+..+.+... ..+..++.+++.++++|++|||+-. +-|----+....++||++.+++|. .+-+++      +....
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kf------sfqe~  344 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQEV  344 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-ccccee------eeecc
Confidence            99999987664 5677889999999999999999873 334444688999999999887775 222232      12233


Q ss_pred             cccCCccccCccccccCccC---cccchhhHHHHHHHHHhCCCCcchh-------------------------hhhhhcc
Q 041689          586 QTLATIGYIAPEYGREGRVF---ANGDVYSFGIMLMEIHSAKQQCVSF-------------------------VFNLAME  637 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~---~~sDvwslG~vl~elltg~~p~~~~-------------------------l~~l~~~  637 (652)
                      .....+.||+||.++..+-+   .++|+|||.+++||+.|+.-||.+-                         +..++.-
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~i  424 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNI  424 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHH
Confidence            34567899999998877654   5689999999999999999997653                         6789999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      |..+||.+||.++.|
T Consensus       425 cmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  425 CMNEDPGKRPKFDMI  439 (448)
T ss_pred             HhcCCCCcCCCccee
Confidence            999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=8.6e-23  Score=194.38  Aligned_cols=169  Identities=11%  Similarity=0.104  Sum_probs=132.9

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhh---h------HHHHHHHHHhcCCCeeeeEEeeeecC-
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK---S------FDIECEIMKSIHYRNLVKIISSCSNE-  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~~-  493 (652)
                      .++|+..+.+|.|+||.||.+.. ++..+|+|.++........   .      +++|++.+.++.|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999766 5778999999755322222   2      68999999999999999998886533 


Q ss_pred             -------CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          494 -------EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       494 -------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                             +..++||||++|.+|.++..     .++    ....+++.++..+|..   |++|||+||+||++++++ +++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence                   35789999999999988632     222    2466999999999999   999999999999999988 999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHH
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI  620 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~el  620 (652)
                      +|||......... .             ...+.....++.++|+||||+++...
T Consensus       176 iDfg~~~~~~e~~-a-------------~d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        176 IDLSGKRCTAQRK-A-------------KDRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EECCCcccccchh-h-------------HHHHHHHhHhcccccccceeEeehHH
Confidence            9999887541110 0             01134555677899999999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.8e-23  Score=228.48  Aligned_cols=219  Identities=18%  Similarity=0.189  Sum_probs=174.2

Q ss_pred             ccceeccccceEEEEEEeC-CCcEEEEEEee----cc-cch-hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          429 ENNLIGKGGFGTIYKSRIG-DGMEVAVKVFH----LQ-CGR-AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ..+.+|.|++|.|+.+... ....++.|.++    .. ... ....+..|.-+-..+.|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999988777533 33444444332    11 111 11225567777788899999888887776665556699


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||++ +|..++.... .+...++..++.|+..|++|+|..   ||.|||+|++|++++..|.+||+|||.+....-....
T Consensus       402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 9999888763 588888999999999999999999   9999999999999999999999999998765333222


Q ss_pred             --cccccccCCccccCccccccCccCcc-cchhhHHHHHHHHHhCCCCcchh----------------------------
Q 041689          582 --MTQTQTLATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHSAKQQCVSF----------------------------  630 (652)
Q Consensus       582 --~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltg~~p~~~~----------------------------  630 (652)
                        ......+|+.+|+|||++.+..|++. .||||.|+++..|.+|+.||...                            
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence              44566789999999999999999866 59999999999999999995332                            


Q ss_pred             ----hhhhhcccchhhhccccCccCC
Q 041689          631 ----VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 ----l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          .+.++.+|++.||.+|.|+++|
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~ti~~i  582 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRITIEQI  582 (601)
T ss_pred             chhhHHHHHHHHccCChhheecHHHH
Confidence                5779999999999999999875

>PLN03210 Resistant to P

Probab=99.87  E-value=2.6e-21  Score=230.17  Aligned_cols=283  Identities=23%  Similarity=0.247  Sum_probs=224.6

Q ss_pred             eeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCC
Q 041689            3 SISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST   81 (652)
Q Consensus         3 ~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~   81 (652)
                      |.+|..|+|..|.++   .+|..+ .+++|+.|+|++|+..+.+| .+..+++|+.|+|++|..-...|           
T Consensus       610 ~~~L~~L~L~~s~l~---~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp-----------  674 (1153)
T PLN03210        610 PENLVKLQMQGSKLE---KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELP-----------  674 (1153)
T ss_pred             ccCCcEEECcCcccc---ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccc-----------
Confidence            568999999999887   678877 78999999999986544666 48899999999999986432222           


Q ss_pred             CCcccccccCCCCCCcEEEcccC-CCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccC
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNN-PLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI  160 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  160 (652)
                            ..+.++++|+.|++++| .+..++..  + ++++ |+.|++++|...+.+|..   .++|++|+|++|.+. .+
T Consensus       675 ------~si~~L~~L~~L~L~~c~~L~~Lp~~--i-~l~s-L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~l  740 (1153)
T PLN03210        675 ------SSIQYLNKLEDLDMSRCENLEILPTG--I-NLKS-LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EF  740 (1153)
T ss_pred             ------hhhhccCCCCEEeCCCCCCcCccCCc--C-CCCC-CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cc
Confidence                  35788999999999996 45555433  2 4554 999999999766566643   468999999999998 45


Q ss_pred             CccccCCCCCcEEecccCccc-------cccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCC
Q 041689          161 PFTLRELQKLQYVGLKDNKLE-------GTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLP  231 (652)
Q Consensus       161 ~~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~  231 (652)
                      |..+ .+++|++|.+.++...       ...+..+...++|+.|+|++|...+.+|..++++++|+.|++++|.  ..+|
T Consensus       741 P~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP  819 (1153)
T PLN03210        741 PSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP  819 (1153)
T ss_pred             cccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence            6554 6888999999874432       1222233345689999999998888889999999999999999874  6677


Q ss_pred             cccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccc-cccCCCCchhhcCCC
Q 041689          232 LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN-NNLSGAIPLLLEKLS  310 (652)
Q Consensus       232 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~  310 (652)
                      ..+ ++++|+.|++++|......|..   ..+|+.|+|++|.++ .+|..+..+++|+.|+|++ |+|. .+|..+..++
T Consensus       820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~  893 (1153)
T PLN03210        820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLK  893 (1153)
T ss_pred             CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccccc
Confidence            666 7999999999998655445543   368999999999998 7888999999999999998 6776 5777788999


Q ss_pred             CCceEEeecCc
Q 041689          311 YLEHLNLSFNK  321 (652)
Q Consensus       311 ~L~~L~L~~N~  321 (652)
                      +|+.++++++.
T Consensus       894 ~L~~L~l~~C~  904 (1153)
T PLN03210        894 HLETVDFSDCG  904 (1153)
T ss_pred             CCCeeecCCCc
Confidence            99999999875

syringae 6; Provisional

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=9.4e-22  Score=185.67  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=108.3

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccch--h-------h-----------------hhHHHHHHHHHhcCCCee
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR--A-------F-----------------KSFDIECEIMKSIHYRNL  483 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  483 (652)
                      ...||+|+||.||+|...+|++||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999999754211  0       1                 122459999999987776


Q ss_pred             eeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCCCCeeeCCCC
Q 041689          484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDLKPSNVLLDDTM  562 (652)
Q Consensus       484 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dlkp~NIll~~~~  562 (652)
                      .....+...  ..++||||++++++....... ..++..++..++.|++.+|.|+ |+.   ||+||||||+||++++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~-~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD-G  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-C
Confidence            433332222  238999999998776543322 3688889999999999999999 688   9999999999999984 7


Q ss_pred             cEEEecccCCccc
Q 041689          563 VAHLSDFGITKLL  575 (652)
Q Consensus       563 ~~kl~Dfg~~~~~  575 (652)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=9.9e-21  Score=196.28  Aligned_cols=199  Identities=32%  Similarity=0.440  Sum_probs=168.6

Q ss_pred             CCccceeccccceEEEEEEeCCCcEEEEEEeecccch---hhhhHHHHHHHHHhcCCC-eeeeEEeeeecCCceEEEEEc
Q 041689          427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR---AFKSFDIECEIMKSIHYR-NLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  502 (652)
                      |...+.+|.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677789999999999999876  78999998765332   467889999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~  579 (652)
                      +.++++.+++....  ..+.......++.|++.+++|+|..   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997766554  2588889999999999999999999   999999999999999888 79999999998553322


Q ss_pred             Ccc----ccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcchh
Q 041689          580 QSM----TQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       580 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~  630 (652)
                      ...    ......++..|+|||...+   ..++...|+||+|++++++++|..|+...
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~  214 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE  214 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            211    2355679999999999887   57888999999999999999999885443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.5e-20  Score=178.39  Aligned_cols=138  Identities=21%  Similarity=0.203  Sum_probs=109.9

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccch--------------------------hhhhHHHHHHHHHhcCCCee
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR--------------------------AFKSFDIECEIMKSIHYRNL  483 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  483 (652)
                      ...||+|++|.||+|...+|+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999778999999999754210                          01224578999999999987


Q ss_pred             eeEEeeeecCCceEEEEEccCCCChhhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCC
Q 041689          484 VKIISSCSNEEFKELVLEHMPHGSLEKC-LYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDT  561 (652)
Q Consensus       484 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~  561 (652)
                      .....+...  ..++||||++|+++... +..  ..++..+...++.|++.++.++|+ .   ||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence            544433332  24899999998855433 332  257788889999999999999999 8   999999999999999 7


Q ss_pred             CcEEEecccCCccc
Q 041689          562 MVAHLSDFGITKLL  575 (652)
Q Consensus       562 ~~~kl~Dfg~~~~~  575 (652)
                      +.++|+|||+++..
T Consensus       154 ~~~~liDFG~a~~~  167 (190)
T cd05145         154 GKPYIIDVSQAVEL  167 (190)
T ss_pred             CCEEEEEcccceec
Confidence            89999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=5.3e-22  Score=215.85  Aligned_cols=219  Identities=21%  Similarity=0.230  Sum_probs=172.3

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeeccc-chhhhhHH---HHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFD---IECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      +|...+.+|++.|=+|.+|++..|. |+||++-++. .-....+.   +|++ ...++|||++++..+...+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            4667789999999999999998777 9999986553 22333333   3444 555689999999998888888899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc-CCCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~-~~~~  580 (652)
                      |+.. +|++.+..++ .+...+...|+.|++.|+..+|..   ||+|||||.+||||+.-.++.|+||..-+... +.+.
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9977 9999888766 677888889999999999999999   99999999999999999999999998776432 1111


Q ss_pred             cccc----ccccCCccccCccccccC----------c-cCcccchhhHHHHHHHHHh-CCCCcch---------------
Q 041689          581 SMTQ----TQTLATIGYIAPEYGREG----------R-VFANGDVYSFGIMLMEIHS-AKQQCVS---------------  629 (652)
Q Consensus       581 ~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~vl~ellt-g~~p~~~---------------  629 (652)
                      ....    .....-..|.|||.+...          + .+++-||||+||+++|+++ |++||.-               
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE  256 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence            1111    222344569999976542          2 4567799999999999987 5666432               


Q ss_pred             ---------hhhhhhcccchhhhccccCccC
Q 041689          630 ---------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 ---------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                               .+++++..|++.||++|.+|+|
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAed  287 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAED  287 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHH
Confidence                     2789999999999999999976

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=5.9e-22  Score=205.91  Aligned_cols=204  Identities=25%  Similarity=0.271  Sum_probs=169.4

Q ss_pred             eccccceEEEEEEe----CCCcEEEEEEeecccc--hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEccCC
Q 041689          433 IGKGGFGTIYKSRI----GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       433 lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +|+|+||.|+.++.    ..|.-||+|+.++...  +.......|..++...+ ||.+|++...++.+...+++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998752    3477799998865422  22235566888899987 99999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT  585 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  585 (652)
                      |++...+.... .+++.....+...++-|++++|+.   +|+|||+|++||+++.+|++|+.|||.++......      
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------  151 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------  151 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence            99998887766 566666777888899999999999   99999999999999999999999999998753222      


Q ss_pred             cccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh-------------------hhhhhcccchhhhccc
Q 041689          586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF-------------------VFNLAMECTIESLELR  646 (652)
Q Consensus       586 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~-------------------l~~l~~~~l~~~p~~R  646 (652)
                      ..+||..|||||++.  ....++|.||||++++||+||..||..+                   .++++.++...+|..|
T Consensus       152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr  229 (612)
T KOG0603|consen  152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR  229 (612)
T ss_pred             hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence            228999999999987  6678899999999999999999998773                   4556667778888777


Q ss_pred             cC
Q 041689          647 IN  648 (652)
Q Consensus       647 pt  648 (652)
                      --
T Consensus       230 Lg  231 (612)
T KOG0603|consen  230 LG  231 (612)
T ss_pred             hc
Confidence            53

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=3.6e-20  Score=172.37  Aligned_cols=184  Identities=14%  Similarity=0.081  Sum_probs=136.6

Q ss_pred             CccceeccccceEEEEEEeCCCcEEEEEEeecccc----hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEc
Q 041689          428 NENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG----RAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .+...+++|+||+||.+.. .+.+++.+.+.....    .....+.+|+++|+++. |++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998766 678888777754321    11225789999999995 5889999886    346899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCC-CCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL-KPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dl-kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ++|.+|.+....        ....++.|++.+++++|.+   ||+|||| ||+||+++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        1235788999999999999   9999999 799999999999999999999854321110


Q ss_pred             ---cc--------cccccCCccccCccccccC-ccC-cccchhhHHHHHHHHHhCCCCc
Q 041689          582 ---MT--------QTQTLATIGYIAPEYGREG-RVF-ANGDVYSFGIMLMEIHSAKQQC  627 (652)
Q Consensus       582 ---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslG~vl~elltg~~p~  627 (652)
                         ..        ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|+..|.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence               00        0112357778888743221 233 5568899999999999998773

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.8e-19  Score=171.43  Aligned_cols=138  Identities=14%  Similarity=0.221  Sum_probs=108.4

Q ss_pred             CCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-----CCCeeeeEEeeeecCC---ceE-
Q 041689          427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-----HYRNLVKIISSCSNEE---FKE-  497 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-  497 (652)
                      +...+.||+|+||.||. ...++.. +||++........+.+.+|+.+++++     .||||++++|+++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            44568899999999996 3234444 69988765444567889999999999     5799999999998873   433 


Q ss_pred             EEEEc--cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCCCCCCeeeCC----CCcEEEeccc
Q 041689          498 LVLEH--MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVL-EYLHFNFLVPVIHCDLKPSNVLLDD----TMVAHLSDFG  570 (652)
Q Consensus       498 lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~dlkp~NIll~~----~~~~kl~Dfg  570 (652)
                      +||||  +++++|.+++...  .+++.  ..++.|++.++ +|||++   +|+||||||+||+++.    ++.++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5589999999764  35554  35678888777 999999   9999999999999973    3489999954


Q ss_pred             CCc
Q 041689          571 ITK  573 (652)
Q Consensus       571 ~~~  573 (652)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.81  E-value=3.9e-22  Score=173.23  Aligned_cols=169  Identities=33%  Similarity=0.515  Sum_probs=139.8

Q ss_pred             CCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCC
Q 041689           15 DIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCK   94 (652)
Q Consensus        15 ~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~   94 (652)
                      .+.+..++|..+++.+++.|-||+|+++ ..|..+..+.+|++|++++|+|+..++                  +++.++
T Consensus        19 giSsf~~~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~------------------~issl~   79 (264)
T KOG0617|consen   19 GISSFEELPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPT------------------SISSLP   79 (264)
T ss_pred             ccccHhhcccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcCh------------------hhhhch
Confidence            4455667888888999999999999998 677788999999999999999986665                  466788


Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccc-cCCccccCCCCCCEEEecCccccccCCccccCCCCCcEE
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG-GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYV  173 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  173 (652)
                      +|+.|+++-|++... |. .|+.+|. |+.|||.+|++.. .+|+.|..++.|+.|+|+.|.+. ++|..++++++|+.|
T Consensus        80 klr~lnvgmnrl~~l-pr-gfgs~p~-levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil  155 (264)
T KOG0617|consen   80 KLRILNVGMNRLNIL-PR-GFGSFPA-LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQIL  155 (264)
T ss_pred             hhhheecchhhhhcC-cc-ccCCCch-hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEE
Confidence            899999999998754 44 6888887 8999998888874 36888888888888888888888 778888888888888


Q ss_pred             ecccCccccccCccccCCCCCcEEEccCCccccc
Q 041689          174 GLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGS  207 (652)
Q Consensus       174 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  207 (652)
                      .+.+|.+- .+|..++.++.|+.|++.+|+++-.
T Consensus       156 ~lrdndll-~lpkeig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  156 SLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             eeccCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence            88888888 7888888888888888888888743

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=2.8e-21  Score=199.98  Aligned_cols=61  Identities=20%  Similarity=0.206  Sum_probs=32.3

Q ss_pred             CCCcEEEccCCcCCC----cccccccccccCcceeccccccCCC----CchhhcCC-CCCceEEeecCcC
Q 041689          262 KDLQYLFLGYNILKG----SIPDSVGDLISLKSLNFSNNNLSGA----IPLLLEKL-SYLEHLNLSFNKL  322 (652)
Q Consensus       262 ~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l  322 (652)
                      +.|++|++++|.++.    .+...+..+++|+++++++|.++..    ....+... +.|+.|++.+|++
T Consensus       250 ~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         250 ISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            556666666666641    1223344445666666666666533    23333333 4566666665553

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-21  Score=170.15  Aligned_cols=161  Identities=34%  Similarity=0.568  Sum_probs=109.2

Q ss_pred             CCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEE
Q 041689          142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTL  221 (652)
Q Consensus       142 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  221 (652)
                      ++.+.+.|-||+|+++ ..|..+..+.+|+.|++++|+|+ .+|..+.++++|+.|+++-|++. +.|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4455555666666665 34445566666666666666666 55556666666666666666665 555666666666666


Q ss_pred             EccCCC---CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceecccccc
Q 041689          222 SLSYND---GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNL  298 (652)
Q Consensus       222 ~Ls~N~---~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  298 (652)
                      ||++|.   ..+|..|..+..|..|+|+.|.+. ++|..++.+++|+.|.+..|.+- .+|..++.+.+|+.|.+.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            666652   456777777777888888888887 56777888888888888888777 6778888888888888888888


Q ss_pred             CCCCchhhcC
Q 041689          299 SGAIPLLLEK  308 (652)
Q Consensus       299 ~~~~~~~~~~  308 (652)
                      + .+|..+++
T Consensus       186 ~-vlppel~~  194 (264)
T KOG0617|consen  186 T-VLPPELAN  194 (264)
T ss_pred             e-ecChhhhh
Confidence            7 55555444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=3.4e-19  Score=174.91  Aligned_cols=211  Identities=21%  Similarity=0.258  Sum_probs=139.2

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcC----------CCeeeeEEeeee-
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIH----------YRNLVKIISSCS-  491 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~niv~~~~~~~-  491 (652)
                      +...+.||.|+++.||.+.+. +|+++|+|++....   ....+++++|.-....+.          |-.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456689999999999999976 59999999986442   234556666665444432          212222222211 


Q ss_pred             --------cC---C-----ceEEEEEccCCCChhhhhh---cCCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 041689          492 --------NE---E-----FKELVLEHMPHGSLEKCLY---SSNC---ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC  549 (652)
Q Consensus       492 --------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  549 (652)
                              ..   .     ..+++|+-+. +||.+++.   ....   .+....+..+..|+++.+++||..   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     2357788774 48887754   2221   233344566779999999999999   99999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCcccccc--------CccCcccchhhHHHHHHHHH
Q 041689          550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE--------GRVFANGDVYSFGIMLMEIH  621 (652)
Q Consensus       550 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~ell  621 (652)
                      ||||+|++++++|.++|+||+......   ..  ......+..|.+||....        -.++.+.|.|++|+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g---~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAG---TR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETT---EE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecC---ce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999998876431   11  111345577999997543        24788889999999999999


Q ss_pred             hCCCCcch-------------------hhhhhhcccchhhhccc
Q 041689          622 SAKQQCVS-------------------FVFNLAMECTIESLELR  646 (652)
Q Consensus       622 tg~~p~~~-------------------~l~~l~~~~l~~~p~~R  646 (652)
                      +|..||+-                   .++.++..+|+++|++|
T Consensus       245 C~~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999542                   27889999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=9.1e-20  Score=178.36  Aligned_cols=166  Identities=19%  Similarity=0.258  Sum_probs=127.0

Q ss_pred             CCCeeeeEEeeeec---------------------------CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHH
Q 041689          479 HYRNLVKIISSCSN---------------------------EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV  531 (652)
Q Consensus       479 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  531 (652)
                      +|||||++.++|.+                           +...|+||..++. +|++|+....  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999988743                           1256899988876 9999988765  5556667789999


Q ss_pred             HHHHHHHHcCCCCCeEecCCCCCCeee--CCC--CcEEEecccCCccccCCCCccc----cccccCCccccCccccccCc
Q 041689          532 ASVLEYLHFNFLVPVIHCDLKPSNVLL--DDT--MVAHLSDFGITKLLIGEDQSMT----QTQTLATIGYIAPEYGREGR  603 (652)
Q Consensus       532 ~~~L~~LH~~~~~~iiH~dlkp~NIll--~~~--~~~kl~Dfg~~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~  603 (652)
                      ++|+.|||++   ||.|||+|.+||++  |+|  -.+.|+|||++-.-....-...    .-...|...-||||+....+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999   99999999999999  333  4688999998753211100111    11234667789999876432


Q ss_pred             ------cCcccchhhHHHHHHHHHhCCCCcch-------------------------hhhhhhcccchhhhccccCcc
Q 041689          604 ------VFANGDVYSFGIMLMEIHSAKQQCVS-------------------------FVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       604 ------~~~~sDvwslG~vl~elltg~~p~~~-------------------------~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                            -..|+|.|+.|.+.||+++..-||-.                         .+++++...++.||.+|+++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                  24789999999999999998888433                         378999999999999999863

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=1.8e-19  Score=187.90  Aligned_cols=175  Identities=30%  Similarity=0.409  Sum_probs=145.7

Q ss_pred             HHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EecCCCC
Q 041689          475 MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV-IHCDLKP  553 (652)
Q Consensus       475 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-iH~dlkp  553 (652)
                      |+.+.|.|+.+++|.+.++...++|.+||.-|+|.+.+......+++.....++++++.||+|+|..   +| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            3568899999999999999999999999999999999998777899999999999999999999987   55 9999999


Q ss_pred             CCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCc-------cCcccchhhHHHHHHHHHhCCCC
Q 041689          554 SNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR-------VFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwslG~vl~elltg~~p  626 (652)
                      .|.++|..+.+|++|||+....................-|.|||.++...       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987653211111111222445699999887642       35678999999999999998887


Q ss_pred             cch----------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          627 CVS----------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ~~~----------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      |+.                                  .+..++.+||.++|++||++++|
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i  217 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI  217 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence            444                                  25668999999999999998764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.6e-19  Score=199.39  Aligned_cols=201  Identities=22%  Similarity=0.233  Sum_probs=161.2

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC---CCeeeeEEeeeecCCc
Q 041689          419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH---YRNLVKIISSCSNEEF  495 (652)
Q Consensus       419 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~  495 (652)
                      +.......|.+.+.+|+|+||.||+|...+|+.||+|+=+.....   +|..=.+++.+++   -+-|..+...+...+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            344556778899999999999999999888999999987655322   1222233444444   2445566666666777


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-------CCCcEEEec
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-------DTMVAHLSD  568 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-------~~~~~kl~D  568 (652)
                      .++|+||.+.|+|.+++...+ ..++.-++.+..|++..+++||..   +|||+||||+|+++.       +...++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            889999999999999998444 788999999999999999999999   999999999999994       245699999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      ||.+..+.--.........++|-.+-.+|+..+.+++.++|.|.++.+++-|+.|++-
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9999766433333444566788899999999999999999999999999999998864

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=1.9e-18  Score=168.79  Aligned_cols=146  Identities=17%  Similarity=0.113  Sum_probs=113.8

Q ss_pred             HHHhcCCCccceeccccceEEEEEE--eCCCcEEEEEEeecccch------------------------hhhhHHHHHHH
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGR------------------------AFKSFDIECEI  474 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  474 (652)
                      ......|.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....++.|+++
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            3344458888999999999999998  568999999998743210                        11235789999


Q ss_pred             HHhcCCC--eeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCC
Q 041689          475 MKSIHYR--NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP-VIHCDL  551 (652)
Q Consensus       475 l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~dl  551 (652)
                      ++++.+.  .+++++++    ...++||||++++++........ .....+...++.|++.++++||..   | ++||||
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di  175 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKE---GELVHGDL  175 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence            9999753  34455543    23589999999988876543322 456666788999999999999999   9 999999


Q ss_pred             CCCCeeeCCCCcEEEecccCCccc
Q 041689          552 KPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       552 kp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 789999999998754

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=2.1e-20  Score=193.33  Aligned_cols=256  Identities=23%  Similarity=0.217  Sum_probs=189.2

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCc---cchhcccccCcEEEccCCccc------ccCCccccCCCCCCEEEecCcccccc
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPR---MSIGNLSHSLEIFDMSKCNVS------GGIPEEIGNLTNLTAIYLGGNKLNGS  159 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~~L~~L~L~~N~l~------~~~~~~~~~l~~L~~L~L~~N~l~~~  159 (652)
                      .|..+.+|+.|+++++.++.....   ..+...+. |+.|++++|.+.      ..++..+..+++|+.|++++|.+.+.
T Consensus        18 ~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~-l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~   96 (319)
T cd00116          18 LLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPS-LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPD   96 (319)
T ss_pred             HHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCC-ceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChh
Confidence            355677799999999998543111   02334443 999999999887      23456788899999999999999866


Q ss_pred             CCccccCCCC---CcEEecccCcccc----ccCccccCC-CCCcEEEccCCcccc----cccccCCCCCCCCEEEccCCC
Q 041689          160 IPFTLRELQK---LQYVGLKDNKLEG----TIPYDIFRL-VKLYKLDLGGNKLSG----SILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       160 ~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      .+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++    .....+..+++|++|++++|.
T Consensus        97 ~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~  176 (319)
T cd00116          97 GCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNG  176 (319)
T ss_pred             HHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCC
Confidence            6666666665   9999999999983    333455666 899999999999984    234467778899999999996


Q ss_pred             CC------CCcccCCCCccceEecccccCCccC----cccccCCCCCcEEEccCCcCCCcccccccc-----cccCccee
Q 041689          228 GP------LPLEIGNLKVLIGIDFSMNNFSSVI----PTTIGSLKDLQYLFLGYNILKGSIPDSVGD-----LISLKSLN  292 (652)
Q Consensus       228 ~~------~~~~~~~l~~L~~L~ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~  292 (652)
                      ..      ++..+..+++|+.|++++|.+++..    ...+..+++|++|++++|++++.....+..     .+.|+.|+
T Consensus       177 l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~  256 (319)
T cd00116         177 IGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLS  256 (319)
T ss_pred             CchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEE
Confidence            22      3344566679999999999987542    345667889999999999998633333322     37999999


Q ss_pred             ccccccCC----CCchhhcCCCCCceEEeecCcCcccC----C-CCCCC-CCcccccccCCcc
Q 041689          293 FSNNNLSG----AIPLLLEKLSYLEHLNLSFNKLEGEI----P-KGGSF-GNFSAESFEGNKL  345 (652)
Q Consensus       293 L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~----p-~~~~~-~~l~~~~~~~N~~  345 (652)
                      +++|.++.    .+...+..+++|+++++++|.++...    . ....+ ..+..+++.+|+|
T Consensus       257 l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         257 LSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            99999972    33456677789999999999998542    1 12333 5677777777775

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.1e-17  Score=159.98  Aligned_cols=144  Identities=19%  Similarity=0.123  Sum_probs=113.6

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccc----------------------hhhhhHHHHHHHH
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG----------------------RAFKSFDIECEIM  475 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l  475 (652)
                      .++......|.+.+.||+|+||.||+|...+|+.||||++.....                      ........|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            445555555888899999999999999988899999998764320                      0112357789999


Q ss_pred             HhcCCC--eeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 041689          476 KSIHYR--NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKP  553 (652)
Q Consensus       476 ~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  553 (652)
                      .++.|+  .++..++.    ...++||||++|+++.+....       .....++.+++.++.++|+.   ||+||||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p  153 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE  153 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence            999877  44455442    345899999999998775321       23456889999999999998   999999999


Q ss_pred             CCeeeCCCCcEEEecccCCccc
Q 041689          554 SNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      +||++++++.++|+|||.+...
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.3e-17  Score=161.48  Aligned_cols=134  Identities=22%  Similarity=0.255  Sum_probs=113.3

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccc--------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG--------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      +.||+|++|.||+|.. .|..|++|+......        .....+.+|++++..+.|++++....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 678899998654321        1124577899999999999988777777677788999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ++|++|.+++....    . ++..++.+++.++.++|..   +++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886533    1 7788999999999999999   999999999999999 78899999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=3.3e-17  Score=180.51  Aligned_cols=145  Identities=19%  Similarity=0.205  Sum_probs=115.1

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--c------chhhhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          417 YLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--C------GRAFKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       417 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      +.........|...+.||+|+||.||+|.+... .+++|+....  .      ....+.+.+|++++++++|++++....
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333344455567789999999999999987543 4444433211  1      112356789999999999999988877


Q ss_pred             eeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       489 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      ++......++||||+++++|.+++.         ....++.|++.+|.|||+.   +++|||+||+||++ +++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEe
Confidence            7777777899999999999998775         3467899999999999999   99999999999999 567899999


Q ss_pred             ccCCccc
Q 041689          569 FGITKLL  575 (652)
Q Consensus       569 fg~~~~~  575 (652)
                      ||+++..
T Consensus       471 FGla~~~  477 (535)
T PRK09605        471 FGLGKYS  477 (535)
T ss_pred             CcccccC
Confidence            9999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=7e-19  Score=179.70  Aligned_cols=151  Identities=25%  Similarity=0.344  Sum_probs=125.9

Q ss_pred             ceEEEEEccCCCChhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      +.||.|++|...+|.+++...+  ...++.....++.|++.|++|   +   +.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999996443  356778889999999999999   6   8999999999999999989999999998


Q ss_pred             ccccCCC----CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-----------------CCCC--c--
Q 041689          573 KLLIGED----QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-----------------AKQQ--C--  627 (652)
Q Consensus       573 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-----------------g~~p--~--  627 (652)
                      .......    .....+...||..||+||.+.+..|+.++||||+|++++|+++                 |..|  |  
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~  483 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQ  483 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhh
Confidence            8764333    1223456679999999999999999999999999999999987                 4444  1  


Q ss_pred             c-hhhhhhhcccchhhhccccCccC
Q 041689          628 V-SFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       628 ~-~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                      + +.-..++.+++...|.+||++.+
T Consensus       484 d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  484 DYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCcHHHHHHHHhcCCCcccCchHHH
Confidence            1 11357999999999999997654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=2.4e-18  Score=187.64  Aligned_cols=184  Identities=25%  Similarity=0.292  Sum_probs=136.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...+|..++.|..|+||.||.++++ +.+++|+|+=+ +.     .+.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee-----------------
Confidence            3467999999999999999999876 47788885422 21     11110  33333344433                 


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC---
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE---  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  578 (652)
                          ||....++..+ .++..        ++.+++|+|+.   ||+|||+||+|.+|+.-|++|++|||+++.....   
T Consensus       136 ----gDc~tllk~~g-~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG-PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCC-CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                56666555433 33332        27799999999   9999999999999999999999999998753110   


Q ss_pred             ----------CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcchh------------------
Q 041689          579 ----------DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF------------------  630 (652)
Q Consensus       579 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~------------------  630 (652)
                                .......+.+||+.|+|||++....|+..+|+|++|+++||.+.|..||..+                  
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                      0111224568999999999999999999999999999999999999986554                  


Q ss_pred             --------hhhhhcccchhhhcccc
Q 041689          631 --------VFNLAMECTIESLELRI  647 (652)
Q Consensus       631 --------l~~l~~~~l~~~p~~Rp  647 (652)
                              +++++.+.+..+|..|-
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    67788888888887773

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=2.2e-17  Score=158.34  Aligned_cols=131  Identities=20%  Similarity=0.261  Sum_probs=106.5

Q ss_pred             eeccccceEEEEEEeCCCcEEEEEEeecccc--------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG--------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .||+|+||.||+|.+ +|..|++|+......        ....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998653211        12356778999999999887655555555566678999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      +|+++.+++.....        .++.+++.+|.++|+.   |++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987754321        7899999999999999   999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=3.7e-16  Score=142.46  Aligned_cols=135  Identities=20%  Similarity=0.263  Sum_probs=114.7

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC--CeeeeEEeeeecCCceEEEEEccCCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY--RNLVKIISSCSNEEFKELVLEHMPHG  506 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  506 (652)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+.+|+.+++.++|  ..+++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35789999999999999754 7899999865433  4678899999999976  58999999988888899999999988


Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653        4456677899999999999986445799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.7e-17  Score=181.84  Aligned_cols=226  Identities=23%  Similarity=0.241  Sum_probs=181.6

Q ss_pred             hcCCCccceeccccceEEEEEEeCC--CcEEEEEEeeccc--chhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD--GMEVAVKVFHLQC--GRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  498 (652)
                      ...|...+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+.+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4467777889999999998876533  4456777665432  233444556777777776 9999999999999999999


Q ss_pred             EEEccCCCChhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCL-YSSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~  575 (652)
                      +++|..|+++.+-+ .......+...+..+..|+..++.|+| ..   ++.|||+||+|.+++..+ ..|++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            99999999999888 333224566677789999999999999 77   999999999999999999 9999999999887


Q ss_pred             cC-CCCccccccccC-CccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcchh----------------------
Q 041689          576 IG-EDQSMTQTQTLA-TIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVSF----------------------  630 (652)
Q Consensus       576 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~----------------------  630 (652)
                      .. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++..                      
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            55 344444456678 9999999998874 4457789999999999999999984332                      


Q ss_pred             ------hhhhhcccchhhhccccCccCC
Q 041689          631 ------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 ------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            ..+++.+++..+|+.|.+.+++
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~  283 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEEL  283 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccc
Confidence                  5678888888999999998774

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.65  E-value=8.8e-16  Score=145.60  Aligned_cols=135  Identities=21%  Similarity=0.208  Sum_probs=98.1

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccch--hhhh----------------------HHHHHHHHHhcCCCe--e
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR--AFKS----------------------FDIECEIMKSIHYRN--L  483 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  483 (652)
                      .+.||+|+||.||+|...++++||||+++.....  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998753211  1111                      135666666664432  4


Q ss_pred             eeEEeeeecCCceEEEEEccCCCChhhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCC
Q 041689          484 VKIISSCSNEEFKELVLEHMPHGSLEKC-LYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDT  561 (652)
Q Consensus       484 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~  561 (652)
                      .+.++.    ...++||||++++++... +....  .. .++..++.+++.++.++|. .   +|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence            444443    235899999999543221 11111  11 5577899999999999999 7   999999999999999 8


Q ss_pred             CcEEEecccCCccc
Q 041689          562 MVAHLSDFGITKLL  575 (652)
Q Consensus       562 ~~~kl~Dfg~~~~~  575 (652)
                      +.++++|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            89999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=6.7e-15  Score=144.15  Aligned_cols=135  Identities=19%  Similarity=0.222  Sum_probs=104.8

Q ss_pred             ceec-cccceEEEEEEeCCCcEEEEEEeeccc-------------chhhhhHHHHHHHHHhcCCCee--eeEEeeeecC-
Q 041689          431 NLIG-KGGFGTIYKSRIGDGMEVAVKVFHLQC-------------GRAFKSFDIECEIMKSIHYRNL--VKIISSCSNE-  493 (652)
Q Consensus       431 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~-  493 (652)
                      ..|| .|+.|+||.+... +..+|||.+....             ......+.+|++++.+++|++|  ++.+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5677 7888899988774 7789999885321             1223467889999999998775  6677664332 


Q ss_pred             C---ceEEEEEccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          494 E---FKELVLEHMPH-GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       494 ~---~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      +   ..++|||+++| .+|.+++...  .++..    .+.+++.++.+||.+   ||+||||||+|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence            2   23599999997 6998887653  34443    367899999999999   9999999999999998889999999


Q ss_pred             cCCccc
Q 041689          570 GITKLL  575 (652)
Q Consensus       570 g~~~~~  575 (652)
                      |.+...
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            998753

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.56  E-value=7.3e-17  Score=165.03  Aligned_cols=212  Identities=25%  Similarity=0.356  Sum_probs=146.7

Q ss_pred             EEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccC
Q 041689           99 FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN  178 (652)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (652)
                      |.|++-+++..+...+--.+.. -...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..+.++..|++|||+.|
T Consensus        55 l~Ls~rrlk~fpr~a~~~~ltd-t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLKEFPRGAASYDLTD-TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhhcCCCccccccccc-hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            4555555655443322223333 556788888887 67778888888888888888887 77778888888888888888


Q ss_pred             ccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCccc
Q 041689          179 KLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTT  257 (652)
Q Consensus       179 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~  257 (652)
                      +++ ..|..++.++ |+.|-+++|+++ ..|..++.+..|..||.+.|+ ..+|..++++.+|+.|.+..|++.. +|..
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~-lp~E  207 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLED-LPEE  207 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhh-CCHH
Confidence            888 7777777765 788888888887 556666677777777777775 6667777777777777777777774 4555


Q ss_pred             ccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCC---CceEEeecC
Q 041689          258 IGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSY---LEHLNLSFN  320 (652)
Q Consensus       258 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N  320 (652)
                      +..| .|..||+|.|+++ .+|-.|..|+.|++|-|.+|.|+ ..|..++....   .++|+.+-.
T Consensus       208 l~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  208 LCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             HhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence            5544 3777777777777 66777777777777777777776 55555433222   345555544

>PLN03150 hypothetical protein; Provisional

Probab=99.55  E-value=8.5e-15  Score=163.05  Aligned_cols=118  Identities=34%  Similarity=0.589  Sum_probs=105.9

Q ss_pred             ccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEee
Q 041689          239 VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLS  318 (652)
Q Consensus       239 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  318 (652)
                      .++.|+|++|.+.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCcCcccCCCC--CCCCCcccccccCCccCCCCCCCCCCCCC
Q 041689          319 FNKLEGEIPKG--GSFGNFSAESFEGNKLLCGSPNLHVPPCK  358 (652)
Q Consensus       319 ~N~l~~~~p~~--~~~~~l~~~~~~~N~~~c~~~~~~~~~~~  358 (652)
                      +|+++|.+|..  .....+..+++.+|+..|+.|.  ...|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCc
Confidence            99999999874  2233556788999999998763  45674

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=6.3e-14  Score=149.24  Aligned_cols=141  Identities=20%  Similarity=0.201  Sum_probs=100.6

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccchh----------------------------------------hhhHH
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRA----------------------------------------FKSFD  469 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  469 (652)
                      .+.||.|++|.||+|+..+|+.||||+.+......                                        .-++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986542110                                        01345


Q ss_pred             HHHHHHHhcC-----CCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHcCCC
Q 041689          470 IECEIMKSIH-----YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS-VLEYLHFNFL  543 (652)
Q Consensus       470 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~  543 (652)
                      +|++.+.++.     ++++.-..-+.......++||||++|+++.++........+   ...++.+++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC--
Confidence            5666666652     34332111122223457899999999999887653221222   3446666665 46788988  


Q ss_pred             CCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       544 ~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                       |++|+|+||.||++++++.++++|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999998763

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.50  E-value=4e-14  Score=150.84  Aligned_cols=203  Identities=35%  Similarity=0.462  Sum_probs=157.7

Q ss_pred             CEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccccc
Q 041689           56 KDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG  135 (652)
Q Consensus        56 ~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~  135 (652)
                      ..|+++.|.+.....                  ....++.++.|++.+|.++.+.+.  ...+..+|+.|++++|++. .
T Consensus        96 ~~l~~~~~~~~~~~~------------------~~~~~~~l~~L~l~~n~i~~i~~~--~~~~~~nL~~L~l~~N~i~-~  154 (394)
T COG4886          96 PSLDLNLNRLRSNIS------------------ELLELTNLTSLDLDNNNITDIPPL--IGLLKSNLKELDLSDNKIE-S  154 (394)
T ss_pred             ceeeccccccccCch------------------hhhcccceeEEecCCcccccCccc--cccchhhcccccccccchh-h
Confidence            368888887742222                  234557889999999999888764  2222114999999999998 4


Q ss_pred             CCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCC
Q 041689          136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNL  215 (652)
Q Consensus       136 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  215 (652)
                      +|..+..+++|+.|++++|+++ ..|.....+++|+.|++++|+++ .+|........|++|++++|++. ..+..+..+
T Consensus       155 l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~  231 (394)
T COG4886         155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNL  231 (394)
T ss_pred             hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhc
Confidence            5567889999999999999998 55555558889999999999999 77766666667999999999644 456778888


Q ss_pred             CCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccc
Q 041689          216 ASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD  284 (652)
Q Consensus       216 ~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  284 (652)
                      .++..|.+++|+ ...+..++.+++++.|++++|+++.+.+  ++.+.+++.|++++|.+....|.....
T Consensus       232 ~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         232 KNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             ccccccccCCceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence            899999999987 3447888999999999999999997544  888999999999999998766654443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.48  E-value=4.8e-14  Score=150.23  Aligned_cols=202  Identities=35%  Similarity=0.502  Sum_probs=168.4

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCC-CCCEEEecCccccccCCccccCCCCCcEEec
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLT-NLTAIYLGGNKLNGSIPFTLRELQKLQYVGL  175 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  175 (652)
                      ..|+++.|.+.....  ....++. ++.|++.+|.++. ++.....+. +|+.|++++|++. .+|..+..+++|+.|++
T Consensus        96 ~~l~~~~~~~~~~~~--~~~~~~~-l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l  170 (394)
T COG4886          96 PSLDLNLNRLRSNIS--ELLELTN-LTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDL  170 (394)
T ss_pred             ceeeccccccccCch--hhhcccc-eeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhcccccccccc
Confidence            478999999843322  2334444 9999999999994 566666774 9999999999999 56677899999999999


Q ss_pred             ccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCC-CCCCCcccCCCCccceEecccccCCccC
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN-DGPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      ++|+++ .+|.....+++|+.|++++|+++. +|.....+..|++|.+++| ....+..+.++.++..+.+++|++.. .
T Consensus       171 ~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~  247 (394)
T COG4886         171 SFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-L  247 (394)
T ss_pred             CCchhh-hhhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-c
Confidence            999999 777666688999999999999994 5555456677999999999 48888889999999999999999985 4


Q ss_pred             cccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcC
Q 041689          255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEK  308 (652)
Q Consensus       255 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  308 (652)
                      +..+..+.+++.|++++|+++. ++. +..+.+|+.|++++|.++...|.....
T Consensus       248 ~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         248 PESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             cchhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhhhcc
Confidence            7888999999999999999994 444 999999999999999999777665443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=1e-15  Score=156.67  Aligned_cols=194  Identities=26%  Similarity=0.386  Sum_probs=161.9

Q ss_pred             eeEeccCCCcCCccCCCCC---CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCc
Q 041689            8 KLELNVDDIESPCEIPSEI---NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPEL   84 (652)
Q Consensus         8 ~l~l~~~~~~~~~~ip~~~---~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~   84 (652)
                      .|.|++-..+   ++|..-   ++......||+.|++. .+|..+..+-.|+.|.|.+|.|..++.              
T Consensus        54 ~l~Ls~rrlk---~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~--------------  115 (722)
T KOG0532|consen   54 RLLLSGRRLK---EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPE--------------  115 (722)
T ss_pred             ccccccchhh---cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecch--------------
Confidence            3455555555   566433   6778889999999998 789899999999999999999986655              


Q ss_pred             ccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccc
Q 041689           85 SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTL  164 (652)
Q Consensus        85 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  164 (652)
                          +..++..|++|||+.|+++.++..  ++.+|  |+.|.+++|+++ .+|+.++.+..|..||.+.|.|. .+|..+
T Consensus       116 ----~i~~L~~lt~l~ls~NqlS~lp~~--lC~lp--Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql  185 (722)
T KOG0532|consen  116 ----AICNLEALTFLDLSSNQLSHLPDG--LCDLP--LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQL  185 (722)
T ss_pred             ----hhhhhhHHHHhhhccchhhcCChh--hhcCc--ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHh
Confidence                467889999999999999977664  66666  999999999998 67888889999999999999998 678889


Q ss_pred             cCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCc
Q 041689          165 RELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPL  232 (652)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~  232 (652)
                      +++.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .+|-.|.+|..|++|-|.+|....|.
T Consensus       186 ~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  186 GYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             hhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence            99999999999999999 677777754 5899999999998 67888999999999999988644444

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.45  E-value=6.5e-14  Score=128.14  Aligned_cols=139  Identities=26%  Similarity=0.304  Sum_probs=48.3

Q ss_pred             eccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCcccc-CCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccc
Q 041689           11 LNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIF-DVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS   89 (652)
Q Consensus        11 l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~   89 (652)
                      |+.+.++   .+|...++.++++|+|++|.|+.+  +.++ .+.+|+.|+||+|.|+.+                   +.
T Consensus         4 lt~~~i~---~~~~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-------------------~~   59 (175)
T PF14580_consen    4 LTANMIE---QIAQYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-------------------EG   59 (175)
T ss_dssp             -------------------------------------S--TT-TT--EEE-TTS--S---------------------TT
T ss_pred             ccccccc---cccccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-------------------cC
Confidence            4555666   688888888999999999999965  3455 688999999999999743                   23


Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCC---cccc
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIP---FTLR  165 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~  165 (652)
                      +..++.|+.|++++|+|+.+.+. ....+|+ |++|+|++|+|..... ..+..+++|+.|+|.+|.++....   ..+.
T Consensus        60 l~~L~~L~~L~L~~N~I~~i~~~-l~~~lp~-L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~  137 (175)
T PF14580_consen   60 LPGLPRLKTLDLSNNRISSISEG-LDKNLPN-LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIY  137 (175)
T ss_dssp             ----TT--EEE--SS---S-CHH-HHHH-TT---EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHH
T ss_pred             ccChhhhhhcccCCCCCCccccc-hHHhCCc-CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHH
Confidence            67789999999999999877432 2235665 9999999999875432 456778888888888888874321   2356


Q ss_pred             CCCCCcEEec
Q 041689          166 ELQKLQYVGL  175 (652)
Q Consensus       166 ~l~~L~~L~L  175 (652)
                      .+|+|+.||-
T Consensus       138 ~lP~Lk~LD~  147 (175)
T PF14580_consen  138 KLPSLKVLDG  147 (175)
T ss_dssp             H-TT-SEETT
T ss_pred             HcChhheeCC
Confidence            6777776664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=1.3e-13  Score=144.17  Aligned_cols=221  Identities=23%  Similarity=0.205  Sum_probs=172.8

Q ss_pred             CCCccceecc--ccceEEEEEEe---CCCcEEEEEEeecc--cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceE
Q 041689          426 GFNENNLIGK--GGFGTIYKSRI---GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       426 ~y~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  497 (652)
                      .|.+.+.+|.  |.+|.||.++.   .++..+|+|.-+..  .......=.+|+...+++ .|++.++.+..++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667788999  99999999875   36888999874322  112223334566666666 4999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS----VLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGIT  572 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~  572 (652)
                      +-+|++. .++.++.......++....+.+..+..+    |+.++|..   +++|-|+||+||++..+ ...+++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCccee
Confidence            9999985 5888887766656888889999999988    99999999   99999999999999988 89999999999


Q ss_pred             ccccCCCCccc---cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-----------------------
Q 041689          573 KLLIGEDQSMT---QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-----------------------  626 (652)
Q Consensus       573 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-----------------------  626 (652)
                      ..+.+......   .....+...|++||.. .+-++..+|+|++|.+..+..++..+                       
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            87754332111   1222577789999975 45778899999999999998776543                       


Q ss_pred             -cchhhhhhhcccchhhhccccCccC
Q 041689          627 -CVSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       627 -~~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                       -+.++...+..|++.+|-.|+++++
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~q~  375 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTAQI  375 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHHHH
Confidence             1122566888999999999998765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=3.7e-13  Score=129.53  Aligned_cols=178  Identities=19%  Similarity=0.235  Sum_probs=132.3

Q ss_pred             HHHhcCCCeeeeEEeeeecCC-----ceEEEEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 041689          474 IMKSIHYRNLVKIISSCSNEE-----FKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVP  545 (652)
Q Consensus       474 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  545 (652)
                      -+-++.|.|+|+++.|+.+..     ...++.||++.|++..++++.+   ..+....-.+|+.||..||.|||+. .|.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            345667999999999886543     4678999999999999987533   2566666778999999999999976 778


Q ss_pred             eEecCCCCCCeeeCCCCcEEEecccCCccccCCC--CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhC
Q 041689          546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED--QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA  623 (652)
Q Consensus       546 iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg  623 (652)
                      |+|+++..+-|++..+|-+|+.--.-........  .........+-++|.|||.-.....+.++|||+||....||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888875321111000000  00111223467889999987777778889999999999999776


Q ss_pred             CCC---------------------cchhhhhhhcccchhhhccccCccCC
Q 041689          624 KQQ---------------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       624 ~~p---------------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .-.                     -++.-.+++..|+...|..||++.++
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhh
Confidence            543                     11224679999999999999998753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.4e-12  Score=119.92  Aligned_cols=131  Identities=20%  Similarity=0.158  Sum_probs=97.5

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee-eeEEeeeecCCceEEEEEccCCCCh
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL-VKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      .+.++.|.++.||+++.. +..|++|+...... ....+++|+++++.+.+.++ ++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467899999999999874 77899998764422 23456889999999865444 45555433  335799999999887


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF--LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      .+.    .     .....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            653    0     111345688999999999882  12359999999999999 56899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.36  E-value=9.3e-14  Score=148.22  Aligned_cols=262  Identities=27%  Similarity=0.316  Sum_probs=135.7

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      ...++.++..++.+....-. ...+..++.+++..|.|..+.                  ..+..+++|+.|++..|+|.
T Consensus        48 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~~~------------------~~l~~~~~l~~l~l~~n~i~  108 (414)
T KOG0531|consen   48 PSDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAKIL------------------NHLSKLKSLEALDLYDNKIE  108 (414)
T ss_pred             cchhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhhhh------------------cccccccceeeeeccccchh
Confidence            45556666666655432211 145666666667777665311                  12556677777777777776


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD  187 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  187 (652)
                      .+...  +..+++ |++|++++|+|+.+.+  +..++.|+.|++++|.|+.+  ..+..+++|+.+++++|++....+ .
T Consensus       109 ~i~~~--l~~~~~-L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~  180 (414)
T KOG0531|consen  109 KIENL--LSSLVN-LQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-D  180 (414)
T ss_pred             hcccc--hhhhhc-chheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhh-h
Confidence            65431  334454 6667777777665433  45555566666666666632  234445666666666666663322 1


Q ss_pred             -ccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCC--C
Q 041689          188 -IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD--L  264 (652)
Q Consensus       188 -~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~--L  264 (652)
                       ...+.+++.+++++|.+.                        ....+..+..+..+++..|.++.+-+  +..+..  |
T Consensus       181 ~~~~~~~l~~l~l~~n~i~------------------------~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L  234 (414)
T KOG0531|consen  181 ELSELISLEELDLGGNSIR------------------------EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHL  234 (414)
T ss_pred             hhhhccchHHHhccCCchh------------------------cccchHHHHHHHHhhcccccceeccC--cccchhHHH
Confidence             344445555555555554                        33333333344444555555553321  122222  5


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccC-----CCCCCCCCccccc
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEI-----PKGGSFGNFSAES  339 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~~~l~~~~  339 (652)
                      +.+++++|++. ..+..+..+..+..|++++|++...-.  +.....+..+.+..|++....     +.......+....
T Consensus       235 ~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (414)
T KOG0531|consen  235 RELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLT  311 (414)
T ss_pred             HHHhcccCccc-cccccccccccccccchhhcccccccc--ccccchHHHhccCcchhcchhhhhccccccccccccccc
Confidence            66666666665 333455556666666666666653221  334445555555555554211     1123334445555


Q ss_pred             ccCCcc
Q 041689          340 FEGNKL  345 (652)
Q Consensus       340 ~~~N~~  345 (652)
                      +.+|+.
T Consensus       312 ~~~~~~  317 (414)
T KOG0531|consen  312 LELNPI  317 (414)
T ss_pred             cccCcc
Confidence            555544

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=2.3e-12  Score=138.67  Aligned_cols=141  Identities=16%  Similarity=0.146  Sum_probs=92.8

Q ss_pred             cCCCccceeccccceEEEEEEeCC-CcEEEEEEeecccch----------------------------------hh----
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGR----------------------------------AF----  465 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~----  465 (652)
                      .+|+. +.||+|++|.||+|+.++ |+.||||+.+++...                                  ..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34666 789999999999999877 999999999754210                                  00    


Q ss_pred             --hhHHHHHHHHHhcC----CCeeeeEEeeee-cCCceEEEEEccCCCChhhhh--hcCCC---CCCHHHHHHHHHHHHH
Q 041689          466 --KSFDIECEIMKSIH----YRNLVKIISSCS-NEEFKELVLEHMPHGSLEKCL--YSSNC---ILDIFQRLNIMIDVAS  533 (652)
Q Consensus       466 --~~~~~E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~---~l~~~~~~~i~~~i~~  533 (652)
                        -++.+|+..+.+++    +...+.+-.++. .....++||||++|+.+.++.  ...+.   .+....+..++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence              12444555555552    333333222222 234568999999999997743  22210   1222222223333   


Q ss_pred             HHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCCcccc
Q 041689          534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGITKLLI  576 (652)
Q Consensus       534 ~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~~~~~  576 (652)
                          +...   |++|+|+||.||+++.++    +++++|||++..+.
T Consensus       276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                3446   999999999999999887    99999999998763

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=7.4e-12  Score=132.29  Aligned_cols=168  Identities=16%  Similarity=0.205  Sum_probs=128.5

Q ss_pred             EeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHH
Q 041689          445 RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR  524 (652)
Q Consensus       445 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~  524 (652)
                      +..++.+|.|...+...........+.++-++.++||+|+++++.++..+..|+|+|.+.  .|..++++..    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            455788999998876655445667788999999999999999999999999999999985  5666666533    5566


Q ss_pred             HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCcc
Q 041689          525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV  604 (652)
Q Consensus       525 ~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  604 (652)
                      ...++||+.||.|||..+  +++|++|.-+.|++++.|..||++|.++....+...  ......--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            668899999999998654  899999999999999999999999998865422211  111111122366666543222 


Q ss_pred             CcccchhhHHHHHHHHHhCC
Q 041689          605 FANGDVYSFGIMLMEIHSAK  624 (652)
Q Consensus       605 ~~~sDvwslG~vl~elltg~  624 (652)
                       -..|.|-|||+++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             3459999999999999993

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.31  E-value=1.6e-12  Score=119.11  Aligned_cols=101  Identities=26%  Similarity=0.282  Sum_probs=31.6

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccC-ccccCCCCCcEEEcc
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP-YDIFRLVKLYKLDLG  200 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~  200 (652)
                      |+.|+|++|+|+.+.  .+..+++|++|+|++|+|+.+.+.....+++|++|+|++|+|...-. ..+..+++|+.|+|.
T Consensus        44 L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~  121 (175)
T PF14580_consen   44 LEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLE  121 (175)
T ss_dssp             --EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-T
T ss_pred             CCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeecc
Confidence            555555555554331  24445555555555555553222111235555555555555542211 234455566666666


Q ss_pred             CCcccccc---cccCCCCCCCCEEEcc
Q 041689          201 GNKLSGSI---LTCFSNLASLRTLSLS  224 (652)
Q Consensus       201 ~N~l~~~~---~~~~~~l~~L~~L~Ls  224 (652)
                      +|.++...   .-.+..+|+|+.||-.
T Consensus       122 ~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen  122 GNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             T-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             CCcccchhhHHHHHHHHcChhheeCCE
Confidence            66665321   1134556677777653

>PLN03150 hypothetical protein; Provisional

Probab=99.31  E-value=5.9e-12  Score=140.46  Aligned_cols=111  Identities=36%  Similarity=0.531  Sum_probs=101.3

Q ss_pred             CCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceecc
Q 041689          217 SLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFS  294 (652)
Q Consensus       217 ~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  294 (652)
                      .++.|+|++|.  +.+|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999995  7789999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCchhhcCC-CCCceEEeecCcCcccCC
Q 041689          295 NNNLSGAIPLLLEKL-SYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       295 ~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p  327 (652)
                      +|++++.+|..+..+ .++..+++++|+..|..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999988764 467899999999776555

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.30  E-value=2.1e-13  Score=145.48  Aligned_cols=213  Identities=28%  Similarity=0.295  Sum_probs=137.9

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG  201 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  201 (652)
                      ++.+.+..|.|.. +-..+..+++|+.|+|.+|+|..+.. .+..+++|++|+|++|+|+...+  +..++.|+.|++++
T Consensus        74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~  149 (414)
T KOG0531|consen   74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG  149 (414)
T ss_pred             HHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence            5555566666653 22335556666666666666663222 25566666666666666663332  44455577777777


Q ss_pred             CcccccccccCCCCCCCCEEEccCCCCCCCcc--cCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccc
Q 041689          202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLE--IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP  279 (652)
Q Consensus       202 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~--~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  279 (652)
                      |.|+.+  ..+..+++|+.+++++|+......  ...+..++.+++++|.+..+  ..+..+..+..+++..|.++..-+
T Consensus       150 N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~  225 (414)
T KOG0531|consen  150 NLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG  225 (414)
T ss_pred             Ccchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC
Confidence            777632  344556777777777775332223  57788899999999999854  556666777788999999984332


Q ss_pred             cccccccc--CcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccC
Q 041689          280 DSVGDLIS--LKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       280 ~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~  346 (652)
                        +..+..  |+.+++++|++. ..+..+..+..+..|++.+|.++.. ........+.......|+..
T Consensus       226 --l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~-~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  226 --LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL-EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             --cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc-ccccccchHHHhccCcchhc
Confidence              333333  899999999998 5546778889999999999999843 22334444555555555543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.29  E-value=4.4e-11  Score=111.81  Aligned_cols=135  Identities=19%  Similarity=0.187  Sum_probs=98.5

Q ss_pred             ceeccccceEEEEEEeCC-------CcEEEEEEeeccc------------c----------hhhhhH----HHHHHHHHh
Q 041689          431 NLIGKGGFGTIYKSRIGD-------GMEVAVKVFHLQC------------G----------RAFKSF----DIECEIMKS  477 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~~  477 (652)
                      ..||.|.=+.||.|...+       +..+|||+.+...            .          ...+.+    ++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997543       4799999985321            0          011222    379999999


Q ss_pred             cCC--CeeeeEEeeeecCCceEEEEEccCCCChhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCCCC
Q 041689          478 IHY--RNLVKIISSCSNEEFKELVLEHMPHGSLEK-CLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDLKP  553 (652)
Q Consensus       478 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~dlkp  553 (652)
                      +..  -++++.+++    ...++||||+.+..+.. .++..  .++..+...+..+++.++..+ |..   |++|+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            853  456666664    45679999997754422 22221  345556677889999999999 888   999999999


Q ss_pred             CCeeeCCCCcEEEecccCCccc
Q 041689          554 SNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .||++++ +.+.++|||.+...
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 57999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.29  E-value=3.7e-13  Score=134.25  Aligned_cols=215  Identities=22%  Similarity=0.240  Sum_probs=130.2

Q ss_pred             CCCCCCEEECCCCcCcccCC--ccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccC
Q 041689           27 NPHNLEELLLGQNNLVGVVP--AAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNN  104 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N  104 (652)
                      ++.+|++..|.+..+. ..+  +....+++++.||||+|-++...+-               .+-...|++|+.|+||.|
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v---------------~~i~eqLp~Le~LNls~N  182 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPV---------------LKIAEQLPSLENLNLSSN  182 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHH---------------HHHHHhcccchhcccccc
Confidence            4678888888888876 333  3567788888888888887643221               012457888888888888


Q ss_pred             CCcccCCccchhcccccCcEEEccCCccccc-CCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccc
Q 041689          105 PLNGILPRMSIGNLSHSLEIFDMSKCNVSGG-IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGT  183 (652)
Q Consensus       105 ~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  183 (652)
                      ++........-..+++ |+.|.|+.|.++.. +......+|+|+.|+|..|....+......-+..|++|||++|.+. .
T Consensus       183 rl~~~~~s~~~~~l~~-lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~  260 (505)
T KOG3207|consen  183 RLSNFISSNTTLLLSH-LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-D  260 (505)
T ss_pred             cccCCccccchhhhhh-hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-c
Confidence            8875433322334444 88888888888733 2334566788888888888543344445566777888888888876 3


Q ss_pred             cC--ccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCcc-CcccccC
Q 041689          184 IP--YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV-IPTTIGS  260 (652)
Q Consensus       184 ~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~  260 (652)
                      .+  .....++.|..|.++.+.|..+.-...      ..++          .....++|++|+++.|++... .-..+..
T Consensus       261 ~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~------~s~~----------kt~~f~kL~~L~i~~N~I~~w~sl~~l~~  324 (505)
T KOG3207|consen  261 FDQGYKVGTLPGLNQLNLSSTGIASIAEPDV------ESLD----------KTHTFPKLEYLNISENNIRDWRSLNHLRT  324 (505)
T ss_pred             cccccccccccchhhhhccccCcchhcCCCc------cchh----------hhcccccceeeecccCccccccccchhhc
Confidence            33  344556677777777777664321111      0000          022344555555555555321 0122334


Q ss_pred             CCCCcEEEccCCcCC
Q 041689          261 LKDLQYLFLGYNILK  275 (652)
Q Consensus       261 l~~L~~L~L~~N~l~  275 (652)
                      +++|+.|....|.|+
T Consensus       325 l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  325 LENLKHLRITLNYLN  339 (505)
T ss_pred             cchhhhhhccccccc
Confidence            456666666666665

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.25  E-value=1.1e-12  Score=124.60  Aligned_cols=132  Identities=27%  Similarity=0.264  Sum_probs=91.4

Q ss_pred             CCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEcc
Q 041689          191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG  270 (652)
Q Consensus       191 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~  270 (652)
                      +..|+.||||+|.|+ .+.....-+|.++.|++|+|.......+..+++|+.||||+|.++. ..++-..+.+++.|.|+
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence            344566666666665 3444555566666666666654455556777777778888888775 44566667788888888


Q ss_pred             CCcCCCcccccccccccCcceeccccccCCCCc-hhhcCCCCCceEEeecCcCcccC
Q 041689          271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKLSYLEHLNLSFNKLEGEI  326 (652)
Q Consensus       271 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~  326 (652)
                      .|.|...  ..+..+-+|..||+++|+|..... ..+++++.|+.+.|.+|++.+.+
T Consensus       361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            8888732  346677788888999998874322 35788899999999999998554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=3.1e-12  Score=134.05  Aligned_cols=224  Identities=21%  Similarity=0.136  Sum_probs=167.2

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC--CCcEEEEEEeecccchhhh--hHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCGRAFK--SFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      -.....+|..+..||.|.|+.|+.+..+  ++..|++|...........  .-..|+.+...+ .|.++++++..|...+
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            3445567888999999999999998643  5788999987654322212  223466666655 5899999888888888


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITK  573 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~  573 (652)
                      ..|+--|||++++......-. ..+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +.-++.|||.++
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence            888999999999887655222 2577788899999999999999988   99999999999999875 889999999987


Q ss_pred             cccCCCCccccccccCCccc-cCccccccCccCcccchhhHHHHHHHHHhCCCC--------------------cchhhh
Q 041689          574 LLIGEDQSMTQTQTLATIGY-IAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ--------------------CVSFVF  632 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p--------------------~~~~l~  632 (652)
                      .+.-    ........+..| .+|+......+..++|++|||.-+.|..++..-                    ......
T Consensus       416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q  491 (524)
T KOG0601|consen  416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQ  491 (524)
T ss_pred             ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhh
Confidence            4311    001111133334 356666667788999999999999998886542                    124467


Q ss_pred             hhhcccchhhhccccCccC
Q 041689          633 NLAMECTIESLELRINAKE  651 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~e  651 (652)
                      .+.+.+..+++..||.+.+
T Consensus       492 ~~~kv~~~~~~~~~~l~~~  510 (524)
T KOG0601|consen  492 VLLKVMINPDRKRRPSAVE  510 (524)
T ss_pred             hhhhhhcCCccccchhhhh
Confidence            7888888899999998865

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.22  E-value=2.1e-12  Score=122.64  Aligned_cols=131  Identities=23%  Similarity=0.246  Sum_probs=80.9

Q ss_pred             CCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEe
Q 041689          166 ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGID  244 (652)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~  244 (652)
                      ..+.|++||||+|.|+ .+.....-++.++.|++|+|.|..+  +.+..+++|+.||||+|. ..+-.+-..+-+++.|.
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLK  358 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEeeee
Confidence            3455667777777776 5566666666777777777777633  226666777777777775 33333334455666677


Q ss_pred             cccccCCccCcccccCCCCCcEEEccCCcCCCc-ccccccccccCcceeccccccCCC
Q 041689          245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGS-IPDSVGDLISLKSLNFSNNNLSGA  301 (652)
Q Consensus       245 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~  301 (652)
                      |++|.|...  ..++.+.+|..||+++|+|... --..++++|-|+.|.|.+|.|.+.
T Consensus       359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            777766643  4555666677777777766531 123566677777777777777643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.21  E-value=1.4e-10  Score=113.11  Aligned_cols=142  Identities=18%  Similarity=0.195  Sum_probs=110.6

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCC--CeeeeEEeeeecC---CceEEEEEccC
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHY--RNLVKIISSCSNE---EFKELVLEHMP  504 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  504 (652)
                      +.++.|..+.||++...+|..+++|+...... .....+..|+++++.+.+  ..+++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999886678999999764422 234678899999999975  3456777776654   36689999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF------------------------------------------  542 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------  542 (652)
                      |.++.+.+..  ..++..+...++.+++++|.+||+..                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775532  24677777788888888888888521                                          


Q ss_pred             -----------CCCeEecCCCCCCeeeCC--CCcEEEecccCCcc
Q 041689          543 -----------LVPVIHCDLKPSNVLLDD--TMVAHLSDFGITKL  574 (652)
Q Consensus       543 -----------~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~~~~  574 (652)
                                 ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       246799999999999998  67789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.19  E-value=3e-12  Score=127.85  Aligned_cols=203  Identities=26%  Similarity=0.261  Sum_probs=132.8

Q ss_pred             CcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCC--ccccCCCCCcEEecccCccccccCccc-cCCCCCcEE
Q 041689          122 LEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIP--FTLRELQKLQYVGLKDNKLEGTIPYDI-FRLVKLYKL  197 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L  197 (652)
                      |+...|.+..+..... +....|++++.|||++|-+..+.+  .....|++|+.|+|+.|++........ ..++.|+.|
T Consensus       123 L~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L  202 (505)
T KOG3207|consen  123 LREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQL  202 (505)
T ss_pred             hhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheE
Confidence            7777777777662211 356677888888888887765443  335677888888888888763332221 235678888


Q ss_pred             EccCCccccc-ccccCCCCCCCCEEEccCCCCCC--CcccCCCCccceEecccccCCccC-cccccCCCCCcEEEccCCc
Q 041689          198 DLGGNKLSGS-ILTCFSNLASLRTLSLSYNDGPL--PLEIGNLKVLIGIDFSMNNFSSVI-PTTIGSLKDLQYLFLGYNI  273 (652)
Q Consensus       198 ~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~~~~--~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~  273 (652)
                      .|+.+.|+.- +......+|+|+.|+|..|....  ......+..|+.|||++|++-... -...+.++.|..|+++.+.
T Consensus       203 ~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tg  282 (505)
T KOG3207|consen  203 VLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTG  282 (505)
T ss_pred             EeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccC
Confidence            8888887632 22334567788888888884222  223455667888888888876432 1446678888888888888


Q ss_pred             CCCc-cccc-----ccccccCcceeccccccCCC-CchhhcCCCCCceEEeecCcCcc
Q 041689          274 LKGS-IPDS-----VGDLISLKSLNFSNNNLSGA-IPLLLEKLSYLEHLNLSFNKLEG  324 (652)
Q Consensus       274 l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~  324 (652)
                      +..+ .|+.     ...+++|++|+++.|++... .-..+..+++|+.|....|.+..
T Consensus       283 i~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  283 IASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             cchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            8753 2333     34567899999999988521 11234556778888888888864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=4.4e-10  Score=101.11  Aligned_cols=131  Identities=21%  Similarity=0.264  Sum_probs=98.5

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeeccc--------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+++|+-+.+|.+.+. |.++++|.=.++.        .-...+..+|++++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999763 4456666532221        11234567899999998655554444455566677899999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ++|..|.+++...        ...++..+-.-+.-||..   ||+|+|+.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888764        245677777778889999   999999999999998775 89999999974

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.13  E-value=1.3e-11  Score=135.89  Aligned_cols=224  Identities=22%  Similarity=0.229  Sum_probs=163.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+++.+.+-+.+|.++.++.+.-. .|...+.|......   ....+....+-.+.-...+|.+++....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777788899999999988643 34444444432221   1122333334444444566777777666667788899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC-
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-  577 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-  577 (652)
                      |++|..++++...++..++ .+..-.......+.++.+|||..   .+.|||++|.|+++..++..++.|||......- 
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999998887663 44444555677788999999988   799999999999999999999999984322100 


Q ss_pred             -----C-----------------------CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch
Q 041689          578 -----E-----------------------DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS  629 (652)
Q Consensus       578 -----~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~  629 (652)
                           .                       +.........+|+.|.+||...+......+|+|++|++++|.++|.+||.+
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                 0                       000111234589999999999999999999999999999999999999655


Q ss_pred             h--------------------------hhhhhcccchhhhccccCcc
Q 041689          630 F--------------------------VFNLAMECTIESLELRINAK  650 (652)
Q Consensus       630 ~--------------------------l~~l~~~~l~~~p~~Rpt~~  650 (652)
                      .                          .++++.+.+..+|.+|-.+.
T Consensus      1038 ~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4                          67888888889999987764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.08  E-value=1.3e-09  Score=97.39  Aligned_cols=142  Identities=17%  Similarity=0.186  Sum_probs=103.4

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEe-ecc-------cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVF-HLQ-------CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ....+-+|+-+.|+++.+ .|+.++||.= .+.       ..-..++..+|++.+.++.--.|....=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567889999999999988 5777777642 211       1113456778999999986555544444555666677999


Q ss_pred             EccCC-CChhhhhhcCCCCCCHHHH-HHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEecccCCcc
Q 041689          501 EHMPH-GSLEKCLYSSNCILDIFQR-LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKL  574 (652)
Q Consensus       501 e~~~~-g~L~~~l~~~~~~l~~~~~-~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~~~~  574 (652)
                      ||++| .++.+++...-..-...+. ...+.++-+.+.-||..   +|+|+||..+||++..+   ..+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 4777777654332233333 67888999999999999   99999999999999644   3468999999864

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.04  E-value=1.5e-11  Score=119.70  Aligned_cols=233  Identities=21%  Similarity=0.195  Sum_probs=136.4

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCcc---chhcccccCcEEEccCCc---ccccCC-------ccccCCCCCCEEEecCcc
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRM---SIGNLSHSLEIFDMSKCN---VSGGIP-------EEIGNLTNLTAIYLGGNK  155 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~L~~L~L~~N~---l~~~~~-------~~~~~l~~L~~L~L~~N~  155 (652)
                      .+..+..++.++||+|.+.......   .+.+.+ +|+..++|+--   +...+|       +++-.+++|++||||.|-
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~-~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKK-ELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcc-cceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            3556788999999999886432220   233344 37777776532   111222       344567788888888888


Q ss_pred             ccccCCcc----ccCCCCCcEEecccCccccccCc-------------cccCCCCCcEEEccCCcccccc----cccCCC
Q 041689          156 LNGSIPFT----LRELQKLQYVGLKDNKLEGTIPY-------------DIFRLVKLYKLDLGGNKLSGSI----LTCFSN  214 (652)
Q Consensus       156 l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~l~~L~~L~L~~N~l~~~~----~~~~~~  214 (652)
                      +...-+..    +.+++.|++|+|.+|.+...-..             ....-+.|+.+..++|++....    ...|..
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~  183 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS  183 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence            86333333    45678888888888887622111             2233456777777777775322    234566


Q ss_pred             CCCCCEEEccCCCCCC------CcccCCCCccceEecccccCCcc----CcccccCCCCCcEEEccCCcCCCcccccc--
Q 041689          215 LASLRTLSLSYNDGPL------PLEIGNLKVLIGIDFSMNNFSSV----IPTTIGSLKDLQYLFLGYNILKGSIPDSV--  282 (652)
Q Consensus       215 l~~L~~L~Ls~N~~~~------~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~--  282 (652)
                      .+.|+.+.+++|....      ...+..+++|+.|||..|-++..    +...+..+++|++|+++.+.++..-..+|  
T Consensus       184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~  263 (382)
T KOG1909|consen  184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD  263 (382)
T ss_pred             ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH
Confidence            6777777777774221      22356666777777777766532    23345556666677776666654322222  


Q ss_pred             ---cccccCcceeccccccCCC----CchhhcCCCCCceEEeecCcC
Q 041689          283 ---GDLISLKSLNFSNNNLSGA----IPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       283 ---~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  322 (652)
                         ...++|+.|.|.+|.++..    +...+...+.|+.|+|++|.+
T Consensus       264 al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  264 ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence               1245666666666666521    122334455666666666666

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.02  E-value=2.3e-10  Score=86.19  Aligned_cols=59  Identities=32%  Similarity=0.519  Sum_probs=33.9

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCcc
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKL  180 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  180 (652)
                      |++|++++|+|+.+.++.|.++++|++|++++|+|+.+.+.+|.++++|++|++++|+|
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            55555555555555555555555555555555555555555555555555555555543

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.00  E-value=3.7e-10  Score=85.09  Aligned_cols=61  Identities=33%  Similarity=0.426  Sum_probs=43.2

Q ss_pred             CCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcc
Q 041689          144 TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL  204 (652)
Q Consensus       144 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  204 (652)
                      ++|++|++++|+|+.+.+..|.++++|++|++++|+|+...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4567777777777766666777777777777777777766666777777777777777764

...

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.00  E-value=8.7e-12  Score=121.44  Aligned_cols=252  Identities=19%  Similarity=0.225  Sum_probs=140.8

Q ss_pred             CCCCCCEEECCCCcCccc----CCccccCCCCCCEEEcCCCcCeeccCC-CccccccCCCCCcccccccCCCCCCcEEEc
Q 041689           27 NPHNLEELLLGQNNLVGV----VPAAIFDVSTLKDLALQDNYLSGSLSS-IADNYLTSSTPELSFLSSLSNCKSLVVFLL  101 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L  101 (652)
                      ....++.|+||+|.+...    +...+.+.++|+.-++|+= ++|-+.. +.+.       -..+.+++..+++|++|||
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~-------L~~l~~aL~~~~~L~~ldL   99 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEA-------LKMLSKALLGCPKLQKLDL   99 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHH-------HHHHHHHHhcCCceeEeec
Confidence            457888999999988632    3345667778888877753 2221110 0000       0012234566778888888


Q ss_pred             ccCCCcccCCccchh----cccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEeccc
Q 041689          102 SNNPLNGILPRMSIG----NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD  177 (652)
Q Consensus       102 s~N~l~~~~~~~~~~----~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  177 (652)
                      |.|-+..-.+. .+.    ... +|++|.|.+|.+...-...++.  .|..|.  .|+.       ..+-++|+++...+
T Consensus       100 SDNA~G~~g~~-~l~~ll~s~~-~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~r  166 (382)
T KOG1909|consen  100 SDNAFGPKGIR-GLEELLSSCT-DLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGR  166 (382)
T ss_pred             cccccCccchH-HHHHHHHhcc-CHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeec
Confidence            88887643332 222    222 3777777777765322222111  011111  1111       12223455555555


Q ss_pred             Cccccc----cCccccCCCCCcEEEccCCcccc----cccccCCCCCCCCEEEccCCC------CCCCcccCCCCccceE
Q 041689          178 NKLEGT----IPYDIFRLVKLYKLDLGGNKLSG----SILTCFSNLASLRTLSLSYND------GPLPLEIGNLKVLIGI  243 (652)
Q Consensus       178 N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~------~~~~~~~~~l~~L~~L  243 (652)
                      |++...    +...|...+.|+.+.++.|.|..    .....|..+++|+.|||..|.      ..+...+..++.|+.|
T Consensus       167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El  246 (382)
T KOG1909|consen  167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL  246 (382)
T ss_pred             cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence            555421    12234445556666666666541    122345666666666666663      1223446667777777


Q ss_pred             ecccccCCccCcccc-----cCCCCCcEEEccCCcCCC----cccccccccccCcceeccccccC
Q 041689          244 DFSMNNFSSVIPTTI-----GSLKDLQYLFLGYNILKG----SIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       244 ~ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      +++++.++..-..+|     ...++|+.|.|.+|.|+.    .+.......+.|..|+|++|++.
T Consensus       247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            777777765332222     246789999999999874    23344556789999999999994

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=2.7e-09  Score=99.50  Aligned_cols=125  Identities=22%  Similarity=0.188  Sum_probs=83.1

Q ss_pred             EEEEEEeCCCcEEEEEEeeccc-------------c-------------hhhhhHHHHHHHHHhcCCC--eeeeEEeeee
Q 041689          440 TIYKSRIGDGMEVAVKVFHLQC-------------G-------------RAFKSFDIECEIMKSIHYR--NLVKIISSCS  491 (652)
Q Consensus       440 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~  491 (652)
                      .||.|...+|.++|+|+.+...             .             ......++|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998899999999985321             0             0123457899999999755  566777553 


Q ss_pred             cCCceEEEEEccC--CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          492 NEEFKELVLEHMP--HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY-LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       492 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                         ..++||||++  |..+..+....   ++......++.+++..+.. +|..   |++|+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence               3469999998  65554433221   1123455677888886665 5788   99999999999999988 899999


Q ss_pred             ccCCccc
Q 041689          569 FGITKLL  575 (652)
Q Consensus       569 fg~~~~~  575 (652)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=1.5e-08  Score=100.35  Aligned_cols=140  Identities=14%  Similarity=0.084  Sum_probs=99.6

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccch-hhh----------hHHHHHHHHHhcCCCee--eeEEeeeec-----
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFK----------SFDIECEIMKSIHYRNL--VKIISSCSN-----  492 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~~~~~~~~-----  492 (652)
                      +.+-......|+++.. +|+.|.||........ ..+          .+.+|.+.+.++...+|  ++.+++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455444455777665 6788999977433211 111          37789998888843333  334444432     


Q ss_pred             CCceEEEEEccCCC-ChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-------CCc
Q 041689          493 EEFKELVLEHMPHG-SLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-------TMV  563 (652)
Q Consensus       493 ~~~~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-------~~~  563 (652)
                      ....++|||++++. +|.+++... ....+...+..++.+++..+.-||..   ||+|+|+++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23568999999986 788887532 12355667778999999999999999   9999999999999975       578


Q ss_pred             EEEecccCCcc
Q 041689          564 AHLSDFGITKL  574 (652)
Q Consensus       564 ~kl~Dfg~~~~  574 (652)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998863

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=8.6e-09  Score=98.47  Aligned_cols=135  Identities=19%  Similarity=0.137  Sum_probs=101.3

Q ss_pred             CCccceeccccceEEEEEEeCCCcEEEEEEeeccc----------------------chhhhhHHHHHHHHHhcCCC--e
Q 041689          427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC----------------------GRAFKSFDIECEIMKSIHYR--N  482 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  482 (652)
                      +.++..||-|.-+.||.|..+.|.++|||.-+...                      .-.....++|.++|+++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999753221                      01233567899999999654  6


Q ss_pred             eeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC
Q 041689          483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM  562 (652)
Q Consensus       483 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~  562 (652)
                      |++.+++    +...+||||++|-.|...-      ++....-.++..|+.-+..+-..   ||||+|+.+-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence            7777765    4567999999996665532      12333444556666666655567   999999999999999999


Q ss_pred             cEEEecccCCcc
Q 041689          563 VAHLSDFGITKL  574 (652)
Q Consensus       563 ~~kl~Dfg~~~~  574 (652)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.87  E-value=1.8e-11  Score=129.20  Aligned_cols=129  Identities=30%  Similarity=0.203  Sum_probs=68.6

Q ss_pred             CCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCC
Q 041689          193 KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN  272 (652)
Q Consensus       193 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N  272 (652)
                      .|...+.+.|.+. ....++.-++.|+.|+|++|+..--..+..++.|++|||+.|.+..++--...+++ |+.|.+++|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN  242 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNN  242 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhccccccchhhhh-heeeeeccc
Confidence            4556666666665 44455555566666666666543334555566666666666666543222233333 666666666


Q ss_pred             cCCCcccccccccccCcceeccccccCCCCc-hhhcCCCCCceEEeecCcCccc
Q 041689          273 ILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       273 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      .++..  ..+.++++|+.|||++|-|.+..- ..+..|..|+.|+|.+|++.|.
T Consensus       243 ~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  243 ALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             HHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            65522  235555666666666665543211 1123444555566666665543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.86  E-value=3.3e-08  Score=101.80  Aligned_cols=166  Identities=17%  Similarity=0.195  Sum_probs=124.0

Q ss_pred             eEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceEEEEEccCC-CChhhhh
Q 041689          439 GTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKELVLEHMPH-GSLEKCL  512 (652)
Q Consensus       439 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~~l  512 (652)
                      .+.|+|.. .||..|++|+++..........-.-+++++++.|+|||++.+++..    +...++|++|.|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            46788874 4899999999954433333233456888999999999999998863    3467899999986 4777754


Q ss_pred             hcC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          513 YSS--------------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       513 ~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ...              +...++...|.++.|+..||.++|+.   |..-+-|.|.+|+++.+.+++|..-|.......+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            321              11467888999999999999999999   9999999999999999989999887776544221


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      .              .+|  +.+   -.+-|.=.||.++..+.||...
T Consensus       447 ~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 P--------------TEP--LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             C--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            1              001  111   1345888999999999999554

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=3.7e-09  Score=120.68  Aligned_cols=137  Identities=31%  Similarity=0.353  Sum_probs=88.0

Q ss_pred             cCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCc--CeeccCCCccccccCCCCCcccccccCCCCCCcE
Q 041689           21 EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY--LSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVV   98 (652)
Q Consensus        21 ~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~   98 (652)
                      ++|+..+....+...+-+|++. .++..... ++|++|-+..|.  +..+..                 ..|..++.|++
T Consensus       515 ~~~~~~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~-----------------~ff~~m~~LrV  575 (889)
T KOG4658|consen  515 EIPQVKSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISG-----------------EFFRSLPLLRV  575 (889)
T ss_pred             ccccccchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCH-----------------HHHhhCcceEE
Confidence            4666666677777777777776 34444333 367777777775  321111                 12666777777


Q ss_pred             EEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccC
Q 041689           99 FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN  178 (652)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  178 (652)
                      ||||+|.=-+..|. .++.|-+ |++|+|++..|+ .+|..+.+|+.|.+|++..+.-...+|.....|++|++|.+-.-
T Consensus       576 LDLs~~~~l~~LP~-~I~~Li~-LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  576 LDLSGNSSLSKLPS-SIGELVH-LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             EECCCCCccCcCCh-HHhhhhh-hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            77777654444555 5666665 777777777777 56777777777777777776654455666666777777776554


Q ss_pred             c
Q 041689          179 K  179 (652)
Q Consensus       179 ~  179 (652)
                      .
T Consensus       653 ~  653 (889)
T KOG4658|consen  653 A  653 (889)
T ss_pred             c
Confidence            3

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.74  E-value=1.6e-08  Score=115.49  Aligned_cols=287  Identities=22%  Similarity=0.224  Sum_probs=170.5

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCc--CcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCC
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNN--LVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTP   82 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~   82 (652)
                      ..+++.+-.|.+.   .++...+.++|+.|-+..|.  +..+.++.|..++.|++|||++|.=-+.+|            
T Consensus       524 ~~rr~s~~~~~~~---~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP------------  588 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE---HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLP------------  588 (889)
T ss_pred             heeEEEEeccchh---hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCC------------
Confidence            4566666677776   56777656689999999997  665666668889999999999875322222            


Q ss_pred             CcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcccc--ccC
Q 041689           83 ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN--GSI  160 (652)
Q Consensus        83 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~  160 (652)
                           +..++|-+|++|+|++..++.++.  .+.+|.. |.+|++..+.-...+|.....|++|++|.|..-...  ...
T Consensus       589 -----~~I~~Li~LryL~L~~t~I~~LP~--~l~~Lk~-L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~  660 (889)
T KOG4658|consen  589 -----SSIGELVHLRYLDLSDTGISHLPS--GLGNLKK-LIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLL  660 (889)
T ss_pred             -----hHHhhhhhhhcccccCCCccccch--HHHHHHh-hheeccccccccccccchhhhcccccEEEeeccccccchhh
Confidence                 457889999999999999997766  5888886 999999998877677888888999999999876532  222


Q ss_pred             CccccCCCCCcEEecccCccccccCccccCCCCCc----EEEccCCcccccccccCCCCCCCCEEEccCCCCC-C-Cccc
Q 041689          161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY----KLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP-L-PLEI  234 (652)
Q Consensus       161 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~-~-~~~~  234 (652)
                      -..+..|.+|+.+.......  .+-..+..++.|.    .+.+.++... ..+..+..+.+|+.|.+.+.... . ....
T Consensus       661 l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~  737 (889)
T KOG4658|consen  661 LKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWE  737 (889)
T ss_pred             HHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccc
Confidence            23344455555444433222  1111223333332    3333332222 34455667777777777766421 1 1110


Q ss_pred             CC------CCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCC-Cchhhc
Q 041689          235 GN------LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGA-IPLLLE  307 (652)
Q Consensus       235 ~~------l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~  307 (652)
                      ..      ++++..+...+...- ..+.+..-.++|+.|++........+......+..+..+-+..+.+.+. .-....
T Consensus       738 ~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~  816 (889)
T KOG4658|consen  738 ESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLG  816 (889)
T ss_pred             cccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCC
Confidence            00      112222211111111 1122223346788888877665544444555555666656666666654 223334


Q ss_pred             CCCCCceEEee
Q 041689          308 KLSYLEHLNLS  318 (652)
Q Consensus       308 ~l~~L~~L~L~  318 (652)
                      +++++..+.+.
T Consensus       817 ~l~~i~~~~l~  827 (889)
T KOG4658|consen  817 GLPQLYWLPLS  827 (889)
T ss_pred             CCceeEecccC
Confidence            44444444443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.72  E-value=1.1e-10  Score=123.23  Aligned_cols=125  Identities=29%  Similarity=0.317  Sum_probs=93.2

Q ss_pred             CCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcc-cCCCCccceEecc
Q 041689          169 KLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE-IGNLKVLIGIDFS  246 (652)
Q Consensus       169 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~-~~~l~~L~~L~ls  246 (652)
                      .|...+.+.|.|. .....+.-++.|+.|+|++|+++...  .+..++.|++|||++|. ..+|.- ...+. |..|.+.
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4677788888888 77777888888888888888887543  77888888888888886 333332 22333 8888888


Q ss_pred             cccCCccCcccccCCCCCcEEEccCCcCCCccc-ccccccccCcceeccccccC
Q 041689          247 MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP-DSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       247 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~  299 (652)
                      +|.++..  ..+.++++|+.||+++|-|.+... ..++.+..|+.|+|.+|.+.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            8888865  567788888888888888875322 23566778888888888886

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=3.3e-07  Score=92.10  Aligned_cols=192  Identities=13%  Similarity=0.132  Sum_probs=127.3

Q ss_pred             CccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEee------eecCC-ceEEE
Q 041689          428 NENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISS------CSNEE-FKELV  499 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~~~-~~~lv  499 (652)
                      ...+.+|+|+-+.+|-.-  .-...+.|+++........+   .+..|... .||-+-.-+.|      .-.++ ..-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            345789999999999642  22234568876553322222   22333333 56543321211      11222 25678


Q ss_pred             EEccCCCC-hhhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          500 LEHMPHGS-LEKCLY-----SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       500 ~e~~~~g~-L~~~l~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      |+.+++.. ...+..     +.-....|....+.++.++.+.+.||.+   |.+-+|+.++|+|+.+++.+.|+|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            88887642 222221     1112577888999999999999999999   99999999999999999999999865433


Q ss_pred             cccCCCCccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhC-CCCcchh
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSA-KQQCVSF  630 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg-~~p~~~~  630 (652)
                      ..   .........+|...|.+||.-.     +..-+...|-|.+|+++++++.| ++||+..
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            21   2233344567899999999643     33456778999999999999887 8886553

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.67  E-value=1.7e-09  Score=103.09  Aligned_cols=110  Identities=21%  Similarity=0.238  Sum_probs=56.0

Q ss_pred             CCCCEEECCCCcCcccCC-cccc-CCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccc-cccCCCCCCcEEEcccCC
Q 041689           29 HNLEELLLGQNNLVGVVP-AAIF-DVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFL-SSLSNCKSLVVFLLSNNP  105 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p-~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~-~~l~~l~~L~~L~Ls~N~  105 (652)
                      .-++.|-+.++.|..+-- ..|+ ..+.++.|||.+|+|+.-.                .+ .-+.+|+.|++|+|+.|+
T Consensus        45 ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWs----------------eI~~ile~lP~l~~LNls~N~  108 (418)
T KOG2982|consen   45 RALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWS----------------EIGAILEQLPALTTLNLSCNS  108 (418)
T ss_pred             cchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHH----------------HHHHHHhcCccceEeeccCCc
Confidence            344455555555542211 1121 3456677777777765211                11 124566777777777777


Q ss_pred             CcccCCccchhcccccCcEEEccCCccccc-CCccccCCCCCCEEEecCccc
Q 041689          106 LNGILPRMSIGNLSHSLEIFDMSKCNVSGG-IPEEIGNLTNLTAIYLGGNKL  156 (652)
Q Consensus       106 l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l  156 (652)
                      +...+.... ..+. +|++|-|.+..+.-. ....+..+|.++.|.+|.|.+
T Consensus       109 L~s~I~~lp-~p~~-nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  109 LSSDIKSLP-LPLK-NLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL  158 (418)
T ss_pred             CCCccccCc-cccc-ceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence            664332200 1122 366666666666532 223345666666666666644

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.4e-07  Score=101.19  Aligned_cols=139  Identities=19%  Similarity=0.164  Sum_probs=94.2

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccc----------------------------------------hhhhhHHH
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG----------------------------------------RAFKSFDI  470 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------------------------~~~~~~~~  470 (652)
                      +.|+.++-|.||+|+.++|++||||+.++...                                        ..+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            78999999999999999999999999754310                                        01113445


Q ss_pred             HHHHHHhcC-----CCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHH-HHHHHcCCCC
Q 041689          471 ECEIMKSIH-----YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-LEYLHFNFLV  544 (652)
Q Consensus       471 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~  544 (652)
                      |+.-+.+++     .+++.-..=+++......++|||++|-.+.+.........+...   ++..++++ +..+-..   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d---  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD---  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc---
Confidence            666666552     34443222233334566899999999888887432223355333   33333332 2333334   


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       545 ~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      |+.|.|..|.||+++.+|++.+.|||+...+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            9999999999999999999999999998765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.65  E-value=8e-09  Score=110.16  Aligned_cols=121  Identities=18%  Similarity=0.218  Sum_probs=94.1

Q ss_pred             HHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc-------cccccCCccccCcccccc
Q 041689          529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-------QTQTLATIGYIAPEYGRE  601 (652)
Q Consensus       529 ~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  601 (652)
                      .+++.|+.|+|...  ++||++|.|++|.++..+..||+.|+++....+......       .........|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34558999999774  899999999999999999999999999875433111100       011224567999999998


Q ss_pred             CccCcccchhhHHHHHHHHHhCCCC----------------------------cchhhhhhhcccchhhhccccCccC
Q 041689          602 GRVFANGDVYSFGIMLMEIHSAKQQ----------------------------CVSFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       602 ~~~~~~sDvwslG~vl~elltg~~p----------------------------~~~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                      ...+.++|+||+||.+|.+..|..+                            .+.++.+-+.+++..++..||++.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence            8888999999999999999855444                            3344788889999999999996654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=3.3e-07  Score=87.85  Aligned_cols=105  Identities=22%  Similarity=0.238  Sum_probs=81.6

Q ss_pred             hhHHHHHHHHHhcCCCe--eeeEEeeeecC----CceEEEEEccCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 041689          466 KSFDIECEIMKSIHYRN--LVKIISSCSNE----EFKELVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMIDVASVLEYL  538 (652)
Q Consensus       466 ~~~~~E~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L  538 (652)
                      ....+|.+.+..+....  +++.+++.+..    ...++|+|++++. +|.+++..... .+......++.+++..+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            45677888877774332  34555554432    2457999999984 79988876432 55667788999999999999


Q ss_pred             HcCCCCCeEecCCCCCCeeeCCCC---cEEEecccCCcc
Q 041689          539 HFNFLVPVIHCDLKPSNVLLDDTM---VAHLSDFGITKL  574 (652)
Q Consensus       539 H~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~~~~  574 (652)
                      |.+   ||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       135 H~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   999999999999999877   899999998774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.61  E-value=9.3e-09  Score=98.20  Aligned_cols=177  Identities=24%  Similarity=0.243  Sum_probs=100.3

Q ss_pred             CCCCEEEecCccccccC--CccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccc-ccccCCCCCCCCE
Q 041689          144 TNLTAIYLGGNKLNGSI--PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGS-ILTCFSNLASLRT  220 (652)
Q Consensus       144 ~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~  220 (652)
                      +.++.|||.+|+|+.+.  ...+.+||.|+.|+|+.|.+...+...-..+.+|+.|-|.+..+.-. ....+..+|.+++
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte  150 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE  150 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence            44444455555444221  12234445555555555555433322223344555555555544321 1122344555555


Q ss_pred             EEccCCC---CC--------C---CcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCc-cccccccc
Q 041689          221 LSLSYND---GP--------L---PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGS-IPDSVGDL  285 (652)
Q Consensus       221 L~Ls~N~---~~--------~---~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l  285 (652)
                      |++|.|.   ..        .   ...+..++.+..+.++-|++..+       ++++..+.+..|.|+.. ..+.+..+
T Consensus       151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~  223 (418)
T KOG2982|consen  151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPF  223 (418)
T ss_pred             hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCC
Confidence            5555551   00        0   11133444556666666776654       35678888999988753 34566778


Q ss_pred             ccCcceeccccccCCCC-chhhcCCCCCceEEeecCcCcccCC
Q 041689          286 ISLKSLNFSNNNLSGAI-PLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       286 ~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      +.+-.|+|+.|+|.+.. -+++.+++.|..|.+++|++.....
T Consensus       224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~  266 (418)
T KOG2982|consen  224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLR  266 (418)
T ss_pred             CcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccccc
Confidence            88889999999997532 2567889999999999999975443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.55  E-value=2.2e-08  Score=105.41  Aligned_cols=180  Identities=18%  Similarity=0.184  Sum_probs=133.5

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCe-eeeEEeeeecCCceEEEEEccCCC-Ch
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN-LVKIISSCSNEEFKELVLEHMPHG-SL  508 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-~L  508 (652)
                      ..+++|+++++++.+....+....+.+...     ....-++++|.+++||| .++.++-+..+.+.+++|+++.++ +-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            558899999999988654555556666433     44456889999999999 777788888888999999999887 33


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccccc
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL  588 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  588 (652)
                      ..........+...+...+.+.-.++++++|+.   .-+|||    ||+..+ +..|..||+....+...   .......
T Consensus       323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~---~~~~t~~  391 (829)
T KOG0576|consen  323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT---MKPRTAI  391 (829)
T ss_pred             cccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc---cccccCC
Confidence            222222122334444455666778899999977   457998    777665 57899999998766322   2345567


Q ss_pred             CCccccCccccccCccCcccchhhHHHHHHHHHhCCCC
Q 041689          589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       589 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      +++.++|||+.....+..+.|+|+.|+-..+|.-|-+|
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            89999999999999999999999999877788777666

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	652
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-29
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-28
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-26
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-19
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		6e-19
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		9e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-07
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		3e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-07
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		4e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		6e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		6e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-05
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		7e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		9e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-04
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		2e-04
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		3e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-04
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/227 (34%), Positives = 124/227 (54%), Gaps = 10/227 (4%)
Query: 413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK-SFDIE 471
           +RFS  E+  A+  F+  N++G+GGFG +YK R+ DG  VAVK    +  +  +  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY---SSNCILDIFQRLNIM 528
            E++    +RNL+++   C     + LV  +M +GS+  CL     S   LD  +R  I 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           +  A  L YLH +    +IH D+K +N+LLD+   A + DFG+ KL+  +D  +      
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 204
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLA 635
            TIG+IAPEY   G+     DV+ +G+ML+E+ + ++      F+LA
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-----AFDLA 246

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  123 bits (308), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 77/227 (33%), Positives = 122/227 (53%), Gaps = 10/227 (4%)
Query: 413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK-SFDIE 471
           +RFS  E+  A+  F   N++G+GGFG +YK R+ DG  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY---SSNCILDIFQRLNIM 528
            E++    +RNL+++   C     + LV  +M +GS+  CL     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           +  A  L YLH +    +IH D+K +N+LLD+   A + DFG+ KL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLA 635
             IG+IAPEY   G+     DV+ +G+ML+E+ + ++      F+LA
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR-----AFDLA 238

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  115 bits (287), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 82/236 (34%), Positives = 124/236 (52%), Gaps = 11/236 (4%)
Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECE 473
           R   +++  AT  F+   LIG G FG +YK  + DG +VA+K    +  +  + F+ E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 474 IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMID 530
            +    + +LV +I  C       L+ ++M +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
            A  L YLH      +IH D+K  N+LLD+  V  ++DFGI+K     DQ+        T
Sbjct: 148 AARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF----VFNLAMECTIES 642
           +GYI PEY  +GR+    DVYSFG++L E+  A+   V      + NLA E  +ES
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVES 259

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 81/236 (34%), Positives = 123/236 (52%), Gaps = 11/236 (4%)
Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECE 473
           R   +++  AT  F+   LIG G FG +YK  + DG +VA+K    +  +  + F+ E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 474 IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMID 530
            +    + +LV +I  C       L+ ++M +G+L++ LY S+     +   QRL I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
            A  L YLH      +IH D+K  N+LLD+  V  ++DFGI+K      Q+        T
Sbjct: 148 AARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSF----VFNLAMECTIES 642
           +GYI PEY  +GR+    DVYSFG++L E+  A+   V      + NLA E  +ES
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVES 259

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 412 WRRFSYLEVCRATYGFNEN------NLIGKGGFGTIYKSRIGDGMEVAVK----VFHLQC 461
           +  FS+ E+   T  F+E       N +G+GGFG +YK  + +   VAVK    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--- 518
               + FD E ++M    + NLV+++   S+ +   LV  +MP+GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGT 127
Query: 519 --LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L    R  I    A+ + +LH N     IH D+K +N+LLD+   A +SDFG+ +   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              Q++  ++ + T  Y+APE  R G +    D+YSFG++L+EI
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 412 WRRFSYLEVCRATYGFNEN------NLIGKGGFGTIYKSRIGDGMEVAVK----VFHLQC 461
           +  FS+ E+   T  F+E       N +G+GGFG +YK  + +   VAVK    +  +  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--- 518
               + FD E ++M    + NLV+++   S+ +   LV  +MP+GSL   L   +C+   
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGT 127
Query: 519 --LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L    R  I    A+ + +LH N     IH D+K +N+LLD+   A +SDFG+ +   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              Q++   + + T  Y+APE  R G +    D+YSFG++L+EI
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 114/224 (50%), Gaps = 23/224 (10%)
Query: 412 WRRFSYLEVCRATYGFNEN------NLIGKGGFGTIYKSRIGDGMEVAVK----VFHLQC 461
           +  FS+ E+   T  F+E       N +G+GGFG +YK  + +   VAVK    +  +  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--- 518
               + FD E ++M    + NLV+++   S+ +   LV  +MP+GSL   L   +C+   
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL---LDRLSCLDGT 121
Query: 519 --LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L    R  I    A+ + +LH N     IH D+K +N+LLD+   A +SDFG+ +   
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              Q +   + + T  Y+APE  R G +    D+YSFG++L+EI
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK--SFDIECEIMKSIHYRNLVKIISSC 490
           IG G FGT++++    G +VAVK+   Q   A +   F  E  IMK + + N+V  + + 
Sbjct: 45  IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           +      +V E++  GSL + L+ S     LD  +RL++  DVA  + YLH N   P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLK  N+L+D      + DFG+++L       +       T  ++APE  R+       
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 609 DVYSFGIMLMEIHSAKQ 625
           DVYSFG++L E+ + +Q
Sbjct: 221 DVYSFGVILWELATLQQ 237

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFK--SFDIECEIMKSIHYRNLVKIISSC 490
           IG G FGT++++    G +VAVK+   Q   A +   F  E  IMK + + N+V  + + 
Sbjct: 45  IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           +      +V E++  GSL + L+ S     LD  +RL++  DVA  + YLH N   P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            +LK  N+L+D      + DFG+++L       ++      T  ++APE  R+       
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 609 DVYSFGIMLMEIHSAKQ 625
           DVYSFG++L E+ + +Q
Sbjct: 221 DVYSFGVILWELATLQQ 237

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 111/224 (49%), Gaps = 23/224 (10%)
Query: 412 WRRFSYLEVCRATYGFNEN------NLIGKGGFGTIYKSRIGDGMEVAVK----VFHLQC 461
           +  FS+ E+   T  F+E       N  G+GGFG +YK  + +   VAVK    +  +  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--- 518
               + FD E ++     + NLV+++   S+ +   LV  + P+GSL   L   +C+   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL---LDRLSCLDGT 118
Query: 519 --LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
             L    R  I    A+ + +LH N     IH D+K +N+LLD+   A +SDFG+ +   
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              Q +  ++ + T  Y APE  R G +    D+YSFG++L+EI
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEI 218

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 104/355 (29%), Positives = 144/355 (40%), Gaps = 43/355 (12%)
Query: 46  PAAIFDVSTLKDLALQDNYLSG-------SLSSIADNYLTSSTPELSFLSSLSNCKSLVV 98
           P  + + S L  L L  NYLSG       SLS + D  L  +  E      L   K+L  
Sbjct: 408 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 467
Query: 99  FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
            +L  N L G +P   + N ++ L    +S   ++G IP+ IG L NL  + L  N  +G
Sbjct: 468 LILDFNDLTGEIPS-GLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 525
Query: 159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV-KLYKLDLGGNKL------------- 204
           +IP  L + + L ++ L  N   GTIP  +F+   K+    + G +              
Sbjct: 526 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 585
Query: 205 -SGSILTCFSNLASLRTLSLSYND----------GPLPLEIGNLKVLIGIDFSMNNFSSV 253
            +G++L  F  + S +   LS  +          G       N   ++ +D S N  S  
Sbjct: 586 GAGNLLE-FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 644
Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXX 313
           IP  IGS+  L  L LG+N + GSIPD VGD               G IP          
Sbjct: 645 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 704
Query: 314 XXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTS-----IHH 363
               S N L G IP+ G F  F    F  N  LCG P   +P C  S      HH
Sbjct: 705 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHH 756

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 102/347 (29%), Positives = 142/347 (40%), Gaps = 38/347 (10%)
Query: 46  PAAIFDVSTLKDLALQDNYLSG-------SLSSIADNYLTSSTPELSFLSSLSNCKSLVV 98
           P  + + S L  L L  NYLSG       SLS + D  L  +  E      L   K+L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 99  FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
            +L  N L G +P   + N ++ L    +S   ++G IP+ IG L NL  + L  N  +G
Sbjct: 471 LILDFNDLTGEIPS-GLSNCTN-LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528
Query: 159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV-KLYKLDLGGNKL------------- 204
           +IP  L + + L ++ L  N   GTIP  +F+   K+    + G +              
Sbjct: 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECH 588
Query: 205 -SGSILTCFSNLASLRTLSLSYND----------GPLPLEIGNLKVLIGIDFSMNNFSSV 253
            +G++L  F  + S +   LS  +          G       N   ++ +D S N  S  
Sbjct: 589 GAGNLLE-FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXXXXXXXX 313
           IP  IGS+  L  L LG+N + GSIPD VGD               G IP          
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 314 XXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTS 360
               S N L G IP+ G F  F    F  N  LCG P   +P C  S
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 419 EVCRATYGFNENNL-----IGKGGFGTIYKSRIGD--GMEVAVKVFHLQCGRAFKSFDIE 471
           E  R+ +  N   L     IGKG FG +    +GD  G +VAVK   ++     ++F  E
Sbjct: 10  EFYRSGWALNMKELKLLQTIGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAE 64
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK-ELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMI 529
             +M  + + NLV+++     E+    +V E+M  GSL   L S    +L     L   +
Sbjct: 65  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           DV   +EYL  N  V   H DL   NVL+ +  VA +SDFG+TK     + S TQ     
Sbjct: 125 DVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 176
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + + APE  RE +     DV+SFGI+L EI+S
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 419 EVCRATYGFNENNL-----IGKGGFGTIYKSRIGD--GMEVAVKVFHLQCGRAFKSFDIE 471
           E  R+ +  N   L     IGKG FG +    +GD  G +VAVK   ++     ++F  E
Sbjct: 182 EFYRSGWALNMKELKLLQTIGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAE 236
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK-ELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMI 529
             +M  + + NLV+++     E+    +V E+M  GSL   L S    +L     L   +
Sbjct: 237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 296
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           DV   +EYL  N  V   H DL   NVL+ +  VA +SDFG+TK     + S TQ     
Sbjct: 297 DVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 348
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + + APE  RE +     DV+SFGI+L EI+S
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 8/230 (3%)
Query: 131 NVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR 190
           N+ G IP  I  LT L  +Y+    ++G+IP  L +++ L  +    N L GT+P  I  
Sbjct: 88  NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 191 LVKLYKLDLGGNKLSGSI---LTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSM 247
           L  L  +   GN++SG+I      FS L +  T+S +   G +P    NL +   +D S 
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF-VDLSR 206
Query: 248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDXXXXXXXXXXXXXXXGAIPXXXX 307
           N          GS K+ Q + L  N L   +   VG                G +P    
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 308 XXXXXXXXXXSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPC 357
                     SFN L GEIP+GG+   F   ++  NK LCGSP   +P C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 17/194 (8%)
Query: 433 IGKGGFGTIYKSRIGD--GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IGKG FG +    +GD  G +VAVK   ++     ++F  E  +M  + + NLV+++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 491 SNEEFK-ELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             E+    +V E+M  GSL   L S    +L     L   +DV   +EYL  N  V   H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---H 125
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   NVL+ +  VA +SDFG+TK     + S TQ      + + APE  RE +     
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L EI+S
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 69/194 (35%), Positives = 98/194 (50%), Gaps = 17/194 (8%)
Query: 433 IGKGGFGTIYKSRIGD--GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IGKG FG +    +GD  G +VAVK   ++     ++F  E  +M  + + NLV+++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 491 SNEEFK-ELVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             E+    +V E+M  GSL   L S    +L     L   +DV   +EYL  N  V   H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV---H 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   NVL+ +  VA +SDFG+TK     + S TQ      + + APE  RE       
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L EI+S
Sbjct: 187 DVWSFGILLWEIYS 200

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 121 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 176
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 177 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 126 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 181
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 182 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 153 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 208
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 122 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 177
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 125 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 180
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 127 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 182
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 183 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 129 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 184
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 185 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 488 SSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
             C +   +  +L++E++P+GSL   L      +D  + L     +   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 134
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEYGREGR 603
            IH DL   N+L+++     + DFG+TK+L  +D+   + +    + I + APE   E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 128 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 183
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 184 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 125 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 180
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 427 FNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMK 476
           F E +L     +GKG FG++   R        G  VAVK          + F+ E EI+K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 477 SIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           S+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIG 592
           +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +    + I 
Sbjct: 125 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIF 180
Query: 593 YIAPEYGREGRVFANGDVYSFGIMLMEI 620
           + APE   E +     DV+SFG++L E+
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 488 SSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
             C +   +  +L++E++P+GSL   L      +D  + L     +   +EYL       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 152
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEYGREGR 603
            IH DL   N+L+++     + DFG+TK+L  +D+   + +    + I + APE   E +
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 212 FSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 488 SSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
             C +   +  +L++E++P+GSL   L      +D  + L     +   +EYL       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 152
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEYGREGR 603
            IH DL   N+L+++     + DFG+TK+L  +D+   + +    + I + APE   E +
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 212 FSVASDVWSFGVVLYEL 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E +P+GSL + L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH DL   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 125 QICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEXXKVKEPG 180
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 488 SSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
             C +   +  +L++E++P+GSL   L      +D  + L     +   +EYL       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---R 134
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEYGREGR 603
            IH DL   N+L+++     + DFG+TK+L  +D+   + +    + I + APE   E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 194 FSVASDVWSFGVVLYEL 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 432 LIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ----CGRAFKSFDIECEIMKSIHYRNLVKI 486
           +IG GGFG +Y++  IGD  EVAVK           +  ++   E ++   + + N++ +
Sbjct: 14  IIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
              C  E    LV+E    G L + L       DI   +N  + +A  + YLH   +VP+
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 547 IHCDLKPSNVLLDDTM--------VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
           IH DLK SN+L+   +        +  ++DFG+ +    E    T+        ++APE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEV 185
Query: 599 GREGRVFANGDVYSFGIMLMEI 620
            R        DV+S+G++L E+
Sbjct: 186 IRASMFSKGSDVWSYGVLLWEL 207

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 8   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 63
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 64  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 123 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 176
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 177 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 212

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 7   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 62
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 122 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 175
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 176 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 5   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 60
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 120 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 173
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 174 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 1   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 56
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 57  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 115
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 116 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAR 169
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 170 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 5   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 60
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 120 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 173
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 174 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 4   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 59
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 119 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 172
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 173 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W    + EV R T    E   +G G FG ++        +VAVK    Q   +  +
Sbjct: 9   PQKPWWEDEW-EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDA 64
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLN 526
           F  E  +MK + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L+
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 527 IMIDVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +   +A  + ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  
Sbjct: 124 MAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAR 177
Query: 586 QTLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +     I + APE    G      DV+SFGI+L EI
Sbjct: 178 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 74  EEPIX-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 187 DVWSFGILLTELTT 200

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 190 FGVLMWEVFS 199

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 333 EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 387
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 446 DVWSFGILLTEL 457

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 77  EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 131
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 190 DVWSFGILLTELTT 203

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V+E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 304
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 363 DVWSFGILLTEL 374

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK I +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 422 RATYGFNENNL-----IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIE 471
           R    F E +L     +GKG FG++   R        G  VAVK          + F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI 529
            EI+KS+ + N+VK    C +   +  +L++E++P+GSL   L      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-- 587
            +   +EYL        IH +L   N+L+++     + DFG+TK+L  +D+   + +   
Sbjct: 123 QICKGMEYLGTK---RYIHRNLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPG 178
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   E +     DV+SFG++L E+
Sbjct: 179 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 250 EEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 304
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 363 DVWSFGILLTEL 374

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V+E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 193 FGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 190 FGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 188 FGVLMWEVFS 197

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS 477
            EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLE 536
           + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + 
Sbjct: 65  LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + 
Sbjct: 124 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 177
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE    G      DV+SFGI+L EI
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEI 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 81  EEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY----VHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS 477
            EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLE 536
           + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + 
Sbjct: 65  LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + 
Sbjct: 124 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 177
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE    G      DV+SFGI+L EI
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS 477
            EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK 
Sbjct: 9   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 65
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLE 536
           + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + 
Sbjct: 66  LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + 
Sbjct: 125 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT 178
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE    G      DV+SFGI+L EI
Sbjct: 179 APEAINYGTFTIKSDVWSFGILLTEI 204

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS 477
            EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK 
Sbjct: 8   WEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLE 536
           + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + 
Sbjct: 65  LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + 
Sbjct: 124 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT 177
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE    G      DV+SFGI+L EI
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 73  EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 127
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 186 DVWSFGILLTELTT 199

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 81  EEPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY----VHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 191 FGVLMWEVFS 200

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 75  EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 188 DVWSFGILLTELTT 201

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI 478
           EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK +
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 60
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEY 537
            ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + +
Sbjct: 61  QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 538 LH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIA 595
           +   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + A
Sbjct: 120 IEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 173
Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE    G      DV+SFGI+L EI
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEI 198

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 492 NEEFKELVLEHMPHGSLEKCLY-SSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L   +   L + Q +++   +AS + Y+   N+    +H 
Sbjct: 250 EEPIY-IVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 304
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 363 DVWSFGILLTEL 374

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 430 NNLIGKGGFGTIYKSRIG-DG--MEVAVKVFHLQCGRA-FKSFDIECEIM-KSIHYRNLV 484
            ++IG+G FG + K+RI  DG  M+ A+K       +   + F  E E++ K  H+ N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMI 529
            ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           DVA  ++YL        IH DL   N+L+ +  VA ++DFG+++   G++  + +T    
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + ++A E         N DV+S+G++L EI S
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 100/192 (52%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 251 EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 305
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 364 DVWSFGILLTEL 375

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 430 NNLIGKGGFGTIYKSRIG-DG--MEVAVKVFHLQCGRA-FKSFDIECEIM-KSIHYRNLV 484
            ++IG+G FG + K+RI  DG  M+ A+K       +   + F  E E++ K  H+ N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMI 529
            ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           DVA  ++YL        IH DL   N+L+ +  VA ++DFG+++   G++  + +T    
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + ++A E         N DV+S+G++L EI S
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 91/190 (47%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   +   F  E E+M  + +  LV++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    LV E M HG L   L +   +      L + +DV   + YL       VIH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+ +  V  +SDFG+T+ ++ +DQ  + T T   + + +PE     R  +  DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 613 FGIMLMEIHS 622
           FG+++ E+ S
Sbjct: 210 FGVLMWEVFS 219

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 433 IGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +       +  G G  VAVK     CG   +S +  E EI++++++ ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C ++  K  +LV+E++P GSL   L   +C+  + Q L     +   + YLH     
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLHAQH-- 132
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH  L   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E +
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 192 FYYASDVWSFGVTLYEL 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 433 IGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +       +  G G  VAVK     CG   +S +  E EI++++++ ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C ++  K  +LV+E++P GSL   L   +C+  + Q L     +   + YLH     
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLHAQH-- 131
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH  L   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E +
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 191 FYYASDVWSFGVTLYEL 207

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 115/252 (45%), Gaps = 37/252 (14%)
Query: 428 NENNLIGKGGFGTIYKSRIGDG---MEVAVKVFHLQCGRAFKS---FDIECEIMKSIHYR 481
               +IG G FG +YK  +       EV V +  L+ G   K    F  E  IM    + 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HF 540
           N++++    S  +   ++ E+M +G+L+K L   +    + Q + ++  +A+ ++YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYG 599
           N+    +H DL   N+L++  +V  +SDFG++++L  + + + T +     I + APE  
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 600 REGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNL 634
              +  +  DV+SFGI++ E+ +  ++                         C S ++ L
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 282
Query: 635 AMECTIESLELR 646
            M+C  +    R
Sbjct: 283 MMQCWQQERARR 294

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 55/269 (20%)
Query: 433 IGKGGFGTIYKSR------IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D M VAVK        A K F  E E++ ++ + ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYS---------------SNCILDIFQRLNIMIDV 531
              C + +   +V E+M HG L K L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 532 ASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           AS + YL   HF      +H DL   N L+   ++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ---------------------- 626
             I ++ PE     +     DV+SFG++L EI +  +Q                      
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 256
Query: 627 ---CVSFVFNLAMECTIESLELRINAKEI 652
              C   V+++ + C     + R+N KEI
Sbjct: 257 PRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V+E+M  G L   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL  +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D M VAVK        A + F  E E++  + ++++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYS--------------SNCILDIFQRLNIMIDVA 532
              C+      +V E+M HG L + L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 533 SVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLEL 645
            I ++ PE     +     DV+SFG++L EI +  KQ         A++C  +  EL
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI 478
           EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK +
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 61
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEY 537
            ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + +
Sbjct: 62  QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 538 LH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIA 595
           +   N+    IH +L+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + A
Sbjct: 121 IEERNY----IHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTA 174
Query: 596 PEYGREGRVFANGDVYSFGIMLMEI 620
           PE    G      DV+SFGI+L EI
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEI 199

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 433 IGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +       +  G G  VAVK     CG   +S +  E +I++++++ +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C ++  K  +LV+E++P GSL    Y     + + Q L     +   + YLH     
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH +L   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 197 FYYASDVWSFGVTLYEL 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 12/215 (5%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W + ++ E+ R +    +   +G G FG ++ +      +VAVK        + ++
Sbjct: 174 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA 229
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           F  E  +MK++ +  LVK+ +  + E    ++ E M  GSL   L S        Q L  
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPK 285
Query: 528 MIDV-ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
           +ID  A + E + F      IH DL+ +N+L+  ++V  ++DFG+ +++  ED   T  +
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTARE 343
Query: 587 TLA-TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                I + APE    G      DV+SFGI+LMEI
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 430 NNLIGKGGFGTIYKSRIG-DG--MEVAVKVFHLQCGRA-FKSFDIECEIM-KSIHYRNLV 484
            ++IG+G FG + K+RI  DG  M+ A+K       +   + F  E E++ K  H+ N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMI 529
            ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           DVA  ++YL        IH +L   N+L+ +  VA ++DFG+++   G++  + +T    
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + ++A E         N DV+S+G++L EI S
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 433 IGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +       +  G G  VAVK     CG   +S +  E +I++++++ +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C ++  K  +LV+E++P GSL    Y     + + Q L     +   + YLH     
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHSQH-- 137
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH +L   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E +
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 197 FYYASDVWSFGVTLYEL 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D M VAVK        A + F  E E++  + ++++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYS--------------SNCILDIFQRLNIMIDVA 532
              C+      +V E+M HG L + L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 533 SVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLEL 645
            I ++ PE     +     DV+SFG++L EI +  KQ         A++C  +  EL
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 250

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 5/192 (2%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIISSC 490
           IG+G FG ++  R+  D   VAVK          K+ F  E  I+K   + N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           + ++   +V+E +  G     L +    L +   L ++ D A+ +EYL        IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L   N L+ +  V  +SDFG+++       + +       + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 611 YSFGIMLMEIHS 622
           +SFGI+L E  S
Sbjct: 299 WSFGILLWETFS 310

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G FG ++         VA+K   L+ G  + ++F  E ++MK + +  LV++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  G L   L       L + Q +++   +AS + Y+   N+    +H 
Sbjct: 84  EEPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY----VHR 138
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + +V  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D M VAVK        A + F  E E++  + ++++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYS--------------SNCILDIFQRLNIMIDVA 532
              C+      +V E+M HG L + L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 533 SVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLEL 645
            I ++ PE     +     DV+SFG++L EI +  KQ         A++C  +  EL
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 256

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 13/192 (6%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++        +VA+K   L+ G  + +SF  E +IMK + +  LV++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
            E    +V E+M  GSL   L       L +   +++   VA+ + Y+   N+    IH 
Sbjct: 75  EEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG 608
           DL+ +N+L+ + ++  ++DFG+ +L+  ED   T  Q     I + APE    GR     
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 609 DVYSFGIMLMEI 620
           DV+SFGI+L E+
Sbjct: 188 DVWSFGILLTEL 199

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 13/206 (6%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS 477
            EV R T    E   +G G  G ++        +VAVK    Q   +  +F  E  +MK 
Sbjct: 8   WEVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQ 64
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLE 536
           + ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + 
Sbjct: 65  LQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           ++   N+    IH DL+ +N+L+ DT+   ++DFG+ +L+  ED   T  +     I + 
Sbjct: 124 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWT 177
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE    G      DV+SFGI+L EI
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEI 203

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 5/192 (2%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIISSC 490
           IG+G FG ++  R+  D   VAVK          K+ F  E  I+K   + N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           + ++   +V+E +  G     L +    L +   L ++ D A+ +EYL        IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L   N L+ +  V  +SDFG+++       + +       + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 611 YSFGIMLMEIHS 622
           +SFGI+L E  S
Sbjct: 299 WSFGILLWETFS 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 416 SYLEVCRATYGFNEN---------NLIGKGGFGTIY--KSRIGDGMEVAVKVFHLQCG-- 462
           +Y E  RA   F             +IG G  G +   + R+    +V V +  L+ G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 463 -RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDI 521
            R  + F  E  IM    + N++++    +      +V E+M +GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQ 580
            Q + ++  V + + YL     +  +H DL   NVL+D  +V  +SDFG++++L  + D 
Sbjct: 151 MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 581 SMTQTQTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
           + T T     I + APE     R F++  DV+SFG+++ E+
Sbjct: 208 AXTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEV 247

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 416 SYLEVCRATYGFNEN---------NLIGKGGFGTIY--KSRIGDGMEVAVKVFHLQCG-- 462
           +Y E  RA   F             +IG G  G +   + R+    +V V +  L+ G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 463 -RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDI 521
            R  + F  E  IM    + N++++    +      +V E+M +GSL+  L + +    I
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQ 580
            Q + ++  V + + YL     +  +H DL   NVL+D  +V  +SDFG++++L  + D 
Sbjct: 151 MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 581 SMTQTQTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
           + T T     I + APE     R F++  DV+SFG+++ E+
Sbjct: 208 AYTTTGGKIPIRWTAPE-AIAFRTFSSASDVWSFGVVMWEV 247

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 433 IGKGGFGTIYKSRI---GD--GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +   R    GD  G +VAVK    + G         E EI++++++ N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C+ +     +L++E +P GSL++ L  +   +++ Q+L   + +   ++YL     V
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV 148
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QTQTLATIGYIAPEYGREGR 603
              H DL   NVL++      + DFG+TK +  + +  T +    + + + APE   + +
Sbjct: 149 ---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 206 FYIASDVWSFGVTLHEL 222

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIE 471
           W + ++ E+ R +    +   +G G FG ++ +      +VAVK        + ++F  E
Sbjct: 5   WEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAE 60
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
             +MK++ +  LVK+ +  + E    ++ E M  GSL   L S        Q L  +ID 
Sbjct: 61  ANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPKLIDF 116
Query: 532 -ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA- 589
            A + E + F      IH DL+ +N+L+  ++V  ++DFG+ +++  ED   T  +    
Sbjct: 117 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKF 174
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            I + APE    G      DV+SFGI+LMEI
Sbjct: 175 PIKWTAPEAINFGSFTIKSDVWSFGILLMEI 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 433 IGKGGFGTIYKSRI---GD--GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +   R    GD  G +VAVK    + G         E EI++++++ N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C+ +     +L++E +P GSL++ L  +   +++ Q+L   + +   ++YL      
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR--- 133
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QTQTLATIGYIAPEYGREGR 603
             +H DL   NVL++      + DFG+TK +  + +  T +    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 194 FYIASDVWSFGVTLHEL 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 13/194 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHL--QCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+  +       F++F  E  +++   + N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            + +    +V +     SL K L+       +FQ ++I    A  ++YLH      +IH 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHR 156
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR--EGRVFA- 606
           D+K +N+ L + +   + DFG+  +      S    Q   ++ ++APE  R  +   F+ 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 607 NGDVYSFGIMLMEI 620
             DVYS+GI+L E+
Sbjct: 217 QSDVYSYGIVLYEL 230

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 425 YGFNENN---LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           Y ++EN    ++GKG +G +Y  R + + + +A+K    +  R  +    E  + K + +
Sbjct: 19  YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMI-DVASVLEYL 538
           +N+V+ + S S   F ++ +E +P GSL   L S    + D  Q +      +   L+YL
Sbjct: 79  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 138
Query: 539 HFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           H N    ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ Y+APE
Sbjct: 139 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPE 193
Query: 598 YGREG-RVFAN-GDVYSFGIMLMEIHSAK 624
              +G R +    D++S G  ++E+ + K
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R + D  +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 488 SSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 195 SVDARSDVYSLGCVLYEV 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 425 YGFNENN---LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           Y ++EN    ++GKG +G +Y  R + + + +A+K    +  R  +    E  + K + +
Sbjct: 5   YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH 64
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMI-DVASVLEYL 538
           +N+V+ + S S   F ++ +E +P GSL   L S    + D  Q +      +   L+YL
Sbjct: 65  KNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYL 124
Query: 539 HFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           H N    ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ Y+APE
Sbjct: 125 HDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPE 179
Query: 598 YGREG-RVFAN-GDVYSFGIMLMEIHSAK 624
              +G R +    D++S G  ++E+ + K
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 16/216 (7%)
Query: 418 LEVCRATYGFNENNL-----IGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKS 467
           L  C+    F E +L     +GKG FG++   R   +GD  G  VAVK          + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 468 FDIECEIMKSIHYRNLVKI--ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL 525
           F  E +I+K++H   +VK   +S     +   LV+E++P G L   L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 526 NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQ 584
                +   +EYL     V   H DL   N+L++      ++DFG+ KLL + +D  + +
Sbjct: 131 LYSSQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
               + I + APE   +       DV+SFG++L E+
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R + D  +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 488 SSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 195 SVDARSDVYSLGCVLYEV 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 154
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 215 FTSASDVWSYGIVLWEVMS 233

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 421 CRATYGFNENNL-----IGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKSFDI 470
           C+    F E +L     +GKG FG++   R   +GD  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 471 ECEIMKSIHYRNLVKI--ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
           E +I+K++H   +VK   +S     +   LV+E++P G L   L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQT 587
             +   +EYL     V   H DL   N+L++      ++DFG+ KLL + +D  + +   
Sbjct: 121 SQICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + I + APE   +       DV+SFG++L E+
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 137
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 198 FTSASDVWSYGIVLWEVMS 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 164
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 225 FTSASDVWSYGIVLWEVMS 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 28/236 (11%)
Query: 433 IGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++ +         D + VAVK        A K F  E E++ ++ + ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSN------------CILDIFQRLNIMIDVASV 534
              C   +   +V E+M HG L K L +                L   Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 535 LEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           + YL   HF      +H DL   N L+ + ++  + DFG+++ +   D       T+  I
Sbjct: 141 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVSFVFNLAMECTIESLELR 646
            ++ PE     +     DV+S G++L EI +  KQ       N  +EC  +   L+
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ 250

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 427 FNENNL-----IGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKSFDIECEIMK 476
           F E +L     +GKG FG++   R   +GD  G  VAVK          + F  E +I+K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 477 SIHYRNLVKI--ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           ++H   +VK   +S         LV+E++P G L   L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGY 593
           +EYL     V   H DL   N+L++      ++DFG+ KLL + +D  + +    + I +
Sbjct: 124 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
            APE   +       DV+SFG++L E+
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++     +  +VAVK   L+ G  + ++F  E  +MK++ +  LV++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV-ASVLEYLHFNFLVPVIHCD 550
            EE   ++ E+M  GSL   L S      +  +L   ID  A + E + +      IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRD 135
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANGD 609
           L+ +NVL+ ++++  ++DFG+ +++  ED   T  +     I + APE    G      D
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 610 VYSFGIMLMEI 620
           V+SFGI+L EI
Sbjct: 194 VWSFGILLYEI 204

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R + D  +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 488 SSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+L+  T    + DFGI + +     S+ QT   + T  Y++PE  R  
Sbjct: 137 --IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 195 SVDARSDVYSLGCVLYEV 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG+ ++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 427 FNENNL-----IGKGGFGTIYKSR---IGD--GMEVAVKVFHLQCGRAFKSFDIECEIMK 476
           F E +L     +GKG FG++   R   +GD  G  VAVK          + F  E +I+K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 477 SIHYRNLVKI--ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           ++H   +VK   +S     +   LV+E++P G L   L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGY 593
           +EYL     V   H DL   N+L++      ++DFG+ KLL + +D  + +    + I +
Sbjct: 128 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
            APE   +       DV+SFG++L E+
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 433 IGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKI 486
           +G+G FG +       +  G G  VAVK      G   +S +  E +I++++++ +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 487 ISSCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
              C +      +LV+E++P GSL    Y     + + Q L     +   + YLH     
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH DL   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E +
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 604 VFANGDVYSFGIMLMEI 620
            +   DV+SFG+ L E+
Sbjct: 214 FYYASDVWSFGVTLYEL 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 431 NLIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLV 484
            ++G G FGT+YK   + +G    + VA+K+ +   G +A   F  E  IM S+ + +LV
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +++  C +    +LV + MPHG L + ++     +     LN  + +A  + YL    LV
Sbjct: 104 RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 162
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
              H DL   NVL+       ++DFG+ +LL G+++          I ++A E     + 
Sbjct: 163 ---HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S+G+ + E+
Sbjct: 220 THQSDVWSYGVTIWEL 235

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG+ ++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 137
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 198 FTSASDVWSYGIVLWEVMS 216

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VAVK+   +   +   F  E + M  + +  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           E    +V E++ +G L   L S    L+  Q L +  DV   + +L  +     IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLA 131
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L+D  +   +SDFG+T+ ++ +DQ ++   T   + + APE     +  +  DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 613 FGIMLMEIHS 622
           FGI++ E+ S
Sbjct: 191 FGILMWEVFS 200

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
           + ++G G FG +   R+      E++V +  L+ G   +  + F  E  IM    + N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +  +   +V E M +GSL+  L   +    + Q + ++  +AS ++YL     +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + +PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI+L E+ S
Sbjct: 227 FTSASDVWSYGIVLWEVMS 245

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 431 NLIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLV 484
            ++G G FGT+YK   + +G    + VA+K+ +   G +A   F  E  IM S+ + +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +++  C +    +LV + MPHG L + ++     +     LN  + +A  + YL    LV
Sbjct: 81  RLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 139
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
              H DL   NVL+       ++DFG+ +LL G+++          I ++A E     + 
Sbjct: 140 ---HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S+G+ + E+
Sbjct: 197 THQSDVWSYGVTIWEL 212

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 432 LIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKI 486
           +IG G FG + + R+      E  V +  L+ G   R  + F  E  IM    + N++++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               +N     ++ E M +G+L+  L  ++    + Q + ++  +AS + YL     +  
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA---TIGYIAPEYGREGR 603
           +H DL   N+L++  +V  +SDFG+++ L       T+T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  D +S+GI++ E+ S
Sbjct: 200 FTSASDAWSYGIVMWEVMS 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI------DVASVLEYLH-FNFLV 544
            E    +++E M +G+L   L   N      Q +N ++       ++S +EYL   NF  
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 133
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH DL   N L+ +  +  ++DFG+++L+ G D           I + APE     + 
Sbjct: 134 --IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKF 190
Query: 605 FANGDVYSFGIMLMEI 620
               DV++FG++L EI
Sbjct: 191 SIKSDVWAFGVLLWEI 206

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y        + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +V E+MP+G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNF----IHR 154
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  V  ++DFG+++L+ G D           I + APE           D
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 214 VWAFGVLLWEI 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R +    +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 488 SSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           ++   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 195 SVDARSDVYSLGCVLYEV 212

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 147
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 207 FGVLMWEIYS 216

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +++E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 140
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 200 VWAFGVLLWEI 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-------QCGRAFKSFDIECEIMKSIHYRNLV 484
           IGKGGFG ++K R + D   VA+K   L       +    F+ F  E  IM ++++ N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+     N     +V+E +P G L   L      +    +L +M+D+A  +EY+  N   
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 545 PVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLIGEDQSM-TQTQTLATIGYIAPEY 598
           P++H DL+  N+ L        + A ++DFG+++      QS+ + +  L    ++APE 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNFQWMAPET 197
Query: 599 --GREGRVFANGDVYSFGIMLMEI 620
               E       D YSF ++L  I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTI 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS 467
           P+  W + ++ E+ R +    +   +G G FG ++ +      +VAVK        + ++
Sbjct: 168 PQKPWEKDAW-EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEA 223
Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           F  E  +MK++ +  LVK+ +  + E    ++ E M  GSL   L S        Q L  
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSK---QPLPK 279
Query: 528 MIDV-ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
           +ID  A + E + F      IH DL+ +N+L+  ++V  ++DFG+ ++            
Sbjct: 280 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-----------G 328
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
               I + APE    G      DV+SFGI+LMEI
Sbjct: 329 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 362

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +++E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 133
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 193 VWAFGVLLWEI 203

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 133
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 193 VWAFGVLLWEI 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 140
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 200 VWAFGVLLWEI 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG + + R+      E  V +  L+ G   R  + F  E  IM    + N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    +N     ++ E M +G+L+  L  ++    + Q + ++  +AS + YL     +
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA---TIGYIAPEYGRE 601
             +H DL   N+L++  +V  +SDFG+++ L       T T +L     I + APE    
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 602 GRVFANGDVYSFGIMLMEIHS 622
            +  +  D +S+GI++ E+ S
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R +    +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 488 SSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 195 SVDARSDVYSLGCVLYEV 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 98/191 (51%), Gaps = 10/191 (5%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG ++     +  +VAVK   L+ G  + ++F  E  +MK++ +  LV++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV-ASVLEYLHFNFLVPVIHCD 550
            EE   ++ E M  GSL   L S      +  +L   ID  A + E + +      IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRD 134
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANGD 609
           L+ +NVL+ ++++  ++DFG+ +++  ED   T  +     I + APE    G      +
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 610 VYSFGIMLMEI 620
           V+SFGI+L EI
Sbjct: 193 VWSFGILLYEI 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 147
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 207 FGVLMWEIYS 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAF-----KSFDIECEIMKSIHYRNLVKI 486
           +G GGFG + +    D G +VA+K    QC +       + + +E +IMK +++ N+V  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 487 ------ISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYL 538
                 +   +  +   L +E+   G L K L  + + C L       ++ D++S L YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 539 HFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H N    +IH DLKP N++L      ++  + D G  K L   DQ    T+ + T+ Y+A
Sbjct: 139 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 596 PEYGREGRVFANGDVYSFGIMLME 619
           PE   + +     D +SFG +  E
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFE 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAF-----KSFDIECEIMKSIHYRNLVKI 486
           +G GGFG + +    D G +VA+K    QC +       + + +E +IMK +++ N+V  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 487 ------ISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYL 538
                 +   +  +   L +E+   G L K L  + + C L       ++ D++S L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 539 HFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H N    +IH DLKP N++L      ++  + D G  K L   DQ    T+ + T+ Y+A
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 596 PEYGREGRVFANGDVYSFGIMLME 619
           PE   + +     D +SFG +  E
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFE 215

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-------QCGRAFKSFDIECEIMKSIHYRNLV 484
           IGKGGFG ++K R + D   VA+K   L       +    F+ F  E  IM ++++ N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+     N     +V+E +P G L   L      +    +L +M+D+A  +EY+  N   
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 545 PVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLIGEDQSM-TQTQTLATIGYIAPEY 598
           P++H DL+  N+ L        + A ++DFG ++      QS+ + +  L    ++APE 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLLGNFQWMAPET 197
Query: 599 --GREGRVFANGDVYSFGIMLMEI 620
               E       D YSF ++L  I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTI 221

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 140
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 200 VWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +++E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    +++E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 139
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 199 VWAFGVLLWEI 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SAXKSSDLWALGCIIYQL 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG +   R+      +VAV +  L+ G   +  + F  E  IM    + N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +    +  +   +V+E M +G+L+  L   +    + Q + ++  +A+ + YL     +
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA---DM 164
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-TQTQTLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG+++++  + +++ T T     + + APE  +  +
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI++ E+ S
Sbjct: 225 FTSASDVWSYGIVMWEVMS 243

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 132
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 192 FGVLMWEIYS 201

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R +    +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 488 SSCSNEE----FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++   +    + + ++ D    L + H N  
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIADACQALNFSHQNG- 153
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R  
Sbjct: 154 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 211
Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 212 SVDARSDVYSLGCVLYEV 229

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 140
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 200 VWAFGVLLWEI 210

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 138
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 198 FGVLMWEIYS 207

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 431 NLIGKGGFGTIYKS--RIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVK 485
            +IG G FG +     ++    E+ V +  L+ G   +  + F  E  IM    + N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLV 544
           +    +      ++ E M +GSL+  L  ++    + Q + ++  +A+ ++YL   N+  
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY-- 156
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA---TIGYIAPEYGRE 601
             +H DL   N+L++  +V  +SDFG+++ L  +    T T  L     I + APE  + 
Sbjct: 157 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 602 GRVFANGDVYSFGIMLMEIHS 622
            +  +  DV+S+GI++ E+ S
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS 235

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 19/196 (9%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI------DVASVLEYLH-FNFLV 544
            E    ++ E M +G+L   L   N      Q +N ++       ++S +EYL   NF  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 134
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH DL   N L+ +  +  ++DFG+++L+ G D           I + APE     + 
Sbjct: 135 --IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 605 FANGDVYSFGIMLMEI 620
               DV++FG++L EI
Sbjct: 192 SIKSDVWAFGVLLWEI 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 148
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 149 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 208 VWAFGVLLWEI 218

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 132
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 192 FGVLMWEIYS 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 131
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 191 FGVLMWEIYS 200

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 19/196 (9%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI------DVASVLEYLH-FNFLV 544
            E    ++ E M +G+L   L   N      Q +N ++       ++S +EYL   NF  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 134
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH DL   N L+ +  +  ++DFG+++L+ G D           I + APE     + 
Sbjct: 135 --IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKF 191
Query: 605 FANGDVYSFGIMLMEI 620
               DV++FG++L EI
Sbjct: 192 SIKSDVWAFGVLLWEI 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 152
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 153 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 211 SACKSSDLWALGCIIYQL 228

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 129
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 130 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 188 SACKSSDLWALGCIIYQL 205

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SACKSSDLWALGCIIYQL 227

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK 552
           +    ++ E+M +G L   L          Q L +  DV   +EYL        +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLA 127
Query: 553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYS 612
             N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +  D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 613 FGIMLMEIHS 622
           FG+++ EI+S
Sbjct: 187 FGVLMWEIYS 196

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 149
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 208 SACKSSDLWALGCIIYQL 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 128
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 129 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 187 SACKSSDLWALGCIIYQL 204

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 154
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 155 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 213 SACKSSDLWALGCIIYQL 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 152
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 153 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 211 SACKSSDLWALGCIIYQL 228

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMI------DVASVLEYLH-FNFLV 544
            E    ++ E M +G+L   L   N      Q +N ++       ++S +EYL   NF  
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKKNF-- 133
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH DL   N L+ +  +  ++DFG+++L+ G D           I + APE     + 
Sbjct: 134 --IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKF 190
Query: 605 FANGDVYSFGIMLMEIHS 622
               DV++FG++L EI +
Sbjct: 191 SIKSDVWAFGVLLWEIAT 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SACKSSDLWALGCIIYQL 227

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 140
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 141 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 200 VWAFGVLLWEI 210

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 149
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 208 SACKSSDLWALGCIIYQL 225

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SACKSSDLWALGCIIYQL 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 126
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 127 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 185 SACKSSDLWALGCIIYQL 202

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 149
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 208 SACKSSDLWALGCIIYQL 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 135
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 195 VWAFGVLLWEI 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 137
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 138 DLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 197 VWAFGVLLWEI 207

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SACKSSDLWALGCIIYQL 227

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 152 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 210 SASKSSDLWALGCIIYQL 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 148
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 149 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 207 SACKSSDLWALGCIIYQL 224

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 127
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 186 SACKSSDLWALGCIIYQL 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 133
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 134 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 192 SACKSSDLWALGCIIYQL 209

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 145 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 431 NLIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLV 484
            ++G G FGT++K   I +G    + V +KV   + GR +F++       + S+ + ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +++  C      +LV +++P GSL   +      L     LN  + +A  + YL  + +V
Sbjct: 97  RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
              H +L   NVLL       ++DFG+  LL  +D+ +  ++    I ++A E    G+ 
Sbjct: 156 ---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S+G+ + E+
Sbjct: 213 THQSDVWSYGVTVWEL 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 148
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 149 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 207 SACKSSDLWALGCIIYQL 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 145 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFD-------I 470
           L+V      + + + +G+G F T+YK+R  +  ++ V +  ++ G   ++ D        
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E ++++ + + N++ ++ +  ++    LV + M    LE  +  ++ +L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
               LEYLH ++   ++H DLKP+N+LLD+  V  L+DFG+ K     +++      + T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVT 175
Query: 591 IGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
             Y APE     R++  G D+++ G +L E+
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   ++    L +   ++S +EYL   NF    IH 
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----IHR 381
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           +L   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 382 NLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 441 VWAFGVLLWEI 451

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG +   R  +    E+ V +  L+ G   +  + F  E  IM    + N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +    +  +   ++ E+M +GSL+  L  ++    + Q + ++  + S ++YL     +
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 150
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI++ E+ S
Sbjct: 211 FTSASDVWSYGIVMWEVMS 229

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 142 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 228

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-------QCGRAFKSFDIECEIMKSIHYRNLV 484
           IGKGGFG ++K R + D   VA+K   L       +    F+ F  E  IM ++++ N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+     N     +V+E +P G L   L      +    +L +M+D+A  +EY+  N   
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 545 PVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLIGEDQSM-TQTQTLATIGYIAPEY 598
           P++H DL+  N+ L        + A ++DF +++      QS+ + +  L    ++APE 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLLGNFQWMAPET 197
Query: 599 --GREGRVFANGDVYSFGIMLMEI 620
               E       D YSF ++L  I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTI 221

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 133
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 193 VWAFGVLLWEI 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 431 NLIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLV 484
            ++G G FGT++K   I +G    + V +KV   + GR +F++       + S+ + ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +++  C      +LV +++P GSL   +      L     LN  + +A  + YL  + +V
Sbjct: 79  RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
              H +L   NVLL       ++DFG+  LL  +D+ +  ++    I ++A E    G+ 
Sbjct: 138 ---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S+G+ + E+
Sbjct: 195 THQSDVWSYGVTVWEL 210

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G +G +Y+       + VAVK    +     + F  E  +MK I + NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLH-FNFLVPVIHC 549
            E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IHR 342
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           +L   N L+ +  +  ++DFG+++L+ G D           I + APE     +     D
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 610 VYSFGIMLMEI 620
           V++FG++L EI
Sbjct: 402 VWAFGVLLWEI 412

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+     ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 156
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 157 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 215 SACKSSDLWALGCIIYQL 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T   +R +    E A+K+    H+           E ++M  + +  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLHGK- 149
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E 
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D+++ G ++ ++
Sbjct: 208 SACKSSDLWALGCIIYQL 225

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG +   R  +    E+ V +  L+ G   +  + F  E  IM    + N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +    +  +   ++ E+M +GSL+  L  ++    + Q + ++  + S ++YL     +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 129
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI++ E+ S
Sbjct: 190 FTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG +   R  +    E+ V +  L+ G   +  + F  E  IM    + N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +    +  +   ++ E+M +GSL+  L  ++    + Q + ++  + S ++YL     +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 135
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI++ E+ S
Sbjct: 196 FTSASDVWSYGIVMWEVMS 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 145 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 144 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 77  STKPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 132
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR--EGRVFA- 606
           DLK +N+ L +     + DFG+  +      S    Q   +I ++APE  R  +   ++ 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 193 QSDVYAFGIVLYELMTGQ 210

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 138 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 147 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 431 NLIGKGGFGTIYKS--RIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVK 485
            +IG G FG +     ++    E+ V +  L+ G   +  + F  E  IM    + N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLV 544
           +    +      ++ E M +GSL+  L  ++    + Q + ++  +A+ ++YL   N+  
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY-- 130
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA---TIGYIAPEYGRE 601
             +H  L   N+L++  +V  +SDFG+++ L  +    T T  L     I + APE  + 
Sbjct: 131 --VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 602 GRVFANGDVYSFGIMLMEIHS 622
            +  +  DV+S+GI++ E+ S
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHL---QCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G GG  T+Y +      ++VA+K   +   +     K F+ E      + ++N+V +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               ++   LV+E++   +L + +  S+  L +   +N    +   +++ H    + ++H
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MRIVH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT-QTLATIGYIAPEYGREGRVFAN 607
            D+KP N+L+D      + DFGI K L   + S+TQT   L T+ Y +PE  +       
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 608 GDVYSFGIMLMEI 620
            D+YS GI+L E+
Sbjct: 193 TDIYSIGIVLYEM 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 430 NNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLV 484
             +IG G FG +   R+      E+ V +  L+ G   +  + F  E  IM    + N++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +    +  +   +V E+M +GSL+  L  ++    + Q + ++  +++ ++YL     +
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---M 143
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             +H DL   N+L++  +V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 604 VFANGDVYSFGIMLMEIHS 622
             +  DV+S+GI++ E+ S
Sbjct: 204 FTSASDVWSYGIVMWEVVS 222

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 153 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 153 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 175 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 261

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 146 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 232

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 143 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 229

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 194 QSDVYAFGIVLYELMTGQ 211

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 140 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 226

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 146 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 232

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 75  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 130
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 191 QSDVYAFGIVLYELMTGQ 208

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 144 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 230

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H +L   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 146 YLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N ++ +     + DFG+T+ +   D      + L  + +++P
Sbjct: 147 YLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 78  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 133
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 194 QSDVYAFGIVLYELMTGQ 211

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H +L   N ++       + DFG+T+ +   D      + L  + ++AP
Sbjct: 145 YLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 89  STKPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR--EGRVFA- 606
           DLK +N+ L +     + DFG+         S    Q   +I ++APE  R  +   ++ 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
             ++G+G FG + K++     +VA+K    +  R  K+F +E   +  +++ N+VK+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
           C N     LV+E+   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 71  CLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 548 HCDLKPSNVLL-DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           H DLKP N+LL     V  + DFG        D     T    +  ++APE         
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 607 NGDVYSFGIMLMEIHSAKQ 625
             DV+S+GI+L E+ + ++
Sbjct: 184 KCDVFSWGIILWEVITRRK 202

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 156
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 217 QSDVYAFGIVLYELMTGQ 234

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
             ++G+G FG + K++     +VA+K    +  R  K+F +E   +  +++ N+VK+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
           C N     LV+E+   GSL   L+ +  +        ++  +  +  + YLH      +I
Sbjct: 70  CLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 548 HCDLKPSNVLL-DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           H DLKP N+LL     V  + DFG        D     T    +  ++APE         
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 607 NGDVYSFGIMLMEIHSAKQ 625
             DV+S+GI+L E+ + ++
Sbjct: 183 KCDVFSWGIILWEVITRRK 201

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 430 NNLIGKGGFGTIYK----SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
           N ++G+G FG +Y+    +  G+ + VAVK     C    K  F  E  IMK++ + ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+I     EE   +++E  P+G L   L  +   L +   +   + +   + YL     +
Sbjct: 89  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 144
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             +H D+   N+L+       L DFG+++ +  ED        L  I +++PE     R 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 605 FANGDVYSFGIMLMEIHSAKQQ 626
               DV+ F + + EI S  +Q
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQ 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 155
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 216 QSDVYAFGIVLYELMTGQ 233

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ G+AFK  + E +IM+ + + N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE  R   +     
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ G+AFK  + E +IM+ + + N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 430 NNLIGKGGFGTIYK----SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
           N ++G+G FG +Y+    +  G+ + VAVK     C    K  F  E  IMK++ + ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+I     EE   +++E  P+G L   L  +   L +   +   + +   + YL     +
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             +H D+   N+L+       L DFG+++ +  ED        L  I +++PE     R 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 605 FANGDVYSFGIMLMEIHSAKQQ 626
               DV+ F + + EI S  +Q
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQ 213

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ G+AFK  + E +IM+ + + N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 430 NNLIGKGGFGTIYK----SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
           N ++G+G FG +Y+    +  G+ + VAVK     C    K  F  E  IMK++ + ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+I     EE   +++E  P+G L   L  +   L +   +   + +   + YL     +
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 128
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             +H D+   N+L+       L DFG+++ +  ED        L  I +++PE     R 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 605 FANGDVYSFGIMLMEIHSAKQQ 626
               DV+ F + + EI S  +Q
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQ 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 431 NLIGKGGFGTIY----KSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLV 484
            ++G+G FG++     K   G  ++VAVK   L     R  + F  E   MK   + N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 485 KIISSC---SNEEFKE--LVLEHMPHGSLEKCLYSSNCI-----LDIFQRLNIMIDVASV 534
           +++  C   S++   +  ++L  M +G L   L  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 535 LEYL-HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           +EYL + NFL    H DL   N +L D M   ++DFG++K +   D           + +
Sbjct: 160 MEYLSNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           IA E   +    +  DV++FG+ + EI +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDG-MEVAVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R       VA+KV F  Q  +      +  E EI   +H+ N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G L K L  S C  D  +   IM ++A  L Y H      VIH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCHGK---KVIH 146
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S+ +     T+ Y+ PE   EGR+    
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMI-EGRMHNEK 201
Query: 609 -DVYSFGIMLMEI 620
            D++  G++  E+
Sbjct: 202 VDLWCIGVLCYEL 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 425 YGFNENNL-----IGKGGFGTIYKSR-IGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 98
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
            E +IM  +  + N+V ++ +C++     ++ E+  +G L   L   + +L+      I 
Sbjct: 99  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 529 IDVASVLEYLHFNFLVP----------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
              AS  + LHF+  V            IH D+   NVLL +  VA + DFG+ + ++ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E     +++ + T  ++APE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 201 SLGIMAIEM 209

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L++S    ++ + ++I    A  ++YLH      +IH 
Sbjct: 89  STAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR--EGRVFA- 606
           DLK +N+ L +     + DFG+         S    Q   +I ++APE  R  +   ++ 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 205 QSDVYAFGIVLYELMTGQ 222

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIY----KSRIGDGME--VAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y    K  + D  E  VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYS------SNCIL---DIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L+  L S      +N +L    + + + +  ++A  + 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+ N  V   H DL   N  + +     + DFG+T+ +   D      + L  + +++P
Sbjct: 140 YLNANKFV---HRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G      DV+SFG++L EI +  +Q
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 226

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 153 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 210 TQKFTTKSDVWSFGVLLWEL 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 42/216 (19%)
Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF-------------KSFDIECEIMKS 477
            ++GKG FG             A+KV H + G                ++F  E ++M+ 
Sbjct: 16  EVLGKGCFGQ------------AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           + + N++K I     ++    + E++  G+L   + S +      QR++   D+AS + Y
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED---------QSMTQTQTL 588
           LH    + +IH DL   N L+ +     ++DFG+ +L++ E          +   + +  
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 589 ATIG---YIAPEYGREGRVFANG-DVYSFGIMLMEI 620
             +G   ++APE    GR +    DV+SFGI+L EI
Sbjct: 181 TVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEI 215

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 73  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+         S    Q   +I ++APE  R   +     
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 189 QSDVYAFGIVLYELMTGQ 206

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 433 IGKGGFGTIYKSRIGD------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+    D         VAVK  +     R    F  E  +MK     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD---------IFQRLNIMIDVASVLE 536
           ++   S  +   +V+E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           YL+    V   H DL   N ++       + DFG+T+ +          + L  + ++AP
Sbjct: 145 YLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
           E  ++G    + D++SFG++L EI S  +Q
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 414 RFSYLEVCRATYGFNE------NNLIGKGGFGTIYKSR-IGDGMEVA---VKVFHLQCGR 463
           +F   +  R   G+N          IG+G F  +Y++  + DG+ VA   V++F L   +
Sbjct: 15  QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 464 AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL---------EKCLYS 514
           A      E +++K +++ N++K  +S   +    +VLE    G L         +K L  
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 515 SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL 574
              +   F      + + S LE++H      V+H D+KP+NV +  T V  L D G+ + 
Sbjct: 135 ERTVWKYF------VQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                ++      + T  Y++PE   E       D++S G +L E+
Sbjct: 186 F--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 93  STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 148
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+         S    Q   +I ++APE  R   +     
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 209 QSDVYAFGIVLYELMTGQ 226

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 433 IGKGGFGTIYKSRIGDGME------VAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVK 485
           IG+G FG ++++R    +       VAVK+   +     ++ F  E  +M      N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSN----C-------------------ILDIF 522
           ++  C+  +   L+ E+M +G L + L S +    C                    L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
           ++L I   VA+ + YL     V   H DL   N L+ + MV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
                   I ++ PE     R     DV+++G++L EI S
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG G FGT+YK +  GD   VAVK+ ++     +  ++F  E  +++   + N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHR 156
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFA 606
           DLK +N+ L + +   + DFG+         S    Q   +I ++APE  R   +     
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 607 NGDVYSFGIMLMEIHSAK 624
             DVY+FGI+L E+ + +
Sbjct: 217 QSDVYAFGIVLYELMTGQ 234

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E QS   T  + T  ++APE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 201 SLGIMAIEM 209

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 146 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 203 TQKFTTKSDVWSFGVLLWEL 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 173 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 230 TQKFTTKSDVWSFGVLLWEL 249

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 172 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 229 TQKFTTKSDVWSFGVLLWEL 248

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH D+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E     ++  + T  ++APE           D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 201 SLGIMAIEM 209

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 154 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 211 TQKFTTKSDVWSFGVLLWEL 230

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH D+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDI 143
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E     ++  + T  ++APE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 202 SLGIMAIEM 210

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 152 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 209 TQKFTTKSDVWSFGVLLWEL 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 206 TQKFTTKSDVWSFGVLLWEL 225

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 154 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 211 TQKFTTKSDVWSFGVLLWEL 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 153 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 210 TQKFTTKSDVWSFGVLLWEL 229

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  ++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 151 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 208 TQKFTTKSDVWSFGVLLWEL 227

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+  ++++N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+  ++++N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLH 539
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 540 FNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            N     IH D+   N LL       VA + DFG+ + +            +  + ++ P
Sbjct: 173 ENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHS 622
           E   EG   +  D +SFG++L EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + ++ ++      +T A   + ++A E  +
Sbjct: 155 FV---HRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 212 TQKFTTKSDVWSFGVLLWEL 231

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 428 NENNLIGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH 479
           + + +IGKG FG +Y        ++RI   ++   ++  +Q   AF     E  +M+ ++
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLN 80
Query: 480 YRNLVKIIS-SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL 538
           + N++ +I      E    ++L +M HG L + + S      +   ++  + VA  +EYL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAP 596
                V   H DL   N +LD++    ++DFG+ + ++  +    Q    A   + + A 
Sbjct: 141 AEQKFV---HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 597 EYGREGRVFANGDVYSFGIMLMEI 620
           E  +  R     DV+SFG++L E+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWEL 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 213 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 270 TQKFTTKSDVWSFGVLLWEL 289

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 29/224 (12%)
Query: 425 YGFNENNL-----IGKGGFGTIYKSR-IGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 98
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
            E +IM  +  + N+V ++ +C++     ++ E+  +G L   L   + +L+      I 
Sbjct: 99  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 529 IDVASVLEYLHFNFLVP----------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
               S  + LHF+  V            IH D+   NVLL +  VA + DFG+ + ++ +
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 162 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 427 FNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHY 480
           F    ++GKG FG++ ++++    G  ++VAVK+           + F  E   MK   +
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 481 RNLVKIISSCSNEEFK------ELVLEHMPHGSLEKCLYSSNCILDIFQR-----LNIMI 529
            ++ K++        K       ++L  M HG L   L +S    + F       +  M+
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 530 DVASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           D+A  +EYL   NF    IH DL   N +L + M   ++DFG+++ +   D       + 
Sbjct: 145 DIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
             + ++A E   +     + DV++FG+ + EI +  Q
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 147 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G+G +G +YK++   G  VA+K   L        S  I E  ++K +H+ N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            +E    LV E M    L+K L  +   L   Q   I I +  +L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG-D 609
           LKP N+L++      L+DFG+ +      +S   T  + T+ Y AP+     + ++   D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 610 VYSFGIMLMEIHSAK 624
           ++S G +  E+ + K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLH 539
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 540 FNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            N     IH D+   N LL       VA + DFG+ + +            +  + ++ P
Sbjct: 158 ENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHS 622
           E   EG   +  D +SFG++L EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G+G +G +YK++   G  VA+K   L        S  I E  ++K +H+ N+V +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            +E    LV E M    L+K L  +   L   Q   I I +  +L  +       ++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG-D 609
           LKP N+L++      L+DFG+ +      +S   T  + T+ Y AP+     + ++   D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 610 VYSFGIMLMEIHSAK 624
           ++S G +  E+ + K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 172 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLH 539
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 540 FNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            N     IH D+   N LL       VA + DFG+ + +            +  + ++ P
Sbjct: 176 ENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHS 622
           E   EG   +  D +SFG++L EI S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 159 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 216 TQKFTTKSDVWSFGVLLWEL 235

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+++ MP G L   +      +     LN  + +A  + YL  
Sbjct: 78  PHVCRLLGICLTSTV-QLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 136
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 137 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 194 HRIYTHQSDVWSYGVTVWEL 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+++ MP G L   +      +     LN  + +A  + YL  
Sbjct: 81  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 139
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 140 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 197 HRIYTHQSDVWSYGVTVWEL 216

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 154 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 211 TQKFTTKSDVWSFGVLLWEL 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 155 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 212 TQKFTTKSDVWSFGVLLWEL 231

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 224
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAEL 250

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 78  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 126
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 127 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 23/193 (11%)
Query: 437 GFGTIYKSRIGD----GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH------YRNLVKI 486
           G GT  K +IG+    G +VAVK+ + Q     +S D+  +I + I       + +++K+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               S      +V+E++  G L   +     + ++  R  +   + S ++Y H +    V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DLKP NVLLD  M A ++DFG++ ++   D    +T +  +  Y APE    GR++A
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT-SCGSPNYAAPEV-ISGRLYA 188
Query: 607 NG--DVYSFGIML 617
               D++S G++L
Sbjct: 189 GPEVDIWSCGVIL 201

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 152 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 209 TQKFTTKSDVWSFGVLLWEL 228

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + ++LE M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 182 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 239 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 128 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 430 NNLIGKGGFGTIYKSRI----GDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNL 483
           N +IG+G FG +Y   +    G  +  AVK  +     G     F  E  IMK   + N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 484 VKIISSCSNEEFKELV-LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           + ++  C   E   LV L +M HG L   + +      +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGR 600
            V   H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  +
Sbjct: 154 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 601 EGRVFANGDVYSFGIMLMEI 620
             +     DV+SFG++L E+
Sbjct: 211 TQKFTTKSDVWSFGVLLWEL 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+++ MP G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 139 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 196 HRIYTHQSDVWSYGVTVWEL 215

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +  +I  G E A K+ + +    R  +  + E  I + + + N+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
            S E F  LV + +  G L      +  YS    S+CI  I + +N          + H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----------HCHL 121
Query: 541 NFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           N    ++H DLKP N+LL          L+DFG+   + G+ Q+        T GY++PE
Sbjct: 122 N---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176
Query: 598 YGREGRVFANGDVYSFGIML 617
             R+       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 77  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 111 PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 159
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 160 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWEL 246

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E++  GSL   + +  C +D  Q   +  +    LE+LH N    VIH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRNI 143
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL       L+DFG    +  E QS   T  + T  ++APE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 612 SFGIMLMEI 620
           S GIM +E+
Sbjct: 202 SLGIMAIEM 210

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLH 539
            I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 540 FNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            N     IH D+   N LL       VA + DFG+ + +            +  + ++ P
Sbjct: 173 ENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHS 622
           E   EG   +  D +SFG++L EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 89
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 89
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 203 PELIFGATDYTSSIDVWSAGCVLAEL 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 95
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 208
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAEL 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 84
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 197
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAEL 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFK-SFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK     C    +  F +E  I+   +++N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMIDVASVLE 536
            I        + +++E M  G L+  L          SS  +LD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 537 YLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL  N     IH D+   N LL       VA + DFG+ + +            +  + +
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + PE   EG   +  D +SFG++L EI S
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 77
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 190
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAEL 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 115
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 229 PELIFGATDYTSSIDVWSAGCVLAEL 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 113
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 227 PELIFGATDYTSSIDVWSAGCVLAEL 252

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 596 PE--YGREGRVFANGDVYSFGIMLMEI 620
           PE  +G      ++ DV+S G +L E+
Sbjct: 225 PELIFGATDYT-SSIDVWSAGCVLAEL 250

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 8/193 (4%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G+G +G++YK+     G  VA+K   ++     +    E  IM+     ++VK   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
                 +V+E+   GS+   +   N  L   +   I+      LEYLHF   +  IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDI 151
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  N+LL+    A L+DFG+   L   D    +   + T  ++APE  +E       D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 612 SFGIMLMEIHSAK 624
           S GI  +E+   K
Sbjct: 210 SLGITAIEMAEGK 222

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 82
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 195
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 196 PELIFGATDYTSSIDVWSAGCVLAEL 221

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 105
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 218
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 219 PELIFGATDYTSSIDVWSAGCVLAEL 244

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 156
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAEL 295

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 81
Query: 486 II------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        + S     L +      M  +   L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 538 LH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           +H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 194
Query: 596 PEYGREGRVFANG-DVYSFGIMLMEI 620
           PE       + +  DV+S G +L E+
Sbjct: 195 PELIFGATDYTSSIDVWSAGCVLAEL 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 30/200 (15%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +  +I  G E A K+ + +    R  +  + E  I + + + N+V++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
            S E F  LV + +  G L      +  YS    S+CI  I + +N          + H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----------HCHL 121
Query: 541 NFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           N    ++H DLKP N+LL          L+DFG+   + G+ Q+        T GY++PE
Sbjct: 122 N---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 598 YGREGRVFANGDVYSFGIML 617
             R+       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 89
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 202
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAEL 229

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 485 KII------SSCSNEEFKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++           +E +  LVL+++P        + S     L +      M  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 189
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 23/201 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAVK+     L      K F  E  IMK +++ N+VK+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F+V   H
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKFIV---H 129
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAPELF-QGKK 181
Query: 605 F--ANGDVYSFGIMLMEIHSA 623
           +     DV+S G++L  + S 
Sbjct: 182 YDGPEVDVWSLGVILYTLVSG 202

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 77  PHVCRLLGICLTSTV-QLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 136 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 193 HRIYTHQSDVWSYGVTVWEL 212

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 139 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 196 HRIYTHQSDVWSYGVTVWEL 215

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 79  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 128 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 77  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
            +    +IG G FG ++++++ +  EVA+K   LQ  R FK  + E +IM+ + + N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FK--NRELQIMRIVKHPNVVD 96
Query: 486 IIS------SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           + +         +E F  LVLE++P        + +  +      L I + +  +L  L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLA 155
Query: 540 FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE- 597
           +   + + H D+KP N+LLD  + V  L DFG  K+LI  + +++    + +  Y APE 
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYYRAPEL 212
Query: 598 -YGREGRVFANGDVYSFGIMLMEIHSAK 624
            +G       N D++S G ++ E+   +
Sbjct: 213 IFGATNYT-TNIDIWSTGCVMAELMQGQ 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 77  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 80  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 138
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 139 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 196 HRIYTHQSDVWSYGVTVWEL 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 56/270 (20%)
Query: 433 IGKGGFGTIYKSRI-----GDGME-VAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLV- 484
           +G+  FG +YK  +     G+  + VA+K    +  G   + F  E  +   + + N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 485 ------------KIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNI 527
                        I S CS+ +  E ++   PH  +     ++ + S+   L+    +++
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA---LEPPDFVHL 150
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
           +  +A+ +EYL  +    V+H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 151 VAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ--------------------- 626
           L  I ++APE    G+   + D++S+G++L E+ S   Q                     
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 267
Query: 627 ----CVSFVFNLAMECTIESLELRINAKEI 652
               C ++V+ L +EC  E    R   K+I
Sbjct: 268 CPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 80  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 128
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 129 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 426 GFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            + +  +IG G FG +Y++++ D  E VA+K   LQ  R FK  + E +IM+ + + N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIV 76
Query: 485 KI----ISSCSNEE--FKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLE 536
           ++     SS   ++  +  LVL+++P        + S     L +      M  +   L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 537 YLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           Y+H F     + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 189
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEI 620
           APE       + +  DV+S G +L E+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAEL 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 87  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 135
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 136 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWEL 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 83  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 131
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 132 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWEL 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 56/270 (20%)
Query: 433 IGKGGFGTIYKSRI-----GDGME-VAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLV- 484
           +G+  FG +YK  +     G+  + VA+K    +  G   + F  E  +   + + N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 485 ------------KIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNI 527
                        I S CS+ +  E ++   PH  +     ++ + S+   L+    +++
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA---LEPPDFVHL 133
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
           +  +A+ +EYL  +    V+H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 134 VAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ--------------------- 626
           L  I ++APE    G+   + D++S+G++L E+ S   Q                     
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
Query: 627 ----CVSFVFNLAMECTIESLELRINAKEI 652
               C ++V+ L +EC  E    R   K+I
Sbjct: 251 CPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 143 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 200 HRIYTHQSDVWSYGVTVWEL 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 102 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 160
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 161 RRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 218 HRIYTHQSDVWSYGVTVWEL 237

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 127
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI E       + + T  Y++PE  +   
Sbjct: 128 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQGTH 182
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 183 YSVQSDIWSMGLSLVEM 199

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 81  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 129
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG  KLL  E++          
Sbjct: 130 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 420 VCRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKSFDIECEI--- 474
           +CRA   +     IG+G +G ++K+R     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 475 --MKSIHYRNLVKIISSCS----NEEFK-ELVLEHMPHG---SLEKCLYSSNCILDIFQR 524
             +++  + N+V++   C+    + E K  LV EH+       L+K          I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
            ++M  +   L++LH +    V+H DLKP N+L+  +    L+DFG+ ++   +   M  
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           T  + T+ Y APE   +       D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQ-CGRAFKSFDI-- 470
           F + E+ RA         IGKG FG +   +  D  ++ A+K  + Q C    +  ++  
Sbjct: 14  FDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E +IM+ + +  LV +  S  +EE   +V++ +  G L   L  +    +   +L  + +
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICE 123
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA- 589
           +   L+YL       +IH D+KP N+LLD+    H++DF I  +L  E    TQ  T+A 
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 590 TIGYIAPEY--GREGRVFANG-DVYSFGIMLMEI 620
           T  Y+APE    R+G  ++   D +S G+   E+
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG  KLL  E++          
Sbjct: 128 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAVK+     L      K F  E  IMK +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAPELF-QGKK 188
Query: 605 F--ANGDVYSFGIML 617
           +     DV+S G++L
Sbjct: 189 YDGPEVDVWSLGVIL 203

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 79  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG  KLL  E++          
Sbjct: 128 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 120 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWEL 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAVK+     L      K F  E  IMK +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F+V   H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIV---H 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAPELF-QGKK 188
Query: 605 F--ANGDVYSFGIML 617
           +     DV+S G++L
Sbjct: 189 YDGPEVDVWSLGVIL 203

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGR--------AFKSFDIECEIMKS 477
           ++  ++IG+G    + +      G E AVK+  +   R          ++   E  I++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 478 IH-YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLE 536
           +  + +++ +I S  +  F  LV + M  G L   L +    L   +  +IM  +   + 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLATIGYIA 595
           +LH N    ++H DLKP N+LLDD M   LSDFG +  L  GE       +   T GY+A
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLA 267
Query: 596 PE------------YGREGRVFANG 608
           PE            YG+E  ++A G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACG 292

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 74  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 122
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 123 IAEGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWEL 209

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 10/198 (5%)
Query: 431 NLIGKGGFGTIYKS-RIGDG----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLV 484
            ++G G FGT+YK   I DG    + VA+KV       +A K    E  +M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +++  C      +LV + MP+G L   +  +   L     LN  + +A  + YL     V
Sbjct: 83  RLLGICLTSTV-QLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            ++H DL   NVL+       ++DFG+ +LL  ++           I ++A E     R 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 605 FANGDVYSFGIMLMEIHS 622
               DV+S+G+ + E+ +
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 420 VCRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKSFDIECEI--- 474
           +CRA   +     IG+G +G ++K+R     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 475 --MKSIHYRNLVKIISSCS----NEEFK-ELVLEHMPHG---SLEKCLYSSNCILDIFQR 524
             +++  + N+V++   C+    + E K  LV EH+       L+K          I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
            ++M  +   L++LH +    V+H DLKP N+L+  +    L+DFG+ ++   +   M  
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           T  + T+ Y APE   +       D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 437 GFGTIYKSRIGD----GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH------YRNLVKI 486
           G GT  K +IG+    G +VAVK+ + Q     +S D+  +I + I       + +++K+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               S      +V+E++  G L   +     + ++  R  +   + S ++Y H +    V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DLKP NVLLD  M A ++DFG++ ++   D    +  +  +  Y APE    GR++A
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLR-DSCGSPNYAAPEV-ISGRLYA 188
Query: 607 NG--DVYSFGIML 617
               D++S G++L
Sbjct: 189 GPEVDIWSCGVIL 201

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 433 IGKGGFGTI----YKSRIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKII 487
           +G G FG++    Y+ R    ++VA+KV      +A  +    E +IM  +    +V++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPV 546
             C  E    LV+E    G L K L      + +     ++  V+  ++YL   NF    
Sbjct: 77  GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 131
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QTQTLATIGYIAPEYGREGRVF 605
           +H DL   NVLL +   A +SDFG++K L  +D   T ++     + + APE     +  
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 606 ANGDVYSFGIMLMEIHSAKQQ 626
           +  DV+S+G+ + E  S  Q+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQK 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 420 VCRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKSFDIECEI--- 474
           +CRA   +     IG+G +G ++K+R     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 475 --MKSIHYRNLVKIISSCS----NEEFK-ELVLEHMPHG---SLEKCLYSSNCILDIFQR 524
             +++  + N+V++   C+    + E K  LV EH+       L+K          I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
            ++M  +   L++LH +    V+H DLKP N+L+  +    L+DFG+ ++   +   M  
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MAL 176
Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           T  + T+ Y APE   +       D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 186
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 187 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 241
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 242 YSVQSDIWSMGLSLVEM 258

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 431 NLIGKGGFGTIYK------SRIGDGMEVAVKVFHLQCGRAFK-SFDIECEIMKSI-HYRN 482
            ++G G FG +        S+ G  ++VAVK+   +   + + +   E ++M  +  + N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLNIMI 529
           +V ++ +C+      L+ E+  +G L             ++  Y +   L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 530 ---------DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ 580
                     VA  +E+L F      +H DL   NVL+    V  + DFG+ + ++ +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            + +      + ++APE   EG      DV+S+GI+L EI S
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 9/144 (6%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAVK+     L      K F  E  IMK +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F+V   H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIV---H 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGIT 572
            DLK  N+LLD  M   ++DFG +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAV++     L      K F  E  IMK +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS-------NEFTFGNKLDTFCGSPPYAAPELF-QGKK 188
Query: 605 F--ANGDVYSFGIML 617
           +     DV+S G++L
Sbjct: 189 YDGPEVDVWSLGVIL 203

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           IGKG F  + +  ++  G E A K+ + +    R  +  + E  I + + + N+V++  S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            S E F  LV + +  G L    +      + +   +    +  +LE +     + V+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 550 DLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           DLKP N+LL          L+DFG+   + G+ Q+        T GY++PE  R+     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPEVLRKEAYGK 185
Query: 607 NGDVYSFGIML 617
             D+++ G++L
Sbjct: 186 PVDIWACGVIL 196

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 437 GFGTIYKSRIGD----GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH------YRNLVKI 486
           G GT  K ++G     G +VAVK+ + Q     +S D+  +I + I       + +++K+
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
               S      +V+E++  G L   +   N  LD  +   +   + S ++Y H +    V
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DLKP NVLLD  M A ++DFG++ ++   D    +  +  +  Y APE    GR++A
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRX-SCGSPNYAAPEVI-SGRLYA 193
Query: 607 NG--DVYSFGIML 617
               D++S G++L
Sbjct: 194 GPEVDIWSSGVIL 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++  G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+++ MP G          C+LD  +           LN  + 
Sbjct: 84  PHVCRLLGICLTSTV-QLIMQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 133 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 477
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 478 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 179
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 79  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG  KLL  E++          
Sbjct: 128 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G + K L       D  +    + ++A+ L Y H      VIH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 191
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 192 VDLWSLGVLCYEF 204

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 479 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 572

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 120 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C      +L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 84  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 142
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
             LV   H DL   NVL+       ++DFG  KLL  E++          I ++A E   
Sbjct: 143 RRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 601 EGRVFANGDVYSFGIMLMEI 620
                   DV+S+G+ + E+
Sbjct: 200 HRIYTHQSDVWSYGVTVWEL 219

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 179
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 433 IGKGGFGTIYKSRIG------DGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG +Y+ ++         ++VAVK    +   +    F +E  I+   +++N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLH 539
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 540 FNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            N     IH D+   N LL       VA + DFG+ + +            +  + ++ P
Sbjct: 173 ENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 597 EYGREGRVFANGDVYSFGIMLMEIHS 622
           E   EG   +  D +SFG++L EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 179
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 77  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG  KLL  E++          
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 15/191 (7%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAV++     L      K F  E  IMK +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  F+V   H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKFIV---H 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF--A 606
            DLK  N+LLD  M   ++DFG +      ++     +   +  Y APE   +G+ +   
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELF-QGKKYDGP 192
Query: 607 NGDVYSFGIML 617
             DV+S G++L
Sbjct: 193 EVDVWSLGVIL 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR---VIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T+   T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 151
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 152 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 206
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 207 YSVQSDIWSMGLSLVEM 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 120 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 432 LIGKGGFGTIYKSRIGD-GMEVAVKVF-HLQCGRAFKSFDI-ECEIMKSIHYRNLVKIIS 488
           L+G+G +G + K R  D G  VA+K F      +  K   + E +++K + + NLV ++ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 489 SCSNEEFKELVLEHMPHGSLEKC-LYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            C  ++   LV E + H  L+   L+ +     + Q+   +  + + + + H +    +I
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGFCHSH---NII 146
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-------YGR 600
           H D+KP N+L+  + V  L DFG  + L    +       +AT  Y APE       YG+
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGK 204
Query: 601 EGRVFANG 608
              V+A G
Sbjct: 205 AVDVWAIG 212

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 179
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKH- 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 179
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 133
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 134 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 206
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 114 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 433 IGKGGFGTI----YKSRIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKII 487
           +G G FG++    Y+ R    ++VA+KV      +A  +    E +IM  +    +V++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLVPV 546
             C  E    LV+E    G L K L      + +     ++  V+  ++YL   NF    
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 457
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-QTQTLATIGYIAPEYGREGRVF 605
           +H +L   NVLL +   A +SDFG++K L  +D   T ++     + + APE     +  
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 606 ANGDVYSFGIMLMEIHSAKQQ 626
           +  DV+S+G+ + E  S  Q+
Sbjct: 518 SRSDVWSYGVTMWEALSYGQK 538

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 116 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 219
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 136 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 136 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 191
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 24/249 (9%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQ-CGRAFKSFDIECEIMKSIH 479
           R  Y   E  +IG G    +  +      E VA+K  +L+ C  +      E + M   H
Sbjct: 9   RDDYELQE--VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSL--------EKCLYSSNCILDIFQRLNIMIDV 531
           + N+V   +S   ++   LV++ +  GS+         K  + S  +LD      I+ +V
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREV 125
Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQT--L 588
              LEYLH N     IH D+K  N+LL +     ++DFG++  L  G D +  + +   +
Sbjct: 126 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 589 ATIGYIAPEYGREGRVFA-NGDVYSFGIMLMEIHSAKQQCVSF----VFNLAMECTIESL 643
            T  ++APE   + R +    D++SFGI  +E+ +       +    V  L ++    SL
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 644 ELRINAKEI 652
           E  +  KE+
Sbjct: 243 ETGVQDKEM 251

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  +M+ +    +V++I  C  E +  LV+E    G L K L  +  + D    + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 125
Query: 531 VASVLEYLH-FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTL 588
           V+  ++YL   NF    +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 126 VSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 181
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ 626
             + + APE     +  +  DV+SFG+++ E  S  Q+
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV EH+ H  L K    ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MK 476
           AT  +     IG G +GT+YK+R    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 477 SIHYRNLVKIISSCS----NEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
           +  + N+V+++  C+    + E K  LV EH+          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              L++LH N +V   H DLKP N+L+       L+DFG+ ++       M     + T+
Sbjct: 122 LRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTL 175
Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            Y APE   +       D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F + + +G G  G ++K S    G+ +A K+ HL+   A ++  I E +++   +   +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL-NIMIDVASVLEYLHFNFL 543
               +  ++    + +EHM  GSL++ L  +  I +  Q L  + I V   L YL     
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREKH- 143
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             ++H D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +   
Sbjct: 144 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTH 198
Query: 604 VFANGDVYSFGIMLMEI 620
                D++S G+ L+E+
Sbjct: 199 YSVQSDIWSMGLSLVEM 215

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 186
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++  G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 77  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 126 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR---VIH 157
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 212
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 213 VDLWSLGVLCYEF 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 181
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 180
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           IGKG FG +++ +   G EVAVK+F     R  +S+  E EI +++  R  N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
              N  + +L L  ++  HGSL    Y +   + +   + + +  AS L +LH   +   
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------TIGYIA 595
             P I H DLK  N+L+       ++D G   L +  D S T T  +A      T  Y+A
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLG---LAVRHD-SATDTIDIAPNHRVGTKRYMA 183
Query: 596 PEY------GREGRVFANGDVYSFGIMLMEI 620
           PE        +    F   D+Y+ G++  EI
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY 480
           F +  ++  G FGT+YK      G+ +++ V +  L+     +A K    E  +M S+  
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR----------LNIMID 530
            ++ +++  C      +L+ + MP G          C+LD  +           LN  + 
Sbjct: 84  PHVCRLLGICLTSTV-QLITQLMPFG----------CLLDYVREHKDNIGSQYLLNWCVQ 132
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL    LV   H DL   NVL+       ++DFG+ KLL  E++          
Sbjct: 133 IAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           I ++A E           DV+S+G+ + E+
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRN 482
           F   NL+GKG F  +Y++  I  G+EVA+K+   +        +    E +I   + + +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           ++++ +   +  +  LVLE   +G + + L +        +  + M  + + + YLH + 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
              ++H DL  SN+LL   M   ++DFG+ T+L +  ++  T      T  YI+PE    
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEIATR 186
Query: 602 GRVFANGDVYSFGIML 617
                  DV+S G M 
Sbjct: 187 SAHGLESDVWSLGCMF 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 24/249 (9%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQ-CGRAFKSFDIECEIMKSIH 479
           R  Y   E  +IG G    +  +      E VA+K  +L+ C  +      E + M   H
Sbjct: 14  RDDYELQE--VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSL--------EKCLYSSNCILDIFQRLNIMIDV 531
           + N+V   +S   ++   LV++ +  GS+         K  + S  +LD      I+ +V
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREV 130
Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQT--L 588
              LEYLH N     IH D+K  N+LL +     ++DFG++  L  G D +  + +   +
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 589 ATIGYIAPEYGREGRVFA-NGDVYSFGIMLMEIHSAKQQCVSF----VFNLAMECTIESL 643
            T  ++APE   + R +    D++SFGI  +E+ +       +    V  L ++    SL
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 644 ELRINAKEI 652
           E  +  KE+
Sbjct: 248 ETGVQDKEM 256

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MK 476
           AT  +     IG G +GT+YK+R    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 477 SIHYRNLVKIISSC----SNEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
           +  + N+V+++  C    ++ E K  LV EH+          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              L++LH N +V   H DLKP N+L+       L+DFG+ ++       M     + T+
Sbjct: 122 LRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTL 175
Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            Y APE   +       D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 425 YGFNENNLI-----GKGGFGTIYKS-------RIGDGMEVAVKVFHLQCGRA-FKSFDIE 471
           + F   NL+     G+G FG + K+       R G    VAVK+       +  +    E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSE 76
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF--------- 522
             ++K +++ +++K+  +CS +    L++E+  +GSL   L  S  +   +         
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 523 -------QRLNIMIDVAS----VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI 571
                  +R   M D+ S    + + + +   + ++H DL   N+L+ +     +SDFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++ +  ED  + ++Q    + ++A E   +       DV+SFG++L EI
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 425 YGFNENNLI-----GKGGFGTIYKS-------RIGDGMEVAVKVFHLQCGRA-FKSFDIE 471
           + F   NL+     G+G FG + K+       R G    VAVK+       +  +    E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSE 76
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF--------- 522
             ++K +++ +++K+  +CS +    L++E+  +GSL   L  S  +   +         
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 523 -------QRLNIMIDVAS----VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI 571
                  +R   M D+ S    + + + +   + ++H DL   N+L+ +     +SDFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++ +  ED  + ++Q    + ++A E   +       DV+SFG++L EI
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +      G+E A K+ + +    R F+  + E  I + + + N+V++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
              E F  LV + +  G L      +  YS    S+CI  I +           + Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES----------IAYCHS 146
Query: 541 NFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           N    ++H +LKP N+LL          L+DFG   L I  + S        T GY++PE
Sbjct: 147 N---GIVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLSPE 200
Query: 598 YGREGRVFANGDVYSFGIML 617
             ++       D+++ G++L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 15/193 (7%)
Query: 433 IGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSIHYRNLVKIISSC 490
           +G G FG ++       G+E  +K  +    +   +  + E E++KS+ + N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR---LNIMIDVASVLEYLHFNFLVPVI 547
            +     +V+E    G L + + S+              +M  + + L Y H      V+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 548 HCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
           H DLKP N+L  DT       + DFG+ +L   ++ S   T    T  Y+APE  +    
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKRDVT 203
Query: 605 FANGDVYSFGIML 617
           F   D++S G+++
Sbjct: 204 F-KCDIWSAGVVM 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEK 187
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 188 VDLWSLGVLCYEF 200

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G + K L       D  +    + ++A+ L Y H      VIH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLXGTLDYLPPEMI-EGRMHDEK 191
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 192 VDLWSLGVLCYEF 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR---VIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEK 191
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 192 VDLWSLGVLCYEF 204

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 130
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 185
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 186 VDLWSLGVLCYEF 198

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 142
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKT 198
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR---VIH 148
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 203
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 204 VDLWSLGVLCYEF 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRN 482
           F+    +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           ++++     +     L+LE+ P G++ + L       D  +    + ++A+ L Y H   
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHSK- 131
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EG
Sbjct: 132 --RVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EG 184
Query: 603 RVFANG-DVYSFGIMLMEI 620
           R+     D++S G++  E 
Sbjct: 185 RMHDEKVDLWSLGVLCYEF 203

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  + G   A KV   +     + + +E EI+ +  +  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           ++    +++E  P G+++  +   +  L   Q   I +    +LE L+F     +IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GREGRVFA 606
           K  NVL+       L+DFG++   +   Q   +   + T  ++APE       ++     
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 607 NGDVYSFGIMLMEI 620
             D++S GI L+E+
Sbjct: 194 KADIWSLGITLIEM 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 191
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 192 VDLWSLGVLCYEF 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 135
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 136 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 190
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 191 VDLWSLGVLCYEF 203

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 132
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKT 188
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 11/189 (5%)
Query: 434 GKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSCSN 492
           G GG  T  + R   G+ +A K+ HL+   A ++  I E +++   +   +V    +  +
Sbjct: 27  GNGGVVTKVQHR-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 85
Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILD-IFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           +    + +EHM  GSL++ L  +  I + I  +++I   V   L YL     +  +H D+
Sbjct: 86  DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQI--MHRDV 141
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           KPSN+L++      L DFG++  LI    SM  +  + T  Y+APE  +        D++
Sbjct: 142 KPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAPERLQGTHYSVQSDIW 197
Query: 612 SFGIMLMEI 620
           S G+ L+E+
Sbjct: 198 SMGLSLVEL 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/229 (22%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 425 YGFNENNLI-----GKGGFGTIYKS-------RIGDGMEVAVKVFHLQCGRA-FKSFDIE 471
           + F   NL+     G+G FG + K+       R G    VAVK+       +  +    E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSE 76
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF--------- 522
             ++K +++ +++K+  +CS +    L++E+  +GSL   L  S  +   +         
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 523 -------QRLNIMIDVAS----VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI 571
                  +R   M D+ S    + + + +   + ++H DL   N+L+ +     +SDFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++ +  ED  + ++Q    + ++A E   +       DV+SFG++L EI
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVF-HLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G ++K R  D G  VA+K F   +     K   + E  ++K + + NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV----LEYLHFNFLVP 545
              +    LV E+  H  L +        LD +QR      V S+    L+ ++F     
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-------Y 598
            IH D+KP N+L+    V  L DFG  +LL G   S      +AT  Y +PE       Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQY 180
Query: 599 GREGRVFANGDVYS 612
           G    V+A G V++
Sbjct: 181 GPPVDVWAIGCVFA 194

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  + G   A KV   +     + + +E EI+ +  +  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           ++    +++E  P G+++  +   +  L   Q   I +    +LE L+F     +IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GREGRVFA 606
           K  NVL+       L+DFG++   +   Q   +   + T  ++APE       ++     
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 607 NGDVYSFGIMLMEI 620
             D++S GI L+E+
Sbjct: 202 KADIWSLGITLIEM 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R +  G EVAVK+     L      K F  E  IMK +++ N+VK+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV+E+   G +   L +   + +   R      + S ++Y H  ++V   H
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKYIV---H 137
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFS-------NEFTVGNKLDTFCGSPPYAAPELF-QGKK 189
Query: 605 F--ANGDVYSFGIML 617
           +     DV+S G++L
Sbjct: 190 YDGPEVDVWSLGVIL 204

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRA--------------------- 464
           F E  LIG GGFG ++K++   DG    ++       +A                     
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGC 73
Query: 465 FKSFDIECEI----MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC-IL 519
           +  FD + E     ++S  Y       SS S  +   + +E    G+LE+ +       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 520 DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED 579
           D    L +   +   ++Y+H   L   IH DLKPSN+ L DT    + DFG+   L  + 
Sbjct: 134 DKVLALELFEQITKGVDYIHSKKL---IHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 580 QSMTQTQTLATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
           +   +T++  T+ Y++PE      YG+E       D+Y+ G++L E+
Sbjct: 191 K---RTRSKGTLRYMSPEQISSQDYGKE------VDLYALGLILAEL 228

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPPEMI-EGRMHDEK 187
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 188 VDLWSLGVLCYEF 200

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNL 483
           ++    +GKG F  + +      G+E A K+ + +    R F+  + E  I + + + N+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASV 534
           V++  S   E F  LV + +  G L      +  YS    S+CI  I +           
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---------- 117
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           + Y H N    ++H +LKP N+LL          L+DFG   L I  + S        T 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTP 171
Query: 592 GYIAPEYGREGRVFANGDVYSFGIML 617
           GY++PE  ++       D+++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI-----MK 476
           AT  +     IG G +GT+YK+R    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 477 SIHYRNLVKIISSCS----NEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
           +  + N+V+++  C+    + E K  LV EH+          +    L      ++M   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              L++LH N +V   H DLKP N+L+       L+DFG+ ++       M     + T+
Sbjct: 122 LRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTL 175
Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            Y APE   +       D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 29/206 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F +   IGKG FG ++K       +V           A K  D+E    +    +  + +
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAEDEIEDIQQEITV 74
Query: 487 ISSCSNEEFKE------------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S C +    +            +++E++  GS    L +     D FQ   ++ ++   
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKG 132
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+YLH       IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++
Sbjct: 133 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 187
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE  ++    +  D++S GI  +E+
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIEL 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKT 192
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNL 483
           ++    +GKG F  + +      G+E A K+ + +    R F+  + E  I + + + N+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASV 534
           V++  S   E F  LV + +  G L      +  YS    S+CI  I +           
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---------- 117
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           + Y H N    ++H +LKP N+LL          L+DFG   L I  + S        T 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTP 171
Query: 592 GYIAPEYGREGRVFANGDVYSFGIML 617
           GY++PE  ++       D+++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNL 483
           ++    +GKG F  + +      G+E A K+ + +    R F+  + E  I + + + N+
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 484 VKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASV 534
           V++  S   E F  LV + +  G L      +  YS    S+CI  I +           
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---------- 116
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           + Y H N    ++H +LKP N+LL          L+DFG   L I  + S        T 
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTP 170
Query: 592 GYIAPEYGREGRVFANGDVYSFGIML 617
           GY++PE  ++       D+++ G++L
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 142
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKT 198
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 132
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKT 188
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 128
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 183
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 184 VDLWSLGVLCYEF 196

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 415 FSYLEVC-RATYGFNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDI 470
           F  +  C R T  +     +GKG F  + +  +     E A K+ + +    R  +  + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDI 521
           E  I + + + N+V++  S S E F  LV + +  G L      +  YS    S+CI  I
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 139
Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGE 578
            + +N          ++H +    ++H DLKP N+LL          L+DFG+   + GE
Sbjct: 140 LESVN----------HIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIML 617
            Q+        T GY++PE  R+       D+++ G++L
Sbjct: 187 QQAW--FGFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ PE   EGR     
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEXI-EGRXHDEK 191
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 192 VDLWSLGVLCYEF 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 136
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 137 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKT 192
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 187 YYSTAVDIWSLGCIFAEM 204

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIM-------KSIHYRNL 483
           +IGKG FG +  +R   + +  AVKV  LQ     K  + E  IM       K++ +  L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKE-EKHIMSERNVLLKNVKHPFL 101
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V +  S    +    VL+++  G L   L    C L+   R     ++AS L YLH    
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 157
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
           + +++ DLKP N+LLD      L+DFG+ K  I  + + T +    T  Y+APE   +  
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 604 VFANGDVYSFGIMLMEI 620
                D +  G +L E+
Sbjct: 216 YDRTVDWWCLGAVLYEM 232

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R  +   + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---KVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +         K +V E  P GSL   L  +  + +L    R    + VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKRF 132
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE   + 
Sbjct: 133 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKT 188
Query: 603 RVFANG-DVYSFGIMLMEIHSAKQQ 626
           R F++  D + FG+ L E+ +  Q+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + ++APE   +       DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  +  +  A KV   +     + + +E +I+ S  + N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E    +++E    G+++  +      L   Q   +       L YLH N    +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEY-----GREGRV 604
           K  N+L        L+DFG++     ++    Q +   + T  ++APE       ++   
Sbjct: 162 KAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S GI L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + ++APE   +       DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  +  +  A KV   +     + + +E +I+ S  + N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E    +++E    G+++  +      L   Q   +       L YLH N    +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEY-----GREGRV 604
           K  N+L        L+DFG++     ++    Q +   + T  ++APE       ++   
Sbjct: 162 KAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S GI L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 88/191 (46%), Gaps = 12/191 (6%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +  ++  G E A K+ + +    R  +  + E  I + + + N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            S E    L+ + +  G L    +      + +   +    +  +LE +     + V+H 
Sbjct: 90  ISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 550 DLKPSNVLLDDTM---VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           DLKP N+LL   +      L+DFG+   + GE Q+        T GY++PE  R+     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 607 NGDVYSFGIML 617
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS--IHYRNLVKII-- 487
           LIG+G +G +YK  + D   VAVKVF     + F +   E  I +   + + N+ + I  
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIARFIVG 75
Query: 488 ----SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF--- 540
               ++    E+  LV+E+ P+GSL K  Y S    D      +   V   L YLH    
Sbjct: 76  DERVTADGRMEYL-LVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 541 --NFLVPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGE------DQSMTQTQTLATI 591
             +   P I H DL   NVL+ +     +SDFG++  L G       ++       + TI
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 592 GYIAPEYGREGRV--------FANGDVYSFGIMLMEI 620
            Y+APE   EG V            D+Y+ G++  EI
Sbjct: 193 RYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +YK++  +  +  A KV   +     + + +E +I+ S  + N+VK++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            E    +++E    G+++  +      L   Q   +       L YLH N    +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT--LATIGYIAPEY-----GREGRV 604
           K  N+L        L+DFG++     ++    Q +   + T  ++APE       ++   
Sbjct: 162 KAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 605 FANGDVYSFGIMLMEI 620
               DV+S GI L+E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F+ + +IG+GGFG +Y  R  D      K++ ++C    +    + E + +++ R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 487 ISS-------CSNEEFK-----ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S+       C +  F        +L+ M  G L   L        +F   ++    A +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEI 301
Query: 535 ---LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              LE++H  F   V++ DLKP+N+LLD+     +SD G    L  +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTH 354
Query: 592 GYIAPEYGREGRVF-ANGDVYSFGIMLMEI 620
           GY+APE  ++G  + ++ D +S G ML ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F+ + +IG+GGFG +Y  R  D      K++ ++C    +    + E + +++ R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 487 ISS-------CSNEEFK-----ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S+       C +  F        +L+ M  G L   L        +F   ++    A +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEI 301
Query: 535 ---LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              LE++H  F   V++ DLKP+N+LLD+     +SD G    L  +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTH 354
Query: 592 GYIAPEYGREGRVF-ANGDVYSFGIMLMEI 620
           GY+APE  ++G  + ++ D +S G ML ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F+ + +IG+GGFG +Y  R  D      K++ ++C    +    + E + +++ R ++ +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 244
Query: 487 ISS-------CSNEEFK-----ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S+       C +  F        +L+ M  G L   L        +F   ++    A +
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEI 300
Query: 535 ---LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              LE++H  F   V++ DLKP+N+LLD+     +SD G    L  +        ++ T 
Sbjct: 301 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTH 353
Query: 592 GYIAPEYGREGRVF-ANGDVYSFGIMLMEI 620
           GY+APE  ++G  + ++ D +S G ML ++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 383

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F+ + +IG+GGFG +Y  R  D      K++ ++C    +    + E + +++ R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIMLSL 245
Query: 487 ISS-------CSNEEFK-----ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S+       C +  F        +L+ M  G L   L        +F   ++    A +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEI 301
Query: 535 ---LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
              LE++H  F   V++ DLKP+N+LLD+     +SD G    L  +        ++ T 
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTH 354
Query: 592 GYIAPEYGREGRVF-ANGDVYSFGIMLMEI 620
           GY+APE  ++G  + ++ D +S G ML ++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL---QCGRAFKSFDIECEIMKSIHYRN 482
           F++   IG G FG +Y +R + +   VA+K       Q    ++    E   ++ + + N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------L 535
            ++       E    LV+E+        CL S++ +L++ ++    +++A+V       L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
            YLH + +   IH D+K  N+LL +  +  L DFG   ++            + T  ++A
Sbjct: 168 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMA 218
Query: 596 PEY---GREGRVFANGDVYSFGIMLMEIHSAK 624
           PE      EG+     DV+S GI  +E+   K
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 181 YYSTAVDIWSLGCIFAEM 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 128
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 187 YYSTAVDIWSLGCIFAEM 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 422 RATYGFNENNLIGKGGFGTIY--KSRIGDGMEVAVKVFHLQCGR---AFKSFDIECEI-- 474
           R T+ F E  ++G G F  ++  K R+        K+F L+C +   AF+   +E EI  
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVKQRLTG------KLFALKCIKKSPAFRDSSLENEIAV 59
Query: 475 MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMI 529
           +K I + N+V +     +     LV++ +  G L     E+ +Y+      + Q+     
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----- 114
Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
            V S ++YLH N    ++H DLKP N+L    ++     ++DFG++K+    +Q+   + 
Sbjct: 115 -VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMST 166
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIM 616
              T GY+APE   +       D +S G++
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLSFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR---VIH 157
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRDDLCGTLDYLPPEMI-EGRMHDEK 212
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 213 VDLWSLGVLCYEF 225

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR--AFKSFDIECEIMKSIHYRNLVKIIS 488
            LIGKG FG +Y  R     EVA+++  ++       K+F  E    +   + N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           +C +     ++       +L   +  +  +LD+ +   I  ++   + YLH      ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILH 153
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITK----LLIGEDQSMTQTQTLATIGYIAPEYGR---- 600
            DLK  NV  D+  V  ++DFG+      L  G  +   + Q    + ++APE  R    
Sbjct: 154 KDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQLSP 211
Query: 601 ---EGRV--FANGDVYSFGIMLMEIHS 622
              E ++    + DV++ G +  E+H+
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHA 238

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRAALCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F E  LIG GGFG ++K++   DG    +K       +A    + E + +  + + N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 486 I------------ISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIM 528
                         SS ++   K     + +E    G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
             +   ++Y+H   L   I+ DLKPSN+ L DT    + DFG+   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIHSKKL---INRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 589 ATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
            T+ Y++PE      YG+E       D+Y+ G++L E+
Sbjct: 183 GTLRYMSPEQISSQDYGKE------VDLYALGLILAEL 214

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 125
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 184 YYSTAVDIWSLGCIFAEM 201

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISSC 490
           +GKG +G +++     G  VAVK+F     R  KS+  E E+  ++  R  N++  I+S 
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 491 SNEEFKELVLEHMPH----GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
                    L  + H    GSL    Y     LD    L I++ +AS L +LH       
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-----LATIGYIAP 596
             P I H DLK  N+L+       ++D G   L +   QS  Q        + T  Y+AP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLG---LAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 597 EYGREG------RVFANGDVYSFGIMLMEI 620
           E   E         +   D+++FG++L E+
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 133
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       +++FG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 188
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 189 VDLWSLGVLCYEF 201

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       +++FG +        S  +T    T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 131
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEMI-EGRMHDEK 186
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 187 VDLWSLGVLCYEF 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL---QCGRAFKSFDIECEIMKSIHYRN 482
           F++   IG G FG +Y +R + +   VA+K       Q    ++    E   ++ + + N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------L 535
            ++       E    LV+E+        CL S++ +L++ ++    +++A+V       L
Sbjct: 77  TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
            YLH + +   IH D+K  N+LL +  +  L DFG   ++            + T  ++A
Sbjct: 129 AYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMA 179
Query: 596 PEY---GREGRVFANGDVYSFGIMLMEIHSAK 624
           PE      EG+     DV+S GI  +E+   K
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISSC 490
           +GKG +G +++     G  VAVK+F     R  KS+  E E+  ++  R  N++  I+S 
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 491 SNEEFKELVLEHMPH----GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
                    L  + H    GSL    Y     LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-----LATIGYIAP 596
             P I H DLK  N+L+       ++D G   L +   QS  Q        + T  Y+AP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLG---LAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 597 EYGREG------RVFANGDVYSFGIMLMEI 620
           E   E         +   D+++FG++L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 133
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMI-EGRMHDEK 188
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 189 VDLWSLGVLCYEF 201

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEI 620
              + ++APE     RV+ +  DV+SFG+++ EI
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISSC 490
           +GKG +G +++     G  VAVK+F     R  KS+  E E+  ++  R  N++  I+S 
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 491 SNEEFKELVLEHMPH----GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
                    L  + H    GSL    Y     LD    L I++ +AS L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-----LATIGYIAP 596
             P I H DLK  N+L+       ++D G   L +   QS  Q        + T  Y+AP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLG---LAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 597 EYGREG------RVFANGDVYSFGIMLMEI 620
           E   E         +   D+++FG++L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 132
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +   +    S   T    T+ Y+ PE   EGR+    
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDT-LCGTLDYLPPEMI-EGRMHDEK 187
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 188 VDLWSLGVLCYEF 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+LE+ P G++ + L       D  +    + ++A+ L Y H      VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSK---RVIH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EGR+    
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLPPEMI-EGRMHDEK 189
Query: 609 -DVYSFGIMLMEI 620
            D++S G++  E 
Sbjct: 190 VDLWSLGVLCYEF 202

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKV-FHLQCGRAFKSFDI--ECEIMKSIHYRN 482
           F+    +GKG FG +Y +R      + A+KV F  Q  +A     +  E EI   + + N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           ++++     +     L+LE+ P G++ + L       D  +    + ++A+ L Y H   
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCHSK- 131
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              VIH D+KP N+LL       ++DFG +        S  +     T+ Y+ PE   EG
Sbjct: 132 --RVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPPEMI-EG 184
Query: 603 RVFANG-DVYSFGIMLMEI 620
           R+     D++S G++  E 
Sbjct: 185 RMHDEKVDLWSLGVLCYEF 203

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 471 ECEIMKSIHYRNLVKIISSCS--NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
           E  I+K + + N+VK++      NE+   +V E +  G + +         D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
            D+   +EYLH+     +IH D+KPSN+L+ +     ++DFG++    G D  +  + T+
Sbjct: 144 QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTV 198
Query: 589 ATIGYIAPEYGREGRVFANG---DVYSFGIML 617
            T  ++APE   E R   +G   DV++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVF--------HLQCGRAFKSFDIECEIMKSI 478
           F +  ++G+GGFG ++  +    M+   K++         L+  + ++   +E +I+  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---L 535
           H R +V +  +   +    LV+  M  G +   +Y+ +     FQ    +   A +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLA-TIGY 593
           E+LH      +I+ DLKP NVLLDD     +SD G+  +L  G+    T+T+  A T G+
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGF 355
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           +APE         + D ++ G+ L E+ +A+
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+               E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLS--HSLEIFDMS-KCNVSGG 135
           S  P  SF +    C++L +  L +N    +L R+     +    LE  D+S    +   
Sbjct: 45  SHVPAASFRA----CRNLTILWLHSN----VLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKL 194
            P     L  L  ++L    L    P   R L  LQY+ L+DN L+  +P D FR L  L
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNL 155
Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP--LPLEIGNLKVLIGIDFSMNNFSS 252
             L L GN++S      F  L SL  L L  N      P    +L  L+ +    NN S+
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
Query: 253 VIPTTIGSLKDLQYLFLGYN 272
           +    +  L+ LQYL L  N
Sbjct: 216 LPTEALAPLRALQYLRLNDN 235

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVF--------HLQCGRAFKSFDIECEIMKSI 478
           F +  ++G+GGFG ++  +    M+   K++         L+  + ++   +E +I+  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---L 535
           H R +V +  +   +    LV+  M  G +   +Y+ +     FQ    +   A +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLA-TIGY 593
           E+LH      +I+ DLKP NVLLDD     +SD G+  +L  G+    T+T+  A T G+
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGF 355
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           +APE         + D ++ G+ L E+ +A+
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 9/196 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSF-DIECEIMKSIHYRNLV 484
           F +   IGKG FG ++K       +V A+K+  L+           E  ++       + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K   S   +    +++E++  GS    L      LD  Q   I+ ++   L+YLH     
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE--- 143
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++   
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 605 FANGDVYSFGIMLMEI 620
            +  D++S GI  +E+
Sbjct: 202 DSKADIWSLGITAIEL 217

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 433 IGKGGFGTIYKS---RIGDGMEVAVKVFH-----LQCGRAFKSFDIECEIMKSIHYRNLV 484
           +GKG +G ++KS   R G+ + V  K+F          R F+   I  E+    +  NL+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            ++ +  N+    LV ++M    L   + ++  IL+   +  ++  +  V++YLH   L 
Sbjct: 76  NVLRA-DNDRDVYLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGL- 130
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-------------------EDQSMTQT 585
             +H D+KPSN+LL+      ++DFG+++  +                    +D     T
Sbjct: 131 --LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 586 QTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
             +AT  Y APE       +  G D++S G +L EI
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVF--------HLQCGRAFKSFDIECEIMKSI 478
           F +  ++G+GGFG ++  +    M+   K++         L+  + ++   +E +I+  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---L 535
           H R +V +  +   +    LV+  M  G +   +Y+ +     FQ    +   A +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLA-TIGY 593
           E+LH      +I+ DLKP NVLLDD     +SD G+  +L  G+    T+T+  A T G+
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGF 355
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           +APE         + D ++ G+ L E+ +A+
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 431 NLIGKGGFGTIYKSRIGDGMEV----AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNL 483
            ++G+G FG ++  +   G +     A+KV     L+     ++  +E +I+  +++  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK+  +   E    L+L+ +  G L   L S   +         + ++A  L++LH    
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREG 602
           + +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ Y+APE   R G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D +SFG+++ E+
Sbjct: 203 HT-QSADWWSFGVLMFEM 219

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 431 NLIGKGGFGTIY----KSRIGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNL 483
            ++G+G FG ++     +R   G   A+KV     L+     ++  +E +I+  +++  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK+  +   E    L+L+ +  G L   L S   +         + ++A  L++LH    
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREG 602
           + +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ Y+APE   R+G
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 603 RVFANGDVYSFGIMLMEI 620
              +  D +S+G+++ E+
Sbjct: 207 HSHS-ADWWSYGVLMFEM 223

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           R    F E  ++G+G FG + K+R   D    A+K           +   E  ++ S+++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 481 -------------RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
                        RN VK +++   +    + +E+  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK-------LLIGEDQ 580
              +   L Y+H      +IH DLKP N+ +D++    + DFG+ K       +L  + Q
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 581 SM-----TQTQTLATIGYIAPEY-GREGRVFANGDVYSFGIMLMEI 620
           ++       T  + T  Y+A E     G      D+YS GI+  E+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 85/200 (42%), Gaps = 15/200 (7%)
Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLS--HSLEIFDMS-KCNVSGG 135
           S  P  SF +    C++L +  L +N    +L R+     +    LE  D+S    +   
Sbjct: 44  SHVPAASFRA----CRNLTILWLHSN----VLARIDAAAFTGLALLEQLDLSDNAQLRSV 95
Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKL 194
            P     L  L  ++L    L    P   R L  LQY+ L+DN L+  +P D FR L  L
Sbjct: 96  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNL 154
Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP--LPLEIGNLKVLIGIDFSMNNFSS 252
             L L GN++S      F  L SL  L L  N      P    +L  L+ +    NN S+
Sbjct: 155 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 214
Query: 253 VIPTTIGSLKDLQYLFLGYN 272
           +    +  L+ LQYL L  N
Sbjct: 215 LPTEALAPLRALQYLRLNDN 234

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 9/196 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSF-DIECEIMKSIHYRNLV 484
           F +   IGKG FG ++K       +V A+K+  L+           E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K   S   +    +++E++  GS    L      LD  Q   I+ ++   L+YLH     
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE--- 138
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++   
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 605 FANGDVYSFGIMLMEI 620
            +  D++S GI  +E+
Sbjct: 197 DSKADIWSLGITAIEL 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         +S N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVF--------HLQCGRAFKSFDIECEIMKSI 478
           F +  ++G+GGFG ++  +    M+   K++         L+  + ++   +E +I+  +
Sbjct: 187 FLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---L 535
           H R +V +  +   +    LV+  M  G +   +Y+ +     FQ    +   A +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLA-TIGY 593
           E+LH      +I+ DLKP NVLLDD     +SD G+  +L  G+    T+T+  A T G+
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGF 355
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
           +APE         + D ++ G+ L E+ +A+
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME--VAVKVFHLQCGRAFKSF-DIECEIMKSIHYRNL 483
           F +   IGKG FG ++K  I +  +  VA+K+  L+           E  ++       +
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            K   S   +    +++E++  GS    L      LD  Q   I+ ++   L+YLH    
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE-- 123
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++  
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 604 VFANGDVYSFGIMLMEI 620
             +  D++S GI  +E+
Sbjct: 181 YDSKADIWSLGITAIEL 197

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 9/196 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSF-DIECEIMKSIHYRNLV 484
           F +   IGKG FG ++K       +V A+K+  L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K   S   +    +++E++  GS    L      LD  Q   I+ ++   L+YLH     
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE--- 123
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++APE  ++   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 605 FANGDVYSFGIMLMEI 620
            +  D++S GI  +E+
Sbjct: 182 DSKADIWSLGITAIEL 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           IG+G +G +YK++   G   A+K   L+       S  I E  I+K + + N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             ++   LV EH+    L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD 125
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG-D 609
           LKP N+L++      ++DFG+ +      +    T  + T+ Y AP+     + ++   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 610 VYSFGIMLMEI 620
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 431 NLIGKGGFGTIYKSRIGDGMEV----AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNL 483
            ++G+G FG ++  +   G +     A+KV     L+     ++  +E +I+  +++  +
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 88
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK+  +   E    L+L+ +  G L   L S   +         + ++A  L++LH    
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREG 602
           + +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ Y+APE   R G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D +SFG+++ E+
Sbjct: 203 HT-QSADWWSFGVLMFEM 219

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           IG+G +G +YK++   G   A+K   L+       S  I E  I+K + + N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             ++   LV EH+    L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD 125
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG-D 609
           LKP N+L++      ++DFG+ +      +    T  + T+ Y AP+     + ++   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 610 VYSFGIMLMEI 620
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 423 ATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFK-----SFDIECEIMK 476
           AT  +     IG G +GT+YK+R    G  VA+K   +  G         S   E  +++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 477 SIH---YRNLVKIISSCS----NEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
            +    + N+V+++  C+    + E K  LV EH+          +    L      ++M
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
                 L++LH N +V   H DLKP N+L+       L+DFG+ ++       M  T  +
Sbjct: 127 RQFLRGLDFLHANCIV---HRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVV 180
Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            T+ Y APE   +       D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 9/191 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           IG+G +G +YK++   G   A+K   L+       S  I E  I+K + + N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             ++   LV EH+    L+K L      L+     + ++ + + + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRD 125
Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG-D 609
           LKP N+L++      ++DFG+ +      +    T  + T+ Y AP+     + ++   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 610 VYSFGIMLMEI 620
           ++S G +  E+
Sbjct: 184 IWSVGCIFAEM 194

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + ++APE   +       DV+SFG+++ EI +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + ++APE   +       DV+SFG+++ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 431 NLIGKGGFGTIYKSRIGDGMEV----AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNL 483
            ++G+G FG ++  +   G +     A+KV     L+     ++  +E +I+  +++  +
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFI 89
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK+  +   E    L+L+ +  G L   L S   +         + ++A  L++LH    
Sbjct: 90  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 145
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREG 602
           + +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ Y+APE   R G
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 603 RVFANGDVYSFGIMLMEI 620
               + D +SFG+++ E+
Sbjct: 204 HT-QSADWWSFGVLMFEM 220

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 212 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 83/189 (43%), Gaps = 7/189 (3%)
Query: 88  SSLSNCKSLVVFLLSNNPLNGILPRMSIG-NLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           +S  +C++L +  L +N L GI      G  L   L++ D ++  V    P     L +L
Sbjct: 49  ASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVVD--PTTFRGLGHL 106
Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLS 205
             ++L    L    P   R L  LQY+ L+DN L+  +P + FR L  L  L L GN++ 
Sbjct: 107 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQA-LPDNTFRDLGNLTHLFLHGNRIP 165
Query: 206 GSILTCFSNLASLRTLSLSYNDGPL--PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
                 F  L SL  L L  N      P    +L  L+ +    NN S +    +  L+ 
Sbjct: 166 SVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLSMLPAEVLVPLRS 225
Query: 264 LQYLFLGYN 272
           LQYL L  N
Sbjct: 226 LQYLRLNDN 234

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++E+   G+L + L           Y  N + +    F+ L + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
              + ++APE   +       DV+SFG+++ EI +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 183 YYSTAVDIWSLGCIFAEM 200

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 414 RFSYLEVCRATYGFNEN----NLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF 468
           R + L    +T+GF EN     ++G+G    + +        E AVK+  +  G +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 469 DI---------ECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI 518
           ++         E +I++ +  + N++++  +     F  LV + M  G L   L +    
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVT 120
Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           L   +   IM  +  V+  LH    + ++H DLKP N+LLDD M   L+DFG +  L   
Sbjct: 121 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--- 174
Query: 579 DQSMTQTQTLATIGYIAPE------------YGREGRVFANG 608
           D      +   T  Y+APE            YG+E  +++ G
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 182 YYSTAVDIWSLGCIFAEM 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 125
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 184 YYSTAVDIWSLGCIFAEM 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 183 YYSTAVDIWSLGCIFAEM 200

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 182 YYSTAVDIWSLGCIFAEM 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 123
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 182 YYSTAVDIWSLGCIFAEM 199

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMK-SIHYRNLVK 485
           F   +++G G  GTI    + D  +VAVK    +C   F   D E ++++ S  + N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
              +  + +F+ + +E +   +L++ +   +      + + ++    S L +LH    + 
Sbjct: 83  YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 546 VIHCDLKPSNVLLD-----DTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPE 597
           ++H DLKP N+L+        + A +SDFG+  KL +G      ++    T G+IAPE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 181 YYSTAVDIWSLGCIFAEM 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV EH+    L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQ-DLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 183 YYSTAVDIWSLGCIFAEM 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKV---FHL--QCGRAFKSFDIECEIMKSIHYRNLVK 485
           +IG+G FG +   R     +V A+K+   F +  +   AF  F  E +IM   +   +V+
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 133
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +  +  ++ +  +V+E+MP G L   L S+  + + + R     +V   L+ +H    + 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 188
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE----YGRE 601
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  YI+PE     G +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 247
Query: 602 GRVFANGDVYSFGIMLMEI 620
           G      D +S G+ L E+
Sbjct: 248 GYYGRECDWWSVGVFLYEM 266

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 181 YYSTAVDIWSLGCIFAEM 198

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 122
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 181 YYSTAVDIWSLGCIFAEM 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKV---FHL--QCGRAFKSFDIECEIMKSIHYRNLVK 485
           +IG+G FG +   R     +V A+K+   F +  +   AF  F  E +IM   +   +V+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +  +  ++ +  +V+E+MP G L   L S+  + + + R     +V   L+ +H    + 
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE----YGRE 601
            IH D+KP N+LLD +    L+DFG    +  E      T  + T  YI+PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 252
Query: 602 GRVFANGDVYSFGIMLMEI 620
           G      D +S G+ L E+
Sbjct: 253 GYYGRECDWWSVGVFLYEM 271

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 9/101 (8%)
Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           I +A+V    H    + +IH D+KPSN+LLD +    L DFGI+  L+    S+ +T+  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 589 ATIGYIAPEY-----GREGRVFANGDVYSFGIMLMEIHSAK 624
               Y+APE       R+G      DV+S GI L E+ + +
Sbjct: 187 GCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGR 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVA+K+     L      K F  E  IMK +++ N+VK+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   L++E+   G +   L +   + +   R      + S ++Y H      ++H
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 134
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPEYGREGRV 604
            DLK  N+LLD  M   ++DFG +          T    L T      Y APE   +G+ 
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDTFCGSPPYAAPELF-QGKK 186
Query: 605 F--ANGDVYSFGIML 617
           +     DV+S G++L
Sbjct: 187 YDGPEVDVWSLGVIL 201

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         Y  N   +  ++L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDI 470
           W+      V + T  F +  ++GKGGFG +   ++   G   A K    +  +  K   +
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 471 ---ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLN 526
              E +I++ ++ R +V +  +   ++   LVL  M  G L+  +Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
              ++   LE LH      +++ DLKP N+LLDD     +SD G+  + + E Q++    
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KG 344
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + T+GY+APE  +  R   + D ++ G +L E+
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+    L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+    L        S  I E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L+K +  ++ +  I   L I   +  +L+ L F   
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T T  + T+ Y APE     +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 179 YYSTAVDIWSLGCIFAEM 196

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +     +VAVK+       +       E E+MK I  ++N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCILDIFQRLN------I 527
           ++ ++ +C+ +    +++E+   G+L + L         Y  N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
              + ++APE   +       DV+SFG++L EI
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F+    +GKG FG +Y +R      + A+KV     L+          E EI   + + N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           ++++ +   + +   L+LE  P G L K L   +   D  +    M ++A  L Y H   
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHER- 134
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              VIH D+KP N+L+       ++DFG +        S+ +     T+ Y+ PE   EG
Sbjct: 135 --KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMI-EG 187
Query: 603 RVFANG-DVYSFGIMLMEI 620
           +      D++  G++  E 
Sbjct: 188 KTHDEKVDLWCAGVLCYEF 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 485 -KIISSCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ L  H+    L K L + +   D     +I   +  +L  L +  
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 161
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 414 RFSYLEVCRATYGFNEN----NLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF 468
           R + L    +T+GF EN     ++G+G    + +        E AVK+  +  G +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61
Query: 469 DI---------ECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI 518
           ++         E +I++ +  + N++++  +     F  LV + M  G L   L +    
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVT 120
Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
           L   +   IM  +  V+  LH    + ++H DLKP N+LLDD M   L+DFG +  L   
Sbjct: 121 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--- 174
Query: 579 DQSMTQTQTLATIGYIAPE------------YGREGRVFANG 608
           D          T  Y+APE            YG+E  +++ G
Sbjct: 175 DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L K    ++ +  I   L I   +  +L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 183 YYSTAVDIWSLGCIFAEM 200

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDI 470
           W+      V + T  F +  ++GKGGFG +   ++   G   A K    +  +  K   +
Sbjct: 173 WKWLERQPVTKNT--FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 471 ---ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLN 526
              E +I++ ++ R +V +  +   ++   LVL  M  G L+  +Y          + + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
              ++   LE LH      +++ DLKP N+LLDD     +SD G+  + + E Q++    
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KG 344
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + T+GY+APE  +  R   + D ++ G +L E+
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 432 LIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS--------FDIECEIMKSIHYRNL 483
           +IG+G FG +   R     + + KV+ ++    F+         F  E +IM   +   +
Sbjct: 82  VIGRGAFGEVQLVR----HKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 137
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V++  +  ++++  +V+E+MP G L   L S+  + + + +     +V   L+ +H    
Sbjct: 138 VQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---S 192
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE----YG 599
           + +IH D+KP N+LLD      L+DFG T + + E   +     + T  YI+PE     G
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 600 REGRVFANGDVYSFGIMLMEI 620
            +G      D +S G+ L E+
Sbjct: 252 GDGYYGRECDWWSVGVFLFEM 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++ +   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKV---FHL--QCGRAFKSFDIECEIMKSIHYRNLVK 485
           +IG+G FG +   R     +V A+K+   F +  +   AF  F  E +IM   +   +V+
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +  +  ++ +  +V+E+MP G L   L S+  + + + R     +V   L+ +H    + 
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE----YGRE 601
            IH D+KP N+LLD +    L+DFG T + + ++  +     + T  YI+PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 602 GRVFANGDVYSFGIMLMEI 620
           G      D +S G+ L E+
Sbjct: 253 GYYGRECDWWSVGVFLYEM 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 33/210 (15%)
Query: 434 GKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS--IHYRNLVKIISS-- 489
            +G FG ++K+++ +   VAVK+F LQ  ++++S   E EI  +  + + NL++ I++  
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS---EREIFSTPGMKHENLLQFIAAEK 79
Query: 490 -CSNEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP-- 545
             SN E +  L+      GSL    Y    I+   +  ++   ++  L YLH +  VP  
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHED--VPWC 135
Query: 546 --------VIHCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLATIGYIAP 596
                   + H D K  NVLL   + A L+DFG+  +   G+    T  Q + T  Y+AP
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAP 194
Query: 597 EYGREGRV------FANGDVYSFGIMLMEI 620
           E   EG +      F   D+Y+ G++L E+
Sbjct: 195 EV-LEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 14/193 (7%)
Query: 433 IGKGGFGTIYKSRIGDGMEV-AVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +GKG FG +Y +R      + A+KV     L+          E EI   + + N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              + +   L+LE  P G L K L   +   D  +    M ++A  L Y H      VIH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHER---KVIH 137
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+L+       ++DFG +        S+ +     T+ Y+ PE   EG+     
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMI-EGKTHDEK 192
Query: 609 -DVYSFGIMLMEI 620
            D++  G++  E 
Sbjct: 193 VDLWCAGVLCYEF 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 9/144 (6%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVA+K+     L      K F  E  IMK +++ N+VK+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   L++E+   G +   L +   + +   R      + S ++Y H      ++H
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCHQK---RIVH 137
Query: 549 CDLKPSNVLLDDTMVAHLSDFGIT 572
            DLK  N+LLD  M   ++DFG +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFS 161

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     IG G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+MP G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 425 YGFNENNL-----IGKGGFGTIYKSR-IGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 33  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 90
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------L 519
            E +IM  +  + N+V ++ +C++     ++ E+  +G L   L               L
Sbjct: 91  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 520 DIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED 579
           ++   L+    VA  + +L        IH D+   NVLL +  VA + DFG+ + ++ + 
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
             + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     IG G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+MP G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 433 IGKGGFGTIY--------KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG +         K +  + + VAVK+       +       E E+MK I  ++N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCL-----------YSSNCILD---IFQRL-NI 527
           ++ ++ +C+ +    +++ +   G+L + L           Y  N + +    F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
              +A  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 588 LATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHS 622
              + ++APE     RV+ +  DV+SFG+++ EI +
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 425 YGFNENNL-----IGKGGFGTIYKSR-IGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 98
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCL---------YSSNCIL 519
            E +IM  +  + N+V ++ +C++     ++ E+  +G L   L         YS N   
Sbjct: 99  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 520 DIFQRL---NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI 576
           +  ++L   +++   + V + + F      IH D+   NVLL +  VA + DFG+ + ++
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            +   + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 9/144 (6%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IGKG F  +  +R I  G EVAVK+     L      K F  E  I K +++ N+VK+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E+   LV E+   G +   L +     +   R      + S ++Y H  F+V   H
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKFIV---H 136
Query: 549 CDLKPSNVLLDDTMVAHLSDFGIT 572
            DLK  N+LLD      ++DFG +
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS 160

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 485 KIISSCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            ++ +C+      +V+ E    G+L   L S       ++  ++  D  ++   + ++F 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 544 VP----------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           V            IH DL   N+LL +  V  + DFG+ + +  +   + +      + +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           +APE   +       DV+SFG++L EI S
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 24/211 (11%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV 484
           F +   +G G + T+YK      G+ VA+K   L       S  I E  +MK + + N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC----------ILDIFQRLNIMIDVASV 534
           ++      E    LV E M    L+K + S             ++  FQ          +
Sbjct: 67  RLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ--------WQL 117
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+ L F     ++H DLKP N+L++      L DFG+ +         T +  + T+ Y 
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYR 175
Query: 595 APEYGREGRVFANG-DVYSFGIMLMEIHSAK 624
           AP+     R ++   D++S G +L E+ + K
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   + +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPEYGRE 601
            + +I+ DLKP N+L+D      ++DFG  K + G      +T TL  T  Y+APE    
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEIILS 213
Query: 602 GRVFANGDVYSFGIMLMEI 620
                  D ++ G+++ E+
Sbjct: 214 KGYNKAVDWWALGVLIYEM 232

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 425 YGFNENNL-----IGKGGFGTIYKSR-IGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 98
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY-SSNCILDI-----F 522
            E +IM  +  + N+V ++ +C++     ++ E+  +G L   L   +   LD       
Sbjct: 99  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
           +  +++   + V + + F      IH D+   NVLL +  VA + DFG+ + ++ +   +
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 15/199 (7%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   + +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 144
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPEYGRE 601
            + +I+ DLKP N+L+D      ++DFG  K + G      +T TL  T  Y+APE    
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEIILS 198
Query: 602 GRVFANGDVYSFGIMLMEI 620
                  D ++ G+++ E+
Sbjct: 199 KGYNKAVDWWALGVLIYEM 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+ +  + N++  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 143
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 141
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV--- 133
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+  T    L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 192 ASDVWMFGVCMWEI 205

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+ +  + N++  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 143
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 31/226 (13%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           R    F E  ++G+G FG + K+R   D    A+K           +   E  ++ S+++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 481 -------------RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
                        RN VK +++   +    + +E+  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK-------LLIGEDQ 580
              +   L Y+H      +IH DLKP N+ +D++    + DFG+ K       +L  + Q
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 581 SM-----TQTQTLATIGYIAPEY-GREGRVFANGDVYSFGIMLMEI 620
           ++       T  + T  Y+A E     G      D+YS GI+  E+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 141
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 141
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 29/206 (14%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           F + + IGKG FG +YK       EV           A K  D+E    +    +  + +
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVV----------AIKIIDLEEAEDEIEDIQQEITV 70
Query: 487 ISSCSNEEFKE------------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
           +S C +                 +++E++  GS    L      L+      I+ ++   
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKG 128
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           L+YLH       IH D+K +NVLL +     L+DFG+   L   D  + +   + T  ++
Sbjct: 129 LDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWM 183
Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           APE  ++       D++S GI  +E+
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIEL 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E + H  L K    ++ +  I   L I   +  +L+ L F   
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDL-KDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 180 YYSTAVDIWSLGCIFAEM 197

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 29/180 (16%)
Query: 451 EVAVKVFHLQCGRAFKSFDI---------ECEIMKSIH-YRNLVKIISSCSNEEFKELVL 500
           E AVK+  +  G +F + ++         E +I++ +  + N++++  +     F  LV 
Sbjct: 31  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 90
Query: 501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD 560
           + M  G L   L +    L   +   IM  +  V+  LH    + ++H DLKP N+LLDD
Sbjct: 91  DLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 146
Query: 561 TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------------YGREGRVFANG 608
            M   L+DFG +  L   D      +   T  Y+APE            YG+E  +++ G
Sbjct: 147 DMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 203

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 87/191 (45%), Gaps = 12/191 (6%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +  ++  G E A  + + +    R  +  + E  I + + + N+V++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
            S E    L+ + +  G L    +      + +   +    +  +LE +     + V+H 
Sbjct: 79  ISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 550 DLKPSNVLLDDTM---VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +LKP N+LL   +      L+DFG+   + GE Q+        T GY++PE  R+     
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 192
Query: 607 NGDVYSFGIML 617
             D+++ G++L
Sbjct: 193 PVDLWACGVIL 203

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTI-YKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +   +    G +VAVK   L+  +  +    E  IM+  H+ N+V + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L YLH      VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDI 167
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  ++LL       LSDFG    +  E     +   + T  ++APE           D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 612 SFGIMLMEI 620
           S GIM++E+
Sbjct: 226 SLGIMVIEM 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 149
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 141
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +    ++GKG FG +   K +I  G E AVKV     ++     +S   E +++K + + 
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+H N
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN 151
Query: 542 FLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
               ++H DLKP N+LL+         + DFG++      + S      + T  YIAPE 
Sbjct: 152 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV 205
Query: 599 GREGRVFANGDVYSFGIML 617
              G      DV+S G++L
Sbjct: 206 -LHGTYDEKCDVWSTGVIL 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 139
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 146
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 147
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 138
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +    ++GKG FG +   K +I  G E AVKV     ++     +S   E +++K + + 
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+H N
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN 169
Query: 542 FLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
               ++H DLKP N+LL+         + DFG++      + S      + T  YIAPE 
Sbjct: 170 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV 223
Query: 599 GREGRVFANGDVYSFGIML 617
              G      DV+S G++L
Sbjct: 224 -LHGTYDEKCDVWSTGVIL 241

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 141
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 434 GKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS---- 489
            +G FG ++K+++ +   VAVK+F +Q  +++++ + E   +  + + N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF------L 543
            S +    L+      GSL   L ++  ++   +  +I   +A  L YLH +        
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 544 VPVI-HCDLKPSNVLLDDTMVAHLSDFGIT-KLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
            P I H D+K  NVLL + + A ++DFG+  K   G+    T  Q + T  Y+APE   E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEV-LE 206
Query: 602 GRV------FANGDVYSFGIMLMEIHS 622
           G +      F   D+Y+ G++L E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 143
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV--- 513
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+  T    L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 572 ASDVWMFGVCMWEI 585

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 139
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 106
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 161
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +    ++GKG FG +   K +I  G E AVKV     ++     +S   E +++K + + 
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+H N
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN 168
Query: 542 FLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
               ++H DLKP N+LL+         + DFG++      + S      + T  YIAPE 
Sbjct: 169 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV 222
Query: 599 GREGRVFANGDVYSFGIML 617
              G      DV+S G++L
Sbjct: 223 -LHGTYDEKCDVWSTGVIL 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEK---CLYSSNCILDIFQRLNIMIDVASVLEYLH 539
             II + + E+ K++ +++ +    L K   C + SN  +  F     +  +   L+Y+H
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-----LYQILRGLKYIH 145
Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEY 598
                 V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE 
Sbjct: 146 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 599 GREGRVFANG-DVYSFGIMLMEIHSAK 624
               + +    D++S G +L E+ S +
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   + +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV--- 133
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 192 ASDVWMFGVCMWEI 205

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 206
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 207 GYNKAVDWWALGVLIYEM 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   + +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIISS- 489
           +GKG +G +++  +  G  VAVK+F     R  +S+  E EI  ++  R  N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 490 -CSNEEFKELVL--EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL--- 543
             S     +L L   +  HGSL   L      L+    L + +  A  L +LH       
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 544 -VPVI-HCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQ-SMTQTQTLATIGYIAPEYG 599
             P I H D K  NVL+   +   ++D G+  +   G D   +     + T  Y+APE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 600 REG------RVFANGDVYSFGIMLMEI 620
            E         +   D+++FG++L EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 17/199 (8%)
Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +    ++GKG FG +   K +I  G E AVKV     ++     +S   E +++K + + 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N++K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+H N
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMHKN 145
Query: 542 FLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
               ++H DLKP N+LL+         + DFG++      + S      + T  YIAPE 
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEV 199
Query: 599 GREGRVFANGDVYSFGIML 617
              G      DV+S G++L
Sbjct: 200 -LHGTYDEKCDVWSTGVIL 217

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     IG G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 30/163 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIML 617
             M   +TL  T  Y+APE     G  G   A  D +S G++L
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 209

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 30/164 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 247 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 295
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIMLM 618
             M   +TL  T  Y+APE     G  G   A  D +S G++L 
Sbjct: 296 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 335

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 30/163 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 128 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 176
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIML 617
             M   +TL  T  Y+APE     G  G   A  D +S G++L
Sbjct: 177 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 215

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 30/164 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 261 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 309
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIMLM 618
             M   +TL  T  Y+APE     G  G   A  D +S G++L 
Sbjct: 310 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 349

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 30/163 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIML 617
             M   +TL  T  Y+APE     G  G   A  D +S G++L
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 209

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 30/163 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 121 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 169
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIML 617
             M   +TL  T  Y+APE     G  G   A  D +S G++L
Sbjct: 170 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 208

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 30/163 (18%)
Query: 469 DIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL------EKCLYSSNCILDIF 522
           + E EI+K +++  ++KI +    E++  +VLE M  G L       K L  + C L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED 579
           Q L         ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GET 170
Query: 580 QSMTQTQTL-ATIGYIAPE----YGREGRVFANGDVYSFGIML 617
             M   +TL  T  Y+APE     G  G   A  D +S G++L
Sbjct: 171 SLM---RTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 209

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 431 NLIGKGGFGTIYKSRIGDG--------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN 482
            ++GKGG+G +++ R   G        M+V  K   ++  +       E  I++ + +  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           +V +I +        L+LE++  G L   L      ++       + +++  L +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLHQK- 140
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGRE 601
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T T    TI Y+APE   R 
Sbjct: 141 --GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAPEILMRS 196
Query: 602 GRVFANGDVYSFGIMLMEI 620
           G   A  D +S G ++ ++
Sbjct: 197 GHNRAV-DWWSLGALMYDM 214

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEV----AVKVFHLQCGRAFKSFDIECEIMKS 477
           R    +     +GKGGF   Y+    D  EV     V    L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           +   ++V       +++F  +VLE     SL +       + +   R  +   +  V +Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV-QY 157
Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAP 596
           LH N    VIH DLK  N+ L+D M   + DFG+ TK+    ++  T      T  YIAP
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAP 211
Query: 597 EY-GREGRVFANGDVYSFGIML 617
           E   ++G  F   D++S G +L
Sbjct: 212 EVLCKKGHSF-EVDIWSLGCIL 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA++    F  Q  C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE    
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 133
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 192 ASDVWMFGVCMWEI 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E +   S++   +     L       I   +  +L+ L F   
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 183 YYSTAVDIWSLGCIFAEM 200

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   + +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 151
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 206
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 207 GYNKAVDWWALGVLIYEM 224

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 230
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 231 -ILSKGYNKAVDWWALGVLIYEM 252

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 432 LIGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKII 487
           ++GKG FG + K   RI    E AVKV +    +   +  I  E E++K + + N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLEYL 538
                      +LE      +   LY+   + D I +R          I+  V S + Y+
Sbjct: 88  E----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H +    ++H DLKP N+LL+         + DFG++       Q+      + T  YIA
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 596 PEYGREGRVFANGDVYSFGIML 617
           PE  R G      DV+S G++L
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVIL 212

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 12/201 (5%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEV----AVKVFHLQCGRAFKSFDIECEIMKS 477
           R    +     +GKGGF   Y+    D  EV     V    L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           +   ++V       +++F  +VLE     SL +       + +   R  +   +  V +Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV-QY 157
Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LH N    VIH DLK  N+ L+D M   + DFG+   +  E     +     T  YIAPE
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 212
Query: 598 Y-GREGRVFANGDVYSFGIML 617
              ++G  F   D++S G +L
Sbjct: 213 VLCKKGHSF-EVDIWSLGCIL 232

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 9/198 (4%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E +   S++   +     L       I   +  +L+ L F   
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
             V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     +
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 604 VFANG-DVYSFGIMLMEI 620
            ++   D++S G +  E+
Sbjct: 181 YYSTAVDIWSLGCIFAEM 198

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLE-KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           VK++     E    LV E +   S++ K    ++ +  I   L I   +  +L+ L F  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCH 123
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 603 RVFANG-DVYSFGIMLMEI 620
           + ++   D++S G +  E+
Sbjct: 182 KYYSTAVDIWSLGCIFAEM 200

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 12/201 (5%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEV----AVKVFHLQCGRAFKSFDIECEIMKS 477
           R    +     +GKGGF   Y+    D  EV     V    L      +    E  I KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           +   ++V       +++F  +VLE     SL +       + +   R  +   +  V +Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV-QY 141
Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LH N    VIH DLK  N+ L+D M   + DFG+   +  E     +     T  YIAPE
Sbjct: 142 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 196
Query: 598 Y-GREGRVFANGDVYSFGIML 617
              ++G  F   D++S G +L
Sbjct: 197 VLCKKGHSF-EVDIWSLGCIL 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 8/189 (4%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  +R    G +VAVK+  L+  +  +    E  IM+   + N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             E   +++E +  G+L   +  S   L+  Q   +   V   L YLH      VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
           K  ++LL       LSDFG     I +D    +   + T  ++APE           D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCA-QISKDVP-KRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 612 SFGIMLMEI 620
           S GIM++E+
Sbjct: 226 SLGIMVIEM 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/195 (20%), Positives = 87/195 (44%), Gaps = 9/195 (4%)
Query: 425 YGFNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL 483
           Y  ++  ++G G FG ++K      G+++A K+   +  +  +    E  +M  + + NL
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           +++  +  ++    LV+E++  G L   +   +  L     +  M  +   + ++H  + 
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY- 207
Query: 544 VPVIHCDLKPSNVLL--DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
             ++H DLKP N+L    D     + DFG+ +     ++         T  ++APE    
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNY 262
Query: 602 GRVFANGDVYSFGIM 616
             V    D++S G++
Sbjct: 263 DFVSFPTDMWSVGVI 277

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDI-ECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L        S  I E  ++K +++ N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 484 VKIISSCSNEEFKELVLEHMPHGSLE-KCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           VK++     E    LV E +   S++ K    ++ +  I   L I   +  +L+ L F  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCH 122
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              V+H DLKP N+L++      L+DFG+ +         T    + T+ Y APE     
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 603 RVFANG-DVYSFGIMLMEI 620
           + ++   D++S G +  E+
Sbjct: 181 KYYSTAVDIWSLGCIFAEM 199

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIH 479
           R    F     +G+GGFG +++++   D    A+K   L     A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSLE-----------KCLYSSNCILDIFQR---L 525
           +  +V+  ++   +   E +    P   L            K   +  C ++  +R   L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 526 NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT-- 583
           +I + +A  +E+LH   L   +H DLKPSN+      V  + DFG+   +  +++  T  
Sbjct: 122 HIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 584 --------QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                    T  + T  Y++PE           D++S G++L E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 433 IGKGGFGTI---YKSRIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNL 483
           +G G +G++   Y +R+    +VAVK    +  R F+S         E  ++K + + N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 484 VKIIS----SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           + ++     + S E+F E+ L     G+    +  S  + D     ++   V  +L  L 
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD----EHVQFLVYQLLRGLK 145
Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
           +     +IH DLKPSNV +++     + DFG+ +     D+ MT        GY+A  + 
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWY 194
Query: 600 REGRVFANG-------DVYSFGIMLMEIHSAK 624
           R   +  N        D++S G ++ E+   K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 39/207 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  S  +  G+++AVK    +  R F+S         E  ++K + + N++ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 114
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 115 LLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 172
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 173 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 218
Query: 601 EGRVFANG-------DVYSFGIMLMEI 620
              +  N        D++S G ++ E+
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAEL 245

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 12/201 (5%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEV----AVKVFHLQCGRAFKSFDIECEIMKS 477
           R    +     +GKGGF   Y+    D  EV     V    L      +    E  I KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           +   ++V       +++F  +VLE     SL +       + +   R  +   +  V +Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGV-QY 157
Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LH N    VIH DLK  N+ L+D M   + DFG+   +  E     +     T  YIAPE
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPE 212
Query: 598 Y-GREGRVFANGDVYSFGIML 617
              ++G  F   D++S G +L
Sbjct: 213 VLCKKGHSF-EVDIWSLGCIL 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 427 FNENNLIGKGGFGTIY--KSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYR 481
           +    ++GKG FG +   K +I  G E AVKV     ++     +S   E +++K + + 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N+ K+     ++ +  LV E    G L   + S     ++     I+  V S + Y H N
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYXHKN 145
Query: 542 FLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
               ++H DLKP N+LL+         + DFG++      + S      + T  YIAPE 
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIAPEV 199
Query: 599 GREGRVFANGDVYSFGIML 617
              G      DV+S G++L
Sbjct: 200 -LHGTYDEKCDVWSTGVIL 217

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 430 NNLIGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            N IG+G +G +       +RI    +   K F     R    F  E EIMKS+ + N++
Sbjct: 31  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNII 86
Query: 485 KIISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           ++  +  +     LV+E    G L E+ ++    +        IM DV S + Y H    
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---K 141
Query: 544 VPVIHCDLKPSNVL-LDDTMVAHLS--DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
           + V H DLKP N L L D+  + L   DFG+      +   M +T+ + T  Y++P+   
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-L 197
Query: 601 EGRVFANGDVYSFGIML 617
           EG      D +S G+M+
Sbjct: 198 EGLYGPECDEWSAGVMM 214

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 22/197 (11%)
Query: 430 NNLIGKGGFGTIY-----KSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            N IG+G +G +       +RI    +   K F     R    F  E EIMKS+ + N++
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNII 69
Query: 485 KIISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           ++  +  +     LV+E    G L E+ ++    +        IM DV S + Y H    
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---K 124
Query: 544 VPVIHCDLKPSNVL-LDDTMVAHLS--DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
           + V H DLKP N L L D+  + L   DFG+      +   M +T+ + T  Y++P+   
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQV-L 180
Query: 601 EGRVFANGDVYSFGIML 617
           EG      D +S G+M+
Sbjct: 181 EGLYGPECDEWSAGVMM 197

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 25/212 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGDGME---VAVKV---FHLQ--CGRAFKSFDIECEIMKSI 478
           + +   IG+G +G +  S   D +    VA+K    F  Q  C R  +    E +I+   
Sbjct: 45  YTQLQYIGEGAYGMV--SSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRF 98
Query: 479 HYRNLV---KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
            + N++    I+ + + E  +++ +++ +    L K L S     D     +I   +  +
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSND-----HICYFLYQI 153
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGY 593
           L  L +     V+H DLKPSN+L++ T    + DFG+ ++   E D +   T+ +AT  Y
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 594 IAPEYGREGRVFANG-DVYSFGIMLMEIHSAK 624
            APE     + +    D++S G +L E+ S +
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV--- 513
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 572 ASDVWMFGVCMWEI 585

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG+ K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   + S     D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +    + +AT  Y APE    
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKV---FHLQ--CGRAFKSFDIECEIMKSIHYRNLV-- 484
           IG+G +G +  +    + + VA+K    F  Q  C R  +    E +I+    + N++  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 485 -KIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             II + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +  
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIH 146
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGRE 601
              V+H DLKPSN+LL+ T    + DFG+ ++   + D +    + +AT  Y APE    
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            + +    D++S G +L E+ S +
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 485 KIISSCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            ++ +C+      +V+ E    G+L   L S       ++  ++  D  ++   + ++F 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--DLYKDFLTLEHLIXYSFQ 152
Query: 544 VP----------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           V            IH DL   N+LL +  V  + DFG+ + +  +   + +      + +
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           +APE   +       DV+SFG++L EI S
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL------VK 485
           +G+G FG +  +     G +VA+K+ +    +     D++  I + I Y  L      +K
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLE 536
           +     +++   +V+E           Y+ N + D I QR              + S +E
Sbjct: 78  LYDVIKSKDEIIMVIE-----------YAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           Y H +    ++H DLKP N+LLD+ +   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 127 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 180
Query: 597 EYGREGRVFANG--DVYSFGIML 617
           E    G+++A    DV+S G++L
Sbjct: 181 EV-ISGKLYAGPEVDVWSCGVIL 202

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL------VK 485
           +G+G FG +  +     G +VA+K+ +    +     D++  I + I Y  L      +K
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLE 536
           +     +++   +V+E           Y+ N + D I QR              + S +E
Sbjct: 79  LYDVIKSKDEIIMVIE-----------YAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           Y H +    ++H DLKP N+LLD+ +   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 128 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 181
Query: 597 EYGREGRVFANG--DVYSFGIML 617
           E    G+++A    DV+S G++L
Sbjct: 182 EV-ISGKLYAGPEVDVWSCGVIL 203

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I +++++  
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +VLE+ P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 210
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 211 -ILSKGYNKAVDWWALGVLIYEM 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK-----VFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G +G + K R +  G  +AVK     V   +  R     DI    M+++     V  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------NIMIDVASVLEYLHF 540
             +   E    + +E M   SL+K  Y    ++D  Q +       I + +   LE+LH 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-- 598
              + VIH D+KPSNVL++      + DFGI+  L+    S+ +T       Y+APE   
Sbjct: 172 K--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 226
Query: 599 ---GREGRVFANGDVYSFGIMLMEI 620
               ++G      D++S GI ++E+
Sbjct: 227 PELNQKG-YSVKSDIWSLGITMIEL 250

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL------VK 485
           +G+G FG +  +     G +VA+K+ +    +     D++  I + I Y  L      +K
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLE 536
           +     +++   +V+E           Y+ N + D I QR              + S +E
Sbjct: 69  LYDVIKSKDEIIMVIE-----------YAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 117
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           Y H +    ++H DLKP N+LLD+ +   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 118 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 171
Query: 597 EYGREGRVFANG--DVYSFGIML 617
           E    G+++A    DV+S G++L
Sbjct: 172 EV-ISGKLYAGPEVDVWSCGVIL 193

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 432 LIGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKII 487
           ++GKG FG + K   RI    E AVKV +    +   +  I  E E++K + + N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLEYL 538
                      +LE      +   LY+   + D I +R          I+  V S + Y+
Sbjct: 88  E----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H +    ++H DLKP N+LL+         + DFG++       Q+      + T  YIA
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 596 PEYGREGRVFANGDVYSFGIML 617
           PE  R G      DV+S G++L
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVIL 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG+ K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 161
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 220 ASDVWMFGVCMWEI 233

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           IG G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 148
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 149 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT--------GYVATRWYR 194
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL------VK 485
           +G+G FG +  +     G +VA+K+ +    +     D++  I + I Y  L      +K
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIIN---KKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLE 536
           +     +++   +V+E           Y+ N + D I QR              + S +E
Sbjct: 73  LYDVIKSKDEIIMVIE-----------YAGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           Y H +    ++H DLKP N+LLD+ +   ++DFG++ ++   D +  +T +  +  Y AP
Sbjct: 122 YCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP 175
Query: 597 EYGREGRVFANG--DVYSFGIML 617
           E    G+++A    DV+S G++L
Sbjct: 176 EV-ISGKLYAGPEVDVWSCGVIL 197

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 432 LIGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKII 487
           ++GKG FG + K   RI    E AVKV +    +   +  I  E E++K + + N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-IFQR--------LNIMIDVASVLEYL 538
                      +LE      +   LY+   + D I +R          I+  V S + Y+
Sbjct: 88  E----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVA---HLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H +    ++H DLKP N+LL+         + DFG++       Q+      + T  YIA
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 596 PEYGREGRVFANGDVYSFGIML 617
           PE  R G      DV+S G++L
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVIL 212

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 133
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 192 ASDVWMFGVCMWEI 205

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 138
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 197 ASDVWMFGVCMWEI 210

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN------LVKI 486
           IGKG +G ++  +   G +VAVKVF         S+  E EI +++  R+      +   
Sbjct: 45  IGKGRYGEVWMGK-WRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV-- 544
           I    +     L+ ++  +GSL   L S+   LD    L +     S L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 545 --PVI-HCDLKPSNVLLDDTMVAHLSDFGITKLLIGE--DQSMTQTQTLATIGYIAPEYG 599
             P I H DLK  N+L+       ++D G+    I +  +  +     + T  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 600 REG------RVFANGDVYSFGIMLMEIHSAKQQCVS 629
            E       + +   D+YSFG++L E+    ++CVS
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV---ARRCVS 251

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 47/220 (21%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDI---------ECEIMKSIHYRN 482
           IG G +G +  +R    G +VA+K       +   +FD+         E +I+K   + N
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR-LNIMIDVASVLEYLHFN 541
           ++ I         K+++   +P+G   K +Y    +LD+ +  L+ +I  +  L   H  
Sbjct: 116 IIAI---------KDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVR 162
Query: 542 FLV-------------PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE--DQSMTQTQ 586
           + +              VIH DLKPSN+L+++     + DFG+ + L     +     T+
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 222
Query: 587 TLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHSAKQ 625
            +AT  Y APE       +    D++S G +  E+ + +Q
Sbjct: 223 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLV---KII 487
           IG+G +G +  +    + + VA+K       + +    + E +I+    + N++    II
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 488 SSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
            + + E+ K++ +++ +    L K L + +   D     +I   +  +L  L +     V
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSANV 149
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE-DQSMTQTQTLATIGYIAPEYGREGRVF 605
           +H DLKPSN+LL+ T    + DFG+ ++   + D +   T+ +AT  Y APE     + +
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 606 ANG-DVYSFGIMLMEIHSAK 624
               D++S G +L E+ S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 136
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 195 ASDVWMFGVCMWEI 208

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGRE 601
            + +I+ DLKP N+L+D      ++DFG  K + G      +T  LA T  Y+APE    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEI--- 209
Query: 602 GRVFANG-----DVYSFGIMLMEI 620
             + + G     D ++ G+++ E+
Sbjct: 210 --ILSKGYNKAVDWWALGVLIYEM 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 135
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 194 ASDVWMFGVCMWEI 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF-HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K   +       + F  E   M+   + ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              + E    +++E    G L   L      LD+   +     +++ L YL     V   
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV--- 130
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+   NVL+       L DFG+++ +  ED +  + ++    I ++APE     R  +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 607 NGDVYSFGIMLMEI 620
             DV+ FG+ + EI
Sbjct: 189 ASDVWMFGVCMWEI 202

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 431 NLIGKGGFGTIYKSRIGDG--------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN 482
            ++GKGG+G +++ R   G        M+V  K   ++  +       E  I++ + +  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           +V +I +        L+LE++  G L   L      ++       + +++  L +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLHQK- 140
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGRE 601
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T      TI Y+APE   R 
Sbjct: 141 --GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAPEILMRS 196
Query: 602 GRVFANGDVYSFGIMLMEI 620
           G   A  D +S G ++ ++
Sbjct: 197 GHNRAV-DWWSLGALMYDM 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 31/225 (13%)
Query: 422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
           R    F E  ++G+G FG + K+R   D    A+K           +   E  ++ S+++
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 481 -------------RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
                        RN VK  ++   +    +  E+  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK-------LLIGEDQ 580
              +   L Y+H      +IH +LKP N+ +D++    + DFG+ K       +L  + Q
Sbjct: 122 FRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 581 SM-----TQTQTLATIGYIAPEY-GREGRVFANGDVYSFGIMLME 619
           ++       T  + T  Y+A E     G      D YS GI+  E
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 47/220 (21%)
Query: 433 IGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDI---------ECEIMKSIHYRN 482
           IG G +G +  +R    G +VA+K       +   +FD+         E +I+K   + N
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR-LNIMIDVASVLEYLHFN 541
           ++ I         K+++   +P+G   K +Y    +LD+ +  L+ +I  +  L   H  
Sbjct: 115 IIAI---------KDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVR 161
Query: 542 FLV-------------PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE--DQSMTQTQ 586
           + +              VIH DLKPSN+L+++     + DFG+ + L     +     T+
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 221
Query: 587 TLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHSAKQ 625
            +AT  Y APE       +    D++S G +  E+ + +Q
Sbjct: 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 425 YGFNENNL-----IGKGGFGTIYKS-RIGDGME-----VAVKVF----HLQCGRAFKSFD 469
           + F  NNL     +G G FG + ++   G G E     VAVK+     H     A  S  
Sbjct: 26  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-- 83
Query: 470 IECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSL-------------------- 508
            E +IM  +  + N+V ++ +C++     ++ E+  +G L                    
Sbjct: 84  -ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 509 --EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL 566
             E         L++   L+    VA  + +L        IH D+   NVLL +  VA +
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKI 199
Query: 567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            DFG+ + ++ +   + +      + ++APE   +       DV+S+GI+L EI S
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 148
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 149 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT--------GYVATRWYR 194
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 210
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 211 -ILSKGYNKAVDWWALGVLIYEM 232

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 406 MPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRA 464
           MP      R+   E  R  Y F   +++G G F  +  +      + VA+K    +    
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 58
Query: 465 FK-SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCI 518
            + S + E  ++  I + N+V +     +     L+++ +  G L     EK  Y+    
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER-- 116
Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL---LDDTMVAHLSDFGITKLL 575
                   ++  V   ++YLH    + ++H DLKP N+L   LD+     +SDFG++K+ 
Sbjct: 117 ----DASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM- 168
Query: 576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
             ED     +    T GY+APE   +       D +S G++
Sbjct: 169 --EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 179
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 230
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 231 -ILSKGYNKAVDWWALGVLIYEM 252

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 145
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D+     ++DFG  K + G    +       T  Y+APE     
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 200
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 201 GYNKAVDWWALGVLIYEM 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 154
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 155 ---ADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMT--------GYVATRWYR 200
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 25/204 (12%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 179
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPEYGRE 601
            + +I+ DLKP N+L+D      ++DFG  K + G       T TL  T  Y+APE    
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEI--- 230
Query: 602 GRVFANG-----DVYSFGIMLMEI 620
             + + G     D ++ G+++ E+
Sbjct: 231 --ILSKGYNKAVDWWALGVLIYEM 252

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 13  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 127
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 188 DVWSCGIVL 196

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 139
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 185
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 83
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 84  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 141
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 142 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 187
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 153
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 208
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 209 GYNKAVDWWALGVLIYEM 226

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G +G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 15  LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 129
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 190 DVWSCGIVL 198

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 140
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 141 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 186
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 485 KIISSCSNEEFKELVL-EHMPHGSLEKCLYSSNC-------ILDIFQRLNIMI----DVA 532
            ++ +C+      +V+ E    G+L   L S          +   F  L  +I     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
             +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +      + 
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 593 YIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           ++APE   +       DV+SFG++L EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 87/193 (45%), Gaps = 15/193 (7%)
Query: 433 IGKGGFGTIY--KSRIGDGMEVAVKVFHLQCGRAFKSFD---IECEIMKSIHYRNLVKII 487
           +G G FG ++  +SR  +G   A+KV   +     K  +    E  ++  + +  ++++ 
Sbjct: 14  LGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            +  + +   ++++++  G L   L  S    +   +     +V   LEYLH      +I
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSK---DII 128
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           + DLKP N+LLD      ++DFG  K +      +       T  YIAPE         +
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKS 183
Query: 608 GDVYSFGIMLMEI 620
            D +SFGI++ E+
Sbjct: 184 IDWWSFGILIYEM 196

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 148
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 149 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 194
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 196
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 83  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 140
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 141 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 186
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMT--------GYVATRWYR 195
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F   + +G+G    +Y+  + G     A+KV      +  K    E  ++  + + N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 486 IISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           +           LVLE +  G L     EK  YS     D  ++      +   + YLH 
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLHE 166
Query: 541 NFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           N    ++H DLKP N+L           ++DFG++K++  E Q + +T    T GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPE 220
Query: 598 YGREGRVFANGDVYSFGIM 616
             R        D++S GI+
Sbjct: 221 ILRGCAYGPEVDMWSVGII 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 145
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 146 ---ADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMT--------GYVATRWYR 191
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 91  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 148
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 149 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 194
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 84
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 85  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 142
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 143 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 188
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 145
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 146 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 191
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 145
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 146 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 191
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 88  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 145
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 146 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 191
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 431 NLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
            ++GKG FG +  +R+ + G   AVKV  L+     +  D+EC + +        +I+S 
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEK-------RILSL 79
Query: 490 CSNEEFKE-------------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLE 536
             N  F                V+E +  G L   +  S    +   R     ++ S L 
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALM 138
Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           +LH      +I+ DLK  NVLLD      L+DFG+ K  I     +T      T  YIAP
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAP 193
Query: 597 EYGREGRVFANGDVYSFGIMLMEI 620
           E  +E       D ++ G++L E+
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEM 217

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 162
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 163 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 208
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 41/212 (19%)
Query: 433 IGKGGFGTI---YKSRIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNL 483
           +G G +G++   Y +R+    +VAVK    +  R F+S         E  ++K + + N+
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 484 VKIIS----SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           + ++     + S E+F E+ L     G+    +     + D     ++   V  +L  L 
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD----EHVQFLVYQLLRGLK 145
Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
           +     +IH DLKPSNV +++     + DFG+ +     D+ MT        GY+A  + 
Sbjct: 146 YIHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWY 194
Query: 600 REGRVFANG-------DVYSFGIMLMEIHSAK 624
           R   +  N        D++S G ++ E+   K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 166
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 167 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 212
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 155
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 156 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 201
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 155
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 156 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 201
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 163
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 164 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 209
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           L K+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           V+H DLKP+NV LD      L DFG+ ++L   D S  +T  + T  Y++PE        
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-FVGTPYYMSPEQMNRMSYN 194
Query: 606 ANGDVYSFGIMLMEI 620
              D++S G +L E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 75/171 (43%), Gaps = 5/171 (2%)
Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
           N+    +  D+    +S    +    LT L  +YL  NKL        +EL+ L+ + + 
Sbjct: 34  NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93
Query: 177 DNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI 234
           DNKL+  +P  +F +LV L +L L  N+L       F +L  L  LSL YN+   LP  +
Sbjct: 94  DNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGV 152
Query: 235 -GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD 284
              L  L  +    N    V       L +L+ L L  N LK  +P+   D
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFD 202

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 97  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 154
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 155 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 200
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFH------LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK         +   R ++    E  ++K + + N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 98  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 155
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 156 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 201
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 195
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 41/212 (19%)
Query: 433 IGKGGFGTI---YKSRIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNL 483
           +G G +G++   Y +R+    +VAVK    +  R F+S         E  ++K + + N+
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 484 VKIIS----SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           + ++     + S E+F E+ L     G+    +     + D     ++   V  +L  L 
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD----EHVQFLVYQLLRGLK 137
Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
           +     +IH DLKPSNV +++     + DFG+ +     D+ MT        GY+A  + 
Sbjct: 138 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATRWY 186
Query: 600 REGRVFANG-------DVYSFGIMLMEIHSAK 624
           R   +  N        D++S G ++ E+   K
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFK-SFDIE 471
           R+   E  R  Y F   +++G G F  +  +      + VA+K    +     + S + E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLN 526
             ++  I + N+V +     +     L+++ +  G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVL---LDDTMVAHLSDFGITKLLIGEDQSMT 583
           ++  V   ++YLH    + ++H DLKP N+L   LD+     +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
            +    T GY+APE   +       D +S G++
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 22/204 (10%)
Query: 431 NLIGKGGFGTIYKSRIGDG--------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN 482
            ++G G +G ++  R   G        M+V  K   +Q  +  +    E ++++ I    
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 483 LVKIISSCSNEEFK-ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEYL 538
            +  +      E K  L+L+++  G L    ++     + F    + I V  +   LE+L
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY 598
           H    + +I+ D+K  N+LLD      L+DFG++K  +  D++        TI Y+AP+ 
Sbjct: 176 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDI 231
Query: 599 GREGRVFANG--DVYSFGIMLMEI 620
            R G    +   D +S G+++ E+
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYEL 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKD--FLTLEHLIC 154
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 155 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 485 KIISSCSNEEFKELVL-EHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNF 542
            ++ +C+      +V+ E    G+L   L S  N  +      ++  D  ++   + ++F
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 543 LVP----------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
            V            IH DL   N+LL +  V  + DFG+ + +  +   + +      + 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 593 YIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           ++APE   +       DV+SFG++L EI S
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GR 600
           VIH D+KPSN+LLD+     L DFGI+  L+ +D++  ++   A   Y+APE        
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAA--YMAPERIDPPDPT 202
Query: 601 EGRVFANGDVYSFGIMLMEIHSAK 624
           +       DV+S GI L+E+ + +
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 96/195 (49%), Gaps = 23/195 (11%)
Query: 433 IGKGGFGTI-----YKSRIGDGMEVAVKVFHLQC-GRAFKSFDIECEI--MKSIHYRNLV 484
           +G+G FG +     YK++     +VA+K    Q   ++     +E EI  +K + + +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+    +      +V+E+      +  +       D  +R    I  A  +EY H +   
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHRH--- 127
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            ++H DLKP N+LLDD +   ++DFG++ ++   D +  +T +  +  Y APE    G++
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEVI-NGKL 183
Query: 605 FANG--DVYSFGIML 617
           +A    DV+S GI+L
Sbjct: 184 YAGPEVDVWSCGIVL 198

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFK-SFDIE 471
           R+   E  R  Y F   +++G G F  +  +      + VA+K    +     + S + E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLN 526
             ++  I + N+V +     +     L+++ +  G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVL---LDDTMVAHLSDFGITKLLIGEDQSMT 583
           ++  V   ++YLH    + ++H DLKP N+L   LD+     +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
            +    T GY+APE   +       D +S G++
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 39/207 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 195
Query: 601 EGRVFANG-------DVYSFGIMLMEI 620
              +  N        D++S G ++ E+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           E  ++KS+ + N++K+     ++++  LV E    G L + + + +   D     NIM  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQ 154
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQT 587
           + S + YLH +    ++H D+KP N+LL++    +   + DFG++       +       
Sbjct: 155 ILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDR 208
Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIML 617
           L T  YIAPE  ++ +     DV+S G+++
Sbjct: 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIM 237

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGME-VAVKVFHLQCGRAFK-SFDIE 471
           R+   E  R  Y F   +++G G F  +  +      + VA+K    +     + S + E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 472 CEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLN 526
             ++  I + N+V +     +     L+++ +  G L     EK  Y+            
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASR 120
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVL---LDDTMVAHLSDFGITKLLIGEDQSMT 583
           ++  V   ++YLH    + ++H DLKP N+L   LD+     +SDFG++K+   ED    
Sbjct: 121 LIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
            +    T GY+APE   +       D +S G++
Sbjct: 175 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           L K+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 82/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           L K+  S  +     +V+E+ P G +   L       +   R      +    EYLH   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 159
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 214
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 215 GYNKAVDWWALGVLIYEM 232

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 25/234 (10%)
Query: 49  IFDVSTLKDLALQDNYLSGSLSSIAD----------NYLTSSTPELSFLSSLSNCKSLVV 98
           I D+  LK+L    N L  S ++I+D            L+ S+ +++ L  L+N  +L  
Sbjct: 119 ITDIDPLKNLT-NLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKPLANLTTLER 177
Query: 99  FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
             +S+N ++ I     + NL    E    +   +S   P  +G LTNL  + L GN+L  
Sbjct: 178 LDISSNKVSDISVLAKLTNL----ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 231
Query: 159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASL 218
               TL  L  L  + L +N++    P  +  L KL +L LG N++S   ++  + L +L
Sbjct: 232 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 285
Query: 219 RTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
             L L+ N       I NLK L  +    NN S + P  + SL  LQ LF   N
Sbjct: 286 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNN 337

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/226 (22%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 405 NMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--G 462
           N    ++W++ +  E  +  + F E   +G G F  +  +      +   K+F ++C   
Sbjct: 6   NGESSSSWKKQA--EDIKKIFEFKET--LGTGAFSEVVLAE----EKATGKLFAVKCIPK 57
Query: 463 RAFK----SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLY 513
           +A K    S + E  +++ I + N+V +     +     LV++ +  G L     EK  Y
Sbjct: 58  KALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 514 SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFG 570
           +      + ++         VL+ +++   + ++H DLKP N+L    D+     +SDFG
Sbjct: 118 TEKDASTLIRQ---------VLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFG 168
Query: 571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIM 616
           ++K+   E +    +    T GY+APE   +       D +S G++
Sbjct: 169 LSKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 140 IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLD 198
           I  L N+  + LGGNKL+      L+EL  L Y+ L  N+L+ ++P  +F +L  L +L 
Sbjct: 59  IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELV 115
Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSVIPT 256
           L  N+L       F  L +L  L+L++N    LP  +   L  L  +D S N   S+   
Sbjct: 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG 175
Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGD 284
               L  L+ L L  N LK S+PD V D
Sbjct: 176 VFDKLTQLKDLRLYQNQLK-SVPDGVFD 202

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 433 IGKGGFGTIYK--SRIGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           +G+G + T+YK  S++ D + VA+K   L+         I E  ++K + + N+V +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 490 CSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              E+   LV E+     L+K L  Y  +C  +I    N+ + +  +L  L +     V+
Sbjct: 69  IHTEKSLTLVFEY-----LDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITK 573
           H DLKP N+L+++     L+DFG+ +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +  +    D  Q L  +  +   L+Y+H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIHS 139
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 185
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 189
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 190 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +  T          PEY    
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT----------PEYLAPA 208
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEM 231

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 152
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 13/198 (6%)
Query: 427 FNENNLIGKGGFGTIY-KSRIGDGMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F     +G G FG +     +  G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSK 213
Query: 603 RVFANGDVYSFGIMLMEI 620
                 D ++ G+++ E+
Sbjct: 214 GYNKAVDWWALGVLIYEM 231

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           ++S L+ L+N +SL+    +NN ++ I P                            +G 
Sbjct: 190 DISVLAKLTNLESLIA---TNNQISDITP----------------------------LGI 218
Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           LTNL  + L GN+L      TL  L  L  + L +N++    P  +  L KL +L LG N
Sbjct: 219 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 274
Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           ++S   ++  + L +L  L L+ N       I NLK L  +    NN S + P  + SL 
Sbjct: 275 QISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 330
Query: 263 DLQYLFLGYN 272
            LQ LF   N
Sbjct: 331 KLQRLFFANN 340

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + D+G+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 433 IGKGGFG-TIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           IG+G FG  I      DG +  +K  ++     +  +    E  ++ ++ + N+V+   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQR---LNIMIDVASVLEYLHFNFLVPV 546
                   +V+++   G L K + +   +L  FQ    L+  + +   L+++H      +
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVHDR---KI 146
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREGR 603
           +H D+K  N+ L       L DFGI ++L     + T     A IG   Y++PE      
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NSTVELARACIGTPYYLSPEICENKP 201
Query: 604 VFANGDVYSFGIMLMEIHSAKQ 625
                D+++ G +L E+ + K 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKH 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +    E   MT        GY+A  + R
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MT--------GYVATRWYR 196
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 139
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 140 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 185
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 433 IGKGGFGTIYKS------RIGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI-HYRNLV 484
           +G+G FG + ++      +      VAVK+       +  ++   E +I+  I H+ N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 485 KIISSCSNEEFKELVL------------------EHMPHGSLEKCLYSSNCILDIFQRLN 526
            ++ +C+      +V+                  E +P+    + LY     L +   + 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD--FLTLEHLIC 143
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
               VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +  
Sbjct: 144 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
               + ++APE   +       DV+SFG++L EI S
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           ++S L+ L+N +SL+    +NN ++ I P                            +G 
Sbjct: 186 DISVLAKLTNLESLIA---TNNQISDITP----------------------------LGI 214
Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           LTNL  + L GN+L      TL  L  L  + L +N++    P  +  L KL +L LG N
Sbjct: 215 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 270
Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           ++S   ++  + L +L  L L+ N       I NLK L  +    NN S + P  + SL 
Sbjct: 271 QISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 326
Query: 263 DLQYLFLGYN 272
            LQ LF   N
Sbjct: 327 KLQRLFFSNN 336

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +    E   MT        GY+A  + R
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MT--------GYVATRWYR 196
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 150
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +    E   MT        GY+A  + R
Sbjct: 151 ---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MT--------GYVATRWYR 196
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ ++
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYQM 231

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 95
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 96  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 153
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 154 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 199
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  M  T  +AT  Y APE   
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGXVATRWYRAPEIML 195
Query: 601 EGRVFANG-DVYSFGIMLMEIHSAK 624
               +    D++S G ++ E+ + +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 105 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 162
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 163 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 208
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 427 FNENNLIGKGGFGTI-YKSRIGDGMEVAVK--------VFHLQCGRAFKSFDIECEIMKS 477
           F   +L+G+G +G +   +    G  VA+K        +F L+  R       E +I+K 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKILKH 65
Query: 478 IHYRNLVKIIS---SCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
             + N++ I +     S E F E+ +++ +    L + + +     D  Q    +     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLR 123
Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL----------IGEDQSMT 583
            ++ LH +    VIH DLKPSN+L++      + DFG+ +++           G+   M 
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM- 179
Query: 584 QTQTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
            T+ +AT  Y APE       ++   DV+S G +L E+
Sbjct: 180 -TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+++D      ++DFG  K + G    +       T  Y+APE     
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -IISKGYNKAVDWWALGVLIYEM 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 106 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 163
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 164 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 209
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 2/75 (2%)
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           V+H DLKP+NV LD      L DFG+ ++L   D+   + + + T  Y++PE        
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAK-EFVGTPYYMSPEQMNRMSYN 194
Query: 606 ANGDVYSFGIMLMEI 620
              D++S G +L E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 9/189 (4%)
Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAF---KSFDIECEIMKSIHYRNLVKIISS 489
           +G+G  G +  + +    E AV V  +   RA    ++   E  I K +++ N+VK    
Sbjct: 14  LGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                 + L LE+   G L   +     + +   +      +A V+ YLH    + + H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---IGITHR 128
Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A   
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 609 DVYSFGIML 617
           DV+S GI+L
Sbjct: 189 DVWSCGIVL 197

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 26/234 (11%)
Query: 49  IFDVSTLKDLALQDNYLSGSLSSIAD----------NYLTSSTPELSFLSSLSNCKSLVV 98
           I D+  LK+L    N L  S ++I+D            L+ S+ +++ L  L+N  +L  
Sbjct: 119 ITDIDPLKNLT-NLNRLELSSNTISDISALSGLTSLQQLSFSSNQVTDLKPLANLTTLER 177
Query: 99  FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
             +S+N ++ I     + NL    E    +   +S   P  +G LTNL  + L GN+L  
Sbjct: 178 LDISSNKVSDISVLAKLTNL----ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 231
Query: 159 SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASL 218
               TL  L  L  + L +N++    P  +  L KL +L LG N++S   ++  + L +L
Sbjct: 232 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 285
Query: 219 RTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
             L L+ N       I NLK L  +    NN S + P  + SL  LQ LF  YN
Sbjct: 286 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF-YN 336

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 433 IGKGGFGTIYKS--RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI------HYRNLV 484
           +G+G +G +  +  R+ +   VAVK+  ++     ++ D    I K I      ++ N+V
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMK-----RAVDCPENIKKEICINAMLNHENVV 68
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K          + L LE+   G L   +     + +   +      +A V+ YLH    +
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV-YLHG---I 124
Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            + H D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +    
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 605 FANG-DVYSFGIML 617
            A   DV+S GI+L
Sbjct: 185 HAEPVDVWSCGIVL 198

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 427 FNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYR-- 481
           +    L+GKGGFGT++   R+ D ++VA+KV       G +  S  + C +  ++ ++  
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 482 ------NLVKIISSCSNEEFKELVLEH-MPHGSLEKCLYSSNCILDIFQRLNIMIDVASV 534
                  +++++     +E   LVLE  +P   L   +     + +   R      V + 
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAA 151
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           +++ H      V+H D+K  N+L+D     A L DFG   LL   D+  T      T  Y
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD--GTRVY 204
Query: 594 IAPEYGREGRVFA-NGDVYSFGIMLMEI 620
             PE+    +  A    V+S GI+L ++
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDM 232

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 39/207 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G  VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 92  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 149
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  MT        GY+A  + R
Sbjct: 150 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT--------GYVATRWYR 195
Query: 601 EGRVFANG-------DVYSFGIMLMEI 620
              +  N        D++S G ++ E+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAEL 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 109 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 166
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + DFG+ +     D  M         GY+A  + R
Sbjct: 167 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMX--------GYVATRWYR 212
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
           S+ +++ L  L+N  +L    +S+N ++ I     + NL    E    +   +S   P  
Sbjct: 159 SSNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL----ESLIATNNQISDITP-- 212
Query: 140 IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDL 199
           +G LTNL  + L GN+L      TL  L  L  + L +N++    P  +  L KL +L L
Sbjct: 213 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 268
Query: 200 GGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIG 259
           G N++S   ++  + L +L  L L+ N       I NLK L  +    NN S + P  + 
Sbjct: 269 GANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 324
Query: 260 SLKDLQYLFLGYN 272
           SL  LQ LF  YN
Sbjct: 325 SLTKLQRLFF-YN 336

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           V+H DLKP+NV LD      L DFG+ ++L   D S  +   + T  Y++PE        
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKA-FVGTPYYMSPEQMNRMSYN 194
Query: 606 ANGDVYSFGIMLMEI 620
              D++S G +L E+
Sbjct: 195 EKSDIWSLGCLLYEL 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 9/187 (4%)
Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +++ +    G   A K          ++   E + M  + +  LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           ++    ++ E M  G L + +   +  +   + +  M  V   L ++H N  V   H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV---HLDL 281
Query: 552 KPSNVLLDDTMVAHLS--DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           KP N++        L   DFG+T  L   D   +   T  T  + APE      V    D
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 610 VYSFGIM 616
           ++S G++
Sbjct: 339 MWSVGVL 345

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 427 FNENNLIGKGGFGTI-YKSRIGDGMEVAVK--------VFHLQCGRAFKSFDIECEIMKS 477
           F   +L+G+G +G +   +    G  VA+K        +F L+  R       E +I+K 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKILKH 65
Query: 478 IHYRNLVKIIS---SCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
             + N++ I +     S E F E+ +++ +    L + + +     D  Q    +     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLR 123
Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL----------IGEDQSMT 583
            ++ LH +    VIH DLKPSN+L++      + DFG+ +++           G+   M 
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM- 179
Query: 584 QTQTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
            T+ +AT  Y APE       ++   DV+S G +L E+
Sbjct: 180 -TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 3/127 (2%)
Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           LS NPL  IL   S  N S  L+  D+S+C +     +    L +L+ + L GN +    
Sbjct: 34  LSFNPL-KILKSYSFSNFS-ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 91
Query: 161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC-FSNLASLR 219
           P +   L  L+ +   + KL     + I +L+ L KL++  N +    L   FSNL +L 
Sbjct: 92  PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 151
Query: 220 TLSLSYN 226
            + LSYN
Sbjct: 152 HVDLSYN 158

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA  +E+L        IH DL   N+LL +  V  + DFG+ + +      + +  T   
Sbjct: 208 VARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++APE   +       DV+S+G++L EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 139
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVF 605
           H DLK  N+ L++ +   + DFG+ TK+    ++  T      T  YIAPE   ++G  F
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 196
Query: 606 ANGDVYSFGIML 617
              DV+S G ++
Sbjct: 197 -EVDVWSIGCIM 207

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 39/76 (51%)
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE   +     
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 607 NGDVYSFGIMLMEIHS 622
             DV+SFG++L EI S
Sbjct: 275 QSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +      
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++APE   +       DV+SFG++L EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 139
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVF 605
           H DLK  N+ L++ +   + DFG+ TK+    ++  T      T  YIAPE   ++G  F
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 196
Query: 606 ANGDVYSFGIML 617
              DV+S G ++
Sbjct: 197 -EVDVWSIGCIM 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 14/192 (7%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 143
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGI-TKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVF 605
           H DLK  N+ L++ +   + DFG+ TK+    ++  T      T  YIAPE   ++G  F
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSKKGHSF 200
Query: 606 ANGDVYSFGIML 617
              DV+S G ++
Sbjct: 201 -EVDVWSIGCIM 211

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIECEIMK 476
           L++      F  + ++GKG FG ++ +      +  A+K   L+        D+EC +++
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 477 ----SIHYRN--LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
               S+ + +  L  +  +   +E    V+E++  G L   + S +   D+ +      +
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAE 127
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL-LIGEDQSMTQTQTLA 589
           +   L++LH      +++ DLK  N+LLD      ++DFG+ K  ++G+ ++    +   
Sbjct: 128 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCG 181
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           T  YIAPE     +   + D +SFG++L E+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 212

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 40/190 (21%)
Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           ++S L+ L+N +SL+    +NN ++ I P                            +G 
Sbjct: 191 DISVLAKLTNLESLIA---TNNQISDITP----------------------------LGI 219
Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           LTNL  + L GN+L      TL  L  L  + L +N++    P  +  L KL +L LG N
Sbjct: 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275
Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           ++S   ++  + L +L  L L+ N       I NLK L  +    NN S + P  + SL 
Sbjct: 276 QISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 263 DLQYLFLGYN 272
            LQ LF  YN
Sbjct: 332 KLQRLFF-YN 340

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 9/187 (4%)
Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +++ +    G   A K          ++   E + M  + +  LV +  +  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
           ++    ++ E M  G L + +   +  +   + +  M  V   L ++H N  V   H DL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV---HLDL 175
Query: 552 KPSNVLLDDTMVAHLS--DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           KP N++        L   DFG+T  L   D   +   T  T  + APE      V    D
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 610 VYSFGIM 616
           ++S G++
Sbjct: 233 MWSVGVL 239

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 3/127 (2%)
Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           LS NPL  IL   S  N S  L+  D+S+C +     +    L +L+ + L GN +    
Sbjct: 39  LSFNPL-KILKSYSFSNFSE-LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96
Query: 161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC-FSNLASLR 219
           P +   L  L+ +   + KL     + I +L+ L KL++  N +    L   FSNL +L 
Sbjct: 97  PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156
Query: 220 TLSLSYN 226
            + LSYN
Sbjct: 157 HVDLSYN 163

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 40/190 (21%)
Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           ++S L+ L+N +SL+    +NN ++ I P                            +G 
Sbjct: 186 DISVLAKLTNLESLIA---TNNQISDITP----------------------------LGI 214
Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           LTNL  + L GN+L      TL  L  L  + L +N++    P  +  L KL +L LG N
Sbjct: 215 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 270
Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           ++S   ++  + L +L  L L+ N       I NLK L  +    NN S + P  + SL 
Sbjct: 271 QISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 326
Query: 263 DLQYLFLGYN 272
            LQ LF  YN
Sbjct: 327 KLQRLFF-YN 335

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 13/106 (12%)
Query: 525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-- 582
           L+I I +A  +E+LH   L   +H DLKPSN+      V  + DFG+   +  +++    
Sbjct: 167 LHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 583 --------TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                   T    + T  Y++PE           D++S G++L E+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 39/76 (51%)
Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE   +     
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 607 NGDVYSFGIMLMEIHS 622
             DV+SFG++L EI S
Sbjct: 280 QSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   + +      
Sbjct: 209 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           + ++APE   +       DV+SFG++L EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 48/99 (48%), Gaps = 15/99 (15%)
Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
           I ID    L Y         +H D+KP N+L+D      L+DFG + L + ED ++  + 
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 235
Query: 587 TLATIGYIAPEY-----GREGRVFANGDVYSFGIMLMEI 620
            + T  YI+PE      G +GR     D +S G+ + E+
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK-----VFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G +G + K R +  G  +AVK     V   +  R     DI    M+++     V  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------NIMIDVASVLEYLHF 540
             +   E    + +E M   SL+K  Y    ++D  Q +       I + +   LE+LH 
Sbjct: 72  YGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-- 598
              + VIH D+KPSNVL++      + DFGI+  L+ +   + +        Y+APE   
Sbjct: 128 K--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERIN 182
Query: 599 ---GREGRVFANGDVYSFGIMLMEI 620
               ++G      D++S GI ++E+
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIEL 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 196
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 250
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 251 --VDIWSLGIMVIEM 263

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 153
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 207
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 208 --VDIWSLGIMVIEM 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 12/191 (6%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 163
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVFA 606
           H DLK  N+ L++ +   + DFG+   +  E     +     T  YIAPE   ++G  F 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSF- 220
Query: 607 NGDVYSFGIML 617
             DV+S G ++
Sbjct: 221 EVDVWSIGCIM 231

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 273
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 327
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 328 --VDIWSLGIMVIEM 340

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 142
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 196
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 197 --VDIWSLGIMVIEM 209

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 12/191 (6%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 161
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVFA 606
           H DLK  N+ L++ +   + DFG+   +  E     +     T  YIAPE   ++G  F 
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSF- 218
Query: 607 NGDVYSFGIML 617
             DV+S G ++
Sbjct: 219 EVDVWSIGCIM 229

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 151
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 205
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 206 --VDIWSLGIMVIEM 218

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 20/125 (16%)
Query: 121 SLEIFDMSKCNVSGGIPEEI------------------GNLTNLTAIYLGGNKLNGSIPF 162
           ++E +   + +V  GIP +                     LT+LT +YLGGNKL      
Sbjct: 11  TVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70
Query: 163 TLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTL 221
              +L  L Y+ L  N+L+ ++P  +F +L +L +L L  N+L       F  L  L+ L
Sbjct: 71  VFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129
Query: 222 SLSYN 226
            L  N
Sbjct: 130 RLYQN 134

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 431 NLIGKGGFG-----------TIYKSRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKS 477
            +IG+G FG            IY  +I +  E+ +K     C R  +   +  +C+ + +
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEM-LKRAETACFREERDVLVNGDCQWITA 138
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNI--MIDVASV 534
           +HY        +  +E    LV+++   G L   L    + + +   R  I  M+     
Sbjct: 139 LHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           +  LH+      +H D+KP NVLLD      L+DFG + L + +D ++  +  + T  YI
Sbjct: 191 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYI 243
Query: 595 APEYGRE-----GRVFANGDVYSFGIMLMEI 620
           +PE  +      G+     D +S G+ + E+
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEM 274

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G  G +  + +   G  VAVK   L+  +  +    E  IM+   + N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
             +   +V+E +  G+L   +  ++  ++  Q   + + V   L  LH      VIH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDI 146
Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVF 605
           K  ++LL       LSDFG    +  E     +   + T  ++APE      YG E    
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPE---- 200
Query: 606 ANGDVYSFGIMLMEI 620
              D++S GIM++E+
Sbjct: 201 --VDIWSLGIMVIEM 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     +  FG+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 431 NLIGKGGFG-----------TIYKSRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKS 477
            +IG+G FG            IY  +I +  E+ +K     C R  +   +  +C+ + +
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEM-LKRAETACFREERDVLVNGDCQWITA 154
Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYS-SNCILDIFQRLNI--MIDVASV 534
           +HY        +  +E    LV+++   G L   L    + + +   R  I  M+     
Sbjct: 155 LHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           +  LH+      +H D+KP NVLLD      L+DFG + L + +D ++  +  + T  YI
Sbjct: 207 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYI 259
Query: 595 APEYGRE-----GRVFANGDVYSFGIMLMEI 620
           +PE  +      G+     D +S G+ + E+
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEM 290

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + D G+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 20/203 (9%)
Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISS 489
           L+G G +G +YK R +  G   A+KV  +  G   +    E  ++K   H+RN+     +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 490 CSN------EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
                    ++   LV+E    GS+   +   N   +  +   I      +L  L     
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147
Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEY---- 598
             VIH D+K  NVLL +     L DFG++  L   D+++ +  T + T  ++APE     
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 599 -GREGRVFANGDVYSFGIMLMEI 620
              +       D++S GI  +E+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEM 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 36/225 (16%)
Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           C     + +   IG+G FG ++K+R    G +VA+K   ++  +  + F I    E +I+
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 476 KSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY--SSNCILDIFQRL-NIMI--- 529
           + + + N+V +I  C  +          P+   +  +Y     C  D+   L N+++   
Sbjct: 72  QLLKHENVVNLIEICRTKA--------SPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFT 123
Query: 530 --DVASVLE-------YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL--LIGE 578
             ++  V++       Y+H N    ++H D+K +NVL+    V  L+DFG+ +   L   
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHS 622
            Q       + T+ Y  PE     R +    D++  G ++ E+ +
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           C     + +   IG+G FG ++K+R    G +VA+K   ++  +  + F I    E +I+
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 476 KSIHYRNLVKIISSCSNEEFKE--------LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           + + + N+V +I  C  +            LV +   H  L   L +      + +   +
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL--LIGEDQSMTQT 585
           M  + + L Y+H N    ++H D+K +NVL+    V  L+DFG+ +   L    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 586 QTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHS 622
             + T+ Y  PE     R +    D++  G ++ E+ +
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           C     + +   IG+G FG ++K+R    G +VA+K   ++  +  + F I    E +I+
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 476 KSIHYRNLVKIISSCSNEEFKE--------LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           + + + N+V +I  C  +            LV +   H  L   L +      + +   +
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL--LIGEDQSMTQT 585
           M  + + L Y+H N    ++H D+K +NVL+    V  L+DFG+ +   L    Q     
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 586 QTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHS 622
             + T+ Y  PE     R +    D++  G ++ E+ +
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + D G+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           C     + +   IG+G FG ++K+R    G +VA+K   ++  +  + F I    E +I+
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70
Query: 476 KSIHYRNLVKIISSCSNEEFKE--------LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           + + + N+V +I  C  +            LV +   H  L   L +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL--LIGEDQSMTQT 585
           M  + + L Y+H N    ++H D+K +NVL+    V  L+DFG+ +   L    Q     
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 586 QTLATIGYIAPEYGREGRVFANG-DVYSFGIMLMEIHS 622
             + T+ Y  PE     R +    D++  G ++ E+ +
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 3/73 (4%)
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPEYGREGRVFA 606
           H D+KP N+L+     A+L DFGI       D+ +TQ   T+ T+ Y APE   E     
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 607 NGDVYSFGIMLME 619
             D+Y+   +L E
Sbjct: 215 RADIYALTCVLYE 227

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 427 FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI---ECEIMKSIHYRN 482
           F+    +G G FG +   +  + G   A+K+   Q     K  +    E  I++++++  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH--- 158
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
            + +I+ DLKP N+L+D      ++DFG  K + G    +  T        +APE     
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEA-----LAPEI---- 209
Query: 603 RVFANG-----DVYSFGIMLMEI 620
            + + G     D ++ G+++ E+
Sbjct: 210 -ILSKGYNKAVDWWALGVLIYEM 231

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 433 IGKGGFGTIYKSRIGDGME-VAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG+G +GT++K++  +  E VA+K   L     G    +    C ++K + ++N+V++  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +++   LV E      L+K   S N  LD     + +  +   L + H      V+H
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLKP N+L++      L+DFG+ +      +    +  + T+ Y  P+     ++++  
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 609 -DVYSFGIMLMEIHSAKQ 625
            D++S G +  E+ +A +
Sbjct: 183 IDMWSAGCIFAELANAAR 200

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 427 FNENNLIGKGGFGTI-YKSRIGDGMEVAVK--------VFHLQCGRAFKSFDIECEIMKS 477
           F   +L+G+G +G +   +    G  VA+K        +F L+  R       E +I+K 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKILKH 65
Query: 478 IHYRNLVKIIS---SCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
             + N++ I +     S E F E+ +++ +    L + + +     D  Q    +     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLR 123
Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL---IGEDQSMTQTQT--- 587
            ++ LH +    VIH DLKPSN+L++      + DFG+ +++     ++   T  Q+   
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 588 --LATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
             +AT  Y APE       ++   DV+S G +L E+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 430 NNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIECEIMK----SIHYRN-- 482
           + ++GKG FG ++ +      +  A+K   L+        D+EC +++    S+ + +  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           L  +  +   +E    V+E++  G L   + S +   D+ +      ++   L++LH   
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK- 137
Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL-LIGEDQSMTQTQTLATIGYIAPEYGRE 601
              +++ DLK  N+LLD      ++DFG+ K  ++G+ ++        T  YIAPE    
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCGTPDYIAPEILLG 192
Query: 602 GRVFANGDVYSFGIMLMEI 620
            +   + D +SFG++L E+
Sbjct: 193 QKYNHSVDWWSFGVLLYEM 211

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 31/208 (14%)
Query: 407 PPKATWRRFSYLEVCRATYG--FNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQ--- 460
           PPKA       L  C   Y   ++  + +G G FG ++ +   +   EV VK    +   
Sbjct: 6   PPKAV--ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 461 --CG---RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS 515
             C           +E  I+  + + N++K++    N+ F +LV+E   HGS        
Sbjct: 64  EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK--HGSGLDLF--- 118
Query: 516 NCILDIFQRLN------IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF 569
              +D   RL+      I   + S + YL    L  +IH D+K  N+++ +     L DF
Sbjct: 119 -AFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF 174
Query: 570 GITKLLIGEDQSMTQTQTLATIGYIAPE 597
           G    L   ++         TI Y APE
Sbjct: 175 GSAAYL---ERGKLFYTFCGTIEYCAPE 199

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 29/159 (18%)
Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLN---- 526
           E  ++K + + N++K+     ++    LV+E         C        +I  R+     
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVME---------CYKGGELFDEIIHRMKFNEV 136
Query: 527 ----IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD----DTMVAHLSDFGITKLLIGE 578
               I+  V S + YLH +    ++H DLKP N+LL+    D ++  + DFG++ +   E
Sbjct: 137 DAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIK-IVDFGLSAVF--E 190
Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIML 617
           +Q   + + L T  YIAPE  R+ +     DV+S G++L
Sbjct: 191 NQKKMK-ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 433 IGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSF------DIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK    +  R F+S         E  ++K + + N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 486 IIS----SCSNEEFKELVL-EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           ++     + S EEF ++ L  H+    L   +       D  Q L  +  +   L+Y+H 
Sbjct: 86  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIHS 143
Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                +IH DLKPSN+ +++     + D G+ +     D  MT        GY+A  + R
Sbjct: 144 ---ADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMT--------GYVATRWYR 189
Query: 601 EGRVFANG-------DVYSFGIMLMEIHSAK 624
              +  N        D++S G ++ E+ + +
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 12/191 (6%)
Query: 432 LIGKGGFGTIYKSRIGDGMEV-AVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++    D  EV A K+     L      +   +E  I +S+ ++++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R  +   V    +YLH N    VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC-QYLHRNR---VI 137
Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-GREGRVFA 606
           H DLK  N+ L++ +   + DFG+   +  E     +     T  YIAPE   ++G  F 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSF- 194
Query: 607 NGDVYSFGIML 617
             DV+S G ++
Sbjct: 195 EVDVWSIGCIM 205

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 16/200 (8%)
Query: 424 TYGFNENNLIGKGGFGTIYKS-RIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN 482
           T G+     IG G +    +       ME AVK+         +  +I   +++   + N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHPN 77
Query: 483 LVKIISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           ++ +     + ++  +V E M  G L +K L          +   ++  +   +EYLH  
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ 135
Query: 542 FLVPVIHCDLKPSNVLLDDTM----VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
               V+H DLKPSN+L  D         + DFG  K L  E+  +       T  ++APE
Sbjct: 136 ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFVAPE 190
Query: 598 YGREGRVFANGDVYSFGIML 617
                   A  D++S G++L
Sbjct: 191 VLERQGYDAACDIWSLGVLL 210

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 87/219 (39%), Gaps = 22/219 (10%)
Query: 406 MPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA 464
           M PK T   F YL             L+GKG FG +   R    G   A+K+   +   A
Sbjct: 3   MDPKVTMNDFDYL------------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA 50
Query: 465 FKSFD---IECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDI 521
                    E  ++++  +  L  +  +    +    V+E+   G L   L       + 
Sbjct: 51  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 110
Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
             R     ++ S LEYLH      V++ D+K  N++LD      ++DFG+ K  I +  +
Sbjct: 111 RARF-YGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 166
Query: 582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           M       T  Y+APE   +       D +  G+++ E+
Sbjct: 167 M--KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 35/208 (16%)
Query: 431 NLIGKGGFGTIYKS-RIGDGMEVAVKV-----FHLQCGRAFKSFDIECEIMKSIHYRNLV 484
            +IGKG F  + +      G + AVK+     F    G + +    E  I   + + ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNI------------MIDVA 532
           +++ + S++    +V E M    L           +I +R +             M  + 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
             L Y H N    +IH D+KP NVLL   +++    L DFG+  + +GE   +     + 
Sbjct: 141 EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGE-SGLVAGGRVG 195
Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIML 617
           T  ++APE  +        DV+  G++L
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
           ++LE +H      ++H DLKP+N L+ D M+  L DFGI   +  +  S+ +   + T+ 
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVN 221
Query: 593 YIAPE 597
           Y+ PE
Sbjct: 222 YMPPE 226

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	652
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-74
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-71
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-66
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-66
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-50
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-37
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-88
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-39
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-63
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-63
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-53
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-50
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-49
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-45
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-38
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-48
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-46
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-37
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-40
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-31
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-29
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-44
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-38
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-42
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-37
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-08
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-13
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-22
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-37
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-35
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-19
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-36
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-36
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-21
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-35
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-21
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-25
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-22
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-05
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-10
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-25
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-24
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-06
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-07
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-16
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-22
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-08
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-20
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-07
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-18
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-17
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-16
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	8e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-12
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-06
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-15
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-12
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-11
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-06
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-07
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	8e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  291 bits (748), Expect = 9e-89
 Identities = 115/362 (31%), Positives = 162/362 (44%), Gaps = 31/362 (8%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS-------- 71
           +IP  + N   L  L L  N L G +P+++  +S L+DL L  N L G +          
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTL 468

Query: 72  ----IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
               +  N LT   P     S LSNC +L    LSNN L G +P+  IG L  +L I  +
Sbjct: 469 ETLILDFNDLTGEIP-----SGLSNCTNLNWISLSNNRLTGEIPK-WIGRLE-NLAILKL 521

Query: 128 SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
           S  + SG IP E+G+  +L  + L  N  NG+IP  + +        +  N + G     
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVY 577

Query: 188 IFRLVKLYKLDLGGN--KLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGI 243
           I       +    GN  +  G      + L++    +++     G       N   ++ +
Sbjct: 578 IKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP 303
           D S N  S  IP  IGS+  L  L LG+N + GSIPD VGDL  L  L+ S+N L G IP
Sbjct: 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP 697

Query: 304 LLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIHH 363
             +  L+ L  ++LS N L G IP+ G F  F    F  N  LCG P   +P C  S   
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNAD 754

Query: 364 TS 365
             
Sbjct: 755 GY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  252 bits (646), Expect = 4e-74
 Identities = 94/322 (29%), Positives = 144/322 (44%), Gaps = 28/322 (8%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            IP   +   L+ L +  N L G    AI   + LK L +  N   G +           
Sbjct: 215 GIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--------- 265

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                        KSL    L+ N   G +P    G    +L   D+S  +  G +P   
Sbjct: 266 ----------LPLKSLQYLSLAENKFTGEIPDFLSGACD-TLTGLDLSGNHFYGAVPPFF 314

Query: 141 GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFRL-VKLYKLD 198
           G+ + L ++ L  N  +G +P  TL +++ L+ + L  N+  G +P  +  L   L  LD
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374

Query: 199 LGGNKLSGSILT--CFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVI 254
           L  N  SG IL   C +   +L+ L L  N   G +P  + N   L+ +  S N  S  I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
           P+++GSL  L+ L L  N+L+G IP  +  + +L++L    N+L+G IP  L   + L  
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494

Query: 315 LNLSFNKLEGEIPKGGSFGNFS 336
           ++LS N+L GEIPK    G   
Sbjct: 495 ISLSNNRLTGEIPK--WIGRLE 514

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  244 bits (626), Expect = 2e-71
 Identities = 97/338 (28%), Positives = 155/338 (45%), Gaps = 36/338 (10%)

Query: 9   LELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDV---STLKDLALQDNYL 65
           L ++ + ++ P ++   +  ++LE L L  N++ G              LK LA+  N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 66  SGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIF 125
           SG +                    +S C +L    +S+N  +  +P   +G+ S +L+  
Sbjct: 191 SGDV-------------------DVSRCVNLEFLDVSSNNFSTGIP--FLGDCS-ALQHL 228

Query: 126 DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
           D+S   +SG     I   T L  + +  N+  G IP     L+ LQY+ L +NK  G IP
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIP 286

Query: 186 YDIF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLE-IGNLKVLI 241
             +      L  LDL GN   G++   F + + L +L+LS N+  G LP++ +  ++ L 
Sbjct: 287 DFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346

Query: 242 GIDFSMNNFSSVIPTTIGSLK-DLQYLFLGYNILKGSIPDSVGD--LISLKSLNFSNNNL 298
            +D S N FS  +P ++ +L   L  L L  N   G I  ++      +L+ L   NN  
Sbjct: 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406

Query: 299 SGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
           +G IP  L   S L  L+LSFN L G IP   S G+ S
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPS--SLGSLS 442

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  230 bits (588), Expect = 6e-66
 Identities = 93/346 (26%), Positives = 151/346 (43%), Gaps = 30/346 (8%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS-------- 70
           EIP  +      L  L L  N+  G VP      S L+ LAL  N  SG L         
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343

Query: 71  -----SIADNYLTSSTPELSFLSSLSNCK-SLVVFLLSNNPLNGILPRMSIGNLSHSLEI 124
                 ++ N  +   P      SL+N   SL+   LS+N  +G +      N  ++L+ 
Sbjct: 344 GLKVLDLSFNEFSGELP-----ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 125 FDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTI 184
             +     +G IP  + N + L +++L  N L+G+IP +L  L KL+ + L  N LEG I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 185 PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIG 242
           P ++  +  L  L L  N L+G I +  SN  +L  +SLS N   G +P  IG L+ L  
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518

Query: 243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAI 302
           +  S N+FS  IP  +G  + L +L L  N+  G+IP ++       S   + N ++G  
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574

Query: 303 PLLLEKLSYLEHLNLSFN--KLEGEIPKG-GSFGNFSAESFEGNKL 345
            + ++     +  + + N  + +G   +        +  +      
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  229 bits (587), Expect = 7e-66
 Identities = 95/326 (29%), Positives = 149/326 (45%), Gaps = 32/326 (9%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS 79
            + S + +   LE L L  +++ G V       ++L  L L  N LSG +++        
Sbjct: 68  AVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTT-------- 118

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
                  L+SL +C  L    +S+N L+          L+ SLE+ D+S  ++SG     
Sbjct: 119 -------LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSISGANVVG 170

Query: 140 I---GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
                    L  + + GNK++G +  +      L+++ +  N     IP  +     L  
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIP-FLGDCSALQH 227

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVI 254
           LD+ GNKLSG      S    L+ L++S N   GP+P     LK L  +  + N F+  I
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285

Query: 255 PTTI-GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL-LLEKLSYL 312
           P  + G+   L  L L  N   G++P   G    L+SL  S+NN SG +P+  L K+  L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 313 EHLNLSFNKLEGEIPKGGSFGNFSAE 338
           + L+LSFN+  GE+P+  S  N SA 
Sbjct: 346 KVLDLSFNEFSGELPE--SLTNLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  186 bits (474), Expect = 2e-50
 Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 17/237 (7%)

Query: 101 LSNNPLNGILPRM--SIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG 158
           LS+ PLN     +  S+ +L+  LE   +S  +++G +        +LT++ L  N L+G
Sbjct: 57  LSSKPLNVGFSAVSSSLLSLTG-LESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG 114

Query: 159 SIP--FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSI---LTCF 212
            +    +L     L+++ +  N L+         +L  L  LDL  N +SG+        
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174

Query: 213 SNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG 270
                L+ L++S N   G +   +     L  +D S NNFS+ IP  +G    LQ+L + 
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS 231

Query: 271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
            N L G    ++     LK LN S+N   G IP     L  L++L+L+ NK  GEIP
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFTGEIP 286

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  147 bits (373), Expect = 4e-37
 Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 17/206 (8%)

Query: 142 NLTNLTAIYLGGNKLN---GSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLD 198
               +T+I L    LN    ++  +L  L  L+ + L ++ + G++         L  LD
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 199 LGGNKLSGSI--LTCFSNLASLRTLSLSYN--DGPLPLEIG-NLKVLIGIDFSMNNFSSV 253
           L  N LSG +  LT   + + L+ L++S N  D P  +  G  L  L  +D S N+ S  
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 254 IPTTI---GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS 310
                       +L++L +  N + G +   V   ++L+ L+ S+NN S  IP L    S
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG-DCS 223

Query: 311 YLEHLNLSFNKLEGEIPKGGSFGNFS 336
            L+HL++S NKL G+  +  +    +
Sbjct: 224 ALQHLDISGNKLSGDFSR--AISTCT 247

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  276 bits (709), Expect = 4e-88
 Identities = 87/275 (31%), Positives = 130/275 (47%), Gaps = 11/275 (4%)

Query: 88  SSLSNCKSLVVFLLSNNPLNGILP-RMSIGNLSHSLEIFDMSKCN-VSGGIPEEIGNLTN 145
            + +    +    LS   L    P   S+ NL   L    +   N + G IP  I  LT 
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLS 205
           L  +Y+    ++G+IP  L +++ L  +    N L GT+P  I  L  L  +   GN++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 206 GSILTCFSNLASLRT-LSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           G+I   + + + L T +++S N   G +P    NL  L  +D S N          GS K
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDK 221

Query: 263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           + Q + L  N L   +   VG   +L  L+  NN + G +P  L +L +L  LN+SFN L
Sbjct: 222 NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 323 EGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPC 357
            GEIP+GG+   F   ++  NK LCGSP   +P C
Sbjct: 281 CGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  146 bits (370), Expect = 2e-39
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS 79
            IP  +     L  L    N L G +P +I  +  L  +    N +SG++          
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI---------- 165

Query: 80  STPELSFLSSLSNCKSLVVFL-LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
             P      S  +   L   + +S N L G +P  +  NL  +L   D+S+  + G    
Sbjct: 166 --P-----DSYGSFSKLFTSMTISRNRLTGKIPP-TFANL--NLAFVDLSRNMLEGDASV 215

Query: 139 EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLD 198
             G+  N   I+L  N L   +   +   + L  + L++N++ GT+P  + +L  L+ L+
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYND----GPLP 231
           +  N L G I     NL      + + N      PLP
Sbjct: 275 VSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  212 bits (542), Expect = 2e-63
 Identities = 75/213 (35%), Positives = 116/213 (54%), Gaps = 5/213 (2%)

Query: 412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKS-FDI 470
            +RFS  E+  A+  F+  N++G+GGFG +YK R+ DG  VAVK    +  +  +  F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY---SSNCILDIFQRLNI 527
           E E++    +RNL+++   C     + LV  +M +GS+  CL     S   LD  +R  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
            +  A  L YLH +    +IH D+K +N+LLD+   A + DFG+ KL+     +   T  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVTTAV 195

Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             TIG+IAPEY   G+     DV+ +G+ML+E+
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  211 bits (540), Expect = 3e-63
 Identities = 76/216 (35%), Positives = 116/216 (53%), Gaps = 6/216 (2%)

Query: 413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIEC 472
            R   +++  AT  F+   LIG G FG +YK  + DG +VA+K    +  +  + F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 473 EIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMI 529
           E +    + +LV +I  C       L+ ++M +G+L++ LY S+     +   QRL I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
             A  L YLH      +IH D+K  N+LLD+  V  ++DFGI+K     DQ+   T    
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ 625
           T+GYI PEY  +GR+    DVYSFG++L E+  A+ 
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  186 bits (475), Expect = 4e-54
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 17/220 (7%)

Query: 413 RRFSYLEVCRATYGFNE------NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRA-- 464
             FS+ E+   T  F+E       N +G+GGFG +YK  + +   VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 465 --FKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY--SSNCILD 520
              + FD E ++M    + NLV+++   S+ +   LV  +MP+GSL   L        L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 521 IFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ 580
              R  I    A+ + +LH N     IH D+K +N+LLD+   A +SDFG+ +      Q
Sbjct: 132 WHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++  ++ + T  Y+APE  R G +    D+YSFG++L+EI
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  192 bits (490), Expect = 3e-53
 Identities = 58/362 (16%), Positives = 118/362 (32%), Gaps = 44/362 (12%)

Query: 9   LELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG 67
           ++  ++       I           ++    NN+  V   A+  ++ L+   + ++    
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVA 220

Query: 68  S-------LSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH 120
                     +        +           N K L    + N P    LP   +  L  
Sbjct: 221 ENICEAWENENSEYAQQYKTED-----LKWDNLKDLTDVEVYNCPNLTKLPT-FLKALP- 273

Query: 121 SLEIFDMSKCN--------VSGGIPEEIGNLTNLTAIYLGGNKL-NGSIPFTLRELQKLQ 171
            +++ +++                  +      +  IY+G N L    +  +L++++KL 
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 172 YVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---DG 228
            +    N+LEG +P      +KL  L+L  N+++            +  LS ++N     
Sbjct: 334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYI 392

Query: 229 PLPLEIGNLKVLIGIDFSMNNFSSV-------IPTTIGSLKDLQYLFLGYNILKGSIPDS 281
           P   +  ++ V+  IDFS N   SV       +  T     ++  + L  N +     + 
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

Query: 282 VGDLISLKSLNFSNNNLSG-------AIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
                 L S+N   N L+              +    L  ++L FNKL   +        
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATT 511

Query: 335 FS 336
             
Sbjct: 512 LP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  183 bits (467), Expect = 4e-50
 Identities = 55/350 (15%), Positives = 103/350 (29%), Gaps = 43/350 (12%)

Query: 8   KLELNVDDIESPCEIPSEINPHNLEELLLGQNNL-VGVVPAAIFDVSTLKDLALQDNYLS 66
           +        +    +        ++ + +G NNL    V  ++  +  L  L    N L 
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

Query: 67  GSLSSIA-----------DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSI 115
           G L +              N +T               + +     ++N L  I      
Sbjct: 344 GKLPAFGSEIKLASLNLAYNQITEIPANF-----CGFTEQVENLSFAHNKLKYIPNIFDA 398

Query: 116 GNLSHSLEIFDMSKCNVSG-------GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ 168
            ++S  +   D S   +          +        N+++I L  N+++           
Sbjct: 399 KSVS-VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 169 KLQYVGLKDNKLEG-------TIPYDIFRLVKLYKLDLGGNKLSGSILT-CFSNLASLRT 220
            L  + L  N L             +      L  +DL  NKL+        + L  L  
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517

Query: 221 LSLSYND-GPLPLEIGNLKVLIGI------DFSMNNFSSVIPTTIGSLKDLQYLFLGYNI 273
           + LSYN     P +  N   L G       D   N      P  I     L  L +G N 
Sbjct: 518 IDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 274 LKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
           ++  + + +    ++  L+  +N         +          L ++K +
Sbjct: 578 IR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  181 bits (460), Expect = 4e-49
 Identities = 44/341 (12%), Positives = 104/341 (30%), Gaps = 41/341 (12%)

Query: 22  IPSEINP-HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
              + +   +L ++ +     +  +P  +  +  ++ + +  N                 
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS---------GEQL 291

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
             +   L+     + + +  +  N L       S+  +   L + +     + G      
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK-KLGMLECLYNQLEG-KLPAF 349

Query: 141 GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP--YDIFRLVKLYKLD 198
           G+   L ++ L  N++           ++++ +    NKL+  IP  +D   +  +  +D
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID 408

Query: 199 LGGNKLSGSILTCFS-------NLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNN 249
              N++       F           ++ +++LS N               L  I+   N 
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468

Query: 250 FSSV-------IPTTIGSLKDLQYLFLGYNILKGSIPD-SVGDLISLKSLNFSNNNLSGA 301
            + +             +   L  + L +N L     D     L  L  ++ S N+ S  
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK- 527

Query: 302 IPLLLEKLSYLEHL------NLSFNKLEGEIPKGGSFGNFS 336
            P      S L+        +   N+   E P+        
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE--GITLCP 566

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  169 bits (429), Expect = 6e-45
 Identities = 51/314 (16%), Positives = 94/314 (29%), Gaps = 32/314 (10%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
           +   +  L L      G VP AI  ++ L+ LAL  +    +               L  
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN-------------ERLFG 125

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
              +S   S                          L    ++       I +        
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
           T I    N +   +   +  L KL+   + ++        + +        +    +   
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYK 239

Query: 207 SILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSV--------IPT 256
           +    + NL  L  + +        LP  +  L  +  I+ + N   S            
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

Query: 257 TIGSLKDLQYLFLGYNILK-GSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHL 315
                + +Q +++GYN LK   +  S+  +  L  L    N L G +P        L  L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358

Query: 316 NLSFNKLEGEIPKG 329
           NL++N++   IP  
Sbjct: 359 NLAYNQITE-IPAN 371

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  148 bits (376), Expect = 5e-38
 Identities = 43/284 (15%), Positives = 92/284 (32%), Gaps = 42/284 (14%)

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG----IPEEIGNLT 144
           SL++   +    L     +G +P  +IG L+  LE+  +             P+ I    
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPD-AIGQLTE-LEVLALGSHGEKVNERLFGPKGISANM 133

Query: 145 NLTAIYLGGNKLNGSIPFTL--RELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           +             +        +   L    +  +  + +I       +K  ++    N
Sbjct: 134 SDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193

Query: 203 KLSGSILTCFSNLASLRTLSLSYND---------------------GPLPLEIGNLKVLI 241
            ++  +      L  LR   +  +                          L+  NLK L 
Sbjct: 194 NIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLT 252

Query: 242 GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG--------SIPDSVGDLISLKSLNF 293
            ++       + +PT + +L ++Q + +  N                       ++ +  
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312

Query: 294 SNNNL-SGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
             NNL +  +   L+K+  L  L   +N+LEG++P   +FG+  
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP---AFGSEI 353

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  139 bits (353), Expect = 5e-35
 Identities = 33/236 (13%), Positives = 69/236 (29%), Gaps = 13/236 (5%)

Query: 108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG----SIPFT 163
           G  P +S+ +    +    +     SG +P+ IG LT L  + LG +          P  
Sbjct: 70  GAQPGVSLNSNGR-VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128

Query: 164 LRELQKLQYVGLKDNKLEGTIPYDIFRLV--KLYKLDLGGNKLSGSILTCFSNLASLRTL 221
           +      +         + T      R     L K  +  +    SI            +
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

Query: 222 SLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD 280
               N+   +   +  L  L       + F +         ++ +Y          +   
Sbjct: 189 GQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY-----KTEDL 243

Query: 281 SVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
              +L  L  +   N      +P  L+ L  ++ +N++ N+          +   +
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 14/114 (12%), Positives = 32/114 (28%), Gaps = 7/114 (6%)

Query: 246 SMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG----A 301
            ++ + +    ++ S   +  L L      G +PD++G L  L+ L   ++         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 302 IPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS---AESFEGNKLLCGSPNL 352
            P  +      E         +          +FS    +    +         
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  180 bits (459), Expect = 1e-48
 Identities = 76/346 (21%), Positives = 126/346 (36%), Gaps = 40/346 (11%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG-------SLSS-- 71
           ++P ++ P N+  L L  N L  +  A     S L  L +  N +S         L    
Sbjct: 18  QVPDDL-PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +  N L+  + +     + + C +L    L +N +  I           +L   D+S
Sbjct: 77  VLNLQHNELSQLSDK-----TFAFCTNLTELHLMSNSIQKIKNN-PFVKQK-NLITLDLS 129

Query: 129 KCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP--FTLRELQKLQYVGLKDNKLEGTIPY 186
              +S         L NL  + L  NK+         +     L+ + L  N+++   P 
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189

Query: 187 DIFRLVKLYKLDLGGNKLSGSI---LTCFSNLASLRTLSLSYND--GPLPLEIGNLKV-- 239
               + +L+ L L   +L  S+   L       S+R LSLS +            LK   
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTN 249

Query: 240 LIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN--- 296
           L  +D S NN + V   +   L  L+Y FL YN ++     S+  L +++ LN   +   
Sbjct: 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309

Query: 297 ------NLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
                 +L        + L  LEHLN+  N + G       F    
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS--NMFTGLI 353

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  177 bits (452), Expect = 8e-48
 Identities = 70/353 (19%), Positives = 129/353 (36%), Gaps = 34/353 (9%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI------------ADNY 76
            +  +  +   +L  +   +   +  L+ L ++DN + G  S++            ++++
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
            +  T       SL++   L +  L+ N ++ I    +   L   LE+ D+    +   +
Sbjct: 365 TSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESD-AFSWLG-HLEVLDLGLNEIGQEL 421

Query: 137 P-EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEG--TIPYDIFRLVK 193
             +E   L N+  IYL  NK       +   +  LQ + L+   L+   + P     L  
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 194 LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN----------DGPLPLEIGNLKVLIGI 243
           L  LDL  N ++         L  L  L L +N           G     +  L  L  +
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP 303
           +   N F  +       L +L+ + LG N L         + +SLKSLN   N ++    
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

Query: 304 LLLEK-LSYLEHLNLSFNKLEGEIPKGGSFGNFSAES-----FEGNKLLCGSP 350
            +       L  L++ FN  +        F N+  E+        +  LC +P
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  173 bits (441), Expect = 2e-46
 Identities = 61/329 (18%), Positives = 107/329 (32%), Gaps = 36/329 (10%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
              +L++L L  N +    P     +  L  L L +  L  SL+                
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK-------------- 214

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           L       S+    LSN+ L+       +G    +L + D+S  N++    +    L  L
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQY---------VGLKDNKLEGTIPYDIFRLVKLYKL 197
              +L  N +      +L  L  ++Y           +    L     +    L  L  L
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYN---------DGPLPLEIGNLKVLIGIDFSMN 248
           ++  N + G     F+ L +L+ LSLS +         +  + L    L +L   + + N
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL---NLTKN 391

Query: 249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLE 307
             S +       L  L+ L LG N +   +       L ++  +  S N           
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451

Query: 308 KLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
            +  L+ L L    L+        F    
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  165 bits (420), Expect = 1e-43
 Identities = 66/340 (19%), Positives = 119/340 (35%), Gaps = 39/340 (11%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS------------SIADNY 76
             L+ L L  N L  +        + L +L L  N +    +             ++ N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L+S+        +    ++L   LLSNN +  +         + SL+  ++S   +    
Sbjct: 133 LSSTKL-----GTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRE---LQKLQYVGLKDNKLEGTIPYDIF--RL 191
           P     +  L  ++L   +L  S+   L        ++ + L +++L  T        + 
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247

Query: 192 VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVL--------- 240
             L  LDL  N L+      F+ L  L    L YN+        +  L  +         
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307

Query: 241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
                S+ +   +   +   LK L++L +  N + G   +    LI+LK L+ SN+  S 
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367

Query: 301 AIP----LLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
                   +    S L  LNL+ NK+        +F    
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIES--DAFSWLG 405

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  165 bits (420), Expect = 1e-43
 Identities = 74/321 (23%), Positives = 112/321 (34%), Gaps = 31/321 (9%)

Query: 19  PCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
             ++  E+   ++  L L  + L             LK   L    LS        N L 
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG---LKWTNLTMLDLS-------YNNLN 261

Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGI-------LPRMSIGNLSHSLEIFDMSKCN 131
                     S +    L  F L  N +  +       L  +   NL  S     +S  +
Sbjct: 262 VVGN-----DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLE-GTIPYDIFR 190
           +          L  L  + +  N + G        L  L+Y+ L ++     T+  + F 
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376

Query: 191 ---LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLP-LEIGNLKVLIGID 244
                 L+ L+L  NK+S      FS L  L  L L  N+    L   E   L+ +  I 
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIY 436

Query: 245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG--SIPDSVGDLISLKSLNFSNNNLSGAI 302
            S N +  +   +   +  LQ L L    LK   S P     L +L  L+ SNNN++   
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496

Query: 303 PLLLEKLSYLEHLNLSFNKLE 323
             +LE L  LE L+L  N L 
Sbjct: 497 DDMLEGLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  159 bits (403), Expect = 3e-41
 Identities = 59/329 (17%), Positives = 110/329 (33%), Gaps = 35/329 (10%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG--------------SLSSI 72
               LE L +  N++ G+       +  LK L+L +++ S                L  +
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 73  --ADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKC 130
               N ++    +     + S    L V  L  N +   L       L  ++    +S  
Sbjct: 387 NLTKNKISKIESD-----AFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLSYN 440

Query: 131 NVSGGIPEEIGNLTNLTAIYLGGNKLNG--SIPFTLRELQKLQYVGLKDNKLEGTIPYDI 188
                       + +L  + L    L    S P   + L+ L  + L +N +       +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500

Query: 189 FRLVKLYKLDLGGNKLS--------GSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLK 238
             L KL  LDL  N L+        G  +     L+ L  L+L  N  D        +L 
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560

Query: 239 VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNN 297
            L  ID  +NN +++  +   +   L+ L L  N++        G    +L  L+   N 
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620

Query: 298 LSGAIPLLLEKLSYLEHLNLSFNKLEGEI 326
                  +   ++++   + +  +L    
Sbjct: 621 FDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  148 bits (375), Expect = 1e-37
 Identities = 46/247 (18%), Positives = 91/247 (36%), Gaps = 14/247 (5%)

Query: 95  SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGN 154
           S  V   S+  L  +       +L  ++ + +++   +           + LT++ +G N
Sbjct: 5   SHEVADCSHLKLTQVPD-----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 155 KLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSN 214
            ++   P   ++L  L+ + L+ N+L             L +L L  N +       F  
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 215 LASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD--LQYLFLG 270
             +L TL LS+N            L+ L  +  S N   ++    +    +  L+ L L 
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP---LLLEKLSYLEHLNLSFNKLEGEIP 327
            N +K   P     +  L  L  +N  L  ++     L    + + +L+LS ++L     
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 328 KGGSFGN 334
              +F  
Sbjct: 240 --TTFLG 244

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  163 bits (414), Expect = 2e-45
 Identities = 47/227 (20%), Positives = 95/227 (41%), Gaps = 20/227 (8%)

Query: 415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEI 474
                +   +       +  +G FG ++K+++     VAVK+F +Q  ++++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 475 MKSIHYRNLVKIISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID 530
           +  + + N+++ I +       +    L+      GSL   L ++  ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129

Query: 531 VASVLEYLHFNFLV-------PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT 583
           +A  L YLH +           + H D+K  NVLL + + A ++DFG+         +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 584 QTQTLATIGYIAPEYGREG-----RVFANGDVYSFGIMLMEIHSAKQ 625
               + T  Y+APE            F   D+Y+ G++L E+ S   
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  170 bits (433), Expect = 7e-45
 Identities = 55/378 (14%), Positives = 110/378 (29%), Gaps = 51/378 (13%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGV---------VPAAIFDVSTLKDLALQDNYLSGSLS 70
           ++P  + +   L+ L +  N  +           +         ++   +  N L    +
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565

Query: 71  SIADNYLTS------STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEI 124
           S +   +           ++  L +      L    L  N +  I         +  +E 
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPE--DFCAFTDQVEG 623

Query: 125 FDMSKCNVSGGIPE--EIGNLTNLTAIYLGGNKL-----NGSIPFTLRELQKLQYVGLKD 177
              S   +   IP      ++  + ++    NK+     N S      +      V L  
Sbjct: 624 LGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682

Query: 178 NKLEGTIPYDIFRLVKLYKLDLGGNKLS-------GSILTCFSNLASLRTLSLSYN---D 227
           N+++            +  + L  N ++             + N   L T+ L +N    
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742

Query: 228 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYL------FLGYNILKGSIPDS 281
                    L  L  +D S N FSS  PT   +   L+            N +    P  
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801

Query: 282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAE--- 338
           +    SL  L   +N++   +   L     L  L+++ N     I          A    
Sbjct: 802 ITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNI-SIDVTSVCPYIEAGMYV 857

Query: 339 -SFEGNKLLCGSPNLHVP 355
             ++  + + G   L + 
Sbjct: 858 LLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  168 bits (427), Expect = 5e-44
 Identities = 59/332 (17%), Positives = 99/332 (29%), Gaps = 34/332 (10%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
           N   +  L L      G VP AI  ++ LK L+   +  + S     D  LT    E   
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380

Query: 87  LS--------SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH----SLEIFDMSKCNVSG 134
                      L   + L +  L  + +N       I   S       +I +++  N   
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT--NRIT 438

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
            I + I  LT L  IY   +           E     Y      K           L  L
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELSWSNLKDL 493

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYN-----------DGPLPLEIGNLKVLIGI 243
             ++L        +     +L  L++L+++ N              L  +      +   
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553

Query: 244 DFSMNNFSSV-IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAI 302
               NN        ++  +  L  L   +N +     ++ G  + L  L    N +    
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIP 611

Query: 303 PLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
                    +E L  S NKL+  IP   +  +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  158 bits (401), Expect = 1e-40
 Identities = 51/326 (15%), Positives = 99/326 (30%), Gaps = 45/326 (13%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            I  +      +  +    N +  +  AI  ++ L+ +   ++  +              
Sbjct: 416 PIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY------------- 462

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                     +                      S  NL   L   ++  C     +P+ +
Sbjct: 463 ---------DNIAVDWEDANSDYAKQYENEEL-SWSNLK-DLTDVELYNCPNMTQLPDFL 511

Query: 141 GNLTNLTAIYLGGNKLNG---------SIPFTLRELQKLQYVGLKDNKLEG-TIPYDIFR 190
            +L  L ++ +  N+             +        K+Q   +  N LE       + +
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIG-NLKVLIGIDFSMN 248
           +VKL  LD   NK+    L  F     L  L L YN    +P +       + G+ FS N
Sbjct: 572 MVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629

Query: 249 NFSSVIPTT-IGSLKDLQYLFLGYNILKGSIPD-----SVGDLISLKSLNFSNNNLSGAI 302
               +       S+  +  +   YN +     +          I+  ++  S N +    
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689

Query: 303 PLLLEKLSYLEHLNLSFNKLEGEIPK 328
             L    S +  + LS N +   IP+
Sbjct: 690 TELFATGSPISTIILSNNLMT-SIPE 714

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  130 bits (328), Expect = 1e-31
 Identities = 46/312 (14%), Positives = 89/312 (28%), Gaps = 43/312 (13%)

Query: 39  NNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVV 98
           +         + +   +  L+L      G +                   ++     L V
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVP-----------------DAIGQLTELKV 351

Query: 99  FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG------NLTNLTAIYLG 152
                +           G+   + ++ +  K  +     +         NL++L    + 
Sbjct: 352 LSFGTHSETVSGR--LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409

Query: 153 GNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCF 212
            N     I    R   K   +G   N++   I   I RL KL  +    +  +   +   
Sbjct: 410 RNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD 468

Query: 213 SNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
              A+              L   NLK L  ++       + +P  +  L +LQ L +  N
Sbjct: 469 WEDANSDYAKQY---ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

Query: 273 ILKG---------SIPDSVGDLISLKSLNFSNNNLSG-AIPLLLEKLSYLEHLNLSFNKL 322
                         + D       ++      NNL        L+K+  L  L+   NK+
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV 585

Query: 323 EGEIPKGGSFGN 334
              +    +FG 
Sbjct: 586 R-HLE---AFGT 593

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  123 bits (309), Expect = 3e-29
 Identities = 43/273 (15%), Positives = 85/273 (31%), Gaps = 15/273 (5%)

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLN--GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
               + S   N     +    N  L+  G  P + + N    +    ++     G +P+ 
Sbjct: 284 KNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR-VTGLSLAGFGAKGRVPDA 342

Query: 140 IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLD 198
           IG LT L  +  G +    S      E         + +++             +L   D
Sbjct: 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402

Query: 199 LGGNKLSGS------ILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS 252
           L  + ++ +            +L   +  +L+     +   I  L  L  I F+ + F+ 
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY 462

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
                     D +     Y     +   S  +L  L  +   N      +P  L  L  L
Sbjct: 463 DNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517

Query: 313 EHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKL 345
           + LN++ N+          +   + +   G K+
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 20/153 (13%), Positives = 45/153 (29%), Gaps = 22/153 (14%)

Query: 21  EIPSEI---NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYL 77
            +  +        L  + +  N      P    + S LK   ++             N +
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQ------RDAEGNRI 794

Query: 78  TSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSK-CNVSGGI 136
               P       ++ C SL+   + +N +  +        L+  L I D++   N+S  +
Sbjct: 795 LRQWPT-----GITTCPSLIQLQIGSNDIRKVDE-----KLTPQLYILDIADNPNISIDV 844

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK 169
                 +       L  +K           +++
Sbjct: 845 TSVCPYIEAGM-YVLLYDKTQDIRGCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 9/77 (11%), Positives = 24/77 (31%)

Query: 270 GYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
             ++        + +   +  L+ +     G +P  + +L+ L+ L+   +         
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 330 GSFGNFSAESFEGNKLL 346
           G        S E    +
Sbjct: 367 GDEELTPDMSEERKHRI 383

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  166 bits (422), Expect = 3e-44
 Identities = 66/335 (19%), Positives = 110/335 (32%), Gaps = 14/335 (4%)

Query: 3   SISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQD 62
           +++I +  L   D      I       N+    L    +  V   +       + L L +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVN 313

Query: 63  NYLSGSLSSIADN--YLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGI-LPRMSIGNLS 119
                  +    +   LT ++ +     S  +  SL    LS N L+       S    +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 120 HSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDN 178
            SL+  D+S   V   +      L  L  +    + L     F     L+ L Y+ +   
Sbjct: 374 -SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 179 KLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC-FSNLASLRTLSLSYN--DGPLPLEIG 235
                       L  L  L + GN    + L   F+ L +L  L LS    +   P    
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI-SLKSLNFS 294
           +L  L  ++ S NNF S+       L  LQ L    N +  S    +     SL  LN +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 295 NNNLSGAIPL--LLEKLSYLEHLNLSFNKLEGEIP 327
            N+ +        L+ +     L +   ++E   P
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (411), Expect = 9e-43
 Identities = 61/329 (18%), Positives = 111/329 (33%), Gaps = 24/329 (7%)

Query: 35  LLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD--------NYLTSSTPELSF 86
              + NL     +A+  +  L     +  YL   L  I D        +  +  +  +  
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           +   S         L N                 +         +  GG      +L +L
Sbjct: 297 VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-------TSNKGGNAFSEVDLPSL 349

Query: 147 TAIYLGGNKLN--GSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL 204
             + L  N L+  G    +      L+Y+ L  N +  T+  +   L +L  LD   + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 205 SGSI-LTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFS-SVIPTTIGS 260
                 + F +L +L  L +S+             L  L  +  + N+F  + +P     
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 261 LKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
           L++L +L L    L+   P +   L SL+ LN S+NN         + L+ L+ L+ S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 321 KLEGEIPK--GGSFGNFSAESFEGNKLLC 347
            +     +       + +  +   N   C
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  151 bits (383), Expect = 4e-39
 Identities = 66/335 (19%), Positives = 114/335 (34%), Gaps = 40/335 (11%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG-------SLSS-- 71
           +IP  + P + + L L  N L  +   + F    L+ L L    +         SLS   
Sbjct: 21  KIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +  N + S         + S   SL   +     L  +     IG+L  +L+  +++
Sbjct: 80  TLILTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLENF-PIGHLK-TLKELNVA 132

Query: 129 KCNVSGG-IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG----LKDNKLEGT 183
              +    +PE   NLTNL  + L  NK+       LR L ++  +     L  N +   
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSIL-TCFSNLASLRTLSLSYNDGPL-----PLEIGNL 237
            P   F+ ++L+KL L  N  S +++ TC   LA L    L   +          +   L
Sbjct: 193 QP-GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 238 KVLIGIDFSMNNFSSV------IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSL 291
           + L  +       + +      I      L ++    L    ++     S       + L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHL 309

Query: 292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEI 326
              N        L L+ L  L   +        E+
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  147 bits (374), Expect = 9e-38
 Identities = 50/268 (18%), Positives = 86/268 (32%), Gaps = 19/268 (7%)

Query: 90  LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAI 149
           +    ++    +  N    I       NL  S +  D+S   +         +   L  +
Sbjct: 4   VEVVPNITYQCMELN-FYKI-----PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 150 YLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSIL 209
            L   ++        + L  L  + L  N ++         L  L KL      L+    
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 210 TCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY 266
               +L +L+ L++++N      LP    NL  L  +D S N   S+  T +  L  +  
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 267 ----LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKLSYLEHLNLSFNK 321
               L L  N +   I       I L  L   NN  S  +    ++ L+ LE   L   +
Sbjct: 178 LNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 322 LEGEI----PKGGSFGNFSAESFEGNKL 345
              E         +       + E  +L
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRL 264

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  153 bits (388), Expect = 6e-42
 Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 20/198 (10%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IG G FGT++++    G +VAVK+   Q         F  E  IMK + + N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           +      +V E++  GSL + L+ S     LD  +RL++  DVA  + YLH N   P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            +LK  N+L+D      + DFG+++L      S        T  ++APE      V  + 
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPE------VLRDE 214

Query: 609 ------DVYSFGIMLMEI 620
                 DVYSFG++L E+
Sbjct: 215 PSNEKSDVYSFGVILWEL 232

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  151 bits (384), Expect = 1e-41
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA-------FKSFDIECEIMKSIHYRNLV 484
           IGKGGFG ++K R + D   VA+K   L            F+ F  E  IM ++++ N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           K+     N     +V+E +P G L   L      +    +L +M+D+A  +EY+  N   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 545 PVIHCDLKPSNVLLD-----DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-- 597
           P++H DL+  N+ L        + A ++DFG+++         + +  L    ++APE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 598 YGREGRVFANGDVYSFGIMLMEIHSAKQ 625
              E       D YSF ++L  I + + 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEG 226

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  158 bits (401), Expect = 2e-41
 Identities = 63/334 (18%), Positives = 104/334 (31%), Gaps = 31/334 (9%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG-------SLSS-- 71
           EIP  + P++ E L    N L  +       +  L  L L    +         S     
Sbjct: 26  EIPGTL-PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +  N L           +LS  K+L         ++ I   + + N   +LE   + 
Sbjct: 85  TLVLTANPLIFMAET-----ALSGPKALKHLFFIQTGISSI-DFIPLHNQK-TLESLYLG 137

Query: 129 KCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ--YVGLKDNKLEGTIPY 186
             ++S     +      L  +    N ++      +  LQ+     + L  N +   I  
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEP 196

Query: 187 DIFRLVKLYKLDLGGNKLSGSILT--CFSNLASLRTLSLSYND----GPLPLEIGNLKVL 240
             F       L+ GG +    I      S + SL   +    D     P   E      +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
             I+   + F ++   T      LQ L L    L   +P  +  L +LK L  S N    
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315

Query: 301 AIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
              +       L HL++  N    E+   G   N
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGT-GCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  149 bits (377), Expect = 3e-38
 Identities = 58/346 (16%), Positives = 110/346 (31%), Gaps = 25/346 (7%)

Query: 9   LELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIF--DVSTLKDLALQDNYLS 66
           L LN++  +     P   +    + L  G    + V+   +    + +L     +D    
Sbjct: 182 LSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

Query: 67  GSLSSIADNYLTSSTPELSF---------LSSLSNCKSLVVFLLSNNPLNGILPRMSIGN 117
               ++ +     S   ++           ++      L    L+   L+ +     +  
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPS--GLVG 299

Query: 118 LSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI-PFTLRELQKLQYVGLK 176
           LS +L+   +S             N  +LT + + GN     +    L  L+ L+ + L 
Sbjct: 300 LS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358

Query: 177 DNKLE--GTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---DGPLP 231
            + +E        +  L  L  L+L  N+        F     L  L L++         
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418

Query: 232 LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVG---DLISL 288
               NL +L  ++ S +            L  LQ+L L  N               L  L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
           + L  S  +LS         L  + H++LS N+L        +  +
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI--EALSH 522

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  149 bits (377), Expect = 4e-38
 Identities = 63/331 (19%), Positives = 110/331 (33%), Gaps = 26/331 (7%)

Query: 27  NPHNLEELLLG-QNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELS 85
           +      L L    N +  +    FD +  + L          +     N    S    +
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234

Query: 86  F----LSSLSN-------CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG 134
           F       +S          S+    L  +    I    +    S  L+  D++  ++S 
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN-TFHCFS-GLQELDLTATHLSE 292

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVK 193
            +P  +  L+ L  + L  NK       +      L ++ +K N     +       L  
Sbjct: 293 -LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351

Query: 194 LYKLDLGGNKLSGSILT--CFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNN 249
           L +LDL  + +  S        NL+ L++L+LSYN+              L  +D +   
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 250 FSSVIP-TTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL--- 305
                  +   +L  L+ L L +++L  S       L +L+ LN   N+           
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 306 LEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
           L+ L  LE L LSF  L        +F +  
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQ--HAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  145 bits (368), Expect = 5e-37
 Identities = 69/330 (20%), Positives = 117/330 (35%), Gaps = 35/330 (10%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS 89
           ++E + L ++    +        S L++L L   +LS                     S 
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS------------------ELPSG 296

Query: 90  LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE-IGNLTNLTA 148
           L    +L   +LS N    +  ++S  N   SL    +        +    + NL NL  
Sbjct: 297 LVGLSTLKKLVLSANKFENL-CQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRE 354

Query: 149 IYLGGNKLNGS--IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
           + L  + +  S      LR L  LQ + L  N+             +L  LDL   +L  
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414

Query: 207 SI-LTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
               + F NL  L+ L+LS++  D         L  L  ++   N+F         SL+ 
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 264 ---LQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
              L+ L L +  L      +   L  +  ++ S+N L+ +    L  L  + +LNL+ N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533

Query: 321 KLEGEIPKGGSFGNFSAES---FEGNKLLC 347
            +   +P        S +       N L C
Sbjct: 534 HISIILP--SLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  121 bits (305), Expect = 6e-29
 Identities = 47/236 (19%), Positives = 70/236 (29%), Gaps = 12/236 (5%)

Query: 98  VFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN 157
            +   N  LN I      G L +S E  + S   +          L NLT + L   ++ 
Sbjct: 16  TYNCENLGLNEI-----PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 158 GSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLAS 217
                T +   +L  + L  N L       +     L  L      +S        N  +
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 218 LRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ--YLFLGYNI 273
           L +L L  N        +    + L  +DF  N    +    + SL+      L L  N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 274 LKGSIPDSVGDLISLKSLNFSNNNLSGAIP--LLLEKLSYLEHLNLSFNKLEGEIP 327
           +   I     D    +SLNF        I   L    +  L          E   P
Sbjct: 191 IA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 22/194 (11%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS-------------SIADN 75
            +L+ L L  N  + +   A  +   L+ L L    L    +             +++ +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 76  YLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRM--SIGNLSHSLEIFDMSKCNVS 133
            L  S+ +L          +L    L  N       +   S+  L   LEI  +S C++S
Sbjct: 436 LLDISSEQL-----FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG-RLEILVLSFCDLS 489

Query: 134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK 193
                   +L  +  + L  N+L  S    L  L+ + Y+ L  N +   +P  +  L +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548

Query: 194 LYKLDLGGNKLSGS 207
              ++L  N L  +
Sbjct: 549 QRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.0 bits (133), Expect = 6e-08
 Identities = 27/148 (18%), Positives = 54/148 (36%), Gaps = 23/148 (15%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG----------SLSS----- 71
           N H L+ L L  + L          +  L+ L LQ N+             +L       
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482

Query: 72  IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN 131
           ++   L+S         + ++ K +    LS+N L       ++ +L       +++  +
Sbjct: 483 LSFCDLSSIDQH-----AFTSLKMMNHVDLSHNRLTSS-SIEALSHLK--GIYLNLASNH 534

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGS 159
           +S  +P  +  L+    I L  N L+ +
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  149 bits (378), Expect = 7e-41
 Identities = 41/196 (20%), Positives = 86/196 (43%), Gaps = 17/196 (8%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           + +   G ++K R   G ++ VKV  ++    R  + F+ EC  ++   + N++ ++ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 491 SNEEFKEL--VLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
            +        +   MP+GSL   L+      +D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
              L   +V++D+ M A +S   +         S      +    ++APE  ++     N
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 608 G---DVYSFGIMLMEI 620
               D++SF ++L E+
Sbjct: 189 RRSADMWSFAVLLWEL 204

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (376), Expect = 2e-40
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 433 IGKGGFGTIYKSRIGDGM---EVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKII 487
           IG G FGT+YK     G    +VAVK+ ++     +  ++F  E  +++   + N++  +
Sbjct: 32  IGSGSFGTVYK-----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
              +  +   +V +     SL   L++S    ++ + ++I    A  ++YLH      +I
Sbjct: 87  GYSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SII 142

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE---YGREGRV 604
           H DLK +N+ L +     + DFG+         S    Q   +I ++APE          
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 605 FANGDVYSFGIMLMEIHSAKQ 625
               DVY+FGI+L E+ + + 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQL 223

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  148 bits (375), Expect = 4e-40
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G+G FG + K++     +VA+K    +     K+F +E   +  +++ N+VK+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 493 EEFKELVLEHMPHGSLEKCLYSSN--CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
                LV+E+   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 73  PVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 551 LKPSNVLLDDTM-VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG- 608
           LKP N+LL     V  + DFG        D     T    +  ++APE      VF    
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPE------VFEGSN 179

Query: 609 -----DVYSFGIMLMEI 620
                DV+S+GI+L E+
Sbjct: 180 YSEKCDVFSWGIILWEV 196

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (364), Expect = 6e-39
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSIHYRNLVKIIS 488
           IG GGFG +Y++    G EVAVK           +  ++   E ++   + + N++ +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
            C  E    LV+E    G L + L      +     +N  + +A  + YLH   +VP+IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 549 CDLKPSNVLLDDTMVAH--------LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
            DLK SN+L+   +           ++DFG+ +        M+         ++APE   
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAA---GAYAWMAPE--- 184

Query: 601 EGRVFANG------DVYSFGIMLMEI 620
              V          DV+S+G++L E+
Sbjct: 185 ---VIRASMFSKGSDVWSYGVLLWEL 207

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  144 bits (367), Expect = 2e-38
 Identities = 74/323 (22%), Positives = 138/323 (42%), Gaps = 25/323 (7%)

Query: 5   SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY 64
           SI KL +  + + S   I       NLE L L  N +  + P  + ++  L +L +  N 
Sbjct: 45  SITKLVVAGEKVAS---IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99

Query: 65  LSGSLSSIAD----NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH 120
           ++  +S++ +      L  +   +S +S L+N   +    L  N     L    + N++ 
Sbjct: 100 IT-DISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLS--PLSNMT- 155

Query: 121 SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKL 180
            L    +++  V       I NLT+L ++ L  N++    P  L  L  L Y     N++
Sbjct: 156 GLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI 211

Query: 181 EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVL 240
               P  +  + +L  L +G NK++   L+  +NL+ L  L +  N       + +L  L
Sbjct: 212 TDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISDINAVKDLTKL 267

Query: 241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
             ++   N  S +    + +L  L  LFL  N L     + +G L +L +L  S N+++ 
Sbjct: 268 KMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

Query: 301 AIPLLLEKLSYLEHLNLSFNKLE 323
             P  L  LS ++  + +   ++
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  143 bits (363), Expect = 5e-38
 Identities = 61/332 (18%), Positives = 130/332 (39%), Gaps = 42/332 (12%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS-----GSLSS---- 71
           +I  + +       +L + ++  VV     ++ ++  L +    ++       L++    
Sbjct: 14  QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQGIEYLTNLEYL 71

Query: 72  -IADNYLTSSTP---------------ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSI 115
            +  N +T  +P               +++ +S+L N  +L    L+ + ++ I P   +
Sbjct: 72  NLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP---L 128

Query: 116 GNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL 175
            NL+  +   ++   +        + N+T L  + +  +K+    P     L  L  + L
Sbjct: 129 ANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSL 184

Query: 176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIG 235
             N++E   P  +  L  L+      N+++   +T  +N+  L +L +  N       + 
Sbjct: 185 NYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLA 240

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN 295
           NL  L  ++   N  S +    +  L  L+ L +G N +       + +L  L SL  +N
Sbjct: 241 NLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNN 296

Query: 296 NNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
           N L      ++  L+ L  L LS N +    P
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  125 bits (316), Expect = 9e-32
 Identities = 53/252 (21%), Positives = 102/252 (40%), Gaps = 19/252 (7%)

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L +    ++ +   ++    +  +L    +  ++       L  S+    ++   V+   
Sbjct: 5   LATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT---QEELE-SITKLVVAGEKVAS-- 58

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
            + I  LTNL  + L GN++    P +   L KL  + +  NK+  T    +  L  L +
Sbjct: 59  IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLRE 114

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYNDG-PLPLEIGNLKVLIGIDFSMNNFSSVIP 255
           L L  + +S   ++  +NL  + +L+L  N        + N+  L  +  + +    V P
Sbjct: 115 LYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP 172

Query: 256 TTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHL 315
             I +L DL  L L YN ++   P  +  L SL       N ++   P  +  ++ L  L
Sbjct: 173 --IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226

Query: 316 NLSFNKLEGEIP 327
            +  NK+    P
Sbjct: 227 KIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 70.6 bits (174), Expect = 3e-13
 Identities = 24/134 (17%), Positives = 50/134 (37%), Gaps = 8/134 (5%)

Query: 194 LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV 253
              L      ++   +   ++LA      L        +    L+ +  +  +    +S+
Sbjct: 2   AATLATLPAPINQ--IFPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASI 59

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE 313
               I  L +L+YL L  N +    P  + +L+ L +L    N ++      L+ L+ L 
Sbjct: 60  QG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTNLR 113

Query: 314 HLNLSFNKLEGEIP 327
            L L+ + +    P
Sbjct: 114 ELYLNEDNISDISP 127

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  144 bits (364), Expect = 2e-38
 Identities = 46/212 (21%), Positives = 88/212 (41%), Gaps = 26/212 (12%)

Query: 431 NLIGKGGFGTIYKSRIGDGM---EVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVK 485
            LIGKG FG +Y      G    EVA+++  ++       K+F  E    +   + N+V 
Sbjct: 39  ELIGKGRFGQVYH-----GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
            + +C +     ++       +L   +  +  +LD+ +   I  ++   + YLH      
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---G 150

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKL---LIGEDQSMTQTQTLATIGYIAPEYGREG 602
           ++H DLK  NV  D+  V  ++DFG+  +   L    +          + ++APE  R+ 
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 603 RVFANG---------DVYSFGIMLMEIHSAKQ 625
                          DV++ G +  E+H+ + 
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  142 bits (360), Expect = 7e-38
 Identities = 59/242 (24%), Positives = 89/242 (36%), Gaps = 32/242 (13%)

Query: 415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEI 474
            +  E            LIG+G +G +YK  + D   VAVKVF        ++F  E  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNI 58

Query: 475 MK--SIHYRNLVKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
            +   + + N+ + I               LV+E+ P+GSL K L       D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRL 116

Query: 528 MIDVASVLEYLH------FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
              V   L YLH       ++   + H DL   NVL+ +     +SDFG++  L G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 582 MTQTQTLA------TIGYIAPEYGRE-------GRVFANGDVYSFGIMLMEIHSAKQQCV 628
               +  A      TI Y+APE                  D+Y+ G++  EI        
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 629 SF 630
             
Sbjct: 237 PG 238

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  141 bits (357), Expect = 2e-37
 Identities = 54/316 (17%), Positives = 104/316 (32%), Gaps = 36/316 (11%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD-----------NYLT 78
             E L    +  +      +   S  +     D     S    A+             L 
Sbjct: 13  GRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69

Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
           ++   L   +        V   L + PL    P      LSH L+   +    +   +P+
Sbjct: 70  ATADLLEDATQPG----RVALELRSVPLP-QFPD-QAFRLSH-LQHMTIDAAGLME-LPD 121

Query: 139 EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD-NKLE--------GTIPYDIF 189
            +     L  + L  N L  ++P ++  L +L+ + ++   +L              +  
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 190 RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMN 248
            LV L  L L    +  S+    +NL +L++L +  +    L   I +L  L  +D    
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGC 239

Query: 249 NFSSVIPTTIGSLKDLQYLFL-GYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE 307
                 P   G    L+ L L   + L  ++P  +  L  L+ L+         +P L+ 
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298

Query: 308 KLSYLEHLNLSFNKLE 323
           +L     + +  +   
Sbjct: 299 QLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 48/223 (21%), Positives = 83/223 (37%), Gaps = 23/223 (10%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS------GSLSSI- 72
           + P +     +L+ + +    L+  +P  +   + L+ L L  N L        SL+ + 
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLR 153

Query: 73  -----ADNYLTS---STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEI 124
                A   LT                   +L    L    +   LP  SI NL  +L+ 
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPA-SIANLQ-NLKS 210

Query: 125 FDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD-NKLEGT 183
             +    +S  +   I +L  L  + L G     + P        L+ + LKD + L  T
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           +P DI RL +L KLDL G      + +  + L +   + +  +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 32/213 (15%), Positives = 57/213 (26%), Gaps = 22/213 (10%)

Query: 134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK 193
           G       + +    +Y  G+         L + Q+                        
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 194 LYKLDLGGNKLSGSILTCFSNLAS--LRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNF 250
                  G  L  +      +        L L        P +   L  L  +       
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL 116

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP------- 303
              +P T+     L+ L L  N L+ ++P S+  L  L+ L+         +P       
Sbjct: 117 ME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174

Query: 304 --LLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
                + L  L+ L L +  +   +P   S  N
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPA--SIAN 204

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  146 bits (370), Expect = 2e-37
 Identities = 57/301 (18%), Positives = 102/301 (33%), Gaps = 13/301 (4%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS 89
            ++E  L   N           ++ +  ++L    +             S +     L  
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQ 321

Query: 90  LS--NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE--EIGNLTN 145
               +   L    L+ N  +    ++++     SL   D+S+  +S             +
Sbjct: 322 FPTLDLPFLKSLTLTMNKGSISFKKVAL----PSLSYLDLSRNALSFSGCCSYSDLGTNS 377

Query: 146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKL 204
           L  + L  N     +      L++LQ++  + + L+    +  F  L KL  LD+     
Sbjct: 378 LRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436

Query: 205 SGSILTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
                  F  L SL TL ++ N   D  L     N   L  +D S      +      +L
Sbjct: 437 KIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK 321
             LQ L + +N L          L SL +L+ S N +  +  +L      L   NL+ N 
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556

Query: 322 L 322
           +
Sbjct: 557 V 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  139 bits (353), Expect = 5e-35
 Identities = 71/338 (21%), Positives = 122/338 (36%), Gaps = 42/338 (12%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG-------SLSS-- 71
           ++P +I P + + + L  N L  +   +  + S L+ L L    +          L    
Sbjct: 25  KVPDDI-PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +  N + S +P      S S   SL   +     L  +     IG L  +L+  +++
Sbjct: 84  NLILTGNPIQSFSPG-----SFSGLTSLENLVAVETKLASLESF-PIGQL-ITLKKLNVA 136

Query: 129 KCNVSG-GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG----LKDNKLEGT 183
              +    +P    NLTNL  + L  N +       L+ L++   V     +  N ++  
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSIL-TCFSNLASLRTLSLSYND--GPLPLEIGNLKVL 240
           I    F+ +KL++L L GN  S +I+ TC  NLA L    L   +      LEI    ++
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 241 IG--------IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLN 292
            G           +  N  S        L ++  + L    +     + V      +SL+
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLS 313

Query: 293 FSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGG 330
                L          L +L+ L L+ NK      K  
Sbjct: 314 IIRCQLKQ---FPTLDLPFLKSLTLTMNKGSISFKKVA 348

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  136 bits (345), Expect = 5e-34
 Identities = 53/278 (19%), Positives = 92/278 (33%), Gaps = 13/278 (4%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG----SLSSIADNYLTSSTPELS 85
           N+  + L   ++  +           + L++    L       L  +    LT +  + S
Sbjct: 286 NVSAMSLAGVSIKYLEDVPKH--FKWQSLSIIRCQLKQFPTLDLPFL--KSLTLTMNKGS 341

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTN 145
                    SL    LS N L+           ++SL   D+S       +      L  
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEE 400

Query: 146 LTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL 204
           L  +    + L     F     L+KL Y+ +     +         L  L  L + GN  
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460

Query: 205 SGSILTC-FSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
             + L+  F+N  +L  L LS    +         L  L  ++ S NN   +  +    L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS 299
             L  L   +N ++ S         SL   N +NN+++
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  129 bits (327), Expect = 9e-32
 Identities = 56/330 (16%), Positives = 97/330 (29%), Gaps = 34/330 (10%)

Query: 30  NLEELLLGQNNLVGVVPAAIF-DVSTLKDLALQDNYLSG-------------SLSSIADN 75
            L EL L  N     +      +++ L    L                     L  +  +
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 76  YLTSSTPELSFLS--SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVS 133
               +                ++    L+   +  +             +   + +C + 
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED----VPKHFKWQSLSIIRCQLK 320

Query: 134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY--DIFRL 191
              P    +L  L ++ L  NK   SI F    L  L Y+ L  N L  +          
Sbjct: 321 Q-FPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375

Query: 192 VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMN 248
             L  LDL  N     +   F  L  L+ L   ++            +L+ L+ +D S  
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLE 307
           N           L  L  L +  N  K +   +V  +  +L  L+ S   L      + +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 308 KLSYLEHLNLSFNKLEGEIPKGGSFGNFSA 337
            L  L+ LN+S N L         +    +
Sbjct: 495 TLHRLQLLNMSHNNLLFLDS--SHYNQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  128 bits (323), Expect = 3e-31
 Identities = 45/248 (18%), Positives = 83/248 (33%), Gaps = 15/248 (6%)

Query: 85  SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLT 144
           S    +    ++      +  L+ +       ++  S +  D+S   +         N +
Sbjct: 3   SLNPCIEVVPNITYQC-MDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 145 NLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL 204
            L  + L   ++          L  L  + L  N ++   P     L  L  L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 205 SGSILTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
           +         L +L+ L++++N      LP    NL  L+ +D S N   ++    +  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 262 KDL----QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKLSYLEHLN 316
           ++       L +  N +   I D     I L  L    N  S  I    L+ L+ L    
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235

Query: 317 LSFNKLEG 324
           L   + + 
Sbjct: 236 LILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  123 bits (310), Expect = 1e-29
 Identities = 64/310 (20%), Positives = 98/310 (31%), Gaps = 35/310 (11%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
              +LE L+  +  L  +    I  + TLK L +  N++                     
Sbjct: 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS----------------CKL 145

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRM--SIGNLSHSLEIFDMSKCNVSGGIPEEIGNLT 144
            +  SN  +LV   LS N +  I       +          DMS   +   I ++     
Sbjct: 146 PAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI 204

Query: 145 NLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEG-----TIPYDIFR-LVKLYK- 196
            L  + L GN  + +I    L+ L  L    L   + +           I   L  +   
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 197 -LDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
              L         +  F  LA++  +SL+        ++        +            
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQF-- 322

Query: 256 TTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS--GAIPLLLEKLSYLE 313
                L  L+ L L  N  KGSI      L SL  L+ S N LS  G         + L 
Sbjct: 323 -PTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379

Query: 314 HLNLSFNKLE 323
           HL+LSFN   
Sbjct: 380 HLDLSFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 33/202 (16%), Positives = 60/202 (29%), Gaps = 20/202 (9%)

Query: 17  ESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS------ 70
            S C   S++  ++L  L L  N  + ++ A    +  L+ L  Q + L           
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 71  -------SIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLE 123
                   I+                     SL    ++ N            N + +L 
Sbjct: 423 LEKLLYLDISYTNTKIDFDG-----IFLGLTSLNTLKMAGNSFKDNTLSNVFANTT-NLT 476

Query: 124 IFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGT 183
             D+SKC +          L  L  + +  N L         +L  L  +    N++E +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 184 IPYDIFRLVKLYKLDLGGNKLS 205
                     L   +L  N ++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  137 bits (346), Expect = 3e-36
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 25/209 (11%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVKIIS 488
             +GKG +G +++     G  VAVK+F  +     KS+  E E+  ++  R  N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIA 69

Query: 489 SCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           S            L+  +   GSL   L      LD    L I++ +AS L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 545 -----PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA--TIGYIAPE 597
                 + H DLK  N+L+       ++D G+  +       +         T  Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 598 ------YGREGRVFANGDVYSFGIMLMEI 620
                        +   D+++FG++L E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  140 bits (356), Expect = 4e-36
 Identities = 79/326 (24%), Positives = 138/326 (42%), Gaps = 44/326 (13%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NYLTSSTPELS 85
            L ++L+  N +  + P  + +++ L  L L +N ++  +  + +    N L  S+  +S
Sbjct: 91  KLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDPLKNLTNLNRLELSSNTIS 147

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTN 145
            +S+LS   SL      N  +  + P   + NL+ +LE  D+S   VS      +  LTN
Sbjct: 148 DISALSGLTSLQQLSFGNQ-VTDLKP---LANLT-TLERLDISSNKVSD--ISVLAKLTN 200

Query: 146 LTAIYLGGNKLNGSIPF--------------------TLRELQKLQYVGLKDNKLEGTIP 185
           L ++    N+++   P                     TL  L  L  + L +N++    P
Sbjct: 201 LESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP 260

Query: 186 YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDF 245
             +  L KL +L LG N++S   ++  + L +L  L L+ N       I NLK L  +  
Sbjct: 261 --LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 316

Query: 246 SMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL 305
             NN S + P  + SL  LQ LF   N +      S+ +L ++  L+  +N +S   P  
Sbjct: 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP-- 370

Query: 306 LEKLSYLEHLNLSFNKLEGEIPKGGS 331
           L  L+ +  L L+            +
Sbjct: 371 LANLTRITQLGLNDQAWTNAPVNYKA 396

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  133 bits (337), Expect = 1e-33
 Identities = 73/313 (23%), Positives = 131/313 (41%), Gaps = 30/313 (9%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS- 79
           +I ++       + +LG+ N+   V     D+  +  L      +  S+  +   YL + 
Sbjct: 16  QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGV--EYLNNL 70

Query: 80  -----STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG 134
                S  +L+ ++ L N   LV  L++NN +  I P   + NL+ +L    +    ++ 
Sbjct: 71  TQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP---LANLT-NLTGLTLFNNQITD 126

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
              + + NLTNL  + L  N ++     +   L  LQ +    N++    P  +  L  L
Sbjct: 127 --IDPLKNLTNLNRLELSSNTISDISALS--GLTSLQQLSF-GNQVTDLKP--LANLTTL 179

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
            +LD+  NK+S   ++  + L +L +L  + N       +G L  L  +  + N    + 
Sbjct: 180 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIG 237

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
              + SL +L  L L  N +    P  +  L  L  L    N +S   P  L  L+ L +
Sbjct: 238 T--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291

Query: 315 LNLSFNKLEGEIP 327
           L L+ N+LE   P
Sbjct: 292 LELNENQLEDISP 304

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  126 bits (319), Expect = 2e-31
 Identities = 63/307 (20%), Positives = 125/307 (40%), Gaps = 24/307 (7%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NY 76
           +I +     +L++L  G N +  + P  + +++TL+ L +  N +S  +S +A       
Sbjct: 148 DISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVS-DISVLAKLTNLES 203

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L ++  ++S ++ L    +L    L+ N L  I     + +L+ +L   D++   +S   
Sbjct: 204 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGT---LASLT-NLTDLDLANNQISN-- 257

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
              +  LT LT + LG N+++   P     L  L  + L +N+LE   P  I  L  L  
Sbjct: 258 LAPLSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTY 313

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           L L  N +S   ++  S+L  L+ L    N       + NL  +  +    N  S + P 
Sbjct: 314 LTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP- 370

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN 316
            + +L  +  L L       +  +   ++    ++      L    P  +         +
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPD 427

Query: 317 LSFNKLE 323
           +++N   
Sbjct: 428 ITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  125 bits (316), Expect = 6e-31
 Identities = 55/254 (21%), Positives = 104/254 (40%), Gaps = 20/254 (7%)

Query: 71  SIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKC 130
            +    +T  TP ++ + + +     +  +L    +   +      +L   +      + 
Sbjct: 2   PLGSATITQDTP-INQIFTDTALAEKMKTVLGKTNVTDTVS---QTDLD-QVTTLQADRL 56

Query: 131 NVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR 190
            +     + +  L NLT I    N+L    P     L KL  + + +N++    P  +  
Sbjct: 57  GIK--SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LAN 110

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
           L  L  L L  N+++   +    NL +L  L LS N       +  L  L  + F  N  
Sbjct: 111 LTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG-NQV 167

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS 310
           + + P  + +L  L+ L +  N +  S    +  L +L+SL  +NN +S   P  L  L+
Sbjct: 168 TDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILT 221

Query: 311 YLEHLNLSFNKLEG 324
            L+ L+L+ N+L+ 
Sbjct: 222 NLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 95.0 bits (237), Expect = 6e-21
 Identities = 51/263 (19%), Positives = 100/263 (38%), Gaps = 18/263 (6%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN----Y 76
           +I       NL+EL L  N L  +    +  ++ L DL L +N +S +L+ ++       
Sbjct: 213 DITPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQIS-NLAPLSGLTKLTE 269

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L     ++S +S L+   +L    L+ N L  I P   I NL  +L    +   N+S   
Sbjct: 270 LKLGANQISNISPLAGLTALTNLELNENQLEDISP---ISNLK-NLTYLTLYFNNISD-- 323

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
              + +LT L  ++   NK++         L  + ++    N++    P  +  L ++ +
Sbjct: 324 ISPVSSLTKLQRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQ 379

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           L L     + + +   +N++   T+         P  I +       D + N  S     
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNE 438

Query: 257 TIGSLKDLQYLFLGYNILKGSIP 279
              +      +  G     G++ 
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 14/80 (17%), Positives = 29/80 (36%), Gaps = 6/80 (7%)

Query: 248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE 307
              + +      +L +     LG   +  ++  +  DL  + +L      +     +  E
Sbjct: 12  TPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGV--E 65

Query: 308 KLSYLEHLNLSFNKLEGEIP 327
            L+ L  +N S N+L    P
Sbjct: 66  YLNNLTQINFSNNQLTDITP 85

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  137 bits (346), Expect = 7e-36
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 25/209 (11%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKIIS 488
             IGKG +G ++  +   G +VAVKVF         S+  E EI     + + N++  I+
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 489 SCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH----- 539
           +            L+ ++  +GSL   L S+   LD    L +     S L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA--TIGYIAPE 597
                 + H DLK  N+L+       ++D G+    I +   +         T  Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 598 ------YGREGRVFANGDVYSFGIMLMEI 620
                      + +   D+YSFG++L E+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  135 bits (341), Expect = 2e-35
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 28/207 (13%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +GKG FG   K      G  + +K          ++F  E ++M+ + + N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDL 551
            ++    + E++  G+L   + S +      QR++   D+AS + YLH      +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDL 134

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA------------TIGYIAPEYG 599
              N L+ +     ++DFG+ +L++ E       ++L                ++APE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE-- 192

Query: 600 REGRVFANG------DVYSFGIMLMEI 620
               +          DV+SFGI+L EI
Sbjct: 193 ----MINGRSYDEKVDVFSFGIVLCEI 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  134 bits (340), Expect = 5e-35
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKIIS 488
             IGKG FG +++ +   G EVAVK+F  +     +S+  E EI     + + N++  I+
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 489 SCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           + + +        LV ++  HGSL   L      + +   + + +  AS L +LH   + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 545 -----PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA--TIGYIAPE 597
                 + H DLK  N+L+       ++D G+         ++         T  Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 598 ------YGREGRVFANGDVYSFGIMLMEI 620
                   +    F   D+Y+ G++  EI
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  130 bits (330), Expect = 1e-32
 Identities = 76/337 (22%), Positives = 132/337 (39%), Gaps = 37/337 (10%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P  I P     L LG+N +  +          L++L L +N     +S++        
Sbjct: 25  AVPEGI-PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN----IVSAVEPG----- 74

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                   + +N  +L    L +N L  ++P      LS +L   D+S+  +   + + +
Sbjct: 75  --------AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS-NLTKLDISENKIVI-LLDYM 123

Query: 141 -GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKL 197
             +L NL ++ +G N L   I       L  L+ + L+   L  +IP +    L  L  L
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVL 181

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYN-----DGPLPLEIGNLKVLIGIDFSMNNFSS 252
            L    ++      F  L  L+ L +S+        P  L   NL  L     +  N ++
Sbjct: 182 RLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL---SITHCNLTA 238

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
           V    +  L  L++L L YN +       + +L+ L+ +      L+   P     L+YL
Sbjct: 239 VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298

Query: 313 EHLNLSFNKLEGEIPKG--GSFGNFSAESFEGNKLLC 347
             LN+S N+L   + +    S GN      + N L C
Sbjct: 299 RVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  126 bits (317), Expect = 3e-30
 Identities = 69/329 (20%), Positives = 109/329 (33%), Gaps = 34/329 (10%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDV-STLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
            L    L  N+L   V        +  +++ L+   +SG+  ++      S+    S   
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
           SL     ++      + +         G    S+   D+S   V          L +L  
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKV 294

Query: 149 IYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGS 207
           + L  NK+N         L  LQ + L  N L   +    F  L K+  +DL  N ++  
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAII 353

Query: 208 ILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV-------------- 253
               F  L  L+TL L  N       I  +  +  I  S N   ++              
Sbjct: 354 QDQTFKFLEKLQTLDLRDN---ALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSE 410

Query: 254 -------IPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAI--- 302
                  I   +  +  LQ L L  N       D    +  SL+ L    N L  A    
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

Query: 303 --PLLLEKLSYLEHLNLSFNKLEGEIPKG 329
               + E LS+L+ L L+ N L   +P G
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLN-SLPPG 498

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  119 bits (300), Expect = 4e-28
 Identities = 79/375 (21%), Positives = 131/375 (34%), Gaps = 50/375 (13%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS- 79
           ++P     +  E LLL  N +  V  ++   +  L+ L L   Y   ++   A   L + 
Sbjct: 18  QVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 80  -----STPELSFLSS--LSNCKSLVVFLLSNNPL-NGILPRMSIGNLSHSLEIFDMSKCN 131
                 + ++ FL          L    L    L + +L      NL  +L   D+SK  
Sbjct: 76  RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK-ALTRLDLSKNQ 134

Query: 132 -VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ--KLQYVGLKDNKLEGTIPYDI 188
             S  +    G L +L +I    N++       L  LQ   L +  L  N L   +  D 
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194

Query: 189 ------FRLVKLYKLDLGGNKLSGSILTCFSNLAS------------LRTLSLSYN---- 226
                 FR + L  LD+ GN  +  I   FSN  S            +      ++    
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254

Query: 227 ---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVG 283
              +    L   +++ L   D S     S+      +LKDL+ L L YN +     ++  
Sbjct: 255 PDQNTFAGLARSSVRHL---DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 284 DLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSA---ESF 340
            L +L+ LN S N L          L  + +++L  N +   I    +F           
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQD-QTFKFLEKLQTLDL 369

Query: 341 EGNKL--LCGSPNLH 353
             N L  +   P++ 
Sbjct: 370 RDNALTTIHFIPSIP 384

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  102 bits (255), Expect = 1e-22
 Identities = 78/390 (20%), Positives = 137/390 (35%), Gaps = 47/390 (12%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS------STPE 83
           ++  L L    +  +       +  LK L L  N ++  ++  A   L +      S   
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNL 325

Query: 84  LSFL--SSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG 141
           L  L  S+      +    L  N +  I+   +   L   L+  D+    ++      I 
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLE-KLQTLDLRDNALT-----TIH 378

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEG-TIPYDIFRLVKLYKLDLG 200
            + ++  I+L GNKL  ++P        +    L +N+LE   I Y + R+  L  L L 
Sbjct: 379 FIPSIPDIFLSGNKLV-TLPKINLTANLIH---LSENRLENLDILYFLLRVPHLQILILN 434

Query: 201 GNKLSG-SILTCFSNLASLRTLSLSYN-------DGPLPLEIGNLKVLIGIDFSMNNFSS 252
            N+ S  S     S   SL  L L  N                 L  L  +  + N  +S
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
           + P     L  L+ L L  N L   +  +     +L+ L+ S N L        +    L
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLA---PNPDVFVSL 549

Query: 313 EHLNLSFNKLEGEIPKGG--SFGNFSAESFEGN--KLLCGSP---------NLHVPPCKT 359
             L+++ NK   E       ++ N +  +  G    + C  P         +L    C  
Sbjct: 550 SVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDE 609

Query: 360 SIHHTSRKNALFLGIVLSFSTIFMVVVILL 389
                S K +LF+   ++ +   M ++ + 
Sbjct: 610 EEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 98.7 bits (246), Expect = 2e-21
 Identities = 53/224 (23%), Positives = 84/224 (37%), Gaps = 18/224 (8%)

Query: 119 SHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN 178
           S    I     CN++  +P+    L     + L  N +      +   L++LQ + L   
Sbjct: 3   SFDGRIAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58

Query: 179 KLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---DGPLPLEI 234
               TI  + FR L  L  LDLG +K+       F  L  L  L L +    D  L    
Sbjct: 59  YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118

Query: 235 -GNLKVLIGIDFSMNNFSSV-IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDL--ISLKS 290
             NLK L  +D S N   S+ +  + G L  L+ +    N +       +  L   +L  
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178

Query: 291 LNFSNNNLSGAIPLLLEKLS------YLEHLNLSFNKLEGEIPK 328
            + + N+L   + +   K         LE L++S N    +I  
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 29/126 (23%), Positives = 53/126 (42%), Gaps = 8/126 (6%)

Query: 210 TCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL 269
           +    +A  R  +L+     +P  +   + L     S N   +V  ++   L+ LQ L L
Sbjct: 3   SFDGRIAFYRFCNLTQ----VPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLEL 55

Query: 270 GYNILKGSI-PDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK 328
           G      +I  ++  +L +L+ L+  ++ +    P   + L +L  L L F  L   + K
Sbjct: 56  GSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115

Query: 329 GGSFGN 334
            G F N
Sbjct: 116 DGYFRN 121

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 43/265 (16%), Positives = 85/265 (32%), Gaps = 28/265 (10%)

Query: 9   LELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDV-STLKDLALQDNYLSG 67
           + L+ + +E+   +   +   +L+ L+L QN               +L+ L L +N L  
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 68  SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
           +  +                        L V  L++N LN + P     +L+ +L    +
Sbjct: 466 AWETELCW------------DVFEGLSHLQVLYLNHNYLNSL-PPGVFSHLT-ALRGLSL 511

Query: 128 SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
           +   ++  +        NL  + +  N+L    P        L  + +  NK        
Sbjct: 512 NSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELS 566

Query: 188 IFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFS 246
            F   +    + + G     + + C     S   +SL              +VL  + FS
Sbjct: 567 TFINWLNHTNVTIAGPP---ADIYCVYPD-SFSGVSLFSLS---TEGCDEEEVLKSLKFS 619

Query: 247 MNNFSSVIPTTIGSLKDLQYLFLGY 271
           +    +V  T           F G+
Sbjct: 620 LFIVCTVTLTLFLMTILTVTKFRGF 644

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  120 bits (304), Expect = 7e-30
 Identities = 63/334 (18%), Positives = 119/334 (35%), Gaps = 42/334 (12%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
           EI +      H +++L +G N +  + P    +V  L  L L+ N     LSS+      
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN----DLSSLPRG--- 135

Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
                        N   L    +SNN L  I    +    + SL+   +S   ++  +  
Sbjct: 136 ----------IFHNTPKLTTLSMSNNNLERI-EDDTFQATT-SLQNLQLSSNRLTH-VD- 181

Query: 139 EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLD 198
            +  + +L    +  N L+     TL     ++ +    N +   +   +   V+L  L 
Sbjct: 182 -LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--VELTILK 232

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSVIPT 256
           L  N L+        N   L  + LSYN+   +       ++ L  +  S N   + +  
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNL 289

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN 316
               +  L+ L L +N L   +  +      L++L   +N++   +   L     L++L 
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 345

Query: 317 LSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP 350
           LS N  +        F N +  + +     C   
Sbjct: 346 LSHNDWD-CNSLRALFRNVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  113 bits (286), Expect = 2e-27
 Identities = 54/309 (17%), Positives = 111/309 (35%), Gaps = 36/309 (11%)

Query: 23  PSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTP 82
             +I  +N + +    + +  +  A +     ++ L L D      +  I          
Sbjct: 39  FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL----QIEEIDTY------- 87

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI-G 141
                 + +   ++    +  N +   LP     N+   L +  + + ++S  +P  I  
Sbjct: 88  ------AFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP-LLTVLVLERNDLSS-LPRGIFH 138

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG 201
           N   LT + +  N L      T +    LQ + L  N+L   +   +     L+  ++  
Sbjct: 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP--SLFHANVSY 195

Query: 202 NKLSGSILTCFSNLASLRTLSLSYNDGPLP-LEIGNLKVLIGIDFSMNNFSSVIPTTIGS 260
           N L     +  +   ++  L  S+N   +  +       L  +    NN +      + +
Sbjct: 196 NLL-----STLAIPIAVEELDASHN--SINVVRGPVNVELTILKLQHNNLTDT--AWLLN 246

Query: 261 LKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
              L  + L YN L+  +      +  L+ L  SNN L  A+ L  + +  L+ L+LS N
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 305

Query: 321 KLEGEIPKG 329
            L   + + 
Sbjct: 306 HLL-HVERN 313

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  106 bits (267), Expect = 5e-25
 Identities = 51/275 (18%), Positives = 98/275 (35%), Gaps = 27/275 (9%)

Query: 68  SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
                 D ++   T ++ F        +  +    N+ +  + P   + +    +E+ ++
Sbjct: 19  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSFR-QVELLNL 76

Query: 128 SKCNVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY 186
           +   +   I          +  +Y+G N +    P   + +  L  + L+ N L  ++P 
Sbjct: 77  NDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

Query: 187 DIFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLP-LEIGNLKVLIGID 244
            IF    KL  L +  N L       F    SL+ L LS N   L  +++  +  L   +
Sbjct: 135 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN--RLTHVDLSLIPSLFHAN 192

Query: 245 FSMNNFSSVIPTT----------------IGSLKDLQYLFLGYNILKGSIPDSVGDLISL 288
            S N  S++                         +L  L L +N L  +    + +   L
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGL 250

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
             ++ S N L   +     K+  LE L +S N+L 
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 35/222 (15%), Positives = 74/222 (33%), Gaps = 30/222 (13%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKL 194
           I   +        +++     +    F    L   + V  K++ +   +P  +     ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
             L+L   ++       F+   +++ L + +N                          + 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN----------------------AIRYLP 109

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLE 313
           P    ++  L  L L  N L  S+P  +  +   L +L+ SNNNL        +  + L+
Sbjct: 110 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168

Query: 314 HLNLSFNKLEGEIPKGGSFGNFSAESFEGNKL--LCGSPNLH 353
           +L LS N+L   +       +    +   N L  L     + 
Sbjct: 169 NLQLSSNRLT-HVDLSL-IPSLFHANVSYNLLSTLAIPIAVE 208

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 23/150 (15%), Positives = 53/150 (35%), Gaps = 5/150 (3%)

Query: 183 TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVL 240
            I  ++      Y + +               L + + ++   +    LP  +  + + +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLS 299
             ++ +      +          +Q L++G+N ++  +P  V  ++  L  L    N+LS
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 300 GAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
                +      L  L++S N LE  I   
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  119 bits (300), Expect = 6e-29
 Identities = 61/325 (18%), Positives = 115/325 (35%), Gaps = 50/325 (15%)

Query: 23  PSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTP 82
           P  ++   L+E L   +NL   +P    +V +  +     +    +           +  
Sbjct: 5   PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
            L         +      L+N  L+ +       +L    E    S  +++  +PE   +
Sbjct: 64  RLRDCL----DRQAHELELNNLGLSSLPE--LPPHL----ESLVASCNSLTE-LPELPQS 112

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           L +L         L+   P        L+Y+G+ +N+LE  +P ++     L  +D+  N
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNN 163

Query: 203 KLSG------------------SILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGI 243
            L                      L    NL  L  +    N    LP    +L+ +   
Sbjct: 164 SLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESI--- 220

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP 303
               N         + +L  L  ++   N+LK ++PD      SL++LN  +N L+  +P
Sbjct: 221 VAGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLP 273

Query: 304 LLLEKLSYLEHLNLSFNKLEGEIPK 328
            L + L++L+     F+ L    P 
Sbjct: 274 ELPQSLTFLDVSENIFSGLSELPPN 298

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  115 bits (290), Expect = 1e-27
 Identities = 72/343 (20%), Positives = 117/343 (34%), Gaps = 68/343 (19%)

Query: 21  EIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS-SIADNYLT 78
           E+P E  N  +  E     +      P    +   +    L+D     +    + +  L+
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 79  SSTPELSFLSSL--------------SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEI 124
           S       L SL               + KSL+V   +   L+ + P          LE 
Sbjct: 85  SLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPP---------LLEY 135

Query: 125 FDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTI 184
             +S   +   +PE + N + L  I +  N L   +P        L+++   +N+LE  +
Sbjct: 136 LGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLE-EL 188

Query: 185 PYDIFRLVKLYKLDLGGNKLSG------------------SILTCFSNLASLRTLSLSYN 226
           P ++  L  L  +    N L                      L    NL  L T+    N
Sbjct: 189 P-ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 247

Query: 227 D-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDL 285
               LP    +L+ L   +   N  +  +P    SL  L      ++ L    P      
Sbjct: 248 LLKTLPDLPPSLEAL---NVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP------ 297

Query: 286 ISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK 328
            +L  LN S+N +      L +    LE LN+S NKL  E+P 
Sbjct: 298 -NLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPA 334

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  107 bits (269), Expect = 7e-25
 Identities = 76/316 (24%), Positives = 116/316 (36%), Gaps = 47/316 (14%)

Query: 28  PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD-NYLTSSTPELSF 86
           P  LE L +  N L  +    + + S LK + + +N L           ++ +   +L  
Sbjct: 130 PPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 187

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           L  L N   L      NN L        + +L  SLE        +      E+ NL  L
Sbjct: 188 LPELQNLPFLTAIYADNNSLK------KLPDLPLSLESIVAGNNILE--ELPELQNLPFL 239

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
           T IY   N L  ++P     L+ L    ++DN L   +P     L  L   +   + LS 
Sbjct: 240 TTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSE 294

Query: 207 SI-----LTCFSN--------LASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSS 252
                  L   SN          SL  L++S N    LP     L+ L     S N+ + 
Sbjct: 295 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERL---IASFNHLAE 351

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
            +P    +LK    L + YN L+   PD    +  L+      N+    +P L + L   
Sbjct: 352 -VPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNL--- 398

Query: 313 EHLNLSFNKLEGEIPK 328
           + L++  N L  E P 
Sbjct: 399 KQLHVETNPLR-EFPD 413

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 99.7 bits (249), Expect = 2e-22
 Identities = 61/322 (18%), Positives = 107/322 (33%), Gaps = 56/322 (17%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS---GSLSSIADNYL 77
           ++P      +LE +  G N L  +    + ++  L  +   +N L        S+    +
Sbjct: 167 KLPDLP--PSLEFIAAGNNQLEELPE--LQNLPFLTAIYADNNSLKKLPDLPLSL--ESI 220

Query: 78  TSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP 137
            +    L  L  L N   L      NN L       ++ +L  SLE  ++    ++  +P
Sbjct: 221 VAGNNILEELPELQNLPFLTTIYADNNLLK------TLPDLPPSLEALNVRDNYLTD-LP 273

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
           E   +LT L       + L+   P        L Y+    N++  ++         L +L
Sbjct: 274 ELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLC---DLPPSLEEL 322

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           ++  NKL        +    L  L  S+N    +P    NLK L       N      P 
Sbjct: 323 NVSNNKLI----ELPALPPRLERLIASFNHLAEVPELPQNLKQL---HVEYNPLRE-FPD 374

Query: 257 TIGSLKD----------------LQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
              S++D                L+ L +  N L+   PD      S++ L  ++  +  
Sbjct: 375 IPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVD 430

Query: 301 AIPLLLEKLSYLEHLNLSFNKL 322
                 E    LE      +  
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 85.4 bits (212), Expect = 8e-18
 Identities = 52/287 (18%), Positives = 96/287 (33%), Gaps = 50/287 (17%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS------GSLSS--I 72
           ++P      +LE ++ G N L       + ++  L  +   +N L        SL +  +
Sbjct: 209 KLPDLP--LSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNV 264

Query: 73  ADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNV 132
            DNYLT        L+ L          +S N  +       +  L  +L   + S   +
Sbjct: 265 RDNYLTDLPELPQSLTFLD---------VSENIFS------GLSELPPNLYYLNASSNEI 309

Query: 133 SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV 192
              + +   +L  L    +  NKL   +P     L++L       N L   +P     L 
Sbjct: 310 RS-LCDLPPSLEEL---NVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLK 360

Query: 193 KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS 252
           +L    +  N L            S+  L ++ +   +P    NLK L       N    
Sbjct: 361 QL---HVEYNPLR----EFPDIPESVEDLRMNSHLAEVPELPQNLKQL---HVETNPLRE 410

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS 299
             P    S++DL+   +    +      +      L+   F +++  
Sbjct: 411 -FPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  116 bits (293), Expect = 7e-29
 Identities = 50/298 (16%), Positives = 107/298 (35%), Gaps = 35/298 (11%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
           N +  +   +  ++L   + +       +K+L L  N     LS I+             
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN----PLSQISAA----------- 52

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
              L+    L +  LS+N L   L    + +LS +L   D++   V      E+    ++
Sbjct: 53  --DLAPFTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
             ++   N ++       +  + +    L +NK+      D     ++  LDL  N++  
Sbjct: 102 ETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158

Query: 207 -SILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL 264
            +     ++  +L  L+L YN    +  ++     L  +D S N  +  +     S   +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGV 216

Query: 265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS-GAIPLLLEKLSYLEHLNLSFNK 321
            ++ L  N L   I  ++    +L+  +   N    G +     K   ++ +     K
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  115 bits (291), Expect = 1e-28
 Identities = 37/252 (14%), Positives = 78/252 (30%), Gaps = 29/252 (11%)

Query: 92  NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL 151
           N     +  ++++ L   L   S+   + +++  D+S   +S     ++   T L  + L
Sbjct: 8   NGNRYKIEKVTDSSLKQALA--SLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 152 GGNKLNGSIPF-----------------TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
             N L  ++                    L     ++ +   +N +   +     +    
Sbjct: 66  SSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GK 122

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFS 251
             + L  NK++          + ++ L L  N            +   L  ++   N   
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSY 311
             +   +     L+ L L  N L   +         +  ++  NN L   I   L     
Sbjct: 183 D-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 312 LEHLNLSFNKLE 323
           LEH +L  N   
Sbjct: 239 LEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  114 bits (287), Expect = 4e-28
 Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 19/225 (8%)

Query: 115 IGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG 174
             N +   +I  ++  ++   +     +  N+  + L GN L+      L    KL+ + 
Sbjct: 6   KQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE 233
           L  N L      D+  L  L  LDL  N      +       S+ TL  + N+   +   
Sbjct: 65  LSSNVLY-ETL-DLESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNISRVSCS 117

Query: 234 IG-NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG-SIPDSVGDLISLKSL 291
            G   K +     + N  + +     G    +QYL L  N +   +  +      +L+ L
Sbjct: 118 RGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
           N   N +   +   +   + L+ L+LS NKL   +     F + +
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP--EFQSAA 214

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  107 bits (270), Expect = 7e-26
 Identities = 54/302 (17%), Positives = 101/302 (33%), Gaps = 39/302 (12%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
           +  + +  +  N++EL L  N L  +  A +   + L+ L L  N L             
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE----------- 72

Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
                      L +  +L    L+NN +        +     S+E    +  N+S  +  
Sbjct: 73  --------TLDLESLSTLRTLDLNNNYVQ------ELLVGP-SIETLHAANNNIS-RVSC 116

Query: 139 EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF--RLVKLYK 196
                     IYL  NK+            ++QY+ LK N+++ T+ +         L  
Sbjct: 117 SR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEH 173

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
           L+L  N +    +      A L+TL LS N    +  E  +   +  I    N     I 
Sbjct: 174 LNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IE 230

Query: 256 TTIGSLKDLQYLFLGYNILK-GSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
             +   ++L++  L  N    G++ D       ++++                 +  L H
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 315 LN 316
             
Sbjct: 291 YG 292

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  120 bits (303), Expect = 9e-29
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 53/320 (16%)

Query: 28  PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS------GSLSS--IADNYLTS 79
            +    L +G++ L   +P  +   + +  L + DN L+        L +  ++ N LTS
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLTSLPALPPELRTLEVSGNQLTS 95

Query: 80  STPELSFLSSL-----------SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
                  L  L           +    L    +  N L       S+  L   L+   +S
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT------SLPVLPPGLQELSVS 149

Query: 129 KCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI 188
              ++  +P     L  L   +   N+L  S+P     LQ+L    + DN+L  ++P   
Sbjct: 150 DNQLAS-LPALPSELCKL---WAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLP 200

Query: 189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSM 247
             L KL+  +     L           + L+ L +S N    LP+    LK L     S 
Sbjct: 201 SELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLTSLPVLPSELKEL---MVSG 250

Query: 248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE 307
           N  +S +P     L     L +  N L   +P+S+  L S  ++N   N LS      L 
Sbjct: 251 NRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305

Query: 308 KLSYLEHLNLSFNKLEGEIP 327
           +++     +    + +    
Sbjct: 306 EITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 53/255 (20%), Positives = 87/255 (34%), Gaps = 42/255 (16%)

Query: 5   SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY 64
            + KL +  + + S   +P       L+EL +  N L   +PA     S L  L   +N 
Sbjct: 122 GLCKLWIFGNQLTS---LPVLPP--GLQELSVSDNQL-ASLPALP---SELCKLWAYNNQ 172

Query: 65  LS------GSLSS--IADNYLTS---STPELSFLSSLSN--------CKSLVVFLLSNNP 105
           L+        L    ++DN L S      EL  L + +N           L   ++S N 
Sbjct: 173 LTSLPMLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNR 232

Query: 106 LNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLR 165
           L       S+  L   L+   +S   ++  +P     L +L    +  N+L   +P +L 
Sbjct: 233 LT------SLPVLPSELKELMVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLI 281

Query: 166 ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSY 225
            L     V L+ N L         R  ++         +    +   S     R L L+ 
Sbjct: 282 HLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338

Query: 226 NDGPLPLEIGNLKVL 240
            D  +P   G     
Sbjct: 339 ADWLVPAREGEPAPA 353

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 70.7 bits (173), Expect = 6e-13
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 20/138 (14%)

Query: 193 KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFS 251
               L++G + L+ ++  C    A + TL +  N+   LP     L+ L   + S N  +
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSLPALPPELRTL---EVSGNQLT 94

Query: 252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSY 311
           S +P     L +L         L             L  L    N L+ ++P+L      
Sbjct: 95  S-LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPG--- 142

Query: 312 LEHLNLSFNKLEGEIPKG 329
           L+ L++S N+L   +P  
Sbjct: 143 LQELSVSDNQLA-SLPAL 159

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  117 bits (294), Expect = 4e-28
 Identities = 50/298 (16%), Positives = 107/298 (35%), Gaps = 35/298 (11%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
           N +  +   +  ++L   + +       +K+L L  N     LS I+             
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN----PLSQISAA----------- 52

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
              L+    L +  LS+N L   L    + +LS +L   D++   V      E+    ++
Sbjct: 53  --DLAPFTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
             ++   N ++       +  + +    L +NK+      D     ++  LDL  N++  
Sbjct: 102 ETLHAANNNISRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158

Query: 207 -SILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL 264
            +     ++  +L  L+L YN    +  ++     L  +D S N  +  +     S   +
Sbjct: 159 VNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGV 216

Query: 265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS-GAIPLLLEKLSYLEHLNLSFNK 321
            ++ L  N L   I  ++    +L+  +   N    G +     K   ++ +     K
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 5e-26
 Identities = 48/336 (14%), Positives = 106/336 (31%), Gaps = 32/336 (9%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
           +  + +  +  N++EL L  N L  +  A +   + L+ L L  N L      +      
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLDLESL--- 79

Query: 79  SSTPELSFL-------SSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN 131
                L  L         L    S+     +NN ++ +    S        +   ++   
Sbjct: 80  ---STLRTLDLNNNYVQELLVGPSIETLHAANNNISRV----SCSRGQ-GKKNIYLANNK 131

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNG-SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR 190
           ++     + G  + +  + L  N+++  +          L+++ L+ N +   +   +  
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV- 189

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNN 249
             KL  LDL  NKL+  +   F + A +  +SL  N    +   +   + L   D   N 
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNG 248

Query: 250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL 309
           F           K+ +   +    +K     +  +       ++             ++L
Sbjct: 249 FHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 310 SYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKL 345
             L+    +    +G             E     + 
Sbjct: 308 IALKRKEHALLSGQGS-----ETERLECERENQARQ 338

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  110 bits (276), Expect = 1e-25
 Identities = 45/225 (20%), Positives = 83/225 (36%), Gaps = 19/225 (8%)

Query: 115 IGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG 174
             N +   +I  ++  ++   +     +  N+  + L GN L+      L    KL+ + 
Sbjct: 6   KQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE 233
           L  N L      D+  L  L  LDL  N      +       S+ TL  + N+   +   
Sbjct: 65  LSSNVLY-ETL-DLESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNISRVSCS 117

Query: 234 IG-NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKG-SIPDSVGDLISLKSL 291
            G   K +     + N  + +     G    +QYL L  N +   +  +      +L+ L
Sbjct: 118 RGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
           N   N +   +   +   + L+ L+LS NKL   +     F + +
Sbjct: 175 NLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP--EFQSAA 214

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  109 bits (273), Expect = 2e-25
 Identities = 42/321 (13%), Positives = 94/321 (29%), Gaps = 29/321 (9%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS----GSLSS----- 71
           E     +   L  L L  N +       +    +++ L   +N +S              
Sbjct: 72  ETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQGKKNIY 126

Query: 72  IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN 131
           +A+N +T                 +    L  N ++ +       +   +LE  ++    
Sbjct: 127 LANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFAELAASS-DTLEHLNLQYNF 180

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRL 191
           +   +  ++     L  + L  NKL   +    +    + ++ L++NKL   I   +   
Sbjct: 181 IYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 192 VKLYKLDLGGNKLS-GSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
             L   DL GN    G++   FS    ++T++                V     +     
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCC 296

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGS----IPDSVGDLISLKSLNFSNNNLSGAIPLLL 306
             +       L  L+         +GS    +     +    + ++         I  + 
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356

Query: 307 EKLSYLEHLNLSFNKLEGEIP 327
            +      L      L+ ++ 
Sbjct: 357 LRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 24/232 (10%), Positives = 56/232 (24%), Gaps = 46/232 (19%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           ++  ++    L+ L L  N L   +       + +  ++L++N L               
Sbjct: 183 DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-------------- 227

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE-- 138
                   +L   ++L  F L  N  +    R           +   +   ++G   E  
Sbjct: 228 ----LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEEC 283

Query: 139 ----------------EIGNLTNLTAIYLGGNKLN-------GSIPFTLRELQKLQYVGL 175
                                  L A+    + L          +        + + +  
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343

Query: 176 KDNKLEGTIPYDIFRLVK-LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
              +   T+   +    +    L+     L   +       A L        
Sbjct: 344 LKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (294), Expect = 1e-27
 Identities = 56/345 (16%), Positives = 114/345 (33%), Gaps = 40/345 (11%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS-------GSLSS-- 71
            IPS +    ++ L L  N +  +    +   + L+ L L+ + ++        SL S  
Sbjct: 19  SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              ++DN+L+S +             SL    L  NP   +       NL+ +L+   + 
Sbjct: 78  HLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIG 131

Query: 129 KCNVSGGIPEE-IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
                  I       LT+L  + +    L      +L+ ++ + ++ L  ++    +   
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDG------------PLPLEIG 235
              L  +  L+L    L+    +          +      G             L   I 
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKD--------LQYLFLGYNILKGSIPDSVGDLIS 287
            L  +   D ++N      P+    + +        ++ L +    L   +      L  
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 288 LKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSF 332
           +K +   N+ +        + L  LE L+LS N +  E  K  + 
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  113 bits (285), Expect = 1e-26
 Identities = 66/326 (20%), Positives = 126/326 (38%), Gaps = 21/326 (6%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
            ++  L L  +    ++      +S+++ L L+D  L+    S       SS  +     
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH-SLEIFDMSKCNVSGGIPEEIGNLTNLT 147
                      LL        L  +   + +   L  F+ S+ +V   + +       + 
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV--ETVTIR 289

Query: 148 AIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSG 206
            +++    L   +      L+K++ + ++++K+   +P    + L  L  LDL  N +  
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 207 SIL---TCFSNLASLRTLSLSYND----GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIG 259
             L    C     SL+TL LS N           +  LK L  +D S N F   +P +  
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQ 407

Query: 260 SLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF 319
             + +++L L    ++  +   +    +L+ L+ SNNNL  +  L L +L   + L +S 
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRL---QELYISR 460

Query: 320 NKLEGEIPKGGSFGNFSAESFEGNKL 345
           NKL+  +P    F          N+L
Sbjct: 461 NKLK-TLPDASLFPVLLVMKISRNQL 485

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  101 bits (253), Expect = 1e-22
 Identities = 41/236 (17%), Positives = 88/236 (37%), Gaps = 11/236 (4%)

Query: 92  NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL 151
           +C +  V    +     I        L+ +++  D+S   ++     ++    NL  + L
Sbjct: 3   SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 152 GGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSG-SIL 209
             +++N         L  L+++ L DN L  ++    F  L  L  L+L GN      + 
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 210 TCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY 266
           + F NL +L+TL +           ++   L  L  ++    +  +    ++ S++D+ +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           L L  +     +      L S++ L   + NL+      L        +     + 
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.1 bits (164), Expect = 7e-12
 Identities = 28/120 (23%), Positives = 48/120 (40%), Gaps = 6/120 (5%)

Query: 217 SLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL 274
           +             +P  +   +K L   D S N  + +    + +  +LQ L L  + +
Sbjct: 6   ASGVCDGRSRSFTSIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 275 KGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
                D+   L SL+ L+ S+N+LS         LS L++LNL  N  +  +     F N
Sbjct: 63  NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 27/143 (18%), Positives = 49/143 (34%), Gaps = 23/143 (16%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS----GSLSS-----IADNYLTS 79
            NL  L + +N     +P +      ++ L L    +         +     +++N L S
Sbjct: 387 KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
            +  L  L  L          +S N L  +       +L   L +  +S+  +       
Sbjct: 446 FSLFLPRLQELY---------ISRNKLKTLPD----ASLFPVLLVMKISRNQLKSVPDGI 492

Query: 140 IGNLTNLTAIYLGGNKLNGSIPF 162
              LT+L  I+L  N  + S P 
Sbjct: 493 FDRLTSLQKIWLHTNPWDCSCPR 515

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  114 bits (287), Expect = 1e-27
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 5/192 (2%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSC 490
           IG+G FG ++  R+  D   VAVK             F  E  I+K   + N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           + ++   +V+E +  G     L +    L +   L ++ D A+ +EYL        IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRD 238

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L   N L+ +  V  +SDFG+++       + +       + + APE    GR  +  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 611 YSFGIMLMEIHS 622
           +SFGI+L E  S
Sbjct: 299 WSFGILLWETFS 310

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  115 bits (290), Expect = 4e-27
 Identities = 42/197 (21%), Positives = 80/197 (40%), Gaps = 24/197 (12%)

Query: 432 LIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKII- 487
            I  GG G IY +     +G  V +K          ++    E + +  + + ++V+I  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 488 ----SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
               +    +    +V+E++   SL++        L + + +  ++++   L YLH    
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI-- 201

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREG 602
             +++ DLKP N++L +  +  L D G           +        T G+ APE  R G
Sbjct: 202 -GLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVRTG 252

Query: 603 RVFANGDVYSFGIMLME 619
              A  D+Y+ G  L  
Sbjct: 253 PTVA-TDIYTVGRTLAA 268

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  111 bits (280), Expect = 5e-27
 Identities = 61/319 (19%), Positives = 117/319 (36%), Gaps = 60/319 (18%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           ++P ++ P +   L L  N +  +      ++  L  L L +N     +S I+       
Sbjct: 45  KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN----KISKISPG----- 94

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                   + +    L    LS N L  +        +  +L+   + +  ++  + + +
Sbjct: 95  --------AFAPLVKLERLYLSKNQLKELPE-----KMPKTLQELRVHENEIT-KVRKSV 140

Query: 141 -GNLTNLTAIYLGGNKLNGSI--PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
              L  +  + LG N L  S       + ++KL Y+ + D  +  TIP  +     L +L
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTEL 197

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTT 257
            L GNK++         L +L  L LS+                      N+ S+V   +
Sbjct: 198 HLDGNKITKVDAASLKGLNNLAKLGLSF----------------------NSISAVDNGS 235

Query: 258 IGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG------AIPLLLEKLSY 311
           + +   L+ L L  N L   +P  + D   ++ +   NNN+S         P    K + 
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294

Query: 312 LEHLNLSFNKLE-GEIPKG 329
              ++L  N ++  EI   
Sbjct: 295 YSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  105 bits (265), Expect = 4e-25
 Identities = 51/261 (19%), Positives = 95/261 (36%), Gaps = 33/261 (12%)

Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           L NN +  I       NL + L    +    +S   P     L  L  +YL  N+L   +
Sbjct: 59  LQNNKITEI-KDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 115

Query: 161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSIL--TCFSNLAS 217
           P  +   + LQ + + +N++   +   +F  L ++  ++LG N L  S +    F  +  
Sbjct: 116 PEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172

Query: 218 LRTLSLSYN------DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGY 271
           L  + ++         G  P    +L  L       N  + V   ++  L +L  L L +
Sbjct: 173 LSYIRIADTNITTIPQGLPP----SLTEL---HLDGNKITKVDAASLKGLNNLAKLGLSF 225

Query: 272 NILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGS 331
           N +      S+ +   L+ L+ +NN L   +P  L    Y++ + L  N +         
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-------- 276

Query: 332 FGNFSAESFEGNKLLCGSPNL 352
                +  F          + 
Sbjct: 277 --AIGSNDFCPPGYNTKKASY 295

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 46/280 (16%), Positives = 88/280 (31%), Gaps = 68/280 (24%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           E+P ++ P  L+EL + +N +  V  +    ++ +  + L  N L            +S 
Sbjct: 114 ELPEKM-PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-----------SSG 161

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
               +F       K L    +++  +  I                               
Sbjct: 162 IENGAF----QGMKKLSYIRIADTNITTIPQ----------------------------- 188

Query: 141 GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLD 198
           G   +LT ++L GNK+   +   +L+ L  L  +GL  N +   +          L +L 
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELH 246

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI 258
           L  NKL   +    ++   ++ + L  N         N+  +   DF         P   
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNN---------NISAIGSNDFCP-------PGYN 289

Query: 259 GSLKDLQYLFLGYN-ILKGSIPDSV-GDLISLKSLNFSNN 296
                   + L  N +    I  S    +    ++   N 
Sbjct: 290 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 25/122 (20%), Positives = 46/122 (37%), Gaps = 14/122 (11%)

Query: 210 TCFSNLASLRTLSLSYNDGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLF 268
            C   +     L L      +P ++  +  +L   D   N  + +      +LK+L  L 
Sbjct: 30  QCHLRVVQCSDLGLEK----VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLI 82

Query: 269 LGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
           L  N +   I       L+ L+ L  S N L   +P  +     L+ L +  N++  ++ 
Sbjct: 83  LINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVR 137

Query: 328 KG 329
           K 
Sbjct: 138 KS 139

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 27/153 (17%), Positives = 49/153 (32%), Gaps = 40/153 (26%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
           +NL +L L  N++  V   ++ +   L++L L +N     L  +                
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN----KLVKVPGG------------- 258

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
            L++ K + V  L NN ++ I                           P       + + 
Sbjct: 259 -LADHKYIQVVYLHNNNISAIGSNDFCP--------------------PGYNTKKASYSG 297

Query: 149 IYLGGNKLNGSI--PFTLRELQKLQYVGLKDNK 179
           + L  N +      P T R +     V L + K
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  114 bits (287), Expect = 7e-27
 Identities = 78/363 (21%), Positives = 127/363 (34%), Gaps = 61/363 (16%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS-------GSLSS-- 71
           +IP  + P + + L L  N L  +   + F    L+ L L    +         SLS   
Sbjct: 21  KIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 72  ---IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +  N + S           S   SL   +     L   L    IG+L  +L+  +++
Sbjct: 80  TLILTGNPIQSLALGA-----FSGLSSLQKLVAVETNLAS-LENFPIGHLK-TLKELNVA 132

Query: 129 KCN-VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG----LKDNKLEGT 183
                S  +PE   NLTNL  + L  NK+       LR L ++  +     L  N +   
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSIL-TCFSNLASLRTLSLSYNDGP-----LPLEIGNL 237
           I    F+ ++L+KL L  N  S +++ TC   LA L    L   +          +   L
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251

Query: 238 KVLIGIDFS------MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD------- 284
           + L  +         ++ +   I      L ++    L    ++  + D   +       
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLE 310

Query: 285 -------------LISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGS 331
                        L SLK L F++N    A   +   L  LE L+LS N L  +     S
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 332 FGN 334
              
Sbjct: 369 DFG 371

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  114 bits (286), Expect = 9e-27
 Identities = 53/303 (17%), Positives = 111/303 (36%), Gaps = 40/303 (13%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDV-STLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
            +EE  L   +        +F+  + +   +L       ++  + D         L  ++
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV----TIERVKDFSYNFGWQHLELVN 313

Query: 89  SLSNC------KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS--KCNVSGGIPEEI 140
                      KSL     ++N        + +     SLE  D+S    +  G   +  
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL----PSLEFLDLSRNGLSFKGCCSQSD 369

Query: 141 GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDL 199
              T+L  + L  N +  ++      L++L+++  + + L+    + +F  L  L  LD+
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428

Query: 200 GGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIG 259
                  +    F+ L+SL  L ++ N         + +             + +P    
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGN---------SFQ------------ENFLPDIFT 467

Query: 260 SLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF 319
            L++L +L L    L+   P +   L SL+ LN ++N L      + ++L+ L+ + L  
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHT 527

Query: 320 NKL 322
           N  
Sbjct: 528 NPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (284), Expect = 2e-26
 Identities = 47/237 (19%), Positives = 80/237 (33%), Gaps = 16/237 (6%)

Query: 97  VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKL 156
           + +         I       NL  S +  D+S   +         +   L  + L   ++
Sbjct: 10  ITYQCMELNFYKIPD-----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64

Query: 157 NGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCFSNL 215
                   + L  L  + L  N ++ ++    F  L  L KL      L+        +L
Sbjct: 65  QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123

Query: 216 ASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLF---- 268
            +L+ L++++N      LP    NL  L  +D S N   S+  T +  L  +  L     
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 269 LGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKLSYLEHLNLSFNKLEG 324
           L  N +   I       I L  L   NN  S  +    ++ L+ LE   L   +   
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  111 bits (279), Expect = 7e-26
 Identities = 64/322 (19%), Positives = 112/322 (34%), Gaps = 29/322 (9%)

Query: 28  PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS-------- 79
           P     L L  N +   +    F    L  L L++N+ S ++       L          
Sbjct: 176 PLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 80  ----STPELSFL--SSLSNCKSLVVFLLSNNPLNGILPRMS-IGNLSHSLEIFDMSKCNV 132
               +   L     S+L    +L +       L+  L  +  + N   ++  F +    +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 133 SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV 192
              + +   N      + L   K        L+ L++L       NK           L 
Sbjct: 295 ER-VKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGGNAFS--EVDLP 347

Query: 193 KLYKLDLGGNKLSGSILT--CFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNN 249
            L  LDL  N LS             SL+ L LS+N    +      L+ L  +DF  +N
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407

Query: 250 FSSVIPTTI-GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAI-PLLLE 307
              +   ++  SL++L YL + +   + +       L SL+ L  + N+      P +  
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467

Query: 308 KLSYLEHLNLSFNKLEGEIPKG 329
           +L  L  L+LS  +LE ++   
Sbjct: 468 ELRNLTFLDLSQCQLE-QLSPT 488

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  105 bits (263), Expect = 7e-24
 Identities = 62/343 (18%), Positives = 107/343 (31%), Gaps = 56/343 (16%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
              +L++L+  + NL  +    I  + TLK+L +  N +                     
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ----------------SFKL 141

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRM--SIGNLSHSLEIFDMSKCNVSGGIPEEIGNLT 144
               SN  +L    LS+N +  I       +  +       D+S  N    I        
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS-LNPMNFIQPGAFKEI 200

Query: 145 NLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEG-----TIPYDIF-RLVKLYKL 197
            L  + L  N  + ++    ++ L  L+   L   +                 L  L   
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 198 DLGGNKLSGS---ILTCFSNLASLRTLSLSYND---------------------GPLPLE 233
           +     L      I+  F+ L ++ + SL                               
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP 320

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL--KGSIPDSVGDLISLKSL 291
              LK L  + F+ N   +        L  L++L L  N L  KG    S     SLK L
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
           + S N +   +      L  LEHL+   + L+ ++ +   F +
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  102 bits (257), Expect = 3e-23
 Identities = 57/287 (19%), Positives = 92/287 (32%), Gaps = 15/287 (5%)

Query: 3   SISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQD 62
           +++I +  L   D      I       N+    L    +  V   +       + L L +
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVN 313

Query: 63  NYLSGSLSSIADNYLTS---STPELSFLSSLSNCKSLVVFLLSNNPLNGI-LPRMSIGNL 118
                   ++    L     ++ +     S  +  SL    LS N L+       S    
Sbjct: 314 CKFG-QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 119 SHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKD 177
           + SL+  D+S   V   +      L  L  +    + L     F     L+ L Y+ +  
Sbjct: 373 T-SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 178 NKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSILT-CFSNLASLRTLSLSYND-GPLPLEI 234
                     IF  L  L  L + GN    + L   F+ L +L  L LS      L    
Sbjct: 431 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 235 -GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD 280
             +L  L  ++ + N   SV       L  LQ ++L  N    S P 
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (283), Expect = 7e-27
 Identities = 48/204 (23%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMK-SIHYRNLVK 485
           F   +++G G  GTI    + D  +VAVK    +C   F   D E ++++ S  + N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
              +  + +F+ + +E     +L++ +   +      + + ++    S L +LH      
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--- 138

Query: 546 VIHCDLKPSNVLLDDT-----MVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEY- 598
           ++H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G+IAPE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 599 --GREGRVFANGDVYSFGIMLMEI 620
               +       D++S G +   +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYV 222

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (281), Expect = 2e-26
 Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 26/272 (9%)

Query: 363 HTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKR--------ENWPPNDANMPPKATWRR 414
           +T+    L++     F+T+       L+  +               P             
Sbjct: 157 NTASDGKLYVSSESRFNTL-----AELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPN 211

Query: 415 FSYLEVCRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGR-AFKSFDIEC 472
           +   E+ R          +G G +G +Y+       + VAVK   L+      + F  E 
Sbjct: 212 YDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEA 267

Query: 473 EIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDV 531
            +MK I + NLV+++  C+ E    ++ E M +G+L   L   N   +     L +   +
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 532 ASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +S +EYL   NF    IH +L   N L+ +  +  ++DFG+++ L+  D           
Sbjct: 328 SSAMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 382

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
           I + APE     +     DV++FG++L EI +
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  107 bits (269), Expect = 4e-26
 Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 11/193 (5%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IG G FG ++     +  +VA+K    +   + + F  E E+M  + +  LV++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFLVPVIHC 549
           +    LV E M HG L   L +   +      L + +DV   + YL           IH 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHR 128

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   N L+ +  V  +SDFG+T+  + +DQ  + T T   + + +PE     R  +  D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187

Query: 610 VYSFGIMLMEIHS 622
           V+SFG+++ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  107 bits (270), Expect = 4e-26
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 15/195 (7%)

Query: 432 LIGKGGFGTIYKSRIGD---GMEVAVKVFHLQCGR--AFKS-FDIECEIMKSIHYRNLVK 485
            +G GG  T+Y +   D    ++VA+K   +           F+ E      + ++N+V 
Sbjct: 18  KLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +I     ++   LV+E++   +L      S+  L +   +N    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAHDM---R 131

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREGRV 604
           ++H D+KP N+L+D      + DFGI K L   + S+TQT   L T+ Y +PE  +    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 605 FANGDVYSFGIMLME 619
               D+YS GI+L E
Sbjct: 190 DECTDIYSIGIVLYE 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (279), Expect = 5e-26
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
             +G+G FG ++         VA+K        + ++F  E ++MK + +  LV++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHF-NFLVPVIH 548
           S E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H
Sbjct: 332 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 386

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL+ +N+L+ + +V  ++DFG+ + LI +++   +      I + APE    GR     
Sbjct: 387 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 446 DVWSFGILLTELTT 459

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  110 bits (277), Expect = 5e-26
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
             +G+G FG ++         VA+K        + ++F  E ++MK + +  LV++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHF-NFLVPVIH 548
           S E    +V E+M  GSL   L       L + Q +++   +AS + Y+   N+    +H
Sbjct: 249 SEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY----VH 303

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL+ +N+L+ + +V  ++DFG+ + LI +++   +      I + APE    GR     
Sbjct: 304 RDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+L E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (268), Expect = 9e-26
 Identities = 51/199 (25%), Positives = 76/199 (38%), Gaps = 14/199 (7%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG      + +  G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLV 544
           +         K +V E  P GSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ-TLATIGYIAPEYGREGR 603
             IH DL   N+LL    +  + DFG+ + L   D      +       + APE  +   
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 604 VFANGDVYSFGIMLMEIHS 622
                D + FG+ L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  106 bits (267), Expect = 1e-25
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 15/198 (7%)

Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 488 SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLV 544
             C +   +   L++E++P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 135

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGREG 602
             IH DL   N+L+++     + DFG+TK ++ +D+   + +      I + APE   E 
Sbjct: 136 --IHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 603 RVFANGDVYSFGIMLMEI 620
           +     DV+SFG++L E+
Sbjct: 193 KFSVASDVWSFGVVLYEL 210

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (268), Expect = 2e-25
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 24/203 (11%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G G FGT+YK           + VA+K        +A K    E  +M S+   ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFL 543
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE---YGR 600
              +H DL   NVL+       ++DFG+ KLL  E++          I ++A E   +  
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 601 EGRVFAN-GDVYSFGIMLMEIHS 622
               + +  DV+S+G+ + E+ +
Sbjct: 196 ----YTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  106 bits (267), Expect = 2e-25
 Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G G FGT++K           + V +KV   + G ++F++       + S+ + ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFL 543
           +  C     + LV +++P GSL   +      L     LN  + +A  + YL        
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              +H +L   NVLL       ++DFG+  LL  +D+ +  ++    I ++A E    G+
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 604 VFANGDVYSFGIMLMEI 620
                DV+S+G+ + E+
Sbjct: 194 YTHQSDVWSYGVTVWEL 210

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (265), Expect = 3e-25
 Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 15/195 (7%)

Query: 432 LIGKGGFGTIYKSRIGD---GMEVAVKVFHLQCGR--AFKS-FDIECEIMKSIHYRNLVK 485
           L+G+GG G +Y++   D      VA+K+          F++    E      +   ++V 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           I      +    + +  +    L   L      L   + + I+  + S L+  H      
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGAT- 156

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGREGRV 604
             H D+KP N+L+     A+L DFGI       D+ +TQ    + T+ Y+APE   E   
Sbjct: 157 --HRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 605 FANGDVYSFGIMLME 619
               D+Y+   +L E
Sbjct: 213 TYRADIYALTCVLYE 227

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  108 bits (271), Expect = 3e-25
 Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 9/194 (4%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
             +G G FG ++ +      +VAVK        + ++F  E  +MK++ +  LVK+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIH 548
           + E    ++ E M  GSL   L S       + + ++    +A  + ++   N+    IH
Sbjct: 253 TKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IH 307

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL+ +N+L+  ++V  ++DFG+ + +I +++   +      I + APE    G      
Sbjct: 308 RDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 609 DVYSFGIMLMEIHS 622
           DV+SFGI+LMEI +
Sbjct: 367 DVWSFGILLMEIVT 380

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  105 bits (264), Expect = 3e-25
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 429 ENNLIGKGGFGTIYK----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNL 483
            + +IGKG FG +Y      +  + ++ A+K        +  ++F  E  +M+ +++ N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 484 VKIISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---H 539
           + +I      E     +L +M HG L + + S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED--QSMTQTQTLATIGYIAPE 597
           F      +H DL   N +LD++    ++DFG+ + ++  +             + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 598 YGREGRVFANGDVYSFGIMLMEI 620
             +  R     DV+SFG++L E+
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWEL 221

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 3e-25
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)

Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++   R        G  VAVK          + F+ E EI+KS+ + N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 488 SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLV 544
             C +   +   L++E++P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY-- 166

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGR 603
             IH DL   N+L+++     + DFG+TK+L   ++    +    + I + APE   E +
Sbjct: 167 --IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 225 FSVASDVWSFGVVLYEL 241

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (262), Expect = 5e-25
 Identities = 47/194 (24%), Positives = 94/194 (48%), Gaps = 13/194 (6%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +   +     +VA+K+  ++ G  +   F  E ++M ++ +  LV++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFLVPVIH 548
            +    ++ E+M +G L   L          Q L +  DV   +EYL    F      +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LH 143

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  PE     +  +  
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 609 DVYSFGIMLMEIHS 622
           D+++FG+++ EI+S
Sbjct: 203 DIWAFGVLMWEIYS 216

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (272), Expect = 5e-25
 Identities = 51/306 (16%), Positives = 103/306 (33%), Gaps = 48/306 (15%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF 86
           N  +L +     N + G            +  AL     + ++S + +  +         
Sbjct: 9   NNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ------- 60

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
            S L          L+   L+  LP  ++      + + ++++  +   +PE   +L  L
Sbjct: 61  FSELQ---------LNRLNLS-SLPD-NLPP---QITVLEITQNALIS-LPELPASLEYL 105

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
                  N+L+ ++P     L+ L    + +N+L   +P        L  ++   N+L+ 
Sbjct: 106 ---DACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELP---ALLEYINADNNQLT- 153

Query: 207 SILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ 265
                     SL  LS+  N    LP    +L+ L   D S N   S +P         +
Sbjct: 154 ---MLPELPTSLEVLSVRNNQLTFLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSE 206

Query: 266 ----YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK 321
               +     N +   IP+++  L    ++   +N LS  I   L + +     +     
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265

Query: 322 LEGEIP 327
                 
Sbjct: 266 FSMSDG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 41/189 (21%), Positives = 62/189 (32%), Gaps = 31/189 (16%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS------GSLS--SI 72
            +P      +LE L    N L   +P      ++LK L + +N L+        L   + 
Sbjct: 94  SLPELPA--SLEYLDACDNRLS-TLPELP---ASLKHLDVDNNQLTMLPELPALLEYINA 147

Query: 73  ADNYLTSSTPELSFLSSL--SNCK---------SLVVFLLSNNPLNGILPRMSIGNLSHS 121
            +N LT      + L  L   N +         SL    +S N L   LP        HS
Sbjct: 148 DNNQLTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPA-VPVRNHHS 205

Query: 122 LE---IFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN 178
            E    F   +  ++  IPE I +L     I L  N L+  I  +L +            
Sbjct: 206 EETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264

Query: 179 KLEGTIPYD 187
               +    
Sbjct: 265 YFSMSDGQQ 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  104 bits (262), Expect = 5e-25
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 16/199 (8%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +            G +VAVK    + G         E EI++++++ N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 487 ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFL 543
              C+ +      L++E +P GSL++ L  +   +++ Q+L   + +   ++YL    + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY- 147

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYGRE 601
              +H DL   NVL++      + DFG+TK  I  D+     +      + + APE   +
Sbjct: 148 ---VHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 602 GRVFANGDVYSFGIMLMEI 620
            + +   DV+SFG+ L E+
Sbjct: 204 SKFYIASDVWSFGVTLHEL 222

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 6e-25
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 7/191 (3%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG +   +     +VAVK+   +   +   F  E + M  + +  LVK    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDL 551
           E    +V E++ +G L   L S    L+  Q L +  DV   + +L    F    IH DL
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF----IHRDL 130

Query: 552 KPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY 611
              N L+D  +   +SDFG+T+  + +DQ ++   T   + + APE     +  +  DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189

Query: 612 SFGIMLMEIHS 622
           +FGI++ E+ S
Sbjct: 190 AFGILMWEVFS 200

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  104 bits (261), Expect = 6e-25
 Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 32/210 (15%)

Query: 433 IGKGGFGTIYK--------SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLV 484
           +G+G F  I+K               EV +KV         +SF     +M  + +++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFN 541
                C   +   LV E +  GSL+  L  +   ++I  +L +   +A+ + +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 542 FLVPVIHCDLKPSNVLLD--------DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
                IH ++   N+LL         +     LSD GI+  +    + + Q      I +
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQ----ERIPW 183

Query: 594 IAPEYGREGRVF-ANGDVYSFGIMLMEIHS 622
           + PE     +      D +SFG  L EI S
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (262), Expect = 8e-25
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 432 LIGKGGFGTIYKSRIGD---GMEVAVKVFHLQCGR--AFKS-FDIECEIMKSIHYRNLVK 485
           ++G GG   ++ +R  D     +VAVKV      R  +F   F  E +   ++++  +V 
Sbjct: 19  ILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 486 IISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           +  +   E        +V+E++   +L + +  +   +   + + ++ D    L + H N
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT-LATIGYIAPEYGR 600
            ++   H D+KP+N+++  T    + DFGI + +     S+TQT   + T  Y++PE  R
Sbjct: 136 GII---HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 601 EGRVFANGDVYSFGIMLME 619
              V A  DVYS G +L E
Sbjct: 193 GDSVDARSDVYSLGCVLYE 211

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (263), Expect = 8e-25
 Identities = 67/319 (21%), Positives = 111/319 (34%), Gaps = 61/319 (19%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P EI   +   L L  N++  +       +  L  L L +N     +S I +      
Sbjct: 47  AVPKEI-SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN----KISKIHEK----- 96

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                   + S  + L    +S N L  I P     NL  SL    +    +   +P+ +
Sbjct: 97  --------AFSPLRKLQKLYISKNHLVEIPP-----NLPSSLVELRIHDNRIR-KVPKGV 142

Query: 141 -GNLTNLTAIYLGGNKL-NGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLD 198
              L N+  I +GGN L N        +  KL Y+ + + KL   IP D+     L +L 
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--TLNELH 199

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI 258
           L  NK+    L      + L  L L +                      N    +   ++
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGH----------------------NQIRMIENGSL 237

Query: 259 GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-------LLLEKLSY 311
             L  L+ L L  N L   +P  + DL  L+ +    NN++  +            K +Y
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295

Query: 312 LEHLNLSFNKLE-GEIPKG 329
              ++L  N +   E+   
Sbjct: 296 YNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 55/258 (21%), Positives = 92/258 (35%), Gaps = 28/258 (10%)

Query: 101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI 160
           L NN ++ +  +     L H L    +    +S    +    L  L  +Y+  N L   I
Sbjct: 61  LQNNDISEL-RKDDFKGLQH-LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EI 117

Query: 161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILT--CFSNLAS 217
           P  L     L  + + DN++   +P  +F  L  +  +++GGN L  S      F  L  
Sbjct: 118 PPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-K 173

Query: 218 LRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILK 275
           L  L +S      +P ++   L  L       N   ++    +     L  L LG+N ++
Sbjct: 174 LNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230

Query: 276 GSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
             I +     L +L+ L+  NN LS  +P  L  L  L+ + L  N +            
Sbjct: 231 -MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------K 278

Query: 335 FSAESFEGNKLLCGSPNL 352
                F            
Sbjct: 279 VGVNDFCPVGFGVKRAYY 296

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 41/226 (18%), Positives = 73/226 (32%), Gaps = 31/226 (13%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           EIP  + P +L EL +  N +  V       +  +  + +  N L    S          
Sbjct: 116 EIPPNL-PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPL--ENSGFEPGAFDGL 172

Query: 81  TPELSFLSSLSNCK----------SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKC 130
              L++L  +S  K          +L    L +N +  I     +   S  L    +   
Sbjct: 173 K--LNYL-RISEAKLTGIPKDLPETLNELHLDHNKIQAI-ELEDLLRYS-KLYRLGLGHN 227

Query: 131 NVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF 189
            +   I       L  L  ++L  NKL+  +P  L +L+ LQ V L  N +   +  + F
Sbjct: 228 QIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDF 284

Query: 190 -------RLVKLYKLDLGGNKLSGSILT--CFSNLASLRTLSLSYN 226
                  +      + L  N +    +    F  +     +     
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 37/165 (22%), Positives = 56/165 (33%), Gaps = 28/165 (16%)

Query: 170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP 229
           L+ V   D  L+  +P +I     L  LDL  N +S      F  L  L  L L  N   
Sbjct: 35  LRVVQCSDLGLK-AVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVLVNN--- 88

Query: 230 LPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLK 289
                                S +       L+ LQ L++  N L   IP ++    SL 
Sbjct: 89  -------------------KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV 126

Query: 290 SLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
            L   +N +      +   L  +  + +  N LE    + G+F  
Sbjct: 127 ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  103 bits (260), Expect = 8e-25
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 23/202 (11%)

Query: 433 IGKGGFGTIYK---SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIIS 488
           +G G FG++ +         ++VA+KV      +A       E +IM  +    +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFLVP 545
            C  E    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPE---YGRE 601
            +H DL   NVLL +   A +SDFG++K L   +     ++     + + APE   + + 
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK- 189

Query: 602 GRVFAN-GDVYSFGIMLMEIHS 622
              F++  DV+S+G+ + E  S
Sbjct: 190 ---FSSRSDVWSYGVTMWEALS 208

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  104 bits (261), Expect = 8e-25
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 17/203 (8%)

Query: 431 NLIGKGGFGTIY----KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
            +IG+G FG +Y        G  +  AVK  +          F  E  IMK   + N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 486 IISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFN 541
           ++  C   E   L VL +M HG L   + +      +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED--QSMTQTQTLATIGYIAPEYG 599
                +H DL   N +LD+     ++DFG+ + +  ++      +T     + ++A E  
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 600 REGRVFANGDVYSFGIMLMEIHS 622
           +  +     DV+SFG++L E+ +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  107 bits (269), Expect = 1e-24
 Identities = 51/275 (18%), Positives = 98/275 (35%), Gaps = 27/275 (9%)

Query: 68  SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
                 D ++   T ++ F        +  +    N+ +  + P   + +    +E+ ++
Sbjct: 25  YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSFR-QVELLNL 82

Query: 128 SKCNVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY 186
           +   +   I          +  +Y+G N +    P   + +  L  + L+ N L  ++P 
Sbjct: 83  NDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR 140

Query: 187 DIFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLP-LEIGNLKVLIGID 244
            IF    KL  L +  N L       F    SL+ L LS N   L  +++  +  L   +
Sbjct: 141 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN--RLTHVDLSLIPSLFHAN 198

Query: 245 FSMNNFSSVIPTT----------------IGSLKDLQYLFLGYNILKGSIPDSVGDLISL 288
            S N  S++                         +L  L L +N L  +    + +   L
Sbjct: 199 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL--TDTAWLLNYPGL 256

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
             ++ S N L   +     K+  LE L +S N+L 
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 88.8 bits (220), Expect = 1e-18
 Identities = 63/360 (17%), Positives = 127/360 (35%), Gaps = 51/360 (14%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
            +P  I  N   L  L +  NNL  +        ++L++L L  N     L+ +  + + 
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN----RLTHVDLSLIP 192

Query: 79  S-STPELSF--LSSLSNCKSLVVFLLSNNPLN----GILPRMSIGNLSH----------- 120
           S     +S+  LS+L+   ++     S+N +N     +   ++I  L H           
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLN 252

Query: 121 --SLEIFDMSKCNVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD 177
              L   D+S   +   I       +  L  +Y+  N+L  ++    + +  L+ + L  
Sbjct: 253 YPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310

Query: 178 NKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND------GPLP 231
           N L   +  +  +  +L  L L  N +  ++    S   +L+ L+LS+ND        L 
Sbjct: 311 NHLL-HVERNQPQFDRLENLYLDHNSIV-TL--KLSTHHTLKNLTLSHNDWDCNSLRALF 366

Query: 232 LEIGNLKVL-----IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI 286
             +    V        ID+ + +       +     D    ++    +   +  + G   
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEH-GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425

Query: 287 SLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLL 346
           +  ++N   +            L   E L    N+L  E+         + E  +  +LL
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ------QLTNEQIQQEQLL 479

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 86.9 bits (215), Expect = 5e-18
 Identities = 45/232 (19%), Positives = 79/232 (34%), Gaps = 36/232 (15%)

Query: 101 LSNNPLNGILPRM-----SIGNLSHSLEIFDMSKCNVSGGIPE--EIGNLTNLTAIYLGG 153
           +       + PR         NL +    +D+     +  +    E   L N   +    
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 154 NKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCF 212
           + +       L   ++++ + L D ++E  I    F     + KL +G N +       F
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119

Query: 213 SNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
            N+  L  L L  N                      + SS+      +   L  L +  N
Sbjct: 120 QNVPLLTVLVLERN----------------------DLSSLPRGIFHNTPKLTTLSMSNN 157

Query: 273 ILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
            L+  I D       SL++L  S+N L+  +   L  +  L H N+S+N L 
Sbjct: 158 NLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 18/110 (16%), Positives = 38/110 (34%), Gaps = 3/110 (2%)

Query: 221 LSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD 280
           + +   D     E   L     + F  +    +    + S + ++ L L    ++  I  
Sbjct: 34  IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDT 92

Query: 281 SV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
                  +++ L    N +    P + + +  L  L L  N L   +P+G
Sbjct: 93  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 10/101 (9%), Positives = 33/101 (32%), Gaps = 3/101 (2%)

Query: 230 LPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISL 288
           +   +    V   +   M            +L + + +    + ++  +P ++      +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
           + LN ++  +             ++ L + FN +   +P  
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPH 117

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  107 bits (269), Expect = 1e-24
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)

Query: 433 IGKGGFGTIYK---SRIGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIIS 488
           +G G FG++ +         ++VA+KV      +A       E +IM  +    +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVI 547
            C  E    LV+E    G L K L      + +     ++  V+  ++YL   NF    +
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----V 458

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS-MTQTQTLATIGYIAPEYGREGRVFA 606
           H +L   NVLL +   A +SDFG++K L  +D     ++     + + APE     +  +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 607 NGDVYSFGIMLMEIHS 622
             DV+S+G+ + E  S
Sbjct: 519 RSDVWSYGVTMWEALS 534

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (261), Expect = 1e-24
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 13/197 (6%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +GKG FG++            G  VAVK          + F  E +I+K++H   +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 488 SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLV 544
                   +   LV+E++P G L   L      LD  + L     +   +EYL       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC-- 148

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREGR 603
             +H DL   N+L++      ++DFG+ KLL + +D  + +    + I + APE   +  
Sbjct: 149 --VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 604 VFANGDVYSFGIMLMEI 620
                DV+SFG++L E+
Sbjct: 207 FSRQSDVWSFGVVLYEL 223

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  103 bits (260), Expect = 2e-24
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 19/201 (9%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKII 487
           IG G  G       +      + VA+K        R  + F  E  IM    + N++++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPV 546
              +      +V E+M +GSL+  L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIG-EDQSMTQTQTLATIGYIAPE---YGREG 602
           +H DL   NVL+D  +V  +SDFG++++L    D + T T     I + APE   +    
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-- 230

Query: 603 RVFAN-GDVYSFGIMLMEIHS 622
             F++  DV+SFG+++ E+ +
Sbjct: 231 --FSSASDVWSFGVVMWEVLA 249

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (258), Expect = 2e-24
 Identities = 52/261 (19%), Positives = 97/261 (37%), Gaps = 35/261 (13%)

Query: 95  SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVS--GGIPEEIGNLTNLTAIYLG 152
           S     L +N L   LP      L+  L    +S   +S  G   +     T+L  + L 
Sbjct: 29  SATRLELESNKLQ-SLPHGVFDKLTQ-LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 153 GNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTC 211
            N +  ++      L++L+++  + + L+    + +F  L  L  LD+       +    
Sbjct: 87  FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145

Query: 212 FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGY 271
           F+ L+SL  L ++ N                     +   + +P     L++L +L L  
Sbjct: 146 FNGLSSLEVLKMAGN---------------------SFQENFLPDIFTELRNLTFLDLSQ 184

Query: 272 NILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGG 330
             L+  +  +    L SL+ LN S+NN         + L+ L+ L+ S N +     K  
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK-Q 241

Query: 331 SFGNFSAE----SFEGNKLLC 347
              +F +     +   N   C
Sbjct: 242 ELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 62/307 (20%), Positives = 92/307 (29%), Gaps = 72/307 (23%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P+ I P +   L L  N L  +       ++ L  L+L  N LS              
Sbjct: 21  SVPTGI-PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-----------FKG 68

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
               S         SL    LS N +                             +    
Sbjct: 69  CCSQSD----FGTTSLKYLDLSFNGVI---------------------------TMSSNF 97

Query: 141 GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLD 198
             L  L  +    + L     F     L+ L Y+ +            IF  L  L  L 
Sbjct: 98  LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLK 156

Query: 199 LGGNKLSGSILT-CFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTT 257
           + GN    + L   F+ L +L  L LS                            + PT 
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQ----------------------CQLEQLSPTA 194

Query: 258 IGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKL-SYLEHL 315
             SL  LQ L + +N    S+       L SL+ L++S N++  +    L+   S L  L
Sbjct: 195 FNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253

Query: 316 NLSFNKL 322
           NL+ N  
Sbjct: 254 NLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 30/180 (16%), Positives = 58/180 (32%), Gaps = 47/180 (26%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFL 87
            NL  L +   +   V    IF+ +S+L+ L +  N           ++  +  P++   
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGN-----------SFQENFLPDI--- 170

Query: 88  SSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLT 147
              +  ++L    LS   L  +           S   F+               +L++L 
Sbjct: 171 --FTELRNLTFLDLSQCQLEQL-----------SPTAFN---------------SLSSLQ 202

Query: 148 AIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR--LVKLYKLDLGGNKLS 205
            + +  N       F  + L  LQ +    N +  T      +     L  L+L  N  +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  104 bits (260), Expect = 3e-24
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 17/203 (8%)

Query: 431 NLIGKGGFGTIY----KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
            +IG+G FG +Y        G  +  AVK  +          F  E  IMK   + N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 486 IISSCSNEEFKEL-VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFN 541
           ++  C   E   L VL +M HG L   + +      +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPEYG 599
                +H DL   N +LD+     ++DFG+ + +  ++      +T A   + ++A E  
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 600 REGRVFANGDVYSFGIMLMEIHS 622
           +  +     DV+SFG++L E+ +
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (256), Expect = 3e-24
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 31/206 (15%)

Query: 433 IGKGGFGTIYK---SRIGDGMEVAVKVFHLQCG----RAFKSFDIECEIMKSIHYRNLVK 485
           +G G FGT+ K           VAVK+  L+              E  +M+ +    +V+
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNF 542
           +I  C  E +  LV+E    G L K L   N  +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT--IGYIAPE--- 597
               +H DL   NVLL     A +SDFG++K  +  D++  + QT     + + APE   
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 598 YGREGRVFAN-GDVYSFGIMLMEIHS 622
           Y +    F++  DV+SFG+++ E  S
Sbjct: 194 YYK----FSSKSDVWSFGVLMWEAFS 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  101 bits (255), Expect = 4e-24
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)

Query: 433 IGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLVKIISSC 490
           +G G +G +Y+       + VAVK   L+        F  E  +MK I + NLV+++  C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYL-HFNFLVPVIH 548
           + E    ++ E M +G+L   L   N   +     L +   ++S +EYL   NF    IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF----IH 134

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   N L+ +  +  ++DFG+++ L+  D           I + APE     +     
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193

Query: 609 DVYSFGIMLMEIHS 622
           DV++FG++L EI +
Sbjct: 194 DVWAFGVLLWEIAT 207

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (256), Expect = 4e-24
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 16/198 (8%)

Query: 433 IGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG +          G G  VAVK      G +    +  E +I++++++ +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 487 ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFL 543
              C +       LV+E++P GSL   L   +  + + Q L     +   + YLH  ++ 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHY- 155

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREG 602
              IH DL   NVLLD+  +  + DFG+ K +  G +    +    + + + APE  +E 
Sbjct: 156 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 603 RVFANGDVYSFGIMLMEI 620
           + +   DV+SFG+ L E+
Sbjct: 213 KFYYASDVWSFGVTLYEL 230

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (258), Expect = 6e-24
 Identities = 48/197 (24%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 433 IGKGGFGTIY----KSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKII 487
           +G G FG +     K      + VA+K   +    +  + F  E  IM    + N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPV 546
              +  +   +V E+M +GSL+  L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +H DL   N+L++  +V  +SDFG+ ++L    + + T       I + +PE     +  
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 606 ANGDVYSFGIMLMEIHS 622
           +  DV+S+GI+L E+ S
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  102 bits (256), Expect = 6e-24
 Identities = 57/240 (23%), Positives = 115/240 (47%), Gaps = 24/240 (10%)

Query: 395 KRENWPPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYK-----SRIGDG 449
           +   +     + P +A   +F+  E+  +     +  +IG G FG +YK     S     
Sbjct: 18  ENLYFQGAMGSDPNQA-VLKFTT-EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKE 73

Query: 450 MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL 508
           + VA+K        +    F  E  IM    + N++++    S  +   ++ E+M +G+L
Sbjct: 74  VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133

Query: 509 EKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCDLKPSNVLLDDTMVAHLS 567
           +K L   +    + Q + ++  +A+ ++YL + N+    +H DL   N+L++  +V  +S
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAARNILVNSNLVCKVS 189

Query: 568 DFGITKLLIGEDQSMTQTQ-TLATIGYIAPE---YGREGRVF-ANGDVYSFGIMLMEIHS 622
           DFG++++L  + ++   T      I + APE   Y +    F +  DV+SFGI++ E+ +
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK----FTSASDVWSFGIVMWEVMT 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (253), Expect = 6e-24
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 24/202 (11%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKII 487
           +G+G FG     +Y +  G+ + VAVK     C     + F  E  IMK++ + ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFLV 544
                E    +++E  P+G L   L  +   L +   +   + +   + YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE---YGRE 601
             +H D+   N+L+       L DFG+++  I ++     + T   I +++PE   + R 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRR- 190

Query: 602 GRVF-ANGDVYSFGIMLMEIHS 622
              F    DV+ F + + EI S
Sbjct: 191 ---FTTASDVWMFAVCMWEILS 209

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (255), Expect = 7e-24
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 25/207 (12%)

Query: 433 IGKGGFGTIY----KSRIGDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG++     K   G  ++VAVK   L     R  + F  E   MK   + N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 487 ISSCSNEEFKE-----LVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVLE 536
           +  C     +      ++L  M +G L        L +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 537 YL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL   +F      +H DL   N +L D M   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
           IA E   +    +  DV++FG+ + EI
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEI 242

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  102 bits (255), Expect = 7e-24
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 16/197 (8%)

Query: 433 IGKGGFGTIYK-----SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKI 486
           +G G FGT+YK           + VA+K        +A K    E  +M S+   ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFL 543
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR 603
              +H DL   NVL+       ++DFG+ KLL  E++          I ++A E      
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 604 VFANGDVYSFGIMLMEI 620
                DV+S+G+ + E+
Sbjct: 196 YTHQSDVWSYGVTVWEL 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (260), Expect = 8e-24
 Identities = 67/193 (34%), Positives = 97/193 (50%), Gaps = 15/193 (7%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IGKG FG +       G +VAVK   ++     ++F  E  +M  + + NLV+++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 493 EE-FKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHC 549
           E+    +V E+M  GSL   L S    +L     L   +DV   +EYL   NF    +H 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHR 313

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   NVL+ +  VA +SDFG+TK     + S TQ      + + APE  RE +     D
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368

Query: 610 VYSFGIMLMEIHS 622
           V+SFGI+L EI+S
Sbjct: 369 VWSFGILLWEIYS 381

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  100 bits (251), Expect = 1e-23
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 21/201 (10%)

Query: 430 NNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKI 486
           +  IG+G F T+YK       +EVA      +     +    + E   +K + + N+V+ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 487 ISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             S  +    +    LV E M  G+L K       ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 543 LVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEY 598
             P+IH DLK  N+ +        + D G+  L          +   A IG   ++APE 
Sbjct: 150 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------KRASFAKAVIGTPEFMAPEM 201

Query: 599 GREGRVFANGDVYSFGIMLME 619
             E    +  DVY+FG+ ++E
Sbjct: 202 YEEKYDES-VDVYAFGMCMLE 221

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  101 bits (253), Expect = 1e-23
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 433 IGKGGFGTIY----KSRIGDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKI 486
           +GKG FG++     K   G  ++VAVK+           + F  E   MK   + ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 487 ISSCSNEEFKE------LVLEHMPHGSLEKCLYSS-----NCILDIFQRLNIMIDVASVL 535
           +        K       ++L  M HG L   L +S        L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 536 EYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
           EYL   +F      IH DL   N +L + M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 593 YIAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++A E   +     + DV++FG+ + EI
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEI 232

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 54/192 (28%), Positives = 99/192 (51%), Gaps = 9/192 (4%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           +G G FG ++        +VAVK    Q   +  +F  E  +MK + ++ LV++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 493 EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYL-HFNFLVPVIHCD 550
           E    ++ E+M +GSL   L + +   L I + L++   +A  + ++   N+    IH D
Sbjct: 80  EPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY----IHRD 134

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDV 610
           L+ +N+L+ DT+   ++DFG+ + LI +++   +      I + APE    G      DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 611 YSFGIMLMEIHS 622
           +SFGI+L EI +
Sbjct: 194 WSFGILLTEIVT 205

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 12/196 (6%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     + VA+K           + F  E   M+   + ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL-HFNFLVPV 546
              +      +++E    G L   L      LD+   +     +++ L YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H D+   NVL+       L DFG+++  + +      ++    I ++APE     R  +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196

Query: 607 NGDVYSFGIMLMEIHS 622
             DV+ FG+ + EI  
Sbjct: 197 ASDVWMFGVCMWEILM 212

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 67/195 (34%), Positives = 97/195 (49%), Gaps = 15/195 (7%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
             IGKG FG +       G +VAVK   ++     ++F  E  +M  + + NLV+++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 491 SNEE-FKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYL-HFNFLVPVI 547
             E+    +V E+M  GSL   L S    +L     L   +DV   +EYL   NF    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF----V 139

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           H DL   NVL+ +  VA +SDFG+TK     + S TQ      + + APE  RE +    
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 194

Query: 608 GDVYSFGIMLMEIHS 622
            DV+SFGI+L EI+S
Sbjct: 195 SDVWSFGILLWEIYS 209

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (257), Expect = 5e-23
 Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 12/196 (6%)

Query: 433 IGKGGFGT----IYKSRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKII 487
           IG+G FG     IY S     M VA+K           + F  E   M+   + ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPV 546
              +      +++E    G L   L      LD+   +     +++ L YL    F    
Sbjct: 458 GVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H D+   NVL+       L DFG+++  + +      ++    I ++APE     R  +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571

Query: 607 NGDVYSFGIMLMEIHS 622
             DV+ FG+ + EI  
Sbjct: 572 ASDVWMFGVCMWEILM 587

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  100 bits (252), Expect = 8e-23
 Identities = 67/343 (19%), Positives = 122/343 (35%), Gaps = 47/343 (13%)

Query: 28  PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS------ST 81
           P ++  + L  N++  +   +   +  L+ L ++       + +     L+S        
Sbjct: 29  PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 82  PELSFLSS--LSNCKSLVVFLLSNNPLNG-ILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
            +   L +   +   +L V  L+   L+G +L       L+ SLE+  +   N+    P 
Sbjct: 89  NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPA 147

Query: 139 EI-GNLTNLTAIYLGGNKLN----------GSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
               N+     + L  NK+               FTL  L  +    + +  L      +
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207

Query: 188 IFRLVKLYKLDLGGNKLSGSILTCFSNLAS---LRTLSLSYNDGPLP------------- 231
            F+   +  LDL GN    S+   F +  +   +++L LS +                  
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

Query: 232 ----LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LI 286
               LE   +K     D S +   +++ +      DL+ L L  N +   I D+    L 
Sbjct: 268 TFKGLEASGVKTC---DLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT 323

Query: 287 SLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
            L  LN S N L      + E L  LE L+LS+N +   +   
Sbjct: 324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 19/221 (8%)

Query: 144 TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGN 202
            ++  + L  N +      +   LQ LQ++ ++       I  + FR L  L  L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 203 KLSGSILTCFSNLASLRTLSLSYN---DGPLPLEI-GNLKVLIGIDFSMNNFSSVIPTTI 258
           +        F+ LA+L  L+L+        L       L  L  +    NN   + P + 
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 259 -GSLKDLQYLFLGYNILKGSIPDSVGD-----------LISLKSLNFSNNNLSGAIPLLL 306
             +++    L L +N +K SI +               L S+   + +   L        
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 307 EKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLC 347
            K + +  L+LS N  + E      F   +    +   L  
Sbjct: 209 FKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLILSN 248

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 58/302 (19%), Positives = 97/302 (32%), Gaps = 40/302 (13%)

Query: 8   KLELNVDDIESPCEIPSEI--NPHNLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNY 64
            L L   +++    +         +LE L+L  NN+  + PA+ F  +     L L  N 
Sbjct: 107 VLTLTQCNLDGAV-LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 65  LS-------GSLSSIADNYLTSSTPELSFLSSLS----------NCKSLVVFLLSNNPLN 107
           +         +        L  S+  L  ++                S+    LS N   
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

Query: 108 GILPRMSIGNLSHS------LEIFDMSKCNVSGGIPEEIGNLT-------NLTAIYLGGN 154
             + +     ++ +      L        +      ++  N T        +    L  +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285

Query: 155 KLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSILTCF 212
           K+  ++          L+ + L  N++   I  + F  L  L KL+L  N L       F
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMF 343

Query: 213 SNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG 270
            NL  L  L LSYN    L  +    L  L  +    N   SV       L  LQ ++L 
Sbjct: 344 ENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 403

Query: 271 YN 272
            N
Sbjct: 404 TN 405

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 18/181 (9%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            +G+GGF  +     + DG   A+K       +  +    E ++ +  ++ N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 491 SNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIF---QRLNIMIDVASVLEYLHFNFL 543
             E   +    L+L     G+L   +       +     Q L +++ +   LE +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-------TIGYIAP 596
               H DLKP+N+LL D     L D G         +   Q  TL        TI Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 597 E 597
           E
Sbjct: 213 E 213

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  100 bits (251), Expect = 8e-23
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 9/230 (3%)

Query: 95  SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI-GNLTNLTAIYLGG 153
           +  +  L  N +  I+   S  +L   LEI  +S+ ++   I       L NL  + L  
Sbjct: 65  NTRLLNLHENQIQ-IIKVNSFKHLR-HLEILQLSRNHIRT-IEIGAFNGLANLNTLELFD 121

Query: 154 NKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGG-NKLSGSILT 210
           N+L  +IP      L KL+ + L++N +E +IP   F  +  L +LDLG   +LS     
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 211 CFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG 270
            F  L++LR L+L+  +      +  L  L  +D S N+ S++ P +   L  LQ L++ 
Sbjct: 180 AFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
            + ++    ++  +L SL  +N ++NNL+     L   L +LE ++L  N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.4 bits (235), Expect = 8e-21
 Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 10/237 (4%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
            +S +  + ++ +  +         +L +L  + L  N +          L  L  + L 
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120

Query: 177 DNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIG 235
           DN+L  TIP   F  L KL +L L  N +       F+ + SLR L L        +  G
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 236 ---NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLN 292
               L  L  ++ +M N   +    +  L  L  L L  N L    P S   L+ L+ L 
Sbjct: 180 AFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237

Query: 293 FSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG--GSFGNFSAESFEGNKLLC 347
              + +        + L  L  +NL+ N L   +P        +        N   C
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 48/209 (22%)

Query: 21  EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLT 78
            IP+        L+EL L  N +  +   A   + +L+ L L +      LS I++    
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL---KRLSYISEG--- 179

Query: 79  SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE 138
                     +     +L    L+   L  I                             
Sbjct: 180 ----------AFEGLSNLRYLNLAMCNLREI----------------------------P 201

Query: 139 EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKL 197
            +  L  L  + L GN L+   P + + L  LQ + +  ++++  I  + F  L  L ++
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEI 260

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           +L  N L+      F+ L  L  + L +N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  100 bits (251), Expect = 9e-23
 Identities = 45/220 (20%), Positives = 83/220 (37%), Gaps = 36/220 (16%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIM-KSIHYRNLVK 485
                ++G G  GT+       G  VAVK   +          +E +++ +S  + N+++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 486 IISSCSNEEFKELVLEHMPHGSLE------KCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
              S + + F  + LE     +L+           +  +   +  ++++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAH-------------LSDFGITKLLIGEDQSMTQTQ 586
                 +IH DLKP N+L+  +                 +SDFG+ K L     S     
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 587 TLA--TIGYIAPEYGREGRVFANG-------DVYSFGIML 617
                T G+ APE   E              D++S G + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 44/200 (22%), Positives = 76/200 (38%), Gaps = 26/200 (13%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
             +G+G FG +++ +    G + AVK   L+  R       E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
                +  + +E +  GSL + +    C L   + L  +      LEYLH      ++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRR---ILHG 174

Query: 550 DLKPSNVLLDDT-MVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPE------YG 599
           D+K  NVLL      A L DFG    L  +    +        G   ++APE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 600 REGRVFANGDVYSFGIMLME 619
            +       D++S   M++ 
Sbjct: 235 AK------VDIWSSCCMMLH 248

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  100 bits (250), Expect = 1e-22
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 9/230 (3%)

Query: 95  SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI-GNLTNLTAIYLGG 153
           +     L  N +  ++   +  +L   LE+  + + ++   I       L +L  + L  
Sbjct: 76  NTRYLNLMENNIQ-MIQADTFRHLH-HLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFD 132

Query: 154 NKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGG-NKLSGSILT 210
           N L   IP      L KL+ + L++N +E +IP   F  +  L +LDLG   KL      
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 211 CFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG 270
            F  L +L+ L+L   +      +  L  L  ++ S N+F  + P +   L  L+ L++ 
Sbjct: 191 AFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
            + +     ++   L SL  LN ++NNLS     L   L YL  L+L  N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 53/237 (22%), Positives = 82/237 (34%), Gaps = 10/237 (4%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
            +  +    ++ + N+     +   +L +L  + LG N +          L  L  + L 
Sbjct: 72  GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131

Query: 177 DNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLS-YND-GPLPLE 233
           DN L   IP   F  L KL +L L  N +       F+ + SL  L L        +   
Sbjct: 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 234 I-GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLN 292
               L  L  ++  M N   +    +  L  L+ L +  N      P S   L SLK L 
Sbjct: 191 AFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248

Query: 293 FSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG--GSFGNFSAESFEGNKLLC 347
             N+ +S       + L+ L  LNL+ N L   +P                 N   C
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 427 FNENNLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F E  LIG GGFG ++K     DG    +K       +A +    E + +  + + N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68

Query: 486 IISSCSNEEFKE----------------LVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIM 528
                   ++                  + +E    G+LE+ +       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
             +   ++Y+H      +I+ DLKPSN+ L DT    + DFG+   L        +T++ 
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSK 182

Query: 589 ATIGYIAPE------YGREGRVFANGDVYSFGIMLMEI 620
            T+ Y++PE      YG+E       D+Y+ G++L E+
Sbjct: 183 GTLRYMSPEQISSQDYGKE------VDLYALGLILAEL 214

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 12/176 (6%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
            IG G +G   K  R  DG  +  K            +    E  +++ + + N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 489 SCSNEEFKEL--VLEHMPHGSLEKCLYSSNCILDIF---QRLNIMIDVASVLEYLH--FN 541
              +     L  V+E+   G L   +               L +M  +   L+  H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
               V+H DLKP+NV LD      L DFG+ ++L   D S  +T  + T  Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSPE 186

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 15/196 (7%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
           ++GKG +G +Y  R + + + +A+K    +  R  +    E  + K + ++N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL--NIMIDVASVLEYLHFNFLVPVIH 548
           S   F ++ +E +P GSL   L S    L   ++        +   L+YLH N    ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 549 CDLKPSNVLLDDTM-VAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPE---YGREGR 603
            D+K  NVL++    V  +SDFG +K L G       T+T   T+ Y+APE    G  G 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 604 VFANGDVYSFGIMLME 619
             A  D++S G  ++E
Sbjct: 203 GKA-ADIWSLGCTIIE 217

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 97.8 bits (243), Expect = 7e-22
 Identities = 29/227 (12%), Positives = 60/227 (26%), Gaps = 45/227 (19%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNLVKII 487
           ++G+       ++     G    V V +        A K    E   ++ +      K  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIF----------------------- 522
                  F   +++      + +         +L  F                       
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 523 -------QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL 575
                   RL + + V  +L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 576 IGEDQSMTQTQTLATIGYIAPE-----YGREGRVFANGDVYSFGIML 617
            G        +  A     A             +    D ++ G+ +
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 44/207 (21%), Positives = 87/207 (42%), Gaps = 25/207 (12%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG +Y+       +      VA+K  +     R    F  E  +MK  +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 486 IISSCSNEEFKELVLEHMPHGSL---------EKCLYSSNCILDIFQRLNIMIDVASVLE 536
           ++   S  +   +++E M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 537 YL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           YL    F      +H DL   N ++ +     + DFG+T+ +   D      + L  + +
Sbjct: 153 YLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
           ++PE  ++G      DV+SFG++L EI
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEI 233

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 44/236 (18%), Positives = 85/236 (36%), Gaps = 18/236 (7%)

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           +       + +      + +   +      +L   +         V+    E +  L NL
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT---QADLDG-ITTLSAFGTGVTT--IEGVQYLNNL 65

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
             + L  N++   +   L+ L K+  + L  N L+      I  L  +  LDL   +++ 
Sbjct: 66  IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD 121

Query: 207 SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY 266
             +T  + L++L+ L L  N       +  L  L  +       S + P  + +L  L  
Sbjct: 122 --VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177

Query: 267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           L    N +   I   +  L +L  ++  NN +S   PL     S L  + L+   +
Sbjct: 178 LKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 56/324 (17%), Positives = 117/324 (36%), Gaps = 61/324 (18%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS 89
           N  ++  G++N+   V     D+  +  L+                        ++ +  
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT-------------------GVTTIEG 58

Query: 90  LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAI 149
           +    +L+   L +N +  + P   + NL+  +   ++S   +       I  L ++  +
Sbjct: 59  VQYLNNLIGLELKDNQITDLAP---LKNLTK-ITELELSGNPLK--NVSAIAGLQSIKTL 112

Query: 150 YLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSIL 209
            L   ++    P  L  L  LQ + L  N++    P  +  L  L  L +G  ++S   L
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--L 166

Query: 210 TCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL 269
           T  +NL+ L TL    N       + +L  LI +    N  S V P  + +  +L  + L
Sbjct: 167 TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 270 GYN-------------ILKGSIPDSVGDLISLKSL----NFSNNNLSGAIPLLLEKLSYL 312
                           ++   +    G  I+  ++     +++ NL+  +   +  +SY 
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSY- 283

Query: 313 EHLNLSFNKLEGEIPKGGSFGNFS 336
                +FN+    +    +   FS
Sbjct: 284 -----TFNQS---VTFKNTTVPFS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 18/224 (8%)

Query: 100 LLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGS 159
           +     +N I P      L++        K NV+        +L  +T +   G  +  +
Sbjct: 3   ITQPTAINVIFP---DPALAN-AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-T 55

Query: 160 IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
           I   ++ L  L  + LKDN++    P  +  L K+ +L+L GN L    ++  + L S++
Sbjct: 56  IEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIK 110

Query: 220 TLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
           TL L+         +  L  L  +   +N  +++ P  +  L +LQYL +G   +   + 
Sbjct: 111 TLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL- 166

Query: 280 DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
             + +L  L +L   +N +S   PL    L  L  ++L  N++ 
Sbjct: 167 TPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 45/259 (17%), Positives = 107/259 (41%), Gaps = 19/259 (7%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NY 76
           +  ++ +   +  L      +  +    +  ++ L  L L+DN ++  L+ + +      
Sbjct: 33  DTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT-DLAPLKNLTKITE 89

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L  S   L  +S+++  +S+    L++  +  + P   +  LS +L++  +    ++   
Sbjct: 90  LELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP---LAGLS-NLQVLYLDLNQITN-- 143

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
              +  LTNL  + +G  +++   P  L  L KL  +   DNK+   I   +  L  L +
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIE 199

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           + L  N++S   ++  +N ++L  ++L+           N  +++       + + + P 
Sbjct: 200 VHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257

Query: 257 TIGSLKDLQYLFLGYNILK 275
           TI          L +N+  
Sbjct: 258 TISDNGTYASPNLTWNLTS 276

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 54/212 (25%), Positives = 77/212 (36%), Gaps = 13/212 (6%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
            +  + +   +    +S           NLT ++L  N L          L  L+ + L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 177 DNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSI-LTCFSNLASLRTLSLSYND-GPLPLE 233
           DN    ++    F  L +L+ L L    L   +    F  LA+L+ L L  N    LP +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 234 I----GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISL 288
                GNL  L       N  SSV       L  L  L L  N +   +      DL  L
Sbjct: 148 TFRDLGNLTHL---FLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRL 203

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
            +L    NNLS      L  L  L++L L+ N
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 52/199 (26%), Positives = 74/199 (37%), Gaps = 10/199 (5%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKL 194
           +P  I        I+L GN+++     + R  + L  + L  N L   I    F  L  L
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82

Query: 195 YKLDLGGNKLSGSI-LTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFS 251
            +LDL  N    S+    F  L  L TL L       L   +   L  L  +    N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLS 310
           ++   T   L +L +LFL  N +  S+P+     L SL  L    N ++   P     L 
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 311 YLEHLNLSFNKLEGEIPKG 329
            L  L L  N L   +P  
Sbjct: 202 RLMTLYLFANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 62/281 (22%), Positives = 89/281 (31%), Gaps = 71/281 (25%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P  I P   + + L  N +  V  A+      L  L L  N     L+ I        
Sbjct: 25  AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN----VLARIDAA----- 74

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                   + +    L    LS+N     +              F               
Sbjct: 75  --------AFTGLALLEQLDLSDNAQLRSVDP----------ATFH-------------- 102

Query: 141 GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLD 198
             L  L  ++L    L   +     R L  LQY+ L+DN L+  +P D FR L  L  L 
Sbjct: 103 -GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI 258
           L GN++S      F  L SL  L L  N                        + V P   
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQN----------------------RVAHVHPHAF 197

Query: 259 GSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNL 298
             L  L  L+L  N L  ++P      L +L+ L  ++N  
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 96.7 bits (240), Expect = 5e-21
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 31/204 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKII--- 487
           +G GGFG + +      G +VA+K    +   +  + + +E +IMK +++ N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 488 ---SSCSNEEFKELVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
                 +  +   L +E+   G L K L  + + C L       ++ D++S L YLH N 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141

Query: 543 LVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-- 597
              +IH DLKP N++L      ++  + D G  K L  +   +     + T+ Y+APE  
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195

Query: 598 ----YGREGRVFANGDVYSFGIML 617
               Y          D +SFG + 
Sbjct: 196 EQKKYTVT------VDYWSFGTLA 213

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 29/211 (13%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNL 483
           +G G FG +Y+            ++VAVK   L      +    F +E  I+   +++N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSS------NCILDIFQRLNIMIDVASVLEY 537
           V+ I        + +++E M  G L+  L  +         L +   L++  D+A   +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 538 L---HFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           L   HF      IH D+   N LL       VA + DFG+ + +            +  +
Sbjct: 156 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            ++ PE   EG   +  D +SFG++L EI S
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.3 bits (232), Expect = 8e-21
 Identities = 56/314 (17%), Positives = 104/314 (33%), Gaps = 59/314 (18%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST 81
           IPS +    ++ L L  N +  +  + +     L+ L L  N ++             + 
Sbjct: 46  IPSGL-TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-------------TI 91

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG 141
            E SF SSL +   L    LS N L+ +               F                
Sbjct: 92  EEDSF-SSLGS---LEHLDLSYNYLSNLSSSW-----------FK--------------- 121

Query: 142 NLTNLTAIYLGGNKLNGSIP--FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLD 198
            L++LT + L GN    ++        L KLQ + + +      I    F  L  L +L+
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYN----------DGPLPLEIGNLKVLIGIDFSMN 248
           +  + L         ++ ++  L L             D    +E   L+      F  +
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240

Query: 249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEK 308
             S+    ++      + + +    L   +   +  +  L  L FS N L      + ++
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDR 299

Query: 309 LSYLEHLNLSFNKL 322
           L+ L+ + L  N  
Sbjct: 300 LTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.4 bits (209), Expect = 9e-18
 Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 14/197 (7%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKL 194
           IP  +     + ++ L  N++       L+    LQ + L  N +  TI  D F  L  L
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYN------DGPLPLEIGNLKVLIGIDFSMN 248
             LDL  N LS    + F  L+SL  L+L  N      +  L   +  L++L     +M+
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR--VGNMD 160

Query: 249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLE 307
            F+ +       L  L+ L +  + L+ S        + ++  L          + + ++
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219

Query: 308 KLSYLEHLNLSFNKLEG 324
             S +E L L    L+ 
Sbjct: 220 VTSSVECLELRDTDLDT 236

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 24/131 (18%), Positives = 53/131 (40%), Gaps = 16/131 (12%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVST-LKDLALQDNYLSGSLSSIADNYLTSSTPELSFL 87
            N+  L+L     + ++     DV++ ++ L L+D  L     S      T+S  +    
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256

Query: 88  SSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI-GNLTNL 146
            ++          +++  L  ++    +  +S  L   + S+  +   +P+ I   LT+L
Sbjct: 257 RNVK---------ITDESLFQVMK--LLNQIS-GLLELEFSRNQLKS-VPDGIFDRLTSL 303

Query: 147 TAIYLGGNKLN 157
             I+L  N  +
Sbjct: 304 QKIWLHTNPWD 314

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 95.3 bits (237), Expect = 9e-21
 Identities = 60/335 (17%), Positives = 110/335 (32%), Gaps = 12/335 (3%)

Query: 8   KLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG 67
             ++ +   E+  E        +     L            I DVS      L+ + +  
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 68  SLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH-SLEIFD 126
            L     +Y  S   +L     LSN  +L     + N    IL  +    + + S+    
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSN-LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 127 MSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY 186
           +              +L  L+   +  +       +       +       +        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 187 DIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND----GPLPLEIGNLKVLIG 242
              ++     LD   N L+ ++     +L  L TL L  N       +      +K L  
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378

Query: 243 IDFSMNNFSSVIPTTI-GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGA 301
           +D S N+ S           K L  L +  NIL  +I   +     +K L+  +N +  +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435

Query: 302 IPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
           IP  + KL  L+ LN++ N+L+  +P  G F   +
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 11/260 (4%)

Query: 69  LSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
           LS++  N + ++      +  L    ++  F +SN  L G L          SL+   + 
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281

Query: 129 KC--NVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP 185
           +   +V G     I    +N+       +           ++    ++   +N L  T+ 
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 186 YDIFRLVKLYKLDLGGNKLS--GSILTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVL 240
            +   L +L  L L  N+L     I    + + SL+ L +S N         +    K L
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401

Query: 241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
           + ++ S N  +  I   +     ++ L L  N +K SIP  V  L +L+ LN ++N L  
Sbjct: 402 LSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS 458

Query: 301 AIPLLLEKLSYLEHLNLSFN 320
               + ++L+ L+ + L  N
Sbjct: 459 VPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 45/231 (19%), Positives = 94/231 (40%), Gaps = 24/231 (10%)

Query: 12  NVDDIESPCEIPSEINPHNLEELLLGQ--NNLVGVVPAAIFDV-STLKDLALQDNYLS-- 66
           NV           + +  +L+ L + Q  +++ G   + I+++ S +       +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315

Query: 67  -----GSLSSI-----ADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIG 116
                  +S       ++N LT +  E      L+  ++L+   L  N L  +     + 
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFE--NCGHLTELETLI---LQMNQLKELSKIAEMT 370

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEI-GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL 175
               SL+  D+S+ +VS    +       +L ++ +  N L  +I   L    +++ + L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDL 428

Query: 176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
             NK++ +IP  + +L  L +L++  N+L       F  L SL+ + L  N
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 48/355 (13%), Positives = 101/355 (28%), Gaps = 61/355 (17%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG-------------- 67
           +P ++       L + QN +  +  + I  +S L+ L +  N +                
Sbjct: 15  VPKDL-SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEY 73

Query: 68  ------SLSSIADNYLTS------------STPELSFLSSLSNCKSLVVFLLSNNPLNGI 109
                  L  I+ +   +            + P      ++S  K L    LS   L   
Sbjct: 74  LDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG---LSTTHLEKS 130

Query: 110 LPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK 169
              + I +L+ S  +  + +        E+   L +     L            + ++  
Sbjct: 131 -SVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 170 LQYVGLKDNKLEGTIPYDIF-----------RLVKLYKLDLGGNKLSGSILT---CFSNL 215
                L+ + ++  +  +                KL  L L   + + +           
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 216 ASLRTLSLSYND-------GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLF 268
            ++   S+S                  +LK L       + F            ++    
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 269 LGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
              +  +         +     L+FSNN L+  +      L+ LE L L  N+L+
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 43/260 (16%), Positives = 90/260 (34%), Gaps = 14/260 (5%)

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLI 241
           +P D+ +      L++  N +S    +   +L+ LR L +S+N    L + +    + L 
Sbjct: 15  VPKDLSQKTT--ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 242 GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS--VGDLISLKSLNFSNNNLS 299
            +D S N    +   +     +L++L L +N    ++P     G++  LK L  S  +L 
Sbjct: 73  YLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 300 GAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKT 359
            +  L +  L+  + L +       +        +F+ ES           +  +     
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKED-PEGLQDFNTESLHIVFPTNKEFHFILDVSVK 187

Query: 360 SIHHTSRKNALFLGIVLSFSTIFMVVVILLIVKYQKRENWPPNDANMPPKATWRRFSYLE 419
           ++ +    N   +      S    ++  L         N   N+      +  R    + 
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS--NLTLNNIETTWNSFIRILQLVW 245

Query: 420 VCRATY-GFNENNLIGKGGF 438
                Y   +   L G+  F
Sbjct: 246 HTTVWYFSISNVKLQGQLDF 265

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++       S   D M VAVK        A K F  E E++ ++ + ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 487 ISSCSNEEFKELVLEHMPHGSL---------------EKCLYSSNCILDIFQRLNIMIDV 531
              C + +   +V E+M HG L               +     +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 532 ASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
           AS + YL   HF      +H DL   N L+   ++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 589 ATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             I ++ PE     +     DV+SFG++L EI
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 93.6 bits (232), Expect = 1e-20
 Identities = 22/252 (8%), Positives = 54/252 (21%), Gaps = 47/252 (18%)

Query: 406 MPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQC 461
            P  A     S L          E   +  G    ++  R +    + A+KVF       
Sbjct: 45  WPQNAETTVDSLLSQGERKLKLVE--PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCS-NEEFKELVLEHMPHGSLEKCLYSSNCILD 520
               +           +   +  +             + ++  P  +          + +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 521 IF------------------------------QRLNIMIDVASVLEYLHFNFLVPVIHCD 550
                                               +   +  +   L       ++H  
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY--GREGRVFANG 608
             P N+ +       L D       +G     +       + Y   E+            
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASSV----PVTYAPREFLNASTATFTHAL 274

Query: 609 DVYSFGIMLMEI 620
           + +  G+ +  +
Sbjct: 275 NAWQLGLSIYRV 286

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 43/202 (21%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI--HYRNLVKI 486
             IG GG   +++         A+K  +L+    +   S+  E   +  +  H   ++++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                 +++  +V+E   +  L   L      +D ++R +   ++   +  +H +    +
Sbjct: 94  YDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQH---GI 148

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGR 600
           +H DLKP+N L+ D M+  L DFGI   +  +  S+ +   + T+ Y+ PE        R
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 601 EGRVFANG-----DVYSFGIML 617
           E     +      DV+S G +L
Sbjct: 208 ENGKSKSKISPKSDVWSLGCIL 229

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 25/235 (10%)

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
           S     +L      N+ +  +     I  L+  L     +  N++  +   +   TNLT 
Sbjct: 37  SEEQLATLTSLDCHNSSITDMTG---IEKLT-GLTKLICTSNNITT-LD--LSQNTNLTY 89

Query: 149 IYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSI 208
           +    NKL  ++  T   L KL Y+    NKL      D+ +   L  L+   N L+   
Sbjct: 90  LACDSNKLT-NLDVT--PLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT--E 141

Query: 209 LTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLF 268
           +   S+   L  L    N     L++     L  +D S N  + +    +   K L  L 
Sbjct: 142 ID-VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLN 197

Query: 269 LGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
              N +   +   +   I L  L+ S+N L+    + +  L+ L + + S N L 
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 50/300 (16%), Positives = 88/300 (29%), Gaps = 34/300 (11%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS----GSLSSIADNYLTSSTP 82
               L  L    N L  +    +     L  L    N L+       + +    L     
Sbjct: 104 PLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLTEIDVSHNTQL--TELDCHLN 158

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           +      ++    L     S N +  +     +      L   +    N++  +   +  
Sbjct: 159 KKITKLDVTPQTQLTTLDCSFNKITEL----DVSQNK-LLNRLNCDTNNITK-LD--LNQ 210

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
              LT +    NKL   I  T   L +L Y     N L      D+  L KL  L     
Sbjct: 211 NIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQT 264

Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
            L    L   ++   L             L++ +   L  +D      + +    +    
Sbjct: 265 DLLEIDL---THNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNP 318

Query: 263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
            L YL+L    L   +   V     LKSL+  N ++       + K+  L +   +  + 
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 92.1 bits (229), Expect = 6e-20
 Identities = 53/316 (16%), Positives = 101/316 (31%), Gaps = 50/316 (15%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS----GSLSS-----IADNYLT-- 78
            L +L+   NN+  +    +   + L  LA   N L+      L+         N LT  
Sbjct: 65  GLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLTKL 121

Query: 79  --SSTPELSFLS---------SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM 127
             S  P L++L+          +S+   L       N     L    +   +  L   D 
Sbjct: 122 DVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD---VTPQT-QLTTLDC 177

Query: 128 SKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD 187
           S   ++     ++     L  +    N +   +     +  +L ++    NKL      D
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLTE---ID 228

Query: 188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSM 247
           +  L +L   D   N L+       S L+ L TL     D  L +++ +   LI      
Sbjct: 229 VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDL-LEIDLTHNTQLIYFQAEG 284

Query: 248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE 307
                 +   +     L  L      +   +   +     L  L  +N  L+  +   + 
Sbjct: 285 CRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VS 336

Query: 308 KLSYLEHLNLSFNKLE 323
             + L+ L+     ++
Sbjct: 337 HNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 29/137 (21%), Positives = 49/137 (35%), Gaps = 9/137 (6%)

Query: 187 DIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFS 246
           D F             ++  +       LA+L +L    +       I  L  L  +  +
Sbjct: 13  DWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICT 72

Query: 247 MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLL 306
            NN +++    +    +L YL    N L  ++   V  L  L  LN   N L+    L +
Sbjct: 73  SNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDV 123

Query: 307 EKLSYLEHLNLSFNKLE 323
            +   L +LN + N L 
Sbjct: 124 SQNPLLTYLNCARNTLT 140

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 36/217 (16%)

Query: 431 NLIGKGGFGTIYK------SRIGDGMEVAVK----VFHLQCGRAFKSFDIECEIMKSI-H 479
             +G G FG + +       +    ++VAVK      H     A  S   E +IM  +  
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELKIMSHLGQ 108

Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLN 526
           + N+V ++ +C++     ++ E+  +G L             +     +N        L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 527 IMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT 583
               VA  + +L   +       IH D+   NVLL +  VA + DFG+ + ++ +   + 
Sbjct: 169 FSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +      + ++APE   +       DV+S+GI+L EI
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 95.2 bits (236), Expect = 1e-20
 Identities = 47/236 (19%), Positives = 85/236 (36%), Gaps = 16/236 (6%)

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           +         +   L    +   +       L+  ++    +  ++     + I  L N+
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIK--SVQGIQYLPNV 67

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
           T ++L GNKL   I   L  L+ L ++ L +NK++      +  L KL  L L  N +  
Sbjct: 68  TKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI-- 121

Query: 207 SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY 266
           S +    +L  L +L L  N       +  L  L  +    N  S ++P  +  L  LQ 
Sbjct: 122 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 179

Query: 267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           L+L  N +  S   ++  L +L  L   +             L     +  +   L
Sbjct: 180 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.7 bits (214), Expect = 6e-18
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 20/186 (10%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG 201
                    L    +  ++     EL  +  +   ++ ++ ++   I  L  + KL L G
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74

Query: 202 NKLSGSILTCFSNLASLRTLSLSYND----GPLPLEIGNLKVLIGIDFSMNNFSSVIPTT 257
           NKL+   +   +NL +L  L L  N       L     +LK L  +    N  S +    
Sbjct: 75  NKLTD--IKPLTNLKNLGWLFLDENKIKDLSSL----KDLKKLKSLSLEHNGISDING-- 126

Query: 258 IGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNL 317
           +  L  L+ L+LG N  K +    +  L  L +L+  +N +S  +PL    L+ L++L L
Sbjct: 127 LVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYL 182

Query: 318 SFNKLE 323
           S N + 
Sbjct: 183 SKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.8 bits (196), Expect = 1e-15
 Identities = 48/252 (19%), Positives = 98/252 (38%), Gaps = 23/252 (9%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NYLTSSTPELS 85
              +  L + ++   V     +++++  +   ++ +  S+  I        L  +  +L+
Sbjct: 22  ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH--SLEIFDMSKCNVSGGIPEEIGNL 143
            +  L+N K+L    L  N +        + +L     L+   +    +S      + +L
Sbjct: 79  DIKPLTNLKNLGWLFLDENKIK------DLSSLKDLKKLKSLSLEHNGIS--DINGLVHL 130

Query: 144 TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNK 203
             L ++YLG NK+   I   L  L KL  + L+DN++   I   +  L KL  L L  N 
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNH 186

Query: 204 LSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
           +S   L   + L +L  L L   +           +++       + S V P  I    D
Sbjct: 187 IS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 244

Query: 264 LQYLFLGYNILK 275
            +   + +++ +
Sbjct: 245 YEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 76.7 bits (188), Expect = 9e-15
 Identities = 33/178 (18%), Positives = 66/178 (37%), Gaps = 12/178 (6%)

Query: 146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLS 205
           +         +   I F      +     LK   +   +  +   L  + ++    + + 
Sbjct: 1   MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 206 GSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ 265
              +     L ++  L L+ N       + NLK L  +    N    +    +  LK L+
Sbjct: 57  --SVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLK 112

Query: 266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
            L L +N +   I + +  L  L+SL   NN ++    L   +L+ L+ L+L  N++ 
Sbjct: 113 SLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 37/183 (20%), Positives = 69/183 (37%), Gaps = 15/183 (8%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NYLTSSTP 82
           N  NL  L L +N +  +    + D+  LK L+L+ N +S  ++ +        L     
Sbjct: 85  NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNN 141

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           +++ ++ LS    L    L +N ++ I+P   +  L+  L+   +SK ++S      +  
Sbjct: 142 KITDITVLSRLTKLDTLSLEDNQISDIVP---LAGLT-KLQNLYLSKNHIS--DLRALAG 195

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           L NL  + L   +           L     V   D  L    P  I       K ++  +
Sbjct: 196 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 253

Query: 203 KLS 205
              
Sbjct: 254 LPE 256

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 46/260 (17%), Positives = 77/260 (29%), Gaps = 22/260 (8%)

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHS-LEIFDMSKCNVSGGIPEEI 140
            +L   + +    SL    +    +   +   ++  L  S L+   +    V+G  P  +
Sbjct: 56  ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115

Query: 141 GNLT--NLTAIYLGGNKLNGSIPFTLR----ELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
              T  +L  + L          +           L+ + +            +     L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175

Query: 195 YKLDLGGNKLSGSI----LTCFSNLASLRTLSLSYN-----DGPLPLEIGNLKVLIGIDF 245
             LDL  N   G        C     +L+ L+L         G           L G+D 
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235

Query: 246 SMNNFSSVIPTTIGS-LKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL 304
           S N+               L  L L +  LK  +P  +     L  L+ S N L    P 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NPS 291

Query: 305 LLEKLSYLEHLNLSFNKLEG 324
             E L  + +L+L  N    
Sbjct: 292 PDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 52/290 (17%), Positives = 92/290 (31%), Gaps = 35/290 (12%)

Query: 3   SISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPA---AIFDVSTLKDLA 59
             S+  L   VD      +    I   +L+ L +    +   +      +  +S L++L 
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101

Query: 60  LQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMS--IGN 117
           L++  ++G+             P L   +       L +  L N         ++     
Sbjct: 102 LENLEVTGTAP-----------PPLLEATGPD----LNILNLRNVSWATRDAWLAELQQW 146

Query: 118 LSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI-------PFTLRELQKL 170
           L   L++  +++ +      E++     L+ + L  N   G         P     LQ L
Sbjct: 147 LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

Query: 171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSI-LTCFSNLASLRTLSLSYND-G 228
                      G         V+L  LDL  N L  +         + L +L+LS+    
Sbjct: 207 ALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

Query: 229 PLPLEIG-NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGS 277
            +P  +   L VL   D S N        +   L  +  L L  N    S
Sbjct: 267 QVPKGLPAKLSVL---DLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 50/261 (19%), Positives = 86/261 (32%), Gaps = 33/261 (12%)

Query: 88  SSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLT 147
           SS  NC       L     +       +   +   +  D+ K               +L 
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKS-------------LSLK 71

Query: 148 AIYLGGNKLNGSIPFTLREL---QKLQYVGLKDNKLEGTIPYDIFRLV--KLYKLDLGGN 202
            + +   ++   I F    +     LQ + L++ ++ GT P  +       L  L+L   
Sbjct: 72  RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 203 KLSG--SILTCFSNL--ASLRTLSLSYND-GPLPLE-IGNLKVLIGIDFSMNNFSSVIPT 256
             +   + L          L+ LS++         E +     L  +D S N        
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 257 TI----GSLKDLQYLFLGYNILK---GSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEK 308
                      LQ L L    ++   G         + L+ L+ S+N+L  A      + 
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251

Query: 309 LSYLEHLNLSFNKLEGEIPKG 329
            S L  LNLSF  L+ ++PKG
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 36/203 (17%), Positives = 63/203 (31%), Gaps = 32/203 (15%)

Query: 130 CNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF 189
           CN S   P+       L A  +       S+ + L+           D + +     DI 
Sbjct: 15  CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLK---------RVDTEADLGQFTDII 65

Query: 190 RLVKLYKLDLGGNKLSGSILTCFS---NLASLRTLSLSYND--GPLPLEIGNLKVLIGID 244
           + + L +L +   ++   IL        ++ L+ L+L   +  G  P  +          
Sbjct: 66  KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL 304
            ++ N S    T    L +LQ                      LK L+ +  +       
Sbjct: 126 LNLRNVS--WATRDAWLAELQQWLKP----------------GLKVLSIAQAHSLNFSCE 167

Query: 305 LLEKLSYLEHLNLSFNKLEGEIP 327
            +     L  L+LS N   GE  
Sbjct: 168 QVRVFPALSTLDLSDNPELGERG 190

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 39/199 (19%), Positives = 82/199 (41%), Gaps = 21/199 (10%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
            IG+G FG         DG +  +K  ++     +  +    E  ++ ++ + N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 489 SCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
           S        +V+++   G L ++       +    Q L+  + +   L+++H      ++
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KIL 147

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGRE 601
           H D+K  N+ L       L DFGI ++L      + +     T  Y++PE      Y  +
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENKPYNNK 205

Query: 602 GRVFANGDVYSFGIMLMEI 620
                  D+++ G +L E+
Sbjct: 206 ------SDIWALGCVLYEL 218

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.1 bits (232), Expect = 2e-20
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 46/208 (22%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIISS 489
           +GKG F  + +  ++  G E A  + + +   A     +  E  I + + + N+V++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
            S E    L+ + +  G L      +  YS    S+CI  I             + + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL----------EAVLHCHQ 128

Query: 541 NFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIA 595
                V+H +LKP N+LL        V  L+DFG+   + GE Q+       A T GY++
Sbjct: 129 M---GVVHRNLKPENLLLASKLKGAAVK-LADFGLAIEVEGEQQAWF---GFAGTPGYLS 181

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE      YG+        D+++ G++L
Sbjct: 182 PEVLRKDPYGKP------VDLWACGVIL 203

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 42/226 (18%), Positives = 91/226 (40%), Gaps = 41/226 (18%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDIECEIMKSIHYRNLV 484
           F     +G+GGFG +++++   D    A+K   L     A +    E + +  + +  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 485 KIISSCSNEEFKE------------LVLEHMPHGSLEKCL--YSSNCILDIFQRLNIMID 530
           +  ++   +   E            + ++     +L+  +    +    +    L+I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  +E+LH      ++H DLKPSN+      V  + DFG+   +  +++  T    +  
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 591 IG----------YIAPE------YGREGRVFANGDVYSFGIMLMEI 620
                       Y++PE      Y  +       D++S G++L E+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHK------VDIFSLGLILFEL 223

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 43/202 (21%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI--HYRNLVKI 486
             IG GG   +++         A+K  +L+    +   S+  E   +  +  H   ++++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                 +++  +V+E   +  L   L      +D ++R +   ++   +  +H +    +
Sbjct: 75  YDYEITDQYIYMVME-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQH---GI 129

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGR 600
           +H DLKP+N L+ D M+  L DFGI   +  +  S+ +   + T+ Y+ PE        R
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 601 EGRVFANG-----DVYSFGIML 617
           E     +      DV+S G +L
Sbjct: 189 ENGKSKSKISPKSDVWSLGCIL 210

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 46/218 (21%), Positives = 89/218 (40%), Gaps = 38/218 (17%)

Query: 433 IGKGGFGTIYK--------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY- 480
           +G+G FG +           +  + + VAVK+  L+     +       E E+MK I   
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL---------------EKCLYSSNCILDIFQRL 525
           +N++ ++ +C+ +    +++E+   G+L                         +     +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 526 NIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
           +    +A  +EYL           IH DL   NVL+ +  V  ++DFG+ + +   D   
Sbjct: 161 SCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             T     + ++APE   +       DV+SFG+++ EI
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 48/236 (20%), Positives = 82/236 (34%), Gaps = 46/236 (19%)

Query: 400 PPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH 458
           P  D + P     + F  L              +G G +G ++K R   DG   AVK   
Sbjct: 44  PGYDPSRPESFFQQSFQRLSR------------LGHGSYGEVFKVRSKEDGRLYAVKRSM 91

Query: 459 LQCGRAFKSFDI--ECEIMKSI-HYRNLVKIISSCSNEEFKE-----LVLEHMPHGSLEK 510
                         E    + +  +   V++  +     ++E     L  E     SL++
Sbjct: 92  SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYLQTELC-GPSLQQ 145

Query: 511 CLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
              +    L   Q    + D    L +LH      ++H D+KP+N+ L       L DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG 202

Query: 571 ITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRVFANG-----DVYSFGIMLMEI 620
           +   L     +    +       Y+APE      +         DV+S G+ ++E+
Sbjct: 203 LLVEL----GTAGAGEVQEGDPRYMAPE------LLQGSYGTAADVFSLGLTILEV 248

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 29/211 (13%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNL 483
           +G G FG +Y+            ++VAVK   L      +    F +E  I+   +++N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT--LPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSS------NCILDIFQRLNIMIDVASVLEY 537
           V+ I        + ++LE M  G L+  L  +         L +   L++  D+A   +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 538 L---HFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
           L   HF      IH D+   N LL       VA + DFG+ + +            +  +
Sbjct: 197 LEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 592 GYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            ++ PE   EG   +  D +SFG++L EI S
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 44/221 (19%), Positives = 91/221 (41%), Gaps = 39/221 (17%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVK 485
           +G+G FG + K              VAVK+          +    E  ++K +++ +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----------------------EKCLYSSNCILDIF 522
           +  +CS +    L++E+  +GSL                           +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 523 QRLNIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED 579
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             + ++Q    + ++A E   +       DV+SFG++L EI
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 91.3 bits (227), Expect = 5e-20
 Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 46/251 (18%)

Query: 400 PPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYK--------SRIGDGME 451
             ++  +P    W      E+ R      +   +G+G FG +           +     +
Sbjct: 52  GVSEYELPEDPRW------ELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTK 103

Query: 452 VAVKVFHLQCG---RAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEFKELVLEHMPHGS 507
           VAVK+  L+     +       E E+MK I   +N++ ++ +C+ +    +++E+   G+
Sbjct: 104 VAVKM--LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161

Query: 508 L---------------EKCLYSSNCILDIFQRLNIMIDVASVLEYL---HFNFLVPVIHC 549
           L                   ++    L     ++    VA  +EYL           IH 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHR 215

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           DL   NVL+ +  V  ++DFG+ + +   D     T     + ++APE   +       D
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275

Query: 610 VYSFGIMLMEI 620
           V+SFG++L EI
Sbjct: 276 VWSFGVLLWEI 286

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 29/213 (13%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           +G+G FG ++           D M VAVK        A + F  E E++  + ++++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 487 ISSCSNEEFKELVLEHMPHGSL--------------EKCLYSSNCILDIFQRLNIMIDVA 532
              C+      +V E+M HG L                    +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 533 SVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 590 TIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            I ++ PE     +     DV+SFG++L EI +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 44/219 (20%)

Query: 431 NLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSI-HYRNL 483
           ++IG+G FG + K+RI   G  M+ A+K   ++        + F  E E++  + H+ N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 484 VKIISSCSNEEFKELVLEHMPHGSL---------------EKCLYSSNCILDIFQRLNIM 528
           + ++ +C +  +  L +E+ PHG+L                    S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 529 IDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
            DVA  ++YL    F      IH DL   N+L+ +  VA ++DFG+++   G++  + +T
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199

Query: 586 QTLATIGYIAPE---YGREGRVF-ANGDVYSFGIMLMEI 620
                + ++A E   Y     V+  N DV+S+G++L EI
Sbjct: 200 MGRLPVRWMAIESLNY----SVYTTNSDVWSYGVLLWEI 234

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 425 YGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH-LQCGRAFKSFDIECEIMKSIHYRN 482
           + +  ++++G+G    +++ R    G   A+KVF+ +   R       E E++K ++++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 483 LVKIISSCSNEEFKE--LVLEHMPHGSLEKCLYS--SNCILDIFQRLNIMIDVASVLEYL 538
           +VK+ +       +   L++E  P GSL   L    +   L   + L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 539 HFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
             N    ++H ++KP N++     D   V  L+DFG  + L  ED     +    T  Y+
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYL 182

Query: 595 APE-YGREGRVFANG-------DVYSFGIML 617
            P+ Y R      +        D++S G+  
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 91.4 bits (227), Expect = 7e-20
 Identities = 42/202 (20%), Positives = 86/202 (42%), Gaps = 21/202 (10%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI--HYRNLVKI 486
             IG GG   +++         A+K  +L+    +   S+  E   +  +  H   ++++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                 +++  +V+E   +  L   L      +D ++R +   ++   +  +H +    +
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQH---GI 176

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGR 600
           +H DLKP+N L+ D M+  L DFGI   +  +  S+ +   +  + Y+ PE        R
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 601 EGRVFANG-----DVYSFGIML 617
           E     +      DV+S G +L
Sbjct: 236 ENGKSKSKISPKSDVWSLGCIL 257

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 54/217 (24%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI---------ECEIMKSIHY-R 481
           +G+G    + +        E AVK+  +  G +F + ++         E +I++ +    
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVA 532
           N++++  +     F  LV + M  G L     EK   S       +  +           
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL---------- 134

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
            V+  LH      ++H DLKP N+LLDD M   L+DFG +   +   + +   +   T  
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKL--REVCGTPS 188

Query: 593 YIAPE------------YGREGRVFANGDVYSFGIML 617
           Y+APE            YG+E       D++S G+++
Sbjct: 189 YLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 43/226 (19%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F E  ++G+G FG + K+R   D    A+K           +   E  ++ S++++ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66

Query: 486 IISSCSNEEFKE-------------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVA 532
             ++                     + +E+  +G+L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL--------IGEDQSMTQ 584
             L Y+H      +IH DLKP N+ +D++    + DFG+ K +        +        
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 585 TQTLAT-IG---YIAPE-------YGREGRVFANGDVYSFGIMLME 619
           +  L + IG   Y+A E       Y  +       D+YS GI+  E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFE 223

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 46/218 (21%), Positives = 89/218 (40%), Gaps = 38/218 (17%)

Query: 433 IGKGGFGTIYK--------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHY- 480
           +G+G FG +           +  + + VAVK+  L+     +       E E+MK I   
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL---------------EKCLYSSNCILDIFQRL 525
           +N++ ++ +C+ +    +++E+   G+L                         +     +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 526 NIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
           +    +A  +EYL           IH DL   NVL+ +  V  ++DFG+ + +   D   
Sbjct: 207 SCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             T     + ++APE   +       DV+SFG+++ EI
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 42/192 (21%), Positives = 74/192 (38%), Gaps = 20/192 (10%)

Query: 142 NLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDL 199
           +   L  + L   ++  +I     + L  L  + L  N ++ ++    F  L  L KL  
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107

Query: 200 GGNKLSGSI-LTCFSNLASLRTLSLSYND-GPLPLE-----IGNLKVLIGIDFSMNNFSS 252
               L+ S+      +L +L+ L++++N      L      + NL+ L   D S N   S
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL---DLSSNKIQS 163

Query: 253 VIPTTIGSLKDLQY----LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEK 308
           +  T +  L  +      L L  N +   I       I LK L    N L      + ++
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222

Query: 309 LSYLEHLNLSFN 320
           L+ L+ + L  N
Sbjct: 223 LTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 61/216 (28%)

Query: 126 DMSKCNVSG-----------GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG 174
           +     V              IP+ +    +   + L  N L     ++     +LQ + 
Sbjct: 1   EPCVEVVPNITYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58

Query: 175 LKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLE 233
           L   +++ TI    +  L  L  L L GN +    L  FS L+SL+ L            
Sbjct: 59  LSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET------- 110

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNF 293
                          N +S+    IG LK L+ L + +N+++                 F
Sbjct: 111 ---------------NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY----------F 145

Query: 294 SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
           SN             L+ LEHL+LS NK++  I   
Sbjct: 146 SN-------------LTNLEHLDLSSNKIQ-SIYCT 167

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 6/93 (6%)

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAI 302
           D S N    +   +  S  +LQ L L    ++ +I D     L  L +L  + N +  ++
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SL 91

Query: 303 PL-LLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
            L     LS L+ L      L   +      G+
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLA-SLEN-FPIGH 122

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 45/217 (20%), Positives = 91/217 (41%), Gaps = 35/217 (16%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSIHYRNL 483
           +G+  FG +YK      +       VA+K   L+        + F  E  +   + + N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 484 VKIISSCSNEEFKELVLEHMPHGSL---------------EKCLYSSNCILDIFQRLNIM 528
           V ++   + ++   ++  +  HG L                    +    L+    ++++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 529 IDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
             +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D      
Sbjct: 135 AQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188

Query: 586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS 622
            +L  I ++APE    G+   + D++S+G++L E+ S
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 48/191 (25%), Positives = 90/191 (47%), Gaps = 11/191 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIISS 489
           +G G  G ++K      G+ +A K+ HL+   A ++  I  E +++   +   +V    +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYIVGFYGA 99

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
             ++    + +EHM  GSL++ +      +       + I V   L YL       ++H 
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 156

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           D+KPSN+L++      L DFG++  LI    SM  +  + T  Y++PE  +        D
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSD 212

Query: 610 VYSFGIMLMEI 620
           ++S G+ L+E+
Sbjct: 213 IWSMGLSLVEM 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 49/213 (23%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKV-----FHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           IGKG F  + +      G + AVK+     F    G + +    E  I   + + ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 487 ISSCSNEEFKELVLEHMPHGSL---------EKCLYS----SNCILDIFQRLNIMIDVAS 533
           + + S++    +V E M    L            +YS    S+ +  I            
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL----------E 141

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
            L Y H N    +IH D+KP  VLL   +++    L  FG+   L            + T
Sbjct: 142 ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 591 IGYIAPE------YGREGRVFANGDVYSFGIML 617
             ++APE      YG+        DV+  G++L
Sbjct: 197 PHFMAPEVVKREPYGKP------VDVWGCGVIL 223

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 58/202 (28%), Positives = 85/202 (42%), Gaps = 20/202 (9%)

Query: 142 NLTNLTAIYLGGNKLN---GSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKL 197
            + +   +      L      +P     L       L +N L  T          +L +L
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLY-TFSLATLMPYTRLTQL 60

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
           +L   +L+   L     L  L TL LS+N    LPL    L  L  +D S N  +S+   
Sbjct: 61  NLDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL-LLEKLSYLEH 314
            +  L +LQ L+L  N LK ++P  +      L+ L+ +NNNL+  +P  LL  L  L+ 
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 315 LNLSFNKLEGEIPKGGSFGNFS 336
           L L  N L   IPK G FG+  
Sbjct: 177 LLLQENSLYT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 39/183 (21%), Positives = 55/183 (30%), Gaps = 47/183 (25%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           ++  +     L  L L  N L   +P     +  L  L +  N L+ SL   A       
Sbjct: 69  KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA------- 119

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                 L  L   + L    L  N L  + P            +                
Sbjct: 120 ------LRGLGELQELY---LKGNELKTLPPG-----------LLT-------------- 145

Query: 141 GNLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDL 199
                L  + L  N L   +P   L  L+ L  + L++N L  TIP   F    L    L
Sbjct: 146 -PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202

Query: 200 GGN 202
            GN
Sbjct: 203 HGN 205

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 48/217 (22%), Positives = 88/217 (40%), Gaps = 37/217 (17%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG + +       +      VAVK+  L+ G      ++   E +I+  I H+ N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 483 LVKIISSCSNEEFKELV-LEHMPHGSL---------------EKCLYSSNCILDIFQRLN 526
           +V ++ +C+      +V +E    G+L                         L +   + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 527 IMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT 583
               VA  +E+L           IH DL   N+LL +  V  + DFG+ + +  +   + 
Sbjct: 153 YSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           +      + ++APE   +       DV+SFG++L EI
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 34/218 (15%), Positives = 73/218 (33%), Gaps = 36/218 (16%)

Query: 427 FNENNLIGKGGFGTIYKSR------IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY 480
              ++L+G+G F  +Y++         +  +  +KV        F       E +K    
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL----EKCLYSSNCILDIFQRLNIMIDVASVLE 536
              +K  S+   +    LV E   +G+L         +   ++     ++  + +  ++E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAH-----------LSDFGITKLLIGEDQSMTQT 585
            +H      +IH D+KP N +L +  +             L D G +  +    +    T
Sbjct: 187 QVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 586 QTLATIGYIAPE------YGREGRVFANGDVYSFGIML 617
               T G+   E      +  +       D +     +
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATV 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
            +    IG+G  G +  +R    G +VAVK+  L+  +  +    E  IM+   + N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +  S    E   +++E +  G+L   +  S   L+  Q   +   V   L YLH      
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG--- 161

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREG 602
           VIH D+K  ++LL       LSDFG    +    + + + ++L  +G   ++APE     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAPEVISRS 216

Query: 603 RVFANGDVYSFGIMLME 619
                 D++S GIM++E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 33/259 (12%), Positives = 75/259 (28%), Gaps = 58/259 (22%)

Query: 406 MPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL----- 459
                 +R  S L     T       ++G+       ++     G    V V +      
Sbjct: 56  WNTGQPFRVESELGERPRTLVRGT--VLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113

Query: 460 -----------QCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL---------- 498
                         R  +    + +    + +     ++     ++   +          
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173

Query: 499 ---VLEHMPHGSLEKCL------YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
               L      +L+          S++  L    RL + + V  +L  LH      ++H 
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY----------- 598
            L+P +++LD      L+ F         D +   +    + G+  PE            
Sbjct: 231 YLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSSV--SRGFEPPELEARRATISYHR 284

Query: 599 GREGRVFANGDVYSFGIML 617
            R   +  + D ++ G+++
Sbjct: 285 DRRTLMTFSFDAWALGLVI 303

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 49/195 (25%), Positives = 89/195 (45%), Gaps = 12/195 (6%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVK---VFHLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            IG+G F  +Y+ + + DG+ VA+K   +F L   +A      E +++K +++ N++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF---QRLNIMIDVASVLEYLHFNFLV 544
           +S   +    +VLE    G L + +        +          + + S LE++H     
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--- 155

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            V+H D+KP+NV +  T V  L D G+ +       +   +    T  Y++PE   E   
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPERIHENGY 213

Query: 605 FANGDVYSFGIMLME 619
               D++S G +L E
Sbjct: 214 NFKSDIWSLGCLLYE 228

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 425 YGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH-LQCGRAFKSFDIECEIMKSIHYRN 482
           + +  ++++G+G    +++ R    G   A+KVF+ +   R       E E++K ++++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 483 LVKIISSCSNEEFKE--LVLEHMPHGSLEKCLYS--SNCILDIFQRLNIMIDVASVLEYL 538
           +VK+ +       +   L++E  P GSL   L    +   L   + L ++ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 539 HFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
             N    ++H ++KP N++     D   V  L+DFG  + L  ED     +    T  Y+
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYL 182

Query: 595 APE-YGREGRVFANG-------DVYSFGIML 617
            P+ Y R      +        D++S G+  
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 45/207 (21%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +      G+E A K+ + +    R F+  + E  I + + + N+V++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
              E F  LV + +  G L      +  YS    S+CI  I             + Y H 
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCHS 123

Query: 541 NFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           N    ++H +LKP N+LL        V  L+DFG+    + + ++        T GY++P
Sbjct: 124 N---GIVHRNLKPENLLLASKAKGAAVK-LADFGLAI-EVNDSEAW--HGFAGTPGYLSP 176

Query: 597 E------YGREGRVFANGDVYSFGIML 617
           E      Y +        D+++ G++L
Sbjct: 177 EVLKKDPYSKP------VDIWACGVIL 197

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 10/195 (5%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +     IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
            + S    +   +V+E++  GSL   +  +   +D  Q   +  +    LE+LH N    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGRV 604
           VIH D+K  N+LL       L+DFG    +       ++  T+  T  ++APE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 605 FANGDVYSFGIMLME 619
               D++S GIM +E
Sbjct: 194 GPKVDIWSLGIMAIE 208

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 45/207 (21%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG F  + +      G+E A K+ +      R F+  + E  I + + + N+V++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 490 CSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHF 540
              E F  LV + +  G L      +  YS    S+CI  I             + Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----------ESIAYCHS 146

Query: 541 NFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           N    ++H +LKP N+LL        V  L+DFG+    + + ++        T GY++P
Sbjct: 147 N---GIVHRNLKPENLLLASKAKGAAVK-LADFGLAI-EVNDSEAW--HGFAGTPGYLSP 199

Query: 597 E------YGREGRVFANGDVYSFGIML 617
           E      Y +        D+++ G++L
Sbjct: 200 EVLKKDPYSKP------VDIWACGVIL 220

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 42/216 (19%), Positives = 83/216 (38%), Gaps = 34/216 (15%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHY-RNLV 484
           +G G FG + +       +    M VAVK+          ++   E +++  +    N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 485 KIISSCSNEEFKELVLEHMPHGSL-----------------EKCLYSSNCILDIFQRLNI 527
            ++ +C+      ++ E+  +G L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 528 MIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
              VA  + +L   +       IH DL   N+LL    +  + DFG+ + +  +   + +
Sbjct: 151 SYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                 + ++APE           DV+S+GI L E+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 50/221 (22%)

Query: 422 RATYGFNEN----NLIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMK 476
             T    +      ++G G F  ++   +   G   A+K           S + E  ++K
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 477 SIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----EKCLYS----SNCILDIFQRLNI 527
            I + N+V +     +     LV++ +  G L     E+ +Y+    S  I  +      
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL----- 116

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMT 583
                S ++YLH N    ++H DLKP N+L     +++ +  ++DFG++K  + ++  M+
Sbjct: 117 -----SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM-ITDFGLSK--MEQNGIMS 165

Query: 584 QTQTLA-TIGYIAPE------YGREGRVFANGDVYSFGIML 617
              T   T GY+APE      Y +        D +S G++ 
Sbjct: 166 ---TACGTPGYVAPEVLAQKPYSKA------VDCWSIGVIT 197

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 83.9 bits (208), Expect = 1e-18
 Identities = 35/186 (18%), Positives = 59/186 (31%), Gaps = 12/186 (6%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG 201
                    LG +        T  ++  L Y+ L +  +       I     +  L +  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 202 NKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIG 259
              +       S L++L  L +   D        +  L  L  +D S +     I T I 
Sbjct: 76  IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 260 SLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF 319
           +L  +  + L YN     I   +  L  LKSLN   + +       +E    L  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 320 NKLEGE 325
             + G+
Sbjct: 191 QTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.0 bits (198), Expect = 2e-17
 Identities = 32/183 (17%), Positives = 63/183 (34%), Gaps = 12/183 (6%)

Query: 91  SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIY 150
           S  K+ +  LL  +    I    +   ++ SL    ++  NV+      I    N+  + 
Sbjct: 20  STFKAYLNGLLGQSSTANI----TEAQMN-SLTYITLANINVTD--LTGIEYAHNIKDLT 72

Query: 151 LGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILT 210
           +         P  +  L  L+ + +    +      ++  L  L  LD+  +    SILT
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 211 CFSNLASLRTLSLSYNDG-PLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL 269
             + L  + ++ LSYN      + +  L  L  ++   +         I     L  L+ 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188

Query: 270 GYN 272
              
Sbjct: 189 FSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 30/211 (14%), Positives = 65/211 (30%), Gaps = 26/211 (12%)

Query: 16  IESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN 75
                +    I     +  L G              +++L  + L +  ++         
Sbjct: 7   GLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-------- 58

Query: 76  YLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG 135
                      L+ +    ++    ++N       P   I  LS +LE   +   +V+  
Sbjct: 59  -----------LTGIEYAHNIKDLTINNIHATNYNP---ISGLS-NLERLRIMGKDVTSD 103

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY 195
               +  LT+LT + +  +  + SI   +  L K+  + L  N     I   +  L +L 
Sbjct: 104 KIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELK 162

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
            L++  + +         +   L  L     
Sbjct: 163 SLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.0 bits (141), Expect = 8e-10
 Identities = 17/117 (14%), Positives = 39/117 (33%), Gaps = 5/117 (4%)

Query: 213 SNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
           S   +     L  +     +    +  L  I  +  N + +    I    +++ L +   
Sbjct: 20  STFKAYLNGLLGQSST-ANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI 76

Query: 273 ILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
                 P  +  L +L+ L     +++      L  L+ L  L++S +  +  I   
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 4e-06
 Identities = 21/129 (16%), Positives = 44/129 (34%), Gaps = 22/129 (17%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS 89
           NLE L +   ++       +  +++L  L +  +    S               L+ +++
Sbjct: 89  NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS--------------ILTKINT 134

Query: 90  LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAI 149
           L    S+   L  N  +  I+P   +  L   L+  ++    V       I +   L  +
Sbjct: 135 LPKVNSI--DLSYNGAITDIMP---LKTLP-ELKSLNIQFDGVHDYRG--IEDFPKLNQL 186

Query: 150 YLGGNKLNG 158
           Y     + G
Sbjct: 187 YAFSQTIGG 195

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 44/200 (22%), Positives = 78/200 (39%), Gaps = 30/200 (15%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++          A K+     L      +   +E  I +S+ ++++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R   +  +    +YLH N    VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 137

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPE------ 597
           H DLK  N+ L++ +   + DFG+   +          +    +     YIAPE      
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 598 YGREGRVFANGDVYSFGIML 617
           +  E       DV+S G ++
Sbjct: 192 HSFE------VDVWSIGCIM 205

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 45/200 (22%), Positives = 79/200 (39%), Gaps = 30/200 (15%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKGGF   ++          A K+     L      +   +E  I +S+ ++++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               + +F  +VLE     SL +       + +   R   +  +    +YLH N    VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI-G---YIAPE------ 597
           H DLK  N+ L++ +   + DFG+   +          +    + G   YIAPE      
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 598 YGREGRVFANGDVYSFGIML 617
           +  E       DV+S G ++
Sbjct: 218 HSFE------VDVWSIGCIM 231

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 23/197 (11%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           L+GKG F  +Y++  I  G+EVA+K+     +      +    E +I   + + +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
           +   +  +  LVLE   +G + + L +        +  + M  + + + YLH +    ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GIL 134

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE------YGR 600
           H DL  SN+LL   M   ++DFG+   L    +      TL  T  YI+PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGL 191

Query: 601 EGRVFANGDVYSFGIML 617
           E       DV+S G M 
Sbjct: 192 E------SDVWSLGCMF 202

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 48/208 (23%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG FG + K        E AVKV +      +   +   E E++K + + N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEY 537
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 538 LHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           +H +    ++H DLKP N+LL   +      + DFG++     ++  M     + T  YI
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYI 190

Query: 595 APE-----YGREGRVFANGDVYSFGIML 617
           APE     Y  +       DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 42/193 (21%), Positives = 72/193 (37%), Gaps = 34/193 (17%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISS 489
           ++ +GGF  +Y+++ +G G E A+K          ++   E   MK +  + N+V+  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 490 CSNEEFKELVLEHMPHGSLEKCL---YSSNCILDIFQR------------LNIMIDVASV 534
            S  +      E    G  E  L        +++  ++            L I       
Sbjct: 95  ASIGK------EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA----- 589
           ++++H     P+IH DLK  N+LL +     L DFG    +          Q  A     
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 590 -----TIGYIAPE 597
                T  Y  PE
Sbjct: 208 ITRNTTPMYRTPE 220

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 39/221 (17%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVK 485
           IG+G FG +++              VAVK+   +        F  E  +M      N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----------------------EKCLYSSNCILDIF 522
           ++  C+  +   L+ E+M +G L                        +        L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 523 QRLNIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED 579
           ++L I   VA+ + YL    F      +H DL   N L+ + MV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
                      I ++ PE     R     DV+++G++L EI
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 49/209 (23%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +GKG FG +        G E AVKV     ++     +S   E +++K + + N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLE 536
              ++ +  LV E    G L             F  +             I+  V S + 
Sbjct: 94  FFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGIT 140

Query: 537 YLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
           Y+H N    ++H DLKP N+LL          + DFG++       + M     + T  Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYY 194

Query: 594 IAPE-----YGREGRVFANGDVYSFGIML 617
           IAPE     Y  +       DV+S G++L
Sbjct: 195 IAPEVLHGTYDEK------CDVWSTGVIL 217

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.0 bits (218), Expect = 2e-18
 Identities = 58/340 (17%), Positives = 114/340 (33%), Gaps = 16/340 (4%)

Query: 3   SISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQD 62
            + +  + L++            +   N   L L  +            V+ L  L L +
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 63  NYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH-S 121
             L+          L +   EL+   +L N  +L     +      +        + + +
Sbjct: 228 IKLN----DENCQRLMTFLSELTRGPTLLNV-TLQHIETTWKCSVKLFQFFWPRPVEYLN 282

Query: 122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLE 181
           +    +++             L +L   ++       S         ++    L  +   
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 182 GTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND----GPLPLEIGNL 237
                          L+   N  + S+    S L  L+TL L  N       + L   N+
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNM 402

Query: 238 KVLIGIDFSMNNFSS-VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN 296
             L  +D S+N+ +S     T    + +  L L  N+L GS+   +     +K L+  NN
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNN 460

Query: 297 NLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFS 336
            +  +IP  +  L  L+ LN++ N+L+  +P  G F   +
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 42/262 (16%), Positives = 90/262 (34%), Gaps = 24/262 (9%)

Query: 17  ESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNY 76
           +   ++     P  +E L +    +   +    F  S     +L   ++   +   +   
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323

Query: 77  LTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI 136
           L S   E++               LS +     +  +   + S S    + ++   +  +
Sbjct: 324 LYSVFAEMNIKM------------LSISDTP-FIHMVCPPSPS-SFTFLNFTQNVFTDSV 369

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-----L 191
            +    L  L  + L  N L  +        + +  +   D  L  ++    +       
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWA 427

Query: 192 VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNF 250
             +  L+L  N L+GS+  C      ++ L L  N    +P ++ +L+ L  ++ + N  
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485

Query: 251 SSVIPTTIGSLKDLQYLFLGYN 272
            SV       L  LQY++L  N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 67.2 bits (164), Expect = 8e-12
 Identities = 52/316 (16%), Positives = 95/316 (30%), Gaps = 45/316 (14%)

Query: 30  NLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYL-SGSLSSIAD--------NYLTS 79
           +L  L L  N+   +     F  ++ L  L L         L  +A         + ++ 
Sbjct: 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH------SLEIFDMSKCNVS 133
                   S      +++  +   N L  +   MS+  L H       L   +  +    
Sbjct: 182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241

Query: 134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR--- 190
                    L N+T  ++          F     + ++Y+ + +  +   I  + F    
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301

Query: 191 --LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMN 248
             L  L    +       S    +S  A +    LS +D                     
Sbjct: 302 TALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD-------------------TP 342

Query: 249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS--GAIPLLL 306
               V P    S     +L    N+   S+      L  L++L    N L     + L+ 
Sbjct: 343 FIHMVCP---PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399

Query: 307 EKLSYLEHLNLSFNKL 322
           + +S LE L++S N L
Sbjct: 400 KNMSSLETLDVSLNSL 415

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 54/321 (16%), Positives = 96/321 (29%), Gaps = 34/321 (10%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVST-LKDLALQDNYLS----GSLSS-----IADNYLTS 79
            L  L L  N +   +   +F  +  L+ L +  N L       ++S     ++ N    
Sbjct: 77  ELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDV 135

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
             P      +L+    L    LS       L  + + +L  S  + D+   ++ GG  E 
Sbjct: 136 -LPVCKEFGNLTKLTFLG---LSAAKFRQ-LDLLPVAHLHLSCILLDLVSYHIKGGETES 190

Query: 140 IGNL-TNLTAIYLGGNKLNGSIPFT-LRELQKLQYVGLKDNKLEG----TIPYDIFRLVK 193
           +    T +  +    N L        +  L  LQ   +K N        T   ++ R   
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250

Query: 194 LYKLDLGGNKLSGSILTC---FSNLASLRTLSLSYND-------GPLPLEIGNLKVLIGI 243
           L  + L   + +         F     +  L++                    LK L+  
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAI 302
                 F            ++    L  +     I         S   LNF+ N  + ++
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSV 369

Query: 303 PLLLEKLSYLEHLNLSFNKLE 323
                 L  L+ L L  N L+
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 55/321 (17%), Positives = 101/321 (31%), Gaps = 45/321 (14%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST 81
           +P ++ P   + L L QN++  +    I  +S L+ L L  N     + S+         
Sbjct: 46  VPKDL-PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN----RIRSL--------- 91

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN--VSGGIPEE 139
               F     + + L    +S+N L  I    S   ++ SL   D+S  N      + +E
Sbjct: 92  DFHVF-LFNQDLEYLD---VSHNRLQNI----SCCPMA-SLRHLDLS-FNDFDVLPVCKE 141

Query: 140 IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGT-IPYDIFRLVKLYKLD 198
            GNLT LT + L   K    +         L  + L            +  ++     L 
Sbjct: 142 FGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYND---------GPLPLEIGNLKVLIGIDFSMNN 249
           L  +  S   +    ++ +L  L LS                 E+     L+ +      
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 250 FSSVIPTTIGSL---KDLQYLFLGYNILKGSIPDSVGD-----LISLKSLNFSNNNLSGA 301
            +      +      + ++YL +    +   I           L SL   +  N     +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320

Query: 302 IPLLLEKLSYLEHLNLSFNKL 322
              L    + +    LS +  
Sbjct: 321 KEALYSVFAEMNIKMLSISDT 341

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 45/218 (20%), Positives = 72/218 (33%), Gaps = 44/218 (20%)

Query: 9   LELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS 68
             L++ D      +     P +   L   QN     V      +  L+ L LQ N L  +
Sbjct: 334 KMLSISDTPFIHMVCPPS-PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-N 391

Query: 69  LSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
              +A                  N  SL    +S N LN                     
Sbjct: 392 FFKVAL--------------MTKNMSSLETLDVSLNSLN--------------------- 416

Query: 129 KCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI 188
               S           ++  + L  N L GS+   L    K++ + L +N++  +IP D+
Sbjct: 417 ----SHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDV 469

Query: 189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
             L  L +L++  N+L       F  L SL+ + L  N
Sbjct: 470 THLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 14/197 (7%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           F+    +G+G +G++YK+     G  VA+K   ++     +    E  IM+     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
              S        +V+E+   GS+   +   N  L   +   I+      LEYLHF     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--- 145

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREG 602
            IH D+K  N+LL+    A L+DFG+   L     +M +  T+  IG   ++APE  +E 
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVIQEI 200

Query: 603 RVFANGDVYSFGIMLME 619
                 D++S GI  +E
Sbjct: 201 GYNCVADIWSLGITAIE 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 27/204 (13%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI---MKSIHYRNLVKIIS 488
           IG+G +G++ K      G  +AVK          +   +  ++   M+S     +V+   
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK-QLLMDLDVVMRSSDCPYIVQFYG 88

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLN------IMIDVASVLEYLHFNF 542
           +   E    + +E M   S +K          +   +       I +     L +L  N 
Sbjct: 89  ALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR-E 601
              +IH D+KPSN+LLD +    L DFGI+  L+    S+ +T+      Y+APE  R +
Sbjct: 146 --KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPE--RID 198

Query: 602 GRVFANG-----DVYSFGIMLMEI 620
                 G     DV+S GI L E+
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYEL 222

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 46/200 (23%), Positives = 84/200 (42%), Gaps = 26/200 (13%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
             +GKG FG +Y +R       +A+KV     L+          E EI   + + N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                +     L+LE+ P G++ + L   +   +       + ++A+ L Y H      V
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSK---RV 130

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE------YG 599
           IH D+KP N+LL       ++DFG +           +   L  T+ Y+ PE      + 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHD 185

Query: 600 REGRVFANGDVYSFGIMLME 619
            +       D++S G++  E
Sbjct: 186 EK------VDLWSLGVLCYE 199

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 67/264 (25%)

Query: 394 QKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNEN----NLIGKGGFGTIYK-SRIGD 448
           +K  +  P         +      L    A   F +     ++IG+G    + +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 449 GMEVAVKVF--------HLQCGRAFKSFDIECEIMKSI--HYRNLVKIISSCSNEEFKEL 498
           G E AVK+           Q     ++   E  I++ +  H  +++ +I S  +  F  L
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH-PHIITLIDSYESSSFMFL 177

Query: 499 VLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEYLHFNFLVPV 546
           V + M  G L             F  L            +IM  +   + +LH N    +
Sbjct: 178 VFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NI 221

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPE-------- 597
           +H DLKP N+LLDD M   LSDFG +   +   + +     L  T GY+APE        
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAPEILKCSMDE 277

Query: 598 ----YGREGRVFANGDVYSFGIML 617
               YG+E       D+++ G++L
Sbjct: 278 THPGYGKE------VDLWACGVIL 295

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 47/236 (19%), Positives = 86/236 (36%), Gaps = 16/236 (6%)

Query: 87  LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL 146
           + S       +   L    +   +       L+  ++    +  ++     + I  L N+
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIK--SVQGIQYLPNV 70

Query: 147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG 206
           T ++L GNKL   I   L  L+ L ++ L +NK++      +  L KL  L L  N +  
Sbjct: 71  TKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI-- 124

Query: 207 SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY 266
           S +    +L  L +L L  N       +  L  L  +    N  S ++P  +  L  LQ 
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182

Query: 267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           L+L  N +   +  ++  L +L  L   +             L     +  +   L
Sbjct: 183 LYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 12/182 (6%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG 201
                    L    +  ++     EL  +  +   ++ ++ ++   I  L  + KL L G
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77

Query: 202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
           NKL+   +   +NL +L  L L  N       + +LK L  +    N  S +    +  L
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING--LVHL 133

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK 321
             L+ L+LG N +  +    +  L  L +L+  +N +S  +PL    L+ L++L LS N 
Sbjct: 134 PQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKNH 189

Query: 322 LE 323
           + 
Sbjct: 190 IS 191

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 51/279 (18%), Positives = 102/279 (36%), Gaps = 32/279 (11%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD----NYLTSSTPELS 85
              +  L + ++   V     +++++  +   ++ +  S+  I        L  +  +L+
Sbjct: 25  ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 81

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH--SLEIFDMSKCNVSGGIPEEIGNL 143
            +  L+N K+L    L  N +        + +L     L+   +    +S      + +L
Sbjct: 82  DIKPLANLKNLGWLFLDENKVK------DLSSLKDLKKLKSLSLEHNGIS--DINGLVHL 133

Query: 144 TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNK 203
             L ++YLG NK+   I   L  L KL  + L+DN++   I   +  L KL  L L  N 
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNH 189

Query: 204 LSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD 263
           +S   L   + L +L  L L   +           +++       + S V P  I    D
Sbjct: 190 ISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 247

Query: 264 LQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAI 302
            +   + +++ +           +  S  F      G  
Sbjct: 248 YEKPNVKWHLPE---------FTNEVSFIFYQPVTIGKA 277

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 45/246 (18%), Positives = 92/246 (37%), Gaps = 20/246 (8%)

Query: 8   KLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSG 67
           K  L    +       ++   +++++++   +++  V    I  +  +  L L  N L+ 
Sbjct: 28  KDNLKKKSVTD---AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT- 81

Query: 68  SLSSIAD----NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLE 123
            +  +A+     +L     ++  LSSL + K L    L +N ++ I     + +L   LE
Sbjct: 82  DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING---LVHLPQ-LE 137

Query: 124 IFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGT 183
              +    ++      +  LT L  + L  N+++  I   L  L KLQ + L  N +   
Sbjct: 138 SLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL 193

Query: 184 IPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGI 243
               +  L  L  L+L   +     +   SNL    T+  +      P  I +       
Sbjct: 194 RA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 251

Query: 244 DFSMNN 249
           +   + 
Sbjct: 252 NVKWHL 257

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.0 bits (216), Expect = 3e-18
 Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 48/208 (23%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +GKG FG + K        E AVKV +      +   +   E E++K + + N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEY 537
             +     +V E    G L             F  +             I+  V S + Y
Sbjct: 90  LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136

Query: 538 LHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           +H +    ++H DLKP N+LL   +      + DFG++     ++  M     + T  YI
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYI 190

Query: 595 APE-----YGREGRVFANGDVYSFGIML 617
           APE     Y  +       DV+S G++L
Sbjct: 191 APEVLRGTYDEK------CDVWSAGVIL 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 48/221 (21%), Positives = 87/221 (39%), Gaps = 39/221 (17%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHY-RNLV 484
           +G G FG +        S+ G  ++VAVK+   +      ++   E ++M  +    N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 485 KIISSCSNEEFKELVLEHMPHGSL----------------------EKCLYSSNCILDIF 522
            ++ +C+      L+ E+  +G L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 523 QRLNIMIDVASVLEYL---HFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED 579
             L     VA  +E+L           +H DL   NVL+    V  + DFG+ + ++ + 
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
             + +      + ++APE   EG      DV+S+GI+L EI
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 48/208 (23%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISS 489
           +G G +G +         +E A+K+         +      E  ++K + + N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEY 537
             ++    LV+E    G L             F  +             I+  V S + Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 538 LHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           LH +    ++H DLKP N+LL   +   +  + DFG++  +    + M   + L T  YI
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYI 205

Query: 595 APE-----YGREGRVFANGDVYSFGIML 617
           APE     Y  +       DV+S G++L
Sbjct: 206 APEVLRKKYDEK------CDVWSIGVIL 227

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 50/208 (24%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSC 490
           +G+G F    K          AVK+      R   +   E   +K    + N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEYL 538
            ++    LV+E +  G L             F+R+             IM  + S + ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 539 HFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H      V+H DLKP N+L    +D +   + DFG  +L   ++Q +       T+ Y A
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE      Y          D++S G++L
Sbjct: 178 PELLNQNGYDES------CDLWSLGVIL 199

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.3 bits (209), Expect = 7e-18
 Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 54/210 (25%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIM-KSIHYRNLVKIISSC 490
           IG G +    +       ME AVK+            + E EI+ +   + N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTE-EIEILLRYGQHPNIITLKDVY 85

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLEYL 538
            + ++  +V E M  G L               ++             ++  +   +EYL
Sbjct: 86  DDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 539 HFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGY 593
           H      V+H DLKPSN+L      +     + DFG  K L  E+  +    T   T  +
Sbjct: 133 HAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANF 186

Query: 594 IAPE------YGREGRVFANGDVYSFGIML 617
           +APE      Y          D++S G++L
Sbjct: 187 VAPEVLERQGYDAA--C----DIWSLGVLL 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 83.5 bits (207), Expect = 8e-18
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +     +G G FG +YK++    G   A KV   +     + + +E EI+ +  +  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++ +  ++    +++E  P G+++  +   +  L   Q   +   +   L +LH      
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--- 137

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPE----- 597
           +IH DLK  NVL+       L+DFG++       +++ +  +   IG   ++APE     
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAPEVVMCE 192

Query: 598 YGREGRVFANGDVYSFGIMLME 619
             ++       D++S GI L+E
Sbjct: 193 TMKDTPYDYKADIWSLGITLIE 214

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 53/222 (23%), Positives = 86/222 (38%), Gaps = 21/222 (9%)

Query: 413 RRFSYLEVCRATYGFNENNL-----IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFK 466
           ++  YL +    Y    N+L     +G G  G ++K R    G  +AVK       +   
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN 67

Query: 467 SFDIECEI---MKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQ 523
              I  ++   +KS     +V+   +        + +E M     EK        +    
Sbjct: 68  K-RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERI 125

Query: 524 RLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT 583
              + + +   L YL       VIH D+KPSN+LLD+     L DFGI+  L+       
Sbjct: 126 LGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKA 180

Query: 584 QTQTLATIGYIAPEYGREGRVFANG-----DVYSFGIMLMEI 620
           + ++     Y+APE                DV+S GI L+E+
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 46/243 (18%), Positives = 91/243 (37%), Gaps = 39/243 (16%)

Query: 395 KRENWPPNDANMPPKATWRRFSYLEVCRATYGFNEN----NLIGKGGFGTIYKSR-IGDG 449
           K +    ND +   +  W+++    V        +       +G G FG +++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 450 MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL- 508
                K  +        +   E  IM  +H+  L+ +  +  ++    L+LE +  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 509 -----EKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM 562
                E    S +  I       N M      L+++H +    ++H D+KP N++ +   
Sbjct: 137 DRIAAEDYKMSEAEVI-------NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 186

Query: 563 VAHL--SDFGITKLLIGEDQSMTQTQTLATIGYIAPE------YGREGRVFANGDVYSFG 614
            + +   DFG+    +  D+ +    T AT  + APE       G         D+++ G
Sbjct: 187 ASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAPEIVDREPVGFY------TDMWAIG 237

Query: 615 IML 617
           ++ 
Sbjct: 238 VLG 240

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 63/198 (31%), Positives = 85/198 (42%), Gaps = 35/198 (17%)

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVK 193
            IP       +   + L  NKL+         L KL+ + L DNKL+ T+P  IF  L  
Sbjct: 34  NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 194 LYKLDLGGNKLSGSI-LTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS 252
           L  L +  NKL  ++ +  F  L +L  L L  N                         S
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN----------------------QLKS 123

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSY 311
           + P    SL  L YL LGYN L+ S+P  V D L SLK L   NN L        +KL+ 
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182

Query: 312 LEHLNLSFNKLEGEIPKG 329
           L+ L L  N+L+  +P+G
Sbjct: 183 LKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 57/185 (30%), Positives = 79/185 (42%), Gaps = 34/185 (18%)

Query: 142 NLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKL 197
            LT L  +YL  NKL  ++P   F   EL+ L+ + + DNKL+  +P  +F +LV L +L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFK--ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL 114

Query: 198 DLGGNKLSGSI-LTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
            L  N+L  S+    F +L  L  LSL YN                         S+   
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYN----------------------ELQSLPKG 151

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSYLEHL 315
               L  L+ L L  N LK  +P+   D L  LK+L   NN L        + L  L+ L
Sbjct: 152 VFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210

Query: 316 NLSFN 320
            L  N
Sbjct: 211 QLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 54/200 (27%), Positives = 81/200 (40%), Gaps = 49/200 (24%)

Query: 30  NLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
            L  L L  N L   +PA IF  +  L+ L + DN L  +L     + L +    L+ L 
Sbjct: 62  KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVN----LAELR 115

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
                       L  N L  + PR           +FD               +LT LT 
Sbjct: 116 ------------LDRNQLKSLPPR-----------VFD---------------SLTKLTY 137

Query: 149 IYLGGNKLNGSIPFTL-RELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSG 206
           + LG N+L  S+P  +  +L  L+ + L +N+L+  +P   F +L +L  L L  N+L  
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 207 SILTCFSNLASLRTLSLSYN 226
                F +L  L+ L L  N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 42/216 (19%), Positives = 87/216 (40%), Gaps = 25/216 (11%)

Query: 394 QKRENWPPNDANMPPKATWRRF--SYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGM 450
            KR +    D   PP     R   +      + Y  ++  ++G G FG ++K      G+
Sbjct: 56  SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115

Query: 451 EVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-- 508
           ++A K+   +  +  +    E  +M  + + NL+++  +  ++    LV+E++  G L  
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175

Query: 509 ----EKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV 563
               E    +  + I         M  +   + ++H      ++H DLKP N+L  +   
Sbjct: 176 RIIDESYNLTELDTI-------LFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225

Query: 564 AHL--SDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
             +   DFG+ +      + +       T  ++APE
Sbjct: 226 KQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAPE 258

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 50/199 (25%), Positives = 78/199 (39%), Gaps = 32/199 (16%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           IG+G +G +  +   G  +  A K            F  E EIMKS+ + N++++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 492 NEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           +     LV+E    G L      K ++  +    I +      DV S + Y H      V
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCHKL---NV 127

Query: 547 IHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-----Y 598
            H DLKP N L           L DFG+        + M     + T  Y++P+     Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184

Query: 599 GREGRVFANGDVYSFGIML 617
           G E       D +S G+M+
Sbjct: 185 GPE------CDEWSAGVMM 197

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 57/216 (26%), Positives = 87/216 (40%), Gaps = 55/216 (25%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFH---LQCGRAFKSFDI-----ECEIMKSIHYRNL 483
           +G G  G +          +VA+K+        G A ++        E EI+K +++  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 484 VKIISSCSNEEFKE----LVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASV 534
           +KI        F      +VLE M  G L                  F        +   
Sbjct: 78  IKIK-----NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLA 126

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-T 590
           ++YLH N    +IH DLKP NVLL   ++  +  ++DFG +K ++GE   M    TL  T
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGT 179

Query: 591 IGYIAPE---------YGREGRVFANGDVYSFGIML 617
             Y+APE         Y R   V    D +S G++L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 28/204 (13%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI---MKSIHYRNLVKIIS 488
           +G+G +G + K R +  G  +AVK          +   +  ++   M+++     V    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYG 73

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLN------IMIDVASVLEYLHFNF 542
           +   E    + +E M   SL+K  Y    ++D  Q +       I + +   LE+LH   
Sbjct: 74  ALFREGDVWICMELMD-TSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR-E 601
              VIH D+KPSNVL++      + DFGI+  L+     + +        Y+APE  R  
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPE--RIN 182

Query: 602 GRVFANG-----DVYSFGIMLMEI 620
             +   G     D++S GI ++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 47/212 (22%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFH---LQCGRAFKSFDI-----ECEIMKSIHYRNL 483
           +G G  G +          +VA+++        G A ++        E EI+K +++  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 484 VKIISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVLEYL 538
           +KI +    E++  +VLE M  G L                  F        +   ++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 539 HFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYI 594
           H N    +IH DLKP NVLL   ++  +  ++DFG +K ++GE   M    TL  T  Y+
Sbjct: 256 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 308

Query: 595 APE---------YGREGRVFANGDVYSFGIML 617
           APE         Y R   V    D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 58/254 (22%), Positives = 97/254 (38%), Gaps = 61/254 (24%)

Query: 394 QKRENWPPNDANMPPKATWRRFSYLEVCRATYGFNEN----NLIGKGGFGTIYKSR-IGD 448
              ++     A+  P        Y          ++     + +G+G    +Y+ +  G 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 449 GMEVAVKVFHLQCGRAFKSFDI-----ECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM 503
               A+KV         K+ D      E  ++  + + N++K+           LVLE +
Sbjct: 78  QKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130

Query: 504 PHGSL-----EKCLYS----SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPS 554
             G L     EK  YS    ++ +  I             + YLH N    ++H DLKP 
Sbjct: 131 TGGELFDRIVEKGYYSERDAADAVKQIL----------EAVAYLHEN---GIVHRDLKPE 177

Query: 555 NVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPE------YGREGR 603
           N+L      D  +  ++DFG++K ++     M    T+  T GY APE      YG E  
Sbjct: 178 NLLYATPAPDAPLK-IADFGLSK-IVEHQVLMK---TVCGTPGYCAPEILRGCAYGPE-- 230

Query: 604 VFANGDVYSFGIML 617
           V    D++S GI+ 
Sbjct: 231 V----DMWSVGIIT 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 59/221 (26%)

Query: 431 NLIGKGGFGTIYK-SRIGDGMEVAVKV-------------FHLQCGRAFKSFDIECEIMK 476
             +G G +G +          E A+KV              +    +  +    E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 477 SIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL----------- 525
           S+ + N++K+     ++++  LV E    G L             F+++           
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDA 148

Query: 526 -NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQS 581
            NIM  + S + YLH +    ++H D+KP N+LL   +  +   + DFG++     +D  
Sbjct: 149 ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYK 204

Query: 582 MTQTQTLATIGYIAPE-----YGREGRVFANGDVYSFGIML 617
           +     L T  YIAPE     Y  +       DV+S G+++
Sbjct: 205 L--RDRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIM 237

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 80.8 bits (200), Expect = 7e-17
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 17/194 (8%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKIISS 489
           IGKG FG ++K         VA+K+  L+        DI+ EI  +       + K   S
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 88

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
              +    +++E++  GS    L      LD  Q   I+ ++   L+YLH       IH 
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK---KIHR 143

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREGRVFA 606
           D+K +NVLL +     L+DFG+   L     +  +  T   +G   ++APE  ++    +
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAPEVIKQSAYDS 198

Query: 607 NGDVYSFGIMLMEI 620
             D++S GI  +E+
Sbjct: 199 KADIWSLGITAIEL 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 38/202 (18%), Positives = 76/202 (37%), Gaps = 18/202 (8%)

Query: 433 IGKG--GFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKII 487
           IGKG     T+  +R    G  V V+  +L+         ++ E+   K  ++ N+V   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCL-YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           ++   +    +V   M +GS +  +       ++      I+  V   L+Y+H       
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---Y 149

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI------APEYGR 600
           +H  +K S++L+      +LS       +I       +         +      +PE  +
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMI-SHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 601 EGRVFANG--DVYSFGIMLMEI 620
           +     +   D+YS GI   E+
Sbjct: 209 QNLQGYDAKSDIYSVGITACEL 230

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 45/214 (21%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI--HYRNLVKIIS 488
           ++G+G    +     +    E AVK+   Q G        E E++     H RN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH-RNVLELIE 78

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVASVLE 536
               E+   LV E M  GS+                +             ++ DVAS L+
Sbjct: 79  FFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALD 125

Query: 537 YLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLL-IGEDQSMTQTQTLATI- 591
           +LH      + H DLKP N+L    +      + DF +   + +  D S   T  L T  
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 592 ---GYIAPEYGREGRVFANG-----DVYSFGIML 617
               Y+APE        A+      D++S G++L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 36/204 (17%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +GKG FG +Y +R   +   +A+KV     L+          E EI   + + N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLN------IMIDVASVLEYLHFN 541
           +   + +   L+LE  P G L K L           R +       M ++A  L Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER 133

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE---- 597
               VIH D+KP N+L+       ++DFG +           +T    T+ Y+ PE    
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT-MCGTLDYLPPEMIEG 186

Query: 598 --YGREGRVFANGDVYSFGIMLME 619
             +  +       D++  G++  E
Sbjct: 187 KTHDEK------VDLWCAGVLCYE 204

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 35/212 (16%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFH---LQCGRAFKSFDI--------------ECEIM 475
           + +G F  I      D    A+K +    L+  R F   +               E +I+
Sbjct: 39  LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 476 KSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-------EKCLYSSNCILDIFQRLNIM 528
             I     +      +N +   ++ E+M + S+            +  C + I     I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
             V +   Y+H      + H D+KPSN+L+D      LSDFG ++ ++ +       +  
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210

Query: 589 A-TIGYIAPE--YGREGRVFANGDVYSFGIML 617
             T  ++ PE          A  D++S GI L
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKIISS 489
           IG G    +  +       +VA+K  +L+  +     ++  EI  M   H+ N+V   +S
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81

Query: 490 CSNEEFKELVLEHMPHGSL-------EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
              ++   LV++ +  GS+              + +LD      I+ +V   LEYLH N 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYG 599
               IH D+K  N+LL +     ++DFG++  L               +G   ++APE  
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 600 REGRVF-ANGDVYSFGIMLMEI 620
            + R +    D++SFGI  +E+
Sbjct: 199 EQVRGYDFKADIWSFGITAIEL 220

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 49/242 (20%), Positives = 81/242 (33%), Gaps = 66/242 (27%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI-----ECEIMKSIHYRNLVKI 486
           IG+G +G +            A+K+ +    R     D+     E  +MK +H+ N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 487 ISSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRL---------------- 525
                +E++  LV+E    G L          S+        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 526 ------------------NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL- 566
                             NIM  + S L YLH      + H D+KP N L        + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 567 -SDFGITKLLIGEDQSMTQ--TQTLATIGYIAPE--------YGREGRVFANGDVYSFGI 615
             DFG++K     +       T    T  ++APE        YG +       D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264

Query: 616 ML 617
           +L
Sbjct: 265 LL 266

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 44/208 (21%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI-----ECEIMKSI-HYRNLVK 485
           +G+G F  + +      G E A K       R            E  +++       ++ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 486 IISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRL------NIMIDVASVLEYL 538
           +     N     L+LE+   G +   C      + ++ + +       ++  +   + YL
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 539 HFNFLVPVIHCDLKPSNVLLDDTMVAH---LSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
           H N    ++H DLKP N+LL          + DFG+++  IG    +   + + T  Y+A
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLA 201

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE                 D+++ GI+ 
Sbjct: 202 PEILNYDPITTA------TDMWNIGIIA 223

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 39/187 (20%), Positives = 70/187 (37%), Gaps = 17/187 (9%)

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKL 197
                L N     LG   +   +    +EL  +Q     ++ ++      +     L +L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
            L  N++S   L+   +L  L  LS++ N       +    L  L       N       
Sbjct: 69  HLSHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDS 123

Query: 256 TTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHL 315
             +  LK+L+ L +  N LK SI   +G L  L+ L+   N ++    L   +L  +  +
Sbjct: 124 --LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGL--TRLKKVNWI 177

Query: 316 NLSFNKL 322
           +L+  K 
Sbjct: 178 DLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 37/241 (15%), Positives = 84/241 (34%), Gaps = 17/241 (7%)

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
            ++ +       + V   L    +  ++       LS  ++ F+    N+       +  
Sbjct: 8   PINQVFPDPGLANAVKQNLGKQSVTDLVS---QKELSG-VQNFNGDNSNIQ--SLAGMQF 61

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
            TNL  ++L  N+++  +   L++L KL+ + +  N+L+     +      L +L L  N
Sbjct: 62  FTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNN 116

Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
           +L         +L +L  LS+  N     + +G L  L  +D   N  ++     +  LK
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLK 172

Query: 263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
            + ++ L              +L    ++   +       P  +          + +   
Sbjct: 173 KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELP 230

Query: 323 E 323
            
Sbjct: 231 V 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 44/229 (19%), Positives = 84/229 (36%), Gaps = 20/229 (8%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN----YLTSSTPELS 85
           N  +  LG+ ++  +V     ++S +++    ++ +  SL+ +        L  S  ++S
Sbjct: 20  NAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHNQIS 76

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH-SLEIFDMSKCNVSGGIPEEIGNLT 144
            LS L +   L    ++ N L       ++  +    L    +    +     + + +L 
Sbjct: 77  DLSPLKDLTKLEELSVNRNRLK------NLNGIPSACLSRLFLDNNELRD--TDSLIHLK 128

Query: 145 NLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL 204
           NL  + +  NKL  SI   L  L KL+ + L  N++  T    + RL K+  +DL G K 
Sbjct: 129 NLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKC 184

Query: 205 SGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV 253
               +     L    T+         P  I N    +            
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYT 233

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 35/201 (17%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS 491
           +G G FG +++      G   A K          ++   E + M  + +  LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 492 NEEFKELVLEHMPHGSL------EKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++    ++ E M  G L      E    S    +         M  V   L ++H N   
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-------EYMRQVCKGLCHMHEN--- 274

Query: 545 PVIHCDLKPSNVLLDDTMVAHL--SDFGITKLLIGEDQSMTQTQTLATIGYIAPE----- 597
             +H DLKP N++        L   DFG+T   +   QS+    T  T  + APE     
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAPEVAEGK 331

Query: 598 -YGREGRVFANGDVYSFGIML 617
             G         D++S G++ 
Sbjct: 332 PVGYY------TDMWSVGVLS 346

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 49/234 (20%), Positives = 90/234 (38%), Gaps = 42/234 (17%)

Query: 405 NMPPKATWRR-FSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH-LQC 461
           +    ++ R    +       + F     +G G FG ++       G+E  +K  +  + 
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKR--KLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 462 GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILD 520
               +  + E E++KS+ + N++KI     +     +V+E    G L E+       I+ 
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER-------IVS 113

Query: 521 IFQRL---------NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSD 568
              R           +M  + + L Y H      V+H DLKP N+L           + D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIID 170

Query: 569 FGITKLLIGEDQSMTQTQTLATIGYIAPE-----YGREGRVFANGDVYSFGIML 617
           FG+ + L   D+    T    T  Y+APE        +       D++S G+++
Sbjct: 171 FGLAE-LFKSDEHS--TNAAGTALYMAPEVFKRDVTFK------CDIWSAGVVM 215

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 23/198 (11%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSF-DIECEI--MKSIHYRNLVKIIS 488
           IG G FG +Y +R + +   VA+K       ++ + + DI  E+  ++ + + N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               E    LV+E+   GS    L      L   +   +       L YLH +    +IH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIH 177

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPE---YGREG 602
            D+K  N+LL +  +  L DFG           M    +   +G   ++APE      EG
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEG 228

Query: 603 RVFANGDVYSFGIMLMEI 620
           +     DV+S GI  +E+
Sbjct: 229 QYDGKVDVWSLGITCIEL 246

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 79.5 bits (195), Expect = 2e-15
 Identities = 87/691 (12%), Positives = 193/691 (27%), Gaps = 231/691 (33%)

Query: 8   KLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLK---------D 57
               +  D++   ++P  I +   ++ +++ ++ + G +   +F     K         +
Sbjct: 30  VDNFDCKDVQ---DMPKSILSKEEIDHIIMSKDAVSGTL--RLFWTLLSKQEEMVQKFVE 84

Query: 58  LALQDNY--LSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSI 115
             L+ NY  L   +S I       S     ++             L N+           
Sbjct: 85  EVLRINYKFL---MSPIKTEQRQPSMMTRMYIEQRDR--------LYNDN---------- 123

Query: 116 GNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL 175
                  ++F  +K NVS    +    L                    L EL+  + V +
Sbjct: 124 -------QVF--AKYNVS--RLQPYLKLRQ-----------------ALLELRPAKNVLI 155

Query: 176 ----------------KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
                              K++  + + IF     + L+L       ++L     L  L 
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIF-----W-LNLKNCNSPETVLEMLQKL--LY 207

Query: 220 TLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKD-LQYLFL--GYN---- 272
            +  ++                  D S N     I   I S++  L+ L     Y     
Sbjct: 208 QIDPNWTSRS--------------DHSSN-----IKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 273 ILKGSIPDSVGDLISLKSLNFS--------NNNLSGAIPLLLEKLSYLEHLNLSFNKLEG 324
           +L      +V +  +  + N S           ++  +         L+H +++    E 
Sbjct: 249 VL-----LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303

Query: 325 EIPKGGSFGNF--------SAESFEGNKLLCG--SPNLHVPPCKTSIHHTSRKNALFLGI 374
           +         +          E    N       + ++               + L   I
Sbjct: 304 K----SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 375 VLSFSTI--------FMVVVILLIVKYQKRENWPPNDANMPPKA---TWRRFSYLEVCRA 423
             S + +        F  + +             P  A++P       W      +V   
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVF------------PPSAHIPTILLSLIWFDVIKSDVMVV 407

Query: 424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL 483
               ++ +L+ K               E  + +  +          ++ E   ++H R++
Sbjct: 408 VNKLHKYSLVEK------------QPKESTISIPSIYL-----ELKVKLENEYALH-RSI 449

Query: 484 V---KIISSCSNEEFKELVLE-----HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVL 535
           V    I  +  +++     L+     H+ H  L+   +     + +F+ +          
Sbjct: 450 VDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPER--MTLFRMV---------- 496

Query: 536 EYLHFNFL-VPVIHCDLKPS------NVLLD---------------DTMVAHLSDFGI-- 571
            +L F FL   + H     +      N L                 + +V  + DF    
Sbjct: 497 -FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKI 555

Query: 572 -TKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
              L+  +   + +   +A    I  E  ++
Sbjct: 556 EENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 3e-07
 Identities = 84/583 (14%), Positives = 162/583 (27%), Gaps = 214/583 (36%)

Query: 6   IGK--LELNV-DDIESPCEIPSEI------NPHNLEELLLGQNNLVGVVPAAIFDVSTLK 56
            GK  + L+V    +  C++  +I      N ++ E +L     L+              
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-------------- 206

Query: 57  DLALQDNYLSGSLSSIADNYLTSST-PELS-FLSSLSNCKSLVVFLLSNNPLNGILPRMS 114
              +  N+ S S  S        S   EL   L S      L+V  L N           
Sbjct: 207 -YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV--LLN----------- 252

Query: 115 IGNLSHSLEIFDMSKCNV-----SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK 169
           + N       F++  C +        + + +   T  T I L     + S+  T  E++ 
Sbjct: 253 VQNAKA-WNAFNL-SCKILLTTRFKQVTDFLSAATT-THISLD----HHSMTLTPDEVKS 305

Query: 170 L--QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND 227
           L  +Y+  +   L    P ++          L  N    SI+       S+R       D
Sbjct: 306 LLLKYLDCRPQDL----PREV----------LTTNPRRLSIIA-----ESIR-------D 339

Query: 228 GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK--DLQYLFLGYNILKGSIPDSVGDL 285
           G    +  N K       + +  +++I +++  L+  + + +F   ++     P S    
Sbjct: 340 GLATWD--NWK-----HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF----PPSA--H 386

Query: 286 ISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKL 345
           I    L            L+   +   + + +  NKL                       
Sbjct: 387 IPTILL-----------SLIWFDVIKSD-VMVVVNKLH-------------------KYS 415

Query: 346 LCGSPNLHVPPCKTSIHHTSRKNALFLGIVLSFSTIFMVVVIL---LIVKYQKRENWPPN 402
           L             SI            I L           L   ++  Y   + +  +
Sbjct: 416 LV---EKQPKESTISIPS----------IYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 403 DANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG 462
           D   P         Y                        Y S IG          HL+  
Sbjct: 463 DLIPPYL-----DQY-----------------------FY-SHIG---------HHLKNI 484

Query: 463 RAFKSFDIECEIMKSIHYRNL----VKIISSCSN--------------EEFKELVLEHMP 504
              +       + + + + +      KI    +               + +K  + ++ P
Sbjct: 485 EHPERMT----LFRMV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539

Query: 505 H-----GSLEKCL--YSSNCI----LDIFQRLNIMIDVASVLE 536
                  ++   L     N I     D+ + + +M +  ++ E
Sbjct: 540 KYERLVNAILDFLPKIEENLICSKYTDLLR-IALMAEDEAIFE 581

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 29/203 (14%), Positives = 68/203 (33%), Gaps = 40/203 (19%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSIHYRNLVKIISS 489
           +G+G FG +++            K       +      +  E  I+    +RN++ +  S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 490 CSNEEFKELVLEHMPHGSL------EKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNF 542
             + E   ++ E +    +           +    +       + +  V   L++LH + 
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLHSH- 121

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHL--SDFGITKLLIGEDQSMTQTQTLATIGYIAPE--- 597
              + H D++P N++      + +   +FG  +  +    +           Y APE   
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAPEVHQ 176

Query: 598 ---YGREGRVFANGDVYSFGIML 617
                         D++S G ++
Sbjct: 177 HDVVSTA------TDMWSLGTLV 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 52/214 (24%), Positives = 77/214 (35%), Gaps = 54/214 (25%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDI---ECEIMKSIHYRNLVK 485
           +G G F  + K R  G G E A K      L   R   S +    E  I++ I + N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRL------------NIMIDVAS 533
           +     N+    L+LE +  G L             F  L              +  +  
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDEATQFLKQILD 119

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH----LSDFGITKLLIGEDQSMTQTQTLA 589
            + YLH      + H DLKP N++L D  V +    L DFGI    I             
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFG 173

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIML 617
           T  ++APE       G E       D++S G++ 
Sbjct: 174 TPEFVAPEIVNYEPLGLE------ADMWSIGVIT 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 46/208 (22%), Positives = 77/208 (37%), Gaps = 42/208 (20%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFH-LQCGRAFKSFDI-----ECEIMKSIHYRNLVK 485
           +G G F  + K R    G++ A K     +   + +         E  I+K I + N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----EKCLYS-SNCILDIFQRLNIMIDVASVLEYLH 539
           +     N+    L+LE +  G L     EK   +              +  + + + YLH
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVYYLH 131

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAH----LSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
                 + H DLKP N++L D  V      + DFG+    I             T  ++A
Sbjct: 132 SL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVA 185

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE       G E       D++S G++ 
Sbjct: 186 PEIVNYEPLGLE------ADMWSIGVIT 207

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 57/304 (18%), Positives = 89/304 (29%), Gaps = 74/304 (24%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           EIPS++ P N  EL      L  +   A      L+ + +  N +               
Sbjct: 23  EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV-------------LE 68

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
             E    S+L     +   +   N L  I P           E F               
Sbjct: 69  VIEADVFSNLPKLHEI--RIEKANNLLYINP-----------EAFQ-------------- 101

Query: 141 GNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIFR--LVKLYKL 197
            NL NL  + +    +   +P        +   + ++DN    TI  + F     +   L
Sbjct: 102 -NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTT 257
            L  N +   I     N   L  L+LS N                     NN   +    
Sbjct: 160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDN---------------------NNLEELPNDV 197

Query: 258 IGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN 316
                    L +    +  S+P     +L  L++   S  NL       LEKL  L   +
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR--STYNLKKLPT--LEKLVALMEAS 252

Query: 317 LSFN 320
           L++ 
Sbjct: 253 LTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 44/202 (21%), Positives = 77/202 (38%), Gaps = 11/202 (5%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKL 194
           IP ++    N   +     KL             L+ + +  N +   I  D+F  L KL
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 195 YKLDL-GGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLKVLIGIDFSMNNFS 251
           +++ +   N L       F NL +L+ L +S      LP +   +    + +D   N   
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 252 SVIPTTI--GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEK 308
             I      G   +   L+L  N ++  I +S  +   L  LN S+NN    +P  +   
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHG 200

Query: 309 LSYLEHLNLSFNKLEGEIPKGG 330
            S    L++S  ++   +P  G
Sbjct: 201 ASGPVILDISRTRIH-SLPSYG 221

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 30/187 (16%), Positives = 53/187 (28%), Gaps = 8/187 (4%)

Query: 142 NLTNLTAIYLGGNKLNGSIPF-TLRELQKLQYVGL-KDNKLEGTIPYDIFR-LVKLYKLD 198
              +L  I +  N +   I       L KL  + + K N L   I  + F+ L  L  L 
Sbjct: 52  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLL 110

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIG---NLKV-LIGIDFSMNNFSSVI 254
           +    +         +      L +  N     +E      L    + +  + N    + 
Sbjct: 111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 170

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
            +     +  +      N L+    D          L+ S   +       LE L  L  
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 230

Query: 315 LNLSFNK 321
            +    K
Sbjct: 231 RSTYNLK 237

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 42/208 (20%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI------ECEIMKSIHYRNLVK 485
           +G G F  + K R    G+E A K    +  RA +          E  I++ + + N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----EKCLYS-SNCILDIFQRLNIMIDVASVLEYLH 539
           +     N     L+LE +  G L     +K   S            + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAH----LSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
                 + H DLKP N++L D  +      L DFG+    I +           T  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE       G E       D++S G++ 
Sbjct: 187 PEIVNYEPLGLE------ADMWSIGVIT 208

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 29/198 (14%), Positives = 64/198 (32%), Gaps = 13/198 (6%)

Query: 143 LTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLG 200
             +   + L    L  +IP      L  +  + +  +     +    F  L K+  +++ 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 201 GNKLSGSI-LTCFSNLASLRTLSLSYN---DGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
             +    I       L  L+ L +        P   ++ +  +   ++ + N + + IP 
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 257 TI--GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP-LLLEKL-SYL 312
               G   +   L L  N    S+     +   L ++  + N     I       + S  
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207

Query: 313 EHLNLSFNKLEGEIPKGG 330
             L++S   +   +P  G
Sbjct: 208 SLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 33/212 (15%), Positives = 68/212 (32%), Gaps = 27/212 (12%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            IPS   P + + L L + +L  +   A  ++  +  + +  +    +L  +  +     
Sbjct: 25  RIPS--LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID---VTLQQLESH----- 74

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE- 139
                   S  N   +    + N      +   ++  L   L+   +    +    P+  
Sbjct: 75  --------SFYNLSKVTHIEIRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLT 124

Query: 140 -IGNLTNLTAIYLGGNKLNGSIP-FTLRELQK-LQYVGLKDNKLEGTIPYDIFRLVKLYK 196
            + +      + +  N    SIP    + L      + L +N    ++    F   KL  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183

Query: 197 LDLGGNKLSGSI-LTCFSNLAS-LRTLSLSYN 226
           + L  NK    I    F  + S    L +S  
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQT 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 10/94 (10%), Positives = 32/94 (34%), Gaps = 3/94 (3%)

Query: 243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNNLSGA 301
           +     +  ++      +L ++  +++  ++    +      +L  +  +   N      
Sbjct: 36  LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY 95

Query: 302 IPL-LLEKLSYLEHLNLSFNKLEGEIPKGGSFGN 334
           I    L++L  L+ L +    L+   P      +
Sbjct: 96  IDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 45/208 (21%), Positives = 75/208 (36%), Gaps = 42/208 (20%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDI-----ECEIMKSIHYRNLVK 485
           +G G F  + K R    G+E A K     Q   + +         E  I++ + + N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----EKCLYS-SNCILDIFQRLNIMIDVASVLEYLH 539
           +     N     L+LE +  G L     +K   S            + +  +   + YLH
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVNYLH 132

Query: 540 FNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA 595
                 + H DLKP N++L           L DFG+    I +           T  ++A
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVA 186

Query: 596 PE------YGREGRVFANGDVYSFGIML 617
           PE       G E       D++S G++ 
Sbjct: 187 PEIVNYEPLGLE------ADMWSIGVIT 208

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 39/225 (17%), Positives = 86/225 (38%), Gaps = 44/225 (19%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSI-HYRN 482
           F+E   IG G FG+++K     DG   A+K        +    +   E      +  + +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF---QRLNIMIDVASVLEYLH 539
           +V+  S+ + ++   +  E+   GSL   +  +  I+  F   +  ++++ V   L Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 540 FNFLVPVIHCDLKPSNVLLD-------------------DTMVAHLSDFGITKLLIGEDQ 580
                 ++H D+KPSN+ +                    + ++  + D G    +     
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184

Query: 581 SMTQTQTLATIGYIAPE-----YGREGRVFANGDVYSFGIMLMEI 620
           S  Q +      ++A E     Y    +     D+++  + ++  
Sbjct: 185 SSPQVEE-GDSRFLANEVLQENYTHLPKA----DIFALALTVVCA 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 49/246 (19%)

Query: 405 NMPPKATWRRFSYLEVCRA---TYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQ 460
           +M   +  R    +++         F    L+G G +G +YK R +  G   A+KV  + 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 461 CGRAFKSFDIECEIMKSI-HYRNLVKIISS----CSNEEFKEL--VLEHMPHGSLEKCLY 513
            G   +    E  ++K   H+RN+     +           +L  V+E    GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 514 SSNCILDIFQRLN-----------IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM 562
                 D+ +              I  ++   L +LH +    VIH D+K  NVLL +  
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166

Query: 563 VAHLSDFGITKLLIGEDQSMTQTQTLATIG---YIAPEYGREGRVFANG-----DVYSFG 614
              L DFG++  L   D+++ +  T   IG   ++APE                D++S G
Sbjct: 167 EVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

Query: 615 IMLMEI 620
           I  +E+
Sbjct: 222 ITAIEM 227

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 49/199 (24%), Positives = 81/199 (40%), Gaps = 19/199 (9%)

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
                           L    +  ++     EL  +  +   ++ ++         L  +
Sbjct: 16  DAF------AETIKANLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQ--YLPNV 65

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSS 252
             L LGGNKL    ++    L +L  L L+ N    LP  +   L  L  +    N   S
Sbjct: 66  RYLALGGNKLHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS 123

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL-LLEKLS 310
           +       L +L YL L +N L+ S+P  V D L +L  L+ S N L  ++P  + +KL+
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT 181

Query: 311 YLEHLNLSFNKLEGEIPKG 329
            L+ L L  N+L+  +P G
Sbjct: 182 QLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 39/211 (18%), Positives = 72/211 (34%), Gaps = 61/211 (28%)

Query: 45  VPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS---STPELSFLSSLSNCKSLVVFLL 101
            P   F  +      L+   ++ +++    N +     +  ++  +  +    ++    L
Sbjct: 13  FPDDAF--AETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLAL 70

Query: 102 SNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP 161
             N L             H +                    LTNLT + L GN+L  S+P
Sbjct: 71  GGNKL-------------HDISALK---------------ELTNLTYLILTGNQLQ-SLP 101

Query: 162 FTL-RELQKLQYVGLKDNKLEGTIPYDIF-------------------------RLVKLY 195
             +  +L  L+ + L +N+L+ ++P  +F                         +L  L 
Sbjct: 102 NGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           +LDL  N+L       F  L  L+ L L  N
Sbjct: 161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 53/178 (29%)

Query: 30  NLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
           NL  L+L  N L  + P  +FD ++ LK+L L +N L  SL     + LT     L++L+
Sbjct: 86  NLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT----NLTYLN 139

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
                       L++N L  +              +FD                LTNLT 
Sbjct: 140 ------------LAHNQLQSLPKG-----------VFD---------------KLTNLTE 161

Query: 149 IYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGN 202
           + L  N+L  S+P   F   +L +L+ + L  N+L+ ++P  +F RL  L  + L  N
Sbjct: 162 LDLSYNQLQ-SLPEGVFD--KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 43/215 (20%), Positives = 76/215 (35%), Gaps = 61/215 (28%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR-----NLVKI 486
           +G G  G + +        + A+K+                E+   +H+R     ++V+I
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREV--ELHWRASQCPHIVRI 120

Query: 487 ISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILD-IFQRLN----------IMIDV 531
           +    N         +V+E +  G L             I  R +          IM  +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSI 170

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTL 588
              ++YLH      + H D+KP N+L        +  L+DFG  K     +   T     
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PC 224

Query: 589 ATIGYIAPE------YGREGRVFANGDVYSFGIML 617
            T  Y+APE      Y +        D++S G+++
Sbjct: 225 YTPYYVAPEVLGPEKYDKS------CDMWSLGVIM 253

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRN 482
           F    ++G+G F T+  +R +    E A+K+    H+           E ++M  + +  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            VK+  +  ++E     L +  +G L K +       +   R     ++ S LEYLH   
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK- 149

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE---- 597
              +IH DLKP N+LL++ M   ++DFG  K+L  E +      +   T  Y++PE    
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYVSPELLTE 206

Query: 598 --YGREGRVFANGDVYSFGIMLME 619
               +        D+++ G ++ +
Sbjct: 207 KSACKS------SDLWALGCIIYQ 224

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 58/214 (27%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSI-HYRNLVKII 487
           ++G G  G + +      G + A+K+ +        S     E +         ++V I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 488 SSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILD-IFQRLN----------IMIDVA 532
               N    +    +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
           + +++LH +    + H D+KP N+L    +   V  L+DFG  K       ++       
Sbjct: 139 TAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIML 617
           T  Y+APE      Y +        D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 47/222 (21%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF--------------------HLQCGRAFKSFDI 470
            IGKG +G +  +    D    A+KV                         G   +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 471 ------ECEIMKSIHYRNLVKIIS--SCSNEEFKELVLEHMPHGSL----EKCLYSSNCI 518
                 E  I+K + + N+VK++      NE+   +V E +  G +         S +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 519 LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE 578
              FQ      D+   +EYLH+     +IH D+KPSN+L+ +     ++DFG++    G 
Sbjct: 140 RFYFQ------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 579 DQSMTQTQTLATIGYIAPEYGREGRVFANG---DVYSFGIML 617
           D ++    T+ T  ++APE   E R   +G   DV++ G+ L
Sbjct: 191 D-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 44/216 (20%), Positives = 72/216 (33%), Gaps = 52/216 (24%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLSGSLSSIADNYLTS 79
            +P  + P     L L  NNL  +        ++ L  L L  N     L+ I       
Sbjct: 32  NVPQSL-PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN----HLNFI------- 79

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
                +F        +L    LS+N L+ +              +F              
Sbjct: 80  --SSEAF----VPVPNLRYLDLSSNHLHTLDE-----------FLFS------------- 109

Query: 140 IGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIF----RLVKL 194
             +L  L  + L  N +   +      ++ +LQ + L  N++    P ++     +L KL
Sbjct: 110 --DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKL 165

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPL 230
             LDL  NKL    LT    L +     L  ++ PL
Sbjct: 166 MLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 44/179 (24%), Positives = 69/179 (38%), Gaps = 21/179 (11%)

Query: 183 TIPYDIFRLVKLYKLDLGGNKLSGSIL--TCFSNLASLRTLSLSYND-GPLPLEI-GNLK 238
            +P  +        LDL  N LS  +      + L +L +L LS+N    +  E    + 
Sbjct: 32  NVPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 239 VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV-GDLISLKSLNFSNNN 297
            L  +D S N+  ++       L+ L+ L L  N +   +  +   D+  L+ L  S N 
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147

Query: 298 LSGAIP----LLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAE-----SFEGNKLLC 347
           +S   P        KL  L  L+LS NKL+ ++P         A          N L C
Sbjct: 148 IS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL-TDLQKLPAWVKNGLYLHNNPLEC 203

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F +  ++G+GGFG ++  ++    ++ A K   L   R  K    +      +I+  +H 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF--QRLNIMI-DVASVLEY 537
           R +V +  +   +    LV+  M  G +   +Y+ +     F   R       + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAP 596
           LH      +I+ DLKP NVLLDD     +SD G+   L       T+T+  A T G++AP
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358

Query: 597 E------YGREGRVFANGDVYSFGIMLME 619
           E      Y     V    D ++ G+ L E
Sbjct: 359 ELLLGEEYDFS--V----DYFALGVTLYE 381

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 41/199 (20%), Positives = 80/199 (40%), Gaps = 20/199 (10%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH----LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
           L+G+G +G + +          AVK+       +      +   E ++++ + ++N++++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 487 ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           +    NEE ++  +V+E+   G  E           + Q       +   LEYLH     
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG-- 129

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPE--Y 598
            ++H D+KP N+LL       +S  G+ + L           T  T      +  PE   
Sbjct: 130 -IVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 599 GREGRVFANGDVYSFGIML 617
           G +       D++S G+ L
Sbjct: 185 GLDTFSGFKVDIWSAGVTL 203

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 34/171 (19%), Positives = 70/171 (40%), Gaps = 27/171 (15%)

Query: 467 SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI--LDIFQR 524
           +  ++   M     +N V  +   S + +  + ++     +L+  +     +   +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 525 LNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ 584
           L+I I +A  +E+LH      ++H DLKPSN+      V  + DFG+   +  +++  T 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 585 TQTLA----------TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
              +           T  Y++PE      Y  +       D++S G++L E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK------VDIFSLGLILFE 268

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 69.5 bits (171), Expect = 5e-13
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 12/171 (7%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFK-SFDI----ECEIMKSIHYRNLVKI 486
           +G+G F T+YK+R       VA+K   L      K   +     E ++++ + + N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
           + +  ++    LV + M    LE  +  ++ +L        M+     LEYLH ++   +
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---I 133

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           +H DLKP+N+LLD+  V  L+DFG+ K     +++   T  + T  Y APE
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPE 182

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 26/176 (14%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECE-----------IMKSIHYR 481
           +G+G +G +YK++   G  VA+K   L         D E E           ++K +H+ 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAIREISLLKELHHP 79

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N+V +I    +E    LV E M    L+K L  +   L   Q    +  +   + + H +
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
               ++H DLKP N+L++      L+DFG+ +      +S   T  + T+ Y AP+
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 25/194 (12%), Positives = 49/194 (25%), Gaps = 43/194 (22%)

Query: 432 LIGKGGFGTIYKSRIGD---GMEVAVKVFHLQCGRA--FKS-FDIECEIMKSIHYRNLVK 485
             G       +++   D     +VA+     Q                 +  I    + +
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           ++          +V E +  GSL++   +S         +  M  +A+  +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---G 149

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           V      PS V +           G   L              A    +     ++    
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPDANPQD---- 183

Query: 606 ANGDVYSFGIMLME 619
              D+   G  L  
Sbjct: 184 ---DIRGIGASLYA 194

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 61/231 (26%)

Query: 400 PPNDANMPPKATWRRFSYLEVCRATYGFNENN------LIGKGGFGTIYKSRIGDGMEVA 453
           P N   + P     +   +       G           +IG G FG ++++++ +  EVA
Sbjct: 9   PLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVA 68

Query: 454 VKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVK----IISSCSNEEFKE--LVLEHMP 504
           +K          R       E +IM+ + + N+V       S+   ++     LVLE++P
Sbjct: 69  IKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121

Query: 505 HGSLEKCLYSSNCILDIFQRLNIMIDVASV----------LEYLH-FNFLVPVIHCDLKP 553
                + +Y        + +L   + +  +          L Y+H       + H D+KP
Sbjct: 122 -----ETVYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG----ICHRDIKP 169

Query: 554 SNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI------APE 597
            N+LLD  + V  L DFG  K+LI   +            YI      APE
Sbjct: 170 QNLLLDPPSGVLKLIDFGSAKILI-AGEPNV--------SYICSRYYRAPE 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 75/263 (28%)

Query: 433 IGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG---RAFKSFDIECEIMKSI-HYRN 482
           +G+G FG + +       +      VAVK+  L+ G      ++   E +I+  I H+ N
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 483 LVKIISSCSNEEFK-ELVLEHMPHGSLEKCL----------------------YSSNCIL 519
           +V ++ +C+       +++E    G+L   L                      Y     +
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 520 DIFQRLN-------------------IMIDVASVLEYLHFNFLVP--------------- 545
           D+ +RL+                     ++     E L+ +FL                 
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 546 ------VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
                  IH DL   N+LL +  V  + DFG+ + +  +   + +      + ++APE  
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267

Query: 600 REGRVFANGDVYSFGIMLMEIHS 622
            +       DV+SFG++L EI S
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFS 290

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 26/176 (14%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECE-----------IMKSIHYR 481
           IG+G +G +YK++   G   A+K   L         + E E           I+K + + 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREISILKELKHS 60

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           N+VK+      ++   LV EH+    L+K L      L+     + ++ + + + Y H  
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
               V+H DLKP N+L++      ++DFG+ +      +    T  + T+ Y AP+
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPD 170

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 40/177 (22%), Positives = 77/177 (43%), Gaps = 27/177 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECE-----------IMKSIHY 480
           IG+G +GT++K++       VA+K   L         D + E           ++K + +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKELKH 60

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
           +N+V++     +++   LV E      L+K   S N  LD     + +  +   L + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
                V+H DLKP N+L++      L++FG+ +      +    +  + T+ Y  P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 49/208 (23%), Positives = 80/208 (38%), Gaps = 42/208 (20%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKV--------FHLQCGRAFKSFDIECEIMKSIHYRNL 483
           +G G FG ++ +       EV VK                      +E  I+  + + N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF------QRLN------IMIDV 531
           +K++    N+ F +LV+E    G            LD+F       RL+      I   +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG------------LDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
            S + YL       +IH D+K  N+++ +     L DFG    L  E   +  T    TI
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTI 193

Query: 592 GYIAPEYGREGRVF--ANGDVYSFGIML 617
            Y APE    G  +     +++S G+ L
Sbjct: 194 EYCAPEV-LMGNPYRGPELEMWSLGVTL 220

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 9/168 (5%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDI-ECEIMKSIHYRNLVKIISS 489
           IG+G +G ++K R    G  VA+K F   +     K   + E  ++K + + NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
              +    LV E+  H ++   L      +      +I       + + H +     IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHR 126

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           D+KP N+L+    V  L DFG  +LL G          +AT  Y +PE
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.9 bits (165), Expect = 5e-12
 Identities = 41/262 (15%), Positives = 74/262 (28%), Gaps = 48/262 (18%)

Query: 74  DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGI---------LPRMSIGNLSHSLE- 123
              +        +    +  + L    LS      +         L  +   N    L  
Sbjct: 329 KECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTI 388

Query: 124 IFDMSKCNVSGGIPEEIGNLTNLTAI--------YLGGNKLNGSIPFTLRELQKLQYVGL 175
           I  M   +      E +   + L A+            +K          E   ++ + L
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448

Query: 176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIG 235
               L   + + + +L+ +  LDL  N+L  ++    + L  L  L  S N         
Sbjct: 449 AHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDN--------- 496

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD--SVGDLISLKSLNF 293
            L+ + G+                +L  LQ L L  N L+        +     L  LN 
Sbjct: 497 ALENVDGV---------------ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNL 540

Query: 294 SNNNLSGAIPLLLEKLSYLEHL 315
             N+L     +       L  +
Sbjct: 541 QGNSLCQEEGIQERLAEMLPSV 562

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 7e-12
 Identities = 44/207 (21%), Positives = 76/207 (36%), Gaps = 14/207 (6%)

Query: 120 HSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY---VGLK 176
             L   ++S    S  +  E+ +   L  +         +I   +R L  L Y       
Sbjct: 349 EQLFRCELS-VEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQY 407

Query: 177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGN 236
            + L+   P     L  L    L  N +             +R L L++ D  +   +  
Sbjct: 408 FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYAD------VRVLHLAHKDLTVLCHLEQ 461

Query: 237 LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN 296
           L ++  +D S N   + +P  + +L+ L+ L    N L+ ++   V +L  L+ L   NN
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 518

Query: 297 NLSGAIPLL-LEKLSYLEHLNLSFNKL 322
            L  +  +  L     L  LNL  N L
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 61.7 bits (149), Expect = 5e-10
 Identities = 34/190 (17%), Positives = 65/190 (34%), Gaps = 13/190 (6%)

Query: 137 PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK 196
             +      L    L   K    +   L   ++LQ +  ++     TI   +  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
                   S          A L  L  S       +       +  +  +  + + +   
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLR-SKFLLENSVLKMEYADVRVLHLAHKDLTVLCH- 458

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN---NLSGAIPLLLEKLSYLE 313
            +  L  + +L L +N L+ ++P ++  L  L+ L  S+N   N+ G     +  L  L+
Sbjct: 459 -LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-----VANLPRLQ 511

Query: 314 HLNLSFNKLE 323
            L L  N+L+
Sbjct: 512 ELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 34/242 (14%), Positives = 76/242 (31%), Gaps = 35/242 (14%)

Query: 10  ELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY----- 64
           E  +      C          L    L       V+ + +     L++L  ++ +     
Sbjct: 330 ECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI 388

Query: 65  LSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRM----------- 113
           +    +     Y   +    S L ++   ++  +  L +  L                  
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448

Query: 114 ------SIGNLSH--SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLR 165
                  + +L     +   D+S   +   +P  +  L  L  +    N L  ++   + 
Sbjct: 449 AHKDLTVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVA 505

Query: 166 ELQKLQYVGLKDNKLEG-TIPYDIFRLVKLYKLDLGGNKLS------GSILTCFSNLASL 218
            L +LQ + L +N+L+       +    +L  L+L GN L         +     +++S+
Sbjct: 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

Query: 219 RT 220
            T
Sbjct: 566 LT 567

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.1 bits (164), Expect = 8e-12
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 33/209 (15%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F +  ++GKGGFG +   ++    ++ A K   L+  R  K           +I++ ++ 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---LEY 537
           R +V +  +   ++   LVL  M  G L+  +Y  +     F     +   A +   LE 
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAP 596
           LH      +++ DLKP N+LLDD     +SD G+   +          +    T+GY+AP
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP 354

Query: 597 E------YGREGRVFANGDVYSFGIMLME 619
           E      Y          D ++ G +L E
Sbjct: 355 EVVKNERYTFS--P----DWWALGCLLYE 377

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 65.7 bits (161), Expect = 8e-12
 Identities = 39/167 (23%), Positives = 75/167 (44%), Gaps = 8/167 (4%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G+G + T+YK +       VA+K   L+         I E  ++K + + N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             E+   LV E++    L++ L     I+++      +  +   L Y H      V+H D
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125

Query: 551 LKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           LKP N+L+++     L+DFG+ +      ++      + T+ Y  P+
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 67.2 bits (164), Expect = 9e-12
 Identities = 49/210 (23%), Positives = 83/210 (39%), Gaps = 34/210 (16%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC--------EIMKS 477
           F+ + +IG+GGFG +Y  R  D  ++ A+K   L   R                  ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
                +V +  +    +    +L+ M  G L   L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAP 596
           +H  F   V++ DLKP+N+LLD+     +SD G+      +     +      T GY+AP
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

Query: 597 E-------YGREGRVFANGDVYSFGIMLME 619
           E       Y          D +S G ML +
Sbjct: 360 EVLQKGVAYDSS------ADWFSLGCMLFK 383

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 23/99 (23%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA- 589
           +   L+YL       +IH D+KP N+LLD+    H++DF I  +L  E    TQ  T+A 
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176

Query: 590 TIGYIAPE---------YGREGRVFANGDVYSFGIMLME 619
           T  Y+APE         Y     V    D +S G+   E
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYE 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 19/163 (11%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIM 475
           C     + +   IG+G FG ++K+R    G +VA+K   ++     + F I    E +I+
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKIL 70

Query: 476 KSIHYRNLVK---IISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
           + + + N+V    I  + ++   +      LV +   H  L   L +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
           M  + + L Y+H N    ++H D+K +NVL+    V  L+DFG
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 62/211 (29%), Positives = 87/211 (41%), Gaps = 56/211 (26%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST 81
           +PS I P + E+L L    L  +  A    ++ L  L L  N L  +LS+   + LT   
Sbjct: 29  VPSGI-PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLT--- 83

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLE--IFDMSKCNVSGGIPEE 139
            EL  L             L+NN L              SL   +FD             
Sbjct: 84  -ELGTLG------------LANNQL-------------ASLPLGVFD------------- 104

Query: 140 IGNLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLY 195
             +LT L  +YLGGN+L  S+P   F    L KL+ + L  N+L+ +IP   F +L  L 
Sbjct: 105 --HLTQLDKLYLGGNQLK-SLPSGVF--DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQ 158

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
            L L  N+L       F  L  L+T++L  N
Sbjct: 159 TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 50/191 (26%), Positives = 73/191 (38%), Gaps = 32/191 (16%)

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-R 190
           V  GIP       +   + L    L      T R L KL ++ L  N+L+ T+   +F  
Sbjct: 29  VPSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD 81

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
           L +L  L L  N+L+   L  F +L  L  L L  N                        
Sbjct: 82  LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ----------------------L 119

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKL 309
            S+       L  L+ L L  N L+ SIP    D L +L++L+ S N L        ++L
Sbjct: 120 KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL 178

Query: 310 SYLEHLNLSFN 320
             L+ + L  N
Sbjct: 179 GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 47/138 (34%), Positives = 66/138 (47%), Gaps = 7/138 (5%)

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEI-GNLKVLIGIDFSMNNFSSV 253
           KLDL    L+      F  L  L  L+L YN    L   +  +L  L  +  + N  +S+
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL-LLEKLSY 311
                  L  L  L+LG N LK S+P  V D L  LK L  + N L  +IP    +KL+ 
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156

Query: 312 LEHLNLSFNKLEGEIPKG 329
           L+ L+LS N+L+  +P G
Sbjct: 157 LQTLSLSTNQLQS-VPHG 173

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 46/217 (21%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           +    +IG+G FG +   R     +V A+K+  L      K  D        +IM   + 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVA-------- 532
             +V++  +  ++ +  +V+E+MP G L          +++    ++    A        
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVV 178

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIG 592
             L+ +H       IH D+KP N+LLD +    L+DFG    +  E      T  + T  
Sbjct: 179 LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPD 234

Query: 593 YIAPE----------YGREGRVFANGDVYSFGIMLME 619
           YI+PE          YGRE       D +S G+ L E
Sbjct: 235 YISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYE 265

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 56/217 (25%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFH----LQCGRAFKSFDIECEI--MKSIHYR--- 481
           L+GKGGFGT++   R+ D ++VA+KV      L       S     E+  +  +      
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 482 -NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF------QRL------NIM 528
             +++++     +E   LVLE                  D+F        L         
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQT 587
             V + +++ H      V+H D+K  N+L+D     A L DFG   LL   D+  T    
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD- 199

Query: 588 LATIGYIAPEY-------GREGRVFANGDVYSFGIML 617
             T  Y  PE+                  V+S GI+L
Sbjct: 200 -GTRVYSPPEWISRHQYHALP------ATVWSLGILL 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 9/180 (5%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDI-ECEIMKS 477
            ++   +    L+G+G +G + K R    G  VA+K F      +  K   + E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEY 537
           + + NLV ++  C  ++   LV E + H ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
            H +    +IH D+KP N+L+  + V  L DFG  + L    +       +AT  Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPE 194

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 35/163 (21%), Positives = 60/163 (36%), Gaps = 32/163 (19%)

Query: 160 IPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCFSNLASL 218
           +P T+ E++      L+ N ++  IP   F    KL ++DL  N++S      F  L SL
Sbjct: 30  LPETITEIR------LEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 219 RTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSI 278
            +L L  N                        + +  +    L  LQ L L  N +   +
Sbjct: 83  NSLVLYGN----------------------KITELPKSLFEGLFSLQLLLLNANKIN-CL 119

Query: 279 PDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
                  L +L  L+  +N L          L  ++ ++L+ N
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 41/184 (22%), Positives = 67/184 (36%), Gaps = 48/184 (26%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           EIP+ + P  + E+ L QN +  + P A      L+ + L +N +S              
Sbjct: 25  EIPTNL-PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-------------E 70

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
               +F   L +  SLV   L  N +  +              +F+              
Sbjct: 71  LAPDAF-QGLRSLNSLV---LYGNKITELPKS-----------LFE-------------- 101

Query: 141 GNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLD 198
             L +L  + L  NK+N  +     ++L  L  + L DNKL+ TI    F  L  +  + 
Sbjct: 102 -GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMH 158

Query: 199 LGGN 202
           L  N
Sbjct: 159 LAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 3/88 (3%)

Query: 243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGA 301
           I    N    + P      K L+ + L  N +   +       L SL SL    N ++  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95

Query: 302 IPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
              L E L  L+ L L+ NK+   +   
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 35/148 (23%), Positives = 55/148 (37%), Gaps = 27/148 (18%)

Query: 183 TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIG 242
            IP ++   +   ++ L  N +       FS    LR + LS N                
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN---------------- 66

Query: 243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGA 301
                   S + P     L+ L  L L  N +   +P S+ + L SL+ L  + N ++  
Sbjct: 67  ------QISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCL 119

Query: 302 IPLLLEKLSYLEHLNLSFNKLEGEIPKG 329
                + L  L  L+L  NKL+  I KG
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 22/192 (11%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGR-AFKSFDI----ECEI 474
             AT  +     IG G +GT+YK+R    G  VA+K   +  G        I    E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 475 MKSIHYR------NLVKIISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCI-LDIFQRL 525
           ++ +          L+ + ++   +   +  LV EH+    L   L  +    L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 526 NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           ++M      L++LH N    ++H DLKP N+L+       L+DFG+ ++       M  T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177

Query: 586 QTLATIGYIAPE 597
             + T+ Y APE
Sbjct: 178 PVVVTLWYRAPE 189

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 40/216 (18%), Positives = 84/216 (38%), Gaps = 41/216 (18%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F    +IG+G FG +   ++ +  +V A+K+  L      K  +  C     +++ +   
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDS 133

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID---------- 530
           + +  +  +  ++    LV+++   G L          L +  +    +           
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAE 183

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +   ++ +H       +H D+KP N+L+D     H  L+DFG    L+ +    +    +
Sbjct: 184 MVIAIDSVHQL---HYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AV 237

Query: 589 ATIGYIAPEYGREGRVFANG-----DVYSFGIMLME 619
            T  YI+PE  +             D +S G+ + E
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 62/348 (17%), Positives = 116/348 (33%), Gaps = 72/348 (20%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDV----STLKDLALQDNYLSGS-LSSIADNYLTSSTPEL 84
             + + L    L       I         L +L L+ N L    +  +    L + + ++
Sbjct: 29  QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ-GLQTPSCKI 87

Query: 85  SFL----------------SSLSNCKSLVVFLLSNNPLNGI-LPRMSIGNLSH--SLEIF 125
             L                S+L    +L    LS+N L    L  +  G L     LE  
Sbjct: 88  QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKL 147

Query: 126 DMSKCNVS----GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLE 181
            +  C++S      +   +    +   + +  N +N +    +R L +    GLKD+   
Sbjct: 148 QLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQ----GLKDSPC- 199

Query: 182 GTIPYDIFRLVKLYKLDLGGNKLS----GSILTCFSNLASLRTLSLSYN----DGPLPLE 233
                      +L  L L    ++      +    ++ ASLR L+L  N     G   L 
Sbjct: 200 -----------QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248

Query: 234 IGNLKV---LIGIDFSMNNFSSV----IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI 286
            G L     L  +       ++     +   + + + L+ L L  N L       + + +
Sbjct: 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308

Query: 287 -----SLKSLNFSNNNLS--GAIPL--LLEKLSYLEHLNLSFNKLEGE 325
                 L+SL   + + +         +L +  +L  L +S N+LE  
Sbjct: 309 LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 44/246 (17%), Positives = 85/246 (34%), Gaps = 42/246 (17%)

Query: 118 LSHSLEIFDMSKCNVS-GGIPEEIGNLTNLTAIYLGGNKLN----GSIPFTLRELQKLQY 172
           +S  ++  D+    +S     E +  L     + L    L       I   LR    L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 173 VGLKDNKLEGTIPYDIFRLVK-----LYKLDLGGNKLS----GSILTCFSNLASLRTLSL 223
           + L+ N+L     + + + ++     + KL L    L+    G + +    L +L+ L L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 224 SYND----GPLPLEIGNLKV---LIGIDFSMNNFSSVIPTTIGSL----KDLQYLFLGYN 272
           S N     G   L  G L     L  +     + S+     + S+     D + L +  N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 273 ILKGSIPDSVGDLI---------SLKSLNFSNNNLS----GAIPLLLEKLSYLEHLNLSF 319
                I ++   ++          L++L   +  ++      +  ++   + L  L L  
Sbjct: 181 ----DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236

Query: 320 NKLEGE 325
           NKL   
Sbjct: 237 NKLGDV 242

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 66/333 (19%), Positives = 116/333 (34%), Gaps = 74/333 (22%)

Query: 30  NLEELLLGQNNLVGVVPAAIFDV-----STLKDLALQDNYLS-GSLSSIADNYLTSSTPE 83
            L+EL L  N L       + +        L+ L L+   LS  S   +A          
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA---------- 163

Query: 84  LSFLSSLSNCKSLVVFLLSNNPLNG----ILPRMSIGNLSHSLEIFDMSKCNVS----GG 135
               S L          +SNN +N     +L +  + +    LE   +  C V+      
Sbjct: 164 ----SVLRAKPDFKELTVSNNDINEAGVRVLCQG-LKDSPCQLEALKLESCGVTSDNCRD 218

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGS-----IPFTLRELQKLQYVGLKDNKL--EGTIPYDI 188
           +   + +  +L  + LG NKL         P  L    +L+ + + +  +  +G    D+
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG--DL 276

Query: 189 FRLVK----LYKLDLGGNKL--SGSILTC---FSNLASLRTLSLSYNDGPLPLEIGNLKV 239
            R+++    L +L L GN+L   G+ L C         L +L +                
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC------SFT---- 326

Query: 240 LIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI-----SLKSLNFS 294
                   ++FSSV+       + L  L +  N L+ +    +   +      L+ L  +
Sbjct: 327 ----AACCSHFSSVL----AQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA 378

Query: 295 NNNLS--GAIPL--LLEKLSYLEHLNLSFNKLE 323
           + ++S      L   L     L  L+LS N L 
Sbjct: 379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 49/208 (23%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVF------HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           IGKG F  +  +R I  G EVA+K+            + F+    E  IMK +++ N+VK
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD-----IFQRLNIMIDVASVLEYLHF 540
           +      E+   L++E+   G +   L +   + +      F+++       S ++Y H 
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQ 132

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAP 596
                ++H DLK  N+LLD  M   ++DFG +          T    L        Y AP
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYAAP 182

Query: 597 EYGREGRVFANG-------DVYSFGIML 617
           E      +F          DV+S G++L
Sbjct: 183 E------LFQGKKYDGPEVDVWSLGVIL 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 56/193 (29%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKII- 487
           IG G FG +Y++++ D G  VA+K          R       E +IM+ + + N+V++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRY 114

Query: 488 -----SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------- 534
                    +E +  LVL+++P       +Y    +   + R    + V  V        
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-----TVYR---VARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 535 --LEYLH-FNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
             L Y+H F     + H D+KP N+LLD DT V  L DFG  K L+   +          
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV------- 214

Query: 591 IGYI------APE 597
             YI      APE
Sbjct: 215 -SYICSRYYRAPE 226

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.0 bits (154), Expect = 8e-11
 Identities = 33/188 (17%), Positives = 69/188 (36%), Gaps = 31/188 (16%)

Query: 400 PPNDANMPPKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH 458
                           S      +   +     +G+G +G +YK+        VA+K   
Sbjct: 9   MGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR 68

Query: 459 LQCGRAFKSFDIECE-----------IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGS 507
           L         + E E           ++K + +RN++++ S   +     L+ E+  +  
Sbjct: 69  L---------EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118

Query: 508 LEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH-- 565
           L+K +   N  + +    + +  + + + + H       +H DLKP N+LL  +  +   
Sbjct: 119 LKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174

Query: 566 ---LSDFG 570
              + DFG
Sbjct: 175 VLKIGDFG 182

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 32/204 (15%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFH----LQCGRAFKSFDIECEI--MKSIH--YRN 482
           L+G GGFG++Y   R+ D + VA+K          G       +  E+  +K +   +  
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 483 LVKIISSCSNEEFKELVLEH-MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           +++++      +   L+LE   P   L   +     + +   R +    V   + + H  
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 168

Query: 542 FLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-- 598
               V+H D+K  N+L+D +     L DFG   LL     ++       T  Y  PE+  
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIR 221

Query: 599 -----GREGRVFANGDVYSFGIML 617
                GR         V+S GI+L
Sbjct: 222 YHRYHGRS------AAVWSLGILL 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 49/200 (24%), Positives = 85/200 (42%), Gaps = 30/200 (15%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +G G FG +        G +VAVK+     ++          E + +K   + +++K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 488 SSCSNEEFKELVLEHMPHGSL-----EKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
              S      +V+E++  G L     +           +FQ++       S ++Y H + 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCHRHM 131

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI----GYIAPE- 597
              V+H DLKP NVLLD  M A ++DFG++ +       M+  + L T      Y APE 
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAPEV 181

Query: 598 YGREGRVFANGDVYSFGIML 617
                      D++S G++L
Sbjct: 182 ISGRLYAGPEVDIWSCGVIL 201

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 34/171 (19%), Positives = 57/171 (33%), Gaps = 48/171 (28%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDI--ECEIMKSI-HYRNLVKIIS 488
           +G G  G + +        + A+K+                E E+        ++V+I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 489 SCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRL--------------NIMID 530
              N         +V+E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGE 578
           +   ++YLH      + H D+KP N+L        +  L+DFG  K   GE
Sbjct: 126 IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 13/172 (7%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI-ECEIMKSIHYRNLVKIISSC 490
           +G G + T+YK      G+ VA+K   L       S  I E  +MK + + N+V++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCI-----LDIFQRLNIMIDVASVLEYLHFNFLVP 545
             E    LV E M +  L+K + S         L++         +   L + H N    
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           ++H DLKP N+L++      L DFG+ +       +   +  + T+ Y AP+
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPD 178

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 43/215 (20%), Positives = 76/215 (35%), Gaps = 36/215 (16%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVK-----VFHLQCGRAFKSFDI------ECEIMKSIHYR 481
           I  G +G +      +G+ VA+K     V   +         +      E  ++   H+ 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 482 NLVK---IISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLE 536
           N++    I          +  LV E M    L + ++    ++        M  +   L 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148

Query: 537 YLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
            LH      V+H DL P N+LL D     + DF + +     D +   T  +    Y AP
Sbjct: 149 VLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--THYVTHRWYRAP 202

Query: 597 E-------YGREGRVFANGDVYSFGIMLMEIHSAK 624
           E       +          D++S G ++ E+ + K
Sbjct: 203 ELVMQFKGFT------KLVDMWSAGCVMAEMFNRK 231

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 35/185 (18%), Positives = 63/185 (34%), Gaps = 49/185 (26%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLSGSLSSIADNYLTS 79
           +IP  I P    EL L  N    +    IF  +  L+ +   +N ++             
Sbjct: 25  KIPEHI-PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT------------- 70

Query: 80  STPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
              E +F    S    ++   L++N L  +  +M           F              
Sbjct: 71  DIEEGAF-EGASGVNEIL---LTSNRLENVQHKM-----------FK------------- 102

Query: 140 IGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKL 197
              L +L  + L  N++   +   +   L  ++ + L DN++  T+    F  L  L  L
Sbjct: 103 --GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158

Query: 198 DLGGN 202
           +L  N
Sbjct: 159 NLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 30/133 (22%), Positives = 46/133 (34%), Gaps = 26/133 (19%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLG 200
            L  L  I    NK+             +  + L  N+LE  + + +F  L  L  L L 
Sbjct: 55  KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113

Query: 201 GNKLSGSILT-CFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIG 259
            N+++  +    F  L+S+R LSL                        N  ++V P    
Sbjct: 114 SNRIT-CVGNDSFIGLSSVRLLSLYD----------------------NQITTVAPGAFD 150

Query: 260 SLKDLQYLFLGYN 272
           +L  L  L L  N
Sbjct: 151 TLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 24/137 (17%), Positives = 47/137 (34%), Gaps = 28/137 (20%)

Query: 196 KLDLGGNKLSG-SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
           +L L  N+ +       F  L  LR ++ S N                        + + 
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNN----------------------KITDIE 73

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL-LLEKLSYL 312
                    +  + L  N L+ ++   +   L SLK+L   +N ++  +       LS +
Sbjct: 74  EGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV 131

Query: 313 EHLNLSFNKLEGEIPKG 329
             L+L  N++   +  G
Sbjct: 132 RLLSLYDNQIT-TVAPG 147

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 36/194 (18%), Positives = 74/194 (38%), Gaps = 38/194 (19%)

Query: 429 ENNLIGKGGFGTIYKSR---IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYR 481
           E   +G+G +G +YK++     D  + A+K              +    E  +++ + + 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHP 78

Query: 482 NLVK---IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---- 534
           N++    +  S ++ +   L+ ++  H  L               +  + +    V    
Sbjct: 79  NVISLQKVFLSHADRKVW-LLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 535 ------LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH----LSDFGITKLLIGEDQSMTQ 584
                 + YLH N+   V+H DLKP+N+L+           ++D G  +L     + +  
Sbjct: 135 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 585 -TQTLATIGYIAPE 597
               + T  Y APE
Sbjct: 192 LDPVVVTFWYRAPE 205

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 41/218 (18%), Positives = 82/218 (37%), Gaps = 43/218 (19%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F    +IG+G F  +   ++    +V A+K+  +      K  ++ C     +++ +   
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMID---------- 530
           R + ++  +  +E +  LV+E+   G L          L +  +    I           
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAE 170

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +   ++ +H       +H D+KP N+LLD     H  L+DFG    L  +    +    +
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AV 224

Query: 589 ATIGYIAPEYGREGRVFANGDVY-------SFGIMLME 619
            T  Y++PE  +          Y       + G+   E
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 14/173 (8%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI----ECEIMKSIHYRNLVK 485
             IG+G +G +YK+R    G  VA+K   L      +        E  ++K +++ N+VK
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVK 66

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++     E    LV E +    L+K + +S    + +    + +  +   L + H +   
Sbjct: 67  LLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-- 123

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
            V+H DLKP N+L++      L+DFG+ +      ++   T  + T+ Y APE
Sbjct: 124 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 38/240 (15%)

Query: 406 MPPKATWRR-FSYLEVCRATYG----FNENNLIGKGGFGTIYKSR-IGDGMEVAVK---- 455
           M  ++     F  +E+  +T+     +     IG G  G +  +        VA+K    
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 456 VF--HLQCGRAFKSFDIECEIMKSIHYRNLVKI----ISSCSNEEFKE--LVLEHMP--- 504
            F       RA++    E  +MK ++++N++ +        S EEF++  +V+E M    
Sbjct: 61  PFQNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116

Query: 505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA 564
              ++  L        ++Q L         +++LH      +IH DLKPSN+++      
Sbjct: 117 CQVIQMELDHERMSYLLYQMLC-------GIKHLHSA---GIIHRDLKPSNIVVKSDCTL 166

Query: 565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            + DFG+ +       S   T  + T  Y APE         N D++S G ++ E+    
Sbjct: 167 KILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 47/209 (22%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI------ECEIMKSIHYRNLV 484
            +G+G +G +  +        VAVK+  ++     ++ D       E  I K +++ N+V
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 485 KI--ISSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLNIMI 529
           K        N ++  L LE+   G L             +   +        F +L    
Sbjct: 69  KFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL---- 114

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
              + + YLH      + H D+KP N+LLD+     +SDFG+  +    ++     +   
Sbjct: 115 --MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 590 TIGYIAPE-YGREGRVFANGDVYSFGIML 617
           T+ Y+APE   R        DV+S GI+L
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 9/94 (9%)

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVK 193
           GIP       ++T +YL GN+    +P  L   + L  + L +N++  T+    F  + +
Sbjct: 28  GIP------RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 194 LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND 227
           L  L L  N+L       F  L SLR LSL  ND
Sbjct: 80  LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND 113

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 10/96 (10%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKL 194
           +P+E+ N  +LT I L  N+++     +   + +L  + L  N+L   IP   F  L  L
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104

Query: 195 YKLDLGGNKLS----GSILTCFSNLASLRTLSLSYN 226
             L L GN +S    G+    F++L++L  L++  N
Sbjct: 105 RLLSLHGNDISVVPEGA----FNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 35/138 (25%), Positives = 51/138 (36%), Gaps = 31/138 (22%)

Query: 160 IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
           IP  + EL       L  N+    +P ++     L  +DL  N++S      FSN+  L 
Sbjct: 29  IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 220 TLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP 279
           TL LSY                      N    + P T   LK L+ L L  N +   +P
Sbjct: 82  TLILSY----------------------NRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

Query: 280 DSVGD-LISLKSLNFSNN 296
           +   + L +L  L    N
Sbjct: 119 EGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 6/88 (6%)

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAI 302
               N F+  +P  + + K L  + L  N +  ++ +     +  L +L  S N L   I
Sbjct: 37  YLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 303 PL-LLEKLSYLEHLNLSFNKLEGEIPKG 329
           P    + L  L  L+L  N +   +P+G
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 8e-06
 Identities = 37/111 (33%), Positives = 50/111 (45%), Gaps = 11/111 (9%)

Query: 216 ASLRTLSLSYNDGPL-PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL 274
             +  L L  N   L P E+ N K L  ID S N  S++   +  ++  L  L L YN L
Sbjct: 31  RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90

Query: 275 KGSIPDSVGD-LISLKSLNFSNNNLS----GAIPLLLEKLSYLEHLNLSFN 320
           +  IP    D L SL+ L+   N++S    GA       LS L HL +  N
Sbjct: 91  R-CIPPRTFDGLKSLRLLSLHGNDISVVPEGA----FNDLSALSHLAIGAN 136

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 51/206 (24%), Positives = 73/206 (35%), Gaps = 44/206 (21%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            IG G FG     R       VAVK             +    E    +S+ + N+V+  
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82

Query: 488 SSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLNIMIDVASV 534
                     +++E+   G L             E   +        FQ+L       S 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF--------FQQL------LSG 128

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL--SDFGITKLLIGEDQSMTQTQTLATIG 592
           + Y H      + H DLK  N LLD +    L   DFG +K       S  ++ T+ T  
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKS-TVGTPA 182

Query: 593 YIAPE-YGREGRVFANGDVYSFGIML 617
           YIAPE   R+       DV+S G+ L
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTL 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 46/208 (22%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +G G FG +   +    G +VAVK+ +   ++          E + +K   + +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 488 SSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLNIMIDVASV 534
              S      +V+E++  G L             E            FQ++       S 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL--------FQQI------LSG 128

Query: 535 LEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI--- 591
           ++Y H +    V+H DLKP NVLLD  M A ++DFG++ +       M+  + L T    
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGS 178

Query: 592 -GYIAPE-YGREGRVFANGDVYSFGIML 617
             Y APE            D++S G++L
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 37/236 (15%)

Query: 405 NMPPKATWRRFSYLEVCRATY----GFNENNLIGKGGFGTIYKSR-IGDGMEVAVK---- 455
           NM       +F  +EV  +T+     +     IG G  G +  +        VA+K    
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 456 VF--HLQCGRAFKSFDIECEIMKSIHYRNLVKII----SSCSNEEFKE--LVLEHMP--- 504
            F       RA++    E  +MK ++++N++ ++       + EEF++  LV+E M    
Sbjct: 98  PFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153

Query: 505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA 564
              ++  L        ++Q L         +++LH      +IH DLKPSN+++      
Sbjct: 154 CQVIQMELDHERMSYLLYQMLC-------GIKHLHSA---GIIHRDLKPSNIVVKSDCTL 203

Query: 565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
            + DFG+ +   G    M  T  + T  Y APE         N D++S G ++ E+
Sbjct: 204 KILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 47/209 (22%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI------ECEIMKSIHYRNLV 484
            +G+G +G +  +        VAVK+  ++     ++ D       E  I K +++ N+V
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 485 KI--ISSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLNIMI 529
           K        N ++  L LE+   G L             +   +        F +L    
Sbjct: 69  KFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRF--------FHQL---- 114

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA 589
              + + YLH      + H D+KP N+LLD+     +SDFG+  +    ++     +   
Sbjct: 115 --MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 590 TIGYIAPE-YGREGRVFANGDVYSFGIML 617
           T+ Y+APE   R        DV+S GI+L
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVL 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 31/206 (15%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F+    +G G FG +   +  +     A+K+  L   +  K   IE       I++++++
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
             LVK+  S  +     +V+E++  G +   L       +   R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHS 159

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE-- 597
                +I+ DLKP N+L+D      ++DFG  K + G      +T TL  T   +APE  
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEII 210

Query: 598 ----YGREGRVFANGDVYSFGIMLME 619
               Y +   V    D ++ G+++ E
Sbjct: 211 LSKGYNKA--V----DWWALGVLIYE 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 20/190 (10%)

Query: 421 CRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGR-AFKSFDI-ECEIMK 476
           CRA   +     IG+G +G ++K+R     G  VA+K   +Q G        I E  +++
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 477 SIHYR------NLVKIISSCSNEEFKE--LVLEHMPHGSLEKCLYS-SNCILDIFQRLNI 527
            +          L  + +    +   +  LV EH+    L   L       +      ++
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
           M  +   L++LH +    V+H DLKP N+L+  +    L+DFG+ ++       M  T  
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 179

Query: 588 LATIGYIAPE 597
           + T+ Y APE
Sbjct: 180 VVTLWYRAPE 189

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 35/151 (23%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK----VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           IG G +G + ++    +   VA+K    VF   + C R  +    E  I+  +++ ++VK
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVK 116

Query: 486 ---IISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH- 539
              I+     E+F E  +VLE       +K   +   + ++  +  ++ ++   ++Y+H 
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHS 174

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
                 ++H DLKP+N L++      + DFG
Sbjct: 175 AG----ILHRDLKPANCLVNQDCSVKVCDFG 201

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 53/219 (24%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIEC-----EIMKSIHY 480
           F    L+GKG FG +   +    G   A+K+  L+        ++        ++++  +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL-----------EK--CLYSSNCILDIFQRLNI 527
             L  +  S    +    V+E+   G L           E     Y +            
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA------------ 255

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
             ++ S L+YLH      V++ DLK  N++LD      ++DFG+ K  I +  +    +T
Sbjct: 256 --EIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKT 308

Query: 588 L-ATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
              T  Y+APE      YGR   V    D +  G+++ E
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 341

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 45/207 (21%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKII 487
            +G+G FG +  +       +VA+K      L+        + E   +K + + +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 488 SSCSNEEFKELVLEH---------MPHGSL---EKCLYSSNCILDIFQRLNIMIDVASVL 535
              +      +V+E+         +    +   E   +        FQ++         +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRF--------FQQI------ICAI 121

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI---- 591
           EY H +    ++H DLKP N+LLDD +   ++DFG++ +       MT    L T     
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSP 171

Query: 592 GYIAPE-YGREGRVFANGDVYSFGIML 617
            Y APE    +       DV+S GI+L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVL 198

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 11/146 (7%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSC 490
           IG G FG IY  + I  G EVA+K+  ++         IE +I K +     +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
           +  ++  +V+E +   SLE      +    +   L +   + S +EY+H       IH D
Sbjct: 75  AEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF---IHRD 130

Query: 551 LKPSNVLL---DDTMVAHLSDFGITK 573
           +KP N L+       + ++ DFG+ K
Sbjct: 131 VKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 39/205 (19%)

Query: 413 RRFSYLEVCRATY----GFNENNLIGKGGFGTIYKSR-IGDGMEVAVK----VFH--LQC 461
           + F   +V +  +     +     +G G +G++  +     G +VA+K     F   +  
Sbjct: 8   KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA 67

Query: 462 GRAFKSFDIECEIMKSIHYRNLVKI----ISSCSNEEFKE--LVLEHMP---HGSLEKCL 512
            RA++    E  ++K + + N++ +      + S   F +  LV+  M       +    
Sbjct: 68  KRAYR----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF 123

Query: 513 YSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT 572
                   ++Q L         L+Y+H      V+H DLKP N+ +++     + DFG+ 
Sbjct: 124 SEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA 173

Query: 573 KLLIGEDQSMTQTQTLATIGYIAPE 597
           +     D  M  T  + T  Y APE
Sbjct: 174 R---HADAEM--TGYVVTRWYRAPE 193

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 57.6 bits (140), Expect = 4e-09
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 54/214 (25%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIEC-----EIMKSIHYRNLVK 485
           L+GKG FG +   R    G   A+K+  L+        ++        ++++  +  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 486 IISSCSNEEFKELVLEHMPHGSL-----------EK--CLYSSNCILDIFQRLNIMIDVA 532
           +  +    +    V+E+   G L           E+    Y +              ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 533 SVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-ATI 591
           S LEYLH      V++ D+K  N++LD      ++DFG+ K  I +  +    +T   T 
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 592 GYIAPE------YGREGRVFANGDVYSFGIMLME 619
            Y+APE      YGR   V    D +  G+++ E
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYE 197

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 43/190 (22%), Positives = 73/190 (38%), Gaps = 44/190 (23%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVK-VF--HLQCGRAFKSFDIECEIMK---SIHYRNLVK 485
            G+G FGT+   +    GM VA+K V        R       E +IM+    +H+ N+V+
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLAVLHHPNIVQ 83

Query: 486 ---IISSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV---- 534
                 +    + ++    +V+E++P       L+        + R  +      +    
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR---CCRNYYRRQVAPPPILIKVFL 135

Query: 535 ------LEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQT 587
                 +  LH   +  V H D+KP NVL++       L DFG  K L    +       
Sbjct: 136 FQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN--VAY 191

Query: 588 LATIGYIAPE 597
           + +  Y APE
Sbjct: 192 ICSRYYRAPE 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 15/149 (10%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSC 490
           IG G FG +     +     VA+K+  ++         +E    K +     + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 491 SNEEFKELVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
              ++  +VLE +  G SLE      +    +   L I I + S +EY+H   L   I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IYR 129

Query: 550 DLKPSNVLL-----DDTMVAHLSDFGITK 573
           D+KP N L+         V H+ DF + K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 28/148 (18%), Positives = 57/148 (38%), Gaps = 13/148 (8%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSC 490
           IG+G FG I++   + +  +VA+K    +          E    K +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
                  LV++ +   SLE  L        +         + + ++ +H   L   ++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VYRD 131

Query: 551 LKPSNVLL-----DDTMVAHLSDFGITK 573
           +KP N L+      +  + ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK---VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK- 485
           IG+G +G +  +    + + VA+K    F     C R  +    E +I+    + N++  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 486 --IISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
             II + + E+ K+  +V + M    L K L +   + +       +  +   L+Y+H  
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIHSA 147

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATIGYIAPE--- 597
               V+H DLKPSN+LL+ T    + DFG+ ++   +       T+ +AT  Y APE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 598 ----YGREGRVFANGDVYSFGIMLMEIHSAK 624
               Y        + D++S G +L E+ S +
Sbjct: 205 NSKGYT------KSIDIWSVGCILAEMLSNR 229

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 46/190 (24%), Positives = 64/190 (33%), Gaps = 55/190 (28%)

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-R 190
           V  GIP      TN   +YL  N++    P     L  L+ + L  N+L   +P  +F  
Sbjct: 34  VPAGIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS 86

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
           L +L  LDLG N+L+                        LP  +               F
Sbjct: 87  LTQLTVLDLGTNQLTV-----------------------LPSAV---------------F 108

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS 310
                     L  L+ LF+  N L   +P  +  L  L  L    N L        ++LS
Sbjct: 109 DR--------LVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159

Query: 311 YLEHLNLSFN 320
            L H  L  N
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 3/87 (3%)

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAI 302
               N  + + P    SL +L+ L+LG N L  ++P  V D L  L  L+   N L+   
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLP 104

Query: 303 PLLLEKLSYLEHLNLSFNKLEGEIPKG 329
             + ++L +L+ L +  NKL  E+P+G
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRG 130

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 11/146 (7%)

Query: 433 IGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSC 490
           IG G FG IY  + I    EVA+K+ +++          E +I + +     +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
              ++  LV++ +   SLE      +  L +   L +   + + +E++H       +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LHRD 128

Query: 551 LKPSNVLL---DDTMVAHLSDFGITK 573
           +KP N L+         ++ DFG+ K
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 34/167 (20%)

Query: 432 LIGKGGFGTIYK-SRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            IG GGFG IY         + A  V  ++          E +      Y+ + K     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKF-----YQRVAKKDCIK 97

Query: 491 SNEEFKELVLEHMPH----GSLEKCLYSSNCIL---------DIFQR---------LNIM 528
              E K+L    +P     G  E    S   ++          I  +         L + 
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGITK 573
           I +  VLEY+H N     +H D+K +N+LL   +    +L+D+G++ 
Sbjct: 158 IRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 73/240 (30%)

Query: 408 PKATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFK 466
           PK + + F  L              +G G FG ++  R   +G   A+KV  L+     +
Sbjct: 1   PKYSLQDFQILRT------------LGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVR 46

Query: 467 SFDIEC-----EIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSL-----------EK 510
              +E       ++  + +  ++++  +  + +   ++++++  G L             
Sbjct: 47  LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP 106

Query: 511 --CLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--L 566
               Y++              +V   LEYLH      +I+ DLKP N+LLD     H  +
Sbjct: 107 VAKFYAA--------------EVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKI 147

Query: 567 SDFGITKLLIGEDQSMTQTQTL-ATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           +DFG  K +         T TL  T  YIAPE      Y +   +    D +SFGI++ E
Sbjct: 148 TDFGFAKYVP------DVTYTLCGTPDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 12/94 (12%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +   LE+LH      +I+ D+K  N+LLD     H  L+DFG++K  + ++         
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-FC 221

Query: 589 ATIGYIAPE---YGREGRVFANGDVYSFGIMLME 619
            TI Y+AP+    G  G   A  D +S G+++ E
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYE 254

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 28/178 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK----VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G +G++  +     G+ VAVK     F   +   R ++    E  ++K + + N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92

Query: 486 I----ISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           +      + S EEF +  LV   M    L   +       D  Q   ++  +   L+Y+H
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 149

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
                 +IH DLKPSN+ +++     + DFG+ +        M  T  +AT  Y APE
Sbjct: 150 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TGYVATRWYRAPE 199

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 55/220 (25%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEV-AVKVFHLQCGRAFKSFDIECEIM-KSIHYRN-- 482
           FN   ++GKG FG +  S      E+ AVK+  L+     +  D+EC ++ K +      
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 483 ---LVKIISSCSNEEFKELVLEHMPHGSL-------------EKCLYSSNCILDIFQRLN 526
              L ++ S     +    V+E++  G L                 Y++           
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA----------- 449

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
              ++A  L +L       +I+ DLK  NV+LD      ++DFG+ K  I +      T+
Sbjct: 450 ---EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTK 500

Query: 587 TLA-TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           T   T  YIAPE      YG+   V    D ++FG++L E
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYE 534

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 4/93 (4%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVK 193
               +    NLT +Y+   +    +    LR L +L+ + +  + L   +  D F    +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 194 LYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           L +L+L  N L          L SL+ L LS N
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 1e-06
 Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 5/97 (5%)

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPD-SVGDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
               +   ++L  L++        +    +  L  L++L    + L    P        L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 313 EHLNLSFNKLEGEIPKGGSFGNFSAES--FEGNKLLC 347
             LNLSFN LE  +    +    S +     GN L C
Sbjct: 83  SRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 2e-06
 Identities = 13/74 (17%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 154 NKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR-LVKLYKLDLGGNKLSGSILTCF 212
                     L   + L  + +++ +    +     R L +L  L +  + L       F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 213 SNLASLRTLSLSYN 226
                L  L+LS+N
Sbjct: 77  HFTPRLSRLNLSFN 90

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 16/85 (18%), Positives = 31/85 (36%), Gaps = 2/85 (2%)

Query: 121 SLEIFDMSKCNVSGGIPEE-IGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNK 179
           +L    +        +    +  L  L  + +  + L    P       +L  + L  N 
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91

Query: 180 LEGTIPYDIFRLVKLYKLDLGGNKL 204
           LE ++ +   + + L +L L GN L
Sbjct: 92  LE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 23/121 (19%), Positives = 38/121 (31%), Gaps = 22/121 (18%)

Query: 202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL 261
              +   L       +L  L +                         +   +    +  L
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQ---------------------QHLQHLELRDLRGL 55

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK 321
            +L+ L +  + L+   PD+      L  LN S N L       ++ LS L+ L LS N 
Sbjct: 56  GELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNP 114

Query: 322 L 322
           L
Sbjct: 115 L 115

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 23/98 (23%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +A  L++LH      +I+ DLKP N+LLD+    H  L+DFG++K  I  ++      + 
Sbjct: 135 LALALDHLHSL---GIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSF 186

Query: 589 -ATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
             T+ Y+APE      + +        D +SFG+++ E
Sbjct: 187 CGTVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFE 218

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 23/151 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK----VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           IG+G +G +Y +        VA+K    +F   + C R  +    E  I+  +    +++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIR 89

Query: 486 ---IISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH- 539
              +I      +F E  +VLE      L+K   +   + +   +  I+ ++     ++H 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIHE 147

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
                 +IH DLKP+N LL+      + DFG
Sbjct: 148 SG----IIHRDLKPANCLLNQDCSVKVCDFG 174

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.5 bits (132), Expect = 4e-08
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 23/98 (23%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           ++  L +LH      +I+ DLKP N++L+     H  L+DFG+ K  I +      T T 
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTF 181

Query: 589 A-TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
             TI Y+APE      + R   V    D +S G ++ +
Sbjct: 182 CGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYD 213

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 36/166 (21%), Positives = 69/166 (41%), Gaps = 29/166 (17%)

Query: 432 LIGKGGFGTIY------KSRIGDGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIH 479
            IG+GGFG IY         +G      VKV     G      + ++      +I K I 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 480 YRNLVKI---------ISSCSNEEFKELVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMI 529
            R L  +         +   + + ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGITK 573
            +  +LEY+H +     +H D+K SN+LL+  +    +L D+G+  
Sbjct: 160 RILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 33/181 (18%), Positives = 67/181 (37%), Gaps = 33/181 (18%)

Query: 155 KLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSN 214
           +    +     +++    +      +E  +   +  L     L L  N +    ++  S 
Sbjct: 16  ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--KISSLSG 68

Query: 215 LASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL 274
           + +LR LSL  N          +K +  +D   +               L+ L++ YN +
Sbjct: 69  MENLRILSLGRN---------LIKKIENLDAVADT--------------LEELWISYNQI 105

Query: 275 KGSIPDSVGDLISLKSLNFSNNNLSGAIPLL-LEKLSYLEHLNLSFNKLEGEIPKGGSFG 333
             S+   +  L++L+ L  SNN ++    +  L  L  LE L L+ N L  +  +  +  
Sbjct: 106 A-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163

Query: 334 N 334
            
Sbjct: 164 E 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 37/159 (23%), Positives = 61/159 (38%), Gaps = 36/159 (22%)

Query: 192 VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFS 251
            +  +L      +   +    S L + + L+LS N         N++ +  +        
Sbjct: 25  AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTN---------NIEKISSLS------- 67

Query: 252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNN---LSGAIPLLLEK 308
                    +++L+ L LG N++K  I +      +L+ L  S N    LSG     +EK
Sbjct: 68  --------GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSG-----IEK 113

Query: 309 LSYLEHLNLSFNKLE--GEIPKGGSFGNFSAESFEGNKL 345
           L  L  L +S NK+   GEI K  +          GN L
Sbjct: 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 31/189 (16%), Positives = 53/189 (28%), Gaps = 52/189 (27%)

Query: 136 IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY 195
           +   +  L     + L  N +                      K+       +  +  L 
Sbjct: 40  MDATLSTLKACKHLALSTNNI---------------------EKISS-----LSGMENLR 73

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
            L LG N +   I    +   +L  L +SYN          +  L GI+           
Sbjct: 74  ILSLGRNLIK-KIENLDAVADTLEELWISYN---------QIASLSGIE----------- 112

Query: 256 TTIGSLKDLQYLFLGYN-ILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
                L +L+ L++  N I      D +  L  L+ L  + N L            Y   
Sbjct: 113 ----KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168

Query: 315 LNLSFNKLE 323
           +      L+
Sbjct: 169 VVKRLPNLK 177

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 29/165 (17%), Positives = 60/165 (36%), Gaps = 29/165 (17%)

Query: 433 IGKGGFGTIYK---------SRIGDGMEVAVKV-------FHLQ--CGRAFKSFDIECEI 474
             +   G +Y+                + ++K+       F+ Q    RA K   +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 475 -MKSIHYRNLVKIISSCSNE-EFKELVLEHMPHG-SLEKCL-YSSNCILDIFQRLNIMID 530
            + S     +   +    ++ +++ LVL  +  G SL+  L  S   +L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLL--DDTMVAHLSDFGITK 573
           +   LE+LH N     +H ++   N+ +  +D     L+ +G   
Sbjct: 168 LLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 53.8 bits (130), Expect = 8e-08
 Identities = 35/98 (35%), Positives = 47/98 (47%), Gaps = 23/98 (23%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +AS L YLH      +++ DLKP N+LLD     H  L+DFG+ K  I  + +   T T 
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTF 199

Query: 589 -ATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
             T  Y+APE      Y R   V    D +  G +L E
Sbjct: 200 CGTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYE 231

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 53.4 bits (129), Expect = 9e-08
 Identities = 34/96 (35%), Positives = 45/96 (46%), Gaps = 19/96 (19%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-A 589
           + S L +LH      +I+ DLK  NVLLD      L+DFG+ K  I    +   T T   
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           T  YIAPE      YG    V    D ++ G++L E
Sbjct: 187 TPDYIAPEILQEMLYGPA--V----DWWAMGVLLYE 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 29/184 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK---VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK- 485
           +G+G +G +  +     G  VA+K    F   L   R  +    E +I+K   + N++  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 486 --IISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
             I    S E F E  ++ E M    L + + S+  + D   +   +      ++ LH +
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLHGS 131

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ--------TQTLATIGY 593
               VIH DLKPSN+L++      + DFG+ +++       ++         + +AT  Y
Sbjct: 132 ---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 594 IAPE 597
            APE
Sbjct: 189 RAPE 192

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 19/96 (19%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-A 589
           ++  L YLH      +I+ DLK  NVLLD      L+D+G+ K  +        T T   
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG 172

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           T  YIAPE      YG    V    D ++ G+++ E
Sbjct: 173 TPNYIAPEILRGEDYGFS--V----DWWALGVLMFE 202

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 40/136 (29%), Positives = 54/136 (39%), Gaps = 27/136 (19%)

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
            LDL  N L       F  L SL  L L  N                         S+  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNK----------------------LQSLPN 69

Query: 256 TTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL-LLEKLSYLE 313
                L  L YL L  N L+ S+P+ V D L  LK L  + N L  ++P  + +KL+ L+
Sbjct: 70  GVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK 127

Query: 314 HLNLSFNKLEGEIPKG 329
            L L  N+L+  +P G
Sbjct: 128 DLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 2/86 (2%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLG 200
            LT+LT +YLGGNKL         +L  L Y+ L  N+L+ ++P  +F +L +L +L L 
Sbjct: 50  ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALN 108

Query: 201 GNKLSGSILTCFSNLASLRTLSLSYN 226
            N+L       F  L  L+ L L  N
Sbjct: 109 TNQLQSLPDGVFDKLTQLKDLRLYQN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 48/167 (28%), Positives = 64/167 (38%), Gaps = 40/167 (23%)

Query: 160 IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
           IP     L       L+ N L+         L  L +L LGGNKL       F+ L SL 
Sbjct: 26  IPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 220 TLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI-GSLKDLQYLFLGYNILKGSI 278
            L+LS N          L+ L              P  +   L  L+ L L  N L+ S+
Sbjct: 80  YLNLSTN---------QLQSL--------------PNGVFDKLTQLKELALNTNQLQ-SL 115

Query: 279 PDSVGD-LISLKSLNFSNNNL----SGAIPLLLEKLSYLEHLNLSFN 320
           PD V D L  LK L    N L     G      ++L+ L+++ L  N
Sbjct: 116 PDGVFDKLTQLKDLRLYQNQLKSVPDGV----FDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 52/185 (28%)

Query: 22  IPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST 81
           +P+ I P     L L  N+L  +      ++++L  L L  N L              S 
Sbjct: 22  VPTGI-PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-------------SL 67

Query: 82  PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG 141
           P   F + L++   L    LS N L  +              +FD               
Sbjct: 68  PNGVF-NKLTSLTYLN---LSTNQLQSLPNG-----------VFD--------------- 97

Query: 142 NLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKL 197
            LT L  + L  N+L  S+P   F   +L +L+ + L  N+L+ ++P  +F RL  L  +
Sbjct: 98  KLTQLKELALNTNQLQ-SLPDGVFD--KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYI 153

Query: 198 DLGGN 202
            L  N
Sbjct: 154 WLHDN 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 27/95 (28%), Positives = 38/95 (40%), Gaps = 11/95 (11%)

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFT--LRELQKLQYVGLKDNKLEGTIPYDIF-RL 191
            IP       + T + L  N+L   I        L  L  + LK N+L   I  + F   
Sbjct: 26  DIP------LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 192 VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
             + +L LG NK+       F  L  L+TL+L  N
Sbjct: 78  SHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 16/93 (17%)

Query: 142 NLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKL 197
            L +L  + L  N+L   I    F       +Q + L +NK++  I   +F  L +L  L
Sbjct: 52  RLPHLVKLELKRNQLT-GIEPNAF--EGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107

Query: 198 DLGGNKLS----GSILTCFSNLASLRTLSLSYN 226
           +L  N++S    GS    F +L SL +L+L+ N
Sbjct: 108 NLYDNQISCVMPGS----FEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 6/90 (6%)

Query: 243 IDFSMNNFSSVIPTTI-GSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSG 300
           +  + N    +    + G L  L  L L  N L   I  +  +    ++ L    N +  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91

Query: 301 AIPL-LLEKLSYLEHLNLSFNKLEGEIPKG 329
            I   +   L  L+ LNL  N++   +  G
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 34/131 (25%), Positives = 48/131 (36%), Gaps = 33/131 (25%)

Query: 196 KLDLGGNKLSG-SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
           +L L  N+L   S    F  L  L  L L  N                        + + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ----------------------LTGIE 70

Query: 255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLS----GAIPLLLEKL 309
           P        +Q L LG N +K  I + +   L  LK+LN  +N +S    G+     E L
Sbjct: 71  PNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGS----FEHL 125

Query: 310 SYLEHLNLSFN 320
           + L  LNL+ N
Sbjct: 126 NSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 22/77 (28%), Positives = 29/77 (37%), Gaps = 8/77 (10%)

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSYL 312
           IP           L L  N L     D +   L  L  L    N L+G  P   E  S++
Sbjct: 27  IPL------HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 313 EHLNLSFNKLEGEIPKG 329
           + L L  NK++ EI   
Sbjct: 81  QELQLGENKIK-EISNK 96

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 31/96 (32%), Positives = 44/96 (45%), Gaps = 19/96 (19%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-A 589
           ++  L YLH      +I+ DLK  NVLLD      L+D+G+ K  +        T T   
Sbjct: 162 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG 215

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           T  YIAPE      YG    V    D ++ G+++ E
Sbjct: 216 TPNYIAPEILRGEDYGFS--V----DWWALGVLMFE 245

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 52/340 (15%), Positives = 108/340 (31%), Gaps = 78/340 (22%)

Query: 31  LEELLLGQNNL----VGVVPAAIFDVSTLKDLALQDNYLS-GSLSSIADNYLTSSTPELS 85
           +E   L  + +       V A + +  ++K++ L  N +   +   +++           
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSE----------- 54

Query: 86  FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTN 145
              ++++ K L +   S+     +   +                      + + +     
Sbjct: 55  ---NIASKKDLEIAEFSDIFTGRVKDEIPEALRL----------------LLQALLKCPK 95

Query: 146 LTAIYLGGNKL--NGSIPFT--LRELQKLQYVGLKDNKL-------------EGTIPYDI 188
           L  + L  N        P    L +   L+++ L +N L             E  +    
Sbjct: 96  LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKA 155

Query: 189 FRLVKLYKLDLGGNKLSG----SILTCFSNLASLRTLSLSYND-------GPLPLEIGNL 237
                L  +  G N+L           F +   L T+ +  N          L   +   
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215

Query: 238 KVLIGIDFSMNNFS----SVIPTTIGSLKDLQYLFLGYNIL--KGSIP----DSVGDLIS 287
           + L  +D   N F+    S +   + S  +L+ L L   +L  +G+       S  + I 
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275

Query: 288 LKSLNFSNNNLS--GAIPL---LLEKLSYLEHLNLSFNKL 322
           L++L    N +       L   + EK+  L  L L+ N+ 
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 29/130 (22%), Positives = 45/130 (34%), Gaps = 24/130 (18%)

Query: 217 SLRTLSLSYND------GPLPLEIGNLKVLIGIDFSMNNFS----SVIPTTIGSLKDLQY 266
           S+   SL  +         +   +     +  I  S N         +   I S KDL+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 267 LFLGYNI---LKGSIPDSVGDLI-------SLKSLNFSNNNLS--GAIPL--LLEKLSYL 312
                     +K  IP+++  L+        L ++  S+N        PL   L K + L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 313 EHLNLSFNKL 322
           EHL L  N L
Sbjct: 125 EHLYLHNNGL 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 8/96 (8%)

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-R 190
           V  GIP      ++ T + L  NKL         +L +L  + L  N+++ ++P  +F +
Sbjct: 22  VPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           L KL  L L  NKL       F  L  L+ L+L  N
Sbjct: 75  LTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 143 LTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLD 198
           LT LT + L  N++  S+P   F   +L KL  + L +NKL+ ++P  +F +L +L +L 
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFD--KLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELA 106

Query: 199 LGGNKLSGSILTCFSNLASLRTLSLSYN 226
           L  N+L       F  L SL+ + L  N
Sbjct: 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 8e-06
 Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 5/88 (5%)

Query: 244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAI 302
           +   N   S+       L  L  L L  N ++ S+PD V D L  L  L    N L  ++
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 303 PL-LLEKLSYLEHLNLSFNKLEGEIPKG 329
           P  + +KL+ L+ L L  N+L+  +P G
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 35/127 (27%), Positives = 50/127 (39%), Gaps = 26/127 (20%)

Query: 196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
           +L+L  NKL       F  L  L  LSLS N          ++ L              P
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ---------IQSL--------------P 68

Query: 256 TTI-GSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSYLE 313
             +   L  L  L+L  N L+ S+P+ V D L  LK L    N L      + ++L+ L+
Sbjct: 69  DGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ 127

Query: 314 HLNLSFN 320
            + L  N
Sbjct: 128 KIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 25/77 (32%), Positives = 35/77 (45%), Gaps = 9/77 (11%)

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLLEKLSYL 312
           IP+          L L  N L+ S+P  V D L  L  L+ S N +      + +KL+ L
Sbjct: 26  IPS------SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78

Query: 313 EHLNLSFNKLEGEIPKG 329
             L L  NKL+  +P G
Sbjct: 79  TILYLHENKLQ-SLPNG 94

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 19/96 (19%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTL-A 589
           +A  L +L       +I+ DLK  NV+LD      ++DFG+ K  I +      T+T   
Sbjct: 130 IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 183

Query: 590 TIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
           T  YIAPE      YG+   V    D ++FG++L E
Sbjct: 184 TPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYE 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 23/98 (23%)

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTL 588
           +   L++LH      +++ DLK  N+LLD     H  ++DFG+ K  +  D     T T 
Sbjct: 127 IILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTF 178

Query: 589 -ATIGYIAPE------YGREGRVFANGDVYSFGIMLME 619
             T  YIAPE      Y          D +SFG++L E
Sbjct: 179 CGTPDYIAPEILLGQKYNHS------VDWWSFGVLLYE 210

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 37/204 (18%), Positives = 70/204 (34%), Gaps = 46/204 (22%)

Query: 433 IGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIIS--- 488
           +G G FG + +    + G   A+K          +    E +IMK + + N++K++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYL---------- 538
           +  +EE K        +    K    +N    +    +    +  ++EY+          
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 539 -----------HFNFLV-------------PVIHCDLKPSNVLLD-DTMVAHLSDFGITK 573
                        +  +              + H D+KP N+L++       L DFG  K
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK 190

Query: 574 LLIGEDQSMTQTQTLATIGYIAPE 597
            LI   +       + +  Y APE
Sbjct: 191 KLI-PSEPS--VAYICSRFYRAPE 211

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 3e-07
 Identities = 37/218 (16%), Positives = 76/218 (34%), Gaps = 34/218 (15%)

Query: 126 DMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN---------GSIPFTLRELQKLQYVGLK 176
                +++ GI E      +   ++ G                +   L  +  L  + +K
Sbjct: 121 GEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIK 180

Query: 177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILT--CFSNLASLRTLSLSYNDGPLPLEI 234
                  +         L  L++    L  S++     S+L +L  L L           
Sbjct: 181 GT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVE------ 231

Query: 235 GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGD---LISLKSL 291
                  G D  MN F  +         +L++L +     +  + +   +   L  L+++
Sbjct: 232 -----DYGFDGDMNVFRPLFSKD--RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 292 NFSNNNLS--GAIPLL--LEKLSYLEHLNLSFNKLEGE 325
           + S   L+  GA  LL  ++K+ +L+ +N+ +N L  E
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 38/230 (16%), Positives = 83/230 (36%), Gaps = 64/230 (27%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSI--------HYR 481
            +G G F T++ ++ + +   VA+K+  ++  + + ++ + E ++++ +           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKC----LYSSNCILDIFQRLN----------- 526
               I+    +   K     H+            +   N  L    +             
Sbjct: 84  GANHILKLLDHFNHKGPNGVHV-------VMVFEVLGEN--LLALIKKYEHRGIPLIYVK 134

Query: 527 -IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH------LSDFGITKLLIGED 579
            I   +   L+Y+H      +IH D+KP NVL++            ++D G        D
Sbjct: 135 QISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYD 189

Query: 580 QSMTQT-QTLATIGYIAPE------YGREGRVFANGDVYSFGIMLMEIHS 622
           +  T + QT     Y +PE      +G         D++S   ++ E+ +
Sbjct: 190 EHYTNSIQTRE---YRSPEVLLGAPWG------CGADIWSTACLIFELIT 230

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 40/186 (21%), Positives = 76/186 (40%), Gaps = 31/186 (16%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK--VF--HLQCGRAFKSFDIECEIMKSIHYRNLVKII 487
           +G GG G ++ +        VA+K  V         A +    E +I++ + + N+VK+ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 488 ------------SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
                          S  E     +V E+M    L   L     + +  +    M  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLR 131

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQ-TQTLATI 591
            L+Y+H      V+H DLKP+N+ ++ + +V  + DFG+ +++          ++ L T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 592 GYIAPE 597
            Y +P 
Sbjct: 189 WYRSPR 194

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 28/178 (15%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVK----VF--HLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G +G +  +     G +VA+K     F   L   RA++    E  ++K + + N++ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88

Query: 486 II----SSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           ++       + ++F +  LV+  M    L K +      L   +   ++  +   L Y+H
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH 145

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
                 +IH DLKP N+ +++     + DFG+ +     D  M  T  + T  Y APE
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWYRAPE 195

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.0 bits (121), Expect = 6e-07
 Identities = 32/200 (16%), Positives = 55/200 (27%), Gaps = 54/200 (27%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHL--------QCGRAFKSFDI 470
             C  T        IG+G FG ++++   D   VA+K+  +           + F+    
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 471 ECEIMKSIHYRNLVKIISSCSNEEFKE--------------------------------- 497
           E  I K +   +      +                                         
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 498 ------LVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
                 +VLE    G  LE+       +  +    +I+  + + L     +      H D
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASL--RFEHRD 187

Query: 551 LKPSNVLLDDTMVAHLSDFG 570
           L   NVLL  T +  L    
Sbjct: 188 LHWGNVLLKKTSLKKLHYTL 207

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 28/131 (21%), Positives = 43/131 (32%), Gaps = 26/131 (19%)

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
            V+  +LDL G K+   I    + L     +  S N          ++ L G        
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN---------EIRKLDGFP------ 61

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL-LEKL 309
                     L+ L+ L +  N +          L  L  L  +NN+L     L  L  L
Sbjct: 62  ---------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112

Query: 310 SYLEHLNLSFN 320
             L +L +  N
Sbjct: 113 KSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 1e-05
 Identities = 24/112 (21%), Positives = 36/112 (32%), Gaps = 25/112 (22%)

Query: 212 FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGY 271
           ++N    R L L     P    I NL                      +L     +    
Sbjct: 15  YTNAVRDRELDLRGYKIP---VIENLGA--------------------TLDQFDAIDFSD 51

Query: 272 NILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE 323
           N ++  + D    L  LK+L  +NN +      L + L  L  L L+ N L 
Sbjct: 52  NEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 29/138 (21%), Positives = 43/138 (31%), Gaps = 30/138 (21%)

Query: 138 EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN---KLEGTIPYDIFRLVKL 194
            +  N      + L G K+   I      L +   +   DN   KL+G        L +L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRL 66

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
             L +  N++          L  L  L L+ N       +  L  L              
Sbjct: 67  KTLLVNNNRICRIGEGLDQALPDLTELILTNN------SLVELGDL-------------- 106

Query: 255 PTTIGSLKDLQYLFLGYN 272
              + SLK L YL +  N
Sbjct: 107 -DPLASLKSLTYLCILRN 123

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 39/303 (12%), Positives = 94/303 (31%), Gaps = 37/303 (12%)

Query: 29  HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS 88
            NL+ L L +   +  +   +     L++L        G  ++     + S         
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGT------GGYTAEVRPDVYSG-----LSV 259

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG-GIPEEIGNLTNLT 147
           +LS CK L       + +   LP  ++ ++   L   ++S   V    + + +     L 
Sbjct: 260 ALSGCKELRCLSGFWDAVPAYLP--AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQ 317

Query: 148 AIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF----------RLVKLYKL 197
            +++     +  +       + L+ + +  ++     P                 KL  +
Sbjct: 318 RLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESV 377

Query: 198 DLGGNKLSGSILTCFS-NLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT 256
                +++ + L   + N  ++    L   +   P  +    + IG    + +       
Sbjct: 378 LYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC------ 431

Query: 257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGA-IPLLLEKLSYLEHL 315
                KDL+ L L   +              ++ L+ +    S   +  +L     L  L
Sbjct: 432 -----KDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486

Query: 316 NLS 318
            + 
Sbjct: 487 EIR 489

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 39/273 (14%), Positives = 97/273 (35%), Gaps = 22/273 (8%)

Query: 67  GSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPR--MSIGNLSHSLEI 124
           G+  +++   +    P++  +  L        F L  +   G +     ++ +    LE 
Sbjct: 51  GNCYAVSPATVIRRFPKVRSVE-LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE 109

Query: 125 FDMSKCNVSGGIPEEIG-NLTNLTAIYLGGNKL--NGSIPFTLRELQKLQYVGLKDNKLE 181
             + +  V+    E I  +  N   + L   +      +       + L+ + L+++ ++
Sbjct: 110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVD 169

Query: 182 GTIPYDIFRLVK----LYKLDLGG--NKLSGSILTCF-SNLASLRTLSLSYNDG-----P 229
               + +         L  L++    +++S S L    +   +L++L L+          
Sbjct: 170 DVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLAT 229

Query: 230 LPLEIGNLKVLIGIDFSM---NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI 286
           L      L+ L    ++     +  S +   +   K+L+ L   ++ +   +P       
Sbjct: 230 LLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289

Query: 287 SLKSLNFSNNNLSG-AIPLLLEKLSYLEHLNLS 318
            L +LN S   +    +  LL +   L+ L + 
Sbjct: 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.5 bits (111), Expect = 4e-06
 Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 8/96 (8%)

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-R 190
           V  GIP      T    +YL  N++    P     L +L  + L +N+L   +P  +F +
Sbjct: 24  VPTGIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDK 76

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           L +L +L L  N+L       F NL SL  + L  N
Sbjct: 77  LTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 14/85 (16%)

Query: 250 FSSV---IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL- 304
            +SV   IPT        Q L+L  N +   +   V D L  L  L+  NN L+  +P  
Sbjct: 21  LASVPTGIPT------TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAG 72

Query: 305 LLEKLSYLEHLNLSFNKLEGEIPKG 329
           + +KL+ L  L+L+ N+L+  IP+G
Sbjct: 73  VFDKLTQLTQLSLNDNQLKS-IPRG 96

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 5e-06
 Identities = 28/111 (25%), Positives = 40/111 (36%), Gaps = 6/111 (5%)

Query: 214 NLASLRTLSLSYNDGPLPLEIGN---LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG 270
             A++R L L           G       L  +        SV  + +  L  L+ L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL-LEKLSYLEHLNLSFN 320
            N + G +      L +L  LN S N L     L  L+KL  L+ L+L   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 2/76 (2%)

Query: 248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE 307
            +    I        +L++L L    L  S+  ++  L  LK L  S N + G + +L E
Sbjct: 35  KSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 308 KLSYLEHLNLSFNKLE 323
           KL  L HLNLS NKL+
Sbjct: 93  KLPNLTHLNLSGNKLK 108

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 22/149 (14%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIEC-----EIMKSIHYR---NL 483
           +GKG +G ++KS     G  VAVK    +   AF++   +      EIM         N+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK----KIFDAFQN-STDAQRTFREIMILTELSGHENI 71

Query: 484 VKIISSCSNEEFKE--LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           V +++    +  ++  LV ++M    L   + ++  IL+   +  ++  +  V++YLH  
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFG 570
               ++H D+KPSN+LL+      ++DFG
Sbjct: 129 ---GLLHRDMKPSNILLNAECHVKVADFG 154

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 48.0 bits (114), Expect = 8e-06
 Identities = 48/339 (14%), Positives = 105/339 (30%), Gaps = 46/339 (13%)

Query: 27  NPHNLEELLLGQNNLVGVVPAAIFDVST----LKDLALQDNY---------LSGSLSSIA 73
           +  +LE L         + P  +  ++     L  + + D            + +L    
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFC 249

Query: 74  DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN-V 132
              L           +L   + L    LS    N +     +   +  +   D+      
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM---PILFPFAAQIRKLDLLYALLE 306

Query: 133 SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRL- 191
           +      I    NL  +       +  +    +  ++L+ + ++    E  +  +   + 
Sbjct: 307 TEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS 366

Query: 192 -----------VKLYKLDLGGNKLS----GSILTCFSNLASLRTLSLSYNDG--PLPLEI 234
                       +L  + +  + ++     SI T   NL   R + L   +    LPL+ 
Sbjct: 367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426

Query: 235 G------NLKVLIGIDFSMN--NFSSVIPTTIGSL-KDLQYLFLGY-NILKGSIPDSVGD 284
           G        K L    F +     + +  + IG    +++++ LGY       + +    
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486

Query: 285 LISLKSLNFSNNNLS-GAIPLLLEKLSYLEHLNLSFNKL 322
             +L+ L       S  AI   + KL  L +L +   + 
Sbjct: 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 31/96 (32%), Positives = 42/96 (43%), Gaps = 8/96 (8%)

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-R 190
           V  GIP      T+   ++L  N++    P     L  LQ +    NKL   IP  +F +
Sbjct: 27  VPAGIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDK 79

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN 226
           L +L +LDL  N L       F NL SL  + L  N
Sbjct: 80  LTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 14/85 (16%)

Query: 250 FSSV---IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPL- 304
            +SV   IPT      D Q L+L  N +   +   V D L++L+ L F++N L+ AIP  
Sbjct: 24  LASVPAGIPT------DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTG 75

Query: 305 LLEKLSYLEHLNLSFNKLEGEIPKG 329
           + +KL+ L  L+L+ N L+  IP+G
Sbjct: 76  VFDKLTQLTQLDLNDNHLKS-IPRG 99

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 3/110 (2%)

Query: 212 FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGY 271
            S++  L   +   N+G L       + L  +       +S+    +  L  L+ L L  
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 272 NILKGSIPDSVGDLISLKSLNFSNNNLSG-AIPLLLEKLSYLEHLNLSFN 320
           N + G +        +L  LN S N +   +    L+KL  L+ L+L   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 2/70 (2%)

Query: 254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE 313
           +       ++L++L      L  SI + +  L  LK L  S+N +SG + +L EK   L 
Sbjct: 34  LEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91

Query: 314 HLNLSFNKLE 323
           HLNLS NK++
Sbjct: 92  HLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 25/100 (25%), Positives = 48/100 (48%), Gaps = 3/100 (3%)

Query: 142 NLTNLTAIYLGGNKLN-GSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG 200
             +++  + L  ++ N G +     E ++L+++   +  L  +I  ++ +L KL KL+L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 201 GNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVL 240
            N++SG +        +L  L+LS N       I  LK L
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 58/227 (25%), Positives = 85/227 (37%), Gaps = 72/227 (31%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKV------FHLQCGRAFKSFDIECEIMKSIHYR--- 481
           +IGKG FG + K+        VA+K+      FH Q          E  I++ +  +   
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLRKQDKD 156

Query: 482 NLVKIISSCSNEEFKE---LVLEHMPHGSLEKCLYS---SNCILDIFQRLN------IMI 529
           N + +I    N  F+    +  E      L   LY     N     FQ  +         
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNK----FQGFSLPLVRKFAH 207

Query: 530 DVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQT 587
            +   L+ LH N    +IHCDLKP N+LL     +   + DFG          S  + Q 
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG---------SSCYEHQR 255

Query: 588 LATIGYI------APE------YGREGRVFANGDVYSFGIMLMEIHS 622
           + T  YI      APE      YG         D++S G +L E+ +
Sbjct: 256 VYT--YIQSRFYRAPEVILGARYGMP------IDMWSLGCILAELLT 294

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 39/213 (18%), Positives = 86/213 (40%), Gaps = 47/213 (22%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDIECEIMKSI-HYRNLVKIIS- 488
           +G+G +  ++++  I +  +V VK+    +  +  +    E +I++++    N++ +   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 489 SCSNEEFKE-LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASV-------LEYLHF 540
                     LV EH+ +   ++          ++Q L    D+          L+Y H 
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEILKALDYCHS 148

Query: 541 NFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
                ++H D+KP NV++D +     L D+G+ +      Q       +A+  +  PE  
Sbjct: 149 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY--NVRVASRYFKGPE-- 200

Query: 600 REGRVFANG-------DVYSFGIMLMEIHSAKQ 625
               +  +        D++S G ML  +   K+
Sbjct: 201 ----LLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	652
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	100.0
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.88
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.87
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.82
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.82
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.68
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.66
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.49
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.42
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.39
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.16
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.92
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.58
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.58
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.57
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.54
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.52
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.13
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.69
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.62
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.6
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.51
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.5
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.49
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.39
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.36
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.17
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.95
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.83
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.51
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.07
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.08
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.06
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.37

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.8e-54  Score=432.64  Aligned_cols=224  Identities=23%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999865 6999999999754   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |||+||+|.+++...+ .+++.++..|+.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998755 699999999999999999999999   999999999999999999999999999997754444


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..                       .+++++.+
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence            4445567899999999999999999999999999999999999999654                       27899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++|||++|+
T Consensus       268 lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          268 LLVLDATKRLGCEEM  282 (311)
T ss_dssp             HSCSSGGGSTTSGGG
T ss_pred             HccCCHhHCcChHHH
Confidence            999999999999873

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-53  Score=436.22  Aligned_cols=221  Identities=23%  Similarity=0.264  Sum_probs=200.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..|+..+.||+|+||+||+|++. +|+.||||+++.......+.+.+|++++++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46889999999999999999875 69999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +||+|.+++...  .+++.++..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..  ....
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence            999999998764  599999999999999999999999   999999999999999999999999999987632  2223


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||..                          .+.+++.+
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            4557899999999999999999999999999999999999999643                          37889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++|||++|+
T Consensus       307 ~L~~dP~~R~ta~e~  321 (346)
T 4fih_A          307 LLVRDPAQRATAAEL  321 (346)
T ss_dssp             HSCSSTTTSCCHHHH
T ss_pred             HcCCChhHCcCHHHH
Confidence            999999999999874

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.8e-54  Score=438.55  Aligned_cols=223  Identities=19%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++..  .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999865 6999999999754  23456788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+||+|.+++...+ ..+++.++..|+.||+.||+|||++   ||+||||||+|||+++++.+||+|||+|+....  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            999999999997554 3578999999999999999999999   999999999999999999999999999986521  1


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~  636 (652)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..                        .+.+++.
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            1223456799999999999999999999999999999999999999643                        3789999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++|+
T Consensus       259 ~~L~~dP~~R~s~~e~  274 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSI  274 (350)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHccCChhHCcCHHHH
Confidence            9999999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.9e-54  Score=433.99  Aligned_cols=225  Identities=27%  Similarity=0.419  Sum_probs=197.8

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999853      478899999987666677889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEE
Q 041689          499 VLEHMPHGSLEKCLYSSN------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHL  566 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl  566 (652)
                      |||||++|+|.+++...+            ..+++.++..|+.|++.||+|||++   +|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            3689999999999999999999999   9999999999999999999999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch----------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS----------------  629 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~----------------  629 (652)
                      +|||+|+.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||..                
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~  249 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  249 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999987643332233334568999999999999999999999999999999999 8998543                


Q ss_pred             --------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                              .+.+++.+||+.||++|||++||
T Consensus       250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i  280 (299)
T 4asz_A          250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGI  280 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                    38899999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.4e-53  Score=433.55  Aligned_cols=225  Identities=26%  Similarity=0.398  Sum_probs=191.4

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677889999999999999853      478899999987666677889999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          499 VLEHMPHGSLEKCLYSSN--------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      |||||++|+|.+++....              ..+++.++..|+.|++.||+|||++   +||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            999999999999987542              2589999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--------------  629 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--------------  629 (652)
                      ||+|||+++.....+.........||+.|||||++.+..|+.++|||||||++|||+| |+.||..              
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999987644333333455679999999999999999999999999999999999 8998543              


Q ss_pred             ----------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                .+.+++.+||+.||++|||++||
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  310 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDV  310 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence                      37899999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-53  Score=425.07  Aligned_cols=224  Identities=25%  Similarity=0.391  Sum_probs=190.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..++|...+.||+|+||+||+|++.  ..||||+++..  .....+.|.+|++++++++|||||++++++.. +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            3457788899999999999999875  36999998744  23456789999999999999999999998865 5689999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |||++|+|.+++......+++.++..|+.|++.||+|||++   +||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999987766899999999999999999999999   999999999999999999999999999987643333


Q ss_pred             ccccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcch----------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------  629 (652)
                      .......+||+.|||||++.+   ++|+.++|||||||++|||+||+.||..                            
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence            333455689999999999863   4689999999999999999999999643                            


Q ss_pred             -hhhhhhcccchhhhccccCccCC
Q 041689          630 -FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       .+.+++.+||+.||++|||++||
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei  291 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQI  291 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHH
Confidence             26789999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.9e-53  Score=428.01  Aligned_cols=224  Identities=25%  Similarity=0.394  Sum_probs=195.5

Q ss_pred             CCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      +++..+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999852      46789999997543 3345789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          499 VLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      |||||++|+|.+++....               ..+++.++..|+.|||+||+|||++   +||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            999999999999996432               2589999999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch-------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-------------  629 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-------------  629 (652)
                      +||+|||+++.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||..             
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999987644333333455679999999999999999999999999999999998 8888543             


Q ss_pred             -----------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 .+.+++.+||+.||++||||+||
T Consensus       264 ~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei  297 (308)
T 4gt4_A          264 QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI  297 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                       37899999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=437.99  Aligned_cols=221  Identities=23%  Similarity=0.267  Sum_probs=201.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..|+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999865 69999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      +||+|.+++...  .+++.++..|+.||+.||+|||++   |||||||||+|||++.+|.+||+|||+|+.+...  ...
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC--Ccc
Confidence            999999998765  499999999999999999999999   9999999999999999999999999999876322  223


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|+.||..                          .+.+++.+
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            4556899999999999999999999999999999999999999643                          37899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++|||++|+
T Consensus       384 ~L~~dP~~R~ta~el  398 (423)
T 4fie_A          384 LLVRDPAQRATAAEL  398 (423)
T ss_dssp             HSCSSTTTSCCHHHH
T ss_pred             HcCCChhHCcCHHHH
Confidence            999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.9e-52  Score=413.78  Aligned_cols=220  Identities=20%  Similarity=0.297  Sum_probs=183.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ......+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999864 69999999997542   234567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+ +|+|.+++...+ .+++.++..++.|++.||+|||++   ||+||||||+|||+++++.+||+|||+|+....   
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---  164 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence            999 679999988765 799999999999999999999999   999999999999999999999999999986532   


Q ss_pred             ccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                      .......+||+.|||||++.+..| +.++||||+||++|||+||+.||..                       .+.+++.
T Consensus       165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            222345679999999999998876 5789999999999999999999654                       3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++|+
T Consensus       245 ~~L~~dP~~R~s~~ei  260 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEI  260 (275)
T ss_dssp             HHSCSSGGGSCCHHHH
T ss_pred             HHccCChhHCcCHHHH
Confidence            9999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-52  Score=415.90  Aligned_cols=216  Identities=25%  Similarity=0.359  Sum_probs=188.2

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceEEEE
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKELVL  500 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  500 (652)
                      ...+.||+|+||+||+|++. +++.||+|++...  .....+.+.+|++++++++|||||+++++|.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999865 6899999999754  23345679999999999999999999999864    35679999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeC-CCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~  577 (652)
                      |||+||+|.+++.... .+++..+..|+.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+|+... 
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence            9999999999998654 799999999999999999999998   6  99999999999998 47899999999998542 


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FV  631 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l  631 (652)
                         .......+||+.|||||++.+ +|+.++|||||||++|||+||+.||..                          .+
T Consensus       184 ---~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          184 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ---CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence               223345689999999998864 699999999999999999999999743                          26


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~  280 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDL  280 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHH
Confidence            789999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-52  Score=424.91  Aligned_cols=220  Identities=22%  Similarity=0.229  Sum_probs=191.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .+.|...++||+|+||+||+|++. +|+.||||+++.+..     ..+|++++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788899999999999999965 699999999975422     24699999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+||+|.+++...+ .+++.++..|+.|++.||+|||++   +||||||||+|||++.+| ++||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998765 699999999999999999999999   999999999999999887 6999999999876432211


Q ss_pred             c---ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhh
Q 041689          582 M---TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVF  632 (652)
Q Consensus       582 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~  632 (652)
                      .   .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..                          .+.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence            1   12345799999999999999999999999999999999999999643                          268


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       288 ~li~~~L~~dP~~R~sa~el  307 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMEL  307 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHH
Confidence            89999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.6e-52  Score=419.70  Aligned_cols=220  Identities=23%  Similarity=0.279  Sum_probs=189.2

Q ss_pred             cCCCccceeccccceEEEEEEeC----CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999852    47889999997542  2334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |||||+||+|.+++...+ .+++.++..++.|++.||+|||++   ||+||||||+|||+++++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998765 699999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLA  635 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~  635 (652)
                        .......+||+.|||||++.+..|+.++||||+||++|||+||+.||..                       .+.+++
T Consensus       180 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          180 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence              2233456799999999999999999999999999999999999999644                       378999


Q ss_pred             cccchhhhccccCcc
Q 041689          636 MECTIESLELRINAK  650 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~  650 (652)
                      .+||+.||++|||+.
T Consensus       258 ~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          258 RMLFKRNPANRLGAG  272 (304)
T ss_dssp             HHHTCSSGGGSTTCS
T ss_pred             HHHcccCHHHCCCCC
Confidence            999999999999974

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-50  Score=418.07  Aligned_cols=236  Identities=21%  Similarity=0.320  Sum_probs=202.5

Q ss_pred             cccHHHHHHHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCC-Ceeee
Q 041689          414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHY-RNLVK  485 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~  485 (652)
                      .++..+++...++|++.+.||+|+||+||+|++.      +++.||||+++... ....+.+.+|+++++++.| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            3455566667789999999999999999999853      24679999997653 3345679999999999965 89999


Q ss_pred             EEeeeecC-CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 041689          486 IISSCSNE-EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC  549 (652)
Q Consensus       486 ~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  549 (652)
                      ++|+|... +..++|||||++|+|.++++...               ..+++.++..|+.|||+||+|||++   +||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            99998664 57899999999999999997532               2588999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc
Q 041689          550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV  628 (652)
Q Consensus       550 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~  628 (652)
                      ||||+|||+++++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987644433334455679999999999999999999999999999999998 899854


Q ss_pred             h-------------------------hhhhhhcccchhhhccccCccCC
Q 041689          629 S-------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ~-------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .                         .+.+++.+||+.||++||||+||
T Consensus       290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei  338 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  338 (353)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            3                         37899999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.8e-50  Score=405.48  Aligned_cols=222  Identities=20%  Similarity=0.337  Sum_probs=180.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--------
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--------  494 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  494 (652)
                      .+|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999865 69999999997543 334567899999999999999999999986543        


Q ss_pred             ----ceEEEEEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          495 ----FKELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       495 ----~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                          +.|+|||||++|+|.+++.....  ..++..+..|+.|++.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999986543  345667889999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCc----------cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------
Q 041689          569 FGITKLLIGEDQS----------MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------  629 (652)
Q Consensus       569 fg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------  629 (652)
                      ||+|+.+......          ...+..+||+.|||||++.+..|+.++||||+||++|||++   ||..         
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9999876432211          11234579999999999999999999999999999999997   4322         


Q ss_pred             ----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                      ...+++.+||+.||++|||++||
T Consensus       239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  277 (299)
T 4g31_A          239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI  277 (299)
T ss_dssp             HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                            25679999999999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.8e-50  Score=406.64  Aligned_cols=224  Identities=23%  Similarity=0.314  Sum_probs=183.0

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----ceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----FKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  500 (652)
                      .+|...+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+.+++|||||++++++.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3577889999999999999998 689999999975432 2223445666667889999999999997654    579999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN-----FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      |||++|+|.+++...  .+++.++.+++.|++.||+|||++     +.++|+||||||+|||+++++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999875  489999999999999999999976     2458999999999999999999999999999876


Q ss_pred             cCCCCcc--ccccccCCccccCccccccC------ccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          576 IGEDQSM--TQTQTLATIGYIAPEYGREG------RVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       576 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                      .......  .....+||+.|||||++.+.      .++.++|||||||++|||+||++|+.                   
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            4333221  22345799999999998654      47889999999999999999965421                   


Q ss_pred             --------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                ..+.+++.+||+.||++||||+||
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei  288 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence                                      125689999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=405.38  Aligned_cols=223  Identities=25%  Similarity=0.270  Sum_probs=191.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec------CCc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN------EEF  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  495 (652)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999865 69999999996542  2345678899999999999999999998753      367


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+|||||+ |+|.+++...+ .+++.++..|+.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 68999987655 799999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCC--CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          576 IGED--QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       576 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      ....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.                        
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            3321  12233456899999999998775 56899999999999999999999974                        


Q ss_pred             ------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    ..+.+++.+||..||++|||++|+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  342 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA  342 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                          235689999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-47  Score=397.74  Aligned_cols=199  Identities=19%  Similarity=0.258  Sum_probs=170.1

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      +..-.++|++.+.||+|+||+||+|+.+    +++.||+|++....  ...++.+|+++++.+ +|||||++++++.+.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            3445678999999999999999999752    47789999986543  345678899999998 6999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITK  573 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~  573 (652)
                      +.|+||||+++|+|.+++.    .+++.++..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999999884    489999999999999999999999   99999999999999876 799999999998


Q ss_pred             cccCCCCc--------------------------cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCC
Q 041689          574 LLIGEDQS--------------------------MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQ  626 (652)
Q Consensus       574 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p  626 (652)
                      ........                          ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65322110                          112345799999999998775 488999999999999999999999


Q ss_pred             c
Q 041689          627 C  627 (652)
Q Consensus       627 ~  627 (652)
                      |
T Consensus       247 f  247 (361)
T 4f9c_A          247 F  247 (361)
T ss_dssp             S
T ss_pred             C
Confidence            8

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-46  Score=414.07  Aligned_cols=222  Identities=19%  Similarity=0.231  Sum_probs=200.8

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999865 69999999998765566678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC--CcEEEecccCCccccCCCCc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT--MVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~--~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +||+|.+++......+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+..   .
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~  310 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K  310 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---T
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC---C
Confidence            99999999987666899999999999999999999999   99999999999999854  8999999999997632   2


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l  634 (652)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..                           .+.+|
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            333456799999999999999999999999999999999999999643                           26889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||..||++|||++|+
T Consensus       391 i~~~L~~dp~~R~t~~e~  408 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQA  408 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHH
T ss_pred             HHHHccCChhHCcCHHHH
Confidence            999999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-46  Score=410.80  Aligned_cols=217  Identities=21%  Similarity=0.278  Sum_probs=189.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHH---HHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDI---ECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++++..   ........+   ++.+++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999865 69999999997542   112223333   456667789999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +|||||+||+|.+++...+ .+++..+..|+.||+.||+|||++   |||||||||+|||++.+|.+||+|||+|+.+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999998765 799999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------h
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------F  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~  630 (652)
                      .    .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..                          .
T Consensus       345 ~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          345 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             C----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             C----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence            2    2345689999999999865 5799999999999999999999999743                          2


Q ss_pred             hhhhhcccchhhhccccCc
Q 041689          631 VFNLAMECTIESLELRINA  649 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~  649 (652)
                      +++++.+||..||++|++.
T Consensus       421 a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTC
T ss_pred             HHHHHHHHccCCHhHCCCC
Confidence            7899999999999999984

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.2e-45  Score=420.53  Aligned_cols=352  Identities=36%  Similarity=0.532  Sum_probs=309.5

Q ss_pred             eeeceeEeccCCCcCCccCCCC-C-CCCCCCEEECCCCcCcccCCccccCCC-CCCEEEcCCCcCeeccCC---------
Q 041689            4 ISIGKLELNVDDIESPCEIPSE-I-NPHNLEELLLGQNNLVGVVPAAIFDVS-TLKDLALQDNYLSGSLSS---------   71 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~-~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~---------   71 (652)
                      ++|+.|+|+.|.+.  +++|.. + ++++|++|+|++|++++..|..+..++ +|++|+|++|++++..+.         
T Consensus       318 ~~L~~L~L~~n~l~--~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  395 (768)
T 3rgz_A          318 SLLESLALSSNNFS--GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT  395 (768)
T ss_dssp             TTCCEEECCSSEEE--EECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred             CCccEEECCCCccc--CcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence            46888888888876  367765 4 788999999999999888898888887 899999999998865443         


Q ss_pred             CccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEe
Q 041689           72 IADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL  151 (652)
Q Consensus        72 ~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  151 (652)
                      +....+..+......+..+.++++|++|+|++|++++..|. .++.+++ |+.|++++|++++.+|..|..+++|++|+|
T Consensus       396 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~-L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  473 (768)
T 3rgz_A          396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS-SLGSLSK-LRDLKLWLNMLEGEIPQELMYVKTLETLIL  473 (768)
T ss_dssp             CCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCG-GGGGCTT-CCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             ccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccH-HHhcCCC-CCEEECCCCcccCcCCHHHcCCCCceEEEe
Confidence            22222333222223445688999999999999999988887 7888886 999999999999999999999999999999


Q ss_pred             cCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CC
Q 041689          152 GGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GP  229 (652)
Q Consensus       152 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~  229 (652)
                      ++|++++..|..|.++++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|..+..+++|+.|++++|.  +.
T Consensus       474 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~  553 (768)
T 3rgz_A          474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT  553 (768)
T ss_dssp             CSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESB
T ss_pred             cCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999995  45


Q ss_pred             CCcc----------------------------------------------------------------------cCCCCc
Q 041689          230 LPLE----------------------------------------------------------------------IGNLKV  239 (652)
Q Consensus       230 ~~~~----------------------------------------------------------------------~~~l~~  239 (652)
                      +|..                                                                      ++.+++
T Consensus       554 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~  633 (768)
T 3rgz_A          554 IPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS  633 (768)
T ss_dssp             CCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBC
T ss_pred             CChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccc
Confidence            5543                                                                      445678


Q ss_pred             cceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          240 LIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       240 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      |+.|||++|++++.+|..|+++++|+.|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+..++.|++||+++
T Consensus       634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~  713 (768)
T 3rgz_A          634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN  713 (768)
T ss_dssp             CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred             ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCcccCCCCCCCCCcccccccCCccCCCCCCCCCCCCCCccc
Q 041689          320 NKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVPPCKTSIH  362 (652)
Q Consensus       320 N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~~~~~~~~~~~~  362 (652)
                      |+++|.+|..+.+..+....+.||+..||.|.   .+|....+
T Consensus       714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~~  753 (768)
T 3rgz_A          714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSNA  753 (768)
T ss_dssp             SEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC-
T ss_pred             CcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCcc
Confidence            99999999999999999999999999999874   37865543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.4e-44  Score=362.56  Aligned_cols=222  Identities=26%  Similarity=0.341  Sum_probs=199.5

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999986 46899999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++|+|.+++...  .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++......  ..
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS  171 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--cc
Confidence            9999999999765  489999999999999999999999   9999999999999999999999999999865322  22


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAM  636 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~  636 (652)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||..                          .+.+++.
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            23455799999999999999999999999999999999999999633                          2688999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++|+
T Consensus       252 ~~l~~dp~~Rps~~el  267 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKEL  267 (297)
T ss_dssp             HHSCSSTTTSCCHHHH
T ss_pred             HHccCChhHCcCHHHH
Confidence            9999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-43  Score=364.91  Aligned_cols=223  Identities=23%  Similarity=0.281  Sum_probs=198.2

Q ss_pred             HhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ...+|++.+.||+|+||.||+|++ .+|+.||||++...  .....+.+.+|++++++++||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346799999999999999999987 47999999999754  233456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.....  
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS--
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC--
Confidence            99999999999987654 689999999999999999999999   999999999999999999999999999986532  


Q ss_pred             CccccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~  635 (652)
                       .......+||+.|+|||++.+..++ .++||||+||++|||++|+.||+                       ..+.+++
T Consensus       167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  245 (328)
T 3fe3_A          167 -GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL  245 (328)
T ss_dssp             -SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             -CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence             2234456799999999999888775 78999999999999999999974                       3478999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||..||++|||++||
T Consensus       246 ~~~L~~dP~~R~t~~ei  262 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQI  262 (328)
T ss_dssp             HHHCCSSTTTSCCHHHH
T ss_pred             HHHCCCChhHCcCHHHH
Confidence            99999999999999874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-43  Score=367.07  Aligned_cols=242  Identities=33%  Similarity=0.507  Sum_probs=212.5

Q ss_pred             CccccccHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          410 ATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       410 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      ....+++..++....++|++.+.||+|+||.||+|+..+|+.||||++..... .....+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34567899999999999999999999999999999988899999999975532 23347899999999999999999999


Q ss_pred             eeecCCceEEEEEccCCCChhhhhhcCCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEE
Q 041689          489 SCSNEEFKELVLEHMPHGSLEKCLYSSNC---ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAH  565 (652)
Q Consensus       489 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~k  565 (652)
                      ++...+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+++.+||+||||||+||++++++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999976542   489999999999999999999998777999999999999999999999


Q ss_pred             EecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------
Q 041689          566 LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------  628 (652)
Q Consensus       566 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------  628 (652)
                      |+|||+++..... .........||+.|+|||++.+..++.++||||+||++|||++|+.||+                 
T Consensus       175 l~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999999865322 2223344569999999999988999999999999999999999999985                 


Q ss_pred             -------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                               ..+.+++.+||+.||++|||++||
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  302 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV  302 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence                                     347789999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-43  Score=366.40  Aligned_cols=236  Identities=35%  Similarity=0.541  Sum_probs=205.8

Q ss_pred             cccHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      +++..++...+++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|++++++++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34445566678899999999999999999999888999999998876666678899999999999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      +..++||||+++|+|.+++....   ..+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999987553   2589999999999999999999999   99999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------  629 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------  629 (652)
                      +++...............||+.|+|||++.++.++.++|||||||++|||++|+.||..                     
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            99865332222233445689999999999989999999999999999999999988632                     


Q ss_pred             -------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                         .+.+++.+||+.||++|||++||
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  306 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV  306 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence                               15578889999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=358.87  Aligned_cols=226  Identities=23%  Similarity=0.332  Sum_probs=199.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357889999999999999999875 6899999998766666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999988666899999999999999999999999   99999999999999999999999999998753322111


Q ss_pred             ------------ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------
Q 041689          583 ------------TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------  628 (652)
Q Consensus       583 ------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------  628 (652)
                                  ......||+.|+|||++.+..++.++|||||||++|||++|..|+.                      
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP  245 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence                        1114569999999999999999999999999999999999988753                      


Q ss_pred             ----hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          ..+.+++.+||+.||++|||++||
T Consensus       246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l  273 (310)
T 3s95_A          246 PNCPPSFFPITVRCCDLDPEKRPSFVKL  273 (310)
T ss_dssp             TTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                347889999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-42  Score=358.89  Aligned_cols=233  Identities=23%  Similarity=0.267  Sum_probs=205.4

Q ss_pred             ccccHHHHHHHhcC----------CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCC
Q 041689          413 RRFSYLEVCRATYG----------FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR  481 (652)
Q Consensus       413 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  481 (652)
                      ..++.+++..+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888877764          677789999999999999976 6999999999876656667889999999999999


Q ss_pred             eeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC
Q 041689          482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT  561 (652)
Q Consensus       482 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~  561 (652)
                      ||+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||+|||+.   ||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999988754  589999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------
Q 041689          562 MVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------  628 (652)
Q Consensus       562 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------  628 (652)
                      +.+||+|||++......  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.             
T Consensus       178 ~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~  255 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD  255 (321)
T ss_dssp             CCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            99999999999865322  122344579999999999999999999999999999999999999863             


Q ss_pred             -------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                   ..+.+++.+||+.||++|||++||
T Consensus       256 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  292 (321)
T 2c30_A          256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL  292 (321)
T ss_dssp             SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                         236889999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=358.41  Aligned_cols=222  Identities=17%  Similarity=0.251  Sum_probs=198.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.. ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999875 5889999998754 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--CCcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--TMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      +++|+|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.  ++.+||+|||+++....   
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~---  156 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---  156 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---
Confidence            999999999987666799999999999999999999999   9999999999999987  78999999999987632   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFVFN  633 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l~~  633 (652)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.                           ..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            222344568999999999998889999999999999999999999963                           23678


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..||++|||++|+
T Consensus       237 li~~~L~~dp~~Rpt~~e~  255 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHcCCChhHCcCHHHH
Confidence            9999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-42  Score=361.95  Aligned_cols=222  Identities=21%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR------AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            457999999999999999999875 6899999999765321      346789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCC
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGIT  572 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~  572 (652)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++++++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 799999999999999999999999   999999999999998776    7999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      +.....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||..                       
T Consensus       167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             EECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             eEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            876322   223445799999999999999999999999999999999999999632                       


Q ss_pred             ----hhhhhhcccchhhhccccCccCC
Q 041689          630 ----FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          .+.+++.+||..||++|||++|+
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~  270 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEA  270 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                26789999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-42  Score=356.87  Aligned_cols=223  Identities=23%  Similarity=0.309  Sum_probs=193.1

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|++.+|+.||+|+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36799999999999999999999889999999997542  2234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++ ++.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....  .
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP--V  173 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--C
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC--c
Confidence            9985 88888877766799999999999999999999999   9999999999999999999999999999865321  2


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------------  629 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------------  629 (652)
                      .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..                               
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            22344568999999999876 5689999999999999999999999742                               


Q ss_pred             ----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            .+.+++.+||+.||++|||++|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  298 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA  298 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence                                  35689999999999999999874

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-42  Score=359.31  Aligned_cols=218  Identities=21%  Similarity=0.249  Sum_probs=193.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++..   .......+.+|++++++++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            357899999999999999999875 6899999999754   223456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....  
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence            99999999999887654 689999999999999999999999   999999999999999999999999999985422  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~  636 (652)
                      ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.                       ..+.+++.
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            2223345679999999999999999999999999999999999999963                       33688999


Q ss_pred             ccchhhhcccc
Q 041689          637 ECTIESLELRI  647 (652)
Q Consensus       637 ~~l~~~p~~Rp  647 (652)
                      +||+.||++||
T Consensus       238 ~lL~~dP~~R~  248 (337)
T 1o6l_A          238 GLLKKDPKQRL  248 (337)
T ss_dssp             HHTCSSTTTST
T ss_pred             HHhhcCHHHhc
Confidence            99999999999

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-42  Score=365.40  Aligned_cols=226  Identities=22%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             hcCCCccceeccccceEEEEEEe--------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI--------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      .++|.+.+.||+|+||.||+|++        .++..||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36788999999999999999975        235679999997653 34456789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..|+||||+++|+|.+++....               ..+++.++..++.|++.||+|||++   ||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            99999999999999999997653               2478899999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--------  629 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--------  629 (652)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..        
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987643333233344557889999999999999999999999999999999 8888543        


Q ss_pred             ----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                      .+.+++.+||..||++|||++||
T Consensus       317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el  355 (370)
T 2psq_A          317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  355 (370)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                            47889999999999999999874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.4e-43  Score=363.39  Aligned_cols=221  Identities=24%  Similarity=0.270  Sum_probs=191.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  497 (652)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|+++..   .....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3468999999999999999999865 5899999999754   223445678899999988 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++... 
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~-  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc-
Confidence            9999999999999987654 699999999999999999999999   99999999999999999999999999998532 


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNL  634 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l  634 (652)
                       .........+||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.++
T Consensus       176 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          176 -CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             -C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             122334456799999999999999999999999999999999999999643                       37889


Q ss_pred             hcccchhhhccccCc
Q 041689          635 AMECTIESLELRINA  649 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~  649 (652)
                      +.+||+.||++||++
T Consensus       255 i~~lL~~dP~~R~~~  269 (353)
T 3txo_A          255 LKSFMTKNPTMRLGS  269 (353)
T ss_dssp             HHHHTCSSGGGSTTS
T ss_pred             HHHHhhhCHHHccCC
Confidence            999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.4e-43  Score=359.77  Aligned_cols=225  Identities=22%  Similarity=0.276  Sum_probs=195.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999876 68999999997543 2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999987654 689999999999999999999999   9999999999999999999999999999865433333


Q ss_pred             cccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l  634 (652)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..                          .+.++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            33345679999999999987776 7789999999999999999999643                          25689


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++||
T Consensus       242 i~~~L~~dP~~R~t~~ei  259 (323)
T 3tki_A          242 LHKILVENPSARITIPDI  259 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHH
T ss_pred             HHHHccCChhhCcCHHHH
Confidence            999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-42  Score=358.68  Aligned_cols=226  Identities=21%  Similarity=0.278  Sum_probs=197.2

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      ....++|.+.+.||+|+||.||+|+.. +|+.||+|+++...   ......+..|.++++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999975 68999999997642   23445678899999887 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999987654 689999999999999999999999   9999999999999999999999999999854


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhh
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVF  632 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~  632 (652)
                      ..  ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.                       ..+.
T Consensus       169 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  246 (345)
T 1xjd_A          169 ML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  246 (345)
T ss_dssp             CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence            22  1222345679999999999999999999999999999999999999964                       3378


Q ss_pred             hhhcccchhhhccccCcc-CC
Q 041689          633 NLAMECTIESLELRINAK-EI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~-ei  652 (652)
                      +++.+||..||++||++. ||
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i  267 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDI  267 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCG
T ss_pred             HHHHHHhcCCHhHcCCChHHH
Confidence            999999999999999987 54

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-42  Score=358.42  Aligned_cols=221  Identities=21%  Similarity=0.284  Sum_probs=194.7

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|++ .+++.||+|++....   ......+.+|+++++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999996 478999999997542   22345788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+ +|++.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||++.....  
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT--
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC--
Confidence            9999 679999887654 699999999999999999999999   999999999999999999999999999986532  


Q ss_pred             CccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~  635 (652)
                       .......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.                       .+.+++
T Consensus       161 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          161 -GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI  239 (336)
T ss_dssp             -SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred             -CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence             222345579999999999988776 6899999999999999999999654                       378999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       240 ~~~L~~dP~~Rpt~~ei  256 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEI  256 (336)
T ss_dssp             HTTSCSSGGGSCCHHHH
T ss_pred             HHHcCCChhHCcCHHHH
Confidence            99999999999999874

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9e-42  Score=392.79  Aligned_cols=343  Identities=32%  Similarity=0.479  Sum_probs=270.0

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-C-CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCC--------Cc
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-N-PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS--------IA   73 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~-~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--------~~   73 (652)
                      ++|+.|+|+.|.+.  +.+|..+ + +++|++|+|++|++++..|..|.++++|++|+|++|++++..+.        +.
T Consensus       269 ~~L~~L~L~~n~l~--~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~  346 (768)
T 3rgz_A          269 KSLQYLSLAENKFT--GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK  346 (768)
T ss_dssp             TTCCEEECCSSEEE--ESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCC
T ss_pred             CCCCEEECcCCccC--CccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCC
Confidence            35667777777665  2566665 3 36777777777777766777777777777777777766643331        11


Q ss_pred             c-----ccccCCCCC--------------------cccccccCC--CCCCcEEEcccCCCcccCCccchhcccccCcEEE
Q 041689           74 D-----NYLTSSTPE--------------------LSFLSSLSN--CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFD  126 (652)
Q Consensus        74 ~-----~~l~~~~~~--------------------~~~~~~l~~--l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~  126 (652)
                      .     +.+.+..+.                    ...+..+..  +++|++|+|++|++++..|. .+..+++ |++|+
T Consensus       347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~-~l~~l~~-L~~L~  424 (768)
T 3rgz_A          347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP-TLSNCSE-LVSLH  424 (768)
T ss_dssp             EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCG-GGGGCTT-CCEEE
T ss_pred             EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCH-HHhcCCC-CCEEE
Confidence            1     111111110                    011122223  66788888888888877776 6777776 99999


Q ss_pred             ccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccc
Q 041689          127 MSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG  206 (652)
Q Consensus       127 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  206 (652)
                      |++|++++.+|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|++++
T Consensus       425 Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  504 (768)
T 3rgz_A          425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG  504 (768)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred             CcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCC
Confidence            99999998889999999999999999999998889899999999999999999998899999999999999999999998


Q ss_pred             cccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccc--------------------------
Q 041689          207 SILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTI--------------------------  258 (652)
Q Consensus       207 ~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~--------------------------  258 (652)
                      .+|.+|+.+++|++|+|++|.  +.+|..++++++|+.|++++|++++.+|..+                          
T Consensus       505 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (768)
T 3rgz_A          505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK  584 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCC
T ss_pred             cCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccc
Confidence            999999999999999999996  5788889999999999999998887666543                          


Q ss_pred             --------------------------------------------cCCCCCcEEEccCCcCCCcccccccccccCcceecc
Q 041689          259 --------------------------------------------GSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFS  294 (652)
Q Consensus       259 --------------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  294 (652)
                                                                  ..+++|+.|||++|+++|.+|..++.+++|+.|+|+
T Consensus       585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls  664 (768)
T 3rgz_A          585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG  664 (768)
T ss_dssp             TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECC
T ss_pred             ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCc
Confidence                                                        335678899999999999999999999999999999


Q ss_pred             ccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCCCCcccccccCCccCCCCC
Q 041689          295 NNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       295 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      +|+++|.+|..+.++++|+.|||++|+++|.+|.. ..+..++.+++++|++...-|
T Consensus       665 ~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             CCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            99999999999999999999999999999988864 677888999999998754433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-43  Score=375.64  Aligned_cols=232  Identities=18%  Similarity=0.222  Sum_probs=200.4

Q ss_pred             HHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeec
Q 041689          417 YLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSN  492 (652)
Q Consensus       417 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  492 (652)
                      ..++....++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4455556789999999999999999999976 48889999997532   2233458899999999999999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      ++..|+||||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999999987656799999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                      +..... ........+||+.|+|||++.     .+.++.++|||||||++|||++|+.||.                   
T Consensus       223 ~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  301 (437)
T 4aw2_A          223 LKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ  301 (437)
T ss_dssp             EECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred             hhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc
Confidence            865322 222234467999999999987     5678999999999999999999999953                   


Q ss_pred             ---------hhhhhhhcccchhhhcc--ccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLEL--RINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~--Rpt~~ei  652 (652)
                               ..+.+++.+||..+|++  ||+++||
T Consensus       302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei  336 (437)
T 4aw2_A          302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDF  336 (437)
T ss_dssp             CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred             CCcccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence                     23678999999988888  9998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-42  Score=355.12  Aligned_cols=227  Identities=29%  Similarity=0.407  Sum_probs=190.0

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      +.....+|++.+.||+|+||.||+|+. +|+.||||++....  ....+.+.+|++++++++||||+++++++...+..+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            334456789999999999999999987 68899999987543  334567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      +||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +  |+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999986542  389999999999999999999999   8  9999999999999999999999999997


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....  .........||+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       188 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (309)
T 3p86_A          188 LKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN  265 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred             cccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence            5422  12223445689999999999999999999999999999999999999643                        


Q ss_pred             -hhhhhhcccchhhhccccCccCC
Q 041689          630 -FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       .+.+++.+||+.||++|||++||
T Consensus       266 ~~l~~li~~~l~~dP~~Rps~~~l  289 (309)
T 3p86_A          266 PQVAAIIEGCWTNEPWKRPSFATI  289 (309)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHH
Confidence             37889999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.6e-42  Score=362.80  Aligned_cols=220  Identities=21%  Similarity=0.234  Sum_probs=193.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..+++++ +||||+++++++.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            457999999999999999999875 58889999997652   23345678899999887 89999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|..++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++...  
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~--  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc--
Confidence            999999999999887654 699999999999999999999999   99999999999999999999999999998532  


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------------
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------------  628 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------------  628 (652)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||.                              
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            12233455679999999999999999999999999999999999999983                              


Q ss_pred             --hhhhhhhcccchhhhccccCc
Q 041689          629 --SFVFNLAMECTIESLELRINA  649 (652)
Q Consensus       629 --~~l~~l~~~~l~~~p~~Rpt~  649 (652)
                        ..+.+++.+||+.||++||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence              126789999999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=354.67  Aligned_cols=221  Identities=20%  Similarity=0.288  Sum_probs=195.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR------AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|.+.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45889999999999999999875 6899999999754321      3567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~~  573 (652)
                      +||||+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||+++
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999987654 689999999999999999999999   999999999999999877    89999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||..                        
T Consensus       167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          167 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             ECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             ECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            75322   223345699999999999989999999999999999999999999632                        


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||..||++|||++|+
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~  269 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDS  269 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHH
Confidence               26789999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.3e-43  Score=359.91  Aligned_cols=225  Identities=23%  Similarity=0.314  Sum_probs=192.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----ceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----FKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  499 (652)
                      ..+|++.+.||+|+||.||+|++. ++.||||+++... ......+.|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467899999999999999999875 7899999997553 33445667999999999999999999998754    36999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN-------FLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      |||+++|+|.+++....  +++..+..++.|++.||+|||+.       +.++|+||||||+||+++.++.+||+|||++
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            99999999999997754  89999999999999999999975       2348999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      +...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||..                  
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            87644333333344679999999999876     4567889999999999999999888642                  


Q ss_pred             ----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  .+.+++.+||+.||++|||++||
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  309 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV  309 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence                                        17789999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-42  Score=359.74  Aligned_cols=222  Identities=21%  Similarity=0.342  Sum_probs=195.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999865 68999999997542  334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.+   +.+||+|||++.....
T Consensus       108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999887654 689999999999999999999999   99999999999999864   4599999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SF  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~  630 (652)
                      .   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.                           ..
T Consensus       184 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          184 S---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             C---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             C---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            2   22334579999999999999899999999999999999999999963                           23


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++|+
T Consensus       261 ~~~li~~~L~~dP~~R~t~~e~  282 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITADQA  282 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHH
Confidence            7889999999999999998763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-42  Score=351.76  Aligned_cols=222  Identities=23%  Similarity=0.307  Sum_probs=190.6

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|+..+|+.||+|+++...  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5789999999999999999999889999999996542  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ +|.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....  ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence            986 99998887666799999999999999999999999   9999999999999999999999999999865321  12


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..                                
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            23345689999999998764 589999999999999999999998742                                


Q ss_pred             --------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          .+.+++.+||+.||++|||++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  278 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA  278 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                                23489999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=356.28  Aligned_cols=226  Identities=24%  Similarity=0.387  Sum_probs=194.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+|.+.+.||+|+||.||+|++.    .+..||||+++.. .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999874    3456999999765 33445678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987766899999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------------chhhh
Q 041689          579 DQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------------VSFVF  632 (652)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------------~~~l~  632 (652)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||                        +..+.
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  284 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH  284 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence            221 12223346788999999998999999999999999999999 99885                        33478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..||++|||++||
T Consensus       285 ~li~~~l~~dp~~Rps~~ei  304 (325)
T 3kul_A          285 QLMLDCWHKDRAQRPRFSQI  304 (325)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHccCChhhCcCHHHH
Confidence            89999999999999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-42  Score=345.64  Aligned_cols=224  Identities=26%  Similarity=0.351  Sum_probs=198.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467899999999999999999998888999999976532 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++......+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||.+...... ....
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT-CEEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh-hhhc
Confidence            99999999987665799999999999999999999999   9999999999999999999999999999865322 1222


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMEC  638 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~  638 (652)
                      .....+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.                        +.+.+++.+|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  241 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC  241 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence            234456788999999998899999999999999999999 998853                        3478999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||++||
T Consensus       242 l~~~p~~Rps~~~l  255 (268)
T 3sxs_A          242 WHELPEKRPTFQQL  255 (268)
T ss_dssp             TCSSGGGSCCHHHH
T ss_pred             cCCChhhCcCHHHH
Confidence            99999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-42  Score=347.97  Aligned_cols=224  Identities=27%  Similarity=0.374  Sum_probs=197.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357889999999999999999998899999999975532 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc-cccc
Confidence            99999999987776799999999999999999999999   9999999999999999999999999999865221 1112


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMEC  638 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~  638 (652)
                      .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.                        ..+.+++.+|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  243 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  243 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence            233456788999999998999999999999999999999 888853                        3377899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||++|+
T Consensus       244 l~~~p~~Rps~~~l  257 (269)
T 4hcu_A          244 WRERPEDRPAFSRL  257 (269)
T ss_dssp             TCSSGGGSCCHHHH
T ss_pred             ccCCcccCcCHHHH
Confidence            99999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-42  Score=360.32  Aligned_cols=223  Identities=18%  Similarity=0.241  Sum_probs=198.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999875 6899999999866555566889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC--CCCcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      +++|+|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++  ..+.+||+|||+++.....  
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--  204 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  204 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence            999999999987666799999999999999999999999   999999999999997  4578999999999876322  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFN  633 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~  633 (652)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||..                           .+.+
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          205 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence             223345799999999999999999999999999999999999999632                           3688


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..||++|||++|+
T Consensus       284 li~~~L~~dP~~Rpt~~el  302 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDA  302 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHcCCChhHCcCHHHH
Confidence            9999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=368.39  Aligned_cols=224  Identities=21%  Similarity=0.271  Sum_probs=195.9

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3567999999999999999999864 68999999997553  23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCcccc
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLI  576 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~  576 (652)
                      |||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++   +++.+||+|||+++...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999888765 699999999999999999999999   999999999999998   56889999999998653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc---------------------------ch
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC---------------------------VS  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~---------------------------~~  629 (652)
                      ..  ........||+.|+|||++.+..++.++||||+||++|+|++|+.||                           ++
T Consensus       165 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          165 GE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             TT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            22  22234467999999999999999999999999999999999999995                           23


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++|+
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~  265 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEA  265 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHH
Confidence            47899999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.4e-42  Score=359.66  Aligned_cols=217  Identities=24%  Similarity=0.281  Sum_probs=192.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56889999999999999999865 58899999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....   
T Consensus        95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---  167 (384)
T ss_dssp             CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC---
Confidence            9999999999988654 699999999999999999999999   999999999999999999999999999986532   


Q ss_pred             ccccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhh
Q 041689          581 SMTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFV  631 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l  631 (652)
                      .......+||+.|+|||++..   ..++.++||||+||++|||++|+.||.                          ..+
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM  247 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence            223345679999999999864   458999999999999999999999974                          236


Q ss_pred             hhhhcccchhhhccccC
Q 041689          632 FNLAMECTIESLELRIN  648 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt  648 (652)
                      .+++.+||+.||++||+
T Consensus       248 ~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHhcCCHhHhcc
Confidence            78999999999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.1e-42  Score=348.47  Aligned_cols=222  Identities=23%  Similarity=0.263  Sum_probs=192.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999875 68999999997543  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++ ++.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....  ..
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC--cc
Confidence            9986 66666666555799999999999999999999999   999999999999999999999999999986532  22


Q ss_pred             cccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCc---------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQC---------------------------------  627 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~---------------------------------  627 (652)
                      .......+|+.|+|||++.+.. ++.++||||+||++|||++|..|+                                 
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2334457899999999987765 799999999999999999988874                                 


Q ss_pred             --------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 --------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 --------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          +..+.+++.+||+.||++|||++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  280 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence                                2335689999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.6e-43  Score=367.37  Aligned_cols=227  Identities=27%  Similarity=0.364  Sum_probs=196.1

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..++|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3457889999999999999999976 68999999987543 234467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999987665789999999999999999999999   999999999999999999999999999986422111


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~  635 (652)
                      ........+++.|+|||++.++.++.++|||||||++|||++ |+.||.                        ..+.+++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            111112235678999999998999999999999999999998 888853                        3478999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       349 ~~cl~~dP~~Rps~~~i  365 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTI  365 (377)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCchhCcCHHHH
Confidence            99999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.6e-42  Score=348.93  Aligned_cols=222  Identities=23%  Similarity=0.346  Sum_probs=190.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...   .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357999999999999999999865 6899999998643   233456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..... 
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence            99999999999987655 689999999999999999999999   9999999999999999999999999999865322 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------------hh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------FV  631 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------~l  631 (652)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||..                            .+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence            11223345689999999999999999999999999999999999999642                            37


Q ss_pred             hhhhcccchhhhcccc-Ccc
Q 041689          632 FNLAMECTIESLELRI-NAK  650 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rp-t~~  650 (652)
                      .+++.+||+.||++|| +++
T Consensus       245 ~~li~~~l~~dp~~R~~~~~  264 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQ  264 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHH
T ss_pred             HHHHHHHhcCCHhHccccHH
Confidence            8899999999999999 443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-41  Score=354.39  Aligned_cols=219  Identities=21%  Similarity=0.236  Sum_probs=194.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56889999999999999999975 58899999997652   23445678899999988 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....  
T Consensus        89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence            99999999999987654 689999999999999999999999   999999999999999999999999999985321  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------  629 (652)
                      ........+||+.|+|||++.+..++.++||||+||++|||++|+.||..                              
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence            22233456799999999999999999999999999999999999999842                              


Q ss_pred             --hhhhhhcccchhhhccccCc
Q 041689          630 --FVFNLAMECTIESLELRINA  649 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~  649 (652)
                        .+.+++.+||+.||++||++
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence              25789999999999999997

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-42  Score=359.11  Aligned_cols=223  Identities=22%  Similarity=0.274  Sum_probs=193.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...     ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46999999999999999999865 68999999996432     1235678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc---EEEecccCC
Q 041689          499 VLEHMPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV---AHLSDFGIT  572 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~~  572 (652)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998877543   23589999999999999999999999   9999999999999986554   999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      +.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.                        
T Consensus       181 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          181 IQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             EECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence            876322  222344579999999999999999999999999999999999999863                        


Q ss_pred             --hhhhhhhcccchhhhccccCccCC
Q 041689          629 --SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        ..+.+++.+||..||++|||++|+
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~  284 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEA  284 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHH
Confidence              237889999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-42  Score=350.54  Aligned_cols=215  Identities=23%  Similarity=0.287  Sum_probs=192.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357899999999999999999875 69999999997542   23456678899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....  
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            99999999999998754 689999999999999999999999   999999999999999999999999999986521  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~  636 (652)
                         .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.                       ..+.+++.
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence               2234579999999999999999999999999999999999999963                       34789999


Q ss_pred             ccchhhhcccc
Q 041689          637 ECTIESLELRI  647 (652)
Q Consensus       637 ~~l~~~p~~Rp  647 (652)
                      +||..||++||
T Consensus       236 ~lL~~dp~~R~  246 (318)
T 1fot_A          236 RLITRDLSQRL  246 (318)
T ss_dssp             HHTCSCTTTCT
T ss_pred             HHhccCHHHcC
Confidence            99999999999

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=364.81  Aligned_cols=313  Identities=22%  Similarity=0.240  Sum_probs=285.1

Q ss_pred             cCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCC
Q 041689           17 ESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSL   96 (652)
Q Consensus        17 ~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L   96 (652)
                      ..+.++|..+ +.++++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+.                 .|.++++|
T Consensus        21 ~~l~~ip~~~-~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-----------------~~~~l~~L   82 (477)
T 2id5_A           21 KRFVAVPEGI-PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG-----------------AFNNLFNL   82 (477)
T ss_dssp             CCCSSCCSCC-CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----------------TTTTCTTC
T ss_pred             CCcCcCCCCC-CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChh-----------------hhhCCccC
Confidence            3445899988 78999999999999999999999999999999999999877653                 58899999


Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecc
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK  176 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  176 (652)
                      ++|+|++|+++++++. .|..+++ |++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus        83 ~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A           83 RTLGLRSNRLKLIPLG-VFTGLSN-LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             CEEECCSSCCCSCCTT-SSTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred             CEEECCCCcCCccCcc-cccCCCC-CCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence            9999999999988776 6788886 9999999999999999999999999999999999999999999999999999999


Q ss_pred             cCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccC
Q 041689          177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       177 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      +|++++..+..|..+++|+.|+|++|.+.+..+..|..+++|++|++++|.  ..+|.......+|+.|++++|+++++.
T Consensus       161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  240 (477)
T 2id5_A          161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP  240 (477)
T ss_dssp             SCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCC
T ss_pred             CCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccC
Confidence            999997777789999999999999999999999999999999999999985  566777777779999999999999877


Q ss_pred             cccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCCC
Q 041689          255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSFG  333 (652)
Q Consensus       255 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~  333 (652)
                      +..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++.++.. ..+.
T Consensus       241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  320 (477)
T 2id5_A          241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG  320 (477)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred             HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence            788999999999999999999888889999999999999999999998999999999999999999999876653 6778


Q ss_pred             CcccccccCCccCCCC
Q 041689          334 NFSAESFEGNKLLCGS  349 (652)
Q Consensus       334 ~l~~~~~~~N~~~c~~  349 (652)
                      +++.+++.+|+|.|..
T Consensus       321 ~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          321 NLETLILDSNPLACDC  336 (477)
T ss_dssp             GCCEEECCSSCEECSG
T ss_pred             ccCEEEccCCCccCcc
Confidence            8999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.2e-42  Score=351.67  Aligned_cols=224  Identities=24%  Similarity=0.311  Sum_probs=179.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ...+|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3468999999999999999999865 68999999997553 233467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          501 EHMPHGSLEKCLYSSN-----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ||+++ +|.+++....     ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99984 9998876432     2588999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ...  ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..                         
T Consensus       159 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            322  122334568999999999876 4689999999999999999999998732                         


Q ss_pred             --------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                      .+.+++.+||+.||++|||++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  291 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA  291 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence                                            35689999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.5e-42  Score=348.45  Aligned_cols=222  Identities=25%  Similarity=0.322  Sum_probs=188.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--------------------------hhhhhHHHHHHHHH
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--------------------------RAFKSFDIECEIMK  476 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  476 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            467999999999999999999865 688999999965421                          12356889999999


Q ss_pred             hcCCCeeeeEEeeeec--CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCC
Q 041689          477 SIHYRNLVKIISSCSN--EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPS  554 (652)
Q Consensus       477 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~  554 (652)
                      +++||||+++++++.+  .+..++||||+++++|.+++...  .+++.++..++.|++.||+|||++   +|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            9999999999999986  56889999999999998865443  589999999999999999999999   9999999999


Q ss_pred             CeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCc---cCcccchhhHHHHHHHHHhCCCCcc---
Q 041689          555 NVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR---VFANGDVYSFGIMLMEIHSAKQQCV---  628 (652)
Q Consensus       555 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~---  628 (652)
                      ||+++.++.+||+|||+++.....  ........||+.|+|||++.+..   ++.++|||||||++|||++|+.||.   
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999999875322  22234457999999999987665   4788999999999999999999863   


Q ss_pred             ----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            ..+.+++.+||+.||++|||++||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~  290 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI  290 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence                                  237889999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-42  Score=364.96  Aligned_cols=229  Identities=22%  Similarity=0.240  Sum_probs=198.3

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      .++....++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            445556788999999999999999999876 58899999997532   22345688999999999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      +..|+||||++||+|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999998765  489999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCc----cCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGR----VFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      ..... ........+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..                    
T Consensus       217 ~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          217 KMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             ECCTT-SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred             eeccC-CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC
Confidence            65322 122234567999999999987655    88999999999999999999999632                    


Q ss_pred             -------hhhhhhcccchhhhcc--ccCccCC
Q 041689          630 -------FVFNLAMECTIESLEL--RINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~--Rpt~~ei  652 (652)
                             .+.+++.+||..+|++  ||+++||
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei  327 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEI  327 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHH
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCCCHHHH
Confidence                   3788999999999988  9998764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6e-41  Score=363.33  Aligned_cols=310  Identities=19%  Similarity=0.284  Sum_probs=206.6

Q ss_pred             cCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEE
Q 041689           21 EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFL  100 (652)
Q Consensus        21 ~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~  100 (652)
                      ++|. + +++|++|+|++|+|+++.|..|.++++|++|+|++|.+.+..+.                ..|.++++|++|+
T Consensus        24 ~lp~-l-~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~----------------~~~~~l~~L~~L~   85 (455)
T 3v47_A           24 QVPE-L-PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN----------------NTFRGLSSLIILK   85 (455)
T ss_dssp             SCCC-C-CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECT----------------TTTTTCTTCCEEE
T ss_pred             cCCC-C-CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECc----------------ccccccccCCEEe
Confidence            4444 2 34555555555555555555555555555555555555322111                1244444444444


Q ss_pred             cccCCCcccCCccchhcccccCcEEEccCCcccccCCcc--ccCCCCCCEEEecCccccccCCcc-ccCCCCCcEEeccc
Q 041689          101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE--IGNLTNLTAIYLGGNKLNGSIPFT-LRELQKLQYVGLKD  177 (652)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~  177 (652)
                      |++|+++++.|. .+..+++ |++|+|++|++++..+..  |..+++|++|+|++|++++..|.. |.++++|++|+|++
T Consensus        86 Ls~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~  163 (455)
T 3v47_A           86 LDYNQFLQLETG-AFNGLAN-LEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTF  163 (455)
T ss_dssp             CTTCTTCEECTT-TTTTCTT-CCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTT
T ss_pred             CCCCccCccChh-hccCccc-CCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCC
Confidence            444444444443 3444443 444444444444322222  444444444444444444443333 44444444444444


Q ss_pred             CccccccCcccc----------------------------------CCCCCcEEEccCCcccccccccCCC---------
Q 041689          178 NKLEGTIPYDIF----------------------------------RLVKLYKLDLGGNKLSGSILTCFSN---------  214 (652)
Q Consensus       178 N~l~~~~~~~~~----------------------------------~l~~L~~L~L~~N~l~~~~~~~~~~---------  214 (652)
                      |++++..|..+.                                  .+++|++|++++|++++..+..+..         
T Consensus       164 n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~  243 (455)
T 3v47_A          164 NKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQS  243 (455)
T ss_dssp             CCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEE
T ss_pred             CcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceee
Confidence            444444333332                                  3467888888888877655443321         


Q ss_pred             ------------------------------CCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCC
Q 041689          215 ------------------------------LASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK  262 (652)
Q Consensus       215 ------------------------------l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  262 (652)
                                                    .++|++|++++|.  ...|..++.+++|+.|++++|++++..|..|.+++
T Consensus       244 L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  323 (455)
T 3v47_A          244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT  323 (455)
T ss_dssp             EECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             EeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence                                          2578899999886  44677799999999999999999998899999999


Q ss_pred             CCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCCCCccccccc
Q 041689          263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSFGNFSAESFE  341 (652)
Q Consensus       263 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~l~~~~~~  341 (652)
                      +|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++.++.. ..+..++.++++
T Consensus       324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  403 (455)
T 3v47_A          324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH  403 (455)
T ss_dssp             TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence            9999999999999888899999999999999999999888999999999999999999999877654 678899999999


Q ss_pred             CCccCCCCC
Q 041689          342 GNKLLCGSP  350 (652)
Q Consensus       342 ~N~~~c~~~  350 (652)
                      +|++.|..|
T Consensus       404 ~N~l~~~~~  412 (455)
T 3v47_A          404 TNPWDCSCP  412 (455)
T ss_dssp             SSCBCCCTT
T ss_pred             CCCcccCCC
Confidence            999999765

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-42  Score=351.16  Aligned_cols=226  Identities=27%  Similarity=0.422  Sum_probs=192.6

Q ss_pred             hcCCCccceeccccceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  496 (652)
                      ..+|++.+.||+|+||.||+|++     .+++.||||+++.......+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35788999999999999999983     35889999999876666677899999999999999999999998543  568


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999999999987766799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc----------------------------
Q 041689          577 GEDQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC----------------------------  627 (652)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~----------------------------  627 (652)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++|..|+                            
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            32221 1223345778899999999999999999999999999999987663                            


Q ss_pred             ------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                  +..+.+++.+||+.||++|||++||
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  282 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL  282 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                        2447889999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-41  Score=352.92  Aligned_cols=226  Identities=21%  Similarity=0.322  Sum_probs=191.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  494 (652)
                      ..+|++.+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457899999999999999999976 79999999997543 335578899999999999999999999885443       


Q ss_pred             --------------------------------------------------ceEEEEEccCCCChhhhhhcCCC--CCCHH
Q 041689          495 --------------------------------------------------FKELVLEHMPHGSLEKCLYSSNC--ILDIF  522 (652)
Q Consensus       495 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~l~~~  522 (652)
                                                                        ..++||||+++++|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999986543  45666


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc----------cccccccCCcc
Q 041689          523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS----------MTQTQTLATIG  592 (652)
Q Consensus       523 ~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~  592 (652)
                      .+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7899999999999999999   9999999999999999999999999999876433211          12234569999


Q ss_pred             ccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------hhhhhhhcccchhhhccccCcc
Q 041689          593 YIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------SFVFNLAMECTIESLELRINAK  650 (652)
Q Consensus       593 y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------~~l~~l~~~~l~~~p~~Rpt~~  650 (652)
                      |+|||++.+..++.++||||+||++|||++|..|+.                      +.+.+++.+||+.||++|||++
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            999999999999999999999999999999988742                      2367899999999999999998


Q ss_pred             CC
Q 041689          651 EI  652 (652)
Q Consensus       651 ei  652 (652)
                      |+
T Consensus       322 ~~  323 (332)
T 3qd2_B          322 DI  323 (332)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=362.77  Aligned_cols=232  Identities=19%  Similarity=0.244  Sum_probs=199.3

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeee
Q 041689          416 SYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCS  491 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  491 (652)
                      .+.+.....++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|..++.+++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555566789999999999999999999975 69999999997532   223456889999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      +.+..|+||||+++|+|.+++...+..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechh
Confidence            99999999999999999999987555799999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccc-------cCccCcccchhhHHHHHHHHHhCCCCcch---------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGR-------EGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~elltg~~p~~~---------------  629 (652)
                      ++...... .......+||+.|+|||++.       .+.++.++|||||||++|||++|+.||..               
T Consensus       209 a~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          209 CLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             CEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             heeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            98753221 12223457999999999987       45789999999999999999999999532               


Q ss_pred             -------------hhhhhhcccchhhhccc---cCccCC
Q 041689          630 -------------FVFNLAMECTIESLELR---INAKEI  652 (652)
Q Consensus       630 -------------~l~~l~~~~l~~~p~~R---pt~~ei  652 (652)
                                   .+.+++.+||. +|++|   |+++||
T Consensus       288 ~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei  325 (412)
T 2vd5_A          288 HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF  325 (412)
T ss_dssp             HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred             CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence                         36789999999 99998   466653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-41  Score=345.29  Aligned_cols=237  Identities=31%  Similarity=0.490  Sum_probs=206.0

Q ss_pred             ccccccHHHHHHHhcCCCcc------ceeccccceEEEEEEeCCCcEEEEEEeecc----cchhhhhHHHHHHHHHhcCC
Q 041689          411 TWRRFSYLEVCRATYGFNEN------NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ----CGRAFKSFDIECEIMKSIHY  480 (652)
Q Consensus       411 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  480 (652)
                      ....|+..++..++++|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678999999999999887      8999999999999987 6889999998643    22345678999999999999


Q ss_pred             CeeeeEEeeeecCCceEEEEEccCCCChhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS--NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       481 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      |||+++++++...+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||++   ||+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999999988643  23689999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------  629 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------  629 (652)
                      ++++.+||+|||+++...............||+.|+|||.+.+ .++.++|||||||++|||++|+.||..         
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999986543333333344568999999998764 588999999999999999999999753         


Q ss_pred             -----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   .+.+++.+||+.||++|||++||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l  297 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV  297 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHH
Confidence                                         25679999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-42  Score=361.80  Aligned_cols=238  Identities=21%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             cccccHHHHHHHhcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCee
Q 041689          412 WRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNL  483 (652)
Q Consensus       412 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~ni  483 (652)
                      ...+...+.....++|.+.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            34456666777788999999999999999999973      246889999997653 33456789999999999 79999


Q ss_pred             eeEEeeeecCC-ceEEEEEccCCCChhhhhhcCCC---------------------------------------------
Q 041689          484 VKIISSCSNEE-FKELVLEHMPHGSLEKCLYSSNC---------------------------------------------  517 (652)
Q Consensus       484 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------  517 (652)
                      +++++++.+.+ ..++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999988754 48999999999999999876532                                             


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          518 --------------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       518 --------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                                          .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                188999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch-------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-------------------------FV  631 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-------------------------~l  631 (652)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..                         .+
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  325 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM  325 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence            333333445668899999999999999999999999999999998 9998643                         37


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       326 ~~li~~~l~~dP~~Rps~~el  346 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSEL  346 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHH
Confidence            889999999999999999874

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-41  Score=352.90  Aligned_cols=221  Identities=21%  Similarity=0.216  Sum_probs=194.6

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  497 (652)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.++++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3468999999999999999999976 48899999997542   23456678899999988 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||++||+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999987654 689999999999999999999999   999999999999999999999999999985321


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNL  634 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l  634 (652)
                        ........+||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.++
T Consensus       174 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  251 (353)
T 2i0e_A          174 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  251 (353)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             --CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence              12233456799999999999999999999999999999999999999643                       36899


Q ss_pred             hcccchhhhccccCc
Q 041689          635 AMECTIESLELRINA  649 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~  649 (652)
                      +.+||..||++||++
T Consensus       252 i~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGC  266 (353)
T ss_dssp             HHHHTCSCTTSCTTC
T ss_pred             HHHHhhcCHHHcCCC
Confidence            999999999999975

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=365.37  Aligned_cols=329  Identities=21%  Similarity=0.216  Sum_probs=295.2

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS   80 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~   80 (652)
                      +|.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++++.         
T Consensus        30 ~~~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------   98 (477)
T 2id5_A           30 IPTETRLLDLGKNRIKT--LNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG---------   98 (477)
T ss_dssp             CCTTCSEEECCSSCCCE--ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT---------
T ss_pred             CCCCCcEEECCCCccce--ECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc---------
Confidence            56789999999999984  235556 889999999999999999999999999999999999999866553         


Q ss_pred             CCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccC
Q 041689           81 TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI  160 (652)
Q Consensus        81 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  160 (652)
                              .|.++++|++|+|++|+++++.+. .+..+++ |++|+|++|+++++.+..|.++++|++|+|++|++++..
T Consensus        99 --------~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  168 (477)
T 2id5_A           99 --------VFTGLSNLTKLDISENKIVILLDY-MFQDLYN-LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIP  168 (477)
T ss_dssp             --------SSTTCTTCCEEECTTSCCCEECTT-TTTTCTT-CCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCC
T ss_pred             --------cccCCCCCCEEECCCCccccCChh-Hcccccc-CCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccC
Confidence                    478899999999999999998887 7888886 999999999999999999999999999999999999888


Q ss_pred             CccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCC
Q 041689          161 PFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLK  238 (652)
Q Consensus       161 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~  238 (652)
                      +..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+..+..+....+|++|+|++|. ..+| ..+.+++
T Consensus       169 ~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  248 (477)
T 2id5_A          169 TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLV  248 (477)
T ss_dssp             HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCT
T ss_pred             hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcc
Confidence            8889999999999999999998888899999999999999999887777777777799999999997 5555 3589999


Q ss_pred             ccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEee
Q 041689          239 VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLS  318 (652)
Q Consensus       239 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  318 (652)
                      +|+.|+|++|.++++.+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus       249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  328 (477)
T 2id5_A          249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILD  328 (477)
T ss_dssp             TCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECC
T ss_pred             ccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEcc
Confidence            99999999999999988999999999999999999999999999999999999999999998888889999999999999


Q ss_pred             cCcCcccCCCCCCCCCcccccccCCccCCCCCC
Q 041689          319 FNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       319 ~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~  351 (652)
                      +|+|.|.++..+.+.......+.++...|..|.
T Consensus       329 ~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          329 SNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             SSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            999998776443333444566788888997764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-41  Score=349.24  Aligned_cols=214  Identities=21%  Similarity=0.256  Sum_probs=172.7

Q ss_pred             cceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEccCCCC
Q 041689          430 NNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      .+.||+|+||.||+|+.. +++.||||++...   ....+.+|+++++.+. ||||+++++++.+++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999875 6899999999743   3466788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC---cEEEecccCCccccCCCCcccc
Q 041689          508 LEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM---VAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      |.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||+++....  .....
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~--~~~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCC--CCCcc
Confidence            999998764 799999999999999999999999   999999999999997665   899999999986532  22223


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------------------hh
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------------SF  630 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------------~~  630 (652)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.                                  ..
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            44568999999999999999999999999999999999999974                                  23


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..||++|||++|+
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~el  268 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGL  268 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTS
T ss_pred             HHHHHHHHCCCChhHCCCHHHH
Confidence            6789999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-41  Score=353.68  Aligned_cols=215  Identities=22%  Similarity=0.258  Sum_probs=193.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999875 68999999997542   234567888999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....   
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC---
Confidence            9999999999998654 689999999999999999999999   999999999999999999999999999986532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~  637 (652)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.                       ..+.+++.+
T Consensus       194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  271 (350)
T 1rdq_E          194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              1234579999999999999999999999999999999999999963                       347899999


Q ss_pred             cchhhhccccC
Q 041689          638 CTIESLELRIN  648 (652)
Q Consensus       638 ~l~~~p~~Rpt  648 (652)
                      ||+.||++||+
T Consensus       272 lL~~dp~~R~~  282 (350)
T 1rdq_E          272 LLQVDLTKRFG  282 (350)
T ss_dssp             HSCSCTTTCTT
T ss_pred             HhhcCHHhccC
Confidence            99999999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.2e-42  Score=346.25  Aligned_cols=225  Identities=22%  Similarity=0.359  Sum_probs=195.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..++|++.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3457889999999999999999998888999999976532 346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc-ccc
Confidence            999999999987555799999999999999999999999   9999999999999999999999999999865221 111


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~  637 (652)
                      ......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.                        ..+.+++.+
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  256 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  256 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence            2233446788999999998899999999999999999998 998854                        337899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++||
T Consensus       257 ~l~~~p~~Rps~~~l  271 (283)
T 3gen_A          257 CWHEKADERPTFKIL  271 (283)
T ss_dssp             TTCSSGGGSCCHHHH
T ss_pred             HccCChhHCcCHHHH
Confidence            999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=357.48  Aligned_cols=220  Identities=20%  Similarity=0.303  Sum_probs=190.2

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |...+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            344678999999999999864 6899999999876555667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee--CCCCcEEEecccCCccccCCCCccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL--DDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++|.+++......+++.++..++.|++.||+|||+.   +|+||||||+||++  +.++.+||+|||+++.....   ..
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~---~~  244 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EK  244 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT---CB
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc---cc
Confidence            999998877666799999999999999999999999   99999999999999  67789999999999876322   22


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhhhhhhc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFVFNLAM  636 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l~~l~~  636 (652)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.                           ..+.+++.
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            334569999999999998999999999999999999999999953                           23688999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++|+
T Consensus       325 ~~L~~dp~~Rps~~e~  340 (373)
T 2x4f_A          325 KLLIKEKSWRISASEA  340 (373)
T ss_dssp             TTSCSSGGGSCCHHHH
T ss_pred             HHcCCChhhCCCHHHH
Confidence            9999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=349.11  Aligned_cols=223  Identities=22%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--ceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--FKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357899999999999999999876 58999999997543 234567789999999999999999999987654  77999


Q ss_pred             EEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----CCCCcEEEecccCCc
Q 041689          500 LEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITK  573 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~~~  573 (652)
                      |||+++++|.+++.....  .+++.++..++.|++.||+|||++   ||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976543  389999999999999999999999   99999999999999    788899999999998


Q ss_pred             cccCCCCccccccccCCccccCccccc--------cCccCcccchhhHHHHHHHHHhCCCCcch----------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGR--------EGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~vl~elltg~~p~~~----------------  629 (652)
                      .....   .......||+.|+|||++.        +..++.++|||||||++|||++|+.||..                
T Consensus       165 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            76322   2233456999999999876        57889999999999999999999999751                


Q ss_pred             ------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                          .+.+++.+||+.||++|||++|+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el  300 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence                                                36778999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8e-42  Score=359.31  Aligned_cols=225  Identities=23%  Similarity=0.412  Sum_probs=185.3

Q ss_pred             cCCCccceeccccceEEEEEEeC----CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .+|++.+.||+|+||.||+|+..    ++..||||+++.. .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57899999999999999999864    5778999999765 334456799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            999999999999987766799999999999999999999999   99999999999999999999999999998763322


Q ss_pred             Cc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          580 QS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       580 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      .. .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  281 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ  281 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHH
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence            11 11122335778999999999999999999999999999998 999863                        34789


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++||+++||
T Consensus       282 li~~cl~~dp~~RPs~~~i  300 (373)
T 2qol_A          282 LMLDCWQKDRNNRPKFEQI  300 (373)
T ss_dssp             HHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHhCcChhhCcCHHHH
Confidence            9999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-41  Score=351.23  Aligned_cols=220  Identities=23%  Similarity=0.296  Sum_probs=184.6

Q ss_pred             hcCCCccceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|++++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35789999999999999999986    468999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999987654 688999999999999999999999   9999999999999999999999999999754


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhh
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVF  632 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~  632 (652)
                      ...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  249 (327)
T 3a62_A          172 IHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR  249 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred             ccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            221  1223345799999999999999999999999999999999999999643                       378


Q ss_pred             hhhcccchhhhccccCc
Q 041689          633 NLAMECTIESLELRINA  649 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~  649 (652)
                      +++.+||+.||++||++
T Consensus       250 ~li~~~L~~dp~~R~~~  266 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGA  266 (327)
T ss_dssp             HHHHHHSCSCGGGSTTS
T ss_pred             HHHHHHHhcCHhhccCC
Confidence            99999999999999954

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=361.59  Aligned_cols=225  Identities=26%  Similarity=0.361  Sum_probs=193.6

Q ss_pred             cCCCccceeccccceEEEEEEeC------CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|++.+.||+|+||.||+|++.      +++.||||+++.. .......+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999842      4678999999654 3344567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC---cEEEec
Q 041689          498 LVLEHMPHGSLEKCLYSSN------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM---VAHLSD  568 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl~D  568 (652)
                      +||||+++|+|.+++....      ..+++.++..++.|++.||+|||++   ||+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999987543      3589999999999999999999999   999999999999999544   599999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------  629 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------  629 (652)
                      ||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..                  
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~  307 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  307 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999986533222233344567899999999999999999999999999999998 8888543                  


Q ss_pred             ------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            .+.+++.+||+.||++|||++||
T Consensus       308 ~~~~~~~l~~li~~~l~~dP~~Rps~~ei  336 (367)
T 3l9p_A          308 PKNCPGPVYRIMTQCWQHQPEDRPNFAII  336 (367)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence                  37889999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-41  Score=351.52  Aligned_cols=223  Identities=18%  Similarity=0.207  Sum_probs=195.8

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ..+|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35799999999999999999986 478999999987543  235688999999999 99999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc-----EEEecccCCcccc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV-----AHLSDFGITKLLI  576 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~~~~~~  576 (652)
                      |+ +++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+++.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 8999999987656799999999999999999999999   9999999999999998887     9999999998764


Q ss_pred             CCCCcc-----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          577 GEDQSM-----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       577 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..                      
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            332211     12355799999999999999999999999999999999999999753                      


Q ss_pred             --------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                              .+.+++.+||+.||++||++++|
T Consensus       242 ~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l  272 (330)
T 2izr_A          242 EVLCENFPEMATYLRYVRRLDFFEKPDYDYL  272 (330)
T ss_dssp             HHHTTTCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             HHHhccChHHHHHHHHHHhCCCCCCCCHHHH
Confidence                    46789999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=357.82  Aligned_cols=226  Identities=23%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      .++|.+.+.||+|+||.||+|+..        ++..||||+++... ......+.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            457889999999999999999852        24679999997653 34457788999999999 999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||++   +|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            99999999999999999997654               2589999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------  628 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------  628 (652)
                      ++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.         
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~  304 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  304 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987643333233344567889999999999999999999999999999999 988854         


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||+.||++|||++||
T Consensus       305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  343 (382)
T 3tt0_A          305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  343 (382)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                           347889999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-41  Score=357.76  Aligned_cols=203  Identities=20%  Similarity=0.228  Sum_probs=176.2

Q ss_pred             HhcCCCccceeccc--cceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKG--GFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ...+|++.+.||+|  +||.||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            34579999999999  99999999976 69999999997653  334567888999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          498 LVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999987652 3689999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCCC-----ccccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          577 GEDQ-----SMTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       577 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ....     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||.
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            2211     111223468999999999887  679999999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-41  Score=356.08  Aligned_cols=209  Identities=26%  Similarity=0.293  Sum_probs=182.2

Q ss_pred             CccccccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-----CCee
Q 041689          410 ATWRRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-----YRNL  483 (652)
Q Consensus       410 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni  483 (652)
                      ....++++.+.....++|.+.+.||+|+||.||+|+.. +++.||||+++.. ......+..|++++++++     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            34556666666677889999999999999999999874 6899999999743 334566788999999996     9999


Q ss_pred             eeEEeeeecCCceEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--
Q 041689          484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--  560 (652)
Q Consensus       484 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--  560 (652)
                      +++++++...+..++||||+ +++|.+++..... .+++.++..++.|++.||+|||++   ||+||||||+||+++.  
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            99999999999999999999 8899999876542 589999999999999999999999   9999999999999975  


Q ss_pred             -----------------------CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHH
Q 041689          561 -----------------------TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIML  617 (652)
Q Consensus       561 -----------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl  617 (652)
                                             ++.+||+|||+++....     ......||+.|+|||++.+..++.++||||+||++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   78999999999986422     22345689999999999999999999999999999


Q ss_pred             HHHHhCCCCcc
Q 041689          618 MEIHSAKQQCV  628 (652)
Q Consensus       618 ~elltg~~p~~  628 (652)
                      |||++|+.||.
T Consensus       250 ~ell~g~~pf~  260 (360)
T 3llt_A          250 AELYTGSLLFR  260 (360)
T ss_dssp             HHHHHSSCSCC
T ss_pred             HHHHHCCCCCC
Confidence            99999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=352.10  Aligned_cols=223  Identities=21%  Similarity=0.285  Sum_probs=196.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--------RAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++....        .....+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3567999999999999999999864 689999999975421        2345677899999999999999999999999


Q ss_pred             CceEEEEEccCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          494 EFKELVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       494 ~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887665 699999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCc-----------------chhhhhh
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQC-----------------VSFVFNL  634 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~-----------------~~~l~~l  634 (652)
                      +.....   .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||                 +..+.++
T Consensus       178 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          178 AYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             EECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHH
T ss_pred             eECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHH
Confidence            875322   22334569999999999988877 78899999999999999999996                 3458899


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++||
T Consensus       255 i~~~L~~dP~~Rps~~el  272 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKL  272 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHH
T ss_pred             HHHHccCChhhCcCHHHH
Confidence            999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-41  Score=364.34  Aligned_cols=221  Identities=24%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++....   ......+.+|+++++.++||||+++++++...+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57899999999999999999875 79999999997542   223467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....  
T Consensus        96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence            9999999999997654 699999999999999999999999   9999999999999999999999999999875322  


Q ss_pred             ccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..                       .+.+++.
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK  248 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence             22344579999999999988766 6899999999999999999999643                       3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..||++|||++||
T Consensus       249 ~~L~~dP~~Rpt~~ei  264 (476)
T 2y94_A          249 HMLQVDPMKRATIKDI  264 (476)
T ss_dssp             HHTCSSTTTSCCHHHH
T ss_pred             HHcCCCchhCcCHHHH
Confidence            9999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.1e-41  Score=355.05  Aligned_cols=221  Identities=26%  Similarity=0.264  Sum_probs=186.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---hhhhhHHHHHHH-HHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---RAFKSFDIECEI-MKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....   .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            357899999999999999999976 588999999976532   233455667766 567899999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999987654 688999999999999999999999   9999999999999999999999999999864221


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLA  635 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~  635 (652)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 --NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             --CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             --CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence              2233456799999999999999999999999999999999999999643                       378899


Q ss_pred             cccchhhhccccCcc
Q 041689          636 MECTIESLELRINAK  650 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~  650 (652)
                      .+||+.||++||++.
T Consensus       271 ~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHTCSSGGGSTTTT
T ss_pred             HHHcccCHHhCCCCC
Confidence            999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=339.78  Aligned_cols=224  Identities=22%  Similarity=0.333  Sum_probs=177.7

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|+. .+|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999986 479999999997542   22346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC-
Confidence            999999999999987766799999999999999999999999   9999999999999999999999999999865321 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..                       .+.+++.
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          166 -HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred             -CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence             1122345689999999999988999999999999999999999999643                       3688999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       245 ~~l~~dp~~Rps~~~~  260 (278)
T 3cok_A          245 QLLRRNPADRLSLSSV  260 (278)
T ss_dssp             HHSCSSGGGSCCHHHH
T ss_pred             HHcccCHhhCCCHHHH
Confidence            9999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=352.80  Aligned_cols=220  Identities=20%  Similarity=0.274  Sum_probs=180.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            467999999999999999999976 58899999997543  346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++|+|.+++.... .+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++....  
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--  203 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--  203 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence            99999999987654 689999999999999999999999   9999999999999975   88999999999986522  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------------hh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------FV  631 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------~l  631 (652)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||..                            .+
T Consensus       204 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          204 -QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             -ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence             1223345689999999999999999999999999999999999999632                            36


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++|+
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~  303 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQA  303 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHH
Confidence            789999999999999998764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=353.57  Aligned_cols=227  Identities=23%  Similarity=0.377  Sum_probs=195.3

Q ss_pred             HhcCCCccceeccccceEEEEEEe------CCCcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      ..++|.+.+.||+|+||.||+|++      .++..||+|+++.. .....+.+.+|+++++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999985      24668999999754 233456789999999999 8999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNC----------------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLK  552 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlk  552 (652)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||++   ||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            99999999999999999976542                      378899999999999999999999   99999999


Q ss_pred             CCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--
Q 041689          553 PSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--  629 (652)
Q Consensus       553 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--  629 (652)
                      |+||+++.++.+||+|||++................+|+.|+|||++.++.++.++|||||||++|||+| |+.||..  
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987644333333344567889999999998999999999999999999998 9988643  


Q ss_pred             -----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             .+.+++.+||+.||++|||++||
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  325 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  325 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence                                   37789999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=354.52  Aligned_cols=230  Identities=26%  Similarity=0.353  Sum_probs=197.6

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeec
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSN  492 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  492 (652)
                      +....++|++.+.||+|+||.||+|+..      +++.||+|+++... ....+.+.+|++++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678999999999999999999864      35889999997653 3345678999999999999999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSN-----------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC  549 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  549 (652)
                      ++..++||||+++|+|.+++....                       ..+++.++..++.|++.||+|||++   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            999999999999999999987642                       3689999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc
Q 041689          550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV  628 (652)
Q Consensus       550 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~  628 (652)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999986533222222334567899999999998899999999999999999999 988853


Q ss_pred             ------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                              ..+.+++.+||+.||++|||++||
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  326 (343)
T 1luf_A          279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI  326 (343)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence                                    347889999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=346.27  Aligned_cols=220  Identities=21%  Similarity=0.221  Sum_probs=186.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....  .........|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46999999999999999999976 69999999986532  23334455566666555 8999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+ +++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....   
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc---
Confidence            999 6699998887666799999999999999999999999   999999999999999999999999999986532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC----------------------cchhhhhhhccc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ----------------------CVSFVFNLAMEC  638 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p----------------------~~~~l~~l~~~~  638 (652)
                      ........||+.|+|||++.+ .++.++|||||||++|||++|..|                      ++..+.+++.+|
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            222334568999999998875 799999999999999999999665                      234588999999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||++||
T Consensus       289 L~~dP~~Rpt~~el  302 (311)
T 3p1a_A          289 LEPDPKLRATAEAL  302 (311)
T ss_dssp             SCSSTTTSCCHHHH
T ss_pred             cCCChhhCcCHHHH
Confidence            99999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-41  Score=351.84  Aligned_cols=225  Identities=24%  Similarity=0.373  Sum_probs=187.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcE----EEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGME----VAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.++.. .....+.+.+|++++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            356889999999999999999854 4443    588877543 2345578899999999999999999999998764 77


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999988777899999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~  632 (652)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..                        .+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            433333344557889999999999999999999999999999999 9998653                        277


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       250 ~li~~~l~~~p~~Rps~~el  269 (327)
T 3poz_A          250 MIMVKCWMIDADSRPKFREL  269 (327)
T ss_dssp             HHHHHHTCSCGGGSCCHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHH
Confidence            89999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.5e-41  Score=339.39  Aligned_cols=222  Identities=22%  Similarity=0.346  Sum_probs=195.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999865 58999999997552  334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc---EEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV---AHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~  577 (652)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999998887654 689999999999999999999999   9999999999999976555   99999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc---------------------------chh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC---------------------------VSF  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~---------------------------~~~  630 (652)
                         ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||                           +..
T Consensus       161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          161 ---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             ---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             ---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence               22233456899999999999999999999999999999999999985                           334


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++|+
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~  259 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQA  259 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHHHcccChhhCCCHHHH
Confidence            7899999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=353.78  Aligned_cols=223  Identities=19%  Similarity=0.339  Sum_probs=188.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCC--CeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHY--RNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45699999999999999999998889999999997542  3345678999999999976  9999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      || +.+++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++......
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            99 56789999998765 689999999999999999999999   999999999999997 5689999999998764333


Q ss_pred             CccccccccCCccccCcccccc-----------CccCcccchhhHHHHHHHHHhCCCCcch-------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGRE-----------GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~-------------------  629 (652)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..                   
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            3333345679999999999865           6788999999999999999999999753                   


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.||++|||++|+
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~  271 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPEL  271 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence                   37889999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-41  Score=354.64  Aligned_cols=222  Identities=22%  Similarity=0.222  Sum_probs=186.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3467999999999999999999976 68999999997543 234678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc--EEEecccCCccccCCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV--AHLSDFGITKLLIGED  579 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~  579 (652)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.  +||+|||+++...   
T Consensus        97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---  169 (361)
T 3uc3_A           97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---  169 (361)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence            999999999987654 699999999999999999999999   9999999999999987665  9999999997432   


Q ss_pred             CccccccccCCccccCccccccCccCcc-cchhhHHHHHHHHHhCCCCcch-----------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFAN-GDVYSFGIMLMEIHSAKQQCVS-----------------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltg~~p~~~-----------------------------  629 (652)
                      .........||+.|+|||++.+..++.+ +||||+||++|||++|+.||..                             
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence            1222334569999999999988887755 8999999999999999999643                             


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||..||++|||++||
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~el  272 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEI  272 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHH
Confidence            36789999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-41  Score=356.32  Aligned_cols=224  Identities=24%  Similarity=0.316  Sum_probs=182.6

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCC--ce
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEE--FK  496 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~  496 (652)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999864 6899999998543  2344567789999999997 999999999997543  78


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |+||||++ ++|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999998 5999988764  589999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCC-------------------CccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------
Q 041689          577 GED-------------------QSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------  628 (652)
Q Consensus       577 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------  628 (652)
                      ...                   ........+||+.|+|||++.+ ..++.++||||+||++|||++|++||.        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            211                   1112234579999999999876 678999999999999999999999872        


Q ss_pred             --------------------------------------------------------------hhhhhhhcccchhhhccc
Q 041689          629 --------------------------------------------------------------SFVFNLAMECTIESLELR  646 (652)
Q Consensus       629 --------------------------------------------------------------~~l~~l~~~~l~~~p~~R  646 (652)
                                                                                    ..+.+++.+||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence                                                                          346789999999999999


Q ss_pred             cCccCC
Q 041689          647 INAKEI  652 (652)
Q Consensus       647 pt~~ei  652 (652)
                      ||++|+
T Consensus       321 ~t~~e~  326 (388)
T 3oz6_A          321 ISANDA  326 (388)
T ss_dssp             CCHHHH
T ss_pred             CCHHHH
Confidence            999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.4e-41  Score=338.17  Aligned_cols=221  Identities=23%  Similarity=0.257  Sum_probs=195.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356999999999999999999875 5788999999876556677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||++...... 
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-  162 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-  162 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence            99999999887654 689999999999999999999999   99999999999999   78899999999999865322 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFVF  632 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l~  632 (652)
                        .......||+.|+|||++.+ .++.++||||+|+++|||++|+.||.                           ..+.
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          163 --KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             --SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             --cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence              22344568999999998765 48999999999999999999999963                           3478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||+.|+
T Consensus       240 ~li~~~l~~dp~~R~s~~~~  259 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQA  259 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHccCChhhCcCHHHH
Confidence            89999999999999998763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-41  Score=347.73  Aligned_cols=226  Identities=22%  Similarity=0.347  Sum_probs=196.7

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      ..+|.+.+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46788999999999999999975      245789999997543 34456788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC-----------------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKP  553 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~-----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  553 (652)
                      ++||||+++++|.+++.....                       .+++.++..++.|++.||+|||++   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999976432                       378999999999999999999999   999999999


Q ss_pred             CCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc----
Q 041689          554 SNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV----  628 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~----  628 (652)
                      +||++++++.+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||.    
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987643333233344557889999999998899999999999999999999 988854    


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++.+||+.||++|||++||
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  302 (314)
T 2ivs_A          259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI  302 (314)
T ss_dssp             GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                                337899999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.5e-41  Score=341.80  Aligned_cols=223  Identities=14%  Similarity=0.155  Sum_probs=196.2

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+++++++ +|++++++++++..+...++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            45799999999999999999986 479999999986542  345788999999999 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc-----EEEecccCCcccc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV-----AHLSDFGITKLLI  576 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-----~kl~Dfg~~~~~~  576 (652)
                      |+ +++|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 8999999987666799999999999999999999999   9999999999999987766     9999999998764


Q ss_pred             CCCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          577 GEDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       577 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..                      
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            33221     112345699999999999999999999999999999999999999744                      


Q ss_pred             ---------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               .+.+++.+||+.||++|||++||
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l  274 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYL  274 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHH
Confidence                     37889999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=350.90  Aligned_cols=222  Identities=21%  Similarity=0.276  Sum_probs=186.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999875 689999999975432 2223456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++ +|.+++......+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++....  ...
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK  155 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence            974 99999887776799999999999999999999999   999999999999999999999999999975422  122


Q ss_pred             ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..                                
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            2334568999999999876 5689999999999999999999999733                                


Q ss_pred             ---------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                           .+.+++.+||+.||++|||++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  279 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA  279 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence                                 34689999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-41  Score=351.34  Aligned_cols=224  Identities=23%  Similarity=0.373  Sum_probs=190.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcE----EEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGME----VAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|++.+.||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999864 4544    7777775432 234456788999999999999999999986 456889


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999999999987666789999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ..........+++.|+|||++.++.++.++|||||||++|||++ |+.||..                        .+.+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM  248 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence            43334455568889999999999999999999999999999999 9999643                        3778


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..||++|||++||
T Consensus       249 li~~~l~~dp~~Rps~~el  267 (325)
T 3kex_A          249 VMVKCWMIDENIRPTFKEL  267 (325)
T ss_dssp             HHHHHTCSCTTTSCCHHHH
T ss_pred             HHHHHcCCChhhCcCHHHH
Confidence            9999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.3e-41  Score=339.84  Aligned_cols=221  Identities=24%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++....   ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999865 57889999996542   22346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++....   
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~---  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC---
Confidence            99999999999887654 689999999999999999999999   99999999999999999999999999986542   


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ........|++.|+|||++.+..++.++||||+|+++|||++|+.||..                       .+.+++.
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (279)
T 3fdn_A          161 -SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS  239 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             -cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence             1222345689999999999999999999999999999999999999543                       3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       240 ~~l~~~p~~Rps~~e~  255 (279)
T 3fdn_A          240 RLLKHNPSQRPMLREV  255 (279)
T ss_dssp             HHCCSSGGGSCCHHHH
T ss_pred             HHhccChhhCCCHHHH
Confidence            9999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.6e-41  Score=344.75  Aligned_cols=220  Identities=25%  Similarity=0.329  Sum_probs=192.8

Q ss_pred             hcCCCccceeccccceEEEEEEeCC-C-------cEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD-G-------MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      .++|.+.+.||+|+||.||+|+... +       ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578899999999999999998543 3       4799999977666667889999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc--------EEEe
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV--------AHLS  567 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--------~kl~  567 (652)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999988765699999999999999999999999   9999999999999988876        9999


Q ss_pred             cccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCC--------------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQ--------------------  626 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p--------------------  626 (652)
                      |||.+....      ......+|+.|+|||++.+ ..++.++|||||||++|||++|..|                    
T Consensus       164 Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          164 DPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL  237 (289)
T ss_dssp             CCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             cCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence            999987541      1223457889999999887 6789999999999999999996443                    


Q ss_pred             ---cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ---CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ---~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         ++..+.+++.+||+.||++|||++||
T Consensus       238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l  266 (289)
T 4fvq_A          238 PAPKAAELANLINNCMDYEPDHRPSFRAI  266 (289)
T ss_dssp             CCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence               23348899999999999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7.8e-41  Score=345.09  Aligned_cols=221  Identities=21%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch------hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR------AFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46899999999999999999875 6899999999754321      3567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~~  573 (652)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++    .+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            9999999999999997654 689999999999999999999999   999999999999999887    79999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (321)
T 2a2a_A          168 EIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH  244 (321)
T ss_dssp             ECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             ecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence            65322   222345689999999999999999999999999999999999999632                        


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||..||++|||++|+
T Consensus       245 ~~~~~~~li~~~l~~dp~~Rps~~e~  270 (321)
T 2a2a_A          245 TSELAKDFIRKLLVKETRKRLTIQEA  270 (321)
T ss_dssp             CCHHHHHHHHTTSCSSTTTSCCHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHH
Confidence               26889999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.8e-41  Score=343.31  Aligned_cols=220  Identities=26%  Similarity=0.382  Sum_probs=185.6

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHh--cCCCeeeeEEeeeec----CCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS--IHYRNLVKIISSCSN----EEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~  497 (652)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999988 6899999998654   33455667777766  799999999998654    34689


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH--------FNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      +||||+++|+|.+++...  .+++..+..++.|++.||+|||        +.   +|+||||||+||+++.++.+||+||
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence            999999999999999654  5899999999999999999999        77   9999999999999999999999999


Q ss_pred             cCCccccCCCCcc--ccccccCCccccCccccccC------ccCcccchhhHHHHHHHHHhC----------CCCcch--
Q 041689          570 GITKLLIGEDQSM--TQTQTLATIGYIAPEYGREG------RVFANGDVYSFGIMLMEIHSA----------KQQCVS--  629 (652)
Q Consensus       570 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg----------~~p~~~--  629 (652)
                      |+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||..  
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998654332221  12334799999999998876      566799999999999999999          777532  


Q ss_pred             ---------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                       .+.+++.+||+.||++|||++||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence                                             26789999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-41  Score=349.61  Aligned_cols=228  Identities=23%  Similarity=0.395  Sum_probs=180.0

Q ss_pred             HHhcCCCccceeccccceEEEEEEeCC-C---cEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIGD-G---MEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      ...++|++.+.||+|+||.||+|++.. +   ..||||+++..  .....+.+.+|++++++++||||+++++++...+.
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345679999999999999999998654 3   27999999754  34456789999999999999999999999987765


Q ss_pred             e------EEEEEccCCCChhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          496 K------ELVLEHMPHGSLEKCLYSSN-----CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       496 ~------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      .      ++||||+++|+|.+++....     ..+++.++..++.|++.||+|||++   ||+||||||+||++++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            4      89999999999999886432     2589999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--------------  629 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--------------  629 (652)
                      ||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||..              
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            9999999987643332233334457889999999999999999999999999999999 8888643              


Q ss_pred             ----------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                .+.+++.+||+.||++|||+.||
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  289 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCL  289 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence                      37899999999999999997753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.1e-41  Score=346.75  Aligned_cols=226  Identities=21%  Similarity=0.322  Sum_probs=197.1

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeecccc-hhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .++|.+.+.||+|+||.||+|++      .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            45788999999999999999974      3478899999975532 3457789999999999 99999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          496 KELVLEHMPHGSLEKCLYSSNC-----------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      .++||||+++|+|.+++.....                 .+++.++..++.|++.||+|||++   ||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            9999999999999999876542                 489999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--------  629 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--------  629 (652)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..        
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            9999999999999987644333223334557889999999999999999999999999999999 8888533        


Q ss_pred             -----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                       .+.+++.+||+.||++|||++||
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  298 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence                             37889999999999999999874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.8e-40  Score=357.02  Aligned_cols=308  Identities=19%  Similarity=0.226  Sum_probs=256.7

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcc-cCCccccCCCCCCEEEcCCCcCeeccCCCccccccC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVG-VVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS   79 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~   79 (652)
                      +|.+++.|+|+.|.+..  ..|..+ ++++|++|+|++|.+.+ +.+..|.++++|++|+|++|++++..+.        
T Consensus        28 l~~~l~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~--------   97 (455)
T 3v47_A           28 LPAHVNYVDLSLNSIAE--LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG--------   97 (455)
T ss_dssp             CCTTCCEEECCSSCCCE--ECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT--------
T ss_pred             CCCccCEEEecCCccCc--CChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh--------
Confidence            46789999999999984  357767 89999999999999974 4577899999999999999999877653        


Q ss_pred             CCCCcccccccCCCCCCcEEEcccCCCcccCCc-cchhcccccCcEEEccCCcccccCCcc-ccCCCCCCEEEecCcccc
Q 041689           80 STPELSFLSSLSNCKSLVVFLLSNNPLNGILPR-MSIGNLSHSLEIFDMSKCNVSGGIPEE-IGNLTNLTAIYLGGNKLN  157 (652)
Q Consensus        80 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~  157 (652)
                               .|.++++|++|+|++|++++..+. ..+..+++ |++|+|++|++++..|.. |.++++|++|+|++|+++
T Consensus        98 ---------~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           98 ---------AFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS-LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             ---------TTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTT-CCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             ---------hccCcccCCEEeCCCCCCCccccCcccccCccc-CCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence                     466777777777777777653222 13556665 777777777777666655 677777777777777777


Q ss_pred             ccCCccccC----------------------------------CCCCcEEecccCccccccCccccC-------------
Q 041689          158 GSIPFTLRE----------------------------------LQKLQYVGLKDNKLEGTIPYDIFR-------------  190 (652)
Q Consensus       158 ~~~~~~~~~----------------------------------l~~L~~L~L~~N~l~~~~~~~~~~-------------  190 (652)
                      +..+..+..                                  +++|++|++++|++++..|..+..             
T Consensus       168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~  247 (455)
T 3v47_A          168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS  247 (455)
T ss_dssp             CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred             ccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence            666655544                                  378999999999988766654432             


Q ss_pred             --------------------------CCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccce
Q 041689          191 --------------------------LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIG  242 (652)
Q Consensus       191 --------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~  242 (652)
                                                .++|+.|++++|++++..|..|..+++|++|+|++|.  ...|..+.++++|+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  327 (455)
T 3v47_A          248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK  327 (455)
T ss_dssp             TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCE
Confidence                                      2589999999999999999999999999999999997  345668999999999


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcC
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  322 (652)
                      |++++|.+++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|++++|++
T Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  407 (455)
T 3v47_A          328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW  407 (455)
T ss_dssp             EECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCc
Confidence            99999999999899999999999999999999988899999999999999999999988888889999999999999999


Q ss_pred             cccCCCC
Q 041689          323 EGEIPKG  329 (652)
Q Consensus       323 ~~~~p~~  329 (652)
                      +|.+|..
T Consensus       408 ~~~~~~~  414 (455)
T 3v47_A          408 DCSCPRI  414 (455)
T ss_dssp             CCCTTTT
T ss_pred             ccCCCcc
Confidence            9999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.6e-41  Score=350.12  Aligned_cols=218  Identities=24%  Similarity=0.319  Sum_probs=191.4

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..|...+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4488899999999999999986 478999999997542   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||++ |++.+++......+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....   
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9997 588888866555799999999999999999999999   999999999999999999999999999986521   


Q ss_pred             ccccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVF  632 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~  632 (652)
                         .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.                         ..+.
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence               23456899999999874   5678999999999999999999999853                         2367


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       284 ~li~~~l~~dP~~Rps~~~l  303 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVL  303 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHcccChhhCcCHHHH
Confidence            89999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-41  Score=344.18  Aligned_cols=222  Identities=24%  Similarity=0.290  Sum_probs=188.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999975 58999999986542  2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++++.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+......  .
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--S  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--c
Confidence            999999998876554 689999999999999999999999   9999999999999999999999999999865322  2


Q ss_pred             cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcchh------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVSF------------------------------  630 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~------------------------------  630 (652)
                      .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...                              
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            22334568999999999876 56899999999999999999999986432                              


Q ss_pred             ------------------------hhhhhcccchhhhccccCccCC
Q 041689          631 ------------------------VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 ------------------------l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                              +.+++.+||+.||++|||++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  282 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL  282 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence                                    5579999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-41  Score=342.82  Aligned_cols=223  Identities=27%  Similarity=0.353  Sum_probs=188.8

Q ss_pred             HhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc-----chhhhhHHHHHHHHHhcC---CCeeeeEEeeeecC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIH---YRNLVKIISSCSNE  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  493 (652)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|+++...     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999996 468999999997432     112346677888877764   99999999998765


Q ss_pred             C-----ceEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 041689          494 E-----FKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLS  567 (652)
Q Consensus       494 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~  567 (652)
                      .     ..++||||+++ +|.+++..... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence            4     57899999975 99999876553 489999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      |||+++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||..                  
T Consensus       163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999986532   2223456789999999999999999999999999999999999999732                  


Q ss_pred             --------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                      .+.+++.+||+.||++|||++|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  294 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA  294 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence                                            24679999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-41  Score=338.30  Aligned_cols=224  Identities=27%  Similarity=0.369  Sum_probs=197.3

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ..+|++.+.||+|+||.||+|+..+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357889999999999999999988889999999976533 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++..... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            99999999987766789999999999999999999999   9999999999999999999999999999865221 1111


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhccc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMEC  638 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~  638 (652)
                      .....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.                        ..+.+++.+|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~  241 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  241 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence            233457788999999988899999999999999999999 888864                        2378899999


Q ss_pred             chhhhccccCccCC
Q 041689          639 TIESLELRINAKEI  652 (652)
Q Consensus       639 l~~~p~~Rpt~~ei  652 (652)
                      |+.||++|||++|+
T Consensus       242 l~~~p~~Rps~~~l  255 (267)
T 3t9t_A          242 WRERPEDRPAFSRL  255 (267)
T ss_dssp             TCSSGGGSCCHHHH
T ss_pred             ccCChhhCcCHHHH
Confidence            99999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-41  Score=348.31  Aligned_cols=224  Identities=22%  Similarity=0.358  Sum_probs=186.5

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc----
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF----  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  495 (652)
                      .++|++.+.||+|+||.||+|++ .+++.||||+++...   ......+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999986 478999999997642   2334578899999999999999999999876543    


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999987654 689999999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          576 IGEDQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       576 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.                          
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            332221 12234568999999999999999999999999999999999999964                          


Q ss_pred             -hhhhhhhcccchhhhccccCccC
Q 041689          629 -SFVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                       ..+.+++.+||+.||++||++.+
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~  270 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAA  270 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHH
Confidence             23788999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.5e-41  Score=344.90  Aligned_cols=224  Identities=22%  Similarity=0.291  Sum_probs=188.8

Q ss_pred             cCCCcc-ceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNEN-NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|.+. +.||+|+||.||+|+.. +++.||||+++.........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 78999999999999864 6899999999876555567889999999985 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc---EEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV---AHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~  578 (652)
                      |+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++......
T Consensus        92 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             cCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999987654 689999999999999999999999   9999999999999987765   999999998765321


Q ss_pred             CC-----ccccccccCCccccCcccccc-----CccCcccchhhHHHHHHHHHhCCCCcch-------------------
Q 041689          579 DQ-----SMTQTQTLATIGYIAPEYGRE-----GRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------  629 (652)
Q Consensus       579 ~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~-------------------  629 (652)
                      ..     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||..                   
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            11     111223458999999999875     5688999999999999999999999732                   


Q ss_pred             -----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             .+.+++.+||+.||++|||++|+
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  293 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV  293 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence                                   36789999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.7e-41  Score=355.66  Aligned_cols=222  Identities=19%  Similarity=0.339  Sum_probs=188.7

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcC--CCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIH--YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|++++++++  ||||+++++++...+..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999997542  344577899999999996  599999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      | +.+++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++.+.....
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999998765 788999999999999999999999   999999999999996 57899999999987643332


Q ss_pred             ccccccccCCccccCcccccc-----------CccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGRE-----------GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||..                    
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  289 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  289 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence            223345679999999999865           4688999999999999999999999743                    


Q ss_pred             ------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            .+.+++.+||..||++|||++||
T Consensus       290 ~~~~~~~~~~li~~~L~~dP~~Rps~~el  318 (390)
T 2zmd_A          290 PDIPEKDLQDVLKCCLKRDPKQRISIPEL  318 (390)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CccchHHHHHHHHHHcccChhhCCCHHHH
Confidence                  26789999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.5e-41  Score=351.08  Aligned_cols=220  Identities=23%  Similarity=0.319  Sum_probs=190.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...    ....+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3457999999999999999999875 68999999997543    2345788888888 7999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC----CcEEEecccCCcccc
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT----MVAHLSDFGITKLLI  576 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~~~~~~  576 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||++.++    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999987654 689999999999999999999999   99999999999998432    359999999998753


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------  629 (652)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..                           
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            322  223445789999999999888899999999999999999999999742                           


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||..||++|||++|+
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~i  275 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALV  275 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHH
Confidence               26789999999999999998764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-40  Score=336.88  Aligned_cols=223  Identities=21%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            457889999999999999999976 58889999997542   23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+...... 
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-  168 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC-
Confidence            99999999999887654 689999999999999999999999   9999999999999999999999999999865322 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ........||+.|+|||++.+..++.++||||+|+++|||++|+.||..                       .+.+++.
T Consensus       169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          169 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             -TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             -ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence             1223345689999999999988999999999999999999999999643                       3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++|+
T Consensus       248 ~~l~~~p~~Rps~~~l  263 (294)
T 2rku_A          248 KMLQTDPTARPTINEL  263 (294)
T ss_dssp             HHTCSSGGGSCCGGGG
T ss_pred             HHcccChhhCcCHHHH
Confidence            9999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.2e-41  Score=337.09  Aligned_cols=222  Identities=25%  Similarity=0.388  Sum_probs=182.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc----chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+|++.+.||+|+||.||+|++. ++.||||+++...    ....+.+.+|++++++++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357889999999999999999984 8899999986542    22346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--------CCcEEEecccC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--------TMVAHLSDFGI  571 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--------~~~~kl~Dfg~  571 (652)
                      |||+++++|.+++...  .+++..+..++.|++.||+|||++...+|+||||||+||+++.        ++.+||+|||.
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            9999999999988644  5899999999999999999999992122999999999999985        77899999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      ++.....    ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..                      
T Consensus       163 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3dtc_A          163 AREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST  238 (271)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred             ccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence            9865321    22245689999999999988999999999999999999999999643                      


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||+.||++|||++||
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~  264 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNI  264 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHH
Confidence               37899999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-40  Score=345.48  Aligned_cols=222  Identities=25%  Similarity=0.350  Sum_probs=189.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57889999999999999999875 58999999986542  2334567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |++++++.++..... .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++.....  .
T Consensus       105 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  178 (331)
T 4aaa_A          105 FVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G  178 (331)
T ss_dssp             CCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC--c
Confidence            999999888765544 689999999999999999999999   9999999999999999999999999999865322  2


Q ss_pred             cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.                                
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            223445689999999998775 78899999999999999999999863                                


Q ss_pred             ----------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            ..+.+++.+||+.||++|||++|+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  304 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL  304 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence                                  346789999999999999999885

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-41  Score=362.47  Aligned_cols=219  Identities=22%  Similarity=0.231  Sum_probs=185.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------C
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------E  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  494 (652)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999865 6899999999754  334456788999999999999999999998654      3


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..|+||||+++ ++.+.+..   .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            56999999986 56666543   488999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ...   ........||+.|+|||++.+..|+.++||||+||++|||++|+.||..                         
T Consensus       214 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            532   2233456799999999999999999999999999999999999999742                         


Q ss_pred             ----------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                              .+.+++.+||..||++|||++|+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  353 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  353 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                                                    36789999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-40  Score=361.20  Aligned_cols=221  Identities=23%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888999999999999999975 69999999997542   233467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||++||+|.+++....   ..+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++.+..
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999887543   3689999999999999999999999   999999999999999999999999999987532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------h
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------F  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~  630 (652)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..                           .
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  419 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPA  419 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHH
Confidence            21  223345799999999999999999999999999999999999999743                           2


Q ss_pred             hhhhhcccchhhhccccCcc
Q 041689          631 VFNLAMECTIESLELRINAK  650 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~  650 (652)
                      +.+++.+||+.||++||++.
T Consensus       420 ~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCB
T ss_pred             HHHHHHHhccCCHhHCCCCc
Confidence            67899999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-40  Score=364.52  Aligned_cols=219  Identities=23%  Similarity=0.320  Sum_probs=194.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456889999999999999999875 69999999997542   23345678999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          500 LEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |||++||+|.+++..... .+++..+..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999876542 589999999999999999999999   9999999999999999999999999999875322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FV  631 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l  631 (652)
                         ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..                           .+
T Consensus       340 ---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~  416 (576)
T 2acx_A          340 ---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA  416 (576)
T ss_dssp             ---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             ---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence               223445799999999999999999999999999999999999999753                           26


Q ss_pred             hhhhcccchhhhccccC
Q 041689          632 FNLAMECTIESLELRIN  648 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt  648 (652)
                      .+++.+||+.||++||+
T Consensus       417 ~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             HHHHHHHTCSSGGGSTT
T ss_pred             HHHHHHhccCCHHHcCC
Confidence            78999999999999993

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-40  Score=335.84  Aligned_cols=225  Identities=22%  Similarity=0.276  Sum_probs=196.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457999999999999999999875 68999999997543 3345778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999887654 689999999999999999999999   9999999999999999999999999999865333222


Q ss_pred             cccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l  634 (652)
                      .......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||..                          .+.++
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            23345568999999999987765 6789999999999999999999642                          26789


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++||
T Consensus       242 i~~~l~~~p~~Rps~~~i  259 (276)
T 2yex_A          242 LHKILVENPSARITIPDI  259 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHH
T ss_pred             HHHHCCCCchhCCCHHHH
Confidence            999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.2e-41  Score=346.56  Aligned_cols=226  Identities=22%  Similarity=0.359  Sum_probs=195.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC--------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      .++|++.+.||+|+||.||+|++.        ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467899999999999999999853        46789999997553 34456788999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNC---------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      +..++||||+++|+|.+++.....               .+++.++..++.|++.||+|||++   ||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            999999999999999999976542               488999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch--------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS--------  629 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~--------  629 (652)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..        
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            9999999999999987643322222334457889999999988899999999999999999999 9888643        


Q ss_pred             ----------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                      .+.+++.+||+.||++|||++||
T Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  309 (334)
T 2pvf_A          271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL  309 (334)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                            37889999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.3e-41  Score=342.64  Aligned_cols=225  Identities=24%  Similarity=0.402  Sum_probs=193.0

Q ss_pred             cCCCccceeccccceEEEEEEe-----CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--Cce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  496 (652)
                      .+|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3488889999999999999983     368899999997542 33457789999999999999999999999876  668


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence            999999999999999976666799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc----------------------------
Q 041689          577 GEDQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC----------------------------  627 (652)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~----------------------------  627 (652)
                      ..... .......+|..|+|||++.+..++.++||||+||++|||++|..|+                            
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            33221 1223456888899999999999999999999999999999998763                            


Q ss_pred             -----------chhhhhhhcccchhhhccccCccCC
Q 041689          628 -----------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -----------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 +..+.+++.+||+.||++|||++||
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  293 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL  293 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence                       2347899999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-40  Score=336.80  Aligned_cols=219  Identities=27%  Similarity=0.408  Sum_probs=189.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccch-------hhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGR-------AFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367889999999999999999874 7899999998654221       1267889999999999999999999987665 


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeCCCCc-----EEEec
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLDDTMV-----AHLSD  568 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~-----~kl~D  568 (652)
                       ++||||+++|+|.+++......+++..+..++.|++.||+|||++   +  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999999887777899999999999999999999999   8  999999999999987776     99999


Q ss_pred             ccCCccccCCCCccccccccCCccccCcccc--ccCccCcccchhhHHHHHHHHHhCCCCcch-----------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYG--REGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------  629 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------  629 (652)
                      ||+++...     .......||+.|+|||++  ....++.++||||+||++|||++|+.||..                 
T Consensus       173 fg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            99997532     223446789999999998  455678999999999999999999999643                 


Q ss_pred             ----------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                .+.+++.+||+.||++|||++||
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  280 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI  280 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                      27889999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.6e-41  Score=348.44  Aligned_cols=230  Identities=21%  Similarity=0.285  Sum_probs=191.9

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-----cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-----CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      +....++|.+.+.||+|+||.||+|+.. +++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3455677999999999999999999864 6889999999754     234557889999999999999999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 041689          494 EFKELVLEHMPHGSLEKCLYSS---------------------------------------NCILDIFQRLNIMIDVASV  534 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~  534 (652)
                      +..++||||+++|+|.+++...                                       ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988521                                       1123567788899999999


Q ss_pred             HHHHHcCCCCCeEecCCCCCCeeeCCCC--cEEEecccCCccccCCCCc--cccccccCCccccCcccccc--CccCccc
Q 041689          535 LEYLHFNFLVPVIHCDLKPSNVLLDDTM--VAHLSDFGITKLLIGEDQS--MTQTQTLATIGYIAPEYGRE--GRVFANG  608 (652)
Q Consensus       535 L~~LH~~~~~~iiH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~s  608 (652)
                      |+|||++   +|+||||||+||+++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998766  8999999999865332221  12345569999999999865  6788999


Q ss_pred             chhhHHHHHHHHHhCCCCcc---------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          609 DVYSFGIMLMEIHSAKQQCV---------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       609 DvwslG~vl~elltg~~p~~---------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      |||||||++|||++|+.||.                           ..+.+++.+||+.||++|||++|+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            99999999999999999963                           347899999999999999999764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.4e-41  Score=347.27  Aligned_cols=225  Identities=26%  Similarity=0.349  Sum_probs=196.7

Q ss_pred             cCCCccceeccccceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeee--cCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS--NEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~  497 (652)
                      ++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999983     368899999998766666678999999999999999999999886  456789


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++++|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            99999999999999987555799999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCcc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-----------------------------
Q 041689          578 EDQSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-----------------------------  627 (652)
Q Consensus       578 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-----------------------------  627 (652)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||                             
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            22211 223345888899999999999999999999999999999998874                             


Q ss_pred             ----------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ----------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ----------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                +..+.+++.+||+.||++|||++||
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                      2347899999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-41  Score=346.35  Aligned_cols=236  Identities=22%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             cccHHHHHHHhcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeee
Q 041689          414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVK  485 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~  485 (652)
                      .+...+.....++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            455556666678999999999999999999973      357889999997653 23456788999999999 7999999


Q ss_pred             EEeeeecCC-ceEEEEEccCCCChhhhhhcCCCC---------------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 041689          486 IISSCSNEE-FKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLNIMIDVASVLEYLHFNFLVPVIHC  549 (652)
Q Consensus       486 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  549 (652)
                      +++++...+ ..++||||+++++|.+++......               +++..+..++.|++.||.|||++   ||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987654 589999999999999999865432               78999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc
Q 041689          550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV  628 (652)
Q Consensus       550 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~  628 (652)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999986643333333344567889999999999999999999999999999998 998863


Q ss_pred             h-------------------------hhhhhhcccchhhhccccCccCC
Q 041689          629 S-------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ~-------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .                         .+.+++.+||+.||++|||++||
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  301 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  301 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            2                         37889999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.6e-40  Score=352.55  Aligned_cols=217  Identities=20%  Similarity=0.242  Sum_probs=180.7

Q ss_pred             cCCCcc-ceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHh-cCCCeeeeEEeeeec----CCceE
Q 041689          425 YGFNEN-NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKS-IHYRNLVKIISSCSN----EEFKE  497 (652)
Q Consensus       425 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~  497 (652)
                      ++|.+. +.||+|+||.||+|+.. +++.||||+++..     ..+.+|++++.+ .+||||+++++++..    .+..|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999865 6899999998632     456788888754 489999999998865    56789


Q ss_pred             EEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~  573 (652)
                      +||||+++|+|.+++.... ..+++.++..|+.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998754 3689999999999999999999999   9999999999999997   7899999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ....   .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.                         
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          213 ETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             ccCC---CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            6522   122345678999999999999999999999999999999999999863                         


Q ss_pred             ------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            ..+.+++.+||..||++|||++||
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei  319 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEF  319 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                  236789999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.1e-41  Score=364.01  Aligned_cols=223  Identities=22%  Similarity=0.253  Sum_probs=186.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++..   .......+.+|++++++++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999865 6899999999754   223345677899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||+ .   ||+||||||+||+++.++.+||+|||+++.... 
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence            99999999999887654 68999999999999999999998 8   999999999999999999999999999985422 


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLA  635 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~  635 (652)
                       .........||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++
T Consensus       302 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          302 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             -CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence             22233456799999999999999999999999999999999999999633                       378899


Q ss_pred             cccchhhhcccc-----CccCC
Q 041689          636 MECTIESLELRI-----NAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rp-----t~~ei  652 (652)
                      .+||+.||++||     +++|+
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~el  402 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEI  402 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHH
T ss_pred             HHHcccCHHHhCCCCCCCHHHH
Confidence            999999999999     77653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1e-40  Score=361.48  Aligned_cols=195  Identities=21%  Similarity=0.279  Sum_probs=154.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-----CCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-----EEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~  495 (652)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999865 6899999999653  23345678899999999999999999999843     357


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999985 69999887654 699999999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCCCc-------------------------cccccccCCccccCcccc-ccCccCcccchhhHHHHHHHHHhC
Q 041689          576 IGEDQS-------------------------MTQTQTLATIGYIAPEYG-REGRVFANGDVYSFGIMLMEIHSA  623 (652)
Q Consensus       576 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg  623 (652)
                      ......                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            322111                         122345689999999976 566799999999999999999983

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.8e-41  Score=338.60  Aligned_cols=221  Identities=23%  Similarity=0.323  Sum_probs=188.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45889999999999999999865 68999999997653 33457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCcccc
Q 041689          503 MPHGSLEKCLYSS---NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       503 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~  576 (652)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988542   24689999999999999999999999   99999999999999   456889999999998653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hh
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SF  630 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~  630 (652)
                      ..   .......||+.|+|||++. +.++.++||||+||++|||++|+.||.                          +.
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHH
Confidence            22   2234456899999999875 578999999999999999999999963                          34


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++||
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~  276 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQV  276 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHH
Confidence            7789999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.8e-41  Score=339.22  Aligned_cols=224  Identities=21%  Similarity=0.310  Sum_probs=183.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|++..    +..||+|+++.. .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678899999999999999998642    456999998654 2334567899999999999999999999985 457889


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++++|.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            9999999999999987766799999999999999999999999   9999999999999999999999999999865322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      . ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.+
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          170 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             c-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1 112233456788999999998899999999999999999997 888864                        23778


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++|||++||
T Consensus       249 li~~~l~~~p~~Rps~~~l  267 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFTEL  267 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHccCChhhCcCHHHH
Confidence            9999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-40  Score=342.42  Aligned_cols=223  Identities=21%  Similarity=0.255  Sum_probs=197.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+|.+.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999876 58899999997542   23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..... 
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC-
Confidence            99999999999887654 689999999999999999999999   9999999999999999999999999999865322 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||..                       .+.+++.
T Consensus       195 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          195 -GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  273 (335)
T ss_dssp             -TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             -cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence             1223345689999999999988999999999999999999999999643                       3688999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..||++|||++||
T Consensus       274 ~~l~~dp~~Rps~~el  289 (335)
T 2owb_A          274 KMLQTDPTARPTINEL  289 (335)
T ss_dssp             HHTCSSGGGSCCGGGG
T ss_pred             HHccCChhHCcCHHHH
Confidence            9999999999999885

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-40  Score=348.74  Aligned_cols=232  Identities=20%  Similarity=0.230  Sum_probs=193.4

Q ss_pred             cccHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccc-----------hhhhhHHHHHHHHHhcCCCe
Q 041689          414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG-----------RAFKSFDIECEIMKSIHYRN  482 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n  482 (652)
                      +....++....++|.+.+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            4456788888999999999999999999999988899999999864321           12367899999999999999


Q ss_pred             eeeEEeeeec-----CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          483 LVKIISSCSN-----EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       483 iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                      |+++++++..     ....++||||++ |++.+++......+++..+..++.|++.||+|||++   ||+||||||+||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            9999999843     346799999998 589888887766799999999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEecccCCccccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch-------
Q 041689          558 LDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS-------  629 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~-------  629 (652)
                      ++.++.+||+|||+++....   ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..       
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999975422   222344568999999998876 6789999999999999999999999743       


Q ss_pred             ------------------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                                      .+.+++.+||+.||++|||++|+
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence                                                            36789999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-40  Score=334.62  Aligned_cols=221  Identities=21%  Similarity=0.291  Sum_probs=192.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999876 689999999975421      13567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~~  573 (652)
                      +||||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++    .+||+|||.+.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999987644 689999999999999999999999   999999999999998877    89999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .....   .......+++.|+|||++.+..++.++||||||+++|||++|+.||..                        
T Consensus       161 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          161 KIEAG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eccCC---CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            65321   122345689999999999989999999999999999999999999632                        


Q ss_pred             ---hhhhhhcccchhhhccccCccCC
Q 041689          630 ---FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                         .+.+++.+||..||++|||++|+
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~  263 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQS  263 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHH
Confidence               26889999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.7e-41  Score=363.15  Aligned_cols=225  Identities=24%  Similarity=0.393  Sum_probs=195.1

Q ss_pred             HHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3456788999999999999999999888999999997653 34678999999999999999999999986 567899999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|+|.+++.... ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... .
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN-E  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-H
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-c
Confidence            999999999997543 2588899999999999999999999   9999999999999999999999999999865221 1


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~  635 (652)
                      ........+++.|+|||++..+.++.++|||||||++|||++ |+.||.                        ..+.+++
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  418 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  418 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            111223346788999999998999999999999999999999 998864                        3478899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||+++|
T Consensus       419 ~~cl~~dp~~RPt~~~i  435 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYI  435 (454)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHccCChhHCcCHHHH
Confidence            99999999999999764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-40  Score=340.72  Aligned_cols=221  Identities=20%  Similarity=0.276  Sum_probs=192.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|+++.........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            356899999999999999999875 6899999999865444556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +++++|.+++.... .+++.++..++.|++.||+|||+.   ||+||||||+||++   ++++.+||+|||+++...   
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---  160 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---  160 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC---
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC---
Confidence            99999999887654 689999999999999999999999   99999999999999   788999999999987542   


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SFVF  632 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~l~  632 (652)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.                           ..+.
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          161 -NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             -CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             -CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence             122234468999999999999999999999999999999999999863                           3478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..||++|||++|+
T Consensus       240 ~li~~~l~~dp~~Rps~~~~  259 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKA  259 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHH
Confidence            89999999999999999764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7e-41  Score=346.12  Aligned_cols=225  Identities=24%  Similarity=0.368  Sum_probs=186.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcE----EEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGME----VAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ..+|++.+.||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999864 4554    567766533 3345678899999999999999999999998765 78


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999999988776899999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~  632 (652)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..                        .+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  249 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            333333344557889999999999999999999999999999999 9998653                        378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..||++|||++||
T Consensus       250 ~li~~~l~~dp~~Rps~~el  269 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFREL  269 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHH
Confidence            89999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-40  Score=338.93  Aligned_cols=224  Identities=25%  Similarity=0.365  Sum_probs=181.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ..++|++.+.||+|+||.||+|+..  ..||+|+++...  ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3567999999999999999999864  369999997542  34456789999999999999999999965 455689999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999977766899999999999999999999999   999999999999999999999999999986533233


Q ss_pred             ccccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcch----------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------------  629 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------------  629 (652)
                      ........||+.|+|||++.   +..++.++||||+||++|||++|+.||..                            
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence            33334456899999999986   56788899999999999999999999643                            


Q ss_pred             -hhhhhhcccchhhhccccCccCC
Q 041689          630 -FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       .+.+++.+||+.||++|||++||
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~el  279 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRI  279 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHH
Confidence             36789999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.4e-40  Score=345.95  Aligned_cols=225  Identities=22%  Similarity=0.309  Sum_probs=191.7

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec--------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN--------  492 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  492 (652)
                      ..+|++.+.||+|+||.||+|+. .+|+.||+|++....  ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36799999999999999999987 478999999986542  2234567899999999999999999999876        


Q ss_pred             CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      .+..++||||+++ ++.+.+......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999986 88887777666799999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCC--ccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc---------------------
Q 041689          573 KLLIGEDQ--SMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV---------------------  628 (652)
Q Consensus       573 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~---------------------  628 (652)
                      +.+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.                     
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            86542221  122244568999999998876 458999999999999999999999863                     


Q ss_pred             ----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                        ..+.+++.+||+.||++|||++|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  309 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  309 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHH
Confidence                                              236689999999999999999864

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.7e-39  Score=363.31  Aligned_cols=344  Identities=19%  Similarity=0.168  Sum_probs=240.2

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCc-------
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIA-------   73 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------   73 (652)
                      +|.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+...       
T Consensus        30 ~~~~l~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  107 (606)
T 3vq2_A           30 IPSSTKNIDLSFNPLKI--LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE  107 (606)
T ss_dssp             SCTTCCEEECTTSCCCE--ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCC
T ss_pred             CCCCcCEEECCCCCcCE--eChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCC
Confidence            56788999999998873  234355 88999999999999998889999999999999999999988755432       


Q ss_pred             cccccCCCCCcccccccCCCCCCcEEEcccCCCcccC-CccchhcccccCcEEEccCCcccccCCccccCCC--------
Q 041689           74 DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGIL-PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLT--------  144 (652)
Q Consensus        74 ~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--------  144 (652)
                      ...+..+.........+.++++|++|+|++|.++++. |. .++++++ |++|++++|++++..+..|..++        
T Consensus       108 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~-~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~  185 (606)
T 3vq2_A          108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA-YFSNLTN-LVHVDLSYNYIQTITVNDLQFLRENPQVNLS  185 (606)
T ss_dssp             EEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCG-GGGTCTT-CCEEECCSSCCCEECTTTTHHHHHCTTCCCE
T ss_pred             EEEccCCccccccccccCCCCCCCEEeCCCCcccceechH-hHhhcCC-CCEEEccCCcceecChhhhhhhhccccccce
Confidence            1223332222222245788888888888888888643 54 6777876 88888888888766554332221        


Q ss_pred             --------------------------------------------------------------------------------
Q 041689          145 --------------------------------------------------------------------------------  144 (652)
Q Consensus       145 --------------------------------------------------------------------------------  144 (652)
                                                                                                      
T Consensus       186 L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~  265 (606)
T 3vq2_A          186 LDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE  265 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEE
T ss_pred             eeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 041689          145 --------------------------------------------------------------------------------  144 (652)
Q Consensus       145 --------------------------------------------------------------------------------  144 (652)
                                                                                                      
T Consensus       266 l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~  345 (606)
T 3vq2_A          266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFK  345 (606)
T ss_dssp             EEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECC
T ss_pred             eeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchh
Confidence                                                                                            


Q ss_pred             -----CCCEEEecCcccccc--CCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccccc-ccCCCCC
Q 041689          145 -----NLTAIYLGGNKLNGS--IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSIL-TCFSNLA  216 (652)
Q Consensus       145 -----~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~  216 (652)
                           +|++|+|++|++++.  .|..+..+++|++|++++|.++ .+|..+..+++|+.|++++|++.+..+ ..|..++
T Consensus       346 ~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  424 (606)
T 3vq2_A          346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE  424 (606)
T ss_dssp             CCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT
T ss_pred             hccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccc
Confidence                 222222222222222  1333334444444444444444 234455566666666666666666555 5667777


Q ss_pred             CCCEEEccCCC--CCCCcccCCCCccceEecccccCCc-cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceec
Q 041689          217 SLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSS-VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNF  293 (652)
Q Consensus       217 ~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  293 (652)
                      +|++|++++|.  ...|..++++++|+.|++++|++++ .+|..|..+++|++|+|++|++++..|..|..+++|+.|+|
T Consensus       425 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  504 (606)
T 3vq2_A          425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM  504 (606)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEEC
Confidence            77777777775  3456667788888888888888876 46777888888888888888888777888888888888888


Q ss_pred             cccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCC-CcccccccCCccCCCCC
Q 041689          294 SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFG-NFSAESFEGNKLLCGSP  350 (652)
Q Consensus       294 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~l~~~~~~~N~~~c~~~  350 (652)
                      ++|++++..|..|..+++|+.|++++|+++..++....++ .++.+++.+||+.|..+
T Consensus       505 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            8888888778888888888888888888886555555554 48888888888888655

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-40  Score=357.64  Aligned_cols=219  Identities=31%  Similarity=0.401  Sum_probs=191.1

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC-ceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE-FKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  501 (652)
                      ...+|.+.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999884 7899999997653  4578899999999999999999999987654 7899999


Q ss_pred             ccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|+|.+++..... .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....   
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---  341 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc---
Confidence            9999999999986543 478999999999999999999999   999999999999999999999999999985421   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~  635 (652)
                        ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.+++
T Consensus       342 --~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          342 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             --cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence              1122357889999999999999999999999999999998 998854                        3478999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||+.||
T Consensus       420 ~~cl~~dp~~Rpt~~~l  436 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQL  436 (450)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCChhHCcCHHHH
Confidence            99999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.3e-41  Score=346.95  Aligned_cols=225  Identities=20%  Similarity=0.257  Sum_probs=184.5

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ....++|++.+.||+|+||.||+|+.. +++.||||+++....  ...+.+.+|++++++++||||+++++++.+++..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            445578999999999999999999865 689999999975432  23456778999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee-----CCCCcEEEecccCC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL-----DDTMVAHLSDFGIT  572 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll-----~~~~~~kl~Dfg~~  572 (652)
                      +||||+++ +|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||++     ++.+.+||+|||++
T Consensus       110 lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999985 9999988765 689999999999999999999999   99999999999999     45566999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-----------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-----------------------  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-----------------------  628 (652)
                      +.....  ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||.                       
T Consensus       185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            865321  2223445689999999998774 48999999999999999999999963                       


Q ss_pred             ------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    ..+.+++.+||+.||++|||++|+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  316 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA  316 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence                                          335689999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.2e-40  Score=336.08  Aligned_cols=222  Identities=24%  Similarity=0.340  Sum_probs=196.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .+.|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999864 68999999997553 3446788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++...  .+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||.+......  .
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--B
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc--c
Confidence            99999999998754  589999999999999999999999   9999999999999999999999999999865322  1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------hhhhhhcc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------FVFNLAME  637 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~l~~l~~~  637 (652)
                      .......|++.|+|||++.+..++.++||||||+++|||++|+.||..                        .+.+++.+
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence            223445689999999999999999999999999999999999998643                        37889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||..||++|||++||
T Consensus       254 ~l~~dp~~Rps~~~l  268 (303)
T 3a7i_A          254 CLNKEPSFRPTAKEL  268 (303)
T ss_dssp             HCCSSGGGSCCHHHH
T ss_pred             HcCCChhhCcCHHHH
Confidence            999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.7e-41  Score=350.95  Aligned_cols=226  Identities=17%  Similarity=0.226  Sum_probs=188.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC------CcEEEEEEeecccchh-----------hhhHHHHHHHHHhcCCCeeee
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD------GMEVAVKVFHLQCGRA-----------FKSFDIECEIMKSIHYRNLVK  485 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~  485 (652)
                      ...+|.+.+.||+|+||.||+|.+..      ++.||||++.......           ......|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998754      4789999987543211           112334556677788999999


Q ss_pred             EEeeeecC----CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC--
Q 041689          486 IISSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--  559 (652)
Q Consensus       486 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~--  559 (652)
                      +++++...    ...++||||+ +++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||+++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            99998764    4589999999 9999999988766899999999999999999999999   999999999999998  


Q ss_pred             CCCcEEEecccCCccccCCCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----
Q 041689          560 DTMVAHLSDFGITKLLIGEDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----  629 (652)
Q Consensus       560 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----  629 (652)
                      .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..     
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999865322111     111334599999999999999999999999999999999999999764     


Q ss_pred             -----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   .+.+++.+||+.||++||++++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l  320 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENL  320 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence                                         26789999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-41  Score=348.51  Aligned_cols=231  Identities=24%  Similarity=0.381  Sum_probs=197.5

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeee
Q 041689          419 EVCRATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCS  491 (652)
Q Consensus       419 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  491 (652)
                      ++....++|++.+.||+|+||.||+|++.      +++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455678999999999999999999753      37789999997543 234557889999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSN---------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM  562 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~  562 (652)
                      +.+..++||||+++|+|.+++....         ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence            9999999999999999999987532         2568899999999999999999999   999999999999999999


Q ss_pred             cEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------
Q 041689          563 VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------  629 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------  629 (652)
                      .+||+|||+++...............+|+.|+|||++.+..++.++||||+||++|||++ |+.||..            
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  255 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence            999999999986533222222334457889999999998899999999999999999999 7888532            


Q ss_pred             ------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                  .+.+++.+||+.||++|||++||
T Consensus       256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~  290 (322)
T 1p4o_A          256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  290 (322)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence                        37889999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-40  Score=334.33  Aligned_cols=220  Identities=23%  Similarity=0.293  Sum_probs=195.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999875 57889999996542   223467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.....   
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~---  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred             EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence            9999999999987654 689999999999999999999999   999999999999999999999999999876422   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~~~  637 (652)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.||.                       ..+.+++.+
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          167 -LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             -SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             -cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence             12234568999999999999999999999999999999999999964                       236889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++||
T Consensus       246 ~l~~~p~~Rps~~~l  260 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGV  260 (284)
T ss_dssp             HSCSSGGGSCCHHHH
T ss_pred             HhhcCHhhCCCHHHH
Confidence            999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=346.89  Aligned_cols=226  Identities=24%  Similarity=0.303  Sum_probs=188.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-----hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-----RAFKSFDIECEIMKSIHYRNLVKIISSCSNEE  494 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  494 (652)
                      .....+|.+.+.||+|+||.||+|+.. +|+.||||+++....     .....+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999975 589999999964321     12346789999999999999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..++||||+++ ++.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999986 89998887766788999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ....  ........+|+.|+|||++.+. .++.++|||||||++|||++|.+||.                         
T Consensus       162 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            5322  2223445689999999998654 58899999999999999999998853                         


Q ss_pred             --------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                ..+.+++.+||..||++|||++|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  289 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  289 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence                                      346789999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.8e-41  Score=351.35  Aligned_cols=221  Identities=23%  Similarity=0.343  Sum_probs=194.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57899999999999999999876 68999999997652 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +++++|.+++.... .+++..+..++.|++.||+|||+.+  ||+||||||+||+++.++.+||+|||++.....    .
T Consensus       113 ~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S  185 (360)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----H
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc----c
Confidence            99999999997654 6899999999999999999999831  899999999999999999999999999975521    1


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------------------  628 (652)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.                                  
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            2234568999999999999999999999999999999999999973                                  


Q ss_pred             ---------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                       ..+.+++.+||+.||++|||++|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  322 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL  322 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence                                             346789999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=348.27  Aligned_cols=221  Identities=16%  Similarity=0.129  Sum_probs=191.4

Q ss_pred             HhcCCCccceeccccceEEEEEE------eCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC---CCeeeeEEeeeecC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSR------IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH---YRNLVKIISSCSNE  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~  493 (652)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|+++..   ....+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45779999999999999999994      446889999999754   3456778888888886   99999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---------
Q 041689          494 EFKELVLEHMPHGSLEKCLYS----SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---------  560 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---------  560 (652)
                      +..++||||+++|+|.+++..    ....+++..+..|+.|++.||+|||++   +|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999874    234699999999999999999999999   9999999999999998         


Q ss_pred             --CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------
Q 041689          561 --TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------  629 (652)
Q Consensus       561 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------  629 (652)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||..         
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999765433333444566799999999999999999999999999999999999988532         


Q ss_pred             ----------hhhhhhcccchhhhccccCc
Q 041689          630 ----------FVFNLAMECTIESLELRINA  649 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~  649 (652)
                                ...+++.+|++.+|.+|++.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~  326 (365)
T 3e7e_A          297 GLFRRLPHLDMWNEFFHVMLNIPDCHHLPS  326 (365)
T ss_dssp             SCCTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred             hhccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence                      37789999999999999653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.5e-40  Score=340.16  Aligned_cols=216  Identities=19%  Similarity=0.284  Sum_probs=189.9

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeec--CCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSN--EEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  499 (652)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36789999999999999999986 46899999999743   3467889999999997 9999999999987  5678999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccccCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLLIGE  578 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  578 (652)
                      |||+++++|.+++.    .+++.++..++.|++.||+|||++   ||+||||||+||+++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999875    378899999999999999999999   999999999999999766 8999999999865322


Q ss_pred             CCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCc------------------------------
Q 041689          579 DQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQC------------------------------  627 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~------------------------------  627 (652)
                         .......++..|+|||++.+ ..++.++||||+||++|||++|+.||                              
T Consensus       185 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence               22344568999999999877 67899999999999999999999997                              


Q ss_pred             -------------------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 -------------------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -------------------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                     +..+.+++.+||+.||++|||++|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~  317 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA  317 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence                                           4557889999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-40  Score=363.27  Aligned_cols=224  Identities=25%  Similarity=0.394  Sum_probs=196.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+|.+.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4568889999999999999999764 8899999997553 3457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence            99999999997643 3689999999999999999999999   9999999999999999999999999999865322 11


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~  636 (652)
                      .......+++.|+|||++..+.++.++|||||||++|||++ |+.||.                        ..+.+++.
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22233446788999999999999999999999999999999 888853                        34789999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       454 ~cl~~dP~~RPs~~el  469 (495)
T 1opk_A          454 ACWQWNPSDRPSFAEI  469 (495)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHcCcChhHCcCHHHH
Confidence            9999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-40  Score=332.88  Aligned_cols=217  Identities=22%  Similarity=0.344  Sum_probs=190.3

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  500 (652)
                      ++|.+.+.||+|+||.||+|++. ++.||||+++...  ....+.+.+|++++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56889999999999999999984 8899999997552  34456789999999999999999999999877  7889999


Q ss_pred             EccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++|+|.+++..... .+++.++..++.|++.||+|||++   +  |+||||||+||+++.++.++|+|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999987654 589999999999999999999998   8  9999999999999999999999999876421 


Q ss_pred             CCCccccccccCCccccCccccccCccCc---ccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFA---NGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                            .....+|+.|+|||++.+..++.   ++|||||||++|||++|+.||..                         
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                  12346899999999988766554   79999999999999999999643                         


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++||
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~i  261 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMI  261 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHH
Confidence            37889999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.6e-40  Score=353.87  Aligned_cols=195  Identities=22%  Similarity=0.295  Sum_probs=164.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  495 (652)
                      .++|.+.+.||+|+||.||+|++. +++.||||+++..  .....+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999865 5889999999753  233456788999999999999999999998766     57


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||++ ++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999997 59999987654 699999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCc--------------------cccccccCCccccCcccc-ccCccCcccchhhHHHHHHHHHhC
Q 041689          576 IGEDQS--------------------MTQTQTLATIGYIAPEYG-REGRVFANGDVYSFGIMLMEIHSA  623 (652)
Q Consensus       576 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg  623 (652)
                      ......                    ......+||+.|+|||++ ....++.++||||+||++|||++|
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g  248 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM  248 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence            432211                    122456799999999985 566799999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=337.95  Aligned_cols=224  Identities=26%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|++++++++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34567999999999999999999875 58999999997643  3467889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++++|.+++......+++..+..++.|++.||.|||+.   |++||||||+||+++.++.+||+|||.+......  
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--  178 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence            99999999999875555799999999999999999999999   9999999999999999999999999999865322  


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------hhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------SFVFNL  634 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------~~l~~l  634 (652)
                      ........|++.|+|||++.+..++.++||||||+++|||++|+.||.                          ..+.++
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            122334568999999999999999999999999999999999999863                          347889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||..||++|||++|+
T Consensus       259 i~~~l~~dp~~Rpt~~~l  276 (314)
T 3com_A          259 VKQCLVKSPEQRATATQL  276 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHH
T ss_pred             HHHHccCChhhCcCHHHH
Confidence            999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.6e-40  Score=344.49  Aligned_cols=228  Identities=25%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--------hhhhhHHHHHHHHHhc-CCCeeeeEE
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--------RAFKSFDIECEIMKSI-HYRNLVKII  487 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~  487 (652)
                      .......++|.+.+.||+|+||.||+|+.. +|+.||||+++....        ...+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334455677999999999999999999975 699999999975431        2245678899999999 799999999


Q ss_pred             eeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 041689          488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLS  567 (652)
Q Consensus       488 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~  567 (652)
                      +++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999987654 689999999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCccccccccCCccccCcccccc------CccCcccchhhHHHHHHHHHhCCCCcch------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE------GRVFANGDVYSFGIMLMEIHSAKQQCVS------------  629 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~~~------------  629 (652)
                      |||++..+...   .......||+.|+|||++.+      ..++.++|||||||++|||++|+.||..            
T Consensus       243 DfG~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~  319 (365)
T 2y7j_A          243 DFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME  319 (365)
T ss_dssp             CCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ecCcccccCCC---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            99999876322   22344679999999998753      3588999999999999999999999632            


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||..||++|||++|+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  357 (365)
T 2y7j_A          320 GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA  357 (365)
T ss_dssp             TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                           27889999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-40  Score=336.99  Aligned_cols=224  Identities=25%  Similarity=0.375  Sum_probs=193.9

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..++|++.+.||+|+||.||+|+..++..||+|+++... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            446789999999999999999998888899999997543 345678999999999999999999999864 468899999


Q ss_pred             cCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++..... .+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||.+....... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            999999999875432 589999999999999999999999   99999999999999999999999999998763221 1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~  636 (652)
                      .......+++.|+|||++.++.++.++||||||+++|||++ |+.||..                        .+.+++.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  244 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR  244 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence            22233456788999999988899999999999999999999 8888642                        4778999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       245 ~~l~~~p~~Rps~~~l  260 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYL  260 (279)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHhccChhhCCCHHHH
Confidence            9999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=334.50  Aligned_cols=224  Identities=24%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             cCCCccc-eeccccceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENN-LIGKGGFGTIYKSRIG---DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 9999999999999753   57889999997643 34567789999999999999999999999 45568999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            999999999999987666799999999999999999999999   99999999999999999999999999998763322


Q ss_pred             Ccc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          580 QSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       580 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                      ... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.+
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  244 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  244 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHH
Confidence            211 1223346889999999988899999999999999999998 998864                        33788


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++||+++||
T Consensus       245 li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          245 LMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             HHHHTTCSSGGGSCCHHHH
T ss_pred             HHHHHcCCChhhCcCHHHH
Confidence            9999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-40  Score=345.57  Aligned_cols=228  Identities=22%  Similarity=0.347  Sum_probs=196.2

Q ss_pred             HHhcCCCccceeccccceEEEEEEeCC-C-----cEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecC
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIGD-G-----MEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNE  493 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  493 (652)
                      ...++|.+.+.||+|+||.||+|.... +     ..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999998642 2     479999997553 23456789999999999 899999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC
Q 041689          494 EFKELVLEHMPHGSLEKCLYSS-------------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD  560 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~  560 (652)
                      +..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||++   ||+||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence            9999999999999999998743             22578999999999999999999999   9999999999999999


Q ss_pred             CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch----------
Q 041689          561 TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS----------  629 (652)
Q Consensus       561 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~----------  629 (652)
                      ++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..          
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  279 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL  279 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence            99999999999986644333333334557889999999998899999999999999999998 8888643          


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||+.||++|||++||
T Consensus       280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  317 (333)
T 2i1m_A          280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI  317 (333)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence                           36789999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=338.30  Aligned_cols=218  Identities=25%  Similarity=0.356  Sum_probs=183.4

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|++.+.||+|+||.||+|++. ++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            56888999999999999999884 788999998643  345778999999999999999999998874  4789999999


Q ss_pred             CCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc-EEEecccCCccccCCCCc
Q 041689          505 HGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV-AHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       505 ~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~~  581 (652)
                      +|+|.+++.....  .+++..+..++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||++.....    
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence            9999999986553  4788999999999999999999932229999999999999988876 79999999975421    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLA  635 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~  635 (652)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..                          .+.+++
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM  237 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence             12234589999999999999999999999999999999999999752                          367899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       238 ~~~l~~dp~~Rps~~el  254 (307)
T 2eva_A          238 TRCWSKDPSQRPSMEEI  254 (307)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHhcCChhhCcCHHHH
Confidence            99999999999999864

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=372.65  Aligned_cols=229  Identities=25%  Similarity=0.257  Sum_probs=126.6

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG  201 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  201 (652)
                      |+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus       268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  347 (844)
T 3j0a_A          268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK  347 (844)
T ss_dssp             CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCS
T ss_pred             ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCC
Confidence            44445555555545555555566666666666666655555566666666666666666655555666666666666666


Q ss_pred             CcccccccccCCCCCCCCEEEccCCC-CCCCc-----------------------------------------ccCCCCc
Q 041689          202 NKLSGSILTCFSNLASLRTLSLSYND-GPLPL-----------------------------------------EIGNLKV  239 (652)
Q Consensus       202 N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~-----------------------------------------~~~~l~~  239 (652)
                      |+++++.+..|..+++|++|+|++|. ..++.                                         .+.++++
T Consensus       348 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~  427 (844)
T 3j0a_A          348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH  427 (844)
T ss_dssp             CCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTT
T ss_pred             CCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCc
Confidence            66665555556666666666666553 11110                                         0113444


Q ss_pred             cceEecccccCCccCcc-cccCCCCCcEEEccCCcCC-----CcccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          240 LIGIDFSMNNFSSVIPT-TIGSLKDLQYLFLGYNILK-----GSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       240 L~~L~ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      |+.|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|..+++|+.|+|++|+|++..|..|.++++|+
T Consensus       428 L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  507 (844)
T 3j0a_A          428 LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR  507 (844)
T ss_dssp             CCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCS
T ss_pred             cceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhh
Confidence            44455554444432211 1222333333333333333     12233455666666666666666666666666666666


Q ss_pred             eEEeecCcCcccCCCC--------------------CCCCCcccccccCCccCCCCC
Q 041689          314 HLNLSFNKLEGEIPKG--------------------GSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       314 ~L~L~~N~l~~~~p~~--------------------~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      .|+|++|++++.+|..                    ..+..++.+++.+|||.|..+
T Consensus       508 ~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          508 GLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred             eeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence            6666666666544321                    235577888999999999554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-40  Score=346.56  Aligned_cols=218  Identities=23%  Similarity=0.293  Sum_probs=184.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      ..+|++.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|++++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999874 6999999998543  2334567889999999999999999999987653      


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 78999998764  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ...     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.                         
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            522     2334578999999999877 679999999999999999999999974                         


Q ss_pred             -----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   ..+.+++.+||..||++|||++|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~  305 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  305 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence                                         235689999999999999999763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=347.18  Aligned_cols=224  Identities=20%  Similarity=0.219  Sum_probs=185.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecccch-----------hhhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQCGR-----------AFKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      .++|.+.+.||+|+||.||+|+..    ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999875    5788999998754321           1224567888999999999999999


Q ss_pred             eeec----CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC--
Q 041689          489 SCSN----EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM--  562 (652)
Q Consensus       489 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~--  562 (652)
                      ++..    ....++||||+ +++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence            9877    67899999999 999999988765 799999999999999999999999   999999999999998877  


Q ss_pred             cEEEecccCCccccCCCC-----ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------
Q 041689          563 VAHLSDFGITKLLIGEDQ-----SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------  629 (652)
Q Consensus       563 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------  629 (652)
                      .+||+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||++|||++|+.||..        
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999986532211     1112345699999999999999999999999999999999999999844        


Q ss_pred             --------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                .+.+++.+||+.||++|||++||
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  319 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQAL  319 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence                                      46789999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.7e-40  Score=334.30  Aligned_cols=221  Identities=19%  Similarity=0.249  Sum_probs=191.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++..  .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999876 7999999999754  233456788899999999 99999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---------------
Q 041689          499 VLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---------------  560 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---------------  560 (652)
                      ||||+++++|.+++....   ..+++.++..++.|++.||+|||++   +|+||||||+||+++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999987542   3689999999999999999999999   9999999999999984               


Q ss_pred             ----CCcEEEecccCCccccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCC---------
Q 041689          561 ----TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQ---------  626 (652)
Q Consensus       561 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p---------  626 (652)
                          ...+||+|||.+......      ....||+.|+|||++.+. .++.++|||||||++|||++|.+|         
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence                447999999999865321      223589999999998766 566899999999999999999875         


Q ss_pred             ------------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                  ++..+.+++.+||+.||++|||++|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  277 (289)
T 1x8b_A          240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL  277 (289)
T ss_dssp             HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHH
Confidence                        34558999999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.3e-40  Score=352.56  Aligned_cols=222  Identities=23%  Similarity=0.274  Sum_probs=182.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      ..++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4578999999999999999999865 68999999997542        1223458899999999999999999999864 


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEeccc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFG  570 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg  570 (652)
                      +..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.+   +.+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence            45789999999999999887654 689999999999999999999999   99999999999999754   459999999


Q ss_pred             CCccccCCCCccccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      +++....   ........||+.|+|||++.+   ..++.++||||+||++|||++|+.||..                  
T Consensus       288 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          288 HSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             cceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            9986532   222344679999999999853   5788999999999999999999999642                  


Q ss_pred             ----------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                .+.+++.+||+.||++|||++|+
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~  397 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  397 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHH
Confidence                      36789999999999999999864

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=341.66  Aligned_cols=226  Identities=27%  Similarity=0.424  Sum_probs=195.5

Q ss_pred             hcCCCccceeccccceEEEEEEe-----CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--ce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-----GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--FK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~  496 (652)
                      ..+|++.+.||+|+||.||+|+.     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999983     368899999998766666778999999999999999999999987654  78


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999999999988766799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCccc-cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          577 GEDQSMT-QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       577 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      ....... .....++..|+|||++.+..++.++|||||||++|||++|..|+.                           
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            3322111 223457788999999998899999999999999999999977643                           


Q ss_pred             -------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                   ..+.+++.+||+.||++|||++||
T Consensus       277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el  313 (326)
T 2w1i_A          277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL  313 (326)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                         346789999999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.1e-40  Score=334.79  Aligned_cols=224  Identities=21%  Similarity=0.268  Sum_probs=189.2

Q ss_pred             HhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeee-ecCCceEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC-SNEEFKELVL  500 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  500 (652)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+|++++++++|++++..++++ ..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999986 478999999876543  335688999999999988776666554 6677889999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+ +++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||++   ++++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 8899999986666799999999999999999999999   99999999999999   7889999999999987643


Q ss_pred             CCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          578 EDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       578 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      ....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.                        
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            3221     12234568999999999999999999999999999999999999974                        


Q ss_pred             -------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             ..+.+++.+||+.||++|||++||
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  271 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence                   347899999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.5e-40  Score=331.71  Aligned_cols=222  Identities=23%  Similarity=0.293  Sum_probs=187.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999976 69999999997542   23355788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            99999999999987654 689999999999999999999999   9999999999999999999999999999865321 


Q ss_pred             CccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcc-----------------------hhhhhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCV-----------------------SFVFNLA  635 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~-----------------------~~l~~l~  635 (652)
                        .......+++.|+|||.+.+..+ +.++||||+|+++|||++|+.||.                       ..+.+++
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL  242 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence              22234568999999999887765 588999999999999999999964                       3478899


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       243 ~~~l~~~p~~Rps~~~~  259 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDI  259 (276)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHccCChhhCCCHHHH
Confidence            99999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-40  Score=334.83  Aligned_cols=225  Identities=24%  Similarity=0.356  Sum_probs=191.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ..++|.+.+.||+|+||.||+|++..    +..||+|+++.. .....+.+.+|++++++++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            34678899999999999999998532    346999999765 234567789999999999999999999998654 568


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++++|.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.+.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            99999999999999987666799999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      .. ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY  244 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            21 112234457889999999988899999999999999999998 999863                        2378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       245 ~li~~~l~~~p~~Rps~~el  264 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRFTEL  264 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHccCCchhCcCHHHH
Confidence            99999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-41  Score=354.74  Aligned_cols=219  Identities=16%  Similarity=0.163  Sum_probs=182.6

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHH---HHHhcCCCeeeeEE-------ee
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECE---IMKSIHYRNLVKII-------SS  489 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~  489 (652)
                      .++|.+.+.||+|+||.||+|++ .+|+.||||++...   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 46999999999743   3345678889994   55556899999998       55


Q ss_pred             eecCC-----------------ceEEEEEccCCCChhhhhhcCCC------CCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 041689          490 CSNEE-----------------FKELVLEHMPHGSLEKCLYSSNC------ILDIFQRLNIMIDVASVLEYLHFNFLVPV  546 (652)
Q Consensus       490 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  546 (652)
                      +...+                 ..|+||||+ +|+|.+++.....      .+++..+..|+.|++.||+|||++   ||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 6799999875431      223578888999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccC-----------ccCcccchhhHHH
Q 041689          547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-----------RVFANGDVYSFGI  615 (652)
Q Consensus       547 iH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~  615 (652)
                      +||||||+||+++.++.+||+|||+++...     .......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            999999999999999999999999998531     12334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCcch-------------------hhhhhhcccchhhhccccCccCC
Q 041689          616 MLMEIHSAKQQCVS-------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       616 vl~elltg~~p~~~-------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++|||++|+.||..                   .+.+++.+||+.||++|||+.|+
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            99999999999643                   47899999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.3e-40  Score=345.74  Aligned_cols=219  Identities=22%  Similarity=0.227  Sum_probs=182.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999865 6899999999754  2334567889999999999999999999987654      


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..++||||+++ ++.+++..   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            68999999975 78887753   488999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ...   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.                          
T Consensus       177 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            522   122334578999999999999999999999999999999999999873                          


Q ss_pred             ---------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                             ..+.+++.+||..||++|||++|+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  316 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  316 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence                                                   246789999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.8e-40  Score=332.17  Aligned_cols=218  Identities=24%  Similarity=0.344  Sum_probs=188.7

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l  498 (652)
                      .|.+.+.||+|+||.||+|.+. ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3677889999999999999865 6888999999754  23445678999999999999999999998764    456899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeC-CCCcEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLD-DTMVAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~  575 (652)
                      ||||+++++|.+++.... .+++..+..++.|++.||+|||+.   +  |+||||||+||+++ +++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997654 689999999999999999999998   7  99999999999997 7899999999999754


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      .    ........||+.|+|||++. +.++.++||||+||++|+|++|+.||..                          
T Consensus       183 ~----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          183 R----ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             C----TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             c----ccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            2    12233456899999999876 5689999999999999999999999643                          


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++||
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~el  280 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDL  280 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHH
Confidence            37889999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.2e-40  Score=359.16  Aligned_cols=221  Identities=25%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356999999999999999999875 6899999999654  2334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||.|||++   ||+||||||+||+++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999887654 689999999999999999999999   999999999999995   556899999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------SF  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~~  630 (652)
                      .   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.                           +.
T Consensus       177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            2   22344579999999999875 69999999999999999999999962                           23


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..||++|||++|+
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~  274 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQC  274 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHH
Confidence            7899999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.8e-40  Score=332.57  Aligned_cols=221  Identities=25%  Similarity=0.371  Sum_probs=188.6

Q ss_pred             CCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      |.....||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            445569999999999999864 6889999999876656667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCCccccCCCCcc
Q 041689          506 GSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       506 g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||+++. ++.+||+|||.++.....  ..
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~  178 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NP  178 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC--CC
Confidence            999999876533  467888999999999999999999   9999999999999987 899999999999865321  12


Q ss_pred             ccccccCCccccCccccccCc--cCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhh
Q 041689          583 TQTQTLATIGYIAPEYGREGR--VFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNL  634 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l  634 (652)
                      ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||..                          .+.++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF  258 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence            233456899999999987654  78999999999999999999999642                          26789


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||..||++|||++|+
T Consensus       259 i~~~l~~dp~~Rps~~~l  276 (295)
T 2clq_A          259 ILKCFEPDPDKRACANDL  276 (295)
T ss_dssp             HHHTTCSSTTTSCCHHHH
T ss_pred             HHHHccCChhhCCCHHHH
Confidence            999999999999999764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-40  Score=339.91  Aligned_cols=225  Identities=21%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467999999999999999999976 589999999976655667788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+++++|.+++......+++..+..++.|++.||.|||+.   |++||||||+||+++.++.+||+|||++.....  ..
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence            9999999999877555799999999999999999999999   999999999999999999999999998754311  11


Q ss_pred             cccccccCCccccCcccc-----ccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------h
Q 041689          582 MTQTQTLATIGYIAPEYG-----REGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------F  630 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~  630 (652)
                      .......||+.|+|||++     ....++.++|||||||++|||++|+.||..                          .
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence            112334689999999987     466788999999999999999999998542                          3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++||
T Consensus       252 l~~li~~~l~~dp~~Rps~~~l  273 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQL  273 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHcccChhhCCCHHHH
Confidence            6889999999999999999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.3e-40  Score=336.67  Aligned_cols=226  Identities=23%  Similarity=0.388  Sum_probs=189.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCC----CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeee-ecCCceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSC-SNEEFKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~  497 (652)
                      ..+|.+.+.||+|+||.||+|+..+    +..||+|.+.... ....+.+.+|++++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4568888999999999999998542    3358999987542 34456789999999999999999999985 4556889


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999987666789999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCC--ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhC-CCCc------------------------chh
Q 041689          578 EDQ--SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA-KQQC------------------------VSF  630 (652)
Q Consensus       578 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~------------------------~~~  630 (652)
                      ...  ........+|+.|+|||.+.+..++.++||||+||++|||++| .+||                        ++.
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            221  1122344578899999999999999999999999999999994 4443                        344


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++||
T Consensus       261 l~~li~~~l~~~p~~Rps~~el  282 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSEL  282 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHH
Confidence            8899999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=352.05  Aligned_cols=223  Identities=22%  Similarity=0.289  Sum_probs=192.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC--ceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE--FKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999876 58999999997543 234567789999999999999999999987654  77999


Q ss_pred             EEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----CCCCcEEEecccCCc
Q 041689          500 LEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSDFGITK  573 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~Dfg~~~  573 (652)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||++   ||+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999876442  389999999999999999999999   99999999999999    788889999999998


Q ss_pred             cccCCCCccccccccCCccccCcccccc--------CccCcccchhhHHHHHHHHHhCCCCcch----------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGRE--------GRVFANGDVYSFGIMLMEIHSAKQQCVS----------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltg~~p~~~----------------  629 (652)
                      ....   ........||+.|+|||++.+        ..++.++|||||||++|||++|+.||..                
T Consensus       165 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            6532   222334569999999998765        5778899999999999999999999752                


Q ss_pred             ------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                          .+.+++.+||+.||++||+++|+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~  300 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF  300 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence                                                25688999999999999999763

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.1e-40  Score=337.91  Aligned_cols=221  Identities=24%  Similarity=0.398  Sum_probs=190.7

Q ss_pred             CCccceeccccceEEEEEEeC-----CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC--CceEE
Q 041689          427 FNENNLIGKGGFGTIYKSRIG-----DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE--EFKEL  498 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  498 (652)
                      |++.+.||+|+||.||+|.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999988642     58889999997653 34456789999999999999999999999874  57899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++....  +++.++..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997754  89999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------------
Q 041689          579 DQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------------  628 (652)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------------  628 (652)
                      ... .......+|..|+|||++.+..++.++||||+||++|||++|+.||.                             
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            221 12234457888999999999899999999999999999999988753                             


Q ss_pred             ----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ..+.+++.+||+.||++|||++||
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  301 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL  301 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence                      337889999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-40  Score=333.66  Aligned_cols=220  Identities=25%  Similarity=0.372  Sum_probs=191.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec---------
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN---------  492 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  492 (652)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+++...    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456899999999999999999976 79999999997543    456789999999999999999998754         


Q ss_pred             -------CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          493 -------EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       493 -------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                             ....++||||+++++|.+++.... ..+++..+..++.|++.||.|||++   +|+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence                   345789999999999999997542 3689999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-----------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-----------------  627 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-----------------  627 (652)
                      ||+|||++......   .......+++.|+|||++.+..++.++||||||+++|||++|..|+                 
T Consensus       162 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 2a19_B          162 KIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD  238 (284)
T ss_dssp             EECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCT
T ss_pred             EECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccc
Confidence            99999999875322   1223456899999999999999999999999999999999998873                 


Q ss_pred             --chhhhhhhcccchhhhccccCccCC
Q 041689          628 --VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 --~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        +..+.+++.+||+.||++|||++|+
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~  265 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEI  265 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence              3447889999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.9e-40  Score=358.11  Aligned_cols=224  Identities=25%  Similarity=0.385  Sum_probs=189.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..++|+..+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            446788899999999999999999888889999997653 235678999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++|+|.+++.... ..+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997532 3589999999999999999999999   99999999999999999999999999998653221 1


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~  636 (652)
                      .......+++.|+|||++.++.++.++|||||||++|||++ |+.||..                        .+.+++.
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  415 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            12233456789999999998999999999999999999999 8888642                        3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||+++|
T Consensus       416 ~cl~~dP~~Rpt~~~l  431 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYL  431 (452)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHccCChhhCcCHHHH
Confidence            9999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.1e-40  Score=338.30  Aligned_cols=226  Identities=18%  Similarity=0.242  Sum_probs=192.5

Q ss_pred             HHHhcCCCcc-ceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          421 CRATYGFNEN-NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       421 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      ....++|.+. +.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+.+++++ .||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445567777 88999999999999865 68999999997542  23456788999999999 56999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccC
Q 041689          496 KELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGI  571 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~  571 (652)
                      .++||||+++|+|.+++... ...+++.++..++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999988653 34689999999999999999999999   9999999999999987   78999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch----------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS----------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~----------------------  629 (652)
                      ++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||..                      
T Consensus       181 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  257 (327)
T 3lm5_A          181 SRKIGH---ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF  257 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             ccccCC---ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence            986532   1223345699999999999999999999999999999999999999632                      


Q ss_pred             -----hhhhhhcccchhhhccccCccCC
Q 041689          630 -----FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           .+.+++.+||+.||++|||++|+
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~l  285 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEIC  285 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence                 37889999999999999999864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-40  Score=341.10  Aligned_cols=225  Identities=24%  Similarity=0.411  Sum_probs=188.2

Q ss_pred             cCCCccceeccccceEEEEEEeCC-----CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-----GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|+..+.||+|+||.||+|+...     +..||+|+++... ......+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999997542     3459999997553 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999999999987766799999999999999999999999   9999999999999999999999999999875332


Q ss_pred             CCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          579 DQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      ... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.                        ..+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  280 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  280 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHH
Confidence            211 11223346788999999998999999999999999999999 998863                        3378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++||+++||
T Consensus       281 ~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          281 QLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             HHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHH
Confidence            99999999999999999764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=338.84  Aligned_cols=227  Identities=20%  Similarity=0.213  Sum_probs=191.8

Q ss_pred             HhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeee----cCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS----NEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~  497 (652)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|++++++++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346799999999999999999986 479999999997665566778999999999999999999999986    345789


Q ss_pred             EEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          498 LVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      +||||+++|+|.+++..   ....+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999998875   344789999999999999999999999   999999999999999999999999999875


Q ss_pred             ccCCCCcc-------ccccccCCccccCccccccCc---cCcccchhhHHHHHHHHHhCCCCcch---------------
Q 041689          575 LIGEDQSM-------TQTQTLATIGYIAPEYGREGR---VFANGDVYSFGIMLMEIHSAKQQCVS---------------  629 (652)
Q Consensus       575 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~---------------  629 (652)
                      ........       ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||..               
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  263 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ  263 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence            42111000       012334799999999987543   68999999999999999999999643               


Q ss_pred             -----------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                 .+.+++.+||+.||++|||++||
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  297 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL  297 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence                       37889999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.2e-40  Score=369.04  Aligned_cols=221  Identities=21%  Similarity=0.212  Sum_probs=195.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  497 (652)
                      ...+|++.+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4568999999999999999999865 5888999999754   223456678899999987 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++|+|.+++.... .+++..+..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998754 699999999999999999999999   999999999999999999999999999986422


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNL  634 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l  634 (652)
                        ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||..                       .+.++
T Consensus       495 --~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  572 (674)
T ss_dssp             --TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred             --CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence              22234456799999999999999999999999999999999999999643                       37899


Q ss_pred             hcccchhhhccccCc
Q 041689          635 AMECTIESLELRINA  649 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~  649 (652)
                      +.+||+.||++||++
T Consensus       573 i~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHHHSCSSSTTCTTC
T ss_pred             HHHHccCCHHHCCCC
Confidence            999999999999997

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3e-40  Score=335.17  Aligned_cols=225  Identities=25%  Similarity=0.390  Sum_probs=197.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|+++.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567899999999999999999876 4889999999754 3345778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...... .
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-S
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC-c
Confidence            999999999997643 3689999999999999999999999   9999999999999999999999999999865322 2


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~  635 (652)
                      ........+++.|+|||++.+..++.++||||+|+++|+|++ |..||.                        ..+.+++
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  245 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            222334457888999999998999999999999999999999 888854                        3378999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||..||++|||++||
T Consensus       246 ~~~l~~dp~~Rps~~~~  262 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEI  262 (288)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHhCCChhhCcCHHHH
Confidence            99999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.9e-40  Score=335.24  Aligned_cols=223  Identities=20%  Similarity=0.220  Sum_probs=185.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999875 68899999997542   22346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999987654 689999999999999999999999   99999999999999999999999999997653221


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhh
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFN  633 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~  633 (652)
                       ........+++.|+|||++.+..++.++||||||+++|||++|+.||..                          .+.+
T Consensus       189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence             1222345689999999999999999999999999999999999999632                          3778


Q ss_pred             hhcccchhhhcccc-CccC
Q 041689          634 LAMECTIESLELRI-NAKE  651 (652)
Q Consensus       634 l~~~~l~~~p~~Rp-t~~e  651 (652)
                      ++.+||+.||++|| +++|
T Consensus       268 li~~~l~~dP~~Rp~s~~~  286 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGD  286 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHH
T ss_pred             HHHHhccCCHHHHHHhHHH
Confidence            99999999999999 7765

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.9e-39  Score=359.68  Aligned_cols=335  Identities=17%  Similarity=0.224  Sum_probs=286.2

Q ss_pred             eeeceeEeccCCCcCCcc-----------------CCCCCC---CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCC
Q 041689            4 ISIGKLELNVDDIESPCE-----------------IPSEIN---PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDN   63 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~-----------------ip~~~~---~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N   63 (652)
                      ++|+.|+|+.|.+..  .                 +|..+.   +++|++|+|++|++.+.+|..|.++++|++|+|++|
T Consensus       206 ~~L~~L~Ls~n~l~~--~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  283 (636)
T 4eco_A          206 TKLRQFYMGNSPFVA--ENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN  283 (636)
T ss_dssp             TTCCEEEEESCCCCG--GGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred             cCCCEEECcCCcccc--ccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence            468999999999873  2                 898874   899999999999999999999999999999999999


Q ss_pred             c-Cee--cc------------CCCccccccCCCCCccccc--ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEE
Q 041689           64 Y-LSG--SL------------SSIADNYLTSSTPELSFLS--SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFD  126 (652)
Q Consensus        64 ~-l~~--~~------------~~~~~~~l~~~~~~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~  126 (652)
                      + +++  ++            +.+....+..+... ..+.  .+.++++|++|+|++|++++..|  .+..+++ |++|+
T Consensus       284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip--~~~~l~~-L~~L~  359 (636)
T 4eco_A          284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP--AFGSEIK-LASLN  359 (636)
T ss_dssp             TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC--CCEEEEE-ESEEE
T ss_pred             CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh--hhCCCCC-CCEEE
Confidence            8 886  33            33444444444443 3344  68899999999999999996666  5778876 99999


Q ss_pred             ccCCcccccCCccccCCCC-CCEEEecCccccccCCccccCCC--CCcEEecccCccccccCcccc-------CCCCCcE
Q 041689          127 MSKCNVSGGIPEEIGNLTN-LTAIYLGGNKLNGSIPFTLRELQ--KLQYVGLKDNKLEGTIPYDIF-------RLVKLYK  196 (652)
Q Consensus       127 L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~  196 (652)
                      |++|+++ .+|..+..+++ |++|+|++|+++ .+|..+..++  +|++|++++|++++.+|..+.       .+++|++
T Consensus       360 L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~  437 (636)
T 4eco_A          360 LAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS  437 (636)
T ss_dssp             CCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEE
T ss_pred             CCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCE
Confidence            9999999 77888999999 999999999999 6777777755  899999999999999998888       7889999


Q ss_pred             EEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCC--------CCccceEecccccCCccCccccc--CCCCCc
Q 041689          197 LDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGN--------LKVLIGIDFSMNNFSSVIPTTIG--SLKDLQ  265 (652)
Q Consensus       197 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~--------l~~L~~L~ls~N~l~~~~~~~~~--~l~~L~  265 (652)
                      |+|++|+++.+++..+..+++|++|+|++|. ..+|..+..        +++|+.|+|++|+++. +|..+.  .+++|+
T Consensus       438 L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~l~~L~  516 (636)
T 4eco_A          438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV  516 (636)
T ss_dssp             EECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCB-CCGGGSTTTCTTCC
T ss_pred             EECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCc-cChhhhhccCCCcC
Confidence            9999999997777778889999999999997 556665433        3399999999999994 677776  999999


Q ss_pred             EEEccCCcCCCcccccccccccCcceec------cccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCccccc
Q 041689          266 YLFLGYNILKGSIPDSVGDLISLKSLNF------SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAES  339 (652)
Q Consensus       266 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~  339 (652)
                      .|+|++|+|++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|+++ .+|.. ..+.++.++
T Consensus       517 ~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~-~~~~L~~L~  593 (636)
T 4eco_A          517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK-ITPNISVLD  593 (636)
T ss_dssp             EEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSC-CCTTCCEEE
T ss_pred             EEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHh-HhCcCCEEE
Confidence            99999999997 8999999999999999      568888999999999999999999999994 56654 337999999


Q ss_pred             ccCCccCCCCC
Q 041689          340 FEGNKLLCGSP  350 (652)
Q Consensus       340 ~~~N~~~c~~~  350 (652)
                      +++|++.|-..
T Consensus       594 Ls~N~l~~~~~  604 (636)
T 4eco_A          594 IKDNPNISIDL  604 (636)
T ss_dssp             CCSCTTCEEEC
T ss_pred             CcCCCCccccH
Confidence            99999988553

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-40  Score=335.15  Aligned_cols=224  Identities=21%  Similarity=0.359  Sum_probs=190.2

Q ss_pred             CCCccceeccccceEEEEEEeC-C---CcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce-EEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-D---GMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK-ELV  499 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv  499 (652)
                      .|...+.||+|+||.||+|++. +   +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999853 2   3369999987543 34457788999999999999999999999776555 999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+.+|+|.+++......+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999988666789999999999999999999999   99999999999999999999999999998653221


Q ss_pred             --CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhh
Q 041689          580 --QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVF  632 (652)
Q Consensus       580 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~  632 (652)
                        .........+++.|+|||.+.+..++.++|||||||++|||++|..|                         ++..+.
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence              11122344578899999999999999999999999999999996555                         234488


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       259 ~li~~~l~~~p~~Rps~~~l  278 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTFRVL  278 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHccCChhhCcCHHHH
Confidence            99999999999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.1e-40  Score=358.48  Aligned_cols=220  Identities=23%  Similarity=0.313  Sum_probs=188.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||.||+|+.. ++..||+|+++...  ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45899999999999999999975 68899999997542  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999887654 689999999999999999999999   9999999999999975   455999999999876322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FV  631 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l  631 (652)
                         .......||+.|+|||++. +.++.++||||+||++|+|++|+.||..                           .+
T Consensus       193 ---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          193 ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             ---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             ---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence               2234467999999999876 5799999999999999999999999632                           36


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++|+
T Consensus       269 ~~li~~~L~~dp~~R~s~~e~  289 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISAQQA  289 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHCCCChhhCccHHHH
Confidence            789999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=346.07  Aligned_cols=223  Identities=22%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             hcCCCccceeccccceEEEEEEe----CCCcEEEEEEeeccc----chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQC----GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEE  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  494 (652)
                      .++|.+.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35789999999999999999986    368999999986432    23446677899999999 6999999999999999


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999987654 689999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      +... .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||..                       
T Consensus       209 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  287 (355)
T 1vzo_A          209 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  287 (355)
T ss_dssp             CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             cccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence            5321 1222334569999999999875  3478999999999999999999999742                       


Q ss_pred             ----hhhhhhcccchhhhcccc-----CccC
Q 041689          630 ----FVFNLAMECTIESLELRI-----NAKE  651 (652)
Q Consensus       630 ----~l~~l~~~~l~~~p~~Rp-----t~~e  651 (652)
                          .+.+++.+||..||++||     +++|
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~e  318 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADE  318 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHH
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHH
Confidence                267899999999999999     6654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-40  Score=346.10  Aligned_cols=221  Identities=22%  Similarity=0.303  Sum_probs=184.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-------
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-------  492 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  492 (652)
                      .....+|++.+.||+|+||.||+|+. .+|+.||||++....    ....+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            44567899999999999999999986 479999999986542    223479999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 041689          493 -------------------------------EEFKELVLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYL  538 (652)
Q Consensus       493 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~L  538 (652)
                                                     ..+.++||||+++ +|.+.+..   ....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999985 87776653   334799999999999999999999


Q ss_pred             HcCCCCCeEecCCCCCCeeeC-CCCcEEEecccCCccccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHH
Q 041689          539 HFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIM  616 (652)
Q Consensus       539 H~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~v  616 (652)
                      |++   ||+||||||+||+++ .++.+||+|||+++.....   .......+|+.|+|||++.+. .++.++||||+||+
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999   999999999999998 6889999999999865322   223345689999999988765 48999999999999


Q ss_pred             HHHHHhCCCCcch----------------------------------------------------hhhhhhcccchhhhc
Q 041689          617 LMEIHSAKQQCVS----------------------------------------------------FVFNLAMECTIESLE  644 (652)
Q Consensus       617 l~elltg~~p~~~----------------------------------------------------~l~~l~~~~l~~~p~  644 (652)
                      +|||++|+.||..                                                    .+.+++.+||+.||+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999753                                                    267899999999999


Q ss_pred             cccCccCC
Q 041689          645 LRINAKEI  652 (652)
Q Consensus       645 ~Rpt~~ei  652 (652)
                      +|||++|+
T Consensus       312 ~R~t~~e~  319 (383)
T 3eb0_A          312 LRINPYEA  319 (383)
T ss_dssp             GSCCHHHH
T ss_pred             hCCCHHHH
Confidence            99999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.7e-40  Score=349.90  Aligned_cols=195  Identities=23%  Similarity=0.291  Sum_probs=170.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc------CCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI------HYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~  496 (652)
                      .++|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 5899999999754 23446778899988887      577999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc--EEEecccCCc
Q 041689          497 ELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV--AHLSDFGITK  573 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~--~kl~Dfg~~~  573 (652)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999887654 3589999999999999999999999   9999999999999999887  9999999997


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       251 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          251 YEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             ETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            542     12234578999999999999999999999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-39  Score=357.05  Aligned_cols=221  Identities=23%  Similarity=0.317  Sum_probs=191.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc-------------hhhhhHHHHHHHHHhcCCCeeeeEEee
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-------------RAFKSFDIECEIMKSIHYRNLVKIISS  489 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~  489 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|+++....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            567999999999999999999875 588999999975421             235678899999999999999999999


Q ss_pred             eecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC---cEEE
Q 041689          490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM---VAHL  566 (652)
Q Consensus       490 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~---~~kl  566 (652)
                      +.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999887654 699999999999999999999999   999999999999998765   6999


Q ss_pred             ecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc------------------
Q 041689          567 SDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV------------------  628 (652)
Q Consensus       567 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~------------------  628 (652)
                      +|||+++....   ........||+.|+|||++. +.++.++||||+||++|+|++|+.||.                  
T Consensus       191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EECCCCEEcCC---CCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999987632   22334567999999999976 569999999999999999999999963                  


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||..||++|||++|+
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~  299 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA  299 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence                     337889999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.5e-40  Score=359.86  Aligned_cols=220  Identities=25%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            46899999999999999999876 78999999996542   334677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||++   +.++.+||+|||+++.+..
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999887654 689999999999999999999999   99999999999999   5678999999999987632


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------h
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------F  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~  630 (652)
                      .   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..                           .
T Consensus       182 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          182 S---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             C---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             c---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence            2   22344569999999999865 799999999999999999999999632                           3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++|+
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~  279 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDA  279 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHCCCChhHCcCHHHH
Confidence            7889999999999999999764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.8e-40  Score=335.16  Aligned_cols=224  Identities=22%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeee--cCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCS--NEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999875 68999999997542  334567899999999999999999999874  4678899


Q ss_pred             EEEccCCCChhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEecCCCCCCeeeCCCCcEEEeccc
Q 041689          499 VLEHMPHGSLEKCLYSSN---CILDIFQRLNIMIDVASVLEYLHFNFLVP-----VIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532   2589999999999999999999998   7     9999999999999999999999999


Q ss_pred             CCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc----------------------
Q 041689          571 ITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV----------------------  628 (652)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~----------------------  628 (652)
                      .++.....  ........|++.|+|||++.+..++.++||||||+++|||++|+.||.                      
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            99865221  112234468999999999998899999999999999999999999853                      


Q ss_pred             --hhhhhhhcccchhhhccccCccCC
Q 041689          629 --SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        ..+.+++.+||+.||++|||++||
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~l  265 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEI  265 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHH
Confidence              347899999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.5e-40  Score=335.24  Aligned_cols=224  Identities=23%  Similarity=0.358  Sum_probs=184.8

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+|++.+.||+|+||.||+|.. .+|+.||+|+++..   .......+.+|++++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35689999999999999999986 47899999999753   234556788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          500 LEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |||+++++|.+++..   ....+++..+..++.|++.||.|||++   |++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999998864   334689999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------h
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------S  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~  629 (652)
                      ..  ........+++.|+|||++.+..++.++||||||+++|||++|+.||.                           .
T Consensus       188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            21  122234468999999999999999999999999999999999999863                           2


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++||
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~i  288 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYV  288 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHH
Confidence            37899999999999999999864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-40  Score=341.15  Aligned_cols=226  Identities=25%  Similarity=0.356  Sum_probs=190.0

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      ..+|.+.+.||+|+||.||+|++      .++..||||++... .......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            45789999999999999999983      24778999999644 334556788999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEe
Q 041689          497 ELVLEHMPHGSLEKCLYSSN------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLS  567 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~  567 (652)
                      ++||||+++++|.+++....      ..+++.++..++.|++.||.|||++   ||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      3588999999999999999999999   9999999999999984   4569999


Q ss_pred             cccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch-----------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS-----------------  629 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~-----------------  629 (652)
                      |||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||..                 
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            9999976543332233334567899999999988999999999999999999998 8888642                 


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.||++|||++||
T Consensus       266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  295 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAII  295 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                   36789999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-39  Score=331.92  Aligned_cols=223  Identities=21%  Similarity=0.267  Sum_probs=191.7

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeee-ecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC-SNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+|++++++++|++++..++++ ..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999986 579999999987543  235688999999999988866655554 66678899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+ +++|.+++......+++.++..++.|++.||+|||++   +|+||||||+||++   ++++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 8899999986666799999999999999999999999   99999999999999   48889999999999876433


Q ss_pred             CCcc-----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          579 DQSM-----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       579 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            2211     12345699999999999999999999999999999999999999743                        


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.||++|||++||
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  271 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence                   36889999999999999999864

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-39  Score=330.95  Aligned_cols=223  Identities=23%  Similarity=0.289  Sum_probs=194.2

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---------chhhhhHHHHHHHHHhcC-CCeeeeEEeeee
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---------GRAFKSFDIECEIMKSIH-YRNLVKIISSCS  491 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  491 (652)
                      ..++|.+.+.||+|+||.||+|+.. +|+.||||+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3468999999999999999999875 68999999997542         123456789999999995 999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ..+..++||||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999987654 689999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCCccccccccCCccccCccccc------cCccCcccchhhHHHHHHHHHhCCCCcc-----------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGR------EGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------  628 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~-----------------  628 (652)
                      +......   .......+++.|+|||++.      ...++.++||||||+++|||++|+.||.                 
T Consensus       171 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          171 SCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             hhhcCCC---cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            9865322   2233456899999999875      4568899999999999999999999852                 


Q ss_pred             ----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ..+.+++.+||+.||++|||++|+
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  281 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA  281 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence                      337889999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=341.32  Aligned_cols=234  Identities=22%  Similarity=0.298  Sum_probs=191.6

Q ss_pred             ccccHHHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeee
Q 041689          413 RRFSYLEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSC  490 (652)
Q Consensus       413 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  490 (652)
                      ..++..++....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34444555566788999999999999999999874 68999999997543 3456788999999999 899999999998


Q ss_pred             ec------CCceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          491 SN------EEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       491 ~~------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      ..      .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence            76      467899999999999999987643 3689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcc----------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCV----------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~----------  628 (652)
                      +||+|||++......  ........|++.|+|||++.     +..++.++|||||||++|||++|+.||.          
T Consensus       168 ~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            999999999865321  12223456899999999986     5678899999999999999999999863          


Q ss_pred             ---------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ..+.+++.+||..||++|||++||
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  284 (326)
T 2x7f_A          246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL  284 (326)
T ss_dssp             HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence                           347899999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.6e-40  Score=337.48  Aligned_cols=230  Identities=23%  Similarity=0.355  Sum_probs=183.8

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeC----CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIG----DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE  493 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  493 (652)
                      +....++|.+.+.||+|+||.||+|+..    ++..||+|+++..  .....+.+.+|++++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3345567889999999999999999753    3558999998754  233456788999999999999999999998765


Q ss_pred             C-----ceEEEEEccCCCChhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc
Q 041689          494 E-----FKELVLEHMPHGSLEKCLYS-----SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV  563 (652)
Q Consensus       494 ~-----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~  563 (652)
                      +     ..++||||+++++|.+++..     ....+++.++..++.|++.||.|||++   +|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            4     35999999999999998843     223689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc--------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV--------------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~--------------  628 (652)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.              
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  265 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG  265 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence            99999999986643322223334457889999999999999999999999999999999 887753              


Q ss_pred             ----------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                ..+.+++.+||+.||++|||++||
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  299 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL  299 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence                      347899999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=347.78  Aligned_cols=225  Identities=23%  Similarity=0.379  Sum_probs=181.7

Q ss_pred             cCCCccceeccccceEEEEEEeC--C--CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeee-cCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--D--GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCS-NEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l  498 (652)
                      ..|...+.||+|+||.||+|+..  +  +..||+|.++.. .....+.+.+|+.++++++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            34667789999999999999853  2  245899998654 3345678899999999999999999999865 4567899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999987766789999999999999999999999   9999999999999999999999999999865332


Q ss_pred             CCc--cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhh
Q 041689          579 DQS--MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFV  631 (652)
Q Consensus       579 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l  631 (652)
                      ...  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.                        ..+
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            211  11233457889999999999999999999999999999999 566643                        347


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       326 ~~li~~cl~~dp~~RPs~~el  346 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSEL  346 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHH
Confidence            899999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.6e-40  Score=339.61  Aligned_cols=222  Identities=28%  Similarity=0.446  Sum_probs=188.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcE--EEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGME--VAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|.+.+.||+|+||.||+|+.. ++..  ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            56888999999999999999864 5664  499998753 233456789999999999 899999999999999999999


Q ss_pred             EEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          500 LEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      |||+++++|.+++....               ..+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999987653               3689999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc---------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV---------------  628 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~---------------  628 (652)
                      ||+|||+++...   .........+++.|+|||++.+..++.++|||||||++|||++ |+.||.               
T Consensus       182 kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          182 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            999999987431   1112233456889999999988889999999999999999998 998863               


Q ss_pred             ---------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ---------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ---------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               ..+.+++.+||+.||++|||++|+
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  291 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  291 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                     347889999999999999999764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=341.29  Aligned_cols=223  Identities=27%  Similarity=0.386  Sum_probs=181.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHH--HHhcCCCeeeeEEeeee-----cCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEI--MKSIHYRNLVKIISSCS-----NEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~-----~~~~~  496 (652)
                      .++|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|.++  ++.++||||+++++++.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46789999999999999999987 68999999997542   2334444444  45589999999997543     23367


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF------LVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      ++||||+++|+|.+++....  .++..+..++.|++.||+|||+..      .++|+||||||+||+++.++.+||+|||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            89999999999999997765  588899999999999999999763      2389999999999999999999999999


Q ss_pred             CCccccCCCC------ccccccccCCccccCcccccc-------CccCcccchhhHHHHHHHHHhCCCCcc---------
Q 041689          571 ITKLLIGEDQ------SMTQTQTLATIGYIAPEYGRE-------GRVFANGDVYSFGIMLMEIHSAKQQCV---------  628 (652)
Q Consensus       571 ~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltg~~p~~---------  628 (652)
                      +++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+.         
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987643211      112234569999999999876       467788999999999999999966531         


Q ss_pred             ----------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                              ..+.+++.+||+.||++|||++|+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence                                                    147899999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-39  Score=342.12  Aligned_cols=223  Identities=23%  Similarity=0.246  Sum_probs=190.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  496 (652)
                      ..+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999865 68899999997542 33456788999999999999999999998654     468


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++ +|.+++...  .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            999999975 999988765  489999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCc-cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          577 GEDQS-MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.                          
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            22111 11234579999999998654 458999999999999999999999973                          


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||+.||++|||++|+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  311 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA  311 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence                                        346789999999999999999864

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.7e-38  Score=350.47  Aligned_cols=158  Identities=24%  Similarity=0.270  Sum_probs=129.0

Q ss_pred             cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CC---CCcccCCCCccceEecccccCCc-cCcccccCCCC
Q 041689          189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GP---LPLEIGNLKVLIGIDFSMNNFSS-VIPTTIGSLKD  263 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~---~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~  263 (652)
                      ..+++|++|++++|++++..|..|..+++|++|+|++|. ..   +|..++++++|+.|++++|++++ +.+..+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            567788888999998888888888888899999999886 32   24568888889999999999887 44456888889


Q ss_pred             CcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC-CCCCCCcccccccC
Q 041689          264 LQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK-GGSFGNFSAESFEG  342 (652)
Q Consensus       264 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~l~~~~~~~  342 (652)
                      |++|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.++. ...++.++.+++++
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence            99999999988877666554  68999999999998 5666666899999999999999966655 67788889999999


Q ss_pred             CccCCCC
Q 041689          343 NKLLCGS  349 (652)
Q Consensus       343 N~~~c~~  349 (652)
                      |+|.|..
T Consensus       507 N~~~c~c  513 (562)
T 3a79_B          507 NPWDCTC  513 (562)
T ss_dssp             CCBCCCH
T ss_pred             CCcCCCc
Confidence            9998854

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.9e-40  Score=334.96  Aligned_cols=226  Identities=25%  Similarity=0.337  Sum_probs=190.6

Q ss_pred             HHhcCCCccc-eeccccceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc
Q 041689          422 RATYGFNENN-LIGKGGFGTIYKSRI---GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF  495 (652)
Q Consensus       422 ~~~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  495 (652)
                      ....+|.+.+ .||+|+||.||+|.+   .+++.||||+++...  ....+.+.+|++++++++||||+++++++ ..+.
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            3446677777 999999999999953   247889999997542  23456789999999999999999999999 5567


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++||||+++++|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            899999999999999998754 689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------h
Q 041689          576 IGEDQSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------S  629 (652)
Q Consensus       576 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~  629 (652)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.                        .
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR  247 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            4332211 1223346788999999988889999999999999999999 999864                        3


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++||+++||
T Consensus       248 ~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          248 EMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHH
Confidence            47899999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=331.05  Aligned_cols=225  Identities=18%  Similarity=0.239  Sum_probs=189.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc----chhhhhHHHHHHHHHhcCCCeeeeEEeeee--cCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC----GRAFKSFDIECEIMKSIHYRNLVKIISSCS--NEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~  496 (652)
                      .++|.+.+.||+|+||.||+|... +++.||+|+++...    ......+.+|++++++++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 68899999997542    234577899999999999999999999984  45688


Q ss_pred             EEEEEccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          497 ELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ++||||++++ +.+++... ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.+...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999886 66666543 34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCccccccccCCccccCccccccCc--cCcccchhhHHHHHHHHHhCCCCcch-----------------------h
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGR--VFANGDVYSFGIMLMEIHSAKQQCVS-----------------------F  630 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~-----------------------~  630 (652)
                      .............||+.|+|||++.+..  ++.++||||+||++|||++|+.||..                       .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP  239 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHH
Confidence            4333333334556899999999987643  47899999999999999999999643                       3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||..||++|||++|+
T Consensus       240 l~~li~~~l~~dp~~Rps~~~l  261 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQI  261 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHH
Confidence            7899999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-40  Score=343.76  Aligned_cols=218  Identities=21%  Similarity=0.275  Sum_probs=172.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------C
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------E  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  494 (652)
                      ..+|++.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999864 6899999998653  233456788999999999999999999998654      5


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 67999988753  589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ...     ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..                        
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            421     2334578999999999876 6789999999999999999999999742                        


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    .+.+++.+||..||++|||++|+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~  309 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  309 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence                                          25689999999999999999763

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=335.00  Aligned_cols=223  Identities=21%  Similarity=0.252  Sum_probs=184.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeee-----------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS-----------  491 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----------  491 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367899999999999999999976 48999999998766666778899999999999999999999873           


Q ss_pred             ---cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEe
Q 041689          492 ---NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLS  567 (652)
Q Consensus       492 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~  567 (652)
                         .....++||||++ |+|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999998 5999988654  589999999999999999999999   999999999999997 67799999


Q ss_pred             cccCCccccCCCC-ccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-----------------
Q 041689          568 DFGITKLLIGEDQ-SMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-----------------  628 (652)
Q Consensus       568 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-----------------  628 (652)
                      |||.++....... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.                 
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999986532211 112234457899999998765 678999999999999999999999863                 


Q ss_pred             ------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                          ..+.+++.+||+.||++|||++|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence                                                346789999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.3e-40  Score=347.46  Aligned_cols=220  Identities=10%  Similarity=0.058  Sum_probs=172.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhc--CCCeeeeEE-------eee
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSI--HYRNLVKII-------SSC  490 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~  490 (652)
                      ..+|.+.+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999965 78999999998653   23455677886555555  699988865       333


Q ss_pred             ecC-----------------CceEEEEEccCCCChhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeE
Q 041689          491 SNE-----------------EFKELVLEHMPHGSLEKCLYSSNCILDIFQR------LNIMIDVASVLEYLHFNFLVPVI  547 (652)
Q Consensus       491 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ii  547 (652)
                      ...                 ...|+||||++ |+|.+++......+++..+      ..++.|++.||+|||++   ||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence            322                 23799999999 7999999865434555555      67789999999999999   999


Q ss_pred             ecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCC
Q 041689          548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQ  625 (652)
Q Consensus       548 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~  625 (652)
                      ||||||+|||++.++.+||+|||+++...     .......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999998652     11224456799999999987  689999999999999999999999


Q ss_pred             Ccch--------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          626 QCVS--------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       626 p~~~--------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ||..                                .+.+++.+||+.||++|||++|+
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  350 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA  350 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            8533                                37889999999999999999764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=348.21  Aligned_cols=327  Identities=20%  Similarity=0.257  Sum_probs=205.7

Q ss_pred             eeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCc-------cccccCC
Q 041689            8 KLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIA-------DNYLTSS   80 (652)
Q Consensus         8 ~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------~~~l~~~   80 (652)
                      .|+++.|.++   ++|..+ +++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..+       ...++.+
T Consensus         4 ~l~ls~n~l~---~ip~~~-~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            4 LVDRSKNGLI---HVPKDL-SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             EEECTTSCCS---SCCCSC-CTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             eEecCCCCcc---cccccc-cccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            4666666665   466655 3667777777777766666666677777777777776665543210       0111111


Q ss_pred             CCCcccccccCCCCCCcEEEcccCCCcccC-CccchhcccccCcEEEccCCcccccCCccccCCCCC--CEEEecCccc-
Q 041689           81 TPELSFLSSLSNCKSLVVFLLSNNPLNGIL-PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL--TAIYLGGNKL-  156 (652)
Q Consensus        81 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l-  156 (652)
                      ...  .+... .+++|++|+|++|+++++. |. .++.+++ |++|++++|+|++   ..|..+++|  +.|+|++|.+ 
T Consensus        80 ~l~--~lp~~-~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~-L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~  151 (520)
T 2z7x_B           80 KLV--KISCH-PTVNLKHLDLSFNAFDALPICK-EFGNMSQ-LKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY  151 (520)
T ss_dssp             CCC--EEECC-CCCCCSEEECCSSCCSSCCCCG-GGGGCTT-CCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred             cee--ecCcc-ccCCccEEeccCCccccccchh-hhccCCc-ceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence            110  01111 4555666666666665532 23 4555554 6666666655543   233444444  4444444444 


Q ss_pred             -cccCCccccCCC-------------------------------------------------------------------
Q 041689          157 -NGSIPFTLRELQ-------------------------------------------------------------------  168 (652)
Q Consensus       157 -~~~~~~~~~~l~-------------------------------------------------------------------  168 (652)
                       .+..|..+..++                                                                   
T Consensus       152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEE
T ss_pred             ccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccc
Confidence             333444443322                                                                   


Q ss_pred             ----------------CCcEEecccCccccccCccc--------------------------------------------
Q 041689          169 ----------------KLQYVGLKDNKLEGTIPYDI--------------------------------------------  188 (652)
Q Consensus       169 ----------------~L~~L~L~~N~l~~~~~~~~--------------------------------------------  188 (652)
                                      +|++|++++|++++.+|..+                                            
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~  311 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG  311 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEES
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCC
Confidence                            56666666666665555544                                            


Q ss_pred             ---------cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCC----CCCcccCCCCccceEecccccCCccCc
Q 041689          189 ---------FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDG----PLPLEIGNLKVLIGIDFSMNNFSSVIP  255 (652)
Q Consensus       189 ---------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~----~~~~~~~~l~~L~~L~ls~N~l~~~~~  255 (652)
                               ..+++|++|++++|++++..|..+..+++|++|+|++|..    .+|..++.+++|+.|++++|++++.+|
T Consensus       312 n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~  391 (520)
T 2z7x_B          312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK  391 (520)
T ss_dssp             SCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGG
T ss_pred             CccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccc
Confidence                     4566777777777777777777777778888888887762    234557777788888888888876333


Q ss_pred             -ccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC-CCCCC
Q 041689          256 -TTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK-GGSFG  333 (652)
Q Consensus       256 -~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~  333 (652)
                       ..+..+++|++|++++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|++++|++++.++. ...+.
T Consensus       392 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~  468 (520)
T 2z7x_B          392 KGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT  468 (520)
T ss_dssp             GCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             cchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCC
Confidence             3477777888888888887766666554  67888888888887 6666666888888888888888865554 56677


Q ss_pred             CcccccccCCccCCCC
Q 041689          334 NFSAESFEGNKLLCGS  349 (652)
Q Consensus       334 ~l~~~~~~~N~~~c~~  349 (652)
                      .++.+++++|++.|..
T Consensus       469 ~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          469 SLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             TCCEEECCSSCBCCCH
T ss_pred             cccEEECcCCCCcccC
Confidence            8888888888888853

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=337.75  Aligned_cols=226  Identities=21%  Similarity=0.242  Sum_probs=178.6

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeee--------c
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCS--------N  492 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~  492 (652)
                      ...+|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4457999999999999999999965 68999999997665566678899999999996 999999999983        3


Q ss_pred             CCceEEEEEccCCCChhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeCCCCcEEEec
Q 041689          493 EEFKELVLEHMPHGSLEKCLYS--SNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      ....++||||+. |+|.+++..  ....+++.++..++.|++.||+|||++   +  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            345789999996 699888764  334699999999999999999999998   8  99999999999999999999999


Q ss_pred             ccCCccccCCCCcc----------ccccccCCccccCcccc---ccCccCcccchhhHHHHHHHHHhCCCCcch------
Q 041689          569 FGITKLLIGEDQSM----------TQTQTLATIGYIAPEYG---REGRVFANGDVYSFGIMLMEIHSAKQQCVS------  629 (652)
Q Consensus       569 fg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~------  629 (652)
                      ||+++.........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||..      
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99998753322110          11134589999999998   566788999999999999999999999653      


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||+.||++|||++|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~  299 (337)
T 3ll6_A          262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV  299 (337)
T ss_dssp             ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHH
Confidence                           37799999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.3e-39  Score=340.06  Aligned_cols=221  Identities=20%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchh-----------------hhhHHHHHHHHHhcCCCeeeeE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRA-----------------FKSFDIECEIMKSIHYRNLVKI  486 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~~  486 (652)
                      .++|.+.+.||+|+||.||+|+. +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999997542211                 1788999999999999999999


Q ss_pred             EeeeecCCceEEEEEccCCCChhhh------hhcC-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeee
Q 041689          487 ISSCSNEEFKELVLEHMPHGSLEKC------LYSS-NCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       487 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll  558 (652)
                      ++++.+.+..++||||+++++|.++      +... ...+++..+..++.|++.||.|||+ +   ||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999998      5542 3478999999999999999999998 8   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccC-ccCc-ccchhhHHHHHHHHHhCCCCcc--------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFA-NGDVYSFGIMLMEIHSAKQQCV--------  628 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~vl~elltg~~p~~--------  628 (652)
                      +.++.+||+|||.+......    ......|++.|+|||++.+. .++. ++|||||||++|||++|+.||.        
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999865321    33455689999999999877 6666 8999999999999999998863        


Q ss_pred             -----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                         ..+.+++.+||+.||++|||++|+
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~  320 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA  320 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence                                               235789999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=334.81  Aligned_cols=226  Identities=25%  Similarity=0.342  Sum_probs=185.1

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc--CCCeeeeEEeeeecC----C
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI--HYRNLVKIISSCSNE----E  494 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~  494 (652)
                      ....++|++.+.||+|+||.||+|+.. ++.||||++...   ....+..|.+++...  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            334568999999999999999999885 899999998644   223445566666554  899999999998877    6


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF-----LVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                      ..++||||+++|+|.+++...  .+++..+..++.|++.||+|||++.     .++|+||||||+||+++.++.+||+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            789999999999999999765  4899999999999999999999752     348999999999999999999999999


Q ss_pred             cCCccccCCCCcc--ccccccCCccccCccccccCccCcc------cchhhHHHHHHHHHhC----------CCCcch--
Q 041689          570 GITKLLIGEDQSM--TQTQTLATIGYIAPEYGREGRVFAN------GDVYSFGIMLMEIHSA----------KQQCVS--  629 (652)
Q Consensus       570 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~vl~elltg----------~~p~~~--  629 (652)
                      |+++.+.......  ......||+.|+|||++.+..++.+      +|||||||++|||++|          +.||..  
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            9997653322211  1224569999999999887766655      9999999999999999          555432  


Q ss_pred             ---------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                       .+.+++.+||+.||++|||++||
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence                                             26789999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-39  Score=336.17  Aligned_cols=221  Identities=24%  Similarity=0.280  Sum_probs=186.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  494 (652)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++....        ......+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357999999999999999999865 58899999986432        122346889999999999999999999987665


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc---EEEecccC
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV---AHLSDFGI  571 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~  571 (652)
                       .++||||+++++|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.   +||+|||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999999887654 689999999999999999999999   9999999999999986654   99999999


Q ss_pred             CccccCCCCccccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHhCCCCcch-------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------  629 (652)
                      ++....   ........||+.|+|||++.   ...++.++|||||||++|||++|+.||..                   
T Consensus       164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            986521   12223456899999999863   56788999999999999999999999632                   


Q ss_pred             ---------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               .+.+++.+||..||++|||++|+
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~  272 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEA  272 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHH
Confidence                     26789999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3e-40  Score=337.62  Aligned_cols=229  Identities=23%  Similarity=0.310  Sum_probs=177.0

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            344678999999999999999999864 68999999986542 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          499 VLEHMPHGSLEKCLYS-------SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ||||+++++|.+++..       ....+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||.
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999998864       233689999999999999999999999   999999999999999999999999999


Q ss_pred             CccccCCCC---ccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          572 TKLLIGEDQ---SMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       572 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      +........   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..                  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            876532211   111234468999999999876 5689999999999999999999998643                  


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||+.||++|||++||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  285 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL  285 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence                           35779999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=347.29  Aligned_cols=220  Identities=20%  Similarity=0.266  Sum_probs=173.0

Q ss_pred             CCc-cceeccccceEEEEEEeC---CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeee--cCCceEEEE
Q 041689          427 FNE-NNLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCS--NEEFKELVL  500 (652)
Q Consensus       427 y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  500 (652)
                      |.+ .++||+|+||.||+|+..   +++.||+|++....  ....+.+|++++++++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            555 468999999999999865   57889999996542  2356789999999999999999999994  467899999


Q ss_pred             EccCCCChhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----CCCCcEEEec
Q 041689          501 EHMPHGSLEKCLYSS--------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----DDTMVAHLSD  568 (652)
Q Consensus       501 e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----~~~~~~kl~D  568 (652)
                      ||+++ +|.+++...        ...+++..+..++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 887776522        12489999999999999999999999   99999999999999    6788999999


Q ss_pred             ccCCccccCCCCc-cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCc-------------------
Q 041689          569 FGITKLLIGEDQS-MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQC-------------------  627 (652)
Q Consensus       569 fg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~-------------------  627 (652)
                      ||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||                   
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            9999876322111 223445789999999998774 5899999999999999999999998                   


Q ss_pred             ---------------------------------------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ---------------------------------------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ---------------------------------------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                                         +..+.+++.+||..||++|||++|+
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                                                               3446689999999999999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=343.52  Aligned_cols=220  Identities=13%  Similarity=0.152  Sum_probs=188.1

Q ss_pred             hcCCCccceeccccceEEEEEEeCC---------CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeee---------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD---------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK---------  485 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  485 (652)
                      .++|.+.+.||+|+||.||+|+...         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3678999999999999999998753         789999998743     56889999999999999987         


Q ss_pred             ------EEeeeec-CCceEEEEEccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          486 ------IISSCSN-EEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       486 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                            +++++.. ++..++||||+ +++|.+++... ...+++.++..++.|++.||+|||++   ||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                  5666655 67889999999 99999999875 24799999999999999999999999   9999999999999


Q ss_pred             eCCCC--cEEEecccCCccccCCCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--
Q 041689          558 LDDTM--VAHLSDFGITKLLIGEDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--  628 (652)
Q Consensus       558 l~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--  628 (652)
                      ++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.  
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999865322111     11133468999999999999999999999999999999999999964  


Q ss_pred             --------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                      ..+.+++.+||+.||++|||++||
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  327 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML  327 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence                                            346789999999999999999864

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3e-38  Score=354.83  Aligned_cols=235  Identities=21%  Similarity=0.206  Sum_probs=148.0

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC-ccccCC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP-FTLREL  167 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l  167 (652)
                      .|.++++|++|+|++|+++.+++  .+..+++ |++|++++|++++..|..+..+++|++|++++|.+.+..| ..|..+
T Consensus       273 ~~~~l~~L~~L~l~~n~l~~lp~--~l~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l  349 (606)
T 3t6q_A          273 TFHCFSGLQELDLTATHLSELPS--GLVGLST-LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL  349 (606)
T ss_dssp             TTTTCTTCSEEECTTSCCSCCCS--SCCSCTT-CCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTC
T ss_pred             HhccccCCCEEeccCCccCCCCh--hhccccc-CCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhcc
Confidence            36778888888888888886544  4566665 8888888888887777777777777777777777764443 346777


Q ss_pred             CCCcEEecccCcccccc--CccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCc-ccCCCCccce
Q 041689          168 QKLQYVGLKDNKLEGTI--PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPL-EIGNLKVLIG  242 (652)
Q Consensus       168 ~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~-~~~~l~~L~~  242 (652)
                      ++|++|++++|.+++..  +..+..+++|++|++++|++.+..+..|..+++|++|++++|.  ...+. .+.++++|+.
T Consensus       350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  429 (606)
T 3t6q_A          350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV  429 (606)
T ss_dssp             TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCE
T ss_pred             CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCE
Confidence            77777777777776554  5566666777777777777766666666666666666666664  22222 2555666666


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCc---ccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGS---IPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      |++++|.+++..|..|..+++|++|++++|++++.   .+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus       430 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~  509 (606)
T 3t6q_A          430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH  509 (606)
T ss_dssp             EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCC
Confidence            66666666555555555555555555555555431   123345555555555555555544455555555555555555


Q ss_pred             CcCcccC
Q 041689          320 NKLEGEI  326 (652)
Q Consensus       320 N~l~~~~  326 (652)
                      |++++.+
T Consensus       510 N~l~~~~  516 (606)
T 3t6q_A          510 NRLTSSS  516 (606)
T ss_dssp             SCCCGGG
T ss_pred             CccCcCC
Confidence            5554443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=364.32  Aligned_cols=223  Identities=24%  Similarity=0.355  Sum_probs=187.2

Q ss_pred             CCCccc-eeccccceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          426 GFNENN-LIGKGGFGTIYKSRIG---DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       426 ~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            334444 7999999999999753   46679999997653 3356789999999999999999999999976 5689999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999999987766799999999999999999999999   999999999999999999999999999987532221


Q ss_pred             cc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhh
Q 041689          581 SM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNL  634 (652)
Q Consensus       581 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l  634 (652)
                      .. ......+++.|+|||++.++.++.++|||||||++|||++ |+.||.                        ..+.++
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  571 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  571 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            11 1122345688999999999999999999999999999998 998854                        347899


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||..||++||+++||
T Consensus       572 i~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          572 MSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             HHHTTCSSTTTSCCHHHH
T ss_pred             HHHHcCCChhHCcCHHHH
Confidence            999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-39  Score=344.48  Aligned_cols=196  Identities=23%  Similarity=0.236  Sum_probs=167.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC--------CCeeeeEEeeee---
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH--------YRNLVKIISSCS---  491 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~---  491 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            367999999999999999999864 6889999999754 334567889999999985        788999999987   


Q ss_pred             -cCCceEEEEEccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-------
Q 041689          492 -NEEFKELVLEHMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-------  562 (652)
Q Consensus       492 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-------  562 (652)
                       .....++||||+.+ ++.+.+... ...+++..+..++.|++.||+|||+++  ||+||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence             55688999999954 665555443 346999999999999999999999853  899999999999999775       


Q ss_pred             ------------------------------------------cEEEecccCCccccCCCCccccccccCCccccCccccc
Q 041689          563 ------------------------------------------VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR  600 (652)
Q Consensus       563 ------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  600 (652)
                                                                .+||+|||.++....     ......||+.|+|||++.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhc
Confidence                                                      799999999986522     133456899999999999


Q ss_pred             cCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          601 EGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       601 ~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      +..++.++|||||||++|||++|+.||.
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~  294 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFE  294 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence            9999999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.6e-39  Score=334.27  Aligned_cols=228  Identities=25%  Similarity=0.370  Sum_probs=191.7

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHh--cCCCeeeeEEeeeecC
Q 041689          416 SYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKS--IHYRNLVKIISSCSNE  493 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~  493 (652)
                      +........++|.+.+.||+|+||.||+|+. +++.||||++...   ....+.+|+++++.  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3333444566899999999999999999998 5899999999643   34567788998887  7899999999999877


Q ss_pred             C----ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCCCCCCeeeCCC
Q 041689          494 E----FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH--------FNFLVPVIHCDLKPSNVLLDDT  561 (652)
Q Consensus       494 ~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~dlkp~NIll~~~  561 (652)
                      +    ..++||||+++|+|.+++...  .+++.++..++.|++.||+|||        +.   +|+||||||+||+++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence            5    789999999999999999765  4899999999999999999999        77   99999999999999999


Q ss_pred             CcEEEecccCCccccCCCCcc--ccccccCCccccCccccccC------ccCcccchhhHHHHHHHHHhC----------
Q 041689          562 MVAHLSDFGITKLLIGEDQSM--TQTQTLATIGYIAPEYGREG------RVFANGDVYSFGIMLMEIHSA----------  623 (652)
Q Consensus       562 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg----------  623 (652)
                      +.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999998764332211  22345699999999998765      344789999999999999999          


Q ss_pred             CCCcch-----------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          624 KQQCVS-----------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       624 ~~p~~~-----------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.||..                                   .+.+++.+||+.||++|||++||
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence            566422                                   25689999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-39  Score=343.56  Aligned_cols=218  Identities=24%  Similarity=0.330  Sum_probs=181.6

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------ceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------FKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  498 (652)
                      .+|++.+.||+|+||.||+|+...+..||+|++....    ....+|+++++.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            4689999999999999999998777779999886432    22246999999999999999999985433      3789


Q ss_pred             EEEccCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCLY--SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~  575 (652)
                      ||||++++.+.....  .....+++..+..++.|++.||+|||++   ||+||||||+||+++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998754433221  2234789999999999999999999999   999999999999999 7999999999999875


Q ss_pred             cCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ...   .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..                         
T Consensus       193 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          193 IAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            322   223345689999999998765 589999999999999999999999742                         


Q ss_pred             ---------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                 .+.+++.+||+.||++|||+.|+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA  319 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHH
Confidence                                       36789999999999999998763

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.2e-39  Score=334.50  Aligned_cols=219  Identities=20%  Similarity=0.249  Sum_probs=190.9

Q ss_pred             hcCCCccceeccccceEEEEEEe-C-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCe------eeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-G-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN------LVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|.+ . +++.||||+++.. ....+.+.+|+++++.++|++      |+++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35799999999999999999986 3 6889999999754 344567889999999987664      9999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--------------
Q 041689          496 KELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--------------  560 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--------------  560 (652)
                      .++||||+ +++|.+++..... .+++.++..++.|++.||+|||++   ||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 7899998876543 688999999999999999999999   9999999999999987              


Q ss_pred             -----CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------
Q 041689          561 -----TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------  629 (652)
Q Consensus       561 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------  629 (652)
                           ++.+||+|||.++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..      
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 66899999999986421     22345689999999999999999999999999999999999999742      


Q ss_pred             -------------------------------------------------------------hhhhhhcccchhhhccccC
Q 041689          630 -------------------------------------------------------------FVFNLAMECTIESLELRIN  648 (652)
Q Consensus       630 -------------------------------------------------------------~l~~l~~~~l~~~p~~Rpt  648 (652)
                                                                                   .+.+++.+||+.||++|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence                                                                         2458999999999999999


Q ss_pred             ccCC
Q 041689          649 AKEI  652 (652)
Q Consensus       649 ~~ei  652 (652)
                      ++||
T Consensus       323 ~~el  326 (339)
T 1z57_A          323 LREA  326 (339)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.3e-40  Score=360.49  Aligned_cols=224  Identities=25%  Similarity=0.383  Sum_probs=193.8

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..++|++.+.||+|+||.||+|++.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            456788899999999999999999888889999997653 235678999999999999999999999876 678999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++|+|.+++.... ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EY  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HH
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ce
Confidence            99999999997532 3589999999999999999999999   9999999999999999999999999999865211 11


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~  636 (652)
                      .......++..|+|||++..+.++.++|||||||++|||++ |+.||..                        .+.+++.
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  498 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  498 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            11223446788999999998999999999999999999999 8888643                        3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       499 ~cl~~dP~~RPt~~~l  514 (535)
T 2h8h_A          499 QCWRKEPEERPTFEYL  514 (535)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHcCCChhHCcCHHHH
Confidence            9999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-39  Score=332.96  Aligned_cols=231  Identities=19%  Similarity=0.336  Sum_probs=190.5

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcC--CCeeeeEEeeee
Q 041689          416 SYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIH--YRNLVKIISSCS  491 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~  491 (652)
                      .+..+....++|++.+.||+|+||.||+|+..+++.||||++...  .....+.+.+|++++++++  ||||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            333344456779999999999999999999888999999999754  2345577899999999997  599999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccC
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGI  571 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~  571 (652)
                      ..+..++||| +.+++|.+++.... .+++.++..++.|++.||.|||++   +|+||||||+||++++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 56789999998755 689999999999999999999999   9999999999999975 7999999999


Q ss_pred             CccccCCCCccccccccCCccccCcccccc-----------CccCcccchhhHHHHHHHHHhCCCCcch-----------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGRE-----------GRVFANGDVYSFGIMLMEIHSAKQQCVS-----------  629 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~-----------  629 (652)
                      ++...............|++.|+|||++.+           ..++.++|||||||++|||++|+.||..           
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI  252 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence            987643322222334568999999999865           4788899999999999999999999643           


Q ss_pred             ---------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+.+++.+||+.||++|||++|+
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  290 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  290 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence                           37889999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.3e-39  Score=332.78  Aligned_cols=224  Identities=26%  Similarity=0.376  Sum_probs=191.1

Q ss_pred             HHhcCCCccceeccccceEEEEEEe--CCCcEEEEEEeecccc--hhhhhHHHHHHHHHhc---CCCeeeeEEeeee---
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRI--GDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSI---HYRNLVKIISSCS---  491 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---  491 (652)
                      ...++|++.+.||+|+||.||+|+.  .+|+.||+|+++....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            4567899999999999999999987  3688999999975432  2234677888888776   8999999999987   


Q ss_pred             --cCCceEEEEEccCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          492 --NEEFKELVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       492 --~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                        .....++||||++ |+|.+++..... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence              5567899999998 599999876543 589999999999999999999999   999999999999999999999999


Q ss_pred             ccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------  629 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------  629 (652)
                      ||.++...   .........+|+.|+|||++.+..++.++|||||||++|||++|+.||..                   
T Consensus       164 fg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             Cccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            99998642   12233445689999999999999999999999999999999999999743                   


Q ss_pred             -------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                     .+.+++.+||+.||++|||++|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  294 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  294 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                                           13589999999999999998764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-39  Score=339.47  Aligned_cols=217  Identities=20%  Similarity=0.247  Sum_probs=186.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce----
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK----  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----  496 (652)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467999999999999999999865 6899999999754  233456788999999999999999999999877654    


Q ss_pred             --EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          497 --ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       497 --~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                        ++||||++ ++|.+++..   .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588887643   489999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc-------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------  628 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~-------------------------  628 (652)
                      ...     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.                         
T Consensus       194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            421     2334568999999999877 678999999999999999999999974                         


Q ss_pred             -----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                   ..+.+++.+||+.||++|||++|+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence                                         346889999999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.5e-37  Score=350.92  Aligned_cols=135  Identities=23%  Similarity=0.302  Sum_probs=110.2

Q ss_pred             CCCCCEEEccCCC--CCCCcccCCCCccceEecccccC-CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcce
Q 041689          215 LASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNF-SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSL  291 (652)
Q Consensus       215 l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  291 (652)
                      +++++.+++++|.  ...+..+..++.|+.|++++|.+ .+..|..|..+++|++|+|++|+|++..|..|..+++|+.|
T Consensus       444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L  523 (635)
T 4g8a_A          444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  523 (635)
T ss_dssp             CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence            3334444444443  22334456677788888888874 44578889999999999999999999999999999999999


Q ss_pred             eccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-CCC-CCcccccccCCccCCCC
Q 041689          292 NFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-GSF-GNFSAESFEGNKLLCGS  349 (652)
Q Consensus       292 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~-~~l~~~~~~~N~~~c~~  349 (652)
                      +|++|+|++..|..|.++++|+.|+|++|+|++.+|.. ..+ .+++.+++++|||.|..
T Consensus       524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            99999999999999999999999999999999988864 344 57999999999999964

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-38  Score=348.85  Aligned_cols=344  Identities=20%  Similarity=0.185  Sum_probs=253.3

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCcc------
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIAD------   74 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------   74 (652)
                      +|.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|+++++.|..|.++++|++|+|++|++++.++..+.      
T Consensus        26 l~~~l~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (570)
T 2z63_A           26 LPFSTKNLDLSFNPLRH--LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ  103 (570)
T ss_dssp             SCSSCCEEECCSCCCCE--ECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred             ccccccEEEccCCccCc--cChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccc
Confidence            57789999999999884  223345 789999999999999998899999999999999999999887754321      


Q ss_pred             -ccccCCCCCcccccccCCCCCCcEEEcccCCCcccC-CccchhcccccCcEEEccCCcccccCCccccCCCCC----CE
Q 041689           75 -NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGIL-PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNL----TA  148 (652)
Q Consensus        75 -~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~  148 (652)
                       ..+..+.........+.++++|++|+|++|.++++. |. .++++++ |++|++++|++++..+..|..+++|    +.
T Consensus       104 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~  181 (570)
T 2z63_A          104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFSNLTN-LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  181 (570)
T ss_dssp             EEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCG-GGGGCTT-CCEEECTTSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             cccccccccccCCCccccccccccEEecCCCccceecChh-hhcccCC-CCEEeCcCCccceecHHHccchhccchhhhh
Confidence             222222211111124788889999999999888753 54 6778876 9999999888876655555444444    44


Q ss_pred             EEecCccccccC--------------------------------------------------------------------
Q 041689          149 IYLGGNKLNGSI--------------------------------------------------------------------  160 (652)
Q Consensus       149 L~L~~N~l~~~~--------------------------------------------------------------------  160 (652)
                      |++++|.+++..                                                                    
T Consensus       182 L~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~  261 (570)
T 2z63_A          182 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE  261 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEE
T ss_pred             cccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhh
Confidence            444444333222                                                                    


Q ss_pred             ------------------------------------Cccc----------------------------------------
Q 041689          161 ------------------------------------PFTL----------------------------------------  164 (652)
Q Consensus       161 ------------------------------------~~~~----------------------------------------  164 (652)
                                                          |..+                                        
T Consensus       262 l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~  341 (570)
T 2z63_A          262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF  341 (570)
T ss_dssp             EEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBC
T ss_pred             hhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccc
Confidence                                                1111                                        


Q ss_pred             --cCCCCCcEEecccCcccccc--CccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCC-cccCCC
Q 041689          165 --RELQKLQYVGLKDNKLEGTI--PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLP-LEIGNL  237 (652)
Q Consensus       165 --~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~-~~~~~l  237 (652)
                        ..+++|++|++++|++++..  |..+..+++|++|++++|.+++..+. |..+++|++|++++|.  ...+ ..+.++
T Consensus       342 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  420 (570)
T 2z63_A          342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSL  420 (570)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTC
T ss_pred             ccccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcC
Confidence              22344445555555554332  44555666677777777776655544 7778888888888875  2223 457888


Q ss_pred             CccceEecccccCCccCcccccCCCCCcEEEccCCcCC-CcccccccccccCcceeccccccCCCCchhhcCCCCCceEE
Q 041689          238 KVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILK-GSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLN  316 (652)
Q Consensus       238 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  316 (652)
                      ++|+.|++++|.+++..|..|.++++|++|++++|+++ +.+|..+..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus       421 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  500 (570)
T 2z63_A          421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN  500 (570)
T ss_dssp             TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEe
Confidence            99999999999998888888999999999999999987 57888899999999999999999988888999999999999


Q ss_pred             eecCcCcccCCC-CCCCCCcccccccCCccCCCCC
Q 041689          317 LSFNKLEGEIPK-GGSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       317 L~~N~l~~~~p~-~~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      +++|++++.+|. ...+..++.+++++|++.|..+
T Consensus       501 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            999999988775 4677889999999999988755

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.3e-39  Score=344.95  Aligned_cols=217  Identities=24%  Similarity=0.331  Sum_probs=181.1

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------CceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------EFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  497 (652)
                      .+|+..+.||+|+||.||+|++. +|+.||||++....    ....+|++++++++||||+++++++...      .+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            45888999999999999999975 58999999986542    2334799999999999999999988432      2467


Q ss_pred             EEEEccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLY---SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~  573 (652)
                      +||||+++ ++.+.+.   .....+++..+..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 6665543   2334789999999999999999999999   99999999999999954 678999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV------------------------  628 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~------------------------  628 (652)
                      .+...   .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.                        
T Consensus       206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            75322   222345689999999998764 78999999999999999999999973                        


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||..||++|||+.|+
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~  334 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  334 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHH
Confidence                                        236789999999999999998763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5e-39  Score=337.16  Aligned_cols=227  Identities=22%  Similarity=0.238  Sum_probs=178.5

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-  495 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  495 (652)
                      .+.....++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+|++.++.++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677789999999999999999999875 68999999986542 334556778888999999999999999865332 


Q ss_pred             ------eEEEEEccCCCChhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEecCCCCCCeeeCC-CCc
Q 041689          496 ------KELVLEHMPHGSLEKCLY---SSNCILDIFQRLNIMIDVASVLEYLH--FNFLVPVIHCDLKPSNVLLDD-TMV  563 (652)
Q Consensus       496 ------~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~iiH~dlkp~NIll~~-~~~  563 (652)
                            .++||||+++ ++.+.+.   .....+++..+..++.|++.||.|||  +.   ||+||||||+||+++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999987 5544333   23346889999999999999999999  77   9999999999999996 899


Q ss_pred             EEEecccCCccccCCCCccccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCcc--------------
Q 041689          564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQCV--------------  628 (652)
Q Consensus       564 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~--------------  628 (652)
                      +||+|||+++.....   .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.              
T Consensus       171 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            999999999865322   2233456899999999986654 8999999999999999999999974              


Q ss_pred             -----------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                               ..+.+++.+||+.||++|||++|+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence                                                     246789999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-39  Score=329.37  Aligned_cols=218  Identities=31%  Similarity=0.405  Sum_probs=183.7

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-CceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-EFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||.||+|+. +|+.||+|+++...  ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46789999999999999999987 48899999997543  456789999999999999999999987544 578999999


Q ss_pred             cCCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++++|.+++..... .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.....    
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----  169 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  169 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc----
Confidence            999999999876432 378899999999999999999999   999999999999999999999999999875421    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~  636 (652)
                       ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..                        .+.+++.
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          170 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence             1223357889999999998899999999999999999998 9988542                        3788999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++|||++||
T Consensus       249 ~~l~~~p~~Rps~~~l  264 (278)
T 1byg_A          249 NCWHLDAAMRPSFLQL  264 (278)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHhcCChhhCCCHHHH
Confidence            9999999999999864

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1e-37  Score=350.48  Aligned_cols=325  Identities=18%  Similarity=0.166  Sum_probs=206.1

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS   80 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~   80 (652)
                      +|.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|+++++.|.+|.++++|++|+|++|++++..+.         
T Consensus        31 l~~~l~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---------   99 (606)
T 3t6q_A           31 LPNSTECLEFSFNVLPT--IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET---------   99 (606)
T ss_dssp             SCTTCCEEECTTCCCSE--ECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTT---------
T ss_pred             CCCcCcEEEccCCccCc--CChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChh---------
Confidence            45667777777777763  235555 677777777777777777777777777777777777777765542         


Q ss_pred             CCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccC
Q 041689           81 TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI  160 (652)
Q Consensus        81 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  160 (652)
                              .|.++++|++|+|++|+++++.+. .+..+++ |++|++++|+++++....+..+++|++|+|++|++++..
T Consensus       100 --------~~~~l~~L~~L~L~~n~i~~l~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  169 (606)
T 3t6q_A          100 --------ALSGPKALKHLFFIQTGISSIDFI-PLHNQKT-LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS  169 (606)
T ss_dssp             --------TTSSCTTCCEEECTTSCCSCGGGS-CCTTCTT-CCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred             --------hhcccccccEeeccccCcccCCcc-hhccCCc-ccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence                    355666666666666666655444 4555554 666666666666544344444666666666666666555


Q ss_pred             CccccCCCCCc--EEecccCccccccCccccCC-----------------------------------------------
Q 041689          161 PFTLRELQKLQ--YVGLKDNKLEGTIPYDIFRL-----------------------------------------------  191 (652)
Q Consensus       161 ~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l-----------------------------------------------  191 (652)
                      |..|..+++|+  .|++++|.+++..|..|...                                               
T Consensus       170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~  249 (606)
T 3t6q_A          170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE  249 (606)
T ss_dssp             HHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred             hhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence            66666666666  66666666665544433221                                               


Q ss_pred             ----CCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcE
Q 041689          192 ----VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY  266 (652)
Q Consensus       192 ----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  266 (652)
                          .+|+.|++++|.++++.+..|..+++|++|++++|. ..+|..+.++++|++|++++|.+++..|..+..+++|++
T Consensus       250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  329 (606)
T 3t6q_A          250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH  329 (606)
T ss_dssp             GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred             hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence                045566666666666666666667777777777765 456666666777777777777776666666666667777


Q ss_pred             EEccCCcCCCccc-ccccccccCcceeccccccCCCC--chhhcCCCCCceEEeecCcCcccCCC-CCCCCCcccccccC
Q 041689          267 LFLGYNILKGSIP-DSVGDLISLKSLNFSNNNLSGAI--PLLLEKLSYLEHLNLSFNKLEGEIPK-GGSFGNFSAESFEG  342 (652)
Q Consensus       267 L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~~~l~~~~~~~  342 (652)
                      |++++|.+.+.+| ..+..+++|+.|++++|++++..  +..+..+++|+.|++++|.+++..|. ...+..++.+++++
T Consensus       330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~  409 (606)
T 3t6q_A          330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF  409 (606)
T ss_dssp             EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred             EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence            7777776664443 33666666667777666666544  55666666666666666666655443 24555666666666


Q ss_pred             CccCC
Q 041689          343 NKLLC  347 (652)
Q Consensus       343 N~~~c  347 (652)
                      |....
T Consensus       410 n~l~~  414 (606)
T 3t6q_A          410 TRLKV  414 (606)
T ss_dssp             CCEEC
T ss_pred             CcCCC
Confidence            65543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-39  Score=328.82  Aligned_cols=225  Identities=21%  Similarity=0.290  Sum_probs=185.5

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----------  492 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------  492 (652)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457999999999999999999865 7899999999654 3445778899999999999999999998754          


Q ss_pred             ---CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          493 ---EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       493 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                         .+..++||||+++++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence               3567899999999999999987666788899999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCC------------ccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCC----------
Q 041689          570 GITKLLIGEDQ------------SMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQ----------  626 (652)
Q Consensus       570 g~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p----------  626 (652)
                      |.++.......            ........|++.|+|||++.+. .++.++||||+||++|||+++..+          
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~~~~  240 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK  240 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHHHHh
Confidence            99986532110            1122345689999999998764 689999999999999999984332          


Q ss_pred             ---------------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ---------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ---------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     .+..+.+++.+||+.||++|||++|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  281 (303)
T 1zy4_A          241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL  281 (303)
T ss_dssp             HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHH
Confidence                           11226889999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.7e-39  Score=327.43  Aligned_cols=223  Identities=22%  Similarity=0.279  Sum_probs=176.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|+++....  .....+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467999999999999999999864 789999999975422  22233445555678889999999999999999999999


Q ss_pred             EccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++ ++.+++..   ....+++..+..++.|++.||+|||++.  ||+||||||+||+++.++.+||+|||+++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            99975 88777653   3447999999999999999999999842  899999999999999999999999999986532


Q ss_pred             CCCccccccccCCccccCcccc----ccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          578 EDQSMTQTQTLATIGYIAPEYG----REGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .   .......||+.|+|||++    .+..++.++||||+||++|||++|+.||..                        
T Consensus       163 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          163 D---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             c---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            2   222334689999999995    566789999999999999999999999753                        


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+||+.||++|||++|+
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~  264 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPEL  264 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHH
Confidence              37889999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-39  Score=330.58  Aligned_cols=225  Identities=24%  Similarity=0.347  Sum_probs=184.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC--CCc--EEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG--DGM--EVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|++.+.||+|+||.||+|++.  +++  .||+|+++..   .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            357899999999999999999852  333  6899998754   2345678899999999999999999999998765 8


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            899999999999999987655799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCcc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------h
Q 041689          577 GEDQSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------S  629 (652)
Q Consensus       577 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~  629 (652)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.                         .
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            332211 1233457888999999988889999999999999999999 998863                         2


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++||
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l  275 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVAL  275 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHccCCcccCcCHHHH
Confidence            37899999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.7e-39  Score=335.78  Aligned_cols=223  Identities=23%  Similarity=0.269  Sum_probs=188.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  496 (652)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999875 68999999996442 33456778999999999999999999987654     678


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999988764  589999999999999999999999   99999999999999999999999999998753


Q ss_pred             CCCCcc--------ccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          577 GEDQSM--------TQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       577 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      ......        ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..                  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            221111        1123468999999998754 6789999999999999999999998742                  


Q ss_pred             -------------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                           .+.+++.+||+.||++|||++|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA  303 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence                                                 24689999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.8e-39  Score=333.16  Aligned_cols=224  Identities=23%  Similarity=0.263  Sum_probs=193.4

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc------hhhhhHHHHHHHHHhcC--CCeeeeEEeeee
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIH--YRNLVKIISSCS  491 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~  491 (652)
                      .....+|++.+.||+|+||.||+|+.. +++.||||+++....      .....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            344578999999999999999999864 689999999975532      12356778999999996  599999999999


Q ss_pred             cCCceEEEEEccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEEEecc
Q 041689          492 NEEFKELVLEHMPH-GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDF  569 (652)
Q Consensus       492 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~kl~Df  569 (652)
                      ..+..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++ +++.+||+||
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            99999999999986 89999987654 689999999999999999999999   999999999999999 7899999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcc-----------------hhh
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCV-----------------SFV  631 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~-----------------~~l  631 (652)
                      |+++....    .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.                 ..+
T Consensus       195 g~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  270 (320)
T 3a99_A          195 GSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC  270 (320)
T ss_dssp             TTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHH
T ss_pred             cccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHH
Confidence            99986532    22234568999999999887766 678899999999999999999964                 348


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       271 ~~li~~~l~~dp~~Rps~~~l  291 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEI  291 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHH
Confidence            899999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-38  Score=337.05  Aligned_cols=198  Identities=23%  Similarity=0.294  Sum_probs=169.5

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CC-----eeeeEEeeeecCCc
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YR-----NLVKIISSCSNEEF  495 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~  495 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++.. ......+..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4578999999999999999999865 6889999999754 234566788999988885 44     49999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC--CCCcEEEecccCC
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGIT  572 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~~  572 (652)
                      .++||||+++ +|.+++.... ..+++..+..++.|++.||.|||.+ ..||+||||||+||+++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999965 9999887654 3689999999999999999999952 22999999999999994  5788999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      +....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       209 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          209 CQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            86522     2234578999999999999999999999999999999999999975

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-37  Score=329.84  Aligned_cols=309  Identities=19%  Similarity=0.183  Sum_probs=261.7

Q ss_pred             eeeceeEeccCCCcCCccCCCCC--CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST   81 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~   81 (652)
                      .+++.|+++.|.+.   ++|..+  ++++|++|+|++|+|+++.+..|..+++|++|+|++|++++.++.          
T Consensus        45 ~~l~~l~l~~~~l~---~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~----------  111 (390)
T 3o6n_A           45 NNQKIVTFKNSTMR---KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH----------  111 (390)
T ss_dssp             CCCSEEEEESCEES---EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT----------
T ss_pred             CCceEEEecCCchh---hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH----------
Confidence            46778888888776   577754  678899999999999888888899999999999999988866553          


Q ss_pred             CCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP  161 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  161 (652)
                             .|.++++|++|+|++|+++.+++. .+..+++ |++|++++|++++..+..|..+++|++|+|++|++++.  
T Consensus       112 -------~~~~l~~L~~L~L~~n~l~~l~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--  180 (390)
T 3o6n_A          112 -------VFQNVPLLTVLVLERNDLSSLPRG-IFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV--  180 (390)
T ss_dssp             -------TTTTCTTCCEEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC--
T ss_pred             -------HhcCCCCCCEEECCCCccCcCCHH-HhcCCCC-CcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc--
Confidence                   477888999999999999877665 5677776 99999999999888888899999999999999998854  


Q ss_pred             ccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccc
Q 041689          162 FTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLI  241 (652)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~  241 (652)
                       .+..+++|+.|++++|.+++     +....+|+.|++++|.++.....   ..++|+.|++++|....+..+..+++|+
T Consensus       181 -~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~~~l~~l~~L~  251 (390)
T 3o6n_A          181 -DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDTAWLLNYPGLV  251 (390)
T ss_dssp             -CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCCGGGGGCTTCS
T ss_pred             -ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCcccHHHcCCCCcc
Confidence             35677888999999998884     23445899999999999866433   2478999999999855567899999999


Q ss_pred             eEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCc
Q 041689          242 GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK  321 (652)
Q Consensus       242 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  321 (652)
                      .|++++|.+++..|..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~  329 (390)
T 3o6n_A          252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS  329 (390)
T ss_dssp             EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSC
T ss_pred             EEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCc
Confidence            9999999999988999999999999999999999 46777889999999999999998 567778889999999999999


Q ss_pred             CcccCCCCCCCCCcccccccCCccCCCC
Q 041689          322 LEGEIPKGGSFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       322 l~~~~p~~~~~~~l~~~~~~~N~~~c~~  349 (652)
                      ++...  ...+..++.+++++|++.|..
T Consensus       330 i~~~~--~~~~~~L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          330 IVTLK--LSTHHTLKNLTLSHNDWDCNS  355 (390)
T ss_dssp             CCCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred             cceeC--chhhccCCEEEcCCCCccchh
Confidence            98664  567889999999999999853

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-38  Score=343.20  Aligned_cols=223  Identities=18%  Similarity=0.224  Sum_probs=192.5

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC-CeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++....  ....+..|+++++.++| ++|+.+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999986 468999999887543  23568899999999976 556666667778888999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee---CCCCcEEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL---DDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      |+ +++|.+++......+++.++..|+.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 8899999986666799999999999999999999999   99999999999999   68899999999999876433


Q ss_pred             CCcc-----ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          579 DQSM-----TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       579 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..                        
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            2211     12255699999999999999999999999999999999999999743                        


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             .+.+++.+||+.||++||++++|
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el  269 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYL  269 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence                   37889999999999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.2e-39  Score=324.12  Aligned_cols=222  Identities=25%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999875 68999999997542  23456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC---CcEEEecccCCcccc
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT---MVAHLSDFGITKLLI  576 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~  576 (652)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999887654 689999999999999999999999   99999999999999754   479999999998653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------h
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------S  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------~  629 (652)
                      ..   .......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.                           .
T Consensus       176 ~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             CC---SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             CC---CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            22   12223458899999998765 58999999999999999999999853                           2


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++|+
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~el  274 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQC  274 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHcccChhhCcCHHHH
Confidence            36789999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-39  Score=359.62  Aligned_cols=217  Identities=26%  Similarity=0.360  Sum_probs=183.4

Q ss_pred             ceeccccceEEEEEEe---CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|.+   .+++.||||+++...  ....+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999964   246789999997643  2345789999999999999999999999965 458899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc-ccc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS-MTQ  584 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~  584 (652)
                      |+|.+++.... .+++.++..|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 689999999999999999999999   9999999999999999999999999999876432221 122


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l  639 (652)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..                        .+.+++.+||
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  609 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  609 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            33446789999999999999999999999999999998 9998643                        3788999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.||++|||++||
T Consensus       610 ~~dP~~RPs~~~l  622 (635)
T 4fl3_A          610 TYDVENRPGFAAV  622 (635)
T ss_dssp             CSSTTTSCCHHHH
T ss_pred             CCCHhHCcCHHHH
Confidence            9999999999864

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.1e-37  Score=352.68  Aligned_cols=344  Identities=23%  Similarity=0.206  Sum_probs=246.3

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CC--CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccc-----
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NP--HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN-----   75 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----   75 (652)
                      ++|+.|+|+.|.+..  ..|..+ ++  ++|++|+|++|+++++.|..|..+++|++|+|++|++++..+.....     
T Consensus       222 ~~L~~L~L~~n~l~~--~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  299 (680)
T 1ziw_A          222 TSIRNLSLSNSQLST--TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR  299 (680)
T ss_dssp             SCCCEEECTTSCCCE--ECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCC
T ss_pred             ccccEEEccCCcccc--cChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCcc
Confidence            567888888887763  345555 44  34888899888888888888888888888888888888766543211     


Q ss_pred             --cccCCCC---------CcccccccCCCCCCcEEEcccCCCcccCCccchhcccc------------------------
Q 041689           76 --YLTSSTP---------ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH------------------------  120 (652)
Q Consensus        76 --~l~~~~~---------~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~------------------------  120 (652)
                        .+.....         .......|..+++|++|++++|+++++.+. .+..+++                        
T Consensus       300 ~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~  378 (680)
T 1ziw_A          300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSN-MFTGLINLKYLSLSNSFTSLRTLTNETFVSL  378 (680)
T ss_dssp             EEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTT-TTTTCTTCCEEECTTCBSCCCEECTTTTGGG
T ss_pred             EEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChh-HhccccCCcEEECCCCchhhhhcchhhhccc
Confidence              1111000         000001466677777777777777766554 4444433                        


Q ss_pred             ---cCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC-ccccCCCCCcEEecccCccccccCccccCCCCCcE
Q 041689          121 ---SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK  196 (652)
Q Consensus       121 ---~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  196 (652)
                         +|+.|++++|+++++.|.+|..+++|+.|+|++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.
T Consensus       379 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~  458 (680)
T 1ziw_A          379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR  458 (680)
T ss_dssp             TTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCE
T ss_pred             ccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCccccc
Confidence               25555566666666667777777777777777777765443 56777777777777777777777777777777777


Q ss_pred             EEccCCccc--ccccccCCCCCCCCEEEccCCC-CCC-CcccCCCCccceEecccccCCccCc--------ccccCCCCC
Q 041689          197 LDLGGNKLS--GSILTCFSNLASLRTLSLSYND-GPL-PLEIGNLKVLIGIDFSMNNFSSVIP--------TTIGSLKDL  264 (652)
Q Consensus       197 L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~-~~~-~~~~~~l~~L~~L~ls~N~l~~~~~--------~~~~~l~~L  264 (652)
                      |++++|.++  +..|..|..+++|++|+|++|. ..+ +..+.++++|+.|++++|+++++.+        ..|.++++|
T Consensus       459 L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L  538 (680)
T 1ziw_A          459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL  538 (680)
T ss_dssp             EECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTC
T ss_pred             chhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCC
Confidence            777777776  4567778888888888888886 333 3447788888888888888876422        236778888


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-C-CCCCcccccccC
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-G-SFGNFSAESFEG  342 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~-~~~~l~~~~~~~  342 (652)
                      ++|+|++|+++.+.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.+|.. . .+..++.+++++
T Consensus       539 ~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~  618 (680)
T 1ziw_A          539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF  618 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred             CEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence            88888888888555567888888888888888888777777888888889999988888776643 2 467888999999


Q ss_pred             CccCCCCC
Q 041689          343 NKLLCGSP  350 (652)
Q Consensus       343 N~~~c~~~  350 (652)
                      |||.|..+
T Consensus       619 N~~~c~c~  626 (680)
T 1ziw_A          619 NPFDCTCE  626 (680)
T ss_dssp             CCCCBCCC
T ss_pred             CCcccCCc
Confidence            99999765

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=330.98  Aligned_cols=226  Identities=24%  Similarity=0.297  Sum_probs=185.0

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc------hhhhhHHHHHHHHHhc----CCCeeeeEE
Q 041689          419 EVCRATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG------RAFKSFDIECEIMKSI----HYRNLVKII  487 (652)
Q Consensus       419 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~  487 (652)
                      +.....++|++.+.||+|+||.||+|+.. +++.||||+++....      .....+.+|+.+++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            33445678999999999999999999864 688999999965422      2234566799999998    899999999


Q ss_pred             eeeecCCceEEEEEc-cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC-CCCcEE
Q 041689          488 SSCSNEEFKELVLEH-MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD-DTMVAH  565 (652)
Q Consensus       488 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~-~~~~~k  565 (652)
                      +++...+..++|||| +++++|.+++.... .+++..+..++.|++.||+|||++   +|+||||||+||+++ +++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999998754 689999999999999999999999   999999999999999 889999


Q ss_pred             EecccCCccccCCCCccccccccCCccccCccccccCccC-cccchhhHHHHHHHHHhCCCCcc----------------
Q 041689          566 LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF-ANGDVYSFGIMLMEIHSAKQQCV----------------  628 (652)
Q Consensus       566 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~----------------  628 (652)
                      |+|||+++.....    ......|+..|+|||++.+..+. .++||||+||++|||++|+.||.                
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  256 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV  256 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTS
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccC
Confidence            9999999875321    23345689999999998777664 58999999999999999999964                


Q ss_pred             -hhhhhhhcccchhhhccccCccCC
Q 041689          629 -SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                       ..+.+++.+||+.||++|||++|+
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~  281 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEI  281 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHH
Confidence             347899999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.6e-38  Score=332.49  Aligned_cols=219  Identities=22%  Similarity=0.256  Sum_probs=188.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CC-cEEEEEEeecccchhhhhHHHHHHHHHhcCCCe------eeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DG-MEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN------LVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||.||+|+.. ++ +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            367999999999999999999864 34 68999999754 344567888999999998766      9999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee----------------
Q 041689          496 KELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL----------------  558 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll----------------  558 (652)
                      .++||||+ ++++.+++.... ..+++.++..++.|++.||+|||++   ||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 556766665543 4689999999999999999999999   99999999999999                


Q ss_pred             ---CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------
Q 041689          559 ---DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------  629 (652)
Q Consensus       559 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------  629 (652)
                         +.++.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..      
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               5678999999999986421     22345689999999999999999999999999999999999999743      


Q ss_pred             -------------------------------------------------------------hhhhhhcccchhhhccccC
Q 041689          630 -------------------------------------------------------------FVFNLAMECTIESLELRIN  648 (652)
Q Consensus       630 -------------------------------------------------------------~l~~l~~~~l~~~p~~Rpt  648 (652)
                                                                                   .+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence                                                                         3558999999999999999


Q ss_pred             ccCC
Q 041689          649 AKEI  652 (652)
Q Consensus       649 ~~ei  652 (652)
                      ++|+
T Consensus       328 ~~e~  331 (355)
T 2eu9_A          328 LAEA  331 (355)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-38  Score=330.50  Aligned_cols=218  Identities=19%  Similarity=0.223  Sum_probs=166.7

Q ss_pred             hcCCCccc-eeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceE
Q 041689          424 TYGFNENN-LIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKE  497 (652)
Q Consensus       424 ~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  497 (652)
                      .++|.+.+ .||+|+||.||+|+.. +++.||||++....    ....+....++.++||||+++++++..    +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45788854 6999999999999876 69999999996431    122223334566799999999999875    45589


Q ss_pred             EEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~  573 (652)
                      +||||+++|+|.+++.... ..+++.++..++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|||+++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998654 3689999999999999999999999   9999999999999975   4569999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc--------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC--------------------------  627 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~--------------------------  627 (652)
                      ....    .......+|+.|+|||++.+..++.++|||||||++|||++|+.||                          
T Consensus       180 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          180 ETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             eccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            6521    2223456899999999998889999999999999999999999996                          


Q ss_pred             -----chhhhhhhcccchhhhccccCccCC
Q 041689          628 -----VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -----~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           +..+.+++.+||+.||++|||++|+
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  285 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQF  285 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                 2347889999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=332.71  Aligned_cols=217  Identities=20%  Similarity=0.243  Sum_probs=185.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-----
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-----  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  495 (652)
                      ..+|.+.+.||+|+||.||+|++. +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357899999999999999999865 68999999996542  2345678899999999999999999999987654     


Q ss_pred             -eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          496 -KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       496 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                       .++||||++ ++|.+++..   .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887643   489999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ...     ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..                        
T Consensus       176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            421     1234568999999999876 6789999999999999999999999742                        


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    .+.+++.+||..||++|||++|+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence                                          36789999999999999999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=341.63  Aligned_cols=223  Identities=23%  Similarity=0.326  Sum_probs=181.4

Q ss_pred             HhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ...+|...+.||+|+||.||.....+++.||||++....   ...+.+|+++++++ +||||+++++++.+.+..|+|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            445688899999999999765556689999999996542   23457899999999 79999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-----CCcEEEecccCCcccc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLI  576 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~~~~~~  576 (652)
                      |++ |+|.+++........+.++..++.|++.||+|||++   +|+||||||+||+++.     ...+||+|||+++...
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 599999987765566666788999999999999999   9999999999999953     3368899999998764


Q ss_pred             CCCCc-cccccccCCccccCccccc---cCccCcccchhhHHHHHHHHHh-CCCCcchh---------------------
Q 041689          577 GEDQS-MTQTQTLATIGYIAPEYGR---EGRVFANGDVYSFGIMLMEIHS-AKQQCVSF---------------------  630 (652)
Q Consensus       577 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~ellt-g~~p~~~~---------------------  630 (652)
                      ..... .......||+.|+|||++.   ...++.++||||+||++|||++ |+.||...                     
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK  254 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence            32211 2234456999999999987   4567889999999999999999 88886432                     


Q ss_pred             -----hhhhhcccchhhhccccCccCC
Q 041689          631 -----VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 -----l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           +.+++.+||+.||++|||++||
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~ev  281 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHV  281 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHH
Confidence                 5789999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=331.47  Aligned_cols=227  Identities=21%  Similarity=0.305  Sum_probs=189.5

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .....++|++.+.||+|+||.||+|+...  .||+|+++...  ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            33446789999999999999999998753  59999987542  233456788999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++++|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++ ++.+||+|||+++....
T Consensus       106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999999999987766789999999999999999999999   999999999999998 67999999999875421


Q ss_pred             CC---CccccccccCCccccCcccccc---------CccCcccchhhHHHHHHHHHhCCCCcc-----------------
Q 041689          578 ED---QSMTQTQTLATIGYIAPEYGRE---------GRVFANGDVYSFGIMLMEIHSAKQQCV-----------------  628 (652)
Q Consensus       578 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~vl~elltg~~p~~-----------------  628 (652)
                      ..   .........|++.|+|||++.+         ..++.++|||||||++|||++|+.||.                 
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence            11   1122233458999999998864         457889999999999999999999854                 


Q ss_pred             --------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                              ..+.+++.+||..||++|||++||
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  293 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKL  293 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence                    347899999999999999999764

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.3e-37  Score=348.23  Aligned_cols=293  Identities=18%  Similarity=0.233  Sum_probs=202.5

Q ss_pred             CCccccCCCCCCEEEcCCCcCee------------------ccCCCc--------cccccCCCCCcccccccCCCCCCcE
Q 041689           45 VPAAIFDVSTLKDLALQDNYLSG------------------SLSSIA--------DNYLTSSTPELSFLSSLSNCKSLVV   98 (652)
Q Consensus        45 ~p~~~~~l~~L~~L~Ls~N~l~~------------------~~~~~~--------~~~l~~~~~~~~~~~~l~~l~~L~~   98 (652)
                      +|..|+++++|++|+|++|+|++                  +++.+.        ...+..+......+..|.++++|++
T Consensus       198 ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  277 (636)
T 4eco_A          198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL  277 (636)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCE
T ss_pred             CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCE
Confidence            56667777777777777777776                  333322        1112222111222346777888888


Q ss_pred             EEcccCC-Ccc-cCCccchhcc------cccCcEEEccCCcccccCCc--cccCCCCCCEEEecCccccccCCccccCCC
Q 041689           99 FLLSNNP-LNG-ILPRMSIGNL------SHSLEIFDMSKCNVSGGIPE--EIGNLTNLTAIYLGGNKLNGSIPFTLRELQ  168 (652)
Q Consensus        99 L~Ls~N~-l~~-~~~~~~~~~l------~~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  168 (652)
                      |+|++|+ +++ ..|. .++.+      ++ |++|+|++|+++ .+|.  .|.++++|++|+|++|+++|.+| .|..++
T Consensus       278 L~Ls~n~~l~~~~lp~-~~~~L~~~~~l~~-L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~  353 (636)
T 4eco_A          278 INVACNRGISGEQLKD-DWQALADAPVGEK-IQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI  353 (636)
T ss_dssp             EECTTCTTSCHHHHHH-HHHHHHHSGGGGT-CCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEE
T ss_pred             EECcCCCCCccccchH-HHHhhhccccCCC-CCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCC
Confidence            8888887 776 4444 45555      54 888888888887 5666  78888888888888888887777 777888


Q ss_pred             CCcEEecccCccccccCccccCCCC-CcEEEccCCcccccccccCCCCC--CCCEEEccCCC--CCCCcccC-------C
Q 041689          169 KLQYVGLKDNKLEGTIPYDIFRLVK-LYKLDLGGNKLSGSILTCFSNLA--SLRTLSLSYND--GPLPLEIG-------N  236 (652)
Q Consensus       169 ~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~--~~~~~~~~-------~  236 (652)
                      +|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +|++|++++|.  +..|..+.       .
T Consensus       354 ~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~  431 (636)
T 4eco_A          354 KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK  431 (636)
T ss_dssp             EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCC
T ss_pred             CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccccccc
Confidence            8888888888887 77777777877 888888888887 5566666544  78888888875  45566666       6


Q ss_pred             CCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccccccc-------ccCcceeccccccCCCCchhhc--
Q 041689          237 LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDL-------ISLKSLNFSNNNLSGAIPLLLE--  307 (652)
Q Consensus       237 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-------~~L~~L~L~~N~l~~~~~~~~~--  307 (652)
                      +++|+.|++++|+++++++..+..+++|++|+|++|+++...+..+...       ++|+.|+|++|+|+ .+|..+.  
T Consensus       432 ~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~  510 (636)
T 4eco_A          432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRAT  510 (636)
T ss_dssp             CCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTT
T ss_pred             CCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhc
Confidence            6778888888888876555556667888888888888873333333322       27888888888887 5666665  


Q ss_pred             CCCCCceEEeecCcCcccCCCCCCCCCcccccccCCc
Q 041689          308 KLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNK  344 (652)
Q Consensus       308 ~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~  344 (652)
                      .+++|+.|+|++|++++.++....+..++.+++++|+
T Consensus       511 ~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~  547 (636)
T 4eco_A          511 TLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR  547 (636)
T ss_dssp             TCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCB
T ss_pred             cCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCc
Confidence            7788888888888887744445667777777776655

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-38  Score=355.74  Aligned_cols=225  Identities=22%  Similarity=0.310  Sum_probs=190.3

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ..++|.+.+.||+|+||.||+|.+..    +..||+|+++.. .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678889999999999999998642    457999998654 2334567899999999999999999999985 45689


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||+++....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            99999999999999987766799999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVF  632 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~  632 (652)
                      .. ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.                        ..+.
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            21 122233457789999999998899999999999999999997 888864                        3478


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||..||++|||+.||
T Consensus       623 ~li~~~l~~dP~~RPs~~el  642 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFTEL  642 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHH
Confidence            99999999999999999874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.9e-37  Score=349.86  Aligned_cols=334  Identities=17%  Similarity=0.198  Sum_probs=264.4

Q ss_pred             eeeceeEeccCCCcCC---------------ccCCCCC---CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCc-
Q 041689            4 ISIGKLELNVDDIESP---------------CEIPSEI---NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY-   64 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~---------------~~ip~~~---~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-   64 (652)
                      ++|+.|+|+.|.+..-               +.+|..+   ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+ 
T Consensus       448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~  527 (876)
T 4ecn_A          448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG  527 (876)
T ss_dssp             TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred             CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence            4689999999998730               0289887   58999999999999999999999999999999999998 


Q ss_pred             Cee-ccC--------------CCccccccCCCCCccccc--ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEc
Q 041689           65 LSG-SLS--------------SIADNYLTSSTPELSFLS--SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDM  127 (652)
Q Consensus        65 l~~-~~~--------------~~~~~~l~~~~~~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L  127 (652)
                      +++ ..|              .+....+..+... ..+.  .|.++++|+.|+|++|+++.++   .++.+++ |+.|+|
T Consensus       528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp---~~~~L~~-L~~L~L  602 (876)
T 4ecn_A          528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE---AFGTNVK-LTDLKL  602 (876)
T ss_dssp             SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC---CCCTTSE-ESEEEC
T ss_pred             cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch---hhcCCCc-ceEEEC
Confidence            886 232              3333444444443 3334  5788888888888888888443   4667776 888888


Q ss_pred             cCCcccccCCccccCCCC-CCEEEecCccccccCCccccCCCC--CcEEecccCccccccCccc---c--CCCCCcEEEc
Q 041689          128 SKCNVSGGIPEEIGNLTN-LTAIYLGGNKLNGSIPFTLRELQK--LQYVGLKDNKLEGTIPYDI---F--RLVKLYKLDL  199 (652)
Q Consensus       128 ~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L  199 (652)
                      ++|+++ .+|..+..+++ |+.|+|++|+|+ .+|..+..++.  |+.|+|++|+|++.+|...   .  .+++|+.|+|
T Consensus       603 s~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~L  680 (876)
T 4ecn_A          603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL  680 (876)
T ss_dssp             CSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEEC
T ss_pred             cCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEc
Confidence            888888 67777888888 888888888888 66777776654  8888888888887665322   2  3457889999


Q ss_pred             cCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCC--------CCccceEecccccCCccCccccc--CCCCCcEEE
Q 041689          200 GGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGN--------LKVLIGIDFSMNNFSSVIPTTIG--SLKDLQYLF  268 (652)
Q Consensus       200 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~--------l~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~  268 (652)
                      ++|+++.+++..+..+++|+.|+|++|. ..+|..+..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+
T Consensus       681 s~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~  759 (876)
T 4ecn_A          681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMD  759 (876)
T ss_dssp             CSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEE
T ss_pred             cCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEE
Confidence            9999986666666788999999999996 556665443        338999999999999 4677776  899999999


Q ss_pred             ccCCcCCCcccccccccccCcceeccc------cccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccC
Q 041689          269 LGYNILKGSIPDSVGDLISLKSLNFSN------NNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEG  342 (652)
Q Consensus       269 L~~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~  342 (652)
                      |++|+|++ +|..+..+++|+.|+|++      |++.+.+|..+..+++|+.|+|++|++ +.+|.. ..+.++.+++++
T Consensus       760 Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~  836 (876)
T 4ecn_A          760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIAD  836 (876)
T ss_dssp             CCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCS
T ss_pred             eCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCC
Confidence            99999996 788889999999999976      788889999999999999999999999 566654 336889999999


Q ss_pred             CccCCC
Q 041689          343 NKLLCG  348 (652)
Q Consensus       343 N~~~c~  348 (652)
                      |++..-
T Consensus       837 N~l~~i  842 (876)
T 4ecn_A          837 NPNISI  842 (876)
T ss_dssp             CTTCEE
T ss_pred             CCCCcc
Confidence            987553

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.4e-38  Score=333.57  Aligned_cols=196  Identities=17%  Similarity=0.250  Sum_probs=167.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-----------CCeeeeEEeeee
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-----------YRNLVKIISSCS  491 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~  491 (652)
                      ..+|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            357999999999999999999864 6899999999754 234567888999999886           899999999987


Q ss_pred             cCC----ceEEEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC------C
Q 041689          492 NEE----FKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD------D  560 (652)
Q Consensus       492 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~------~  560 (652)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++  ||+||||||+||+++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence            654    789999999 889999987643 35899999999999999999999842  899999999999994      4


Q ss_pred             CCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          561 TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       561 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      .+.+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            45899999999986532     2234568999999999999999999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.5e-38  Score=339.60  Aligned_cols=220  Identities=24%  Similarity=0.288  Sum_probs=176.3

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEEEEccC
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+++..|+||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            35556889999999998777678999999998754   235678899999886 89999999999999999999999996


Q ss_pred             CCChhhhhhcCCCC------CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-------------CcEE
Q 041689          505 HGSLEKCLYSSNCI------LDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-------------MVAH  565 (652)
Q Consensus       505 ~g~L~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-------------~~~k  565 (652)
                       |+|.+++......      .++..+..++.|++.||+|||++   +|+||||||+||+++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             5999999765421      12234577999999999999999   99999999999999754             4899


Q ss_pred             EecccCCccccCCCCcc--ccccccCCccccCcccccc-------CccCcccchhhHHHHHHHHHh-CCCCcch------
Q 041689          566 LSDFGITKLLIGEDQSM--TQTQTLATIGYIAPEYGRE-------GRVFANGDVYSFGIMLMEIHS-AKQQCVS------  629 (652)
Q Consensus       566 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~------  629 (652)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||..      
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            99999998764322111  1234569999999999865       678999999999999999999 8998642      


Q ss_pred             ----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            .+.+++.+||+.||++|||++||
T Consensus       249 ~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  293 (434)
T 2rio_A          249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV  293 (434)
T ss_dssp             HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence                                  36789999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3e-38  Score=348.31  Aligned_cols=222  Identities=24%  Similarity=0.289  Sum_probs=188.8

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec------CCce
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN------EEFK  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~  496 (652)
                      ++|++.+.||+|+||.||+|.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999864 6899999998754 33445678999999999999999999998765      6778


Q ss_pred             EEEEEccCCCChhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCc---EEEecccC
Q 041689          497 ELVLEHMPHGSLEKCLYSSNC--ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV---AHLSDFGI  571 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~---~kl~Dfg~  571 (652)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.   +||+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976442  588889999999999999999999   9999999999999986664   99999999


Q ss_pred             CccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------------
Q 041689          572 TKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------------  628 (652)
Q Consensus       572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------------  628 (652)
                      +......   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.                       
T Consensus       171 a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          171 AKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             ccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9875322   22344578999999999999999999999999999999999999973                       


Q ss_pred             ------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                              ..+.+++.+||..||++|||++|+
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                                    237889999999999999999874

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.5e-37  Score=342.49  Aligned_cols=308  Identities=19%  Similarity=0.185  Sum_probs=256.4

Q ss_pred             eeceeEeccCCCcCCccCCCCC--CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCC
Q 041689            5 SIGKLELNVDDIESPCEIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTP   82 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~   82 (652)
                      +++.|+++.|.+.   .+|..+  ++++|++|+|++|+|+++.|..|..+++|++|+|++|.|++.++.           
T Consensus        52 ~l~~l~l~~~~l~---~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----------  117 (597)
T 3oja_B           52 NQKIVTFKNSTMR---KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----------  117 (597)
T ss_dssp             CCSEEEESSCEES---EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----------
T ss_pred             CceEEEeeCCCCC---CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----------
Confidence            4667777777766   577654  678888888888888888778888888888888888888766553           


Q ss_pred             CcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCc
Q 041689           83 ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF  162 (652)
Q Consensus        83 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  162 (652)
                            .|.++++|++|+|++|.|+++++. .|+.+++ |++|+|++|.|++..|..|.++++|++|+|++|.+++..  
T Consensus       118 ------~~~~l~~L~~L~L~~n~l~~l~~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--  187 (597)
T 3oja_B          118 ------VFQNVPLLTVLVLERNDLSSLPRG-IFHNTPK-LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--  187 (597)
T ss_dssp             ------TTTTCTTCCEEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--
T ss_pred             ------HHcCCCCCCEEEeeCCCCCCCCHH-HhccCCC-CCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--
Confidence                  467888888888888888877765 5677776 888888888888888888888888888888888888543  


Q ss_pred             cccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccce
Q 041689          163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIG  242 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~  242 (652)
                       +..+++|+.|++++|.+++     +....+|+.|++++|.++...+..   .++|+.|+|++|...-+..++.+++|+.
T Consensus       188 -~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~~~l~~l~~L~~  258 (597)
T 3oja_B          188 -LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDTAWLLNYPGLVE  258 (597)
T ss_dssp             -GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCCGGGGGCTTCSE
T ss_pred             -hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCChhhccCCCCCE
Confidence             5567788888888888874     334568999999999998665443   3689999999998666788999999999


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcC
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  322 (652)
                      |+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++
T Consensus       259 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l  336 (597)
T 3oja_B          259 VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI  336 (597)
T ss_dssp             EECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred             EECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCC
Confidence            9999999999999999999999999999999995 6777888999999999999998 6777889999999999999999


Q ss_pred             cccCCCCCCCCCcccccccCCccCCCC
Q 041689          323 EGEIPKGGSFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       323 ~~~~p~~~~~~~l~~~~~~~N~~~c~~  349 (652)
                      ++..  ...++.++.+++++|+|.|..
T Consensus       337 ~~~~--~~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          337 VTLK--LSTHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             CCCC--CCTTCCCSEEECCSSCEEHHH
T ss_pred             CCcC--hhhcCCCCEEEeeCCCCCChh
Confidence            8764  457789999999999999853

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5e-37  Score=340.69  Aligned_cols=339  Identities=21%  Similarity=0.258  Sum_probs=208.7

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCC-------Cc
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS-------IA   73 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~   73 (652)
                      ++.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|+|+++.|+.|.++++|++|+|++|++++.++.       +.
T Consensus        24 ~~~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  101 (549)
T 2z81_A           24 LTAAMKSLDLSFNKITY--IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK  101 (549)
T ss_dssp             CCTTCCEEECCSSCCCE--ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCC
T ss_pred             CCCCccEEECcCCccCc--cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCc
Confidence            34689999999999873  345666 789999999999999998889999999999999999999876653       22


Q ss_pred             cccccCCCCCc-ccccccCCCCCCcEEEcccCC-CcccCCccchhcccccCcEEEccCCcccccCCccccCC--------
Q 041689           74 DNYLTSSTPEL-SFLSSLSNCKSLVVFLLSNNP-LNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNL--------  143 (652)
Q Consensus        74 ~~~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l--------  143 (652)
                      ...+..+.... ..+..+.++++|++|++++|. +..+++. .+..+++ |++|++++|++++..|..+..+        
T Consensus       102 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l  179 (549)
T 2z81_A          102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI-DFAGLTS-LNELEIKALSLRNYQSQSLKSIRDIHHLTL  179 (549)
T ss_dssp             EEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-TTTTCCE-EEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred             EEECCCCcccccchhhhhhccCCccEEECCCCccccccCHh-hhhcccc-cCeeeccCCcccccChhhhhccccCceEec
Confidence            23333332221 223457788888888888887 4444443 6777776 8888888888887777776554        


Q ss_pred             ----------------CCCCEEEecCccccccC--Ccc-c----------------------------------------
Q 041689          144 ----------------TNLTAIYLGGNKLNGSI--PFT-L----------------------------------------  164 (652)
Q Consensus       144 ----------------~~L~~L~L~~N~l~~~~--~~~-~----------------------------------------  164 (652)
                                      ++|++|+|++|++++..  |.. .                                        
T Consensus       180 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~  259 (549)
T 2z81_A          180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD  259 (549)
T ss_dssp             ECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEE
T ss_pred             ccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccc
Confidence                            45555555555554321  000 0                                        


Q ss_pred             -----------------------------------------------cCCCCCcEEecccCccccccCccc-cCCCCCcE
Q 041689          165 -----------------------------------------------RELQKLQYVGLKDNKLEGTIPYDI-FRLVKLYK  196 (652)
Q Consensus       165 -----------------------------------------------~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~  196 (652)
                                                                     ...++|+.|++++|+++ .+|..+ ..+++|++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~  338 (549)
T 2z81_A          260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF  338 (549)
T ss_dssp             SCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCE
T ss_pred             cccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccE
Confidence                                                           00012223333333332 233333 24566666


Q ss_pred             EEccCCccccccc---ccCCCCCCCCEEEccCCCC-CCC---cccCCCCccceEecccccCCccCcccccCCCCCcEEEc
Q 041689          197 LDLGGNKLSGSIL---TCFSNLASLRTLSLSYNDG-PLP---LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL  269 (652)
Q Consensus       197 L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~~-~~~---~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  269 (652)
                      |+|++|++++..|   ..++.+++|++|+|++|.. .++   ..+..+++|+.|++++|++++ +|..+..+++|++|+|
T Consensus       339 L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~L  417 (549)
T 2z81_A          339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNL  417 (549)
T ss_dssp             EECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEEC
T ss_pred             EEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEEC
Confidence            6666666665442   2355566666666666642 222   235566666666666666663 4555555566666666


Q ss_pred             cCCcCCCcccccc------------------cccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC-CC
Q 041689          270 GYNILKGSIPDSV------------------GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK-GG  330 (652)
Q Consensus       270 ~~N~l~~~~p~~~------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~  330 (652)
                      ++|++++ +|..+                  ..+++|+.|+|++|+|+ .+|. ...+++|+.|+|++|++++.+|. ..
T Consensus       418 s~N~l~~-l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~  494 (549)
T 2z81_A          418 SSTGIRV-VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFD  494 (549)
T ss_dssp             TTSCCSC-CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGG
T ss_pred             CCCCccc-ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHh
Confidence            6665552 22211                  25666777777777776 4444 34567777777777777766665 35


Q ss_pred             CCCCcccccccCCccCCCC
Q 041689          331 SFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       331 ~~~~l~~~~~~~N~~~c~~  349 (652)
                      .+..++.+++++|+|.|..
T Consensus       495 ~l~~L~~L~l~~N~~~~~~  513 (549)
T 2z81_A          495 RLTSLQKIWLHTNPWDCSC  513 (549)
T ss_dssp             GCTTCCEEECCSSCBCCCH
T ss_pred             cCcccCEEEecCCCccCCC
Confidence            6666777777777776643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=5.9e-37  Score=346.04  Aligned_cols=165  Identities=24%  Similarity=0.250  Sum_probs=136.7

Q ss_pred             ccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC---CCCCcccCCCCccceEecccccCCccCcccccCCCCC
Q 041689          188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND---GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL  264 (652)
Q Consensus       188 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  264 (652)
                      |..+.+++.+++++|.+.+..+..+..+++|+.|+|++|.   ...|..+..+++|+.|+|++|+|+++.|..|.++++|
T Consensus       441 ~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L  520 (635)
T 4g8a_A          441 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  520 (635)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCC
Confidence            4455667777777888888888889999999999999995   3467889999999999999999999999999999999


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCC-CCCceEEeecCcCcccCCCCCCCCCcc---cccc
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL-SYLEHLNLSFNKLEGEIPKGGSFGNFS---AESF  340 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~l~---~~~~  340 (652)
                      ++|+|++|+|++..|..|..+++|+.|||++|+|++..|..+..+ ++|+.|+|++|+|+|.+.-.....+++   ....
T Consensus       521 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~  600 (635)
T 4g8a_A          521 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV  600 (635)
T ss_dssp             CEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBS
T ss_pred             CEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccC
Confidence            999999999999889999999999999999999999999999988 689999999999999775321111111   1112


Q ss_pred             cCCccCCCCCCC
Q 041689          341 EGNKLLCGSPNL  352 (652)
Q Consensus       341 ~~N~~~c~~~~~  352 (652)
                      ......|+.|..
T Consensus       601 ~~~~~~C~~P~~  612 (635)
T 4g8a_A          601 EVERMECATPSD  612 (635)
T ss_dssp             CGGGCBBCSSTT
T ss_pred             CCCCceeCCchH
Confidence            234567887753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=324.16  Aligned_cols=222  Identities=22%  Similarity=0.279  Sum_probs=172.0

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc--hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.....  ...+.+.++..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999975 689999999975532  22233445556788889999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||+ ++.+..+.......+++..+..++.|++.||.|||+ .   ||+||||||+||+++.++.+||+|||++...... 
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-  178 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence            999 556666655444578999999999999999999998 6   8999999999999999999999999999765321 


Q ss_pred             CccccccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                        .......+++.|+|||++.     ...++.++|||||||++|||++|+.||..                         
T Consensus       179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred             --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence              2223456899999999984     45688999999999999999999998643                         


Q ss_pred             --hhhhhhcccchhhhccccCccCC
Q 041689          630 --FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                        .+.+++.+||+.||++|||++||
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~l  281 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKL  281 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHH
Confidence              37889999999999999999864

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.5e-38  Score=323.26  Aligned_cols=223  Identities=25%  Similarity=0.327  Sum_probs=169.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHH-HHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECE-IMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .++|...+.||+|+||.||+|... +|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            367889999999999999999875 68999999997653 233345555665 677789999999999999999999999


Q ss_pred             EccCCCChhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          501 EHMPHGSLEKCLYS----SNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       501 e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||+..  ||+||||||+||+++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99986 88777652    2346899999999999999999999842  89999999999999999999999999998653


Q ss_pred             CCCCccccccccCCccccCcccc----ccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYG----REGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      ..   .......||+.|+|||++    .+..++.++|||||||++|||++|+.||..                       
T Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3aln_A          178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE  254 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCS
T ss_pred             cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcc
Confidence            21   222334689999999998    456789999999999999999999988643                       


Q ss_pred             ------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                            .+.+++.+||+.||++|||++||
T Consensus       255 ~~~~~~~l~~li~~~l~~dp~~Rps~~el  283 (327)
T 3aln_A          255 EREFSPSFINFVNLCLTKDESKRPKYKEL  283 (327)
T ss_dssp             SCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence                  36789999999999999999864

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.5e-36  Score=334.57  Aligned_cols=310  Identities=19%  Similarity=0.161  Sum_probs=243.5

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      +.+++++|.++   ++|..+ +++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+.               
T Consensus        34 ~~l~ls~~~L~---~ip~~~-~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------   94 (562)
T 3a79_B           34 SMVDYSNRNLT---HVPKDL-PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFH---------------   94 (562)
T ss_dssp             CEEECTTSCCC---SCCTTS-CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTT---------------
T ss_pred             cEEEcCCCCCc---cCCCCC-CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHH---------------
Confidence            57888888887   588877 68999999999999988888999999999999999999877653               


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccC-CccccCCCCCCEEEecCccccccCCcccc
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGI-PEEIGNLTNLTAIYLGGNKLNGSIPFTLR  165 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  165 (652)
                        .|.++++|++|+|++|+|+.++..    .+++ |++|+|++|+++++. |..|.++++|++|+|++|++++.   .+.
T Consensus        95 --~~~~l~~L~~L~Ls~N~l~~lp~~----~l~~-L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~  164 (562)
T 3a79_B           95 --VFLFNQDLEYLDVSHNRLQNISCC----PMAS-LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLL  164 (562)
T ss_dssp             --TTTTCTTCCEEECTTSCCCEECSC----CCTT-CSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTG
T ss_pred             --HhCCCCCCCEEECCCCcCCccCcc----cccc-CCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chh
Confidence              577888899999999988876543    4555 888999999888743 57888888899999988888753   345


Q ss_pred             CCCCC--cEEecccCcc--ccccCccccCCC-------------------------------------------------
Q 041689          166 ELQKL--QYVGLKDNKL--EGTIPYDIFRLV-------------------------------------------------  192 (652)
Q Consensus       166 ~l~~L--~~L~L~~N~l--~~~~~~~~~~l~-------------------------------------------------  192 (652)
                      .+++|  ++|+|++|++  ++..|..+..+.                                                 
T Consensus       165 ~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~  244 (562)
T 3a79_B          165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE  244 (562)
T ss_dssp             GGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHH
T ss_pred             hhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHH
Confidence            55555  8888888887  666665555433                                                 


Q ss_pred             --------------------------------CCcEEEccCCcccccccccC----------------------------
Q 041689          193 --------------------------------KLYKLDLGGNKLSGSILTCF----------------------------  212 (652)
Q Consensus       193 --------------------------------~L~~L~L~~N~l~~~~~~~~----------------------------  212 (652)
                                                      +|++|++++|.+++.+|..+                            
T Consensus       245 l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~  324 (562)
T 3a79_B          245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL  324 (562)
T ss_dssp             HHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHH
T ss_pred             HhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhh
Confidence                                            56677777777776555544                            


Q ss_pred             -------------------------CCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccC--cccccCCCC
Q 041689          213 -------------------------SNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVI--PTTIGSLKD  263 (652)
Q Consensus       213 -------------------------~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~--~~~~~~l~~  263 (652)
                                               ..+++|++|++++|.  ...|..++++++|+.|++++|+++++.  |..|.++++
T Consensus       325 ~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  404 (562)
T 3a79_B          325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS  404 (562)
T ss_dssp             HHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTT
T ss_pred             hhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCC
Confidence                                     677888888888886  446778888889999999999888743  466888889


Q ss_pred             CcEEEccCCcCCCccc-ccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccC
Q 041689          264 LQYLFLGYNILKGSIP-DSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEG  342 (652)
Q Consensus       264 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~  342 (652)
                      |++|+|++|++++.+| ..+..+++|+.|+|++|++++..|..+.  ++|+.|+|++|+++..++....+..++.+++++
T Consensus       405 L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~  482 (562)
T 3a79_B          405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVAS  482 (562)
T ss_dssp             CCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCS
T ss_pred             CCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCC
Confidence            9999999999887344 4578888899999999988876665443  689999999999986666666788889999999


Q ss_pred             CccCC
Q 041689          343 NKLLC  347 (652)
Q Consensus       343 N~~~c  347 (652)
                      |.+..
T Consensus       483 N~l~~  487 (562)
T 3a79_B          483 NQLKS  487 (562)
T ss_dssp             SCCCC
T ss_pred             CCCCC
Confidence            98764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2e-36  Score=339.90  Aligned_cols=151  Identities=20%  Similarity=0.188  Sum_probs=113.6

Q ss_pred             eeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCc-------cccccCC
Q 041689            8 KLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIA-------DNYLTSS   80 (652)
Q Consensus         8 ~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------~~~l~~~   80 (652)
                      .++.+++.++   ++|..+ ++++++|+|++|+++++.+..|.++++|++|+|++|+|+++.+..+       ...+..+
T Consensus        15 ~~~c~~~~l~---~ip~~~-~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           15 TYQCMDQKLS---KVPDDI-PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             EEECTTSCCS---SCCTTS-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             ceEccCCCcc---cCCCCC-CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            4555555555   799988 7899999999999999999999999999999999999998866432       2233333


Q ss_pred             CCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccc-cCCccccCCCCCCEEEecCcccccc
Q 041689           81 TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG-GIPEEIGNLTNLTAIYLGGNKLNGS  159 (652)
Q Consensus        81 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~  159 (652)
                      ......+..|.++++|++|+|++|.++++++. .++.+++ |++|++++|++++ .+|..|.++++|++|+|++|++++.
T Consensus        91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~  168 (606)
T 3vq2_A           91 PIQSFSPGSFSGLTSLENLVAVETKLASLESF-PIGQLIT-LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI  168 (606)
T ss_dssp             CCCCCCTTSSTTCTTCCEEECTTSCCCCSSSS-CCTTCTT-CCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEE
T ss_pred             cccccChhhcCCcccCCEEEccCCcccccccc-ccCCCCC-CCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceec
Confidence            33333345677888888888888888777665 5777775 8888888888875 3577888888888888888877765


Q ss_pred             CCccc
Q 041689          160 IPFTL  164 (652)
Q Consensus       160 ~~~~~  164 (652)
                      .+..|
T Consensus       169 ~~~~~  173 (606)
T 3vq2_A          169 TVNDL  173 (606)
T ss_dssp             CTTTT
T ss_pred             Chhhh
Confidence            55433

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=333.40  Aligned_cols=315  Identities=21%  Similarity=0.219  Sum_probs=251.4

Q ss_pred             ceeeeceeEeccCCCcCCccCC-CCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCC----Cccc
Q 041689            2 FSISIGKLELNVDDIESPCEIP-SEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS----IADN   75 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip-~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~   75 (652)
                      ++++++.|+|+.|.+..   +| ..+ ++++|++|+|++|+|+++.|..|.++++|++|+|++|+|++++..    +...
T Consensus        19 ~~~~L~~L~Ls~n~i~~---~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L   95 (520)
T 2z7x_B           19 LSQKTTILNISQNYISE---LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL   95 (520)
T ss_dssp             CCTTCSEEECCSSCCCC---CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECCCCCCCSEE
T ss_pred             ccccccEEECCCCcccc---cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCccccCCccEE
Confidence            45689999999999884   44 455 789999999999999998899999999999999999999976653    2333


Q ss_pred             cccCCCCCc-ccccccCCCCCCcEEEcccCCCcccCCccchhcccccC--cEEEccCCcc--cccCCccccCCC------
Q 041689           76 YLTSSTPEL-SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSL--EIFDMSKCNV--SGGIPEEIGNLT------  144 (652)
Q Consensus        76 ~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L--~~L~L~~N~l--~~~~~~~~~~l~------  144 (652)
                      .+..+.... ..+..|.++++|++|+|++|++++.    .+..++. |  +.|++++|++  .+..|..+..+.      
T Consensus        96 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~-L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l  170 (520)
T 2z7x_B           96 DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS----SVLPIAH-LNISKVLLVLGETYGEKEDPEGLQDFNTESLHI  170 (520)
T ss_dssp             ECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG----GGGGGTT-SCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEE
T ss_pred             eccCCccccccchhhhccCCcceEEEecCcccchh----hcccccc-ceeeEEEeecccccccccccccccccccceEEE
Confidence            344443322 2346788899999999999988752    3444443 5  6666666666  444444444322      


Q ss_pred             -----------------------------------------------------------------------------CCC
Q 041689          145 -----------------------------------------------------------------------------NLT  147 (652)
Q Consensus       145 -----------------------------------------------------------------------------~L~  147 (652)
                                                                                                   +|+
T Consensus       171 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~  250 (520)
T 2z7x_B          171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW  250 (520)
T ss_dssp             ECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCS
T ss_pred             EeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCccc
Confidence                                                                                         455


Q ss_pred             EEEecCccccccCCccc-----------------------------------------------------cCCCCCcEEe
Q 041689          148 AIYLGGNKLNGSIPFTL-----------------------------------------------------RELQKLQYVG  174 (652)
Q Consensus       148 ~L~L~~N~l~~~~~~~~-----------------------------------------------------~~l~~L~~L~  174 (652)
                      +|++++|++++.+|..+                                                     ..+++|++|+
T Consensus       251 ~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~  330 (520)
T 2z7x_B          251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD  330 (520)
T ss_dssp             EEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEE
T ss_pred             EEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEE
Confidence            55666666554444433                                                     6788999999


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccc--cccccCCCCCCCCEEEccCCC--CCCCcc-cCCCCccceEeccccc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG--SILTCFSNLASLRTLSLSYND--GPLPLE-IGNLKVLIGIDFSMNN  249 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~--~~~~~~-~~~l~~L~~L~ls~N~  249 (652)
                      +++|++++.+|..+..+++|++|+|++|++++  ..|..|..+++|++|++++|.  ..+|.. +..+++|+.|++++|+
T Consensus       331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~  410 (520)
T 2z7x_B          331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI  410 (520)
T ss_dssp             CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred             eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence            99999998899999999999999999999997  456789999999999999997  326665 8889999999999999


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      +++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|+++|.++
T Consensus       411 l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            9987777665  79999999999999 778878899999999999999995544459999999999999999998765

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=9.2e-37  Score=313.00  Aligned_cols=254  Identities=33%  Similarity=0.522  Sum_probs=240.6

Q ss_pred             CCCcEEEcccCCCcc--cCCccchhcccccCcEEEccC-CcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC
Q 041689           94 KSLVVFLLSNNPLNG--ILPRMSIGNLSHSLEIFDMSK-CNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL  170 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~--~~~~~~~~~l~~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  170 (652)
                      .+++.|+|++|.+++  ..|. .+..++. |++|+|++ |++.+.+|..|.++++|++|+|++|++++..|..|.++++|
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~-~l~~l~~-L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L  127 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPS-SLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL  127 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCG-GGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred             ceEEEEECCCCCccCCcccCh-hHhCCCC-CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC
Confidence            579999999999998  6676 7888887 99999995 99999999999999999999999999999999999999999


Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCC-CCCEEEccCCC--CCCCcccCCCCccceEeccc
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLA-SLRTLSLSYND--GPLPLEIGNLKVLIGIDFSM  247 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~  247 (652)
                      ++|+|++|+|++.+|..+..+++|++|+|++|++++..|..+..++ +|++|++++|.  +.+|..+..++ |+.|++++
T Consensus       128 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~  206 (313)
T 1ogq_A          128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR  206 (313)
T ss_dssp             CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCS
T ss_pred             CEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcC
Confidence            9999999999999999999999999999999999999999999998 99999999996  57888899997 99999999


Q ss_pred             ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       248 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..+..+++|+.|+|++|++++.+|
T Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip  285 (313)
T 1ogq_A          207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence            999999999999999999999999999977665 8899999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccCCccCCCCCC
Q 041689          328 KGGSFGNFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       328 ~~~~~~~l~~~~~~~N~~~c~~~~  351 (652)
                      ....++.++.+++.+|++.|+.|.
T Consensus       286 ~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          286 QGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CCccccccChHHhcCCCCccCCCC
Confidence            998999999999999999999874

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.2e-35  Score=338.17  Aligned_cols=321  Identities=21%  Similarity=0.269  Sum_probs=261.1

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeec-----c--------
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS-----L--------   69 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~--------   69 (652)
                      ++|+.|+|+.|.+..  ..|..+ ++++|++|+|++|+++++.|..|.++++|+.|+|++|...+.     .        
T Consensus       248 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~  325 (680)
T 1ziw_A          248 TNLTMLDLSYNNLNV--VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF  325 (680)
T ss_dssp             SCCCEEECTTSCCCE--ECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTT
T ss_pred             CCCCEEECCCCCcCc--cCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhc
Confidence            359999999999873  345556 789999999999999988887777777666666665543210     0        


Q ss_pred             ---CCCccccccCCCCCcccccccCCC----------------------------CCCcEEEcccCCCcccCCccchhcc
Q 041689           70 ---SSIADNYLTSSTPELSFLSSLSNC----------------------------KSLVVFLLSNNPLNGILPRMSIGNL  118 (652)
Q Consensus        70 ---~~~~~~~l~~~~~~~~~~~~l~~l----------------------------~~L~~L~Ls~N~l~~~~~~~~~~~l  118 (652)
                         +.+....+..+.........|.++                            ++|+.|+|++|+++++.+. .+..+
T Consensus       326 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~-~~~~l  404 (680)
T 1ziw_A          326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD-AFSWL  404 (680)
T ss_dssp             TTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTT-TTTTC
T ss_pred             ccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChh-hhhCC
Confidence               011111111111000011112222                            4677777788888888776 67888


Q ss_pred             cccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccc--cccCccccCCCCCc
Q 041689          119 SHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLE--GTIPYDIFRLVKLY  195 (652)
Q Consensus       119 ~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~  195 (652)
                      ++ |+.|+|++|++++.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.++  +.+|..|..+++|+
T Consensus       405 ~~-L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~  483 (680)
T 1ziw_A          405 GH-LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT  483 (680)
T ss_dssp             TT-CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred             CC-CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence            76 9999999999987655 78999999999999999999999999999999999999999997  57889999999999


Q ss_pred             EEEccCCcccccccccCCCCCCCCEEEccCCCCC-C-----C----cccCCCCccceEecccccCCccCcccccCCCCCc
Q 041689          196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP-L-----P----LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ  265 (652)
Q Consensus       196 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~-~-----~----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  265 (652)
                      .|+|++|+|+++.+..|..+++|++|+|++|... +     |    ..+.++++|+.|++++|+++.+.+..|.++++|+
T Consensus       484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~  563 (680)
T 1ziw_A          484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK  563 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence            9999999999999999999999999999999622 1     2    2378999999999999999987777899999999


Q ss_pred             EEEccCCcCCCcccccccccccCcceeccccccCCCCchhhc-CCCCCceEEeecCcCcccCCC
Q 041689          266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLE-KLSYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       266 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~  328 (652)
                      .|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+. .+++|+.|++++|++.|.++.
T Consensus       564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            999999999988888899999999999999999998888887 789999999999999998874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=335.82  Aligned_cols=342  Identities=19%  Similarity=0.231  Sum_probs=267.2

Q ss_pred             eeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCC-------Cccc
Q 041689            4 ISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSS-------IADN   75 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-------~~~~   75 (652)
                      ++|+.|+|+.|.+..  ..|..+ ++++|++|+|++|+++++.|..|.++++|++|+|++|++++..+.       +...
T Consensus        52 ~~L~~L~Ls~n~i~~--i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L  129 (570)
T 2z63_A           52 PELQVLDLSRCEIQT--IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL  129 (570)
T ss_dssp             SSCCEEECTTCCCCE--ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEE
T ss_pred             CCceEEECCCCcCCc--cCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEE
Confidence            468999999998873  234445 789999999999999988889999999999999999999876552       2223


Q ss_pred             cccCCCCCc-ccccccCCCCCCcEEEcccCCCcccCCccchhcccc----------------------------------
Q 041689           76 YLTSSTPEL-SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSH----------------------------------  120 (652)
Q Consensus        76 ~l~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~----------------------------------  120 (652)
                      .+..+.... ..+..|.++++|++|++++|+++++.+. .+..+.+                                  
T Consensus       130 ~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~  208 (570)
T 2z63_A          130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT-DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR  208 (570)
T ss_dssp             ECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG-GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred             ecCCCccceecChhhhcccCCCCEEeCcCCccceecHH-HccchhccchhhhhcccCCCCceecCHHHhccCcceeEecc
Confidence            333332221 2356688888999999998888766443 2322222                                  


Q ss_pred             --------------------------------------------------------------------------cCcEEE
Q 041689          121 --------------------------------------------------------------------------SLEIFD  126 (652)
Q Consensus       121 --------------------------------------------------------------------------~L~~L~  126 (652)
                                                                                                +|+.|+
T Consensus       209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~  288 (570)
T 2z63_A          209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS  288 (570)
T ss_dssp             SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred             cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence                                                                                      244444


Q ss_pred             ccCCcccccCCccc------------------------------------------cCCCCCCEEEecCccccccC--Cc
Q 041689          127 MSKCNVSGGIPEEI------------------------------------------GNLTNLTAIYLGGNKLNGSI--PF  162 (652)
Q Consensus       127 L~~N~l~~~~~~~~------------------------------------------~~l~~L~~L~L~~N~l~~~~--~~  162 (652)
                      +++|.+++ +|..+                                          ..+++|++|++++|++++..  +.
T Consensus       289 l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~  367 (570)
T 2z63_A          289 LVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ  367 (570)
T ss_dssp             EESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEH
T ss_pred             ecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCccccccc
Confidence            44444442 22222                                          34567777778888777544  67


Q ss_pred             cccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccccc-ccCCCCCCCCEEEccCCC--CCCCcccCCCCc
Q 041689          163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSIL-TCFSNLASLRTLSLSYND--GPLPLEIGNLKV  239 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~  239 (652)
                      .+.++++|++|++++|.+++..+ .+..+++|++|++++|.+.+..+ ..|..+++|++|++++|.  ...|..+.++++
T Consensus       368 ~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  446 (570)
T 2z63_A          368 SDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS  446 (570)
T ss_dssp             HHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred             cccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCc
Confidence            78999999999999999996555 49999999999999999998766 679999999999999996  456778999999


Q ss_pred             cceEecccccCC-ccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEee
Q 041689          240 LIGIDFSMNNFS-SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLS  318 (652)
Q Consensus       240 L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  318 (652)
                      |+.|++++|.++ +.+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+++
T Consensus       447 L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  526 (570)
T 2z63_A          447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH  526 (570)
T ss_dssp             CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEec
Confidence            999999999998 5688999999999999999999998889999999999999999999999888899999999999999


Q ss_pred             cCcCcccCCCCCCC-CCcc--cccccCCccCCCCCC
Q 041689          319 FNKLEGEIPKGGSF-GNFS--AESFEGNKLLCGSPN  351 (652)
Q Consensus       319 ~N~l~~~~p~~~~~-~~l~--~~~~~~N~~~c~~~~  351 (652)
                      +|+++|.+|....+ .+++  ...+.+.+ .|+.|.
T Consensus       527 ~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~~  561 (570)
T 2z63_A          527 TNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGSG  561 (570)
T ss_dssp             SSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTTC
T ss_pred             CCcccCCCcchHHHHHHHHhccccCCCch-hhCCCC
Confidence            99999998875433 2221  12344555 787663

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.7e-35  Score=308.64  Aligned_cols=301  Identities=23%  Similarity=0.336  Sum_probs=261.7

Q ss_pred             eeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      .+|+.|++++|.+..   +|..-.+++|++|+|++|+++++.+  |..+++|++|+|++|.+++.               
T Consensus        44 ~~L~~L~l~~~~i~~---~~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~---------------  103 (347)
T 4fmz_A           44 ESITKLVVAGEKVAS---IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI---------------  103 (347)
T ss_dssp             TTCSEEECCSSCCCC---CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC---------------
T ss_pred             ccccEEEEeCCcccc---chhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc---------------
Confidence            368899999999884   6653378999999999999996544  99999999999999998743               


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                          +.+.++++|++|+|++|.++++.+   +..+++ |++|++++|.....++ .+..+++|++|++++|.+.+..+  
T Consensus       104 ----~~~~~l~~L~~L~l~~n~i~~~~~---~~~l~~-L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--  172 (347)
T 4fmz_A          104 ----SALQNLTNLRELYLNEDNISDISP---LANLTK-MYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--  172 (347)
T ss_dssp             ----GGGTTCTTCSEEECTTSCCCCCGG---GTTCTT-CCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--
T ss_pred             ----hHHcCCCcCCEEECcCCcccCchh---hccCCc-eeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--
Confidence                247899999999999999998754   667776 9999999997664444 49999999999999999986554  


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccce
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIG  242 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~  242 (652)
                      +..+++|++|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|. ..++. +..+++|+.
T Consensus       173 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~  247 (347)
T 4fmz_A          173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTW  247 (347)
T ss_dssp             GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCE
T ss_pred             hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCE
Confidence            8999999999999999995443  8899999999999999997665  8899999999999997 33444 999999999


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcC
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  322 (652)
                      |++++|.+++.  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++
T Consensus       248 L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l  323 (347)
T 4fmz_A          248 LEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI  323 (347)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred             EECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence            99999999975  5789999999999999999964  4689999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCcccccccCCcc
Q 041689          323 EGEIPKGGSFGNFSAESFEGNKL  345 (652)
Q Consensus       323 ~~~~p~~~~~~~l~~~~~~~N~~  345 (652)
                      ++.+| ...++.++.+++.+|++
T Consensus       324 ~~~~~-~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          324 TDIRP-LASLSKMDSADFANQVI  345 (347)
T ss_dssp             CCCGG-GGGCTTCSEESSSCC--
T ss_pred             ccccC-hhhhhccceeehhhhcc
Confidence            98877 67888999999999986

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.1e-35  Score=303.52  Aligned_cols=287  Identities=19%  Similarity=0.255  Sum_probs=232.7

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCc
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPEL   84 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~   84 (652)
                      +++.++++.+.++   ++|..+ ++++++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+              
T Consensus        32 ~l~~l~~~~~~l~---~lp~~~-~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------------   93 (330)
T 1xku_A           32 HLRVVQCSDLGLE---KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP--------------   93 (330)
T ss_dssp             ETTEEECTTSCCC---SCCCSC-CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT--------------
T ss_pred             CCeEEEecCCCcc---ccCccC-CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCH--------------
Confidence            6778888877776   688877 6789999999999998888889999999999999999986654              


Q ss_pred             ccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccc--cCCc
Q 041689           85 SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG--SIPF  162 (652)
Q Consensus        85 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~  162 (652)
                         ..|.++++|++|+|++|+++.++.. .+    ++|++|++++|++++..+..|.++++|+.|+|++|+++.  ..+.
T Consensus        94 ---~~~~~l~~L~~L~Ls~n~l~~l~~~-~~----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  165 (330)
T 1xku_A           94 ---GAFAPLVKLERLYLSKNQLKELPEK-MP----KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG  165 (330)
T ss_dssp             ---TTTTTCTTCCEEECCSSCCSBCCSS-CC----TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTT
T ss_pred             ---HHhcCCCCCCEEECCCCcCCccChh-hc----ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChh
Confidence               2578889999999999999877554 22    359999999999998888889999999999999999963  6778


Q ss_pred             cccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-C-CCCcccCCCCcc
Q 041689          163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-G-PLPLEIGNLKVL  240 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~-~~~~~~~~l~~L  240 (652)
                      .|.++++|++|++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|. . ..+..+..+++|
T Consensus       166 ~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  242 (330)
T 1xku_A          166 AFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL  242 (330)
T ss_dssp             GGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred             hccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCC
Confidence            8999999999999999998 4665554  689999999999998888889999999999999886 2 234467888888


Q ss_pred             ceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccccccc------ccCcceeccccccCC--CCchhhcCCCCC
Q 041689          241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDL------ISLKSLNFSNNNLSG--AIPLLLEKLSYL  312 (652)
Q Consensus       241 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L  312 (652)
                      +.|++++|+++ .+|..+..+++|++|++++|+|++..+..|...      +.|+.|++++|.+..  ..|..|..+..+
T Consensus       243 ~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l  321 (330)
T 1xku_A          243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR  321 (330)
T ss_dssp             CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred             CEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccce
Confidence            88888888888 467778888888888888888887766666543      678888888888753  566778888888


Q ss_pred             ceEEeecCc
Q 041689          313 EHLNLSFNK  321 (652)
Q Consensus       313 ~~L~L~~N~  321 (652)
                      +.++|++|+
T Consensus       322 ~~l~L~~N~  330 (330)
T 1xku_A          322 AAVQLGNYK  330 (330)
T ss_dssp             GGEEC----
T ss_pred             eEEEecccC
Confidence            888888874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=6.5e-36  Score=342.28  Aligned_cols=330  Identities=18%  Similarity=0.228  Sum_probs=208.8

Q ss_pred             eeceeEeccCCCcCCccCCCCC-CCCCCCEEEC-CCCcCccc--------------------------------------
Q 041689            5 SIGKLELNVDDIESPCEIPSEI-NPHNLEELLL-GQNNLVGV--------------------------------------   44 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~L-s~N~l~~~--------------------------------------   44 (652)
                      .+..|+|++|.+.  +.+|..+ ++++|++|+| ++|.++|.                                      
T Consensus       324 ~V~~L~Ls~~~L~--G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s  401 (876)
T 4ecn_A          324 RVTGLSLAGFGAK--GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS  401 (876)
T ss_dssp             CEEEEECTTTCCE--EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred             CEEEEECccCCCC--CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhh
Confidence            4667788888777  4688877 8888888888 66654433                                      


Q ss_pred             --------------------------------------CCccccCCCCCCEEEcCCCcCee------------------c
Q 041689           45 --------------------------------------VPAAIFDVSTLKDLALQDNYLSG------------------S   68 (652)
Q Consensus        45 --------------------------------------~p~~~~~l~~L~~L~Ls~N~l~~------------------~   68 (652)
                                                            +|..|.++++|+.|+|++|+|++                  +
T Consensus       402 ~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                                                  67778888888888888888887                  3


Q ss_pred             cCCCc--------cccccCCCCCcccccccCCCCCCcEEEcccCC-Ccc-cCCccchhccc------ccCcEEEccCCcc
Q 041689           69 LSSIA--------DNYLTSSTPELSFLSSLSNCKSLVVFLLSNNP-LNG-ILPRMSIGNLS------HSLEIFDMSKCNV  132 (652)
Q Consensus        69 ~~~~~--------~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~~l~------~~L~~L~L~~N~l  132 (652)
                      ++.+.        ...+..+......+..|.++++|++|+|++|+ +++ ..|. .++.++      ++|++|+|++|++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~-~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA-DWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHH-HHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchH-HHHhhhhcccccCCccEEEeeCCcC
Confidence            33321        11122221111223456666677777777776 665 3333 344443      1277777777777


Q ss_pred             cccCCc--cccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCC-CcEEEccCCccccccc
Q 041689          133 SGGIPE--EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK-LYKLDLGGNKLSGSIL  209 (652)
Q Consensus       133 ~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~  209 (652)
                      + .+|.  .|.++++|+.|+|++|+++ .+| .|..+++|+.|+|++|+|+ .+|..+..+++ |+.|+|++|+++ .+|
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp  635 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP  635 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence            6 5555  6677777777777777776 455 6667777777777777776 66666666666 777777777776 455


Q ss_pred             ccCCCCCC--CCEEEccCCC--CCCC---cccC--CCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccc
Q 041689          210 TCFSNLAS--LRTLSLSYND--GPLP---LEIG--NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD  280 (652)
Q Consensus       210 ~~~~~l~~--L~~L~Ls~N~--~~~~---~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  280 (652)
                      ..+..++.  |+.|+|++|.  +.+|   ..+.  .+++|+.|+|++|+++.+++..+..+++|+.|+|++|+|+ .+|.
T Consensus       636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~  714 (876)
T 4ecn_A          636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE  714 (876)
T ss_dssp             SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred             hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence            55555543  6667776664  2222   1122  2346777777777777544444456777777777777777 4444


Q ss_pred             cccc--------cccCcceeccccccCCCCchhhc--CCCCCceEEeecCcCcccCCCCCCCCCcccccccCCc
Q 041689          281 SVGD--------LISLKSLNFSNNNLSGAIPLLLE--KLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNK  344 (652)
Q Consensus       281 ~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~  344 (652)
                      .+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++.++....+.+++.+++++|+
T Consensus       715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~  787 (876)
T 4ecn_A          715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR  787 (876)
T ss_dssp             TSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB
T ss_pred             HHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC
Confidence            3322        237777777777777 5666665  7777777777777777754445666677777776655

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-35  Score=305.98  Aligned_cols=286  Identities=22%  Similarity=0.260  Sum_probs=180.4

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCc
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPEL   84 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~   84 (652)
                      +++.++++.+.++   ++|..+ +++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+              
T Consensus        34 ~l~~l~~~~~~l~---~ip~~~-~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------------   95 (332)
T 2ft3_A           34 HLRVVQCSDLGLK---AVPKEI-SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHE--------------   95 (332)
T ss_dssp             ETTEEECCSSCCS---SCCSCC-CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECG--------------
T ss_pred             cCCEEECCCCCcc---ccCCCC-CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCH--------------
Confidence            4666666666655   566665 4567777777777776666667777777777777777765443              


Q ss_pred             ccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcccc--ccCCc
Q 041689           85 SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN--GSIPF  162 (652)
Q Consensus        85 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~  162 (652)
                         ..|.++++|++|+|++|+++.+++. .+    .+|++|++++|+|+++.+..|.++++|++|++++|.++  +..+.
T Consensus        96 ---~~~~~l~~L~~L~L~~n~l~~l~~~-~~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  167 (332)
T 2ft3_A           96 ---KAFSPLRKLQKLYISKNHLVEIPPN-LP----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG  167 (332)
T ss_dssp             ---GGSTTCTTCCEEECCSSCCCSCCSS-CC----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTT
T ss_pred             ---hHhhCcCCCCEEECCCCcCCccCcc-cc----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcc
Confidence               2466677777777777777655443 11    23777777777777666666777777777777777774  25566


Q ss_pred             cccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCcc
Q 041689          163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVL  240 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L  240 (652)
                      .|..+ +|++|++++|++++ +|..+.  ++|++|++++|++++..+..|..+++|++|+|++|.  ...+..+..+++|
T Consensus       168 ~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  243 (332)
T 2ft3_A          168 AFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL  243 (332)
T ss_dssp             SSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTC
T ss_pred             cccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCC
Confidence            66666 67777777777763 444443  467777777777776666666666777777776664  2223346666666


Q ss_pred             ceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccccccc------ccCcceeccccccC--CCCchhhcCCCCC
Q 041689          241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDL------ISLKSLNFSNNNLS--GAIPLLLEKLSYL  312 (652)
Q Consensus       241 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L  312 (652)
                      +.|++++|+++ .+|..+..+++|++|++++|+|++..+..|..+      .+|+.|++++|.+.  +..|.+|..+++|
T Consensus       244 ~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L  322 (332)
T 2ft3_A          244 RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR  322 (332)
T ss_dssp             CEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCS
T ss_pred             CEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchh
Confidence            66666666666 345556666666666666666665555555442      45666666666665  4555666666666


Q ss_pred             ceEEeecCc
Q 041689          313 EHLNLSFNK  321 (652)
Q Consensus       313 ~~L~L~~N~  321 (652)
                      +.+++++|+
T Consensus       323 ~~l~l~~n~  331 (332)
T 2ft3_A          323 LAIQFGNYK  331 (332)
T ss_dssp             TTEEC----
T ss_pred             hhhhccccc
Confidence            666666653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=344.47  Aligned_cols=321  Identities=22%  Similarity=0.212  Sum_probs=226.7

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCc-ccCCccccCCCCCCEEEcCCCcCeeccCCCccccccC
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLV-GVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTS   79 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~   79 (652)
                      +|.+++.|+|+.|.++.  ..|..+ ++++|++|+|++|++. .+.|.+|.++++|++|+|++|+|++..+         
T Consensus        22 lp~~l~~LdLs~N~i~~--i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p---------   90 (844)
T 3j0a_A           22 VLNTTERLLLSFNYIRT--VTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP---------   90 (844)
T ss_dssp             SCTTCCEEEEESCCCCE--ECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT---------
T ss_pred             CCCCcCEEECCCCcCCc--cChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH---------
Confidence            35566677777766663  234445 6667777777777433 3336667777777777777777665544         


Q ss_pred             CCCCcccccccCCCCCCcEEEcccCCCcccCCc-cchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCcccc
Q 041689           80 STPELSFLSSLSNCKSLVVFLLSNNPLNGILPR-MSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLN  157 (652)
Q Consensus        80 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  157 (652)
                              ..|.++++|++|+|++|.+++..+. ..+.++++ |++|+|++|++++..+ ..|+++++|++|+|++|.++
T Consensus        91 --------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~-L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           91 --------DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA-LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             --------TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSS-CCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             --------hHccCCcccCEeeCcCCCCCcccccCccccccCC-CCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence                    2466777777777777777764332 23666665 7777777777776644 46777777777777777777


Q ss_pred             ccCCccccCC--CCCcEEecccCccccccCccccCCCC------CcEEEccCCcccccccccCC----------------
Q 041689          158 GSIPFTLREL--QKLQYVGLKDNKLEGTIPYDIFRLVK------LYKLDLGGNKLSGSILTCFS----------------  213 (652)
Q Consensus       158 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~N~l~~~~~~~~~----------------  213 (652)
                      +..+..|..+  ++|+.|+|++|.+.+..|..+..+.+      |+.|++++|.+++..+..+.                
T Consensus       162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~  241 (844)
T 3j0a_A          162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH  241 (844)
T ss_dssp             CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSS
T ss_pred             eeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccc
Confidence            7777777766  77777777777777766666655554      88888888876654443322                


Q ss_pred             --------------------C--CCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEc
Q 041689          214 --------------------N--LASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL  269 (652)
Q Consensus       214 --------------------~--l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  269 (652)
                                          +  .++|+.|+|++|.  ...|..+..+++|+.|+|++|++++..|..|.++++|++|+|
T Consensus       242 ~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L  321 (844)
T 3j0a_A          242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL  321 (844)
T ss_dssp             CCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEE
T ss_pred             cccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEEC
Confidence                                1  2578888888885  334566788888888888888888887888888888888888


Q ss_pred             cCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccC
Q 041689          270 GYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       270 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~  346 (652)
                      ++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+++...    ++.++.+.+.+|.+.
T Consensus       322 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~----~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF----IPSIPDIFLSGNKLV  394 (844)
T ss_dssp             ESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS----CCSCSEEEEESCCCC
T ss_pred             CCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC----CCCcchhccCCCCcc
Confidence            8888887778888888888888888888887777778888888888888888875432    555666666666654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.1e-37  Score=348.12  Aligned_cols=213  Identities=21%  Similarity=0.253  Sum_probs=183.0

Q ss_pred             cCCCccceeccccceEEEEEEeC--CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCc-----e
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEF-----K  496 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~  496 (652)
                      ++|++.+.||+|+||.||+|.+.  +|+.||||++... .......+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999875  5899999998644 23445678899999999999999999999987655     6


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcccc
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI  576 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  576 (652)
                      |+||||+++++|.+++..   .+++.++..|+.|++.||.|||++   ||+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987654   589999999999999999999999   99999999999999986 89999999998653


Q ss_pred             CCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc-----------------hhhhhhhcccc
Q 041689          577 GEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV-----------------SFVFNLAMECT  639 (652)
Q Consensus       577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~-----------------~~l~~l~~~~l  639 (652)
                      ..      ....||+.|+|||++.++ ++.++|||||||++|||++|..|+.                 ..+.+++.+||
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  305 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI  305 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHT
T ss_pred             cC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhc
Confidence            21      345699999999998765 4889999999999999999988753                 34778999999


Q ss_pred             hhhhccccCccC
Q 041689          640 IESLELRINAKE  651 (652)
Q Consensus       640 ~~~p~~Rpt~~e  651 (652)
                      ..||++||+..+
T Consensus       306 ~~dP~~R~~~~~  317 (681)
T 2pzi_A          306 DPDPRQRFTTAE  317 (681)
T ss_dssp             CSSGGGSCSSHH
T ss_pred             cCChhhCCCHHH
Confidence            999999997643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.6e-36  Score=306.13  Aligned_cols=196  Identities=19%  Similarity=0.262  Sum_probs=170.3

Q ss_pred             cCCCcc-ceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHH-HhcCCCeeeeEEeeeec----CCceE
Q 041689          425 YGFNEN-NLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIM-KSIHYRNLVKIISSCSN----EEFKE  497 (652)
Q Consensus       425 ~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~  497 (652)
                      ++|.+. +.||+|+||.||+|... +++.||+|+++..     ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            457666 78999999999999864 6899999998632     4567888888 55699999999999876    67789


Q ss_pred             EEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~  573 (652)
                      +||||+++|+|.+++.... ..+++.++..++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999998754 3689999999999999999999999   9999999999999997   7899999999987


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc--------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC--------------------------  627 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~--------------------------  627 (652)
                      ...                        +..++.++||||+||++|||++|+.||                          
T Consensus       169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            531                        245678899999999999999999996                          


Q ss_pred             -----chhhhhhhcccchhhhccccCccCC
Q 041689          628 -----VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 -----~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                           +..+.+++.+||+.||++|||++|+
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~  254 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEF  254 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence                 3347889999999999999999874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.9e-35  Score=325.46  Aligned_cols=156  Identities=19%  Similarity=0.214  Sum_probs=97.7

Q ss_pred             EeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccc
Q 041689           10 ELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSS   89 (652)
Q Consensus        10 ~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~   89 (652)
                      +.+.+.++   ++|..+ +++|++|+|++|+|+++.|..|.++++|++|+|++|+|++.++.                 +
T Consensus        11 ~~~~~~l~---~ip~~~-~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----------------~   69 (549)
T 2z81_A           11 DGRSRSFT---SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD-----------------A   69 (549)
T ss_dssp             ECTTSCCS---SCCSCC-CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT-----------------T
T ss_pred             ECCCCccc---cccccC-CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh-----------------h
Confidence            44444444   899987 68999999999999999999999999999999999999987763                 3


Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccccc-CCccccCCCCCCEEEecCcc-ccccCCccccCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG-IPEEIGNLTNLTAIYLGGNK-LNGSIPFTLREL  167 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l  167 (652)
                      |.++++|++|+|++|+++++++. .++.+++ |++|+|++|++++. .|..|.++++|++|+|++|+ +..+.+..|.++
T Consensus        70 ~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l  147 (549)
T 2z81_A           70 FYSLGSLEHLDLSDNHLSSLSSS-WFGPLSS-LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL  147 (549)
T ss_dssp             TTTCTTCCEEECTTSCCCSCCHH-HHTTCTT-CCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             ccccccCCEEECCCCccCccCHH-HhccCCC-CcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence            44555555555555555554443 3444443 55555555555532 23445555555555555554 232223445555


Q ss_pred             CCCcEEecccCccccccCccc
Q 041689          168 QKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       168 ~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      ++|++|++++|++++..|..+
T Consensus       148 ~~L~~L~L~~n~l~~~~~~~l  168 (549)
T 2z81_A          148 TSLNELEIKALSLRNYQSQSL  168 (549)
T ss_dssp             CEEEEEEEEETTCCEECTTTT
T ss_pred             cccCeeeccCCcccccChhhh
Confidence            555555555555554444433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.3e-34  Score=314.22  Aligned_cols=322  Identities=24%  Similarity=0.350  Sum_probs=231.4

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccC-----CCccccccC
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS-----SIADNYLTS   79 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~~~~~~l~~   79 (652)
                      +++.|+++.|.+.   .+|..-.+++|++|+|++|+++++.|  |.++++|++|+|++|++++..+     .+....+..
T Consensus        47 ~l~~L~l~~~~i~---~l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~  121 (466)
T 1o6v_A           47 QVTTLQADRLGIK---SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN  121 (466)
T ss_dssp             TCCEEECCSSCCC---CCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCS
T ss_pred             cccEEecCCCCCc---cCcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChhhcCCCCCCEEECCC
Confidence            5667777777766   35543366777777777777775443  7777777777777777765543     111122222


Q ss_pred             CCCCcccccccCCCCCCcEEEcccCCCcccCCc------------------cchhcccccCcEEEccCCcccccCCcccc
Q 041689           80 STPELSFLSSLSNCKSLVVFLLSNNPLNGILPR------------------MSIGNLSHSLEIFDMSKCNVSGGIPEEIG  141 (652)
Q Consensus        80 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~------------------~~~~~l~~~L~~L~L~~N~l~~~~~~~~~  141 (652)
                      +.  +..+..+.++++|++|++++|.++++..-                  ..+..++. |++|++++|++++.  ..+.
T Consensus       122 n~--l~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~-L~~L~l~~n~l~~~--~~l~  196 (466)
T 1o6v_A          122 NQ--ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT-LERLDISSNKVSDI--SVLA  196 (466)
T ss_dssp             SC--CCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT-CCEEECCSSCCCCC--GGGG
T ss_pred             CC--CCCChHHcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCC-CCEEECcCCcCCCC--hhhc
Confidence            21  11222366777777777777777654210                  02445554 88888888888754  3477


Q ss_pred             CCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEE
Q 041689          142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTL  221 (652)
Q Consensus       142 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  221 (652)
                      .+++|++|++++|++++..|  +..+++|++|++++|++++.  +.+..+++|+.|++++|.+++..+  +..+++|++|
T Consensus       197 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  270 (466)
T 1o6v_A          197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL  270 (466)
T ss_dssp             GCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred             cCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEE
Confidence            88888888888888876555  67788888888888888743  357788888888888888887655  7888888888


Q ss_pred             EccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCC
Q 041689          222 SLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGA  301 (652)
Q Consensus       222 ~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  301 (652)
                      ++++|.......+..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++.
T Consensus       271 ~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          271 KLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             ECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred             ECCCCccCccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence            8888863222237888888888888888887544  7788888888888888887655  77888888888888888865


Q ss_pred             CchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCC
Q 041689          302 IPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       302 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~  349 (652)
                        ..+..+++|+.|++++|++++.+| ...++.++.+++.+|++...+
T Consensus       347 --~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          347 --SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             --GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred             --hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccCCc
Confidence              367888889999999999888777 677788888888888887643

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-36  Score=323.32  Aligned_cols=218  Identities=18%  Similarity=0.162  Sum_probs=171.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCC-Cee---------------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHY-RNL---------------  483 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~ni---------------  483 (652)
                      ...|...+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|+.+++.++| ++.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345778899999999999999954 69999999987432   2335778999999999977 211               


Q ss_pred             ee------EEeeeec-----CCceEEEEEccCCCChhhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 041689          484 VK------IISSCSN-----EEFKELVLEHMPHGSLEKCLY------SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV  546 (652)
Q Consensus       484 v~------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  546 (652)
                      +.      +..++..     ....+++|+++ +++|.+++.      .....+++..+..++.|++.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            11      1111111     22456777765 579999884      2233577888999999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCcccc----------ccCccCcccchhhHHHH
Q 041689          547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG----------REGRVFANGDVYSFGIM  616 (652)
Q Consensus       547 iH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslG~v  616 (652)
                      +||||||+|||++.++.+||+|||+++...     .......| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecC-----CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999988642     11344567 999999998          56678899999999999


Q ss_pred             HHHHHhCCCCcch-------------------hhhhhhcccchhhhccccCccC
Q 041689          617 LMEIHSAKQQCVS-------------------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       617 l~elltg~~p~~~-------------------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                      +|||++|+.||..                   .+.+++.+||+.||++|||+.|
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999654                   3788999999999999999865

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.9e-35  Score=301.80  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=157.1

Q ss_pred             CCCCEEECCCCcCcc--cCCccccCCCCCCEEEcCC-CcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCC
Q 041689           29 HNLEELLLGQNNLVG--VVPAAIFDVSTLKDLALQD-NYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNP  105 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  105 (652)
                      .++++|+|++|++++  .+|..|.++++|++|+|++ |.+++..|                 ..|.++++|++|+|++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p-----------------~~l~~l~~L~~L~Ls~n~  112 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----------------PAIAKLTQLHYLYITHTN  112 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----------------GGGGGCTTCSEEEEEEEC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCC-----------------hhHhcCCCCCEEECcCCe
Confidence            466777777777766  6666777777777777773 66664443                 235566666666666666


Q ss_pred             CcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCC-CCcEEecccCcccccc
Q 041689          106 LNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ-KLQYVGLKDNKLEGTI  184 (652)
Q Consensus       106 l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~  184 (652)
                      +++..|. .+..+++ |++|+|++|+|++.+|..|..+++|++|+|++|++++..|..+..++ +|++|+|++|++++.+
T Consensus       113 l~~~~p~-~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~  190 (313)
T 1ogq_A          113 VSGAIPD-FLSQIKT-LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI  190 (313)
T ss_dssp             CEEECCG-GGGGCTT-CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred             eCCcCCH-HHhCCCC-CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccC
Confidence            6655555 5555654 66666666666666666666666666666666666666666666665 6666666666666666


Q ss_pred             CccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCC
Q 041689          185 PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL  264 (652)
Q Consensus       185 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  264 (652)
                      |..+..+. |++|+|++|++++..|..|..+++|++|+|++                      |++++.+|. +..+++|
T Consensus       191 ~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~----------------------N~l~~~~~~-~~~l~~L  246 (313)
T 1ogq_A          191 PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK----------------------NSLAFDLGK-VGLSKNL  246 (313)
T ss_dssp             CGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCS----------------------SEECCBGGG-CCCCTTC
T ss_pred             ChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCC----------------------CceeeecCc-ccccCCC
Confidence            66666665 66666666666665555555555555555554                      555543333 5556666


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCc
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK  321 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  321 (652)
                      ++|+|++|++++.+|..|..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus       247 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             CEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            66666666666666666666666666666666666666554 556666666666666

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.9e-36  Score=302.27  Aligned_cols=192  Identities=13%  Similarity=0.040  Sum_probs=168.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|++. +++.||||+++...   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999975 58999999997653   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||++|++|.+++...   ....++..++.|++.||+|||++   ||+||||||+||+++.++.+||+++|          
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            999999999998643   35567888999999999999999   99999999999999999999998543          


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------------h
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------------F  630 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------------~  630 (652)
                                  |++|       ++.++|||||||++|||++|+.||..                              .
T Consensus       175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                        3333       67889999999999999999999643                              2


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++| |++|+
T Consensus       236 l~~li~~~l~~dP~~R-s~~el  256 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTL  256 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHH
T ss_pred             HHHHHHHHcccCCccC-CHHHH
Confidence            6889999999999999 98764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-36  Score=316.26  Aligned_cols=192  Identities=17%  Similarity=0.157  Sum_probs=159.4

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--------chhhhhHHHHHHHHHhcC---------CCeeeeE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--------GRAFKSFDIECEIMKSIH---------YRNLVKI  486 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~  486 (652)
                      .++|++.+.||+|+||.||+|++ +|+.||||+++...        ....+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45688999999999999999998 78999999997552        223467889999999886         6666555


Q ss_pred             Eee-----------------eec-------------CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 041689          487 ISS-----------------CSN-------------EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLE  536 (652)
Q Consensus       487 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~  536 (652)
                      .+.                 +.+             .+..|+||||+++|++.+.+..  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999977666644  35899999999999999999


Q ss_pred             HHH-cCCCCCeEecCCCCCCeeeCCCC--------------------cEEEecccCCccccCCCCccccccccCCccccC
Q 041689          537 YLH-FNFLVPVIHCDLKPSNVLLDDTM--------------------VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIA  595 (652)
Q Consensus       537 ~LH-~~~~~~iiH~dlkp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  595 (652)
                      ||| ++   +|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+|
T Consensus       176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a  245 (336)
T 2vuw_A          176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD  245 (336)
T ss_dssp             HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred             HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence            999 89   999999999999999887                    999999999987532       23479999999


Q ss_pred             ccccccCccCcccchhhHHHH-HHHHHhCCCCcch
Q 041689          596 PEYGREGRVFANGDVYSFGIM-LMEIHSAKQQCVS  629 (652)
Q Consensus       596 PE~~~~~~~~~~sDvwslG~v-l~elltg~~p~~~  629 (652)
                      ||++.+.. +.++||||+|++ .+++++|..||..
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            99998766 889999998777 7778888888753

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=5.1e-34  Score=295.50  Aligned_cols=296  Identities=20%  Similarity=0.222  Sum_probs=236.7

Q ss_pred             CccCCCCCC--C-----CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccC
Q 041689           19 PCEIPSEIN--P-----HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLS   91 (652)
Q Consensus        19 ~~~ip~~~~--~-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~   91 (652)
                      +.++|..+.  .     .+++.+++++|.++ .+|..+.  ++|+.|+|++|.|+++++.                 .|.
T Consensus        16 l~~lp~~~~~~cp~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~-----------------~~~   75 (332)
T 2ft3_A           16 LDSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKD-----------------DFK   75 (332)
T ss_dssp             ---------CCCCSSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTT-----------------TTT
T ss_pred             cccCCCcccCCCCCCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHh-----------------Hhh
Confidence            346776541  1     37999999999998 5666553  6899999999999876652                 578


Q ss_pred             CCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCc
Q 041689           92 NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ  171 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  171 (652)
                      ++++|++|+|++|+++++.+. .+..+++ |++|+|++|+++.+ |..+.  ++|++|+|++|++++..+..|.++++|+
T Consensus        76 ~l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~  150 (332)
T 2ft3_A           76 GLQHLYALVLVNNKISKIHEK-AFSPLRK-LQKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMN  150 (332)
T ss_dssp             TCTTCCEEECCSSCCCEECGG-GSTTCTT-CCEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCC
T ss_pred             CCCCCcEEECCCCccCccCHh-HhhCcCC-CCEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCC
Confidence            899999999999999988776 7888886 99999999999954 44443  8999999999999988888899999999


Q ss_pred             EEecccCcccc--ccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEeccc
Q 041689          172 YVGLKDNKLEG--TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSM  247 (652)
Q Consensus       172 ~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~  247 (652)
                      +|++++|.++.  ..+..+..+ +|++|++++|++++++.. +.  ++|++|++++|.  ...+..+..+++|+.|++++
T Consensus       151 ~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~-~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~  226 (332)
T 2ft3_A          151 CIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKD-LP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH  226 (332)
T ss_dssp             EEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSS-SC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCS
T ss_pred             EEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcc-cc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            99999999963  677778887 999999999999975443 33  789999999996  33446789999999999999


Q ss_pred             ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCC------CCCceEEeecCc
Q 041689          248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL------SYLEHLNLSFNK  321 (652)
Q Consensus       248 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~  321 (652)
                      |++++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|...      ..|+.|++++|+
T Consensus       227 N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~  305 (332)
T 2ft3_A          227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNP  305 (332)
T ss_dssp             SCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSS
T ss_pred             CcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCc
Confidence            9999888888999999999999999998 778889999999999999999998777777653      678999999999


Q ss_pred             Cc--ccCCC-CCCCCCcccccccCCc
Q 041689          322 LE--GEIPK-GGSFGNFSAESFEGNK  344 (652)
Q Consensus       322 l~--~~~p~-~~~~~~l~~~~~~~N~  344 (652)
                      ++  +..|. ...+..++.+++++|.
T Consensus       306 ~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          306 VPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ccccccCcccccccchhhhhhccccc
Confidence            87  33332 3566777888887774

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.9e-34  Score=308.57  Aligned_cols=297  Identities=23%  Similarity=0.328  Sum_probs=184.8

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccC-----CCccccccCCCCCcccccccCCCCCCcEEEc
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS-----SIADNYLTSSTPELSFLSSLSNCKSLVVFLL  101 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L  101 (652)
                      ++.+++.|++++|.++. +| .+..+++|++|+|++|.+++.++     .+....+..+..  .....+.++++|++|+|
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~l~~n~l--~~~~~~~~l~~L~~L~L  119 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTL  119 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCC--CCCGGGTTCTTCCEEEC
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchhhhccccCCEEECCCCcc--ccChhhcCCCCCCEEEC
Confidence            36799999999999985 45 48899999999999999986653     111112222111  11122556666666666


Q ss_pred             ccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccc
Q 041689          102 SNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLE  181 (652)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  181 (652)
                      ++|.++++++   +..+++ |++|++++|++++. + .+..+++|+.|+++ |.+.+..  .+.++++|++|++++|.++
T Consensus       120 ~~n~l~~~~~---~~~l~~-L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          120 FNNQITDIDP---LKNLTN-LNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS  190 (466)
T ss_dssp             CSSCCCCCGG---GTTCTT-CSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCChH---HcCCCC-CCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence            6666665532   445554 66666666666542 2 24444444444443 2222221  2666777777777777776


Q ss_pred             cccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCC
Q 041689          182 GTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL  261 (652)
Q Consensus       182 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  261 (652)
                      +. + .+..+++|++|++++|.+++..+  ++.+++|++|++++|.......+..+++|+.|++++|.+++..+  +..+
T Consensus       191 ~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l  264 (466)
T 1o6v_A          191 DI-S-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGL  264 (466)
T ss_dssp             CC-G-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             CC-h-hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh--hhcC
Confidence            43 2 36677777777777777776554  56667777777777753333456666777777777777765433  6666


Q ss_pred             CCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCccccccc
Q 041689          262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE  341 (652)
Q Consensus       262 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~  341 (652)
                      ++|++|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|++++|++++..| ...+..++.+++.
T Consensus       265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~  339 (466)
T 1o6v_A          265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFY  339 (466)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECC
T ss_pred             CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECC
Confidence            777777777777764433  6666677777777777765443  5666677777777777666555 4455666666666


Q ss_pred             CCccCC
Q 041689          342 GNKLLC  347 (652)
Q Consensus       342 ~N~~~c  347 (652)
                      +|++..
T Consensus       340 ~n~l~~  345 (466)
T 1o6v_A          340 NNKVSD  345 (466)
T ss_dssp             SSCCCC
T ss_pred             CCccCC
Confidence            666544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.9e-34  Score=305.73  Aligned_cols=293  Identities=18%  Similarity=0.184  Sum_probs=258.5

Q ss_pred             CCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcc
Q 041689           23 PSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLS  102 (652)
Q Consensus        23 p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls  102 (652)
                      +..+.+.+++.|++++|.++.+.+..|..+++|++|+|++|+|+++++.                 .|.++++|++|+|+
T Consensus        39 ~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~-----------------~~~~l~~L~~L~L~  101 (390)
T 3o6n_A           39 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----------------AFAYAHTIQKLYMG  101 (390)
T ss_dssp             CSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----------------TTTTCTTCCEEECC
T ss_pred             ccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChh-----------------hccCCCCcCEEECC
Confidence            4445679999999999999987777789999999999999999876653                 58899999999999


Q ss_pred             cCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCcccc
Q 041689          103 NNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEG  182 (652)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  182 (652)
                      +|.++++++. .+..+++ |++|+|++|+|+.+.+..|.++++|++|+|++|++++..+..|.++++|++|++++|++++
T Consensus       102 ~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          102 FNAIRYLPPH-VFQNVPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             SSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred             CCCCCcCCHH-HhcCCCC-CCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence            9999999887 7888887 9999999999997777778999999999999999998889999999999999999999995


Q ss_pred             ccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCC
Q 041689          183 TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL  261 (652)
Q Consensus       183 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  261 (652)
                      .   .+..+++|+.|++++|.+++.     ...++|++|++++|. ..+|..  ..++|+.|++++|.+++.  ..+..+
T Consensus       180 ~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l  247 (390)
T 3o6n_A          180 V---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDT--AWLLNY  247 (390)
T ss_dssp             C---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC--CCSSCCEEECCSSCCCCC--GGGGGC
T ss_pred             c---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeecccc--ccccccEEECCCCCCccc--HHHcCC
Confidence            4   366788999999999999854     345689999999997 334433  357899999999999974  688999


Q ss_pred             CCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCccccccc
Q 041689          262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE  341 (652)
Q Consensus       262 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~  341 (652)
                      ++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++.++....+..++.+++.
T Consensus       248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~  326 (390)
T 3o6n_A          248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLD  326 (390)
T ss_dssp             TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECC
T ss_pred             CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECC
Confidence            999999999999998889999999999999999999984 5667788999999999999999777666778899999999


Q ss_pred             CCccCC
Q 041689          342 GNKLLC  347 (652)
Q Consensus       342 ~N~~~c  347 (652)
                      +|++.-
T Consensus       327 ~N~i~~  332 (390)
T 3o6n_A          327 HNSIVT  332 (390)
T ss_dssp             SSCCCC
T ss_pred             CCccce
Confidence            998754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7.5e-34  Score=296.17  Aligned_cols=281  Identities=25%  Similarity=0.382  Sum_probs=244.7

Q ss_pred             eeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      ++|+.|+|+.|.+..   +|..-++++|++|+|++|+++.+  ..|..+++|++|+|++|++++..              
T Consensus        66 ~~L~~L~l~~n~i~~---~~~~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~--------------  126 (347)
T 4fmz_A           66 TNLEYLNLNGNQITD---ISPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDIS--------------  126 (347)
T ss_dssp             TTCCEEECCSSCCCC---CGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCG--------------
T ss_pred             CCccEEEccCCcccc---chhhhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCch--------------
Confidence            578999999998884   55533789999999999999964  46999999999999999997432              


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                           .+.++++|++|++++|......+  .+..++. |++|++++|.+.+..+  +..+++|++|++++|.+.+..+  
T Consensus       127 -----~~~~l~~L~~L~l~~n~~~~~~~--~~~~l~~-L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--  194 (347)
T 4fmz_A          127 -----PLANLTKMYSLNLGANHNLSDLS--PLSNMTG-LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--  194 (347)
T ss_dssp             -----GGTTCTTCCEEECTTCTTCCCCG--GGTTCTT-CCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--
T ss_pred             -----hhccCCceeEEECCCCCCccccc--chhhCCC-CcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--
Confidence                 26789999999999996655444  3677776 9999999999996654  8999999999999999996544  


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceE
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGI  243 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L  243 (652)
                      +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|++|++++|.......+..+++|+.|
T Consensus       195 ~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L  270 (347)
T 4fmz_A          195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLTKLKML  270 (347)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCTTCCEE
T ss_pred             ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCCCcCEE
Confidence            8999999999999999996544  8899999999999999997665  89999999999999974445679999999999


Q ss_pred             ecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCc
Q 041689          244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       244 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  323 (652)
                      ++++|++++.  ..+..+++|+.|++++|++++..|..+..+++|+.|+|++|++++..|  +..+++|+.|++++|+++
T Consensus       271 ~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          271 NVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             ECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            9999999975  568999999999999999998889999999999999999999997766  889999999999999986

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.7e-33  Score=291.38  Aligned_cols=287  Identities=20%  Similarity=0.182  Sum_probs=232.0

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .+++.++++++.++. +|..+.  ++|+.|+|++|+|+++++.                 .|.++++|++|+|++|++++
T Consensus        31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~-----------------~~~~l~~L~~L~L~~n~l~~   90 (330)
T 1xku_A           31 CHLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDG-----------------DFKNLKNLHTLILINNKISK   90 (330)
T ss_dssp             EETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTT-----------------TTTTCTTCCEEECCSSCCCC
T ss_pred             CCCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChh-----------------hhccCCCCCEEECCCCcCCe
Confidence            378999999999984 666553  6899999999999876552                 47889999999999999998


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCcccc--ccCc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEG--TIPY  186 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~  186 (652)
                      +.|. .+..+++ |++|++++|+|+.+ |..+.  ++|++|++++|++++..+..|.++++|++|++++|.++.  ..+.
T Consensus        91 ~~~~-~~~~l~~-L~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  165 (330)
T 1xku_A           91 ISPG-AFAPLVK-LERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG  165 (330)
T ss_dssp             BCTT-TTTTCTT-CCEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTT
T ss_pred             eCHH-HhcCCCC-CCEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChh
Confidence            8777 7888886 99999999999854 44443  789999999999998888889999999999999999964  6778


Q ss_pred             cccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCC
Q 041689          187 DIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDL  264 (652)
Q Consensus       187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L  264 (652)
                      .+..+++|++|++++|.++.++...+   ++|++|++++|.  ...|..+..+++|+.|++++|.+++..+..|..+++|
T Consensus       166 ~~~~l~~L~~L~l~~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  242 (330)
T 1xku_A          166 AFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL  242 (330)
T ss_dssp             GGGGCTTCCEEECCSSCCCSCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred             hccCCCCcCEEECCCCccccCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCC
Confidence            88999999999999999986543332   789999999986  3346678889999999999999998877788889999


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCC------CCCceEEeecCcCcc--cC-CCCCCCCCc
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL------SYLEHLNLSFNKLEG--EI-PKGGSFGNF  335 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~-p~~~~~~~l  335 (652)
                      ++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|...      ..|+.|++++|++..  .. +....+..+
T Consensus       243 ~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l  321 (330)
T 1xku_A          243 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR  321 (330)
T ss_dssp             CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG
T ss_pred             CEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccce
Confidence            99999999998 778888889999999999999987777777543      678889999998864  22 223456667


Q ss_pred             ccccccCCc
Q 041689          336 SAESFEGNK  344 (652)
Q Consensus       336 ~~~~~~~N~  344 (652)
                      +.+++++|.
T Consensus       322 ~~l~L~~N~  330 (330)
T 1xku_A          322 AAVQLGNYK  330 (330)
T ss_dssp             GGEEC----
T ss_pred             eEEEecccC
Confidence            777777763

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.1e-34  Score=317.87  Aligned_cols=294  Identities=18%  Similarity=0.179  Sum_probs=260.5

Q ss_pred             CCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcc
Q 041689           23 PSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLS  102 (652)
Q Consensus        23 p~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls  102 (652)
                      +..+.+.+++.|++++|.++.+.+..|.++++|++|+|++|.|+++++.                 .|.++++|++|+|+
T Consensus        45 ~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~-----------------~~~~l~~L~~L~L~  107 (597)
T 3oja_B           45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----------------AFAYAHTIQKLYMG  107 (597)
T ss_dssp             CSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----------------TTTTCTTCCEEECC
T ss_pred             cccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChH-----------------HhcCCCCCCEEECC
Confidence            3445678999999999999988888899999999999999999977663                 58899999999999


Q ss_pred             cCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCcccc
Q 041689          103 NNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEG  182 (652)
Q Consensus       103 ~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  182 (652)
                      +|.++++++. .++.++. |++|+|++|+|+++++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.|++
T Consensus       108 ~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          108 FNAIRYLPPH-VFQNVPL-LTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             SSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CCcCCCCCHH-HHcCCCC-CCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence            9999999887 7888887 9999999999998888889999999999999999999999999999999999999999996


Q ss_pred             ccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCC
Q 041689          183 TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL  261 (652)
Q Consensus       183 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  261 (652)
                      . +  +..+++|+.|++++|.+++.     ...++|+.|++++|. ..++..+  .++|+.|+|++|.+++  +..+..+
T Consensus       186 ~-~--~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l  253 (597)
T 3oja_B          186 V-D--LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNY  253 (597)
T ss_dssp             C-C--GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGC
T ss_pred             c-C--hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccC
Confidence            4 3  56688999999999999864     345789999999997 3344333  3689999999999997  4789999


Q ss_pred             CCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCccccccc
Q 041689          262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE  341 (652)
Q Consensus       262 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~  341 (652)
                      ++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++++.++....++.++.++++
T Consensus       254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~  332 (597)
T 3oja_B          254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLD  332 (597)
T ss_dssp             TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECC
T ss_pred             CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECC
Confidence            999999999999999999999999999999999999995 5777788999999999999999776666778899999999


Q ss_pred             CCccCCC
Q 041689          342 GNKLLCG  348 (652)
Q Consensus       342 ~N~~~c~  348 (652)
                      +|++...
T Consensus       333 ~N~l~~~  339 (597)
T 3oja_B          333 HNSIVTL  339 (597)
T ss_dssp             SSCCCCC
T ss_pred             CCCCCCc
Confidence            9997543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.4e-33  Score=298.41  Aligned_cols=295  Identities=17%  Similarity=0.136  Sum_probs=236.4

Q ss_pred             eeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      ++|+.|+|+.|.+..   +|..-.+++|++|+|++|+|+++ |  |..+++|++|+|++|+|++.               
T Consensus        42 ~~L~~L~Ls~n~l~~---~~~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~---------------  100 (457)
T 3bz5_A           42 ATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL---------------  100 (457)
T ss_dssp             TTCCEEECCSSCCCC---CTTGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC---------------
T ss_pred             CCCCEEEccCCCccc---ChhhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee---------------
Confidence            468899999998884   56433789999999999999975 4  89999999999999998753               


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                           .+.++++|++|+|++|++++++    ++.+++ |++|++++|+++++ +  ++.+++|++|++++|+..+..  .
T Consensus       101 -----~~~~l~~L~~L~L~~N~l~~l~----~~~l~~-L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~  165 (457)
T 3bz5_A          101 -----DVTPLTKLTYLNCDTNKLTKLD----VSQNPL-LTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--D  165 (457)
T ss_dssp             -----CCTTCTTCCEEECCSSCCSCCC----CTTCTT-CCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--C
T ss_pred             -----ecCCCCcCCEEECCCCcCCeec----CCCCCc-CCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--c
Confidence                 1667889999999999998862    567776 99999999999874 3  888999999999999655444  4


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccce
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIG  242 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~  242 (652)
                      +..+++|++|++++|+|++ +|  +..+++|+.|++++|++++.   .+..+++|++|++++|+ ..+|  ++.+++|+.
T Consensus       166 ~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~  237 (457)
T 3bz5_A          166 VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTY  237 (457)
T ss_dssp             CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSE
T ss_pred             cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCE
Confidence            7888999999999999995 45  78888999999999999876   38888999999999997 3455  888899999


Q ss_pred             EecccccCCccCcccccCCC-------CCcEEEccCCcCCCcccccccccccCcceeccccccCCCCch--------hhc
Q 041689          243 IDFSMNNFSSVIPTTIGSLK-------DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL--------LLE  307 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~  307 (652)
                      |++++|++++..+..+.+++       +|+.|++++|.+.+.+|  +..+++|+.|+|++|.+.+.+|.        .+.
T Consensus       238 L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~  315 (457)
T 3bz5_A          238 FDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLS  315 (457)
T ss_dssp             EECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCT
T ss_pred             EEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechh
Confidence            99999999987655555554       55666666666665555  56778899999999987665553        255


Q ss_pred             CCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccC
Q 041689          308 KLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       308 ~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~  346 (652)
                      ++++|+.|++++|++++. + ...++.++.+++++|.+.
T Consensus       316 ~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~  352 (457)
T 3bz5_A          316 QNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQ  352 (457)
T ss_dssp             TCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred             hcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCCC
Confidence            667889999999999885 3 667788888888888775

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-33  Score=290.56  Aligned_cols=279  Identities=18%  Similarity=0.200  Sum_probs=196.0

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      ++.....++++|+++. +|..+.  ++|++|+|++|+|+++++.                 .|.++++|++|+|++|+++
T Consensus        30 C~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~-----------------~~~~l~~L~~L~L~~n~l~   89 (353)
T 2z80_A           30 CDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNS-----------------DLQRCVNLQALVLTSNGIN   89 (353)
T ss_dssp             ECTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTT-----------------TTTTCTTCCEEECTTSCCC
T ss_pred             CCCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHH-----------------HhccCCCCCEEECCCCccC
Confidence            3444557777777763 444443  3677777777777655442                 3566777777777777777


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC-ccccCCCCCcEEecccC-ccccccC
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDN-KLEGTIP  185 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~  185 (652)
                      ++.+. .+..+++ |++|+|++|+|+++.+..|.++++|++|+|++|+++++.+ ..|.++++|++|++++| .+++..+
T Consensus        90 ~~~~~-~~~~l~~-L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~  167 (353)
T 2z80_A           90 TIEED-SFSSLGS-LEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR  167 (353)
T ss_dssp             EECTT-TTTTCTT-CCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred             ccCHh-hcCCCCC-CCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence            66655 5666665 7777777777776555557777777777777777775444 46777777777777777 4665556


Q ss_pred             ccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcc-cCCCCccceEecccccCCccCccccc---C
Q 041689          186 YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE-IGNLKVLIGIDFSMNNFSSVIPTTIG---S  260 (652)
Q Consensus       186 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~-~~~l~~L~~L~ls~N~l~~~~~~~~~---~  260 (652)
                      ..|..+++|++|++++|++++..|..|..+++|++|++++|. ..+|.. +..+++|+.|++++|.+++..+..+.   .
T Consensus       168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~  247 (353)
T 2z80_A          168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET  247 (353)
T ss_dssp             TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred             HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence            667777777777777777777777777777777777777775 333333 34567788888888888776554433   3


Q ss_pred             CCCCcEEEccCCcCCC----cccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC
Q 041689          261 LKDLQYLFLGYNILKG----SIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       261 l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  328 (652)
                      ...++.++|++|.+++    .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++|.+|.
T Consensus       248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            5678888888888875    3677888899999999999999855555568999999999999999988763

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.9e-31  Score=287.37  Aligned_cols=287  Identities=18%  Similarity=0.167  Sum_probs=227.4

Q ss_pred             eeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      ++|+.|+|+.|.+..   +| .-++++|++|+|++|+|+++ +  |..+++|++|+|++|+++++               
T Consensus        64 ~~L~~L~Ls~n~l~~---~~-~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l---------------  121 (457)
T 3bz5_A           64 TGLTKLICTSNNITT---LD-LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL---------------  121 (457)
T ss_dssp             TTCSEEECCSSCCSC---CC-CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC---------------
T ss_pred             CCCCEEEccCCcCCe---Ec-cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee---------------
Confidence            578999999999885   55 22789999999999999975 3  99999999999999999743               


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcc
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFT  163 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  163 (652)
                           .+.++++|++|++++|+++++    .++.++. |++|++++|+..+.+  .+..+++|+.|+|++|+++++ |  
T Consensus       122 -----~~~~l~~L~~L~l~~N~l~~l----~l~~l~~-L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--  186 (457)
T 3bz5_A          122 -----DVSQNPLLTYLNCARNTLTEI----DVSHNTQ-LTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--  186 (457)
T ss_dssp             -----CCTTCTTCCEEECTTSCCSCC----CCTTCTT-CCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--
T ss_pred             -----cCCCCCcCCEEECCCCcccee----ccccCCc-CCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--
Confidence                 156789999999999999986    2556765 999999999655444  488899999999999999964 4  


Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCC---
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLK---  238 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~---  238 (652)
                      +..+++|+.|++++|++++.   .+..+++|++|++++|+++++ |  +..+++|++|++++|. ..+| ..+.++.   
T Consensus       187 l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~  260 (457)
T 3bz5_A          187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLH  260 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEE
T ss_pred             cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEe
Confidence            88899999999999999964   388889999999999999974 4  8889999999999996 2233 2333333   


Q ss_pred             ----ccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccc--------cccccccCcceeccccccCCCCchhh
Q 041689          239 ----VLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPD--------SVGDLISLKSLNFSNNNLSGAIPLLL  306 (652)
Q Consensus       239 ----~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~--------~~~~l~~L~~L~L~~N~l~~~~~~~~  306 (652)
                          +|+.|++++|.+.+.+|  ++.+++|+.|++++|...+.+|.        .+..+++|+.|+|++|+|++. +  +
T Consensus       261 l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l  335 (457)
T 3bz5_A          261 CIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--V  335 (457)
T ss_dssp             CTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--C
T ss_pred             ccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--c
Confidence                45566666666665554  56789999999999987666553        356678899999999999974 3  8


Q ss_pred             cCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCcc
Q 041689          307 EKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKL  345 (652)
Q Consensus       307 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~  345 (652)
                      ..+++|+.|++++|++++.       +.+..+.+..|.+
T Consensus       336 ~~l~~L~~L~l~~N~l~~l-------~~L~~L~l~~n~l  367 (457)
T 3bz5_A          336 SHNTKLKSLSCVNAHIQDF-------SSVGKIPALNNNF  367 (457)
T ss_dssp             TTCTTCSEEECCSSCCCBC-------TTGGGSSGGGTSE
T ss_pred             ccCCcCcEEECCCCCCCCc-------cccccccccCCcE
Confidence            8999999999999999973       2344455555544

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-32  Score=286.73  Aligned_cols=272  Identities=17%  Similarity=0.145  Sum_probs=232.3

Q ss_pred             eEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccccc
Q 041689            9 LELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLS   88 (652)
Q Consensus         9 l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~   88 (652)
                      .+++.+.++   ++|..+ .++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+.                 
T Consensus        36 c~~~~~~l~---~iP~~~-~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----------------   94 (353)
T 2z80_A           36 CKGSSGSLN---SIPSGL-TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED-----------------   94 (353)
T ss_dssp             EECCSTTCS---SCCTTC-CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----------------
T ss_pred             eeCCCCCcc---cccccc-cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh-----------------
Confidence            455555555   799987 67999999999999988888999999999999999999977653                 


Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCc-cccccCCccccC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGN-KLNGSIPFTLRE  166 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~  166 (652)
                      .|.++++|++|+|++|+++++++. .+..+++ |++|+|++|+++++.+ ..|.++++|++|++++| .+....+..|.+
T Consensus        95 ~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~-L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  172 (353)
T 2z80_A           95 SFSSLGSLEHLDLSYNYLSNLSSS-WFKPLSS-LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG  172 (353)
T ss_dssp             TTTTCTTCCEEECCSSCCSSCCHH-HHTTCTT-CSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred             hcCCCCCCCEEECCCCcCCcCCHh-HhCCCcc-CCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence            588999999999999999987665 5788886 9999999999997655 58999999999999999 588777889999


Q ss_pred             CCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCC-Ccc---cCCCCccc
Q 041689          167 LQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPL-PLE---IGNLKVLI  241 (652)
Q Consensus       167 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~-~~~---~~~l~~L~  241 (652)
                      +++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|++|++++|. ... +..   ......++
T Consensus       173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~  252 (353)
T 2z80_A          173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK  252 (353)
T ss_dssp             CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCC
T ss_pred             CCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhh
Confidence            9999999999999999889999999999999999999987766667779999999999996 222 222   23456778


Q ss_pred             eEecccccCCc----cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCc
Q 041689          242 GIDFSMNNFSS----VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP  303 (652)
Q Consensus       242 ~L~ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  303 (652)
                      .+++++|.+++    .+|..+..+++|++|+|++|+|+...+..|..+++|+.|+|++|++++..|
T Consensus       253 ~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            88888888875    357789999999999999999995544456999999999999999997654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=100.00  E-value=1.4e-31  Score=289.30  Aligned_cols=252  Identities=24%  Similarity=0.257  Sum_probs=223.4

Q ss_pred             CCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccc
Q 041689           54 TLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVS  133 (652)
Q Consensus        54 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~  133 (652)
                      +...++.+++.++.++..+                    .++|++|+|++|+|+++.+. .|.++++ |++|+|++|+|+
T Consensus        55 ~~~~v~c~~~~l~~iP~~~--------------------~~~l~~L~L~~n~i~~~~~~-~~~~l~~-L~~L~Ls~n~i~  112 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGI--------------------PSNTRYLNLMENNIQMIQAD-TFRHLHH-LEVLQLGRNSIR  112 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCC--------------------CTTCSEEECCSSCCCEECTT-TTTTCTT-CCEEECCSSCCC
T ss_pred             CCcEEEECCCCcCccCCCC--------------------CCCccEEECcCCcCceECHH-HcCCCCC-CCEEECCCCccC
Confidence            4567888888887655431                    25789999999999998877 7888887 999999999999


Q ss_pred             ccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC-CcccccccccC
Q 041689          134 GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG-NKLSGSILTCF  212 (652)
Q Consensus       134 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~  212 (652)
                      ++.+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++ |.+..+.+..|
T Consensus       113 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~  192 (452)
T 3zyi_A          113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF  192 (452)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTT
T ss_pred             CcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhc
Confidence            98889999999999999999999988888899999999999999999977777899999999999998 67777777789


Q ss_pred             CCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCccee
Q 041689          213 SNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLN  292 (652)
Q Consensus       213 ~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  292 (652)
                      ..+++|++|+|++|.......+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus       193 ~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  272 (452)
T 3zyi_A          193 EGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN  272 (452)
T ss_dssp             TTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             cCCCCCCEEECCCCcccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence            99999999999999744445688999999999999999999999999999999999999999988899999999999999


Q ss_pred             ccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          293 FSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       293 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |++|+|++..+..|..+++|+.|+|++|++.|.+.
T Consensus       273 L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          273 LAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             CCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence            99999998888889999999999999999998765

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.98  E-value=1.9e-31  Score=287.15  Aligned_cols=231  Identities=26%  Similarity=0.291  Sum_probs=154.5

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +++.|+|++|+|+++.+. .|.++++ |++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|..+++|++|+
T Consensus        65 ~l~~L~L~~n~i~~~~~~-~~~~l~~-L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  142 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVN-SFKHLRH-LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW  142 (440)
T ss_dssp             TCSEEECCSCCCCEECTT-TTSSCSS-CCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred             CCcEEEccCCcCCeeCHH-HhhCCCC-CCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence            344444444444444433 3444443 55555555555544445555555555555555555544444555555555555


Q ss_pred             cccCccccccCccccCCCCCcEEEccC-CcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCcc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGG-NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                      |++|+|+...+..|..+++|++|+|++ |.+..+.+..|.++++|++|+|++|.......+..+++|+.|+|++|+++++
T Consensus       143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~~~  222 (440)
T 3zyj_A          143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAI  222 (440)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCEEECTTSCCCEE
T ss_pred             CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCEEECCCCccCcc
Confidence            555555544444555555556666655 3444444445666666666666666522223467778888888888888888


Q ss_pred             CcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       254 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      .|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.|.+.
T Consensus       223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence            88899999999999999999998888889999999999999999998888888889999999999999987654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=2.4e-32  Score=279.51  Aligned_cols=273  Identities=20%  Similarity=0.198  Sum_probs=234.2

Q ss_pred             CEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccccc
Q 041689           56 KDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGG  135 (652)
Q Consensus        56 ~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~  135 (652)
                      +.++.+++.++.++..                  +  .++|++|+|++|+++.+++. .+..+++ |++|+|++|+++..
T Consensus        10 ~~l~c~~~~l~~ip~~------------------~--~~~l~~L~L~~n~l~~i~~~-~~~~l~~-L~~L~L~~n~l~~~   67 (306)
T 2z66_A           10 TEIRCNSKGLTSVPTG------------------I--PSSATRLELESNKLQSLPHG-VFDKLTQ-LTKLSLSSNGLSFK   67 (306)
T ss_dssp             TEEECCSSCCSSCCSC------------------C--CTTCCEEECCSSCCCCCCTT-TTTTCTT-CSEEECCSSCCCEE
T ss_pred             CEEEcCCCCcccCCCC------------------C--CCCCCEEECCCCccCccCHh-Hhhcccc-CCEEECCCCccCcc
Confidence            4678888888755442                  1  25799999999999987765 6788886 99999999999844


Q ss_pred             --CCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccC-ccccCCCCCcEEEccCCcccccccccC
Q 041689          136 --IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSILTCF  212 (652)
Q Consensus       136 --~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~  212 (652)
                        .+..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|
T Consensus        68 ~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  146 (306)
T 2z66_A           68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF  146 (306)
T ss_dssp             EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred             cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence              3677888999999999999998 466679999999999999999996655 578999999999999999999999999


Q ss_pred             CCCCCCCEEEccCCCC---CCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCc
Q 041689          213 SNLASLRTLSLSYNDG---PLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLK  289 (652)
Q Consensus       213 ~~l~~L~~L~Ls~N~~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  289 (652)
                      ..+++|++|++++|..   ..|..+..+++|+.|++++|++++..|..|..+++|++|+|++|++++..+..+..+++|+
T Consensus       147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  226 (306)
T 2z66_A          147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ  226 (306)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCC
T ss_pred             ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCC
Confidence            9999999999999962   4788899999999999999999998899999999999999999999988777899999999


Q ss_pred             ceeccccccCCCCchhhcCCC-CCceEEeecCcCcccCCCC---CCCCCcccccccCCccCCCCCC
Q 041689          290 SLNFSNNNLSGAIPLLLEKLS-YLEHLNLSFNKLEGEIPKG---GSFGNFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       290 ~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~---~~~~~l~~~~~~~N~~~c~~~~  351 (652)
                      .|+|++|++++..|..+..++ +|+.|+|++|+++|.++..   ..+...+.+.+..+...|..|.
T Consensus       227 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             EEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             EeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            999999999999999999985 9999999999999876532   1222334455667888888764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=7e-32  Score=276.06  Aligned_cols=278  Identities=22%  Similarity=0.222  Sum_probs=165.1

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      +.++.+.+.++   ++|..+ +++|++|+|++|+++.+.+..|.++++|++|+|++|+|+....               .
T Consensus        10 ~~l~c~~~~l~---~ip~~~-~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~---------------~   70 (306)
T 2z66_A           10 TEIRCNSKGLT---SVPTGI-PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC---------------C   70 (306)
T ss_dssp             TEEECCSSCCS---SCCSCC-CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE---------------E
T ss_pred             CEEEcCCCCcc---cCCCCC-CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC---------------c
Confidence            34445554444   566665 5677777777777775555556777777777777777653210               0


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCCcccc
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIPFTLR  165 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~  165 (652)
                      ...+..+++|++|+|++|.++++++  .+..+++ |++|++++|++++..+ ..|..+++|++|+|++|.+.+..+..|.
T Consensus        71 ~~~~~~~~~L~~L~Ls~n~i~~l~~--~~~~l~~-L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  147 (306)
T 2z66_A           71 SQSDFGTTSLKYLDLSFNGVITMSS--NFLGLEQ-LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  147 (306)
T ss_dssp             EHHHHSCSCCCEEECCSCSEEEEEE--EEETCTT-CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred             ccccccccccCEEECCCCccccChh--hcCCCCC-CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcc
Confidence            0123345666666666666665433  2444444 6666666666654443 4555566666666666666555555555


Q ss_pred             CCCCCcEEecccCcccc-ccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEe
Q 041689          166 ELQKLQYVGLKDNKLEG-TIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGID  244 (652)
Q Consensus       166 ~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~  244 (652)
                      ++++|++|+|++|.+++ ..|..+..+++|++|+|++|++++..+..|                      ..+++|+.|+
T Consensus       148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~----------------------~~l~~L~~L~  205 (306)
T 2z66_A          148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF----------------------NSLSSLQVLN  205 (306)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT----------------------TTCTTCCEEE
T ss_pred             cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHh----------------------cCCCCCCEEE
Confidence            55666666666665554 345555555555555555555555444444                      4455555555


Q ss_pred             cccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccc-cCcceeccccccCCCCc--hhhcCCCCCceEEeecCc
Q 041689          245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI-SLKSLNFSNNNLSGAIP--LLLEKLSYLEHLNLSFNK  321 (652)
Q Consensus       245 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~  321 (652)
                      +++|++++..+..|..+++|++|+|++|++++..|..+..++ +|+.|+|++|++++..+  .....+...+.+....+.
T Consensus       206 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~  285 (306)
T 2z66_A          206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVER  285 (306)
T ss_dssp             CTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGG
T ss_pred             CCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccc
Confidence            566666666666677777777888888877777777777774 78888888887765322  112223344555566677


Q ss_pred             CcccCCC
Q 041689          322 LEGEIPK  328 (652)
Q Consensus       322 l~~~~p~  328 (652)
                      +.|..|.
T Consensus       286 ~~C~~p~  292 (306)
T 2z66_A          286 MECATPS  292 (306)
T ss_dssp             CBEEESG
T ss_pred             cccCCch
Confidence            7776654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=8.1e-32  Score=272.66  Aligned_cols=251  Identities=23%  Similarity=0.190  Sum_probs=225.2

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEec
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL  175 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  175 (652)
                      -+.++.+++.++.++..     ++.+|++|++++|+|+++.+..|..+++|++|+|++|+++++.|..|.++++|++|+|
T Consensus        13 ~~~~~c~~~~l~~ip~~-----~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l   87 (285)
T 1ozn_A           13 KVTTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL   87 (285)
T ss_dssp             SCEEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CeEEEcCcCCcccCCcC-----CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeC
Confidence            37899999999987543     2446999999999999988899999999999999999999888999999999999999


Q ss_pred             ccCc-cccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCCccceEecccccCCc
Q 041689          176 KDNK-LEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       176 ~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      ++|. ++...|..|..+++|++|++++|++++..+..|..+++|++|++++|. ..++ ..++.+++|+.|++++|++++
T Consensus        88 ~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  167 (285)
T 1ozn_A           88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS  167 (285)
T ss_dssp             CSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc
Confidence            9997 887778899999999999999999999989999999999999999997 4444 448999999999999999998


Q ss_pred             cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCC
Q 041689          253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSF  332 (652)
Q Consensus       253 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  332 (652)
                      +.+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|++.|..+....+
T Consensus       168 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~  247 (285)
T 1ozn_A          168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW  247 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHH
T ss_pred             cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHH
Confidence            88888999999999999999999888999999999999999999999888888999999999999999999887655445


Q ss_pred             CCcccccccCCccCCCCCC
Q 041689          333 GNFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       333 ~~l~~~~~~~N~~~c~~~~  351 (652)
                      ..++......+.+.|..|.
T Consensus       248 ~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          248 AWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHHCCSEECCCBEEESG
T ss_pred             HHHHhcccccCccccCCch
Confidence            5666677788888898764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.97  E-value=1.2e-30  Score=280.83  Aligned_cols=280  Identities=26%  Similarity=0.284  Sum_probs=143.6

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCC---ccccccCCCCCcccccccCCCCCCcEEEcccCC
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI---ADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNP  105 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  105 (652)
                      ++|++|+|++|++++ +| .|.++++|++|++++|++++++...   ....+..+...  .+..+.++++|++|++++|+
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~~~L~~L~L~~n~l~--~l~~~~~l~~L~~L~l~~N~  206 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNS  206 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCcccccEEECcCCcCC--cCccccCCCCCCEEECCCCc
Confidence            578888888888886 55 5888888888888888887644321   11122222111  12245666666666666666


Q ss_pred             CcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccC
Q 041689          106 LNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP  185 (652)
Q Consensus       106 l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  185 (652)
                      +++++..      +.+|++|++++|+++ .+| .|..+++|++|++++|++++ +|..   +++|++|++++|++++ +|
T Consensus       207 l~~l~~~------~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~  273 (454)
T 1jl5_A          207 LKKLPDL------PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LP  273 (454)
T ss_dssp             CSSCCCC------CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CC
T ss_pred             CCcCCCC------cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cC
Confidence            6654321      123666666666666 344 26666666666666666664 2321   3566666666666663 34


Q ss_pred             ccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCC-CccceEecccccCCccCcccccCCCCC
Q 041689          186 YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNL-KVLIGIDFSMNNFSSVIPTTIGSLKDL  264 (652)
Q Consensus       186 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L  264 (652)
                      ..   .++|++|++++|+++++. .   -.++|++|++++|....   +..+ ++|+.|++++|++++ +|..   +++|
T Consensus       274 ~~---~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~---i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L  339 (454)
T 1jl5_A          274 EL---PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRS---LCDLPPSLEELNVSNNKLIE-LPAL---PPRL  339 (454)
T ss_dssp             CC---CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSE---ECCCCTTCCEEECCSSCCSC-CCCC---CTTC
T ss_pred             cc---cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCc---ccCCcCcCCEEECCCCcccc-cccc---CCcC
Confidence            32   256666666666666532 1   12466666666664211   1122 366677777777765 3332   4667


Q ss_pred             cEEEccCCcCCCcccccccccccCcceeccccccCC--CCchhhcCC-------------CCCceEEeecCcCcc--cCC
Q 041689          265 QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG--AIPLLLEKL-------------SYLEHLNLSFNKLEG--EIP  327 (652)
Q Consensus       265 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l-------------~~L~~L~L~~N~l~~--~~p  327 (652)
                      +.|++++|+++ .+|.   .+++|+.|+|++|++++  .+|..+..+             ++|+.|++++|++++  .+|
T Consensus       340 ~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP  415 (454)
T 1jl5_A          340 ERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP  415 (454)
T ss_dssp             CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------
T ss_pred             CEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch
Confidence            77777777776 3444   35667777777777766  556666555             566666666666665  333


Q ss_pred             CCCCCCCcccccccCCccCCC
Q 041689          328 KGGSFGNFSAESFEGNKLLCG  348 (652)
Q Consensus       328 ~~~~~~~l~~~~~~~N~~~c~  348 (652)
                      .     .++.+.+.+|.+.|.
T Consensus       416 ~-----sl~~L~~~~~~~~~~  431 (454)
T 1jl5_A          416 E-----SVEDLRMNSERVVDP  431 (454)
T ss_dssp             ---------------------
T ss_pred             h-----hHhheeCcCcccCCc
Confidence            2     234444555555444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.97  E-value=2.3e-30  Score=278.74  Aligned_cols=296  Identities=30%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccC---CCccccccCCC
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLS---SIADNYLTSST   81 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~~l~~~~   81 (652)
                      +++.|+++.|.++   .+|..  +++|++|++++|++++ +|..   +++|++|++++|+++++..   .+....+..+.
T Consensus        72 ~l~~L~l~~~~l~---~lp~~--~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~  142 (454)
T 1jl5_A           72 QAHELELNNLGLS---SLPEL--PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQ  142 (454)
T ss_dssp             TCSEEECTTSCCS---CCCSC--CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCCTTCCEEECCSSC
T ss_pred             CCCEEEecCCccc---cCCCC--cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCCCCCCEEECcCCC
Confidence            4688899999877   46663  5789999999999997 5543   4789999999999886432   33333343333


Q ss_pred             CCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP  161 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  161 (652)
                      ..  .+..|.++++|++|++++|++++++..      +.+|++|++++|++++ +| .|.++++|++|++++|++++ +|
T Consensus       143 l~--~lp~~~~l~~L~~L~l~~N~l~~lp~~------~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~  211 (454)
T 1jl5_A          143 LE--KLPELQNSSFLKIIDVDNNSLKKLPDL------PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LP  211 (454)
T ss_dssp             CS--SCCCCTTCTTCCEEECCSSCCSCCCCC------CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CC
T ss_pred             CC--CCcccCCCCCCCEEECCCCcCcccCCC------cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CC
Confidence            22  123588999999999999999876432      1259999999999997 45 58999999999999999986 44


Q ss_pred             ccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCcc
Q 041689          162 FTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVL  240 (652)
Q Consensus       162 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L  240 (652)
                      ...   ++|++|++++|+++ .+| .+..+++|++|++++|++++++ .   .+++|++|++++|. ..+|..   +++|
T Consensus       212 ~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~-~---~~~~L~~L~l~~N~l~~l~~~---~~~L  279 (454)
T 1jl5_A          212 DLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP-D---LPPSLEALNVRDNYLTDLPEL---PQSL  279 (454)
T ss_dssp             CCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC-S---CCTTCCEEECCSSCCSCCCCC---CTTC
T ss_pred             CCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccc-c---cccccCEEECCCCcccccCcc---cCcC
Confidence            332   58999999999998 667 4888999999999999998643 3   24788999999986 344543   3678


Q ss_pred             ceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecC
Q 041689          241 IGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       241 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                      +.|++++|+++++. ..   .++|+.|++++|++++ ++..   .++|+.|++++|++++ +|..   +++|+.|++++|
T Consensus       280 ~~L~ls~N~l~~l~-~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N  347 (454)
T 1jl5_A          280 TFLDVSENIFSGLS-EL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFN  347 (454)
T ss_dssp             CEEECCSSCCSEES-CC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred             CEEECcCCccCccc-Cc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCC
Confidence            88888888888632 11   1466677777776663 2211   1366677777777764 3432   456667777777


Q ss_pred             cCcccCCCCCCCCCcccccccCCccCC
Q 041689          321 KLEGEIPKGGSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       321 ~l~~~~p~~~~~~~l~~~~~~~N~~~c  347 (652)
                      .+++ +|.  .+..++.+++++|++.+
T Consensus       348 ~l~~-lp~--~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          348 HLAE-VPE--LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             CCSC-CCC--CCTTCCEEECCSSCCSS
T ss_pred             cccc-ccc--hhhhccEEECCCCCCCc
Confidence            7664 333  35566666666666655

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=7.1e-31  Score=282.69  Aligned_cols=245  Identities=19%  Similarity=0.200  Sum_probs=157.1

Q ss_pred             CCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccC
Q 041689           31 LEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGIL  110 (652)
Q Consensus        31 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  110 (652)
                      ...++.++++++ .+|..+.  ++++.|+|++|+|+++.+.                 .|.++++|++|+|++|+|+++.
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~-----------------~~~~l~~L~~L~Ls~n~i~~i~  104 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVN-----------------SFKHLRHLEILQLSRNHIRTIE  104 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTT-----------------TTSSCSSCCEEECCSSCCCEEC
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHH-----------------HhhCCCCCCEEECCCCcCCccC
Confidence            445566666665 3444332  4566666666666544431                 3555566666666666666555


Q ss_pred             CccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEeccc-CccccccCcccc
Q 041689          111 PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD-NKLEGTIPYDIF  189 (652)
Q Consensus       111 ~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~  189 (652)
                      +. .|.++++ |++|+|++|+|+++.+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++ |.++...+..|.
T Consensus       105 ~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~  182 (440)
T 3zyj_A          105 IG-AFNGLAN-LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE  182 (440)
T ss_dssp             GG-GGTTCSS-CCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTT
T ss_pred             hh-hccCCcc-CCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhh
Confidence            44 4555554 66666666666655555566666666666666666655555666666666666665 334433334555


Q ss_pred             CCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEE
Q 041689          190 RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYL  267 (652)
Q Consensus       190 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  267 (652)
                      .+++|++|+|++|+++.++  .+..+++|++|+|++|.  ...|..|.++++|+.|+|++|+++++.+..|.++++|+.|
T Consensus       183 ~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  260 (440)
T 3zyj_A          183 GLSNLRYLNLAMCNLREIP--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI  260 (440)
T ss_dssp             TCSSCCEEECTTSCCSSCC--CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred             cccccCeecCCCCcCcccc--ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence            6666666666666665332  35566666666666664  2235556677777777777888888888888888999999


Q ss_pred             EccCCcCCCcccccccccccCcceeccccccC
Q 041689          268 FLGYNILKGSIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       268 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      +|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            99999998877788888899999999999886

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=8.5e-31  Score=283.07  Aligned_cols=207  Identities=20%  Similarity=0.189  Sum_probs=119.7

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      |.++++|++|+|++|+|+++.+. .|.++++ |++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++
T Consensus        95 ~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  172 (452)
T 3zyi_A           95 FRHLHHLEVLQLGRNSIRQIEVG-AFNGLAS-LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS  172 (452)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTT
T ss_pred             cCCCCCCCEEECCCCccCCcChh-hccCccc-CCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCc
Confidence            44444444455554444444443 3444443 555555555554444444555555555555555555444444555555


Q ss_pred             CcEEeccc-CccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecc
Q 041689          170 LQYVGLKD-NKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFS  246 (652)
Q Consensus       170 L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls  246 (652)
                      |++|+|++ |.++...+..|..+++|++|+|++|+++++  ..+..+++|++|+|++|.  ...|..|.++++|+.|+++
T Consensus       173 L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  250 (452)
T 3zyi_A          173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM  250 (452)
T ss_dssp             CCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECT
T ss_pred             ccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeC
Confidence            55555554 333323333444455555555555555433  124455555555555553  2234445566666666677


Q ss_pred             cccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          247 MNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       247 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      +|+++++.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus       251 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          251 NSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            777777778888888888888888888887777778888888888888888763

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.1e-30  Score=264.17  Aligned_cols=184  Identities=29%  Similarity=0.334  Sum_probs=96.0

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCc-ccccCCccccCCCCCCEEEecCccccccCCccccCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN-VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ  168 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  168 (652)
                      |.++++|++|+|++|.++++.+. .+..+++ |++|++++|+ ++...+..|..+++|++|+|++|++++..|..|.+++
T Consensus        52 ~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  129 (285)
T 1ozn_A           52 FRACRNLTILWLHSNVLARIDAA-AFTGLAL-LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA  129 (285)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTT-TTTTCTT-CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred             cccCCCCCEEECCCCccceeCHh-hcCCccC-CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCc
Confidence            44445555555555555544443 3444443 5555555554 5544455555566666666666666555555566666


Q ss_pred             CCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecc
Q 041689          169 KLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFS  246 (652)
Q Consensus       169 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls  246 (652)
                      +|++|+|++|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|.  ...|..+..+++|+.|+++
T Consensus       130 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  209 (285)
T 1ozn_A          130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF  209 (285)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence            66666666666664444455566666666666666665555555555555555544442  1112233333334444444


Q ss_pred             cccCCccCcccccCCCCCcEEEccCCcCC
Q 041689          247 MNNFSSVIPTTIGSLKDLQYLFLGYNILK  275 (652)
Q Consensus       247 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  275 (652)
                      +|++++..+..+..+++|+.|++++|++.
T Consensus       210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  238 (285)
T 1ozn_A          210 ANNLSALPTEALAPLRALQYLRLNDNPWV  238 (285)
T ss_dssp             SSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             CCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence            44444444444555555555555555544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=3.4e-32  Score=279.68  Aligned_cols=247  Identities=21%  Similarity=0.216  Sum_probs=173.8

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      .+++|++|+|++|+|+++.|..|..+++|++|+|++|++++.++                   |..+++|++|+|++|++
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-------------------~~~l~~L~~L~Ls~n~l   92 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-------------------LESLSTLRTLDLNNNYV   92 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-------------------ETTCTTCCEEECCSSEE
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-------------------hhhcCCCCEEECcCCcc
Confidence            35688888888888887777788888888888888888875432                   56778888888888888


Q ss_pred             cccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCc
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY  186 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  186 (652)
                      +++++.      + +|++|++++|+|++..+..   +++|++|+|++|++++..+..|..+++|++|+|++|++++..+.
T Consensus        93 ~~l~~~------~-~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  162 (317)
T 3o53_A           93 QELLVG------P-SIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA  162 (317)
T ss_dssp             EEEEEC------T-TCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred             ccccCC------C-CcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence            765432      3 3888888888887665543   46778888888888777677777777778888887777766666


Q ss_pred             ccc-CCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCc
Q 041689          187 DIF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ  265 (652)
Q Consensus       187 ~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  265 (652)
                      .+. .+++|++|+|++|+|++....                        ..+++|+.|++++|+++++. ..|..+++|+
T Consensus       163 ~~~~~l~~L~~L~L~~N~l~~~~~~------------------------~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~  217 (317)
T 3o53_A          163 ELAASSDTLEHLNLQYNFIYDVKGQ------------------------VVFAKLKTLDLSSNKLAFMG-PEFQSAAGVT  217 (317)
T ss_dssp             GGGGGTTTCCEEECTTSCCCEEECC------------------------CCCTTCCEEECCSSCCCEEC-GGGGGGTTCS
T ss_pred             HHhhccCcCCEEECCCCcCcccccc------------------------cccccCCEEECCCCcCCcch-hhhcccCccc
Confidence            654 567777777777777654221                        12445555555666666543 3466777777


Q ss_pred             EEEccCCcCCCcccccccccccCcceeccccccC-CCCchhhcCCCCCceEEee-cCcCcccCCC
Q 041689          266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS-GAIPLLLEKLSYLEHLNLS-FNKLEGEIPK  328 (652)
Q Consensus       266 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~  328 (652)
                      +|+|++|+|+ .+|..+..+++|+.|+|++|+++ +..|..+..+++|+.|+++ .+.+++..|.
T Consensus       218 ~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             EEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             EEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            7777777777 45666777777777777777776 5666777777777777777 4455555554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=3.2e-32  Score=279.90  Aligned_cols=259  Identities=18%  Similarity=0.114  Sum_probs=155.2

Q ss_pred             CCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccC
Q 041689           31 LEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGIL  110 (652)
Q Consensus        31 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  110 (652)
                      ++.++++.+++....+..+..+++|++|+|++|+|++..+                 ..|.++++|++|+|++|++++..
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~-----------------~~~~~l~~L~~L~Ls~n~l~~~~   74 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA-----------------ADLAPFTKLELLNLSSNVLYETL   74 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCH-----------------HHHTTCTTCCEEECTTSCCEEEE
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCH-----------------HHhhCCCcCCEEECCCCcCCcch
Confidence            4444555555554444444555555555555555553322                 13445555555555555555443


Q ss_pred             CccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccC
Q 041689          111 PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR  190 (652)
Q Consensus       111 ~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  190 (652)
                      +   +..+++ |++|++++|+|+++.     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..
T Consensus        75 ~---~~~l~~-L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~  142 (317)
T 3o53_A           75 D---LESLST-LRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGC  142 (317)
T ss_dssp             E---ETTCTT-CCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGG
T ss_pred             h---hhhcCC-CCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhc
Confidence            2   334443 555555555555322     1245555555555554333322   334455555555555444444444


Q ss_pred             CCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEcc
Q 041689          191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLG  270 (652)
Q Consensus       191 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~  270 (652)
                      +++|++|+|++|++++..+..+                     +..+++|+.|++++|.+++. + ....+++|++|+|+
T Consensus       143 l~~L~~L~Ls~N~l~~~~~~~~---------------------~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls  199 (317)
T 3o53_A          143 RSRVQYLDLKLNEIDTVNFAEL---------------------AASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLS  199 (317)
T ss_dssp             GSSEEEEECTTSCCCEEEGGGG---------------------GGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECC
T ss_pred             cCCCCEEECCCCCCCcccHHHH---------------------hhccCcCCEEECCCCcCccc-c-cccccccCCEEECC
Confidence            4455555555554444333332                     13456677777777777765 2 33358999999999


Q ss_pred             CCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcc-cCCC-CCCCCCcccccccCC
Q 041689          271 YNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG-EIPK-GGSFGNFSAESFEGN  343 (652)
Q Consensus       271 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~-~~~~~~l~~~~~~~N  343 (652)
                      +|+|++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++| .+|. ...++.++.+++.++
T Consensus       200 ~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          200 SNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             SSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             CCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            999995 4556999999999999999999 578889999999999999999993 3332 245666777777744

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.5e-31  Score=294.75  Aligned_cols=209  Identities=18%  Similarity=0.063  Sum_probs=145.2

Q ss_pred             eeccccceEEEEEEe-CCCcEEEEEEeecc----------cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          432 LIGKGGFGTIYKSRI-GDGMEVAVKVFHLQ----------CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       432 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ..+.|++|.+..++. -.|+.||||++...          .....+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            355666666666542 35889999999654          123456799999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||++|++|.+++...+ .++..   +|+.||+.||+|+|++   |||||||||+|||++++|.+||+|||+|+..... 
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC-
Confidence            99999999999998765 56654   4889999999999999   9999999999999999999999999999865322 


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC----------cchhhhhhhcccchhhhccccCc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ----------CVSFVFNLAMECTIESLELRINA  649 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p----------~~~~l~~l~~~~l~~~p~~Rpt~  649 (652)
                       .......+||+.|||||++.+ .+..++|+||+|++++++.++..+          .......+...+...+|..||..
T Consensus       393 -~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~~~~~  470 (569)
T 4azs_A          393 -CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWLYAVWQEPVERWNFVLLLALFEKKAKLPSAEQ  470 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHHHHHHHTSCGGGCSHHHHHHHHHTGGGSCCGGG
T ss_pred             -CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhHHHhhcCCCCCCcHHHHHHHHhCCCCCCCCCh
Confidence             223345679999999999865 567789999999998887655443          33334556666667777777765


Q ss_pred             c
Q 041689          650 K  650 (652)
Q Consensus       650 ~  650 (652)
                      .
T Consensus       471 ~  471 (569)
T 4azs_A          471 Q  471 (569)
T ss_dssp             S
T ss_pred             h
Confidence            4

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=4.8e-30  Score=264.59  Aligned_cols=226  Identities=19%  Similarity=0.244  Sum_probs=208.6

Q ss_pred             CCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcE
Q 041689           93 CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY  172 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  172 (652)
                      ..+++.|+|++|.++.+++  .++.+++ |++|+|++|+|+ .+|..|.++++|++|+|++|+++ .+|..|.++++|++
T Consensus        80 ~~~l~~L~L~~n~l~~lp~--~l~~l~~-L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~  154 (328)
T 4fcg_A           80 QPGRVALELRSVPLPQFPD--QAFRLSH-LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE  154 (328)
T ss_dssp             STTCCEEEEESSCCSSCCS--CGGGGTT-CSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCE
T ss_pred             ccceeEEEccCCCchhcCh--hhhhCCC-CCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCE
Confidence            4789999999999997655  4677876 999999999999 78899999999999999999999 77889999999999


Q ss_pred             EecccCccccccCccccC---------CCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccce
Q 041689          173 VGLKDNKLEGTIPYDIFR---------LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIG  242 (652)
Q Consensus       173 L~L~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~  242 (652)
                      |+|++|.+.+.+|..+..         +++|++|+|++|+++ .+|..|..+++|++|+|++|. ..+|..++.+++|+.
T Consensus       155 L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~  233 (328)
T 4fcg_A          155 LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEE  233 (328)
T ss_dssp             EEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCE
T ss_pred             EECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCE
Confidence            999999888899987765         999999999999999 677889999999999999997 667888999999999


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcC
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  322 (652)
                      |++++|++.+.+|..|.++++|++|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+
T Consensus       234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998887


Q ss_pred             cc
Q 041689          323 EG  324 (652)
Q Consensus       323 ~~  324 (652)
                      ..
T Consensus       314 ~~  315 (328)
T 4fcg_A          314 AQ  315 (328)
T ss_dssp             CC
T ss_pred             HH
Confidence            63

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=3.8e-29  Score=277.45  Aligned_cols=261  Identities=23%  Similarity=0.238  Sum_probs=218.9

Q ss_pred             eeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCc
Q 041689            5 SIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPEL   84 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~   84 (652)
                      .++.|+++.|.+.   ++|..+ +++|++|+|++|+|+. +|.   .+++|++|+|++|+|++++.              
T Consensus        41 ~l~~L~ls~n~L~---~lp~~l-~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~--------------   98 (622)
T 3g06_A           41 GNAVLNVGESGLT---TLPDCL-PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV--------------   98 (622)
T ss_dssp             CCCEEECCSSCCS---CCCSCC-CTTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC--------------
T ss_pred             CCcEEEecCCCcC---ccChhh-CCCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC--------------
Confidence            5788999999988   789887 5899999999999995 554   57999999999999975332              


Q ss_pred             ccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccc
Q 041689           85 SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTL  164 (652)
Q Consensus        85 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  164 (652)
                             .+++|++|+|++|+|++++.     . +.+|+.|++++|+|++ +|..   +++|++|+|++|+|+++ |.  
T Consensus        99 -------~l~~L~~L~Ls~N~l~~l~~-----~-l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~--  158 (622)
T 3g06_A           99 -------LPPGLLELSIFSNPLTHLPA-----L-PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA--  158 (622)
T ss_dssp             -------CCTTCCEEEECSCCCCCCCC-----C-CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC--
T ss_pred             -------CCCCCCEEECcCCcCCCCCC-----C-CCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC--
Confidence                   46889999999999998755     2 3359999999999996 4443   58999999999999954 43  


Q ss_pred             cCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceE
Q 041689          165 RELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGI  243 (652)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L  243 (652)
                       .+++|+.|++++|+|++ +|   ..+++|+.|+|++|+|+++++    .+++|+.|++++|. ..+|.   .+++|+.|
T Consensus       159 -~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~~---~~~~L~~L  226 (622)
T 3g06_A          159 -LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSLPA---LPSGLKEL  226 (622)
T ss_dssp             -CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCC---CCTTCCEE
T ss_pred             -ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccccCC---CCCCCCEE
Confidence             35789999999999994 66   456899999999999996443    35899999999997 44554   34789999


Q ss_pred             ecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCc
Q 041689          244 DFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       244 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  323 (652)
                      ++++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++
T Consensus       227 ~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~  297 (622)
T 3g06_A          227 IVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS  297 (622)
T ss_dssp             ECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred             EccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCC
Confidence            999999997 44   56689999999999999 5565   6789999999999999 77888999999999999999999


Q ss_pred             ccCCC
Q 041689          324 GEIPK  328 (652)
Q Consensus       324 ~~~p~  328 (652)
                      +.+|.
T Consensus       298 ~~~~~  302 (622)
T 3g06_A          298 ERTLQ  302 (622)
T ss_dssp             HHHHH
T ss_pred             CcCHH
Confidence            87664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.3e-29  Score=259.52  Aligned_cols=233  Identities=20%  Similarity=0.228  Sum_probs=136.9

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      ..++++|+|++|+++ .+|..+..+++|++|+|++|.|+.++.                  .+.++++|++|+|++|+++
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~------------------~~~~l~~L~~L~Ls~n~l~  140 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPD------------------TMQQFAGLETLTLARNPLR  140 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCS------------------CGGGGTTCSEEEEESCCCC
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhH------------------HHhccCCCCEEECCCCccc
Confidence            356777777777776 456666667777777777777662221                  3556666666666666666


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD  187 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  187 (652)
                      .+ |. .+..+++ |++|+|++|++.+.+|..+...               ..+..|.++++|++|+|++|+|+ .+|..
T Consensus       141 ~l-p~-~l~~l~~-L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~  201 (328)
T 4fcg_A          141 AL-PA-SIASLNR-LRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPAS  201 (328)
T ss_dssp             CC-CG-GGGGCTT-CCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGG
T ss_pred             cC-cH-HHhcCcC-CCEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHh
Confidence            43 33 4555554 6666666666555555554330               00011223444555555555554 44444


Q ss_pred             ccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCc
Q 041689          188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ  265 (652)
Q Consensus       188 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  265 (652)
                      +..+++|++|+|++|+++++ |..|..+++|++|+|++|.  ..+|..++.+++|+.|++++|++.+.+|..+..+++|+
T Consensus       202 l~~l~~L~~L~L~~N~l~~l-~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~  280 (328)
T 4fcg_A          202 IANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE  280 (328)
T ss_dssp             GGGCTTCCEEEEESSCCCCC-CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCC
T ss_pred             hcCCCCCCEEEccCCCCCcC-chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCC
Confidence            44455555555555555432 2234445555555555542  34455555556666666666666667777777777777


Q ss_pred             EEEccCCcCCCcccccccccccCcceeccccccC
Q 041689          266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       266 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      +|+|++|.+.+.+|..+..+++|+.+++..|.+.
T Consensus       281 ~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             EEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             EEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            7777777777777777777777777777776665

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.96  E-value=1.4e-32  Score=298.08  Aligned_cols=341  Identities=17%  Similarity=0.131  Sum_probs=215.5

Q ss_pred             ceeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCccc----CCccccCCCCCCEEEcCCCcCeeccC------
Q 041689            2 FSISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGV----VPAAIFDVSTLKDLALQDNYLSGSLS------   70 (652)
Q Consensus         2 ~~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~------   70 (652)
                      +|++++.|+|+.|.+... .+...+ .+++|++|+|++|+++..    ++..|..+++|++|+|++|.++....      
T Consensus         1 l~~~l~~L~Ls~~~l~~~-~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~   79 (461)
T 1z7x_W            1 MSLDIQSLDIQCEELSDA-RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG   79 (461)
T ss_dssp             -CEEEEEEEEESCCCCHH-HHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHT
T ss_pred             CCccceehhhhhcccCch-hHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHH
Confidence            588999999999988742 122223 578999999999998843    46678888999999999998864211      


Q ss_pred             ------CCccccccCCCCCc----ccccccCCCCCCcEEEcccCCCcccCCccchhc-----ccccCcEEEccCCccccc
Q 041689           71 ------SIADNYLTSSTPEL----SFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGN-----LSHSLEIFDMSKCNVSGG  135 (652)
Q Consensus        71 ------~~~~~~l~~~~~~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~-----l~~~L~~L~L~~N~l~~~  135 (652)
                            .+....+..+....    .....+.++++|++|+|++|.+++..+. .+..     .+ +|++|+|++|++++.
T Consensus        80 l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~-~l~~~l~~~~~-~L~~L~L~~n~l~~~  157 (461)
T 1z7x_W           80 LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQ-LLCEGLLDPQC-RLEKLQLEYCSLSAA  157 (461)
T ss_dssp             TCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHH-HHHHHHTSTTC-CCCEEECTTSCCBGG
T ss_pred             HhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHH-HHHHHHhcCCC-cceEEECCCCCCCHH
Confidence                  23333333333221    1234566777777777777777654332 1111     12 377777777777753


Q ss_pred             ----CCccccCCCCCCEEEecCccccccCCcccc-----CCCCCcEEecccCccccc----cCccccCCCCCcEEEccCC
Q 041689          136 ----IPEEIGNLTNLTAIYLGGNKLNGSIPFTLR-----ELQKLQYVGLKDNKLEGT----IPYDIFRLVKLYKLDLGGN  202 (652)
Q Consensus       136 ----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N  202 (652)
                          ++..+..+++|++|+|++|.++...+..+.     ..++|++|+|++|.+++.    ++..+..+++|++|++++|
T Consensus       158 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n  237 (461)
T 1z7x_W          158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN  237 (461)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSS
T ss_pred             HHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCC
Confidence                255566677777777777777644333332     255777777777777753    4556666777777777777


Q ss_pred             cccccc-----cccCCCCCCCCEEEccCCCCC------CCcccCCCCccceEecccccCCccCcccccC-----CCCCcE
Q 041689          203 KLSGSI-----LTCFSNLASLRTLSLSYNDGP------LPLEIGNLKVLIGIDFSMNNFSSVIPTTIGS-----LKDLQY  266 (652)
Q Consensus       203 ~l~~~~-----~~~~~~l~~L~~L~Ls~N~~~------~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~  266 (652)
                      ++++..     +..+..+++|++|++++|...      ++..+..+++|+.|++++|.++...+..+..     .++|++
T Consensus       238 ~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~  317 (461)
T 1z7x_W          238 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES  317 (461)
T ss_dssp             BCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCE
T ss_pred             cCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCcccee
Confidence            776432     333445677777777777521      3555666777777777777776443333322     257777


Q ss_pred             EEccCCcCCCc----ccccccccccCcceeccccccCCCCchhhcC-----CCCCceEEeecCcCcc----cCCC-CCCC
Q 041689          267 LFLGYNILKGS----IPDSVGDLISLKSLNFSNNNLSGAIPLLLEK-----LSYLEHLNLSFNKLEG----EIPK-GGSF  332 (652)
Q Consensus       267 L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~-~~~~  332 (652)
                      |+|++|.+++.    ++..+..+++|+.|+|++|++++..+..+..     .++|+.|++++|.+++    .+|. ...+
T Consensus       318 L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~  397 (461)
T 1z7x_W          318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN  397 (461)
T ss_dssp             EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             eEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhC
Confidence            77777777654    3455566677777777777776554444432     5677777777777764    3332 2345


Q ss_pred             CCcccccccCCcc
Q 041689          333 GNFSAESFEGNKL  345 (652)
Q Consensus       333 ~~l~~~~~~~N~~  345 (652)
                      ++++.+++++|++
T Consensus       398 ~~L~~L~l~~N~i  410 (461)
T 1z7x_W          398 HSLRELDLSNNCL  410 (461)
T ss_dssp             CCCCEEECCSSSC
T ss_pred             CCccEEECCCCCC
Confidence            6677777777754

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.1e-30  Score=267.75  Aligned_cols=253  Identities=18%  Similarity=0.185  Sum_probs=197.5

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeec-cCCCccccccCCCCCcccccccCCCCCCcEEEcccCC
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS-LSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNP  105 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  105 (652)
                      +..+|++|++++|++  .+|..+...  |+.|+|++|+++.. .+....          ...-.+.++++|++|+|++|+
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~----------~~~~~~~~l~~L~~L~L~~n~  106 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRIL----------FGALRVLGISGLQELTLENLE  106 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHH----------HHHHHHHTTSCCCEEEEEEEB
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHH----------HHHHHhcCcCCccEEEccCCc
Confidence            356789999999999  567666554  88999999998532 110000          000012267899999999999


Q ss_pred             CcccCCccch-hcccccCcEEEccCCcccccCCccccCC-----CCCCEEEecCccccccCCccccCCCCCcEEecccCc
Q 041689          106 LNGILPRMSI-GNLSHSLEIFDMSKCNVSGGIPEEIGNL-----TNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNK  179 (652)
Q Consensus       106 l~~~~~~~~~-~~l~~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  179 (652)
                      +++..|...+ ..+++ |++|+|++|++++. |..+..+     ++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus       107 l~~~~~~~~~~~~l~~-L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  184 (312)
T 1wwl_A          107 VTGTAPPPLLEATGPD-LNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP  184 (312)
T ss_dssp             CBSCCCCCSSSCCSCC-CSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred             ccchhHHHHHHhcCCC-ccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence            9877666332 67775 99999999999977 7888877     899999999999998888899999999999999999


Q ss_pred             cccc--cCccc--cCCCCCcEEEccCCcccc---cccccCCCCCCCCEEEccCCC--CCCC-cccCCCCccceEeccccc
Q 041689          180 LEGT--IPYDI--FRLVKLYKLDLGGNKLSG---SILTCFSNLASLRTLSLSYND--GPLP-LEIGNLKVLIGIDFSMNN  249 (652)
Q Consensus       180 l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~--~~~~-~~~~~l~~L~~L~ls~N~  249 (652)
                      +.+.  .+..+  ..+++|++|+|++|+|++   .....+..+++|++|+|++|.  ...| ..+..+++|+.|+|++|+
T Consensus       185 l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~  264 (312)
T 1wwl_A          185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG  264 (312)
T ss_dssp             TCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSC
T ss_pred             cCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCc
Confidence            8765  23344  788999999999999983   333556788999999999996  2233 456778999999999999


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      |+. +|..+.  ++|++|+|++|+|++. |. +..+++|+.|+|++|++++
T Consensus       265 l~~-ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          265 LKQ-VPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CSS-CCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCh-hhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            994 566665  8999999999999966 66 9999999999999999985

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=9.7e-30  Score=276.50  Aligned_cols=245  Identities=22%  Similarity=0.229  Sum_probs=187.0

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      +++|++|+|++|+|+++.|..|..+++|++|+|++|.|++.++                   |..+++|++|+|++|.|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------------l~~l~~L~~L~Ls~N~l~   93 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-------------------LESLSTLRTLDLNNNYVQ   93 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-------------------CTTCTTCCEEECCSSEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-------------------cccCCCCCEEEecCCcCC
Confidence            4489999999999999888999999999999999999986543                   678899999999999998


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD  187 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  187 (652)
                      ++++.      + +|++|++++|+|++..+.   .+++|+.|+|++|.|++..|..|..+++|++|+|++|.|++.+|..
T Consensus        94 ~l~~~------~-~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  163 (487)
T 3oja_A           94 ELLVG------P-SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE  163 (487)
T ss_dssp             EEEEC------T-TCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGG
T ss_pred             CCCCC------C-CcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHH
Confidence            76542      3 499999999999977664   3578899999999998888888888889999999999988878877


Q ss_pred             cc-CCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcE
Q 041689          188 IF-RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY  266 (652)
Q Consensus       188 ~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  266 (652)
                      +. .+++|+.|+|++|.|++..+  +..+++                      |+.|+|++|.+++++| .|..+++|+.
T Consensus       164 l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~----------------------L~~L~Ls~N~l~~~~~-~~~~l~~L~~  218 (487)
T 3oja_A          164 LAASSDTLEHLNLQYNFIYDVKG--QVVFAK----------------------LKTLDLSSNKLAFMGP-EFQSAAGVTW  218 (487)
T ss_dssp             GGGGTTTCCEEECTTSCCCEEEC--CCCCTT----------------------CCEEECCSSCCCEECG-GGGGGTTCSE
T ss_pred             HhhhCCcccEEecCCCccccccc--cccCCC----------------------CCEEECCCCCCCCCCH-hHcCCCCccE
Confidence            76 68888888888888886532  223444                      4555555566665433 3666777777


Q ss_pred             EEccCCcCCCcccccccccccCcceeccccccC-CCCchhhcCCCCCceEEee-------cCcCcccCC
Q 041689          267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS-GAIPLLLEKLSYLEHLNLS-------FNKLEGEIP  327 (652)
Q Consensus       267 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-------~N~l~~~~p  327 (652)
                      |+|++|.|+ .+|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++       .|+..|..+
T Consensus       219 L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~  286 (487)
T 3oja_A          219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP  286 (487)
T ss_dssp             EECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred             EEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCC
Confidence            777777777 35666777777777777777776 5566667777777777775       555555443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=3e-30  Score=280.50  Aligned_cols=241  Identities=18%  Similarity=0.140  Sum_probs=155.9

Q ss_pred             CCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEE
Q 041689           94 KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYV  173 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  173 (652)
                      ++|++|+|++|.++++++. .+..+++ |++|+|++|.|++..|  |..+++|++|+|++|.|++..+     .++|++|
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~-L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L  104 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAA-DLAPFTK-LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL  104 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGG-GGTTCTT-CCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred             CCccEEEeeCCcCCCCCHH-HHhCCCC-CCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence            3555555555555554443 4445544 5555555555554433  5555555555555555553322     1555555


Q ss_pred             ecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC--CCCCcccC-CCCccceEecccccC
Q 041689          174 GLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND--GPLPLEIG-NLKVLIGIDFSMNNF  250 (652)
Q Consensus       174 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--~~~~~~~~-~l~~L~~L~ls~N~l  250 (652)
                      +|++|.|++..+.   .+++|+.|+|++|.+++..|..|..+++|++|+|++|.  ...|..+. .+++|+.|+|++|.+
T Consensus       105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            5555555544332   23455566666666655555555555666666666654  22344443 567777777778888


Q ss_pred             CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcc-cCC-C
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG-EIP-K  328 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p-~  328 (652)
                      ++..  .+..+++|+.|+|++|.|++..| .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++.| .+| .
T Consensus       182 ~~~~--~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~  257 (487)
T 3oja_A          182 YDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF  257 (487)
T ss_dssp             CEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHH
T ss_pred             cccc--ccccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHH
Confidence            8753  23468999999999999996544 59999999999999999994 67789999999999999999983 222 2


Q ss_pred             CCCCCCccccccc-------CCccCCCCC
Q 041689          329 GGSFGNFSAESFE-------GNKLLCGSP  350 (652)
Q Consensus       329 ~~~~~~l~~~~~~-------~N~~~c~~~  350 (652)
                      ...++.+..+.+.       +|++.|..+
T Consensus       258 ~~~l~~L~~l~~~~~~~~~~~~~~~c~~~  286 (487)
T 3oja_A          258 FSKNQRVQTVAKQTVKKLTGQNEEECTVP  286 (487)
T ss_dssp             HTTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred             HHhCCCCcEEeccccccccCCCcccccCC
Confidence            3555666666665       788888765

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.96  E-value=1.6e-28  Score=247.19  Aligned_cols=227  Identities=20%  Similarity=0.175  Sum_probs=197.1

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecc
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK  176 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  176 (652)
                      ..++.++..++.++..     ++.+|++|++++|+|+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|+
T Consensus        10 ~~~~c~~~~l~~ip~~-----l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~   84 (276)
T 2z62_A           10 ITYQCMELNFYKIPDN-----LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT   84 (276)
T ss_dssp             TEEECTTSCCSSCCSS-----SCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             ceEEecCCCccccCCC-----CCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECC
Confidence            3466677777766543     34469999999999998888899999999999999999998888889999999999999


Q ss_pred             cCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCC---CCCcccCCCCccceEecccccCCcc
Q 041689          177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDG---PLPLEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       177 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~---~~~~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                      +|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|..   .+|..++++++|+.|++++|++++.
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~  164 (276)
T 2z62_A           85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  164 (276)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred             CCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence            9999988888899999999999999999988888899999999999999962   3688899999999999999999998


Q ss_pred             CcccccCCCCCc----EEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC
Q 041689          254 IPTTIGSLKDLQ----YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG  329 (652)
Q Consensus       254 ~~~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  329 (652)
                      .+..|..+.+|+    .|++++|++++..+..+.. .+|+.|+|++|++++..+..|..+++|+.|++++|+++|.+|..
T Consensus       165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             CHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            888888777777    8999999999666655544 58999999999999887788899999999999999999988754

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=4.6e-30  Score=263.17  Aligned_cols=248  Identities=21%  Similarity=0.197  Sum_probs=208.2

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccc-ccCCcccc-------CCCCCCEEEecCccccccC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVS-GGIPEEIG-------NLTNLTAIYLGGNKLNGSI  160 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~  160 (652)
                      .+...++|+.|++++|.+ .+ |. .+.   ..|+.|+|++|+++ ..+|..+.       ++++|++|+|++|++++..
T Consensus        38 ~~~~~~~L~~l~l~~n~l-~~-p~-~~~---~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~  111 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE-AD-LG-QFT---DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTA  111 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT-CC-CH-HHH---HHHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCC
T ss_pred             EEccCCCceeEeeccccc-cc-HH-HHH---HHHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchh
Confidence            356678899999999999 33 43 233   33999999999995 44666665       7999999999999999888


Q ss_pred             Cccc--cCCCCCcEEecccCccccccCccccCC-----CCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCC----
Q 041689          161 PFTL--RELQKLQYVGLKDNKLEGTIPYDIFRL-----VKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP----  229 (652)
Q Consensus       161 ~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~----  229 (652)
                      |..+  ..+++|++|+|++|+|++. |..+..+     ++|++|+|++|++++..+..|..+++|++|+|++|+..    
T Consensus       112 ~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  190 (312)
T 1wwl_A          112 PPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG  190 (312)
T ss_dssp             CCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH
T ss_pred             HHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH
Confidence            8876  8999999999999999976 8888877     89999999999999999899999999999999999721    


Q ss_pred             CCccc--CCCCccceEecccccCCcc---CcccccCCCCCcEEEccCCcCCCccc-ccccccccCcceeccccccCCCCc
Q 041689          230 LPLEI--GNLKVLIGIDFSMNNFSSV---IPTTIGSLKDLQYLFLGYNILKGSIP-DSVGDLISLKSLNFSNNNLSGAIP  303 (652)
Q Consensus       230 ~~~~~--~~l~~L~~L~ls~N~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~  303 (652)
                      .|..+  +.+++|++|++++|++++.   ....+..+++|++|+|++|++++..| ..+..+++|+.|+|++|+|+ .+|
T Consensus       191 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip  269 (312)
T 1wwl_A          191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP  269 (312)
T ss_dssp             HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCC
T ss_pred             HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhh
Confidence            34444  8999999999999999842   23445688999999999999998775 55677899999999999998 667


Q ss_pred             hhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCC
Q 041689          304 LLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       304 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c  347 (652)
                      ..+.  ++|+.|+|++|++++. |....++.++.+++++|++..
T Consensus       270 ~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          270 KGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTC
T ss_pred             hhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCC
Confidence            6665  7999999999999987 558888999999999998854

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=3.1e-27  Score=262.03  Aligned_cols=258  Identities=24%  Similarity=0.227  Sum_probs=213.5

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .++++|++++|+|+ .+|..+.  ++|+.|+|++|+|+.+++                     .+++|++|+|++|+|++
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---------------------~l~~L~~L~Ls~N~l~~   95 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---------------------LPPELRTLEVSGNQLTS   95 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---------------------CCTTCCEEEECSCCCSC
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---------------------cCCCCCEEEcCCCcCCc
Confidence            46999999999999 5676665  899999999999984432                     36889999999999998


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      ++.     .++ +|++|+|++|+|+++.+    .+++|+.|+|++|+|++ +|..   +++|++|+|++|+|++ +|.  
T Consensus        96 lp~-----~l~-~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~--  158 (622)
T 3g06_A           96 LPV-----LPP-GLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA--  158 (622)
T ss_dssp             CCC-----CCT-TCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--
T ss_pred             CCC-----CCC-CCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC--
Confidence            755     344 49999999999996544    67899999999999996 4443   4899999999999994 454  


Q ss_pred             cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEE
Q 041689          189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYL  267 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L  267 (652)
                       ...+|+.|++++|+|++++    ..+++|+.|++++|. ..+|..   +++|+.|++++|.++.+ |.   .+++|+.|
T Consensus       159 -~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~l-~~---~~~~L~~L  226 (622)
T 3g06_A          159 -LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTSL-PA---LPSGLKEL  226 (622)
T ss_dssp             -CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSSC-CC---CCTTCCEE
T ss_pred             -ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccccc-CC---CCCCCCEE
Confidence             3468999999999999754    557899999999997 445543   47899999999999964 43   35889999


Q ss_pred             EccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCC
Q 041689          268 FLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       268 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c  347 (652)
                      +|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|.|+..++....+++++.+++.+|++..
T Consensus       227 ~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~  298 (622)
T 3g06_A          227 IVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE  298 (622)
T ss_dssp             ECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred             EccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence            999999995 55   45689999999999999 4554   6789999999999999665556788899999999999864

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.7e-27  Score=239.69  Aligned_cols=225  Identities=22%  Similarity=0.257  Sum_probs=125.0

Q ss_pred             CCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCC
Q 041689           14 DDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNC   93 (652)
Q Consensus        14 ~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l   93 (652)
                      |....+.++|..+ +++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+.                 .|.++
T Consensus        14 c~~~~l~~ip~~l-~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----------------~~~~l   75 (276)
T 2z62_A           14 CMELNFYKIPDNL-PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----------------AYQSL   75 (276)
T ss_dssp             CTTSCCSSCCSSS-CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT-----------------TTTTC
T ss_pred             ecCCCccccCCCC-CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH-----------------HccCC
Confidence            3333445677776 56778888888887777666777777777777777777655442                 35566


Q ss_pred             CCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEE
Q 041689           94 KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYV  173 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  173 (652)
                      ++|++|+|++|+++++.+. .+..+++ |++|++++|++++..+..+..+++|++|+|++|++++..             
T Consensus        76 ~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-------------  140 (276)
T 2z62_A           76 SHLSTLILTGNPIQSLALG-AFSGLSS-LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-------------  140 (276)
T ss_dssp             TTCCEEECTTCCCCEECTT-TTTTCTT-CCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC-------------
T ss_pred             cCCCEEECCCCccCccChh-hhcCCcc-ccEEECCCCCccccCchhcccCCCCCEEECcCCccceec-------------
Confidence            6666666666666655444 4444443 555555555555444444555555555555555544321             


Q ss_pred             ecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCcc
Q 041689          174 GLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       174 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                                +|..+..+++|++|+|++|+++++.+..|..+++|+.|.+                  .|++++|.++++
T Consensus       141 ----------l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l------------------~L~ls~n~l~~~  192 (276)
T 2z62_A          141 ----------LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL------------------SLDLSLNPMNFI  192 (276)
T ss_dssp             ----------CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE------------------EEECCSSCCCEE
T ss_pred             ----------CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce------------------eeecCCCccccc
Confidence                      3445555555555555555555444444443333331110                  344444445443


Q ss_pred             CcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       254 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      .+..+.. .+|+.|+|++|++++..+..|..+++|+.|+|++|++++
T Consensus       193 ~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          193 QPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             CTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             CccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            3333332 256666666666665555555666666666666666653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.95  E-value=1.1e-30  Score=283.08  Aligned_cols=233  Identities=16%  Similarity=0.092  Sum_probs=187.0

Q ss_pred             CCCCCcEEEcccCCCcccCCc---cchhcccccCcEEEccCCcccccCCcccc-----CCCCCCEEEecCcccccc----
Q 041689           92 NCKSLVVFLLSNNPLNGILPR---MSIGNLSHSLEIFDMSKCNVSGGIPEEIG-----NLTNLTAIYLGGNKLNGS----  159 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----  159 (652)
                      ..++|++|+|++|++++....   ..+..+++ |++|++++|.++...+..+.     .+++|++|+|++|.++..    
T Consensus       140 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~-L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  218 (461)
T 1z7x_W          140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPD-FKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD  218 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHHHHCTT-CCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHH
T ss_pred             CCCcceEEECCCCCCCHHHHHHHHHHHhhCCC-CCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHH
Confidence            467899999999999875321   13455565 99999999999876555554     367999999999999864    


Q ss_pred             CCccccCCCCCcEEecccCcccccc-----CccccCCCCCcEEEccCCccccc----ccccCCCCCCCCEEEccCCCCC-
Q 041689          160 IPFTLRELQKLQYVGLKDNKLEGTI-----PYDIFRLVKLYKLDLGGNKLSGS----ILTCFSNLASLRTLSLSYNDGP-  229 (652)
Q Consensus       160 ~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~~~-  229 (652)
                      ++..+..+++|++|+|++|++++..     +..+..+++|++|++++|.++..    ++..+..+++|++|++++|... 
T Consensus       219 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~  298 (461)
T 1z7x_W          219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD  298 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred             HHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch
Confidence            4777889999999999999998643     22333588999999999999864    5677888999999999999621 


Q ss_pred             -----CCccc-CCCCccceEecccccCCcc----CcccccCCCCCcEEEccCCcCCCcccccccc-----cccCcceecc
Q 041689          230 -----LPLEI-GNLKVLIGIDFSMNNFSSV----IPTTIGSLKDLQYLFLGYNILKGSIPDSVGD-----LISLKSLNFS  294 (652)
Q Consensus       230 -----~~~~~-~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~  294 (652)
                           +...+ ...++|+.|++++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|+.|+|+
T Consensus       299 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  378 (461)
T 1z7x_W          299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA  378 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECC
Confidence                 11112 2336999999999999875    4666778899999999999998765555543     6799999999


Q ss_pred             ccccCC----CCchhhcCCCCCceEEeecCcCccc
Q 041689          295 NNNLSG----AIPLLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       295 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      +|++++    .+|..+..+++|++|++++|++++.
T Consensus       379 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             CCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            999986    7788899999999999999999854

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=7.2e-27  Score=234.19  Aligned_cols=206  Identities=26%  Similarity=0.259  Sum_probs=155.8

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +.+.+++++|.++.++..     ++.+|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+
T Consensus        17 ~~~~l~~~~~~l~~ip~~-----~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAIPSN-----IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTEEECTTSCCSSCCSC-----CCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCEEEccCCCCCccCCC-----CCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            577888888888876543     234588888888888877777888888888888888888876667777888888888


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      |++|+|++..+..|..+++|++|+|++|+++++.+..|..+++|++|+                      +++|+++++.
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~----------------------Ls~n~l~~~~  149 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS----------------------LGYNELQSLP  149 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE----------------------CCSSCCCCCC
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE----------------------CCCCcCCccC
Confidence            888888866666677777788888888877766665555555555554                      5556666666


Q ss_pred             cccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       255 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      +..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.|..+
T Consensus       150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            6667778888888888888887666778888888888888888887766778888888888888888877654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=1.4e-26  Score=231.99  Aligned_cols=197  Identities=24%  Similarity=0.313  Sum_probs=111.9

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      +.++++.+.++   ++|..+ +.++++|+|++|+|+++.+..|.++++|++|+|++|+|+.+++.               
T Consensus        19 ~~l~~~~~~l~---~ip~~~-~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~---------------   79 (270)
T 2o6q_A           19 NSVDCSSKKLT---AIPSNI-PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG---------------   79 (270)
T ss_dssp             TEEECTTSCCS---SCCSCC-CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT---------------
T ss_pred             CEEEccCCCCC---ccCCCC-CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh---------------
Confidence            44555555544   455554 45566666666666655555566666666666666666543332               


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccC
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRE  166 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  166 (652)
                        .|.++++|++|+|++|+++++++. .+..+++ |++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..
T Consensus        80 --~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  155 (270)
T 2o6q_A           80 --IFKELKNLETLWVTDNKLQALPIG-VFDQLVN-LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK  155 (270)
T ss_dssp             --TTSSCTTCCEEECCSSCCCCCCTT-TTTTCSS-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             --hhcCCCCCCEEECCCCcCCcCCHh-HcccccC-CCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccC
Confidence              245556666666666666655444 4445544 666666666666555555566666666666666665555555555


Q ss_pred             CCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCC
Q 041689          167 LQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       167 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  226 (652)
                      +++|++|+|++|+|++..+..|..+++|++|+|++|+++++++..|..+++|+.|+|++|
T Consensus       156 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  215 (270)
T 2o6q_A          156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN  215 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             CcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCC
Confidence            666666666666665444445555556666666666665555555555555555555554

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=1.3e-26  Score=234.56  Aligned_cols=201  Identities=23%  Similarity=0.185  Sum_probs=112.5

Q ss_pred             hcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCc
Q 041689          116 GNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY  195 (652)
Q Consensus       116 ~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  195 (652)
                      .++++ ++++++++|+++.+ |..+.  ++++.|+|++|+|++..+..|.++++|++|+|++|.|++..+.  ..+++|+
T Consensus         7 ~~l~~-l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~   80 (290)
T 1p9a_G            7 SKVAS-HLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG   80 (290)
T ss_dssp             ECSTT-CCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred             cccCC-ccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence            34444 77777777777643 33332  5667777777777666666677777777777777777643332  5566666


Q ss_pred             EEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCc
Q 041689          196 KLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNI  273 (652)
Q Consensus       196 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  273 (652)
                      +|+|++|+|+ .+|..+..+++|++|+|++|+ ..+| ..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            6666666666 344455555566666555554 2222 335555555555555555555444445555555555555555


Q ss_pred             CCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcc
Q 041689          274 LKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG  324 (652)
Q Consensus       274 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  324 (652)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++.|
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            55444444455555555555555555 334444444455555555555544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=1.3e-26  Score=234.41  Aligned_cols=202  Identities=22%  Similarity=0.200  Sum_probs=183.6

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      +.++++|+.+++++|.++.+++.     ++.+|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.+.  ..+++
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~-----~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~   78 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPD-----LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPV   78 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSC-----CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTT
T ss_pred             ccccCCccEEECCCCCCCcCCCC-----CCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCc
Confidence            66889999999999999988764     234699999999999999999999999999999999999976553  78999


Q ss_pred             CcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCc-ccCCCCccceEeccc
Q 041689          170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPL-EIGNLKVLIGIDFSM  247 (652)
Q Consensus       170 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~-~~~~l~~L~~L~ls~  247 (652)
                      |++|+|++|+|+ .+|..+..+++|++|+|++|+|+++.+..|..+++|++|+|++|+ ..+|. .|..+++|+.|+|++
T Consensus        79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (290)
T 1p9a_G           79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (290)
T ss_dssp             CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence            999999999999 788889999999999999999999999999999999999999997 44444 478999999999999


Q ss_pred             ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       248 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      |+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus       158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            9999988888899999999999999999 778888888999999999999974

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=8.9e-27  Score=233.74  Aligned_cols=209  Identities=22%  Similarity=0.263  Sum_probs=111.6

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      ++++|++|++++|.++..  ..+..+++|++|+|++|++++.                   ..+.++++|++|+|++|.+
T Consensus        39 ~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~-------------------~~l~~l~~L~~L~L~~n~l   97 (272)
T 3rfs_A           39 ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI-------------------SALKELTNLTYLILTGNQL   97 (272)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC-------------------GGGTTCTTCCEEECTTSCC
T ss_pred             cccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc-------------------hhhcCCCCCCEEECCCCcc
Confidence            345555666665555522  2355555566666655555421                   1244555555555555555


Q ss_pred             cccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCc
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY  186 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  186 (652)
                      +++++. .+..+++ |++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+.
T Consensus        98 ~~~~~~-~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  175 (272)
T 3rfs_A           98 QSLPNG-VFDKLTN-LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG  175 (272)
T ss_dssp             CCCCTT-TTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CccChh-HhcCCcC-CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHH
Confidence            555443 3444443 55555555555555555555555555555555555554455555555555555555555544444


Q ss_pred             cccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcE
Q 041689          187 DIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY  266 (652)
Q Consensus       187 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  266 (652)
                      .|..+++|++|++++|++++..+..|..+++|++|++                      ++|.+.+.       +++|+.
T Consensus       176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l----------------------~~N~~~~~-------~~~l~~  226 (272)
T 3rfs_A          176 VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWL----------------------HDNPWDCT-------CPGIRY  226 (272)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC----------------------CSSCBCCC-------TTTTHH
T ss_pred             HhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEc----------------------cCCCcccc-------CcHHHH
Confidence            4555555555555555555555444555555555555                      45544432       334566


Q ss_pred             EEccCCcCCCccccccccccc
Q 041689          267 LFLGYNILKGSIPDSVGDLIS  287 (652)
Q Consensus       267 L~L~~N~l~~~~p~~~~~l~~  287 (652)
                      |+++.|.++|.+|..++.++.
T Consensus       227 l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          227 LSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             HHHHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHHHhCCCcccCcccccCC
Confidence            666666666666665555443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2.6e-27  Score=259.55  Aligned_cols=186  Identities=18%  Similarity=0.150  Sum_probs=144.1

Q ss_pred             CccceeccccceEEEEEEeCCCcEEEEEEeecccc--------hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          428 NENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG--------RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ...+.||+|+||.||+|.. .++.+|+|+......        ...+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999954 578899998643211        1234588999999999999999666555567778999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++++|.+++..         +..++.|+++||+|||++   +|+||||||+||++++  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999998875         457999999999999999   9999999999999998  99999999999763211


Q ss_pred             Ccc-----ccccccCCccccCcccccc--CccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          580 QSM-----TQTQTLATIGYIAPEYGRE--GRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       580 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                      ...     ......||+.|||||++..  ..|+...|+|+..+-..+...++.++.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            111     1134579999999999887  668888999999988888887776653

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=3e-26  Score=229.90  Aligned_cols=219  Identities=25%  Similarity=0.273  Sum_probs=134.4

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      ++..+++..+.+.+..   ....++. |+.|++++|.++..  ..+..+++|++|+|++|++++.  ..+..+++|++|+
T Consensus        20 ~l~~l~l~~~~~~~~~---~~~~l~~-L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAV---TQNELNS-IDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHTCSCTTSEE---CHHHHTT-CCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHhcCccccccc---ccccccc-eeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            3334444444444332   2233333 55555555555522  2355555555555555555532  2455555555555


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCCccceEecccccCCc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      |++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|. ..++ ..++.+++|+.|++++|++++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            55555554444445555556666666666555555555556666666666554 2222 235666667777777777777


Q ss_pred             cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC
Q 041689          253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       253 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  328 (652)
                      ..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+.+.       ++.|+.|++..|.++|.+|.
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~  240 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN  240 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence            7777777888888888888888877777778888888888888887643       44678888888888887775

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=1.1e-25  Score=221.27  Aligned_cols=185  Identities=18%  Similarity=0.197  Sum_probs=143.7

Q ss_pred             CccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCc-CeeccCCCccccccCCCCCcccccccCCCCCCc
Q 041689           19 PCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY-LSGSLSSIADNYLTSSTPELSFLSSLSNCKSLV   97 (652)
Q Consensus        19 ~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~   97 (652)
                      +.++|. + +.+|++|+|++|+|+++.+..|.++++|++|+|++|+ ++++.+.                 .|.++++|+
T Consensus        23 l~~ip~-~-~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~-----------------~f~~l~~L~   83 (239)
T 2xwt_C           23 IQRIPS-L-PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH-----------------SFYNLSKVT   83 (239)
T ss_dssp             CSSCCC-C-CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTT-----------------TEESCTTCC
T ss_pred             ccccCC-C-CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHh-----------------HcCCCcCCc
Confidence            557888 6 6789999999999998888889999999999999996 8766552                 477888899


Q ss_pred             EEEccc-CCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCC---EEEecCc-cccccCCccccCCCCCc-
Q 041689           98 VFLLSN-NPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLT---AIYLGGN-KLNGSIPFTLRELQKLQ-  171 (652)
Q Consensus        98 ~L~Ls~-N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-  171 (652)
                      +|+|++ |+++++++. .|..+++ |++|++++|++++ +|. |..+++|+   +|++++| +++++.+..|.++++|+ 
T Consensus        84 ~L~l~~~n~l~~i~~~-~f~~l~~-L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~  159 (239)
T 2xwt_C           84 HIEIRNTRNLTYIDPD-ALKELPL-LKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL  159 (239)
T ss_dssp             EEEEEEETTCCEECTT-SEECCTT-CCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEE
T ss_pred             EEECCCCCCeeEcCHH-HhCCCCC-CCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhccee
Confidence            999988 888887766 6777776 8888888888886 454 77888887   8888888 88877777788888888 


Q ss_pred             EEecccCccccccCccccCCCCCcEEEccCCc-ccccccccCCCC-CCCCEEEccCCC
Q 041689          172 YVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNK-LSGSILTCFSNL-ASLRTLSLSYND  227 (652)
Q Consensus       172 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~  227 (652)
                      +|++++|+++ .+|...+..++|+.|+|++|+ ++++.+..|..+ ++|++|++++|.
T Consensus       160 ~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~  216 (239)
T 2xwt_C          160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS  216 (239)
T ss_dssp             EEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCC
T ss_pred             EEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCc
Confidence            8888888888 444443344788888888884 877666677666 666666665553

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=2.4e-25  Score=227.86  Aligned_cols=225  Identities=16%  Similarity=0.178  Sum_probs=172.6

Q ss_pred             CCCcEEEcccCCCcccCCc--cchhcccccCcEEEccCCcccccCCccc--cCCCCCCEEEecCccccccCC----cccc
Q 041689           94 KSLVVFLLSNNPLNGILPR--MSIGNLSHSLEIFDMSKCNVSGGIPEEI--GNLTNLTAIYLGGNKLNGSIP----FTLR  165 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~--~~~~~l~~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~  165 (652)
                      ..++.|.++++.++...-.  ..+..+++ |++|++++|++++..|..+  ..+++|++|+|++|++++..+    ..+.
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~-L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~  142 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSR-LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQW  142 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSC-CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTT
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCc-eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhh
Confidence            3578888888887642110  01223444 9999999999998888888  899999999999999986544    4456


Q ss_pred             CCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccc---c-cccCCCCCCCCEEEccCCCCC-CCc----ccCC
Q 041689          166 ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGS---I-LTCFSNLASLRTLSLSYNDGP-LPL----EIGN  236 (652)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~Ls~N~~~-~~~----~~~~  236 (652)
                      .+++|++|+|++|+|++..+..|..+++|++|+|++|++.+.   . +..+..+++|++|+|++|... ++.    .+++
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~  222 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAA  222 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHH
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhc
Confidence            788999999999999988888888999999999999998652   2 233477888999999988733 233    1467


Q ss_pred             CCccceEecccccCCccCcccccCC---CCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          237 LKVLIGIDFSMNNFSSVIPTTIGSL---KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       237 l~~L~~L~ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      +++|++|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            7888888888888888777777666   58888888888888 5666664  6888888888888854 33 67788888


Q ss_pred             eEEeecCcCcc
Q 041689          314 HLNLSFNKLEG  324 (652)
Q Consensus       314 ~L~L~~N~l~~  324 (652)
                      .|+|++|+|+.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            88888888863

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.92  E-value=6.7e-25  Score=228.48  Aligned_cols=242  Identities=18%  Similarity=0.146  Sum_probs=133.8

Q ss_pred             CEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCC
Q 041689           32 EELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILP  111 (652)
Q Consensus        32 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  111 (652)
                      ++++.++|+++ .+|..+  .+++++|+|++|+|+.+++.                 +|.++++|++|+|++|++.+..+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~-----------------~f~~l~~L~~L~Ls~N~i~~~i~   71 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKG-----------------AFSGFGDLEKIEISQNDVLEVIE   71 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTT-----------------SSTTCTTCCEEEEECCTTCCEEC
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHH-----------------HHcCCCCCCEEECcCCCCCCccC
Confidence            34555555555 234333  24555666666665544432                 35555666666666666544333


Q ss_pred             ccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEeccc-CccccccCccccC
Q 041689          112 RMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD-NKLEGTIPYDIFR  190 (652)
Q Consensus       112 ~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~  190 (652)
                      ...|.++++.++.+.++.|+|+++.|+.|.++++|++|++++|+|+...+..+....++..|++.+ |++....+..|..
T Consensus        72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~  151 (350)
T 4ay9_X           72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG  151 (350)
T ss_dssp             TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred             hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence            324555554233455666777766677777777777777777777766666666666677777754 5666555555555


Q ss_pred             CC-CCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEc
Q 041689          191 LV-KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFL  269 (652)
Q Consensus       191 l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L  269 (652)
                      +. .++.|+|++|+|+.+.+..|. .++|++|++++                     +|.++.+.+..|.++++|++|+|
T Consensus       152 ~~~~l~~L~L~~N~i~~i~~~~f~-~~~L~~l~l~~---------------------~n~l~~i~~~~f~~l~~L~~LdL  209 (350)
T 4ay9_X          152 LSFESVILWLNKNGIQEIHNSAFN-GTQLDELNLSD---------------------NNNLEELPNDVFHGASGPVILDI  209 (350)
T ss_dssp             SBSSCEEEECCSSCCCEECTTSST-TEEEEEEECTT---------------------CTTCCCCCTTTTTTEECCSEEEC
T ss_pred             cchhhhhhccccccccCCChhhcc-ccchhHHhhcc---------------------CCcccCCCHHHhccCcccchhhc
Confidence            54 466777777777655544443 23444444443                     24444444445555666666666


Q ss_pred             cCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          270 GYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       270 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      ++|+|+...+..|.++++|+.+++  +.++ .+| .+..+++|+.+++++
T Consensus       210 s~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          210 SRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TLEKLVALMEASLTY  255 (350)
T ss_dssp             TTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSC
T ss_pred             CCCCcCccChhhhccchHhhhccC--CCcC-cCC-CchhCcChhhCcCCC
Confidence            666665444444444444443332  2333 333 245556666666553

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.92  E-value=5.6e-25  Score=216.20  Aligned_cols=193  Identities=18%  Similarity=0.184  Sum_probs=101.1

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCcc-ccccCCccccCCCCCcEEeccc-CccccccCccccCCCCCcEEEc
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK-LNGSIPFTLRELQKLQYVGLKD-NKLEGTIPYDIFRLVKLYKLDL  199 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L  199 (652)
                      |++|++++|+|+++.+..|.++++|++|+|++|+ ++.+.+..|.++++|++|+|++ |+|++..+..|..+++|++|++
T Consensus        33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l  112 (239)
T 2xwt_C           33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI  112 (239)
T ss_dssp             CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred             ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence            4444444444444444444444444444444443 4444444444444444444444 4444333344444444555555


Q ss_pred             cCCcccccccccCCCCCCCC---EEEccCC-C-CCCCc-ccCCCCccc-eEecccccCCccCcccccCCCCCcEEEccCC
Q 041689          200 GGNKLSGSILTCFSNLASLR---TLSLSYN-D-GPLPL-EIGNLKVLI-GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN  272 (652)
Q Consensus       200 ~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~-~~~~~-~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N  272 (652)
                      ++|+++++ |. |..+++|+   +|++++| . ..+|. .|.++++|+ .|++++|+++.+.+..|.. ++|+.|+|++|
T Consensus       113 ~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          113 FNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence            54444432 22 44444444   5555554 3 22222 245555555 5666666666444444444 66777777777


Q ss_pred             c-CCCccccccccc-ccCcceeccccccCCCCchhhcCCCCCceEEeecC
Q 041689          273 I-LKGSIPDSVGDL-ISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       273 ~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                      + +++..+..|..+ ++|+.|+|++|+|++..+.   .+++|+.|+++++
T Consensus       190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             TTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            4 665556666666 7777777777777643333   4556777776654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=8.1e-27  Score=244.22  Aligned_cols=162  Identities=17%  Similarity=0.139  Sum_probs=69.6

Q ss_pred             EECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCC-CCcEEEcccCCCcccCCc
Q 041689           34 LLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCK-SLVVFLLSNNPLNGILPR  112 (652)
Q Consensus        34 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~  112 (652)
                      ++|++|++++.+|..+...++|++|+|++|.|++....             .....|.+++ +|++|+|++|++++..+.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-------------~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~   69 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTV-------------ELIQAFANTPASVTSLNLSGNSLGFKNSD   69 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHH-------------HHHHHHHTCCTTCCEEECCSSCGGGSCHH
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHH-------------HHHHHHHhCCCceeEEECcCCCCCHHHHH
Confidence            34455555544444444444455555555554422210             0001233444 455555555555444333


Q ss_pred             cchhcc----cccCcEEEccCCcccccCCcccc----CC-CCCCEEEecCccccccCCcccc----C-CCCCcEEecccC
Q 041689          113 MSIGNL----SHSLEIFDMSKCNVSGGIPEEIG----NL-TNLTAIYLGGNKLNGSIPFTLR----E-LQKLQYVGLKDN  178 (652)
Q Consensus       113 ~~~~~l----~~~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N  178 (652)
                       .+..+    ..+|++|+|++|+|++..+..+.    .+ ++|++|+|++|+|++..+..+.    . .++|++|+|++|
T Consensus        70 -~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N  148 (362)
T 3goz_A           70 -ELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN  148 (362)
T ss_dssp             -HHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTS
T ss_pred             -HHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCC
Confidence             23322    11255555555555544433222    22 4555555555555543333322    2 135555555555


Q ss_pred             cccccc----CccccCCC-CCcEEEccCCccccccc
Q 041689          179 KLEGTI----PYDIFRLV-KLYKLDLGGNKLSGSIL  209 (652)
Q Consensus       179 ~l~~~~----~~~~~~l~-~L~~L~L~~N~l~~~~~  209 (652)
                      +|++..    +..+..++ +|++|+|++|+|++..+
T Consensus       149 ~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~  184 (362)
T 3goz_A          149 DLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC  184 (362)
T ss_dssp             CGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             cCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence            555322    22223333 55555555555544333

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.92  E-value=1.1e-24  Score=226.92  Aligned_cols=232  Identities=21%  Similarity=0.203  Sum_probs=183.4

Q ss_pred             cCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCC
Q 041689           17 ESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSL   96 (652)
Q Consensus        17 ~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L   96 (652)
                      ..+++||+.+ ++++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.++.                .+|.++++|
T Consensus        19 ~~Lt~iP~~l-~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~----------------~~f~~L~~l   81 (350)
T 4ay9_X           19 SKVTEIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA----------------DVFSNLPKL   81 (350)
T ss_dssp             TTCCSCCTTC-CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT----------------TSBCSCTTC
T ss_pred             CCCCccCcCc-CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh----------------hHhhcchhh
Confidence            3345899998 88999999999999988888999999999999999998654442                357888887


Q ss_pred             cE-EEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecC-ccccccCCccccCCC-CCcEE
Q 041689           97 VV-FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGG-NKLNGSIPFTLRELQ-KLQYV  173 (652)
Q Consensus        97 ~~-L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L  173 (652)
                      +. ++++.|+|+.++++ .|..+++ |++|++++|+|+...+..+....++..|++.+ |++..+.+..|..+. .++.|
T Consensus        82 ~~~l~~~~N~l~~l~~~-~f~~l~~-L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L  159 (350)
T 4ay9_X           82 HEIRIEKANNLLYINPE-AFQNLPN-LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL  159 (350)
T ss_dssp             CEEEEEEETTCCEECTT-SBCCCTT-CCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred             hhhhcccCCcccccCch-hhhhccc-cccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhh
Confidence            64 77788999999887 7888887 99999999999988888888888999999966 688877788888875 68999


Q ss_pred             ecccCccccccCccccCCCCCcEEEcc-CCcccccccccCCCCCCCCEEEccCCC-CCCCcc-cCCCCccceEecccccC
Q 041689          174 GLKDNKLEGTIPYDIFRLVKLYKLDLG-GNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE-IGNLKVLIGIDFSMNNF  250 (652)
Q Consensus       174 ~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~-~~~l~~L~~L~ls~N~l  250 (652)
                      +|++|+|+ .+|...+...+|+.|+++ +|.++.+++++|..+++|++|+|++|+ ..+|.. +.+++.|+.+++  +++
T Consensus       160 ~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l  236 (350)
T 4ay9_X          160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL  236 (350)
T ss_dssp             ECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTC
T ss_pred             cccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCc
Confidence            99999999 556566667789999997 588887777889999999999888886 445543 444444433332  334


Q ss_pred             CccCcccccCCCCCcEEEccCC
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYN  272 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N  272 (652)
                      +. +| .+..+++|+.++++++
T Consensus       237 ~~-lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          237 KK-LP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             CC-CC-CTTTCCSCCEEECSCH
T ss_pred             Cc-CC-CchhCcChhhCcCCCC
Confidence            43 34 3667777777777654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.92  E-value=2.3e-24  Score=213.49  Aligned_cols=177  Identities=23%  Similarity=0.260  Sum_probs=94.9

Q ss_pred             eceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcc
Q 041689            6 IGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELS   85 (652)
Q Consensus         6 l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~   85 (652)
                      .+.++++++.++   ++|..+ +++++.|+|++|+|+++.+..|.++++|++|+|++|+|++..+.              
T Consensus        16 ~~~l~~~~~~l~---~~p~~~-~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------------   77 (251)
T 3m19_A           16 KKEVDCQGKSLD---SVPSGI-PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG--------------   77 (251)
T ss_dssp             GTEEECTTCCCS---SCCSCC-CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT--------------
T ss_pred             CeEEecCCCCcc---ccCCCC-CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh--------------
Confidence            344555555554   455555 45666666666666665555666666666666666666544331              


Q ss_pred             cccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcccc
Q 041689           86 FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLR  165 (652)
Q Consensus        86 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  165 (652)
                         .|.++++|++|+|++|+++++++. .+..+++ |++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|.
T Consensus        78 ---~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  152 (251)
T 3m19_A           78 ---VFDDLTELGTLGLANNQLASLPLG-VFDHLTQ-LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD  152 (251)
T ss_dssp             ---TTTTCTTCCEEECTTSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             ---HhccCCcCCEEECCCCcccccChh-HhcccCC-CCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcC
Confidence               345555566666666655555444 3444443 55555555555544444455555555555555555544444455


Q ss_pred             CCCCCcEEecccCccccccCccccCCCCCcEEEccCCccc
Q 041689          166 ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  205 (652)
                      .+++|++|+|++|+|++..+..|..+++|+.|+|++|.++
T Consensus       153 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             cCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            5555555555555555444444444555555555555544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=4.1e-24  Score=218.24  Aligned_cols=215  Identities=20%  Similarity=0.276  Sum_probs=162.0

Q ss_pred             CCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEE
Q 041689           94 KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYV  173 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  173 (652)
                      .++..+.+..+.+++..   ....+++ |++|++++|+++.. + .+..+++|++|+|++|++++..+  +..+++|++|
T Consensus        19 ~~~~~~~l~~~~~~~~~---~~~~l~~-L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L   90 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDTV---TQADLDG-ITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (308)
T ss_dssp             HHHHHHHTTCSSTTSEE---CHHHHHT-CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHhCCCCcCcee---cHHHcCC-cCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEE
Confidence            33444456666666543   2345555 88888888888753 3 57778888888888888875544  7888888888


Q ss_pred             ecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCcc
Q 041689          174 GLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       174 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                      +|++|++++ ++ .+..+++|++|+|++|++++..+  +..+++|++|++++|.......++.+++|+.|++++|++++.
T Consensus        91 ~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~  166 (308)
T 1h6u_A           91 ELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL  166 (308)
T ss_dssp             ECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred             EccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCCCC
Confidence            888888874 33 57778888888888888876532  788888888888888633333378888888888888988875


Q ss_pred             CcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccC
Q 041689          254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEI  326 (652)
Q Consensus       254 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  326 (652)
                      .+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|++++|++++.+
T Consensus       167 ~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~  233 (308)
T 1h6u_A          167 TP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP  233 (308)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred             hh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence            44  8888999999999999986544  8888999999999999986553  788999999999999998643

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=1.1e-26  Score=245.65  Aligned_cols=135  Identities=19%  Similarity=0.186  Sum_probs=60.1

Q ss_pred             CCCcEEecccCccc-cccC---ccccCCCCCcEEEccCCcccc-----cccccCCCCCCCCEEEccCCCC------CCCc
Q 041689          168 QKLQYVGLKDNKLE-GTIP---YDIFRLVKLYKLDLGGNKLSG-----SILTCFSNLASLRTLSLSYNDG------PLPL  232 (652)
Q Consensus       168 ~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~~------~~~~  232 (652)
                      ++|++|+|++|+|+ +.++   ..+..+++|++|+|++|+|+.     ..+..+..+++|++|+|++|..      .+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            44445555555444 1222   233344455555555555441     2222344444444444444421      1223


Q ss_pred             ccCCCCccceEecccccCCcc----Cccccc--CCCCCcEEEccCCcCCC----cccccc-cccccCcceeccccccCCC
Q 041689          233 EIGNLKVLIGIDFSMNNFSSV----IPTTIG--SLKDLQYLFLGYNILKG----SIPDSV-GDLISLKSLNFSNNNLSGA  301 (652)
Q Consensus       233 ~~~~l~~L~~L~ls~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~  301 (652)
                      .+..+++|+.|+|++|.+++.    ++..+.  .+++|++|+|++|.+++    .+|..+ .++++|+.|+|++|++++.
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            333444444444444444432    233332  25555555555555554    244444 3355555555555555544


Q ss_pred             C
Q 041689          302 I  302 (652)
Q Consensus       302 ~  302 (652)
                      .
T Consensus       319 ~  319 (386)
T 2ca6_A          319 D  319 (386)
T ss_dssp             S
T ss_pred             h
Confidence            4

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=5.9e-26  Score=237.63  Aligned_cols=251  Identities=16%  Similarity=0.146  Sum_probs=175.9

Q ss_pred             EEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCC----ccchhcccccCcEEEccCCcc
Q 041689           57 DLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILP----RMSIGNLSHSLEIFDMSKCNV  132 (652)
Q Consensus        57 ~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~~l~~~L~~L~L~~N~l  132 (652)
                      .++|++|.+++.++.                 .+...++|++|+|++|.+++..+    . .+..++.+|++|+|++|+|
T Consensus         2 ~~~ls~n~~~~~~~~-----------------~~~~~~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~~L~~L~Ls~N~l   63 (362)
T 3goz_A            2 NYKLTLHPGSNPVEE-----------------FTSIPHGVTSLDLSLNNLYSISTVELIQ-AFANTPASVTSLNLSGNSL   63 (362)
T ss_dssp             EEECCCCTTCCHHHH-----------------HHTSCTTCCEEECTTSCGGGSCHHHHHH-HHHTCCTTCCEEECCSSCG
T ss_pred             ccccccccchHHHHH-----------------HHhCCCCceEEEccCCCCChHHHHHHHH-HHHhCCCceeEEECcCCCC
Confidence            467888888766553                 23445569999999999887765    3 4566663499999999999


Q ss_pred             cccCCccccCC-----CCCCEEEecCccccccCCccc----cCC-CCCcEEecccCccccccCccccC-----CCCCcEE
Q 041689          133 SGGIPEEIGNL-----TNLTAIYLGGNKLNGSIPFTL----REL-QKLQYVGLKDNKLEGTIPYDIFR-----LVKLYKL  197 (652)
Q Consensus       133 ~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L  197 (652)
                      ++..+..|..+     ++|++|+|++|++++..+..+    ..+ ++|++|+|++|+|++..+..+..     .++|++|
T Consensus        64 ~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L  143 (362)
T 3goz_A           64 GFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL  143 (362)
T ss_dssp             GGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEE
T ss_pred             CHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEE
Confidence            88777777775     889999999999887666644    444 78999999999988665554433     2589999


Q ss_pred             EccCCcccccc----cccCCCCC-CCCEEEccCCCC--CCCc----ccCCC-CccceEecccccCCcc----CcccccC-
Q 041689          198 DLGGNKLSGSI----LTCFSNLA-SLRTLSLSYNDG--PLPL----EIGNL-KVLIGIDFSMNNFSSV----IPTTIGS-  260 (652)
Q Consensus       198 ~L~~N~l~~~~----~~~~~~l~-~L~~L~Ls~N~~--~~~~----~~~~l-~~L~~L~ls~N~l~~~----~~~~~~~-  260 (652)
                      +|++|++++..    +..+..++ +|++|+|++|..  ..+.    .+..+ ++|+.|||++|.++..    ++..+.. 
T Consensus       144 ~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~  223 (362)
T 3goz_A          144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI  223 (362)
T ss_dssp             ECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHS
T ss_pred             EccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcC
Confidence            99999888533    33445555 888888888862  2222    23344 4788888888888763    3344444 


Q ss_pred             CCCCcEEEccCCcCCCccc----ccccccccCcceeccccccCCCCc-------hhhcCCCCCceEEeecCcCccc
Q 041689          261 LKDLQYLFLGYNILKGSIP----DSVGDLISLKSLNFSNNNLSGAIP-------LLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       261 l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~-------~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      .++|++|+|++|+|++..+    ..+..+++|+.|+|++|.+.+..+       ..+..+++|+.||+++|++.+.
T Consensus       224 ~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             CTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             CCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            3578888888888876443    344666788888888888554433       2456677788888888887654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.5e-25  Score=232.22  Aligned_cols=250  Identities=17%  Similarity=0.169  Sum_probs=127.1

Q ss_pred             CCCEEECCCCcCcccCCccccCC--CCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           30 NLEELLLGQNNLVGVVPAAIFDV--STLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        30 ~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      .++.|++++|++.   +..+..+  ++++.|++++|.+++..+.                  +.++++|++|+|++|.++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~------------------~~~~~~L~~L~L~~~~l~  106 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE------------------HFSPFRVQHMDLSNSVIE  106 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS------------------CCCCBCCCEEECTTCEEC
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh------------------hccCCCCCEEEccCCCcC
Confidence            4556666666554   3444444  5566666666655543331                  234555555555555554


Q ss_pred             cc-CCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCc-ccccc-CCccccCCCCCcEEecccC-ccccc
Q 041689          108 GI-LPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGN-KLNGS-IPFTLRELQKLQYVGLKDN-KLEGT  183 (652)
Q Consensus       108 ~~-~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~  183 (652)
                      +. .+. .+..+++ |++|+|++|++++..+..+..+++|++|+|++| .+++. .+..+.++++|++|++++| .+++.
T Consensus       107 ~~~~~~-~~~~~~~-L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~  184 (336)
T 2ast_B          107 VSTLHG-ILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK  184 (336)
T ss_dssp             HHHHHH-HHTTBCC-CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH
T ss_pred             HHHHHH-HHhhCCC-CCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH
Confidence            32 222 3344443 555555555555445555555555555555555 34431 3334445555555555555 55432


Q ss_pred             -cCccccCCC-CCcEEEccCC--ccc-ccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEeccccc-CCccCccc
Q 041689          184 -IPYDIFRLV-KLYKLDLGGN--KLS-GSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNN-FSSVIPTT  257 (652)
Q Consensus       184 -~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~-l~~~~~~~  257 (652)
                       ++..+..++ +|++|++++|  .++ +..                      |..+..+++|+.|++++|. +++..+..
T Consensus       185 ~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l----------------------~~~~~~~~~L~~L~l~~~~~l~~~~~~~  242 (336)
T 2ast_B          185 HVQVAVAHVSETITQLNLSGYRKNLQKSDL----------------------STLVRRCPNLVHLDLSDSVMLKNDCFQE  242 (336)
T ss_dssp             HHHHHHHHSCTTCCEEECCSCGGGSCHHHH----------------------HHHHHHCTTCSEEECTTCTTCCGGGGGG
T ss_pred             HHHHHHHhcccCCCEEEeCCCcccCCHHHH----------------------HHHHhhCCCCCEEeCCCCCcCCHHHHHH
Confidence             334444455 5555555555  222 222                      3334445555555555555 44445556


Q ss_pred             ccCCCCCcEEEccCCc-CCCcccccccccccCcceeccccccCCCCchhhcCC-CCCceEEeecCcCcccCCC
Q 041689          258 IGSLKDLQYLFLGYNI-LKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKL-SYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       258 ~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~  328 (652)
                      +..+++|++|++++|. +.......+..+++|+.|++++| ++.   ..+..+ ..+..|++++|.+++..|.
T Consensus       243 l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          243 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             HhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence            6666677777777664 22111124566677777777766 332   122222 2355555677777766554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=8.4e-24  Score=209.39  Aligned_cols=178  Identities=22%  Similarity=0.242  Sum_probs=84.9

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +.+.+++++|.++.++..     ++.+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus        15 ~~~~l~~~~~~l~~~p~~-----~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   89 (251)
T 3m19_A           15 GKKEVDCQGKSLDSVPSG-----IPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG   89 (251)
T ss_dssp             GGTEEECTTCCCSSCCSC-----CCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCeEEecCCCCccccCCC-----CCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEE
Confidence            345555666655554432     122355555555555555555555555555555555555544444455555555555


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      |++|+|++..+..|..+++|++|+|++|+|+++.+..|..                      +++|+.|+|++|+++++.
T Consensus        90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------------------l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR----------------------LTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT----------------------CTTCCEEECCSSCCCCCC
T ss_pred             CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhcc----------------------CCcccEEECcCCcCCccC
Confidence            5555554433344444444444444444444333222222                      223333333344444444


Q ss_pred             cccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccC
Q 041689          255 PTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       255 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      +..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  192 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD  192 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence            444555555555555555555444444455555555555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=1.1e-24  Score=222.91  Aligned_cols=222  Identities=18%  Similarity=0.201  Sum_probs=186.0

Q ss_pred             CcEEEccCCcccccCCc---cccCCCCCCEEEecCccccccCCccc--cCCCCCcEEecccCccccccC----ccccCCC
Q 041689          122 LEIFDMSKCNVSGGIPE---EIGNLTNLTAIYLGGNKLNGSIPFTL--RELQKLQYVGLKDNKLEGTIP----YDIFRLV  192 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~  192 (652)
                      ++.|.+.++.++...-.   .+..+++|++|+|++|.+++..|..+  ..+++|++|+|++|++++..+    ..+..++
T Consensus        66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~  145 (310)
T 4glp_A           66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP  145 (310)
T ss_dssp             CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred             eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence            78888888887632111   13345779999999999999999888  999999999999999997655    4556799


Q ss_pred             CCcEEEccCCcccccccccCCCCCCCCEEEccCCCCC----C--CcccCCCCccceEecccccCCccCcc---cccCCCC
Q 041689          193 KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP----L--PLEIGNLKVLIGIDFSMNNFSSVIPT---TIGSLKD  263 (652)
Q Consensus       193 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~----~--~~~~~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~  263 (652)
                      +|++|+|++|++++..+..|..+++|++|+|++|+..    +  +..++.+++|++|++++|+++...+.   .+..+++
T Consensus       146 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~  225 (310)
T 4glp_A          146 GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQ  225 (310)
T ss_dssp             CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCC
T ss_pred             CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCC
Confidence            9999999999999999999999999999999999722    3  23357899999999999999853221   3578899


Q ss_pred             CcEEEccCCcCCCccccccccc---ccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccc
Q 041689          264 LQYLFLGYNILKGSIPDSVGDL---ISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESF  340 (652)
Q Consensus       264 L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~  340 (652)
                      |++|+|++|+|++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|++++. |....++.++.+++
T Consensus       226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L  301 (310)
T 4glp_A          226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTL  301 (310)
T ss_dssp             CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEEC
T ss_pred             CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEEC
Confidence            9999999999998878888777   69999999999999 6676664  7999999999999975 44678899999999


Q ss_pred             cCCccCC
Q 041689          341 EGNKLLC  347 (652)
Q Consensus       341 ~~N~~~c  347 (652)
                      ++|++..
T Consensus       302 ~~N~l~~  308 (310)
T 4glp_A          302 DGNPFLV  308 (310)
T ss_dssp             SSTTTSC
T ss_pred             cCCCCCC
Confidence            9999854

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.91  E-value=6.2e-24  Score=216.90  Aligned_cols=195  Identities=19%  Similarity=0.279  Sum_probs=171.4

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      +.++++|++|++++|.++.++   .+..+++ |++|+|++|++++..+  +..+++|++|+|++|++++.  ..+..+++
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l~---~~~~l~~-L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~  108 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTTIE---GVQYLNN-LIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQS  108 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCCCT---TGGGCTT-CCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTT
T ss_pred             HHHcCCcCEEEeeCCCccCch---hhhccCC-CCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCC
Confidence            557889999999999998763   4677776 9999999999997655  99999999999999999964  36999999


Q ss_pred             CcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEeccccc
Q 041689          170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNN  249 (652)
Q Consensus       170 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~  249 (652)
                      |++|+|++|++++. + .+..+++|++|++++|++++..+  +..+++|++|++++|.......+..+++|+.|++++|+
T Consensus       109 L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          109 IKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK  184 (308)
T ss_dssp             CCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred             CCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCc
Confidence            99999999999964 4 38999999999999999997665  89999999999999973333339999999999999999


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      +++..+  +..+++|++|+|++|++++..+  +..+++|+.|+|++|++++
T Consensus       185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            997644  8899999999999999996553  8999999999999999984

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=4.9e-26  Score=240.58  Aligned_cols=238  Identities=25%  Similarity=0.277  Sum_probs=187.2

Q ss_pred             cccCCCCCCcEEEcccCCCcccCCcc---chhcccccCcEEEccCCc---ccccCCccc-------cCCCCCCEEEecCc
Q 041689           88 SSLSNCKSLVVFLLSNNPLNGILPRM---SIGNLSHSLEIFDMSKCN---VSGGIPEEI-------GNLTNLTAIYLGGN  154 (652)
Q Consensus        88 ~~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~L~~L~L~~N~---l~~~~~~~~-------~~l~~L~~L~L~~N  154 (652)
                      ..+..+++|++|+|++|.+++..+..   .+..+++ |++|+|++|.   +++.+|..+       ..+++|++|+|++|
T Consensus        26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~-L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n  104 (386)
T 2ca6_A           26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD-LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  104 (386)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTT-CCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCC-ccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence            34667889999999999998754331   2445665 9999999964   444555555       78899999999999


Q ss_pred             cccc----cCCccccCCCCCcEEecccCccccccCccccC----C---------CCCcEEEccCCccc-cccc---ccCC
Q 041689          155 KLNG----SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR----L---------VKLYKLDLGGNKLS-GSIL---TCFS  213 (652)
Q Consensus       155 ~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~N~l~-~~~~---~~~~  213 (652)
                      +++.    .++..+..+++|++|+|++|.|+...+..+..    +         ++|++|+|++|+++ ...+   ..+.
T Consensus       105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  184 (386)
T 2ca6_A          105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  184 (386)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH
Confidence            9986    46778899999999999999997554444443    3         89999999999997 3344   4677


Q ss_pred             CCCCCCEEEccCCCCC-------CCcccCCCCccceEecccccCC----ccCcccccCCCCCcEEEccCCcCCCc----c
Q 041689          214 NLASLRTLSLSYNDGP-------LPLEIGNLKVLIGIDFSMNNFS----SVIPTTIGSLKDLQYLFLGYNILKGS----I  278 (652)
Q Consensus       214 ~l~~L~~L~Ls~N~~~-------~~~~~~~l~~L~~L~ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~  278 (652)
                      .+++|++|+|++|...       .+..+..+++|+.|+|++|.++    ..+|..+..+++|++|+|++|.+++.    +
T Consensus       185 ~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l  264 (386)
T 2ca6_A          185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  264 (386)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHH
Confidence            8889999999999633       3337888999999999999985    55677888899999999999999865    4


Q ss_pred             cccc--cccccCcceeccccccCC----CCchhh-cCCCCCceEEeecCcCcccC
Q 041689          279 PDSV--GDLISLKSLNFSNNNLSG----AIPLLL-EKLSYLEHLNLSFNKLEGEI  326 (652)
Q Consensus       279 p~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~  326 (652)
                      +..+  +.+++|+.|+|++|++++    .+|..+ .++++|+.|++++|++++..
T Consensus       265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            5666  338899999999999986    367666 66899999999999988554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=2.3e-25  Score=230.75  Aligned_cols=255  Identities=16%  Similarity=0.204  Sum_probs=193.0

Q ss_pred             eeeeceeEeccCCCcCCccCCCCC-CC--CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeec-cCCCcccccc
Q 041689            3 SISIGKLELNVDDIESPCEIPSEI-NP--HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGS-LSSIADNYLT   78 (652)
Q Consensus         3 ~~~l~~l~l~~~~~~~~~~ip~~~-~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~   78 (652)
                      |..++.++++.+.+.     |..+ .+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++. .+        
T Consensus        46 ~~~~~~l~l~~~~~~-----~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~--------  111 (336)
T 2ast_B           46 ESLWQTLDLTGKNLH-----PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH--------  111 (336)
T ss_dssp             STTSSEEECTTCBCC-----HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH--------
T ss_pred             chhheeeccccccCC-----HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH--------
Confidence            344788888887766     2223 33  7999999999999987665 56899999999999998743 22        


Q ss_pred             CCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCC-ccccc-CCccccCCCCCCEEEecCc-c
Q 041689           79 SSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKC-NVSGG-IPEEIGNLTNLTAIYLGGN-K  155 (652)
Q Consensus        79 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~  155 (652)
                               ..+.++++|++|+|++|.+++..+. .++.+++ |++|+|++| .+++. ++..+.++++|++|+|++| .
T Consensus       112 ---------~~~~~~~~L~~L~L~~~~l~~~~~~-~l~~~~~-L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~  180 (336)
T 2ast_B          112 ---------GILSQCSKLQNLSLEGLRLSDPIVN-TLAKNSN-LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  180 (336)
T ss_dssp             ---------HHHTTBCCCSEEECTTCBCCHHHHH-HHTTCTT-CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             ---------HHHhhCCCCCEEeCcCcccCHHHHH-HHhcCCC-CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence                     2467899999999999999876665 6777776 999999999 78863 6777999999999999999 9


Q ss_pred             cccc-CCccccCCC-CCcEEecccC--ccc-cccCccccCCCCCcEEEccCCc-ccccccccCCCCCCCCEEEccCCCCC
Q 041689          156 LNGS-IPFTLRELQ-KLQYVGLKDN--KLE-GTIPYDIFRLVKLYKLDLGGNK-LSGSILTCFSNLASLRTLSLSYNDGP  229 (652)
Q Consensus       156 l~~~-~~~~~~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~~~  229 (652)
                      +++. .+..+..++ +|++|+|++|  .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|++|++++|...
T Consensus       181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~  260 (336)
T 2ast_B          181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI  260 (336)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred             cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence            9854 577789999 9999999999  455 4667788889999999999999 77777778888888888888877422


Q ss_pred             CCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccc-cCcceeccccccCCCCchhhc
Q 041689          230 LPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI-SLKSLNFSNNNLSGAIPLLLE  307 (652)
Q Consensus       230 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~  307 (652)
                      .+..                     ...+..+++|+.|++++| ++   ...+..+. +|..|++++|++++..|..+.
T Consensus       261 ~~~~---------------------~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          261 IPET---------------------LLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             CGGG---------------------GGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CHHH---------------------HHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            2211                     123445666666666666 22   22344442 366677777777776666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.1e-24  Score=215.60  Aligned_cols=166  Identities=15%  Similarity=0.086  Sum_probs=130.2

Q ss_pred             cHHHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccc------------------hhhhhHHHHHHHHHh
Q 041689          416 SYLEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG------------------RAFKSFDIECEIMKS  477 (652)
Q Consensus       416 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~  477 (652)
                      .+..+......|.+.+.||+|+||.||+|++.+|+.||+|+++....                  .....+.+|++++++
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            34455566677888899999999999999997799999999964321                  134568899999999


Q ss_pred             cCCCeeeeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          478 IHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       478 l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                      ++|   +++.+++.. +..++||||++|++|.+ +..       .+...++.|++.||+|||++   ||+||||||+||+
T Consensus       161 l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL  225 (282)
T 1zar_A          161 LQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL  225 (282)
T ss_dssp             TTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             ccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence            994   555554433 55699999999999998 432       12446999999999999999   9999999999999


Q ss_pred             eCCCCcEEEecccCCccccCCCCccccccccCCccccCcccccc----------CccCcccchhh
Q 041689          558 LDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE----------GRVFANGDVYS  612 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDvws  612 (652)
                      ++ ++.+||+|||+++..               ..|+|||++..          ..|+..+|+|.
T Consensus       226 l~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EE-TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EE-CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99 999999999999742               34788997653          34556667664

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.89  E-value=8.7e-23  Score=195.98  Aligned_cols=182  Identities=23%  Similarity=0.224  Sum_probs=142.8

Q ss_pred             eceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcc
Q 041689            6 IGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELS   85 (652)
Q Consensus         6 l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~   85 (652)
                      .+.++.+.+.+.   ++|..+ +++|++|+|++|+++++.+..|.++++|++|+|++|+|+++++.              
T Consensus         9 ~~~v~c~~~~l~---~~p~~~-~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------------   70 (208)
T 2o6s_A            9 GTTVECYSQGRT---SVPTGI-PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG--------------   70 (208)
T ss_dssp             TTEEECCSSCCS---SCCSCC-CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT--------------
T ss_pred             CCEEEecCCCcc---CCCCCC-CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh--------------
Confidence            455666666655   688777 67899999999999887777888899999999999988865542              


Q ss_pred             cccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcccc
Q 041689           86 FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLR  165 (652)
Q Consensus        86 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  165 (652)
                         .|.++++|++|+|++|+++++++. .+..+++ |++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.
T Consensus        71 ---~~~~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  145 (208)
T 2o6s_A           71 ---VFNKLTSLTYLNLSTNQLQSLPNG-VFDKLTQ-LKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD  145 (208)
T ss_dssp             ---TTTTCTTCCEEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ---hcCCCCCcCEEECCCCcCCccCHh-HhcCccC-CCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhc
Confidence               367788889999999988877665 5677776 88888888888877777788888888888888888877777788


Q ss_pred             CCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCC
Q 041689          166 ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLAS  217 (652)
Q Consensus       166 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  217 (652)
                      .+++|++|+|++|.+.+.       +++|++|+++.|+++|.+|..++.++.
T Consensus       146 ~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          146 RLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             cCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccCccccC
Confidence            888888888888877643       346788888888888887777665543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=4.1e-22  Score=191.28  Aligned_cols=130  Identities=22%  Similarity=0.204  Sum_probs=71.1

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +|++|+|++|+++++++. .+..+++ |++|++++|+|+++.+..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  106 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNG-VFDELTS-LTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA  106 (208)
T ss_dssp             TCSEEECCSSCCCCCCTT-TTTTCTT-CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCcEEEcCCCccCcCChh-hhccccc-CcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence            455556666655555443 3444443 55555555555555444555555555555555555554444555555555555


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  226 (652)
                      |++|+|++..+..|..+++|++|+|++|+++++.+..|..+++|++|++++|
T Consensus       107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  158 (208)
T 2o6s_A          107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN  158 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred             cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence            5555555444444555555555555555555554444555555555555554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.88  E-value=3.3e-24  Score=239.80  Aligned_cols=233  Identities=15%  Similarity=0.109  Sum_probs=139.4

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCcccc-ccCCccccC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLN-GSIPFTLRE  166 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~  166 (652)
                      .+..+++|+.|+++++....+ +. .+..+++ |++|+|++|.+++... ..+..+++|++|+|+ |.+. ..++..+..
T Consensus       265 ~l~~~~~L~~L~l~~~~~~~l-~~-~~~~~~~-L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~  340 (592)
T 3ogk_B          265 NLVFPRKLCRLGLSYMGPNEM-PI-LFPFAAQ-IRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQY  340 (592)
T ss_dssp             CCCCCTTCCEEEETTCCTTTG-GG-GGGGGGG-CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHH
T ss_pred             HhhccccccccCccccchhHH-HH-HHhhcCC-CcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHh
Confidence            455566666666666543332 22 3445554 7777777777654433 335677777777777 3333 223333456


Q ss_pred             CCCCcEEecc-----------cCccccccC-ccccCCCCCcEEEccCCcccccccccCCC-CCCCCEEEcc----CCC-C
Q 041689          167 LQKLQYVGLK-----------DNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSILTCFSN-LASLRTLSLS----YND-G  228 (652)
Q Consensus       167 l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~-~  228 (652)
                      +++|++|+|+           .|.+++... ..+..+++|++|+++.|.+++..+..+.. +++|++|+++    .|. .
T Consensus       341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~  420 (592)
T 3ogk_B          341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT  420 (592)
T ss_dssp             CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred             CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence            6777777777           356654322 22344677777777777777655555554 7777777775    332 2


Q ss_pred             CCC------cccCCCCccceEecccc--cCCccCccccc-CCCCCcEEEccCCcCCC-cccccccccccCcceecccccc
Q 041689          229 PLP------LEIGNLKVLIGIDFSMN--NFSSVIPTTIG-SLKDLQYLFLGYNILKG-SIPDSVGDLISLKSLNFSNNNL  298 (652)
Q Consensus       229 ~~~------~~~~~l~~L~~L~ls~N--~l~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l  298 (652)
                      ..|      ..+.++++|+.|+++.|  .+++..+..+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|.+
T Consensus       421 ~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l  500 (592)
T 3ogk_B          421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF  500 (592)
T ss_dssp             SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred             CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence            111      22555777777777643  35543333333 36777777777777765 2344456677777777777777


Q ss_pred             CCC-CchhhcCCCCCceEEeecCcCccc
Q 041689          299 SGA-IPLLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       299 ~~~-~~~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      ++. ++..+..+++|+.|+|++|+++..
T Consensus       501 ~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          501 SERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             BHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             cHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            543 334445677777777777777643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.87  E-value=6.3e-25  Score=245.67  Aligned_cols=39  Identities=8%  Similarity=-0.024  Sum_probs=17.5

Q ss_pred             cccCcceeccccccCC-CCchhhcCCCCCceEEeecCcCc
Q 041689          285 LISLKSLNFSNNNLSG-AIPLLLEKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       285 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~  323 (652)
                      +++|+.|+|++|++++ .++..+..+++|+.|++++|+++
T Consensus       462 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          462 SPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             CTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             CccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            3444444554444443 12233344445555555555443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.87  E-value=6.7e-22  Score=206.63  Aligned_cols=174  Identities=26%  Similarity=0.206  Sum_probs=120.7

Q ss_pred             CEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccC-CCCCCcEEEcccCCCcccC
Q 041689           32 EELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLS-NCKSLVVFLLSNNPLNGIL  110 (652)
Q Consensus        32 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~  110 (652)
                      +.+++++|+++. +|..+.  +.++.|+|++|+|+++.+.                 .|. ++++|++|+|++|+|+++.
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~-----------------~~~~~l~~L~~L~L~~N~i~~i~   80 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAE-----------------WTPTRLTNLHSLLLSHNHLNFIS   80 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTT-----------------SSSSCCTTCCEEECCSSCCCEEC
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChh-----------------hhhhcccccCEEECCCCcCCccC
Confidence            567777777764 454443  3467777777777665543                 244 6677777777777777776


Q ss_pred             CccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc--
Q 041689          111 PRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI--  188 (652)
Q Consensus       111 ~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~--  188 (652)
                      +. .|..+++ |++|+|++|+|+++.+..|.++++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|  
T Consensus        81 ~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~  158 (361)
T 2xot_A           81 SE-AFVPVPN-LRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD  158 (361)
T ss_dssp             TT-TTTTCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-
T ss_pred             hh-hccCCCC-CCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcC
Confidence            65 5666665 7777777777777767777777777777777777777777777777777777777777774433334  


Q ss_pred             -cCCCCCcEEEccCCcccccccccCCCCCC--CCEEEccCCC
Q 041689          189 -FRLVKLYKLDLGGNKLSGSILTCFSNLAS--LRTLSLSYND  227 (652)
Q Consensus       189 -~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~Ls~N~  227 (652)
                       ..+++|+.|+|++|+|+++.+..|..++.  |+.|+|++|.
T Consensus       159 ~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             ---CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence             45777888888888887776677777766  3778888874

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=1.1e-21  Score=214.99  Aligned_cols=187  Identities=20%  Similarity=0.256  Sum_probs=144.1

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +|+.|+|++|.|+++++.  +.  + +|++|+|++|+|+. +|   ..+++|++|+|++|+|++ +|. |.+  +|++|+
T Consensus        60 ~L~~L~Ls~n~L~~lp~~--l~--~-~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~  126 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDN--LP--P-QITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLD  126 (571)
T ss_dssp             TCSEEECCSSCCSCCCSC--CC--T-TCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEE
T ss_pred             CccEEEeCCCCCCccCHh--Hc--C-CCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEE
Confidence            899999999999986554  21  3 49999999999984 55   457899999999999987 555 655  899999


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCcc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                      |++|+|++ +|.   .+++|+.|+|++|+|++++ .   .+++|++|+|++|. ..+|. +.  ++|+.|+|++|+|+. 
T Consensus       127 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp-~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~~-  194 (571)
T 3cvr_A          127 VDNNQLTM-LPE---LPALLEYINADNNQLTMLP-E---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLES-  194 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSS-
T ss_pred             CCCCcCCC-CCC---cCccccEEeCCCCccCcCC-C---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCCc-
Confidence            99999986 565   5788999999999998744 3   56788888888886 44666 55  788888888888885 


Q ss_pred             CcccccCCCCC-------cEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCC
Q 041689          254 IPTTIGSLKDL-------QYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS  310 (652)
Q Consensus       254 ~~~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  310 (652)
                      +|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus       195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          195 LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            444 554  66       88888888888 5677777788888888888888887777776543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=2.7e-21  Score=211.89  Aligned_cols=181  Identities=23%  Similarity=0.297  Sum_probs=153.8

Q ss_pred             cCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEcc
Q 041689          121 SLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG  200 (652)
Q Consensus       121 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  200 (652)
                      +|+.|+|++|+|++ +|..+  .++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            49999999999997 55544  389999999999999 455   457999999999999996 776 665  99999999


Q ss_pred             CCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccc
Q 041689          201 GNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIP  279 (652)
Q Consensus       201 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  279 (652)
                      +|+|++++ .   .+++|+.|+|++|. ..+|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+|
T Consensus       129 ~N~l~~lp-~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp  196 (571)
T 3cvr_A          129 NNQLTMLP-E---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP  196 (571)
T ss_dssp             SSCCSCCC-C---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred             CCcCCCCC-C---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence            99999844 4   68999999999997 44665   67899999999999998 555 66  89999999999999 666


Q ss_pred             ccccccccC-------cceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC
Q 041689          280 DSVGDLISL-------KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       280 ~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  328 (652)
                      . |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|.
T Consensus       197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            6 665  77       99999999999 5777777899999999999999987664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=7.2e-22  Score=191.11  Aligned_cols=156  Identities=22%  Similarity=0.267  Sum_probs=107.3

Q ss_pred             CEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCC
Q 041689          147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       147 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  226 (652)
                      +.+++++|.++. +|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|        
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L--------   82 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL--------   82 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC--------
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC--------
Confidence            456777777763 343332  456666666666665555566666666666666666665555555555554        


Q ss_pred             CCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhh
Q 041689          227 DGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLL  306 (652)
Q Consensus       227 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  306 (652)
                                    +.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|
T Consensus        83 --------------~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  148 (220)
T 2v9t_B           83 --------------NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF  148 (220)
T ss_dssp             --------------CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             --------------CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHH
Confidence                          555555566666666667777888888888888887777778888888888888888887777777


Q ss_pred             cCCCCCceEEeecCcCcccCC
Q 041689          307 EKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       307 ~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      ..+++|+.|+|++|+|.|...
T Consensus       149 ~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          149 SPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             TTCTTCCEEECCSSCEECSGG
T ss_pred             hCCCCCCEEEeCCCCcCCCCc
Confidence            888888888888888876543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=5.6e-22  Score=200.56  Aligned_cols=192  Identities=25%  Similarity=0.356  Sum_probs=115.5

Q ss_pred             CCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcE
Q 041689           93 CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY  172 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  172 (652)
                      +.++..+.+..+.+++..+   ...+++ |+.|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++
T Consensus        23 l~~~~~~~l~~~~~~~~~~---~~~l~~-L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~   94 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGW   94 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEEC---HHHHHT-CCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HHHHHHHHhcCCCcccccc---hhhcCc-ccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCE
Confidence            3445555666666665432   345554 77777777777754 2 36777777777777777775444  777777777


Q ss_pred             EecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCc
Q 041689          173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       173 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      |+|++|++++ +| .+..+++|++|+|++|++++.  ..+..+++|++|++++                      |++++
T Consensus        95 L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~----------------------n~l~~  148 (291)
T 1h6t_A           95 LFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGN----------------------NKITD  148 (291)
T ss_dssp             EECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCS----------------------SCCCC
T ss_pred             EECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccC----------------------CcCCc
Confidence            7777777764 33 366677777777777777643  2344555555555554                      44444


Q ss_pred             cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcc
Q 041689          253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG  324 (652)
Q Consensus       253 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  324 (652)
                      .  ..+..+++|++|+|++|++++..|  +..+++|+.|+|++|+|++. + .+..+++|+.|++++|+++.
T Consensus       149 ~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          149 I--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             c--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            3  345555556666666665554333  55555666666666666532 2 25556666666666666554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=6.5e-22  Score=191.41  Aligned_cols=156  Identities=23%  Similarity=0.240  Sum_probs=114.7

Q ss_pred             CEEEecCccccccCCccccCCCCCcEEecccCccccccC-ccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccC
Q 041689          147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSY  225 (652)
Q Consensus       147 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  225 (652)
                      +.+++++|.++. +|..+.  +.+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|..+++|       
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L-------   83 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV-------   83 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC-------
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC-------
Confidence            477778887774 444432  245677777777775544 346677777777777777776665555555555       


Q ss_pred             CCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchh
Q 041689          226 NDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL  305 (652)
Q Consensus       226 N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  305 (652)
                                     +.|+|++|+++++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..
T Consensus        84 ---------------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  148 (220)
T 2v70_A           84 ---------------NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGA  148 (220)
T ss_dssp             ---------------CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTT
T ss_pred             ---------------CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHH
Confidence                           45555566677777777888888888888888888777888888888888888888888777888


Q ss_pred             hcCCCCCceEEeecCcCcccCC
Q 041689          306 LEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       306 ~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |..+++|+.|+|++|+|+|.++
T Consensus       149 ~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          149 FDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTTCTTCCEEECCSCCEECSGG
T ss_pred             hcCCCCCCEEEecCcCCcCCCc
Confidence            8888888888888888887665

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=3.6e-21  Score=194.65  Aligned_cols=191  Identities=22%  Similarity=0.293  Sum_probs=137.5

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG  201 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  201 (652)
                      +..+.+..+.++...+  +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|+|++
T Consensus        26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~   99 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE   99 (291)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence            4444555665554322  34566666666666666633 2 25566666666666666664332  55556666666666


Q ss_pred             CcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccc
Q 041689          202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS  281 (652)
Q Consensus       202 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  281 (652)
                      |++++                        +..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.  ..
T Consensus       100 n~l~~------------------------~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~  151 (291)
T 1h6t_A          100 NKVKD------------------------LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV  151 (291)
T ss_dssp             SCCCC------------------------GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred             CcCCC------------------------ChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh
Confidence            65553                        22355566666777777777764  4688899999999999999965  57


Q ss_pred             ccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCC
Q 041689          282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       282 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~  349 (652)
                      +..+++|+.|+|++|++++..+  +..+++|+.|++++|.+++. |....+.+++.+++.+|++.+.+
T Consensus       152 l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~~~~  216 (291)
T 1h6t_A          152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNKP  216 (291)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEECCC
T ss_pred             hccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCcccCCc
Confidence            9999999999999999997665  89999999999999999975 55788899999999999987643

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=5.8e-21  Score=184.69  Aligned_cols=114  Identities=23%  Similarity=0.250  Sum_probs=64.6

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      |.++++|++|+|++|+|+++.+. .|..+++ |++|+|++|+|+.+.+..|.++++|++|+|++|+|++..|..|..+++
T Consensus        52 ~~~l~~L~~L~Ls~N~i~~~~~~-~~~~l~~-L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  129 (220)
T 2v9t_B           52 FSPYKKLRRIDLSNNQISELAPD-AFQGLRS-LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN  129 (220)
T ss_dssp             STTCTTCCEEECCSSCCCEECTT-TTTTCSS-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hhCCCCCCEEECCCCcCCCcCHH-HhhCCcC-CCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCC
Confidence            44445555555555555554444 4444443 555555555555444455555666666666666666555555666666


Q ss_pred             CcEEecccCccccccCccccCCCCCcEEEccCCccc
Q 041689          170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       170 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  205 (652)
                      |++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       130 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          130 LNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            666666666666555555556666666666666654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=2.1e-21  Score=202.85  Aligned_cols=177  Identities=27%  Similarity=0.231  Sum_probs=136.1

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCcccc-CCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG-NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      -+.+++++|.|+.++..     ++..++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus        20 ~~~l~c~~~~l~~iP~~-----~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~   94 (361)
T 2xot_A           20 SNILSCSKQQLPNVPQS-----LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLD   94 (361)
T ss_dssp             TTEEECCSSCCSSCCSS-----CCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCEEEeCCCCcCccCcc-----CCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEE
Confidence            36889999999877553     344588999999999988888887 889999999999999888888888899999999


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      |++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|                      +|+++.
T Consensus        95 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N----------------------~l~~l~  152 (361)
T 2xot_A           95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN----------------------QISRFP  152 (361)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS----------------------CCCSCC
T ss_pred             CCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCC----------------------cCCeeC
Confidence            9999998777777888888888888888888777777777766666666655                      454444


Q ss_pred             cccc---cCCCCCcEEEccCCcCCCccccccccccc--CcceeccccccC
Q 041689          255 PTTI---GSLKDLQYLFLGYNILKGSIPDSVGDLIS--LKSLNFSNNNLS  299 (652)
Q Consensus       255 ~~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~  299 (652)
                      +..|   ..+++|+.|+|++|+|++..+..+..++.  |+.|+|++|.+.
T Consensus       153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            4444   45777777888888777655566777766  477888888876

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.85  E-value=1.2e-21  Score=216.91  Aligned_cols=192  Identities=19%  Similarity=0.234  Sum_probs=110.0

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      +.++..+.++.+.++.+.+  +..+++|+.|+|++|.|+.+.                   .+..+++|+.|+|++|+|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-------------------~l~~l~~L~~L~Ls~N~l~   78 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-------------------GIQYLPNVTKLFLNGNKLT   78 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-------------------TGGGCTTCCEEECTTSCCC
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-------------------HHccCCCCCEEEeeCCCCC
Confidence            3445555666666654433  455666666666666664321                   2455666666666666666


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD  187 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  187 (652)
                      ++++   +..+++ |+.|+|++|+|++.  +.+..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|+|++.  ..
T Consensus        79 ~~~~---l~~l~~-L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~  148 (605)
T 1m9s_A           79 DIKP---LTNLKN-LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV  148 (605)
T ss_dssp             CCGG---GGGCTT-CCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GG
T ss_pred             CChh---hccCCC-CCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hh
Confidence            5543   445554 66666666666642  2466666666666666666642  2456666666666666666643  45


Q ss_pred             ccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCc
Q 041689          188 IFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       188 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      +..+++|+.|+|++|+|++..|  +..+++|+.|+|++|...-...+..+++|+.|+|++|.+.+
T Consensus       149 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          149 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCSEEEEC
T ss_pred             hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCChHHccCCCCCEEEccCCcCcC
Confidence            6666666666666666665544  55666666666666542222345555555555555555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=1.1e-20  Score=182.64  Aligned_cols=131  Identities=20%  Similarity=0.219  Sum_probs=88.1

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEec
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL  175 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  175 (652)
                      +++|+|++|+|+++.+...|..+++ |++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~-L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  112 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQ-LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML  112 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTT-CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEEC
T ss_pred             CCEEEcCCCcCCccCchhhhccCCC-CCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEEC
Confidence            4667777777776654434566665 777777777777666666777777777777777776666666677777777777


Q ss_pred             ccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      ++|+|++..|..|..+++|++|+|++|+|+++.|..|..+++|++|+|++|.
T Consensus       113 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  164 (220)
T 2v70_A          113 RSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP  164 (220)
T ss_dssp             TTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence            7777776666666667777777777777766666666666666666666653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.84  E-value=6.9e-21  Score=210.93  Aligned_cols=194  Identities=23%  Similarity=0.323  Sum_probs=139.9

Q ss_pred             CCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCc
Q 041689           92 NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ  171 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  171 (652)
                      .+.++..+.++.+.+.++.+   +..++. |+.|++++|.|..+ + .+..+++|+.|+|++|+|++..+  +..+++|+
T Consensus        19 ~l~~l~~l~l~~~~i~~~~~---~~~L~~-L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~   90 (605)
T 1m9s_A           19 AFAETIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLG   90 (605)
T ss_dssp             HHHHHHHHHTTCSCTTSEEC---HHHHTT-CCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCC
T ss_pred             HHHHHHHHhccCCCcccccc---hhcCCC-CCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCC
Confidence            34566677788888776643   455665 88888888888854 3 57888888888888888886555  78888888


Q ss_pred             EEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCC
Q 041689          172 YVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFS  251 (652)
Q Consensus       172 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~  251 (652)
                      .|+|++|+|++ +| .+..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|.......+..+++|+.|+|++|+|+
T Consensus        91 ~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           91 WLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             EEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGSCTTCSEEECCSSCCC
T ss_pred             EEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCchhhcccCCCCEEECcCCcCC
Confidence            88888888874 33 677888888888888888754  347777777777777776333356677777777777777777


Q ss_pred             ccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCC
Q 041689          252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGA  301 (652)
Q Consensus       252 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  301 (652)
                      +..|  +..+++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.
T Consensus       167 ~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          167 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECC
T ss_pred             Cchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCC
Confidence            6544  66777777777777777643 3 466677777777777777643

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=3.8e-20  Score=180.23  Aligned_cols=151  Identities=24%  Similarity=0.289  Sum_probs=83.0

Q ss_pred             ceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCccc
Q 041689            7 GKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSF   86 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~   86 (652)
                      +.++.+.+.+.   ++|..+ +++|++|+|++|+|+++.|..|.++++|++|+|++|+|+.+++.               
T Consensus        22 ~~v~c~~~~l~---~ip~~~-~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~---------------   82 (229)
T 3e6j_A           22 TTVDCRSKRHA---SVPAGI-PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG---------------   82 (229)
T ss_dssp             TEEECTTSCCS---SCCSCC-CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT---------------
T ss_pred             CEeEccCCCcC---ccCCCC-CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChh---------------
Confidence            34444444444   566555 45666666666666666566666666666666666666544332               


Q ss_pred             ccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccC
Q 041689           87 LSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRE  166 (652)
Q Consensus        87 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  166 (652)
                        .|.++++|++|+|++|+|+++++. .+..+++ |++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..
T Consensus        83 --~~~~l~~L~~L~Ls~N~l~~l~~~-~~~~l~~-L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  157 (229)
T 3e6j_A           83 --VFDSLTQLTVLDLGTNQLTVLPSA-VFDRLVH-LKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR  157 (229)
T ss_dssp             --TTTTCTTCCEEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred             --hcccCCCcCEEECCCCcCCccChh-HhCcchh-hCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhC
Confidence              245555666666666666555443 3444443 555555555555 34445555555555555555555444444555


Q ss_pred             CCCCcEEecccCccc
Q 041689          167 LQKLQYVGLKDNKLE  181 (652)
Q Consensus       167 l~~L~~L~L~~N~l~  181 (652)
                      +++|+.|+|++|.+.
T Consensus       158 l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          158 LSSLTHAYLFGNPWD  172 (229)
T ss_dssp             CTTCCEEECTTSCBC
T ss_pred             CCCCCEEEeeCCCcc
Confidence            555555555555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=7.3e-20  Score=178.16  Aligned_cols=156  Identities=25%  Similarity=0.309  Sum_probs=109.6

Q ss_pred             CCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccC
Q 041689          146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSY  225 (652)
Q Consensus       146 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  225 (652)
                      -+.++.++|.++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|+.+.+..|             
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~-------------   84 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF-------------   84 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc-------------
Confidence            455666666666 3333222  556666666666665555556666666666666666654444444             


Q ss_pred             CCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchh
Q 041689          226 NDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL  305 (652)
Q Consensus       226 N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  305 (652)
                               ..+++|+.|+|++|+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..
T Consensus        85 ---------~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~  154 (229)
T 3e6j_A           85 ---------DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA  154 (229)
T ss_dssp             ---------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred             ---------ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence                     44555555666667777777777888888888888888888 67788888888889999999888777777


Q ss_pred             hcCCCCCceEEeecCcCcccCC
Q 041689          306 LEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       306 ~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |..+++|+.|+|++|++.|.++
T Consensus       155 ~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          155 FDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTCTTCCEEECTTSCBCTTBG
T ss_pred             HhCCCCCCEEEeeCCCccCCcc
Confidence            8888889999999998887765

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.82  E-value=1.3e-22  Score=227.00  Aligned_cols=250  Identities=12%  Similarity=0.066  Sum_probs=119.2

Q ss_pred             CCCCCcEEEcccCC--CcccCCccchhcccccCcEEEccCC-cccccCCccccCCCCCCEEEecCcc-------------
Q 041689           92 NCKSLVVFLLSNNP--LNGILPRMSIGNLSHSLEIFDMSKC-NVSGGIPEEIGNLTNLTAIYLGGNK-------------  155 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~--l~~~~~~~~~~~l~~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~-------------  155 (652)
                      .+++|+.|+|++|.  ++..........+++ |++|++++| .+++ ++..+..+++|+.|+++.+.             
T Consensus       182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~-L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~  259 (594)
T 2p1m_B          182 TYTSLVSLNISCLASEVSFSALERLVTRCPN-LKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV  259 (594)
T ss_dssp             TCCCCCEEECTTCCSCCCHHHHHHHHHHCTT-CCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHH
T ss_pred             cCCcCcEEEecccCCcCCHHHHHHHHHhCCC-CcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHH
Confidence            56677777777776  211100001122344 777777777 3333 55555666666666544331             


Q ss_pred             -------------ccc----cCCccccCCCCCcEEecccCccccccCc-cccCCCCCcEEEccCCccccc-ccccCCCCC
Q 041689          156 -------------LNG----SIPFTLRELQKLQYVGLKDNKLEGTIPY-DIFRLVKLYKLDLGGNKLSGS-ILTCFSNLA  216 (652)
Q Consensus       156 -------------l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~  216 (652)
                                   +..    .++..+..+++|++|+|++|.+++.... .+..+++|+.|++++| +... .+.....++
T Consensus       260 ~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~  338 (594)
T 2p1m_B          260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK  338 (594)
T ss_dssp             HHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred             HHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence                         111    1222233567788888888876643322 2446777888887777 4321 222223466


Q ss_pred             CCCEEEccC---------CCCC--CCccc-CCCCccceEecccccCCccCccccc-CCCCCcEEEcc--C----CcCCCc
Q 041689          217 SLRTLSLSY---------NDGP--LPLEI-GNLKVLIGIDFSMNNFSSVIPTTIG-SLKDLQYLFLG--Y----NILKGS  277 (652)
Q Consensus       217 ~L~~L~Ls~---------N~~~--~~~~~-~~l~~L~~L~ls~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~  277 (652)
                      +|++|++++         |...  ....+ .++++|+.|+++.|.++......+. .+++|+.|+|+  +    |.+++.
T Consensus       339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~  418 (594)
T 2p1m_B          339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE  418 (594)
T ss_dssp             TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC
T ss_pred             CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC
Confidence            777777733         1100  00011 2355566666666665543333333 35556666665  2    344411


Q ss_pred             c-----cccccccccCcceeccccccCCCCchhhcC-CCCCceEEeecCcCcccCCC-C-CCCCCcccccccCCcc
Q 041689          278 I-----PDSVGDLISLKSLNFSNNNLSGAIPLLLEK-LSYLEHLNLSFNKLEGEIPK-G-GSFGNFSAESFEGNKL  345 (652)
Q Consensus       278 ~-----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~-~-~~~~~l~~~~~~~N~~  345 (652)
                      .     +..+..+++|+.|+|++ .++...+..+.. +++|+.|+|++|.+++..+. . ..+++++.+++++|+.
T Consensus       419 ~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          419 PLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             CTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             chhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            1     11133445555555544 333333333332 44555555555554322110 0 1234455555555543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.82  E-value=4.6e-22  Score=222.43  Aligned_cols=334  Identities=15%  Similarity=0.130  Sum_probs=189.4

Q ss_pred             eeceeEeccCCCcCCccCCCCC--CCCCCCEEECCCC-cCccc-CCccccCCCCCCEEEcCCCcCeeccC----------
Q 041689            5 SIGKLELNVDDIESPCEIPSEI--NPHNLEELLLGQN-NLVGV-VPAAIFDVSTLKDLALQDNYLSGSLS----------   70 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~--~~~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~----------   70 (652)
                      +|+.|+|+.|.+..  ..+..+  .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++...          
T Consensus       106 ~L~~L~L~~~~~~~--~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~  183 (594)
T 2p1m_B          106 WLEEIRLKRMVVTD--DCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY  183 (594)
T ss_dssp             TCCEEEEESCBCCH--HHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred             CCCeEEeeCcEEcH--HHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence            56666666665542  222222  3456666666666 44322 22333456666666666666543211          


Q ss_pred             -CCccccccCCC--CCcccccc-cCCCCCCcEEEcccC-CCcccCCccchhcccccCcEEEccCCc--------------
Q 041689           71 -SIADNYLTSST--PELSFLSS-LSNCKSLVVFLLSNN-PLNGILPRMSIGNLSHSLEIFDMSKCN--------------  131 (652)
Q Consensus        71 -~~~~~~l~~~~--~~~~~~~~-l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~~L~~L~L~~N~--------------  131 (652)
                       .+....+....  .....+.. ..++++|++|+|++| .+.+ .+. .+..+++ |++|+++.+.              
T Consensus       184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~-~~~~~~~-L~~L~l~~~~~~~~~~~~~~l~~~  260 (594)
T 2p1m_B          184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LAT-LLQRAPQ-LEELGTGGYTAEVRPDVYSGLSVA  260 (594)
T ss_dssp             CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHH-HHHHCTT-CSEEECSBCCCCCCHHHHHHHHHH
T ss_pred             CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHH-HHhcCCc-ceEcccccccCccchhhHHHHHHH
Confidence             11111121111  00011111 234688888888888 4443 222 3445554 7777654431              


Q ss_pred             ------------cc----ccCCccccCCCCCCEEEecCccccccC-CccccCCCCCcEEecccCccccc-cCccccCCCC
Q 041689          132 ------------VS----GGIPEEIGNLTNLTAIYLGGNKLNGSI-PFTLRELQKLQYVGLKDNKLEGT-IPYDIFRLVK  193 (652)
Q Consensus       132 ------------l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~  193 (652)
                                  +.    ..++..+..+++|++|+|++|.+++.. ...+..+++|++|++++| ++.. ++.....+++
T Consensus       261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~  339 (594)
T 2p1m_B          261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD  339 (594)
T ss_dssp             HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred             HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence                        11    123334446788888888888876432 223567888888888887 4422 2222334778


Q ss_pred             CcEEEc---------cCCcccccccccCC-CCCCCCEEEccCCCCC--CCccc-CCCCccceEecc--c----ccCCccC
Q 041689          194 LYKLDL---------GGNKLSGSILTCFS-NLASLRTLSLSYNDGP--LPLEI-GNLKVLIGIDFS--M----NNFSSVI  254 (652)
Q Consensus       194 L~~L~L---------~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~~~--~~~~~-~~l~~L~~L~ls--~----N~l~~~~  254 (652)
                      |++|++         +.|.+++.....+. .+++|++|.++.|...  .+..+ ..+++|+.|+++  +    |.++...
T Consensus       340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~  419 (594)
T 2p1m_B          340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP  419 (594)
T ss_dssp             CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred             CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence            888888         33555543333333 3678888877766421  12223 247788888888  4    5565321


Q ss_pred             -----cccccCCCCCcEEEccCCcCCCcccccccc-cccCcceeccccccCCCCchhh-cCCCCCceEEeecCcCcccCC
Q 041689          255 -----PTTIGSLKDLQYLFLGYNILKGSIPDSVGD-LISLKSLNFSNNNLSGAIPLLL-EKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       255 -----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p  327 (652)
                           +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....+ ..+++|+.|+|++|++++...
T Consensus       420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~  498 (594)
T 2p1m_B          420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL  498 (594)
T ss_dssp             THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHH
T ss_pred             hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHH
Confidence                 12256677888888876 566554445554 7788888888888865444444 567888888888888854322


Q ss_pred             --CCCCCCCcccccccCCcc
Q 041689          328 --KGGSFGNFSAESFEGNKL  345 (652)
Q Consensus       328 --~~~~~~~l~~~~~~~N~~  345 (652)
                        ....+++++.+++++|+.
T Consensus       499 ~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          499 LANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHhCCCCCEEeeeCCCC
Confidence              123456778888887765

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=1.5e-22  Score=223.03  Aligned_cols=203  Identities=20%  Similarity=0.158  Sum_probs=120.5

Q ss_pred             CCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCc-------------ccccCCccccCCCCCCEEE-ecCccc
Q 041689           91 SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN-------------VSGGIPEEIGNLTNLTAIY-LGGNKL  156 (652)
Q Consensus        91 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l  156 (652)
                      ..+++|+.|+|++|+|+.+++  .++++++ |+.|++++|.             +.+..|..++++++|+.|+ ++.|.+
T Consensus       346 ~~~~~L~~L~Ls~n~L~~Lp~--~i~~l~~-L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKSTVLQS--ELESCKE-LQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHHHHHH--HHHHHHH-HHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH
T ss_pred             ccCccceeccCChhhHHhhHH--HHHHHHH-HHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc
Confidence            456666677777777665433  4566655 7777765554             3444555555555555555 444443


Q ss_pred             cccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccC
Q 041689          157 NGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIG  235 (652)
Q Consensus       157 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~  235 (652)
                      .           +|..+.+++|.|+...+      ..|+.|+|++|+|+++ |. |..+++|+.|+|++|. ..+|..++
T Consensus       423 ~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~~lp~~~~  483 (567)
T 1dce_A          423 D-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLRALPPALA  483 (567)
T ss_dssp             H-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCCCCCGGGG
T ss_pred             c-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCcccccccchhhh
Confidence            2           23334455555553221      1466777777777653 33 6666666666666665 45566666


Q ss_pred             CCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcc-cccccccccCcceeccccccCCCCch---hhcCCCC
Q 041689          236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSI-PDSVGDLISLKSLNFSNNNLSGAIPL---LLEKLSY  311 (652)
Q Consensus       236 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~  311 (652)
                      ++++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|.   .+..+++
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~  561 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS  561 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTT
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcc
Confidence            66666666666666665 34 6666667777777777766554 66666666777777777766654442   2334566


Q ss_pred             CceEEe
Q 041689          312 LEHLNL  317 (652)
Q Consensus       312 L~~L~L  317 (652)
                      |+.|++
T Consensus       562 L~~L~l  567 (567)
T 1dce_A          562 VSSILT  567 (567)
T ss_dssp             CSEEEC
T ss_pred             cCccCC
Confidence            666653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.82  E-value=1.8e-20  Score=186.45  Aligned_cols=167  Identities=20%  Similarity=0.245  Sum_probs=109.8

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG  201 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  201 (652)
                      +..+++++|.++++.  .+..+++|++|++++|.|+. ++ .+..+++|++|+|++|+|++..+  +..+++|++|+|++
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~   94 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNR   94 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCS
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCC
Confidence            666777777777543  46677777777777777764 33 56677777777777777774433  66677777777777


Q ss_pred             CcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccc
Q 041689          202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS  281 (652)
Q Consensus       202 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  281 (652)
                      |+++++.+                        +.. ++|+.|++++|++++.  ..+..+++|+.|+|++|+|++. + .
T Consensus        95 N~l~~l~~------------------------~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~  145 (263)
T 1xeu_A           95 NRLKNLNG------------------------IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-M  145 (263)
T ss_dssp             SCCSCCTT------------------------CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-G
T ss_pred             CccCCcCc------------------------ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-H
Confidence            77664322                        111 4555556666666653  2466777777777777777643 3 5


Q ss_pred             ccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCccc
Q 041689          282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGE  325 (652)
Q Consensus       282 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  325 (652)
                      +..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       146 l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          146 LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             GGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             HccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            66777777777777777654  5567777777777777777655

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.81  E-value=1.4e-20  Score=187.37  Aligned_cols=169  Identities=22%  Similarity=0.261  Sum_probs=123.6

Q ss_pred             CCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCc
Q 041689           92 NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ  171 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  171 (652)
                      ++.+++.+++++|.++++.   .+..+++ |++|++++|+|+.+ + .+..+++|++|+|++|+|++..+  +..+++|+
T Consensus        17 ~l~~l~~l~l~~~~i~~~~---~~~~l~~-L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~   88 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV---SQKELSG-VQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLE   88 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE---CHHHHTT-CSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCC
T ss_pred             HHHHHHHHHhcCCCccccc---chhhcCc-CcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccCCCCC
Confidence            5777888999999998875   3667776 99999999999954 4 78999999999999999997665  99999999


Q ss_pred             EEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCC
Q 041689          172 YVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFS  251 (652)
Q Consensus       172 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~  251 (652)
                      +|+|++|+|++ +|.. .. ++|+.|+|++|+|++.  ..+..+++|++|+|++|+......+..+++|+.|++++|+++
T Consensus        89 ~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           89 ELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             EEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCC
T ss_pred             EEECCCCccCC-cCcc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCc
Confidence            99999999995 4432 23 8999999999999864  246777777777777665221124555555555555555555


Q ss_pred             ccCcccccCCCCCcEEEccCCcCC
Q 041689          252 SVIPTTIGSLKDLQYLFLGYNILK  275 (652)
Q Consensus       252 ~~~~~~~~~l~~L~~L~L~~N~l~  275 (652)
                      +.  ..+..+++|+.|++++|+++
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEE
T ss_pred             ch--HHhccCCCCCEEeCCCCccc
Confidence            43  34455555555555555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=1.6e-22  Score=222.68  Aligned_cols=189  Identities=22%  Similarity=0.178  Sum_probs=154.3

Q ss_pred             ccccCcEEEccCCcccccCCccccCCCCCCEEEecCcc-------------ccccCCccccCCCCCcEEe-cccCccccc
Q 041689          118 LSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK-------------LNGSIPFTLRELQKLQYVG-LKDNKLEGT  183 (652)
Q Consensus       118 l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~~  183 (652)
                      .++ |+.|+|++|+|+ .+|..+++|++|+.|++++|.             +.+..|..+.++++|+.|+ ++.|.+.  
T Consensus       348 ~~~-L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--  423 (567)
T 1dce_A          348 DEQ-LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--  423 (567)
T ss_dssp             TTT-SSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred             Ccc-ceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence            344 888888888887 567888888888888887765             3445566666677777776 5666553  


Q ss_pred             cCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCC
Q 041689          184 IPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK  262 (652)
Q Consensus       184 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  262 (652)
                               +|..+.+++|.|+.+.+.      .|+.|+|++|. ..+|. ++.+++|+.|+|++|+|+ .+|..|+.++
T Consensus       424 ---------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  486 (567)
T 1dce_A          424 ---------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR  486 (567)
T ss_dssp             ---------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred             ---------hhhhhhhhcccccccCcc------CceEEEecCCCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence                     344556677777755432      58999999997 55665 999999999999999999 5788999999


Q ss_pred             CCcEEEccCCcCCCcccccccccccCcceeccccccCCCC-chhhcCCCCCceEEeecCcCcccCCCC
Q 041689          263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAI-PLLLEKLSYLEHLNLSFNKLEGEIPKG  329 (652)
Q Consensus       263 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~  329 (652)
                      +|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|..
T Consensus       487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            99999999999996 67 8999999999999999999887 999999999999999999999888754

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=3.6e-20  Score=183.75  Aligned_cols=143  Identities=18%  Similarity=0.204  Sum_probs=109.4

Q ss_pred             HHHHhcCCCccceeccccceEEEEEEe-CCCcE--EEEEEeecccch------------------------hhhhHHHHH
Q 041689          420 VCRATYGFNENNLIGKGGFGTIYKSRI-GDGME--VAVKVFHLQCGR------------------------AFKSFDIEC  472 (652)
Q Consensus       420 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~  472 (652)
                      +.....-|.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+
T Consensus        42 ~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  121 (258)
T 1zth_A           42 LSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEF  121 (258)
T ss_dssp             HHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHH
T ss_pred             HHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHH
Confidence            333333467889999999999999987 67889  999997543111                        113678899


Q ss_pred             HHHHhcCCCee--eeEEeeeecCCceEEEEEccCC-C----ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCC
Q 041689          473 EIMKSIHYRNL--VKIISSCSNEEFKELVLEHMPH-G----SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH-FNFLV  544 (652)
Q Consensus       473 ~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~  544 (652)
                      ++++++.|+++  +.++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.||.||| +.   
T Consensus       122 ~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---  190 (258)
T 1zth_A          122 RNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---  190 (258)
T ss_dssp             HHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---
T ss_pred             HHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---
Confidence            99999988754  444443    356899999942 3    66665432    223456789999999999999 88   


Q ss_pred             CeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       545 ~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ||+||||||+|||+++  .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999999998  8999999999754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=1.3e-20  Score=213.85  Aligned_cols=177  Identities=21%  Similarity=0.174  Sum_probs=69.9

Q ss_pred             CCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccc---------cCCccccCCCCCCEEEecCccccccCCccc
Q 041689           94 KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG---------GIPEEIGNLTNLTAIYLGGNKLNGSIPFTL  164 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  164 (652)
                      +.++.|+|++|.+......        .|+.++|+.|.|.+         ..++.|..+++|+.|+|++|.|. .+|..+
T Consensus       173 ~~~~~l~L~~n~~~~~~~~--------~l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~  243 (727)
T 4b8c_D          173 PLTPKIELFANGKDEANQA--------LLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANI  243 (727)
T ss_dssp             ---------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGG
T ss_pred             CccceEEeeCCCCCcchhh--------HhhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhh
Confidence            5577888888888764322        15555555555543         23444555555555555555554 333333


Q ss_pred             cCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEe
Q 041689          165 RELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGID  244 (652)
Q Consensus       165 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~  244 (652)
                      .++++|++|+|++|.|+ .+|..|..+++|++|+|++|+|+                       .+|..++++++|+.|+
T Consensus       244 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-----------------------~lp~~~~~l~~L~~L~  299 (727)
T 4b8c_D          244 FKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-----------------------SLPAELGSCFQLKYFY  299 (727)
T ss_dssp             GGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-----------------------SCCSSGGGGTTCSEEE
T ss_pred             cCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-----------------------ccChhhcCCCCCCEEE
Confidence            34555555555555555 44444555555555555555554                       3444455555555555


Q ss_pred             cccccCCccCcccccCCCCCcEEEccCCcCCCccccccccccc-CcceeccccccCCCCch
Q 041689          245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLIS-LKSLNFSNNNLSGAIPL  304 (652)
Q Consensus       245 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~  304 (652)
                      |++|.|+. +|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus       300 L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          300 FFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             CCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             CCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            55555552 3444555556666666666665555555544321 22355566666555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=4.3e-19  Score=168.49  Aligned_cols=155  Identities=17%  Similarity=0.274  Sum_probs=95.4

Q ss_pred             hhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCC
Q 041689          115 IGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL  194 (652)
Q Consensus       115 ~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  194 (652)
                      ...+++ |++|++++|+|+. +| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..+..+++|
T Consensus        40 ~~~l~~-L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           40 EAQMNS-LTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             HHHHHT-CCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             hhhcCC-ccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            344554 7777777777773 33 56777777777777776652  2356777777777777777776666667777777


Q ss_pred             cEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcC
Q 041689          195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNIL  274 (652)
Q Consensus       195 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  274 (652)
                      ++|+|++|++++..+..|..+++|++|++++|.                     .++. +| .+..+++|++|++++|++
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~---------------------~i~~-~~-~l~~l~~L~~L~l~~n~i  171 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNG---------------------AITD-IM-PLKTLPELKSLNIQFDGV  171 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT---------------------BCCC-CG-GGGGCSSCCEEECTTBCC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCC---------------------Cccc-cH-hhcCCCCCCEEECCCCCC
Confidence            777777777776566666666666666665553                     0332 22 355556666666666666


Q ss_pred             CCcccccccccccCcceeccccccC
Q 041689          275 KGSIPDSVGDLISLKSLNFSNNNLS  299 (652)
Q Consensus       275 ~~~~p~~~~~l~~L~~L~L~~N~l~  299 (652)
                      ++ ++ .+..+++|+.|++++|++.
T Consensus       172 ~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          172 HD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CC-CT-TGGGCSSCCEEEECBC---
T ss_pred             cC-hH-HhccCCCCCEEEeeCcccC
Confidence            53 22 4556666666666666654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=2e-19  Score=170.82  Aligned_cols=151  Identities=18%  Similarity=0.234  Sum_probs=74.0

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      +++|++|++++|+|+. +| .+..+++|++|++++|.++..                   ..+..+++|++|++++|+++
T Consensus        43 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~~-------------------~~l~~l~~L~~L~l~~n~l~  101 (197)
T 4ezg_A           43 MNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATNY-------------------NPISGLSNLERLRIMGKDVT  101 (197)
T ss_dssp             HHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSCC-------------------GGGTTCTTCCEEEEECTTCB
T ss_pred             cCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCcc-------------------hhhhcCCCCCEEEeECCccC
Confidence            4455555555555552 33 355555555555555544311                   12444555555555555555


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcc-ccccCCccccCCCCCcEEecccCccccccCc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK-LNGSIPFTLRELQKLQYVGLKDNKLEGTIPY  186 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  186 (652)
                      +..+. .+..+++ |++|++++|++++..+..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ 
T Consensus       102 ~~~~~-~l~~l~~-L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-  175 (197)
T 4ezg_A          102 SDKIP-NLSGLTS-LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-  175 (197)
T ss_dssp             GGGSC-CCTTCTT-CCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-
T ss_pred             cccCh-hhcCCCC-CCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-
Confidence            43333 3444443 5555555555554445555555555555555554 33 222 34555555555555555552 22 


Q ss_pred             cccCCCCCcEEEccCCccc
Q 041689          187 DIFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       187 ~~~~l~~L~~L~L~~N~l~  205 (652)
                      .+..+++|++|++++|+|.
T Consensus       176 ~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          176 GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             TGGGCSSCCEEEECBC---
T ss_pred             HhccCCCCCEEEeeCcccC
Confidence            3444555555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=2.3e-19  Score=169.53  Aligned_cols=127  Identities=26%  Similarity=0.273  Sum_probs=68.5

Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccc-cCCCCCCCCEEEccCCC--CCCCcccCCCCccceEeccc
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILT-CFSNLASLRTLSLSYND--GPLPLEIGNLKVLIGIDFSM  247 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~  247 (652)
                      +.+++++|.|+ .+|..+..  +|++|+|++|+|+++.+. .|..+++|++|+|++|.  ...|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777776 56655544  677777777777765553 35666666666555553  22233444444444444444


Q ss_pred             ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCC
Q 041689          248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG  300 (652)
Q Consensus       248 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  300 (652)
                      |+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            44444444444444444444444444444444444444444444444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.78  E-value=1.8e-19  Score=185.76  Aligned_cols=281  Identities=15%  Similarity=0.128  Sum_probs=150.3

Q ss_pred             CCCCCEEECCCCcCcccCCccccC-CCCCCEEEcCCCcCe--eccCCCccc-cccCCCCCcccccccCC--------CCC
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFD-VSTLKDLALQDNYLS--GSLSSIADN-YLTSSTPELSFLSSLSN--------CKS   95 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~~~~~~~-~l~~~~~~~~~~~~l~~--------l~~   95 (652)
                      +.++++|.++++ +....-..+.. +++|+.|||++|+|+  ......... .+...........+|.+        +++
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~  102 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQT  102 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTT
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCC
Confidence            467888888865 22222223333 788999999999887  332221110 00000000000122333        444


Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcc----ccccCCccccCCCCCc
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK----LNGSIPFTLRELQKLQ  171 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L~  171 (652)
                      |+.|+|.+ .++.+.+. .|.++++ |+.|++++|.+..+.+.+|.++.++..+.+..+.    ...+.+.+|.++.+|+
T Consensus       103 L~~l~L~~-~i~~I~~~-aF~~~~~-L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~  179 (329)
T 3sb4_A          103 LEKVILSE-KIKNIEDA-AFKGCDN-LKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE  179 (329)
T ss_dssp             CCC-CBCT-TCCEECTT-TTTTCTT-CCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred             CcEEECCc-cccchhHH-HhhcCcc-cceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence            44445544 44444333 3444443 4444444444444444444444444444443321    1122233333333333


Q ss_pred             -EEecccCccccccCccc----cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCCc-ccCCCCccceEe
Q 041689          172 -YVGLKDNKLEGTIPYDI----FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPL-EIGNLKVLIGID  244 (652)
Q Consensus       172 -~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~-~~~~l~~L~~L~  244 (652)
                       .+.+....   .++..+    ....++..+.+.++-...........+++|+.|+|++|. ..+|. .|.++++|+.|+
T Consensus       180 ~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~  256 (329)
T 3sb4_A          180 TTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIK  256 (329)
T ss_dssp             EEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEE
T ss_pred             eeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEE
Confidence             22222111   111111    012233444444332211111111235677777777764 34443 377777777788


Q ss_pred             cccccCCccCcccccCCCCCc-EEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEe
Q 041689          245 FSMNNFSSVIPTTIGSLKDLQ-YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNL  317 (652)
Q Consensus       245 ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  317 (652)
                      +++| ++.+.+.+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus       257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             CCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            8777 7777788888888898 888888 677677788899999999999888888777888888888888864

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.77  E-value=1.6e-17  Score=174.96  Aligned_cols=263  Identities=10%  Similarity=0.111  Sum_probs=137.6

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .+++.+.+.+ +++.+...+|.+. +|+.++|..| ++.+...                 +|.++ +|+.+.|.+ .++.
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~-----------------aF~~~-~L~~i~lp~-~l~~  170 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDM-----------------AFFNS-TVQEIVFPS-TLEQ  170 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTT-----------------TTTTC-CCCEEECCT-TCCE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHH-----------------hcCCC-CceEEEeCC-CccE
Confidence            3455555533 3444555555553 5666665554 4433321                 34442 455555553 4554


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      +... .|.++++ |+.++|++|+++.+...+|. +.+|+.+.|..| ++.+...+|.++++|+.+++.+| ++.....+|
T Consensus       171 I~~~-aF~~c~~-L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF  245 (401)
T 4fdw_A          171 LKED-IFYYCYN-LKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAF  245 (401)
T ss_dssp             ECSS-TTTTCTT-CCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTT
T ss_pred             ehHH-HhhCccc-CCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccc
Confidence            4444 4555544 66666666666555555554 355666666533 55455555666666666666543 343444444


Q ss_pred             cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCC------C-CcccCCCCccceEecccccCCccCcccccCC
Q 041689          189 FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGP------L-PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSL  261 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~------~-~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l  261 (652)
                      .+ .+|+.+.+ .|.++.+...+|.++++|+.+++.+|...      + ...|.++++|+.+++. |.++.+...+|.++
T Consensus       246 ~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c  322 (401)
T 4fdw_A          246 RE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGN  322 (401)
T ss_dssp             TT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTC
T ss_pred             cc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCC
Confidence            44 55666666 33445455556666666666666555321      2 2235555555555555 33555555556666


Q ss_pred             CCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCC-CCceEEeecCcCc
Q 041689          262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLS-YLEHLNLSFNKLE  323 (652)
Q Consensus       262 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  323 (652)
                      .+|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+.
T Consensus       323 ~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          323 RKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            66666666443 444445556655 566666666655555555555553 4555555555443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.7e-19  Score=204.77  Aligned_cols=163  Identities=24%  Similarity=0.249  Sum_probs=49.9

Q ss_pred             CCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      .+.++.|+|++|.+.. .+..     .|+.++|++|.|++....  .+.+.      .....|..+++|+.|+|++|.+.
T Consensus       172 ~~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~~~~~--~n~~~------~~~~~~~~l~~L~~L~Ls~n~l~  237 (727)
T 4b8c_D          172 TPLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDEDDDI--ENRMV------MPKDSKYDDQLWHALDLSNLQIF  237 (727)
T ss_dssp             ----------------------------------------------------------------CCCCCCEEECTTSCCS
T ss_pred             CCccceEEeeCCCCCc-chhh-----HhhcCccCcccccCcccc--cccee------cChhhhccCCCCcEEECCCCCCC
Confidence            3567788888888775 2322     355566666665532110  00000      00123444444555555555544


Q ss_pred             ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcc
Q 041689          108 GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYD  187 (652)
Q Consensus       108 ~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  187 (652)
                      .+++.  +..++. |++|+|++|+|+ .+|..|.+|++|++|+|++|+|+ .+|..|.+|++|++|+|++|.|+ .+|..
T Consensus       238 ~l~~~--~~~l~~-L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~  311 (727)
T 4b8c_D          238 NISAN--IFKYDF-LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWE  311 (727)
T ss_dssp             CCCGG--GGGCCS-CSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSS
T ss_pred             CCChh--hcCCCC-CCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChh
Confidence            33222  223333 444444444444 33444444444444444444444 33444444444444444444444 33434


Q ss_pred             ccCCCCCcEEEccCCcccccccc
Q 041689          188 IFRLVKLYKLDLGGNKLSGSILT  210 (652)
Q Consensus       188 ~~~l~~L~~L~L~~N~l~~~~~~  210 (652)
                      |..+++|+.|+|++|.|++.+|.
T Consensus       312 ~~~l~~L~~L~L~~N~l~~~~p~  334 (727)
T 4b8c_D          312 FGNLCNLQFLGVEGNPLEKQFLK  334 (727)
T ss_dssp             TTSCTTCCCEECTTSCCCSHHHH
T ss_pred             hhcCCCccEEeCCCCccCCCChH
Confidence            44444444444444444443333

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=2.2e-18  Score=162.84  Aligned_cols=128  Identities=26%  Similarity=0.263  Sum_probs=82.9

Q ss_pred             CEEEecCccccccCCccccCCCCCcEEecccCccccccCc-cccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccC
Q 041689          147 TAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY-DIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSY  225 (652)
Q Consensus       147 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  225 (652)
                      +.+++++|.|+ .+|..+..  +|++|+|++|+|++..+. .|..+++|++|+|++|+|+++.|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56677777775 34443332  667777777777655443 366677777777777777766666777777777777777


Q ss_pred             CC--CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCc
Q 041689          226 ND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGS  277 (652)
Q Consensus       226 N~--~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  277 (652)
                      |.  ...+..|.++++|+.|+|++|++++..|..|..+++|++|+|++|++.+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            75  22333466677777777777777766666677777777777777766643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.75  E-value=3.9e-18  Score=175.67  Aligned_cols=265  Identities=12%  Similarity=0.094  Sum_probs=185.9

Q ss_pred             eeceeEeccCCCc-CCccCCCCCCCCCCCEEECCCCcCc--------------------ccCCccccC--------CCCC
Q 041689            5 SIGKLELNVDDIE-SPCEIPSEINPHNLEELLLGQNNLV--------------------GVVPAAIFD--------VSTL   55 (652)
Q Consensus         5 ~l~~l~l~~~~~~-~~~~ip~~~~~~~L~~L~Ls~N~l~--------------------~~~p~~~~~--------l~~L   55 (652)
                      +|+.|.++++-.. ....++.  .+++|++|||++|+|.                    .+.+.+|.+        +++|
T Consensus        26 ~l~~L~l~g~i~~~~~~~l~~--~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L  103 (329)
T 3sb4_A           26 SITHLTLTGKLNAEDFRHLRD--EFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTL  103 (329)
T ss_dssp             HCSEEEEEEEECHHHHHHHHH--SCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTC
T ss_pred             ceeEEEEeccccHHHHHHHHH--hhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCC
Confidence            4566777654321 1111111  1677888888888887                    456678888        9999


Q ss_pred             CEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCc----
Q 041689           56 KDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN----  131 (652)
Q Consensus        56 ~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~----  131 (652)
                      +.|+|++ .++.+.+                 .+|.++++|+.|+|++|.+..+.+. .|..... +..+.+..+.    
T Consensus       104 ~~l~L~~-~i~~I~~-----------------~aF~~~~~L~~l~l~~n~i~~i~~~-aF~~~~~-l~~l~~~~~~~~~~  163 (329)
T 3sb4_A          104 EKVILSE-KIKNIED-----------------AAFKGCDNLKICQIRKKTAPNLLPE-ALADSVT-AIFIPLGSSDAYRF  163 (329)
T ss_dssp             CC-CBCT-TCCEECT-----------------TTTTTCTTCCEEEBCCSSCCEECTT-SSCTTTC-EEEECTTCTHHHHT
T ss_pred             cEEECCc-cccchhH-----------------HHhhcCcccceEEcCCCCccccchh-hhcCCCc-eEEecCcchhhhhc
Confidence            9999999 8876655                 3689999999999999999988887 6766554 7777766632    


Q ss_pred             ccccCCccccCCCCCC-EEEecCccc-cccCCccccCCCCCcEEecccCccccccCcccc-CCCCCcEEEccCCcccccc
Q 041689          132 VSGGIPEEIGNLTNLT-AIYLGGNKL-NGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF-RLVKLYKLDLGGNKLSGSI  208 (652)
Q Consensus       132 l~~~~~~~~~~l~~L~-~L~L~~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~  208 (652)
                      ...+...+|.++.+|+ .+.+....- .......-....++..+.+.++-.. .....+. .+++|+.|+|++|+++.+.
T Consensus       164 ~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~  242 (329)
T 3sb4_A          164 KNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIP  242 (329)
T ss_dssp             STTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEEC
T ss_pred             cccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceec
Confidence            3344566788888888 565554321 1011111123556677777665332 2222222 3678888888888888888


Q ss_pred             cccCCCCCCCCEEEccCCCCCC-CcccCCCCccc-eEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccc
Q 041689          209 LTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLI-GIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI  286 (652)
Q Consensus       209 ~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  286 (652)
                      +.+|.++++|++|+|++|-..+ +..|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++.+.+.+|.+++
T Consensus       243 ~~aF~~~~~L~~l~l~~ni~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~  321 (329)
T 3sb4_A          243 DFTFAQKKYLLKIKLPHNLKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV  321 (329)
T ss_dssp             TTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC
T ss_pred             HhhhhCCCCCCEEECCcccceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc
Confidence            8888888888888888874333 34588888888 888887 77778888999999999999999999877788899999


Q ss_pred             cCcceec
Q 041689          287 SLKSLNF  293 (652)
Q Consensus       287 ~L~~L~L  293 (652)
                      +|+.++.
T Consensus       322 ~L~~ly~  328 (329)
T 3sb4_A          322 PSKLIYK  328 (329)
T ss_dssp             CCCEEEC
T ss_pred             chhhhcc
Confidence            9988763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=8.7e-17  Score=169.32  Aligned_cols=242  Identities=11%  Similarity=0.118  Sum_probs=207.7

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .+|+.++|..| ++.+...+|.+. +|+.+.|.. .++.+..                 .+|.++++|+.++|++|+++.
T Consensus       135 ~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~-----------------~aF~~c~~L~~l~l~~n~l~~  194 (401)
T 4fdw_A          135 SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKE-----------------DIFYYCYNLKKADLSKTKITK  194 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECS-----------------STTTTCTTCCEEECTTSCCSE
T ss_pred             CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehH-----------------HHhhCcccCCeeecCCCcceE
Confidence            48999999876 888888999994 799999986 6665544                 368999999999999999999


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      +... .|.. . +|+.+.|.. .++.+...+|.++++|+.++|..| ++.+...+|.+ .+|+.+.+ .|.++...+.+|
T Consensus       195 I~~~-aF~~-~-~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF  267 (401)
T 4fdw_A          195 LPAS-TFVY-A-GIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAF  267 (401)
T ss_dssp             ECTT-TTTT-C-CCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTT
T ss_pred             echh-hEee-c-ccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHh
Confidence            8877 5653 4 499999985 488889999999999999999986 67688889988 89999999 566776778899


Q ss_pred             cCCCCCcEEEccCCccc-----ccccccCCCCCCCCEEEccCCCCCC-CcccCCCCccceEecccccCCccCcccccCCC
Q 041689          189 FRLVKLYKLDLGGNKLS-----GSILTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK  262 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  262 (652)
                      .++.+|+.+++.+|.+.     .+.+.+|.++++|+.++|.++-..+ ...|.++++|+.+++..| ++.+.+.+|.++ 
T Consensus       268 ~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-  345 (401)
T 4fdw_A          268 YYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-  345 (401)
T ss_dssp             TTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-
T ss_pred             hCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-
Confidence            99999999999998876     5788999999999999999664333 456899999999999655 887888999999 


Q ss_pred             CCcEEEccCCcCCCcccccccccc-cCcceeccccccC
Q 041689          263 DLQYLFLGYNILKGSIPDSVGDLI-SLKSLNFSNNNLS  299 (652)
Q Consensus       263 ~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~  299 (652)
                      +|+.+++++|.+....+..|.+++ +++.|++..|.+.
T Consensus       346 ~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          346 GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            999999999999877888899885 7899999988765

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=2.1e-18  Score=162.91  Aligned_cols=111  Identities=30%  Similarity=0.359  Sum_probs=90.5

Q ss_pred             CCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccc
Q 041689          217 SLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN  295 (652)
Q Consensus       217 ~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  295 (652)
                      +|++|+|++|. ..+|..+.++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        32 ~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~  111 (193)
T 2wfh_A           32 DVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG  111 (193)
T ss_dssp             TCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCS
T ss_pred             CCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCC
Confidence            44555555554 34455566677777777788888888888899999999999999999988888899999999999999


Q ss_pred             cccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          296 NNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       296 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |+|++..+..|..+++|+.|+|++|++.|...
T Consensus       112 N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          112 NDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            99997777789999999999999999987654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.74  E-value=7e-18  Score=155.70  Aligned_cols=137  Identities=21%  Similarity=0.206  Sum_probs=107.2

Q ss_pred             CCCCCEEECCCCcCc-ccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           28 PHNLEELLLGQNNLV-GVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      +++|++|+|++|+++ +.+|..|..+++|++|+|++|.|++.                   ..+..+++|++|+|++|++
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-------------------~~~~~l~~L~~L~Ls~N~l   83 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-------------------SNLPKLPKLKKLELSENRI   83 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-------------------SSCCCCSSCCEEEEESCCC
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-------------------hhhccCCCCCEEECcCCcC
Confidence            678999999999998 56788888999999999999988754                   1467788889999999988


Q ss_pred             cccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCC---ccccCCCCCcEEecccCcccc
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKDNKLEG  182 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~  182 (652)
                      ++..|. .+..+++ |++|+|++|+|++... ..+..+++|+.|+|++|++++..+   ..|..+++|++|++++|.+. 
T Consensus        84 ~~~~~~-~~~~l~~-L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-  160 (168)
T 2ell_A           84 FGGLDM-LAEKLPN-LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-  160 (168)
T ss_dssp             CSCCCH-HHHHCTT-CCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-
T ss_pred             chHHHH-HHhhCCC-CCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-
Confidence            886555 5556765 8888888888886532 678888888888888888886555   46778888888888888877 


Q ss_pred             ccCc
Q 041689          183 TIPY  186 (652)
Q Consensus       183 ~~~~  186 (652)
                      .+|+
T Consensus       161 ~~~~  164 (168)
T 2ell_A          161 EAPD  164 (168)
T ss_dssp             BCCS
T ss_pred             hccc
Confidence            4443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=5.6e-17  Score=153.10  Aligned_cols=126  Identities=23%  Similarity=0.260  Sum_probs=111.7

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEec
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL  175 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  175 (652)
                      -+.+++++|.++.++..     ++.+|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+++.+..|.++++|++|+|
T Consensus        12 ~~~l~~~~~~l~~ip~~-----~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~L   85 (193)
T 2wfh_A           12 DTVVRCSNKGLKVLPKG-----IPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL   85 (193)
T ss_dssp             TTEEECTTSCCSSCCSC-----CCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCEEEcCCCCCCcCCCC-----CCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEEC
Confidence            36899999999977654     2346999999999998 56789999999999999999999888889999999999999


Q ss_pred             ccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      ++|+|++..|..|..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|.
T Consensus        86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  137 (193)
T 2wfh_A           86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANP  137 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCC
Confidence            9999998888889999999999999999998888888888999988888884

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=5.6e-18  Score=174.23  Aligned_cols=144  Identities=15%  Similarity=0.129  Sum_probs=104.1

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccc--------------hhhh--------hHHHHHHHH
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG--------------RAFK--------SFDIECEIM  475 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l  475 (652)
                      ..+.....=|++.+.||+|++|.||+|...+|+.||||+++....              ....        ...+|...+
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            334444445899999999999999999998999999999753210              0001        123466666


Q ss_pred             HhcCCCee--eeEEeeeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 041689          476 KSIHYRNL--VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKP  553 (652)
Q Consensus       476 ~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  553 (652)
                      .++.+.++  ...+++    ...++||||++|+++.++...       .....++.|++.+|.|||++   |||||||||
T Consensus       168 ~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp  233 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNE  233 (397)
T ss_dssp             HHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             HHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence            66644433  222222    124799999999888765332       12456889999999999999   999999999


Q ss_pred             CCeeeCCCC----------cEEEecccCCccc
Q 041689          554 SNVLLDDTM----------VAHLSDFGITKLL  575 (652)
Q Consensus       554 ~NIll~~~~----------~~kl~Dfg~~~~~  575 (652)
                      .|||+++++          .+.|+||+-+...
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999998776          4899999987643

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=3.6e-17  Score=150.92  Aligned_cols=131  Identities=20%  Similarity=0.233  Sum_probs=86.4

Q ss_pred             CCCCcEEEcccCCCc-ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCc
Q 041689           93 CKSLVVFLLSNNPLN-GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQ  171 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~-~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  171 (652)
                      .++|+.|+|++|.++ +..|. .+..+++ |++|++++|+|++.  ..|..+++|++|+|++|++++.+|..+..+++|+
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~-~~~~l~~-L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEG-LTAEFVN-LEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSS-CCGGGGG-CCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             cccCCEEECCCCCCChhhHHH-HHHhCCC-CCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            466777777777776 33343 3556665 77777777777754  6667777777777777777765666666677777


Q ss_pred             EEecccCccccccC-ccccCCCCCcEEEccCCccccccc---ccCCCCCCCCEEEccCCC
Q 041689          172 YVGLKDNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSIL---TCFSNLASLRTLSLSYND  227 (652)
Q Consensus       172 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~  227 (652)
                      +|+|++|+|++..+ ..+..+++|+.|++++|.+++..+   ..|..+++|++|++++|.
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence            77777777764322 566667777777777777765544   356666666666666654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=2.7e-17  Score=148.44  Aligned_cols=129  Identities=20%  Similarity=0.223  Sum_probs=98.8

Q ss_pred             CCCCCEEECCCCcCc-ccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           28 PHNLEELLLGQNNLV-GVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      +++|++|++++|+++ +.+|..|..+++|++|+|++|+|++.                   ..+.++++|++|+|++|++
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------~~~~~l~~L~~L~Ls~n~i   76 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-------------------ANLPKLNKLKKLELSDNRV   76 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-------------------TTCCCCTTCCEEECCSSCC
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-------------------hhhhcCCCCCEEECCCCcc
Confidence            578999999999998 67888888999999999999988744                   2467788888888888888


Q ss_pred             cccCCccchhcccccCcEEEccCCccccc-CCccccCCCCCCEEEecCccccccCC---ccccCCCCCcEEeccc
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGG-IPEEIGNLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVGLKD  177 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~  177 (652)
                      ++..|. .+..+++ |++|++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|++|++++
T Consensus        77 ~~~~~~-~~~~l~~-L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           77 SGGLEV-LAEKCPN-LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CSCTHH-HHHHCTT-CCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             cchHHH-HhhhCCC-CCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            875554 5555665 88888888888764 24677778888888888888776555   4677777777777653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.70  E-value=1.1e-16  Score=149.11  Aligned_cols=93  Identities=19%  Similarity=0.222  Sum_probs=51.0

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      |.++++|++|+|++|+|+++++. .+..+++ |++|+|++|+|++..+..|..+++|++|+|++|+|+++.+..|..+++
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  125 (177)
T 2o6r_A           48 FDKLTQLTKLSLSQNQIQSLPDG-VFDKLTK-LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTS  125 (177)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTT-TTTTCTT-CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred             hcCcccccEEECCCCcceEeChh-HccCCCc-cCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcc
Confidence            34445555555555555544443 3444443 555555555555555555555666666666666666555555555666


Q ss_pred             CcEEecccCcccccc
Q 041689          170 LQYVGLKDNKLEGTI  184 (652)
Q Consensus       170 L~~L~L~~N~l~~~~  184 (652)
                      |++|+|++|.+.+..
T Consensus       126 L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A          126 LQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCEEECCSSCBCCCH
T ss_pred             cCEEEecCCCeeccC
Confidence            666666666665433

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=2.7e-16  Score=146.33  Aligned_cols=128  Identities=22%  Similarity=0.200  Sum_probs=104.4

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      +.+.+++++|+++.++..     ++.+|++|++++|+++++.+..|..+++|++|+|++|+|+++.+..|..+++|++|+
T Consensus         8 ~~~~l~~~~~~l~~~p~~-----~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSVPTG-----IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY   82 (177)
T ss_dssp             ETTEEECCSSCCSSCCTT-----CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEEecCCCCccCCCC-----CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence            357888999998877543     223589999999999887777888899999999999999877777788889999999


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      |++|+|++..+..|..+++|++|+|++|+++++++..|..+++|++|+|++|.
T Consensus        83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (177)
T 2o6r_A           83 LHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP  135 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCC
Confidence            99999987777777888889999999998887777777777777777777774

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=4.2e-17  Score=147.17  Aligned_cols=129  Identities=19%  Similarity=0.235  Sum_probs=95.0

Q ss_pred             CCCCCcEEEcccCCCc-ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC
Q 041689           92 NCKSLVVFLLSNNPLN-GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL  170 (652)
Q Consensus        92 ~l~~L~~L~Ls~N~l~-~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  170 (652)
                      ..++|+.|++++|.++ +..|. .+..+++ |++|++++|+|++.  ..+..+++|++|+|++|++++.+|..+..+++|
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~-~~~~l~~-L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L   90 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEG-LTDEFEE-LEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL   90 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCS-CCTTCTT-CCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC
T ss_pred             CCccCeEEEccCCcCChhHHHH-HHhhcCC-CcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC
Confidence            3467888888888887 44444 5566665 88888888888765  667778888888888888876677777778888


Q ss_pred             cEEecccCccccc-cCccccCCCCCcEEEccCCccccccc---ccCCCCCCCCEEEcc
Q 041689          171 QYVGLKDNKLEGT-IPYDIFRLVKLYKLDLGGNKLSGSIL---TCFSNLASLRTLSLS  224 (652)
Q Consensus       171 ~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls  224 (652)
                      ++|++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|++|+++
T Consensus        91 ~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           91 THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            8888888888753 23677778888888888888876655   467777777777765

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.68  E-value=1.1e-16  Score=148.79  Aligned_cols=136  Identities=14%  Similarity=0.173  Sum_probs=97.9

Q ss_pred             CCCCCCCCCCCEEECCCCcCcccCCccccCCC-CCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEE
Q 041689           22 IPSEINPHNLEELLLGQNNLVGVVPAAIFDVS-TLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFL  100 (652)
Q Consensus        22 ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~  100 (652)
                      .|.+.++.+|++|+|++|+++.+ |. +..+. +|++|+|++|+|++. +                  .|.++++|++|+
T Consensus        12 ~~~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~-~------------------~l~~l~~L~~L~   70 (176)
T 1a9n_A           12 AAQYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL-D------------------GFPLLRRLKTLL   70 (176)
T ss_dssp             SCEEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE-C------------------CCCCCSSCCEEE
T ss_pred             HHhcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc-c------------------ccccCCCCCEEE
Confidence            45555788889999999988854 54 44444 888888888888754 2                  367788888888


Q ss_pred             cccCCCcccCCccchhcccccCcEEEccCCcccccCCc--cccCCCCCCEEEecCccccccCCc---cccCCCCCcEEec
Q 041689          101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE--EIGNLTNLTAIYLGGNKLNGSIPF---TLRELQKLQYVGL  175 (652)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L  175 (652)
                      |++|+|+++++. .+..+++ |++|+|++|+|+. +|.  .+..+++|+.|+|++|.++...+.   .+..+++|++|++
T Consensus        71 Ls~N~l~~~~~~-~~~~l~~-L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~  147 (176)
T 1a9n_A           71 VNNNRICRIGEG-LDQALPD-LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  147 (176)
T ss_dssp             CCSSCCCEECSC-HHHHCTT-CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             CCCCcccccCcc-hhhcCCC-CCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCC
Confidence            888888877654 4566765 8888888888864 343  677777888888888877743322   3677777777777


Q ss_pred             ccCccc
Q 041689          176 KDNKLE  181 (652)
Q Consensus       176 ~~N~l~  181 (652)
                      ++|.+.
T Consensus       148 ~~n~~~  153 (176)
T 1a9n_A          148 QKVKLK  153 (176)
T ss_dssp             EECCHH
T ss_pred             CcCCHH
Confidence            777765

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.66  E-value=1.4e-16  Score=148.06  Aligned_cols=133  Identities=15%  Similarity=0.117  Sum_probs=109.8

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ  168 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  168 (652)
                      .+.++.+|+.|+|++|+++.+ +  .+..+.++|++|+|++|+|++.  ..|..+++|++|+|++|+|++..+..|..++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~--~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   88 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-E--NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   88 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-C--CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             hcCCcCCceEEEeeCCCCchh-H--HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence            467889999999999999976 3  2455553599999999999976  6789999999999999999977767779999


Q ss_pred             CCcEEecccCccccccCc--cccCCCCCcEEEccCCcccccccc---cCCCCCCCCEEEccCCC
Q 041689          169 KLQYVGLKDNKLEGTIPY--DIFRLVKLYKLDLGGNKLSGSILT---CFSNLASLRTLSLSYND  227 (652)
Q Consensus       169 ~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~  227 (652)
                      +|++|+|++|+|+ .+|.  .+..+++|+.|++++|.++...+.   .+..+++|+.|++++|.
T Consensus        89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECC
T ss_pred             CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCC
Confidence            9999999999997 5555  788899999999999999854332   47778888888888774

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=1.4e-17  Score=158.12  Aligned_cols=152  Identities=26%  Similarity=0.274  Sum_probs=90.1

Q ss_pred             CCCCCEEECCCCcCcccCCc------cccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEc
Q 041689           28 PHNLEELLLGQNNLVGVVPA------AIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLL  101 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~L  101 (652)
                      ..+++.++++.|.+++..|.      .|..+++|++|+|++|+|++++                   .+.++++|++|+|
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-------------------~~~~l~~L~~L~l   77 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-------------------SLSGMENLRILSL   77 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-------------------CHHHHTTCCEEEE
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-------------------ccccCCCCCEEEC
Confidence            34556666666666665555      6677777777777777765421                   2455666777777


Q ss_pred             ccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC-ccccCCCCCcEEecccCcc
Q 041689          102 SNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKL  180 (652)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l  180 (652)
                      ++|+++.++.  .+..+++ |++|+|++|+|+++ | .+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+
T Consensus        78 ~~n~l~~l~~--~~~~~~~-L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l  152 (198)
T 1ds9_A           78 GRNLIKKIEN--LDAVADT-LEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             EEEEECSCSS--HHHHHHH-CSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred             CCCCcccccc--hhhcCCc-CCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence            7777665432  3444444 77777777766653 3 46666666666666666664332 3566666666666666666


Q ss_pred             ccccCcc----------ccCCCCCcEEEccCCccc
Q 041689          181 EGTIPYD----------IFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       181 ~~~~~~~----------~~~l~~L~~L~L~~N~l~  205 (652)
                      ++.+|..          +..+++|+.||  +|.++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          153 YNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             ccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            6544432          45555555554  44443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=1.5e-17  Score=158.02  Aligned_cols=81  Identities=20%  Similarity=0.251  Sum_probs=36.0

Q ss_pred             CcEEEccCCcccccCCc------cccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCc
Q 041689          122 LEIFDMSKCNVSGGIPE------EIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLY  195 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  195 (652)
                      ++.++++.|.+++..|.      .|..+++|++|+|++|++++ +| .+..+++|++|+|++|+|+ .+|..+..+++|+
T Consensus        20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~   96 (198)
T 1ds9_A           20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE   96 (198)
T ss_dssp             CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred             ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence            44444444444444433      44444444444444444443 23 4444444444444444444 3333333334444


Q ss_pred             EEEccCCccc
Q 041689          196 KLDLGGNKLS  205 (652)
Q Consensus       196 ~L~L~~N~l~  205 (652)
                      +|+|++|+++
T Consensus        97 ~L~L~~N~l~  106 (198)
T 1ds9_A           97 ELWISYNQIA  106 (198)
T ss_dssp             EEEEEEEECC
T ss_pred             EEECcCCcCC
Confidence            4444444443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=8e-15  Score=135.23  Aligned_cols=91  Identities=20%  Similarity=0.176  Sum_probs=78.3

Q ss_pred             CccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEe
Q 041689          238 KVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNL  317 (652)
Q Consensus       238 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  317 (652)
                      +.|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            56777788888888888888889999999999999999777778889999999999999998777778889999999999


Q ss_pred             ecCcCcccCCC
Q 041689          318 SFNKLEGEIPK  328 (652)
Q Consensus       318 ~~N~l~~~~p~  328 (652)
                      ++|+|+|.++.
T Consensus       110 ~~N~~~c~c~~  120 (170)
T 3g39_A          110 LNNPWDCACSD  120 (170)
T ss_dssp             CSSCBCTTBGG
T ss_pred             CCCCCCCCchh
Confidence            99999887763

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=9.5e-15  Score=134.74  Aligned_cols=108  Identities=19%  Similarity=0.160  Sum_probs=82.2

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      ..+.|++++|.++.++..     ++.+|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus        10 ~~~~l~~s~n~l~~ip~~-----~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~   84 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTG-----IPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLS   84 (170)
T ss_dssp             ETTEEECTTSCCSSCCSC-----CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEEeCCCCcCccCcc-----CCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEE
Confidence            356788888888876543     124588888888888877778888888888888888888877777778888888888


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCccccc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGS  207 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  207 (652)
                      |++|+|++..+..|..+++|++|+|++|.++..
T Consensus        85 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           85 LNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            888888866666677777888888888877643

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=1.8e-14  Score=133.41  Aligned_cols=107  Identities=20%  Similarity=0.230  Sum_probs=81.7

Q ss_pred             EEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceecccccc
Q 041689          220 TLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNL  298 (652)
Q Consensus       220 ~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  298 (652)
                      .+++++|. ..+|..+.  ++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus        16 ~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l   93 (174)
T 2r9u_A           16 LVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL   93 (174)
T ss_dssp             EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence            44444443 33444433  5677777788888887788888888888888888888876666778888888888888888


Q ss_pred             CCCCchhhcCCCCCceEEeecCcCcccCCC
Q 041689          299 SGAIPLLLEKLSYLEHLNLSFNKLEGEIPK  328 (652)
Q Consensus       299 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  328 (652)
                      ++..+..|..+++|+.|+|++|+|++.++.
T Consensus        94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           94 KSIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             ceeCHHHhccccCCCEEEeCCCCccccccc
Confidence            877666788888888899888888877653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.54  E-value=2.4e-14  Score=132.49  Aligned_cols=106  Identities=19%  Similarity=0.188  Sum_probs=76.2

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEec
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL  175 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  175 (652)
                      -+.+++++|+++.++..     ++.+|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus        14 ~~~l~~~~n~l~~iP~~-----~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L   88 (174)
T 2r9u_A           14 QTLVNCQNIRLASVPAG-----IPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDL   88 (174)
T ss_dssp             SSEEECCSSCCSSCCSC-----CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CcEEEeCCCCCCccCCC-----cCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEEC
Confidence            36778888888766543     1234788888888887777777777777888888777777666666777777777777


Q ss_pred             ccCccccccCccccCCCCCcEEEccCCcccc
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSG  206 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  206 (652)
                      ++|+|++..+..|..+++|++|+|++|.+..
T Consensus        89 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           89 NDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             CCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence            7777775555557777777777777777663

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.54  E-value=3.5e-13  Score=142.18  Aligned_cols=287  Identities=14%  Similarity=0.054  Sum_probs=149.2

Q ss_pred             cCCCCC--CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCcccc--ccCC----CCCcccccccCC
Q 041689           21 EIPSEI--NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNY--LTSS----TPELSFLSSLSN   92 (652)
Q Consensus        21 ~ip~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~--l~~~----~~~~~~~~~l~~   92 (652)
                      +|...-  ++.+|+++.|.. +++.+...+|.++++|+.++|..| ++.+....+.+-  +...    ........+|.+
T Consensus        61 sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~  138 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKG  138 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTT
T ss_pred             EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeec
Confidence            455433  677888888864 477777788888888888888755 444433322210  0000    000011122333


Q ss_pred             CCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcE
Q 041689           93 CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY  172 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  172 (652)
                      +..+........  ..+... .|.+... |+.+.+.++- ..+...+|.++.+|+.+++..| ++.+...+|.+++.|+.
T Consensus       139 ~~~~~~~~~~~~--~~i~~~-aF~~c~~-L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~  212 (394)
T 4fs7_A          139 CDFKEITIPEGV--TVIGDE-AFATCES-LEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLEN  212 (394)
T ss_dssp             CCCSEEECCTTC--CEECTT-TTTTCTT-CCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCB
T ss_pred             ccccccccCccc--cccchh-hhcccCC-CcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccce
Confidence            332222222211  112222 3444433 5555554332 2244444555555555555444 33344444444444444


Q ss_pred             EecccCcc---------------------ccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCC
Q 041689          173 VGLKDNKL---------------------EGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLP  231 (652)
Q Consensus       173 L~L~~N~l---------------------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~  231 (652)
                      +.+..+..                     +......|....+|+.+.+..+... +...+|..+..++.+....+. ...
T Consensus       213 i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~-i~~  290 (394)
T 4fs7_A          213 MEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI-VPE  290 (394)
T ss_dssp             CCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE-ECT
T ss_pred             eecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee-ecc
Confidence            44443332                     2233344555555555555554333 445555555555555554431 111


Q ss_pred             cccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCC
Q 041689          232 LEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSY  311 (652)
Q Consensus       232 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  311 (652)
                      ..|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.+...+|.++.+
T Consensus       291 ~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~  367 (394)
T 4fs7_A          291 KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN  367 (394)
T ss_dssp             TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred             ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence            23556667777777544 55556667777777777777644 55455667777777777777665 55556667777777


Q ss_pred             CceEEeecC
Q 041689          312 LEHLNLSFN  320 (652)
Q Consensus       312 L~~L~L~~N  320 (652)
                      |+.+++..+
T Consensus       368 L~~i~lp~~  376 (394)
T 4fs7_A          368 LKKVELPKR  376 (394)
T ss_dssp             CCEEEEEGG
T ss_pred             CCEEEECCC
Confidence            777777543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.49  E-value=8.1e-13  Score=139.39  Aligned_cols=268  Identities=14%  Similarity=0.064  Sum_probs=161.9

Q ss_pred             cCcccCCccccCCCCCCEEEcCCCcCeeccCCCccc--cccCC----CCCcccccccCCCCCCcEEEcccCCCcccCCcc
Q 041689           40 NLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN--YLTSS----TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRM  113 (652)
Q Consensus        40 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--~l~~~----~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  113 (652)
                      +++.+-..+|.++++|+.+.|..+ ++.+....+.+  .|...    ......-.+|.++.+|+.+.+..+ +..+... 
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~-  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDSVKMIGRCTFSGCYALKSILLPLM-LKSIGVE-  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTTCCEECTTTTTTCTTCCCCCCCTT-CCEECTT-
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCCceEccchhhcccccchhhcccCc-eeeecce-
Confidence            577788899999999999999854 77665543321  11100    001111234555566665555433 3334333 


Q ss_pred             chhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCC
Q 041689          114 SIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK  193 (652)
Q Consensus       114 ~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  193 (652)
                      .|.+..  +...... +.+..+...+|.++++|+.+.+..+. ..+...+|.++++|+.+.+..| ++......|.....
T Consensus       135 aF~~~~--~~~~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~  209 (394)
T 4fs7_A          135 AFKGCD--FKEITIP-EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL  209 (394)
T ss_dssp             TTTTCC--CSEEECC-TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred             eeeccc--ccccccC-ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence            444432  3333322 33444567889999999999998765 4478889999999999999887 55466677777777


Q ss_pred             CcEEEccCCccc---------------------ccccccCCCCCCCCEEEccCCCCCC-CcccCCCCccceEecccccCC
Q 041689          194 LYKLDLGGNKLS---------------------GSILTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLIGIDFSMNNFS  251 (652)
Q Consensus       194 L~~L~L~~N~l~---------------------~~~~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~~L~ls~N~l~  251 (652)
                      |+.+.+..+...                     .+...+|..+..|+.+.+..+...+ ...|..+..++.+....+.+ 
T Consensus       210 L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i-  288 (394)
T 4fs7_A          210 LENMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV-  288 (394)
T ss_dssp             CCBCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE-
T ss_pred             cceeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee-
Confidence            777777655432                     1222334444455555554443221 22344555555555544432 


Q ss_pred             ccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecC
Q 041689          252 SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       252 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                        ....|.++.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..|
T Consensus       289 --~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          289 --PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             --CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             --ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence              2345666677777777654 44455666777777777777544 55555667777777777777655

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.42  E-value=1.2e-11  Score=130.44  Aligned_cols=283  Identities=12%  Similarity=0.106  Sum_probs=172.4

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCc---CeeccCCCccc--cccCC----CCCcccccccCCCCCCcEE
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNY---LSGSLSSIADN--YLTSS----TPELSFLSSLSNCKSLVVF   99 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~--~l~~~----~~~~~~~~~l~~l~~L~~L   99 (652)
                      ..|+.+.+.. .++.+-..+|.++++|+.+.++.|.   ++.+....+..  .+...    ......-.+|.++.+|+.+
T Consensus        64 ~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~~~~I~~~aF~~c~~L~~i  142 (394)
T 4gt6_A           64 YVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDSVTEIDSEAFHHCEELDTV  142 (394)
T ss_dssp             SCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTTCSEECTTTTTTCTTCCEE
T ss_pred             CcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCccceehhhhhhhhcccccc
Confidence            3588888865 4787888899999999999998774   44443332211  00000    0000111234555555555


Q ss_pred             EcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCc
Q 041689          100 LLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNK  179 (652)
Q Consensus       100 ~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  179 (652)
                      .+..+ +..+... .|..... |+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. +...+|.+..+|.......+.
T Consensus       143 ~lp~~-~~~I~~~-~F~~c~~-L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~  216 (394)
T 4gt6_A          143 TIPEG-VTSVADG-MFSYCYS-LHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSES  216 (394)
T ss_dssp             ECCTT-CCEECTT-TTTTCTT-CCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSS
T ss_pred             cccce-eeeeccc-ceecccc-cccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccc
Confidence            55432 2333332 3444433 555555433 33344444443 34555555544332 445555555555555554444


Q ss_pred             cccccCccc--------------cCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCC-CcccCCCCccceEe
Q 041689          180 LEGTIPYDI--------------FRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLIGID  244 (652)
Q Consensus       180 l~~~~~~~~--------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~~L~  244 (652)
                      .. .....+              .....+..+.+. +.++.+...+|.++.+|+.+.+..+...+ ...|.+++.|+.+.
T Consensus       217 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~  294 (394)
T 4gt6_A          217 YP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIE  294 (394)
T ss_dssp             SC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEE
T ss_pred             cc-cccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccceecCccccccccccccc
Confidence            33 111111              111223333332 23444556788889999999988775333 34578889999999


Q ss_pred             cccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCc
Q 041689          245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       245 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  323 (652)
                      +. +.++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+++.+|...
T Consensus       295 l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          295 FS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             CC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             CC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            86 5677777788999999999999865 66567788999999999999655 76677788999999999999887654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.41  E-value=2e-13  Score=141.39  Aligned_cols=95  Identities=23%  Similarity=0.160  Sum_probs=64.0

Q ss_pred             CCcccCCCCccceEeccc-ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcC
Q 041689          230 LPLEIGNLKVLIGIDFSM-NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEK  308 (652)
Q Consensus       230 ~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  308 (652)
                      +|. +..+++|+.|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..
T Consensus        24 ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  102 (347)
T 2ifg_A           24 LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (347)
T ss_dssp             TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHccc
Confidence            444 55555566666664 6666666666777777777777777777666667777777777777777777666666665


Q ss_pred             CCCCceEEeecCcCcccC
Q 041689          309 LSYLEHLNLSFNKLEGEI  326 (652)
Q Consensus       309 l~~L~~L~L~~N~l~~~~  326 (652)
                      ++ |+.|+|++|+|.|.+
T Consensus       103 ~~-L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A          103 LS-LQELVLSGNPLHCSC  119 (347)
T ss_dssp             CC-CCEEECCSSCCCCCG
T ss_pred             CC-ceEEEeeCCCccCCC
Confidence            55 777777777777654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.41  E-value=4e-15  Score=155.08  Aligned_cols=162  Identities=19%  Similarity=0.132  Sum_probs=76.4

Q ss_pred             CCCCCEEECCCCcCcccCCccccCC-----CCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcc
Q 041689           28 PHNLEELLLGQNNLVGVVPAAIFDV-----STLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLS  102 (652)
Q Consensus        28 ~~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls  102 (652)
                      +++|++|+|++|+|+......|..+     ++|+.|+|++|.|+.....                .-...+++|+.|+|+
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~----------------~l~~~L~~L~~L~Ls  134 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR----------------TLLPVFLRARKLGLQ  134 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHH----------------HTHHHHHTEEEEECC
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHH----------------HHHHHHHhccHhhcC
Confidence            3456666666666654333333222     4666666666665421100                001123455666666


Q ss_pred             cCCCcccCCccchhcc----cccCcEEEccCCccccc----CCccccCCCCCCEEEecCcccccc----CCccccCCCCC
Q 041689          103 NNPLNGILPRMSIGNL----SHSLEIFDMSKCNVSGG----IPEEIGNLTNLTAIYLGGNKLNGS----IPFTLRELQKL  170 (652)
Q Consensus       103 ~N~l~~~~~~~~~~~l----~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L  170 (652)
                      +|.|++.... .+...    ..+|++|+|++|.|+..    ++..+..+++|++|+|++|.|+..    +...+...++|
T Consensus       135 ~n~l~~~~~~-~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L  213 (372)
T 3un9_A          135 LNSLGPEACK-DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL  213 (372)
T ss_dssp             SSCCCHHHHH-HHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCC
T ss_pred             CCCCCHHHHH-HHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCc
Confidence            6666543222 11110    12266666666665432    233334555566666666655432    13334445555


Q ss_pred             cEEecccCccccc----cCccccCCCCCcEEEccCCcccc
Q 041689          171 QYVGLKDNKLEGT----IPYDIFRLVKLYKLDLGGNKLSG  206 (652)
Q Consensus       171 ~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~  206 (652)
                      ++|+|++|.|+..    ++..+...++|++|+|++|.|+.
T Consensus       214 ~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             CEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            5555555555532    22223334555555555555553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.39  E-value=5.5e-15  Score=154.07  Aligned_cols=168  Identities=17%  Similarity=0.181  Sum_probs=77.2

Q ss_pred             cCcEEEccCCcccccCCccccCC-----CCCCEEEecCccccccCCccc-cCCCCCcEEecccCccccccCcccc-----
Q 041689          121 SLEIFDMSKCNVSGGIPEEIGNL-----TNLTAIYLGGNKLNGSIPFTL-RELQKLQYVGLKDNKLEGTIPYDIF-----  189 (652)
Q Consensus       121 ~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~-----  189 (652)
                      .|+.|+|++|.|+......+..+     ++|++|+|++|.|+......+ ..+++|++|+|++|.|+......+.     
T Consensus        73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~  152 (372)
T 3un9_A           73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH  152 (372)
T ss_dssp             TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred             hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence            36666666666654433333222     456666666666543222222 2334555555555555433222221     


Q ss_pred             CCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCcc----CcccccCCCCCc
Q 041689          190 RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV----IPTTIGSLKDLQ  265 (652)
Q Consensus       190 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~  265 (652)
                      ..++|+.|+|++|.|+......                  ++..+..+++|++|+|++|.|+..    ++..+...++|+
T Consensus       153 ~~~~L~~L~Ls~n~l~~~~~~~------------------l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~  214 (372)
T 3un9_A          153 DQCQITTLRLSNNPLTAAGVAV------------------LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQ  214 (372)
T ss_dssp             TTCCCCEEECCSSCCHHHHHHH------------------HHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCC
T ss_pred             cCCccceeeCCCCCCChHHHHH------------------HHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcC
Confidence            2344555555555544211111                  111222333444444444444421    133444555666


Q ss_pred             EEEccCCcCCCc----ccccccccccCcceeccccccCCCCchhh
Q 041689          266 YLFLGYNILKGS----IPDSVGDLISLKSLNFSNNNLSGAIPLLL  306 (652)
Q Consensus       266 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  306 (652)
                      .|+|++|.|++.    ++..+...++|+.|||++|.|+......+
T Consensus       215 ~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          215 ELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             EEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             eEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            666666666532    22233344566666666666654333333

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=1.8e-12  Score=128.51  Aligned_cols=147  Identities=13%  Similarity=0.056  Sum_probs=116.3

Q ss_pred             HHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEE
Q 041689          421 CRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       421 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  499 (652)
                      .....+|++....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888898999999999754 6899999987542233457899999999984 67788999999888899999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN--------------------------------------  541 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------  541 (652)
                      |||++|.++.+....      ......++.++++++..||+.                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999875321      122346889999999999981                                      


Q ss_pred             ------------------CCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          542 ------------------FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       542 ------------------~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                                        ..+.++|+|++|.||++++++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              013699999999999998776677999998763

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.36  E-value=3e-11  Score=127.29  Aligned_cols=283  Identities=13%  Similarity=0.120  Sum_probs=195.2

Q ss_pred             CCCCCCEEECCCCc---CcccCCccccCCCCCCEEEcCCCcCeeccCCCccc-------cccCCCCCcccccccCCCCCC
Q 041689           27 NPHNLEELLLGQNN---LVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADN-------YLTSSTPELSFLSSLSNCKSL   96 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-------~l~~~~~~~~~~~~l~~l~~L   96 (652)
                      ++.+|+.+.++.|.   ++.+-..+|.+..+|+.+.+..+ ++.+....+..       .+.... ....-.+|.++.+|
T Consensus        85 ~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L  162 (394)
T 4gt6_A           85 NCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSL  162 (394)
T ss_dssp             TCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTC
T ss_pred             CCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccccccee-eeecccceeccccc
Confidence            67899999988764   77667788888888888877654 44333332211       111111 11122468899999


Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCcccc-----------
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLR-----------  165 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----------  165 (652)
                      +.+.+..+ ++.+... .|.. . .|+.+.+..+-. .+...+|.++.+|+......+.........+.           
T Consensus       163 ~~i~~~~~-~~~I~~~-aF~~-~-~l~~i~ip~~~~-~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (394)
T 4gt6_A          163 HTVTLPDS-VTAIEER-AFTG-T-ALTQIHIPAKVT-RIGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIR  237 (394)
T ss_dssp             CEEECCTT-CCEECTT-TTTT-C-CCSEEEECTTCC-EECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEE
T ss_pred             ccccccce-eeEeccc-cccc-c-ceeEEEECCccc-ccccchhhhccccceecccccccccccceeecccccccccccc
Confidence            99999865 6666655 5554 3 499999986644 47788999999999998887766532222121           


Q ss_pred             --CCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCC-cccCCCCccce
Q 041689          166 --ELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLP-LEIGNLKVLIG  242 (652)
Q Consensus       166 --~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~-~~~~~l~~L~~  242 (652)
                        ....+..+.+. +.++.....+|..+.+|+.+.+..+..+ +...+|.++++|+.+.+..+-..++ ..|.++.+|+.
T Consensus       238 ~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~~i~~I~~~aF~~c~~L~~  315 (394)
T 4gt6_A          238 YPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSSRITELPESVFAGCISLKS  315 (394)
T ss_dssp             CCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCE
T ss_pred             cccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCCCcccccCceeecCCCCcCE
Confidence              22334444443 3344455678889999999999876654 7788999999999999986644444 45889999999


Q ss_pred             EecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcC
Q 041689          243 IDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL  322 (652)
Q Consensus       243 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  322 (652)
                      +++..+ ++.+...+|.++.+|+.+.+..+ ++.+...+|.++++|+.+++.+|...   -..+.....|+.+.+..|.+
T Consensus       316 i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          316 IDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             EECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred             EEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            999765 77777889999999999999765 66677889999999999999998764   24677788899988877765


Q ss_pred             c
Q 041689          323 E  323 (652)
Q Consensus       323 ~  323 (652)
                      .
T Consensus       391 ~  391 (394)
T 4gt6_A          391 D  391 (394)
T ss_dssp             -
T ss_pred             E
Confidence            4

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.32  E-value=3.4e-12  Score=132.16  Aligned_cols=99  Identities=22%  Similarity=0.258  Sum_probs=56.8

Q ss_pred             EEccCC-cccccCCccccCCCCCCEEEecC-ccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCC
Q 041689          125 FDMSKC-NVSGGIPEEIGNLTNLTAIYLGG-NKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN  202 (652)
Q Consensus       125 L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  202 (652)
                      ++++++ +|++ +|. +..+++|+.|+|++ |+|+++.+..|.+|++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus        13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            455555 5553 344 55556666666664 6666555555666666666666666666555555666666666666666


Q ss_pred             cccccccccCCCCCCCCEEEccCC
Q 041689          203 KLSGSILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       203 ~l~~~~~~~~~~l~~L~~L~Ls~N  226 (652)
                      +|+++++..|..++ |+.|+|++|
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N  113 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGN  113 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCC
Confidence            66655555554443 555555544

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=1.4e-11  Score=121.97  Aligned_cols=137  Identities=14%  Similarity=0.097  Sum_probs=102.7

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCe--eeeEEeeeecCCceEEEEEcc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN--LVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +|.+....+.|..+.||++...+|..+++|+....   ....+..|+++++.+.+.+  +++++++...++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34443333456679999998777888999997543   3356788999999986444  566888888878899999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF-----------------------------------------  542 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  542 (652)
                      +|.++.  ...    .+   ...++.++++.+..||+..                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998884  211    12   2357788888888888742                                         


Q ss_pred             --------------CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          543 --------------LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       543 --------------~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                                    ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          11399999999999998877778999999863

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.16  E-value=2.9e-09  Score=111.43  Aligned_cols=282  Identities=12%  Similarity=0.076  Sum_probs=170.6

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCcccc-ccC----CCCCcccccccCCCCCCcEEEc
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNY-LTS----STPELSFLSSLSNCKSLVVFLL  101 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-l~~----~~~~~~~~~~l~~l~~L~~L~L  101 (652)
                      ...+|+.+.+. ..++.+-..+|.++.+|+.++|..+ ++.+....+.+- +..    .......-.+|.+. +|+.+.+
T Consensus        44 ~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c~l~~i~~~~~l~~I~~~aF~~~-~L~~i~l  120 (379)
T 4h09_A           44 DRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADTKLQSYTGMERVKKFGDYVFQGT-DLDDFEF  120 (379)
T ss_dssp             GGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCCCCEEEECTTCCEECTTTTTTC-CCSEEEC
T ss_pred             cccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCCCCceEECCceeeEeccceeccC-CcccccC
Confidence            45678888885 4577777888999999999988754 665544332210 000    00000011123332 5666666


Q ss_pred             ccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccc------------cCCccccCCCC
Q 041689          102 SNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG------------SIPFTLRELQK  169 (652)
Q Consensus       102 s~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~~~~~~~l~~  169 (652)
                      ..+ ++.+... .|.+.  +|+.+.+.. .++.+...+|..+.+++.+.+..+....            .....+.....
T Consensus       121 p~~-~~~i~~~-~F~~~--~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (379)
T 4h09_A          121 PGA-TTEIGNY-IFYNS--SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKT  195 (379)
T ss_dssp             CTT-CCEECTT-TTTTC--CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCC
T ss_pred             CCc-ccccccc-ccccc--eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccccc
Confidence            543 2223322 33322  255544433 3444555666666666666665543321            11122333344


Q ss_pred             CcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCC-CcccCCCCccceEecccc
Q 041689          170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLIGIDFSMN  248 (652)
Q Consensus       170 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~~L~ls~N  248 (652)
                      +..+.+..+.-. .....+....+|+.+.+..+ +..+...+|.++..|+.+.+..+-..+ ...|.++.+|+.+.+..+
T Consensus       196 ~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~v~~I~~~aF~~~~~l~~i~l~~~  273 (379)
T 4h09_A          196 GTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKNVTSIGSFLLQNCTALKTLNFYAK  273 (379)
T ss_dssp             CSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTTCCEECTTTTTTCTTCCEEEECCC
T ss_pred             ccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCCccEeCccccceeehhcccccccc
Confidence            444444333322 44556667778888887655 455667788888888888887763233 345777888888888644


Q ss_pred             cCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecC
Q 041689          249 NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       249 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                       +..+...+|.++.+|+.+.+.++.++.+.+.+|.++.+|+.++|.++ ++.+-..+|.++.+|+.+.+..+
T Consensus       274 -i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          274 -VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             -CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             -ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence             66566678888888888888888887666778888888888888655 66566778888888888877544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.13  E-value=3.9e-09  Score=110.40  Aligned_cols=266  Identities=12%  Similarity=0.095  Sum_probs=184.6

Q ss_pred             ccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEE
Q 041689           47 AAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFD  126 (652)
Q Consensus        47 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~  126 (652)
                      .+|....+|+.+.+..+ ++.+..                 .+|.++.+|+.++|..+ ++.+... +|.+.  +|+.+.
T Consensus        40 ~~~~~~~~i~~v~ip~~-vt~Ig~-----------------~aF~~C~~L~~I~lp~~-v~~Ig~~-aF~~c--~l~~i~   97 (379)
T 4h09_A           40 PWYKDRDRISEVRVNSG-ITSIGE-----------------ANFNSCYNMTKVTVAST-VTSIGDG-AFADT--KLQSYT   97 (379)
T ss_dssp             TTGGGGGGCSEEEECTT-EEEECT-----------------TTTTTCTTCCEEEECTT-CCEECTT-TTTTC--CCCEEE
T ss_pred             cccccccCCEEEEeCCC-ccChHH-----------------HHhhCCCCCCEEEeCCc-ceEechh-hhcCC--CCceEE
Confidence            35677788999988753 665544                 36889999999999754 7777665 66665  388887


Q ss_pred             ccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcc--
Q 041689          127 MSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKL--  204 (652)
Q Consensus       127 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l--  204 (652)
                      +.. +++.+...+|.++ +|+.+.+..+- +.+...+|.+. +|+...+..+ ++......|....+++.+.+..+..  
T Consensus        98 ~~~-~l~~I~~~aF~~~-~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~  172 (379)
T 4h09_A           98 GME-RVKKFGDYVFQGT-DLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNY  172 (379)
T ss_dssp             ECT-TCCEECTTTTTTC-CCSEEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSE
T ss_pred             CCc-eeeEeccceeccC-CcccccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhccccccccccccccccee
Confidence            764 4666667777765 78888887653 32444555443 4555544433 3324444555555555555443221  


Q ss_pred             ---------------------------------cccccccCCCCCCCCEEEccCCCCCC-CcccCCCCccceEecccccC
Q 041689          205 ---------------------------------SGSILTCFSNLASLRTLSLSYNDGPL-PLEIGNLKVLIGIDFSMNNF  250 (652)
Q Consensus       205 ---------------------------------~~~~~~~~~~l~~L~~L~Ls~N~~~~-~~~~~~l~~L~~L~ls~N~l  250 (652)
                                                       .......|....+|+.+.+..+-..+ ...+.++..|+.+.+..+ +
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~~~~i~~~~f~~~~~L~~i~lp~~-v  251 (379)
T 4h09_A          173 VAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSGVTTLGDGAFYGMKALDEIAIPKN-V  251 (379)
T ss_dssp             EEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTTCCEECTTTTTTCSSCCEEEECTT-C
T ss_pred             ecccceecccccceeccccccccccccccccceeEEeecccccccccceeeeccceeEEccccccCCccceEEEcCCC-c
Confidence                                             12334567778899999998774333 445888999999999876 7


Q ss_pred             CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCC-
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKG-  329 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-  329 (652)
                      +.+...+|.++.+|+.+.+..+ ++.+...+|..+++|+.+.+.++.++.+...+|.++.+|+.++|..+ ++ .+... 
T Consensus       252 ~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~a  328 (379)
T 4h09_A          252 TSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYA  328 (379)
T ss_dssp             CEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTT
T ss_pred             cEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHH
Confidence            7777889999999999999765 55567788999999999999999998788899999999999999755 54 23322 


Q ss_pred             -CCCCCcccccccCC
Q 041689          330 -GSFGNFSAESFEGN  343 (652)
Q Consensus       330 -~~~~~l~~~~~~~N  343 (652)
                       ....+|+.+.+..+
T Consensus       329 F~~C~~L~~i~ip~~  343 (379)
T 4h09_A          329 FKNCKALSTISYPKS  343 (379)
T ss_dssp             TTTCTTCCCCCCCTT
T ss_pred             hhCCCCCCEEEECCc
Confidence             23345666666443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=3.9e-10  Score=117.20  Aligned_cols=142  Identities=15%  Similarity=0.180  Sum_probs=107.1

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEee--ccc-chhhhhHHHHHHHHHhcC--CCeeeeEEeeeecC---CceEEEE
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFH--LQC-GRAFKSFDIECEIMKSIH--YRNLVKIISSCSNE---EFKELVL  500 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  500 (652)
                      ..+.++.|.++.||++... +..+++|+..  ... ......+.+|.++++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4578899999999998875 4688898875  332 123457889999999996  45578888888766   4589999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF--------------------------------------  542 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  542 (652)
                      ||++|..+.+...   ..++..++..++.+++++|..||+..                                      
T Consensus       121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999988754211   13677888889999999999999731                                      


Q ss_pred             -----------------CCCeEecCCCCCCeeeCCCC--cEEEecccCCcc
Q 041689          543 -----------------LVPVIHCDLKPSNVLLDDTM--VAHLSDFGITKL  574 (652)
Q Consensus       543 -----------------~~~iiH~dlkp~NIll~~~~--~~kl~Dfg~~~~  574 (652)
                                       .+.++|+|++|.||+++.++  .+.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             24799999999999998765  368999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.05  E-value=4.2e-10  Score=113.99  Aligned_cols=194  Identities=16%  Similarity=0.161  Sum_probs=128.1

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCe--eeeEEeeeecCC---ceEEEEEcc
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRN--LVKIISSCSNEE---FKELVLEHM  503 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  503 (652)
                      .+.++.|....||++.    ..+++|+....  .....+.+|.++++.+. +..  +++++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999863    56899986533  34567889999998883 332  445555544333   458999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN------------------------------------------  541 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  541 (652)
                      +|.++.+....   .++..++..++.+++..+..||+.                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888753332   367777888889999999988861                                          


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC--CCcEEEecccCCccccCCCCccccc-c------------ccCCccc
Q 041689          542 -------------FLVPVIHCDLKPSNVLLDD--TMVAHLSDFGITKLLIGEDQSMTQT-Q------------TLATIGY  593 (652)
Q Consensus       542 -------------~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~-~------------~~gt~~y  593 (652)
                                   ..+.++|+|++|.||++++  +..+.|+||+.+..-... ...... .            .....++
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                         1136899999999999998  567899999998743110 000000 0            0000011


Q ss_pred             cC-ccccccCccCcccchhhHHHHHHHHHhCCCCcchhhhhhh
Q 041689          594 IA-PEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVSFVFNLA  635 (652)
Q Consensus       594 ~a-PE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~l~~l~  635 (652)
                      .. |+...  ......+.|++|.++|.+.+|..++-..-...+
T Consensus       255 ~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~~~g~~~~  295 (304)
T 3sg8_A          255 KDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWYEEGLNEI  295 (304)
T ss_dssp             SCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHHHHHHHHH
T ss_pred             CCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHHH
Confidence            11 22211  112335899999999999999999766544433

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.99  E-value=1.8e-10  Score=118.84  Aligned_cols=153  Identities=20%  Similarity=0.219  Sum_probs=70.5

Q ss_pred             ccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCC--CCCCCCEEEccCC--C-C-C-----CCc
Q 041689          164 LRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFS--NLASLRTLSLSYN--D-G-P-----LPL  232 (652)
Q Consensus       164 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N--~-~-~-----~~~  232 (652)
                      +..+|+|+.|.|++|.-. .++. + .+++|+.|+|..+.+.......+.  .+++|++|+|+.+  . + .     +..
T Consensus       168 l~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~  244 (362)
T 2ra8_A          168 LDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP  244 (362)
T ss_dssp             HHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGG
T ss_pred             HhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHH
Confidence            344455555555554211 1121 2 245566666655555432222222  4556666655421  0 0 0     000


Q ss_pred             cc--CCCCccceEecccccCCccCcccc---cCCCCCcEEEccCCcCCCc----ccccccccccCcceeccccccCCCCc
Q 041689          233 EI--GNLKVLIGIDFSMNNFSSVIPTTI---GSLKDLQYLFLGYNILKGS----IPDSVGDLISLKSLNFSNNNLSGAIP  303 (652)
Q Consensus       233 ~~--~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~  303 (652)
                      .+  ..+++|+.|+|.+|.+....+..+   ..+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.|+...-
T Consensus       245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~  324 (362)
T 2ra8_A          245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK  324 (362)
T ss_dssp             GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred             HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence            11  234556666666665543222222   2355666666666666542    23333455666666666666653333


Q ss_pred             hhhcC-CCCCceEEeecCc
Q 041689          304 LLLEK-LSYLEHLNLSFNK  321 (652)
Q Consensus       304 ~~~~~-l~~L~~L~L~~N~  321 (652)
                      ..+.. +  ...+++++|+
T Consensus       325 ~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          325 KELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHc--CCEEEecCCc
Confidence            33332 2  2345666555

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.92  E-value=2.3e-10  Score=118.15  Aligned_cols=209  Identities=14%  Similarity=0.154  Sum_probs=118.0

Q ss_pred             CCCCCCEEECCCCcCcc-c-------CCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcE
Q 041689           27 NPHNLEELLLGQNNLVG-V-------VPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVV   98 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~-~-------~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~   98 (652)
                      .+..++.|.+......+ .       +..+...+++|+.|.+..+......       ++.... ......+..+++|+.
T Consensus       105 ~~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~-------is~~~~-~~L~~ll~~~P~L~~  176 (362)
T 2ra8_A          105 KLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQE-------ISWIEQ-VDLSPVLDAMPLLNN  176 (362)
T ss_dssp             TGGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCC-------GGGCBC-CBCHHHHHTCTTCCE
T ss_pred             CchhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcc-------cccccc-cCHHHHHhcCCCCcE
Confidence            34566777777555432 1       1223445678888887665321100       000000 000122456678888


Q ss_pred             EEcccCCCcccCCccchhcccccCcEEEccCCcccccCCcccc--CCCCCCEEEecC--cccccc-----CCccc--cCC
Q 041689           99 FLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIG--NLTNLTAIYLGG--NKLNGS-----IPFTL--REL  167 (652)
Q Consensus        99 L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~-----~~~~~--~~l  167 (652)
                      |+|++|.-..+.+   + .+++ |+.|+|..|.++......+.  .+++|++|+|+.  |...+.     +...+  ..+
T Consensus       177 L~L~g~~~l~l~~---~-~~~~-L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~  251 (362)
T 2ra8_A          177 LKIKGTNNLSIGK---K-PRPN-LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF  251 (362)
T ss_dssp             EEEECCBTCBCCS---C-BCTT-CSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTC
T ss_pred             EEEeCCCCceecc---c-cCCC-CcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCC
Confidence            8888773112221   1 2444 88888888887654434443  688888888863  222111     11122  247


Q ss_pred             CCCcEEecccCccccccCcccc---CCCCCcEEEccCCcccccc----cccCCCCCCCCEEEccCCCCCCCcccCCCCc-
Q 041689          168 QKLQYVGLKDNKLEGTIPYDIF---RLVKLYKLDLGGNKLSGSI----LTCFSNLASLRTLSLSYNDGPLPLEIGNLKV-  239 (652)
Q Consensus       168 ~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~-  239 (652)
                      ++|++|+|++|.+....+..+.   .+++|++|+|+.|.|++..    +..+..+++|+.|+|++|... ......+.. 
T Consensus       252 p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~-d~~~~~l~~a  330 (362)
T 2ra8_A          252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS-DEMKKELQKS  330 (362)
T ss_dssp             TTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC-HHHHHHHHHH
T ss_pred             CCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC-HHHHHHHHHH
Confidence            8899999988888754443333   4678999999999887642    333356788999999888411 111222222 


Q ss_pred             -cceEeccccc
Q 041689          240 -LIGIDFSMNN  249 (652)
Q Consensus       240 -L~~L~ls~N~  249 (652)
                       ...++++.|+
T Consensus       331 lg~~~~~~~~~  341 (362)
T 2ra8_A          331 LPMKIDVSDSQ  341 (362)
T ss_dssp             CCSEEECCSBC
T ss_pred             cCCEEEecCCc
Confidence             2568888887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.58  E-value=4.4e-07  Score=91.64  Aligned_cols=136  Identities=13%  Similarity=0.105  Sum_probs=96.8

Q ss_pred             cceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCC---eeeeEEeeee-cCCceEEEEEccCC
Q 041689          430 NNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR---NLVKIISSCS-NEEFKELVLEHMPH  505 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  505 (652)
                      .+.++.|....||+.    |..+++|+...  ......+.+|.++++.+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899987    57789998532  23456788999999999642   3566666664 45667899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN--------------------------------------------  541 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  541 (652)
                      .++.+....   .++..+...++.++++.|..||+.                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888763221   234455555666666666666642                                            


Q ss_pred             -------------CCCCeEecCCCCCCeeeCC---CCc-EEEecccCCcc
Q 041689          542 -------------FLVPVIHCDLKPSNVLLDD---TMV-AHLSDFGITKL  574 (652)
Q Consensus       542 -------------~~~~iiH~dlkp~NIll~~---~~~-~kl~Dfg~~~~  574 (652)
                                   ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2235799999999999987   345 58999998864

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.58  E-value=8.6e-09  Score=100.84  Aligned_cols=96  Identities=21%  Similarity=0.265  Sum_probs=56.4

Q ss_pred             EEccCCccc---ccCCccccCCCCCCEEEecCcccccc--CCccccCCCCCcEEecccCccccccCccccCCC--CCcEE
Q 041689          125 FDMSKCNVS---GGIPEEIGNLTNLTAIYLGGNKLNGS--IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV--KLYKL  197 (652)
Q Consensus       125 L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L  197 (652)
                      ++++.|...   ...+-...++++|+.|+|++|+|+++  +|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            556666433   11222234567777777777777753  345566777777777777777754  2233333  77777


Q ss_pred             EccCCccccccc-------ccCCCCCCCCEEE
Q 041689          198 DLGGNKLSGSIL-------TCFSNLASLRTLS  222 (652)
Q Consensus       198 ~L~~N~l~~~~~-------~~~~~l~~L~~L~  222 (652)
                      +|++|.+.+..|       ..+..+++|+.||
T Consensus       226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            777777765433       2345566666664

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.57  E-value=8.9e-09  Score=100.74  Aligned_cols=108  Identities=24%  Similarity=0.254  Sum_probs=79.0

Q ss_pred             cccCCCCCCcE--EEcccCCCcccCC--ccchhcccccCcEEEccCCccccc--CCccccCCCCCCEEEecCccccccCC
Q 041689           88 SSLSNCKSLVV--FLLSNNPLNGILP--RMSIGNLSHSLEIFDMSKCNVSGG--IPEEIGNLTNLTAIYLGGNKLNGSIP  161 (652)
Q Consensus        88 ~~l~~l~~L~~--L~Ls~N~l~~~~~--~~~~~~l~~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~  161 (652)
                      +.|...+.|+.  ++++.|+...+..  .....+++. |+.|+|++|+|+++  +|..+..+++|+.|+|++|+|++.  
T Consensus       135 s~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~-L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--  211 (267)
T 3rw6_A          135 KGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPE-LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--  211 (267)
T ss_dssp             TTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTT-CCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--
T ss_pred             HHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCC-CCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--
Confidence            34555566666  7788886543321  102245665 99999999999984  457788999999999999999965  


Q ss_pred             ccccCCC--CCcEEecccCccccccCc-------cccCCCCCcEEE
Q 041689          162 FTLRELQ--KLQYVGLKDNKLEGTIPY-------DIFRLVKLYKLD  198 (652)
Q Consensus       162 ~~~~~l~--~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~  198 (652)
                      ..+..+.  +|++|+|++|.+.+..|+       .+..+++|+.||
T Consensus       212 ~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          212 RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            3344444  999999999999976663       467788999885

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.54  E-value=1.8e-08  Score=93.71  Aligned_cols=116  Identities=14%  Similarity=0.107  Sum_probs=69.5

Q ss_pred             ccCCCCCCcEEEcccC-CCcccCCcc---chhcccccCcEEEccCCccccc----CCccccCCCCCCEEEecCcccccc-
Q 041689           89 SLSNCKSLVVFLLSNN-PLNGILPRM---SIGNLSHSLEIFDMSKCNVSGG----IPEEIGNLTNLTAIYLGGNKLNGS-  159 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N-~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-  159 (652)
                      .+...++|++|+|++| .|.......   .+...+ +|++|+|++|+|...    +...+...++|++|+|++|.|... 
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~-~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNT-YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCC-SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCC-CcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            3567788888888888 876431110   122223 377777777777642    334455556777777777777632 


Q ss_pred             ---CCccccCCCCCcEEec--ccCccccc----cCccccCCCCCcEEEccCCccc
Q 041689          160 ---IPFTLRELQKLQYVGL--KDNKLEGT----IPYDIFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       160 ---~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  205 (652)
                         +...+...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence               2444556666777777  66776643    2233444456666666666664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.52  E-value=9e-07  Score=87.61  Aligned_cols=136  Identities=19%  Similarity=0.096  Sum_probs=99.0

Q ss_pred             ceeccccce-EEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEEccCCCC
Q 041689          431 NLIGKGGFG-TIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       431 ~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      +.+..|..| .||+.... ++..+++|+-...   ....+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345556555 68988754 4678999986543   3456788999998884 3336788888888899999999999988


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 041689          508 LEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF---------------------------------------------  542 (652)
Q Consensus       508 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------------  542 (652)
                      +.+......     .....+..+++..|..||...                                             
T Consensus       107 ~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            877543221     223346667777777777421                                             


Q ss_pred             ----------CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          543 ----------LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       543 ----------~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                                .+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      11379999999999999887778999998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=3.5e-08  Score=91.73  Aligned_cols=105  Identities=14%  Similarity=0.239  Sum_probs=56.0

Q ss_pred             CcEEEccCC-ccccc----CCccccCCCCCCEEEecCcccccc----CCccccCCCCCcEEecccCccccc----cCccc
Q 041689          122 LEIFDMSKC-NVSGG----IPEEIGNLTNLTAIYLGGNKLNGS----IPFTLRELQKLQYVGLKDNKLEGT----IPYDI  188 (652)
Q Consensus       122 L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~  188 (652)
                      |++|+|++| .|...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|+..    +...+
T Consensus        38 L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L  117 (185)
T 1io0_A           38 LEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEAL  117 (185)
T ss_dssp             CCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGG
T ss_pred             CCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHH
Confidence            777777776 66532    334455566677777777766521    223344455666666666666532    23344


Q ss_pred             cCCCCCcEEEc--cCCcccccc----cccCCCCCCCCEEEccCC
Q 041689          189 FRLVKLYKLDL--GGNKLSGSI----LTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       189 ~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~Ls~N  226 (652)
                      ...++|++|+|  ++|.|....    ...+...++|++|+|++|
T Consensus       118 ~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n  161 (185)
T 1io0_A          118 QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  161 (185)
T ss_dssp             GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCC
Confidence            45555666666  556665321    222333344555555444

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=4e-07  Score=94.15  Aligned_cols=81  Identities=5%  Similarity=-0.070  Sum_probs=57.6

Q ss_pred             ccee-ccccceEEEEEEeC-------CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcC-C--CeeeeEEeeeecC--
Q 041689          430 NNLI-GKGGFGTIYKSRIG-------DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIH-Y--RNLVKIISSCSNE--  493 (652)
Q Consensus       430 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--  493 (652)
                      .+.| +.|..+.+|+....       ++..+++|+.....   ......+.+|+++++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998754       26789999865432   111356788999998884 3  3567788877655  


Q ss_pred             -CceEEEEEccCCCChhh
Q 041689          494 -EFKELVLEHMPHGSLEK  510 (652)
Q Consensus       494 -~~~~lv~e~~~~g~L~~  510 (652)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.13  E-value=9e-06  Score=85.27  Aligned_cols=75  Identities=15%  Similarity=0.142  Sum_probs=50.3

Q ss_pred             cceeccccceEEEEEEeC-CCcEEEEEEeecccc-------hhhhhHHHHHHHHHhcCC--C-eeeeEEeeeecCCceEE
Q 041689          430 NNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-------RAFKSFDIECEIMKSIHY--R-NLVKIISSCSNEEFKEL  498 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l  498 (652)
                      .+.+|.|..+.||++... +++.|+||.......       .....+..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 468899998653211       123456789999988742  3 34566654  3445689


Q ss_pred             EEEccCCC
Q 041689          499 VLEHMPHG  506 (652)
Q Consensus       499 v~e~~~~g  506 (652)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.04  E-value=2e-05  Score=80.69  Aligned_cols=139  Identities=14%  Similarity=0.124  Sum_probs=79.8

Q ss_pred             ceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC--CeeeeEEee------eecCCceEEEEEc
Q 041689          431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY--RNLVKIISS------CSNEEFKELVLEH  502 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~------~~~~~~~~lv~e~  502 (652)
                      +.++.|..+.||++...+| .+++|+....    ...+..|.++++.+..  -.+++++..      ....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987554 5999998652    1334456666655531  123334331      1245678899999


Q ss_pred             cCCCChh-----h------h---hhc----C--CC-------CCCHHHH-------------------------------
Q 041689          503 MPHGSLE-----K------C---LYS----S--NC-------ILDIFQR-------------------------------  524 (652)
Q Consensus       503 ~~~g~L~-----~------~---l~~----~--~~-------~l~~~~~-------------------------------  524 (652)
                      ++|..+.     .      .   ++.    .  ..       ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0      0   110    0  00       0112110                               


Q ss_pred             HHHHHHHHHHHHHHHc----------CCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          525 LNIMIDVASVLEYLHF----------NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       525 ~~i~~~i~~~L~~LH~----------~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ..+..++..++++|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223445666653          1234899999999999998888999999998863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=4.7e-05  Score=76.49  Aligned_cols=137  Identities=14%  Similarity=0.083  Sum_probs=92.1

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC---CCeeeeEEeeeecCCceEEEEEccCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH---YRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|.+.++.+.   ...+++++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999876 5678999987643   3466888999998883   35688889888888889999999998


Q ss_pred             CChhh-----------hhhcCCC---------------------CCCHHHHH---HHH----------------HHHHHH
Q 041689          506 GSLEK-----------CLYSSNC---------------------ILDIFQRL---NIM----------------IDVASV  534 (652)
Q Consensus       506 g~L~~-----------~l~~~~~---------------------~l~~~~~~---~i~----------------~~i~~~  534 (652)
                      ..+..           .++....                     .-+|.+..   ++.                .+++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            75421           1111110                     01333211   111                111112


Q ss_pred             H-HHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEeccc
Q 041689          535 L-EYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFG  570 (652)
Q Consensus       535 L-~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg  570 (652)
                      + ..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23321 2246899999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=0.00014  Score=72.42  Aligned_cols=78  Identities=13%  Similarity=0.074  Sum_probs=57.8

Q ss_pred             CCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-C--CeeeeEEeeeecCCceEEEEEc
Q 041689          426 GFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-Y--RNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .....+.+|.|..+.||+.+..+|+.|++|+...........++.|++.|+.+. .  --+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            345567899999999999999999999999876544344456889999999884 2  2345555542    34789999


Q ss_pred             cCCCC
Q 041689          503 MPHGS  507 (652)
Q Consensus       503 ~~~g~  507 (652)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=0.00014  Score=73.58  Aligned_cols=158  Identities=13%  Similarity=0.121  Sum_probs=90.1

Q ss_pred             cccHHHHHHHhcCCCcc-----ceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCe--eeeE
Q 041689          414 RFSYLEVCRATYGFNEN-----NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN--LVKI  486 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~  486 (652)
                      .++.+++.....+|...     +.|+.|....+|+....+| .+++|+....  .....+..|.++++.+....  ++++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            45666666666666542     4566688889999887555 7889988653  12345667888887774222  3344


Q ss_pred             Eee------eecCCceEEEEEccCCCChhh-----h---------hhcC----CCC----CC---HHHHHH---------
Q 041689          487 ISS------CSNEEFKELVLEHMPHGSLEK-----C---------LYSS----NCI----LD---IFQRLN---------  526 (652)
Q Consensus       487 ~~~------~~~~~~~~lv~e~~~~g~L~~-----~---------l~~~----~~~----l~---~~~~~~---------  526 (652)
                      +..      ....+..+++|+|++|..+..     +         ++..    ...    ..   |.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            322      122356789999999865321     0         1110    000    01   111000         


Q ss_pred             ---HHHHHHHHHHHHHcC----CCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          527 ---IMIDVASVLEYLHFN----FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       527 ---i~~~i~~~L~~LH~~----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                         +...+...+++++..    ...+++|+|+.+.||++++++.+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               001133445555432    134799999999999999876668999998763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=0.00013  Score=77.06  Aligned_cols=74  Identities=7%  Similarity=0.045  Sum_probs=46.2

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeeccc-------c--hhhhhHHHHHHHHH-hcCCCeeeeEEeeeecCCceEE
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC-------G--RAFKSFDIECEIMK-SIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~--~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..+.+|.|..+.||++.. +++.++||......       .  .....++.|+..+. ......+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            346789999999999965 56789999532210       0  02223444443332 22334567777665  466789


Q ss_pred             EEEcc-CC
Q 041689          499 VLEHM-PH  505 (652)
Q Consensus       499 v~e~~-~~  505 (652)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.69  E-value=1.8e-05  Score=71.74  Aligned_cols=84  Identities=15%  Similarity=0.090  Sum_probs=58.2

Q ss_pred             CccceEecccccCCccCcccccCCCCCcEEEccCCc-CCCccccccccc----ccCcceecccc-ccCCCCchhhcCCCC
Q 041689          238 KVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNI-LKGSIPDSVGDL----ISLKSLNFSNN-NLSGAIPLLLEKLSY  311 (652)
Q Consensus       238 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N-~l~~~~~~~~~~l~~  311 (652)
                      ..|+.||++++.++..--..+.++++|++|+|+++. |++.--..+..+    ++|+.|+|+++ ++|..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            457777777777765444556778888888888884 664333344443    46888888887 476443445677888


Q ss_pred             CceEEeecCc
Q 041689          312 LEHLNLSFNK  321 (652)
Q Consensus       312 L~~L~L~~N~  321 (652)
                      |+.|++++++
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888888765

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.65  E-value=1.8e-05  Score=71.66  Aligned_cols=81  Identities=11%  Similarity=0.058  Sum_probs=42.6

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCcc-ccccCCccccCC----CCCcEEecccCc-cccccCccccCCCCCc
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNK-LNGSIPFTLREL----QKLQYVGLKDNK-LEGTIPYDIFRLVKLY  195 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~L~  195 (652)
                      |+.||++++.|+..--..+.++++|++|+|+++. |+..--..+..+    ++|++|+|++|. |+..--..+..+++|+
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~  142 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK  142 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence            7777777777765544556667777777777764 442222223332    245555555543 4432222334444555


Q ss_pred             EEEccCC
Q 041689          196 KLDLGGN  202 (652)
Q Consensus       196 ~L~L~~N  202 (652)
                      +|+|+++
T Consensus       143 ~L~L~~c  149 (176)
T 3e4g_A          143 YLFLSDL  149 (176)
T ss_dssp             EEEEESC
T ss_pred             EEECCCC
Confidence            5555444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.62  E-value=0.00027  Score=71.92  Aligned_cols=139  Identities=11%  Similarity=0.055  Sum_probs=74.3

Q ss_pred             ceeccccceE-EEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC--CeeeeEEeeeecCCceEEEEEccCCCC
Q 041689          431 NLIGKGGFGT-IYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY--RNLVKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       431 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      +.++.|.... +|+....+|..+++|......   ...+..|+++++.+..  -.+++++.+....+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566665554 667765447788888654321   1345667777777742  23556666643333  78999997766


Q ss_pred             hhhhhhcCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 041689          508 LEKCLYSSN-------------------------CILDIFQRL-------N-I------------MIDVASVLEYLH---  539 (652)
Q Consensus       508 L~~~l~~~~-------------------------~~l~~~~~~-------~-i------------~~~i~~~L~~LH---  539 (652)
                      +.+.+....                         ..++.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            643332110                         011111100       0 0            001111222221   


Q ss_pred             cCCCCCeEecCCCCCCeeeCCC----CcEEEecccCCcc
Q 041689          540 FNFLVPVIHCDLKPSNVLLDDT----MVAHLSDFGITKL  574 (652)
Q Consensus       540 ~~~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~~~~  574 (652)
                      ......++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123489999999999999874    6899999998874

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.60  E-value=8.3e-05  Score=64.17  Aligned_cols=52  Identities=23%  Similarity=0.324  Sum_probs=45.1

Q ss_pred             CCCcCCc--cCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCe
Q 041689           14 DDIESPC--EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLS   66 (652)
Q Consensus        14 ~~~~~~~--~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~   66 (652)
                      |..+.++  ++|..+ +.+|++|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus        15 Cs~~~L~~~~vP~~l-p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           15 CGRRGLTWASLPTAF-PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CCSSCCCTTTSCSCC-CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             eCCCCCccccCCCCC-CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3344444  799988 889999999999999988899999999999999999875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.51  E-value=0.00025  Score=71.09  Aligned_cols=72  Identities=4%  Similarity=-0.016  Sum_probs=46.6

Q ss_pred             ccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee-eeEEeeeecCCceEEEEEcc-CCC
Q 041689          429 ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL-VKIISSCSNEEFKELVLEHM-PHG  506 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g  506 (652)
                      ..+.|+.|....+|++     ..+++|+...... ......+|..+++.+....+ .+++++.  .+..++++||+ +|.
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            3678999999999998     5689998765422 12334678888877742222 4566543  33356899999 665


Q ss_pred             Ch
Q 041689          507 SL  508 (652)
Q Consensus       507 ~L  508 (652)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.50  E-value=0.00027  Score=72.97  Aligned_cols=139  Identities=12%  Similarity=0.113  Sum_probs=83.0

Q ss_pred             ceeccccceEEEEEEeC--------CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEEE
Q 041689          431 NLIGKGGFGTIYKSRIG--------DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      +.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-.+++++.+..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777888999999864        2578999986332 123455678999998884 3334667776654    28999


Q ss_pred             ccCCCChhhh-----------------hhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 041689          502 HMPHGSLEKC-----------------LYSSN----CILD--IFQRLNIMIDVAS-------------------VLEYLH  539 (652)
Q Consensus       502 ~~~~g~L~~~-----------------l~~~~----~~l~--~~~~~~i~~~i~~-------------------~L~~LH  539 (652)
                      |++|.++..-                 ++...    ....  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311                 01111    0112  2344444443321                   223332


Q ss_pred             ----cC-CCCCeEecCCCCCCeeeCCC----CcEEEecccCCcc
Q 041689          540 ----FN-FLVPVIHCDLKPSNVLLDDT----MVAHLSDFGITKL  574 (652)
Q Consensus       540 ----~~-~~~~iiH~dlkp~NIll~~~----~~~kl~Dfg~~~~  574 (652)
                          .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                21 23479999999999999876    7899999998874

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.49  E-value=0.00013  Score=62.93  Aligned_cols=56  Identities=14%  Similarity=0.147  Sum_probs=43.7

Q ss_pred             cEEEcccCCCc--ccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcccc
Q 041689           97 VVFLLSNNPLN--GILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN  157 (652)
Q Consensus        97 ~~L~Ls~N~l~--~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  157 (652)
                      ..++.+++.|+  .++..     +|.+|+.|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~-----lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTA-----FPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSC-----CCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCC-----CCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47888888887  55432     4556888888888888877788888888888888888775

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.44  E-value=4.8e-05  Score=70.21  Aligned_cols=17  Identities=12%  Similarity=0.089  Sum_probs=9.4

Q ss_pred             CCCCCCcEEEcccC-CCc
Q 041689           91 SNCKSLVVFLLSNN-PLN  107 (652)
Q Consensus        91 ~~l~~L~~L~Ls~N-~l~  107 (652)
                      .+-+.|+.|+|++| +|.
T Consensus        38 ~~n~~L~~L~L~~nn~ig   55 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVS   55 (197)
T ss_dssp             TTCSSCCEEECTTCCSSC
T ss_pred             hcCCCccEEECCCCCCCC
Confidence            34455666666654 554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.44  E-value=0.0007  Score=68.57  Aligned_cols=158  Identities=10%  Similarity=0.098  Sum_probs=88.9

Q ss_pred             ccccHHHHHHHhcCCC-----ccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCC--eeee
Q 041689          413 RRFSYLEVCRATYGFN-----ENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYR--NLVK  485 (652)
Q Consensus       413 ~~~~~~~~~~~~~~y~-----~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~  485 (652)
                      ...+.+++...-..|.     ....++ |....||++...+|+.+++|+..... .....+..|..+++.+...  .+++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            3444444444433332     224566 77889999877678789999986431 1235667788888877422  2444


Q ss_pred             EEee-----eecCCceEEEEEccCCCChh-----hh---------hh----cC----CCCCCHHHH----HHH-------
Q 041689          486 IISS-----CSNEEFKELVLEHMPHGSLE-----KC---------LY----SS----NCILDIFQR----LNI-------  527 (652)
Q Consensus       486 ~~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~----~~----~~~l~~~~~----~~i-------  527 (652)
                      ++..     ....+..+++|||++|..+.     .+         ++    ..    ...++....    ..+       
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     12245667899999885432     10         10    00    001222110    001       


Q ss_pred             --------HHHHHHHHHHHHcC----CCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          528 --------MIDVASVLEYLHFN----FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       528 --------~~~i~~~L~~LH~~----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                              ...+...++.+...    ....++|+|+++.||+++ + .+.++||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    01111222333211    234789999999999999 4 899999988764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.39  E-value=0.00037  Score=73.54  Aligned_cols=73  Identities=16%  Similarity=0.137  Sum_probs=49.7

Q ss_pred             cceeccccceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEE
Q 041689          430 NNLIGKGGFGTIYKSRIGD--------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+.|+.|....+|++...+        +..|++|+.....  ....+..|..+++.+. +.-.+++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578888889999998653        5789999884321  1144557999888884 3223567766543    2899


Q ss_pred             EccCCCCh
Q 041689          501 EHMPHGSL  508 (652)
Q Consensus       501 e~~~~g~L  508 (652)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.39  E-value=5.4e-05  Score=69.89  Aligned_cols=107  Identities=13%  Similarity=0.199  Sum_probs=81.1

Q ss_pred             cCcEEEccCC-ccccc----CCccccCCCCCCEEEecCcccccc----CCccccCCCCCcEEecccCcccccc----Ccc
Q 041689          121 SLEIFDMSKC-NVSGG----IPEEIGNLTNLTAIYLGGNKLNGS----IPFTLRELQKLQYVGLKDNKLEGTI----PYD  187 (652)
Q Consensus       121 ~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~  187 (652)
                      +|++|+|++| +|...    +.+++..-+.|+.|+|++|+|...    +..++..-+.|++|+|++|.|+..-    ...
T Consensus        42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a  121 (197)
T 1pgv_A           42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS  121 (197)
T ss_dssp             SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred             CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence            4999999996 88632    456677788999999999999733    3344567789999999999998543    335


Q ss_pred             ccCCCCCcEEEccCC---cccc----cccccCCCCCCCCEEEccCCC
Q 041689          188 IFRLVKLYKLDLGGN---KLSG----SILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       188 ~~~l~~L~~L~L~~N---~l~~----~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      +..-+.|+.|+|++|   .+..    .+..++..-+.|+.|+++.|.
T Consensus       122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence            556678999999876   4442    234456677899999999885

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.36  E-value=0.0008  Score=71.33  Aligned_cols=74  Identities=16%  Similarity=0.119  Sum_probs=49.2

Q ss_pred             cceeccccceEEEEEEeCC-CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee-eeEEeeeecCCceEEEEEccCCCC
Q 041689          430 NNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL-VKIISSCSNEEFKELVLEHMPHGS  507 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  507 (652)
                      .+.|+.|-...+|++...+ +..|++|+...... ...+..+|..+++.+...++ +++++.+..    ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            3578888889999998765 57899998754322 12233689999998864444 577777632    25999999854


Q ss_pred             h
Q 041689          508 L  508 (652)
Q Consensus       508 L  508 (652)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.00078  Score=69.58  Aligned_cols=73  Identities=11%  Similarity=0.163  Sum_probs=45.4

Q ss_pred             ceeccccceEEEEEEeCC---------CcEEEEEEeecccchhhhhHHHHHHHHHhcCCCe-eeeEEeeeecCCceEEEE
Q 041689          431 NLIGKGGFGTIYKSRIGD---------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRN-LVKIISSCSNEEFKELVL  500 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  500 (652)
                      +.++.|....+|++...+         +..|++|+...... .......|.++++.+...+ ++++++...    -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            567788888999998653         26889998754322 2223467888888874223 456665542    36899


Q ss_pred             EccCCCCh
Q 041689          501 EHMPHGSL  508 (652)
Q Consensus       501 e~~~~g~L  508 (652)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.17  E-value=0.00096  Score=67.98  Aligned_cols=64  Identities=13%  Similarity=0.135  Sum_probs=42.6

Q ss_pred             ceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC---CCeeeeEEee------eecCCceEEEEEccCCCCh
Q 041689          438 FGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH---YRNLVKIISS------CSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       438 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~g~L  508 (652)
                      ...||+....+| .+++|+......      ..|..+++.+.   -|.+++++..      ....+..++||+|++|..+
T Consensus        36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            679999987667 999998765431      35666666553   2324555432      2335677899999998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.83  E-value=0.0019  Score=59.87  Aligned_cols=117  Identities=13%  Similarity=0.014  Sum_probs=78.7

Q ss_pred             ChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccccc
Q 041689          507 SLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ  586 (652)
Q Consensus       507 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  586 (652)
                      +|.+.+...+.++++.+++.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-------------
Confidence            88999988888999999999999999998876221111  1233456888888888887664 1111             


Q ss_pred             ccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC------cchhhhhhhcccchh
Q 041689          587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------CVSFVFNLAMECTIE  641 (652)
Q Consensus       587 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p------~~~~l~~l~~~~l~~  641 (652)
                       .....+.|||... ...+.+.=|||+|+++|.-+-=..|      .++.+.+++..|...
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhc
Confidence             1122466888753 3456778999999999998864444      666788888888755

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.51  E-value=0.0065  Score=63.49  Aligned_cols=74  Identities=12%  Similarity=0.177  Sum_probs=49.9

Q ss_pred             cceeccccceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEE
Q 041689          430 NNLIGKGGFGTIYKSRIGD--------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+.+..|-...+|++...+        +..|++|+..... ....+..+|.++++.+. +.-.+++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567778888999998653        5789999865432 22234567888888874 333456665432    26899


Q ss_pred             EccCCCCh
Q 041689          501 EHMPHGSL  508 (652)
Q Consensus       501 e~~~~g~L  508 (652)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.07  E-value=0.068  Score=55.50  Aligned_cols=30  Identities=27%  Similarity=0.368  Sum_probs=25.8

Q ss_pred             CeEecCCCCCCeee------CCCCcEEEecccCCcc
Q 041689          545 PVIHCDLKPSNVLL------DDTMVAHLSDFGITKL  574 (652)
Q Consensus       545 ~iiH~dlkp~NIll------~~~~~~kl~Dfg~~~~  574 (652)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567899999999874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.08  E-value=1.3  Score=40.98  Aligned_cols=116  Identities=9%  Similarity=0.160  Sum_probs=77.4

Q ss_pred             CCCeeeeEEeeeecCCceEEEEEccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          479 HYRNLVKIISSCSNEEFKELVLEHMPH-GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       479 ~h~niv~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                      .||+.+.. .+-.+.+.+.+.++.-+. -++.. ++    ..+...+++++.+|+...++++..     +|--+.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence            57888765 455556655555554332 23333 22    367889999999999888766644     68899999999


Q ss_pred             eCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchh-hHHHHHHHHHhCCCCcchh
Q 041689          558 LDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY-SFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw-slG~vl~elltg~~p~~~~  630 (652)
                      ++.++.+++.-.|+...+                   +|.-     .+ ..|.| .+=|++..+++++..|++-
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~~-----~~-ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPLP-----VS-EAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCCC-----CC-HHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            999999999988865432                   2211     11 12333 4667888888888876553

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.06  E-value=2.7  Score=38.87  Aligned_cols=115  Identities=9%  Similarity=0.150  Sum_probs=76.3

Q ss_pred             CCCeeeeEEeeeecCCceEEEEEccCCC-ChhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEecCCCCCCe
Q 041689          479 HYRNLVKIISSCSNEEFKELVLEHMPHG-SLEKCLYSSNCILDIFQRLNIMIDVASVLE-YLHFNFLVPVIHCDLKPSNV  556 (652)
Q Consensus       479 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiH~dlkp~NI  556 (652)
                      .||++  -...-.+++.+.+.++.-+++ +.. .++    ..+..++++++.+++.... +++.     -+|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            57887  344446667776666655343 333 333    3678889999998888776 5553     47888999999


Q ss_pred             eeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchh-hHHHHHHHHHhCCCCcchh
Q 041689          557 LLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVY-SFGIMLMEIHSAKQQCVSF  630 (652)
Q Consensus       557 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw-slG~vl~elltg~~p~~~~  630 (652)
                      ++|.++.+++.-.|+-..+                   +|.-+.      ..|.| .+=|++..++.++..|++-
T Consensus       116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e~~------ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL-------------------PPDEWD------DERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             EECTTCCEEESCCEETTTB-------------------SSCSCC------HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EEeCCCcEEEEEcCCcccC-------------------CCCCCC------HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999988865422                   232111      12333 4667777777777776654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.37  E-value=1.8  Score=28.60  Aligned_cols=17  Identities=18%  Similarity=0.354  Sum_probs=7.2

Q ss_pred             chhhhhhHhhhhhhhhh
Q 041689          369 ALFLGIVLSFSTIFMVV  385 (652)
Q Consensus       369 ~~~~~~v~~~~~~~~~~  385 (652)
                      .+.+|++.+++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii~   28 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVA   28 (44)
T ss_dssp             SSTHHHHHHHHHHHHHH
T ss_pred             eEEeehhHHHHHHHHHH
Confidence            34444444444443333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	652
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-42
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-41
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-40
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-39
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-37
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-37
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-31
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-31
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-31
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-30
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.003
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	7e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	8e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 54/256 (21%), Positives = 103/256 (40%), Gaps = 40/256 (15%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
             IG G FGT+YK +     +VAVK+ ++     +  ++F  E  +++   + N++  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             +  +   +V +     SL   L+      ++ + ++I    A  ++YLH      +IH
Sbjct: 72  YSTAPQLA-IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY---GREGRVF 605
            DLK +N+ L + +   + DFG+  +      S    Q   +I ++APE      +    
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 606 ANGDVYSFGIMLMEIHSAK-----------------------------QQCVSFVFNLAM 636
              DVY+FGI+L E+ + +                               C   +  L  
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247

Query: 637 ECTIESLELRINAKEI 652
           EC  +  + R    +I
Sbjct: 248 ECLKKKRDERPLFPQI 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  161 bits (408), Expect = 2e-45
 Identities = 57/280 (20%), Positives = 112/280 (40%), Gaps = 45/280 (16%)

Query: 415 FSYLEVCRATYGFNEN---------NLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQ- 460
           F++ +   A   F +           +IG G FG +    +       + VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 461 CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILD 520
             +  + F  E  IM    + N++ +    +      ++ E M +GSL+  L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 521 IFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ 580
           + Q + ++  +A+ ++YL        +H DL   N+L++  +V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 581 SMTQTQTL---ATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ------------ 625
             T T  L     I + APE  +  +  +  DV+S+GI++ E+ S  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243

Query: 626 -------------QCVSFVFNLAMECTIESLELRINAKEI 652
                         C S +  L ++C  +    R    +I
Sbjct: 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 4e-44
 Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 34/260 (13%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI 478
           EV R T    E   +G G FG ++        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65

Query: 479 HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI-LDIFQRLNIMIDVASVLEY 537
            ++ LV++ +  + E    ++ E+M +GSL   L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 538 LHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE 597
           +        IH DL+ +N+L+ DT+   ++DFG+ + LI +++   +      I + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPE 180

Query: 598 YGREGRVFANGDVYSFGIMLMEIHSAKQ-------------------------QCVSFVF 632
               G      DV+SFGI+L EI +  +                          C   ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240

Query: 633 NLAMECTIESLELRINAKEI 652
            L   C  E  E R     +
Sbjct: 241 QLMRLCWKERPEDRPTFDYL 260

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-42
 Identities = 56/252 (22%), Positives = 107/252 (42%), Gaps = 32/252 (12%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
                 +G+G FG ++         VA+K        + ++F  E ++MK + +  LV++
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIF-QRLNIMIDVASVLEYLHFNFLVP 545
            +  S E    +V E+M  GSL   L           Q +++   +AS + Y+       
Sbjct: 78  YAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 133

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
            +H DL+ +N+L+ + +V  ++DFG+ + LI +++   +      I + APE    GR  
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 606 ANGDVYSFGIMLMEIHSAKQ-------------------------QCVSFVFNLAMECTI 640
              DV+SFGI+L E+ +  +                         +C   + +L  +C  
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252

Query: 641 ESLELRINAKEI 652
           +  E R   + +
Sbjct: 253 KEPEERPTFEYL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-42
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 9/203 (4%)

Query: 429 ENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLV 484
            +  +G G FG++ +         ++VA+KV      +A  +    E +IM  +    +V
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++I  C  E    LV+E    G L K L      + +     ++  V+  ++YL      
Sbjct: 73  RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 128

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREGR 603
             +H DL   NVLL +   A +SDFG++K L  +D   T        + + APE     +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188

Query: 604 VFANGDVYSFGIMLMEIHSAKQQ 626
             +  DV+S+G+ + E  S  Q+
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQK 211

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 9/196 (4%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKS-FDIECEIMKSIHYRNLV 484
           F + + +G G  G ++K      G+ +A K+ HL+   A ++    E +++   +   +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
               +  ++    + +EHM  GSL++ L  +   +       + I V   L YL      
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKH-- 124

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            ++H D+KPSN+L++      L DFG++  L     SM  +    T  Y++PE  +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMSPERLQGTHY 180

Query: 605 FANGDVYSFGIMLMEI 620
               D++S G+ L+E+
Sbjct: 181 SVQSDIWSMGLSLVEM 196

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 50/251 (19%), Positives = 102/251 (40%), Gaps = 30/251 (11%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
                 +G G FG +   +     +VA+K+   +   +   F  E ++M ++ +  LV++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
              C+ +    ++ E+M +G L   L          Q L +  DV   +EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           +H DL   N L++D  V  +SDFG+++ ++ +D+  +   +   + +  PE     +  +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 607 NGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAMECTIE 641
             D+++FG+++ EI+S  +                              V+ +   C  E
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240

Query: 642 SLELRINAKEI 652
             + R   K +
Sbjct: 241 KADERPTFKIL 251

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-42
 Identities = 57/251 (22%), Positives = 99/251 (39%), Gaps = 30/251 (11%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
                 IG G FG ++     +  +VA+K        + + F  E E+M  + +  LV++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
              C  +    LV E M HG L   L +   +      L + +DV   + YL       V
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CV 122

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DL   N L+ +  V  +SDFG+T+ ++ +  + +   T   + + +PE     R  +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSS 181

Query: 607 NGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAMECTIE 641
             DV+SFG+++ E+ S  +                            + V+ +   C  E
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

Query: 642 SLELRINAKEI 652
             E R     +
Sbjct: 242 RPEDRPAFSRL 252

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 9e-41
 Identities = 56/258 (21%), Positives = 110/258 (42%), Gaps = 35/258 (13%)

Query: 427 FNENNLIGKGGFGTIYKSRIGDG-----MEVAVKVFHLQCG-RAFKSFDIECEIMKSIHY 480
                +IG G FG +YK  +        + VA+K        +    F  E  IM    +
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            N++++    S  +   ++ E+M +G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYG 599
                 +H DL   N+L++  +V  +SDFG++++L    + + T +     I + APE  
Sbjct: 129 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 600 REGRVFANGDVYSFGIMLMEIHSAKQ-------------------------QCVSFVFNL 634
              +  +  DV+SFGI++ E+ +  +                          C S ++ L
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245

Query: 635 AMECTIESLELRINAKEI 652
            M+C  +    R    +I
Sbjct: 246 MMQCWQQERARRPKFADI 263

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 57/255 (22%), Positives = 99/255 (38%), Gaps = 36/255 (14%)

Query: 429 ENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNL 483
           E+  +G G FGT+ K           VAVK+   +            E  +M+ +    +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           V++I  C  E +  LV+E    G L K L  +   +     + ++  V+  ++YL  +  
Sbjct: 71  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREG 602
              +H DL   NVLL     A +SDFG++K L  ++            + + APE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 603 RVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAME 637
           +  +  DV+SFG+++ E  S  Q+                         C   +++L   
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245

Query: 638 CTIESLELRINAKEI 652
           C    +E R     +
Sbjct: 246 CWTYDVENRPGFAAV 260

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 5e-40
 Identities = 48/200 (24%), Positives = 85/200 (42%), Gaps = 11/200 (5%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
             +G G FG +YK++     +  A KV   +     + + +E +I+ S  + N+VK++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
              E    +++E    G+++  +      L   Q   +       L YLH N    +IH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 134

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY-----GREGRV 604
           DLK  N+L        L+DFG++       Q         T  ++APE       ++   
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 192

Query: 605 FANGDVYSFGIMLMEIHSAK 624
               DV+S GI L+E+   +
Sbjct: 193 DYKADVWSLGITLIEMAEIE 212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (363), Expect = 1e-39
 Identities = 70/249 (28%), Positives = 104/249 (41%), Gaps = 38/249 (15%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
             IGKG FG +       G +VAVK          ++F  E  +M  + + NLV+++   
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 491 SNEEFKE-LVLEHMPHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
             E+    +V E+M  GSL   L S    +L     L   +DV   +EYL  N     +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DL   NVL+ +  VA +SDFG+TK       S TQ      + + APE  RE +     
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 609 DVYSFGIMLMEIHSAKQ-------------------------QCVSFVFNLAMECTIESL 643
           DV+SFGI+L EI+S  +                          C   V+ +   C     
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDA 241

Query: 644 ELRINAKEI 652
            +R +  ++
Sbjct: 242 AMRPSFLQL 250

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-39
 Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 7/200 (3%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHL-QCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
             +G+G +G +  +        VAVK+  + +     ++   E  I K +++ N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
                  + L LE+   G L   +   +  +           + + + YLH      + H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITH 126

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            D+KP N+LLD+     +SDFG+  +    ++     +   T+ Y+APE  +     A  
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186

Query: 609 -DVYSFGIMLMEIHSAKQQC 627
            DV+S GI+L  + + +   
Sbjct: 187 VDVWSCGIVLTAMLAGELPW 206

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 49/208 (23%), Positives = 80/208 (38%), Gaps = 12/208 (5%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNL 483
           +     IG G +G   K R   DG  +  K            +    E  +++ + + N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 484 VKIISSCSNEEFKEL--VLEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYL 538
           V+      +     L  V+E+   G L   +         LD    L +M  +   L+  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 539 HFNFLV--PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           H        V+H DLKP+NV LD      L DFG+ ++L   D S  +     T  Y++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV-GTPYYMSP 183

Query: 597 EYGREGRVFANGDVYSFGIMLMEIHSAK 624
           E           D++S G +L E+ +  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM 211

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 12/194 (6%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
             +GKG FG +Y +R       +A+KV     L+          E EI   + + N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                +     L+LE+ P G++ + L   +   D  +    + ++A+ L Y H      V
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK---RV 127

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH D+KP N+LL       ++DFG +       ++        T+ Y+ PE         
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDE 183

Query: 607 NGDVYSFGIMLMEI 620
             D++S G++  E 
Sbjct: 184 KVDLWSLGVLCYEF 197

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 17/201 (8%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL---QCGRAFKSFDIECEIMKSIHYRN 482
           F++   IG G FG +Y +R + +   VA+K       Q    ++    E   ++ + + N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
            ++       E    LV+E+    + +         L   +   +       L YLH + 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSH- 134

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEY---G 599
              +IH D+K  N+LL +  +  L DFG   ++            + T  ++APE     
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAM 186

Query: 600 REGRVFANGDVYSFGIMLMEI 620
            EG+     DV+S GI  +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 59/253 (23%), Positives = 100/253 (39%), Gaps = 32/253 (12%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
               + +G G +G +Y+       + VAVK          + F  E  +MK I + NLV+
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLV 544
           ++  C+ E    ++ E M +G+L   L   N   +     L +   ++S +EYL      
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--- 134

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
             IH DL   N L+ +  +  ++DFG+++L+ G D           I + APE     + 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 605 FANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAMECT 639
               DV++FG++L EI +                             C   V+ L   C 
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253

Query: 640 IESLELRINAKEI 652
             +   R +  EI
Sbjct: 254 QWNPSDRPSFAEI 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 54/277 (19%), Positives = 101/277 (36%), Gaps = 59/277 (21%)

Query: 432 LIGKGGFGTIYK------SRIGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSI-HYRNL 483
           ++G G FG +        S+ G  ++VAVK+   +   +  ++   E ++M  +  + N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSN----------------------CILDI 521
           V ++ +C+      L+ E+  +G L   L S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
              L     VA  +E+L F      +H DL   NVL+    V  + DFG+ + ++ +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ---------------- 625
           + +      + ++APE   EG      DV+S+GI+L EI S                   
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 626 ----------QCVSFVFNLAMECTIESLELRINAKEI 652
                          ++ +   C       R +   +
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 8e-38
 Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 8/194 (4%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVF---HLQCGRAFKSFDIECEIMKSIHYRNLVKI 486
            ++G+G F T+  +R +    E A+K+    H+           E ++M  + +   VK+
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             +  ++E     L +  +G L K +       D         ++ S LEYLH      +
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKG---I 129

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           IH DLKP N+LL++ M   ++DFG  K+L  E +       + T  Y++PE   E     
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 607 NGDVYSFGIMLMEI 620
           + D+++ G ++ ++
Sbjct: 190 SSDLWALGCIIYQL 203

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-37
 Identities = 52/258 (20%), Positives = 104/258 (40%), Gaps = 36/258 (13%)

Query: 428 NENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRN 482
           + N +IG+G FG +Y   +    G  +  AVK  +          F  E  IMK   + N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 483 LVKIISSCSNEEFKE-LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
           ++ ++  C   E    +VL +M HG L   + +      +   +   + VA  +++L   
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED--QSMTQTQTLATIGYIAPEYG 599
                +H DL   N +LD+     ++DFG+ + +  ++      +T     + ++A E  
Sbjct: 150 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 600 REGRVFANGDVYSFGIMLMEIHSAK-------------------------QQCVSFVFNL 634
           +  +     DV+SFG++L E+ +                           + C   ++ +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266

Query: 635 AMECTIESLELRINAKEI 652
            ++C     E+R +  E+
Sbjct: 267 MLKCWHPKAEMRPSFSEL 284

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 8/191 (4%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISS 489
             IG+G  GT+Y +  +  G EVA++  +LQ     +    E  +M+     N+V  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 490 CSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHC 549
               +   +V+E++  GSL   +  +    D  Q   +  +    LE+LH N    VIH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 550 DLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGD 609
           D+K  N+LL       L+DFG    +  E    +      T  ++APE           D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVD 198

Query: 610 VYSFGIMLMEI 620
           ++S GIM +E+
Sbjct: 199 IWSLGIMAIEM 209

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 54/257 (21%), Positives = 102/257 (39%), Gaps = 35/257 (13%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKV-----FHLQCGRAFKSFDIECEIMKSIHY 480
           F +  ++G G FGT+YK   I +G +V + V           +A K    E  +M S+  
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF 540
            ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 541 NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
                ++H DL   NVL+       ++DFG+ KLL  E++          I ++A E   
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 601 EGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLA 635
                   DV+S+G+ + E+ +   +                         C   V+ + 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 246

Query: 636 MECTIESLELRINAKEI 652
           ++C +   + R   +E+
Sbjct: 247 VKCWMIDADSRPKFREL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  139 bits (350), Expect = 7e-37
 Identities = 42/196 (21%), Positives = 77/196 (39%), Gaps = 9/196 (4%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            +G G FG +++      G   A K          ++   E + M  + +  LV +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            ++    ++ E M  G L + +   +  +   + +  M  V   L ++H N     +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 149

Query: 551 LKPSNVLL--DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
           LKP N++     +    L DFG+T  L  +      T T     + APE      V    
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 609 DVYSFGIMLMEIHSAK 624
           D++S G++   + S  
Sbjct: 207 DMWSVGVLSYILLSGL 222

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 62/294 (21%), Positives = 107/294 (36%), Gaps = 60/294 (20%)

Query: 414 RFSYLEVCRATYGFNENNLIGKGGFGTIYKSR------IGDGMEVAVKVFHLQCGRAF-K 466
           +   LE  R    +     IG+G FG ++++R            VAVK+   +       
Sbjct: 4   KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 467 SFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNC--------- 517
            F  E  +M      N+VK++  C+  +   L+ E+M +G L + L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 518 --------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMV 563
                          L   ++L I   VA+ + YL        +H DL   N L+ + MV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 178

Query: 564 AHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA 623
             ++DFG+++ +   D           I ++ PE     R     DV+++G++L EI S 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 624 K-------------------------QQCVSFVFNLAMECTIESLELRINAKEI 652
                                     + C   ++NL   C  +    R +   I
Sbjct: 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-37
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 433 IGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN 492
           IGKG FG +++ +   G EVAVK+F  +  R++   + E      + + N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 493 EEFK----ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV---- 544
           +        LV ++  HGSL   L      + +   + + +  AS L +LH   +     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 545 -PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT--QTQTLATIGYIAPEY--- 598
             + H DLK  N+L+       ++D G+         ++       + T  Y+APE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 599 ---GREGRVFANGDVYSFGIMLMEI 620
               +    F   D+Y+ G++  EI
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEI 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-36
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 430 NNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKI 486
           +  IG+G F T+YK       +EVA      +       + F  E E++K + + N+V+ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 487 ISSC----SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             S       ++   LV E M  G+L+  L     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR- 131

Query: 543 LVPVIHCDLKPSNVLLDD-TMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
             P+IH DLK  N+ +   T    + D G+  L      S  +   + T  ++APE   E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAPEM-YE 186

Query: 602 GRVFANGDVYSFGIMLMEIHSAK 624
            +   + DVY+FG+ ++E+ +++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSE 209

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 9e-36
 Identities = 57/254 (22%), Positives = 89/254 (35%), Gaps = 38/254 (14%)

Query: 433 IGKGGFGTIYKSRI----GDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVK 485
           +G G FG + +       G  + VAVK      L    A   F  E   M S+ +RNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 486 IISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP 545
           +         K +V E  P GSL   L        +       + VA  + YL       
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---R 131

Query: 546 VIHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGRV 604
            IH DL   N+LL    +  + DFG+ + L   +D  + Q        + APE  +    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 605 FANGDVYSFGIMLMEIHSAKQ--------------------------QCVSFVFNLAMEC 638
               D + FG+ L E+ +  Q                           C   ++N+ ++C
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251

Query: 639 TIESLELRINAKEI 652
                E R     +
Sbjct: 252 WAHKPEDRPTFVAL 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 12/207 (5%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQCGRAFKS-FDIECE 473
           E+ R          IG+G FG +++          + VA+K        + +  F  E  
Sbjct: 3   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 474 IMKSIHYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVAS 533
            M+   + ++VK+I   + E    +++E    G L   L      LD+   +     +++
Sbjct: 61  TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 534 VLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGY 593
            L YL        +H D+   NVL+       L DFG+++ +  +      ++    I +
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175

Query: 594 IAPEYGREGRVFANGDVYSFGIMLMEI 620
           +APE     R  +  DV+ FG+ + EI
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEI 202

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  134 bits (339), Expect = 2e-35
 Identities = 38/192 (19%), Positives = 80/192 (41%), Gaps = 9/192 (4%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            +G G FG +++      G     K  +        +   E  IM  +H+  L+ +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            ++    L+LE +  G L   + + +  +   + +N M      L+++H +    ++H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLD 152

Query: 551 LKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
           +KP N++ +    +   + DFG+   L   +       T AT  + APE      V    
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 609 DVYSFGIMLMEI 620
           D+++ G++   +
Sbjct: 210 DMWAIGVLGYVL 221

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-35
 Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 51/271 (18%)

Query: 427 FNENNLIGKGGFGTIYKSRI---GDGMEVAVKVFHLQCGR-AFKSFDIECEIMKSI-HYR 481
               ++IG+G FG + K+RI   G  M+ A+K       +   + F  E E++  + H+ 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCI---------------LDIFQRLN 526
           N++ ++ +C +  +  L +E+ PHG+L   L  S  +               L   Q L+
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 527 IMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQ 586
              DVA  ++YL        IH DL   N+L+ +  VA ++DFG+++   G++  + +T 
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 185

Query: 587 TLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ--------------------- 625
               + ++A E         N DV+S+G++L EI S                        
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245

Query: 626 ----QCVSFVFNLAMECTIESLELRINAKEI 652
                C   V++L  +C  E    R +  +I
Sbjct: 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGR---AFKSFDIECEIMKSIHYRNLVKII 487
           ++G GG   ++ +R +    +VAVKV      R    +  F  E +   ++++  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 488 SSCSNEEFKE----LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
            +   E        +V+E++   +L   +++    +   + + ++ D    L + H N  
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN-- 130

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLA-TIGYIAPEYGREG 602
             +IH D+KP+N+++  T    + DFGI + +     S+TQT  +  T  Y++PE  R  
Sbjct: 131 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189

Query: 603 RVFANGDVYSFGIMLMEI 620
            V A  DVYS G +L E+
Sbjct: 190 SVDARSDVYSLGCVLYEV 207

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 53/267 (19%), Positives = 106/267 (39%), Gaps = 44/267 (16%)

Query: 427 FNENNLIGKGGFGTIYK------SRIGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSIH 479
              +  +G+G FG +Y+       +      VA+K  +     R    F  E  +MK  +
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLY---------SSNCILDIFQRLNIMID 530
             ++V+++   S  +   +++E M  G L+  L                 + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 531 VASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLAT 590
           +A  + YL+ N     +H DL   N ++ +     + DFG+T+ +   D      + L  
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 591 IGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ------------------------ 626
           + +++PE  ++G      DV+SFG++L EI +  +Q                        
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258

Query: 627 -CVSFVFNLAMECTIESLELRINAKEI 652
            C   +F L   C   + ++R +  EI
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEI 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 51/285 (17%), Positives = 99/285 (34%), Gaps = 56/285 (19%)

Query: 419 EVCRATYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQCGRAF-KSFDIE 471
           E  R    F +   +G G FG + ++           M VAVK+          ++   E
Sbjct: 19  EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 472 CEIMKSI-HYRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSS--------------- 515
            +++  + ++ N+V ++ +C+      ++ E+  +G L   L                  
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 516 --NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK 573
                LD+   L+    VA  + +L        IH DL   N+LL    +  + DFG+ +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ-------- 625
            +  +   + +      + ++APE           DV+S+GI L E+ S           
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 626 ------------------QCVSFVFNLAMECTIESLELRINAKEI 652
                                + ++++   C       R   K+I
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 43/198 (21%), Positives = 85/198 (42%), Gaps = 13/198 (6%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKI 486
             +G G FG ++  R   +G   A+KV     +   +  +  + E  ++  + +  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 487 ISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
             +  + +   ++++++  G     L   +             +V   LEYLH      +
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DI 125

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFA 606
           I+ DLKP N+LLD      ++DFG  K +     ++       T  YIAPE         
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 607 NGDVYSFGIMLMEIHSAK 624
           + D +SFGI++ E+ +  
Sbjct: 181 SIDWWSFGILIYEMLAGY 198

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 2e-31
 Identities = 35/192 (18%), Positives = 78/192 (40%), Gaps = 10/192 (5%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            +G+G FG +++            K   ++ G        E  I+    +RN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
            + E   ++ E +    + + + +S   L+  + ++ +  V   L++LH +    + H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFD 127

Query: 551 LKPSNVLLDDTMVAH--LSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
           ++P N++      +   + +FG  + L   D             Y APE  +   V    
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTAT 184

Query: 609 DVYSFGIMLMEI 620
           D++S G ++  +
Sbjct: 185 DMWSLGTLVYVL 196

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  123 bits (309), Expect = 3e-31
 Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 16/202 (7%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHL------QCGRAFKSFDIECEIMKSIH 479
           F+ + +IG+GGFG +Y  R    G   A+K          Q      +  I   ++ +  
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 480 YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
              +V +  +    +    +L+ M  G L   L       +         ++   LE++H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH 124

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
             F   V++ DLKP+N+LLD+     +SD G+               ++ T GY+APE  
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVL 177

Query: 600 REGRVF-ANGDVYSFGIMLMEI 620
           ++G  + ++ D +S G ML ++
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKL 199

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 4e-31
 Identities = 53/272 (19%), Positives = 103/272 (37%), Gaps = 53/272 (19%)

Query: 431 NLIGKGGFGTIYKSR--------IGDGMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HY 480
             +G+G FG +  +              +VAVK+       +       E E+MK I  +
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSLEKCL---------------YSSNCILDIFQRL 525
           +N++ ++ +C+ +    +++E+   G+L + L               ++    L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 526 NIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQT 585
           +    VA  +EYL        IH DL   NVL+ +  V  ++DFG+ + +   D     T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 586 QTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ-------------------- 625
                + ++APE   +       DV+SFG++L EI +                       
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255

Query: 626 -----QCVSFVFNLAMECTIESLELRINAKEI 652
                 C + ++ +  +C       R   K++
Sbjct: 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (302), Expect = 8e-31
 Identities = 37/192 (19%), Positives = 73/192 (38%), Gaps = 6/192 (3%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIIS 488
           +++G G F  +  +        VA+K    +       S + E  ++  I + N+V +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
              +     L+++ +  G L   +              ++  V   ++YLH   +V    
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
                    LD+     +SDFG++K+   ED     +    T GY+APE   +       
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190

Query: 609 DVYSFGIMLMEI 620
           D +S G++   +
Sbjct: 191 DCWSIGVIAYIL 202

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  119 bits (299), Expect = 1e-30
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 427 FNEN----NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDI---------EC 472
           F EN     ++G+G    + +        E AVK+  +  G +F + ++         E 
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 473 EIMKSIH-YRNLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDV 531
           +I++ +  + N++++  +     F  LV + M  G L   L +    L   +   IM  +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRAL 119

Query: 532 ASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATI 591
             V+  LH      ++H DLKP N+LLDD M   L+DFG +  L   D      +   T 
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173

Query: 592 GYIAPEYGREGRVFANG------DVYSFGIMLMEI 620
            Y+APE         +       D++S G+++  +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 6e-30
 Identities = 44/199 (22%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIM-KSIHYR 481
           F  + ++GKG FG ++ +         A+K      +      +   +E  ++  +  + 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
            L  +  +   +E    V+E++  G L   + S +   D+ +      ++   L++LH  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSK 122

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
               +++ DLK  N+LLD      ++DFG+ K  +  D          T  YIAPE    
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLG 177

Query: 602 GRVFANGDVYSFGIMLMEI 620
            +   + D +SFG++L E+
Sbjct: 178 QKYNHSVDWWSFGVLLYEM 196

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (294), Expect = 8e-30
 Identities = 46/198 (23%), Positives = 71/198 (35%), Gaps = 14/198 (7%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            IG G FG IY    I  G EVA+K+  ++         IE +I K +     +  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             E    +++  +   SLE      +    +   L +   + S +EY+H       IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRD 128

Query: 551 LKPSNVL---LDDTMVAHLSDFGITKLLIGED-----QSMTQTQTLATIGYIAPEYGREG 602
           +KP N L        + ++ DFG+ K                     T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 603 RVFANGDVYSFGIMLMEI 620
                 D+ S G +LM  
Sbjct: 189 EQSRRDDLESLGYVLMYF 206

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 7e-29
 Identities = 51/276 (18%), Positives = 97/276 (35%), Gaps = 53/276 (19%)

Query: 427 FNENNLIGKGGFGTIYKSR------IGDGMEVAVKVFHLQCGRA-FKSFDIECEIMKSI- 478
                 +G+G FG + ++             VAVK+       +  ++   E +I+  I 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 479 HYRNLVKIISSCSNEEFK-ELVLEHMPHGSLEKCLYSSNC---------------ILDIF 522
           H+ N+V ++ +C+       +++E    G+L   L S                   L + 
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 523 QRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM 582
             +     VA  +E+L        IH DL   N+LL +  V  + DFG+ + +  +   +
Sbjct: 135 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ----------------- 625
            +      + ++APE   +       DV+SFG++L EI S                    
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 626 ---------QCVSFVFNLAMECTIESLELRINAKEI 652
                         ++   ++C       R    E+
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 7e-29
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 13/197 (6%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQC-----GRAFKSFDIECEIMKSIHYRNLV 484
           + +G+G F T+YK+R       VA+K   L           ++   E ++++ + + N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            ++ +  ++    LV + M        +  ++ +L        M+     LEYLH ++  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 545 PVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRV 604
            ++H DLKP+N+LLD+  V  L+DFG+ K       +   T  + T  Y APE     R+
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 605 F-ANGDVYSFGIMLMEI 620
           +    D+++ G +L E+
Sbjct: 178 YGVGVDMWAVGCILAEL 194

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 8e-29
 Identities = 44/204 (21%), Positives = 78/204 (38%), Gaps = 18/204 (8%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF------KSFDIECEIMKSIH--YRN 482
           L+G GGFG++Y    + D + VA+K         +          +E  ++K +   +  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           +++++      +   L+LE            +    L      +    V   + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC- 129

Query: 543 LVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
              V+H D+K  N+L+D +     L DFG   LL    +    T    T  Y  PE+ R 
Sbjct: 130 --GVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183

Query: 602 GRVFANG-DVYSFGIMLMEIHSAK 624
            R       V+S GI+L ++    
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGD 207

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-28
 Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 18/213 (8%)

Query: 420 VCRATYGFNENNLIGKGGFGTIYKSR--IGDGMEVAVKVFHLQCGRAFKSFDIECEI--- 474
           +CRA   +     IG+G +G ++K+R     G  VA+K   +Q G          E+   
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 475 --MKSIHYRNLVKIISSCSNEEFKE-----LVLEHMPHGSLEKCLYSSNCILDIFQRLNI 527
             +++  + N+V++   C+           LV EH+               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 528 MIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT 587
           M  +   L++LH +    V+H DLKP N+L+  +    L+DFG+ ++       M  T  
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 588 LATIGYIAPEYGREGRVFANGDVYSFGIMLMEI 620
           + T+ Y APE   +       D++S G +  E+
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  112 bits (281), Expect = 3e-28
 Identities = 42/196 (21%), Positives = 82/196 (41%), Gaps = 7/196 (3%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIIS 488
             IG+G +G +YK++   G   A+K   L+        +   E  I+K + + N+VK+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
               ++   LV EH+    L+K L      L+     + ++ + + + Y H      V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLKP N+L++      ++DFG+ +   G        + +              +     
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 609 DVYSFGIMLMEIHSAK 624
           D++S G +  E+ +  
Sbjct: 183 DIWSVGCIFAEMVNGT 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-28
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHL------QCGRAFKSFDIECEIMKSIHYRNLV 484
            +G G F  + K R    G++ A K          + G + +  + E  I+K I + N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 485 KIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
            +     N+    L+LE +  G L     +    L   +    +  + + + YLH     
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHSLQ-- 133

Query: 545 PVIHCDLKPSNVLLDDTMVA----HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGR 600
            + H DLKP N++L D  V      + DFG+   +   D          T  ++APE   
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189

Query: 601 EGRVFANGDVYSFGIMLMEIHSAKQ 625
              +    D++S G++   + S   
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGAS 214

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-28
 Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 9/200 (4%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAF-KSFDIECEIMKSIHYRNLVKIIS 488
           + IG+G +G +  +    + + VA+K       + + +    E +I+    + N++ I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYS--SNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
                  +++   ++    +   LY       L        +  +   L+Y+H      V
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 130

Query: 547 IHCDLKPSNVLLDDTMVAHLSDFGITKLLI-GEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +H DLKPSN+LL+ T    + DFG+ ++     D +   T+ +AT  Y APE     + +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 606 AN-GDVYSFGIMLMEIHSAK 624
               D++S G +L E+ S +
Sbjct: 191 TKSIDIWSVGCILAEMLSNR 210

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 5e-28
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVK 485
           + +  +IG G FG +Y+++    G  VA+K          +  + E +IM+ + + N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 486 IISSC------SNEEFKELVLEHMPHGSLEKCLY--SSNCILDIFQRLNIMIDVASVLEY 537
           +           +E +  LVL+++P        +   +   L +      M  +   L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 538 LHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAP 596
           +H      + H D+KP N+LLD DT V  L DFG  K L+  + +++    + +  Y AP
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191

Query: 597 EYGREGRVFANG-DVYSFGIMLMEI 620
           E       + +  DV+S G +L E+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAEL 216

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 5e-28
 Identities = 39/203 (19%), Positives = 78/203 (38%), Gaps = 21/203 (10%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIM-KSIHYRNLVKIISS 489
           ++G G  G + +        + A+K+      +       E E+  ++    ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 490 CSNEEFKE----LVLEHMPHGSLEKCLYS-SNCILDIFQRLNIMIDVASVLEYLHFNFLV 544
             N         +V+E +  G L   +    +      +   IM  +   ++YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130

Query: 545 PVIHCDLKPSNVLLDDTM---VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
            + H D+KP N+L        +  L+DFG  K     +   T      T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 602 GRVFANGDVYSFGIMLMEIHSAK 624
            +   + D++S G+++  +    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY 210

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-27
 Identities = 47/202 (23%), Positives = 88/202 (43%), Gaps = 9/202 (4%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNL 483
           F +   IG+G +G +YK+R    G  VA+K   L         +   E  ++K +++ N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 484 VKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFL 543
           VK++     E    LV E +     +    S+   + +    + +  +   L + H +  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 544 VPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPE-YGREG 602
             V+H DLKP N+L++      L+DFG+ +      ++ T      T+ Y APE      
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCK 178

Query: 603 RVFANGDVYSFGIMLMEIHSAK 624
                 D++S G +  E+ + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 31/207 (14%), Positives = 66/207 (31%), Gaps = 16/207 (7%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            IG+G FG I++   + +  +VA+K    +          E    K +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 491 SNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCD 550
             E    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRD 126

Query: 551 LKPSNVLLDDTMVAH-----LSDFGITKLLIGEDQS-----MTQTQTLATIGYIAPEYGR 600
           +KP N L+      +     + DFG+ K               +     T  Y++     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 601 EGRVFANGDVYSFGIMLMEIHSAKQQC 627
                   D+ + G + M         
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPW 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 46/198 (23%), Positives = 83/198 (41%), Gaps = 10/198 (5%)

Query: 427 FNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRA---FKSFDIECEIMKSIHYRN 482
           F+   L+GKG FG +   R    G   A+K+   +   A         E  ++++  +  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 483 LVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
           L  +  +    +    V+E+   G L   L S   +    +      ++ S LEYLH   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLHSR- 124

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              V++ D+K  N++LD      ++DFG+ K  I +  +M       T  Y+APE   + 
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDN 180

Query: 603 RVFANGDVYSFGIMLMEI 620
                 D +  G+++ E+
Sbjct: 181 DYGRAVDWWGLGVVMYEM 198

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 37/198 (18%), Positives = 81/198 (40%), Gaps = 8/198 (4%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCG--RAFKSFDIECEIMKSIHYRNLVKII 487
             IG+G +GT++K++       VA+K   L         S   E  ++K + ++N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 488 SSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVI 547
               +++   LV E       +     +  + D     + +  +   L + H      V+
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSR---NVL 123

Query: 548 HCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFAN 607
           H DLKP N+L++      L++FG+ +      +  +  + +                  +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKLYSTS 182

Query: 608 GDVYSFGIMLMEIHSAKQ 625
            D++S G +  E+ +A +
Sbjct: 183 IDMWSAGCIFAELANAGR 200

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (267), Expect = 7e-26
 Identities = 41/192 (21%), Positives = 79/192 (41%), Gaps = 13/192 (6%)

Query: 433 IGKGGFGTIYKSR-IGDGMEVAVKVFH---LQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
           +G G FG +   +    G   A+K+     +   +  +    E  I++++++  LVK+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIH 548
           S  +     +V+E++  G +   L                  +    EYLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSL---DLIY 164

Query: 549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANG 608
            DLKP N+L+D      ++DFG  K + G   ++       T   +APE           
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAV 219

Query: 609 DVYSFGIMLMEI 620
           D ++ G+++ E+
Sbjct: 220 DWWALGVLIYEM 231

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-24
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 18/215 (8%)

Query: 420 VCRATYGFNENNLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQC--GRAFKSFDIECEIMK 476
            C     + +   IG+G FG ++K+R    G +VA+K   ++        +   E +I++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 477 SIHYRNLVKIISSCSNEEFKE--------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIM 528
            + + N+V +I  C  +            LV +   H               + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 529 IDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQT- 587
             + + L Y+H N    ++H D+K +NVL+    V  L+DFG+ +       S     T 
Sbjct: 124 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 588 -LATIGYIAPEYGREGRVFANG-DVYSFGIMLMEI 620
            + T+ Y  PE     R +    D++  G ++ E+
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 16/205 (7%)

Query: 431 NLIGKGGFGTIYKSR----IGDGMEVAVKVFH----LQCGRAFKSFDIECEIMKSI-HYR 481
            ++G G +G ++  R       G   A+KV      +Q  +  +    E ++++ I    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 482 NLVKIISSCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN 541
            LV +  +   E    L+L+++  G L   L         F    + I V  ++  L   
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145

Query: 542 FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGRE 601
             + +I+ D+K  N+LLD      L+DFG++K  + ++          TI Y+AP+  R 
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRG 204

Query: 602 GRVFANG--DVYSFGIMLMEIHSAK 624
           G    +   D +S G+++ E+ +  
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGA 229

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 8e-23
 Identities = 40/223 (17%), Positives = 84/223 (37%), Gaps = 23/223 (10%)

Query: 415 FSYLEVCRATYGFNEN----NLIGKGGFGTIYKSR-IGDGMEVAVKVFH--LQCGRAFKS 467
           F   EV +  +           +G G +G +  +     G +VA+K  +   Q     K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 468 FDIECEIMKSIHYRNLVKIISSCSNEEFKE------LVLEHMPHGSLEKCLYSSNCILDI 521
              E  ++K + + N++ ++   + +E  +      LV+  M     +      +  L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120

Query: 522 FQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS 581
            +   ++  +   L Y+H      +IH DLKP N+ +++     + DFG+ +    +  S
Sbjct: 121 DRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 173

Query: 582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
                 +              R     D++S G ++ E+ + K
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 97.6 bits (242), Expect = 8e-23
 Identities = 38/200 (19%), Positives = 87/200 (43%), Gaps = 19/200 (9%)

Query: 431 NLIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY-RNLVKIIS 488
             +G+G +  ++++  I +  +V VK+      +  K    E +I++++    N++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 489 SCSNEEFK--ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPV 546
              +   +   LV EH+ +   ++   +    L  +     M ++   L+Y H      +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSM---GI 150

Query: 547 IHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVF 605
           +H D+KP NV++D +     L D+G+ +              +A+  +  PE   + +++
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 606 ANG-DVYSFGIMLMEIHSAK 624
               D++S G ML  +   K
Sbjct: 208 DYSLDMWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 7e-22
 Identities = 41/221 (18%), Positives = 84/221 (38%), Gaps = 19/221 (8%)

Query: 415 FSYLEVCRATYGFNEN----NLIGKGGFGTIYKSR-IGDGMEVAVKVFH--LQCGRAFKS 467
           F   E+ +  +   E     + +G G +G++  +     G+ VAVK      Q     K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 468 FDIECEIMKSIHYRNLVKIISSCSNE----EFKELVLEHMPHGSLEKCLYSSNCILDIFQ 523
              E  ++K + + N++ ++   +      EF ++ L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 524 RLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT 583
              ++  +   L+Y+H      +IH DLKPSN+ +++     + DFG+ +    E     
Sbjct: 123 VQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179

Query: 584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK 624
            T                       D++S G ++ E+ + +
Sbjct: 180 AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 93.6 bits (231), Expect = 3e-21
 Identities = 38/206 (18%), Positives = 79/206 (38%), Gaps = 20/206 (9%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSC 490
            +G G F T++ ++ + +   VA+K+         ++ + E ++++ ++  +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 491 SNEEFK---------------ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVL 535
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 536 EYLHFNFLVPVIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYI 594
           +Y+H      +IH D+KP NVL++      +L    I  L          T ++ T  Y 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 595 APEYGREGRVFANGDVYSFGIMLMEI 620
           +PE           D++S   ++ E+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFEL 222

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.1 bits (230), Expect = 4e-21
 Identities = 45/202 (22%), Positives = 83/202 (41%), Gaps = 19/202 (9%)

Query: 432 LIGKGGFGTIYKSR-IGDGMEVAVKVFH--LQCGRAFKSFDIECEIMKSIHYRNLVKIIS 488
            IG G  G +  +        VA+K      Q     K    E  +MK ++++N++ +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 489 SCSNEEFKE------LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF 542
             + ++  E      LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLHSAG 139

Query: 543 LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREG 602
              +IH DLKPSN+++       + DFG+ +       S   T  + T  Y APE     
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 603 RVFANGDVYSFGIMLMEIHSAK 624
               N D++S G ++ E+   K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.7 bits (221), Expect = 9e-20
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 14/196 (7%)

Query: 125 FDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTI 184
              +   +S   P  I   TNL  + L GN+L      TL  L  L  + L +N++    
Sbjct: 202 LIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257

Query: 185 PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGID 244
           P  +  L KL +L LG N++S   ++  + L +L  L L+ N       I NLK L  + 
Sbjct: 258 P--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 313

Query: 245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL 304
              NN S + P  + SL  LQ LF   N +      S+ +L ++  L+  +N +S   P 
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP- 368

Query: 305 LLEKLSYLEHLNLSFN 320
            L  L+ +  L L+  
Sbjct: 369 -LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.9 bits (193), Expect = 3e-16
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 12/211 (5%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
            L++   +  +   +        +  LTNL ++    N+++   P  +     L  + L 
Sbjct: 170 PLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLN 227

Query: 177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGN 236
            N+L+      +  L  L  LDL  N++S       S L  L  L L  N       +  
Sbjct: 228 GNQLKD--IGTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAG 283

Query: 237 LKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNN 296
           L  L  ++ + N    + P +   LK+L YL L +N +    P  V  L  L+ L F+NN
Sbjct: 284 LTALTNLELNENQLEDISPISN--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339

Query: 297 NLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
            +S      L  L+ +  L+   N++    P
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 77.3 bits (189), Expect = 1e-15
 Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 14/198 (7%)

Query: 75  NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG 134
             L ++  ++S ++ L    +L    L+ N L  I    ++ +L++ L   D++   +S 
Sbjct: 200 ESLIATNNQISDITPLGILTNLDELSLNGNQLKDI---GTLASLTN-LTDLDLANNQISN 255

Query: 135 GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKL 194
             P  +  LT LT + LG N+++   P                N+ +      I  L  L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISPISNLKNL 309

Query: 195 YKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI 254
             L L  N +S       S+L  L+ L  + N       + NL  +  +    N  S + 
Sbjct: 310 TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLT 367

Query: 255 PTTIGSLKDLQYLFLGYN 272
           P  + +L  +  L L   
Sbjct: 368 P--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.1 bits (178), Expect = 2e-14
 Identities = 47/206 (22%), Positives = 76/206 (36%), Gaps = 33/206 (16%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           +I       NL+EL L  N L       +  ++ L DL L +N +S              
Sbjct: 211 DITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN------------- 255

Query: 81  TPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEI 140
                 L+ LS    L    L  N ++ I P   +  L++     +  +          I
Sbjct: 256 ------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI------SPI 303

Query: 141 GNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLG 200
            NL NLT + L  N ++   P +   L KLQ +   +NK+       +  L  +  L  G
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 201 GNKLSGSILTCFSNLASLRTLSLSYN 226
            N++S       +NL  +  L L+  
Sbjct: 360 HNQISDLT--PLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 6e-08
 Identities = 49/274 (17%), Positives = 86/274 (31%), Gaps = 49/274 (17%)

Query: 91  SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIY 150
           +     +  +L    +   + +  +  ++         +  +     + +  L NLT I 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTT----LQADRLGIKS--IDGVEYLNNLTQIN 72

Query: 151 LGGNKLNGSIPFT-LRELQKLQYVGLKDNKLEGTIP------------------------ 185
              N+L    P   L +L  +     +   +                             
Sbjct: 73  FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 186 ------------YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLE 233
                        DI  L  L  L         + L   +NL +L  L +S N       
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNF 293
           +  L  L  +  + N  S + P  I +  +L  L L  N LK     ++  L +L  L+ 
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 294 SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
           +NN +S   P  L  L+ L  L L  N++    P
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.4 bits (202), Expect = 9e-18
 Identities = 48/241 (19%), Positives = 83/241 (34%), Gaps = 4/241 (1%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
           +L     + D+    ++     +  NL NL  + L  NK++   P     L KL+ + L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIG 235
            N+L+         L +L   +    K+  S+    + +  +   +      G       
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 236 NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN 295
            +K L  I  +  N +++     G    L  L L  N +      S+  L +L  L  S 
Sbjct: 148 GMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204

Query: 296 NNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSPNLHVP 355
           N++S      L    +L  L+L+ NKL                    N +     N   P
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 356 P 356
           P
Sbjct: 265 P 265

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 7e-16
 Identities = 44/259 (16%), Positives = 85/259 (32%), Gaps = 33/259 (12%)

Query: 94  KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGG 153
               +  L NN +  I       NL + L    +    +S   P     L  L  +YL  
Sbjct: 31  PDTALLDLQNNKITEIKDG-DFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88

Query: 154 NKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFS 213
           N+L        + LQ+L+    +  K+  ++   + +++ +  L     K SG     F 
Sbjct: 89  NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQ 147

Query: 214 NLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNI 273
            +  L  + ++       +  G    L  +    N  + V   ++  L +L  L L +N 
Sbjct: 148 GMKKLSYIRIADT-NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 274 LKGSI-----------------------PDSVGDLISLKSLNFSNNNLSG------AIPL 304
           +                           P  + D   ++ +   NNN+S         P 
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 305 LLEKLSYLEHLNLSFNKLE 323
              K +    ++L  N ++
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.3 bits (124), Expect = 7e-08
 Identities = 25/140 (17%), Positives = 44/140 (31%), Gaps = 4/140 (2%)

Query: 230 LPLEIG-NLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISL 288
           +P ++  +  +L   D   N  + +      +LK+L  L L  N +    P +   L+ L
Sbjct: 25  VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 289 KSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCG 348
           + L  S N L      + + L  L        K+   +  G +            K    
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 349 SPNLHVPPCKTSIHHTSRKN 368
                    K S    +  N
Sbjct: 142 ENGAFQGMKKLSYIRIADTN 161

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 1e-17
 Identities = 25/200 (12%), Positives = 60/200 (30%), Gaps = 25/200 (12%)

Query: 431 NLIGKGGFGTIYKSRIGDGMEVAVKVFHL----------QCGRAFKSFDIECEIMKSIHY 480
            L+G+G    ++        E  VK   +          +       F +         +
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 481 RNLVKIISSCSNEEFKELVLEHMPHGSL-EKCLYSSNCILDIFQRLNIMIDVASVLEYLH 539
           R L K+      + +         +  L E         + +     ++  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 540 FNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYG 599
                 ++H DL   NVL+ +  +  + DF  +   +   +   +      +  I   + 
Sbjct: 121 HRG---IVHGDLSQYNVLVSEEGI-WIIDFPQS---VEVGEEGWREILERDVRNIITYFS 173

Query: 600 REGRVFANGDVYSFGIMLME 619
           R  R     D+ S    +++
Sbjct: 174 RTYRT--EKDINSAIDRILQ 191

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.6 bits (197), Expect = 4e-17
 Identities = 73/316 (23%), Positives = 112/316 (35%), Gaps = 44/316 (13%)

Query: 43  GVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLS 102
           GV+         + +L L    L                      SSL+N   L    + 
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYP---------------IPSSLANLPYLNFLYIG 84

Query: 103 NNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF 162
               N + P          L    ++  NVSG IP+ +  +  L  +    N L+G++P 
Sbjct: 85  GIN-NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

Query: 163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYK-LDLGGNKLSGSILTCFSNLASLRTL 221
           ++  L  L  +    N++ G IP       KL+  + +  N+L+G I   F+NL      
Sbjct: 144 SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203

Query: 222 SLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS 281
                       +              N  +     +G  K+L  L L  N + G++P  
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG 263

Query: 282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFE 341
           +  L  L SLN S NNL                         GEIP+GG+   F   ++ 
Sbjct: 264 LTQLKFLHSLNVSFNNLC------------------------GEIPQGGNLQRFDVSAYA 299

Query: 342 GNKLLCGSPNLHVPPC 357
            NK LCGSP   +P C
Sbjct: 300 NNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.2 bits (87), Expect = 0.003
 Identities = 13/72 (18%), Positives = 21/72 (29%), Gaps = 18/72 (25%)

Query: 35  LLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCK 94
            L  N + G +P  +  +  L  L +  N L G                   +    N +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE------------------IPQGGNLQ 291

Query: 95  SLVVFLLSNNPL 106
              V   +NN  
Sbjct: 292 RFDVSAYANNKC 303

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.9 bits (177), Expect = 9e-15
 Identities = 64/282 (22%), Positives = 104/282 (36%), Gaps = 26/282 (9%)

Query: 45  VPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNN 104
           VP  I   +  + + L  N +S   ++                 S   C++L +  L +N
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAA-----------------SFRACRNLTILWLHSN 66

Query: 105 PLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTL 164
            L  I      G      ++       +    P     L  L  ++L    L    P   
Sbjct: 67  VLARIDAAAFTGLALLE-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125

Query: 165 RELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLS 224
           R L  LQY+ L+DN L+         L  L  L L GN++S      F  L SL  L L 
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 225 YND--GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV 282
            N      P    +L  L+ +    NN S++    +  L+ LQYL L  N        + 
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RAR 244

Query: 283 GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEG 324
                L+    S++ +  ++P   ++L+  +   L+ N L+G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.7 bits (153), Expect = 1e-11
 Identities = 53/237 (22%), Positives = 81/237 (34%), Gaps = 3/237 (1%)

Query: 117 NLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK 176
            +  + +   +    +S           NLT ++L  N L          L  L+ + L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 177 DNKLEGTI-PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYN--DGPLPLE 233
           DN    ++ P     L +L+ L L    L       F  LA+L+ L L  N         
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNF 293
             +L  L  +    N  SSV       L  L  L L  N +    P +  DL  L +L  
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 294 SNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP 350
             NNLS      L  L  L++L L+ N    +      +          +++ C  P
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (143), Expect = 2e-10
 Identities = 54/288 (18%), Positives = 91/288 (31%), Gaps = 37/288 (12%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P  I P   + + L  N +  V  A+      L  L L  N L+   ++         
Sbjct: 25  AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 81  TPELSFLSSL--------SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNV 132
             +LS  + L             L    L    L  +     +     +L+   +    +
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQYLYLQDNAL 141

Query: 133 SGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLV 192
                +   +L NLT ++L GN+++       R L  L  + L  N++    P+    L 
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 193 KLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS 252
           +L  L L  N LS       + L +L+ L L+ N    P            D        
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN----PWV---------CDCRARPL-- 246

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
                      LQ      + +  S+P     L        + N+L G
Sbjct: 247 --------WAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 1e-08
 Identities = 32/211 (15%), Positives = 55/211 (26%), Gaps = 9/211 (4%)

Query: 89  SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTA 148
            +S   S +        L  + P     +L     I  +S+  +       +   T LT 
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 149 IYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSI 208
           + L   +L          L  L  + L  N+L+                       S  +
Sbjct: 60  LNLDRAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 209 LTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGI-DFSMNNFSSVIPTTIGSLKDLQYL 267
                                LP  +      +     + NN + +    +  L++L  L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 268 FLGYNILKGSIPDSVGDLISLKSLNFSNNNL 298
            L  N L  +IP        L       N  
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 5e-08
 Identities = 47/208 (22%), Positives = 67/208 (32%), Gaps = 26/208 (12%)

Query: 163 TLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLS 222
            + ++     V      L   +P D+ +      L L  N L    L        L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 223 LSYNDGPLPLEIGNLKVLIGIDFSMN-----------------------NFSSVIPTTIG 259
           L   +       G L VL  +D S N                         +S+    + 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 260 SLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF 319
            L +LQ L+L  N LK   P  +     L+ L+ +NNNL+     LL  L  L+ L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 320 NKLEGEIPKGGSFGNFSAESFEGNKLLC 347
           N L                   GN  LC
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 4e-07
 Identities = 37/201 (18%), Positives = 59/201 (29%), Gaps = 9/201 (4%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
            +P ++ P +   L L +N L     A +   + L  L L    L+          L + 
Sbjct: 24  ALPPDL-PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82

Query: 81  TPELS-FLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEE 139
               +   S     ++L    + +   N +                   K N    +P  
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 140 IGNLTNLTAIYLGG-NKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLD 198
           +   T          N L       L  L+ L  + L++N L  TIP   F    L    
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 199 LGGNKLSGSILTCFSNLASLR 219
           L GN        C   +   R
Sbjct: 202 LHGNPWL-----CNCEILYFR 217

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.5 bits (120), Expect = 2e-08
 Identities = 27/122 (22%), Positives = 43/122 (35%), Gaps = 6/122 (4%)

Query: 197 LDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIP 255
           L L    L+  +L     L  +  L LS+N    LP  +  L+ L  +  S N   +V  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 256 TTIGSLKDLQYLFLGYN-ILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEH 314
                   LQ L L  N + + +    +     L  LN   N+L     +       L  
Sbjct: 61  VANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 315 LN 316
           ++
Sbjct: 119 VS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 3e-06
 Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 4/108 (3%)

Query: 219 RTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSI 278
           R L L++ D  +   +  L ++  +D S N   ++ P  + +L+ L+ L    +      
Sbjct: 1   RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57

Query: 279 PDSVGDLISLKSLNFSNNNL-SGAIPLLLEKLSYLEHLNLSFNKLEGE 325
            D V +L  L+ L   NN L   A    L     L  LNL  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 4e-06
 Identities = 25/115 (21%), Positives = 36/115 (31%), Gaps = 5/115 (4%)

Query: 175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEI 234
           L    L  T+   + +L+ +  LDL  N+L        + L  L  L  S N       +
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALENVDGV 61

Query: 235 GNLKVLIGIDFSMNNFSSV-IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISL 288
            NL  L  +    N          + S   L  L L  N L          L  +
Sbjct: 62  ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.001
 Identities = 20/105 (19%), Positives = 38/105 (36%), Gaps = 6/105 (5%)

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
           +L+ L  L     +    LS+N L  + P      L+    +  +   + +    + + N
Sbjct: 9   DLTVLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNALENVDGVAN 63

Query: 143 LTNLTAIYLGGNKLNG-SIPFTLRELQKLQYVGLKDNKLEGTIPY 186
           L  L  + L  N+L   +    L    +L  + L+ N L      
Sbjct: 64  LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 4e-07
 Identities = 42/264 (15%), Positives = 88/264 (33%), Gaps = 21/264 (7%)

Query: 94  KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG-GIPEEIGNLTNLTAIYLG 152
           + ++ F    + ++  L           ++  D+S   +    +   +   + L  + L 
Sbjct: 23  QGVIAFRCPRSFMDQPLAE---HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79

Query: 153 GNKLNGSIPFTLRELQKLQYVGLKD--NKLEGTIPYDIFRLVKLYKLDLGGNKLSG---- 206
           G +L+  I  TL +   L  + L       E  +   +    +L +L+L           
Sbjct: 80  GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 139

Query: 207 ----SILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMN-NFSSVIPTTIGSL 261
               + ++      +L     +     L   +     L+ +D S +    +        L
Sbjct: 140 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199

Query: 262 KDLQYLFLGY-NILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFN 320
             LQ+L L     +       +G++ +LK+L        G + LL E L    HL ++ +
Sbjct: 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCS 256

Query: 321 KLEGEIPKGGSFGNFSAESFEGNK 344
                     + GN   +   G K
Sbjct: 257 HFTTIAR--PTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 5/105 (4%)

Query: 196 KLDLGGNKLSGSILT--CFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFS-S 252
            LDL G  L   +        + + R    S+ D PL       + +  +D S +    S
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQGVIAFR-CPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61

Query: 253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNN 297
            +   +     LQ L L    L   I +++    +L  LN S  +
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 3e-06
 Identities = 21/92 (22%), Positives = 30/92 (32%), Gaps = 9/92 (9%)

Query: 175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLPLE 233
              N     I         L +L++  NKL        +    L  L  S+N    +P  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI----ELPALPPRLERLIASFNHLAEVPEL 322

Query: 234 IGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ 265
             NLK L       N      P    S++DL+
Sbjct: 323 PQNLKQL---HVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 3e-06
 Identities = 25/95 (26%), Positives = 39/95 (41%), Gaps = 12/95 (12%)

Query: 202 NKLSGSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGS 260
           N  S  I +      SL  L++S N    LP     L+ L     S N+ +  +P    +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLERL---IASFNHLAE-VPELPQN 325

Query: 261 LKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN 295
           LK    L + YN L+   PD      S++ L  ++
Sbjct: 326 LK---QLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 1e-05
 Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 9/83 (10%)

Query: 245 FSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL 304
           + +N  S+ I +       L+ L +  N L   +P        L+ L  S N+L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 305 LLEKLSYLEHLNLSFNKLEGEIP 327
           L + L   + L++ +N L  E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 12/90 (13%)

Query: 223 LSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV 282
            S     L     +L+ L   + S N     +P     L   + L   +N L   +P+  
Sbjct: 272 SSNEIRSLCDLPPSLEEL---NVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELP 323

Query: 283 GDLISLKSLNFSNNNLSGAIPLLLEKLSYL 312
               +LK L+   N L    P + E +  L
Sbjct: 324 Q---NLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 8e-05
 Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 11/80 (13%)

Query: 92  NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL 151
              SL    +SNN L        +  L   LE    S  +++  +PE   NL  L   ++
Sbjct: 282 LPPSLEELNVSNNKLI------ELPALPPRLERLIASFNHLAE-VPELPQNLKQL---HV 331

Query: 152 GGNKLNGSIPFTLRELQKLQ 171
             N L    P     ++ L+
Sbjct: 332 EYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 3e-04
 Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 9/95 (9%)

Query: 125 FDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTI 184
                   S  I        +L  + +  NKL   +P     L++L       N L   +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EV 319

Query: 185 PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLR 219
           P     L    +L +  N L         ++  LR
Sbjct: 320 PELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 25/78 (32%), Positives = 30/78 (38%), Gaps = 7/78 (8%)

Query: 268 FLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP 327
               N     I        SL+ LN SNN L   +P L  +   LE L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 328 KGGSFGNFSAESFEGNKL 345
           +     N      E N L
Sbjct: 321 E--LPQNLKQLHVEYNPL 336

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 38/208 (18%), Positives = 65/208 (31%), Gaps = 34/208 (16%)

Query: 136 IPEEIG------NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF 189
           +P  I                L    +  ++  T  EL  +  +   ++ ++      I 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQ 65

Query: 190 RLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-------------------GPL 230
            L  + KL L GNKL+       +NL +L  L L  N                       
Sbjct: 66  YLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123

Query: 231 PLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKS 290
             +I  L  L  ++      + +   T+ S           +     I   +  L  L++
Sbjct: 124 ISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQN 182

Query: 291 LNFSNNNLSGAIPLLLEKLSYLEHLNLS 318
           L  S N++S    L    L  L+ L L 
Sbjct: 183 LYLSKNHISDLRAL--AGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 6e-04
 Identities = 30/202 (14%), Positives = 63/202 (31%), Gaps = 25/202 (12%)

Query: 45  VPAAIFDVSTLKDLA------LQDNYLSGSLSSIADNYLTS---STPELSFLSSLSNCKS 95
           VP  I  + +    A      L+   ++ +++    N +     +  ++  +  +    +
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPN 69

Query: 96  LVVFLLSNNPLNGI-----LPRMSIGNLSHSLE--------IFDMSKCNVSGGIPEEIGN 142
           +    L+ N L  I     L  +    L  +          +  +   ++      +I  
Sbjct: 70  VTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           L +L  +       N     T+            ++     I   +  L KL  L L  N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKN 188

Query: 203 KLSGSILTCFSNLASLRTLSLS 224
            +S   L   + L +L  L L 
Sbjct: 189 HISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 34/213 (15%), Positives = 69/213 (32%), Gaps = 16/213 (7%)

Query: 83  ELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGN 142
            +  + S       +   L    +   + +  +    +S++    +  ++       I  
Sbjct: 13  PIKQIFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIKSVQG--IQY 66

Query: 143 LTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN 202
           L N+T ++L GNKL    P    +     ++     K   ++                  
Sbjct: 67  LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL------E 120

Query: 203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLK 262
               S +    +L  L +L L  N       +  L  L  +    N  S ++P  +  L 
Sbjct: 121 HNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178

Query: 263 DLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN 295
            LQ L+L  N +      ++  L +L  L   +
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 8e-06
 Identities = 31/227 (13%), Positives = 60/227 (26%), Gaps = 18/227 (7%)

Query: 92  NCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYL 151
              + +      + +   + +  +  ++            V+    E +  L NL  + L
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITT----LSAFGTGVTT--IEGVQYLNNLIGLEL 70

Query: 152 GGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC 211
             N++    P           +     K    I                    S  I   
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT--------STQITDV 122

Query: 212 FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGY 271
                      L  +   +        +      S+ N      T + +L  L  L    
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 272 NILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLS 318
           N +    P  +  L +L  ++  NN +S   P  L   S L  + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 39/204 (19%), Positives = 69/204 (33%), Gaps = 26/204 (12%)

Query: 142 NLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG 201
            L N   I  G + +  ++  T  +L  +  +      +  TI   +  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSV-------- 253
           N+++   L    NL  +  L LS N       I  L+ +  +D +    + V        
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 254 ----------IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIP 303
                     I             +L     + S    + +L  L +L   +N +S   P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 304 LLLEKLSYLEHLNLSFNKLEGEIP 327
           L    L  L  ++L  N++    P
Sbjct: 191 L--ASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 38/230 (16%), Positives = 76/230 (33%), Gaps = 28/230 (12%)

Query: 16  IESPCEIPSEINPHNLEELL---LGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSI 72
           I  P  I        L   +    G++N+   V  A  D+  +  L+     ++ ++  +
Sbjct: 3   ITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGV 59

Query: 73  AD----NYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMS 128
                   L     +++ L+ L N   +    LS NPL  +     + ++          
Sbjct: 60  QYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQI 119

Query: 129 KCNVSGGIPEEIGNLTNLTAIYLGGNKL--------------NGSIPFTLRELQKLQYVG 174
                      +  L          + L                S    L  L KL  + 
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179

Query: 175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLS 224
             DNK+    P  +  L  L ++ L  N++S   ++  +N ++L  ++L+
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 13/58 (22%), Positives = 22/58 (37%), Gaps = 4/58 (6%)

Query: 120 HSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKD 177
             L         +S   P  + +L NL  ++L  N+++   P  L     L  V L +
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 9e-06
 Identities = 13/71 (18%), Positives = 23/71 (32%), Gaps = 5/71 (7%)

Query: 263 DLQYLFLGYN-ILKGSIPDSVGDLISLKSLNFSNNNLSG----AIPLLLEKLSYLEHLNL 317
           D+Q L +    +      + +  L   + +   +  L+      I   L     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 318 SFNKLEGEIPK 328
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 19/74 (25%), Positives = 29/74 (39%), Gaps = 9/74 (12%)

Query: 264 LQYLFLGYNILKG----SIPDSVGDLISLKSLNFSNNNLSGAIPLLL-----EKLSYLEH 314
           L+ L+L    +      S+  ++    SL+ L+ SNN L  A  L L     +    LE 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 315 LNLSFNKLEGEIPK 328
           L L       E+  
Sbjct: 431 LVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 13/93 (13%)

Query: 236 NLKVLIGIDFSMNNFSSV-IPTTIGSLKDLQYLFLGYNILKG----SIPDSVGDLISLKS 290
           +++ L   D      S       +  L+  Q + L    L       I  ++    +L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 291 LNFSNNNLSGAIP-----LLLEKLSYLEHLNLS 318
           LN  +N L           L      ++ L+L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 6e-04
 Identities = 15/110 (13%), Positives = 28/110 (25%), Gaps = 19/110 (17%)

Query: 192 VKLYKLDLGGNKLSGSILTC-FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
           + +  LD+   +LS +        L   + + L          +   +            
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCG------LTEARC----------- 44

Query: 251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG 300
              I + +     L  L L  N L       V   +   S      +L  
Sbjct: 45  -KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 8e-04
 Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 10/92 (10%)

Query: 145 NLTAIYLGGNKLNGS-IPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVK----LYKLDL 199
           ++ ++ +   +L+ +     L  LQ+ Q V L D  L      DI   ++    L +L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 200 GGNKLSGSILTCF-----SNLASLRTLSLSYN 226
             N+L    + C      +    ++ LSL   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 12/83 (14%)

Query: 236 NLKVLIGIDFSMNNFS----SVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLI----- 286
            L+VL     +  + S    S +  T+ +   L+ L L  N L  +    + + +     
Sbjct: 370 VLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 287 SLKSLNFSNNNLSGAIPLLLEKL 309
            L+ L   +   S  +   L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.001
 Identities = 10/46 (21%), Positives = 18/46 (39%), Gaps = 4/46 (8%)

Query: 287 SLKSLNFSNNNLSG----AIPLLLEKLSYLEHLNLSFNKLEGEIPK 328
            L+ L  ++ ++S     ++   L     L  L+LS N L      
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 11/44 (25%), Positives = 17/44 (38%), Gaps = 1/44 (2%)

Query: 286 ISLKSLNFSNNNLSGA-IPLLLEKLSYLEHLNLSFNKLEGEIPK 328
           + ++SL+     LS A    LL  L   + + L    L     K
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK 45

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 5e-05
 Identities = 26/132 (19%), Positives = 47/132 (35%), Gaps = 5/132 (3%)

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF 250
            V+  +LDL G K+   I    + L     +  S N+         L+ L  +  + N  
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRI 75

Query: 251 SSVIPTTIGSLKDLQYLFLG-YNILKGSIPDSVGDLISLKSLNFSNNN---LSGAIPLLL 306
             +      +L DL  L L   ++++    D +  L SL  L    N           ++
Sbjct: 76  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 135

Query: 307 EKLSYLEHLNLS 318
            K+  +  L+  
Sbjct: 136 YKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.003
 Identities = 6/39 (15%), Positives = 16/39 (41%), Gaps = 1/39 (2%)

Query: 284 DLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKL 322
           + +  + L+     +   I  L   L   + ++ S N++
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 5e-05
 Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 4/155 (2%)

Query: 198 DLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTT 257
           +L   ++   +    S        +L         ++    + + ++   ++ ++ +   
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR-SSMAATLRII 60

Query: 258 IGSLKDLQYLFLGYNILKG--SIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHL 315
             ++ +L  L L  N L     +   V    +LK LN S N L     L   K   LE L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 316 NLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP 350
            L  N L        ++ +   E F     L G  
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHE 155

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 7e-04
 Identities = 40/221 (18%), Positives = 69/221 (31%), Gaps = 13/221 (5%)

Query: 21  EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSS 80
           EIPS++ P N  EL      L  +   A      L+ + +  N +   + +   + L   
Sbjct: 22  EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 81  TPELSFLSSLSNCK---------SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN 131
                  ++              +L   L+SN  +  +     I +L   L     +   
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFR- 190
            +      +G       ++L  N +           Q  +     DN     +P D+F  
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL-SDNNNLEELPNDVFHG 199

Query: 191 LVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLP 231
                 LD+   ++         NL  LR  S  YN   LP
Sbjct: 200 ASGPVILDISRTRIHSLPSYGLENLKKLRARST-YNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 8/44 (18%), Positives = 11/44 (25%)

Query: 278 IPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK 321
             D          L+ S   +       LE L  L   +    K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 8e-04
 Identities = 34/138 (24%), Positives = 51/138 (36%), Gaps = 3/138 (2%)

Query: 216 ASLRTLSLSYNDGPLPLEI---GNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYN 272
                L L+ N+          G L  L+ ++   N  + + P        +Q L LG N
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88

Query: 273 ILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSF 332
            +K         L  LK+LN  +N +S  +P   E L+ L  LNL+ N            
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148

Query: 333 GNFSAESFEGNKLLCGSP 350
                +S  G    CG+P
Sbjct: 149 EWLRKKSLNGGAARCGAP 166

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 12/90 (13%), Positives = 25/90 (27%), Gaps = 5/90 (5%)

Query: 262 KDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSG----AIPLLLEKLSYLEHLNL 317
           K L+   +     K S+   + +  S+K +  S N +       +   +     LE    
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 318 SFNKLEGEIPKGGSFGNFSAESFEGNKLLC 347
           S         +         ++      L 
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 17/72 (23%), Positives = 26/72 (36%), Gaps = 11/72 (15%)

Query: 265 QYLFLGYNILKGSIPDSVGD------LISLKSLNFSNNNLSGAIPLLL-----EKLSYLE 313
           + L L   +L      +V D       I L++L    N +       L     EK+  L 
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305

Query: 314 HLNLSFNKLEGE 325
            L L+ N+   E
Sbjct: 306 FLELNGNRFSEE 317

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	652
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.7
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.69
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.68
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.63
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.59
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.55
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.52
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.46
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.41
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.66
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.65
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.83
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.09
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.07
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.05
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.0

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=414.65  Aligned_cols=225  Identities=22%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999875 69999999997553 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||++|+|.+++.... .+++.++..++.|++.||+|||++   ||+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999987654 799999999999999999999999   9999999999999999999999999999876444333


Q ss_pred             cccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l  634 (652)
                      ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||..                          .+.++
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            34456679999999999988876 5779999999999999999999633                          26789


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++||
T Consensus       240 i~~~L~~dP~~R~t~~ei  257 (271)
T d1nvra_         240 LHKILVENPSARITIPDI  257 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHH
T ss_pred             HHHHcCCChhHCcCHHHH
Confidence            999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=414.62  Aligned_cols=221  Identities=26%  Similarity=0.335  Sum_probs=199.8

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .+|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999864 69999999998765556678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++|+|.+++...  .+++.++..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+.+...  ...
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc--ccc
Confidence            999999988764  499999999999999999999999   9999999999999999999999999999876322  223


Q ss_pred             cccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhhhhhcc
Q 041689          584 QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVFNLAME  637 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~~l~~~  637 (652)
                      ....+||+.|+|||++.++.++.++||||+||++|||++|+.||..                          .+++++.+
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            3456799999999999999999999999999999999999999543                          37889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++|+
T Consensus       253 ~L~~dP~~R~s~~ei  267 (293)
T d1yhwa1         253 CLDMDVEKRGSAKEL  267 (293)
T ss_dssp             HTCSSTTTSCCHHHH
T ss_pred             HccCChhHCcCHHHH
Confidence            999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=408.74  Aligned_cols=220  Identities=23%  Similarity=0.307  Sum_probs=197.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|++. +++.||+|++...   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999975 6899999999754   2334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |||++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+....   
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence            9999999999988655 699999999999999999999999   999999999999999999999999999986532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                       .......||+.|||||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+
T Consensus       159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  237 (263)
T d2j4za1         159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR  237 (263)
T ss_dssp             -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             -CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence             223446799999999999999999999999999999999999999543                       37899999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++||
T Consensus       238 ~L~~dp~~R~t~~ei  252 (263)
T d2j4za1         238 LLKHNPSQRPMLREV  252 (263)
T ss_dssp             HTCSSGGGSCCHHHH
T ss_pred             HccCCHhHCcCHHHH
Confidence            999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=411.84  Aligned_cols=224  Identities=23%  Similarity=0.340  Sum_probs=196.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999874 69999999997542   334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+++|+|.+++...+ .+++.++..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887655 699999999999999999999999   999999999999999999999999999987643333


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.+
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            3344456799999999999999999999999999999999999999643                       27889999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++|+
T Consensus       244 ~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         244 LLVLDATKRLGCEEM  258 (288)
T ss_dssp             TSCSSGGGSTTSGGG
T ss_pred             HccCCHhHCcCHHHH
Confidence            999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=411.12  Aligned_cols=223  Identities=22%  Similarity=0.316  Sum_probs=198.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      +.|++.+.||+|+||.||+|++. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999865 68999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCccc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMT  583 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  583 (652)
                      ++|+|.+++......+++.++..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+....  ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC--Cccc
Confidence            99999999876655799999999999999999999999   999999999999999999999999999976421  1122


Q ss_pred             cccccCCccccCccccc-----cCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hhh
Q 041689          584 QTQTLATIGYIAPEYGR-----EGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FVF  632 (652)
Q Consensus       584 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l~  632 (652)
                      .....||+.|+|||++.     +..|+.++||||+||++|||++|+.||..                          .+.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            34567999999999873     45689999999999999999999999543                          378


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       247 ~li~~~L~~dp~~R~t~~el  266 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQL  266 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHccCChhHCcCHHHH
Confidence            89999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=406.12  Aligned_cols=223  Identities=24%  Similarity=0.371  Sum_probs=189.8

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|.+.+.||+|+||+||+|+.+  ..||||+++..  .....+.+.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999864  36999998654  34456789999999999999999999998754 56899999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||++|+|.+++...+..+++.++..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999987766799999999999999999999999   9999999999999999999999999999876433333


Q ss_pred             cccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcch-----------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------------  629 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------------  629 (652)
                      .......||+.|||||++.+   +.|+.++|||||||++|||+||+.||..                             
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  240 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK  240 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence            34455679999999999864   3589999999999999999999999543                             


Q ss_pred             hhhhhhcccchhhhccccCccCC
Q 041689          630 FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+.+++.+||+.||++|||++||
T Consensus       241 ~l~~li~~cl~~dp~~RPt~~~i  263 (276)
T d1uwha_         241 AMKRLMAECLKKKRDERPLFPQI  263 (276)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHH
Confidence            37889999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=403.04  Aligned_cols=223  Identities=26%  Similarity=0.378  Sum_probs=189.3

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      .+|+..+.||+|+||.||+|++.+++.||||+++... ...+++.+|++++++++|||||+++|++..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999888999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++...... ....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC-ceee
Confidence            9999999887777899999999999999999999999   99999999999999999999999999998763322 2222


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHhC-CCC------------------------cchhhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSA-KQQ------------------------CVSFVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p------------------------~~~~l~~l~~~~l  639 (652)
                      ....||+.|+|||++.+..++.++|||||||++|||+|+ ++|                        ++..+.+++.+||
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW  239 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence            345689999999999999999999999999999999995 444                        3344889999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.||++|||++||
T Consensus       240 ~~~p~~Rps~~~i  252 (263)
T d1sm2a_         240 KERPEDRPAFSRL  252 (263)
T ss_dssp             CSSGGGSCCHHHH
T ss_pred             cCCHhHCcCHHHH
Confidence            9999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=418.11  Aligned_cols=221  Identities=23%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ......+.+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            568999999999999999999965 68999999997653 3445678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||+ +   ||+||||||+|||+++++.+||+|||+|+....   
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            999999999997655 69999999999999999999996 6   899999999999999999999999999987532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                       ......+||+.|+|||++.+.+|+.++||||+||++|||++|+.||.                                
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence             22335679999999999999999999999999999999999999973                                


Q ss_pred             -----------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 -----------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 -----------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                         .++.+++.+||..||++||||+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~  295 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL  295 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                                               236789999999999999999874

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=404.86  Aligned_cols=226  Identities=22%  Similarity=0.263  Sum_probs=184.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec--CCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN--EEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  499 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|++++++++|||||++++++.+  ++..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999865 68999999997542  3345678899999999999999999999864  4568999


Q ss_pred             EEccCCCChhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          500 LEHMPHGSLEKCLYS---SNCILDIFQRLNIMIDVASVLEYLHFNF--LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ||||++|+|.+++..   ....+++..++.++.|++.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999998864   2346999999999999999999999861  11499999999999999999999999999987


Q ss_pred             ccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------h
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------F  630 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------~  630 (652)
                      +...  ........||+.|||||++.+..|+.++|||||||++|||+||+.||..                        .
T Consensus       164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            6322  2223456799999999999999999999999999999999999999543                        3


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++|||++||
T Consensus       242 l~~li~~~L~~dp~~Rps~~el  263 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEI  263 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHH
Confidence            7899999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-50  Score=394.36  Aligned_cols=223  Identities=22%  Similarity=0.366  Sum_probs=200.7

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMP  504 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  504 (652)
                      ++|+..+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999888999999998653 345689999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcccc
Q 041689          505 HGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQ  584 (652)
Q Consensus       505 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  584 (652)
                      +|++.+++......+++..+.+++.|+++||+|||+.   ||+||||||+||++++++.+||+|||+++...... ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence            9999999887776899999999999999999999999   99999999999999999999999999998764322 2233


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~l~~~~l  639 (652)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..                        .+.+++.+||
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  238 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW  238 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence            34568999999999999999999999999999999998 7888543                        3889999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.||++|||++||
T Consensus       239 ~~dP~~RPt~~ei  251 (258)
T d1k2pa_         239 HEKADERPTFKIL  251 (258)
T ss_dssp             CSSGGGSCCHHHH
T ss_pred             cCCHhHCcCHHHH
Confidence            9999999999874

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-50  Score=396.16  Aligned_cols=216  Identities=25%  Similarity=0.359  Sum_probs=187.6

Q ss_pred             CccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec----CCceEEEE
Q 041689          428 NENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN----EEFKELVL  500 (652)
Q Consensus       428 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  500 (652)
                      +..+.||+|+||+||+|++. +++.||+|++...  .....+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999875 6889999999754  23345678999999999999999999999864    35679999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCCCCCCeeeC-CCCcEEEecccCCccccC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVP--VIHCDLKPSNVLLD-DTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~  577 (652)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||++   +  |+||||||+|||++ +++.+||+|||+|+... 
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence            9999999999997654 689999999999999999999998   6  99999999999996 57899999999998542 


Q ss_pred             CCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------------hh
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------FV  631 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~l  631 (652)
                         ........||+.|||||++.+ +++.++||||+||++|||++|+.||..                          .+
T Consensus       167 ---~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         167 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ---CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence               222345679999999998865 699999999999999999999999643                          27


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       243 ~~li~~~l~~dp~~R~s~~el  263 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDL  263 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHH
Confidence            899999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.2e-50  Score=411.19  Aligned_cols=222  Identities=19%  Similarity=0.233  Sum_probs=199.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47999999999999999999865 69999999998765566678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC--CCCcEEEecccCCccccCCCCc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +||+|.+++......+++.++..|+.||+.||+|||++   ||+||||||+|||++  .++.+||+|||+++.+..   .
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~---~  179 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---K  179 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---T
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc---c
Confidence            99999999977666799999999999999999999999   999999999999996  467899999999987632   2


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l  634 (652)
                      .......||+.|||||++.+..++.++||||+||++|||++|+.||..                           .+.++
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            233456799999999999999999999999999999999999999643                           26789


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++|+
T Consensus       260 i~~~L~~dP~~R~t~~ei  277 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQA  277 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHH
T ss_pred             HHHHccCChhHCcCHHHH
Confidence            999999999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.4e-49  Score=409.79  Aligned_cols=222  Identities=18%  Similarity=0.241  Sum_probs=200.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46999999999999999999864 69999999998765556678889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC--CCCcEEEecccCCccccCCCCc
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD--DTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~--~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +||+|.+++......+++.++..|+.||+.||+|||++   ||+||||||+|||++  .++.+||+|||+|+.+..   .
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~---~  182 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---D  182 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---T
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC---C
Confidence            99999998877766799999999999999999999999   999999999999997  678999999999987632   2


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFNL  634 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~l  634 (652)
                      .......||+.|+|||++.+..++.++||||+||++|||+||+.||..                           .+.++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            233456799999999999999999999999999999999999999643                           26889


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++|+
T Consensus       263 i~~~L~~dp~~R~s~~ei  280 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDA  280 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHH
T ss_pred             HHHHccCChhHCcCHHHH
Confidence            999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-50  Score=406.34  Aligned_cols=222  Identities=18%  Similarity=0.246  Sum_probs=181.7

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .+.|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356999999999999999999875 68999999997553 2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCccccCC
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||+||+|.+++...+ .+++.++..++.|++.||+|||++   +|+||||||+||+++   +++.+||+|||+++.... 
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-  162 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-  162 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence            999999999997654 799999999999999999999999   999999999999994   578999999999986532 


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FV  631 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l  631 (652)
                        .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..                           .+
T Consensus       163 --~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         163 --GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             --CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence              2223446799999999999999999999999999999999999999643                           26


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++|+
T Consensus       241 ~~li~~~L~~dP~~R~s~~ei  261 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQA  261 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHH
Confidence            889999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.3e-50  Score=406.13  Aligned_cols=225  Identities=23%  Similarity=0.382  Sum_probs=184.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CC---cEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DG---MEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      .+|++.+.||+|+||+||+|++. ++   ..||||.+... .....+.|.+|++++++++|||||+++|++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34566789999999999999865 33   35889988654 334556899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||||++|+|.+++......+++.++..++.|+++||+|||++   +|+||||||+|||+++++++||+|||+++......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999999999887766899999999999999999999999   99999999999999999999999999998764332


Q ss_pred             Cccc---cccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hh
Q 041689          580 QSMT---QTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FV  631 (652)
Q Consensus       580 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l  631 (652)
                      ....   .....||+.|||||++.++.++.++|||||||++|||+| |+.||..                        .+
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  262 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL  262 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence            2211   122357899999999999999999999999999999998 8888543                        37


Q ss_pred             hhhhcccchhhhccccCccCC
Q 041689          632 FNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       632 ~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      .+++.+||+.||++|||++||
T Consensus       263 ~~li~~cl~~~P~~RPs~~ei  283 (299)
T d1jpaa_         263 HQLMLDCWQKDRNHRPKFGQI  283 (299)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHH
Confidence            899999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=399.61  Aligned_cols=223  Identities=26%  Similarity=0.387  Sum_probs=194.1

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            45788899999999999999999888999999997543 345679999999999999999999998765 5678999999


Q ss_pred             CCCChhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSNC-ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|+|.+++..... .+++.++..|+.||++||+|||++   +|+||||||+||++++++.+||+|||+|+..... ...
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            99999997764432 589999999999999999999999   9999999999999999999999999999876332 222


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~~l~~~  637 (652)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|                         ++..+.+++.+
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            33445689999999999999999999999999999999996554                         33348999999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++||
T Consensus       246 cl~~~P~~Rpt~~ei  260 (272)
T d1qpca_         246 CWKERPEDRPTFDYL  260 (272)
T ss_dssp             HTCSSGGGSCCHHHH
T ss_pred             HcCCCHhHCcCHHHH
Confidence            999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-50  Score=406.24  Aligned_cols=225  Identities=25%  Similarity=0.399  Sum_probs=197.7

Q ss_pred             HhcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||++++++.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3457888999999999999999875 58899999997553 345779999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          502 HMPHGSLEKCLYSS-NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       502 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+++|++.+++... ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+..... .
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            99999999998754 34789999999999999999999999   9999999999999999999999999999876332 2


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhhhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLA  635 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~~l~  635 (652)
                      ........|++.|+|||++.++.|+.++|||||||++|||++|..|                         ++..+.+++
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence            2233445688999999999999999999999999999999997665                         333488999


Q ss_pred             cccchhhhccccCccCC
Q 041689          636 MECTIESLELRINAKEI  652 (652)
Q Consensus       636 ~~~l~~~p~~Rpt~~ei  652 (652)
                      .+||+.||++|||++||
T Consensus       250 ~~cl~~dP~~Rps~~ei  266 (287)
T d1opja_         250 RACWQWNPSDRPSFAEI  266 (287)
T ss_dssp             HHHTCSSGGGSCCHHHH
T ss_pred             HHHcCCCHhHCcCHHHH
Confidence            99999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-49  Score=402.49  Aligned_cols=217  Identities=22%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      .|+..+.||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4899999999999999999864 68899999997543   2344678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ||++|++..++.... .+++.++..++.|++.||.|||++   ||+||||||+|||+++++.+||+|||+|+....    
T Consensus        96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            999999987665544 799999999999999999999999   999999999999999999999999999986421    


Q ss_pred             cccccccCCccccCcccccc---CccCcccchhhHHHHHHHHHhCCCCcc-------------------------hhhhh
Q 041689          582 MTQTQTLATIGYIAPEYGRE---GRVFANGDVYSFGIMLMEIHSAKQQCV-------------------------SFVFN  633 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~-------------------------~~l~~  633 (652)
                        .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.                         ..+.+
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence              234579999999999853   468999999999999999999999953                         33789


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++|||++|+
T Consensus       246 li~~~L~~dP~~Rpt~~el  264 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVL  264 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHCcCChhHCcCHHHH
Confidence            9999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=396.34  Aligned_cols=224  Identities=24%  Similarity=0.361  Sum_probs=193.5

Q ss_pred             cCCCccce-eccccceEEEEEEeC---CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNL-IGKGGFGTIYKSRIG---DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||+++... ....+++.+|++++++++|||||++++++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45666674 999999999999754   35679999997553 3456789999999999999999999999875 457899


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++...+..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            999999999999877666899999999999999999999999   99999999999999999999999999998764332


Q ss_pred             Ccc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          580 QSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       580 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||..                        .+.+
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  243 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA  243 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            222 2234568999999999999999999999999999999998 8998543                        3789


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++|||+.+|
T Consensus       244 li~~cl~~~p~~RPs~~~i  262 (285)
T d1u59a_         244 LMSDCWIYKWEDRPDFLTV  262 (285)
T ss_dssp             HHHHTTCSSGGGSCCHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHH
Confidence            9999999999999999764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=395.68  Aligned_cols=222  Identities=20%  Similarity=0.293  Sum_probs=196.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc------chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC------GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++...      ....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999974 69999999997542      12356789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC----cEEEecccCC
Q 041689          497 ELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM----VAHLSDFGIT  572 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~----~~kl~Dfg~~  572 (652)
                      |+|||||++|+|.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++.++    .+|++|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999987755 699999999999999999999999   999999999999998776    5999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      +....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||..                       
T Consensus       165 ~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (293)
T d1jksa_         165 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  241 (293)
T ss_dssp             EECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             hhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence            87632   2223445789999999999999999999999999999999999999643                       


Q ss_pred             ----hhhhhhcccchhhhccccCccCC
Q 041689          630 ----FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          .+.+++++||+.||++|||++||
T Consensus       242 ~~s~~~~~li~~~L~~dP~~R~s~~ei  268 (293)
T d1jksa_         242 NTSALAKDFIRRLLVKDPKKRMTIQDS  268 (293)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                26789999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=402.99  Aligned_cols=226  Identities=23%  Similarity=0.369  Sum_probs=194.2

Q ss_pred             hcCCCccceeccccceEEEEEEeCC------CcEEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD------GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .++|++.+.||+|+||+||+|++..      ...||+|.+... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4578899999999999999998532      236999998654 334456789999999998 89999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 041689          496 KELVLEHMPHGSLEKCLYSSN----------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKP  553 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  553 (652)
                      .++|||||++|+|.+++....                      ..+++.++..|+.|+++||+|||++   +|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            999999999999999997653                      2478899999999999999999999   999999999


Q ss_pred             CCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch---
Q 041689          554 SNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS---  629 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~---  629 (652)
                      +||+++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||..   
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333445668999999999999999999999999999999998 8988543   


Q ss_pred             ----------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                            .+.+++.+||+.||++|||++||
T Consensus       273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei  317 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL  317 (325)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                                  37899999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=399.70  Aligned_cols=218  Identities=21%  Similarity=0.251  Sum_probs=195.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999864 7999999999754   2234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |||+||+|.+++.... .+++..+..++.|++.||+|||++   ||+||||||+|||++++|.+||+|||+|+....  .
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--D  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--T
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc--C
Confidence            9999999999988765 689999999999999999999999   999999999999999999999999999986532  2


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                      .......+||+.|+|||++.+..|+.++||||+||++|||++|++||..                       .+.+++.+
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            2334456799999999999999999999999999999999999999533                       37899999


Q ss_pred             cchhhhccccC
Q 041689          638 CTIESLELRIN  648 (652)
Q Consensus       638 ~l~~~p~~Rpt  648 (652)
                      ||+.||++||+
T Consensus       239 ~L~~dP~~R~~  249 (337)
T d1o6la_         239 LLKKDPKQRLG  249 (337)
T ss_dssp             HTCSSTTTSTT
T ss_pred             hccCCchhhcc
Confidence            99999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=393.27  Aligned_cols=225  Identities=25%  Similarity=0.427  Sum_probs=188.7

Q ss_pred             cCCCccceeccccceEEEEEEeCC-C----cEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGD-G----MEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      ..|+..+.||+|+||.||+|.++. +    ..||||+++... .....++.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            468888999999999999998643 2    469999997543 3345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+.++++.+++......+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999998887777899999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCc-cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhh
Q 041689          579 DQS-MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVF  632 (652)
Q Consensus       579 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~  632 (652)
                      ... .......||+.|+|||++.++.++.++|||||||++|||++|..|                         ++..+.
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  243 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence            221 222345689999999999999999999999999999999996555                         233489


Q ss_pred             hhhcccchhhhccccCccCC
Q 041689          633 NLAMECTIESLELRINAKEI  652 (652)
Q Consensus       633 ~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +++.+||+.||++|||++||
T Consensus       244 ~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         244 QLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             HHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHCcCCHhHCcCHHHH
Confidence            99999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-49  Score=391.92  Aligned_cols=217  Identities=26%  Similarity=0.355  Sum_probs=185.5

Q ss_pred             ceeccccceEEEEEEeC---CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEccCC
Q 041689          431 NLIGKGGFGTIYKSRIG---DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHMPH  505 (652)
Q Consensus       431 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  505 (652)
                      +.||+|+||.||+|.+.   +++.||||+++..  .....+.+.+|++++++++|||||++++++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            47999999999999753   3568999999654  233456799999999999999999999998654 57899999999


Q ss_pred             CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc-cc
Q 041689          506 GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM-TQ  584 (652)
Q Consensus       506 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~~  584 (652)
                      |+|.+++.... .+++.++..|+.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++......... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999988755 699999999999999999999999   99999999999999999999999999998764332222 22


Q ss_pred             ccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhhhhcccc
Q 041689          585 TQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFNLAMECT  639 (652)
Q Consensus       585 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~l~~~~l  639 (652)
                      ....||+.|+|||++.++.++.++|||||||++|||+| |+.||.                        +.+.+++.+||
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            34568999999999999999999999999999999998 898854                        33789999999


Q ss_pred             hhhhccccCccCC
Q 041689          640 IESLELRINAKEI  652 (652)
Q Consensus       640 ~~~p~~Rpt~~ei  652 (652)
                      +.||++|||++||
T Consensus       248 ~~dp~~RPs~~~i  260 (277)
T d1xbba_         248 TYDVENRPGFAAV  260 (277)
T ss_dssp             CSSTTTSCCHHHH
T ss_pred             CCCHhHCcCHHHH
Confidence            9999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-48  Score=394.84  Aligned_cols=214  Identities=23%  Similarity=0.289  Sum_probs=193.0

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|+.+ +|+.||||+++..   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46999999999999999999974 6999999999754   2334567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||++||++..++.... .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+|+....   
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc---
Confidence            9999999999887765 688889999999999999999999   999999999999999999999999999987532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                        .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..                       .+.+++.+
T Consensus       157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              23346799999999999999999999999999999999999999643                       37899999


Q ss_pred             cchhhhcccc
Q 041689          638 CTIESLELRI  647 (652)
Q Consensus       638 ~l~~~p~~Rp  647 (652)
                      ||..||++||
T Consensus       235 ~L~~dp~~R~  244 (316)
T d1fota_         235 LITRDLSQRL  244 (316)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999997

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=393.06  Aligned_cols=222  Identities=17%  Similarity=0.243  Sum_probs=197.4

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999875 68899999997653 3345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC--CCcEEEecccCCccccCCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD--TMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~--~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      |+||+|.+++...+..+++.++..|+.||+.||+|||++   ||+||||||+||+++.  .+.+||+|||+++....   
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---  156 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---  156 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence            999999999987766799999999999999999999999   9999999999999984  45899999999986532   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch---------------------------hhhh
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS---------------------------FVFN  633 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~---------------------------~l~~  633 (652)
                      ........+|+.|+|||...+..++.++||||+||++|||++|+.||..                           .+.+
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            2233446789999999999999999999999999999999999999543                           2678


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||..||++|||++|+
T Consensus       237 li~~~L~~dp~~R~s~~ei  255 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHccCChhHCcCHHHH
Confidence            9999999999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=391.05  Aligned_cols=222  Identities=21%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHH-hcCCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMK-SIHYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++...   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999875 69999999997542   233455667777765 68999999999999999999999


Q ss_pred             EEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCC
Q 041689          500 LEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....  
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML--  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc--
Confidence            99999999999998655 689999999999999999999999   999999999999999999999999999986532  


Q ss_pred             CccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhc
Q 041689          580 QSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAM  636 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~  636 (652)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||..                       .+.+++.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            22333456799999999999999999999999999999999999999643                       3789999


Q ss_pred             ccchhhhccccCcc-CC
Q 041689          637 ECTIESLELRINAK-EI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~-ei  652 (652)
                      +||+.||++|||+. ||
T Consensus       236 ~~L~~dP~~R~s~~~~l  252 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDI  252 (320)
T ss_dssp             HHSCSSGGGSBTTBSCG
T ss_pred             HhcccCCCCCcCHHHHH
Confidence            99999999999985 54

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=388.67  Aligned_cols=223  Identities=25%  Similarity=0.398  Sum_probs=189.2

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEcc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEHM  503 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  503 (652)
                      .++|++.+.||+|+||.||+|++++++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            35799999999999999999999888899999997553 345789999999999999999999999855 5678999999


Q ss_pred             CCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          504 PHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       504 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++|++..++.... ..+++.++..++.||+.||+|||++   +|+||||||+|||+|+++.+||+|||+++..... ...
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC-Cce
Confidence            9999998876532 3689999999999999999999999   9999999999999999999999999999865322 222


Q ss_pred             ccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCC-------------------------cchhhhhhhcc
Q 041689          583 TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQ-------------------------CVSFVFNLAME  637 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p-------------------------~~~~l~~l~~~  637 (652)
                      ......||+.|+|||++..+.++.++|||||||++|||++|..|                         ++..+.+++.+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  249 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence            33445689999999999999999999999999999999997655                         33448999999


Q ss_pred             cchhhhccccCccCC
Q 041689          638 CTIESLELRINAKEI  652 (652)
Q Consensus       638 ~l~~~p~~Rpt~~ei  652 (652)
                      ||+.||++|||++||
T Consensus       250 cl~~dP~~Rps~~~i  264 (285)
T d1fmka3         250 CWRKEPEERPTFEYL  264 (285)
T ss_dssp             HTCSSGGGSCCHHHH
T ss_pred             HcccCHhHCcCHHHH
Confidence            999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.6e-47  Score=379.96  Aligned_cols=221  Identities=24%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc---------hhhhhHHHHHHHHHhcC-CCeeeeEEeeeecC
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG---------RAFKSFDIECEIMKSIH-YRNLVKIISSCSNE  493 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  493 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999864 689999999975421         22346889999999997 99999999999999


Q ss_pred             CceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCc
Q 041689          494 EFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITK  573 (652)
Q Consensus       494 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~  573 (652)
                      +..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++   ||+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998755 799999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCCccccccccCCccccCcccccc------CccCcccchhhHHHHHHHHHhCCCCcch------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGRE------GRVFANGDVYSFGIMLMEIHSAKQQCVS------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslG~vl~elltg~~p~~~------------------  629 (652)
                      ....   ........||+.|+|||++.+      ..++.++||||+||++|||++|+.||..                  
T Consensus       159 ~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         159 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EccC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            7632   223345679999999998753      3468899999999999999999998543                  


Q ss_pred             ---------hhhhhhcccchhhhccccCccCC
Q 041689          630 ---------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ---------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                               .+.+++.+||+.||++|||++||
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei  267 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA  267 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                     37899999999999999999874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-47  Score=393.79  Aligned_cols=218  Identities=21%  Similarity=0.258  Sum_probs=195.6

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  500 (652)
                      ++|++.+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999875 69999999997542   234567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQ  580 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  580 (652)
                      ||+.+|++.+++...+ .+++.++..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+....   
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            9999999999987665 699999999999999999999999   999999999999999999999999999987632   


Q ss_pred             ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------hhhhhhcc
Q 041689          581 SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------FVFNLAME  637 (652)
Q Consensus       581 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------~l~~l~~~  637 (652)
                        ......||+.|||||++.+..++.++||||+||++|||+||+.||..                       .+.+++++
T Consensus       194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence              22346799999999999999999999999999999999999999543                       38999999


Q ss_pred             cchhhhcccc-----CccC
Q 041689          638 CTIESLELRI-----NAKE  651 (652)
Q Consensus       638 ~l~~~p~~Rp-----t~~e  651 (652)
                      ||..||.+|+     |++|
T Consensus       272 ~L~~dP~kR~~~~r~t~~e  290 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVND  290 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHH
T ss_pred             HhhhCHHhccccccccHHH
Confidence            9999999995     6665

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-47  Score=383.62  Aligned_cols=224  Identities=22%  Similarity=0.351  Sum_probs=187.3

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----c
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----F  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  495 (652)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++...   ....+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999864 79999999997542   234567899999999999999999999987643    4


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||++|++|.+++...+ .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.++++|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887665 699999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCC-ccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          576 IGEDQ-SMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       576 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ..... ........||+.|+|||++.+..++.++||||+||++|||+||+.||..                         
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            32222 2233455799999999999999999999999999999999999999643                         


Q ss_pred             --hhhhhhcccchhhhcccc-CccC
Q 041689          630 --FVFNLAMECTIESLELRI-NAKE  651 (652)
Q Consensus       630 --~l~~l~~~~l~~~p~~Rp-t~~e  651 (652)
                        .+.+++.+||+.||++|| |++|
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~  266 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAE  266 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHH
Confidence              378899999999999999 6655

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.3e-48  Score=390.72  Aligned_cols=231  Identities=26%  Similarity=0.366  Sum_probs=198.1

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeee
Q 041689          419 EVCRATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCS  491 (652)
Q Consensus       419 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  491 (652)
                      +++...++|++.+.||+|+||.||+|++.      +++.||||+++... ....+++.+|++++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      35789999997553 334567999999999999999999999999


Q ss_pred             cCCceEEEEEccCCCChhhhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 041689          492 NEEFKELVLEHMPHGSLEKCLYSSN-----------------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIH  548 (652)
Q Consensus       492 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  548 (652)
                      +.+..++||||+++|+|.+++....                       ..+++.++..|+.|++.||+|||++   +|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            9999999999999999999986432                       1478889999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCC-CC-
Q 041689          549 CDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK-QQ-  626 (652)
Q Consensus       549 ~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p-  626 (652)
                      |||||+||++|.++.+||+|||+|+.+.............+++.|+|||.+.+..++.++|||||||++|||++|. +| 
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998764433333344567899999999999999999999999999999999986 45 


Q ss_pred             -----------------------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 -----------------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 -----------------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                             ++..+.+++.+||+.||++||||.||
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                                   33348899999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.7e-47  Score=394.75  Aligned_cols=217  Identities=21%  Similarity=0.278  Sum_probs=188.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc---chhhhhHHH---HHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC---GRAFKSFDI---ECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+   |+++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999875 69999999996432   112223333   466777778999999999999999999


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||++||+|.+++.... .+++.++..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999997765 689999999999999999999999   999999999999999999999999999987632


Q ss_pred             CCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------h
Q 041689          578 EDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------F  630 (652)
Q Consensus       578 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------~  630 (652)
                      .    ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||..                          .
T Consensus       160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            2    2344679999999999865 5689999999999999999999999643                          3


Q ss_pred             hhhhhcccchhhhccccCc
Q 041689          631 VFNLAMECTIESLELRINA  649 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~  649 (652)
                      +.+++.+||+.||++|||.
T Consensus       236 ~~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTT
T ss_pred             HHHHHHHHcccCHHHhCCC
Confidence            7899999999999999994

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=390.51  Aligned_cols=224  Identities=24%  Similarity=0.369  Sum_probs=189.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc----EEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM----EVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .+|++.+.||+|+||+||+|++. +|+    +||+|.++.. ..+..+.+.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999864 444    5888888644 334567899999999999999999999999875 5678


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      +|||+.+|+|.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            8999999999998888777899999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcch------------------------hhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCVS------------------------FVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~------------------------~l~~  633 (652)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |+.||..                        .+.+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            43333445568999999999999999999999999999999998 7777433                        3789


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++|||+.||
T Consensus       245 li~~cl~~dP~~RPs~~ei  263 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFREL  263 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHhCCCChhhCcCHHHH
Confidence            9999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=382.93  Aligned_cols=224  Identities=21%  Similarity=0.310  Sum_probs=184.0

Q ss_pred             hcCCCccceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  498 (652)
                      .++|++.+.||+|+||.||+|++..    +..||||.++.. .....+.+.+|++++++++|||||++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4578999999999999999998642    456889988644 3344567999999999999999999999986 467899


Q ss_pred             EEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCC
Q 041689          499 VLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGE  578 (652)
Q Consensus       499 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  578 (652)
                      ||||+++|++.+++......+++..+..++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            9999999999998887777899999999999999999999999   9999999999999999999999999999875322


Q ss_pred             CCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc------------------------hhhhh
Q 041689          579 DQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV------------------------SFVFN  633 (652)
Q Consensus       579 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~------------------------~~l~~  633 (652)
                       .........||+.|+|||++.++.++.++|||||||++|||++ |.+||.                        ..+.+
T Consensus       162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             2223344568999999999999999999999999999999998 788743                        34899


Q ss_pred             hhcccchhhhccccCccCC
Q 041689          634 LAMECTIESLELRINAKEI  652 (652)
Q Consensus       634 l~~~~l~~~p~~Rpt~~ei  652 (652)
                      ++.+||+.||++|||++||
T Consensus       241 li~~cl~~dp~~Rps~~ei  259 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFTEL  259 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHH
Confidence            9999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=388.31  Aligned_cols=217  Identities=20%  Similarity=0.248  Sum_probs=188.0

Q ss_pred             cCCCccc-eeccccceEEEEEEe-CCCcEEEEEEeecccchhhhhHHHHHHHHHhc-CCCeeeeEEeeeec----CCceE
Q 041689          425 YGFNENN-LIGKGGFGTIYKSRI-GDGMEVAVKVFHLQCGRAFKSFDIECEIMKSI-HYRNLVKIISSCSN----EEFKE  497 (652)
Q Consensus       425 ~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~  497 (652)
                      ++|.+.+ .||+|+||.||+|++ .+++.||||+++..     ..+.+|++++.++ +|||||+++++|.+    +...|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788765 599999999999986 46999999998632     4567899987665 89999999999865    46789


Q ss_pred             EEEEccCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC---CCcEEEecccCCc
Q 041689          498 LVLEHMPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD---TMVAHLSDFGITK  573 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~---~~~~kl~Dfg~~~  573 (652)
                      +|||||+||+|.+++.... ..+++.++..|+.|++.||+|||++   ||+||||||+||++++   .+.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence            9999999999999997653 3699999999999999999999999   9999999999999975   5679999999998


Q ss_pred             cccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          574 LLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .....   .......||+.|+|||++.+..|+.++||||+||++|||+||+.||..                        
T Consensus       163 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~  239 (335)
T d2ozaa1         163 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  239 (335)
T ss_dssp             ECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred             eccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence            76322   223456799999999999999999999999999999999999999643                        


Q ss_pred             -------hhhhhhcccchhhhccccCccCC
Q 041689          630 -------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                             ++.+++.+||+.||++|||++||
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ei  269 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEF  269 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                   26789999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=385.16  Aligned_cols=218  Identities=24%  Similarity=0.282  Sum_probs=184.4

Q ss_pred             ccceeccccceEEEEEEeC-CCcEEEEEEeecccc-----hhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          429 ENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG-----RAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       429 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ..+.||+|+||+||+|++. +|+.||||+++....     ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999965 699999999865421     1235688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      ++++++..+... ...+++.++..++.|++.||+|||++   ||+||||||+||++++++.+||+|||+++.....  ..
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~  155 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NR  155 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CC
T ss_pred             hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC--cc
Confidence            998777665543 44788899999999999999999999   9999999999999999999999999999865322  22


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc---------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV---------------------------------  628 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~---------------------------------  628 (652)
                      .....+||+.|+|||++... .|+.++||||+||++|||++|++||.                                 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            23445799999999988654 57999999999999999999998873                                 


Q ss_pred             ------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                        ..+.+++.+||+.||++||||+|+
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~  277 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA  277 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence                              236679999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=380.55  Aligned_cols=224  Identities=23%  Similarity=0.337  Sum_probs=184.7

Q ss_pred             cCCCccceeccccceEEEEEEeC--C--CcEEEEEEeecc---cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG--D--GMEVAVKVFHLQ---CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  497 (652)
                      .+|++.+.||+|+||.||+|+..  +  +..||||+++..   .....+++.+|++++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56899999999999999999753  2  346899998654   234456899999999999999999999999764 678


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      +||||+++|++.+++......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999998877666799999999999999999999999   999999999999999999999999999997643


Q ss_pred             CCCcc-ccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCcc-------------------------hh
Q 041689          578 EDQSM-TQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQCV-------------------------SF  630 (652)
Q Consensus       578 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~-------------------------~~  630 (652)
                      ..... ......++..|+|||++.+..++.++|||||||++|||+| |+.||.                         +.
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            33222 2234457889999999999999999999999999999998 898853                         33


Q ss_pred             hhhhhcccchhhhccccCccCC
Q 041689          631 VFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       631 l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+++.+||+.||++||||+||
T Consensus       244 l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHH
Confidence            8899999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=379.64  Aligned_cols=221  Identities=23%  Similarity=0.262  Sum_probs=190.6

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccc------hhhhhHHHHHHHHHhcC--CCeeeeEEeeeecCC
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCG------RAFKSFDIECEIMKSIH--YRNLVKIISSCSNEE  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  494 (652)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++....      ....++.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999864 699999999975421      12345678999999996  899999999999999


Q ss_pred             ceEEEEEccCC-CChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-CCcEEEecccCC
Q 041689          495 FKELVLEHMPH-GSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-TMVAHLSDFGIT  572 (652)
Q Consensus       495 ~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-~~~~kl~Dfg~~  572 (652)
                      ..++||||+.+ +++.+++.... .+++.++..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57777776554 699999999999999999999999   9999999999999984 579999999999


Q ss_pred             ccccCCCCccccccccCCccccCccccccCcc-CcccchhhHHHHHHHHHhCCCCcch-----------------hhhhh
Q 041689          573 KLLIGEDQSMTQTQTLATIGYIAPEYGREGRV-FANGDVYSFGIMLMEIHSAKQQCVS-----------------FVFNL  634 (652)
Q Consensus       573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~-----------------~l~~l  634 (652)
                      +...    ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||..                 ++.++
T Consensus       159 ~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         159 ALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             EECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHH
T ss_pred             eecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHH
Confidence            8652    223345679999999999987776 5678999999999999999999644                 47899


Q ss_pred             hcccchhhhccccCccCC
Q 041689          635 AMECTIESLELRINAKEI  652 (652)
Q Consensus       635 ~~~~l~~~p~~Rpt~~ei  652 (652)
                      +.+||+.||++|||++|+
T Consensus       235 i~~~L~~dp~~R~s~~ei  252 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEI  252 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHH
T ss_pred             HHHHccCCHhHCcCHHHH
Confidence            999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=385.06  Aligned_cols=232  Identities=22%  Similarity=0.332  Sum_probs=187.2

Q ss_pred             HHHHHHhcCCCccceeccccceEEEEEEeC------CCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEee
Q 041689          418 LEVCRATYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISS  489 (652)
Q Consensus       418 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~  489 (652)
                      .+++...++|++.+.||+|+||.||+|++.      +++.||||+++... ....+.+.+|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344444578999999999999999999852      35689999997543 33456677888888877 68999999998


Q ss_pred             eecC-CceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCC
Q 041689          490 CSNE-EFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKP  553 (652)
Q Consensus       490 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp  553 (652)
                      +... +..++|||||++|+|.+++....               ..+++.++..++.|+++||+|||++   +|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence            7654 56899999999999999987532               2488999999999999999999999   999999999


Q ss_pred             CCeeeCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCC-CCc-----
Q 041689          554 SNVLLDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK-QQC-----  627 (652)
Q Consensus       554 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~-----  627 (652)
                      +|||+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. +||     
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998764444444445567999999999999999999999999999999999975 453     


Q ss_pred             --------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 --------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 --------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ++.+.+++.+||+.||++|||++||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                                2337899999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=382.72  Aligned_cols=223  Identities=24%  Similarity=0.273  Sum_probs=190.3

Q ss_pred             cCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...  ....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999986 469999999996542  2335678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      |+.++.+..........+++.++..++.|++.||+|||++   |||||||||+|||++.++.+||+|||.|+....  ..
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence            9976544444344455799999999999999999999999   999999999999999999999999999987632  22


Q ss_pred             cccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCcc--------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQCV--------------------------------  628 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~--------------------------------  628 (652)
                      .......||+.|+|||++.... ++.++||||+||++|||++|+.||.                                
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            3344567999999999877665 4788999999999999999999974                                


Q ss_pred             --------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          ..+.+++++||..||++|||++||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el  280 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA  280 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                235789999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=376.86  Aligned_cols=218  Identities=31%  Similarity=0.404  Sum_probs=183.6

Q ss_pred             hcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCceEEEEEc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEFKELVLEH  502 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  502 (652)
                      .++|+..+.||+|+||.||+|++ .|++||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35688889999999999999998 5789999999754  345779999999999999999999998855 4668999999


Q ss_pred             cCCCChhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          503 MPHGSLEKCLYSSN-CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       503 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      +++|+|.+++.... ..+++..++.|+.|++.||.|||+.   +|+||||||+||+++.++.+|++|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999987543 2589999999999999999999999   999999999999999999999999999986422    


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc------------------------chhhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC------------------------VSFVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~------------------------~~~l~~l~~  636 (652)
                       ......+++.|+|||++.++.++.++|||||||++|||+| |+.||                        ++.+.+++.
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence             2233457889999999999999999999999999999998 67763                        344899999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||+.||++||||+||
T Consensus       235 ~cl~~dP~~Rps~~~l  250 (262)
T d1byga_         235 NCWHLDAAMRPSFLQL  250 (262)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHcccCHhHCcCHHHH
Confidence            9999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=378.62  Aligned_cols=227  Identities=23%  Similarity=0.344  Sum_probs=192.9

Q ss_pred             HhcCCCccceeccccceEEEEEEeCC--------CcEEEEEEeecccc-hhhhhHHHHHHHHHhc-CCCeeeeEEeeeec
Q 041689          423 ATYGFNENNLIGKGGFGTIYKSRIGD--------GMEVAVKVFHLQCG-RAFKSFDIECEIMKSI-HYRNLVKIISSCSN  492 (652)
Q Consensus       423 ~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  492 (652)
                      ..++|.+.+.||+|+||.||+|+...        +..||||+++.+.. .....+.+|...+.++ +|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34578899999999999999997422        34799999976543 4457788899999888 89999999999999


Q ss_pred             CCceEEEEEccCCCChhhhhhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCee
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSN---------------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVL  557 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIl  557 (652)
                      ++..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||++   +|+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            999999999999999999997553               2589999999999999999999999   9999999999999


Q ss_pred             eCCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCCc---------
Q 041689          558 LDDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQC---------  627 (652)
Q Consensus       558 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~---------  627 (652)
                      ++.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |++||         
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            99999999999999997755444444455678999999999999999999999999999999998 67774         


Q ss_pred             ---------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 ---------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 ---------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                     ++.+.+++.+||+.||++||||+||
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei  287 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL  287 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence                           3348999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=379.16  Aligned_cols=225  Identities=25%  Similarity=0.335  Sum_probs=191.1

Q ss_pred             HHhcCCCccceeccccceEEEEEEeC-C-CcEEEEEEeeccc--chhhhhHHHHHHHHHhc---CCCeeeeEEeeeec--
Q 041689          422 RATYGFNENNLIGKGGFGTIYKSRIG-D-GMEVAVKVFHLQC--GRAFKSFDIECEIMKSI---HYRNLVKIISSCSN--  492 (652)
Q Consensus       422 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~--  492 (652)
                      +..++|++.+.||+|+||+||+|++. + ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..  
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            45678999999999999999999863 4 6679999997542  22344667888887766   79999999998853  


Q ss_pred             ---CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecc
Q 041689          493 ---EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDF  569 (652)
Q Consensus       493 ---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Df  569 (652)
                         ....+++|||++++.+..........+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence               3467999999999877666555555799999999999999999999999   9999999999999999999999999


Q ss_pred             cCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          570 GITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       570 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      |+++...   .........||+.|+|||++.+.+|+.++||||+||++|||++|+.||..                    
T Consensus       161 g~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9988542   23334566799999999999999999999999999999999999999742                    


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    .+.+++.+||+.||++|||++|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~  290 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA  290 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                          24679999999999999999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-46  Score=379.51  Aligned_cols=222  Identities=28%  Similarity=0.440  Sum_probs=187.9

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCc--EEEEEEeecc-cchhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCceEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGM--EVAVKVFHLQ-CGRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEFKELV  499 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  499 (652)
                      ++|++.+.||+|+||.||+|++. +|.  .||||+++.. .....+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56888899999999999999865 444  4778887643 334567899999999998 799999999999999999999


Q ss_pred             EEccCCCChhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcE
Q 041689          500 LEHMPHGSLEKCLYSS---------------NCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVA  564 (652)
Q Consensus       500 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~  564 (652)
                      |||+++|+|.+++...               ...+++.++..++.|++.||.|+|++   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998654               23789999999999999999999999   99999999999999999999


Q ss_pred             EEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCC-Cc----------------
Q 041689          565 HLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQ-QC----------------  627 (652)
Q Consensus       565 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~-p~----------------  627 (652)
                      ||+|||+++...   .........||..|+|||.+.++.++.++|||||||++|||++|.. ||                
T Consensus       167 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         167 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            999999997542   1222234568999999999999999999999999999999999765 43                


Q ss_pred             --------chhhhhhhcccchhhhccccCccCC
Q 041689          628 --------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 --------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                              ++.+.+++.+||+.||++|||++||
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei  276 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI  276 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence                    3348999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-46  Score=375.60  Aligned_cols=222  Identities=22%  Similarity=0.279  Sum_probs=190.0

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||+||+|++++|+.||||+++...  ....+++.+|+.++++++|||||++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999899999999996542  23356889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCcc
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQSM  582 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  582 (652)
                      +.++.+..+... ...+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.+.....  ...
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR  155 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhh-cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceeccc--Ccc
Confidence            988666665544 44799999999999999999999999   999999999999999999999999999987532  222


Q ss_pred             ccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------------------
Q 041689          583 TQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------------  629 (652)
Q Consensus       583 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------------------  629 (652)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+                                
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            23445689999999998754 568999999999999999999999742                                


Q ss_pred             --------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          .+.+++++||+.||++|||++|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el  278 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA  278 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                24689999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=378.70  Aligned_cols=226  Identities=21%  Similarity=0.320  Sum_probs=196.9

Q ss_pred             hcCCCccceeccccceEEEEEEe------CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhc-CCCeeeeEEeeeecCCc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI------GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSI-HYRNLVKIISSCSNEEF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  495 (652)
                      .++|+..+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +|||||++++++.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46788899999999999999974      246789999997653 33455788999999999 69999999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeee
Q 041689          496 KELVLEHMPHGSLEKCLYSSNC-----------------ILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLL  558 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll  558 (652)
                      .++|||||++|+|.+++.....                 .+++..+..++.||+.||+|||++   +++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence            9999999999999999875432                 588899999999999999999999   99999999999999


Q ss_pred             CCCCcEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHh-CCCC-----------
Q 041689          559 DDTMVAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHS-AKQQ-----------  626 (652)
Q Consensus       559 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p-----------  626 (652)
                      +.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+| |++|           
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999997654444444455678999999999999999999999999999999999 4554           


Q ss_pred             --------------cchhhhhhhcccchhhhccccCccCC
Q 041689          627 --------------CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 --------------~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                    ++..+.+++.+||+.||++||||+||
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i  298 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI  298 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence                          23348899999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=373.92  Aligned_cols=220  Identities=23%  Similarity=0.391  Sum_probs=190.2

Q ss_pred             cceeccccceEEEEEEeCC----CcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec-CCceEEEEEcc
Q 041689          430 NNLIGKGGFGTIYKSRIGD----GMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN-EEFKELVLEHM  503 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  503 (652)
                      .++||+|+||+||+|++.+    ...||||+++.. .....+++.+|++++++++||||++++|++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998643    235899999743 44456789999999999999999999999765 56889999999


Q ss_pred             CCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc--
Q 041689          504 PHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS--  581 (652)
Q Consensus       504 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--  581 (652)
                      ++|+|.+++.......++..+.+++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            99999999987777788999999999999999999999   9999999999999999999999999999876433221  


Q ss_pred             cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCc-------------------------chhhhhhhc
Q 041689          582 MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQC-------------------------VSFVFNLAM  636 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~-------------------------~~~l~~l~~  636 (652)
                      .......||+.|+|||.+..+.++.++||||||+++|||+||..||                         ++.+.+++.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence            1223456899999999999999999999999999999999977763                         334899999


Q ss_pred             ccchhhhccccCccCC
Q 041689          637 ECTIESLELRINAKEI  652 (652)
Q Consensus       637 ~~l~~~p~~Rpt~~ei  652 (652)
                      +||..||++||++.||
T Consensus       269 ~cl~~dP~~RPs~~ei  284 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSEL  284 (311)
T ss_dssp             HHTCSSGGGSCCHHHH
T ss_pred             HHcCCCHhHCcCHHHH
Confidence            9999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-46  Score=376.86  Aligned_cols=226  Identities=24%  Similarity=0.401  Sum_probs=196.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC------CCcEEEEEEeecc-cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCce
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG------DGMEVAVKVFHLQ-CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFK  496 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  496 (652)
                      .++|...+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|++++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467889999999999999999753      3578999999754 334456789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEe
Q 041689          497 ELVLEHMPHGSLEKCLYSSN---------CILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLS  567 (652)
Q Consensus       497 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~  567 (652)
                      ++||||+++|+|.+++....         ..+++..+..++.|+++||.|||++   +|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999999876422         2468899999999999999999999   99999999999999999999999


Q ss_pred             cccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCC-CC--------------------
Q 041689          568 DFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAK-QQ--------------------  626 (652)
Q Consensus       568 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p--------------------  626 (652)
                      |||+++...............+|+.|+|||.+.++.++.++|||||||++|||+||. +|                    
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~  255 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  255 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            999998764443333444556899999999999999999999999999999999985 55                    


Q ss_pred             ----cchhhhhhhcccchhhhccccCccCC
Q 041689          627 ----CVSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       627 ----~~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                          ++..+.+++.+||+.||++|||++||
T Consensus       256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~i  285 (308)
T d1p4oa_         256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEI  285 (308)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence                33458999999999999999999764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=372.25  Aligned_cols=224  Identities=23%  Similarity=0.314  Sum_probs=182.2

Q ss_pred             cCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----ceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----FKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  500 (652)
                      .+|...+.||+|+||.||+|+. +|+.||||+++.... .....+.|+..+.+++|||||++++++.+.+    ..|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4577789999999999999987 688999999975422 2222344555566789999999999987653    578999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFN-----FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      ||+++|+|.++++..  .+++.++..++.|++.||+|+|+.     +.+||+||||||+|||+++++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999875  489999999999999999999963     1249999999999999999999999999999876


Q ss_pred             cCCCCcc--ccccccCCccccCccccccC------ccCcccchhhHHHHHHHHHhCCCCcc-------------------
Q 041689          576 IGEDQSM--TQTQTLATIGYIAPEYGREG------RVFANGDVYSFGIMLMEIHSAKQQCV-------------------  628 (652)
Q Consensus       576 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~-------------------  628 (652)
                      .......  ......||+.|+|||++.+.      .++.++|||||||++|||+||..|+.                   
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            4433221  22346799999999997654      36788999999999999999976531                   


Q ss_pred             --------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                ..+.+++.+||+.||++|||+.||
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei  288 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  288 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence                                      116789999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=368.06  Aligned_cols=224  Identities=22%  Similarity=0.241  Sum_probs=186.2

Q ss_pred             hcCCCccceeccccceEEEEEEe-CCCcEEEEEEeeccc-chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC----ceE
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRI-GDGMEVAVKVFHLQC-GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE----FKE  497 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  497 (652)
                      +.+|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999986 479999999997542 344567889999999999999999999986543    234


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccC
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIG  577 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  577 (652)
                      ++++|+.+|+|.+++...  .+++..+..++.|++.||+|||++   ||+||||||+|||+++++.+||+|||+++....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667789999999765  489999999999999999999999   999999999999999999999999999986533


Q ss_pred             CCCc-cccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcch--------------------------
Q 041689          578 EDQS-MTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCVS--------------------------  629 (652)
Q Consensus       578 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~--------------------------  629 (652)
                      .... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||..                          
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            2221 22345569999999999854 4678899999999999999999999742                          


Q ss_pred             ----------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ----------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ----------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  .+.+++.+||+.||++||||+|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~  292 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA  292 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                        36789999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-44  Score=365.03  Aligned_cols=225  Identities=21%  Similarity=0.291  Sum_probs=186.2

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeec--------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSN--------  492 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  492 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  ......++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            468999999999999999999964 7999999998644  23345678899999999999999999998754        


Q ss_pred             CCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCC
Q 041689          493 EEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGIT  572 (652)
Q Consensus       493 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~  572 (652)
                      .+..|+||||++++.+... ......+++..+..++.|++.||.|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence            3468999999988666544 34444789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccCCCCc--cccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch--------------------
Q 041689          573 KLLIGEDQS--MTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS--------------------  629 (652)
Q Consensus       573 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~--------------------  629 (652)
                      +........  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..                    
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            865432211  122345699999999998755 688999999999999999999999752                    


Q ss_pred             -----------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 -----------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 -----------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                         .+.+++.+||+.||++||||+|+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el  302 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA  302 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                               23579999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-44  Score=369.68  Aligned_cols=218  Identities=23%  Similarity=0.293  Sum_probs=183.1

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeecc--cchhhhhHHHHHHHHHhcCCCeeeeEEeeeecCC------
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQ--CGRAFKSFDIECEIMKSIHYRNLVKIISSCSNEE------  494 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  494 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999865 6999999999754  2334567889999999999999999999997654      


Q ss_pred             ceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          495 FKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       495 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      +.|+||||+ +.++..+.+..  .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence            579999999 56888877654  599999999999999999999999   999999999999999999999999999986


Q ss_pred             ccCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          575 LIGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       575 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      ...     ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||..                        
T Consensus       171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            522     23456799999999998764 568999999999999999999999732                        


Q ss_pred             ------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 ------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 ------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                    .+.+++.+||..||++|||++||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei  298 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  298 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                          35689999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-44  Score=368.29  Aligned_cols=217  Identities=24%  Similarity=0.319  Sum_probs=181.1

Q ss_pred             CCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCeeeeEEeeeecC------CceEE
Q 041689          426 GFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNLVKIISSCSNE------EFKEL  498 (652)
Q Consensus       426 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  498 (652)
                      +|+..+.||+|+||+||+|++. +|+.||||+++...    ....+|++++++++||||++++++|...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999975 69999999997543    2234799999999999999999998532      35789


Q ss_pred             EEEccCCCChhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCC-cEEEecccCCccc
Q 041689          499 VLEHMPHGSLEKCLY--SSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTM-VAHLSDFGITKLL  575 (652)
Q Consensus       499 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~-~~kl~Dfg~~~~~  575 (652)
                      ||||++++.+..+..  .....+++.++..++.|++.||+|||++   ||+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764433322  2334799999999999999999999999   999999999999999764 8999999999876


Q ss_pred             cCCCCccccccccCCccccCcccccc-CccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGRE-GRVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                      ...   .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.                          
T Consensus       174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            322   22344679999999998765 568999999999999999999999973                          


Q ss_pred             --------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                +.+.+++.+||..||++||||+|+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  300 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA  300 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                      235679999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=358.30  Aligned_cols=222  Identities=21%  Similarity=0.229  Sum_probs=193.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecCCceEEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNEEFKELVLE  501 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  501 (652)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...  .....++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999964 68999999997542  3446788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccccCCCCc
Q 041689          502 HMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLLIGEDQS  581 (652)
Q Consensus       502 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  581 (652)
                      ++.++++..++...+ .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||.++.....  .
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--C
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC--C
Confidence            999998888776554 789999999999999999999999   9999999999999999999999999999876322  2


Q ss_pred             cccccccCCccccCccccccCc-cCcccchhhHHHHHHHHHhCCCCc---------------------------------
Q 041689          582 MTQTQTLATIGYIAPEYGREGR-VFANGDVYSFGIMLMEIHSAKQQC---------------------------------  627 (652)
Q Consensus       582 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~---------------------------------  627 (652)
                      .......+++.|+|||.+.... ++.++||||+||++|||++|+.||                                 
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            2233445788999999887665 689999999999999999999885                                 


Q ss_pred             --------------------chhhhhhhcccchhhhccccCccCC
Q 041689          628 --------------------VSFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       628 --------------------~~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                          +..+.+++.+||+.||.+||||+||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~  280 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                1235689999999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=361.83  Aligned_cols=220  Identities=22%  Similarity=0.312  Sum_probs=189.0

Q ss_pred             cCCCccceeccccceEEEEEEe----CCCcEEEEEEeecc----cchhhhhHHHHHHHHHhcCC-CeeeeEEeeeecCCc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRI----GDGMEVAVKVFHLQ----CGRAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEF  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  495 (652)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999974    25889999998643    22345678899999999976 899999999999999


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .++||||+.+|+|.+++.... .+++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999987765 578889999999999999999999   9999999999999999999999999999865


Q ss_pred             cCCCCccccccccCCccccCccccccC--ccCcccchhhHHHHHHHHHhCCCCcch------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREG--RVFANGDVYSFGIMLMEIHSAKQQCVS------------------------  629 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~------------------------  629 (652)
                      .... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||..                        
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            3222 2223445699999999998764  467899999999999999999999643                        


Q ss_pred             ---hhhhhhcccchhhhccccCc
Q 041689          630 ---FVFNLAMECTIESLELRINA  649 (652)
Q Consensus       630 ---~l~~l~~~~l~~~p~~Rpt~  649 (652)
                         .+.+++.+||.+||++|||+
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CCHHHHHHHHHHcccCHHHcCCC
Confidence               27889999999999999963

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-43  Score=354.01  Aligned_cols=221  Identities=21%  Similarity=0.229  Sum_probs=186.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee-eeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL-VKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||.||+|++. +|+.||||++....  ...++..|++++++++|+++ +.+.+++.+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999864 68999999987543  33568899999999987665 5556666778889999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeC---CCCcEEEecccCCccccCCC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLD---DTMVAHLSDFGITKLLIGED  579 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~  579 (652)
                      +. +++.+.+......+++..+..++.|++.||+|||++   ||+||||||+||+++   .+..+|++|||+|+.+....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            95 577777766666899999999999999999999999   999999999999985   45679999999999764332


Q ss_pred             Cc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-------------------------
Q 041689          580 QS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-------------------------  629 (652)
Q Consensus       580 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-------------------------  629 (652)
                      ..     .......||+.|||||++.+..++.++|||||||++|||++|+.||..                         
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            21     122345699999999999999999999999999999999999999632                         


Q ss_pred             ------hhhhhhcccchhhhccccCccC
Q 041689          630 ------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 ------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                            ++.+++.+||+.+|++||++++
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~  268 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSY  268 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence                  2678999999999999999865

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.7e-43  Score=358.70  Aligned_cols=215  Identities=19%  Similarity=0.276  Sum_probs=185.3

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeec--CCceEEEE
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSN--EEFKELVL  500 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  500 (652)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..   ..+++.+|+++++++. ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999874 6899999999753   3467889999999995 9999999999874  35689999


Q ss_pred             EccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCC-CcEEEecccCCccccCCC
Q 041689          501 EHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDT-MVAHLSDFGITKLLIGED  579 (652)
Q Consensus       501 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~  579 (652)
                      ||+++++|..+.+    .+++.++..++.||+.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-  183 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-  183 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC-
Confidence            9999999987642    589999999999999999999999   99999999999999865 46999999999875322 


Q ss_pred             CccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcch-----------------------------
Q 041689          580 QSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------------  629 (652)
Q Consensus       580 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~-----------------------------  629 (652)
                        .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..                             
T Consensus       184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence              233456789999999997765 478999999999999999999998532                             


Q ss_pred             --------------------------------hhhhhhcccchhhhccccCccCC
Q 041689          630 --------------------------------FVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       630 --------------------------------~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                      ++.+++++||..||++|||++|+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~  316 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA  316 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                                            25679999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-42  Score=349.36  Aligned_cols=221  Identities=14%  Similarity=0.154  Sum_probs=191.4

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcCC-CeeeeEEeeeecCCceEEEEEc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY-RNLVKIISSCSNEEFKELVLEH  502 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  502 (652)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+|+++++.++| +|++.+++++..+...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999965 68999999986542  33567889999999965 8999999999999999999999


Q ss_pred             cCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCC-----CCcEEEecccCCccccC
Q 041689          503 MPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDD-----TMVAHLSDFGITKLLIG  577 (652)
Q Consensus       503 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~-----~~~~kl~Dfg~~~~~~~  577 (652)
                      + +++|.+++......+++.++..++.|++.||+|||++   ||+||||||+||+++.     ++.+||+|||+|+.+..
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 6799999887776899999999999999999999999   9999999999999974     57899999999987643


Q ss_pred             CCCc-----cccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcch-----------------------
Q 041689          578 EDQS-----MTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCVS-----------------------  629 (652)
Q Consensus       578 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~-----------------------  629 (652)
                      ....     .......||+.|||||++.+..++.++|||||||++|||+||+.||..                       
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            3221     122345699999999999999999999999999999999999999642                       


Q ss_pred             --------hhhhhhcccchhhhccccCccC
Q 041689          630 --------FVFNLAMECTIESLELRINAKE  651 (652)
Q Consensus       630 --------~l~~l~~~~l~~~p~~Rpt~~e  651 (652)
                              ++.+++..|+..+|++||+++.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~  268 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDY  268 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence                    2677888999999999998653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-43  Score=360.85  Aligned_cols=219  Identities=20%  Similarity=0.269  Sum_probs=184.9

Q ss_pred             hcCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeecC-----Cc
Q 041689          424 TYGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSNE-----EF  495 (652)
Q Consensus       424 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  495 (652)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ....+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999864 79999999997542  23455788999999999999999999998643     33


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .+++|+|+.+|+|.+++...  .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+|++|||.+...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence            46677788899999998654  599999999999999999999999   9999999999999999999999999999754


Q ss_pred             cCCCCccccccccCCccccCccccccC-ccCcccchhhHHHHHHHHHhCCCCcc--------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREG-RVFANGDVYSFGIMLMEIHSAKQQCV--------------------------  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~--------------------------  628 (652)
                           ........|++.|+|||...+. .++.++||||+||++|+|++|+.||.                          
T Consensus       172 -----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 -----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             -----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             -----CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence                 2233456789999999987665 46889999999999999999999973                          


Q ss_pred             ----------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 ----------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 ----------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                  ..+.+++.+||..||++|||++|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence                                        235789999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=359.36  Aligned_cols=218  Identities=22%  Similarity=0.225  Sum_probs=178.5

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeeccc--chhhhhHHHHHHHHHhcCCCeeeeEEeeeec------CCc
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQC--GRAFKSFDIECEIMKSIHYRNLVKIISSCSN------EEF  495 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  495 (652)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  .....++.+|+.++++++||||++++++|..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 69999999997542  3344578899999999999999999999854      367


Q ss_pred             eEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEecccCCccc
Q 041689          496 KELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKLL  575 (652)
Q Consensus       496 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~~  575 (652)
                      .|+||||+.++.+. .+.   ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence            89999999775444 343   2589999999999999999999999   9999999999999999999999999998864


Q ss_pred             cCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc---------------------------
Q 041689          576 IGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV---------------------------  628 (652)
Q Consensus       576 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~---------------------------  628 (652)
                      .   .........+|+.|+|||++.+..++.++||||+||++|||++|+.||.                           
T Consensus       170 ~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 G---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             c---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            2   2233345578999999999999999999999999999999999999973                           


Q ss_pred             --------------------------------------hhhhhhhcccchhhhccccCccCC
Q 041689          629 --------------------------------------SFVFNLAMECTIESLELRINAKEI  652 (652)
Q Consensus       629 --------------------------------------~~l~~l~~~~l~~~p~~Rpt~~ei  652 (652)
                                                            ..+.+++++||..||++||||+||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el  308 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  308 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence                                                  125779999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-37  Score=321.04  Aligned_cols=195  Identities=17%  Similarity=0.196  Sum_probs=157.7

Q ss_pred             cCCCccceeccccceEEEEEEeC-CCcEEEEEEeecccchhhhhHHHHHHHHHhcC-----------CCeeeeEEeeeec
Q 041689          425 YGFNENNLIGKGGFGTIYKSRIG-DGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-----------YRNLVKIISSCSN  492 (652)
Q Consensus       425 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  492 (652)
                      .+|++.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            35999999999999999999864 79999999997553 23456788999988875           5789999988754


Q ss_pred             C--CceEEEEEccCCCChhh-h-hhcCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCCCCCCeeeCCCC-----
Q 041689          493 E--EFKELVLEHMPHGSLEK-C-LYSSNCILDIFQRLNIMIDVASVLEYLHF-NFLVPVIHCDLKPSNVLLDDTM-----  562 (652)
Q Consensus       493 ~--~~~~lv~e~~~~g~L~~-~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiH~dlkp~NIll~~~~-----  562 (652)
                      .  ...+++|+++..+.... . .......+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence            3  45667777665543322 2 22333478899999999999999999997 6   999999999999998654     


Q ss_pred             -cEEEecccCCccccCCCCccccccccCCccccCccccccCccCcccchhhHHHHHHHHHhCCCCcc
Q 041689          563 -VAHLSDFGITKLLIGEDQSMTQTQTLATIGYIAPEYGREGRVFANGDVYSFGIMLMEIHSAKQQCV  628 (652)
Q Consensus       563 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~  628 (652)
                       .+|++|||.+....     .......||+.|+|||++....++.++||||+||+++||++|+.||.
T Consensus       169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             ceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence             49999999998542     22345679999999999999999999999999999999999999863

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.1e-32  Score=280.59  Aligned_cols=258  Identities=33%  Similarity=0.541  Sum_probs=237.0

Q ss_pred             CCCcEEEcccCCCccc--CCccchhcccccCcEEEccC-CcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC
Q 041689           94 KSLVVFLLSNNPLNGI--LPRMSIGNLSHSLEIFDMSK-CNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL  170 (652)
Q Consensus        94 ~~L~~L~Ls~N~l~~~--~~~~~~~~l~~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  170 (652)
                      .+++.|+|++|.+++.  .|. .+++++. |++|+|++ |++++.+|..|+++++|++|+|++|++.+..+..+..+.+|
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~-~l~~L~~-L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L  127 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPS-SLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL  127 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCG-GGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred             EEEEEEECCCCCCCCCCCCCh-HHhcCcc-ccccccccccccccccccccccccccchhhhccccccccccccccchhhh
Confidence            4689999999999974  455 7899987 99999996 89999999999999999999999999999999999999999


Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCC-CEEEccCCC--CCCCcccCCCCccceEeccc
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASL-RTLSLSYND--GPLPLEIGNLKVLIGIDFSM  247 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~--~~~~~~~~~l~~L~~L~ls~  247 (652)
                      +.++++.|.+.+.+|..+..+++|+.+++++|.+.+.+|..+..+.++ +.+++++|+  +..|..+..+..+ .+++++
T Consensus       128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~  206 (313)
T d1ogqa_         128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSR  206 (313)
T ss_dssp             CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCS
T ss_pred             cccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence            999999999999999999999999999999999999999999988886 899999996  5667778777655 799999


Q ss_pred             ccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCC
Q 041689          248 NNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIP  327 (652)
Q Consensus       248 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  327 (652)
                      |...+.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|+|++|+|++.+|..|.++++|++|+|++|+|+|.+|
T Consensus       207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             cccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            99999999999999999999999999997655 68899999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccccccCCccCCCCCCCCCCCCC
Q 041689          328 KGGSFGNFSAESFEGNKLLCGSPNLHVPPCK  358 (652)
Q Consensus       328 ~~~~~~~l~~~~~~~N~~~c~~~~~~~~~~~  358 (652)
                      ....+..++.+++.+|+..|+.|.   ++|+
T Consensus       286 ~~~~L~~L~~l~l~~N~~l~g~pl---p~c~  313 (313)
T d1ogqa_         286 QGGNLQRFDVSAYANNKCLCGSPL---PACT  313 (313)
T ss_dssp             CSTTGGGSCGGGTCSSSEEESTTS---SCCC
T ss_pred             CcccCCCCCHHHhCCCccccCCCC---CCCC
Confidence            988899999999999999999873   4563

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=8e-32  Score=274.11  Aligned_cols=248  Identities=28%  Similarity=0.410  Sum_probs=133.2

Q ss_pred             CCCEEECCCCcCcc--cCCccccCCCCCCEEEcCC-CcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           30 NLEELLLGQNNLVG--VVPAAIFDVSTLKDLALQD-NYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        30 ~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      .+++|+|++|++++  .+|..++++++|++|+|++ |++++.+|                 +.|.+|++|++|+|++|++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP-----------------~~i~~L~~L~~L~Ls~N~l  113 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----------------PAIAKLTQLHYLYITHTNV  113 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----------------GGGGGCTTCSEEEEEEECC
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccc-----------------cccccccccchhhhccccc
Confidence            35555555555554  2455555555555555554 45543333                 1344555555555555555


Q ss_pred             cccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC-cEEecccCccccccC
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL-QYVGLKDNKLEGTIP  185 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~  185 (652)
                      .++.+. .+..+.. |+.+++++|++.+.+|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|
T Consensus       114 ~~~~~~-~~~~~~~-L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~  191 (313)
T d1ogqa_         114 SGAIPD-FLSQIKT-LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP  191 (313)
T ss_dssp             EEECCG-GGGGCTT-CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECC
T ss_pred             cccccc-cccchhh-hcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccc
Confidence            554443 3344433 5555555555555555555555555555555555554445444444443 444555555554444


Q ss_pred             ccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCc
Q 041689          186 YDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQ  265 (652)
Q Consensus       186 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~  265 (652)
                      ..+..+..+ .+++++|.+.+.+                      |..+..+++++.+++++|.+.+.+ ..+..+++|+
T Consensus       192 ~~~~~l~~~-~l~l~~~~~~~~~----------------------~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~  247 (313)
T d1ogqa_         192 PTFANLNLA-FVDLSRNMLEGDA----------------------SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLN  247 (313)
T ss_dssp             GGGGGCCCS-EEECCSSEEEECC----------------------GGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCC
T ss_pred             ccccccccc-ccccccccccccc----------------------cccccccccccccccccccccccc-cccccccccc
Confidence            444443322 3444444444444                      444455555555555556665533 3456666666


Q ss_pred             EEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCc
Q 041689          266 YLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNK  321 (652)
Q Consensus       266 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  321 (652)
                      .|+|++|+++|.+|..|+.+++|++|+|++|+|+|.+|. +.++++|+.+++++|+
T Consensus       248 ~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             cccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            666666666666666666666666666666666666663 4556666666666666

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=2.4e-29  Score=263.07  Aligned_cols=297  Identities=24%  Similarity=0.361  Sum_probs=226.1

Q ss_pred             eeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            5 SIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         5 ~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      +|+.|++++|.++++   + .+ .+++|++|+|++|+|+++.  .|.++++|++|++++|+|+++.              
T Consensus        45 ~l~~L~l~~~~I~~l---~-gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--------------  104 (384)
T d2omza2          45 QVTTLQADRLGIKSI---D-GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--------------  104 (384)
T ss_dssp             TCCEEECCSSCCCCC---T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--------------
T ss_pred             CCCEEECCCCCCCCc---c-ccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--------------
Confidence            588899999999854   2 34 6789999999999999654  3999999999999999987542              


Q ss_pred             cccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCccc------------------------------
Q 041689           84 LSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVS------------------------------  133 (652)
Q Consensus        84 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~------------------------------  133 (652)
                           .+.++++|+.|++++|.+++..+...   .. .+..+....|.+.                              
T Consensus       105 -----~l~~l~~L~~L~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (384)
T d2omza2         105 -----PLANLTNLTGLTLFNNQITDIDPLKN---LT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT  175 (384)
T ss_dssp             -----GGTTCTTCCEEECCSSCCCCCGGGTT---CT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT
T ss_pred             -----cccccccccccccccccccccccccc---cc-cccccccccccccccccccccccccccccccccchhhhhcccc
Confidence                 26778889999999888876543211   11 1333333332221                              


Q ss_pred             -----------ccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCC
Q 041689          134 -----------GGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGN  202 (652)
Q Consensus       134 -----------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  202 (652)
                                 ......+..+++++.+++++|.+++..|  +...++|++|++++|+++. + +.+..+++|+.|++++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n  251 (384)
T d2omza2         176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANN  251 (384)
T ss_dssp             TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred             ccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccC
Confidence                       1133567788889999999998886554  4667889999999998884 3 36778889999999999


Q ss_pred             cccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccc
Q 041689          203 KLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSV  282 (652)
Q Consensus       203 ~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  282 (652)
                      .+++..+  +..+++|++|++++|...-...+..++.++.++++.|++++.  ..+..+++++.|++++|++++..  .+
T Consensus       252 ~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l  325 (384)
T d2omza2         252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PV  325 (384)
T ss_dssp             CCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GG
T ss_pred             ccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--cc
Confidence            9886553  778889999999888744444577888888999999988863  45778888999999999998654  37


Q ss_pred             cccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCC
Q 041689          283 GDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGN  343 (652)
Q Consensus       283 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N  343 (652)
                      ..+++|+.|+|++|+|++ ++ .+.++++|++|++++|++++.+| ...+++++.+++++|
T Consensus       326 ~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         326 SSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             ccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            888899999999999874 44 58888999999999999987665 567778888888877

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1e-28  Score=249.93  Aligned_cols=262  Identities=22%  Similarity=0.298  Sum_probs=193.0

Q ss_pred             cCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCC
Q 041689           13 VDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSN   92 (652)
Q Consensus        13 ~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~   92 (652)
                      .|....++++|+.+ ++++++|+|++|+|+.+.+.+|.++++|++|++++|.++.+.+.                 .|.+
T Consensus        16 ~C~~~~L~~lP~~l-~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~-----------------~f~~   77 (305)
T d1xkua_          16 QCSDLGLEKVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----------------AFAP   77 (305)
T ss_dssp             ECTTSCCCSCCCSC-CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-----------------TTTT
T ss_pred             EecCCCCCccCCCC-CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh-----------------hhhC
Confidence            45566677999988 78999999999999987778899999999999999999876553                 5889


Q ss_pred             CCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcccc--ccCCccccCCCCC
Q 041689           93 CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLN--GSIPFTLRELQKL  170 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L  170 (652)
                      +++|++|++++|+++.++.. .    ...+..|++++|.+.++.+..+.....+..++...|...  ...+..|..+++|
T Consensus        78 l~~L~~L~l~~n~l~~l~~~-~----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L  152 (305)
T d1xkua_          78 LVKLERLYLSKNQLKELPEK-M----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL  152 (305)
T ss_dssp             CTTCCEEECCSSCCSBCCSS-C----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred             CCccCEecccCCccCcCccc-h----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccccccc
Confidence            99999999999999987654 2    224899999999999888888888889999999888654  3445678888888


Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccC
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF  250 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l  250 (652)
                      +.+++++|.++ .+|..+  .++|+.|++++|.+++..+..|..++.++.|++++                      |.+
T Consensus       153 ~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~----------------------n~l  207 (305)
T d1xkua_         153 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF----------------------NSI  207 (305)
T ss_dssp             CEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS----------------------SCC
T ss_pred             CccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccc----------------------ccc
Confidence            88888888887 455443  45788888888888877777776666666666655                      445


Q ss_pred             CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhh------cCCCCCceEEeecCcCc
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLL------EKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~  323 (652)
                      +++.+..|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+....|      ..+.+|+.|+|++|+++
T Consensus       208 ~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             cccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            5555555555666666666666665 345556666666666666666654333222      34456666777777665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.4e-28  Score=257.17  Aligned_cols=284  Identities=24%  Similarity=0.312  Sum_probs=236.0

Q ss_pred             CCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCC
Q 041689           27 NPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPL  106 (652)
Q Consensus        27 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  106 (652)
                      ++.+|++|++++|+|+.+  +.+..+++|++|+|++|+|++++                   .+.++++|++|++++|++
T Consensus        42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~-------------------~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT-------------------PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-------------------GGTTCTTCCEEECCSSCC
T ss_pred             HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc-------------------cccCCccccccccccccc
Confidence            578999999999999964  46889999999999999998543                   378899999999999999


Q ss_pred             cccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccc----------------------------
Q 041689          107 NGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNG----------------------------  158 (652)
Q Consensus       107 ~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------------------------  158 (652)
                      .++.+   ++.+++ |+.|++++|.+++..+  ......+..+....|.+..                            
T Consensus       101 ~~i~~---l~~l~~-L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (384)
T d2omza2         101 ADITP---LANLTN-LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL  174 (384)
T ss_dssp             CCCGG---GTTCTT-CCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTC
T ss_pred             ccccc---cccccc-cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence            98743   667776 9999999999986543  3455667777776666532                            


Q ss_pred             -------------cCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccC
Q 041689          159 -------------SIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSY  225 (652)
Q Consensus       159 -------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  225 (652)
                                   .....+..+++++.+++++|.+++..|  +...++|+.|++++|+++..  +.+..+++|+.|++++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~  250 (384)
T d2omza2         175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN  250 (384)
T ss_dssp             TTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             cccccccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhcccc
Confidence                         123456778999999999999996654  56678999999999999864  4688899999999999


Q ss_pred             CCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchh
Q 041689          226 NDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLL  305 (652)
Q Consensus       226 N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  305 (652)
                      |...-...++.+++|+.|++++|++++..  .+..+..++.++++.|++++.  ..+..+++++.|++++|++++..+  
T Consensus       251 n~l~~~~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--  324 (384)
T d2omza2         251 NQISNLAPLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--  324 (384)
T ss_dssp             SCCCCCGGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--
T ss_pred             CccCCCCcccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--
Confidence            98554556899999999999999999753  478899999999999999853  358889999999999999997643  


Q ss_pred             hcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCC
Q 041689          306 LEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCG  348 (652)
Q Consensus       306 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~  348 (652)
                      +..+++|+.|++++|++++ ++....+++++.+++++|.+..-
T Consensus       325 l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l  366 (384)
T d2omza2         325 VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDL  366 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBC
T ss_pred             cccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCC
Confidence            8899999999999999986 45567788999999999987643

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.8e-28  Score=243.98  Aligned_cols=264  Identities=22%  Similarity=0.250  Sum_probs=152.4

Q ss_pred             CCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCC
Q 041689           14 DDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNC   93 (652)
Q Consensus        14 ~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l   93 (652)
                      |..+.+.++|..+ ++++++|+|++|+|+++.+..|.++++|++|++++|+|..+.+.                 .+.++
T Consensus        18 c~~~~L~~iP~~i-p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~-----------------~~~~~   79 (284)
T d1ozna_          18 CPQQGLQAVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-----------------AFTGL   79 (284)
T ss_dssp             CCSSCCSSCCTTC-CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----------------TTTTC
T ss_pred             cCCCCCCccCCCC-CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccc-----------------ccccc
Confidence            4444556778777 67778888888888777777788888888888888877765543                 34455


Q ss_pred             CCCcEEEcc-cCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcE
Q 041689           94 KSLVVFLLS-NNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY  172 (652)
Q Consensus        94 ~~L~~L~Ls-~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  172 (652)
                      ..++.++.+ .|.++.+.+. .+.++++ |++|++++|.+....+..+..+++|+.+++++|+|+++.+..|..+++|++
T Consensus        80 ~~~~~l~~~~~~~~~~l~~~-~~~~l~~-L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~  157 (284)
T d1ozna_          80 ALLEQLDLSDNAQLRSVDPA-TFHGLGR-LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH  157 (284)
T ss_dssp             TTCCEEECCSCTTCCCCCTT-TTTTCTT-CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccccccccccccccccccch-hhccccc-CCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhh
Confidence            666665543 4445544444 4555554 666666666555555555555555555555555555555555555555555


Q ss_pred             EecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCc
Q 041689          173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       173 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      |++++|+|++..+..|.++++|+.+++++|+++++.|..|..                      +++|++||+++|++.+
T Consensus       158 L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~----------------------l~~L~~L~l~~N~i~~  215 (284)
T d1ozna_         158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD----------------------LGRLMTLYLFANNLSA  215 (284)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT----------------------CTTCCEEECCSSCCSC
T ss_pred             cccccCcccccchhhhccccccchhhhhhccccccChhHhhh----------------------hhhccccccccccccc
Confidence            555555555444555555555555555555555444444444                      4444445555566666


Q ss_pred             cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCc
Q 041689          253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLE  323 (652)
Q Consensus       253 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  323 (652)
                      ..+..|+.+++|++|+|++|++...-+ .-.-...++.+....+++....|..+.+   ....+++.+.|+
T Consensus       216 ~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         216 LPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             CCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             ccccccccccccCEEEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            666677777777777777777664221 1111123455555556665555555443   233334444443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-28  Score=245.36  Aligned_cols=250  Identities=22%  Similarity=0.187  Sum_probs=218.6

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEec-
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGL-  175 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-  175 (652)
                      ..++.++++++.++..     +|.++++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+..++.++.++. 
T Consensus        14 ~~v~c~~~~L~~iP~~-----ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~   88 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (284)
T ss_dssp             CEEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             eEEEcCCCCCCccCCC-----CCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc
Confidence            3467888888876543     4566999999999999888889999999999999999999888999999999999875 


Q ss_pred             ccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC-CCCC-cccCCCCccceEecccccCCcc
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND-GPLP-LEIGNLKVLIGIDFSMNNFSSV  253 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~-~~~~~l~~L~~L~ls~N~l~~~  253 (652)
                      ..|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|. ..+| ..|..+++|+.|++++|+++++
T Consensus        89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l  168 (284)
T d1ozna_          89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (284)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence            4777887778889999999999999999998888899999999999999997 4444 5688999999999999999999


Q ss_pred             CcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCC
Q 041689          254 IPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFG  333 (652)
Q Consensus       254 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  333 (652)
                      .+.+|.++++|+++++++|++++..|..|..+++|++|++++|++++..+..|..+++|++|++++|++.|.++......
T Consensus       169 ~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~  248 (284)
T d1ozna_         169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA  248 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred             chhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876443334


Q ss_pred             CcccccccCCccCCCCCC
Q 041689          334 NFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       334 ~l~~~~~~~N~~~c~~~~  351 (652)
                      .++......+...|..|.
T Consensus       249 ~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             HHHHCCSEECCCBEEESG
T ss_pred             HHHhCcCCCCceEeCCch
Confidence            556666677788886553

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.3e-27  Score=238.73  Aligned_cols=269  Identities=20%  Similarity=0.247  Sum_probs=174.5

Q ss_pred             CCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCccc
Q 041689           30 NLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGI  109 (652)
Q Consensus        30 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  109 (652)
                      ..+.+|-++++++. +|..+.  +++++|+|++|+|+.+++.                 +|.++++|++|++++|.+..+
T Consensus        11 ~~~~~~C~~~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~-----------------~f~~l~~L~~L~l~~n~~~~i   70 (305)
T d1xkua_          11 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDG-----------------DFKNLKNLHTLILINNKISKI   70 (305)
T ss_dssp             ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTT-----------------TTTTCTTCCEEECCSSCCCCB
T ss_pred             cCCEEEecCCCCCc-cCCCCC--CCCCEEECcCCcCCCcChh-----------------Hhhcccccccccccccccccc
Confidence            44556666666663 344442  4566666666666544432                 355555566666666555555


Q ss_pred             CCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCcccc
Q 041689          110 LPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIF  189 (652)
Q Consensus       110 ~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  189 (652)
                      .+. .|.+++. |++|++++|+|+.+... +  ...|+.|++++|.+.++.+..+..                       
T Consensus        71 ~~~-~f~~l~~-L~~L~l~~n~l~~l~~~-~--~~~l~~L~~~~n~l~~l~~~~~~~-----------------------  122 (305)
T d1xkua_          71 SPG-AFAPLVK-LERLYLSKNQLKELPEK-M--PKTLQELRVHENEITKVRKSVFNG-----------------------  122 (305)
T ss_dssp             CTT-TTTTCTT-CCEEECCSSCCSBCCSS-C--CTTCCEEECCSSCCCBBCHHHHTT-----------------------
T ss_pred             chh-hhhCCCc-cCEecccCCccCcCccc-h--hhhhhhhhccccchhhhhhhhhhc-----------------------
Confidence            444 3444443 55555555555532221 1  134444455555544444444444                       


Q ss_pred             CCCCCcEEEccCCccc--ccccccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEecccccCCccCcccccCCCCCcE
Q 041689          190 RLVKLYKLDLGGNKLS--GSILTCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQY  266 (652)
Q Consensus       190 ~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~  266 (652)
                       ...+..++...|...  ...+..|..+++|+.+++++|. ..+|..  ..++|+.|++++|.+++..+..|.+++.++.
T Consensus       123 -~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~  199 (305)
T d1xkua_         123 -LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAK  199 (305)
T ss_dssp             -CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred             -cccccccccccccccccCCCccccccccccCccccccCCccccCcc--cCCccCEEECCCCcCCCCChhHhhccccccc
Confidence             444444444444332  2223345555555666665554 333333  2467788888889999888999999999999


Q ss_pred             EEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCC-------CCCCCCccccc
Q 041689          267 LFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK-------GGSFGNFSAES  339 (652)
Q Consensus       267 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-------~~~~~~l~~~~  339 (652)
                      |++++|.+++..+..|..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+.....       ......++.++
T Consensus       200 L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~  278 (305)
T d1xkua_         200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS  278 (305)
T ss_dssp             EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEE
T ss_pred             cccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEE
Confidence            999999999888999999999999999999998 6688999999999999999999964322       13456788899


Q ss_pred             ccCCccCCCCC
Q 041689          340 FEGNKLLCGSP  350 (652)
Q Consensus       340 ~~~N~~~c~~~  350 (652)
                      +.+|||.+..-
T Consensus       279 L~~N~~~~~~~  289 (305)
T d1xkua_         279 LFSNPVQYWEI  289 (305)
T ss_dssp             CCSSSSCGGGS
T ss_pred             CCCCcCccCcC
Confidence            99999987543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.5e-26  Score=224.16  Aligned_cols=205  Identities=21%  Similarity=0.170  Sum_probs=148.5

Q ss_pred             CCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC
Q 041689           91 SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL  170 (652)
Q Consensus        91 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  170 (652)
                      .+...+.+.|.+++.|+.+++.     +|++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.  .+..+++|
T Consensus         7 ~~~~~~~~v~C~~~~L~~iP~~-----lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L   79 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTALPPD-----LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVL   79 (266)
T ss_dssp             ECSTTCCEEECTTSCCSSCCSC-----CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTC
T ss_pred             cccCCCeEEEccCCCCCeeCcC-----cCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccc
Confidence            4556677778888888876543     3445888888888888777778888888888888888887433  35677788


Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccC
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF  250 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l  250 (652)
                      ++|+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++                      ..|++++|.+
T Consensus        80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l----------------------~~L~l~~n~l  136 (266)
T d1p9ag_          80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL----------------------QELYLKGNEL  136 (266)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC----------------------CEEECTTSCC
T ss_pred             ccccccccccc-ccccccccccccccccccccccceeecccccccccc----------------------cccccccccc
Confidence            88888888877 455567777777777777777766555555555544                      4455555666


Q ss_pred             CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccC
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEI  326 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  326 (652)
                      +.+.+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+
T Consensus       137 ~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            6666667777777888888888887777777777788888888888887 56666667777888888888777653

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.9e-25  Score=220.81  Aligned_cols=200  Identities=28%  Similarity=0.248  Sum_probs=147.2

Q ss_pred             CcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccC
Q 041689          122 LEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGG  201 (652)
Q Consensus       122 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  201 (652)
                      +.+.+.++++|+. +|+.+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+. +| .+..+++|++|+|++
T Consensus        12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccc
Confidence            4445666666663 343332  355666666666655555555566666666666665552 22 234455555555555


Q ss_pred             CcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCccccc
Q 041689          202 NKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDS  281 (652)
Q Consensus       202 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  281 (652)
                      |+++                       ..+..+.++++|+.|++++|.+.++.+..+..+.++++|++++|.++...+..
T Consensus        87 N~l~-----------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~  143 (266)
T d1p9ag_          87 NQLQ-----------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL  143 (266)
T ss_dssp             SCCS-----------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred             cccc-----------------------ccccccccccccccccccccccceeeccccccccccccccccccccceecccc
Confidence            5554                       23444556666777777778888778888999999999999999999888888


Q ss_pred             ccccccCcceeccccccCCCCchhhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCC
Q 041689          282 VGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGS  349 (652)
Q Consensus       282 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~  349 (652)
                      +..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++....+..++.+++.||||.|..
T Consensus       144 ~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         144 LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence            99999999999999999988889999999999999999999966666677889999999999999963

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=2e-24  Score=201.98  Aligned_cols=163  Identities=14%  Similarity=0.088  Sum_probs=121.1

Q ss_pred             CCccceeccccceEEEEEEeCCCcEEEEEEeecccc------------------hhhhhHHHHHHHHHhcCCCeeeeEEe
Q 041689          427 FNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCG------------------RAFKSFDIECEIMKSIHYRNLVKIIS  488 (652)
Q Consensus       427 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~  488 (652)
                      +.+.+.||+|+||.||+|+..+|++||||+++....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356789999999999999988999999998753210                  11234456888999999999998887


Q ss_pred             eeecCCceEEEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCCCCCCeeeCCCCcEEEec
Q 041689          489 SCSNEEFKELVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNFLVPVIHCDLKPSNVLLDDTMVAHLSD  568 (652)
Q Consensus       489 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~dlkp~NIll~~~~~~kl~D  568 (652)
                      +..    .+++|||+++....+        ++...+..++.|++.|++|||++   ||+||||||+|||+++++ ++|+|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEE
Confidence            632    379999999866544        23334567899999999999999   999999999999999764 89999


Q ss_pred             ccCCccccCCCCccccccccCCccccC------ccccccCccCcccchhhHHHH
Q 041689          569 FGITKLLIGEDQSMTQTQTLATIGYIA------PEYGREGRVFANGDVYSFGIM  616 (652)
Q Consensus       569 fg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwslG~v  616 (652)
                      ||.|+.......          ..|..      .| +..+.|+.++|+||..--
T Consensus       146 FG~a~~~~~~~~----------~~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         146 FPQSVEVGEEGW----------REILERDVRNIIT-YFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CTTCEETTSTTH----------HHHHHHHHHHHHH-HHHHHHCCCCCHHHHHHH
T ss_pred             CCCcccCCCCCc----------HHHHHHHHHHHHH-HHcCCCCCcccHHHHHHH
Confidence            999975421110          01111      11 124678899999997543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=2e-20  Score=191.89  Aligned_cols=137  Identities=27%  Similarity=0.294  Sum_probs=96.8

Q ss_pred             eeeceeEeccCCCcCCccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCC
Q 041689            4 ISIGKLELNVDDIESPCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPE   83 (652)
Q Consensus         4 ~~l~~l~l~~~~~~~~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~   83 (652)
                      .++++|||+.+.++   ++|..  +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++.+.              
T Consensus        38 ~~l~~LdLs~~~L~---~lp~~--~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~--------------   94 (353)
T d1jl5a_          38 RQAHELELNNLGLS---SLPEL--PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALS--------------   94 (353)
T ss_dssp             HTCSEEECTTSCCS---CCCSC--CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC--------------
T ss_pred             cCCCEEEeCCCCCC---CCCCC--CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhh--------------
Confidence            46789999999877   68864  578999999999998 46754   468999999999987332              


Q ss_pred             cccccccCCC-CCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCc
Q 041689           84 LSFLSSLSNC-KSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPF  162 (652)
Q Consensus        84 ~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  162 (652)
                              .+ +.|++|++++|.+..++.   ++.++. |+.|++++|.+.....    ....+..+.+..+...  ...
T Consensus        95 --------~lp~~L~~L~L~~n~l~~lp~---~~~l~~-L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~  156 (353)
T d1jl5a_          95 --------DLPPLLEYLGVSNNQLEKLPE---LQNSSF-LKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELP  156 (353)
T ss_dssp             --------SCCTTCCEEECCSSCCSSCCC---CTTCTT-CCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCC
T ss_pred             --------hhccccccccccccccccccc---hhhhcc-ceeecccccccccccc----ccccccchhhcccccc--ccc
Confidence                    12 358888888888887643   345555 8888888888874322    2345566666665554  334


Q ss_pred             cccCCCCCcEEecccCccc
Q 041689          163 TLRELQKLQYVGLKDNKLE  181 (652)
Q Consensus       163 ~~~~l~~L~~L~L~~N~l~  181 (652)
                      .+..++.++.|++++|.+.
T Consensus       157 ~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         157 ELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             CCTTCTTCCEEECCSSCCS
T ss_pred             cccccccceeccccccccc
Confidence            4666777777777777665

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.85  E-value=3.5e-21  Score=185.10  Aligned_cols=209  Identities=21%  Similarity=0.273  Sum_probs=171.6

Q ss_pred             CCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcE
Q 041689           93 CKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQY  172 (652)
Q Consensus        93 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  172 (652)
                      +.++..++++.+++++..   ....+.. |+.|++++|+|+.+  +.+..+++|++|++++|++++..|  +.++++|++
T Consensus        18 l~~~~~~~l~~~~~~d~~---~~~~l~~-L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~   89 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV---TQADLDG-ITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITE   89 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE---CHHHHHT-CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCE
T ss_pred             HHHHHHHHhCCCCcCCcC---CHHHcCC-cCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccc
Confidence            445556778888888764   3455665 99999999999865  358999999999999999986544  899999999


Q ss_pred             EecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCc
Q 041689          173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSS  252 (652)
Q Consensus       173 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (652)
                      +++++|.++ .++ .+..+++|+.++++++...+.  ..+...+.++.+.++.+.......+.++++|+.|++++|.++.
T Consensus        90 l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~  165 (227)
T d1h6ua2          90 LELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD  165 (227)
T ss_dssp             EECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             ccccccccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhhhhcccccccccccccccccc
Confidence            999999998 443 588899999999999988754  3467788999999988875555668888999999999999986


Q ss_pred             cCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          253 VIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       253 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      .  ..+.++++|+.|+|++|++++. + .+..+++|++|+|++|+|++..|  +.++++|+.|++++
T Consensus       166 ~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         166 L--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             C--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             c--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            4  3488999999999999999854 3 38899999999999999986543  88999999999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=9.5e-21  Score=183.92  Aligned_cols=219  Identities=13%  Similarity=0.030  Sum_probs=158.8

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCcccccc-CCccccCCCCCcEEe
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGS-IPFTLRELQKLQYVG  174 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~  174 (652)
                      .+.++.+++.++.+++.     ++.++++|+|++|+|+.+.+.+|.++++|++|+|++|.+... .+.+|.+++++++|.
T Consensus        10 ~~~i~c~~~~l~~iP~~-----l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~   84 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSD-----LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   84 (242)
T ss_dssp             SSEEEEESCSCSSCCSC-----SCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEE
T ss_pred             CCEEEEeCCCCCCcCCC-----CCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccc
Confidence            36788888888876654     244599999999999887777899999999999999988754 456788899999998


Q ss_pred             cc-cCccccccCccccCCCCCcEEEccCCccccccccc-CCCCCCCCEEEccCCC-CCC-CcccCCCC-ccceEeccccc
Q 041689          175 LK-DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC-FSNLASLRTLSLSYND-GPL-PLEIGNLK-VLIGIDFSMNN  249 (652)
Q Consensus       175 L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~-~~~-~~~~~~l~-~L~~L~ls~N~  249 (652)
                      +. .|.+....+..|.++++|+.|++++|++....+.. +..+..+..+..+++. ..+ +..+.+++ .++.|++++|+
T Consensus        85 ~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~  164 (242)
T d1xwdc1          85 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  164 (242)
T ss_dssp             EECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             ccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence            76 47788777888889999999999999887543322 3344455555555554 223 23455543 67788888888


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      ++.+.+..|.....++.+++++|+|+...+..|..+++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus       165 l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         165 IQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            8876555554433334445788888866566788888888888888888866666777777777776644

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=9.8e-21  Score=183.82  Aligned_cols=209  Identities=20%  Similarity=0.167  Sum_probs=106.4

Q ss_pred             CccCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcE
Q 041689           19 PCEIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVV   98 (652)
Q Consensus        19 ~~~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~   98 (652)
                      ++++|..+ ++++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...++.                .+|.+++++++
T Consensus        20 l~~iP~~l-~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~----------------~~f~~l~~l~~   82 (242)
T d1xwdc1          20 VTEIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA----------------DVFSNLPKLHE   82 (242)
T ss_dssp             CSSCCSCS-CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS----------------SSEESCTTCCE
T ss_pred             CCCcCCCC-CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec----------------ccccccccccc
Confidence            33566665 45667777777777665555666677777777776666543321                23555566666


Q ss_pred             EEccc-CCCcccCCccchhcccccCcEEEccCCcccccCCc-cccCCCCCCEEEecCccccccCCccccCCC-CCcEEec
Q 041689           99 FLLSN-NPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPE-EIGNLTNLTAIYLGGNKLNGSIPFTLRELQ-KLQYVGL  175 (652)
Q Consensus        99 L~Ls~-N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L  175 (652)
                      |++.. |++....+. .+..++. |++|++++|++....+. .+..++.+..+..+++.+..+.+..|.+++ .++.|++
T Consensus        83 l~~~~~n~l~~~~~~-~~~~l~~-L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l  160 (242)
T d1xwdc1          83 IRIEKANNLLYINPE-AFQNLPN-LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL  160 (242)
T ss_dssp             EEEECCTTCCEECTT-SEECCTT-CCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEEC
T ss_pred             ccccccccccccccc-ccccccc-ccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeec
Confidence            65543 455544444 4444444 55555555555433221 223344444444455555544444444443 4555555


Q ss_pred             ccCccccccCccccCCCCCcEE-EccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccC
Q 041689          176 KDNKLEGTIPYDIFRLVKLYKL-DLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVI  254 (652)
Q Consensus       176 ~~N~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (652)
                      ++|+++. ++...+...+++.+ ++++|+|+.+.++.|.                      ++++|+.|++++|+|+.+.
T Consensus       161 ~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~----------------------~l~~L~~L~Ls~N~l~~l~  217 (242)
T d1xwdc1         161 NKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFH----------------------GASGPVILDISRTRIHSLP  217 (242)
T ss_dssp             CSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTT----------------------TSCCCSEEECTTSCCCCCC
T ss_pred             ccccccc-cccccccchhhhccccccccccccccHHHhc----------------------CCCCCCEEECCCCcCCccC
Confidence            5555552 22222333333322 3444555544444444                      4555555555555555544


Q ss_pred             cccccCCCCCcEEEc
Q 041689          255 PTTIGSLKDLQYLFL  269 (652)
Q Consensus       255 ~~~~~~l~~L~~L~L  269 (652)
                      +..|.++++|+.+++
T Consensus       218 ~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         218 SYGLENLKKLRARST  232 (242)
T ss_dssp             SSSCTTCCEEESSSE
T ss_pred             HHHHcCCcccccCcC
Confidence            445555555554444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=6.9e-19  Score=180.29  Aligned_cols=266  Identities=27%  Similarity=0.265  Sum_probs=177.1

Q ss_pred             CCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcc
Q 041689           29 HNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNG  108 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  108 (652)
                      .++++|||++|+|+. +|+.   .++|++|+|++|+|+.++.                     .+.+|+.|++++|+++.
T Consensus        38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~lp~---------------------~~~~L~~L~l~~n~l~~   92 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTELPE---------------------LPQSLKSLLVDNNNLKA   92 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSCCC---------------------CCTTCCEEECCSSCCSC
T ss_pred             cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCccccc---------------------chhhhhhhhhhhcccch
Confidence            479999999999985 6753   5789999999999985432                     24579999999999986


Q ss_pred             cCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccc
Q 041689          109 ILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDI  188 (652)
Q Consensus       109 ~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  188 (652)
                      +.      .+++.|++|++++|+|+.+ |. +..+++|+.|++++|.+... +.   ....+..+.+..+...  ....+
T Consensus        93 l~------~lp~~L~~L~L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~--~~~~l  158 (353)
T d1jl5a_          93 LS------DLPPLLEYLGVSNNQLEKL-PE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE--ELPEL  158 (353)
T ss_dssp             CC------SCCTTCCEEECCSSCCSSC-CC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS--SCCCC
T ss_pred             hh------hhccccccccccccccccc-cc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc--ccccc
Confidence            53      3456699999999999954 43 67899999999999999843 32   3456778888877765  34457


Q ss_pred             cCCCCCcEEEccCCccccccc------------------ccCCCCCCCCEEEccCCC-CCCCcccCCCCccceEeccccc
Q 041689          189 FRLVKLYKLDLGGNKLSGSIL------------------TCFSNLASLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMNN  249 (652)
Q Consensus       189 ~~l~~L~~L~L~~N~l~~~~~------------------~~~~~l~~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N~  249 (652)
                      ..++.++.|++++|.+.....                  ..+..++.|+.+++++|. ...+..   ..++..+++.+|.
T Consensus       159 ~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~---~~~l~~~~~~~~~  235 (353)
T d1jl5a_         159 QNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNY  235 (353)
T ss_dssp             TTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSC
T ss_pred             cccccceecccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccc
Confidence            788899999999988764321                  124456677777777774 333322   2334455555555


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCc----------------ccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGS----------------IPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~----------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      +... +..   ...+...++..|.+.+.                ++.....+++|++|+|++|+|+ .+|.   .+++|+
T Consensus       236 ~~~~-~~~---~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~  307 (353)
T d1jl5a_         236 LTDL-PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLE  307 (353)
T ss_dssp             CSCC-CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCC
T ss_pred             cccc-ccc---cccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCC
Confidence            5432 111   12233333333222210                0011123467888888888887 4553   356788


Q ss_pred             eEEeecCcCcccCCCCCCCCCcccccccCCccCC
Q 041689          314 HLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLC  347 (652)
Q Consensus       314 ~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c  347 (652)
                      .|+|++|+|+. +|.  ...+++.+++++|++..
T Consensus       308 ~L~L~~N~L~~-l~~--~~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         308 RLIASFNHLAE-VPE--LPQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             EEECCSSCCSC-CCC--CCTTCCEEECCSSCCSS
T ss_pred             EEECCCCcCCc-ccc--ccCCCCEEECcCCcCCC
Confidence            88888888874 343  34567778888887654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=3.3e-20  Score=178.15  Aligned_cols=209  Identities=18%  Similarity=0.264  Sum_probs=173.1

Q ss_pred             CCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCc
Q 041689           52 VSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCN  131 (652)
Q Consensus        52 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~  131 (652)
                      +.++..++++.+++++..                   .+..+.+|+.|++++|.|+++ +  .+..+++ |++|++++|+
T Consensus        18 l~~~~~~~l~~~~~~d~~-------------------~~~~l~~L~~L~l~~~~i~~l-~--~l~~l~~-L~~L~ls~n~   74 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV-------------------TQADLDGITTLSAFGTGVTTI-E--GVQYLNN-LIGLELKDNQ   74 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE-------------------CHHHHHTCCEEECTTSCCCCC-T--TGGGCTT-CCEEECCSSC
T ss_pred             HHHHHHHHhCCCCcCCcC-------------------CHHHcCCcCEEECCCCCCCcc-h--hHhcCCC-CcEeecCCce
Confidence            344455667777665432                   356788999999999999987 2  4678886 9999999999


Q ss_pred             ccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEccCCccccccccc
Q 041689          132 VSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTC  211 (652)
Q Consensus       132 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  211 (652)
                      |++..|  +..+++|+++++++|.++.+  ..+.++++|+.+++++|...+..  .+...+.+..++++++.+....  .
T Consensus        75 i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~  146 (227)
T d1h6ua2          75 ITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--P  146 (227)
T ss_dssp             CCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--G
T ss_pred             eecccc--cccccccccccccccccccc--ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--h
Confidence            997544  89999999999999999843  35889999999999999987543  4677889999999999997543  4


Q ss_pred             CCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcce
Q 041689          212 FSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSL  291 (652)
Q Consensus       212 ~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  291 (652)
                      +...++|++|++++|.......++++++|+.|+|++|+++++  ..+.++++|++|+|++|+|++..|  +.++++|+.|
T Consensus       147 ~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L  222 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV  222 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             hccccccccccccccccccchhhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEE
Confidence            778899999999999855556689999999999999999975  348899999999999999996543  8899999999


Q ss_pred             eccc
Q 041689          292 NFSN  295 (652)
Q Consensus       292 ~L~~  295 (652)
                      ++++
T Consensus       223 ~lsn  226 (227)
T d1h6ua2         223 TLTN  226 (227)
T ss_dssp             EEEE
T ss_pred             EeeC
Confidence            9974

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=1.5e-20  Score=175.45  Aligned_cols=127  Identities=21%  Similarity=0.233  Sum_probs=114.4

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCCcccc-cCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSG-GIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      .+.++.++|+++.++++     +|.++++|+|++|+|++ ..+..|.++++|+.|+|++|++....+..|..+++|++|+
T Consensus        10 ~~~v~Cs~~~L~~iP~~-----lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~   84 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRD-----IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ   84 (192)
T ss_dssp             TTEEECTTSCCSSCCSC-----CCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCEEEEeCCCcCccCCC-----CCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceee
Confidence            46899999999988654     35569999999999986 4567889999999999999999999999999999999999


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCC
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYND  227 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  227 (652)
                      |++|+|++..|..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.
T Consensus        85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~  137 (192)
T d1w8aa_          85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP  137 (192)
T ss_dssp             CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred             eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccc
Confidence            99999998888889999999999999999999999999999999999998885

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=8.9e-20  Score=172.66  Aligned_cols=183  Identities=25%  Similarity=0.333  Sum_probs=101.9

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecc
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK  176 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  176 (652)
                      ...+++.+.+++..+.   ..+.. |++|++++|.|+...  .+..+++|++|+|++|+|+++.+  +..+++|++|+++
T Consensus        27 i~~~l~~~~~~~~~~~---~~L~~-L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~   98 (210)
T d1h6ta2          27 IKDNLKKKSVTDAVTQ---NELNS-IDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD   98 (210)
T ss_dssp             HHHHTTCSCTTSEECH---HHHHT-CCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHhCcCccCCccCH---HHhcC-ccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCccccccccc
Confidence            3345555655554332   22332 666666666665432  25556666666666666654332  4555566666666


Q ss_pred             cCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcc
Q 041689          177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT  256 (652)
Q Consensus       177 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  256 (652)
                      +|+|++ +| .+..+++|+.|++++|.+.                        ....+..++.++.+++++|.+++.  .
T Consensus        99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~------------------------~~~~l~~l~~l~~l~~~~n~l~~~--~  150 (210)
T d1h6ta2          99 ENKVKD-LS-SLKDLKKLKSLSLEHNGIS------------------------DINGLVHLPQLESLYLGNNKITDI--T  150 (210)
T ss_dssp             SSCCCC-GG-GGTTCTTCCEEECTTSCCC------------------------CCGGGGGCTTCCEEECCSSCCCCC--G
T ss_pred             cccccc-cc-ccccccccccccccccccc------------------------cccccccccccccccccccccccc--c
Confidence            666552 22 3455555555555555544                        223344455555555555655532  3


Q ss_pred             cccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceEEeec
Q 041689          257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHLNLSF  319 (652)
Q Consensus       257 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  319 (652)
                      .+..+++|+++++++|++++. + .+..+++|+.|+|++|+|+. +| .+.++++|++|+|++
T Consensus       151 ~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         151 VLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             GGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             ccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            455566677777777777643 2 26666777777777777763 33 366677777777653

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.81  E-value=2.7e-20  Score=173.68  Aligned_cols=177  Identities=23%  Similarity=0.255  Sum_probs=108.4

Q ss_pred             CCEEEecCccccccCCccccCCCCCcEEecccCcccccc-CccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEcc
Q 041689          146 LTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTI-PYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLS  224 (652)
Q Consensus       146 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  224 (652)
                      .++++.++|+++ .+|..+.  +++++|+|++|+|++.+ +..|..+++|+.|+|++|++..+.++.|..+++|++    
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~----   82 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE----   82 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE----
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce----
Confidence            346677777776 3443332  45666666666665433 444556666666666666666655555555555554    


Q ss_pred             CCCCCCCcccCCCCccceEecccccCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCch
Q 041689          225 YNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPL  304 (652)
Q Consensus       225 ~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  304 (652)
                                        |+|++|+|+++.|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+....+.
T Consensus        83 ------------------L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~  144 (192)
T d1w8aa_          83 ------------------LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL  144 (192)
T ss_dssp             ------------------EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred             ------------------eeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch
Confidence                              55555666666666677777777777777777766666777777777777777777643221


Q ss_pred             hhcCCCCCceEEeecCcCcccCCCCCCCCCcccccccCCccCCCCC
Q 041689          305 LLEKLSYLEHLNLSFNKLEGEIPKGGSFGNFSAESFEGNKLLCGSP  350 (652)
Q Consensus       305 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~  350 (652)
                      .+ -...++.+.+..|.++|..|.  .+..++..++..|.+.|.++
T Consensus       145 ~~-~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         145 AW-FAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HH-HHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             HH-HhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCCC
Confidence            11 112355556667777765553  34556666777787778655

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=1.7e-19  Score=170.70  Aligned_cols=167  Identities=26%  Similarity=0.424  Sum_probs=122.9

Q ss_pred             CCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCC
Q 041689           91 SNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKL  170 (652)
Q Consensus        91 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  170 (652)
                      ..+.+|++|++++|.++++.   .+..+++ |++|+|++|+|+++.  .+..+++|++|++++|+|++ ++ .+.++++|
T Consensus        43 ~~L~~L~~L~l~~~~i~~l~---~l~~l~~-L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L  114 (210)
T d1h6ta2          43 NELNSIDQIIANNSDIKSVQ---GIQYLPN-VTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKL  114 (210)
T ss_dssp             HHHHTCCEEECTTSCCCCCT---TGGGCTT-CCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTC
T ss_pred             HHhcCccEEECcCCCCCCch---hHhhCCC-CCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccc
Confidence            35789999999999998764   3566776 999999999999754  37899999999999999995 34 58999999


Q ss_pred             cEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccC
Q 041689          171 QYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNF  250 (652)
Q Consensus       171 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l  250 (652)
                      +.|++++|.+.. + ..+..+++|+.+++++|.+++.  ..+..+++|+++++++                      |++
T Consensus       115 ~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~----------------------n~l  168 (210)
T d1h6ta2         115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED----------------------NQI  168 (210)
T ss_dssp             CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS----------------------SCC
T ss_pred             cccccccccccc-c-cccccccccccccccccccccc--cccccccccccccccc----------------------ccc
Confidence            999999999973 3 3588889999999999998743  2344555555555555                      445


Q ss_pred             CccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceeccc
Q 041689          251 SSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSN  295 (652)
Q Consensus       251 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  295 (652)
                      +++.  .+.++++|++|+|++|+|++ +| .+..+++|++|+|++
T Consensus       169 ~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         169 SDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            4321  25556666666666666653 33 356666666666653

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=3.3e-19  Score=167.14  Aligned_cols=179  Identities=25%  Similarity=0.384  Sum_probs=91.9

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecc
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK  176 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  176 (652)
                      ..+.++.+.+++....   ..++. +++|++++|+|+.+  +.+..+++|++|+|++|+|++..|  +.++++|++|+++
T Consensus        21 i~~~l~~~~~~~~~~~---~~l~~-l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~   92 (199)
T d2omxa2          21 MKTVLGKTNVTDTVSQ---TDLDQ-VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN   92 (199)
T ss_dssp             HHHHTTCSSTTSEECH---HHHTT-CCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHhCCCCCCCccCH---HHhcC-CCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccc
Confidence            3344555555544321   23333 55555555555532  234555555555555555553322  4555555555555


Q ss_pred             cCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCcc
Q 041689          177 DNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIPT  256 (652)
Q Consensus       177 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  256 (652)
                      +|.+.. ++ .+..+++|+.|++++|.+.                        ....+..+++|+.|++++|++...  .
T Consensus        93 ~n~~~~-~~-~l~~l~~L~~L~l~~~~~~------------------------~~~~~~~l~~L~~L~l~~n~l~~~--~  144 (199)
T d2omxa2          93 NNQIAD-IT-PLANLTNLTGLTLFNNQIT------------------------DIDPLKNLTNLNRLELSSNTISDI--S  144 (199)
T ss_dssp             SSCCCC-CG-GGTTCTTCSEEECCSSCCC------------------------CCGGGTTCTTCSEEECCSSCCCCC--G
T ss_pred             cccccc-cc-ccccccccccccccccccc------------------------cccccchhhhhHHhhhhhhhhccc--c
Confidence            555542 22 2444444444444444443                        233344555555555555665532  2


Q ss_pred             cccCCCCCcEEEccCCcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCceE
Q 041689          257 TIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLEHL  315 (652)
Q Consensus       257 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  315 (652)
                      .+..+++|+.|++++|++++. + .+.++++|+.|++++|++++ ++ .+.++++|+.|
T Consensus       145 ~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         145 ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            455666666666666666643 2 25666666666666666663 22 35566666654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=5.1e-19  Score=165.85  Aligned_cols=164  Identities=23%  Similarity=0.353  Sum_probs=121.4

Q ss_pred             cCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCC
Q 041689           90 LSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQK  169 (652)
Q Consensus        90 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  169 (652)
                      ...+.++++|++++|.++.+.   .+..+++ |++|++++|+|++..+  +.++++|++|++++|.+....  .+.++++
T Consensus        36 ~~~l~~l~~L~l~~~~i~~l~---~l~~l~n-L~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~  107 (199)
T d2omxa2          36 QTDLDQVTTLQADRLGIKSID---GVEYLNN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTN  107 (199)
T ss_dssp             HHHHTTCCEEECTTSCCCCCT---TGGGCTT-CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTT
T ss_pred             HHHhcCCCEEECCCCCCCCcc---ccccCCC-cCcCccccccccCccc--ccCCccccccccccccccccc--ccccccc
Confidence            456789999999999999763   3667776 9999999999997544  999999999999999998543  4899999


Q ss_pred             CcEEecccCccccccCccccCCCCCcEEEccCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEeccccc
Q 041689          170 LQYVGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNN  249 (652)
Q Consensus       170 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~  249 (652)
                      |+.|++++|.+...  ..+..+++|+.|++++|++...  +.+..+++|++|++++|                      +
T Consensus       108 L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n----------------------~  161 (199)
T d2omxa2         108 LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSN----------------------Q  161 (199)
T ss_dssp             CSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSS----------------------C
T ss_pred             cccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccc----------------------c
Confidence            99999999999843  3477889999999999988743  24666666666666555                      4


Q ss_pred             CCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcce
Q 041689          250 FSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSL  291 (652)
Q Consensus       250 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  291 (652)
                      ++++  ..++++++|++|++++|++++ ++ .++.+++|+.|
T Consensus       162 l~~l--~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         162 VTDL--KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccCC--ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            4432  125556666666666666653 22 35555555543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=8.4e-18  Score=151.29  Aligned_cols=132  Identities=13%  Similarity=0.116  Sum_probs=102.9

Q ss_pred             cCCCCCCCCCCCEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEE
Q 041689           21 EIPSEINPHNLEELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFL  100 (652)
Q Consensus        21 ~ip~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~  100 (652)
                      ..|++.++.++++|||++|+|+.+ +..+..+++|+.|+|++|+|+.+.                   .|..+++|++|+
T Consensus        10 ~~~~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l~-------------------~~~~l~~L~~L~   69 (162)
T d1a9na_          10 QAAQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLD-------------------GFPLLRRLKTLL   69 (162)
T ss_dssp             TSCEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEEC-------------------CCCCCSSCCEEE
T ss_pred             hhHhccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCccC-------------------CcccCcchhhhh
Confidence            467777888999999999999864 677788999999999999997542                   367788999999


Q ss_pred             cccCCCcccCCccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccCC---ccccCCCCCcEEe
Q 041689          101 LSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSIP---FTLRELQKLQYVG  174 (652)
Q Consensus       101 Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~  174 (652)
                      +++|+++++++. .+..+++ |+.|++++|+|+.... ..+..+++|++|++++|.++....   ..+..+++|++||
T Consensus        70 ls~N~i~~l~~~-~~~~l~~-L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          70 VNNNRICRIGEG-LDQALPD-LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSSCCCEECSC-HHHHCTT-CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccccccCCCcc-ccccccc-cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            999999887765 5666776 8888888888875432 467788888888888888874331   2466777777766

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=6.8e-19  Score=187.00  Aligned_cols=328  Identities=16%  Similarity=0.103  Sum_probs=197.5

Q ss_pred             eeeeceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCcc----cCCccccCCCCCCEEEcCCCcCeeccC-CCcccc
Q 041689            3 SISIGKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVG----VVPAAIFDVSTLKDLALQDNYLSGSLS-SIADNY   76 (652)
Q Consensus         3 ~~~l~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~~   76 (652)
                      |++|+.||++.+++... .+.+-+ .++++++|+|++|+|+.    .+..++..+++|+.|||++|.|+...- .+    
T Consensus         1 ~~~l~~ld~~~~~i~~~-~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l----   75 (460)
T d1z7xw1           1 SLDIQSLDIQCEELSDA-RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCV----   75 (460)
T ss_dssp             CEEEEEEEEESCCCCHH-HHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHH----
T ss_pred             CCCCCEEEeeCCcCChH-HHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHH----
Confidence            67899999999999742 222222 46789999999998873    234567788999999999998862100 00    


Q ss_pred             ccCCCCCcccccccC-CCCCCcEEEcccCCCcccCCcc---chhcccccCcEEEccCCcccccCC---------------
Q 041689           77 LTSSTPELSFLSSLS-NCKSLVVFLLSNNPLNGILPRM---SIGNLSHSLEIFDMSKCNVSGGIP---------------  137 (652)
Q Consensus        77 l~~~~~~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~~~~~---------------  137 (652)
                                ...+. ...+|++|+|++|++++.....   .+...+. |++|+|++|.|+....               
T Consensus        76 ----------~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~-L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~  144 (460)
T d1z7xw1          76 ----------LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT-LQELHLSDNLLGDAGLQLLCEGLLDPQCRLE  144 (460)
T ss_dssp             ----------HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTT-CCEEECCSSBCHHHHHHHHHHHHTSTTCCCC
T ss_pred             ----------HHHHhcCCCCCCEEECCCCCccccccccccchhhcccc-ccccccccccchhhhhhhhhhcccccccccc
Confidence                      00111 2235666666666655331110   1222333 6666666665532100               


Q ss_pred             ------------------ccccCCCCCCEEEec-----------------------------Ccccccc----CCccccC
Q 041689          138 ------------------EEIGNLTNLTAIYLG-----------------------------GNKLNGS----IPFTLRE  166 (652)
Q Consensus       138 ------------------~~~~~l~~L~~L~L~-----------------------------~N~l~~~----~~~~~~~  166 (652)
                                        ..+.....++.++++                             .+.+...    ....+..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~  224 (460)
T d1z7xw1         145 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS  224 (460)
T ss_dssp             EEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHH
T ss_pred             cccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccc
Confidence                              001122334444444                             3333211    1122345


Q ss_pred             CCCCcEEecccCcccc-----ccCccccCCCCCcEEEccCCcccccc----cccCCCCCCCCEEEccCCCCC------CC
Q 041689          167 LQKLQYVGLKDNKLEG-----TIPYDIFRLVKLYKLDLGGNKLSGSI----LTCFSNLASLRTLSLSYNDGP------LP  231 (652)
Q Consensus       167 l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~~~------~~  231 (652)
                      .+.++.+++++|++..     ..+..+.....++.|++++|.+....    ...+...+.++.+++++|...      +.
T Consensus       225 ~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~  304 (460)
T d1z7xw1         225 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  304 (460)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             cccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhh
Confidence            6788999999998753     22334445678999999999886432    234556788999999988521      11


Q ss_pred             cc-cCCCCccceEecccccCCccCcc----cccCCCCCcEEEccCCcCCCc----cccccc-ccccCcceeccccccCCC
Q 041689          232 LE-IGNLKVLIGIDFSMNNFSSVIPT----TIGSLKDLQYLFLGYNILKGS----IPDSVG-DLISLKSLNFSNNNLSGA  301 (652)
Q Consensus       232 ~~-~~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~  301 (652)
                      .. ......|+.+++++|.++.....    .+...++|++|+|++|+|++.    ++..+. ..+.|++|+|++|.|+..
T Consensus       305 ~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~  384 (460)
T d1z7xw1         305 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS  384 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             ccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence            11 12345788999999988754322    334567899999999998642    223332 456799999999998742


Q ss_pred             ----CchhhcCCCCCceEEeecCcCcccCCC-----C-CCCCCcccccccCCccC
Q 041689          302 ----IPLLLEKLSYLEHLNLSFNKLEGEIPK-----G-GSFGNFSAESFEGNKLL  346 (652)
Q Consensus       302 ----~~~~~~~l~~L~~L~L~~N~l~~~~p~-----~-~~~~~l~~~~~~~N~~~  346 (652)
                          ++..+..+++|++|+|++|+++..-..     . .....++.+.+.+|.+.
T Consensus       385 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             HHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             HHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence                345566778999999999998642110     0 12235777777777764

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=7e-19  Score=186.91  Aligned_cols=305  Identities=17%  Similarity=0.130  Sum_probs=207.6

Q ss_pred             CCCCEEECCCCcCcccC-CccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCc
Q 041689           29 HNLEELLLGQNNLVGVV-PAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLN  107 (652)
Q Consensus        29 ~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  107 (652)
                      .+|++||++.|+|++.. ...+..+++|++|+|++|.|+..--.             .....+..+++|++|||++|.|+
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~-------------~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-------------DISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHH-------------HHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHH-------------HHHHHHhcCCCCCEEECcCCcCC
Confidence            37999999999998642 34567789999999999998721100             00123678899999999999997


Q ss_pred             ccCCcc---chhcccccCcEEEccCCccccc----CCccccCCCCCCEEEecCccccccCC-------------------
Q 041689          108 GILPRM---SIGNLSHSLEIFDMSKCNVSGG----IPEEIGNLTNLTAIYLGGNKLNGSIP-------------------  161 (652)
Q Consensus       108 ~~~~~~---~~~~l~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~-------------------  161 (652)
                      ......   .+.....+|++|+|++|+|+..    ++..+..+++|++|+|++|.|.....                   
T Consensus        69 ~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~  148 (460)
T d1z7xw1          69 DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL  148 (460)
T ss_dssp             HHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             hHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccc
Confidence            432110   1111122599999999999854    45678889999999999998752100                   


Q ss_pred             --------------ccccCCCCCcEEecccCcccc-----------------------------c----cCccccCCCCC
Q 041689          162 --------------FTLRELQKLQYVGLKDNKLEG-----------------------------T----IPYDIFRLVKL  194 (652)
Q Consensus       162 --------------~~~~~l~~L~~L~L~~N~l~~-----------------------------~----~~~~~~~l~~L  194 (652)
                                    ..+.....++.++++++.+..                             .    ....+.....+
T Consensus       149 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~  228 (460)
T d1z7xw1         149 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL  228 (460)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTC
T ss_pred             cccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccc
Confidence                          001223456666666554321                             0    00123446789


Q ss_pred             cEEEccCCcccc-----cccccCCCCCCCCEEEccCCCCC------CCcccCCCCccceEecccccCCccCccc-----c
Q 041689          195 YKLDLGGNKLSG-----SILTCFSNLASLRTLSLSYNDGP------LPLEIGNLKVLIGIDFSMNNFSSVIPTT-----I  258 (652)
Q Consensus       195 ~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~~~------~~~~~~~l~~L~~L~ls~N~l~~~~~~~-----~  258 (652)
                      +.+++++|++..     .....+.....++.|++++|...      ....+...+.+..+++++|.++......     .
T Consensus       229 ~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~  308 (460)
T d1z7xw1         229 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL  308 (460)
T ss_dssp             CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHT
T ss_pred             cccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccc
Confidence            999999998753     23445667789999999999522      2233566788999999999986422222     1


Q ss_pred             cCCCCCcEEEccCCcCCCcccc----cccccccCcceeccccccCCC----Cchhhc-CCCCCceEEeecCcCccc----
Q 041689          259 GSLKDLQYLFLGYNILKGSIPD----SVGDLISLKSLNFSNNNLSGA----IPLLLE-KLSYLEHLNLSFNKLEGE----  325 (652)
Q Consensus       259 ~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~----  325 (652)
                      .....|+.+++++|.++.....    .+...++|++|+|++|+|+..    ++..+. ..+.|++|+|++|+++..    
T Consensus       309 ~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~  388 (460)
T d1z7xw1         309 EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS  388 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH
T ss_pred             ccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHH
Confidence            2346899999999998854333    334556899999999999743    233333 467799999999999752    


Q ss_pred             CCC-CCCCCCcccccccCCccC
Q 041689          326 IPK-GGSFGNFSAESFEGNKLL  346 (652)
Q Consensus       326 ~p~-~~~~~~l~~~~~~~N~~~  346 (652)
                      ++. ....++++.+++++|++.
T Consensus       389 l~~~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         389 LAATLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             HHHHHHHCCCCCEEECCSSSCC
T ss_pred             HHHHHhcCCCCCEEECCCCcCC
Confidence            111 123467889999999863

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.63  E-value=1.6e-16  Score=142.83  Aligned_cols=130  Identities=16%  Similarity=0.099  Sum_probs=102.3

Q ss_pred             ccCCCCCCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCC
Q 041689           89 SLSNCKSLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQ  168 (652)
Q Consensus        89 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  168 (652)
                      .|.++.+|++|||++|+|+.++ . .+..+++ |+.|+|++|+|+.+  +.|..+++|++|+|++|+|+.+.+..+..++
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~i~-~-~~~~l~~-L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPVIE-N-LGATLDQ-FDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCSCC-C-GGGGTTC-CSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             hccCcCcCcEEECCCCCCCccC-c-ccccccc-CCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccc
Confidence            4677888999999999998874 3 4556665 99999999999865  3588899999999999999877777778899


Q ss_pred             CCcEEecccCccccccC-ccccCCCCCcEEEccCCcccccc---cccCCCCCCCCEEEc
Q 041689          169 KLQYVGLKDNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSI---LTCFSNLASLRTLSL  223 (652)
Q Consensus       169 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~L  223 (652)
                      +|++|+|++|+|+.... ..+..+++|++|++++|.++...   +..+..+++|+.||-
T Consensus        88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            99999999999984332 46778889999999999887543   124666777777764

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=2.2e-15  Score=128.56  Aligned_cols=118  Identities=21%  Similarity=0.285  Sum_probs=91.1

Q ss_pred             cEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecc
Q 041689           97 VVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLK  176 (652)
Q Consensus        97 ~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  176 (652)
                      ++|+|++|+|+.+.   .+..++. |++|++++|+|+. +|+.|..+++|+.|++++|+|++. | .+..+++|++|+++
T Consensus         1 R~L~Ls~n~l~~l~---~l~~l~~-L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~   73 (124)
T d1dcea3           1 RVLHLAHKDLTVLC---HLEQLLL-VTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLC   73 (124)
T ss_dssp             SEEECTTSCCSSCC---CGGGGTT-CCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECC
T ss_pred             CEEEcCCCCCCCCc---ccccCCC-CCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECC
Confidence            57899999998663   3677776 9999999999984 567788999999999999999854 3 48889999999999


Q ss_pred             cCccccccC-ccccCCCCCcEEEccCCcccccc---cccCCCCCCCCEE
Q 041689          177 DNKLEGTIP-YDIFRLVKLYKLDLGGNKLSGSI---LTCFSNLASLRTL  221 (652)
Q Consensus       177 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L  221 (652)
                      +|+|+...+ ..+..+++|+.|++++|+++...   ...+..+++|+.|
T Consensus        74 ~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            999985442 56788889999999999987432   2233445666554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3.9e-16  Score=154.51  Aligned_cols=87  Identities=21%  Similarity=0.168  Sum_probs=47.1

Q ss_pred             CCCccceEecccc-cCCccCcccccCCCCCcEEEccC-CcCCCcccccccccccCcceeccccccCCCCchhhcCCCCCc
Q 041689          236 NLKVLIGIDFSMN-NFSSVIPTTIGSLKDLQYLFLGY-NILKGSIPDSVGDLISLKSLNFSNNNLSGAIPLLLEKLSYLE  313 (652)
Q Consensus       236 ~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  313 (652)
                      ++++|++|++++| .++......+..+++|++|+|++ +.+++.....++.+++|+.|+++++--.+.++.....+++| 
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L-  251 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL-  251 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTS-
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCccc-
Confidence            3445555555543 34444445566667777777776 35665555566667777777777662112222222334444 


Q ss_pred             eEEeecCcCccc
Q 041689          314 HLNLSFNKLEGE  325 (652)
Q Consensus       314 ~L~L~~N~l~~~  325 (652)
                        .+..++++..
T Consensus       252 --~i~~~~ls~~  261 (284)
T d2astb2         252 --QINCSHFTTI  261 (284)
T ss_dssp             --EESCCCSCCT
T ss_pred             --cccCccCCCC
Confidence              3455666644

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=5.5e-16  Score=153.40  Aligned_cols=178  Identities=17%  Similarity=0.172  Sum_probs=94.9

Q ss_pred             CcEEEccCCccccc-CCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccC-ccccc-cCccccCCCCCcEEE
Q 041689          122 LEIFDMSKCNVSGG-IPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDN-KLEGT-IPYDIFRLVKLYKLD  198 (652)
Q Consensus       122 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~  198 (652)
                      |++||+++|.++.. +...+.++++|++|+|+++.++...+..+..+++|++|+|+++ .++.. +...+..+++|++|+
T Consensus        48 L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~  127 (284)
T d2astb2          48 VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN  127 (284)
T ss_dssp             CCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEE
T ss_pred             CCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccc
Confidence            55555555555422 2333455555555555555554444444555555555555552 33311 111122344444444


Q ss_pred             ccCC-ccccc-ccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccc--cCCcc-CcccccCCCCCcEEEccCC-
Q 041689          199 LGGN-KLSGS-ILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMN--NFSSV-IPTTIGSLKDLQYLFLGYN-  272 (652)
Q Consensus       199 L~~N-~l~~~-~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N--~l~~~-~~~~~~~l~~L~~L~L~~N-  272 (652)
                      ++++ .++.. ....+..                     ..+.|+.|+++++  .++.. +...+.++++|++|++++| 
T Consensus       128 ls~c~~~~~~~~~~~~~~---------------------~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~  186 (284)
T d2astb2         128 LSWCFDFTEKHVQVAVAH---------------------VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV  186 (284)
T ss_dssp             CCCCTTCCHHHHHHHHHH---------------------SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred             cccccccccccchhhhcc---------------------cccccchhhhccccccccccccccccccccccccccccccc
Confidence            4442 22210 0011111                     1234445555432  23221 2223456788888888875 


Q ss_pred             cCCCcccccccccccCcceeccc-cccCCCCchhhcCCCCCceEEeecC
Q 041689          273 ILKGSIPDSVGDLISLKSLNFSN-NNLSGAIPLLLEKLSYLEHLNLSFN  320 (652)
Q Consensus       273 ~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N  320 (652)
                      .+++.....+..+++|++|+|++ +.++......+.++++|+.|+++++
T Consensus       187 ~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            57766677788888888888888 4677666666788888888888876

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.57  E-value=4.8e-17  Score=166.15  Aligned_cols=119  Identities=16%  Similarity=0.201  Sum_probs=66.1

Q ss_pred             ceeEeccCCCcCCccCCCCC-CCCCCCEEECCCCcCccc----CCccccCCCCCCEEEcCCCcCeeccCCCccccccCCC
Q 041689            7 GKLELNVDDIESPCEIPSEI-NPHNLEELLLGQNNLVGV----VPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSST   81 (652)
Q Consensus         7 ~~l~l~~~~~~~~~~ip~~~-~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~   81 (652)
                      +.|.++...-+....+...+ +..++++|+|++|.|...    +...+...++|+.|+++++.+..........      
T Consensus         8 ~~L~l~~~~~e~~~~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~------   81 (344)
T d2ca6a1           8 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA------   81 (344)
T ss_dssp             CCCEESSCCSHHHHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH------
T ss_pred             CCCCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchH------
Confidence            34444444444444555555 567888888888887532    2345667788888888877654221110000      


Q ss_pred             CCcccccccCCCCCCcEEEcccCCCcccCCcc---chhcccccCcEEEccCCccc
Q 041689           82 PELSFLSSLSNCKSLVVFLLSNNPLNGILPRM---SIGNLSHSLEIFDMSKCNVS  133 (652)
Q Consensus        82 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~  133 (652)
                       -....+.+..+++|+.|+|++|.++......   .+...++ |++|++++|++.
T Consensus        82 -~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~-L~~L~l~~n~l~  134 (344)
T d2ca6a1          82 -LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP-LEHLYLHNNGLG  134 (344)
T ss_dssp             -HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTT-CCEEECCSSCCH
T ss_pred             -HHHHHHHHhhCCCcccccccccccccccccchhhhhccccc-chheeccccccc
Confidence             0011234566777888888888776532110   1222333 677777766664

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=8.2e-15  Score=124.97  Aligned_cols=118  Identities=19%  Similarity=0.219  Sum_probs=76.5

Q ss_pred             CEEECCCCcCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCCCcccCC
Q 041689           32 EELLLGQNNLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNPLNGILP  111 (652)
Q Consensus        32 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  111 (652)
                      ++|||++|+|+. ++ .+..+++|++|+|++|+|+++++                  .|..+++|+.|++++|+|++++ 
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~~lp~------------------~~~~l~~L~~L~l~~N~i~~l~-   59 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLRALPP------------------ALAALRCLEVLQASDNALENVD-   59 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCCCCCG------------------GGGGCTTCCEEECCSSCCCCCG-
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccCcchh------------------hhhhhhcccccccccccccccC-
Confidence            467777777763 33 36777777777777777764432                  3556677777777777777652 


Q ss_pred             ccchhcccccCcEEEccCCcccccCC-ccccCCCCCCEEEecCccccccC---CccccCCCCCcEE
Q 041689          112 RMSIGNLSHSLEIFDMSKCNVSGGIP-EEIGNLTNLTAIYLGGNKLNGSI---PFTLRELQKLQYV  173 (652)
Q Consensus       112 ~~~~~~l~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L  173 (652)
                        .+..+++ |++|++++|+|+.... ..+..+++|+.|++++|+++...   ...+..+|+|+.|
T Consensus        60 --~~~~l~~-L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          60 --GVANLPR-LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             --GGTTCSS-CCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             --ccccccc-cCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence              3556665 7777777777775432 46777778888888888776332   2334556666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.55  E-value=3.3e-16  Score=159.85  Aligned_cols=236  Identities=20%  Similarity=0.210  Sum_probs=161.5

Q ss_pred             cccCCCCCCcEEEcccCCCcccCCcc---chhcccccCcEEEccCCccccc----------CCccccCCCCCCEEEecCc
Q 041689           88 SSLSNCKSLVVFLLSNNPLNGILPRM---SIGNLSHSLEIFDMSKCNVSGG----------IPEEIGNLTNLTAIYLGGN  154 (652)
Q Consensus        88 ~~l~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~L~~N  154 (652)
                      .++.+...|+.|+|++|.+.......   .+...+ +|+.|+++++.+...          +...+..+++|+.|+|++|
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~-~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCC-CCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34667889999999999886432110   233344 499999998765422          2334567889999999999


Q ss_pred             ccccc----CCccccCCCCCcEEecccCccccccCc-------------cccCCCCCcEEEccCCccccc----ccccCC
Q 041689          155 KLNGS----IPFTLRELQKLQYVGLKDNKLEGTIPY-------------DIFRLVKLYKLDLGGNKLSGS----ILTCFS  213 (652)
Q Consensus       155 ~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~l~~L~~L~L~~N~l~~~----~~~~~~  213 (652)
                      .+...    +...+...++|++|++++|.++.....             .....+.|+.|++++|+++..    ....+.
T Consensus       104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~  183 (344)
T d2ca6a1         104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ  183 (344)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH
T ss_pred             ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh
Confidence            98753    233456778999999999987632111             123466889999999988632    233456


Q ss_pred             CCCCCCEEEccCCCCC-------CCcccCCCCccceEecccccCCcc----CcccccCCCCCcEEEccCCcCCCcccccc
Q 041689          214 NLASLRTLSLSYNDGP-------LPLEIGNLKVLIGIDFSMNNFSSV----IPTTIGSLKDLQYLFLGYNILKGSIPDSV  282 (652)
Q Consensus       214 ~l~~L~~L~Ls~N~~~-------~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  282 (652)
                      ..+.|++|+|++|...       +...+..+++|+.|++++|.++..    +...+..+++|++|+|++|.|++.....+
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l  263 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  263 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence            6788999999988622       223466778889999999887642    33456778889999999998875422222


Q ss_pred             ----c--ccccCcceeccccccCCC----Cchhh-cCCCCCceEEeecCcCcc
Q 041689          283 ----G--DLISLKSLNFSNNNLSGA----IPLLL-EKLSYLEHLNLSFNKLEG  324 (652)
Q Consensus       283 ----~--~l~~L~~L~L~~N~l~~~----~~~~~-~~l~~L~~L~L~~N~l~~  324 (652)
                          .  ..+.|+.|++++|+|+..    +...+ .+++.|+.|+|++|++..
T Consensus       264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence                2  235688899999988642    22333 256788899998888863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.52  E-value=2.4e-16  Score=146.77  Aligned_cols=133  Identities=25%  Similarity=0.232  Sum_probs=92.3

Q ss_pred             CCCCCEEECCCC--cCcccCCccccCCCCCCEEEcCCCcCeeccCCCccccccCCCCCcccccccCCCCCCcEEEcccCC
Q 041689           28 PHNLEELLLGQN--NLVGVVPAAIFDVSTLKDLALQDNYLSGSLSSIADNYLTSSTPELSFLSSLSNCKSLVVFLLSNNP  105 (652)
Q Consensus        28 ~~~L~~L~Ls~N--~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  105 (652)
                      ...++.++++++  .++ .++..|..+++|++|+|++|+|+.+                   +.|.++++|++|+|++|+
T Consensus        22 ~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-------------------~~l~~l~~L~~L~Ls~N~   81 (198)
T d1m9la_          22 ATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-------------------SSLSGMENLRILSLGRNL   81 (198)
T ss_dssp             CTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-------------------CCHHHHTTCCEEECCEEE
T ss_pred             ccccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-------------------ccccCCccccChhhcccc
Confidence            445667777665  343 3556788888888888888888633                   136677888888888888


Q ss_pred             CcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccCC-ccccCCCCCcEEecccCcccccc
Q 041689          106 LNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSIP-FTLRELQKLQYVGLKDNKLEGTI  184 (652)
Q Consensus       106 l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~  184 (652)
                      |+.+++  .+..++ +|+.|++++|+|+.+  +.+..+++|+.|+|++|+|+.... ..|..+++|++|+|++|.+....
T Consensus        82 i~~i~~--~~~~~~-~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_          82 IKKIEN--LDAVAD-TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             ECSCSS--HHHHHH-HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             cccccc--cccccc-ccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCc
Confidence            876643  233334 388888888888754  347778888888888888874432 45777788888888888776444


Q ss_pred             C
Q 041689          185 P  185 (652)
Q Consensus       185 ~  185 (652)
                      +
T Consensus       157 ~  157 (198)
T d1m9la_         157 K  157 (198)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=4.6e-14  Score=125.53  Aligned_cols=134  Identities=18%  Similarity=0.095  Sum_probs=99.8

Q ss_pred             CCCEEEccCCC-CCCCcccCCCCccceEecccc-cCCccCcccccCCCCCcEEEccCCcCCCcccccccccccCcceecc
Q 041689          217 SLRTLSLSYND-GPLPLEIGNLKVLIGIDFSMN-NFSSVIPTTIGSLKDLQYLFLGYNILKGSIPDSVGDLISLKSLNFS  294 (652)
Q Consensus       217 ~L~~L~Ls~N~-~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  294 (652)
                      ..+.++.+++. ...|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|+
T Consensus         9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls   88 (156)
T d2ifga3           9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (156)
T ss_dssp             SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence            34456666654 456666777778888888765 5888888889999999999999999998888999999999999999


Q ss_pred             ccccCCCCchhhcCCCCCceEEeecCcCcccCCC--CCCCCCcccccccCCccCCCCCC
Q 041689          295 NNNLSGAIPLLLEKLSYLEHLNLSFNKLEGEIPK--GGSFGNFSAESFEGNKLLCGSPN  351 (652)
Q Consensus       295 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~~~l~~~~~~~N~~~c~~~~  351 (652)
                      +|+|+...+..|..+ +|+.|+|++|+|.|....  ...|.......+..+...|.+|.
T Consensus        89 ~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3          89 FNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             SSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence            999996666677655 699999999999865421  11111122333455677887764

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=1.1e-15  Score=142.11  Aligned_cols=126  Identities=18%  Similarity=0.172  Sum_probs=66.5

Q ss_pred             CcEEEccCC--cccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCccccCCCCCcEEEc
Q 041689          122 LEIFDMSKC--NVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPYDIFRLVKLYKLDL  199 (652)
Q Consensus       122 L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  199 (652)
                      ++.++++++  .++ .++..+..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+ .+|..+..+++|++|++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l  100 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI  100 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence            455555543  232 3345566666666666666666633 2 3556666666666666665 33433333344555555


Q ss_pred             cCCcccccccccCCCCCCCCEEEccCCCCCCCcccCCCCccceEecccccCCccCc-ccccCCCCCcEEEccCCcCC
Q 041689          200 GGNKLSGSILTCFSNLASLRTLSLSYNDGPLPLEIGNLKVLIGIDFSMNNFSSVIP-TTIGSLKDLQYLFLGYNILK  275 (652)
Q Consensus       200 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  275 (652)
                      ++|+|+.+                        ..+..+++|+.|++++|+|+.... ..+..+++|+.|+|++|++.
T Consensus       101 ~~N~i~~l------------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         101 SYNQIASL------------------------SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEECCCH------------------------HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccc------------------------ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            55555422                        123344455555555565554321 34556666666666666655

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3e-13  Score=120.21  Aligned_cols=105  Identities=16%  Similarity=0.145  Sum_probs=48.4

Q ss_pred             CcEEEcccCCCcccCCccchhcccccCcEEEccCC-cccccCCccccCCCCCCEEEecCccccccCCccccCCCCCcEEe
Q 041689           96 LVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKC-NVSGGIPEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVG  174 (652)
Q Consensus        96 L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  174 (652)
                      .+.++.+++.+...+.  .+..+++ |++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|.++++|++|+
T Consensus        10 ~~~l~c~~~~~~~~p~--~l~~l~~-l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3          10 SSGLRCTRDGALDSLH--HLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSCEECCSSCCCTTTT--TSCSCSC-CSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCeEEecCCCCccCcc--cccCccc-cCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            3445555555544332  2333333 555555433 24444444455555555555555555544444555555555555


Q ss_pred             cccCccccccCccccCCCCCcEEEccCCcc
Q 041689          175 LKDNKLEGTIPYDIFRLVKLYKLDLGGNKL  204 (652)
Q Consensus       175 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  204 (652)
                      |++|+|+ .+|.......+|+.|+|++|.+
T Consensus        87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~  115 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQGLSLQELVLSGNPL  115 (156)
T ss_dssp             CCSSCCS-CCCSTTTCSCCCCEEECCSSCC
T ss_pred             ccCCCCc-ccChhhhccccccccccCCCcc
Confidence            5555554 2222222223444444444444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.66  E-value=1.1e-07  Score=91.46  Aligned_cols=149  Identities=13%  Similarity=0.087  Sum_probs=105.6

Q ss_pred             HHHHHhcCCCccceeccccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceE
Q 041689          419 EVCRATYGFNENNLIGKGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKE  497 (652)
Q Consensus       419 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  497 (652)
                      |+.+--..|+..+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555556777666555555678998864 56778899887655445567788999988774 434677888888888899


Q ss_pred             EEEEccCCCChhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 041689          498 LVLEHMPHGSLEKCLYSSNCILDIFQRLNIMIDVASVLEYLHFNF-----------------------------------  542 (652)
Q Consensus       498 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  542 (652)
                      +||++++|.++.+......      ....++.++++.+..||+..                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            9999999988866433211      12234556666666666421                                   


Q ss_pred             ---------------------CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          543 ---------------------LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       543 ---------------------~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                                           ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 11379999999999999887778999998864

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=7.2e-10  Score=98.59  Aligned_cols=121  Identities=18%  Similarity=0.160  Sum_probs=75.6

Q ss_pred             CCcEEEcccCCCcccCCccchhcccccCcEEEccCCcccccCCccccCCCCCCEEEecCccccccC--CccccCCCCCcE
Q 041689           95 SLVVFLLSNNPLNGILPRMSIGNLSHSLEIFDMSKCNVSGGIPEEIGNLTNLTAIYLGGNKLNGSI--PFTLRELQKLQY  172 (652)
Q Consensus        95 ~L~~L~Ls~N~l~~~~~~~~~~~l~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~  172 (652)
                      ..+.||++++....     .+..+.. +..++..+|.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.
T Consensus        23 ~~~~Ldls~l~~~~-----~l~~~~~-~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~   95 (162)
T d1koha1          23 SQQALDLKGLRSDP-----DLVAQNI-DVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI   95 (162)
T ss_dssp             SSCCBCCCCCSSCT-----TTTTTTC-CCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCC
T ss_pred             hhCeeecccCCCCc-----hhhhccc-hhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccc
Confidence            45556666655321     1222222 444444544443 45566677888888888888888543  345677888888


Q ss_pred             EecccCccccccCccccCCCCCcEEEccCCcccccccc-------cCCCCCCCCEEE
Q 041689          173 VGLKDNKLEGTIPYDIFRLVKLYKLDLGGNKLSGSILT-------CFSNLASLRTLS  222 (652)
Q Consensus       173 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~  222 (652)
                      |+|++|+|+...+-.+....+|+.|++++|.+......       .+..+|+|+.||
T Consensus        96 L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            88888888854444455556788888888888754332       245566666664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=6.6e-10  Score=98.85  Aligned_cols=86  Identities=26%  Similarity=0.264  Sum_probs=56.3

Q ss_pred             hcccccCcEEEccCCcccccC--CccccCCCCCCEEEecCccccccCCccccCCCCCcEEecccCccccccCc-------
Q 041689          116 GNLSHSLEIFDMSKCNVSGGI--PEEIGNLTNLTAIYLGGNKLNGSIPFTLRELQKLQYVGLKDNKLEGTIPY-------  186 (652)
Q Consensus       116 ~~l~~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------  186 (652)
                      ..++. |++|+|++|+|+.+.  +..+..+++|+.|+|++|.|+.+.+-.+....+|+.|++++|.+......       
T Consensus        62 ~~~~~-L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~  140 (162)
T d1koha1          62 ENIPE-LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISA  140 (162)
T ss_dssp             HHCTT-CCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHH
T ss_pred             HhCCC-CCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHH
Confidence            44554 777777777777543  34566778888888888888755554444555677888888887754432       


Q ss_pred             cccCCCCCcEEEccCCcc
Q 041689          187 DIFRLVKLYKLDLGGNKL  204 (652)
Q Consensus       187 ~~~~l~~L~~L~L~~N~l  204 (652)
                      .+..+++|+.||  ++.+
T Consensus       141 i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         141 IRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             HHTTSTTCCEET--TEEC
T ss_pred             HHHHCCCCCEEC--cCCC
Confidence            245677787764  4444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=1.8e-06  Score=82.11  Aligned_cols=131  Identities=15%  Similarity=0.116  Sum_probs=88.3

Q ss_pred             eeccccc-eEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCC--CeeeeEEeeeecCCceEEEEEccCCCCh
Q 041689          432 LIGKGGF-GTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHY--RNLVKIISSCSNEEFKELVLEHMPHGSL  508 (652)
Q Consensus       432 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L  508 (652)
                      .+..|.. +.||+....++..+++|.....   ....+..|.+.++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 6789998878888999986543   23457788888887742  3366788888888889999999998765


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 041689          509 EKCLYSSNCILDIFQRLNIMIDVASVLEYLHF------------------------------------------------  540 (652)
Q Consensus       509 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~------------------------------------------------  540 (652)
                      .+..      ...   ...+.++.+.+..||+                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            4311      111   1112233333333332                                                


Q ss_pred             ---CC----CCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          541 ---NF----LVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       541 ---~~----~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                         ..    .+.++|+|+.|.||+++++..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence               11    12479999999999999887778999998763

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.83  E-value=3.5e-06  Score=74.39  Aligned_cols=86  Identities=12%  Similarity=0.162  Sum_probs=36.1

Q ss_pred             cCCCCCCEEEecCcccccc----CCccccCCCCCcEEecccCcccccc----CccccCCCCCcEEEccCCccccc-----
Q 041689          141 GNLTNLTAIYLGGNKLNGS----IPFTLRELQKLQYVGLKDNKLEGTI----PYDIFRLVKLYKLDLGGNKLSGS-----  207 (652)
Q Consensus       141 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----  207 (652)
                      ...++|++|+|++|.+...    +...+...+.|++|+|++|.|+..-    -..+...++|++|+|++|.+..+     
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~  120 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  120 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence            3334444455554444311    1122233344555555555544211    12233344555555555543321     


Q ss_pred             --ccccCCCCCCCCEEEccCC
Q 041689          208 --ILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       208 --~~~~~~~l~~L~~L~Ls~N  226 (652)
                        +...+...++|+.|+++.+
T Consensus       121 ~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         121 MDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHHhCCCccEeeCcCC
Confidence              1223333455555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.71  E-value=8.1e-06  Score=71.96  Aligned_cols=114  Identities=13%  Similarity=0.091  Sum_probs=81.2

Q ss_pred             CCCCCCcEEEcccC-CCcccCCcc---chhcccccCcEEEccCCccccc----CCccccCCCCCCEEEecCcccccc---
Q 041689           91 SNCKSLVVFLLSNN-PLNGILPRM---SIGNLSHSLEIFDMSKCNVSGG----IPEEIGNLTNLTAIYLGGNKLNGS---  159 (652)
Q Consensus        91 ~~l~~L~~L~Ls~N-~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~---  159 (652)
                      .+.++|+.|+|+++ .++...-..   .+...+ +|++|+|++|.+...    +...+...+.|++|+|++|.|+..   
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~-~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~   90 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSK-HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA   90 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCS-CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCC-ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence            45688999999974 565321110   123333 499999999999743    334566789999999999999742   


Q ss_pred             -CCccccCCCCCcEEecccCccccc-------cCccccCCCCCcEEEccCCccc
Q 041689          160 -IPFTLRELQKLQYVGLKDNKLEGT-------IPYDIFRLVKLYKLDLGGNKLS  205 (652)
Q Consensus       160 -~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~l~  205 (652)
                       +-.++...+.|++|+|++|.+...       +...+...++|+.|+++.+...
T Consensus        91 ~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_          91 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence             233567788999999999976632       3445566789999999887653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.68  E-value=6.6e-05  Score=75.82  Aligned_cols=76  Identities=14%  Similarity=0.157  Sum_probs=49.8

Q ss_pred             cceeccccceEEEEEEeCC-CcEEEEEEeeccc-------chhhhhHHHHHHHHHhcC-C--CeeeeEEeeeecCCceEE
Q 041689          430 NNLIGKGGFGTIYKSRIGD-GMEVAVKVFHLQC-------GRAFKSFDIECEIMKSIH-Y--RNLVKIISSCSNEEFKEL  498 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~l  498 (652)
                      .+.||.|....||++...+ ++.|+||.-....       .....+...|.+.++.+. +  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3578999999999998654 6789999754321       112344567888887662 2  346666655  3445679


Q ss_pred             EEEccCCCC
Q 041689          499 VLEHMPHGS  507 (652)
Q Consensus       499 v~e~~~~g~  507 (652)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.17  E-value=0.00049  Score=67.27  Aligned_cols=133  Identities=14%  Similarity=0.139  Sum_probs=77.9

Q ss_pred             eEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee--eeEEe-----eeecCCceEEEEEccCCCChh--
Q 041689          439 GTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL--VKIIS-----SCSNEEFKELVLEHMPHGSLE--  509 (652)
Q Consensus       439 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~g~L~--  509 (652)
                      ..||++...+|..|++|+.+.+. ...+++..|.+.+..+....+  +..+.     .+...+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            58999999899999999987552 234667789888888743222  11111     223456778899999874331  


Q ss_pred             ---hh------h-------hcC----CCCCCHH----------------------HHHHHHHHHHHHHHHHH-cCCCCCe
Q 041689          510 ---KC------L-------YSS----NCILDIF----------------------QRLNIMIDVASVLEYLH-FNFLVPV  546 (652)
Q Consensus       510 ---~~------l-------~~~----~~~l~~~----------------------~~~~i~~~i~~~L~~LH-~~~~~~i  546 (652)
                         .+      +       ...    +...+..                      .....+.++...+.-.- .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11      0       000    0111111                      11112222222222221 1223579


Q ss_pred             EecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          547 IHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       547 iH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                      ||+|+.+.||+++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.09  E-value=0.001  Score=64.56  Aligned_cols=158  Identities=12%  Similarity=0.057  Sum_probs=86.7

Q ss_pred             cccHHHHHHHhcCCCccceec-----cccceEEEEEEeCCCcEEEEEEeecccchhhhhHHHHHHHHHhcCCCee--eeE
Q 041689          414 RFSYLEVCRATYGFNENNLIG-----KGGFGTIYKSRIGDGMEVAVKVFHLQCGRAFKSFDIECEIMKSIHYRNL--VKI  486 (652)
Q Consensus       414 ~~~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~  486 (652)
                      .++.+|+.....+|...+...     .|--...|+....+| .+++|++....  ..+.+..|++++..+...++  +..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            356778888888888765443     455577899887555 58999986432  23456667777777743222  221


Q ss_pred             Eee------eecCCceEEEEEccCCCChhhh--------------hh----cC--C--CCCCHH----------------
Q 041689          487 ISS------CSNEEFKELVLEHMPHGSLEKC--------------LY----SS--N--CILDIF----------------  522 (652)
Q Consensus       487 ~~~------~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~--~--~~l~~~----------------  522 (652)
                      +..      ....+....++.+..+......              +.    ..  .  ......                
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            111      1223455667777766433110              00    00  0  000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHcC-CCCCeEecCCCCCCeeeCCCCcEEEecccCCcc
Q 041689          523 --QRLNIMIDVASVLEYLHFN-FLVPVIHCDLKPSNVLLDDTMVAHLSDFGITKL  574 (652)
Q Consensus       523 --~~~~i~~~i~~~L~~LH~~-~~~~iiH~dlkp~NIll~~~~~~kl~Dfg~~~~  574 (652)
                        .....+......+...+.. ...|+||+|+.++||+++.+...-|+||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence              0111122222222322221 234899999999999999988788999999864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.07  E-value=8.1e-05  Score=65.19  Aligned_cols=66  Identities=12%  Similarity=0.102  Sum_probs=31.1

Q ss_pred             CCCCCCcEEEccc-CCCcccCCcc---chhcccccCcEEEccCCccccc----CCccccCCCCCCEEEecCcccc
Q 041689           91 SNCKSLVVFLLSN-NPLNGILPRM---SIGNLSHSLEIFDMSKCNVSGG----IPEEIGNLTNLTAIYLGGNKLN  157 (652)
Q Consensus        91 ~~l~~L~~L~Ls~-N~l~~~~~~~---~~~~l~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  157 (652)
                      .+.++|++|+|++ |.++...-..   .+...++ |++|+|++|.++..    +...+...++++.+++++|.+.
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~-L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTY-VKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCS-CCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCc-cCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            3556777777776 3454221110   1122232 55556665555422    2223344455555555555553

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.05  E-value=6.6e-05  Score=65.79  Aligned_cols=105  Identities=15%  Similarity=0.241  Sum_probs=58.4

Q ss_pred             CcEEEccC-Cccccc----CCccccCCCCCCEEEecCcccccc----CCccccCCCCCcEEecccCccccc----cCccc
Q 041689          122 LEIFDMSK-CNVSGG----IPEEIGNLTNLTAIYLGGNKLNGS----IPFTLRELQKLQYVGLKDNKLEGT----IPYDI  188 (652)
Q Consensus       122 L~~L~L~~-N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~  188 (652)
                      |++|+|++ +.|+..    +-.++...++|++|+|++|.++..    +-..+...+.++.+++++|.++..    +...+
T Consensus        19 L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l   98 (166)
T d1io0a_          19 LEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEAL   98 (166)
T ss_dssp             CCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGG
T ss_pred             CcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHH
Confidence            78888876 456422    333445677777777777777532    222345566777777777776532    22344


Q ss_pred             cCCCCCcEEEc--cCCcccc----cccccCCCCCCCCEEEccCC
Q 041689          189 FRLVKLYKLDL--GGNKLSG----SILTCFSNLASLRTLSLSYN  226 (652)
Q Consensus       189 ~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~L~Ls~N  226 (652)
                      ...++|+.++|  ++|.+..    .+...+...++|+.|+++.+
T Consensus        99 ~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          99 QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence            55566665444  3455542    22233445556666665544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.00  E-value=0.0012  Score=66.34  Aligned_cols=73  Identities=16%  Similarity=0.156  Sum_probs=50.3

Q ss_pred             cceeccccceEEEEEEeCC--------CcEEEEEEeecccchhhhhHHHHHHHHHhcC-CCeeeeEEeeeecCCceEEEE
Q 041689          430 NNLIGKGGFGTIYKSRIGD--------GMEVAVKVFHLQCGRAFKSFDIECEIMKSIH-YRNLVKIISSCSNEEFKELVL  500 (652)
Q Consensus       430 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  500 (652)
                      .+.|+.|-.-.+|++...+        .+.|++++.. .. .......+|.++++.+. +.-.+++++++..    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3678888899999998643        3457777764 22 22345668999988884 4444577887753    5899


Q ss_pred             EccCCCCh
Q 041689          501 EHMPHGSL  508 (652)
Q Consensus       501 e~~~~g~L  508 (652)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544